,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
363,GO:0000981,1.18592810499191e-05,0.999997456723556,15,713,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,NR1D1;HES5;TSC22D3;HOXA9;HES1;HOXC13;ID3;DDIT3;SNAI2;OTX1;ZNF44;ZNF160;SALL2;HOXC5;ZKSCAN3
3495,GO:0007389,1.74225664199658e-05,0.999997743186826,9,249,pattern specification process,BP,HES5;HOXA9;GDNF;HES1;HOXC13;DCHS1;DDIT3;APC2;OTX1
1449,GO:0003677,4.43787674993411e-05,0.999984554868393,28,1910,DNA binding,MF,NR1D1;HES5;HOXA9;HES1;HOXC13;TIGD2;DDIT3;SNAI2;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;RPS27;ZNF485;HIST1H4D;ZNF57
1096,GO:0002683,6.8192536113987e-05,0.99998815943033,10,266,negative regulation of immune system process,BP,NR1D1;HES5;TSC22D3;HOXA9;HES1;RNF125;HIST1H4F;SPN;HIST1H4I;HIST1H4D
10596,GO:0043565,7.41679941180452e-05,0.999982191977499,14,752,sequence-specific DNA binding,MF,NR1D1;HOXA9;HES1;HOXC13;DDIT3;SNAI2;OTX1;PHF12;SALL2;HOXC5;ZNF169;IVNS1ABP;ZKSCAN3;CIART
364,GO:0000982,0.000102569990096459,0.999985351954794,8,267,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,NR1D1;HES5;HES1;HOXC13;DDIT3;SNAI2;OTX1;ZKSCAN3
1460,GO:0003700,0.000116475240036262,0.99996652665981,17,1082,DNA binding transcription factor activity,MF,NR1D1;HES5;TSC22D3;HOXA9;HES1;HOXC13;ID3;DDIT3;SNAI2;OTX1;ZNF44;ZNF160;SALL2;HOXC5;ZNF169;IVNS1ABP;ZKSCAN3
1379,GO:0003273,0.000142247668895069,0.999999543482053,2,4,cell migration involved in endocardial cushion formation,BP,DCHS1;SNAI2
15596,GO:0072078,0.000167255443389546,0.999991897835233,4,47,nephron tubule morphogenesis,BP,HES5;GDNF;HES1;DCHS1
10131,GO:0042668,0.000176575474553497,1,2,2,auditory receptor cell fate determination,BP,HES5;HES1
20168,GO:2000977,0.000176575474553497,1,2,2,regulation of forebrain neuron differentiation,BP,HES5;HES1
20169,GO:2000978,0.000176575474553497,1,2,2,negative regulation of forebrain neuron differentiation,BP,HES5;HES1
1253,GO:0003002,0.000177434915390874,0.999976774935558,7,196,regionalization,BP,HES5;HOXA9;GDNF;HES1;HOXC13;DDIT3;OTX1
14271,GO:0061333,0.000190387051305546,0.999990436066019,4,49,renal tubule morphogenesis,BP,HES5;GDNF;HES1;DCHS1
15602,GO:0072088,0.000190387119258743,0.999990436061708,4,49,nephron epithelium morphogenesis,BP,HES5;GDNF;HES1;DCHS1
15570,GO:0072028,0.0002027722822114,0.999989632494501,4,50,nephron morphogenesis,BP,HES5;GDNF;HES1;DCHS1
402,GO:0001078,0.000207443981005778,0.999983296549767,5,100,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,NR1D1;HES5;HES1;SNAI2;ZKSCAN3
15715,GO:0072273,0.00023128071441213,0.999994334571974,3,17,metanephric nephron morphogenesis,BP,HES5;GDNF;HES1
12397,GO:0048839,0.000245874448602203,0.999979463882233,5,99,inner ear development,BP,HES5;LRIG3;HES1;DCHS1;OTX1
59,GO:0000122,0.000289659171890231,0.999929059314721,12,602,negative regulation of transcription by RNA polymerase II,BP,TXNIP;NR1D1;HES5;TSC22D3;HES1;ID3;DDIT3;SNAI2;PHF12;HIST1H1D;SALL2;ZKSCAN3
19272,GO:1905457,0.00032241932340215,0.999998893584962,2,3,negative regulation of lymphoid progenitor cell differentiation,BP,HES5;HES1
20167,GO:2000974,0.00032241932340215,0.999998893584962,2,3,negative regulation of pro-B cell differentiation,BP,HES5;HES1
12313,GO:0048664,0.000339229325703708,0.999998805610082,2,3,neuron fate determination,BP,HES5;HES1
1406,GO:0003338,0.00034800443720924,0.99998998103827,3,20,metanephros morphogenesis,BP,HES5;GDNF;HES1
14130,GO:0060993,0.000373619542580167,0.99997735449624,4,60,kidney morphogenesis,BP,HES5;GDNF;HES1;DCHS1
12902,GO:0051241,0.000399276337040116,0.999886758469255,14,679,negative regulation of multicellular organismal process,BP,HES5;TSC22D3;RGS2;HOXA9;HES1;ID3;RNF125;DDIT3;SNAI2;HIST1H4F;TMSB4X;HIST1H4I;ARRDC3;HIST1H4D
15598,GO:0072080,0.00039939439838464,0.999975359762878,4,60,nephron tubule development,BP,HES5;GDNF;HES1;DCHS1
538,GO:0001656,0.000404344303307335,0.999975029178324,4,57,metanephros development,BP,HES5;GDNF;HES1;ID3
14270,GO:0061326,0.000420344054960966,0.999973694170197,4,61,renal tubule development,BP,HES5;GDNF;HES1;DCHS1
358,GO:0000976,0.00045651482304332,0.999898552490182,10,495,transcription regulatory region sequence-specific DNA binding,MF,NR1D1;HOXA9;HES1;DDIT3;OTX1;PHF12;SALL2;IVNS1ABP;ZKSCAN3;CIART
11314,GO:0045632,0.000475685066333894,0.99999719375074,2,4,negative regulation of mechanoreceptor differentiation,BP,HES5;HES1
20171,GO:2000981,0.000475685066333894,0.99999719375074,2,4,negative regulation of inner ear receptor cell differentiation,BP,HES5;HES1
15684,GO:0072210,0.00055773105330652,0.999980668530043,3,25,metanephric nephron development,BP,HES5;GDNF;HES1
3511,GO:0007423,0.000564595568923971,0.99989576332284,8,310,sensory organ development,BP,HES5;LRIG3;HES1;HOXC13;DCHS1;OTX1;SALL2;ABCB5
15580,GO:0072049,0.000566262404006974,0.999996351376082,2,4,comma-shaped body morphogenesis,BP,HES5;HES1
18526,GO:1903707,0.000570589632986346,0.999926101585531,6,95,negative regulation of hemopoiesis,BP,HES5;HOXA9;HES1;HIST1H4F;HIST1H4I;HIST1H4D
1456,GO:0003690,0.000584943657679407,0.99985469522403,11,600,double-stranded DNA binding,MF,NR1D1;HES5;HOXA9;HES1;DDIT3;OTX1;PHF12;SALL2;IVNS1ABP;ZKSCAN3;CIART
10604,GO:0043583,0.000587456186725323,0.999940359118297,5,115,ear development,BP,HES5;LRIG3;HES1;DCHS1;OTX1
15561,GO:0072009,0.000608394564962905,0.999957799999147,4,68,nephron epithelium development,BP,HES5;GDNF;HES1;DCHS1
11296,GO:0045607,0.000643827149614417,0.99999486101213,2,5,regulation of inner ear auditory receptor cell differentiation,BP,HES5;HES1
11313,GO:0045631,0.000643827149614417,0.99999486101213,2,5,regulation of mechanoreceptor differentiation,BP,HES5;HES1
20170,GO:2000980,0.000643827149614417,0.99999486101213,2,5,regulation of inner ear receptor cell differentiation,BP,HES5;HES1
4348,GO:0009912,0.000652786716091166,0.999994752913798,2,5,auditory receptor cell fate commitment,BP,HES5;HES1
13629,GO:0060120,0.000652786716091166,0.999994752913798,2,5,inner ear receptor cell fate commitment,BP,HES5;HES1
4357,GO:0009952,0.000658509290989215,0.999931333556899,5,122,anterior/posterior pattern specification,BP,HOXA9;HES1;HOXC13;DDIT3;OTX1
19647,GO:1990837,0.000704884449730474,0.999834137825923,10,528,sequence-specific double-stranded DNA binding,MF,NR1D1;HOXA9;HES1;DDIT3;OTX1;PHF12;SALL2;IVNS1ABP;ZKSCAN3;CIART
7318,GO:0031326,0.000747215432936784,0.999662400624647,37,3347,regulation of cellular biosynthetic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;ACTR5;DDIT3;SNAI2;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;ZNF485;HIST1H4D;ZNF57
6611,GO:0022821,0.000771491894588697,0.999991714035583,2,9,potassium ion antiporter activity,MF,SLC24A4;SLC9A4
359,GO:0000977,0.000776296768193373,0.999831271569584,9,432,RNA polymerase II regulatory region sequence-specific DNA binding,MF,NR1D1;HOXA9;HES1;DDIT3;OTX1;PHF12;SALL2;ZKSCAN3;CIART
380,GO:0001012,0.000807958902094933,0.999823376879681,9,435,RNA polymerase II regulatory region DNA binding,MF,NR1D1;HOXA9;HES1;DDIT3;OTX1;PHF12;SALL2;ZKSCAN3;CIART
11477,GO:0045934,0.000814258355509639,0.999712985906738,18,1095,negative regulation of nucleobase-containing compound metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;GDNF;HES1;ID3;DDIT3;SNAI2;HIST1H4F;PHF12;HIST1H1D;SALL2;ZKSCAN3;HIST1H4I;CIART;HIST1H4D
15718,GO:0072282,0.000829160082136694,0.999991815051297,2,6,metanephric nephron tubule morphogenesis,BP,HES5;HES1
20166,GO:2000973,0.00082927637172398,0.99999181332157,2,6,regulation of pro-B cell differentiation,BP,HES5;HES1
17673,GO:1901533,0.000829636698530511,0.999991807961172,2,6,negative regulation of hematopoietic progenitor cell differentiation,BP,HES5;HES1
12910,GO:0051253,0.000845704196071779,0.999709623913796,17,990,negative regulation of RNA metabolic process,BP,TXNIP;NR1D1;HES5;TSC22D3;GDNF;HES1;ID3;DDIT3;SNAI2;HIST1H4F;PHF12;HIST1H1D;SALL2;ZKSCAN3;HIST1H4I;CIART;HIST1H4D
11445,GO:0045892,0.000887688390021958,0.999703748502801,16,891,negative regulation of transcription, DNA-templated,BP,TXNIP;NR1D1;HES5;TSC22D3;HES1;ID3;DDIT3;SNAI2;HIST1H4F;PHF12;HIST1H1D;SALL2;ZKSCAN3;HIST1H4I;CIART;HIST1H4D
4507,GO:0010556,0.000941604263260414,0.999570507718917,36,3253,regulation of macromolecule biosynthetic process,BP,TXNIP;NR1D1;HES5;TSC22D3;RGS2;HOXA9;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;ACTR5;DDIT3;SNAI2;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;ZNF485;HIST1H4D;ZNF57
15581,GO:0072050,0.000953272223348435,0.999989900306502,2,6,S-shaped body morphogenesis,BP,HES5;HES1
2865,GO:0006357,0.00102116149704798,0.999605193335841,21,1594,regulation of transcription by RNA polymerase II,BP,TXNIP;NR1D1;HES5;TSC22D3;HOXA9;GDNF;HES1;HOXC13;ID3;DDIT3;SNAI2;NUPR1;OTX1;ZNF44;PHF12;ZNF160;HIST1H1D;SALL2;HOXC5;IVNS1ABP;ZKSCAN3
15655,GO:0072173,0.0010326343883175,0.999987969490788,2,7,metanephric tubule morphogenesis,BP,HES5;HES1
19271,GO:1905456,0.00103276556824095,0.999987967187123,2,7,regulation of lymphoid progenitor cell differentiation,BP,HES5;HES1
4338,GO:0009889,0.00104387713369147,0.99951810756379,37,3397,regulation of biosynthetic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;ACTR5;DDIT3;SNAI2;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;ZNF485;HIST1H4D;ZNF57
360,GO:0000978,0.00116491318032494,0.99978944487109,7,288,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,NR1D1;HOXA9;HES1;DDIT3;OTX1;ZKSCAN3;CIART
18081,GO:1902679,0.00122991275924854,0.999576021096185,16,924,negative regulation of RNA biosynthetic process,BP,TXNIP;NR1D1;HES5;TSC22D3;HES1;ID3;DDIT3;SNAI2;HIST1H4F;PHF12;HIST1H1D;SALL2;ZKSCAN3;HIST1H4I;CIART;HIST1H4D
18428,GO:1903507,0.00122991275924854,0.999576021096185,16,924,negative regulation of nucleic acid-templated transcription,BP,TXNIP;NR1D1;HES5;TSC22D3;HES1;ID3;DDIT3;SNAI2;HIST1H4F;PHF12;HIST1H1D;SALL2;ZKSCAN3;HIST1H4I;CIART;HIST1H4D
6501,GO:0021861,0.00125092091842736,0.999983936212164,2,7,forebrain radial glial cell differentiation,BP,HES5;HES1
4473,GO:0010468,0.00127913156613574,0.999396382837656,39,3511,regulation of gene expression,BP,TXNIP;NR1D1;HES5;TSC22D3;RGS2;HOXA9;RPL37;GDNF;HES1;HOXC13;ID3;ZC3H12D;ACTR5;DDIT3;SNAI2;RPL31;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;RPL28;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;RPS27;ZNF485;HIST1H4D;ZNF57
366,GO:0000987,0.00130662879490607,0.999759005879448,7,295,proximal promoter sequence-specific DNA binding,MF,NR1D1;HOXA9;HES1;DDIT3;OTX1;ZKSCAN3;CIART
14120,GO:0060973,0.00136704275963822,0.999979598357471,2,11,cell migration involved in heart development,BP,DCHS1;SNAI2
2863,GO:0006355,0.00137692558425967,0.999372382559565,32,2826,regulation of transcription, DNA-templated,BP,TXNIP;NR1D1;HES5;TSC22D3;HOXA9;GDNF;HES1;HOXC13;ID3;ACTR5;DDIT3;SNAI2;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;ZNF485;HIST1H4D;ZNF57
17308,GO:0140110,0.00143597902192865,0.999466055505343,18,1400,transcription regulator activity,MF,NR1D1;HES5;TSC22D3;HOXA9;HES1;HOXC13;ID3;DDIT3;SNAI2;OTX1;ZNF44;PHF12;ZNF160;SALL2;HOXC5;ZNF169;IVNS1ABP;ZKSCAN3
11287,GO:0045598,0.00144940484034931,0.999872096954068,4,83,regulation of fat cell differentiation,BP,NR1D1;HES1;DDIT3;SNAI2
19745,GO:2000112,0.00147132839084906,0.999312574879011,35,3204,regulation of cellular macromolecule biosynthetic process,BP,TXNIP;NR1D1;HES5;TSC22D3;RGS2;HOXA9;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;ACTR5;DDIT3;SNAI2;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;ZNF485;HIST1H4D;ZNF57
15558,GO:0072006,0.00147265087592055,0.999869390820169,4,85,nephron development,BP,HES5;GDNF;HES1;DCHS1
4550,GO:0010629,0.00147428687085647,0.999391058436449,23,1429,negative regulation of gene expression,BP,TXNIP;NR1D1;HES5;TSC22D3;RPL37;GDNF;HES1;ID3;ZC3H12D;DDIT3;SNAI2;RPL31;HIST1H4F;PHF12;RPL23A;HIST1H1D;SALL2;RPL28;ZKSCAN3;HIST1H4I;CIART;RPS27;HIST1H4D
932,GO:0002328,0.00149532569734118,0.999977535139243,2,9,pro-B cell differentiation,BP,HES5;HES1
18427,GO:1903506,0.00155244077265768,0.999286384844209,32,2843,regulation of nucleic acid-templated transcription,BP,TXNIP;NR1D1;HES5;TSC22D3;HOXA9;GDNF;HES1;HOXC13;ID3;ACTR5;DDIT3;SNAI2;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;ZNF485;HIST1H4D;ZNF57
20220,GO:2001141,0.0015812905326522,0.999272177521672,32,2845,regulation of RNA biosynthetic process,BP,TXNIP;NR1D1;HES5;TSC22D3;HOXA9;GDNF;HES1;HOXC13;ID3;ACTR5;DDIT3;SNAI2;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;ZNF485;HIST1H4D;ZNF57
15591,GO:0072073,0.00158725089428436,0.999856050295267,4,91,kidney epithelium development,BP,HES5;GDNF;HES1;DCHS1
13971,GO:0060675,0.00160032468288327,0.999917339126271,3,40,ureteric bud morphogenesis,BP,GDNF;HES1;DCHS1
15653,GO:0072171,0.00160032468288327,0.999917339126271,3,40,mesonephric tubule morphogenesis,BP,GDNF;HES1;DCHS1
15502,GO:0071875,0.00172989913374807,0.999970901393009,2,11,adrenergic receptor signaling pathway,BP,RGS2;ARRDC3
454,GO:0001227,0.00180091171582442,0.99976325019439,5,160,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,NR1D1;HES5;HES1;SNAI2;ZKSCAN3
7216,GO:0031109,0.00189089245489298,0.999820385604711,4,86,microtubule polymerization or depolymerization,BP,RGS2;APC2;MAP7D3;MAP1A
12802,GO:0051093,0.00192897743523746,0.999443709699873,11,565,negative regulation of developmental process,BP,HES5;TSC22D3;HOXA9;HES1;ID3;DDIT3;SNAI2;HIST1H4F;ZKSCAN3;HIST1H4I;HIST1H4D
10766,GO:0044212,0.00203930910107429,0.999445884845617,10,607,transcription regulatory region DNA binding,MF,NR1D1;HOXA9;HES1;DDIT3;OTX1;PHF12;SALL2;IVNS1ABP;ZKSCAN3;CIART
12909,GO:0051252,0.00205377131028695,0.999030145854799,33,3021,regulation of RNA metabolic process,BP,TXNIP;NR1D1;HES5;TSC22D3;HOXA9;GDNF;HES1;HOXC13;ID3;ZC3H12D;ACTR5;DDIT3;SNAI2;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;ZNF485;HIST1H4D;ZNF57
15644,GO:0072148,0.00205525083382778,0.999962257693952,2,11,epithelial cell fate commitment,BP,HES5;HES1
12352,GO:0048715,0.00205775557544018,0.999963628533003,2,9,negative regulation of oligodendrocyte differentiation,BP,HES5;HES1
396,GO:0001067,0.00205977670876448,0.999439546815871,10,608,regulatory region nucleic acid binding,MF,NR1D1;HOXA9;HES1;DDIT3;OTX1;PHF12;SALL2;IVNS1ABP;ZKSCAN3;CIART
1378,GO:0003272,0.0021239836202218,0.999958907819014,2,14,endocardial cushion formation,BP,DCHS1;SNAI2
13705,GO:0060255,0.00214081821259716,0.998938660728821,46,4565,regulation of macromolecule metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;RPL37;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;RNF125;ACTR5;DDIT3;SNAI2;APC2;RPL31;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;RPL28;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;SPDYE1;CIART;ARRDC3;RPS27;ZNF485;HIST1H4D;ZNF57
4028,GO:0009059,0.00218952463608082,0.998915588652665,44,4112,macromolecule biosynthetic process,BP,TXNIP;NR1D1;HES5;TSC22D3;RGS2;HOXA9;RPL37;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;MUC6;ACTR5;DDIT3;SNAI2;RPL31;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;RPS27;ZNF485;HIST1H4D;MUC12;ZNF57
11244,GO:0045444,0.00221145620633201,0.999695754798049,5,147,fat cell differentiation,BP,NR1D1;RGS2;HES1;DDIT3;SNAI2
7319,GO:0031327,0.00231312373923465,0.999100669436234,18,1202,negative regulation of cellular biosynthetic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;HES1;ID3;ZC3H12D;DDIT3;SNAI2;HIST1H4F;PHF12;HIST1H1D;SALL2;ZKSCAN3;HIST1H4I;CIART;HIST1H4D
13559,GO:0060019,0.00251359467065235,0.99995079348287,2,9,radial glial cell differentiation,BP,HES5;HES1
19746,GO:2000113,0.00276866090223789,0.998932531269621,17,1114,negative regulation of cellular macromolecule biosynthetic process,BP,TXNIP;NR1D1;HES5;TSC22D3;HES1;ID3;ZC3H12D;DDIT3;SNAI2;HIST1H4F;PHF12;HIST1H1D;SALL2;ZKSCAN3;HIST1H4I;CIART;HIST1H4D
4339,GO:0009890,0.00285958777930527,0.998865042569378,18,1218,negative regulation of biosynthetic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;HES1;ID3;ZC3H12D;DDIT3;SNAI2;HIST1H4F;PHF12;HIST1H1D;SALL2;ZKSCAN3;HIST1H4I;CIART;HIST1H4D
926,GO:0002320,0.00286778339594418,0.999935959065799,2,13,lymphoid progenitor cell differentiation,BP,HES5;HES1
8850,GO:0034645,0.00300754856379672,0.998481435738044,43,4041,cellular macromolecule biosynthetic process,BP,TXNIP;NR1D1;HES5;TSC22D3;RGS2;HOXA9;RPL37;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;MUC6;ACTR5;DDIT3;SNAI2;RPL31;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;PIGH;RPL28;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;RPS27;ZNF485;HIST1H4D;MUC12;ZNF57
15696,GO:0072234,0.0030413748554785,0.999929324413541,2,14,metanephric nephron tubule development,BP,HES5;HES1
5124,GO:0015491,0.00323120313147684,0.999920402907732,2,18,cation:cation antiporter activity,MF,SLC24A4;SLC9A4
15702,GO:0072243,0.00339583983306702,0.999915808873958,2,15,metanephric nephron epithelium development,BP,HES5;HES1
15652,GO:0072170,0.00339583987192827,0.999915808872501,2,15,metanephric tubule development,BP,HES5;HES1
1343,GO:0003203,0.00342747479449166,0.999912981222831,2,18,endocardial cushion morphogenesis,BP,DCHS1;SNAI2
15597,GO:0072079,0.00345667732786441,0.999917202572209,2,11,nephron tubule formation,BP,HES5;GDNF
286,GO:0000790,0.00347011544909382,0.999063822926752,9,304,nuclear chromatin,CC,NR1D1;ACTR5;SNAI2;HIST1H4F;PHF12;HIST1H1D;SALL2;HIST1H4I;HIST1H4D
11353,GO:0045686,0.00356267364404583,0.999911095998222,2,13,negative regulation of glial cell differentiation,BP,HES5;HES1
6072,GO:0019219,0.00360277455296601,0.998217252050756,34,3264,regulation of nucleobase-containing compound metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;HOXA9;GDNF;HES1;HOXC13;ID3;ZC3H12D;ACTR5;DDIT3;SNAI2;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;ZNF485;HIST1H4D;ZNF57
11285,GO:0045596,0.00360376111894092,0.9990187705643,9,422,negative regulation of cell differentiation,BP,HES5;HOXA9;HES1;ID3;DDIT3;SNAI2;HIST1H4F;HIST1H4I;HIST1H4D
449,GO:0001222,0.00363440734601211,0.999908374372362,2,13,transcription corepressor binding,MF,NR1D1;PHF12
20087,GO:2000737,0.00369589057681367,0.999903616956009,2,16,negative regulation of stem cell differentiation,BP,HES5;HES1
12228,GO:0048486,0.00375080578668776,0.999906314408065,2,11,parasympathetic nervous system development,BP,GDNF;HES1
5335,GO:0016070,0.00377392991537756,0.998078415492969,40,3757,RNA metabolic process,BP,TXNIP;NR1D1;HES5;TSC22D3;HOXA9;RPL37;GDNF;HES1;HOXC13;ID3;ZC3H12D;ACTR5;SNRPD2;DDIT3;SNAI2;RPL31;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;RPL28;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;RPS27;ZNF485;HIST1H4D;ZNF57
2859,GO:0006351,0.00397213485972033,0.998044501725634,32,2972,transcription, DNA-templated,BP,TXNIP;NR1D1;HES5;TSC22D3;HOXA9;GDNF;HES1;HOXC13;ID3;ACTR5;DDIT3;SNAI2;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;ZNF485;HIST1H4D;ZNF57
4509,GO:0010558,0.0040170971206732,0.998391063252597,17,1160,negative regulation of macromolecule biosynthetic process,BP,TXNIP;NR1D1;HES5;TSC22D3;HES1;ID3;ZC3H12D;DDIT3;SNAI2;HIST1H4F;PHF12;HIST1H1D;SALL2;ZKSCAN3;HIST1H4I;CIART;HIST1H4D
18226,GO:1903026,0.00406747585249017,0.999916817609598,2,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,DDIT3;TMSB4X
16467,GO:0097150,0.00408127081836985,0.999887308086961,2,17,neuronal stem cell population maintenance,BP,HES5;HES1
15681,GO:0072207,0.0041581986021919,0.999884078375417,2,17,metanephric epithelium development,BP,HES5;HES1
635,GO:0001822,0.00428396754850714,0.99931038045334,5,182,kidney development,BP,HES5;GDNF;HES1;ID3;DCHS1
16701,GO:0097659,0.00445039398657482,0.997790058618463,32,2986,nucleic acid-templated transcription,BP,TXNIP;NR1D1;HES5;TSC22D3;HOXA9;GDNF;HES1;HOXC13;ID3;ACTR5;DDIT3;SNAI2;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;ZNF485;HIST1H4D;ZNF57
4829,GO:0014032,0.0044525244971585,0.999665395152728,3,54,neural crest cell development,BP,GDNF;HES1;SNAI2
5076,GO:0015298,0.00448730347766007,0.999867975666902,2,20,solute:cation antiporter activity,MF,SLC24A4;SLC9A4
10491,GO:0043392,0.00456263913206064,0.99965821147563,3,41,negative regulation of DNA binding,BP,ID3;DDIT3;TMSB4X
7488,GO:0031651,0.0046330091738586,1,1,1,negative regulation of heat generation,BP,ARRDC3
7515,GO:0031699,0.0046330091738586,1,1,1,beta-3 adrenergic receptor binding,MF,ARRDC3
16267,GO:0090327,0.0046330091738586,1,1,1,negative regulation of locomotion involved in locomotory behavior,BP,ARRDC3
12090,GO:0048058,0.00463311075745903,1,1,1,compound eye corneal lens development,BP,ABCB5
12366,GO:0048749,0.00463311075745903,1,1,1,compound eye development,BP,ABCB5
15133,GO:0071228,0.00463338807460415,1,1,1,cellular response to tumor cell,BP,TXNIP
8093,GO:0032774,0.00470220370369754,0.997655166909916,32,2996,RNA biosynthetic process,BP,TXNIP;NR1D1;HES5;TSC22D3;HOXA9;GDNF;HES1;HOXC13;ID3;ACTR5;DDIT3;SNAI2;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;ZNF485;HIST1H4D;ZNF57
2872,GO:0006366,0.00471369767275318,0.997913295307502,21,1760,transcription by RNA polymerase II,BP,TXNIP;NR1D1;HES5;TSC22D3;HOXA9;GDNF;HES1;HOXC13;ID3;DDIT3;SNAI2;NUPR1;OTX1;ZNF44;PHF12;ZNF160;HIST1H1D;SALL2;HOXC5;IVNS1ABP;ZKSCAN3
4828,GO:0014031,0.00481283930805309,0.999627617260835,3,56,mesenchymal cell development,BP,GDNF;HES1;SNAI2
539,GO:0001657,0.00511027782011062,0.999594420392791,3,63,ureteric bud development,BP,GDNF;HES1;DCHS1
15555,GO:0072001,0.00512788087189406,0.999138110337151,5,192,renal system development,BP,HES5;GDNF;HES1;ID3;DCHS1
4830,GO:0014033,0.00520065358719396,0.999585771338853,3,58,neural crest cell differentiation,BP,GDNF;HES1;SNAI2
12416,GO:0048864,0.00526666061076937,0.999578865086214,3,57,stem cell development,BP,GDNF;HES1;SNAI2
15649,GO:0072163,0.00530312995375758,0.999573276486509,3,64,mesonephric epithelium development,BP,GDNF;HES1;DCHS1
15650,GO:0072164,0.00530312995375758,0.999573276486509,3,64,mesonephric tubule development,BP,GDNF;HES1;DCHS1
6529,GO:0021915,0.00549705729035292,0.999291405043884,4,124,neural tube development,BP,HES5;HES1;DCHS1;SALL2
7217,GO:0031110,0.00558562573460457,0.999543827921493,3,57,regulation of microtubule polymerization or depolymerization,BP,RGS2;APC2;MAP1A
636,GO:0001823,0.00562433696753276,0.999537552406387,3,65,mesonephros development,BP,GDNF;HES1;DCHS1
11126,GO:0045165,0.00571518679516077,0.999255468807919,4,121,cell fate commitment,BP,HES5;HES1;APC2;SPN
9384,GO:0035921,0.00575211739644407,1,1,1,desmosome disassembly,BP,SNAI2
17482,GO:1900387,0.00575211739644407,1,1,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,SNAI2
4359,GO:0009954,0.00593531423012774,0.999797546974199,2,21,proximal/distal pattern formation,BP,HES5;HOXA9
1340,GO:0003197,0.00627016826549114,0.999777842257873,2,24,endocardial cushion development,BP,DCHS1;SNAI2
570,GO:0001709,0.00633707610340374,0.999780539980628,2,17,cell fate determination,BP,HES5;HES1
7221,GO:0031114,0.0065227940836604,0.999765574294881,2,22,regulation of microtubule depolymerization,BP,APC2;MAP1A
9799,GO:0040019,0.0067376023777014,0.999755592718983,2,20,positive regulation of embryonic development,BP,GDNF;HES1
12347,GO:0048710,0.00689157089526804,0.999749390335944,2,18,regulation of astrocyte differentiation,BP,HES5;HES1
13630,GO:0060122,0.00693076425017487,0.999750167755884,2,16,inner ear receptor cell stereocilium organization,BP,HES5;HES1
11338,GO:0045662,0.00718654827613625,0.999737917070068,2,15,negative regulation of myoblast differentiation,BP,ID3;DDIT3
10038,GO:0042491,0.0072327069163262,0.999727832097011,2,20,inner ear auditory receptor cell differentiation,BP,HES5;HES1
18225,GO:1903025,0.00728110114902463,0.999753576067585,2,9,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,DDIT3;TMSB4X
6922,GO:0030513,0.00755213749132306,0.999707214385465,2,22,positive regulation of BMP signaling pathway,BP,HES5;HES1
12810,GO:0051101,0.00765523532798093,0.998922591660361,4,92,regulation of DNA binding,BP,HES1;ID3;DDIT3;TMSB4X
15633,GO:0072132,0.00805670809944709,0.999672614421759,2,27,mesenchyme morphogenesis,BP,DCHS1;SNAI2
537,GO:0001655,0.00814891665534389,0.998467646698808,5,215,urogenital system development,BP,HES5;GDNF;HES1;ID3;DCHS1
7928,GO:0032501,0.00817381853716684,0.995599064636907,40,4171,multicellular organismal process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;NRSN1;S1PR5;TCHH;LRIG3;GDNF;HES1;HOXC13;ID3;SLC24A4;MUC6;RNF125;SLC9A4;DCHS1;DDIT3;SNAI2;APC2;NUPR1;OTX1;HIST1H4F;ZNF160;SPN;SALL2;HOXC5;TMSB4X;FXYD3;PRR15;HIST1H4I;CIART;ARRDC3;HIST1H4D;BTN3A1;MAP1A;ABCB5
12415,GO:0048863,0.00820983629317288,0.997898275595215,7,200,stem cell differentiation,BP,HES5;GDNF;HES1;SNAI2;HIST1H4F;HIST1H4I;HIST1H4D
16148,GO:0090162,0.00831995998936882,0.999657854399708,2,25,establishment of epithelial cell polarity,BP,HES5;HES1
16116,GO:0090102,0.00838839111207112,0.999655501929808,2,23,cochlea development,BP,HES1;DCHS1
1448,GO:0003676,0.00881456768356909,0.995309623563717,35,3231,nucleic acid binding,MF,NR1D1;HES5;HOXA9;RPL37;HES1;HOXC13;TIGD2;IFIT2;SNRPD2;DDIT3;SNAI2;RPL31;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;RPL28;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;RPS27;ZNF485;HIST1H4D;ZNF57
4336,GO:0009887,0.0089995238668698,0.996973039845235,10,643,animal organ morphogenesis,BP,HES5;LRIG3;GDNF;HES1;HOXC13;ID3;SLC24A4;DCHS1;SNAI2;OTX1
541,GO:0001659,0.00902258400297042,0.999619225569886,2,20,temperature homeostasis,BP,NR1D1;ARRDC3
12350,GO:0048713,0.00904956147417467,0.999612290530046,2,24,regulation of oligodendrocyte differentiation,BP,HES5;HES1
3736,GO:0008273,0.00924480015074151,0.999978781448218,1,2,calcium, potassium:sodium antiporter activity,MF,SLC24A4
15638,GO:0072137,0.00924480015138541,0.999978781448215,1,2,condensed mesenchymal cell proliferation,BP,DCHS1
913,GO:0002296,0.00924480016073809,0.999978781448171,1,2,T-helper 1 cell lineage commitment,BP,SPN
8389,GO:0033300,0.00924481253285428,0.999978781391245,1,2,dehydroascorbic acid transmembrane transporter activity,MF,SLC2A3
14943,GO:0070837,0.00924481253285428,0.999978781391245,1,2,dehydroascorbic acid transport,BP,SLC2A3
16265,GO:0090325,0.00924491123226291,0.999978780937108,1,2,regulation of locomotion involved in locomotory behavior,BP,ARRDC3
13617,GO:0060086,0.00924582397745397,0.999978776737142,1,2,circadian temperature homeostasis,BP,NR1D1
11318,GO:0045638,0.0093716574940838,0.998614948129704,4,67,negative regulation of myeloid cell differentiation,BP,HOXA9;HIST1H4F;HIST1H4I;HIST1H4D
10796,GO:0044271,0.00938046193317284,0.994885657617418,41,3945,cellular nitrogen compound biosynthetic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;RPL37;NME9;GDNF;HES1;HOXC13;ID3;ZC3H12D;ACTR5;DDIT3;SNAI2;RPL31;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;RPL28;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;RPS27;ZNF485;HIST1H4D;ZNF57
12312,GO:0048663,0.00954424427512271,0.999579627091234,2,24,neuron fate commitment,BP,HES5;HES1
6075,GO:0019222,0.00974760688893309,0.994636072772193,46,4903,regulation of metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;RPL37;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;RNF125;ACTR5;DDIT3;SNAI2;APC2;RPL31;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;RPL28;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;SPDYE1;CIART;ARRDC3;RPS27;ZNF485;HIST1H4D;ZNF57
9286,GO:0035725,0.0102015085119157,0.998954582360732,3,76,sodium ion transmembrane transport,BP,SLC24A4;SLC9A4;FXYD3
12225,GO:0048483,0.0102427652053956,0.999531967872911,2,24,autonomic nervous system development,BP,GDNF;HES1
14823,GO:0070563,0.0103587825934766,0.999973344635626,1,2,negative regulation of vitamin D receptor signaling pathway,BP,SNAI2
20086,GO:2000736,0.0103819332489538,0.997570333807521,6,121,regulation of stem cell differentiation,BP,HES5;GDNF;HES1;HIST1H4F;HIST1H4I;HIST1H4D
8857,GO:0034654,0.0103908931774888,0.99442341079262,34,3379,nucleobase-containing compound biosynthetic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;HOXA9;NME9;GDNF;HES1;HOXC13;ID3;ACTR5;DDIT3;SNAI2;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;ZNF485;HIST1H4D;ZNF57
1310,GO:0003156,0.0104181106443447,0.999526156333388,2,20,regulation of animal organ formation,BP,GDNF;HES1
3378,GO:0007157,0.0107285393166315,0.999502583105083,2,21,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,LGALS7B;DCHS1
9073,GO:0035315,0.0108079046123217,0.999489528811307,2,26,hair cell differentiation,BP,HES5;HES1
20060,GO:2000678,0.0109536131573022,0.999506696645293,2,14,negative regulation of transcription regulatory region DNA binding,BP,DDIT3;TMSB4X
4821,GO:0014014,0.0110520684937122,0.999477752257474,2,22,negative regulation of gliogenesis,BP,HES5;HES1
12240,GO:0048513,0.0110564257419702,0.994474780092615,24,2133,animal organ development,BP,TXNIP;HES5;DDIT4;TSC22D3;HOXA9;TCHH;LRIG3;GDNF;HES1;HOXC13;ID3;SLC24A4;DCHS1;SNAI2;NUPR1;OTX1;HIST1H4F;ZNF160;SPN;SALL2;HIST1H4I;ARRDC3;HIST1H4D;ABCB5
4586,GO:0010675,0.0120372881728249,0.998687171542025,3,81,regulation of cellular carbohydrate metabolic process,BP,NR1D1;DDIT4;PPP1R3D
1398,GO:0003310,0.0121291183141082,1,1,1,pancreatic A cell differentiation,BP,HES1
6375,GO:0021558,0.0121291183141082,1,1,1,trochlear nerve development,BP,HES1
11498,GO:0045977,0.0121291183141082,1,1,1,positive regulation of mitotic cell cycle, embryonic,BP,HES1
13657,GO:0060164,0.0121291183141082,1,1,1,regulation of timing of neuron differentiation,BP,HES1
14199,GO:0061102,0.0121291183141082,1,1,1,stomach neuroendocrine cell differentiation,BP,HES1
14200,GO:0061105,0.0121291183141082,1,1,1,regulation of stomach neuroendocrine cell differentiation,BP,HES1
14201,GO:0061106,0.0121291183141082,1,1,1,negative regulation of stomach neuroendocrine cell differentiation,BP,HES1
15475,GO:0071820,0.0121291183141082,1,1,1,N-box binding,MF,HES1
15590,GO:0072071,0.0121291183141082,1,1,1,kidney interstitial fibroblast differentiation,BP,HES1
15641,GO:0072141,0.0121291183141082,1,1,1,renal interstitial fibroblast development,BP,HES1
19797,GO:2000226,0.0121291183141082,1,1,1,regulation of pancreatic A cell differentiation,BP,HES1
19798,GO:2000227,0.0121291183141082,1,1,1,negative regulation of pancreatic A cell differentiation,BP,HES1
3384,GO:0007163,0.0123988991276594,0.997972533302741,4,159,establishment or maintenance of cell polarity,BP,HES5;HES1;SPN;RHOF
13628,GO:0060119,0.0124277434556714,0.999370153824929,2,25,inner ear receptor cell development,BP,HES5;HES1
3314,GO:0007019,0.0130310072380902,0.99931364094925,2,32,microtubule depolymerization,BP,APC2;MAP1A
3262,GO:0006933,0.0130808884294471,0.999957435758898,1,2,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,SNAI2
6150,GO:0019438,0.0133307472994526,0.992698940740109,34,3425,aromatic compound biosynthetic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;HOXA9;NME9;GDNF;HES1;HOXC13;ID3;ACTR5;DDIT3;SNAI2;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;ZNF485;HIST1H4D;ZNF57
5910,GO:0018130,0.0134829599512712,0.992608647826964,34,3428,heterocycle biosynthetic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;HOXA9;NME9;GDNF;HES1;HOXC13;ID3;ACTR5;DDIT3;SNAI2;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;ZNF485;HIST1H4D;ZNF57
4535,GO:0010605,0.0137029799648385,0.99294014925148,25,2011,negative regulation of macromolecule metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;RPL37;GDNF;HES1;ID3;ZC3H12D;DDIT3;SNAI2;RPL31;HIST1H4F;PHF12;RPL23A;HIST1H1D;SALL2;RPL28;ZKSCAN3;HIST1H4I;CIART;RPS27;HIST1H4D
18030,GO:1902532,0.013742998166373,0.996085348951673,7,390,negative regulation of intracellular signal transduction,BP,DDIT4;RGS2;RNF125;DDIT3;SNAI2;TMSB4X;IVNS1ABP
15503,GO:0071877,0.0138004014177698,1,1,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,RGS2
15507,GO:0071881,0.0138004014177698,1,1,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,RGS2
16053,GO:0086096,0.0138004014177698,1,1,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,RGS2
17316,GO:0140193,0.0138004014177698,1,1,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,RGS2
17317,GO:0140194,0.0138004014177698,1,1,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,RGS2
1337,GO:0003192,0.0138356038757614,0.999936535199092,1,3,mitral valve formation,BP,DCHS1
7906,GO:0032474,0.0138499007310992,0.999936403557242,1,3,otolith morphogenesis,BP,LRIG3
110,GO:0000226,0.0142556136737749,0.995907387235553,7,427,microtubule cytoskeleton organization,BP,RGS2;GOLGA2P5;APC2;SPC25;KIAA0753;MAP7D3;MAP1A
17557,GO:1901099,0.0143190743411227,0.99922514401545,2,22,negative regulation of signal transduction in absence of ligand,BP,GDNF;SNAI2
20278,GO:2001240,0.0143190743411227,0.99922514401545,2,22,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,GDNF;SNAI2
6436,GO:0021700,0.0143253364955995,0.997558536599322,4,148,developmental maturation,BP,HES5;HES1;DCHS1;DDIT3
14960,GO:0070859,0.0143413076838042,0.999931795356279,1,3,positive regulation of bile acid biosynthetic process,BP,NR1D1
18767,GO:1904253,0.0143413076838042,0.999931795356279,1,3,positive regulation of bile acid metabolic process,BP,NR1D1
3460,GO:0007275,0.014445966855094,0.992113835882589,32,3302,multicellular organism development,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;HOXA9;NRSN1;S1PR5;TCHH;LRIG3;GDNF;HES1;HOXC13;ID3;SLC24A4;DCHS1;DDIT3;SNAI2;APC2;NUPR1;OTX1;HIST1H4F;ZNF160;SPN;SALL2;HOXC5;PRR15;HIST1H4I;ARRDC3;HIST1H4D;MAP1A;ABCB5
15505,GO:0071879,0.014580957661705,0.999929489170863,1,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,ARRDC3
12406,GO:0048852,0.0146543647898425,0.999928775041324,1,3,diencephalon morphogenesis,BP,OTX1
8674,GO:0034247,0.0148093593226369,1,1,1,snoRNA splicing,BP,RNF113A
11329,GO:0045653,0.0148539065134801,0.998410312947619,3,17,negative regulation of megakaryocyte differentiation,BP,HIST1H4F;HIST1H4I;HIST1H4D
15941,GO:0072750,0.0149163940601467,1,1,1,cellular response to leptomycin B,BP,ID3
17634,GO:1901344,0.0149163940601467,1,1,1,response to leptomycin B,BP,ID3
17756,GO:1901707,0.0149163940601467,1,1,1,leptomycin B binding,MF,ID3
4773,GO:0010957,0.0150454118025024,0.999924909750337,1,3,negative regulation of vitamin D biosynthetic process,BP,SNAI2
11583,GO:0046137,0.0150454118025024,0.999924909750337,1,3,negative regulation of vitamin metabolic process,BP,SNAI2
17039,GO:0099516,0.0153457655333819,0.999114636414246,2,36,ion antiporter activity,MF,SLC24A4;SLC9A4
6508,GO:0021879,0.0154535522620462,0.999117871172479,2,27,forebrain neuron differentiation,BP,HES5;HES1
3188,GO:0006813,0.0155797445701845,0.998124624394433,3,94,potassium ion transport,BP,SLC24A4;SLC9A4;FXYD3
12809,GO:0051100,0.0157434141858256,0.997249244552857,4,123,negative regulation of binding,BP,ID3;IFIT2;DDIT3;TMSB4X
13871,GO:0060485,0.0159111334432061,0.997198997199169,4,163,mesenchyme development,BP,GDNF;HES1;DCHS1;SNAI2
15970,GO:0080090,0.0162758988924974,0.990737978073416,41,4499,regulation of primary metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;RNF125;ACTR5;DDIT3;SNAI2;APC2;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;SPDYE1;CIART;ARRDC3;ZNF485;HIST1H4D;ZNF57
14142,GO:0061005,0.0164795645213648,0.999016715470724,2,33,cell differentiation involved in kidney development,BP,GDNF;HES1
6373,GO:0021555,0.0167065740784353,0.999930441435316,1,2,midbrain-hindbrain boundary morphogenesis,BP,HES1
11128,GO:0045168,0.0167066759416214,0.999930440583461,1,2,cell-cell signaling involved in cell fate commitment,BP,HES1
11628,GO:0046331,0.0167066759416214,0.999930440583461,1,2,lateral inhibition,BP,HES1
6374,GO:0021557,0.0167066816350935,0.999930440535848,1,2,oculomotor nerve development,BP,HES1
10787,GO:0044249,0.0178221665067579,0.98973082338509,46,4829,cellular biosynthetic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;RPL37;NME9;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;MUC6;ACTR5;DDIT3;SNAI2;RPL31;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;RPS27;ZNF485;HIST1H4D;MUC12;ZNF57
540,GO:0001658,0.0180171944878782,0.998868844925831,2,36,branching involved in ureteric bud morphogenesis,BP,GDNF;DCHS1
12410,GO:0048856,0.0181846326845485,0.989777165827025,34,3611,anatomical structure development,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;HOXA9;NRSN1;S1PR5;TCHH;LRIG3;GDNF;HES1;HOXC13;ID3;SLC24A4;SLC9A4;DCHS1;DDIT3;SNAI2;APC2;NUPR1;OTX1;HIST1H4F;ZNF160;SPN;SALL2;HOXC5;PRR15;HIST1H4I;RHOF;ARRDC3;HIST1H4D;MAP1A;ABCB5
6590,GO:0022600,0.0182031787228756,0.998853819643259,2,34,digestive system process,BP,MUC6;SLC9A4
4313,GO:0009790,0.0183008245687082,0.993516223713075,9,673,embryo development,BP,HES5;HOXA9;LRIG3;GDNF;HES1;ID3;DCHS1;OTX1;SALL2
3911,GO:0008559,0.0184052436123975,0.999873453956912,1,4,xenobiotic transmembrane transporting ATPase activity,MF,ABCB5
1336,GO:0003190,0.018405245548165,0.999873453930189,1,4,atrioventricular valve formation,BP,DCHS1
8626,GO:0034144,0.0184061729643531,0.999873441126761,1,4,negative regulation of toll-like receptor 4 signaling pathway,BP,NR1D1
5130,GO:0015562,0.0184178887778047,0.999873279328098,1,4,efflux transmembrane transporter activity,MF,ABCB5
12398,GO:0048840,0.0184196111929757,0.999873255532279,1,4,otolith development,BP,LRIG3
12856,GO:0051171,0.0184946266975223,0.98938755977247,40,4382,regulation of nitrogen compound metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;GDNF;HES1;HOXC13;ID3;ZC3H12D;RNF125;ACTR5;DDIT3;SNAI2;APC2;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;SPDYE1;CIART;ARRDC3;ZNF485;HIST1H4D;ZNF57
13626,GO:0060113,0.018758893825906,0.998801551771234,2,33,inner ear receptor cell differentiation,BP,HES5;HES1
6357,GO:0021536,0.0187753842449389,0.99879994107299,2,33,diencephalon development,BP,HES1;OTX1
11337,GO:0045661,0.0192248433070137,0.99876372746447,2,29,regulation of myoblast differentiation,BP,ID3;DDIT3
13915,GO:0060563,0.0198037677502254,0.998697998612532,2,33,neuroepithelial cell differentiation,BP,HES5;HES1
11381,GO:0045747,0.0202905363057596,0.998645156798966,2,35,positive regulation of Notch signaling pathway,BP,HES5;HES1
10517,GO:0043426,0.020382840016886,0.99984466766602,1,4,MRF binding,MF,TSC22D3
13981,GO:0060688,0.0204818678238592,0.998627322400297,2,34,regulation of morphogenesis of a branching structure,BP,GDNF;SNAI2
448,GO:0001221,0.0207368366690046,0.998599300938001,2,35,transcription cofactor binding,MF,NR1D1;PHF12
17639,GO:1901362,0.0209629328443946,0.988070793308669,34,3521,organic cyclic compound biosynthetic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;HOXA9;NME9;GDNF;HES1;HOXC13;ID3;ACTR5;DDIT3;SNAI2;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;ZNF485;HIST1H4D;ZNF57
10908,GO:0044454,0.0210120769713006,0.992394913855624,9,464,nuclear chromosome part,CC,NR1D1;ACTR5;SNAI2;HIST1H4F;PHF12;HIST1H1D;SALL2;HIST1H4I;HIST1H4D
4710,GO:0010871,0.021015142269998,0.999834836296441,1,4,negative regulation of receptor biosynthetic process,BP,NR1D1
9377,GO:0035905,0.0212630631327982,0.999849596758452,1,3,ascending aorta development,BP,HES1
9380,GO:0035910,0.0212630631327982,0.999849596758452,1,3,ascending aorta morphogenesis,BP,HES1
815,GO:0002085,0.0212631645295642,0.999849595317035,1,3,inhibition of neuroepithelial cell differentiation,BP,HES1
11297,GO:0045608,0.0212631645295642,0.999849595317035,1,3,negative regulation of inner ear auditory receptor cell differentiation,BP,HES1
7929,GO:0032502,0.0214622817076725,0.987667835372844,36,3894,developmental process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;NRSN1;S1PR5;TCHH;LRIG3;GDNF;HES1;HOXC13;ID3;SLC24A4;SLC9A4;DCHS1;DDIT3;SNAI2;APC2;NUPR1;OTX1;HIST1H4F;ZNF160;SPN;SALL2;HOXC5;ZKSCAN3;PRR15;HIST1H4I;RHOF;ARRDC3;HIST1H4D;MAP1A;ABCB5
14144,GO:0061009,0.0214658422807183,0.999846700188286,1,3,common bile duct development,BP,HES1
16248,GO:0090304,0.0216970281531493,0.987386019564712,40,4171,nucleic acid metabolic process,BP,TXNIP;NR1D1;HES5;TSC22D3;HOXA9;RPL37;GDNF;HES1;HOXC13;ID3;ZC3H12D;ACTR5;SNRPD2;DDIT3;SNAI2;RPL31;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;RPL28;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;RPS27;ZNF485;HIST1H4D;ZNF57
17696,GO:1901576,0.022354485808588,0.986883375380235,46,4894,organic substance biosynthetic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;RPL37;NME9;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;MUC6;ACTR5;DDIT3;SNAI2;RPL31;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;RPS27;ZNF485;HIST1H4D;MUC12;ZNF57
2643,GO:0005978,0.0223633038668243,0.99842399449761,2,37,glycogen biosynthetic process,BP,NR1D1;PPP1R3D
4177,GO:0009250,0.0223633038668243,0.99842399449761,2,37,glucan biosynthetic process,BP,NR1D1;PPP1R3D
7070,GO:0030856,0.0224686566148723,0.9968973917714,3,94,regulation of epithelial cell differentiation,BP,HES5;GDNF;HES1
10830,GO:0044324,0.0225129854587797,1,1,1,regulation of transcription involved in anterior/posterior axis specification,BP,DDIT3
19699,GO:2000016,0.0225129854587797,1,1,1,negative regulation of determination of dorsal identity,BP,DDIT3
6505,GO:0021872,0.0226089847847303,0.998401146192491,2,35,forebrain generation of neurons,BP,HES5;HES1
9401,GO:0035947,0.0229550435796685,0.999789706520787,1,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,NR1D1
10037,GO:0042490,0.0232174476650993,0.998334765342182,2,35,mechanoreceptor differentiation,BP,HES5;HES1
14648,GO:0070236,0.0232890684301923,0.999796962122173,1,4,negative regulation of activation-induced cell death of T cells,BP,TSC22D3
7579,GO:0031941,0.0234383241052673,0.998335882612508,2,26,filamentous actin,CC,APC2;TMSB4X
14959,GO:0070857,0.0234553113064904,0.999780395451142,1,5,regulation of bile acid biosynthetic process,BP,NR1D1
13498,GO:0055056,0.0240946054655287,0.999768200328941,1,5,D-glucose transmembrane transporter activity,MF,SLC2A3
8185,GO:0032922,0.0241369164822052,0.99821443507544,2,46,circadian regulation of gene expression,BP,NR1D1;CIART
5420,GO:0016266,0.0242870230308346,0.99820294787737,2,42,O-glycan processing,BP,MUC6;MUC12
443,GO:0001191,0.0245004304857636,0.998191686727592,2,35,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,ID3;PHF12
1466,GO:0003714,0.0250412932903586,0.994943236067389,4,178,transcription corepressor activity,MF,NR1D1;ID3;DDIT3;PHF12
11352,GO:0045685,0.0254065347756574,0.998074410747953,2,42,regulation of glial cell differentiation,BP,HES5;HES1
2646,GO:0005981,0.0254971724256937,0.999756405102744,1,4,regulation of glycogen catabolic process,BP,PPP1R3D
19016,GO:1904837,0.0258015868090452,0.996340737470515,3,41,beta-catenin-TCF complex assembly,BP,HIST1H4F;HIST1H4I;HIST1H4D
4316,GO:0009794,0.0258365568251331,0.999749840676693,1,4,regulation of mitotic cell cycle, embryonic,BP,HES1
11247,GO:0045448,0.0258365568251331,0.999749840676693,1,4,mitotic cell cycle, embryonic,BP,HES1
12306,GO:0048645,0.0259595058167559,0.99802393835771,2,35,animal organ formation,BP,GDNF;HES1
12900,GO:0051239,0.0260600111769981,0.986490311238182,20,1830,regulation of multicellular organismal process,BP,HES5;TSC22D3;RGS2;HOXA9;S1PR5;GDNF;HES1;ID3;RNF125;DDIT3;SNAI2;NUPR1;HIST1H4F;SPN;TMSB4X;FXYD3;HIST1H4I;ARRDC3;HIST1H4D;BTN3A1
4027,GO:0009058,0.0260703843911912,0.984508861210399,46,4934,biosynthetic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;RPL37;NME9;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;MUC6;ACTR5;DDIT3;SNAI2;RPL31;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;RPS27;ZNF485;HIST1H4D;MUC12;ZNF57
111,GO:0000228,0.0261929385283648,0.990146383136924,9,495,nuclear chromosome,CC,NR1D1;ACTR5;SNAI2;HIST1H4F;PHF12;HIST1H1D;SALL2;HIST1H4I;HIST1H4D
13834,GO:0060429,0.0262108439293836,0.989085175165539,11,809,epithelium development,BP,TXNIP;HES5;TCHH;GDNF;HES1;HOXC13;ID3;SLC9A4;DCHS1;SNAI2;SALL2
12284,GO:0048598,0.026775211580285,0.992151040188977,6,380,embryonic morphogenesis,BP,HES5;HOXA9;LRIG3;GDNF;HES1;OTX1
4341,GO:0009892,0.0267816519337469,0.98527316987149,25,2160,negative regulation of metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;RPL37;GDNF;HES1;ID3;ZC3H12D;DDIT3;SNAI2;RPL31;HIST1H4F;PHF12;RPL23A;HIST1H1D;SALL2;RPL28;ZKSCAN3;HIST1H4I;CIART;RPS27;HIST1H4D
7118,GO:0030917,0.0269406824635278,0.99972787366276,1,4,midbrain-hindbrain boundary development,BP,HES1
10227,GO:0042908,0.0274818397024992,0.999685541058676,1,6,xenobiotic transport,BP,ABCB5
10228,GO:0042910,0.0274818397024992,0.999685541058676,1,6,xenobiotic transmembrane transporter activity,MF,ABCB5
10027,GO:0042472,0.027645616162884,0.997798299005676,2,48,inner ear morphogenesis,BP,LRIG3;OTX1
6465,GO:0021784,0.0278179465945371,1,1,1,postganglionic parasympathetic fiber development,BP,GDNF
5095,GO:0015368,0.0279736711750506,0.99967412056274,1,6,calcium:cation antiporter activity,MF,SLC24A4
2295,GO:0005253,0.0280131388011109,0.99776706528856,2,40,anion channel activity,MF,FXYD3;GPR89A
19584,GO:1990622,0.0283872062937424,0.999797962942974,1,2,CHOP-ATF3 complex,CC,DDIT3
14320,GO:0061469,0.0284643448634471,0.999662521645557,1,6,regulation of type B pancreatic cell proliferation,BP,NR1D1
13897,GO:0060536,0.028878371465088,0.999687060307839,1,4,cartilage morphogenesis,BP,SNAI2
10416,GO:0043255,0.0290371178875862,0.997617774464338,2,54,regulation of carbohydrate biosynthetic process,BP,NR1D1;PPP1R3D
19191,GO:1905271,0.0290685204407792,1,1,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,TMSB4X
19192,GO:1905273,0.0290685204407792,1,1,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,TMSB4X
1095,GO:0002682,0.0291424376858914,0.98676143540056,13,926,regulation of immune system process,BP,NR1D1;HES5;TSC22D3;HOXA9;HES1;MUC6;RNF125;HIST1H4F;SPN;HIST1H4I;HIST1H4D;BTN3A1;MUC12
12857,GO:0051172,0.0291464805241082,0.984700858742547,20,1772,negative regulation of nitrogen compound metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;GDNF;HES1;ID3;ZC3H12D;DDIT3;SNAI2;HIST1H4F;PHF12;HIST1H1D;SALL2;ZKSCAN3;HIST1H4I;CIART;HIST1H4D
14822,GO:0070562,0.0296112409573396,0.999634609927068,1,6,regulation of vitamin D receptor signaling pathway,BP,SNAI2
17672,GO:1901532,0.0298143690163961,0.992330007314015,5,103,regulation of hematopoietic progenitor cell differentiation,BP,HES5;HES1;HIST1H4F;HIST1H4I;HIST1H4D
9622,GO:0036488,0.0298331519176317,0.999776689719261,1,2,CHOP-C/EBP complex,CC,DDIT3
14647,GO:0070235,0.0298906417280364,0.999642412893047,1,5,regulation of activation-induced cell death of T cells,BP,TSC22D3
3580,GO:0007626,0.0299368327004602,0.995381513737355,3,102,locomotory behavior,BP,GDNF;CIART;ARRDC3
14511,GO:0065007,0.029970116771378,0.982861118964928,64,7896,biological regulation,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RIN2;RGS2;HOXA9;S1PR5;RPL37;NME9;PPP1R3D;GDNF;HES1;HOXC13;ID3;SLC24A4;ZC3H12D;MUC6;IFIT2;RNF125;ACTR5;SLC9A4;DCHS1;DDIT3;SNAI2;APC2;RPL31;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;RPL28;TMSB4X;ZNF169;FAM110C;FXYD3;GPR89A;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;SPDYE1;RHOF;CIART;ARRDC3;RPS27;ZNF485;HIST1H4D;RAB15;BTN3A1;MUC12;ZNF57;STAC2;MAP1A;ABCB5
9674,GO:0038036,0.0302242474194143,0.999619231091551,1,6,sphingosine-1-phosphate receptor activity,MF,S1PR5
4971,GO:0015079,0.0304350698273828,0.99744063401287,2,53,potassium ion transmembrane transporter activity,MF,SLC24A4;SLC9A4
12355,GO:0048731,0.0305341677880306,0.98258493921846,28,2940,system development,BP,TXNIP;HES5;DDIT4;TSC22D3;HOXA9;NRSN1;S1PR5;TCHH;LRIG3;GDNF;HES1;HOXC13;ID3;SLC24A4;DCHS1;DDIT3;SNAI2;NUPR1;OTX1;HIST1H4F;ZNF160;SPN;SALL2;HIST1H4I;ARRDC3;HIST1H4D;MAP1A;ABCB5
5136,GO:0015631,0.0307509029615093,0.991908176768356,5,276,tubulin binding,MF,RGS2;APC2;FAM110C;MAP7D3;MAP1A
6555,GO:0021984,0.0308855565500104,0.999618054952617,1,5,adenohypophysis development,BP,HES1
1452,GO:0003682,0.0309100445227854,0.989621877956037,7,437,chromatin binding,MF,HES5;HOXC13;SNAI2;NUPR1;PHF12;HIST1H1D;ZKSCAN3
19582,GO:1990617,0.0309379141441591,0.999759707157043,1,2,CHOP-ATF4 complex,CC,DDIT3
15578,GO:0072047,0.0312198748778723,0.9996338866812,1,4,proximal/distal pattern formation involved in nephron development,BP,HES5
15599,GO:0072081,0.0312198748778723,0.9996338866812,1,4,specification of nephron tubule identity,BP,HES5
15600,GO:0072086,0.0312198748778723,0.9996338866812,1,4,specification of loop of Henle identity,BP,HES5
18766,GO:1904251,0.0313984822533002,0.999588876014377,1,6,regulation of bile acid metabolic process,BP,NR1D1
19698,GO:2000015,0.0315524080771794,0.999667249500524,1,3,regulation of determination of dorsal identity,BP,DDIT3
3189,GO:0006814,0.032254177479578,0.99486632827146,3,119,sodium ion transport,BP,SLC24A4;SLC9A4;FXYD3
6899,GO:0030432,0.0323235314936453,0.999737512786408,1,2,peristalsis,BP,GDNF
4472,GO:0010467,0.0323872291985212,0.980484483947432,41,4264,gene expression,BP,TXNIP;NR1D1;HES5;TSC22D3;RGS2;HOXA9;RPL37;GDNF;HES1;HOXC13;ID3;ZC3H12D;ACTR5;SNRPD2;DDIT3;SNAI2;RPL31;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;RPL28;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;RPS27;ZNF485;HIST1H4D;ZNF57
5398,GO:0016233,0.0324016986945513,0.994938348230105,3,51,telomere capping,BP,HIST1H4F;HIST1H4I;HIST1H4D
3550,GO:0007586,0.032556142619302,0.997184287809125,2,41,digestion,BP,MUC6;SLC9A4
5104,GO:0015386,0.0326305008184683,0.999543188211725,1,7,potassium:proton antiporter activity,MF,SLC9A4
10048,GO:0042531,0.0326467496997419,0.9971897782237,2,35,positive regulation of tyrosine phosphorylation of STAT protein,BP,HES5;HES1
6525,GO:0021903,0.0328254845258885,0.999568221502109,1,5,rostrocaudal neural tube patterning,BP,HES1
6462,GO:0021781,0.0329749699936197,0.999564252976933,1,5,glial cell fate commitment,BP,HES5
13852,GO:0060452,0.0330061395635008,0.999563423171659,1,5,positive regulation of cardiac muscle contraction,BP,RGS2
13985,GO:0060693,0.0330358439482013,0.999544579600771,1,6,regulation of branching involved in salivary gland morphogenesis,BP,SNAI2
9363,GO:0035878,0.0330880520483033,0.999530202625828,1,7,nail development,BP,HOXC13
6919,GO:0030510,0.0331695134455309,0.997080168624606,2,52,regulation of BMP signaling pathway,BP,HES5;HES1
14198,GO:0061101,0.0332283692482253,0.999584904968281,1,4,neuroendocrine cell differentiation,BP,HES1
20059,GO:2000677,0.0334677801520674,0.997083939393474,2,34,regulation of transcription regulatory region DNA binding,BP,DDIT3;TMSB4X
8585,GO:0034080,0.033720467895302,0.994704368740113,3,40,CENP-A containing nucleosome assembly,BP,HIST1H4F;HIST1H4I;HIST1H4D
14389,GO:0061641,0.033720467895302,0.994704368740113,3,40,CENP-A containing chromatin organization,BP,HIST1H4F;HIST1H4I;HIST1H4D
12345,GO:0048708,0.0344374024479009,0.996929987974435,2,41,astrocyte differentiation,BP,HES5;HES1
20277,GO:2001239,0.034739707100952,0.996911543291849,2,34,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,GDNF;SNAI2
12349,GO:0048712,0.0350696979135782,0.999506704929077,1,5,negative regulation of astrocyte differentiation,BP,HES5
10086,GO:0042587,0.0354833329490447,0.999494913136545,1,5,glycogen granule,CC,PPP1R3D
12237,GO:0048505,0.0355795890168576,0.999471203268335,1,6,regulation of timing of cell differentiation,BP,HES1
11412,GO:0045820,0.0358177134593732,0.999464049914266,1,6,negative regulation of glycolytic process,BP,DDIT4
12878,GO:0051198,0.0358177134593732,0.999464049914266,1,6,negative regulation of coenzyme metabolic process,BP,DDIT4
12612,GO:0050789,0.0363112979218435,0.978509720347677,61,7500,regulation of biological process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RIN2;RGS2;HOXA9;S1PR5;RPL37;NME9;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;MUC6;IFIT2;RNF125;ACTR5;DCHS1;DDIT3;SNAI2;APC2;RPL31;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;RPL28;TMSB4X;ZNF169;FAM110C;FXYD3;GPR89A;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;SPDYE1;RHOF;CIART;ARRDC3;RPS27;ZNF485;HIST1H4D;RAB15;BTN3A1;MUC12;ZNF57;STAC2;MAP1A
4337,GO:0009888,0.0363164151767443,0.982490638440046,14,1227,tissue development,BP,TXNIP;HES5;TSC22D3;TCHH;GDNF;HES1;HOXC13;ID3;SLC9A4;DCHS1;SNAI2;NUPR1;SALL2;ARRDC3
10052,GO:0042535,0.0363470864708549,0.999502659257821,1,4,positive regulation of tumor necrosis factor biosynthetic process,BP,SPN
7175,GO:0031055,0.0364665168677353,0.994082565386491,3,42,chromatin remodeling at centromere,BP,HIST1H4F;HIST1H4I;HIST1H4D
17484,GO:1900402,0.0364765171219749,0.999416509303766,1,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,NR1D1
14211,GO:0061138,0.0364798725953304,0.993903463651642,3,129,morphogenesis of a branching epithelium,BP,GDNF;DCHS1;SNAI2
2540,GO:0005796,0.0365255448374535,0.996618866093866,2,49,Golgi lumen,CC,MUC6;MUC12
7069,GO:0030855,0.0366336747726391,0.987253299867028,7,434,epithelial cell differentiation,BP,TXNIP;HES5;TCHH;GDNF;HES1;ID3;SLC9A4
8106,GO:0032792,0.0367052989078822,0.999492729416772,1,4,negative regulation of CREB transcription factor activity,BP,DDIT3
12407,GO:0048853,0.036766333039372,0.999419102247873,1,7,forebrain morphogenesis,BP,OTX1
15619,GO:0072108,0.0368084764529454,0.99954605662225,1,3,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,GDNF
15617,GO:0072106,0.036808718961114,0.99954605058988,1,3,regulation of ureteric bud formation,BP,GDNF
15618,GO:0072107,0.036808718961114,0.99954605058988,1,3,positive regulation of ureteric bud formation,BP,GDNF
19196,GO:1905278,0.036808718961114,0.99954605058988,1,3,positive regulation of epithelial tube formation,BP,GDNF
8464,GO:0033603,0.0368192372301403,0.999545788909608,1,3,positive regulation of dopamine secretion,BP,GDNF
7607,GO:0031987,0.0370213720598188,0.9993988202712,1,8,locomotion involved in locomotory behavior,BP,ARRDC3
5103,GO:0015385,0.0371144475727824,0.999395771722916,1,8,sodium:proton antiporter activity,MF,SLC9A4
12155,GO:0048263,0.0374175885616799,0.999472688005107,1,4,determination of dorsal identity,BP,DDIT3
12303,GO:0048642,0.0376461269176227,0.999390756633519,1,7,negative regulation of skeletal muscle tissue development,BP,TSC22D3
283,GO:0000785,0.038100019855947,0.984684793588425,9,458,chromatin,CC,NR1D1;ACTR5;SNAI2;HIST1H4F;PHF12;HIST1H1D;SALL2;HIST1H4I;HIST1H4D
17796,GO:1901879,0.0383968376402055,0.996336330109396,2,55,regulation of protein depolymerization,BP,APC2;MAP1A
14260,GO:0061309,0.0385881393307167,0.999377237819035,1,6,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,HES1
2731,GO:0006109,0.0388199628711126,0.993353535942412,3,129,regulation of carbohydrate metabolic process,BP,NR1D1;DDIT4;PPP1R3D
7361,GO:0031402,0.0388646726739123,0.999336988310312,1,8,sodium ion binding,MF,SLC24A4
2745,GO:0006139,0.0392063247013999,0.975916541183659,43,4605,nucleobase-containing compound metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;HOXA9;RPL37;NME9;GDNF;HES1;HOXC13;ID3;ZC3H12D;ACTR5;SNRPD2;DDIT3;SNAI2;RPL31;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;RPL28;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;COX7C;HIST1H4I;CIART;RPS27;ZNF485;HIST1H4D;ZNF57
5075,GO:0015297,0.0392302757280543,0.996218717462064,2,52,antiporter activity,MF,SLC24A4;SLC9A4
3186,GO:0006811,0.0392941277616852,0.982552159054398,11,861,ion transport,BP,TSC22D3;GDNF;SLC24A4;SLC2A3;SLC9A4;DDIT3;CNNM1;TMSB4X;FXYD3;GPR89A;COX7C
9864,GO:0042118,0.0393121301481936,0.999321515277068,1,8,endothelial cell activation,BP,HOXA9
13908,GO:0060556,0.0397155505515581,0.999340015475673,1,6,regulation of vitamin D biosynthetic process,BP,SNAI2
13914,GO:0060562,0.0401537269926756,0.990595300346632,4,222,epithelial tube morphogenesis,BP,HES5;GDNF;HES1;DCHS1
10698,GO:0043983,0.0403265054455956,0.999300170182921,1,7,histone H4-K12 acetylation,BP,JADE2
14381,GO:0061626,0.0403416384185033,0.999318870515413,1,6,pharyngeal arch artery morphogenesis,BP,HES1
7315,GO:0031323,0.0405029906690041,0.975144756835131,40,4607,regulation of cellular metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;RNF125;ACTR5;DDIT3;SNAI2;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;SPDYE1;CIART;ARRDC3;ZNF485;HIST1H4D;ZNF57
728,GO:0001955,0.0405087160344134,0.999340337879278,1,5,blood vessel maturation,BP,DDIT3
8512,GO:0033692,0.0405808534663674,0.996013889042808,2,53,cellular polysaccharide biosynthetic process,BP,NR1D1;PPP1R3D
11293,GO:0045604,0.0407468565806726,0.996000115452529,2,48,regulation of epidermal cell differentiation,BP,HES5;HES1
598,GO:0001763,0.0407592184125099,0.992882432657553,3,136,morphogenesis of a branching structure,BP,GDNF;DCHS1;SNAI2
16056,GO:0086103,0.0409160358586425,0.999279390654166,1,7,G-protein coupled receptor signaling pathway involved in heart process,BP,RGS2
11191,GO:0045295,0.040941285144297,0.999252105124317,1,9,gamma-catenin binding,MF,APC2
15887,GO:0072643,0.040946003369996,0.999251931373271,1,9,interferon-gamma secretion,BP,BTN3A1
8034,GO:0032677,0.0410171891333676,0.99598739700328,2,39,regulation of interleukin-8 production,BP,DDIT3;TMSB4X
9132,GO:0035457,0.0411309085221601,0.999245106002547,1,9,cellular response to interferon-alpha,BP,IFIT2
12911,GO:0051254,0.0414321257232217,0.980769426586931,12,1118,positive regulation of RNA metabolic process,BP,NR1D1;HES5;HOXA9;GDNF;HES1;HOXC13;ZC3H12D;DDIT3;OTX1;SALL2;IVNS1ABP;ZKSCAN3
16827,GO:0098719,0.0415770469710157,0.99922850810541,1,9,sodium ion import across plasma membrane,BP,SLC9A4
2356,GO:0005451,0.0415775573177809,0.999228489013728,1,9,monovalent cation:proton antiporter activity,MF,SLC9A4
8804,GO:0034508,0.0415782022377303,0.992846822536707,3,50,centromere complex assembly,BP,HIST1H4F;HIST1H4I;HIST1H4D
708,GO:0001931,0.0417253328958084,0.999234939894782,1,8,uropod,CC,SPN
7275,GO:0031254,0.0417253328958084,0.999234939894782,1,8,cell trailing edge,CC,SPN
6606,GO:0022625,0.0417298074001816,0.990338482602159,4,63,cytosolic large ribosomal subunit,CC,RPL37;RPL31;RPL23A;RPL28
12154,GO:0048262,0.0418794845884349,0.999294535257456,1,5,determination of dorsal/ventral asymmetry,BP,DDIT3
1243,GO:0002934,0.0420205727253748,0.999211825593162,1,9,desmosome organization,BP,SNAI2
20068,GO:2000698,0.0420294248433986,0.999333359514347,1,4,positive regulation of epithelial cell differentiation involved in kidney development,BP,GDNF
16432,GO:0097084,0.042139370513445,0.999256270618675,1,6,vascular smooth muscle cell development,BP,HES1
1332,GO:0003183,0.0426083030562198,0.999201942390205,1,8,mitral valve morphogenesis,BP,DCHS1
1335,GO:0003188,0.0426085294722767,0.999201933837969,1,8,heart valve formation,BP,DCHS1
4896,GO:0014821,0.0429270770080419,0.999304308239098,1,4,phasic smooth muscle contraction,BP,GDNF
10679,GO:0043931,0.0430308657570237,0.999173147755741,1,9,ossification involved in bone maturation,BP,DCHS1
14821,GO:0070561,0.0430458013608768,0.999172568899487,1,9,vitamin D receptor signaling pathway,BP,SNAI2
2850,GO:0006336,0.0430675460724935,0.992487242842828,3,50,DNA replication-independent nucleosome assembly,BP,HIST1H4F;HIST1H4I;HIST1H4D
2394,GO:0005536,0.0431130559902173,0.9991699597736,1,9,glucose binding,MF,SLC2A3
8010,GO:0032637,0.0432207316136218,0.995641564295911,2,41,interleukin-8 production,BP,DDIT3;TMSB4X
7132,GO:0030955,0.0433200837549831,0.999161901971979,1,9,potassium ion binding,MF,SLC24A4
13972,GO:0060676,0.0435861900617178,0.999282574974336,1,4,ureteric bud formation,BP,GDNF
15654,GO:0072172,0.0435861900617178,0.999282574974336,1,4,mesonephric tubule formation,BP,GDNF
4972,GO:0015081,0.0436353974195489,0.995515833011082,2,67,sodium ion transmembrane transporter activity,MF,SLC24A4;SLC9A4
8903,GO:0034724,0.0437350795126798,0.992318871123932,3,51,DNA replication-independent nucleosome organization,BP,HIST1H4F;HIST1H4I;HIST1H4D
2642,GO:0005977,0.04374449934155,0.995519470640652,2,55,glycogen metabolic process,BP,NR1D1;PPP1R3D
10538,GO:0043486,0.0437452731970025,0.992333641042781,3,48,histone exchange,BP,HIST1H4F;HIST1H4I;HIST1H4D
13947,GO:0060613,0.0439184262933499,0.999191563810898,1,6,fat pad development,BP,ARRDC3
3943,GO:0008630,0.0440505442859117,0.99211542198664,3,94,intrinsic apoptotic signaling pathway in response to DNA damage,BP,DDIT4;SNAI2;NUPR1
12246,GO:0048521,0.0441499629217863,0.999263715065889,1,4,negative regulation of behavior,BP,ARRDC3
11664,GO:0046427,0.0447129460958984,0.995402866222132,2,42,positive regulation of JAK-STAT cascade,BP,HES5;HES1
7040,GO:0030812,0.0447355133597086,0.999119535248053,1,8,negative regulation of nucleotide catabolic process,BP,DDIT4
2834,GO:0006303,0.0448112659765531,0.991986315629846,3,67,double-strand break repair via nonhomologous end joining,BP,HIST1H4F;HIST1H4I;HIST1H4D
12671,GO:0050872,0.0448239090671941,0.999102182526142,1,9,white fat cell differentiation,BP,SNAI2
2708,GO:0006073,0.0448514933544434,0.995340838339394,2,56,cellular glucan metabolic process,BP,NR1D1;PPP1R3D
10720,GO:0044042,0.0448514933544434,0.995340838339394,2,56,glucan metabolic process,BP,NR1D1;PPP1R3D
1426,GO:0003376,0.0448823813385065,0.999099818264227,1,9,sphingosine-1-phosphate signaling pathway,BP,S1PR5
16321,GO:0090520,0.0448823813385065,0.999099818264227,1,9,sphingolipid mediated signaling pathway,BP,S1PR5
10530,GO:0043470,0.045036279774983,0.99530698135904,2,58,regulation of carbohydrate catabolic process,BP,DDIT4;PPP1R3D
56,GO:0000118,0.0451371713262205,0.995297072451371,2,55,histone deacetylase complex,CC,PHF12;SALL2
9771,GO:0039536,0.0451398744313589,0.999121458774366,1,7,negative regulation of RIG-I signaling pathway,BP,RNF125
11252,GO:0045475,0.0451741832983786,0.99910202896183,1,8,locomotor rhythm,BP,CIART
14315,GO:0061448,0.045182531643275,0.991781488872115,3,140,connective tissue development,BP,HES5;SNAI2;ARRDC3
7316,GO:0031324,0.0452558850639958,0.974999577376635,20,1887,negative regulation of cellular metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;GDNF;HES1;ID3;ZC3H12D;DDIT3;SNAI2;HIST1H4F;PHF12;HIST1H1D;SALL2;ZKSCAN3;HIST1H4I;CIART;HIST1H4D
6820,GO:0030277,0.0454238629997039,0.999091986502158,1,8,maintenance of gastrointestinal epithelium,BP,MUC6
2336,GO:0005355,0.0454751031218976,0.999075673633855,1,9,glucose transmembrane transporter activity,MF,SLC2A3
4495,GO:0010519,0.0457039690905565,0.999123857102696,1,6,negative regulation of phospholipase activity,BP,RGS2
12226,GO:0048484,0.0457168140891976,0.999157984029488,1,5,enteric nervous system development,BP,GDNF
1407,GO:0003339,0.045716897873361,0.999157980913704,1,5,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,GDNF
10047,GO:0042509,0.0459062089254631,0.995204187912901,2,44,regulation of tyrosine phosphorylation of STAT protein,BP,HES5;HES1
13618,GO:0060087,0.0460980337332743,0.99919662474454,1,4,relaxation of vascular smooth muscle,BP,RGS2
9851,GO:0042098,0.0464519965432051,0.991490492194586,3,107,T cell proliferation,BP,HES1;SPN;BTN3A1
19050,GO:1904894,0.0465813622871268,0.995098389780134,2,43,positive regulation of STAT cascade,BP,HES5;HES1
4146,GO:0009206,0.0466075324712419,0.991454753461268,3,104,purine ribonucleoside triphosphate biosynthetic process,BP,DDIT4;NME9;TMSB4X
3429,GO:0007219,0.0467021166701084,0.99140357071326,3,128,Notch signaling pathway,BP,HES5;HES1;SNAI2
8466,GO:0033605,0.0467523093901765,0.99911902693106,1,5,positive regulation of catecholamine secretion,BP,GDNF
9412,GO:0035976,0.0467557892157851,0.999118894499778,1,5,transcription factor AP-1 complex,CC,DDIT3
7084,GO:0030877,0.0468138887292719,0.999007867516916,1,10,beta-catenin destruction complex,CC,APC2
6566,GO:0022010,0.0469249563478535,0.999030411664526,1,8,central nervous system myelination,BP,HES5
7772,GO:0032291,0.0469249563478535,0.999030411664526,1,8,axon ensheathment in central nervous system,BP,HES5
10518,GO:0043433,0.0469504107163569,0.991347592617294,3,120,negative regulation of DNA binding transcription factor activity,BP,ID3;DDIT3;TMSB4X
1325,GO:0003174,0.0470463058261634,0.999010095990266,1,9,mitral valve development,BP,DCHS1
562,GO:0001696,0.0470816272528746,0.999069720853918,1,6,gastric acid secretion,BP,SLC9A4
4092,GO:0009145,0.0474632783224851,0.991233655837141,3,105,purine nucleoside triphosphate biosynthetic process,BP,DDIT4;NME9;TMSB4X
15031,GO:0070977,0.0474667578221121,0.998979746581082,1,10,bone maturation,BP,DCHS1
16495,GO:0097193,0.047534395232176,0.985962393681127,5,245,intrinsic apoptotic signaling pathway,BP,DDIT4;DDIT3;SNAI2;NUPR1;IVNS1ABP
10608,GO:0043587,0.0477626280705747,0.998995155796963,1,8,tongue morphogenesis,BP,HOXC13
3448,GO:0007260,0.0481812804886265,0.994823996726897,2,46,tyrosine phosphorylation of STAT protein,BP,HES5;HES1
13080,GO:0051584,0.0481840916197017,0.999121470992455,1,4,regulation of dopamine uptake involved in synaptic transmission,BP,GDNF
13263,GO:0051940,0.0481840916197017,0.999121470992455,1,4,regulation of catecholamine uptake involved in synaptic transmission,BP,GDNF
912,GO:0002295,0.0482635474030472,0.998994411657865,1,7,T-helper cell lineage commitment,BP,SPN
10480,GO:0043373,0.0482635474030472,0.998994411657865,1,7,CD4-positive, alpha-beta T cell lineage commitment,BP,SPN
5146,GO:0015672,0.0482678827213958,0.985684035690913,5,249,monovalent inorganic cation transport,BP,SLC24A4;SLC9A4;TMSB4X;FXYD3;COX7C
14141,GO:0061004,0.0482957328078975,0.998993057099455,1,7,pattern specification involved in kidney development,BP,HES5
15579,GO:0072048,0.0482957328078975,0.998993057099455,1,7,renal system pattern specification,BP,HES5
12372,GO:0048762,0.0484091553273985,0.990953975807541,3,137,mesenchymal cell differentiation,BP,GDNF;HES1;SNAI2
8481,GO:0033629,0.0487404737400291,0.998974244526009,1,7,negative regulation of cell adhesion mediated by integrin,BP,SNAI2
3652,GO:0008134,0.0487688107743501,0.981938560762741,7,505,transcription factor binding,MF,NR1D1;HES5;TSC22D3;HES1;ID3;DDIT3;PHF12
8661,GO:0034220,0.0489770514847235,0.980494976961524,8,582,ion transmembrane transport,BP,TSC22D3;SLC24A4;SLC9A4;DDIT3;TMSB4X;FXYD3;GPR89A;COX7C
3266,GO:0006939,0.0491361976431496,0.994639500621136,2,54,smooth muscle contraction,BP,RGS2;GDNF
9977,GO:0042368,0.0491452188180777,0.998956969473959,1,7,vitamin D biosynthetic process,BP,SNAI2
20235,GO:2001170,0.0491696831897735,0.998917833220735,1,9,negative regulation of ATP biosynthetic process,BP,DDIT4
131,GO:0000271,0.0493753935176818,0.99458472253452,2,60,polysaccharide biosynthetic process,BP,NR1D1;PPP1R3D
11837,GO:0046785,0.0496098344325734,0.994547048081382,2,59,microtubule polymerization,BP,RGS2;MAP7D3
12875,GO:0051195,0.0496232581022697,0.998897581907899,1,9,negative regulation of cofactor metabolic process,BP,DDIT4
9806,GO:0040034,0.0497309815442708,0.998931707808811,1,7,regulation of development, heterochronic,BP,HES1
8625,GO:0034143,0.0498157461634689,0.998888929817253,1,9,regulation of toll-like receptor 4 signaling pathway,BP,NR1D1
14258,GO:0061307,0.0498461281822044,0.998904681561795,1,8,cardiac neural crest cell differentiation involved in heart development,BP,HES1
14259,GO:0061308,0.0498461281822044,0.998904681561795,1,8,cardiac neural crest cell development involved in heart development,BP,HES1
1255,GO:0003007,0.0498695854619618,0.990560410018795,3,150,heart morphogenesis,BP,HES1;DCHS1;SNAI2
260,GO:0000726,0.0498822988257416,0.99066918917139,3,74,non-recombinational repair,BP,HIST1H4F;HIST1H4I;HIST1H4D
10531,GO:0043471,0.0499090397601821,0.998901887837551,1,8,regulation of cellular carbohydrate catabolic process,BP,PPP1R3D
1376,GO:0003266,0.0500295024396026,0.998989805367547,1,5,regulation of secondary heart field cardioblast proliferation,BP,HES1
1374,GO:0003263,0.0500334559755391,0.998989644026554,1,5,cardioblast proliferation,BP,HES1
5005,GO:0015149,0.0500335482140939,0.998865304484467,1,10,hexose transmembrane transporter activity,MF,SLC2A3
2734,GO:0006112,0.0500361138367926,0.994472079788867,2,60,energy reserve metabolic process,BP,NR1D1;PPP1R3D
10026,GO:0042471,0.050061537745577,0.994467728436147,2,60,ear morphogenesis,BP,LRIG3;OTX1
10932,GO:0044557,0.0505198643303213,0.998969693662541,1,5,relaxation of smooth muscle,BP,RGS2
8594,GO:0034098,0.0507894462376446,0.998844634770324,1,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,RNF125
66,GO:0000137,0.0510302352324082,0.998819194940995,1,10,Golgi cis cisterna,CC,GOLGA2P5
11484,GO:0045944,0.0518580562524309,0.977872590541332,9,791,positive regulation of transcription by RNA polymerase II,BP,NR1D1;HES5;HOXA9;GDNF;HES1;HOXC13;DDIT3;OTX1;SALL2
20234,GO:2001169,0.0523155790583983,0.994076982914182,2,60,regulation of ATP biosynthetic process,BP,DDIT4;TMSB4X
4141,GO:0009201,0.0528903450083468,0.989794588128672,3,110,ribonucleoside triphosphate biosynthetic process,BP,DDIT4;NME9;TMSB4X
20032,GO:2000647,0.0529152355251609,0.998729427551064,1,10,negative regulation of stem cell proliferation,BP,SNAI2
7280,GO:0031262,0.0534516698787823,0.998916393184475,1,4,Ndc80 complex,CC,SPC25
15589,GO:0072070,0.0534652095322131,0.998718358689594,1,9,loop of Henle development,BP,HES5
16342,GO:0090596,0.0536109740917473,0.989562829623717,3,142,sensory organ morphogenesis,BP,LRIG3;HOXC13;OTX1
7971,GO:0032580,0.0536141194481038,0.99383226584163,2,67,Golgi cisterna membrane,CC,GOLGA2P5;GPR89A
11245,GO:0045445,0.0536999249963494,0.993854657026075,2,52,myoblast differentiation,BP,ID3;DDIT3
3577,GO:0007623,0.0537149133014674,0.989542058285784,3,134,circadian rhythm,BP,NR1D1;ID3;CIART
2849,GO:0006335,0.0539618719990352,0.989916431418722,3,32,DNA replication-dependent nucleosome assembly,BP,HIST1H4F;HIST1H4I;HIST1H4D
8902,GO:0034723,0.0539618719990352,0.989916431418722,3,32,DNA replication-dependent nucleosome organization,BP,HIST1H4F;HIST1H4I;HIST1H4D
11478,GO:0045935,0.0540284089111931,0.973098539635272,13,1276,positive regulation of nucleobase-containing compound metabolic process,BP,NR1D1;HES5;HOXA9;GDNF;HES1;HOXC13;ZC3H12D;DDIT3;OTX1;SALL2;TMSB4X;IVNS1ABP;ZKSCAN3
12420,GO:0048869,0.0540842094068859,0.967964538328203,25,2675,cellular developmental process,BP,TXNIP;NR1D1;HES5;DDIT4;RGS2;HOXA9;S1PR5;TCHH;GDNF;HES1;ID3;SLC9A4;DCHS1;DDIT3;SNAI2;APC2;NUPR1;HIST1H4F;SPN;ZKSCAN3;HIST1H4I;RHOF;HIST1H4D;MAP1A;ABCB5
1341,GO:0003198,0.0540963005094317,0.998658280641531,1,11,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,SNAI2
14225,GO:0061158,0.0541836358745021,0.998653899973517,1,11,3'-UTR-mediated mRNA destabilization,BP,ZC3H12D
12346,GO:0048709,0.0542677291528203,0.993733230655397,2,59,oligodendrocyte differentiation,BP,HES5;HES1
19542,GO:1990442,0.0543204698402084,0.99900328920124,1,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,DDIT3
1375,GO:0003264,0.0544372536092477,0.998752600268169,1,6,regulation of cardioblast proliferation,BP,HES1
5004,GO:0015145,0.0544373519833198,0.998641132444146,1,11,monosaccharide transmembrane transporter activity,MF,SLC2A3
2274,GO:0005216,0.0544500949769077,0.989326727136015,3,150,ion channel activity,MF,SLC24A4;FXYD3;GPR89A
940,GO:0002347,0.0545593002365697,0.998648392632636,1,10,response to tumor cell,BP,TXNIP
11294,GO:0045605,0.0548036586495119,0.998636130009058,1,10,negative regulation of epidermal cell differentiation,BP,HES1
9989,GO:0042393,0.0549264125944078,0.985821811796476,4,172,histone binding,MF,HIST1H4F;PHF12;HIST1H4I;HIST1H4D
11107,GO:0045125,0.0550428599872324,0.998624071404949,1,10,bioactive lipid receptor activity,MF,S1PR5
9561,GO:0036342,0.0550601311707105,0.99860953197234,1,11,post-anal tail morphogenesis,BP,DCHS1
882,GO:0002244,0.0552230624213548,0.983091476805075,5,158,hematopoietic progenitor cell differentiation,BP,HES5;HES1;HIST1H4F;HIST1H4I;HIST1H4D
19952,GO:2000483,0.0556549618272183,0.998746895726595,1,5,negative regulation of interleukin-8 secretion,BP,TMSB4X
6982,GO:0030656,0.0557811213592527,0.998652708554799,1,7,regulation of vitamin metabolic process,BP,SNAI2
4820,GO:0014013,0.0559225838916381,0.993421867817669,2,64,regulation of gliogenesis,BP,HES5;HES1
11695,GO:0046483,0.0559567017506791,0.964496200284997,43,4707,heterocycle metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;HOXA9;RPL37;NME9;GDNF;HES1;HOXC13;ID3;ZC3H12D;ACTR5;SNRPD2;DDIT3;SNAI2;RPL31;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;RPL28;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;COX7C;HIST1H4I;CIART;RPS27;ZNF485;HIST1H4D;ZNF57
455,GO:0001228,0.0561305134493881,0.985352383543841,4,260,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,HOXC13;DDIT3;OTX1;SALL2
8843,GO:0034637,0.0564900080813188,0.993320300533209,2,63,cellular carbohydrate biosynthetic process,BP,NR1D1;PPP1R3D
5517,GO:0016477,0.0574160256050854,0.973863348980478,10,886,cell migration,BP,DDIT4;GDNF;HES1;DCHS1;SNAI2;APC2;SPN;TMSB4X;FAM110C;RHOF
3657,GO:0008140,0.0574428663398883,0.99854101938113,1,8,cAMP response element binding protein binding,MF,DDIT3
8230,GO:0032993,0.0575767226703963,0.97994198972803,6,163,protein-DNA complex,CC,DDIT3;NUPR1;HIST1H4F;HIST1H1D;HIST1H4I;HIST1H4D
1405,GO:0003337,0.0576919400476263,0.998557717673147,1,7,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,GDNF
10179,GO:0042771,0.0581399082608281,0.993087893461695,2,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,DDIT4;NUPR1
6618,GO:0022838,0.0582894702855232,0.988255676272516,3,153,substrate-specific channel activity,MF,SLC24A4;FXYD3;GPR89A
12615,GO:0050793,0.0583145881832389,0.968121934333447,17,1657,regulation of developmental process,BP,NR1D1;HES5;TSC22D3;HOXA9;S1PR5;GDNF;HES1;ID3;DDIT3;SNAI2;APC2;NUPR1;HIST1H4F;ZKSCAN3;HIST1H4I;RHOF;HIST1H4D
948,GO:0002363,0.05912168301029,0.998429365637955,1,9,alpha-beta T cell lineage commitment,BP,SPN
3054,GO:0006614,0.059424613346747,0.98162494862176,5,91,SRP-dependent cotranslational protein targeting to membrane,BP,RPL37;RPL31;RPL23A;RPL28;RPS27
10686,GO:0043951,0.0595236765939596,0.998407684159116,1,9,negative regulation of cAMP-mediated signaling,BP,RGS2
9767,GO:0039532,0.0595274002852574,0.998387945251562,1,10,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,RNF125
5464,GO:0016342,0.0595418759171986,0.998346583463704,1,13,catenin complex,CC,APC2
3134,GO:0006725,0.0596097970394739,0.961952709501813,43,4721,cellular aromatic compound metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;HOXA9;RPL37;NME9;GDNF;HES1;HOXC13;ID3;ZC3H12D;ACTR5;SNRPD2;DDIT3;SNAI2;RPL31;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;RPL28;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;COX7C;HIST1H4I;CIART;RPS27;ZNF485;HIST1H4D;ZNF57
4740,GO:0010906,0.0598191361111993,0.992689128066683,2,67,regulation of glucose metabolic process,BP,NR1D1;PPP1R3D
16813,GO:0098662,0.0599809533426315,0.978715338589062,6,373,inorganic cation transmembrane transport,BP,SLC24A4;SLC9A4;DDIT3;TMSB4X;FXYD3;COX7C
12807,GO:0051098,0.0604329689583267,0.980909078562328,5,283,regulation of binding,BP,HES1;ID3;IFIT2;DDIT3;TMSB4X
12385,GO:0048799,0.0606531996198061,0.998283564586904,1,13,animal organ maturation,BP,DCHS1
5077,GO:0015299,0.0606610434621599,0.998294808760065,1,12,solute:proton antiporter activity,MF,SLC9A4
4349,GO:0009913,0.0606685059601818,0.983814726959413,4,183,epidermal cell differentiation,BP,TXNIP;HES5;TCHH;HES1
16114,GO:0090100,0.0607740097413,0.992509277256598,2,66,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,HES5;HES1
11446,GO:0045893,0.0608365822244903,0.970939049582646,11,1056,positive regulation of transcription, DNA-templated,BP,NR1D1;HES5;HOXA9;GDNF;HES1;HOXC13;DDIT3;OTX1;SALL2;IVNS1ABP;ZKSCAN3
18429,GO:1903508,0.0608365822244903,0.970939049582646,11,1056,positive regulation of nucleic acid-templated transcription,BP,NR1D1;HES5;HOXA9;GDNF;HES1;HOXC13;DDIT3;OTX1;SALL2;IVNS1ABP;ZKSCAN3
10294,GO:0043044,0.0608705178165251,0.987689815944481,3,69,ATP-dependent chromatin remodeling,BP,HIST1H4F;HIST1H4I;HIST1H4D
7374,GO:0031420,0.0609371218957606,0.998267271047531,1,13,alkali metal ion binding,MF,SLC24A4
3906,GO:0008544,0.0609892345164275,0.980691749458864,5,269,epidermis development,BP,TXNIP;HES5;TCHH;HES1;HOXC13
18082,GO:1902680,0.0610853024314924,0.970799894748309,11,1057,positive regulation of RNA biosynthetic process,BP,NR1D1;HES5;HOXA9;GDNF;HES1;HOXC13;DDIT3;OTX1;SALL2;IVNS1ABP;ZKSCAN3
4731,GO:0010893,0.0611783665467773,0.998279319133872,1,11,positive regulation of steroid biosynthetic process,BP,NR1D1
10050,GO:0042533,0.0612916542600004,0.998336429329882,1,8,tumor necrosis factor biosynthetic process,BP,SPN
10051,GO:0042534,0.0612916542600004,0.998336429329882,1,8,regulation of tumor necrosis factor biosynthetic process,BP,SPN
11284,GO:0045595,0.061310296784289,0.968882305224624,13,1155,regulation of cell differentiation,BP,NR1D1;HES5;HOXA9;S1PR5;GDNF;HES1;ID3;DDIT3;SNAI2;APC2;HIST1H4F;HIST1H4I;HIST1H4D
10476,GO:0043369,0.0614390522834963,0.998281473281908,1,10,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,SPN
14790,GO:0070507,0.0615161783816382,0.987338809049167,3,148,regulation of microtubule cytoskeleton organization,BP,RGS2;APC2;MAP1A
11504,GO:0045989,0.0619168900134199,0.998335912995227,1,7,positive regulation of striated muscle contraction,BP,RGS2
12533,GO:0050678,0.0620021770301996,0.983311876955799,4,219,regulation of epithelial cell proliferation,BP,NR1D1;HES5;HES1;SNAI2
7993,GO:0032609,0.0620137511051787,0.992310647718923,2,53,interferon-gamma production,BP,SPN;BTN3A1
9973,GO:0042362,0.0621395010609483,0.998262881189073,1,9,fat-soluble vitamin biosynthetic process,BP,SNAI2
5803,GO:0017053,0.062150029536247,0.99222805956472,2,73,transcriptional repressor complex,CC,PHF12;SALL2
3256,GO:0006924,0.0622077143308488,0.998285708322523,1,8,activation-induced cell death of T cells,BP,TSC22D3
3491,GO:0007379,0.0622216813981777,0.99821941745124,1,11,segment specification,BP,HES5
7106,GO:0030901,0.0626934115053396,0.992157906958621,2,59,midbrain development,BP,HES1;OTX1
11064,GO:0045063,0.0627244620067918,0.998175394232823,1,12,T-helper 1 cell differentiation,BP,SPN
3290,GO:0006983,0.0628476582144046,0.998200787245832,1,10,ER overload response,BP,DDIT3
285,GO:0000788,0.0629345753337088,0.987507662522852,3,31,nuclear nucleosome,CC,HIST1H4F;HIST1H4I;HIST1H4D
15306,GO:0071500,0.0630688039138923,0.998385759275752,1,5,cellular response to nitrosative stress,BP,DDIT3
3053,GO:0006613,0.0632585949318535,0.980066380183575,5,96,cotranslational protein targeting to membrane,BP,RPL37;RPL31;RPL23A;RPL28;RPS27
17588,GO:1901223,0.0633682258023014,0.998220331125837,1,8,negative regulation of NIK/NF-kappaB signaling,BP,TMSB4X
17640,GO:1901363,0.0634784488660199,0.95937622129584,40,4571,heterocyclic compound binding,MF,NR1D1;HES5;HOXA9;RPL37;HES1;HOXC13;ID3;TIGD2;IFIT2;SNRPD2;DDIT3;SNAI2;RPL31;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;RPL28;TMSB4X;ZNF169;IVNS1ABP;HSP90AB4P;ZNF799;ZKSCAN3;HIST1H4I;RHOF;CIART;RPS27;ZNF485;HIST1H4D;RAB15;ZNF57;ABCB5
12918,GO:0051261,0.0635492461554756,0.991950016828533,2,75,protein depolymerization,BP,APC2;MAP1A
9673,GO:0038034,0.0636197495872763,0.991994549594216,2,54,signal transduction in absence of ligand,BP,GDNF;SNAI2
16494,GO:0097192,0.0636197495872763,0.991994549594216,2,54,extrinsic apoptotic signaling pathway in absence of ligand,BP,GDNF;SNAI2
19782,GO:2000194,0.0637366030740854,0.998235368406483,1,7,regulation of female gonad development,BP,NUPR1
6464,GO:0021783,0.0637611584303514,0.998147447274057,1,10,preganglionic parasympathetic fiber development,BP,HES1
13599,GO:0060065,0.0639087780435935,0.99809200442828,1,13,uterus development,BP,HOXA9
13686,GO:0060216,0.0642227390892379,0.998061748843963,1,14,definitive hemopoiesis,BP,HOXA9
10846,GO:0044342,0.0647133551016083,0.998072108146944,1,11,type B pancreatic cell proliferation,BP,NR1D1
10827,GO:0044321,0.0650431201942331,0.998011297539429,1,14,response to leptin,BP,NR1D1
15123,GO:0071216,0.0650802947261026,0.98632137238269,3,128,cellular response to biotic stimulus,BP,TXNIP;NR1D1;DDIT3
391,GO:0001046,0.0654480284454313,0.991581280273634,2,71,core promoter sequence-specific DNA binding,MF,NR1D1;CIART
4089,GO:0009142,0.0655963901483553,0.986182519386872,3,119,nucleoside triphosphate biosynthetic process,BP,DDIT4;NME9;TMSB4X
11341,GO:0045665,0.0656174247808669,0.98614218182351,3,144,negative regulation of neuron differentiation,BP,HES5;HES1;ID3
5570,GO:0016580,0.0660442137789995,0.997990967337826,1,11,Sin3 complex,CC,PHF12
19540,GO:1990440,0.0660752513563761,0.998032830866324,1,9,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,DDIT3
15719,GO:0072283,0.0664093234069577,0.998012628176082,1,9,metanephric renal vesicle morphogenesis,BP,GDNF
401,GO:0001077,0.0667791014331018,0.985770777129671,3,170,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,HOXC13;DDIT3;OTX1
16311,GO:0090482,0.0675779633503524,0.99785121035946,1,14,vitamin transmembrane transporter activity,MF,SLC2A3
7677,GO:0032105,0.067618880305358,0.99797014216783,1,8,negative regulation of response to extracellular stimulus,BP,SNAI2
7680,GO:0032108,0.067618880305358,0.99797014216783,1,8,negative regulation of response to nutrient levels,BP,SNAI2
9632,GO:0036500,0.0676305286029749,0.997912643712842,1,10,ATF6-mediated unfolded protein response,BP,DDIT3
12817,GO:0051119,0.067830379591848,0.997834921100913,1,14,sugar transmembrane transporter activity,MF,SLC2A3
11350,GO:0045683,0.0678893414592374,0.997843661335063,1,13,negative regulation of epidermis development,BP,HES1
12628,GO:0050810,0.068008245719547,0.99107877174059,2,65,regulation of steroid biosynthetic process,BP,NR1D1;SNAI2
426,GO:0001133,0.0680321005948572,0.997834465268685,1,13,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,NR1D1
12270,GO:0048565,0.0682388293815657,0.991005950007713,2,75,digestive tract development,BP,HES1;DCHS1
4585,GO:0010669,0.0682952168394781,0.99781746359258,1,13,epithelial structure maintenance,BP,MUC6
799,GO:0002065,0.0685834231319982,0.99095231641412,2,68,columnar/cuboidal epithelial cell differentiation,BP,HES5;HES1
7108,GO:0030903,0.0686463685772324,0.997827356504376,1,11,notochord development,BP,ID3
15170,GO:0071305,0.0688547971858118,0.997768164097626,1,14,cellular response to vitamin D,BP,SNAI2
4691,GO:0010839,0.0689473777236822,0.997775029011923,1,13,negative regulation of keratinocyte proliferation,BP,SNAI2
10792,GO:0044264,0.0689504459146944,0.990863933466075,2,73,cellular polysaccharide metabolic process,BP,NR1D1;PPP1R3D
14505,GO:0062014,0.0689532294747991,0.990887807354783,2,64,negative regulation of small molecule metabolic process,BP,DDIT4;SNAI2
1331,GO:0003181,0.0693371264143277,0.997736372476638,1,14,atrioventricular valve morphogenesis,BP,DCHS1
400,GO:0001076,0.0695983337449164,0.984941894403987,3,147,transcription factor activity, RNA polymerase II transcription factor binding,MF,NR1D1;ID3;PHF12
7320,GO:0031328,0.0696108542943778,0.963948599162802,13,1308,positive regulation of cellular biosynthetic process,BP,NR1D1;HES5;HOXA9;GDNF;HES1;HOXC13;DDIT3;OTX1;SPN;SALL2;TMSB4X;IVNS1ABP;ZKSCAN3
16603,GO:0097435,0.0696244412803067,0.974326956430238,6,468,supramolecular fiber organization,BP,RGS2;APC2;TMSB4X;RHOF;MAP7D3;MAP1A
11379,GO:0045745,0.069625115521675,0.997730485741564,1,13,positive regulation of G-protein coupled receptor protein signaling pathway,BP,ARRDC3
12689,GO:0050901,0.0696438957214299,0.997784776464572,1,10,leukocyte tethering or rolling,BP,SPN
94,GO:0000184,0.0700119916841063,0.977192006992321,5,119,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,RPL37;RPL31;RPL23A;RPL28;RPS27
12936,GO:0051290,0.0706643184022955,0.985047841607793,3,43,protein heterotetramerization,BP,HIST1H4F;HIST1H4I;HIST1H4D
7487,GO:0031650,0.0709048987183632,0.997730441376894,1,9,regulation of heat generation,BP,ARRDC3
5571,GO:0016581,0.0709154338451251,0.9976188574343,1,15,NuRD complex,CC,SALL2
16329,GO:0090545,0.0709154338451251,0.9976188574343,1,15,CHD-type complex,CC,SALL2
15688,GO:0072216,0.0709734800461297,0.997698193950747,1,10,positive regulation of metanephros development,BP,GDNF
13539,GO:0055119,0.0710174176790526,0.997672546682507,1,11,relaxation of cardiac muscle,BP,RGS2
11053,GO:0045047,0.07112024176654,0.976804396801291,5,101,protein targeting to ER,BP,RPL37;RPL31;RPL23A;RPL28;RPS27
1152,GO:0002758,0.0712026505098954,0.979964018276755,4,196,innate immune response-activating signal transduction,BP,NR1D1;MUC6;RNF125;MUC12
9770,GO:0039535,0.0713948340584396,0.997612035284748,1,13,regulation of RIG-I signaling pathway,BP,RNF125
13076,GO:0051580,0.0714401580306667,0.997695560375959,1,9,regulation of neurotransmitter uptake,BP,GDNF
2833,GO:0006302,0.0715545058171742,0.979834131445906,4,194,double-strand break repair,BP,ACTR5;HIST1H4F;HIST1H4I;HIST1H4D
17925,GO:1902237,0.0716398454464195,0.997654158332016,1,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,DDIT3
16476,GO:0097159,0.0720006421298325,0.953350501954277,40,4609,organic cyclic compound binding,MF,NR1D1;HES5;HOXA9;RPL37;HES1;HOXC13;ID3;TIGD2;IFIT2;SNRPD2;DDIT3;SNAI2;RPL31;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;RPL28;TMSB4X;ZNF169;IVNS1ABP;HSP90AB4P;ZNF799;ZKSCAN3;HIST1H4I;RHOF;CIART;RPS27;ZNF485;HIST1H4D;RAB15;ZNF57;ABCB5
13704,GO:0060253,0.0720963733970057,0.997652423758825,1,9,negative regulation of glial cell proliferation,BP,HES1
3744,GO:0008283,0.0722893061742007,0.961465051834143,14,1331,cell proliferation,BP,TXNIP;NR1D1;HES5;DDIT4;GDNF;HES1;DCHS1;SNAI2;APC2;NUPR1;RPL23A;SPN;RPS27;BTN3A1
3442,GO:0007253,0.0723285561214452,0.997719630466929,1,7,cytoplasmic sequestering of NF-kappaB,BP,TMSB4X
378,GO:0001010,0.0723537683487901,0.997532296131395,1,14,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,NR1D1
15563,GO:0072012,0.0725275000786919,0.997551323183375,1,12,glomerulus vasculature development,BP,HES1
20066,GO:2000696,0.0726889973558364,0.997560114151573,1,11,regulation of epithelial cell differentiation involved in kidney development,BP,GDNF
15874,GO:0072599,0.0727332954346918,0.976110451264949,5,104,establishment of protein localization to endoplasmic reticulum,BP,RPL37;RPL31;RPL23A;RPL28;RPS27
4263,GO:0009607,0.0727791375527842,0.968568591266078,8,548,response to biotic stimulus,BP,TXNIP;NR1D1;DDIT4;IFIT2;RNF125;DDIT3;SPN;IVNS1ABP
6628,GO:0022857,0.0730637738753687,0.97037653490852,7,537,transmembrane transporter activity,MF,SLC24A4;SLC2A3;SLC9A4;FXYD3;GPR89A;COX7C;ABCB5
5059,GO:0015267,0.0730872202196052,0.983849208560757,3,164,channel activity,MF,SLC24A4;FXYD3;GPR89A
6609,GO:0022803,0.0730872202196052,0.983849208560757,3,164,passive transmembrane transporter activity,MF,SLC24A4;FXYD3;GPR89A
10408,GO:0043244,0.0732845980257022,0.989937785645006,2,79,regulation of protein complex disassembly,BP,APC2;MAP1A
14847,GO:0070603,0.0734023581066826,0.989944085990086,2,67,SWI/SNF superfamily-type complex,CC,ACTR5;SALL2
13079,GO:0051583,0.0734164405107917,0.997713378752078,1,6,dopamine uptake involved in synaptic transmission,BP,GDNF
13259,GO:0051934,0.0734164405107917,0.997713378752078,1,6,catecholamine uptake involved in synaptic transmission,BP,GDNF
16312,GO:0090493,0.0734164405107917,0.997713378752078,1,6,catecholamine uptake,BP,GDNF
16313,GO:0090494,0.0734164405107917,0.997713378752078,1,6,dopamine uptake,BP,GDNF
11501,GO:0045986,0.0736502104956278,0.997518705505345,1,10,negative regulation of smooth muscle contraction,BP,RGS2
4534,GO:0010604,0.0737307092961947,0.956274064999665,21,2216,positive regulation of macromolecule metabolic process,BP,NR1D1;HES5;HOXA9;GDNF;HES1;HOXC13;ZC3H12D;RNF125;DDIT3;SNAI2;APC2;NUPR1;OTX1;HIST1H4F;SPN;SALL2;IVNS1ABP;ZKSCAN3;HIST1H4I;ARRDC3;HIST1H4D
13021,GO:0051453,0.0739619801201994,0.989844804490119,2,61,regulation of intracellular pH,BP,SLC9A4;GPR89A
7792,GO:0032331,0.074177468973335,0.997437017044866,1,12,negative regulation of chondrocyte differentiation,BP,SNAI2
4982,GO:0015103,0.0746689269807633,0.989644060295423,2,77,inorganic anion transmembrane transporter activity,MF,FXYD3;GPR89A
15595,GO:0072077,0.0750469843229987,0.997396872093862,1,11,renal vesicle morphogenesis,BP,GDNF
15601,GO:0072087,0.0750469843229987,0.997396872093862,1,11,renal vesicle development,BP,GDNF
16169,GO:0090190,0.0753704412773954,0.99737405499308,1,11,positive regulation of branching involved in ureteric bud morphogenesis,BP,GDNF
4340,GO:0009891,0.0754458021941248,0.960423183171378,13,1322,positive regulation of biosynthetic process,BP,NR1D1;HES5;HOXA9;GDNF;HES1;HOXC13;DDIT3;OTX1;SPN;SALL2;TMSB4X;IVNS1ABP;ZKSCAN3
17586,GO:1901216,0.0754834314710106,0.989505337534605,2,64,positive regulation of neuron death,BP,DDIT4;DDIT3
630,GO:0001817,0.0756340981530878,0.971541354011614,6,413,regulation of cytokine production,BP,RNF125;DDIT3;SNAI2;SPN;TMSB4X;BTN3A1
93,GO:0000183,0.07638575092912,0.983381323546252,3,39,chromatin silencing at rDNA,BP,HIST1H4F;HIST1H4I;HIST1H4D
947,GO:0002360,0.0764559056111073,0.997256170082463,1,13,T cell lineage commitment,BP,SPN
9368,GO:0035886,0.0767881024464236,0.997231922275759,1,13,vascular smooth muscle cell differentiation,BP,HES1
18055,GO:1902600,0.0770221803821432,0.982786405165776,3,82,proton transmembrane transport,BP,SLC9A4;TMSB4X;COX7C
6738,GO:0030154,0.0772404848506038,0.953076842968715,23,2519,cell differentiation,BP,TXNIP;NR1D1;HES5;DDIT4;RGS2;HOXA9;S1PR5;TCHH;GDNF;HES1;ID3;SLC9A4;DCHS1;DDIT3;SNAI2;APC2;NUPR1;HIST1H4F;SPN;HIST1H4I;HIST1H4D;MAP1A;ABCB5
4365,GO:0009968,0.0777171542855729,0.962617071011691,10,885,negative regulation of signal transduction,BP,NR1D1;DDIT4;RGS2;GDNF;RNF125;DDIT3;SNAI2;APC2;TMSB4X;IVNS1ABP
10696,GO:0043981,0.0778392651635999,0.997123655874693,1,15,histone H4-K5 acetylation,BP,JADE2
10697,GO:0043982,0.0778392651635999,0.997123655874693,1,15,histone H4-K8 acetylation,BP,JADE2
7128,GO:0030950,0.0781139585729973,0.997153455594888,1,12,establishment or maintenance of actin cytoskeleton polarity,BP,RHOF
1324,GO:0003171,0.0784922603983896,0.997061743108619,1,16,atrioventricular valve development,BP,DCHS1
16811,GO:0098660,0.0785020853337742,0.97018444048947,6,406,inorganic ion transmembrane transport,BP,SLC24A4;SLC9A4;DDIT3;TMSB4X;FXYD3;COX7C
12268,GO:0048562,0.0786931821327741,0.982072764010207,3,166,embryonic organ morphogenesis,BP,LRIG3;HES1;OTX1
6977,GO:0030641,0.0787002656336118,0.98879766031279,2,64,regulation of cellular pH,BP,SLC9A4;GPR89A
4968,GO:0015075,0.0788611223336489,0.969998437819236,6,445,ion transmembrane transporter activity,MF,SLC24A4;SLC2A3;SLC9A4;FXYD3;GPR89A;COX7C
11349,GO:0045682,0.0793513695638083,0.988637917318897,2,68,regulation of epidermis development,BP,HES5;HES1
19754,GO:2000136,0.0794969418448858,0.997073957096878,1,11,regulation of cell proliferation involved in heart morphogenesis,BP,HES1
4342,GO:0009893,0.079636780361955,0.951858737973034,22,2360,positive regulation of metabolic process,BP,NR1D1;HES5;HOXA9;GDNF;HES1;HOXC13;ZC3H12D;RNF125;DDIT3;SNAI2;APC2;NUPR1;OTX1;HIST1H4F;SPN;SALL2;TMSB4X;IVNS1ABP;ZKSCAN3;HIST1H4I;ARRDC3;HIST1H4D
9764,GO:0039529,0.0799869092345436,0.996960264144008,1,15,RIG-I signaling pathway,BP,RNF125
597,GO:0001759,0.0799962315294234,0.997036511137544,1,11,organ induction,BP,GDNF
14267,GO:0061323,0.0800401078246658,0.997033208745732,1,11,cell proliferation involved in heart morphogenesis,BP,HES1
12996,GO:0051409,0.0803692508438364,0.997073195580907,1,9,response to nitrosative stress,BP,DDIT3
12858,GO:0051173,0.0805900703973984,0.952701568579475,19,2093,positive regulation of nitrogen compound metabolic process,BP,NR1D1;HES5;HOXA9;GDNF;HES1;HOXC13;ZC3H12D;RNF125;DDIT3;SNAI2;APC2;NUPR1;OTX1;SPN;SALL2;TMSB4X;IVNS1ABP;ZKSCAN3;ARRDC3
12227,GO:0048485,0.0806430642857724,0.996942495451811,1,13,sympathetic nervous system development,BP,GDNF
2641,GO:0005976,0.0809169023472824,0.988247140143713,2,81,polysaccharide metabolic process,BP,NR1D1;PPP1R3D
14307,GO:0061437,0.0812088910048157,0.996880791394999,1,14,renal system vasculature development,BP,HES1
14310,GO:0061440,0.0812088910048157,0.996880791394999,1,14,kidney vasculature development,BP,HES1
20130,GO:2000810,0.0812802752909202,0.996833935659327,1,17,regulation of bicellular tight junction assembly,BP,SNAI2
13848,GO:0060445,0.0813203131458098,0.996830767779508,1,17,branching involved in salivary gland morphogenesis,BP,SNAI2
16807,GO:0098655,0.0813502994522482,0.968816933531006,6,414,cation transmembrane transport,BP,SLC24A4;SLC9A4;DDIT3;TMSB4X;FXYD3;COX7C
3923,GO:0008593,0.0816361525898092,0.988102219518496,2,74,regulation of Notch signaling pathway,BP,HES5;HES1
16876,GO:0098810,0.0819900004232033,0.996998429166637,1,8,neurotransmitter reuptake,BP,GDNF
16490,GO:0097186,0.0820753929156458,0.996796908481333,1,15,amelogenesis,BP,SLC24A4
4841,GO:0014046,0.0821368534278676,0.99694089260949,1,9,dopamine secretion,BP,GDNF
4849,GO:0014059,0.0821368534278676,0.99694089260949,1,9,regulation of dopamine secretion,BP,GDNF
4268,GO:0009615,0.0822516456174099,0.975684727792539,4,223,response to virus,BP,DDIT4;IFIT2;RNF125;IVNS1ABP
8157,GO:0032886,0.0824057321396339,0.980866445623565,3,166,regulation of microtubule-based process,BP,RGS2;APC2;MAP1A
14439,GO:0061756,0.0825269124919377,0.996795657136406,1,13,leukocyte adhesion to vascular endothelial cell,BP,SPN
12348,GO:0048711,0.0825461877204177,0.996815810199736,1,12,positive regulation of astrocyte differentiation,BP,HES1
12272,GO:0048568,0.0826159083741156,0.975502940408051,4,273,embryonic organ development,BP,LRIG3;HES1;ID3;OTX1
7572,GO:0031932,0.0826456489567295,0.996786283050142,1,13,TORC2 complex,CC,RPL23A
11510,GO:0045995,0.0831110083027378,0.987732318832618,2,86,regulation of embryonic development,BP,GDNF;HES1
10563,GO:0043522,0.0832518995432977,0.996817607007819,1,10,leucine zipper domain binding,MF,DDIT3
20131,GO:2000811,0.0832803827117541,0.996717028412558,1,14,negative regulation of anoikis,BP,SNAI2
4658,GO:0010801,0.0833286096594135,0.996696767163138,1,15,negative regulation of peptidyl-threonine phosphorylation,BP,DDIT4
7731,GO:0032225,0.0833766946524988,0.996776513781439,1,11,regulation of synaptic transmission, dopaminergic,BP,GDNF
5869,GO:0017176,0.0834336069505287,0.996951874480542,1,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,PIGH
6607,GO:0022626,0.0835739460619633,0.97139366227989,5,110,cytosolic ribosome,CC,RPL37;RPL31;RPL23A;RPL28;RPS27
10031,GO:0042476,0.0836980590065952,0.987611044764743,2,80,odontogenesis,BP,ID3;SLC24A4
19413,GO:1905939,0.083989605689002,0.996728164522402,1,11,regulation of gonad development,BP,NUPR1
14992,GO:0070914,0.0840824588840387,0.996720807404175,1,11,UV-damage excision repair,BP,ACTR5
4542,GO:0010614,0.0841126082463606,0.996650018364254,1,14,negative regulation of cardiac muscle hypertrophy,BP,RGS2
4880,GO:0014741,0.0841126082463606,0.996650018364254,1,14,negative regulation of muscle hypertrophy,BP,RGS2
13541,GO:0055123,0.084610467250977,0.98739353354679,2,82,digestive system development,BP,HES1;DCHS1
14159,GO:0061037,0.0849583192112581,0.9965812062027,1,14,negative regulation of cartilage development,BP,SNAI2
7107,GO:0030902,0.0852517654074003,0.987235983648345,2,85,hindbrain development,BP,HES1;OTX1
18478,GO:1903578,0.0852695713242868,0.987262204361762,2,74,regulation of ATP metabolic process,BP,DDIT4;TMSB4X
9766,GO:0039531,0.085391225656647,0.996513418928168,1,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,RNF125
3764,GO:0008308,0.0856409147179005,0.996568463764837,1,12,voltage-gated anion channel activity,MF,GPR89A
11343,GO:0045667,0.0861470815910536,0.987046787168502,2,77,regulation of osteoblast differentiation,BP,ID3;SNAI2
14092,GO:0060914,0.0863587170441282,0.996537778894386,1,11,heart formation,BP,HES1
3312,GO:0007017,0.0866065448433921,0.963458729357962,7,605,microtubule-based process,BP,RGS2;GOLGA2P5;APC2;SPC25;KIAA0753;MAP7D3;MAP1A
13692,GO:0060231,0.0866324412659477,0.996463315891724,1,13,mesenchymal to epithelial transition,BP,GDNF
14935,GO:0070822,0.0866988430628817,0.996437311456284,1,14,Sin3-type complex,CC,PHF12
871,GO:0002218,0.0867207615437181,0.973914377848538,4,211,activation of innate immune response,BP,NR1D1;MUC6;RNF125;MUC12
3230,GO:0006885,0.08694689120857,0.986884679604204,2,69,regulation of pH,BP,SLC9A4;GPR89A
18158,GO:1902903,0.0871022362616841,0.973724376753899,4,250,regulation of supramolecular fiber organization,BP,RGS2;APC2;TMSB4X;MAP1A
20188,GO:2001028,0.087187406565985,0.996504199827164,1,10,positive regulation of endothelial cell chemotaxis,BP,TMSB4X
15677,GO:0072202,0.0878559647710445,0.996339951239033,1,14,cell differentiation involved in metanephros development,BP,GDNF
16168,GO:0090189,0.0881393658378571,0.996337076642372,1,13,regulation of branching involved in ureteric bud morphogenesis,BP,GDNF
12421,GO:0048870,0.0884610721623737,0.956391954756548,10,957,cell motility,BP,DDIT4;GDNF;HES1;DCHS1;SNAI2;APC2;SPN;TMSB4X;FAM110C;RHOF
13131,GO:0051674,0.0884610721623737,0.956391954756548,10,957,localization of cell,BP,DDIT4;GDNF;HES1;DCHS1;SNAI2;APC2;SPN;TMSB4X;FAM110C;RHOF
16752,GO:0098532,0.0885172664666793,0.996654980212558,1,6,histone H3-K27 trimethylation,BP,HIST1H1D
15027,GO:0070972,0.0885216989917661,0.969114437758756,5,125,protein localization to endoplasmic reticulum,BP,RPL37;RPL31;RPL23A;RPL28;RPS27
1151,GO:0002757,0.0890446603198323,0.968553772846369,5,326,immune response-activating signal transduction,BP,NR1D1;MUC6;RNF125;BTN3A1;MUC12
10607,GO:0043586,0.0891353535091657,0.996230722948453,1,14,tongue development,BP,HOXC13
7509,GO:0031690,0.0893897231619406,0.996230591853181,1,13,adrenergic receptor binding,MF,ARRDC3
6554,GO:0021983,0.0894356710750365,0.996154844887775,1,17,pituitary gland development,BP,HES1
14178,GO:0061061,0.089556739080319,0.96829152209027,5,380,muscle structure development,BP,TSC22D3;HES1;ID3;DDIT3;NUPR1
4549,GO:0010628,0.0896636371582688,0.950577422100513,14,1364,positive regulation of gene expression,BP,NR1D1;HES5;HOXA9;GDNF;HES1;HOXC13;DDIT3;OTX1;HIST1H4F;SALL2;IVNS1ABP;ZKSCAN3;HIST1H4I;HIST1H4D
7606,GO:0031985,0.0902305262158533,0.98604483257354,2,86,Golgi cisterna,CC,GOLGA2P5;GPR89A
17637,GO:1901360,0.0904022004378796,0.939892302102053,43,4854,organic cyclic compound metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;HOXA9;RPL37;NME9;GDNF;HES1;HOXC13;ID3;ZC3H12D;ACTR5;SNRPD2;DDIT3;SNAI2;RPL31;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;RPL28;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;COX7C;HIST1H4I;CIART;RPS27;ZNF485;HIST1H4D;ZNF57
8624,GO:0034142,0.0910867364252623,0.996060920804222,1,14,toll-like receptor 4 signaling pathway,BP,NR1D1
14243,GO:0061213,0.0911861187867134,0.996052169263849,1,14,positive regulation of mesonephros development,BP,GDNF
6918,GO:0030509,0.091442020279853,0.985737196462023,2,91,BMP signaling pathway,BP,HES5;HES1
10684,GO:0043949,0.0916359699850035,0.995975244027763,1,16,regulation of cAMP-mediated signaling,BP,RGS2
2644,GO:0005979,0.0917987513225221,0.99591945953545,1,19,regulation of glycogen biosynthetic process,BP,PPP1R3D
4778,GO:0010962,0.0917987513225221,0.99591945953545,1,19,regulation of glucan biosynthetic process,BP,PPP1R3D
5003,GO:0015144,0.0919558033670287,0.99590524183092,1,19,carbohydrate transmembrane transporter activity,MF,SLC2A3
7486,GO:0031649,0.0923629569093496,0.995971032566578,1,13,heat generation,BP,ARRDC3
9791,GO:0040011,0.0924532947232939,0.952471126030124,11,1101,locomotion,BP,DDIT4;GDNF;HES1;DCHS1;SNAI2;APC2;SPN;TMSB4X;FAM110C;RHOF;ARRDC3
2591,GO:0005884,0.0925459087022446,0.985519019782148,2,73,actin filament,CC,APC2;TMSB4X
5462,GO:0016339,0.0925959747074554,0.995873336078602,1,17,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,DCHS1
6262,GO:0019852,0.0926011943618269,0.996095512284033,1,9,L-ascorbic acid metabolic process,BP,SLC2A3
13672,GO:0060192,0.0927133473064253,0.996038380965586,1,10,negative regulation of lipase activity,BP,RGS2
6657,GO:0030004,0.0927515903163847,0.985468417140255,2,73,cellular monovalent inorganic cation homeostasis,BP,SLC9A4;GPR89A
20108,GO:2000773,0.0929834529987995,0.995892160862739,1,14,negative regulation of cellular senescence,BP,ZKSCAN3
12532,GO:0050673,0.0934447047149536,0.97112314233379,4,258,epithelial cell proliferation,BP,NR1D1;HES5;HES1;SNAI2
14004,GO:0060716,0.0935379233011142,0.995803386190253,1,16,labyrinthine layer blood vessel development,BP,HES1
5572,GO:0016584,0.0935764499010074,0.99614971282988,1,7,nucleosome positioning,BP,HIST1H1D
8896,GO:0034715,0.0936331204544937,0.996249101020015,1,6,pICln-Sm protein complex,CC,SNRPD2
8057,GO:0032717,0.0937262774449951,0.995876976816142,1,12,negative regulation of interleukin-8 production,BP,TMSB4X
13573,GO:0060037,0.0938931042529566,0.995754810153206,1,17,pharyngeal system development,BP,HES1
3880,GO:0008509,0.0939484308101409,0.976935522713712,3,189,anion transmembrane transporter activity,MF,SLC2A3;FXYD3;GPR89A
3740,GO:0008277,0.0940908346588454,0.985119594590783,2,78,regulation of G-protein coupled receptor protein signaling pathway,BP,RGS2;ARRDC3
19071,GO:1904949,0.0942252669326375,0.985076582918782,2,81,ATPase complex,CC,ACTR5;SALL2
13748,GO:0060317,0.0947441823286309,0.995648548085276,1,19,cardiac epithelial to mesenchymal transition,BP,SNAI2
19194,GO:1905276,0.0948859031644857,0.995679329420188,1,16,regulation of epithelial tube formation,BP,GDNF
10189,GO:0042789,0.095074223110191,0.995701881984193,1,14,mRNA transcription by RNA polymerase II,BP,DDIT3
7130,GO:0030952,0.0950980708836526,0.995659632647179,1,16,establishment or maintenance of cytoskeleton polarity,BP,RHOF
2456,GO:0005667,0.095351138511939,0.970329209925905,4,259,transcription factor complex,CC,NR1D1;HOXA9;DDIT3;IVNS1ABP
13180,GO:0051782,0.0957405426477341,0.995640301980349,1,14,negative regulation of cell division,BP,TXNIP
13270,GO:0051954,0.0957993311597415,0.995689081409989,1,12,positive regulation of amine transport,BP,GDNF
10561,GO:0043518,0.0958139679882962,0.995687739326054,1,12,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,SNAI2
12485,GO:0050433,0.0958212394159656,0.995687072511805,1,12,regulation of catecholamine secretion,BP,GDNF
9182,GO:0035556,0.0960485823288647,0.94296476137307,18,1985,intracellular signal transduction,BP,HES5;DDIT4;RIN2;RGS2;GDNF;HES1;RNF125;DCHS1;DDIT3;SNAI2;NUPR1;TMSB4X;FAM110C;GPR89A;IVNS1ABP;RHOF;RAB15;STAC2
13517,GO:0055085,0.0960828856164601,0.951895648205475,10,874,transmembrane transport,BP,TSC22D3;SLC24A4;SLC2A3;SLC9A4;DDIT3;TMSB4X;FXYD3;GPR89A;COX7C;ABCB5
9367,GO:0035883,0.0963399655603602,0.995543408382125,1,16,enteroendocrine cell differentiation,BP,HES1
7676,GO:0032104,0.096583958029442,0.995561703379271,1,14,regulation of response to extracellular stimulus,BP,SNAI2
7679,GO:0032107,0.096583958029442,0.995561703379271,1,14,regulation of response to nutrient levels,BP,SNAI2
4508,GO:0010557,0.0966368368560129,0.948486296675254,12,1249,positive regulation of macromolecule biosynthetic process,BP,NR1D1;HES5;HOXA9;GDNF;HES1;HOXC13;DDIT3;OTX1;SPN;SALL2;IVNS1ABP;ZKSCAN3
9741,GO:0038201,0.096748137472475,0.995504861273229,1,16,TOR complex,CC,RPL23A
12062,GO:0048011,0.0968782064056653,0.995434387753615,1,20,neurotrophin TRK receptor signaling pathway,BP,DDIT4
15167,GO:0071295,0.0969541180350236,0.995427098306014,1,20,cellular response to vitamin,BP,SNAI2
2894,GO:0006402,0.0970980291904388,0.958058515052808,7,322,mRNA catabolic process,BP,RPL37;GDNF;ZC3H12D;RPL31;RPL23A;RPL28;RPS27
3564,GO:0007608,0.09725232534014,0.995498900040325,1,14,sensory perception of smell,BP,SLC24A4
9379,GO:0035909,0.0973546254619761,0.99540089909931,1,19,aorta morphogenesis,BP,HES1
242,GO:0000506,0.0975132625505656,0.995661757193806,1,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,PIGH
12616,GO:0050794,0.0975433156723329,0.935236174662411,55,7108,regulation of cellular process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RIN2;RGS2;HOXA9;S1PR5;NME9;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;MUC6;IFIT2;RNF125;ACTR5;DCHS1;DDIT3;SNAI2;APC2;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;TMSB4X;ZNF169;FAM110C;GPR89A;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;SPDYE1;RHOF;CIART;ARRDC3;ZNF485;HIST1H4D;RAB15;BTN3A1;MUC12;ZNF57;STAC2;MAP1A
18479,GO:1903579,0.0977350550633496,0.995430687368302,1,15,negative regulation of ATP metabolic process,BP,DDIT4
2944,GO:0006473,0.0982067897109734,0.975471872901471,3,162,protein acetylation,BP,SNAI2;NUPR1;JADE2
14976,GO:0070888,0.0984662488996077,0.995293281839686,1,19,E-box binding,MF,CIART
3318,GO:0007026,0.098517071161893,0.995302396598129,1,18,negative regulation of microtubule depolymerization,BP,APC2
5161,GO:0015698,0.0985917804121441,0.983961867254187,2,85,inorganic anion transport,BP,FXYD3;GPR89A
4732,GO:0010894,0.0987099703221646,0.99533732141395,1,15,negative regulation of steroid biosynthetic process,BP,SNAI2
7037,GO:0030809,0.0991321518877195,0.995258359752092,1,17,negative regulation of nucleotide biosynthetic process,BP,DDIT4
17477,GO:1900372,0.0991321518877195,0.995258359752092,1,17,negative regulation of purine nucleotide biosynthetic process,BP,DDIT4
5589,GO:0016605,0.0992345998962442,0.983791065139347,2,87,PML body,CC,SPN;CIART
14503,GO:0062012,0.0993198581621102,0.963776038294226,5,335,regulation of small molecule metabolic process,BP,NR1D1;DDIT4;PPP1R3D;SNAI2;TMSB4X
3280,GO:0006968,0.0993773434292285,0.995204114512651,1,19,cellular defense response,BP,SPN
15687,GO:0072215,0.09953606642169,0.995236963795307,1,16,regulation of metanephros development,BP,GDNF
4568,GO:0010648,0.0996192907484741,0.949766727457688,10,934,negative regulation of cell communication,BP,NR1D1;DDIT4;RGS2;GDNF;RNF125;DDIT3;SNAI2;APC2;TMSB4X;IVNS1ABP
12243,GO:0048518,0.0996482017030945,0.934257310240584,33,3893,positive regulation of biological process,BP,TXNIP;NR1D1;HES5;DDIT4;RGS2;HOXA9;GDNF;HES1;HOXC13;ID3;ZC3H12D;MUC6;IFIT2;RNF125;DDIT3;SNAI2;APC2;NUPR1;OTX1;HIST1H4F;SPN;SALL2;TMSB4X;FAM110C;GPR89A;IVNS1ABP;ZKSCAN3;HIST1H4I;ARRDC3;HIST1H4D;RAB15;BTN3A1;MUC12
14224,GO:0061157,0.099812931003162,0.995136432313255,1,21,mRNA destabilization,BP,ZC3H12D
20186,GO:2001026,0.0998297742510945,0.995279596419511,1,13,regulation of endothelial cell chemotaxis,BP,TMSB4X
15449,GO:0071772,0.0998987346355112,0.983596276334735,2,96,response to BMP,BP,HES5;HES1
15450,GO:0071773,0.0998987346355112,0.983596276334735,2,96,cellular response to BMP stimulus,BP,HES5;HES1
6651,GO:0023057,0.10071034106244,0.94910910941254,10,937,negative regulation of signaling,BP,NR1D1;DDIT4;RGS2;GDNF;RNF125;DDIT3;SNAI2;APC2;TMSB4X;IVNS1ABP
20275,GO:2001237,0.10116836592619,0.983328173546105,2,76,negative regulation of extrinsic apoptotic signaling pathway,BP,GDNF;SNAI2
10609,GO:0043588,0.102667299395051,0.967250184926648,4,239,skin development,BP,TXNIP;TCHH;HOXC13;ARRDC3
12244,GO:0048519,0.103030525673043,0.931778214058526,33,3631,negative regulation of biological process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;RPL37;GDNF;HES1;ID3;ZC3H12D;RNF125;DDIT3;SNAI2;APC2;RPL31;NUPR1;HIST1H4F;PHF12;RPL23A;HIST1H1D;SPN;SALL2;RPL28;TMSB4X;IVNS1ABP;ZKSCAN3;HIST1H4I;CIART;ARRDC3;RPS27;HIST1H4D
11481,GO:0045939,0.10315106006121,0.994877584647937,1,16,negative regulation of steroid metabolic process,BP,SNAI2
7277,GO:0031258,0.103261818248863,0.994814185878707,1,19,lamellipodium membrane,CC,APC2
2733,GO:0006111,0.103413973853737,0.994760557475796,1,22,regulation of gluconeogenesis,BP,NR1D1
14245,GO:0061217,0.103739107184126,0.994817839101098,1,16,regulation of mesonephros development,BP,GDNF
4062,GO:0009110,0.103787957049165,0.994793219329335,1,17,vitamin biosynthetic process,BP,SNAI2
14645,GO:0070233,0.103948640620001,0.994818798121014,1,15,negative regulation of T cell apoptotic process,BP,TSC22D3
12606,GO:0050779,0.103988931655546,0.994700979566735,1,22,RNA destabilization,BP,ZC3H12D
10475,GO:0043368,0.104171145349095,0.9947539284653,1,17,positive T cell selection,BP,SPN
12484,GO:0050432,0.104189845156786,0.99481989138251,1,14,catecholamine secretion,BP,GDNF
10254,GO:0042989,0.104466805270032,0.995309466676346,1,6,sequestering of actin monomers,BP,TMSB4X
10268,GO:0043009,0.104743018061285,0.961145160782194,5,416,chordate embryonic development,BP,HES5;HOXA9;HES1;DCHS1;SALL2
4397,GO:0010092,0.105272742760381,0.994660325267516,1,16,specification of animal organ identity,BP,GDNF
4708,GO:0010869,0.105283948817251,0.994638953853886,1,17,regulation of receptor biosynthetic process,BP,NR1D1
2645,GO:0005980,0.105398142065467,0.994578491978837,1,20,glycogen catabolic process,BP,PPP1R3D
8611,GO:0034122,0.10557576825867,0.994546683933789,1,21,negative regulation of toll-like receptor signaling pathway,BP,NR1D1
2469,GO:0005684,0.105577435451828,0.982266295357822,2,58,U2-type spliceosomal complex,CC,SNRPD2;RNF113A
13099,GO:0051607,0.10578694832919,0.972739897868163,3,159,defense response to virus,BP,DDIT4;IFIT2;RNF125
6543,GO:0021953,0.105817963664418,0.982058238590393,2,89,central nervous system neuron differentiation,BP,HES5;HES1
12408,GO:0048854,0.105918522315396,0.994487488110855,1,23,brain morphogenesis,BP,OTX1
13702,GO:0060251,0.10597122096163,0.994567296896726,1,17,regulation of glial cell proliferation,BP,HES1
7036,GO:0030808,0.106258446321802,0.981949717976144,2,86,regulation of nucleotide biosynthetic process,BP,DDIT4;TMSB4X
17476,GO:1900371,0.106258446321802,0.981949717976144,2,86,regulation of purine nucleotide biosynthetic process,BP,DDIT4;TMSB4X
18525,GO:1903706,0.106526534507894,0.956254068895424,6,330,regulation of hemopoiesis,BP,HES5;HOXA9;HES1;HIST1H4F;HIST1H4I;HIST1H4D
11475,GO:0045932,0.106533638309687,0.994579266588594,1,14,negative regulation of muscle contraction,BP,RGS2
3119,GO:0006699,0.106587664352828,0.994467726666521,1,19,bile acid biosynthetic process,BP,NR1D1
10516,GO:0043425,0.106664452959988,0.99443132756795,1,21,bHLH transcription factor binding,MF,TSC22D3
10346,GO:0043144,0.106787002099997,0.994856772565319,1,8,snoRNA processing,BP,RNF113A
282,GO:0000784,0.106807915427978,0.972474151737672,3,114,nuclear chromosome, telomeric region,CC,HIST1H4F;HIST1H4I;HIST1H4D
8772,GO:0034451,0.106889253209533,0.994395099010071,1,22,centriolar satellite,CC,KIAA0753
10791,GO:0044262,0.10703335209594,0.972234547761421,3,191,cellular carbohydrate metabolic process,BP,NR1D1;DDIT4;PPP1R3D
1158,GO:0002764,0.107494575982084,0.959851358448644,5,350,immune response-regulating signaling pathway,BP,NR1D1;MUC6;RNF125;BTN3A1;MUC12
12595,GO:0050768,0.107509456989995,0.972075355733032,3,178,negative regulation of neurogenesis,BP,HES5;HES1;ID3
629,GO:0001816,0.107518104064095,0.955658791457297,6,452,cytokine production,BP,RNF125;DDIT3;SNAI2;SPN;TMSB4X;BTN3A1
19704,GO:2000026,0.108131715204402,0.939826559620576,13,1275,regulation of multicellular organismal development,BP,HES5;TSC22D3;HOXA9;S1PR5;GDNF;HES1;ID3;DDIT3;SNAI2;NUPR1;HIST1H4F;HIST1H4I;HIST1H4D
11788,GO:0046651,0.108421773258424,0.971784128960317,3,150,lymphocyte proliferation,BP,HES1;SPN;BTN3A1
11249,GO:0045454,0.108691489981658,0.981441047364191,2,57,cell redox homeostasis,BP,NME9;DDIT3
9970,GO:0042359,0.108962381280822,0.99432391019478,1,14,vitamin D metabolic process,BP,SNAI2
9631,GO:0036499,0.108988936504795,0.994227543379132,1,18,PERK-mediated unfolded protein response,BP,DDIT3
20236,GO:2001171,0.109034368430191,0.994222628930326,1,18,positive regulation of ATP biosynthetic process,BP,TMSB4X
12863,GO:0051180,0.109283864878222,0.994214955040498,1,17,vitamin transport,BP,SLC2A3
6071,GO:0019218,0.10942361718122,0.98111570076146,2,80,regulation of steroid metabolic process,BP,NR1D1;SNAI2
8198,GO:0032943,0.109432758233482,0.971406167046844,3,151,mononuclear cell proliferation,BP,HES1;SPN;BTN3A1
4178,GO:0009251,0.10954815429088,0.994119691784676,1,21,glucan catabolic process,BP,PPP1R3D
11188,GO:0045292,0.109587114989824,0.994182123887699,1,17,mRNA cis splicing, via spliceosome,BP,RNF113A
6660,GO:0030010,0.110297483332822,0.980803529758931,2,104,establishment of cell polarity,BP,HES5;HES1
463,GO:0001501,0.110389514425706,0.96382751951548,4,310,skeletal system development,BP,HES5;HOXA9;DCHS1;SNAI2
2960,GO:0006493,0.110391091255652,0.980822305875825,2,88,protein O-linked glycosylation,BP,MUC6;MUC12
4406,GO:0010155,0.111009888006096,0.99434702521428,1,9,regulation of proton transport,BP,TMSB4X
427,GO:0001134,0.111104599364608,0.993922489692271,1,23,transcription factor activity, transcription factor recruiting,MF,NR1D1
737,GO:0001965,0.111203777650076,0.994028012873768,1,16,G-protein alpha-subunit binding,MF,RGS2
16095,GO:0090075,0.111217861088518,0.994026467498931,1,16,relaxation of muscle,BP,RGS2
4315,GO:0009792,0.111246944874313,0.957977880078283,5,426,embryo development ending in birth or egg hatching,BP,HES5;HOXA9;HES1;DCHS1;SALL2
7234,GO:0031128,0.111451816216739,0.993978112763204,1,17,developmental induction,BP,GDNF
4588,GO:0010677,0.111484241972636,0.993920162548791,1,20,negative regulation of cellular carbohydrate metabolic process,BP,DDIT4
11662,GO:0046425,0.111679513319862,0.980496956625094,2,80,regulation of JAK-STAT cascade,BP,HES5;HES1
15423,GO:0071695,0.111684270563295,0.980436100865284,2,98,anatomical structure maturation,BP,DCHS1;DDIT3
11482,GO:0045940,0.111828159179573,0.994014712474109,1,14,positive regulation of steroid metabolic process,BP,NR1D1
9763,GO:0039528,0.112649757755061,0.993774626063432,1,21,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,RNF125
6700,GO:0030097,0.112824132081049,0.946388915891164,8,590,hemopoiesis,BP,HES5;HOXA9;HES1;HIST1H4F;ZNF160;SPN;HIST1H4I;HIST1H4D
13504,GO:0055067,0.113431499697138,0.979987928080602,2,86,monovalent inorganic cation homeostasis,BP,SLC9A4;GPR89A
3531,GO:0007519,0.113470837076129,0.979963231018143,2,90,skeletal muscle tissue development,BP,TSC22D3;NUPR1
132,GO:0000272,0.113679224834845,0.993643964054554,1,22,polysaccharide catabolic process,BP,PPP1R3D
10785,GO:0044247,0.113679224834845,0.993643964054554,1,22,cellular polysaccharide catabolic process,BP,PPP1R3D
12884,GO:0051216,0.113940369588226,0.979792064724579,2,104,cartilage development,BP,HES5;SNAI2
19048,GO:1904892,0.114189081087353,0.979795419772666,2,81,regulation of STAT cascade,BP,HES5;HES1
3259,GO:0006929,0.114231507742055,0.993594694973941,1,21,substrate-dependent cell migration,BP,SNAI2
12238,GO:0048511,0.11443880387473,0.969458083439696,3,188,rhythmic process,BP,NR1D1;ID3;CIART
16108,GO:0090090,0.114497661159226,0.969556167816147,3,128,negative regulation of canonical Wnt signaling pathway,BP,DDIT3;SNAI2;APC2
2893,GO:0006401,0.114667169792634,0.948415617153798,7,346,RNA catabolic process,BP,RPL37;GDNF;ZC3H12D;RPL31;RPL23A;RPL28;RPS27
20280,GO:2001242,0.114934660232604,0.969390000998499,3,128,regulation of intrinsic apoptotic signaling pathway,BP,DDIT3;SNAI2;IVNS1ABP
20185,GO:2001025,0.115074189830166,0.993732443997503,1,12,positive regulation of response to drug,BP,GDNF
8380,GO:0033280,0.11565642065214,0.993415965584516,1,22,response to vitamin D,BP,SNAI2
889,GO:0002253,0.115904381058548,0.955714372175607,5,357,activation of immune response,BP,NR1D1;MUC6;RNF125;BTN3A1;MUC12
14965,GO:0070873,0.116205998790981,0.993366328934031,1,21,regulation of glycogen metabolic process,BP,PPP1R3D
11328,GO:0045652,0.116305665123944,0.969245145940769,3,65,regulation of megakaryocyte differentiation,BP,HIST1H4F;HIST1H4I;HIST1H4D
466,GO:0001504,0.116835582300615,0.993393358784518,1,16,neurotransmitter uptake,BP,GDNF
8156,GO:0032885,0.117404326713769,0.993173667388093,1,25,regulation of polysaccharide biosynthetic process,BP,PPP1R3D
19917,GO:2000406,0.118480058038511,0.993230742364713,1,15,positive regulation of T cell migration,BP,SPN
2756,GO:0006165,0.118526842414493,0.978547008828145,2,86,nucleoside diphosphate phosphorylation,BP,DDIT4;NME9
15872,GO:0072594,0.118827799895468,0.942937811086554,8,462,establishment of protein localization to organelle,BP,TXNIP;RPL37;HES1;DDIT3;RPL31;RPL23A;RPL28;RPS27
12219,GO:0048469,0.119004961586838,0.97839159381621,2,91,cell maturation,BP,HES5;HES1
14504,GO:0062013,0.119157006966613,0.978334653198085,2,95,positive regulation of small molecule metabolic process,BP,NR1D1;TMSB4X
2791,GO:0006228,0.119269978328329,0.99355098413076,1,8,UTP biosynthetic process,BP,NME9
1329,GO:0003179,0.119297686836249,0.992946624386207,1,25,heart valve morphogenesis,BP,DCHS1
13277,GO:0051961,0.119378010766922,0.967553725799535,3,190,negative regulation of nervous system development,BP,HES5;HES1;ID3
15319,GO:0071539,0.119448182259487,0.992917540867153,1,26,protein localization to centrosome,BP,KIAA0753
19951,GO:2000482,0.11957552188869,0.993174853107124,1,13,regulation of interleukin-8 secretion,BP,TMSB4X
18159,GO:1902904,0.119891842199862,0.978139490890344,2,90,negative regulation of supramolecular fiber organization,BP,APC2;TMSB4X
10090,GO:0042592,0.119986314220268,0.933567979152472,12,1101,homeostatic process,BP,NR1D1;TSC22D3;NME9;SLC24A4;MUC6;SLC9A4;DDIT3;HIST1H4F;GPR89A;HIST1H4I;ARRDC3;HIST1H4D
419,GO:0001106,0.120279322735863,0.9928819879228,1,21,RNA polymerase II transcription corepressor activity,MF,PHF12
650,GO:0001838,0.120512373797755,0.977930666370057,2,99,embryonic epithelial tube formation,BP,HES5;GDNF
10529,GO:0043467,0.120582980595916,0.977929093703046,2,93,regulation of generation of precursor metabolites and energy,BP,DDIT4;PPP1R3D
13899,GO:0060538,0.120615533628103,0.977916329620393,2,94,skeletal muscle organ development,BP,TSC22D3;NUPR1
4195,GO:0009299,0.120754413297192,0.992841540847637,1,20,mRNA transcription,BP,DDIT3
3052,GO:0006612,0.121131550981435,0.953397507248913,5,165,protein targeting to membrane,BP,RPL37;RPL31;RPL23A;RPL28;RPS27
12541,GO:0050687,0.121298216075535,0.992758041946642,1,21,negative regulation of defense response to virus,BP,RNF125
13040,GO:0051493,0.121340885983331,0.952964141762641,5,394,regulation of cytoskeleton organization,BP,RGS2;APC2;TMSB4X;RHOF;MAP1A
8114,GO:0032800,0.122094353960043,0.992697452718182,1,19,receptor biosynthetic process,BP,NR1D1
19791,GO:2000209,0.122149005534975,0.992671294070031,1,20,regulation of anoikis,BP,SNAI2
12369,GO:0048754,0.122176782240961,0.977425980592988,2,106,branching morphogenesis of an epithelial tube,BP,GDNF;DCHS1
14872,GO:0070661,0.122276229856478,0.96647868949356,3,157,leukocyte proliferation,BP,HES1;SPN;BTN3A1
765,GO:0002009,0.122377260917417,0.952439490551007,5,394,morphogenesis of an epithelium,BP,HES5;GDNF;HES1;DCHS1;SNAI2
11415,GO:0045823,0.122470491948496,0.992697377894422,1,17,positive regulation of heart contraction,BP,RGS2
6818,GO:0030275,0.123194524307112,0.992636376271492,1,16,LRR domain binding,MF,DDIT3
11529,GO:0046051,0.123370345004469,0.992982786928882,1,9,UTP metabolic process,BP,NME9
19287,GO:1905508,0.123533764838855,0.992402169407982,1,27,protein localization to microtubule organizing center,BP,KIAA0753
15878,GO:0072606,0.12372312268771,0.992639363549062,1,14,interleukin-8 secretion,BP,TMSB4X
718,GO:0001941,0.123835259490559,0.992482647476388,1,19,postsynaptic membrane organization,BP,GDNF
3433,GO:0007224,0.124116624823514,0.976881602474373,2,97,smoothened signaling pathway,BP,HES5;HES1
11457,GO:0045912,0.124407879628593,0.992341066714209,1,23,negative regulation of carbohydrate metabolic process,BP,DDIT4
3187,GO:0006812,0.124487991822721,0.942703468385862,7,576,cation transport,BP,GDNF;SLC24A4;SLC9A4;DDIT3;TMSB4X;FXYD3;COX7C
19219,GO:1905332,0.124657315528901,0.992341469555407,1,21,positive regulation of morphogenesis of an epithelium,BP,GDNF
15657,GO:0072175,0.125120398937765,0.976568838321627,2,102,epithelial tube formation,BP,HES5;GDNF
735,GO:0001963,0.125281576276383,0.992448112772907,1,14,synaptic transmission, dopaminergic,BP,GDNF
11088,GO:0045089,0.125354671351495,0.957115836712471,4,243,positive regulation of innate immune response,BP,NR1D1;MUC6;RNF125;MUC12
6027,GO:0019083,0.126170514120039,0.950828560356508,5,171,viral transcription,BP,RPL37;RPL31;RPL23A;RPL28;RPS27
2767,GO:0006183,0.127162582188705,0.992533145787137,1,9,GTP biosynthetic process,BP,NME9
8303,GO:0033137,0.127178751244679,0.992003395365969,1,22,negative regulation of peptidyl-serine phosphorylation,BP,DDIT4
4468,GO:0010463,0.12719465079402,0.991933892711382,1,27,mesenchymal cell proliferation,BP,DCHS1
7467,GO:0031624,0.127304783692211,0.991908964057187,1,28,ubiquitin conjugating enzyme binding,MF,RNF125
16837,GO:0098742,0.127654963923197,0.975799436757945,2,106,cell-cell adhesion via plasma-membrane adhesion molecules,BP,LGALS7B;DCHS1
4689,GO:0010837,0.128065019697689,0.991844462296536,1,25,regulation of keratinocyte proliferation,BP,SNAI2
19914,GO:2000403,0.128238602598586,0.991975239457585,1,17,positive regulation of lymphocyte migration,BP,SPN
11105,GO:0045123,0.128656942500468,0.991795543512528,1,23,cellular extravasation,BP,SPN
7791,GO:0032330,0.128869883618608,0.991739072315064,1,25,regulation of chondrocyte differentiation,BP,SNAI2
15511,GO:0071889,0.12895307114713,0.991741866448415,1,24,14-3-3 protein binding,MF,DDIT4
11317,GO:0045637,0.128979123145733,0.95553337850276,4,183,regulation of myeloid cell differentiation,BP,HOXA9;HIST1H4F;HIST1H4I;HIST1H4D
12422,GO:0048871,0.129115011134845,0.963683252425745,3,199,multicellular organismal homeostasis,BP,NR1D1;MUC6;ARRDC3
6785,GO:0030219,0.130294898935042,0.963654507764054,3,78,megakaryocyte differentiation,BP,HIST1H4F;HIST1H4I;HIST1H4D
12253,GO:0048534,0.130380594608456,0.935964854992294,8,619,hematopoietic or lymphoid organ development,BP,HES5;HOXA9;HES1;HIST1H4F;ZNF160;SPN;HIST1H4I;HIST1H4D
7322,GO:0031330,0.131065452137604,0.962923841071144,3,180,negative regulation of cellular catabolic process,BP,DDIT4;GDNF;ZKSCAN3
5249,GO:0015872,0.131263742021521,0.991649266311447,1,15,dopamine transport,BP,GDNF
7071,GO:0030857,0.131397318136827,0.991403503408595,1,25,negative regulation of epithelial cell differentiation,BP,HES1
7153,GO:0031011,0.131413046206291,0.991629764491941,1,15,Ino80 complex,CC,ACTR5
8346,GO:0033202,0.131413046206291,0.991629764491941,1,15,DNA helicase complex,CC,ACTR5
10886,GO:0044427,0.131643196816081,0.92990060065234,10,773,chromosomal part,CC,NR1D1;ACTR5;SNAI2;HIST1H4F;PHF12;SPC25;HIST1H1D;SALL2;HIST1H4I;HIST1H4D
10255,GO:0042994,0.13169611899314,0.991497088032777,1,18,cytoplasmic sequestering of transcription factor,BP,TMSB4X
1876,GO:0004550,0.13190881005258,0.991774527025043,1,11,nucleoside diphosphate kinase activity,MF,NME9
12277,GO:0048585,0.13199444297885,0.927493536848796,11,1099,negative regulation of response to stimulus,BP,NR1D1;DDIT4;RGS2;GDNF;RNF125;DDIT3;SNAI2;APC2;TMSB4X;IVNS1ABP;ZKSCAN3
1323,GO:0003170,0.132013548198405,0.991283636826208,1,28,heart valve development,BP,DCHS1
9869,GO:0042129,0.132171391578964,0.974493691840183,2,87,regulation of T cell proliferation,BP,HES1;SPN
886,GO:0002250,0.132350047966901,0.962373067698081,3,197,adaptive immune response,BP,RNF125;SPN;BTN3A1
10271,GO:0043014,0.133158601910283,0.991196052534466,1,23,alpha-tubulin binding,MF,FAM110C
16336,GO:0090568,0.133400322194807,0.991106460297671,1,27,nuclear transcriptional repressor complex,CC,SALL2
6583,GO:0022408,0.133559505113461,0.974019300309512,2,99,negative regulation of cell-cell adhesion,BP,SNAI2;SPN
6610,GO:0022804,0.133641659847694,0.961837131265295,3,202,active transmembrane transporter activity,MF,SLC24A4;SLC9A4;ABCB5
3447,GO:0007259,0.133746002695836,0.973983634518761,2,93,JAK-STAT cascade,BP,HES5;HES1
5082,GO:0015318,0.133995770488167,0.946452377367316,5,399,inorganic molecular entity transmembrane transporter activity,MF,SLC24A4;SLC9A4;FXYD3;GPR89A;COX7C
2860,GO:0006352,0.134131105035162,0.953054833044191,4,206,DNA-templated transcription, initiation,BP,NR1D1;HIST1H4F;HIST1H4I;HIST1H4D
4099,GO:0009152,0.135215793895054,0.961243233530626,3,171,purine ribonucleotide biosynthetic process,BP,DDIT4;NME9;TMSB4X
16711,GO:0097696,0.136369206755628,0.973163032143193,2,94,STAT cascade,BP,HES5;HES1
13041,GO:0051494,0.136562604063513,0.973087266045793,2,98,negative regulation of cytoskeleton organization,BP,APC2;TMSB4X
16277,GO:0090344,0.137066067853531,0.990742872917976,1,19,negative regulation of cell aging,BP,ZKSCAN3
6353,GO:0021532,0.137505737565214,0.990535674405686,1,27,neural tube patterning,BP,HES1
392,GO:0001047,0.137779050332067,0.972648670341286,2,116,core promoter binding,MF,NR1D1;CIART
9310,GO:0035767,0.137826241566682,0.990637118278382,1,19,endothelial cell chemotaxis,BP,TMSB4X
20140,GO:2000826,0.138300210105458,0.990466911174969,1,24,regulation of heart morphogenesis,BP,HES1
3591,GO:0008017,0.138388450659472,0.959857718323766,3,213,microtubule binding,MF,APC2;MAP7D3;MAP1A
4607,GO:0010721,0.138665732526566,0.959756224862278,3,203,negative regulation of cell development,BP,HES5;HES1;ID3
13970,GO:0060674,0.138870872701287,0.990355333485388,1,26,placenta blood vessel development,BP,HES1
6387,GO:0021575,0.139057985255886,0.990328625553077,1,26,hindbrain morphogenesis,BP,HES1
11908,GO:0046939,0.139109860610088,0.972307373280411,2,92,nucleotide phosphorylation,BP,DDIT4;NME9
2654,GO:0005996,0.139358054578353,0.959474529564302,3,198,monosaccharide metabolic process,BP,NR1D1;PPP1R3D;SLC2A3
12302,GO:0048641,0.139425774804882,0.990237720261592,1,29,regulation of skeletal muscle tissue development,BP,TSC22D3
3918,GO:0008584,0.139692168897683,0.972118238906783,2,93,male gonad development,BP,HOXA9;NUPR1
8996,GO:0035115,0.140038211825556,0.990277047814645,1,21,embryonic forelimb morphogenesis,BP,HOXA9
20272,GO:2001234,0.140073127910942,0.959233621687776,3,167,negative regulation of apoptotic signaling pathway,BP,GDNF;SNAI2;IVNS1ABP
20281,GO:2001243,0.1400742758095,0.972065793858076,2,79,negative regulation of intrinsic apoptotic signaling pathway,BP,SNAI2;IVNS1ABP
18029,GO:1902531,0.140082507109307,0.920183830778729,12,1313,regulation of intracellular signal transduction,BP,HES5;DDIT4;RGS2;HES1;RNF125;DDIT3;SNAI2;TMSB4X;FAM110C;GPR89A;IVNS1ABP;RHOF
4816,GO:0014009,0.140349130587935,0.990192217562656,1,23,glial cell proliferation,BP,HES1
15985,GO:0080182,0.140389825306992,0.990372305823065,1,16,histone H3-K4 trimethylation,BP,HIST1H1D
8090,GO:0032770,0.140420998372814,0.990299958623942,1,18,positive regulation of monooxygenase activity,BP,GDNF
536,GO:0001654,0.14067931245872,0.958891243305558,3,218,eye development,BP,HES5;SALL2;ABCB5
14905,GO:0070734,0.140825089324101,0.990242497036386,1,18,histone H3-K27 methylation,BP,HIST1H1D
6024,GO:0019080,0.140873225541518,0.943142969124343,5,185,viral gene expression,BP,RPL37;RPL31;RPL23A;RPL28;RPS27
11410,GO:0045815,0.140883787630071,0.959339635447482,3,77,positive regulation of gene expression, epigenetic,BP,HIST1H4F;HIST1H4I;HIST1H4D
7218,GO:0031111,0.140907142543576,0.990048581331844,1,27,negative regulation of microtubule polymerization or depolymerization,BP,APC2
8155,GO:0032881,0.141131138238568,0.990016051731327,1,27,regulation of polysaccharide metabolic process,BP,PPP1R3D
2755,GO:0006164,0.141159131383965,0.958760454175037,3,175,purine nucleotide biosynthetic process,BP,DDIT4;NME9;TMSB4X
7223,GO:0031116,0.141269380935925,0.990079160923563,1,22,positive regulation of microtubule polymerization,BP,RGS2
11735,GO:0046546,0.141279775422412,0.971607335074076,2,94,development of primary male sexual characteristics,BP,HOXA9;NUPR1
16810,GO:0098659,0.141487555667937,0.98991681825422,1,31,inorganic cation import across plasma membrane,BP,SLC9A4
17076,GO:0099587,0.141487555667937,0.98991681825422,1,31,inorganic ion import across plasma membrane,BP,SLC9A4
6990,GO:0030667,0.141609070332616,0.958532162638861,3,196,secretory granule membrane,CC,SLC2A3;RHOF;RAB15
3308,GO:0007010,0.141962107860386,0.925766682436215,9,980,cytoskeleton organization,BP,RGS2;GOLGA2P5;APC2;SPC25;TMSB4X;KIAA0753;RHOF;MAP7D3;MAP1A
6930,GO:0030522,0.142264522508047,0.958216079574136,3,223,intracellular receptor signaling pathway,BP,NR1D1;RNF125;SNAI2
7159,GO:0031018,0.142407224933492,0.98985942045718,1,25,endocrine pancreas development,BP,HES1
12148,GO:0048255,0.142677884516016,0.989819766619661,1,25,mRNA stabilization,BP,GDNF
15746,GO:0072332,0.14268491424491,0.97127002496315,2,73,intrinsic apoptotic signaling pathway by p53 class mediator,BP,DDIT4;NUPR1
2848,GO:0006334,0.143122481245009,0.949063499827462,4,116,nucleosome assembly,BP,HIST1H4F;HIST1H1D;HIST1H4I;HIST1H4D
4969,GO:0015077,0.144227370333159,0.957483128525288,3,166,monovalent inorganic cation transmembrane transporter activity,MF,SLC24A4;SLC9A4;COX7C
9431,GO:0036003,0.144319013771896,0.989613464503454,1,23,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,DDIT3
3513,GO:0007435,0.144365207605302,0.989540135561727,1,27,salivary gland morphogenesis,BP,SNAI2
3154,GO:0006754,0.144399445819627,0.970596707610666,2,95,ATP biosynthetic process,BP,DDIT4;TMSB4X
5412,GO:0016254,0.144614351527187,0.989728843288456,1,17,preassembly of GPI anchor in ER membrane,BP,PIGH
18480,GO:1903580,0.144861894933263,0.989553507303411,1,22,positive regulation of ATP metabolic process,BP,TMSB4X
10579,GO:0043543,0.14560162550229,0.956833794547402,3,198,protein acylation,BP,SNAI2;NUPR1;JADE2
5817,GO:0017080,0.145681423663837,0.98943158412598,1,22,sodium channel regulator activity,MF,FXYD3
9343,GO:0035850,0.145760271312486,0.9893462117337,1,26,epithelial cell differentiation involved in kidney development,BP,GDNF
6866,GO:0030335,0.14623452239287,0.947044850953098,4,316,positive regulation of cell migration,BP,SNAI2;SPN;TMSB4X;FAM110C
11059,GO:0045058,0.146284316511675,0.9892672796938,1,26,T cell selection,BP,SPN
7478,GO:0031641,0.146506030108974,0.989233792281778,1,26,regulation of myelination,BP,HES5
9728,GO:0038179,0.146520971272173,0.989216390372238,1,27,neurotrophin signaling pathway,BP,DDIT4
5263,GO:0015893,0.14653980737556,0.969877690502183,2,100,drug transport,BP,GDNF;ABCB5
2539,GO:0005795,0.146792693713027,0.969744069628575,2,115,Golgi stack,CC,GOLGA2P5;GPR89A
9949,GO:0042311,0.147106323093283,0.98932620338117,1,18,vasodilation,BP,RGS2
2472,GO:0005687,0.14713296659407,0.98970264442554,1,11,U4 snRNP,CC,SNRPD2
5457,GO:0016331,0.147207262555829,0.969607547224345,2,115,morphogenesis of embryonic epithelium,BP,HES5;GDNF
9004,GO:0035148,0.147564206781333,0.969495815726405,2,113,tube formation,BP,HES5;GDNF
13946,GO:0060612,0.147898963621803,0.989022142035299,1,26,adipose tissue development,BP,ARRDC3
2796,GO:0006241,0.148305850695992,0.989449836390977,1,12,CTP biosynthetic process,BP,NME9
11521,GO:0046036,0.148305850695992,0.989449836390977,1,12,CTP metabolic process,BP,NME9
6366,GO:0021545,0.148445061009798,0.988938569781089,1,26,cranial nerve development,BP,HES1
3590,GO:0008016,0.148545158253645,0.969190938470247,2,107,regulation of heart contraction,BP,RGS2;FXYD3
11354,GO:0045687,0.148934039578506,0.988847807926001,1,27,positive regulation of glial cell differentiation,BP,HES1
7219,GO:0031112,0.149231909572377,0.988852917492091,1,24,positive regulation of microtubule polymerization or depolymerization,BP,RGS2
12937,GO:0051291,0.149318753602863,0.955573592656431,3,100,protein heterooligomerization,BP,HIST1H4F;HIST1H4I;HIST1H4D
6758,GO:0030178,0.149335362062483,0.95533506381388,3,151,negative regulation of Wnt signaling pathway,BP,DDIT3;SNAI2;APC2
2106,GO:0004879,0.149380555863043,0.98872609871061,1,31,nuclear receptor activity,MF,NR1D1
16751,GO:0098531,0.149380555863043,0.98872609871061,1,31,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,NR1D1
10425,GO:0043269,0.150711905008941,0.944842412314126,4,296,regulation of ion transport,BP,GDNF;TMSB4X;FXYD3;GPR89A
16163,GO:0090184,0.15123229374159,0.988490660154319,1,27,positive regulation of kidney development,BP,GDNF
3526,GO:0007507,0.151871532436784,0.944208300716455,4,356,heart development,BP,HES1;ID3;DCHS1;SNAI2
13261,GO:0051937,0.152149445779111,0.988495157221037,1,20,catecholamine transport,BP,GDNF
4149,GO:0009209,0.15225903092534,0.988788026348921,1,13,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,NME9
2903,GO:0006413,0.152408029763464,0.936943209939151,5,186,translational initiation,BP,RPL37;RPL31;RPL23A;RPL28;RPS27
4184,GO:0009260,0.152606558508274,0.953834028617855,3,183,ribonucleotide biosynthetic process,BP,DDIT4;NME9;TMSB4X
17501,GO:1900543,0.153090694383309,0.988231888424188,1,25,negative regulation of purine nucleotide metabolic process,BP,DDIT4
1022,GO:0002520,0.153170060791886,0.921873717835421,8,656,immune system development,BP,HES5;HOXA9;HES1;HIST1H4F;ZNF160;SPN;HIST1H4I;HIST1H4D
801,GO:0002067,0.153917012828966,0.988050378810779,1,28,glandular epithelial cell differentiation,BP,HES1
10809,GO:0044297,0.154126532310007,0.943114918028753,4,310,cell body,CC,NRSN1;CNNM1;RPL28;MAP1A
13821,GO:0060412,0.154203922997429,0.987976419824535,1,30,ventricular septum morphogenesis,BP,HES1
16785,GO:0098609,0.154726525146557,0.935296305630644,5,442,cell-cell adhesion,BP,HES1;LGALS7B;DCHS1;SNAI2;SPN
3698,GO:0008206,0.154845511298578,0.987934000691511,1,26,bile acid metabolic process,BP,NR1D1
10430,GO:0043276,0.155213313245404,0.987842095360932,1,28,anoikis,BP,SNAI2
5069,GO:0015291,0.155218695393651,0.966886613454712,2,127,secondary active transmembrane transporter activity,MF,SLC24A4;SLC9A4
9001,GO:0035136,0.155893178784599,0.987783667825247,1,25,forelimb morphogenesis,BP,HOXA9
11653,GO:0046390,0.156199797211086,0.95224822748895,3,186,ribose phosphate biosynthetic process,BP,DDIT4;NME9;TMSB4X
4148,GO:0009208,0.156207543646581,0.988113347675487,1,14,pyrimidine ribonucleoside triphosphate metabolic process,BP,NME9
4355,GO:0009948,0.156372469564572,0.987654229086743,1,28,anterior/posterior axis specification,BP,DDIT3
15819,GO:0072522,0.156428352268887,0.952149239907467,3,185,purine-containing compound biosynthetic process,BP,DDIT4;NME9;TMSB4X
12886,GO:0051220,0.156564254385933,0.987695253924224,1,24,cytoplasmic sequestering of protein,BP,TMSB4X
3409,GO:0007193,0.156865998015614,0.987531684158422,1,31,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,RGS2
5336,GO:0016071,0.157289228724377,0.913128166872262,10,738,mRNA metabolic process,BP,RPL37;GDNF;ZC3H12D;SNRPD2;DDIT3;RPL31;RNF113A;RPL23A;RPL28;RPS27
11795,GO:0046661,0.157356623728962,0.966228405323266,2,104,male sex differentiation,BP,HOXA9;NUPR1
9842,GO:0042088,0.157651456378373,0.987540734837364,1,23,T-helper 1 type immune response,BP,SPN
17584,GO:1901214,0.158600137394551,0.951146415266637,3,205,regulation of neuron death,BP,DDIT4;GDNF;DDIT3
19915,GO:2000404,0.159259326315012,0.987359215344029,1,20,regulation of T cell migration,BP,SPN
19762,GO:2000147,0.159274690054302,0.940491587172608,4,321,positive regulation of cell motility,BP,SNAI2;SPN;TMSB4X;FAM110C
343,GO:0000956,0.159460683348151,0.933022363204935,5,200,nuclear-transcribed mRNA catabolic process,BP,RPL37;RPL31;RPL23A;RPL28;RPS27
9376,GO:0035904,0.159566205523786,0.987049282066263,1,34,aorta development,BP,HES1
3157,GO:0006766,0.160167143339635,0.965317647022724,2,91,vitamin metabolic process,BP,SLC2A3;SNAI2
4656,GO:0010799,0.160421326533778,0.986917085826777,1,33,regulation of peptidyl-threonine phosphorylation,BP,DDIT4
3529,GO:0007517,0.160822193951561,0.950117248193451,3,227,muscle organ development,BP,TSC22D3;ID3;NUPR1
8922,GO:0034765,0.160861128012046,0.950128080813708,3,209,regulation of ion transmembrane transport,BP,TMSB4X;FXYD3;GPR89A
5339,GO:0016074,0.160943091026694,0.987510854469846,1,12,snoRNA metabolic process,BP,RNF113A
11429,GO:0045843,0.161101627431159,0.986814543510724,1,32,negative regulation of striated muscle tissue development,BP,TSC22D3
17792,GO:1901862,0.161101627431159,0.986814543510724,1,32,negative regulation of muscle tissue development,BP,TSC22D3
1097,GO:0002684,0.161167844864741,0.920798966890207,7,616,positive regulation of immune system process,BP,NR1D1;HES1;MUC6;RNF125;SPN;BTN3A1;MUC12
10541,GO:0043489,0.161415121665945,0.986803236888882,1,29,RNA stabilization,BP,GDNF
8858,GO:0034655,0.161726429927603,0.916512191420681,8,518,nucleobase-containing compound catabolic process,BP,DDIT4;RPL37;GDNF;ZC3H12D;RPL31;RPL23A;RPL28;RPS27
4764,GO:0010942,0.162316051552211,0.925011390536693,6,496,positive regulation of cell death,BP,TXNIP;DDIT4;ID3;IFIT2;DDIT3;NUPR1
3361,GO:0007099,0.162407146433586,0.986635327835543,1,29,centriole replication,BP,KIAA0753
6821,GO:0030278,0.162508855105812,0.964387693783581,2,118,regulation of ossification,BP,ID3;SNAI2
12358,GO:0048736,0.162747213753521,0.964279634732263,2,126,appendage development,BP,HOXA9;HOXC13
13663,GO:0060173,0.162747213753521,0.964279634732263,2,126,limb development,BP,HOXA9;HOXC13
12672,GO:0050873,0.163427031096291,0.986580503823884,1,23,brown fat cell differentiation,BP,RGS2
8975,GO:0035066,0.163705087135448,0.986466720911345,1,26,positive regulation of histone acetylation,BP,SNAI2
12580,GO:0050731,0.163814002231657,0.963984161221772,2,103,positive regulation of peptidyl-tyrosine phosphorylation,BP,HES5;HES1
2271,GO:0005201,0.164712706881675,0.986161372803497,1,35,extracellular matrix structural constituent,MF,MUC6
12297,GO:0048635,0.164996128513242,0.986135486300556,1,33,negative regulation of muscle organ development,BP,TSC22D3
7413,GO:0031497,0.165376517346509,0.937811845336059,4,134,chromatin assembly,BP,HIST1H4F;HIST1H1D;HIST1H4I;HIST1H4D
17541,GO:1901070,0.165822609640048,0.986627667938339,1,13,guanosine-containing compound biosynthetic process,BP,NME9
16754,GO:0098534,0.167203840545373,0.985791566672489,1,30,centriole assembly,BP,KIAA0753
9130,GO:0035455,0.167417486636773,0.986022029232271,1,19,response to interferon-alpha,BP,IFIT2
20100,GO:2000758,0.167587618321887,0.985775598905811,1,27,positive regulation of peptidyl-lysine acetylation,BP,SNAI2
16492,GO:0097190,0.167674010073616,0.921832247047355,6,470,apoptotic signaling pathway,BP,DDIT4;GDNF;DDIT3;SNAI2;NUPR1;IVNS1ABP
11476,GO:0045933,0.167752581918381,0.985787941099752,1,25,positive regulation of muscle contraction,BP,RGS2
12353,GO:0048729,0.168174666712773,0.927776454464587,5,449,tissue morphogenesis,BP,HES5;GDNF;HES1;DCHS1;SNAI2
7105,GO:0030900,0.168234680355441,0.946746041647566,3,230,forebrain development,BP,HES5;HES1;OTX1
17923,GO:1902235,0.168521563045873,0.985652972116438,1,25,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,DDIT3
5231,GO:0015844,0.168645382469156,0.985654655378171,1,24,monoamine transport,BP,GDNF
15329,GO:0071549,0.169328383238785,0.985488784631171,1,26,cellular response to dexamethasone stimulus,BP,DDIT4
9077,GO:0035329,0.169505026122671,0.985284805441971,1,38,hippo signaling,BP,DCHS1
7317,GO:0031325,0.169585586498095,0.8904183164398,18,2176,positive regulation of cellular metabolic process,BP,NR1D1;HES5;HOXA9;GDNF;HES1;HOXC13;ZC3H12D;RNF125;DDIT3;SNAI2;NUPR1;OTX1;SPN;SALL2;TMSB4X;IVNS1ABP;ZKSCAN3;ARRDC3
15890,GO:0072657,0.169634336581995,0.915627917715392,7,451,protein localization to membrane,BP,RPL37;DCHS1;RPL31;RPL23A;RPL28;RPS27;RAB15
279,GO:0000781,0.169910623315611,0.946175225424792,3,146,chromosome, telomeric region,CC,HIST1H4F;HIST1H4I;HIST1H4D
957,GO:0002376,0.170127716675642,0.890038860520737,18,1855,immune system process,BP,NR1D1;HES5;DDIT4;TSC22D3;HOXA9;HES1;MUC6;SLC2A3;IFIT2;RNF125;HIST1H4F;ZNF160;SPN;HIST1H4I;RHOF;HIST1H4D;BTN3A1;MUC12
11499,GO:0045980,0.171300655782258,0.985137153440576,1,26,negative regulation of nucleotide metabolic process,BP,DDIT4
6803,GO:0030246,0.171511265058256,0.961150916727538,2,123,carbohydrate binding,MF,LGALS7B;SLC2A3
14644,GO:0070232,0.171958450237892,0.985065814794976,1,24,regulation of T cell apoptotic process,BP,TSC22D3
17976,GO:1902373,0.172623708612075,0.98479238714924,1,32,negative regulation of mRNA catabolic process,BP,GDNF
4813,GO:0014003,0.173140285644813,0.984783968558953,1,27,oligodendrocyte development,BP,HES5
12925,GO:0051272,0.173156823749052,0.933263809661047,4,330,positive regulation of cellular component movement,BP,SNAI2;SPN;TMSB4X;FAM110C
12915,GO:0051258,0.173543732271655,0.944332122226173,3,205,protein polymerization,BP,RGS2;TMSB4X;MAP7D3
2296,GO:0005254,0.173709888233392,0.984642072251431,1,29,chloride channel activity,MF,FXYD3
13268,GO:0051952,0.174025778818922,0.98466695866485,1,25,regulation of amine transport,BP,GDNF
17500,GO:1900542,0.174125109052766,0.960222618000109,2,115,regulation of purine nucleotide metabolic process,BP,DDIT4;TMSB4X
12523,GO:0050663,0.174136964322252,0.960250686632918,2,107,cytokine secretion,BP,TMSB4X;BTN3A1
5283,GO:0015934,0.175129307417893,0.932863640813014,4,115,large ribosomal subunit,CC,RPL37;RPL31;RPL23A;RPL28
1462,GO:0003707,0.175159199072957,0.984262609152249,1,37,steroid hormone receptor activity,MF,NR1D1
4159,GO:0009220,0.17539859392823,0.984652816833463,1,18,pyrimidine ribonucleotide biosynthetic process,BP,NME9
11578,GO:0046132,0.17539859392823,0.984652816833463,1,18,pyrimidine ribonucleoside biosynthetic process,BP,NME9
11378,GO:0045744,0.176051879182699,0.984229402193143,1,28,negative regulation of G-protein coupled receptor protein signaling pathway,BP,RGS2
1485,GO:0003785,0.176340865137037,0.984481556051521,1,18,actin monomer binding,MF,TMSB4X
284,GO:0000786,0.17643203136226,0.932551574219552,4,84,nucleosome,CC,HIST1H4F;HIST1H1D;HIST1H4I;HIST1H4D
257,GO:0000723,0.176647282597756,0.943018796314867,3,153,telomere maintenance,BP,HIST1H4F;HIST1H4I;HIST1H4D
18344,GO:1903307,0.176883694052525,0.984074759624732,1,28,positive regulation of regulated secretory pathway,BP,RAB15
19705,GO:2000027,0.176927017111711,0.942794245696278,3,184,regulation of organ morphogenesis,BP,GDNF;HES1;SNAI2
5854,GO:0017148,0.177017121478652,0.931395142630583,4,216,negative regulation of translation,BP,ZC3H12D;HIST1H4F;HIST1H4I;HIST1H4D
8846,GO:0034641,0.177583348793028,0.872808282958851,44,5139,cellular nitrogen compound metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;RPL37;NME9;GDNF;HES1;HOXC13;ID3;ZC3H12D;ACTR5;SNRPD2;DDIT3;SNAI2;RPL31;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;RPL28;TMSB4X;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;COX7C;HIST1H4I;CIART;RPS27;ZNF485;HIST1H4D;ZNF57
10899,GO:0044445,0.177634608532289,0.922740070608162,5,203,cytosolic part,CC,RPL37;RPL31;RPL23A;RPL28;RPS27
8905,GO:0034728,0.177789934418077,0.931280693686167,4,139,nucleosome organization,BP,HIST1H4F;HIST1H1D;HIST1H4I;HIST1H4D
8892,GO:0034709,0.177817206401492,0.984647846578372,1,12,methylosome,CC,SNRPD2
2482,GO:0005719,0.178303055789637,0.983996497587566,1,21,nuclear euchromatin,CC,HIST1H1D
11087,GO:0045088,0.178359494760317,0.93054506405926,4,288,regulation of innate immune response,BP,NR1D1;MUC6;RNF125;MUC12
10867,GO:0044390,0.178610425178191,0.983665747396273,1,33,ubiquitin-like protein conjugating enzyme binding,MF,RNF125
12059,GO:0048008,0.178803882492894,0.983535628985361,1,41,platelet-derived growth factor receptor signaling pathway,BP,TXNIP
14157,GO:0061035,0.179099035379674,0.983521115634992,1,37,regulation of cartilage development,BP,SNAI2
10799,GO:0044275,0.179724447942266,0.983426392290274,1,35,cellular carbohydrate catabolic process,BP,PPP1R3D
14147,GO:0061014,0.17980824234218,0.983397696774214,1,36,positive regulation of mRNA catabolic process,BP,ZC3H12D
3512,GO:0007431,0.180407359037202,0.983355033472567,1,31,salivary gland development,BP,SNAI2
17560,GO:1901137,0.180411569614524,0.914045976202574,6,553,carbohydrate derivative biosynthetic process,BP,DDIT4;NME9;MUC6;PIGH;TMSB4X;MUC12
907,GO:0002287,0.180802665217327,0.983247769913643,1,33,alpha-beta T cell activation involved in immune response,BP,SPN
910,GO:0002293,0.180802665217327,0.983247769913643,1,33,alpha-beta T cell differentiation involved in immune response,BP,SPN
911,GO:0002294,0.180802665217327,0.983247769913643,1,33,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,SPN
9847,GO:0042093,0.180802665217327,0.983247769913643,1,33,T-helper cell differentiation,BP,SPN
4200,GO:0009306,0.180949583333345,0.929101404641336,4,331,protein secretion,BP,NR1D1;TMSB4X;RAB15;BTN3A1
8136,GO:0032835,0.181326004693619,0.983132658593662,1,34,glomerulus development,BP,HES1
10620,GO:0043616,0.181703737156222,0.983059773273065,1,34,keratinocyte proliferation,BP,SNAI2
9613,GO:0036477,0.181996607017336,0.919804140773605,5,472,somatodendritic compartment,CC,NR1D1;NRSN1;CNNM1;RPL28;MAP1A
11344,GO:0045668,0.182059379065334,0.983116047528895,1,27,negative regulation of osteoblast differentiation,BP,ID3
10283,GO:0043029,0.182114498420595,0.983083735361478,1,28,T cell homeostasis,BP,TSC22D3
3576,GO:0007622,0.18245655954448,0.983145801951956,1,23,rhythmic behavior,BP,CIART
12239,GO:0048512,0.18245655954448,0.983145801951956,1,23,circadian behavior,BP,CIART
4344,GO:0009895,0.182529676226201,0.94008476911137,3,207,negative regulation of catabolic process,BP,DDIT4;GDNF;ZKSCAN3
14112,GO:0060964,0.183015519219711,0.94028490034509,3,103,regulation of gene silencing by miRNA,BP,HIST1H4F;HIST1H4I;HIST1H4D
4157,GO:0009218,0.183052078371575,0.98313985619362,1,20,pyrimidine ribonucleotide metabolic process,BP,NME9
13236,GO:0051896,0.183067418632707,0.956850528469016,2,123,regulation of protein kinase B signaling,BP,DDIT3;FAM110C
10975,GO:0044764,0.183299490729928,0.982834285307089,1,29,multi-organism cellular process,BP,RNF125
15906,GO:0072678,0.183339649936192,0.982918293818473,1,25,T cell migration,BP,SPN
11003,GO:0044815,0.183363552096229,0.928759888636747,4,91,DNA packaging complex,CC,HIST1H4F;HIST1H1D;HIST1H4I;HIST1H4D
2466,GO:0005681,0.183916516665647,0.939481819723385,3,181,spliceosomal complex,CC,SNRPD2;RNF113A;IVNS1ABP
2273,GO:0005215,0.183926929817377,0.906399265358998,7,683,transporter activity,MF,SLC24A4;SLC2A3;SLC9A4;FXYD3;GPR89A;COX7C;ABCB5
12617,GO:0050795,0.184147176147308,0.982789892476226,1,24,regulation of behavior,BP,ARRDC3
16563,GO:0097346,0.184302641166655,0.98279022724682,1,23,INO80-type complex,CC,ACTR5
7967,GO:0032570,0.184454796227298,0.982609197442252,1,29,response to progesterone,BP,TXNIP
15917,GO:0072698,0.184576077931554,0.982405675014377,1,42,protein localization to microtubule cytoskeleton,BP,KIAA0753
3267,GO:0006940,0.184850470263645,0.982512312447448,1,30,regulation of smooth muscle contraction,BP,RGS2
12402,GO:0048844,0.185045367651501,0.982367261586208,1,37,artery morphogenesis,BP,HES1
18009,GO:1902476,0.185101765770914,0.982427662433712,1,32,chloride transmembrane transport,BP,FXYD3
7618,GO:0032007,0.18527564451994,0.982347943131423,1,35,negative regulation of TOR signaling,BP,DDIT4
593,GO:0001755,0.185338462038058,0.982364943217845,1,33,neural crest cell migration,BP,GDNF
6894,GO:0030425,0.185425641042133,0.92664706949196,4,360,dendrite,CC,NR1D1;CNNM1;RPL28;MAP1A
16609,GO:0097447,0.185425641042133,0.92664706949196,4,360,dendritic tree,CC,NR1D1;CNNM1;RPL28;MAP1A
4079,GO:0009132,0.185504350280508,0.955977220712183,2,109,nucleoside diphosphate metabolic process,BP,DDIT4;NME9
8480,GO:0033628,0.185560612864239,0.982435803568003,1,27,regulation of cell adhesion mediated by integrin,BP,SNAI2
2852,GO:0006338,0.186432156873043,0.938354823869727,3,155,chromatin remodeling,BP,HIST1H4F;HIST1H4I;HIST1H4D
2467,GO:0005682,0.186795707436398,0.982337864030526,1,22,U5 snRNP,CC,SNRPD2
15214,GO:0071364,0.186872550343222,0.9820172338278,1,36,cellular response to epidermal growth factor stimulus,BP,SNAI2
465,GO:0001503,0.187035944380412,0.937852955628864,3,242,ossification,BP,ID3;DCHS1;SNAI2
16162,GO:0090183,0.187086097372187,0.981974580568747,1,36,regulation of kidney development,BP,GDNF
2746,GO:0006140,0.187574523415035,0.955138460687299,2,119,regulation of nucleotide metabolic process,BP,DDIT4;TMSB4X
12107,GO:0048147,0.187647035886514,0.982104280768076,1,24,negative regulation of fibroblast proliferation,BP,NUPR1
19912,GO:2000401,0.187696760216892,0.982013674392936,1,27,regulation of lymphocyte migration,BP,SPN
18440,GO:1903522,0.188203173019574,0.954862408387555,2,128,regulation of blood circulation,BP,RGS2;FXYD3
909,GO:0002292,0.188393440723223,0.981726195917444,1,35,T cell differentiation involved in immune response,BP,SPN
14641,GO:0070229,0.188560785163628,0.981866472103287,1,26,negative regulation of lymphocyte apoptotic process,BP,TSC22D3
11813,GO:0046700,0.188723665504959,0.898824231024828,8,544,heterocycle catabolic process,BP,DDIT4;RPL37;GDNF;ZC3H12D;RPL31;RPL23A;RPL28;RPS27
873,GO:0002221,0.188840035698702,0.954637006553844,2,122,pattern recognition receptor signaling pathway,BP,NR1D1;RNF125
18442,GO:1903524,0.189498030715744,0.981550702859001,1,32,positive regulation of blood circulation,BP,RGS2
16775,GO:0098586,0.189585313483025,0.981458011786148,1,37,cellular response to virus,BP,RNF125
569,GO:0001708,0.189772042973445,0.981462544451959,1,34,cell fate specification,BP,APC2
3284,GO:0006974,0.189811923013719,0.897987376383056,8,740,cellular response to DNA damage stimulus,BP,DDIT4;ACTR5;DDIT3;SNAI2;NUPR1;HIST1H4F;HIST1H4I;HIST1H4D
15238,GO:0071398,0.189956854379549,0.98141005881843,1,35,cellular response to fatty acid,BP,ID3
16757,GO:0098542,0.190496755602574,0.924001280204663,4,260,defense response to other organism,BP,DDIT4;IFIT2;RNF125;SPN
5563,GO:0016573,0.190531078020991,0.953946845559236,2,131,histone acetylation,BP,SNAI2;JADE2
11288,GO:0045599,0.190744035705722,0.981264893832149,1,34,negative regulation of fat cell differentiation,BP,DDIT3
20034,GO:2000649,0.190968340038784,0.981252272857192,1,32,regulation of sodium ion transmembrane transporter activity,BP,FXYD3
4493,GO:0010517,0.191193767500556,0.981189170442299,1,33,regulation of phospholipase activity,BP,RGS2
9797,GO:0040017,0.191250891731407,0.923466375713902,4,346,positive regulation of locomotion,BP,SNAI2;SPN;TMSB4X;FAM110C
4095,GO:0009148,0.191420515879655,0.981660645804648,1,17,pyrimidine nucleoside triphosphate biosynthetic process,BP,NME9
16836,GO:0098739,0.191567001732272,0.98098501581122,1,43,import across plasma membrane,BP,SLC9A4
10795,GO:0044270,0.191754933792908,0.896792452959024,8,544,cellular nitrogen compound catabolic process,BP,DDIT4;RPL37;GDNF;ZC3H12D;RPL31;RPL23A;RPL28;RPS27
4539,GO:0010611,0.191952325045256,0.980987854127542,1,36,regulation of cardiac muscle hypertrophy,BP,RGS2
4882,GO:0014743,0.191952325045256,0.980987854127542,1,36,regulation of muscle hypertrophy,BP,RGS2
10559,GO:0043516,0.192269959936925,0.981146001715002,1,25,regulation of DNA damage response, signal transduction by p53 class mediator,BP,SNAI2
6582,GO:0022407,0.1924328865158,0.935236488734343,3,231,regulation of cell-cell adhesion,BP,HES1;SNAI2;SPN
8898,GO:0034719,0.192612153733297,0.981490230563547,1,16,SMN-Sm protein complex,CC,SNRPD2
12276,GO:0048584,0.193709295237073,0.880304264341683,13,1437,positive regulation of response to stimulus,BP,NR1D1;HES5;GDNF;HES1;MUC6;RNF125;DDIT3;TMSB4X;FAM110C;GPR89A;ARRDC3;BTN3A1;MUC12
2847,GO:0006333,0.193849377621774,0.922477532056823,4,156,chromatin assembly or disassembly,BP,HIST1H4F;HIST1H1D;HIST1H4I;HIST1H4D
5227,GO:0015837,0.194582468172156,0.980568271175581,1,29,amine transport,BP,GDNF
9870,GO:0042130,0.194611393800832,0.980436685827254,1,36,negative regulation of T cell proliferation,BP,SPN
9858,GO:0042108,0.194743874029382,0.980456349834749,1,33,positive regulation of cytokine biosynthetic process,BP,SPN
12257,GO:0048538,0.194916271636688,0.980358850437903,1,37,thymus development,BP,HES1
12838,GO:0051145,0.195015632311691,0.980382870836967,1,34,smooth muscle cell differentiation,BP,HES1
1305,GO:0003143,0.195048175719116,0.980293113852333,1,40,embryonic heart tube morphogenesis,BP,HES1
6252,GO:0019827,0.195138795867808,0.952173660065598,2,120,stem cell population maintenance,BP,HES5;HES1
13645,GO:0060147,0.195140942482289,0.934391043971899,3,106,regulation of posttranscriptional gene silencing,BP,HIST1H4F;HIST1H4I;HIST1H4D
14114,GO:0060966,0.195140942482289,0.934391043971899,3,106,regulation of gene silencing by RNA,BP,HIST1H4F;HIST1H4I;HIST1H4D
9915,GO:0042255,0.195593260789337,0.952599493655739,2,54,ribosome assembly,BP,RPL23A;RPS27
5967,GO:0018393,0.19560020183029,0.951939094194844,2,134,internal peptidyl-lysine acetylation,BP,SNAI2;JADE2
12561,GO:0050710,0.195784548186772,0.980317909454989,1,29,negative regulation of cytokine secretion,BP,TMSB4X
11289,GO:0045600,0.195842428549783,0.980138137816612,1,39,positive regulation of fat cell differentiation,BP,SNAI2
10474,GO:0043367,0.196011589269369,0.980128780882792,1,37,CD4-positive, alpha-beta T cell differentiation,BP,SPN
13238,GO:0051898,0.196411497903934,0.980089894223938,1,34,negative regulation of protein kinase B signaling,BP,DDIT3
8610,GO:0034121,0.196420034860133,0.980056932639557,1,36,regulation of toll-like receptor signaling pathway,BP,NR1D1
13701,GO:0060249,0.19732290242366,0.920170520430748,4,286,anatomical structure homeostasis,BP,MUC6;HIST1H4F;HIST1H4I;HIST1H4D
17828,GO:1901985,0.197521838305606,0.97987236206136,1,33,positive regulation of protein acetylation,BP,SNAI2
2376,GO:0005504,0.197526907679189,0.980667088699645,1,14,fatty acid binding,MF,ID3
8676,GO:0034249,0.197596707728237,0.920123374654207,4,232,negative regulation of cellular amide metabolic process,BP,ZC3H12D;HIST1H4F;HIST1H4I;HIST1H4D
2477,GO:0005694,0.197617059955575,0.885306365409645,10,883,chromosome,CC,NR1D1;ACTR5;SNAI2;HIST1H4F;PHF12;SPC25;HIST1H1D;SALL2;HIST1H4I;HIST1H4D
15604,GO:0072091,0.197635345266215,0.979745927874153,1,40,regulation of stem cell proliferation,BP,SNAI2
4075,GO:0009127,0.197792092261461,0.951138276888162,2,115,purine nucleoside monophosphate biosynthetic process,BP,DDIT4;TMSB4X
4114,GO:0009168,0.197792092261461,0.951138276888162,2,115,purine ribonucleoside monophosphate biosynthetic process,BP,DDIT4;TMSB4X
19398,GO:1905898,0.197881892173118,0.979778736266083,1,34,positive regulation of response to endoplasmic reticulum stress,BP,DDIT3
17975,GO:1902369,0.198214006899153,0.979647975190361,1,38,negative regulation of RNA catabolic process,BP,GDNF
17771,GO:1901797,0.19836877053564,0.979881270122386,1,25,negative regulation of signal transduction by p53 class mediator,BP,SNAI2
16830,GO:0098727,0.198514910103072,0.950818599002095,2,122,maintenance of cell number,BP,HES5;HES1
8407,GO:0033365,0.199006092363885,0.887790811856459,9,731,protein localization to organelle,BP,TXNIP;RPL37;HES1;DDIT3;RPL31;RPL23A;RPL28;KIAA0753;RPS27
14954,GO:0070849,0.200144834148372,0.979220114176846,1,39,response to epidermal growth factor,BP,SNAI2
4985,GO:0015108,0.200199299877224,0.979250667499052,1,36,chloride transmembrane transporter activity,MF,FXYD3
7853,GO:0032412,0.200452967276655,0.95002626451533,2,125,regulation of ion transmembrane transporter activity,BP,TMSB4X;FXYD3
6151,GO:0019439,0.20079908707425,0.89066767818548,8,553,aromatic compound catabolic process,BP,DDIT4;RPL37;GDNF;ZC3H12D;RPL31;RPL23A;RPL28;RPS27
14000,GO:0060711,0.201379465184635,0.97898030289112,1,37,labyrinthine layer development,BP,HES1
11883,GO:0046890,0.201595744169834,0.949559744829132,2,126,regulation of lipid biosynthetic process,BP,NR1D1;SNAI2
2845,GO:0006323,0.201699830602008,0.918050239766124,4,166,DNA packaging,BP,HIST1H4F;HIST1H1D;HIST1H4I;HIST1H4D
8079,GO:0032757,0.201766844449168,0.979097592682638,1,27,positive regulation of interleukin-8 production,BP,DDIT3
4026,GO:0009057,0.201781107607658,0.876695046179091,12,1127,macromolecule catabolic process,BP,NR1D1;RPL37;PPP1R3D;GDNF;ZC3H12D;RNF125;DDIT3;APC2;RPL31;RPL23A;RPL28;RPS27
3386,GO:0007165,0.202195315997636,0.856498468146938,29,3664,signal transduction,BP,TXNIP;NR1D1;HES5;DDIT4;RIN2;RGS2;S1PR5;GDNF;HES1;MUC6;IFIT2;RNF125;DCHS1;DDIT3;SNAI2;APC2;NUPR1;SPN;SALL2;TMSB4X;FAM110C;GPR89A;IVNS1ABP;RHOF;ARRDC3;RAB15;BTN3A1;MUC12;STAC2
3245,GO:0006904,0.202422621826258,0.978753061006665,1,37,vesicle docking involved in exocytosis,BP,RAB15
3162,GO:0006775,0.202705692044007,0.978988743954261,1,24,fat-soluble vitamin metabolic process,BP,SNAI2
3291,GO:0006984,0.20325985651505,0.978528344934887,1,40,ER-nucleus signaling pathway,BP,DDIT3
10862,GO:0044380,0.203898322333958,0.97831125404201,1,47,protein localization to cytoskeleton,BP,KIAA0753
15328,GO:0071548,0.204598056287533,0.978342679745839,1,33,response to dexamethasone,BP,DDIT4
4822,GO:0014015,0.205652464137156,0.978041068152917,1,37,positive regulation of gliogenesis,BP,HES1
9792,GO:0040012,0.205878968323401,0.897989352388865,6,619,regulation of locomotion,BP,SNAI2;SPN;TMSB4X;FAM110C;RHOF;ARRDC3
5328,GO:0016052,0.207668512342901,0.947037346893636,2,135,carbohydrate catabolic process,BP,DDIT4;PPP1R3D
17797,GO:1901880,0.208219075458559,0.977397292270943,1,42,negative regulation of protein depolymerization,BP,APC2
4376,GO:0010001,0.208484787090282,0.946709766911236,2,132,glial cell differentiation,BP,HES5;HES1
12919,GO:0051262,0.208617803598481,0.927548730614041,3,117,protein tetramerization,BP,HIST1H4F;HIST1H4I;HIST1H4D
4970,GO:0015078,0.20865383807354,0.947014674354547,2,75,proton transmembrane transporter activity,MF,SLC9A4;COX7C
2470,GO:0005685,0.209234107816103,0.977734413998137,1,20,U1 snRNP,CC,SNRPD2
1169,GO:0002790,0.209236882359851,0.913339336583968,4,346,peptide secretion,BP,NR1D1;TMSB4X;RAB15;BTN3A1
7038,GO:0030810,0.209560699685708,0.977233581329149,1,33,positive regulation of nucleotide biosynthetic process,BP,TMSB4X
17478,GO:1900373,0.209560699685708,0.977233581329149,1,33,positive regulation of purine nucleotide biosynthetic process,BP,TMSB4X
13583,GO:0060047,0.2096203083707,0.946265195338054,2,125,heart contraction,BP,RGS2;FXYD3
2663,GO:0006006,0.209730964222519,0.946176794093039,2,136,glucose metabolic process,BP,NR1D1;PPP1R3D
6261,GO:0019843,0.210409197978216,0.946588630930109,2,56,rRNA binding,MF,RPL37;RPL23A
15047,GO:0070997,0.210457329857446,0.926156692584025,3,234,neuron death,BP,DDIT4;GDNF;DDIT3
2268,GO:0005198,0.210573610084841,0.884001887600457,8,509,structural molecule activity,MF,RPL37;MUC6;RPL31;RPL23A;RPL28;MAP7D3;RPS27;MAP1A
16110,GO:0090092,0.210604564965254,0.945808500884398,2,137,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,HES5;HES1
11868,GO:0046872,0.210697208655829,0.854516620448199,22,2926,metal ion binding,MF,NR1D1;TCHH;RPL37;SLC24A4;ZC3H12D;RNF125;DCHS1;SNAI2;ZNF44;RNF113A;PHF12;ZNF160;ZNF766;SALL2;JADE2;ZNF169;ZNF799;ZKSCAN3;RPS27;ZNF485;ZNF57;STAC2
7340,GO:0031349,0.211054947661292,0.912358896368273,4,298,positive regulation of defense response,BP,NR1D1;MUC6;RNF125;MUC12
13013,GO:0051443,0.211115847270511,0.976946600113748,1,30,positive regulation of ubiquitin-protein transferase activity,BP,ARRDC3
12248,GO:0048523,0.211427361482088,0.850155160121798,27,3283,negative regulation of cellular process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;GDNF;HES1;ID3;ZC3H12D;RNF125;DDIT3;SNAI2;APC2;NUPR1;HIST1H4F;PHF12;HIST1H1D;SPN;SALL2;TMSB4X;IVNS1ABP;ZKSCAN3;HIST1H4I;CIART;HIST1H4D
1187,GO:0002832,0.211860509140934,0.976653369545982,1,36,negative regulation of response to biotic stimulus,BP,RNF125
6633,GO:0022898,0.211904182740743,0.945297963808274,2,128,regulation of transmembrane transporter activity,BP,TMSB4X;FXYD3
287,GO:0000791,0.211955421281942,0.976807822422621,1,28,euchromatin,CC,HIST1H1D
12783,GO:0051055,0.212085834457743,0.976619181906408,1,35,negative regulation of lipid biosynthetic process,BP,SNAI2
19740,GO:2000107,0.212392286886728,0.976608366120667,1,32,negative regulation of leukocyte apoptotic process,BP,TSC22D3
3563,GO:0007606,0.212730934497366,0.976602815499079,1,29,sensory perception of chemical stimulus,BP,SLC24A4
2946,GO:0006475,0.212740468066148,0.944908726244641,2,138,internal protein amino acid acetylation,BP,SNAI2;JADE2
20107,GO:2000772,0.21276173027158,0.976545945272083,1,31,regulation of cellular senescence,BP,ZKSCAN3
14058,GO:0060828,0.212764521402346,0.92505583759498,3,195,regulation of canonical Wnt signaling pathway,BP,DDIT3;SNAI2;APC2
1263,GO:0003015,0.213017918555428,0.944833813609296,2,127,heart process,BP,RGS2;FXYD3
9382,GO:0035914,0.21475675742847,0.975949132824026,1,38,skeletal muscle cell differentiation,BP,NUPR1
4094,GO:0009147,0.21547616454305,0.976324842450598,1,20,pyrimidine nucleoside triphosphate metabolic process,BP,NME9
1309,GO:0003151,0.215655440952281,0.975644565842771,1,45,outflow tract morphogenesis,BP,HES1
17638,GO:1901361,0.216023884019849,0.880170795621295,8,569,organic cyclic compound catabolic process,BP,DDIT4;RPL37;GDNF;ZC3H12D;RPL31;RPL23A;RPL28;RPS27
10020,GO:0042451,0.216291637439096,0.976137205694332,1,20,purine nucleoside biosynthetic process,BP,NME9
11575,GO:0046129,0.216291637439096,0.976137205694332,1,20,purine ribonucleoside biosynthetic process,BP,NME9
7220,GO:0031113,0.216327381317852,0.975614267320955,1,36,regulation of microtubule polymerization,BP,RGS2
18562,GO:1903779,0.216374546508913,0.975553751782428,1,39,regulation of cardiac conduction,BP,FXYD3
14940,GO:0070830,0.218028135951144,0.975132618660338,1,41,bicellular tight junction assembly,BP,SNAI2
3342,GO:0007062,0.21862630816906,0.942482316140318,2,120,sister chromatid cohesion,BP,SPC25;RPS27
12529,GO:0050670,0.219177928399815,0.942260621305494,2,117,regulation of lymphocyte proliferation,BP,HES1;SPN
11580,GO:0046134,0.219686796957301,0.975148018646588,1,24,pyrimidine nucleoside biosynthetic process,BP,NME9
20274,GO:2001236,0.219749917323165,0.941995102903259,2,121,regulation of extrinsic apoptotic signaling pathway,BP,GDNF;SNAI2
17726,GO:1901654,0.220162333389619,0.941785868803113,2,128,response to ketone,BP,TXNIP;DDIT4
7157,GO:0031016,0.220604074738796,0.974529498288769,1,40,pancreas development,BP,HES1
8199,GO:0032944,0.220948088061668,0.941493619383352,2,118,regulation of mononuclear cell proliferation,BP,HES1;SPN
11524,GO:0046039,0.221039627696833,0.974714941322143,1,27,GTP metabolic process,BP,NME9
2503,GO:0005751,0.221671262449423,0.976102376659381,1,10,mitochondrial respiratory chain complex IV,CC,COX7C
12619,GO:0050798,0.221756009444816,0.974453175776414,1,30,activated T cell proliferation,BP,BTN3A1
14116,GO:0060968,0.223164539490119,0.919916193741221,3,127,regulation of gene silencing,BP,HIST1H4F;HIST1H4I;HIST1H4D
8968,GO:0035050,0.223416366528598,0.973754235271528,1,47,embryonic heart tube development,BP,HES1
13515,GO:0055082,0.22343675264934,0.894631612725988,5,433,cellular chemical homeostasis,BP,NR1D1;SLC24A4;SLC9A4;DDIT3;GPR89A
1476,GO:0003735,0.223467445506363,0.89538147495294,5,154,structural constituent of ribosome,MF,RPL37;RPL31;RPL23A;RPL28;RPS27
4103,GO:0009156,0.223801460190203,0.940217795828488,2,126,ribonucleoside monophosphate biosynthetic process,BP,DDIT4;TMSB4X
2471,GO:0005686,0.224288583229775,0.974254142306577,1,20,U2 snRNP,CC,SNRPD2
6937,GO:0030544,0.224460475519712,0.973658769996244,1,36,Hsp70 protein binding,MF,SPN
5968,GO:0018394,0.22452727212583,0.939843873281802,2,140,peptidyl-lysine acetylation,BP,SNAI2;JADE2
16737,GO:0097755,0.224849423211037,0.973583004259141,1,35,positive regulation of blood vessel diameter,BP,RGS2
17919,GO:1902230,0.224890597414897,0.973820173294249,1,26,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,SNAI2
1384,GO:0003281,0.225546643379825,0.973216995794426,1,48,ventricular septum development,BP,HES1
8479,GO:0033627,0.226382017897348,0.973147703425479,1,38,cell adhesion mediated by integrin,BP,SNAI2
9052,GO:0035272,0.227471244795757,0.972876565600754,1,38,exocrine system development,BP,SNAI2
6416,GO:0021675,0.22874990302286,0.972477337802878,1,43,nerve development,BP,HES1
7205,GO:0031093,0.228937751134122,0.972527560153837,1,37,platelet alpha granule lumen,CC,TMSB4X
9016,GO:0035195,0.22975963992324,0.916350221362808,3,134,gene silencing by miRNA,BP,HIST1H4F;HIST1H4I;HIST1H4D
17109,GO:0101003,0.230134600256443,0.972225891064786,1,37,ficolin-1-rich granule membrane,CC,SLC2A3
13820,GO:0060411,0.230440527395149,0.971986186342502,1,48,cardiac septum morphogenesis,BP,HES1
11882,GO:0046889,0.230515369194548,0.972016771926717,1,44,positive regulation of lipid biosynthetic process,BP,NR1D1
531,GO:0001649,0.230733854626422,0.937101164520649,2,141,osteoblast differentiation,BP,ID3;SNAI2
11730,GO:0046540,0.230981909709159,0.972397372499324,1,24,U4/U6 x U5 tri-snRNP complex,CC,SNRPD2
12307,GO:0048646,0.231346587601173,0.881220800657085,6,693,anatomical structure formation involved in morphogenesis,BP,HES5;GDNF;HES1;SLC24A4;DCHS1;SNAI2
7850,GO:0032409,0.23220767221434,0.9364508362962,2,139,regulation of transporter activity,BP,TMSB4X;FXYD3
3211,GO:0006855,0.232478335315377,0.971488876237887,1,46,drug transmembrane transport,BP,ABCB5
2902,GO:0006412,0.232839363356025,0.859915135178629,10,654,translation,BP,RGS2;RPL37;ZC3H12D;RPL31;HIST1H4F;RPL23A;RPL28;HIST1H4I;RPS27;HIST1H4D
872,GO:0002220,0.233011722199912,0.936336625594217,2,96,innate immune response activating cell surface receptor signaling pathway,BP,MUC6;MUC12
874,GO:0002223,0.233011722199912,0.936336625594217,2,96,stimulatory C-type lectin receptor signaling pathway,BP,MUC6;MUC12
3116,GO:0006694,0.23352260510348,0.935918046283675,2,126,steroid biosynthetic process,BP,NR1D1;SNAI2
10406,GO:0043242,0.234680540712386,0.970895270421979,1,48,negative regulation of protein complex disassembly,BP,APC2
11340,GO:0045664,0.234777862502537,0.898215507840821,4,410,regulation of neuron differentiation,BP,HES5;S1PR5;HES1;ID3
12079,GO:0048029,0.235565136625587,0.970689572193954,1,46,monosaccharide binding,MF,SLC2A3
16812,GO:0098661,0.235634957960389,0.970684581323192,1,45,inorganic anion transmembrane transport,BP,FXYD3
11577,GO:0046131,0.235706521091063,0.971111562394416,1,26,pyrimidine ribonucleoside metabolic process,BP,NME9
12605,GO:0050778,0.235714422762862,0.886776973447962,5,447,positive regulation of immune response,BP,NR1D1;MUC6;RNF125;BTN3A1;MUC12
7072,GO:0030858,0.235730974236712,0.970833646235172,1,35,positive regulation of epithelial cell differentiation,BP,GDNF
5887,GO:0018023,0.236003201183889,0.970720476180819,1,37,peptidyl-lysine trimethylation,BP,HIST1H1D
4302,GO:0009749,0.236502753754522,0.93457436611228,2,126,response to glucose,BP,TXNIP;NR1D1
8200,GO:0032945,0.236797040538684,0.970409134131473,1,43,negative regulation of mononuclear cell proliferation,BP,SPN
12531,GO:0050672,0.236797040538684,0.970409134131473,1,43,negative regulation of lymphocyte proliferation,BP,SPN
10356,GO:0043169,0.237029047105204,0.833326663332049,22,2968,cation binding,MF,NR1D1;TCHH;RPL37;SLC24A4;ZC3H12D;RNF125;DCHS1;SNAI2;ZNF44;RNF113A;PHF12;ZNF160;ZNF766;SALL2;JADE2;ZNF169;ZNF799;ZKSCAN3;RPS27;ZNF485;ZNF57;STAC2
10583,GO:0043547,0.237054113284115,0.911885931949017,3,302,positive regulation of GTPase activity,BP,RIN2;RGS2;APC2
17850,GO:1902036,0.237505126649801,0.912526820891847,3,95,regulation of hematopoietic stem cell differentiation,BP,HIST1H4F;HIST1H4I;HIST1H4D
17954,GO:1902305,0.238257879052629,0.970091643989936,1,39,regulation of sodium ion transmembrane transport,BP,FXYD3
3336,GO:0007051,0.2384711215875,0.933563363695402,2,155,spindle organization,BP,GOLGA2P5;SPC25
9278,GO:0035710,0.238517371292948,0.969941460291047,1,44,CD4-positive, alpha-beta T cell activation,BP,SPN
4111,GO:0009165,0.238960657786129,0.910956328671533,3,233,nucleotide biosynthetic process,BP,DDIT4;NME9;TMSB4X
20271,GO:2001233,0.239409423696439,0.895531965369124,4,308,regulation of apoptotic signaling pathway,BP,GDNF;DDIT3;SNAI2;IVNS1ABP
6822,GO:0030279,0.239468157169419,0.969736482434272,1,41,negative regulation of ossification,BP,ID3
14874,GO:0070663,0.239606204912651,0.933183031456291,2,122,regulation of leukocyte proliferation,BP,HES1;SPN
1392,GO:0003300,0.239896008521941,0.969509847270258,1,49,cardiac muscle hypertrophy,BP,RGS2
4938,GO:0014897,0.239896008521941,0.969509847270258,1,49,striated muscle hypertrophy,BP,RGS2
4301,GO:0009746,0.239939820606943,0.932999945152192,2,128,response to hexose,BP,TXNIP;NR1D1
6212,GO:0019725,0.240174683695329,0.875345157320938,6,549,cellular homeostasis,BP,NR1D1;NME9;SLC24A4;SLC9A4;DDIT3;GPR89A
8919,GO:0034762,0.240280432990888,0.910163236013374,3,265,regulation of transmembrane transport,BP,TMSB4X;FXYD3;GPR89A
15236,GO:0071396,0.240659848761174,0.894660894030245,4,387,cellular response to lipid,BP,NR1D1;DDIT4;ID3;SNAI2
6649,GO:0023052,0.240721146712602,0.824432361676044,30,3925,signaling,BP,TXNIP;NR1D1;HES5;DDIT4;RIN2;RGS2;S1PR5;GDNF;HES1;MUC6;IFIT2;RNF125;DCHS1;DDIT3;SNAI2;APC2;NUPR1;SPN;SALL2;TMSB4X;FAM110C;FXYD3;GPR89A;IVNS1ABP;RHOF;ARRDC3;RAB15;BTN3A1;MUC12;STAC2
16817,GO:0098687,0.24098198252836,0.894564959091738,4,312,chromosomal region,CC,HIST1H4F;SPC25;HIST1H4I;HIST1H4D
6759,GO:0030182,0.241328762630565,0.867633794300481,7,850,neuron differentiation,BP,HES5;DDIT4;S1PR5;GDNF;HES1;ID3;MAP1A
8974,GO:0035065,0.241351540833678,0.969158420048941,1,46,regulation of histone acetylation,BP,SNAI2
10543,GO:0043491,0.241844502503399,0.932033859426472,2,150,protein kinase B signaling,BP,DDIT3;FAM110C
10426,GO:0043270,0.243491069649114,0.931408818399015,2,120,positive regulation of ion transport,BP,GDNF;TMSB4X
16338,GO:0090575,0.24379359896071,0.93121198612478,2,131,RNA polymerase II transcription factor complex,CC,NR1D1;DDIT3
6656,GO:0030003,0.243816372014145,0.892789039599147,4,336,cellular cation homeostasis,BP,SLC24A4;SLC9A4;DDIT3;GPR89A
13687,GO:0060218,0.244071253814747,0.908849923345952,3,100,hematopoietic stem cell differentiation,BP,HIST1H4F;HIST1H4I;HIST1H4D
10573,GO:0043536,0.244481536884973,0.968373277792998,1,42,positive regulation of blood vessel endothelial cell migration,BP,TMSB4X
14065,GO:0060840,0.244803432204603,0.968139712359367,1,53,artery development,BP,HES1
10564,GO:0043523,0.245475258057351,0.930408661239093,2,136,regulation of neuron apoptotic process,BP,GDNF;DDIT3
17608,GO:1901293,0.246078550967321,0.906992513623498,3,236,nucleoside phosphate biosynthetic process,BP,DDIT4;NME9;TMSB4X
12229,GO:0048487,0.246573229586161,0.968025048558792,1,32,beta-tubulin binding,MF,RGS2
9015,GO:0035194,0.247244586687967,0.906713263646748,3,140,posttranscriptional gene silencing by RNA,BP,HIST1H4F;HIST1H4I;HIST1H4D
11184,GO:0045277,0.247666838495531,0.969543547242575,1,11,respiratory chain complex IV,CC,COX7C
12260,GO:0048545,0.248266232148401,0.905694650791961,3,270,response to steroid hormone,BP,TXNIP;NR1D1;DDIT4
3630,GO:0008092,0.248284266913666,0.869723497015749,6,671,cytoskeletal protein binding,MF,RGS2;APC2;TMSB4X;FAM110C;MAP7D3;MAP1A
5501,GO:0016441,0.248499287702579,0.906003065675567,3,141,posttranscriptional gene silencing,BP,HIST1H4F;HIST1H4I;HIST1H4D
2967,GO:0006506,0.248810530150732,0.96741157457342,1,32,GPI anchor biosynthetic process,BP,PIGH
3193,GO:0006821,0.249086893814292,0.967107546032369,1,42,chloride transport,BP,FXYD3
16139,GO:0090150,0.249088663542351,0.878360470795007,5,265,establishment of protein localization to membrane,BP,RPL37;RPL31;RPL23A;RPL28;RPS27
14643,GO:0070231,0.249561876992829,0.96712174732342,1,35,T cell apoptotic process,BP,TSC22D3
10384,GO:0043207,0.249864668186966,0.868735556021784,6,521,response to external biotic stimulus,BP,NR1D1;DDIT4;IFIT2;RNF125;SPN;IVNS1ABP
13144,GO:0051707,0.249864668186966,0.868735556021784,6,521,response to other organism,BP,NR1D1;DDIT4;IFIT2;RNF125;SPN;IVNS1ABP
4358,GO:0009953,0.24993968369146,0.966778500753149,1,48,dorsal/ventral pattern formation,BP,DDIT3
15290,GO:0071478,0.250332747105335,0.928106563765764,2,142,cellular response to radiation,BP,ACTR5;SNAI2
12974,GO:0051353,0.250823326327976,0.966854141029348,1,32,positive regulation of oxidoreductase activity,BP,GDNF
10293,GO:0043043,0.250949473396067,0.84635852257988,10,673,peptide biosynthetic process,BP,RGS2;RPL37;ZC3H12D;RPL31;HIST1H4F;RPL23A;RPL28;HIST1H4I;RPS27;HIST1H4D
2298,GO:0005262,0.251733243462823,0.966213458900844,1,53,calcium channel activity,MF,SLC24A4
14842,GO:0070588,0.251921875322346,0.927301032950645,2,156,calcium ion transmembrane transport,BP,SLC24A4;DDIT3
5669,GO:0016776,0.252089859834972,0.966500694538723,1,32,phosphotransferase activity, phosphate group as acceptor,MF,NME9
8088,GO:0032768,0.25212438751071,0.966315078578241,1,39,regulation of monooxygenase activity,BP,GDNF
4072,GO:0009124,0.252575312684207,0.927076066010845,2,135,nucleoside monophosphate biosynthetic process,BP,DDIT4;TMSB4X
2966,GO:0006505,0.252631004733435,0.966319206841757,1,33,GPI anchor metabolic process,BP,PIGH
977,GO:0002429,0.252674182909993,0.90328614926234,3,229,immune response-activating cell surface receptor signaling pathway,BP,MUC6;BTN3A1;MUC12
8684,GO:0034284,0.253209356742622,0.926789228571775,2,132,response to monosaccharide,BP,TXNIP;NR1D1
13537,GO:0055117,0.25329531283199,0.965945207529003,1,41,regulation of cardiac muscle contraction,BP,RGS2
3816,GO:0008406,0.254367181435913,0.926183123431158,2,144,gonad development,BP,HOXA9;NUPR1
3221,GO:0006873,0.254416308540309,0.886192135435506,4,344,cellular ion homeostasis,BP,SLC24A4;SLC9A4;DDIT3;GPR89A
16275,GO:0090342,0.254565061331929,0.965668887307022,1,37,regulation of cell aging,BP,ZKSCAN3
7500,GO:0031670,0.255334105414595,0.96528000191485,1,46,cellular response to nutrient,BP,SNAI2
10441,GO:0043297,0.255494572076046,0.965191206979139,1,49,apical junction assembly,BP,SNAI2
7060,GO:0030837,0.255495346572922,0.96538107492114,1,38,negative regulation of actin filament polymerization,BP,TMSB4X
7338,GO:0031347,0.255540645763003,0.873756744277779,5,454,regulation of defense response,BP,NR1D1;MUC6;RNF125;TMSB4X;MUC12
15227,GO:0071385,0.255606592233439,0.965250726212958,1,43,cellular response to glucocorticoid stimulus,BP,DDIT4
6564,GO:0022008,0.25574290522685,0.851534270342582,8,1015,neurogenesis,BP,HES5;DDIT4;S1PR5;GDNF;HES1;ID3;DCHS1;MAP1A
3047,GO:0006605,0.255963702805381,0.86470531031905,6,368,protein targeting,BP,RPL37;HES1;RPL31;RPL23A;RPL28;RPS27
15052,GO:0071007,0.256322448613431,0.965409305493862,1,29,U2-type catalytic step 2 spliceosome,CC,SNRPD2
14875,GO:0070664,0.256648473849675,0.964918001989643,1,45,negative regulation of leukocyte proliferation,BP,SPN
2787,GO:0006221,0.258474443144128,0.964834532663295,1,28,pyrimidine nucleotide biosynthetic process,BP,NME9
10566,GO:0043525,0.259274058733424,0.964292714860992,1,38,positive regulation of neuron apoptotic process,BP,DDIT3
10280,GO:0043025,0.259834472835945,0.899099991165071,3,266,neuronal cell body,CC,NRSN1;CNNM1;MAP1A
2732,GO:0006110,0.260601577204634,0.963668813398139,1,52,regulation of glycolytic process,BP,DDIT4
1148,GO:0002753,0.260603269574451,0.963694041171953,1,50,cytoplasmic pattern recognition receptor signaling pathway,BP,RNF125
11114,GO:0045137,0.260752851537431,0.923094311956063,2,147,development of primary sexual characteristics,BP,HOXA9;NUPR1
4145,GO:0009205,0.260785289028798,0.882423358352523,4,232,purine ribonucleoside triphosphate metabolic process,BP,DDIT4;NME9;TMSB4X;COX7C
4937,GO:0014896,0.260924361456282,0.963599615782386,1,50,muscle hypertrophy,BP,RGS2
2594,GO:0005887,0.261101911231324,0.860787372724496,6,734,integral component of plasma membrane,CC,SLC24A4;SLC2A3;SPN;FXYD3;MUC12;ABCB5
6702,GO:0030099,0.26130799445353,0.881933153869574,4,292,myeloid cell differentiation,BP,HOXA9;HIST1H4F;HIST1H4I;HIST1H4D
2871,GO:0006364,0.26183635068922,0.869906177708772,5,255,rRNA processing,BP,RPL37;RPL31;RPL23A;RPL28;RPS27
6603,GO:0022618,0.261943898039321,0.898070948363831,3,194,ribonucleoprotein complex assembly,BP,SNRPD2;RPL23A;RPS27
12855,GO:0051170,0.26266827281909,0.922215531032183,2,135,import into nucleus,BP,TXNIP;SNRPD2
1461,GO:0003705,0.262751491150002,0.962997903408102,1,55,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,SNAI2
15244,GO:0071407,0.262952999845015,0.880698409384241,4,421,cellular response to organic cyclic compound,BP,NR1D1;DDIT4;ID3;SNAI2
1256,GO:0003008,0.263032388665674,0.85215667926185,7,801,system process,BP,RGS2;GDNF;SLC24A4;MUC6;SLC9A4;SNAI2;FXYD3
3784,GO:0008344,0.264585262014228,0.962707925983133,1,39,adult locomotory behavior,BP,GDNF
796,GO:0002062,0.264903113119202,0.962312846091647,1,59,chondrocyte differentiation,BP,SNAI2
17587,GO:1901222,0.265200121581611,0.962358048426428,1,48,regulation of NIK/NF-kappaB signaling,BP,TMSB4X
6865,GO:0030334,0.265424087784196,0.867033711556715,5,540,regulation of cell migration,BP,SNAI2;SPN;TMSB4X;FAM110C;RHOF
14934,GO:0070821,0.265549868182621,0.96231891122664,1,44,tertiary granule membrane,CC,SLC2A3
3272,GO:0006952,0.265778615589217,0.83915906487793,9,911,defense response,BP,NR1D1;DDIT4;MUC6;IFIT2;RNF125;NUPR1;SPN;TMSB4X;MUC12
7168,GO:0031047,0.26645625794036,0.89562660426961,3,155,gene silencing by RNA,BP,HIST1H4F;HIST1H4I;HIST1H4D
11500,GO:0045981,0.267139461316048,0.961878845745575,1,42,positive regulation of nucleotide metabolic process,BP,TMSB4X
17502,GO:1900544,0.267139461316048,0.961878845745575,1,42,positive regulation of purine nucleotide metabolic process,BP,TMSB4X
2205,GO:0005088,0.267220207918474,0.919830772501077,2,172,Ras guanyl-nucleotide exchange factor activity,MF,RIN2;GDNF
12579,GO:0050730,0.267862576013797,0.919595814985069,2,149,regulation of peptidyl-tyrosine phosphorylation,BP,HES5;HES1
5327,GO:0016051,0.268319294922278,0.919333612442997,2,158,carbohydrate biosynthetic process,BP,NR1D1;PPP1R3D
13561,GO:0060021,0.268825701544132,0.961145531146516,1,57,roof of mouth development,BP,SNAI2
7712,GO:0032200,0.268844942875028,0.89416585127162,3,166,telomere organization,BP,HIST1H4F;HIST1H4I;HIST1H4D
9860,GO:0042110,0.269000694403271,0.893742610264981,3,270,T cell activation,BP,HES1;SPN;BTN3A1
13083,GO:0051588,0.269024340753667,0.9612020038989,1,48,regulation of neurotransmitter transport,BP,GDNF
906,GO:0002286,0.269424849951759,0.961095644189965,1,47,T cell activation involved in immune response,BP,SPN
18347,GO:1903313,0.269426732137281,0.960972894834045,1,56,positive regulation of mRNA metabolic process,BP,ZC3H12D
2906,GO:0006417,0.269776689757447,0.864234148383295,5,387,regulation of translation,BP,RGS2;ZC3H12D;HIST1H4F;HIST1H4I;HIST1H4D
891,GO:0002260,0.269804041238022,0.961050746893517,1,43,lymphocyte homeostasis,BP,TSC22D3
4139,GO:0009199,0.270252355333757,0.876352190292242,4,238,ribonucleoside triphosphate metabolic process,BP,DDIT4;NME9;TMSB4X;COX7C
9058,GO:0035282,0.270419634700354,0.960625410272923,1,60,segmentation,BP,HES5
4286,GO:0009653,0.270449635340912,0.821361780798381,13,1703,anatomical structure morphogenesis,BP,HES5;HOXA9;LRIG3;GDNF;HES1;HOXC13;ID3;SLC24A4;DCHS1;SNAI2;OTX1;RHOF;MAP1A
8081,GO:0032760,0.270520654955721,0.9609419922089,1,38,positive regulation of tumor necrosis factor production,BP,SPN
7039,GO:0030811,0.270867225669857,0.960542185562609,1,55,regulation of nucleotide catabolic process,BP,DDIT4
11129,GO:0045171,0.27168860635109,0.960385052797771,1,48,intercellular bridge,CC,APC2
14228,GO:0061178,0.272057547667633,0.96052438465016,1,36,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,NR1D1
11419,GO:0045833,0.272118834869951,0.960236740401407,1,49,negative regulation of lipid metabolic process,BP,SNAI2
11774,GO:0046632,0.272204456174825,0.960141365864418,1,54,alpha-beta T cell differentiation,BP,SPN
14810,GO:0070542,0.272667590552076,0.960023831686002,1,52,response to fatty acid,BP,ID3
13603,GO:0060070,0.272696127613479,0.891628485630141,3,238,canonical Wnt signaling pathway,BP,DDIT3;SNAI2;APC2
3799,GO:0008375,0.273198762095932,0.959902140032093,1,49,acetylglucosaminyltransferase activity,MF,PIGH
20098,GO:2000756,0.27407090632055,0.959615683931897,1,50,regulation of peptidyl-lysine acetylation,BP,SNAI2
10301,GO:0043065,0.274220904087672,0.86109202623292,5,467,positive regulation of apoptotic process,BP,TXNIP;ID3;IFIT2;DDIT3;NUPR1
10550,GO:0043502,0.275026849574042,0.959288330297294,1,52,regulation of muscle adaptation,BP,RGS2
6358,GO:0021537,0.275374158440638,0.915797232809449,2,158,telencephalon development,BP,HES5;HES1
11823,GO:0046717,0.275758668509532,0.959087440097818,1,50,acid secretion,BP,SLC9A4
2543,GO:0005801,0.276225804316469,0.959005862064501,1,46,cis-Golgi network,CC,GOLGA2P5
13671,GO:0060191,0.276635054446876,0.958877127250091,1,46,regulation of lipase activity,BP,RGS2
3377,GO:0007156,0.276838359268861,0.958564754712936,1,66,homophilic cell adhesion via plasma membrane adhesion molecules,BP,DCHS1
10304,GO:0043068,0.277040497000551,0.859146789474356,5,470,positive regulation of programmed cell death,BP,TXNIP;ID3;IFIT2;DDIT3;NUPR1
15226,GO:0071384,0.277081172384454,0.958736537371623,1,46,cellular response to corticosteroid stimulus,BP,DDIT4
18465,GO:1903557,0.277291607531107,0.958793587344993,1,40,positive regulation of tumor necrosis factor superfamily cytokine production,BP,SPN
16236,GO:0090287,0.277601043487214,0.914623302940316,2,170,regulation of cellular response to growth factor stimulus,BP,HES5;HES1
10914,GO:0044464,0.277799640444405,0.847092675212079,82,11076,cell part,CC,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RIN2;RGS2;HOXA9;NRSN1;S1PR5;TCHH;RPL37;LRIG3;NME9;PPP1R3D;GDNF;HES1;HOXC13;ID3;SLC24A4;ZC3H12D;GOLGA2P5;TIGD2;LGALS7B;MUC6;SMIM14;SLC2A3;IFIT2;RNF125;ACTR5;SLC9A4;DCHS1;SNRPD2;DDIT3;SNAI2;APC2;RPL31;FAM217B;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;SPC25;ZNF160;HIST1H1D;ZNF766;CNNM1;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;JADE2;ZNF169;FAM110C;FXYD3;KIAA0753;GPR89A;IVNS1ABP;HSP90AB4P;ZNF799;ZKSCAN3;COX7C;HIST1H4I;RHOF;CIART;ARRDC3;MAP7D3;RPS27;ZNF485;HIST1H4D;RAB15;BTN3A1;MUC12;ZNF57;STAC2;MAP1A;ABCB5
2853,GO:0006342,0.277974890123353,0.889247897350729,3,107,chromatin silencing,BP,HIST1H4F;HIST1H4I;HIST1H4D
4091,GO:0009144,0.278526092482567,0.870975779430434,4,239,purine nucleoside triphosphate metabolic process,BP,DDIT4;NME9;TMSB4X;COX7C
8014,GO:0032642,0.28054048457539,0.957655933028795,1,45,regulation of chemokine production,BP,SNAI2
2718,GO:0006094,0.280619384727564,0.957529381156455,1,51,gluconeogenesis,BP,NR1D1
8785,GO:0034470,0.280852827263512,0.847045585848877,6,396,ncRNA processing,BP,RPL37;RPL31;RNF113A;RPL23A;RPL28;RPS27
3383,GO:0007162,0.282075989261136,0.91233440912548,2,169,negative regulation of cell adhesion,BP,SNAI2;SPN
18446,GO:1903530,0.282298226485734,0.868172962096407,4,399,regulation of secretion by cell,BP,NR1D1;GDNF;TMSB4X;RAB15
4317,GO:0009798,0.283068055747471,0.956696783565618,1,54,axis specification,BP,DDIT3
13020,GO:0051452,0.283349826940646,0.956941520910373,1,37,intracellular pH reduction,BP,GPR89A
3269,GO:0006942,0.283359113803337,0.956768528458794,1,44,regulation of striated muscle contraction,BP,RGS2
15540,GO:0071944,0.283432746980709,0.796035349703226,21,2890,cell periphery,CC,RGS2;S1PR5;TCHH;LRIG3;SLC24A4;MUC6;SLC2A3;SLC9A4;DCHS1;APC2;CNNM1;SPN;FAM110C;FXYD3;RHOF;ARRDC3;RAB15;BTN3A1;MUC12;STAC2;ABCB5
15479,GO:0071826,0.284056835306132,0.884908269701969,3,205,ribonucleoprotein complex subunit organization,BP,SNRPD2;RPL23A;RPS27
15904,GO:0072676,0.284113665471086,0.956589971309247,1,41,lymphocyte migration,BP,SPN
3328,GO:0007040,0.284429559851493,0.956297094487044,1,51,lysosome organization,BP,ZKSCAN3
15984,GO:0080171,0.284429559851493,0.956297094487044,1,51,lytic vacuole organization,BP,ZKSCAN3
2435,GO:0005623,0.284761421286126,0.84229874653492,82,11082,cell,CC,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RIN2;RGS2;HOXA9;NRSN1;S1PR5;TCHH;RPL37;LRIG3;NME9;PPP1R3D;GDNF;HES1;HOXC13;ID3;SLC24A4;ZC3H12D;GOLGA2P5;TIGD2;LGALS7B;MUC6;SMIM14;SLC2A3;IFIT2;RNF125;ACTR5;SLC9A4;DCHS1;SNRPD2;DDIT3;SNAI2;APC2;RPL31;FAM217B;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;SPC25;ZNF160;HIST1H1D;ZNF766;CNNM1;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;JADE2;ZNF169;FAM110C;FXYD3;KIAA0753;GPR89A;IVNS1ABP;HSP90AB4P;ZNF799;ZKSCAN3;COX7C;HIST1H4I;RHOF;CIART;ARRDC3;MAP7D3;RPS27;ZNF485;HIST1H4D;RAB15;BTN3A1;MUC12;ZNF57;STAC2;MAP1A;ABCB5
3510,GO:0007422,0.285142032756262,0.956049388754048,1,52,peripheral nervous system development,BP,GDNF
7909,GO:0032480,0.285302339143327,0.956136937769779,1,44,negative regulation of type I interferon production,BP,RNF125
14640,GO:0070228,0.285951513325459,0.956016265588135,1,40,regulation of lymphocyte apoptotic process,BP,TSC22D3
3281,GO:0006970,0.286342431109967,0.95564112002161,1,53,response to osmotic stress,BP,TSC22D3
10868,GO:0044391,0.286365642599112,0.853465233750974,5,182,ribosomal subunit,CC,RPL37;RPL31;RPL23A;RPL28;RPS27
11431,GO:0045851,0.287461243752947,0.955575161936259,1,38,pH reduction,BP,GPR89A
12356,GO:0048732,0.287547688696472,0.882548963918735,3,296,gland development,BP,HOXA9;HES1;SNAI2
17918,GO:1902229,0.287632919689877,0.955681303561455,1,33,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,SNAI2
632,GO:0001819,0.287676176803105,0.882556642978884,3,254,positive regulation of cytokine production,BP,RNF125;DDIT3;SPN
1161,GO:0002768,0.28821949109653,0.882228643343702,3,252,immune response-regulating cell surface receptor signaling pathway,BP,MUC6;BTN3A1;MUC12
2743,GO:0006123,0.288249769880879,0.957171267639663,1,14,mitochondrial electron transport, cytochrome c to oxygen,BP,COX7C
6193,GO:0019646,0.288249769880879,0.957171267639663,1,14,aerobic electron transport chain,BP,COX7C
9195,GO:0035579,0.288723129211259,0.954826218174285,1,55,specific granule membrane,CC,SLC2A3
4299,GO:0009743,0.28899530591852,0.90883345794602,2,146,response to carbohydrate,BP,TXNIP;NR1D1
10793,GO:0044265,0.289058508422684,0.81677369115474,10,959,cellular macromolecule catabolic process,BP,NR1D1;RPL37;GDNF;ZC3H12D;RNF125;DDIT3;RPL31;RPL23A;RPL28;RPS27
9314,GO:0035773,0.289147009340609,0.954965621283612,1,40,insulin secretion involved in cellular response to glucose stimulus,BP,NR1D1
3497,GO:0007399,0.289201379767912,0.812646269267335,11,1468,nervous system development,BP,HES5;DDIT4;NRSN1;S1PR5;GDNF;HES1;ID3;DCHS1;OTX1;SALL2;MAP1A
15055,GO:0071011,0.289222447126461,0.955239768569718,1,31,precatalytic spliceosome,CC,SNRPD2
10030,GO:0042475,0.289276751514668,0.954628675788873,1,56,odontogenesis of dentin-containing tooth,BP,SLC24A4
4486,GO:0010507,0.290128840146529,0.954295044842249,1,60,negative regulation of autophagy,BP,ZKSCAN3
15745,GO:0072331,0.290726176866367,0.880700919083581,3,247,signal transduction by p53 class mediator,BP,DDIT4;SNAI2;NUPR1
2588,GO:0005881,0.291600145291925,0.953908258926471,1,52,cytoplasmic microtubule,CC,APC2
13068,GO:0051568,0.291642649769203,0.954019085246654,1,45,histone H3-K4 methylation,BP,HIST1H1D
20183,GO:2001023,0.292068571187746,0.953942802567161,1,42,regulation of response to drug,BP,GDNF
6574,GO:0022037,0.292456313852044,0.953500846483454,1,61,metencephalon development,BP,OTX1
4973,GO:0015085,0.292793235162372,0.953344419626794,1,65,calcium ion transmembrane transporter activity,MF,SLC24A4
18346,GO:1903312,0.292825814578955,0.953375865635008,1,61,negative regulation of mRNA metabolic process,BP,GDNF
6100,GO:0019318,0.292885925570094,0.906670987686034,2,173,hexose metabolic process,BP,NR1D1;PPP1R3D
14541,GO:0070059,0.293150076443253,0.953435565847856,1,49,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,DDIT3
2605,GO:0005902,0.293295867481793,0.953386302416467,1,49,microvillus,CC,SPN
3588,GO:0008013,0.294105316974851,0.952919511338358,1,63,beta-catenin binding,MF,APC2
7756,GO:0032271,0.294590249664058,0.90584634888908,2,153,regulation of protein polymerization,BP,RGS2;TMSB4X
10490,GO:0043388,0.294752977789655,0.95303764138185,1,42,positive regulation of DNA binding,BP,HES1
10022,GO:0042455,0.294796069850671,0.953262707608389,1,34,ribonucleoside biosynthetic process,BP,NME9
12247,GO:0048522,0.294954945249103,0.781185212965357,26,3480,positive regulation of cellular process,BP,TXNIP;NR1D1;HES5;DDIT4;RGS2;HOXA9;GDNF;HES1;HOXC13;ID3;ZC3H12D;IFIT2;RNF125;DDIT3;SNAI2;NUPR1;OTX1;SPN;SALL2;TMSB4X;FAM110C;GPR89A;IVNS1ABP;ZKSCAN3;ARRDC3;RAB15
4343,GO:0009894,0.295715264628628,0.827986228970033,7,769,regulation of catabolic process,BP,DDIT4;PPP1R3D;GDNF;ZC3H12D;RNF125;APC2;ZKSCAN3
5051,GO:0015238,0.295928295709638,0.952307617409989,1,62,drug transmembrane transporter activity,MF,ABCB5
5159,GO:0015696,0.296166207054423,0.952447842479984,1,47,ammonium transport,BP,GDNF
11869,GO:0046873,0.296170140461265,0.904839528075363,2,200,metal ion transmembrane transporter activity,MF,SLC24A4;SLC9A4
7203,GO:0031091,0.296302944118943,0.952297166529987,1,53,platelet alpha granule,CC,TMSB4X
6101,GO:0019319,0.29657756535892,0.952187922252109,1,54,hexose biosynthetic process,BP,NR1D1
11409,GO:0045814,0.296590316609156,0.877749477150301,3,121,negative regulation of gene expression, epigenetic,BP,HIST1H4F;HIST1H4I;HIST1H4D
178,GO:0000387,0.296763233007863,0.952492705078002,1,37,spliceosomal snRNP assembly,BP,SNRPD2
17709,GO:1901617,0.297056594638179,0.904495432092757,2,161,organic hydroxy compound biosynthetic process,BP,NR1D1;SNAI2
12942,GO:0051298,0.297513552814219,0.95177378325615,1,61,centrosome duplication,BP,KIAA0753
5834,GO:0017112,0.298620857990738,0.951566733097824,1,49,Rab guanyl-nucleotide exchange factor activity,MF,RIN2
7757,GO:0032272,0.29864007354728,0.951578731910287,1,48,negative regulation of protein polymerization,BP,TMSB4X
6880,GO:0030374,0.29889873620632,0.95134498096938,1,57,ligand-dependent nuclear receptor transcription coactivator activity,MF,NR1D1
6632,GO:0022890,0.298942974912105,0.875544224853628,3,269,inorganic cation transmembrane transporter activity,MF,SLC24A4;SLC9A4;COX7C
5337,GO:0016072,0.298945760604624,0.844115857005314,5,284,rRNA metabolic process,BP,RPL37;RPL31;RPL23A;RPL28;RPS27
12542,GO:0050688,0.299604307185444,0.951158433443812,1,53,regulation of defense response to virus,BP,RNF125
8098,GO:0032781,0.299854959255864,0.951342395656604,1,40,positive regulation of ATPase activity,BP,TMSB4X
8387,GO:0033293,0.299980990350092,0.951494216936814,1,34,monocarboxylic acid binding,MF,ID3
17799,GO:1901888,0.300120268379565,0.950825032529707,1,65,regulation of cell junction assembly,BP,SNAI2
18926,GO:1904659,0.300216468180437,0.950781143745957,1,66,glucose transmembrane transport,BP,SLC2A3
776,GO:0002028,0.300683569165384,0.950737977101321,1,56,regulation of sodium ion transport,BP,FXYD3
14509,GO:0065004,0.300743289344799,0.85626910096666,4,213,protein-DNA complex assembly,BP,HIST1H4F;HIST1H1D;HIST1H4I;HIST1H4D
6059,GO:0019205,0.300978113430702,0.950925963979467,1,41,nucleobase-containing compound kinase activity,MF,NME9
784,GO:0002039,0.301443084831612,0.950407168710185,1,61,p53 binding,MF,RNF125
9822,GO:0042035,0.301488819606384,0.950442472750716,1,57,regulation of cytokine biosynthetic process,BP,SPN
17689,GO:1901566,0.301679460524046,0.788828326535858,16,1531,organonitrogen compound biosynthetic process,BP,DDIT4;RGS2;RPL37;NME9;ZC3H12D;MUC6;RPL31;HIST1H4F;RPL23A;PIGH;RPL28;TMSB4X;HIST1H4I;RPS27;HIST1H4D;MUC12
2474,GO:0005689,0.302358773845562,0.951078544087304,1,26,U12-type spliceosomal complex,CC,SNRPD2
18703,GO:1904062,0.302706646918177,0.901466468375959,2,157,regulation of cation transmembrane transport,BP,TMSB4X;FXYD3
9835,GO:0042063,0.302786677081724,0.901350419535294,2,175,gliogenesis,BP,HES5;HES1
10615,GO:0043604,0.302808827392876,0.805982124313683,10,734,amide biosynthetic process,BP,RGS2;RPL37;ZC3H12D;RPL31;HIST1H4F;RPL23A;RPL28;HIST1H4I;RPS27;HIST1H4D
10997,GO:0044798,0.303403833852678,0.90108760424541,2,157,nuclear transcription factor complex,CC,NR1D1;DDIT3
3258,GO:0006928,0.303983120132678,0.804815751713748,10,1267,movement of cell or subcellular component,BP,DDIT4;GDNF;HES1;DCHS1;SNAI2;APC2;SPN;TMSB4X;FAM110C;RHOF
12286,GO:0048608,0.304548046577681,0.87195247568191,3,299,reproductive structure development,BP,HOXA9;HES1;NUPR1
7260,GO:0031226,0.304685727971582,0.8292472234911,6,771,intrinsic component of plasma membrane,CC,SLC24A4;SLC2A3;SPN;FXYD3;MUC12;ABCB5
15825,GO:0072528,0.304860998221112,0.949720823979355,1,36,pyrimidine-containing compound biosynthetic process,BP,NME9
2782,GO:0006213,0.304946561558205,0.949690702490393,1,36,pyrimidine nucleoside metabolic process,BP,NME9
3539,GO:0007548,0.305046571071569,0.900137752228636,2,170,sex differentiation,BP,HOXA9;NUPR1
17279,GO:0140029,0.305517727867872,0.949034218909119,1,56,exocytic process,BP,RAB15
10689,GO:0043967,0.306161504080091,0.948763063557063,1,59,histone H4 acetylation,BP,JADE2
12994,GO:0051402,0.307132257432665,0.899041251758977,2,159,neuron apoptotic process,BP,GDNF;DDIT3
16651,GO:0097526,0.307265546195306,0.949182172312355,1,29,spliceosomal tri-snRNP complex,CC,SNRPD2
12163,GO:0048278,0.307425456959254,0.948352782375732,1,56,vesicle docking,BP,RAB15
14,GO:0000027,0.307882974971338,0.949149720996764,1,26,ribosomal large subunit assembly,BP,RPL23A
19760,GO:2000145,0.308490518844833,0.836817773627164,5,571,regulation of cell motility,BP,SNAI2;SPN;TMSB4X;FAM110C;RHOF
7855,GO:0032414,0.30905107499665,0.947887668995697,1,49,positive regulation of ion transmembrane transporter activity,BP,TMSB4X
3507,GO:0007417,0.309176274393885,0.836309049031493,5,587,central nervous system development,BP,HES5;DDIT4;HES1;ID3;OTX1
2287,GO:0005244,0.310356692030798,0.94721402814079,1,62,voltage-gated ion channel activity,MF,GPR89A
6614,GO:0022832,0.310356692030798,0.94721402814079,1,62,voltage-gated channel activity,MF,GPR89A
6708,GO:0030111,0.310644166125163,0.868163202030605,3,256,regulation of Wnt signaling pathway,BP,DDIT3;SNAI2;APC2
3509,GO:0007420,0.311391372757959,0.848438852592509,4,449,brain development,BP,HES5;DDIT4;HES1;OTX1
4088,GO:0009141,0.311541336436798,0.848699326973115,4,256,nucleoside triphosphate metabolic process,BP,DDIT4;NME9;TMSB4X;COX7C
10688,GO:0043966,0.312121495834613,0.946668886760536,1,55,histone H3 acetylation,BP,JADE2
15088,GO:0071103,0.312204507305533,0.848278629754452,4,245,DNA conformation change,BP,HIST1H4F;HIST1H1D;HIST1H4I;HIST1H4D
16352,GO:0090630,0.312719265177183,0.946263497847686,1,70,activation of GTPase activity,BP,APC2
3949,GO:0008645,0.31346920449267,0.945987746155226,1,70,hexose transmembrane transport,BP,SLC2A3
12667,GO:0050868,0.313743485002437,0.946001609990885,1,60,negative regulation of T cell activation,BP,SPN
11369,GO:0045732,0.314025835087482,0.895153541847984,2,176,positive regulation of protein catabolic process,BP,RNF125;APC2
13513,GO:0055080,0.314257122288545,0.846535377044714,4,381,cation homeostasis,BP,SLC24A4;SLC9A4;DDIT3;GPR89A
8675,GO:0034248,0.314633022300436,0.832507981165264,5,425,regulation of cellular amide metabolic process,BP,RGS2;ZC3H12D;HIST1H4F;HIST1H4I;HIST1H4D
8954,GO:0035019,0.314940587360057,0.94574225598907,1,49,somatic stem cell population maintenance,BP,HES1
17826,GO:1901983,0.315647691386513,0.94534131019904,1,57,regulation of protein acetylation,BP,SNAI2
10790,GO:0044260,0.315654513295532,0.756671415884509,48,6220,cellular macromolecule metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;RPL37;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;MUC6;RNF125;ACTR5;DDIT3;SNAI2;RPL31;NUPR1;OTX1;ZNF44;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SALL2;HOXC5;PIGH;RPL28;TMSB4X;JADE2;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;SPDYE1;CIART;ARRDC3;RPS27;ZNF485;HIST1H4D;MUC12;ZNF57
14317,GO:0061458,0.315706909085708,0.864801199602665,3,302,reproductive system development,BP,HOXA9;HES1;NUPR1
14272,GO:0061337,0.315890486696855,0.945145686899334,1,65,cardiac conduction,BP,FXYD3
5187,GO:0015749,0.316663701579963,0.944794206506643,1,71,monosaccharide transmembrane transport,BP,SLC2A3
16294,GO:0090398,0.316754107027416,0.945013685105502,1,52,cellular senescence,BP,ZKSCAN3
15603,GO:0072089,0.316901807426463,0.944705379224075,1,71,stem cell proliferation,BP,SNAI2
15892,GO:0072659,0.319179873168579,0.892230011381453,2,183,protein localization to plasma membrane,BP,DCHS1;RAB15
2640,GO:0005975,0.319324996400575,0.842906278316457,4,449,carbohydrate metabolic process,BP,NR1D1;DDIT4;PPP1R3D;SLC2A3
610,GO:0001776,0.320727171687509,0.943457285392712,1,56,leukocyte homeostasis,BP,TSC22D3
15213,GO:0071363,0.321077755689704,0.841668945645364,4,454,cellular response to growth factor stimulus,BP,HES5;DDIT4;HES1;SNAI2
15,GO:0000028,0.321636496222654,0.945035080794587,1,18,ribosomal small subunit assembly,BP,RPS27
13151,GO:0051716,0.321795651416557,0.752646857038015,35,4662,cellular response to stimulus,BP,TXNIP;NR1D1;HES5;DDIT4;RIN2;RGS2;S1PR5;GDNF;HES1;ID3;MUC6;IFIT2;RNF125;ACTR5;DCHS1;DDIT3;SNAI2;APC2;NUPR1;HIST1H4F;SPN;SALL2;TMSB4X;FAM110C;GPR89A;IVNS1ABP;ZKSCAN3;HIST1H4I;RHOF;ARRDC3;HIST1H4D;RAB15;BTN3A1;MUC12;STAC2
12338,GO:0048699,0.321960492370193,0.807759525181297,7,943,generation of neurons,BP,HES5;DDIT4;S1PR5;GDNF;HES1;ID3;MAP1A
1383,GO:0003279,0.32199568431273,0.942756459108969,1,74,cardiac septum development,BP,HES1
10548,GO:0043500,0.32264176038421,0.942685375627934,1,59,muscle adaptation,BP,RGS2
12310,GO:0048661,0.322765675174576,0.942668568721619,1,57,positive regulation of smooth muscle cell proliferation,BP,HES5
4537,GO:0010608,0.322894085502836,0.815725675161417,6,506,posttranscriptional regulation of gene expression,BP,RGS2;GDNF;ZC3H12D;HIST1H4F;HIST1H4I;HIST1H4D
8660,GO:0034219,0.323008818047478,0.942379397067878,1,73,carbohydrate transmembrane transport,BP,SLC2A3
11466,GO:0045921,0.32330833701545,0.94247785349267,1,56,positive regulation of exocytosis,BP,RAB15
15225,GO:0071383,0.323373571620867,0.889810692424189,2,193,cellular response to steroid hormone stimulus,BP,NR1D1;DDIT4
17539,GO:1901068,0.323972067075371,0.942424289084315,1,46,guanosine-containing compound metabolic process,BP,NME9
16852,GO:0098771,0.324836112547774,0.839099093330379,4,389,inorganic ion homeostasis,BP,SLC24A4;SLC9A4;DDIT3;GPR89A
631,GO:0001818,0.325617582239734,0.888655513858008,2,160,negative regulation of cytokine production,BP,RNF125;TMSB4X
17020,GO:0099173,0.325912524782748,0.941339068371653,1,66,postsynapse organization,BP,GDNF
2593,GO:0005886,0.325979247057803,0.761055511956546,20,2818,plasma membrane,CC,RGS2;S1PR5;TCHH;LRIG3;SLC24A4;MUC6;SLC2A3;SLC9A4;DCHS1;APC2;CNNM1;SPN;FXYD3;RHOF;ARRDC3;RAB15;BTN3A1;MUC12;STAC2;ABCB5
5071,GO:0015293,0.326171816247925,0.94114422129856,1,75,symporter activity,MF,SLC24A4
18234,GO:1903037,0.326254246644874,0.88824014089242,2,171,regulation of leukocyte cell-cell adhesion,BP,HES1;SPN
12876,GO:0051196,0.327100577284539,0.940856142017654,1,68,regulation of coenzyme metabolic process,BP,DDIT4
11644,GO:0046364,0.327616543955961,0.940773775560736,1,59,monosaccharide biosynthetic process,BP,NR1D1
2001,GO:0004722,0.328099969455274,0.940542839445784,1,62,protein serine/threonine phosphatase activity,MF,PPP1R3D
719,GO:0001942,0.328994301208935,0.940142673859387,1,66,hair follicle development,BP,HOXC13
9854,GO:0042102,0.329967511548551,0.940042413132688,1,49,positive regulation of T cell proliferation,BP,HES1
7697,GO:0032153,0.330766476332903,0.939402011707017,1,70,cell division site,CC,RHOF
6333,GO:0020037,0.330907481733854,0.939489343815771,1,59,heme binding,MF,NR1D1
12774,GO:0051046,0.331031780280778,0.834643412134413,4,424,regulation of secretion,BP,NR1D1;GDNF;TMSB4X;RAB15
9604,GO:0036464,0.331149806671259,0.885457909778053,2,160,cytoplasmic ribonucleoprotein granule,CC,ZC3H12D;RPL28
1362,GO:0003231,0.331784674385367,0.93894943256545,1,75,cardiac ventricle development,BP,HES1
9843,GO:0042089,0.332112903331662,0.938956769249218,1,63,cytokine biosynthetic process,BP,SPN
4109,GO:0009163,0.332737797799896,0.939205146742117,1,40,nucleoside biosynthetic process,BP,NME9
11773,GO:0046631,0.333705083101225,0.938286937004453,1,66,alpha-beta T cell activation,BP,SPN
2583,GO:0005874,0.334669320689029,0.852249556136468,3,333,microtubule,CC,APC2;FAM110C;MAP1A
6579,GO:0022404,0.335226074974296,0.937656269827978,1,68,molting cycle process,BP,HOXC13
6580,GO:0022405,0.335226074974296,0.937656269827978,1,68,hair cycle process,BP,HOXC13
16854,GO:0098773,0.335226423507463,0.937656130485147,1,68,skin epidermis development,BP,HOXC13
9857,GO:0042107,0.336356587898993,0.937254235166232,1,64,cytokine metabolic process,BP,SPN
9051,GO:0035270,0.33676691283028,0.937063218140313,1,66,endocrine system development,BP,HES1
4345,GO:0009896,0.336767540473612,0.850842758642958,3,331,positive regulation of catabolic process,BP,ZC3H12D;RNF125;APC2
117,GO:0000245,0.336955729879515,0.937174461640049,1,54,spliceosomal complex assembly,BP,SNRPD2
2212,GO:0005096,0.338463337204565,0.88093238230725,2,225,GTPase activator activity,MF,RIN2;RGS2
17731,GO:1901659,0.338935694355192,0.9366752361492,1,42,glycosyl compound biosynthetic process,BP,NME9
6296,GO:0019904,0.339198563121314,0.814108602929947,5,560,protein domain specific binding,MF,ID3;DDIT3;HIST1H4F;HIST1H4I;HIST1H4D
14547,GO:0070069,0.339251380943638,0.937661444241762,1,23,cytochrome complex,CC,COX7C
3476,GO:0007338,0.339680656435887,0.936116172371174,1,52,single fertilization,BP,HOXA9
10265,GO:0043005,0.340401427323784,0.80202560967184,6,755,neuron projection,CC,NR1D1;RGS2;NRSN1;CNNM1;RPL28;MAP1A
3375,GO:0007154,0.341143952668232,0.738544447232182,29,3951,cell communication,BP,TXNIP;NR1D1;HES5;DDIT4;RIN2;RGS2;S1PR5;GDNF;HES1;MUC6;IFIT2;RNF125;DCHS1;DDIT3;SNAI2;APC2;NUPR1;SPN;SALL2;TMSB4X;FAM110C;GPR89A;IVNS1ABP;RHOF;ARRDC3;RAB15;BTN3A1;MUC12;STAC2
19217,GO:1905330,0.341355933314416,0.879539801150424,2,144,regulation of morphogenesis of an epithelium,BP,GDNF;SNAI2
10504,GO:0043407,0.341368099409494,0.935239215156119,1,63,negative regulation of MAP kinase activity,BP,RGS2
2786,GO:0006220,0.341953046479429,0.935487818868054,1,41,pyrimidine nucleotide metabolic process,BP,NME9
18235,GO:1903038,0.341976824027482,0.93497605233724,1,64,negative regulation of leukocyte cell-cell adhesion,BP,SPN
12799,GO:0051090,0.34242297421241,0.847065940193423,3,304,regulation of DNA binding transcription factor activity,BP,ID3;DDIT3;TMSB4X
14639,GO:0070227,0.342669318666411,0.93489930795676,1,52,lymphocyte apoptotic process,BP,TSC22D3
12594,GO:0050767,0.343920648665638,0.825251797964156,4,498,regulation of neurogenesis,BP,HES5;S1PR5;HES1;ID3
7852,GO:0032411,0.343958550437614,0.934290714705103,1,56,positive regulation of transporter activity,BP,TMSB4X
17727,GO:1901655,0.345259854114195,0.933609418806459,1,65,cellular response to ketone,BP,DDIT4
4763,GO:0010941,0.345350476316855,0.771011543990173,10,1190,regulation of cell death,BP,TXNIP;DDIT4;TSC22D3;GDNF;ID3;IFIT2;DDIT3;SNAI2;NUPR1;IVNS1ABP
1345,GO:0003206,0.345885311578533,0.933219617736449,1,76,cardiac chamber morphogenesis,BP,HES1
10165,GO:0042752,0.346038579082064,0.933246406725892,1,68,regulation of circadian rhythm,BP,NR1D1
10357,GO:0043170,0.346544907979822,0.730105813444897,52,6844,macromolecule metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;RPL37;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;MUC6;RNF125;ACTR5;SNRPD2;DDIT3;SNAI2;APC2;RPL31;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;JADE2;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;SPDYE1;CIART;ARRDC3;RPS27;ZNF485;HIST1H4D;MUC12;ZNF57
14953,GO:0070848,0.346704551021102,0.823244104669832,4,471,response to growth factor,BP,HES5;DDIT4;HES1;SNAI2
3192,GO:0006820,0.346746048945833,0.844050066414863,3,338,anion transport,BP,SLC2A3;FXYD3;GPR89A
3565,GO:0007610,0.346843172406592,0.844029124413094,3,313,behavior,BP,GDNF;CIART;ARRDC3
7988,GO:0032602,0.347547795058115,0.932929771357829,1,50,chemokine production,BP,SNAI2
15477,GO:0071824,0.347880915056173,0.822893836883572,4,237,protein-DNA complex subunit organization,BP,HIST1H4F;HIST1H1D;HIST1H4I;HIST1H4D
6654,GO:0030001,0.347882739649609,0.822401802347024,4,452,metal ion transport,BP,SLC24A4;SLC9A4;DDIT3;FXYD3
4262,GO:0009605,0.348049132778011,0.764359800397578,11,1336,response to external stimulus,BP,TXNIP;NR1D1;DDIT4;GDNF;IFIT2;RNF125;DDIT3;SNAI2;SPN;TMSB4X;IVNS1ABP
8374,GO:0033273,0.348749282790908,0.932182758080476,1,63,response to vitamin,BP,SNAI2
9063,GO:0035296,0.348911715844886,0.932071633466468,1,66,regulation of tube diameter,BP,RGS2
16732,GO:0097746,0.348911715844886,0.932071633466468,1,66,regulation of blood vessel diameter,BP,RGS2
10527,GO:0043462,0.349221027299195,0.932207438661656,1,51,regulation of ATPase activity,BP,TMSB4X
19739,GO:2000106,0.34950992805542,0.932001055316862,1,55,regulation of leukocyte apoptotic process,BP,TSC22D3
2881,GO:0006383,0.349615967729522,0.932065262410278,1,50,transcription by RNA polymerase III,BP,IVNS1ABP
10397,GO:0043229,0.349846005974149,0.743019130745673,70,9289,intracellular organelle,CC,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;NRSN1;TCHH;RPL37;LRIG3;NME9;PPP1R3D;HES1;HOXC13;ID3;ZC3H12D;GOLGA2P5;TIGD2;LGALS7B;MUC6;SMIM14;SLC2A3;IFIT2;RNF125;ACTR5;SNRPD2;DDIT3;SNAI2;APC2;RPL31;FAM217B;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;SPC25;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;JADE2;ZNF169;FAM110C;KIAA0753;GPR89A;IVNS1ABP;ZNF799;ZKSCAN3;COX7C;HIST1H4I;RHOF;CIART;ARRDC3;MAP7D3;RPS27;ZNF485;HIST1H4D;RAB15;MUC12;ZNF57;MAP1A
9312,GO:0035770,0.350036037414312,0.874179512262527,2,169,ribonucleoprotein granule,CC,ZC3H12D;RPL28
3264,GO:0006936,0.350163088788024,0.874107043994831,2,168,muscle contraction,BP,RGS2;GDNF
10311,GO:0043087,0.351305361989443,0.840872362569922,3,362,regulation of GTPase activity,BP,RIN2;RGS2;APC2
17036,GO:0099513,0.351384376981583,0.819803046189922,4,471,polymeric cytoskeletal fiber,CC,APC2;TMSB4X;FAM110C;MAP1A
9062,GO:0035295,0.351518080433252,0.804643596399374,5,656,tube development,BP,HES5;GDNF;HES1;DCHS1;SALL2
3405,GO:0007188,0.35194660587905,0.93070167681948,1,73,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,RGS2
13751,GO:0060322,0.353167391024216,0.818473567072296,4,482,head development,BP,HES5;DDIT4;HES1;OTX1
12662,GO:0050863,0.353240431874586,0.872157760806217,2,184,regulation of T cell activation,BP,HES1;SPN
7617,GO:0032006,0.354213459889438,0.929700713216673,1,76,regulation of TOR signaling,BP,DDIT4
10108,GO:0042626,0.354366152706566,0.929757488690145,1,66,ATPase activity, coupled to transmembrane movement of substances,MF,ABCB5
7911,GO:0032482,0.354516842605962,0.929821279138101,1,58,Rab protein signal transduction,BP,RAB15
6306,GO:0019933,0.35453318399871,0.929745945977252,1,62,cAMP-mediated signaling,BP,RGS2
684,GO:0001892,0.354617836479019,0.929596428343757,1,70,embryonic placenta development,BP,HES1
13584,GO:0060048,0.354782870470424,0.929607946091432,1,64,cardiac muscle contraction,BP,RGS2
18342,GO:1903305,0.354988552326587,0.929401119789231,1,73,regulation of regulated secretory pathway,BP,RAB15
5384,GO:0016202,0.355053493181003,0.92928993036202,1,81,regulation of striated muscle tissue development,BP,TSC22D3
17791,GO:1901861,0.355053493181003,0.92928993036202,1,81,regulation of muscle tissue development,BP,TSC22D3
2436,GO:0005634,0.355104092443275,0.72126184376866,44,5696,nucleus,CC,TXNIP;NR1D1;HES5;TSC22D3;RGS2;HOXA9;HES1;HOXC13;ID3;ZC3H12D;TIGD2;LGALS7B;ACTR5;SNRPD2;DDIT3;SNAI2;FAM217B;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;SPC25;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;TMSB4X;JADE2;ZNF169;FAM110C;IVNS1ABP;ZNF799;ZKSCAN3;HIST1H4I;CIART;RPS27;ZNF485;HIST1H4D;ZNF57
8835,GO:0034622,0.35522959618605,0.762861282080119,10,883,cellular protein-containing complex assembly,BP,RGS2;SNRPD2;HIST1H4F;RPL23A;HIST1H1D;TMSB4X;HIST1H4I;MAP7D3;RPS27;HIST1H4D
2561,GO:0005840,0.355666732653576,0.802305175834362,5,225,ribosome,CC,RPL37;RPL31;RPL23A;RPL28;RPS27
15291,GO:0071479,0.355720215350834,0.929220589800763,1,63,cellular response to ionizing radiation,BP,SNAI2
7321,GO:0031329,0.356090107446565,0.789712547825641,6,691,regulation of cellular catabolic process,BP,DDIT4;PPP1R3D;GDNF;ZC3H12D;RNF125;ZKSCAN3
3772,GO:0008324,0.356795770205592,0.837153922860599,3,308,cation transmembrane transporter activity,MF,SLC24A4;SLC9A4;COX7C
11890,GO:0046906,0.357559852560946,0.928396016929711,1,65,tetrapyrrole binding,MF,NR1D1
1670,GO:0004129,0.357757646745473,0.93083679128449,1,18,cytochrome-c oxidase activity,MF,COX7C
4950,GO:0015002,0.357757646745473,0.93083679128449,1,18,heme-copper terminal oxidase activity,MF,COX7C
5623,GO:0016676,0.357757646745473,0.93083679128449,1,18,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,COX7C
12296,GO:0048634,0.358056663531965,0.927980972187595,1,82,regulation of muscle organ development,BP,TSC22D3
16493,GO:0097191,0.358497802870668,0.868975382284702,2,171,extrinsic apoptotic signaling pathway,BP,GDNF;SNAI2
10572,GO:0043535,0.358607921775654,0.927926488284122,1,66,regulation of blood vessel endothelial cell migration,BP,TMSB4X
19662,GO:1990904,0.359539619212,0.76451179366355,9,701,ribonucleoprotein complex,CC,RPL37;ZC3H12D;SNRPD2;RPL31;RNF113A;RPL23A;RPL28;IVNS1ABP;RPS27
10540,GO:0043488,0.359897003751415,0.868282771003121,2,141,regulation of mRNA stability,BP,GDNF;ZC3H12D
12962,GO:0051341,0.360729946448579,0.927192759727083,1,55,regulation of oxidoreductase activity,BP,GDNF
5622,GO:0016675,0.36080383782051,0.929363609093188,1,19,oxidoreductase activity, acting on a heme group of donors,MF,COX7C
15465,GO:0071804,0.361433993273696,0.926522215064886,1,80,cellular potassium ion transport,BP,SLC9A4
15466,GO:0071805,0.361433993273696,0.926522215064886,1,80,potassium ion transmembrane transport,BP,SLC9A4
12275,GO:0048583,0.361533060459251,0.729881190809863,20,2711,regulation of response to stimulus,BP,NR1D1;HES5;DDIT4;RGS2;GDNF;HES1;MUC6;RNF125;DDIT3;SNAI2;APC2;TMSB4X;FAM110C;GPR89A;IVNS1ABP;ZKSCAN3;RHOF;ARRDC3;BTN3A1;MUC12
13012,GO:0051438,0.361887947923584,0.926855291679466,1,48,regulation of ubiquitin-protein transferase activity,BP,ARRDC3
7660,GO:0032088,0.361968322379977,0.92648661858244,1,64,negative regulation of NF-kappaB transcription factor activity,BP,TMSB4X
6933,GO:0030534,0.362263589558616,0.926341254617134,1,65,adult behavior,BP,GDNF
9005,GO:0035150,0.362720695650009,0.926069184575459,1,70,regulation of tube size,BP,RGS2
12676,GO:0050880,0.362720695650009,0.926069184575459,1,70,regulation of blood vessel size,BP,RGS2
4175,GO:0009247,0.364306775729481,0.925663867239518,1,53,glycolipid biosynthetic process,BP,PIGH
6598,GO:0022613,0.364328006538163,0.783396848312775,6,448,ribonucleoprotein complex biogenesis,BP,RPL37;SNRPD2;RPL31;RPL23A;RPL28;RPS27
2719,GO:0006096,0.365191286697968,0.924911609465883,1,75,glycolytic process,BP,DDIT4
3155,GO:0006757,0.365191286697968,0.924911609465883,1,75,ATP generation from ADP,BP,DDIT4
19397,GO:1905897,0.365808872133933,0.924739982490231,1,67,regulation of response to endoplasmic reticulum stress,BP,DDIT3
6782,GO:0030216,0.366202983340434,0.86427057198282,2,151,keratinocyte differentiation,BP,TXNIP;TCHH
12344,GO:0048706,0.366332826777253,0.924390317871047,1,76,embryonic skeletal system development,BP,HOXA9
3919,GO:0008585,0.366414012405526,0.924441397141831,1,69,female gonad development,BP,NUPR1
3331,GO:0007043,0.366602477161736,0.924216352849908,1,81,cell-cell junction assembly,BP,SNAI2
7876,GO:0032436,0.366651048347324,0.924308576054504,1,71,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,RNF125
3397,GO:0007178,0.366867563060878,0.863575142020796,2,212,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,HES5;HES1
4331,GO:0009855,0.366873693304136,0.924171369683679,1,74,determination of bilateral symmetry,BP,DDIT3
8750,GO:0034404,0.367746699642337,0.863209001973285,2,166,nucleobase-containing small molecule biosynthetic process,BP,DDIT4;NME9
12923,GO:0051270,0.36836275068483,0.791578914667465,5,613,regulation of cellular component movement,BP,SNAI2;SPN;TMSB4X;FAM110C;RHOF
7178,GO:0031058,0.368564525628344,0.923399265319644,1,75,positive regulation of histone modification,BP,SNAI2
19629,GO:1990778,0.369136713535716,0.862153860746368,2,207,protein localization to cell periphery,BP,DCHS1;RAB15
12873,GO:0051193,0.369213690107808,0.923083168283615,1,77,regulation of cofactor metabolic process,BP,DDIT4
8969,GO:0035051,0.369508091041981,0.922897298919405,1,82,cardiocyte differentiation,BP,HES1
1026,GO:0002526,0.370097278433011,0.92294779649718,1,59,acute inflammatory response,BP,NUPR1
9914,GO:0042254,0.371081960407864,0.789902750148904,5,317,ribosome biogenesis,BP,RPL37;RPL31;RPL23A;RPL28;RPS27
10219,GO:0042866,0.37116259097776,0.922199090195843,1,77,pyruvate biosynthetic process,BP,DDIT4
4363,GO:0009966,0.371290734338505,0.728830910469145,16,2142,regulation of signal transduction,BP,NR1D1;HES5;DDIT4;RGS2;GDNF;HES1;RNF125;DDIT3;SNAI2;APC2;TMSB4X;FAM110C;GPR89A;IVNS1ABP;RHOF;ARRDC3
4318,GO:0009799,0.371930538169493,0.921872440658233,1,75,specification of symmetry,BP,DDIT3
11132,GO:0045177,0.372152453865877,0.860198974045263,2,217,apical part of cell,CC,SLC9A4;DCHS1
10539,GO:0043487,0.372850015962232,0.86007114240077,2,148,regulation of RNA stability,BP,GDNF;ZC3H12D
12882,GO:0051209,0.373162665104041,0.921432527667459,1,66,release of sequestered calcium ion into cytosol,BP,DDIT3
12931,GO:0051283,0.373162665104041,0.921432527667459,1,66,negative regulation of sequestering of calcium ion,BP,DDIT3
2976,GO:0006518,0.373318971970755,0.747568016811983,10,784,peptide metabolic process,BP,RGS2;RPL37;ZC3H12D;RPL31;HIST1H4F;RPL23A;RPL28;HIST1H4I;RPS27;HIST1H4D
4865,GO:0014706,0.373677989835028,0.859218517872729,2,218,striated muscle tissue development,BP,TSC22D3;NUPR1
1464,GO:0003712,0.37377959514075,0.803012247775938,4,457,transcription cofactor activity,MF,NR1D1;ID3;DDIT3;PHF12
8559,GO:0033993,0.373788968233936,0.787317225968001,5,590,response to lipid,BP,TXNIP;NR1D1;DDIT4;ID3;SNAI2
11734,GO:0046545,0.374389843634866,0.920796964381663,1,71,development of primary female sexual characteristics,BP,NUPR1
3158,GO:0006767,0.37474530211115,0.920722415246011,1,65,water-soluble vitamin metabolic process,BP,SLC2A3
4531,GO:0010595,0.374770668126162,0.920608340337342,1,72,positive regulation of endothelial cell migration,BP,TMSB4X
7674,GO:0032102,0.375154970702039,0.858378517854549,2,188,negative regulation of response to external stimulus,BP,RNF125;SNAI2
3404,GO:0007187,0.375285273785121,0.920297833969778,1,78,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,RGS2
12930,GO:0051282,0.376082470035008,0.920074327309189,1,67,regulation of sequestering of calcium ion,BP,DDIT3
11420,GO:0045834,0.376144049875956,0.919912222942126,1,77,positive regulation of lipid metabolic process,BP,NR1D1
20181,GO:2001021,0.376361171432001,0.920028567685403,1,62,negative regulation of response to DNA damage stimulus,BP,SNAI2
6308,GO:0019935,0.377237947267601,0.919539195638911,1,67,cyclic-nucleotide-mediated signaling,BP,RGS2
2621,GO:0005938,0.377721403433065,0.856590750102378,2,225,cell cortex,CC,FAM110C;RHOF
10912,GO:0044459,0.378095830460447,0.743193841098525,10,1449,plasma membrane part,CC,RGS2;SLC24A4;SLC2A3;SLC9A4;APC2;SPN;FXYD3;BTN3A1;MUC12;ABCB5
599,GO:0001764,0.379024026112999,0.918467799282813,1,87,neuron migration,BP,DDIT4
15977,GO:0080134,0.380943442174832,0.752537898535379,8,984,regulation of response to stress,BP,NR1D1;MUC6;RNF125;DDIT3;SNAI2;TMSB4X;ZKSCAN3;MUC12
10062,GO:0042552,0.381509619866204,0.917370585962322,1,80,myelination,BP,HES5
12316,GO:0048667,0.381748850728891,0.81921103979946,3,385,cell morphogenesis involved in neuron differentiation,BP,GDNF;HES1;MAP1A
16553,GO:0097327,0.381893405481695,0.917261392399221,1,74,response to antineoplastic agent,BP,DDIT4
16616,GO:0097458,0.382264560358077,0.759053259150278,7,940,neuron part,CC,NR1D1;RGS2;NRSN1;CNNM1;RPL28;RAB15;MAP1A
2202,GO:0005085,0.382615141513336,0.853393239626969,2,229,guanyl-nucleotide exchange factor activity,MF,RIN2;GDNF
3380,GO:0007159,0.383043235811131,0.853254979038145,2,189,leukocyte cell-cell adhesion,BP,HES1;SPN
10544,GO:0043492,0.383814050337005,0.916326488820796,1,76,ATPase activity, coupled to movement of substances,MF,ABCB5
12620,GO:0050801,0.383972019778446,0.795220666520839,4,425,ion homeostasis,BP,SLC24A4;SLC9A4;DDIT3;GPR89A
3222,GO:0006874,0.384012146835137,0.852582992475251,2,198,cellular calcium ion homeostasis,BP,SLC24A4;DDIT3
5134,GO:0015629,0.38404484584633,0.817596670752132,3,346,actin cytoskeleton,CC,APC2;TMSB4X;IVNS1ABP
2954,GO:0006486,0.384060139607651,0.852539873041517,2,201,protein glycosylation,BP,MUC6;MUC12
10509,GO:0043413,0.384060139607651,0.852539873041517,2,201,macromolecule glycosylation,BP,MUC6;MUC12
7932,GO:0032507,0.384193978466065,0.916378421929813,1,61,maintenance of protein location in cell,BP,TMSB4X
6463,GO:0021782,0.384400663461904,0.916158837418944,1,68,glial cell development,BP,HES5
5930,GO:0018205,0.386084130921975,0.816118043387548,3,337,peptidyl-lysine modification,BP,SNAI2;HIST1H1D;JADE2
12881,GO:0051208,0.386126944529897,0.915305054283445,1,70,sequestering of calcium ion,BP,DDIT3
3458,GO:0007272,0.387259739147094,0.914609484339068,1,82,ensheathment of neurons,BP,HES5
3796,GO:0008366,0.387259739147094,0.914609484339068,1,82,axon ensheathment,BP,HES5
20282,GO:2001244,0.387717126612206,0.915160673873754,1,44,positive regulation of intrinsic apoptotic signaling pathway,BP,DDIT3
9943,GO:0042303,0.388234385665932,0.914173818230576,1,79,molting cycle,BP,HOXC13
10114,GO:0042633,0.388234385665932,0.914173818230576,1,79,hair cycle,BP,HOXC13
13898,GO:0060537,0.388555796382291,0.849486320137835,2,227,muscle tissue development,BP,TSC22D3;NUPR1
3190,GO:0006816,0.388687136562017,0.849451602117226,2,211,calcium ion transport,BP,SLC24A4;DDIT3
19190,GO:1905269,0.389051926213928,0.913755850808301,1,81,positive regulation of chromatin organization,BP,SNAI2
11516,GO:0046031,0.389867747622222,0.91338365152692,1,79,ADP metabolic process,BP,DDIT4
3376,GO:0007155,0.390072157919315,0.762072160357963,6,796,cell adhesion,BP,HES5;HES1;LGALS7B;DCHS1;SNAI2;SPN
6597,GO:0022612,0.390241227341096,0.91312607993886,1,86,gland morphogenesis,BP,SNAI2
10246,GO:0042981,0.390935175282064,0.737596995794029,9,1099,regulation of apoptotic process,BP,TXNIP;TSC22D3;GDNF;ID3;IFIT2;DDIT3;SNAI2;NUPR1;IVNS1ABP
16667,GO:0097553,0.391227593719123,0.912814116214758,1,72,calcium ion transmembrane import into cytosol,BP,DDIT3
15763,GO:0072359,0.391359796005256,0.773173195841851,5,681,circulatory system development,BP,HES1;ID3;DCHS1;DDIT3;SNAI2
18705,GO:1904064,0.391934835742953,0.912581184169141,1,65,positive regulation of cation transmembrane transport,BP,TMSB4X
12105,GO:0048145,0.392006559228749,0.912601895376802,1,62,regulation of fibroblast proliferation,BP,NUPR1
12535,GO:0050680,0.393330641559004,0.911606599163063,1,87,negative regulation of epithelial cell proliferation,BP,SNAI2
18647,GO:1903955,0.393596956200447,0.911805598341004,1,63,positive regulation of protein targeting to mitochondrion,BP,HES1
6596,GO:0022610,0.393836102105588,0.758947120078766,6,799,biological adhesion,BP,HES5;HES1;LGALS7B;DCHS1;SNAI2;SPN
14557,GO:0070085,0.394273791991236,0.845740770933289,2,207,glycosylation,BP,MUC6;MUC12
12104,GO:0048144,0.394839545332701,0.91119554481381,1,63,fibroblast proliferation,BP,NUPR1
8849,GO:0034644,0.395330286671062,0.910848994796475,1,69,cellular response to UV,BP,ACTR5
19723,GO:2000060,0.395440642817562,0.910643066319828,1,80,positive regulation of ubiquitin-dependent protein catabolic process,BP,RNF125
1111,GO:0002698,0.395583838603905,0.910692805498867,1,71,negative regulation of immune effector process,BP,RNF125
13087,GO:0051592,0.395741101163386,0.910460121528087,1,83,response to calcium ion,BP,TXNIP
7010,GO:0030695,0.396963064978077,0.843802874781371,2,248,GTPase regulator activity,MF,RIN2;RGS2
3562,GO:0007605,0.397286554818974,0.909864985916614,1,70,sensory perception of sound,BP,SNAI2
4807,GO:0012501,0.397460346836996,0.717619050513134,12,1484,programmed cell death,BP,TXNIP;DDIT4;TSC22D3;TCHH;GDNF;ID3;LGALS7B;IFIT2;DDIT3;SNAI2;NUPR1;IVNS1ABP
11794,GO:0046660,0.398080878467519,0.909344708619526,1,79,female sex differentiation,BP,NUPR1
13276,GO:0051960,0.398548490613722,0.783664299864942,4,548,regulation of nervous system development,BP,HES5;S1PR5;HES1;ID3
4254,GO:0009566,0.399105316686802,0.909008675799444,1,67,fertilization,BP,HOXA9
3746,GO:0008285,0.399594803142082,0.782919307203586,4,471,negative regulation of cell proliferation,BP,HES1;SNAI2;NUPR1;SPN
14146,GO:0061013,0.399643258423323,0.842349813900725,2,160,regulation of mRNA catabolic process,BP,GDNF;ZC3H12D
12560,GO:0050709,0.399877701836545,0.908605472604264,1,68,negative regulation of protein secretion,BP,TMSB4X
13508,GO:0055074,0.400903223014228,0.841270087201273,2,205,calcium ion homeostasis,BP,SLC24A4;DDIT3
4859,GO:0014070,0.400971622860601,0.765373522765393,5,634,response to organic cyclic compound,BP,TXNIP;NR1D1;DDIT4;ID3;SNAI2
9025,GO:0035239,0.401818265866874,0.781077494248112,4,541,tube morphogenesis,BP,HES5;GDNF;HES1;DCHS1
17051,GO:0099531,0.402971987380884,0.906874444061536,1,80,presynaptic process involved in chemical synaptic transmission,BP,GDNF
15744,GO:0072330,0.403307594414958,0.839638261452901,2,203,monocarboxylic acid biosynthetic process,BP,NR1D1;DDIT4
1266,GO:0003018,0.403470379349419,0.906574718839894,1,84,vascular process in circulatory system,BP,RGS2
3948,GO:0008643,0.403933770177372,0.906239035143763,1,94,carbohydrate transport,BP,SLC2A3
17248,GO:0120025,0.404168337764836,0.726047499418836,9,1260,plasma membrane bounded cell projection,CC,NR1D1;RGS2;NRSN1;APC2;CNNM1;SPN;RPL28;RAB15;MAP1A
11889,GO:0046903,0.405171792906478,0.731790910989264,8,996,secretion,BP,NR1D1;GDNF;SLC2A3;SLC9A4;TMSB4X;RHOF;RAB15;BTN3A1
6648,GO:0023051,0.406089916365222,0.695361349271026,17,2345,regulation of signaling,BP,NR1D1;HES5;DDIT4;RGS2;GDNF;HES1;RNF125;DDIT3;SNAI2;APC2;TMSB4X;FAM110C;FXYD3;GPR89A;IVNS1ABP;RHOF;ARRDC3
8924,GO:0034767,0.406272150259241,0.905336634420375,1,70,positive regulation of ion transmembrane transport,BP,TMSB4X
5903,GO:0018107,0.406560964461225,0.904914851436205,1,92,peptidyl-threonine phosphorylation,BP,DDIT4
10303,GO:0043067,0.407200009647103,0.723442812650245,9,1111,regulation of programmed cell death,BP,TXNIP;TSC22D3;GDNF;ID3;IFIT2;DDIT3;SNAI2;NUPR1;IVNS1ABP
1171,GO:0002792,0.408582617932659,0.904167414602619,1,69,negative regulation of peptide secretion,BP,TMSB4X
13470,GO:0055001,0.409024449619856,0.903696239808707,1,87,muscle cell development,BP,HES1
8036,GO:0032680,0.409284975439048,0.903840356682877,1,67,regulation of tumor necrosis factor production,BP,SPN
12721,GO:0050954,0.409471916985013,0.903628934712873,1,74,sensory perception of mechanical stimulus,BP,SNAI2
15509,GO:0071887,0.40990742092639,0.90348345962935,1,69,leukocyte apoptotic process,BP,TSC22D3
12862,GO:0051179,0.410320581193626,0.673777095019638,32,4308,localization,BP,TXNIP;NR1D1;DDIT4;TSC22D3;RIN2;RPL37;GDNF;HES1;SLC24A4;SLC2A3;SLC9A4;DCHS1;SNRPD2;DDIT3;SNAI2;APC2;RPL31;RPL23A;CNNM1;SPN;RPL28;TMSB4X;FAM110C;FXYD3;KIAA0753;GPR89A;COX7C;RHOF;RPS27;RAB15;BTN3A1;ABCB5
11574,GO:0046128,0.410872565159293,0.903117439728004,1,62,purine ribonucleoside metabolic process,BP,NME9
12907,GO:0051250,0.410905736014559,0.902802882240711,1,80,negative regulation of lymphocyte activation,BP,SPN
9242,GO:0035637,0.412306513920222,0.901958622618138,1,90,multicellular organismal signaling,BP,FXYD3
10532,GO:0043473,0.41256807708191,0.902035385950258,1,73,pigmentation,BP,SNAI2
12603,GO:0050776,0.413365471019619,0.755181714626698,5,577,regulation of immune response,BP,NR1D1;MUC6;RNF125;BTN3A1;MUC12
13237,GO:0051897,0.414307949926439,0.900952050144902,1,86,positive regulation of protein kinase B signaling,BP,FAM110C
60,GO:0000123,0.414357680828814,0.901011636028308,1,79,histone acetyltransferase complex,CC,JADE2
6858,GO:0030326,0.414853668540172,0.900642773359464,1,88,embryonic limb morphogenesis,BP,HOXA9
8995,GO:0035113,0.414853668540172,0.900642773359464,1,88,embryonic appendage morphogenesis,BP,HOXA9
13816,GO:0060402,0.415298773187299,0.900503049750477,1,80,calcium ion transport into cytosol,BP,DDIT3
5904,GO:0018108,0.415521130783186,0.831077736028332,2,231,peptidyl-tyrosine phosphorylation,BP,HES5;HES1
3253,GO:0006915,0.417066952726606,0.704271922234857,11,1395,apoptotic process,BP,TXNIP;DDIT4;TSC22D3;GDNF;ID3;LGALS7B;IFIT2;DDIT3;SNAI2;NUPR1;IVNS1ABP
11519,GO:0046034,0.417105891671564,0.793171638273925,3,207,ATP metabolic process,BP,DDIT4;TMSB4X;COX7C
2104,GO:0004871,0.417164115382254,0.751922880434284,5,678,signal transducer activity,MF,NR1D1;S1PR5;SPN;GPR89A;RHOF
10210,GO:0042826,0.418879121441982,0.898497126553323,1,89,histone deacetylase binding,MF,HES1
3268,GO:0006941,0.419367155158347,0.898357557969473,1,79,striated muscle contraction,BP,RGS2
15888,GO:0072655,0.419562292145024,0.828578427514678,2,158,establishment of protein localization to mitochondrion,BP,HES1;DDIT3
19804,GO:2000241,0.420118927581787,0.898013306899506,1,75,regulation of reproductive process,BP,NUPR1
5560,GO:0016570,0.42086735051656,0.789710259358843,3,389,histone modification,BP,SNAI2;HIST1H1D;JADE2
18463,GO:1903555,0.421159104604207,0.897537657770214,1,70,regulation of tumor necrosis factor superfamily cytokine production,BP,SPN
5936,GO:0018212,0.421490742774098,0.826853173446197,2,234,peptidyl-tyrosine modification,BP,HES5;HES1
18305,GO:1903214,0.421772702483837,0.897244377173595,1,68,regulation of protein targeting to mitochondrion,BP,HES1
5409,GO:0016247,0.421922295971812,0.897093497175572,1,72,channel regulator activity,MF,FXYD3
8012,GO:0032640,0.421966432902901,0.897103987768169,1,70,tumor necrosis factor production,BP,SPN
10571,GO:0043534,0.422325053247254,0.89673039009765,1,82,blood vessel endothelial cell migration,BP,TMSB4X
1050,GO:0002576,0.422535729448882,0.896699969059916,1,76,platelet degranulation,BP,TMSB4X
9931,GO:0042278,0.42266357530604,0.896844561662845,1,64,purine nucleoside metabolic process,BP,NME9
10396,GO:0043228,0.423368289259326,0.665191601939233,27,3274,non-membrane-bounded organelle,CC,NR1D1;RGS2;TCHH;RPL37;NME9;ZC3H12D;ACTR5;SNAI2;APC2;RPL31;HIST1H4F;PHF12;RPL23A;SPC25;HIST1H1D;SALL2;RPL28;TMSB4X;FAM110C;KIAA0753;IVNS1ABP;HIST1H4I;RHOF;MAP7D3;RPS27;HIST1H4D;MAP1A
10400,GO:0043232,0.423368289259326,0.665191601939233,27,3274,intracellular non-membrane-bounded organelle,CC,NR1D1;RGS2;TCHH;RPL37;NME9;ZC3H12D;ACTR5;SNAI2;APC2;RPL31;HIST1H4F;PHF12;RPL23A;SPC25;HIST1H1D;SALL2;RPL28;TMSB4X;FAM110C;KIAA0753;IVNS1ABP;HIST1H4I;RHOF;MAP7D3;RPS27;HIST1H4D;MAP1A
1344,GO:0003205,0.423842710481938,0.895702108477114,1,102,cardiac chamber development,BP,HES1
14839,GO:0070585,0.424387102956907,0.825131902468906,2,161,protein localization to mitochondrion,BP,HES1;DDIT3
337,GO:0000932,0.424490946456516,0.895673314620495,1,74,P-body,CC,ZC3H12D
9664,GO:0038023,0.42557498371308,0.786034980813166,3,386,signaling receptor activity,MF,NR1D1;S1PR5;SPN
13620,GO:0060089,0.42557498371308,0.786034980813166,3,386,molecular transducer activity,MF,NR1D1;S1PR5;SPN
3558,GO:0007600,0.425992684876341,0.82372661327008,2,210,sensory perception,BP,SLC24A4;SNAI2
417,GO:0001104,0.426368320912794,0.894549070490651,1,81,RNA polymerase II transcription cofactor activity,MF,PHF12
7569,GO:0031929,0.426528987719473,0.894331384035858,1,92,TOR signaling,BP,DDIT4
2297,GO:0005261,0.427050003415423,0.893927472105343,1,105,cation channel activity,MF,SLC24A4
5108,GO:0015399,0.428250768409195,0.893637909300525,1,73,primary active transmembrane transporter activity,MF,ABCB5
5109,GO:0015405,0.428250768409195,0.893637909300525,1,73,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,ABCB5
483,GO:0001533,0.429370551084158,0.893829089017251,1,44,cornified envelope,CC,TCHH
12916,GO:0051259,0.431097883504713,0.757552801470629,4,378,protein complex oligomerization,BP,DDIT3;HIST1H4F;HIST1H4I;HIST1H4D
5559,GO:0016569,0.431249246099792,0.781543816151908,3,397,covalent chromatin modification,BP,SNAI2;HIST1H1D;JADE2
649,GO:0001837,0.432673016110333,0.890916640079893,1,94,epithelial to mesenchymal transition,BP,SNAI2
12686,GO:0050896,0.43342812972887,0.649336361298879,40,5525,response to stimulus,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RIN2;RGS2;S1PR5;GDNF;HES1;ID3;SLC24A4;MUC6;SLC2A3;IFIT2;RNF125;ACTR5;DCHS1;DDIT3;SNAI2;APC2;NUPR1;HIST1H4F;SPN;SALL2;TMSB4X;FAM110C;GPR89A;IVNS1ABP;HSP90AB4P;ZKSCAN3;HIST1H4I;RHOF;ARRDC3;HIST1H4D;RAB15;BTN3A1;MUC12;STAC2;ABCB5
16299,GO:0090407,0.433620696343598,0.755265270702446,4,499,organophosphate biosynthetic process,BP,DDIT4;NME9;PIGH;TMSB4X
6116,GO:0019359,0.434024438587811,0.890141036999116,1,96,nicotinamide nucleotide biosynthetic process,BP,DDIT4
6118,GO:0019363,0.434024438587811,0.890141036999116,1,96,pyridine nucleotide biosynthetic process,BP,DDIT4
15432,GO:0071706,0.436230030478817,0.889185766796856,1,74,tumor necrosis factor superfamily cytokine production,BP,SPN
6595,GO:0022607,0.436969136545237,0.664860311931352,18,2214,cellular component assembly,BP,HES5;RGS2;HES1;GOLGA2P5;SNRPD2;DDIT3;SNAI2;HIST1H4F;RPL23A;HIST1H1D;TMSB4X;FAM110C;KIAA0753;HIST1H4I;RHOF;MAP7D3;RPS27;HIST1H4D
12309,GO:0048660,0.437362351498352,0.888373023739076,1,86,regulation of smooth muscle cell proliferation,BP,HES5
10376,GO:0043197,0.437524129338076,0.888140374338933,1,99,dendritic spine,CC,NR1D1
3695,GO:0008202,0.438430624777572,0.814755290320422,2,197,steroid metabolic process,BP,NR1D1;SNAI2
5934,GO:0018210,0.438927757774023,0.887298285391962,1,104,peptidyl-threonine modification,BP,DDIT4
18448,GO:1903532,0.439194185129322,0.814099347734543,2,219,positive regulation of secretion by cell,BP,GDNF;RAB15
12308,GO:0048659,0.439991334945278,0.88686740835396,1,87,smooth muscle cell proliferation,BP,HES5
1100,GO:0002687,0.440075457123903,0.887061712148721,1,71,positive regulation of leukocyte migration,BP,SPN
7807,GO:0032355,0.440624345750911,0.88657172455205,1,82,response to estradiol,BP,TXNIP
12890,GO:0051225,0.441772034470449,0.885717840298687,1,99,spindle assembly,BP,GOLGA2P5
13815,GO:0060401,0.442179201573283,0.885579232126993,1,90,cytosolic calcium ion transport,BP,DDIT3
8153,GO:0032879,0.442314374924561,0.677049334043451,12,1686,regulation of localization,BP,NR1D1;GDNF;HES1;DDIT3;SNAI2;SPN;TMSB4X;FAM110C;FXYD3;GPR89A;RHOF;RAB15
15822,GO:0072525,0.442475356027234,0.885313659609034,1,99,pyridine-containing compound biosynthetic process,BP,DDIT4
10820,GO:0044309,0.442758554107752,0.88513175575752,1,101,neuron spine,CC,NR1D1
4082,GO:0009135,0.443023297338233,0.885059851241727,1,93,purine nucleoside diphosphate metabolic process,BP,DDIT4
4121,GO:0009179,0.443023297338233,0.885059851241727,1,93,purine ribonucleoside diphosphate metabolic process,BP,DDIT4
3625,GO:0008083,0.443223721987243,0.885340089709204,1,67,growth factor activity,MF,GDNF
5298,GO:0015980,0.4436631538275,0.772152903076247,3,216,energy derivation by oxidation of organic compounds,BP,NR1D1;PPP1R3D;COX7C
9867,GO:0042127,0.444137974992429,0.697346628488056,8,1034,regulation of cell proliferation,BP,TXNIP;NR1D1;HES5;GDNF;HES1;SNAI2;NUPR1;SPN
15121,GO:0071214,0.444397014693876,0.810206751940917,2,230,cellular response to abiotic stimulus,BP,ACTR5;SNAI2
17185,GO:0104004,0.444397014693876,0.810206751940917,2,230,cellular response to environmental stimulus,BP,ACTR5;SNAI2
8302,GO:0033135,0.444544779543118,0.884277876279797,1,85,regulation of peptidyl-serine phosphorylation,BP,DDIT4
1108,GO:0002695,0.444714862497618,0.884117140239604,1,90,negative regulation of leukocyte activation,BP,SPN
12530,GO:0050671,0.44481633135046,0.884342308627738,1,71,positive regulation of lymphocyte proliferation,BP,HES1
15824,GO:0072527,0.444816771693871,0.884466301904896,1,65,pyrimidine-containing compound metabolic process,BP,NME9
6984,GO:0030659,0.445168293202841,0.745579582696281,4,507,cytoplasmic vesicle membrane,CC,LRIG3;SLC2A3;RHOF;RAB15
8935,GO:0034968,0.445621548879299,0.883603508498036,1,89,histone lysine methylation,BP,HIST1H1D
13119,GO:0051651,0.445868559923414,0.883678525852008,1,74,maintenance of location in cell,BP,TMSB4X
10256,GO:0042995,0.446662584946459,0.688133731566668,9,1309,cell projection,CC,NR1D1;RGS2;NRSN1;APC2;CNNM1;SPN;RPL28;RAB15;MAP1A
17774,GO:1901800,0.446866510891663,0.882867480587319,1,90,positive regulation of proteasomal protein catabolic process,BP,RNF125
6289,GO:0019897,0.446953978011501,0.882709514543234,1,100,extrinsic component of plasma membrane,CC,APC2
15294,GO:0071482,0.447430533813444,0.882575510864967,1,87,cellular response to light stimulus,BP,ACTR5
8201,GO:0032946,0.447502447681423,0.882764869941631,1,72,positive regulation of mononuclear cell proliferation,BP,HES1
4097,GO:0009150,0.449200467022736,0.742427944490328,4,356,purine ribonucleotide metabolic process,BP,DDIT4;NME9;TMSB4X;COX7C
14944,GO:0070838,0.449409927395534,0.806406109887094,2,245,divalent metal ion transport,BP,SLC24A4;DDIT3
2379,GO:0005509,0.449851128884303,0.766640435641589,3,367,calcium ion binding,MF,TCHH;SLC24A4;DCHS1
3263,GO:0006935,0.450143604202703,0.766429768658178,3,353,chemotaxis,BP,GDNF;SPN;TMSB4X
15812,GO:0072511,0.450970979939285,0.805227231053122,2,246,divalent inorganic cation transport,BP,SLC24A4;DDIT3
13722,GO:0060284,0.451190810998863,0.74040216550734,4,571,regulation of cell development,BP,HES5;S1PR5;HES1;ID3
12901,GO:0051240,0.45148307949977,0.699028605865847,7,981,positive regulation of multicellular organismal process,BP,RGS2;GDNF;HES1;RNF125;DDIT3;SPN;TMSB4X
12706,GO:0050921,0.451567952326274,0.880292377799428,1,77,positive regulation of chemotaxis,BP,TMSB4X
9959,GO:0042330,0.453727396762449,0.763493929298019,3,354,taxis,BP,GDNF;SPN;TMSB4X
368,GO:0000989,0.454202630510787,0.737888353204163,4,518,transcription factor activity, transcription factor binding,MF,NR1D1;ID3;DDIT3;PHF12
3265,GO:0006937,0.454259279999755,0.878680345045452,1,78,regulation of muscle contraction,BP,RGS2
4127,GO:0009185,0.45473677615987,0.878167390291583,1,95,ribonucleoside diphosphate metabolic process,BP,DDIT4
3689,GO:0008194,0.454808498033883,0.878072154951532,1,100,UDP-glycosyltransferase activity,MF,PIGH
13764,GO:0060337,0.456217369026635,0.87770026201588,1,68,type I interferon signaling pathway,BP,IFIT2
15208,GO:0071357,0.456217369026635,0.87770026201588,1,68,cellular response to type I interferon,BP,IFIT2
14512,GO:0065008,0.45676224816878,0.646279261944931,18,2386,regulation of biological quality,BP,NR1D1;TSC22D3;RGS2;NME9;GDNF;SLC24A4;ZC3H12D;MUC6;SLC9A4;DDIT3;HIST1H4F;TMSB4X;GPR89A;HIST1H4I;RHOF;ARRDC3;HIST1H4D;ABCB5
7187,GO:0031072,0.457280758613149,0.876569656062119,1,102,heat shock protein binding,MF,SPN
14508,GO:0065003,0.457856981319513,0.658937856754338,13,1421,protein-containing complex assembly,BP,HES5;RGS2;HES1;SNRPD2;DDIT3;HIST1H4F;RPL23A;HIST1H1D;TMSB4X;HIST1H4I;MAP7D3;RPS27;HIST1H4D
3337,GO:0007052,0.458588929091958,0.875752109929472,1,105,mitotic spindle organization,BP,SPC25
7270,GO:0031248,0.458599918781685,0.875931600983025,1,88,protein acetyltransferase complex,CC,JADE2
18012,GO:1902493,0.458599918781685,0.875931600983025,1,88,acetyltransferase complex,CC,JADE2
10729,GO:0044085,0.458762801993701,0.63903381536703,21,2477,cellular component biogenesis,BP,HES5;RGS2;RPL37;HES1;GOLGA2P5;SNRPD2;DDIT3;SNAI2;RPL31;HIST1H4F;RPL23A;HIST1H1D;RPL28;TMSB4X;FAM110C;KIAA0753;HIST1H4I;RHOF;MAP7D3;RPS27;HIST1H4D
308,GO:0000819,0.459036048993278,0.799204852843396,2,216,sister chromatid segregation,BP,SPC25;RPS27
2716,GO:0006090,0.459941082903807,0.874961390765163,1,102,pyruvate metabolic process,BP,DDIT4
8992,GO:0035107,0.460091731153079,0.874850742495954,1,104,appendage morphogenesis,BP,HOXA9
8993,GO:0035108,0.460091731153079,0.874850742495954,1,104,limb morphogenesis,BP,HOXA9
6619,GO:0022839,0.461323670339032,0.874073575831359,1,107,ion gated channel activity,MF,GPR89A
10735,GO:0044092,0.461549356107894,0.700434985399628,6,748,negative regulation of molecular function,BP,TXNIP;RGS2;ID3;IFIT2;DDIT3;TMSB4X
5886,GO:0018022,0.461688528074905,0.873971950354055,1,95,peptidyl-lysine methylation,BP,HIST1H1D
875,GO:0002224,0.462118169773886,0.873769796883055,1,90,toll-like receptor signaling pathway,BP,NR1D1
367,GO:0000988,0.462169583337911,0.731032375020427,4,523,transcription factor activity, protein binding,MF,NR1D1;ID3;DDIT3;PHF12
8829,GO:0034613,0.463212680244357,0.657711487438738,12,1459,cellular protein localization,BP,TXNIP;RPL37;HES1;DCHS1;DDIT3;RPL31;RPL23A;RPL28;TMSB4X;KIAA0753;RPS27;RAB15
7663,GO:0032091,0.463474376571541,0.873116837419905,1,78,negative regulation of protein binding,BP,IFIT2
14876,GO:0070665,0.463499459895867,0.873154491352656,1,75,positive regulation of leukocyte proliferation,BP,HES1
7086,GO:0030879,0.463523227646505,0.872805978955583,1,99,mammary gland development,BP,HOXA9
6617,GO:0022836,0.463837409816859,0.872526145893388,1,108,gated channel activity,MF,GPR89A
12752,GO:0051017,0.463876320850896,0.872484837595292,1,110,actin filament bundle assembly,BP,RHOF
4809,GO:0012506,0.46512603875073,0.728470259293067,4,524,vesicle membrane,CC,LRIG3;SLC2A3;RHOF;RAB15
14354,GO:0061572,0.466378286709418,0.870932941208888,1,111,actin filament bundle organization,BP,RHOF
15806,GO:0072503,0.466520400794386,0.793418857601667,2,218,cellular divalent inorganic cation homeostasis,BP,SLC24A4;DDIT3
1260,GO:0003012,0.467130074313897,0.792931952643046,2,221,muscle system process,BP,RGS2;GDNF
10890,GO:0044431,0.467668211566789,0.708270461353242,5,719,Golgi apparatus part,CC,GOLGA2P5;MUC6;RNF125;GPR89A;MUC12
7276,GO:0031256,0.468444619877121,0.869649471555997,1,111,leading edge membrane,CC,APC2
3710,GO:0008219,0.468502079486215,0.652723750773853,12,1570,cell death,BP,TXNIP;DDIT4;TSC22D3;TCHH;GDNF;ID3;LGALS7B;IFIT2;DDIT3;SNAI2;NUPR1;IVNS1ABP
3321,GO:0007030,0.468924441779184,0.869325284685892,1,114,Golgi organization,BP,GOLGA2P5
4183,GO:0009259,0.469182712908589,0.725199860129137,4,370,ribonucleotide metabolic process,BP,DDIT4;NME9;TMSB4X;COX7C
1541,GO:0003924,0.469225162711505,0.791277032519796,2,226,GTPase activity,MF,RHOF;RAB15
8701,GO:0034340,0.469620838795377,0.869412064403438,1,73,response to type I interferon,BP,IFIT2
11086,GO:0045087,0.470172079681612,0.706191196564239,5,555,innate immune response,BP,NR1D1;MUC6;IFIT2;RNF125;MUC12
13773,GO:0060348,0.47090938764786,0.868051252122264,1,118,bone development,BP,DCHS1
14902,GO:0070727,0.471935563730946,0.64951899354022,12,1469,cellular macromolecule localization,BP,TXNIP;RPL37;HES1;DCHS1;DDIT3;RPL31;RPL23A;RPL28;TMSB4X;KIAA0753;RPS27;RAB15
18243,GO:1903052,0.472048149943116,0.867508828162577,1,99,positive regulation of proteolysis involved in cellular protein catabolic process,BP,RNF125
12897,GO:0051235,0.472174890302728,0.788988341845995,2,220,maintenance of location,BP,DDIT3;TMSB4X
10565,GO:0043524,0.472684906878533,0.867190106984748,1,92,negative regulation of neuron apoptotic process,BP,GDNF
12984,GO:0051384,0.473958574604871,0.866398785460382,1,91,response to glucocorticoid,BP,DDIT4
8204,GO:0032956,0.474262666869941,0.787265703209082,2,240,regulation of actin cytoskeleton organization,BP,TMSB4X;RHOF
3589,GO:0008015,0.474604463188497,0.786961574181532,2,250,blood circulation,BP,RGS2;FXYD3
16650,GO:0097525,0.475541779299973,0.86595315662674,1,62,spliceosomal snRNP complex,CC,SNRPD2
18031,GO:1902533,0.476319652300871,0.700569353603483,5,663,positive regulation of intracellular signal transduction,BP,HES5;HES1;DDIT3;FAM110C;GPR89A
10188,GO:0042788,0.477593847600096,0.866669636764906,1,29,polysomal ribosome,CC,RPL31
1261,GO:0003013,0.477641662065435,0.784547024082894,2,252,circulatory system process,BP,RGS2;FXYD3
6856,GO:0030324,0.478826809583957,0.86307944965516,1,111,lung development,BP,HES1
2547,GO:0005814,0.47896626570524,0.862989811237537,1,111,centriole,CC,KIAA0753
905,GO:0002285,0.479199994605688,0.862959615145887,1,99,lymphocyte activation involved in immune response,BP,SPN
681,GO:0001889,0.479262004114916,0.862887053289937,1,102,liver development,BP,HES1
12796,GO:0051087,0.479810462650339,0.862849019946788,1,79,chaperone binding,MF,HES1
2814,GO:0006275,0.480256355734819,0.862279446386832,1,99,regulation of DNA replication,BP,ID3
3545,GO:0007569,0.48042755898968,0.862323105954074,1,87,cell aging,BP,ZKSCAN3
11139,GO:0045185,0.480598547203743,0.862184263891789,1,89,maintenance of protein location,BP,TMSB4X
3334,GO:0007049,0.481025689680579,0.645302703345434,11,1548,cell cycle,BP,TXNIP;RGS2;HES1;ID3;GOLGA2P5;DDIT3;NUPR1;SPC25;KIAA0753;RHOF;RPS27
13930,GO:0060589,0.481092083555638,0.781703577461669,2,283,nucleoside-triphosphatase regulator activity,MF,RIN2;RGS2
7325,GO:0031333,0.481167141408627,0.861763576098116,1,93,negative regulation of protein complex assembly,BP,TMSB4X
7357,GO:0031398,0.481209303309762,0.861762543011446,1,91,positive regulation of protein ubiquitination,BP,ARRDC3
10614,GO:0043603,0.481739162810599,0.649962391742013,10,907,cellular amide metabolic process,BP,RGS2;RPL37;ZC3H12D;RPL31;HIST1H4F;RPL23A;RPL28;HIST1H4I;RPS27;HIST1H4D
10722,GO:0044057,0.482100974534678,0.780995394780472,2,249,regulation of system process,BP,RGS2;FXYD3
14143,GO:0061008,0.484219959605682,0.859653834011383,1,104,hepaticobiliary system development,BP,HES1
4554,GO:0010634,0.484235486911116,0.859654175127373,1,103,positive regulation of epithelial cell migration,BP,TMSB4X
12775,GO:0051047,0.484685025727692,0.778983126088682,2,231,positive regulation of secretion,BP,GDNF;RAB15
4057,GO:0009101,0.484899270030506,0.778718378503782,2,257,glycoprotein biosynthetic process,BP,MUC6;MUC12
2754,GO:0006163,0.48536180116595,0.710930469802592,4,371,purine nucleotide metabolic process,BP,DDIT4;NME9;TMSB4X;COX7C
8861,GO:0034660,0.485375125074248,0.678973315175142,6,545,ncRNA metabolic process,BP,RPL37;RPL31;RNF113A;RPL23A;RPL28;RPS27
1186,GO:0002831,0.48658841675116,0.858205727156744,1,95,regulation of response to biotic stimulus,BP,RNF125
888,GO:0002252,0.486610738961236,0.677620022072611,6,749,immune effector process,BP,DDIT4;SLC2A3;IFIT2;RNF125;SPN;RHOF
4074,GO:0009126,0.486681382060988,0.736069804424539,3,247,purine nucleoside monophosphate metabolic process,BP,DDIT4;TMSB4X;COX7C
4113,GO:0009167,0.486681382060988,0.736069804424539,3,247,purine ribonucleoside monophosphate metabolic process,BP,DDIT4;TMSB4X;COX7C
11138,GO:0045184,0.486819295613906,0.631521572290076,13,1582,establishment of protein localization,BP,TXNIP;NR1D1;RPL37;HES1;DDIT3;RPL31;RPL23A;RPL28;TMSB4X;GPR89A;RPS27;RAB15;BTN3A1
6985,GO:0030660,0.487556409609237,0.857664229118936,1,88,Golgi-associated vesicle membrane,CC,GPR89A
15809,GO:0072507,0.488219557680024,0.776132449410866,2,229,divalent inorganic cation homeostasis,BP,SLC24A4;DDIT3
2717,GO:0006091,0.488287976733405,0.708334470131078,4,364,generation of precursor metabolites and energy,BP,NR1D1;DDIT4;PPP1R3D;COX7C
6855,GO:0030323,0.488516810914337,0.856726534352003,1,115,respiratory tube development,BP,HES1
7758,GO:0032273,0.489127723885834,0.856544315233839,1,94,positive regulation of protein polymerization,BP,RGS2
275,GO:0000777,0.48935599793879,0.856419697527599,1,92,condensed chromosome kinetochore,CC,SPC25
12558,GO:0050707,0.489797478760573,0.85610067751731,1,94,regulation of cytokine secretion,BP,TMSB4X
6069,GO:0019216,0.490333447904886,0.774299286705747,2,261,regulation of lipid metabolic process,BP,NR1D1;SNAI2
3450,GO:0007264,0.490767485862775,0.731999264061573,3,457,small GTPase mediated signal transduction,BP,RIN2;RHOF;RAB15
3403,GO:0007186,0.490880032410297,0.732033044833878,3,377,G-protein coupled receptor signaling pathway,BP,RGS2;S1PR5;ARRDC3
4566,GO:0010646,0.492043203855014,0.617222030315015,16,2313,regulation of cell communication,BP,NR1D1;HES5;DDIT4;RGS2;GDNF;HES1;RNF125;DDIT3;SNAI2;APC2;TMSB4X;FAM110C;GPR89A;IVNS1ABP;RHOF;ARRDC3
6739,GO:0030155,0.492135533286494,0.730860294366646,3,421,regulation of cell adhesion,BP,HES1;SNAI2;SPN
6204,GO:0019693,0.49427330651499,0.702907339234323,4,384,ribose phosphate metabolic process,BP,DDIT4;NME9;TMSB4X;COX7C
4347,GO:0009898,0.494705911292773,0.852553312605486,1,120,cytoplasmic side of plasma membrane,CC,RGS2
12665,GO:0050866,0.496035019444386,0.851795990293042,1,105,negative regulation of cell activation,BP,SPN
11800,GO:0046677,0.49607517358415,0.769760723679193,2,217,response to antibiotic,BP,TXNIP;ID3
11787,GO:0046649,0.497016403654447,0.726637298673319,3,392,lymphocyte activation,BP,HES1;SPN;BTN3A1
8921,GO:0034764,0.497310503382914,0.850954303514526,1,103,positive regulation of transmembrane transport,BP,TMSB4X
7176,GO:0031056,0.497876300111679,0.850424314853025,1,118,regulation of histone modification,BP,SNAI2
10913,GO:0044463,0.498290734883309,0.666679909763341,6,890,cell projection part,CC,NR1D1;NRSN1;APC2;CNNM1;RPL28;MAP1A
17255,GO:0120038,0.498290734883309,0.666679909763341,6,890,plasma membrane bounded cell projection part,CC,NR1D1;NRSN1;APC2;CNNM1;RPL28;MAP1A
1254,GO:0003006,0.498655984658518,0.725155551863156,3,414,developmental process involved in reproduction,BP,HOXA9;HES1;NUPR1
15189,GO:0071333,0.500084306271895,0.849327643109219,1,84,cellular response to glucose stimulus,BP,NR1D1
3360,GO:0007098,0.500434524746826,0.84877228755655,1,108,centrosome cycle,BP,KIAA0753
3271,GO:0006950,0.50150785604126,0.599551108098823,20,2658,response to stress,BP,TXNIP;NR1D1;DDIT4;TSC22D3;ID3;MUC6;IFIT2;RNF125;ACTR5;DDIT3;SNAI2;NUPR1;HIST1H4F;SPN;TMSB4X;HSP90AB4P;ZKSCAN3;HIST1H4I;HIST1H4D;MUC12
8196,GO:0032940,0.502170423356123,0.652298915726927,7,932,secretion by cell,BP,NR1D1;GDNF;SLC2A3;TMSB4X;RHOF;RAB15;BTN3A1
6932,GO:0030532,0.502356126171899,0.848083470848525,1,69,small nuclear ribonucleoprotein complex,CC,SNRPD2
4346,GO:0009897,0.502401870815974,0.847411404286528,1,109,external side of plasma membrane,CC,BTN3A1
15185,GO:0071326,0.502425252276299,0.847707178351668,1,85,cellular response to monosaccharide stimulus,BP,NR1D1
15187,GO:0071331,0.502425252276299,0.847707178351668,1,85,cellular response to hexose stimulus,BP,NR1D1
5453,GO:0016323,0.503060076192327,0.846800993940444,1,127,basolateral plasma membrane,CC,SLC9A4
11937,GO:0046983,0.503157874692289,0.642765064832749,8,855,protein dimerization activity,MF,HES5;GDNF;HES1;ID3;DDIT3;HIST1H4F;HIST1H4I;HIST1H4D
10394,GO:0043226,0.503498810849502,0.607983492291105,72,9767,organelle,CC,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;FCGBP;NRSN1;TCHH;RPL37;LRIG3;NME9;PPP1R3D;HES1;HOXC13;ID3;ZC3H12D;GOLGA2P5;TIGD2;LGALS7B;MUC6;SMIM14;SLC2A3;IFIT2;RNF125;ACTR5;SNRPD2;DDIT3;SNAI2;APC2;RPL31;FAM217B;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;SPC25;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;JADE2;ZNF169;FAM110C;FXYD3;KIAA0753;GPR89A;IVNS1ABP;ZNF799;ZKSCAN3;COX7C;HIST1H4I;RHOF;CIART;ARRDC3;MAP7D3;RPS27;ZNF485;HIST1H4D;RAB15;MUC12;ZNF57;MAP1A
18447,GO:1903531,0.504267649223602,0.846248053508523,1,98,negative regulation of secretion by cell,BP,TMSB4X
4107,GO:0009161,0.504709878666817,0.720224106057156,3,258,ribonucleoside monophosphate metabolic process,BP,DDIT4;TMSB4X;COX7C
8891,GO:0034708,0.505902767222267,0.845224832214305,1,90,methyltransferase complex,CC,SNRPD2
3185,GO:0006810,0.506011109742219,0.588144895650108,25,3348,transport,BP,TXNIP;NR1D1;TSC22D3;RIN2;RPL37;GDNF;HES1;SLC24A4;SLC2A3;SLC9A4;SNRPD2;DDIT3;RPL31;RPL23A;CNNM1;RPL28;TMSB4X;FXYD3;GPR89A;COX7C;RHOF;RPS27;RAB15;BTN3A1;ABCB5
4069,GO:0009119,0.506704565799535,0.844781900844939,1,83,ribonucleoside metabolic process,BP,NME9
2846,GO:0006325,0.507055237852394,0.658618331875833,6,661,chromatin organization,BP,SNAI2;HIST1H4F;HIST1H1D;JADE2;HIST1H4I;HIST1H4D
405,GO:0001085,0.507149435711033,0.844140936080397,1,107,RNA polymerase II transcription factor binding,MF,ID3
2369,GO:0005488,0.508382198238742,0.606325393479177,73,10129,binding,MF,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RIN2;RGS2;HOXA9;FCGBP;NRSN1;TCHH;RPL37;PPP1R3D;GDNF;HES1;HOXC13;ID3;SLC24A4;ZC3H12D;TIGD2;LGALS7B;SMIM14;SLC2A3;IFIT2;RNF125;ACTR5;DCHS1;SNRPD2;DDIT3;SNAI2;APC2;RPL31;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;SPC25;ZNF160;HIST1H1D;ZNF766;CNNM1;SPN;SALL2;HOXC5;RPL28;TMSB4X;JADE2;ZNF169;FAM110C;KIAA0753;IVNS1ABP;HSP90AB4P;ZNF799;ZKSCAN3;TMEM139;HIST1H4I;SPDYE1;RHOF;CIART;ARRDC3;MAP7D3;RPS27;ZNF485;HIST1H4D;RAB15;BTN3A1;ZNF57;STAC2;MAP1A;ABCB5
4530,GO:0010594,0.510505084610342,0.841745588117897,1,111,regulation of endothelial cell migration,BP,TMSB4X
5509,GO:0016458,0.510690031802052,0.714988170751641,3,237,gene silencing,BP,HIST1H4F;HIST1H4I;HIST1H4D
3087,GO:0006661,0.510886890717547,0.841401105175516,1,119,phosphatidylinositol biosynthetic process,BP,PIGH
5561,GO:0016571,0.511137949445676,0.841299053450707,1,111,histone methylation,BP,HIST1H1D
12427,GO:0048878,0.511469584754309,0.668279901077566,5,647,chemical homeostasis,BP,NR1D1;SLC24A4;SLC9A4;DDIT3;GPR89A
6895,GO:0030426,0.512216104798372,0.840443575987626,1,121,growth cone,CC,NRSN1
18543,GO:1903749,0.512228539446032,0.84077482608039,1,91,positive regulation of establishment of protein localization to mitochondrion,BP,HES1
12906,GO:0051249,0.512687284226575,0.755723501235372,2,248,regulation of lymphocyte activation,BP,HES1;SPN
17695,GO:1901575,0.512922275259893,0.606314739474547,13,1625,organic substance catabolic process,BP,NR1D1;DDIT4;RPL37;PPP1R3D;GDNF;ZC3H12D;RNF125;DDIT3;APC2;RPL31;RPL23A;RPL28;RPS27
14664,GO:0070268,0.513958201264817,0.839912743656002,1,72,cornification,BP,TCHH
15183,GO:0071322,0.515184908753037,0.838689598123943,1,90,cellular response to carbohydrate stimulus,BP,NR1D1
8261,GO:0033043,0.515531269387899,0.63952649399553,7,1018,regulation of organelle organization,BP,RGS2;HES1;SNAI2;APC2;TMSB4X;RHOF;MAP1A
2382,GO:0005516,0.515851438793551,0.837788736583219,1,129,calmodulin binding,MF,RGS2
15818,GO:0072521,0.516310376938409,0.682711910148634,4,392,purine-containing compound metabolic process,BP,DDIT4;NME9;TMSB4X;COX7C
7323,GO:0031331,0.516357773065327,0.752473065394295,2,284,positive regulation of cellular catabolic process,BP,ZC3H12D;RNF125
18136,GO:1902850,0.516568194600292,0.837331058641011,1,122,microtubule cytoskeleton organization involved in mitosis,BP,SPC25
10848,GO:0044344,0.516919344961383,0.837224748885871,1,107,cellular response to fibroblast growth factor stimulus,BP,SNAI2
3090,GO:0006664,0.516948550572855,0.837286858485026,1,100,glycolipid metabolic process,BP,PIGH
18430,GO:1903509,0.516948550572855,0.837286858485026,1,100,liposaccharide metabolic process,BP,PIGH
7162,GO:0031023,0.517071453827885,0.837032956764258,1,115,microtubule organizing center organization,BP,KIAA0753
5331,GO:0016055,0.517441030169029,0.708408766185863,3,389,Wnt signaling pathway,BP,DDIT3;SNAI2;APC2
8233,GO:0033002,0.518048249594144,0.836311199475298,1,117,muscle cell proliferation,BP,HES5
16760,GO:0098552,0.518065389129725,0.751071079107648,2,263,side of membrane,CC,RGS2;BTN3A1
10080,GO:0042581,0.518364894014053,0.836255713117243,1,101,specific granule,CC,SLC2A3
5235,GO:0015850,0.518414172453923,0.836220199816131,1,101,organic hydroxy compound transport,BP,GDNF
556,GO:0001678,0.51846233249742,0.836309207791698,1,92,cellular glucose homeostasis,BP,NR1D1
10681,GO:0043933,0.518643991897738,0.594183795452309,15,1671,protein-containing complex subunit organization,BP,HES5;RGS2;HES1;SNRPD2;DDIT3;APC2;HIST1H4F;RPL23A;HIST1H1D;TMSB4X;HIST1H4I;MAP7D3;RPS27;HIST1H4D;MAP1A
3794,GO:0008360,0.518971518991421,0.835591724805463,1,123,regulation of cell shape,BP,RHOF
8216,GO:0032970,0.51916194131035,0.750123946809012,2,264,regulation of actin filament-based process,BP,TMSB4X;RHOF
12903,GO:0051246,0.519568340025096,0.593207441543906,15,2015,regulation of protein metabolic process,BP,HES5;DDIT4;RGS2;HES1;ZC3H12D;RNF125;SNAI2;APC2;NUPR1;HIST1H4F;SPN;HIST1H4I;SPDYE1;ARRDC3;HIST1H4D
17331,GO:0198738,0.52037348249349,0.705739503511161,3,391,cell-cell signaling by wnt,BP,DDIT3;SNAI2;APC2
6896,GO:0030427,0.521267732203254,0.833910056658344,1,125,site of polarized growth,CC,NRSN1
12966,GO:0051345,0.521480139937538,0.677616439415523,4,561,positive regulation of hydrolase activity,BP,RIN2;RGS2;APC2;TMSB4X
16877,GO:0098813,0.52167922348067,0.747987661256944,2,253,nuclear chromosome segregation,BP,SPC25;RPS27
18369,GO:1903364,0.521791557213071,0.833608840900727,1,116,positive regulation of cellular protein catabolic process,BP,RNF125
18449,GO:1903533,0.521995435924277,0.833692557495276,1,96,regulation of protein targeting,BP,HES1
7874,GO:0032434,0.522175181093564,0.833446126788582,1,105,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,RNF125
3884,GO:0008514,0.523276411577904,0.832374793462559,1,134,organic anion transmembrane transporter activity,MF,SLC2A3
6724,GO:0030133,0.524198818229385,0.74580122173515,2,253,transport vesicle,CC,NRSN1;RAB15
12218,GO:0048468,0.524327789157741,0.622186999846286,8,1294,cell development,BP,HES5;S1PR5;GDNF;HES1;ID3;SLC9A4;SNAI2;MAP1A
15451,GO:0071774,0.524333047975914,0.831812419587863,1,110,response to fibroblast growth factor,BP,SNAI2
3310,GO:0007015,0.52476846988528,0.745214124568475,2,281,actin filament organization,BP,TMSB4X;RHOF
3502,GO:0007409,0.524928324913247,0.745007488128754,2,306,axonogenesis,BP,GDNF;MAP1A
277,GO:0000779,0.525738629454386,0.830848242905041,1,104,condensed chromosome, centromeric region,CC,SPC25
548,GO:0001667,0.527929474694329,0.742480048729363,2,272,ameboidal-type cell migration,BP,GDNF;TMSB4X
12618,GO:0050796,0.528046734484324,0.829108056401361,1,107,regulation of insulin secretion,BP,NR1D1
12559,GO:0050708,0.528168054424596,0.742314082400349,2,259,regulation of protein secretion,BP,NR1D1;TMSB4X
2816,GO:0006281,0.529534981379215,0.670140760784042,4,484,DNA repair,BP,ACTR5;HIST1H4F;HIST1H4I;HIST1H4D
13142,GO:0051704,0.52965746046712,0.58990610139459,13,1581,multi-organism process,BP,NR1D1;DDIT4;RGS2;HOXA9;RPL37;IFIT2;RNF125;RPL31;RPL23A;SPN;RPL28;IVNS1ABP;RPS27
1484,GO:0003779,0.529711367664359,0.740859841378746,2,291,actin binding,MF,TMSB4X;MAP1A
7593,GO:0031960,0.52976593409016,0.827879145188482,1,103,response to corticosteroid,BP,DDIT4
4071,GO:0009123,0.530711910277298,0.696599216890178,3,270,nucleoside monophosphate metabolic process,BP,DDIT4;TMSB4X;COX7C
324,GO:0000904,0.530757497501046,0.696056575617423,3,482,cell morphogenesis involved in differentiation,BP,GDNF;HES1;MAP1A
3593,GO:0008021,0.530815395759153,0.827084169574289,1,104,synaptic vesicle,CC,RAB15
3048,GO:0006606,0.53132492454985,0.826580464649377,1,115,protein import into nucleus,BP,TXNIP
2572,GO:0005856,0.532306340805016,0.600962350110871,10,1565,cytoskeleton,CC,TCHH;NME9;APC2;TMSB4X;FAM110C;KIAA0753;IVNS1ABP;RHOF;MAP7D3;MAP1A
15137,GO:0071236,0.533608596153528,0.824965492706588,1,106,cellular response to antibiotic,BP,ID3
12904,GO:0051247,0.534660194129903,0.612143078795331,8,1150,positive regulation of protein metabolic process,BP,HES5;HES1;RNF125;SNAI2;APC2;NUPR1;SPN;ARRDC3
12946,GO:0051302,0.535101835882842,0.823728846814961,1,116,regulation of cell division,BP,TXNIP
6862,GO:0030330,0.535663463760356,0.823477424389639,1,101,DNA damage response, signal transduction by p53 class mediator,BP,SNAI2
7137,GO:0030968,0.536102859261593,0.822960597023298,1,117,endoplasmic reticulum unfolded protein response,BP,DDIT3
16903,GO:0098858,0.536601191234062,0.822525579453867,1,123,actin-based cell projection,CC,SPN
13901,GO:0060541,0.536627017172199,0.82243840955907,1,131,respiratory system development,BP,HES1
682,GO:0001890,0.53700977082099,0.822281796815054,1,116,placenta development,BP,HES1
18353,GO:1903322,0.537123536180237,0.822294141775534,1,107,positive regulation of protein modification by small protein conjugation or removal,BP,ARRDC3
5860,GO:0017157,0.538622243002895,0.820994642105758,1,122,regulation of exocytosis,BP,RAB15
3387,GO:0007166,0.538647875663337,0.580936250467072,13,1866,cell surface receptor signaling pathway,BP,TXNIP;HES5;DDIT4;GDNF;HES1;MUC6;IFIT2;DDIT3;SNAI2;APC2;TMSB4X;BTN3A1;MUC12
2888,GO:0006396,0.538700660288555,0.608311568272112,8,877,RNA processing,BP,RPL37;SNRPD2;RPL31;RNF113A;RPL23A;RPL28;IVNS1ABP;RPS27
11474,GO:0045931,0.541364519009958,0.818959995197056,1,115,positive regulation of mitotic cell cycle,BP,HES1
7908,GO:0032479,0.543651108362788,0.817284631537645,1,107,regulation of type I interferon production,BP,RNF125
18541,GO:1903747,0.544306548646841,0.816882104084082,1,99,regulation of establishment of protein localization to mitochondrion,BP,HES1
10506,GO:0043409,0.544329621775824,0.816535875923492,1,129,negative regulation of MAPK cascade,BP,RGS2
2584,GO:0005875,0.544837457167167,0.816232291591232,1,119,microtubule associated complex,CC,MAP1A
4960,GO:0015031,0.545215970262572,0.578428903778968,12,1501,protein transport,BP,TXNIP;NR1D1;RPL37;HES1;RPL31;RPL23A;RPL28;TMSB4X;GPR89A;RPS27;RAB15;BTN3A1
5314,GO:0016021,0.545925042077978,0.559503989441162,18,2700,integral component of membrane,CC,NRSN1;S1PR5;LRIG3;SLC24A4;SMIM14;SLC2A3;SLC9A4;DCHS1;CNNM1;SPN;FXYD3;GPR89A;COX7C;TMEM139;LOC441081;BTN3A1;MUC12;ABCB5
12776,GO:0051048,0.546493598961147,0.815050076436634,1,109,negative regulation of secretion,BP,TMSB4X
686,GO:0001894,0.548128034215676,0.81363254276417,1,122,tissue homeostasis,BP,MUC6
11936,GO:0046982,0.548366512295297,0.652398517180469,4,352,protein heterodimerization activity,MF,DDIT3;HIST1H4F;HIST1H4I;HIST1H4D
7990,GO:0032606,0.549271619423587,0.812884515402785,1,108,type I interferon production,BP,RNF125
12791,GO:0051082,0.549485031868401,0.812794023475298,1,102,unfolded protein binding,MF,HSP90AB4P
15128,GO:0071222,0.55022418101843,0.812171669954955,1,105,cellular response to lipopolysaccharide,BP,NR1D1
1447,GO:0003674,0.550891090787548,0.628056137436226,82,11300,molecular_function,MF,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RIN2;RGS2;HOXA9;FCGBP;NRSN1;S1PR5;TCHH;RPL37;NME9;PPP1R3D;GDNF;HES1;HOXC13;ID3;SLC24A4;ZC3H12D;TIGD2;LGALS7B;MUC6;SMIM14;SLC2A3;IFIT2;RNF125;ACTR5;SLC9A4;DCHS1;SNRPD2;DDIT3;SNAI2;APC2;RPL31;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;SPC25;ZNF160;HIST1H1D;ZNF766;CNNM1;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;JADE2;ZNF169;FAM110C;FXYD3;KIAA0753;GPR89A;IVNS1ABP;HSP90AB4P;ZNF799;ZKSCAN3;COX7C;TMEM139;HIST1H4I;SPDYE1;RHOF;CIART;ARRDC3;MAP7D3;RPS27;ZNF485;HIST1H4D;RAB15;BTN3A1;MUC12;ZNF57;STAC2;MAP1A;ABCB5
10803,GO:0044283,0.551901824505399,0.648589991940103,4,542,small molecule biosynthetic process,BP,NR1D1;DDIT4;NME9;SNAI2
15520,GO:0071901,0.552230781834123,0.810465346152425,1,115,negative regulation of protein serine/threonine kinase activity,BP,RGS2
4559,GO:0010639,0.552261661946214,0.720629186877589,2,282,negative regulation of organelle organization,BP,APC2;TMSB4X
13877,GO:0060491,0.552564014244144,0.810100790392594,1,125,regulation of cell projection assembly,BP,FAM110C
14726,GO:0070382,0.553510101897388,0.809459082868254,1,114,exocytic vesicle,CC,RAB15
12889,GO:0051224,0.554068789060854,0.809135550450993,1,104,negative regulation of protein transport,BP,TMSB4X
7245,GO:0031175,0.554325766054382,0.646115247946638,4,644,neuron projection development,BP,HES5;GDNF;HES1;MAP1A
12896,GO:0051234,0.554466866487684,0.539984829796116,25,3432,establishment of localization,BP,TXNIP;NR1D1;TSC22D3;RIN2;RPL37;GDNF;HES1;SLC24A4;SLC2A3;SLC9A4;SNRPD2;DDIT3;RPL31;RPL23A;CNNM1;RPL28;TMSB4X;FXYD3;GPR89A;COX7C;RHOF;RPS27;RAB15;BTN3A1;ABCB5
7339,GO:0031348,0.554518876605833,0.808654413364184,1,114,negative regulation of defense response,BP,RNF125
17274,GO:0120114,0.554857538106656,0.808947079081269,1,79,Sm-like protein family complex,CC,SNRPD2
17942,GO:1902275,0.555306328644321,0.807774012805447,1,142,regulation of chromatin organization,BP,SNAI2
11057,GO:0045055,0.556006173254484,0.644621812677403,4,512,regulated exocytosis,BP,SLC2A3;TMSB4X;RHOF;RAB15
17035,GO:0099512,0.556159926682827,0.644365355068523,4,598,supramolecular fiber,CC,APC2;TMSB4X;FAM110C;MAP1A
2506,GO:0005758,0.557942392643872,0.806684845419786,1,71,mitochondrial intermembrane space,CC,TXNIP
2405,GO:0005575,0.55831659304212,0.704713980503931,85,11685,cellular_component,CC,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RIN2;RGS2;HOXA9;FCGBP;NRSN1;S1PR5;TCHH;RPL37;LRIG3;NME9;PPP1R3D;GDNF;HES1;HOXC13;ID3;SLC24A4;ZC3H12D;GOLGA2P5;TIGD2;LGALS7B;MUC6;SMIM14;SLC2A3;IFIT2;RNF125;ACTR5;SLC9A4;DCHS1;SNRPD2;DDIT3;SNAI2;APC2;RPL31;FAM217B;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;SPC25;ZNF160;HIST1H1D;ZNF766;CNNM1;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;JADE2;ZNF169;FAM110C;FXYD3;KIAA0753;GPR89A;IVNS1ABP;HSP90AB4P;ZNF799;ZKSCAN3;COX7C;TMEM139;HIST1H4I;RHOF;CIART;ARRDC3;MAP7D3;RPS27;LOC441081;ZNF485;HIST1H4D;RAB15;BTN3A1;MUC12;ZNF57;STAC2;MAP1A;ABCB5
3201,GO:0006836,0.559279860823849,0.804694032480676,1,127,neurotransmitter transport,BP,GDNF
1858,GO:0004519,0.560009359677519,0.80430656989285,1,108,endonuclease activity,MF,ZC3H12D
3231,GO:0006886,0.560954454133091,0.58612472601819,8,920,intracellular protein transport,BP,TXNIP;RPL37;HES1;RPL31;RPL23A;RPL28;RPS27;RAB15
16226,GO:0090276,0.561761415634445,0.802766088014364,1,118,regulation of peptide hormone secretion,BP,NR1D1
16996,GO:0099081,0.561825376834365,0.638788014551994,4,604,supramolecular polymer,CC,APC2;TMSB4X;FAM110C;MAP1A
16995,GO:0099080,0.562765250038703,0.637858738475571,4,605,supramolecular complex,CC,APC2;TMSB4X;FAM110C;MAP1A
12669,GO:0050870,0.562780427417834,0.801955848580772,1,116,positive regulation of T cell activation,BP,HES1
15125,GO:0071219,0.562989121849165,0.801855118439211,1,110,cellular response to molecule of bacterial origin,BP,NR1D1
5226,GO:0015833,0.563297214311735,0.560244485171749,12,1519,peptide transport,BP,TXNIP;NR1D1;RPL37;HES1;RPL31;RPL23A;RPL28;TMSB4X;GPR89A;RPS27;RAB15;BTN3A1
7056,GO:0030833,0.564123898440154,0.800866665442208,1,115,regulation of actin filament polymerization,BP,TMSB4X
4267,GO:0009612,0.564458645012413,0.800416078552984,1,133,response to mechanical stimulus,BP,TXNIP
19072,GO:1904950,0.565091132996088,0.800156331429924,1,108,negative regulation of establishment of protein localization,BP,TMSB4X
1170,GO:0002791,0.565140419120623,0.70870452031564,2,271,regulation of peptide secretion,BP,NR1D1;TMSB4X
18345,GO:1903311,0.56579484722666,0.708163601731214,2,251,regulation of mRNA metabolic process,BP,GDNF;ZC3H12D
4234,GO:0009411,0.566614018471693,0.79873121503673,1,123,response to UV,BP,ACTR5
7365,GO:0031406,0.56751734408858,0.798180415264321,1,106,carboxylic acid binding,MF,ID3
8834,GO:0034620,0.567955024965923,0.797545767994321,1,131,cellular response to unfolded protein,BP,DDIT3
15057,GO:0071013,0.56799426704653,0.797933896298362,1,96,catalytic step 2 spliceosome,CC,SNRPD2
15280,GO:0071466,0.568450654944469,0.797393299033367,1,107,cellular response to xenobiotic stimulus,BP,DDIT4
10363,GO:0043177,0.569540446774841,0.796487208753398,1,107,organic acid binding,MF,ID3
2551,GO:0005819,0.569625845130125,0.704382262837188,2,299,spindle,CC,FAM110C;MAP7D3
2961,GO:0006497,0.569932572147563,0.796134423024404,1,109,protein lipidation,BP,PIGH
19141,GO:1905114,0.570188038086967,0.658514904499839,3,430,cell surface receptor signaling pathway involved in cell-cell signaling,BP,DDIT3;SNAI2;APC2
6117,GO:0019362,0.57060494588805,0.795356606008498,1,129,pyridine nucleotide metabolic process,BP,DDIT4
11704,GO:0046496,0.57060494588805,0.795356606008498,1,129,nicotinamide nucleotide metabolic process,BP,DDIT4
15134,GO:0071229,0.571379513799012,0.794639307730654,1,137,cellular response to acid chemical,BP,ID3
4370,GO:0009987,0.571415573449178,0.556714264537066,76,10468,cellular process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RIN2;RGS2;HOXA9;S1PR5;TCHH;RPL37;NME9;PPP1R3D;GDNF;HES1;HOXC13;ID3;SLC24A4;ZC3H12D;GOLGA2P5;LGALS7B;MUC6;SLC2A3;IFIT2;RNF125;ACTR5;SLC9A4;DCHS1;SNRPD2;DDIT3;SNAI2;APC2;RPL31;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;SPC25;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;JADE2;ZNF169;FAM110C;KIAA0753;GPR89A;IVNS1ABP;HSP90AB4P;ZNF799;ZKSCAN3;COX7C;HIST1H4I;SPDYE1;RHOF;CIART;ARRDC3;MAP7D3;RPS27;ZNF485;HIST1H4D;RAB15;BTN3A1;MUC12;ZNF57;STAC2;MAP1A;ABCB5
1098,GO:0002685,0.571425390555015,0.795013528336398,1,100,regulation of leukocyte migration,BP,SPN
10092,GO:0042594,0.571722942344575,0.794327489798783,1,140,response to starvation,BP,DDIT3
16214,GO:0090257,0.572197112362016,0.794122453971325,1,119,regulation of muscle system process,BP,RGS2
4067,GO:0009116,0.572369752704695,0.794237789367442,1,99,nucleoside metabolic process,BP,NME9
2390,GO:0005525,0.572524072538599,0.701695226051007,2,277,GTP binding,MF,RHOF;RAB15
4029,GO:0009060,0.573006233669276,0.794412090952465,1,68,aerobic respiration,BP,COX7C
7599,GO:0031970,0.573763025268158,0.793486036185186,1,78,organelle envelope lumen,CC,TXNIP
3452,GO:0007266,0.574172626553494,0.792199179636671,1,149,Rho protein signal transduction,BP,RHOF
14933,GO:0070820,0.574191676076864,0.792589017900618,1,107,tertiary granule,CC,SLC2A3
10220,GO:0042886,0.574454525641928,0.548892504795136,12,1533,amide transport,BP,TXNIP;NR1D1;RPL37;HES1;RPL31;RPL23A;RPL28;TMSB4X;GPR89A;RPS27;RAB15;BTN3A1
11684,GO:0046467,0.574650520234292,0.792067213787749,1,118,membrane lipid biosynthetic process,BP,PIGH
3463,GO:0007283,0.575255293211696,0.699095536053966,2,274,spermatogenesis,BP,RGS2;HOXA9
3453,GO:0007267,0.575843552370761,0.59104197558457,6,906,cell-cell signaling,BP,NR1D1;GDNF;HES1;DDIT3;SNAI2;APC2
3634,GO:0008104,0.576054010904653,0.536577120405779,15,2055,protein localization,BP,TXNIP;NR1D1;RPL37;HES1;DCHS1;DDIT3;RPL31;RPL23A;RPL28;TMSB4X;KIAA0753;GPR89A;RPS27;RAB15;BTN3A1
6783,GO:0030217,0.576211757169506,0.790571144800982,1,136,T cell differentiation,BP,SPN
10058,GO:0042542,0.576306166556436,0.790827790731937,1,105,response to hydrogen peroxide,BP,TXNIP
7953,GO:0032550,0.576544288373658,0.697838900843119,2,280,purine ribonucleoside binding,MF,RHOF;RAB15
1107,GO:0002694,0.577316560265428,0.697083640992213,2,284,regulation of leukocyte activation,BP,HES1;SPN
10904,GO:0044450,0.577390241696371,0.789483102435529,1,147,microtubule organizing center part,CC,KIAA0753
274,GO:0000776,0.577475605354146,0.789637855001675,1,121,kinetochore,CC,SPC25
323,GO:0000902,0.578034740470774,0.622538575464449,4,689,cell morphogenesis,BP,GDNF;HES1;RHOF;MAP1A
10322,GO:0043112,0.57813002388641,0.788990673368063,1,130,receptor metabolic process,BP,NR1D1
798,GO:0002064,0.578612513924241,0.788484815870259,1,141,epithelial cell development,BP,SLC9A4
18236,GO:1903039,0.5788593704474,0.788435926718359,1,123,positive regulation of leukocyte cell-cell adhesion,BP,HES1
10499,GO:0043401,0.580068268776441,0.787177861172549,1,149,steroid hormone mediated signaling pathway,BP,NR1D1
675,GO:0001883,0.580945522603556,0.693587949487198,2,282,purine nucleoside binding,MF,RHOF;RAB15
10354,GO:0043167,0.581378759548549,0.510563349248981,27,4367,ion binding,MF,NR1D1;TCHH;RPL37;ID3;SLC24A4;ZC3H12D;RNF125;DCHS1;SNAI2;ZNF44;RNF113A;PHF12;ZNF160;ZNF766;SALL2;JADE2;ZNF169;HSP90AB4P;ZNF799;ZKSCAN3;RHOF;RPS27;ZNF485;RAB15;ZNF57;STAC2;ABCB5
15821,GO:0072524,0.58167395264972,0.785914488504633,1,134,pyridine-containing compound metabolic process,BP,DDIT4
15431,GO:0071705,0.581716111415236,0.53743926837857,13,1705,nitrogen compound transport,BP,TXNIP;NR1D1;RPL37;GDNF;HES1;RPL31;RPL23A;RPL28;TMSB4X;GPR89A;RPS27;RAB15;BTN3A1
7952,GO:0032549,0.581799162246101,0.692754128663186,2,284,ribonucleoside binding,MF,RHOF;RAB15
11655,GO:0046394,0.582011311878141,0.692541873204825,2,286,carboxylic acid biosynthetic process,BP,NR1D1;DDIT4
7964,GO:0032561,0.583010935973497,0.691577475055786,2,284,guanyl ribonucleotide binding,MF,RHOF;RAB15
9883,GO:0042158,0.583120760118771,0.784909724603582,1,111,lipoprotein biosynthetic process,BP,PIGH
14353,GO:0061564,0.58319212179233,0.691270173576082,2,331,axon development,BP,GDNF;MAP1A
9927,GO:0042274,0.583283962958472,0.78560694546413,1,70,ribosomal small subunit biogenesis,BP,RPS27
5329,GO:0016053,0.58331835807617,0.691268875454468,2,287,organic acid biosynthetic process,BP,NR1D1;DDIT4
17585,GO:1901215,0.583865469558368,0.78405585534765,1,130,negative regulation of neuron death,BP,GDNF
5997,GO:0019001,0.584314582581571,0.690305372094364,2,285,guanyl nucleotide binding,MF,RHOF;RAB15
20287,GO:2001252,0.585303270525497,0.782664594753487,1,147,positive regulation of chromosome organization,BP,SNAI2
10178,GO:0042770,0.58629215239612,0.782035795607003,1,121,signal transduction in response to DNA damage,BP,SNAI2
4112,GO:0009166,0.587853518967636,0.780627563170838,1,125,nucleotide catabolic process,BP,DDIT4
16808,GO:0098656,0.588036406930776,0.780224944959491,1,154,anion transmembrane transport,BP,FXYD3
325,GO:0000910,0.588810575211738,0.77964921707386,1,140,cytokinesis,BP,RHOF
7358,GO:0031399,0.589161323599673,0.55719946257032,8,1261,regulation of protein modification process,BP,HES5;DDIT4;RGS2;HES1;SNAI2;NUPR1;SPDYE1;ARRDC3
2000,GO:0004721,0.589200530297119,0.77927407424786,1,144,phosphoprotein phosphatase activity,MF,PPP1R3D
3182,GO:0006807,0.589484320875468,0.498209889051681,54,7371,nitrogen compound metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;RPL37;NME9;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;MUC6;RNF125;ACTR5;SNRPD2;DDIT3;SNAI2;APC2;RPL31;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;JADE2;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;COX7C;HIST1H4I;SPDYE1;CIART;ARRDC3;RPS27;ZNF485;HIST1H4D;MUC12;ZNF57
10626,GO:0043624,0.589644843423928,0.685638385748469,2,179,cellular protein complex disassembly,BP,APC2;MAP1A
7360,GO:0031401,0.589761433779768,0.591188056583298,5,790,positive regulation of protein modification process,BP,HES5;HES1;SNAI2;NUPR1;ARRDC3
6698,GO:0030073,0.590113921619206,0.77863966098097,1,125,insulin secretion,BP,NR1D1
9926,GO:0042273,0.590995151466788,0.778987899408522,1,67,ribosomal large subunit biogenesis,BP,RPL23A
4419,GO:0010212,0.591420775351764,0.777379532006744,1,136,response to ionizing radiation,BP,SNAI2
17558,GO:1901135,0.591422024012882,0.563950464888571,7,908,carbohydrate derivative metabolic process,BP,DDIT4;NME9;MUC6;PIGH;TMSB4X;COX7C;MUC12
12136,GO:0048232,0.593471482908244,0.68130815288159,2,284,male gamete generation,BP,RGS2;HOXA9
3946,GO:0008637,0.593681481201726,0.775726350783069,1,105,apoptotic mitochondrial changes,BP,IFIT2
3324,GO:0007033,0.594077340008468,0.774967100448475,1,142,vacuole organization,BP,ZKSCAN3
6680,GO:0030041,0.594181630406488,0.775020545986255,1,126,actin filament polymerization,BP,TMSB4X
4482,GO:0010498,0.594429872879908,0.634270937466835,3,415,proteasomal protein catabolic process,BP,NR1D1;RNF125;DDIT3
332,GO:0000922,0.595012680848476,0.774131362257677,1,142,spindle pole,CC,FAM110C
998,GO:0002460,0.595013947345162,0.77419019953471,1,135,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,SPN
12705,GO:0050920,0.595503360106445,0.773893150406153,1,121,regulation of chemotaxis,BP,TMSB4X
4056,GO:0009100,0.595552867375316,0.679166993386653,2,308,glycoprotein metabolic process,BP,MUC6;MUC12
7673,GO:0032101,0.595653731400365,0.632980481673661,3,437,regulation of response to external stimulus,BP,RNF125;SNAI2;TMSB4X
9801,GO:0040029,0.595682952867065,0.633341613421095,3,291,regulation of gene expression, epigenetic,BP,HIST1H4F;HIST1H4I;HIST1H4D
7258,GO:0031224,0.596017770789536,0.508442072932383,18,2765,intrinsic component of membrane,CC,NRSN1;S1PR5;LRIG3;SLC24A4;SMIM14;SLC2A3;SLC9A4;DCHS1;CNNM1;SPN;FXYD3;GPR89A;COX7C;TMEM139;LOC441081;BTN3A1;MUC12;ABCB5
674,GO:0001882,0.596071687846908,0.678704478220982,2,290,nucleoside binding,MF,RHOF;RAB15
609,GO:0001775,0.596591014578096,0.569739191315487,6,861,cell activation,BP,HOXA9;HES1;SLC2A3;SPN;RHOF;BTN3A1
7375,GO:0031424,0.596792252517724,0.77331614367498,1,85,keratinization,BP,TCHH
11150,GO:0045202,0.597206670381752,0.631280505474687,3,510,synapse,CC,NR1D1;RAB15;MAP1A
3803,GO:0008380,0.597293516591664,0.631392420019855,3,392,RNA splicing,BP,SNRPD2;RNF113A;IVNS1ABP
16766,GO:0098562,0.597558024496767,0.771871286279148,1,139,cytoplasmic side of membrane,CC,RGS2
19721,GO:2000058,0.597910588761452,0.771697723949982,1,124,regulation of ubiquitin-dependent protein catabolic process,BP,RNF125
3275,GO:0006955,0.602279833992525,0.53621991415083,9,1222,immune response,BP,NR1D1;MUC6;SLC2A3;IFIT2;RNF125;SPN;RHOF;BTN3A1;MUC12
2111,GO:0004888,0.602286315169304,0.672383715568926,2,322,transmembrane signaling receptor activity,MF,S1PR5;SPN
3615,GO:0008064,0.602613104595515,0.767359243113007,1,131,regulation of actin polymerization or depolymerization,BP,TMSB4X
12926,GO:0051276,0.602772428128162,0.543128014124344,8,1049,chromosome organization,BP,SNAI2;HIST1H4F;SPC25;HIST1H1D;JADE2;HIST1H4I;RPS27;HIST1H4D
17607,GO:1901292,0.602984206605586,0.767030026690218,1,130,nucleoside phosphate catabolic process,BP,DDIT4
7055,GO:0030832,0.604473831681294,0.765645743906743,1,132,regulation of actin filament length,BP,TMSB4X
5920,GO:0018193,0.604555273140727,0.561373337249687,6,944,peptidyl-amino acid modification,BP,HES5;DDIT4;HES1;SNAI2;HIST1H1D;JADE2
16809,GO:0098657,0.605538737308173,0.62270631799257,3,499,import into cell,BP,RIN2;GDNF;SLC9A4
3503,GO:0007411,0.606099994944774,0.763862274958815,1,170,axon guidance,BP,GDNF
3417,GO:0007204,0.606492182823416,0.763787748929764,1,132,positive regulation of cytosolic calcium ion concentration,BP,DDIT3
16627,GO:0097485,0.607945641503198,0.762148641180471,1,171,neuron projection guidance,BP,GDNF
10730,GO:0044087,0.608376792720194,0.591342365227406,4,667,regulation of cellular component biogenesis,BP,RGS2;SNAI2;TMSB4X;FAM110C
10670,GO:0043901,0.608850165652932,0.761745671304105,1,119,negative regulation of multi-organism process,BP,RNF125
5466,GO:0016358,0.609012744468663,0.761206366717554,1,163,dendrite development,BP,MAP1A
4305,GO:0009755,0.610039457391765,0.760269663549362,1,160,hormone-mediated signaling pathway,BP,NR1D1
6731,GO:0030141,0.610745412286099,0.588996900479685,4,538,secretory granule,CC,SLC2A3;TMSB4X;RHOF;RAB15
2130,GO:0004930,0.611166875797841,0.759415662599051,1,135,G-protein coupled receptor activity,MF,S1PR5
12778,GO:0051050,0.611203615031449,0.588428428364752,4,608,positive regulation of transport,BP,GDNF;HES1;TMSB4X;RAB15
9408,GO:0035967,0.613078655549018,0.757526555319575,1,146,cellular response to topologically incorrect protein,BP,DDIT3
710,GO:0001933,0.613336891661784,0.661119280852942,2,325,negative regulation of protein phosphorylation,BP,DDIT4;RGS2
15429,GO:0071702,0.614191210723506,0.500123971466296,14,1935,organic substance transport,BP,TXNIP;NR1D1;RPL37;GDNF;HES1;SLC2A3;RPL31;RPL23A;RPL28;TMSB4X;GPR89A;RPS27;RAB15;BTN3A1
5848,GO:0017137,0.6145223478286,0.756075890495285,1,158,Rab GTPase binding,MF,RIN2
11699,GO:0046488,0.615670783711823,0.754975892871081,1,160,phosphatidylinositol metabolic process,BP,PIGH
10736,GO:0044093,0.615695173891463,0.529426153374852,8,1258,positive regulation of molecular function,BP,RIN2;RGS2;GDNF;HES1;DDIT3;APC2;TMSB4X;ARRDC3
11158,GO:0045216,0.616344065009035,0.754249642133189,1,174,cell-cell junction organization,BP,SNAI2
6670,GO:0030027,0.617146232170887,0.753610610017647,1,155,lamellipodium,CC,APC2
12664,GO:0050865,0.618736070646744,0.655578453660383,2,309,regulation of cell activation,BP,HES1;SPN
6909,GO:0030496,0.619098131362778,0.751741926869077,1,156,midbody,CC,APC2
12315,GO:0048666,0.619141377478055,0.579931339465038,4,705,neuron development,BP,HES5;GDNF;HES1;MAP1A
3340,GO:0007059,0.619208154871497,0.655111502232012,2,301,chromosome segregation,BP,SPC25;RPS27
5317,GO:0016032,0.619604866676867,0.545661932390634,6,679,viral process,BP,RPL37;RPL31;RPL23A;RPL28;IVNS1ABP;RPS27
2434,GO:0005622,0.619756329075139,0.50773259994654,76,10506,intracellular,CC,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RIN2;RGS2;HOXA9;NRSN1;TCHH;RPL37;LRIG3;NME9;PPP1R3D;GDNF;HES1;HOXC13;ID3;SLC24A4;ZC3H12D;GOLGA2P5;TIGD2;LGALS7B;MUC6;SMIM14;SLC2A3;IFIT2;RNF125;ACTR5;DCHS1;SNRPD2;DDIT3;SNAI2;APC2;RPL31;FAM217B;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;SPC25;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;JADE2;ZNF169;FAM110C;KIAA0753;GPR89A;IVNS1ABP;HSP90AB4P;ZNF799;ZKSCAN3;COX7C;HIST1H4I;RHOF;CIART;ARRDC3;MAP7D3;RPS27;ZNF485;HIST1H4D;RAB15;MUC12;ZNF57;STAC2;MAP1A
8694,GO:0034329,0.620810459292518,0.749977613420939,1,175,cell junction assembly,BP,SNAI2
6584,GO:0022409,0.620928750786404,0.750090228709929,1,143,positive regulation of cell-cell adhesion,BP,HES1
17729,GO:1901657,0.621190371947424,0.75014067161149,1,115,glycosyl compound metabolic process,BP,NME9
10578,GO:0043542,0.623528398115457,0.747601416442018,1,141,endothelial cell migration,BP,TMSB4X
3139,GO:0006733,0.625384190970415,0.745774746694839,1,144,oxidoreduction coenzyme metabolic process,BP,DDIT4
12777,GO:0051049,0.626226347277688,0.527173096232548,7,1112,regulation of transport,BP,NR1D1;GDNF;HES1;TMSB4X;FXYD3;GPR89A;RAB15
16087,GO:0090066,0.627090105998287,0.646776578922265,2,326,regulation of anatomical structure size,BP,RGS2;TMSB4X
2562,GO:0005844,0.627121486300029,0.745444385602643,1,69,polysome,CC,RPL31
13033,GO:0051480,0.628223436371395,0.743011353233157,1,143,regulation of cytosolic calcium ion concentration,BP,DDIT3
12627,GO:0050808,0.629029096967652,0.741989326656334,1,175,synapse organization,BP,GDNF
3388,GO:0007167,0.629348902301506,0.569000961562583,4,692,enzyme linked receptor protein signaling pathway,BP,TXNIP;HES5;DDIT4;HES1
18160,GO:1902905,0.629437388376599,0.741810699558115,1,144,positive regulation of supramolecular fiber organization,BP,RGS2
10040,GO:0042493,0.629817268160509,0.56857462770955,4,610,response to drug,BP,TXNIP;DDIT4;GDNF;ABCB5
12808,GO:0051099,0.629892961275539,0.741398405687654,1,140,positive regulation of binding,BP,HES1
6608,GO:0022627,0.630022463357348,0.744213403578273,1,43,cytosolic small ribosomal subunit,CC,RPS27
6697,GO:0030072,0.630459231961865,0.740822138624158,1,142,peptide hormone secretion,BP,NR1D1
3223,GO:0006875,0.631015002168552,0.642752270455653,2,282,cellular metal ion homeostasis,BP,SLC24A4;DDIT3
3138,GO:0006732,0.63138863910644,0.642309990417212,2,295,coenzyme metabolic process,BP,DDIT4;SLC2A3
5660,GO:0016758,0.631917608901998,0.739296493885702,1,152,transferase activity, transferring hexosyl groups,MF,PIGH
4552,GO:0010632,0.632492804158857,0.738673465498958,1,159,regulation of epithelial cell migration,BP,TMSB4X
545,GO:0001664,0.632752603712824,0.738728664822423,1,125,G-protein coupled receptor binding,MF,ARRDC3
17070,GO:0099568,0.634857221204776,0.638481207115833,2,338,cytoplasmic region,CC,FAM110C;RHOF
7497,GO:0031667,0.635375040523569,0.637973706443158,2,320,response to nutrient levels,BP,DDIT3;SNAI2
10330,GO:0043123,0.636688049080609,0.734635947979995,1,141,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,GPR89A
2950,GO:0006479,0.636850924727423,0.734402080262396,1,149,protein methylation,BP,HIST1H1D
3704,GO:0008213,0.636850924727423,0.734402080262396,1,149,protein alkylation,BP,HIST1H1D
3451,GO:0007265,0.637562921300586,0.6355084897643,2,366,Ras protein signal transduction,BP,RHOF;RAB15
11876,GO:0046883,0.637627821425471,0.733664615993941,1,144,regulation of hormone secretion,BP,NR1D1
5454,GO:0016324,0.637953639102854,0.733127083795629,1,172,apical plasma membrane,CC,SLC9A4
10621,GO:0043618,0.638531492223372,0.73326879572212,1,103,regulation of transcription from RNA polymerase II promoter in response to stress,BP,DDIT3
7409,GO:0031490,0.639465961693542,0.732543433638887,1,92,chromatin DNA binding,MF,HIST1H1D
10302,GO:0043066,0.639791996902963,0.557723200934214,4,618,negative regulation of apoptotic process,BP,TSC22D3;GDNF;SNAI2;IVNS1ABP
3664,GO:0008154,0.640327695780392,0.730903944311983,1,148,actin polymerization or depolymerization,BP,TMSB4X
7499,GO:0031669,0.640339390443512,0.730748599257138,1,167,cellular response to nutrient levels,BP,SNAI2
2542,GO:0005798,0.641119243294186,0.730212509710866,1,136,Golgi-associated vesicle,CC,GPR89A
3548,GO:0007584,0.641459196112935,0.729781707315199,1,145,response to nutrient,BP,SNAI2
9893,GO:0042176,0.642512044361123,0.630325621966067,2,300,regulation of protein catabolic process,BP,RNF125;APC2
9882,GO:0042157,0.643276503778273,0.728057731162161,1,132,lipoprotein metabolic process,BP,PIGH
4068,GO:0009117,0.643406414414893,0.553959894292159,4,475,nucleotide metabolic process,BP,DDIT4;NME9;TMSB4X;COX7C
1469,GO:0003723,0.644863426358123,0.474912069107195,12,1484,RNA binding,MF,RPL37;IFIT2;SNRPD2;RPL31;HIST1H4F;RPL23A;HIST1H1D;RPL28;TMSB4X;HIST1H4I;RPS27;HIST1H4D
3251,GO:0006913,0.644894090989583,0.627720134746869,2,303,nucleocytoplasmic transport,BP,TXNIP;SNRPD2
17289,GO:0140056,0.645260996472511,0.725812933020083,1,155,organelle localization by membrane tethering,BP,RAB15
17707,GO:1901615,0.646121871159813,0.626304074519648,2,328,organic hydroxy compound metabolic process,BP,NR1D1;SNAI2
10623,GO:0043620,0.647008509005953,0.724547312358953,1,108,regulation of DNA-templated transcription in response to stress,BP,DDIT3
3662,GO:0008150,0.649363634863785,0.516664455225934,81,11215,biological_process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RIN2;RGS2;HOXA9;NRSN1;S1PR5;TCHH;RPL37;LRIG3;NME9;PPP1R3D;GDNF;HES1;HOXC13;ID3;SLC24A4;ZC3H12D;GOLGA2P5;LGALS7B;MUC6;SLC2A3;IFIT2;RNF125;ACTR5;SLC9A4;DCHS1;SNRPD2;DDIT3;SNAI2;APC2;RPL31;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;SPC25;ZNF160;HIST1H1D;ZNF766;CNNM1;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;JADE2;ZNF169;FAM110C;FXYD3;KIAA0753;GPR89A;IVNS1ABP;HSP90AB4P;ZNF799;ZKSCAN3;PRR15;COX7C;HIST1H4I;SPDYE1;RHOF;CIART;ARRDC3;MAP7D3;RPS27;ZNF485;HIST1H4D;RAB15;BTN3A1;MUC12;ZNF57;STAC2;MAP1A;ABCB5
3292,GO:0006986,0.649544704892828,0.721370378863367,1,157,response to unfolded protein,BP,DDIT3
3153,GO:0006753,0.650104053908944,0.546553539591973,4,480,nucleoside phosphate metabolic process,BP,DDIT4;NME9;TMSB4X;COX7C
12854,GO:0051169,0.652117583183899,0.619766535724652,2,306,nuclear transport,BP,TXNIP;SNRPD2
12888,GO:0051223,0.652935697839826,0.571744051756883,3,476,regulation of protein transport,BP,NR1D1;HES1;TMSB4X
9683,GO:0038061,0.653101377621636,0.718164920339781,1,111,NIK/NF-kappaB signaling,BP,TMSB4X
9956,GO:0042326,0.654590243314889,0.616903008741148,2,349,negative regulation of phosphorylation,BP,DDIT4;RGS2
14997,GO:0070925,0.656528463065234,0.53918144331272,4,636,organelle assembly,BP,GOLGA2P5;RPL23A;KIAA0753;RPS27
7753,GO:0032268,0.657506115054369,0.457188666121012,13,1897,regulation of cellular protein metabolic process,BP,HES5;DDIT4;RGS2;HES1;ZC3H12D;RNF125;SNAI2;NUPR1;HIST1H4F;HIST1H4I;SPDYE1;ARRDC3;HIST1H4D
4207,GO:0009314,0.65794811684108,0.613174638198105,2,341,response to radiation,BP,ACTR5;SNAI2
8227,GO:0032989,0.658076481218825,0.537349592410415,4,747,cellular component morphogenesis,BP,GDNF;HES1;RHOF;MAP1A
467,GO:0001505,0.658865697583455,0.711473933016838,1,168,regulation of neurotransmitter levels,BP,GDNF
10305,GO:0043069,0.659075453225617,0.536330870167851,4,631,negative regulation of programmed cell death,BP,TSC22D3;GDNF;SNAI2;IVNS1ABP
10905,GO:0044451,0.660469928347151,0.500872993905612,6,976,nucleoplasm part,CC,NR1D1;PHF12;SPN;SALL2;JADE2;CIART
10872,GO:0044403,0.660735672224561,0.500764319681644,6,714,symbiont process,BP,RPL37;RPL31;RPL23A;RPL28;IVNS1ABP;RPS27
6581,GO:0022406,0.662318321910999,0.707809410784011,1,163,membrane docking,BP,RAB15
3232,GO:0006887,0.662495162790248,0.532515279355294,4,600,exocytosis,BP,SLC2A3;TMSB4X;RHOF;RAB15
10786,GO:0044248,0.663015528655236,0.451187287730525,13,1799,cellular catabolic process,BP,NR1D1;DDIT4;RPL37;PPP1R3D;GDNF;ZC3H12D;RNF125;DDIT3;RPL31;RPL23A;RPL28;ZKSCAN3;RPS27
8422,GO:0033500,0.663030983498869,0.707173427663345,1,147,carbohydrate homeostasis,BP,NR1D1
10091,GO:0042593,0.663030983498869,0.707173427663345,1,147,glucose homeostasis,BP,NR1D1
3931,GO:0008610,0.664253178146587,0.558952276923398,3,511,lipid biosynthetic process,BP,NR1D1;SNAI2;PIGH
4516,GO:0010565,0.666024388657477,0.704196269558667,1,123,regulation of cellular ketone metabolic process,BP,NR1D1
11196,GO:0045321,0.667120404254561,0.507784725912641,5,766,leukocyte activation,BP,HES1;SLC2A3;SPN;RHOF;BTN3A1
8983,GO:0035091,0.668125125931713,0.701348412935854,1,187,phosphatidylinositol binding,MF,PHF12
10781,GO:0044238,0.668994666779895,0.415457983665661,55,7688,primary metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;RPL37;NME9;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;MUC6;SLC2A3;RNF125;ACTR5;SNRPD2;DDIT3;SNAI2;APC2;RPL31;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;JADE2;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;COX7C;HIST1H4I;SPDYE1;CIART;ARRDC3;RPS27;ZNF485;HIST1H4D;MUC12;ZNF57
13110,GO:0051641,0.669558330431553,0.437541520430087,15,2184,cellular localization,BP,TXNIP;NR1D1;RPL37;GDNF;HES1;DCHS1;SNRPD2;DDIT3;RPL31;RPL23A;RPL28;TMSB4X;KIAA0753;RPS27;RAB15
13042,GO:0051495,0.670607815353634,0.698827559067037,1,157,positive regulation of cytoskeleton organization,BP,RGS2
4675,GO:0010822,0.671564826638227,0.697928314314055,1,140,positive regulation of mitochondrion organization,BP,HES1
10415,GO:0043254,0.671617611294094,0.597676139574603,2,337,regulation of protein complex assembly,BP,RGS2;TMSB4X
16260,GO:0090316,0.672002943971272,0.697287705804039,1,157,positive regulation of intracellular protein transport,BP,HES1
14210,GO:0061136,0.673980273581514,0.695128928853909,1,153,regulation of proteasomal protein catabolic process,BP,RNF125
12945,GO:0051301,0.674168496590714,0.547611350168209,3,506,cell division,BP,TXNIP;SPC25;RHOF
17330,GO:0150034,0.674187713417038,0.694705125146702,1,179,distal axon,CC,NRSN1
13117,GO:0051649,0.674350621156908,0.442587927243171,12,1673,establishment of localization in cell,BP,TXNIP;NR1D1;RPL37;GDNF;HES1;SNRPD2;DDIT3;RPL31;RPL23A;RPL28;RPS27;RAB15
10269,GO:0043010,0.674926869660354,0.693815775226503,1,190,camera-type eye development,BP,HES5
12623,GO:0050804,0.676083630865294,0.692564594965035,1,183,modulation of chemical synaptic transmission,BP,GDNF
17023,GO:0099177,0.676083630865294,0.692564594965035,1,183,regulation of trans-synaptic signaling,BP,GDNF
7754,GO:0032269,0.676889090733293,0.482461367304493,6,847,negative regulation of cellular protein metabolic process,BP,DDIT4;RGS2;ZC3H12D;HIST1H4F;HIST1H4I;HIST1H4D
6305,GO:0019932,0.677263826654347,0.691379331761959,1,163,second-messenger-mediated signaling,BP,RGS2
10158,GO:0042742,0.677377952391118,0.692199509079448,1,93,defense response to bacterium,BP,SPN
8695,GO:0034330,0.677401821426581,0.690966926916056,1,205,cell junction organization,BP,SNAI2
20180,GO:2001020,0.677635330710815,0.690969989612251,1,162,regulation of response to DNA damage stimulus,BP,SNAI2
4025,GO:0009056,0.678118466789038,0.431139825697783,14,1984,catabolic process,BP,NR1D1;DDIT4;RPL37;PPP1R3D;GDNF;ZC3H12D;RNF125;DDIT3;APC2;RPL31;RPL23A;RPL28;ZKSCAN3;RPS27
12908,GO:0051251,0.679879670440823,0.68847326122788,1,158,positive regulation of lymphocyte activation,BP,HES1
16105,GO:0090087,0.679956602704973,0.540928528306321,3,490,regulation of peptide transport,BP,NR1D1;HES1;TMSB4X
3063,GO:0006626,0.679984462695137,0.68875435467623,1,121,protein targeting to mitochondrion,BP,HES1
273,GO:0000775,0.681881294797241,0.686090963649795,1,173,chromosome, centromeric region,CC,SPC25
4372,GO:0009991,0.684049117085412,0.583198133142949,2,343,response to extracellular stimulus,BP,DDIT3;SNAI2
4558,GO:0010638,0.684245145328385,0.535882707997708,3,515,positive regulation of organelle organization,BP,RGS2;HES1;SNAI2
11689,GO:0046474,0.685406443008784,0.681933284763785,1,194,glycerophospholipid biosynthetic process,BP,PIGH
6290,GO:0019898,0.686086337314416,0.681192183711146,1,187,extrinsic component of membrane,CC,APC2
10880,GO:0044419,0.686154549492907,0.471972774858395,6,726,interspecies interaction between organisms,BP,RPL37;RPL31;RPL23A;RPL28;IVNS1ABP;RPS27
5789,GO:0017016,0.686529952584529,0.580130896585382,2,406,Ras GTPase binding,MF,RIN2;GDNF
172,GO:0000377,0.687426728417887,0.579340831974011,2,299,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,SNRPD2;RNF113A
184,GO:0000398,0.687426728417887,0.579340831974011,2,299,mRNA splicing, via spliceosome,BP,SNRPD2;RNF113A
15302,GO:0071495,0.687462796057214,0.484417784805554,5,909,cellular response to endogenous stimulus,BP,NR1D1;HES5;DDIT4;HES1;SNAI2
9407,GO:0035966,0.689583475238237,0.677233875941101,1,174,response to topologically incorrect protein,BP,DDIT3
289,GO:0000793,0.689665860521277,0.677131257384178,1,175,condensed chromosome,CC,SPC25
2873,GO:0006367,0.689830341269462,0.677131830912385,1,151,transcription initiation from RNA polymerase II promoter,BP,NR1D1
4369,GO:0009986,0.690203875603176,0.575831278401752,2,375,cell surface,CC,SPN;BTN3A1
10309,GO:0043085,0.691770010574652,0.465298980529547,6,1025,positive regulation of catalytic activity,BP,RIN2;RGS2;GDNF;APC2;TMSB4X;ARRDC3
7274,GO:0031253,0.693110188722966,0.672948536004261,1,202,cell projection membrane,CC,APC2
17033,GO:0099503,0.693389484576717,0.496895124085366,4,608,secretory vesicle,CC,SLC2A3;TMSB4X;RHOF;RAB15
171,GO:0000375,0.694550785902609,0.570830045628664,2,302,RNA splicing, via transesterification reactions,BP,SNRPD2;RNF113A
11665,GO:0046434,0.694942911032429,0.670977071806746,1,172,organophosphate catabolic process,BP,DDIT4
11872,GO:0046879,0.694990068640996,0.670914302982274,1,173,hormone secretion,BP,NR1D1
4293,GO:0009719,0.696181329406723,0.460165920809705,6,1067,response to endogenous stimulus,BP,TXNIP;NR1D1;HES5;DDIT4;HES1;SNAI2
14629,GO:0070201,0.696814659149976,0.521002870493232,3,515,regulation of establishment of protein localization,BP,NR1D1;HES1;TMSB4X
6592,GO:0022603,0.697488980122174,0.491950958011486,4,713,regulation of anatomical structure morphogenesis,BP,GDNF;HES1;SNAI2;RHOF
12423,GO:0048872,0.698570964635814,0.666678495765975,1,172,homeostasis of number of cells,BP,TSC22D3
15978,GO:0080135,0.698588341349711,0.51885034996037,3,536,regulation of cellular response to stress,BP,DDIT3;SNAI2;ZKSCAN3
4350,GO:0009914,0.699267934364552,0.665819234970281,1,176,hormone transport,BP,NR1D1
68,GO:0000139,0.701572670378977,0.515206344795267,3,583,Golgi membrane,CC,GOLGA2P5;RNF125;GPR89A
13503,GO:0055065,0.703000004718645,0.56052009452718,2,325,metal ion homeostasis,BP,SLC24A4;DDIT3
7498,GO:0031668,0.703529719592254,0.660624671077188,1,188,cellular response to extracellular stimulus,BP,SNAI2
4024,GO:0009055,0.706493923329163,0.658356395094193,1,88,electron transfer activity,MF,COX7C
12651,GO:0050852,0.706795736147949,0.657061922145154,1,140,T cell receptor signaling pathway,BP,BTN3A1
10492,GO:0043393,0.708542611455841,0.654659281417011,1,169,regulation of protein binding,BP,IFIT2
3075,GO:0006643,0.70859384274311,0.654523826993741,1,179,membrane lipid metabolic process,BP,PIGH
17236,GO:0110053,0.70866326240608,0.654386221381951,1,187,regulation of actin filament organization,BP,TMSB4X
13755,GO:0060326,0.709052996130778,0.654281734449311,1,142,cell chemotaxis,BP,TMSB4X
12905,GO:0051248,0.709077052129969,0.445160784255542,6,885,negative regulation of protein metabolic process,BP,DDIT4;RGS2;ZC3H12D;HIST1H4F;HIST1H4I;HIST1H4D
3606,GO:0008047,0.709377724940695,0.552511294499151,2,393,enzyme activator activity,MF,RIN2;RGS2
2446,GO:0005654,0.709481196190041,0.380898173559123,21,3043,nucleoplasm,CC,NR1D1;HES5;HES1;ZC3H12D;ACTR5;SNRPD2;DDIT3;SNAI2;FAM217B;HIST1H4F;PHF12;SPN;SALL2;HOXC5;JADE2;IVNS1ABP;ZKSCAN3;HIST1H4I;CIART;RPS27;HIST1H4D
17108,GO:0101002,0.709522344120916,0.65366346980761,1,146,ficolin-1-rich granule,CC,SLC2A3
10133,GO:0042692,0.709959080235443,0.652702716483269,1,203,muscle cell differentiation,BP,HES1
8257,GO:0033036,0.71173379263961,0.390511917570549,15,2264,macromolecule localization,BP,TXNIP;NR1D1;RPL37;HES1;DCHS1;DDIT3;RPL31;RPL23A;RPL28;TMSB4X;KIAA0753;GPR89A;RPS27;RAB15;BTN3A1
949,GO:0002366,0.712789474242682,0.501726291166952,3,468,leukocyte activation involved in immune response,BP,SLC2A3;SPN;RHOF
5797,GO:0017038,0.712911131724421,0.649292528589028,1,167,protein import,BP,TXNIP
1109,GO:0002696,0.714708317143939,0.647005251650542,1,174,positive regulation of leukocyte activation,BP,HES1
893,GO:0002263,0.715229281326922,0.498721325118995,3,471,cell activation involved in immune response,BP,SLC2A3;SPN;RHOF
17770,GO:1901796,0.716389230610741,0.64500090955007,1,162,regulation of signal transduction by p53 class mediator,BP,SNAI2
5901,GO:0018105,0.716709468260245,0.644284193253345,1,210,peptidyl-serine phosphorylation,BP,DDIT4
7355,GO:0031396,0.71699915541773,0.644236726853937,1,162,regulation of protein ubiquitination,BP,ARRDC3
12388,GO:0048812,0.717290779283695,0.542573664032465,2,430,neuron projection morphogenesis,BP,GDNF;MAP1A
4775,GO:0010959,0.717898905322738,0.642921877579264,1,187,regulation of metal ion transport,BP,FXYD3
5681,GO:0016791,0.719382598067522,0.640935904420798,1,207,phosphatase activity,MF,PPP1R3D
6175,GO:0019538,0.719885216605479,0.360334490722979,30,4204,protein metabolic process,BP,NR1D1;HES5;DDIT4;RGS2;RPL37;PPP1R3D;GDNF;HES1;ZC3H12D;MUC6;RNF125;ACTR5;DDIT3;SNAI2;APC2;RPL31;NUPR1;HIST1H4F;RPL23A;HIST1H1D;SPN;PIGH;RPL28;JADE2;HIST1H4I;SPDYE1;ARRDC3;RPS27;HIST1H4D;MUC12
4233,GO:0009410,0.72007194814497,0.64030116656875,1,170,response to xenobiotic stimulus,BP,DDIT4
3461,GO:0007276,0.720075280457112,0.539172724841173,2,375,gamete generation,BP,RGS2;HOXA9
11286,GO:0045597,0.720104735717669,0.492516063002973,3,601,positive regulation of cell differentiation,BP,GDNF;HES1;SNAI2
14385,GO:0061630,0.721619456197118,0.638151121692608,1,198,ubiquitin protein ligase activity,MF,RNF125
10329,GO:0043122,0.722284567522144,0.637412261002082,1,181,regulation of I-kappaB kinase/NF-kappaB signaling,BP,GPR89A
4060,GO:0009108,0.722714514972725,0.636792816412374,1,192,coenzyme biosynthetic process,BP,DDIT4
11039,GO:0045017,0.72339213651257,0.635816670491548,1,212,glycerolipid biosynthetic process,BP,PIGH
9987,GO:0042391,0.723586341578708,0.635667733991543,1,194,regulation of membrane potential,BP,ABCB5
709,GO:0001932,0.724849766457898,0.44004033569533,5,938,regulation of protein phosphorylation,BP,HES5;DDIT4;RGS2;HES1;SPDYE1
1857,GO:0004518,0.725029663052069,0.633931847287693,1,177,nuclease activity,MF,ZC3H12D
20273,GO:2001235,0.725885368815536,0.633064464755251,1,150,positive regulation of apoptotic signaling pathway,BP,DDIT3
12666,GO:0050867,0.726438039663045,0.632092549184807,1,181,positive regulation of cell activation,BP,HES1
4272,GO:0009628,0.726647660729284,0.437891991381616,5,869,response to abiotic stimulus,BP,TXNIP;DDIT4;TSC22D3;ACTR5;SNAI2
10794,GO:0044267,0.726728257288544,0.354061823491444,28,3915,cellular protein metabolic process,BP,NR1D1;HES5;DDIT4;RGS2;RPL37;PPP1R3D;GDNF;HES1;ZC3H12D;MUC6;RNF125;ACTR5;DDIT3;SNAI2;RPL31;NUPR1;HIST1H4F;RPL23A;HIST1H1D;PIGH;RPL28;JADE2;HIST1H4I;SPDYE1;ARRDC3;RPS27;HIST1H4D;MUC12
4269,GO:0009617,0.727734229636895,0.529647126315396,2,296,response to bacterium,BP,NR1D1;SPN
13907,GO:0060548,0.727898750742463,0.455166845434541,4,689,negative regulation of cell death,BP,TSC22D3;GDNF;SNAI2;IVNS1ABP
7283,GO:0031267,0.728631417548722,0.528129264748843,2,446,small GTPase binding,MF,RIN2;GDNF
14398,GO:0061659,0.729517243964853,0.627970448700043,1,203,ubiquitin-like protein ligase activity,MF,RNF125
7675,GO:0032103,0.730065166436456,0.627552977869139,1,161,positive regulation of response to external stimulus,BP,TMSB4X
18241,GO:1903050,0.730188732845221,0.627285389723952,1,174,regulation of proteolysis involved in cellular protein catabolic process,BP,RNF125
17256,GO:0120039,0.730401657989331,0.525855387320499,2,442,plasma membrane bounded cell projection morphogenesis,BP,GDNF;MAP1A
12800,GO:0051091,0.731250993639697,0.625834933860064,1,183,positive regulation of DNA binding transcription factor activity,BP,DDIT3
3733,GO:0008270,0.731253211852758,0.478574761999967,3,571,zinc ion binding,MF,NR1D1;RNF125;RPS27
5135,GO:0015630,0.731468923112885,0.431944878572498,5,968,microtubule cytoskeleton,CC,APC2;FAM110C;KIAA0753;MAP7D3;MAP1A
12412,GO:0048858,0.731533398347046,0.524391573212998,2,443,cell projection morphogenesis,BP,GDNF;MAP1A
13518,GO:0055086,0.73183474231181,0.450448603871359,4,545,nucleobase-containing small molecule metabolic process,BP,DDIT4;NME9;TMSB4X;COX7C
855,GO:0002181,0.732220377633923,0.626025377567506,1,85,cytoplasmic translation,BP,RPL31
506,GO:0001568,0.732307358516193,0.523398009696338,2,438,blood vessel development,BP,HES1;DDIT3
10910,GO:0044456,0.73280905221186,0.522781113485795,2,419,synapse part,CC,NR1D1;RAB15
2518,GO:0005770,0.735126650608025,0.620691022330319,1,191,late endosome,CC,DDIT3
2538,GO:0005794,0.73534302793171,0.41354600394387,6,1147,Golgi apparatus,CC,GOLGA2P5;MUC6;RNF125;APC2;GPR89A;MUC12
6701,GO:0030098,0.737951099472164,0.616878353043991,1,202,lymphocyte differentiation,BP,SPN
4551,GO:0010631,0.738567930298742,0.61605039667914,1,203,epithelial cell migration,BP,TMSB4X
9793,GO:0040013,0.738573531928129,0.616009899957681,1,209,negative regulation of locomotion,BP,ARRDC3
7836,GO:0032388,0.739230297396733,0.615213055065819,1,195,positive regulation of intracellular transport,BP,HES1
17754,GO:1901701,0.739326624368838,0.44088936878789,4,715,cellular response to oxygen-containing compound,BP,NR1D1;DDIT4;ID3;SNAI2
2941,GO:0006469,0.739643935503044,0.614629810942677,1,200,negative regulation of protein kinase activity,BP,RGS2
16131,GO:0090132,0.73979797164235,0.614400662181877,1,204,epithelium migration,BP,TMSB4X
11894,GO:0046914,0.741577032074422,0.438041536506693,4,730,transition metal ion binding,MF,NR1D1;TCHH;RNF125;RPS27
16129,GO:0090130,0.742510191536054,0.610749133097618,1,205,tissue migration,BP,TMSB4X
148,GO:0000302,0.742553212885459,0.61096944602625,1,165,response to reactive oxygen species,BP,TXNIP
15871,GO:0072593,0.743419641569507,0.609798999343942,1,165,reactive oxygen species metabolic process,BP,DDIT4
2841,GO:0006310,0.743872811280215,0.60885308959542,1,215,DNA recombination,BP,ACTR5
12650,GO:0050851,0.743985290973449,0.609068846265874,1,161,antigen receptor-mediated signaling pathway,BP,BTN3A1
3274,GO:0006954,0.74418127708116,0.507979085590493,2,364,inflammatory response,BP,NUPR1;TMSB4X
8801,GO:0034504,0.745053366069602,0.607304343979473,1,205,protein localization to nucleus,BP,TXNIP
10884,GO:0044424,0.746148230868818,0.360867644538778,74,10384,intracellular part,CC,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RIN2;RGS2;HOXA9;NRSN1;TCHH;RPL37;LRIG3;NME9;PPP1R3D;HES1;HOXC13;ID3;SLC24A4;ZC3H12D;GOLGA2P5;TIGD2;LGALS7B;MUC6;SMIM14;SLC2A3;IFIT2;RNF125;ACTR5;SNRPD2;DDIT3;SNAI2;APC2;RPL31;FAM217B;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;SPC25;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;JADE2;ZNF169;FAM110C;KIAA0753;GPR89A;IVNS1ABP;HSP90AB4P;ZNF799;ZKSCAN3;COX7C;HIST1H4I;RHOF;CIART;ARRDC3;MAP7D3;RPS27;ZNF485;HIST1H4D;RAB15;MUC12;ZNF57;STAC2;MAP1A
5659,GO:0016757,0.746586568565277,0.605204101575639,1,207,transferase activity, transferring glycosyl groups,MF,PIGH
16872,GO:0098803,0.746865621344033,0.607282231604486,1,66,respiratory chain complex,CC,COX7C
5933,GO:0018209,0.747068213312898,0.604440381253125,1,228,peptidyl-serine modification,BP,DDIT4
8349,GO:0033209,0.74799353610769,0.603853408019813,1,138,tumor necrosis factor-mediated signaling pathway,BP,TMSB4X
4276,GO:0009636,0.74925218601338,0.501324615488618,2,324,response to toxic substance,BP,TXNIP;NUPR1
10198,GO:0042803,0.750154126854773,0.45432904394693,3,530,protein homodimerization activity,MF,GDNF;HES1;DDIT3
2801,GO:0006259,0.750690968296631,0.40814311474939,5,843,DNA metabolic process,BP,ID3;ACTR5;HIST1H4F;HIST1H4I;HIST1H4D
7326,GO:0031334,0.752717918379515,0.596808436343477,1,198,positive regulation of protein complex assembly,BP,RGS2
8224,GO:0032984,0.753190296831281,0.496202012267758,2,275,protein-containing complex disassembly,BP,APC2;MAP1A
12673,GO:0050877,0.753414276317542,0.495510589344809,2,408,nervous system process,BP,SLC24A4;SNAI2
10892,GO:0044433,0.754433649826946,0.390062276176298,6,1039,cytoplasmic vesicle part,CC,LRIG3;SLC2A3;TMSB4X;GPR89A;RHOF;RAB15
5284,GO:0015935,0.757625011193802,0.592282414215309,1,68,small ribosomal subunit,CC,RPS27
10395,GO:0043227,0.757761495038255,0.32816995469923,66,9232,membrane-bounded organelle,CC,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;FCGBP;NRSN1;LRIG3;PPP1R3D;HES1;HOXC13;ID3;ZC3H12D;GOLGA2P5;TIGD2;LGALS7B;MUC6;SMIM14;SLC2A3;IFIT2;RNF125;ACTR5;SNRPD2;DDIT3;SNAI2;APC2;RPL31;FAM217B;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;SPC25;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;JADE2;ZNF169;FAM110C;FXYD3;GPR89A;IVNS1ABP;ZNF799;ZKSCAN3;COX7C;HIST1H4I;RHOF;CIART;ARRDC3;RPS27;ZNF485;HIST1H4D;RAB15;MUC12;ZNF57
12576,GO:0050727,0.758034739175473,0.589488931072782,1,179,regulation of inflammatory response,BP,TMSB4X
720,GO:0001944,0.758621045603983,0.488341782766168,2,457,vasculature development,BP,HES1;DDIT3
16862,GO:0098793,0.758634641609334,0.588447033210226,1,209,presynapse,CC,RAB15
8495,GO:0033673,0.758888825039738,0.588070920803591,1,212,negative regulation of kinase activity,BP,RGS2
7755,GO:0032270,0.759192929699125,0.384090062026629,6,1080,positive regulation of cellular protein metabolic process,BP,HES5;HES1;RNF125;SNAI2;NUPR1;ARRDC3
9896,GO:0042180,0.759695848079395,0.587280307487675,1,162,cellular ketone metabolic process,BP,NR1D1
1110,GO:0002697,0.759847946079036,0.586767771930972,1,202,regulation of immune effector process,BP,RNF125
4364,GO:0009967,0.760713392284635,0.382187473945563,6,1063,positive regulation of signal transduction,BP,HES5;HES1;DDIT3;FAM110C;GPR89A;ARRDC3
12784,GO:0051056,0.760740807923141,0.585209333716866,1,266,regulation of small GTPase mediated signal transduction,BP,RHOF
18351,GO:1903320,0.761215997272812,0.584911331377801,1,188,regulation of protein modification by small protein conjugation or removal,BP,ARRDC3
3745,GO:0008284,0.763109502850754,0.437196745595186,3,543,positive regulation of cell proliferation,BP,HES5;GDNF;HES1
3953,GO:0008654,0.764775014861688,0.57956979028287,1,231,phospholipid biosynthetic process,BP,PIGH
8228,GO:0032990,0.766828359588858,0.47701204438433,2,461,cell part morphogenesis,BP,GDNF;MAP1A
2499,GO:0005746,0.767390353001976,0.578145200192097,1,72,mitochondrial respiratory chain,CC,COX7C
16863,GO:0098794,0.767988190983975,0.574810504851998,1,257,postsynapse,CC,NR1D1
10351,GO:0043161,0.76815384578574,0.475340566556147,2,370,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,RNF125;DDIT3
15762,GO:0072358,0.768390382748324,0.47483142037391,2,463,cardiovascular system development,BP,HES1;DDIT3
4237,GO:0009416,0.768568274359157,0.574106812859297,1,224,response to light stimulus,BP,ACTR5
3439,GO:0007249,0.769147018274942,0.573353073218124,1,207,I-kappaB kinase/NF-kappaB signaling,BP,GPR89A
6291,GO:0019899,0.769218834968937,0.341449380669426,10,1825,enzyme binding,MF,TXNIP;RIN2;HOXA9;PPP1R3D;GDNF;HES1;RNF125;TMSB4X;SPDYE1;RHOF
6586,GO:0022411,0.77070161500179,0.427084655001367,3,476,cellular component disassembly,BP,SNAI2;APC2;MAP1A
18367,GO:1903362,0.771288788946627,0.570252786580573,1,201,regulation of cellular protein catabolic process,BP,RNF125
4674,GO:0010821,0.775243846724552,0.564480483616746,1,190,regulation of mitochondrion organization,BP,HES1
5833,GO:0017111,0.776522892587581,0.418948809382501,3,646,nucleoside-triphosphatase activity,MF,RHOF;RAB15;ABCB5
11479,GO:0045936,0.777955667505769,0.461375538018847,2,439,negative regulation of phosphate metabolic process,BP,DDIT4;RGS2
10183,GO:0042775,0.778554168965075,0.561391757032718,1,79,mitochondrial ATP synthesis coupled electron transport,BP,COX7C
4514,GO:0010563,0.778866643913529,0.460073998760603,2,440,negative regulation of phosphorus metabolic process,BP,DDIT4;RGS2
6672,GO:0030030,0.779587003913897,0.370942492734397,5,1045,cell projection organization,BP,HES5;GDNF;HES1;FAM110C;MAP1A
10181,GO:0042773,0.779598110098878,0.559785024794932,1,80,ATP synthesis coupled electron transport,BP,COX7C
8319,GO:0033157,0.780358290331171,0.556677356825544,1,213,regulation of intracellular protein transport,BP,HES1
3335,GO:0007050,0.781140677012711,0.555478413867778,1,216,cell cycle arrest,BP,DDIT3
6746,GO:0030163,0.781155149280224,0.386546838102738,4,741,protein catabolic process,BP,NR1D1;RNF125;DDIT3;APC2
14768,GO:0070469,0.781766900613043,0.556594959616866,1,78,respiratory chain,CC,COX7C
414,GO:0001101,0.782915247808032,0.552729211226865,1,227,response to acid chemical,BP,ID3
7602,GO:0031981,0.783230722311302,0.292708614203632,24,3517,nuclear lumen,CC,NR1D1;HES5;RGS2;HES1;ZC3H12D;ACTR5;SNRPD2;DDIT3;SNAI2;FAM217B;HIST1H4F;PHF12;RPL23A;HIST1H1D;SPN;SALL2;HOXC5;JADE2;IVNS1ABP;ZKSCAN3;HIST1H4I;CIART;RPS27;HIST1H4D
10889,GO:0044430,0.783582894624732,0.352951248202125,6,1191,cytoskeletal part,CC,APC2;TMSB4X;FAM110C;KIAA0753;MAP7D3;MAP1A
6073,GO:0019220,0.783719139693507,0.352774367226485,6,1192,regulation of phosphate metabolic process,BP,HES5;DDIT4;RGS2;HES1;TMSB4X;SPDYE1
15303,GO:0071496,0.783872841376839,0.551218730551759,1,238,cellular response to external stimulus,BP,SNAI2
563,GO:0001701,0.783900321775978,0.5511220299187,1,251,in utero embryonic development,BP,HES1
8104,GO:0032787,0.784051826440027,0.452667613280901,2,417,monocarboxylic acid metabolic process,BP,NR1D1;DDIT4
10510,GO:0043414,0.785035913242977,0.54945863994621,1,234,macromolecule methylation,BP,HIST1H1D
2942,GO:0006470,0.78559480991851,0.548557730942016,1,244,protein dephosphorylation,BP,PPP1R3D
12069,GO:0048018,0.785781767033613,0.548757229758808,1,166,receptor ligand activity,MF,GDNF
7923,GO:0032496,0.786322703481096,0.547648810484221,1,203,response to lipopolysaccharide,BP,NR1D1
10454,GO:0043312,0.786461594007213,0.449329661093861,2,350,neutrophil degranulation,BP,SLC2A3;RHOF
904,GO:0002283,0.787219878147443,0.448224843518855,2,351,neutrophil activation involved in immune response,BP,SLC2A3;RHOF
13768,GO:0060341,0.788203301662023,0.402822955842884,3,618,regulation of cellular localization,BP,NR1D1;GDNF;HES1
15430,GO:0071704,0.788491912236443,0.282069230867785,55,7900,organic substance metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;RPL37;NME9;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;MUC6;SLC2A3;RNF125;ACTR5;SNRPD2;DDIT3;SNAI2;APC2;RPL31;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;JADE2;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;COX7C;HIST1H4I;SPDYE1;CIART;ARRDC3;RPS27;ZNF485;HIST1H4D;MUC12;ZNF57
16860,GO:0098791,0.78872271555974,0.40205733089586,3,660,Golgi subcompartment,CC,GOLGA2P5;RNF125;GPR89A
6677,GO:0030036,0.788896912030313,0.445542949028084,2,469,actin cytoskeleton organization,BP,TMSB4X;RHOF
3544,GO:0007568,0.789878673476666,0.542093106080521,1,213,aging,BP,ZKSCAN3
8370,GO:0033267,0.789955388440973,0.541831022436013,1,242,axon part,CC,NRSN1
12859,GO:0051174,0.790912993176565,0.343402029043422,6,1205,regulation of phosphorus metabolic process,BP,HES5;DDIT4;RGS2;HES1;TMSB4X;SPDYE1
7367,GO:0031410,0.79098992401082,0.319759711430617,9,1603,cytoplasmic vesicle,CC,NRSN1;LRIG3;SLC2A3;DDIT3;TMSB4X;GPR89A;RHOF;ARRDC3;RAB15
16715,GO:0097708,0.791824207242931,0.318705771027942,9,1605,intracellular vesicle,CC,NRSN1;LRIG3;SLC2A3;DDIT3;TMSB4X;GPR89A;RHOF;ARRDC3;RAB15
991,GO:0002446,0.794677843138238,0.437264440814651,2,359,neutrophil mediated immunity,BP,SLC2A3;RHOF
9865,GO:0042119,0.794872844718138,0.436983761430719,2,356,neutrophil activation,BP,SLC2A3;RHOF
4295,GO:0009725,0.796083451868219,0.391696629863699,3,651,response to hormone,BP,TXNIP;NR1D1;DDIT4
6588,GO:0022414,0.797501301623424,0.364269787648004,4,826,reproductive process,BP,RGS2;HOXA9;HES1;NUPR1
2,GO:0000003,0.798054283684529,0.363507082750522,4,827,reproduction,BP,RGS2;HOXA9;HES1;NUPR1
8940,GO:0034976,0.798451890671089,0.528443400723646,1,242,response to endoplasmic reticulum stress,BP,DDIT3
6653,GO:0023061,0.798797266114327,0.527887295992428,1,243,signal release,BP,NR1D1
880,GO:0002237,0.799185996387448,0.527420182022745,1,212,response to molecule of bacterial origin,BP,NR1D1
9524,GO:0036230,0.799411050889776,0.430223604942288,2,360,granulocyte activation,BP,SLC2A3;RHOF
2517,GO:0005769,0.800098756202413,0.525741258589166,1,258,early endosome,CC,ARRDC3
8145,GO:0032870,0.800543004306791,0.428304335211632,2,476,cellular response to hormone stimulus,BP,NR1D1;DDIT4
11398,GO:0045785,0.800649946544396,0.524935097140846,1,239,positive regulation of cell adhesion,BP,HES1
13096,GO:0051603,0.80167587722979,0.383782926579507,3,590,proteolysis involved in cellular protein catabolic process,BP,NR1D1;RNF125;DDIT3
6311,GO:0019953,0.801735346516444,0.426575253729841,2,438,sexual reproduction,BP,RGS2;HOXA9
9955,GO:0042325,0.803264391119063,0.339377420774112,5,1039,regulation of phosphorylation,BP,HES5;DDIT4;RGS2;HES1;SPDYE1
4386,GO:0010038,0.804229710850932,0.519251462976651,1,218,response to metal ion,BP,TXNIP
6191,GO:0019637,0.80598168367786,0.335778036311527,5,849,organophosphate metabolic process,BP,DDIT4;NME9;PIGH;TMSB4X;COX7C
12287,GO:0048609,0.806080580939223,0.419977444560498,2,459,multicellular organismal reproductive process,BP,RGS2;HOXA9
5167,GO:0015711,0.806254187000712,0.515731274899034,1,267,organic anion transport,BP,SLC2A3
10078,GO:0042578,0.80659078885907,0.515180090472335,1,267,phosphoric ester hydrolase activity,MF,PPP1R3D
14513,GO:0065009,0.808103291851647,0.281817352790198,13,2244,regulation of molecular function,BP,TXNIP;RIN2;RGS2;GDNF;HES1;ID3;IFIT2;DDIT3;APC2;TMSB4X;FXYD3;SPDYE1;ARRDC3
12755,GO:0051020,0.808114080075126,0.416796215687228,2,522,GTPase binding,MF,RIN2;GDNF
6635,GO:0022904,0.808330388259191,0.514118019460858,1,94,respiratory electron transport chain,BP,COX7C
10885,GO:0044425,0.808759813062159,0.26440128269857,22,3698,membrane part,CC,RGS2;NRSN1;S1PR5;LRIG3;SLC24A4;SMIM14;SLC2A3;RNF125;SLC9A4;DCHS1;APC2;CNNM1;SPN;PIGH;FXYD3;GPR89A;COX7C;TMEM139;LOC441081;BTN3A1;MUC12;ABCB5
10502,GO:0043405,0.809163659127696,0.510969768022196,1,261,regulation of MAP kinase activity,BP,RGS2
2739,GO:0006119,0.809334102529455,0.512405726042883,1,96,oxidative phosphorylation,BP,COX7C
3749,GO:0008289,0.810196120523732,0.413706660408362,2,455,lipid binding,MF,ID3;PHF12
2802,GO:0006260,0.811746762429088,0.506688904600876,1,260,DNA replication,BP,ID3
3297,GO:0006996,0.811773640998941,0.263223704641516,20,3094,organelle organization,BP,RGS2;HES1;GOLGA2P5;IFIT2;SNAI2;APC2;HIST1H4F;RPL23A;SPC25;HIST1H1D;TMSB4X;JADE2;KIAA0753;ZKSCAN3;HIST1H4I;RHOF;MAP7D3;RPS27;HIST1H4D;MAP1A
6938,GO:0030545,0.811974717595407,0.506738992527028,1,182,receptor regulator activity,MF,GDNF
3078,GO:0006650,0.812038036483804,0.506159313325727,1,272,glycerophospholipid metabolic process,BP,PIGH
12688,GO:0050900,0.81266184960867,0.50530828674819,1,227,leukocyte migration,BP,SPN
5588,GO:0016604,0.812780535861885,0.367632327865756,3,653,nuclear body,CC,NR1D1;SPN;CIART
6578,GO:0022402,0.812856591164635,0.314263640883251,6,1141,cell cycle process,BP,GOLGA2P5;DDIT3;SPC25;KIAA0753;RHOF;RPS27
10442,GO:0043299,0.813849248005129,0.408237379003214,2,376,leukocyte degranulation,BP,SLC2A3;RHOF
10399,GO:0043231,0.814431745054203,0.253345362115752,58,8291,intracellular membrane-bounded organelle,CC,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;PPP1R3D;HES1;HOXC13;ID3;ZC3H12D;GOLGA2P5;TIGD2;LGALS7B;MUC6;SMIM14;IFIT2;RNF125;ACTR5;SNRPD2;DDIT3;SNAI2;APC2;FAM217B;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;SPC25;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;PIGH;TMSB4X;JADE2;ZNF169;FAM110C;GPR89A;IVNS1ABP;ZNF799;ZKSCAN3;COX7C;HIST1H4I;RHOF;CIART;ARRDC3;RPS27;ZNF485;HIST1H4D;MUC12;ZNF57
16869,GO:0098800,0.814507645150879,0.503709924683802,1,99,inner mitochondrial membrane protein complex,CC,COX7C
7930,GO:0032504,0.815267265312433,0.405874595000355,2,464,multicellular organism reproduction,BP,RGS2;HOXA9
7359,GO:0031400,0.815677202070223,0.405249472408429,2,457,negative regulation of protein modification process,BP,DDIT4;RGS2
898,GO:0002275,0.816000093272319,0.404895058118847,2,380,myeloid cell activation involved in immune response,BP,SLC2A3;RHOF
9267,GO:0035690,0.816161833641815,0.499357145153059,1,242,cellular response to drug,BP,DDIT4
12870,GO:0051188,0.81727520591489,0.497472640626646,1,242,cofactor biosynthetic process,BP,DDIT4
12969,GO:0051348,0.818064265293407,0.496165204387528,1,235,negative regulation of transferase activity,BP,RGS2
989,GO:0002444,0.819109164859998,0.400040199063747,2,383,myeloid leukocyte mediated immunity,BP,SLC2A3;RHOF
8262,GO:0033044,0.819676768786483,0.493237081393182,1,280,regulation of chromosome organization,BP,SNAI2
4567,GO:0010647,0.820043918990811,0.304508904239327,6,1148,positive regulation of cell communication,BP,HES5;HES1;DDIT3;FAM110C;GPR89A;ARRDC3
5513,GO:0016462,0.821382176634668,0.354902124747915,3,684,pyrophosphatase activity,MF,RHOF;RAB15;ABCB5
6650,GO:0023056,0.823150828341206,0.300258996140204,6,1154,positive regulation of signaling,BP,HES5;HES1;DDIT3;FAM110C;GPR89A;ARRDC3
4485,GO:0010506,0.823701950139827,0.486335619067746,1,273,regulation of autophagy,BP,ZKSCAN3
7946,GO:0032535,0.823864411773368,0.486087066589549,1,264,regulation of cellular component size,BP,TMSB4X
2935,GO:0006457,0.825397619534667,0.483680607303532,1,210,protein folding,BP,HSP90AB4P
2516,GO:0005768,0.826028710496932,0.347953783585151,3,677,endosome,CC,DDIT3;ARRDC3;RAB15
10105,GO:0042623,0.826130221857771,0.482056188531761,1,290,ATPase activity, coupled,MF,ABCB5
3390,GO:0007169,0.826413061137715,0.38831033148636,2,497,transmembrane receptor protein tyrosine kinase signaling pathway,BP,TXNIP;DDIT4
12596,GO:0050769,0.826504133646641,0.481378468060674,1,298,positive regulation of neurogenesis,BP,HES1
5698,GO:0016817,0.826746017746425,0.346867214148816,3,686,hydrolase activity, acting on acid anhydrides,MF,RHOF;RAB15;ABCB5
5699,GO:0016818,0.826746017746425,0.346867214148816,3,686,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,RHOF;RAB15;ABCB5
1465,GO:0003713,0.82903332173562,0.477063908631119,1,261,transcription coactivator activity,MF,NR1D1
16866,GO:0098797,0.829035264270777,0.476998478165314,1,278,plasma membrane protein complex,CC,APC2
6293,GO:0019901,0.829275662838389,0.383698340386097,2,526,protein kinase binding,MF,SPDYE1;RHOF
6671,GO:0030029,0.829912727338333,0.382691590384056,2,513,actin filament-based process,BP,TMSB4X;RHOF
4513,GO:0010562,0.831979773506237,0.33893289611153,3,700,positive regulation of phosphorus metabolic process,BP,HES5;HES1;TMSB4X
11480,GO:0045937,0.831979773506237,0.33893289611153,3,700,positive regulation of phosphate metabolic process,BP,HES5;HES1;TMSB4X
3454,GO:0007268,0.833011892880404,0.469891341230995,1,293,chemical synaptic transmission,BP,GDNF
16936,GO:0098916,0.833011892880404,0.469891341230995,1,293,anterograde trans-synaptic signaling,BP,GDNF
17054,GO:0099537,0.834588153308425,0.467060982840562,1,295,trans-synaptic signaling,BP,GDNF
12827,GO:0051129,0.835044741628027,0.374420766491537,2,493,negative regulation of cellular component organization,BP,APC2;TMSB4X
17053,GO:0099536,0.835370530073277,0.465650503087964,1,296,synaptic signaling,BP,GDNF
8229,GO:0032991,0.836297534397647,0.226084299388994,28,3843,protein-containing complex,CC,NR1D1;HOXA9;RPL37;ZC3H12D;RNF125;ACTR5;SNRPD2;DDIT3;APC2;RPL31;NUPR1;RNF113A;HIST1H4F;PHF12;RPL23A;SPC25;HIST1H1D;SALL2;PIGH;RPL28;TMSB4X;JADE2;IVNS1ABP;COX7C;HIST1H4I;RPS27;HIST1H4D;MAP1A
7273,GO:0031252,0.836803535208837,0.463047935633568,1,301,cell leading edge,CC,APC2
10789,GO:0044257,0.837264191479365,0.330900767076568,3,633,cellular protein catabolic process,BP,NR1D1;RNF125;DDIT3
10887,GO:0044428,0.83838247461631,0.225530962105169,25,3795,nuclear part,CC,NR1D1;HES5;RGS2;HES1;ZC3H12D;ACTR5;SNRPD2;DDIT3;SNAI2;FAM217B;RNF113A;HIST1H4F;PHF12;RPL23A;HIST1H1D;SPN;SALL2;HOXC5;JADE2;IVNS1ABP;ZKSCAN3;HIST1H4I;CIART;RPS27;HIST1H4D
15207,GO:0071356,0.839571544847619,0.458447765726173,1,202,cellular response to tumor necrosis factor,BP,TMSB4X
2399,GO:0005543,0.841195619608279,0.455055107673057,1,295,phospholipid binding,MF,PHF12
2889,GO:0006397,0.84294960870331,0.361510633657947,2,440,mRNA processing,BP,SNRPD2;RNF113A
8435,GO:0033554,0.843551112697671,0.251247485723502,9,1619,cellular response to stress,BP,DDIT4;ACTR5;DDIT3;SNAI2;NUPR1;HIST1H4F;ZKSCAN3;HIST1H4I;HIST1H4D
7468,GO:0031625,0.8458012058058,0.446614036472869,1,268,ubiquitin protein ligase binding,MF,TXNIP
11891,GO:0046907,0.847122535465716,0.246454487902619,9,1459,intracellular transport,BP,TXNIP;RPL37;HES1;SNRPD2;RPL31;RPL23A;RPL28;RPS27;RAB15
12826,GO:0051128,0.847461174627752,0.245932180526846,9,1805,regulation of cellular component organization,BP,RGS2;HES1;SNAI2;APC2;TMSB4X;FAM110C;RHOF;MUC12;MAP1A
4474,GO:0010469,0.849140949609205,0.440592361717861,1,214,regulation of signaling receptor activity,BP,GDNF
8154,GO:0032880,0.851798588163,0.308132862393769,3,690,regulation of protein localization,BP,NR1D1;HES1;TMSB4X
13278,GO:0051962,0.85234100459473,0.434070136667811,1,330,positive regulation of nervous system development,BP,HES1
12779,GO:0051051,0.853170357085976,0.432685545674837,1,264,negative regulation of transport,BP,TMSB4X
8828,GO:0034612,0.853586948045089,0.432112256228707,1,216,response to tumor necrosis factor,BP,TMSB4X
17753,GO:1901700,0.853662897724816,0.268145866119819,5,1023,response to oxygen-containing compound,BP,TXNIP;NR1D1;DDIT4;ID3;SNAI2
5569,GO:0016579,0.85445255718791,0.430309510463488,1,243,protein deubiquitination,BP,ACTR5
16249,GO:0090305,0.854651741508027,0.429903454328022,1,248,nucleic acid phosphodiester bond hydrolysis,BP,ZC3H12D
7747,GO:0032259,0.856209769976812,0.426751378079736,1,285,methylation,BP,HIST1H1D
897,GO:0002274,0.856919446992455,0.337918018653657,2,427,myeloid leukocyte activation,BP,SLC2A3;RHOF
18585,GO:1903829,0.857927689588291,0.423401069537663,1,288,positive regulation of cellular protein localization,BP,HES1
4670,GO:0010817,0.858592647341192,0.422125640562453,1,281,regulation of hormone levels,BP,NR1D1
10780,GO:0044237,0.85937384320266,0.196583108194401,54,7883,cellular metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;RPL37;NME9;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;MUC6;SLC2A3;RNF125;ACTR5;SNRPD2;DDIT3;SNAI2;RPL31;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;JADE2;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;COX7C;HIST1H4I;SPDYE1;CIART;ARRDC3;RPS27;ZNF485;HIST1H4D;MUC12;ZNF57
1023,GO:0002521,0.860081068407394,0.419149727393255,1,299,leukocyte differentiation,BP,SPN
5850,GO:0017144,0.861062595055441,0.29341743987706,3,534,drug metabolic process,BP,DDIT4;TMSB4X;COX7C
10866,GO:0044389,0.86210539105031,0.415212308803708,1,281,ubiquitin-like protein ligase binding,MF,TXNIP
2094,GO:0004857,0.862301826150238,0.415035184421047,1,230,enzyme inhibitor activity,MF,TXNIP
8927,GO:0034774,0.862590256346282,0.414510752619667,1,221,secretory granule lumen,CC,TMSB4X
12780,GO:0051052,0.863231972000608,0.412851716845961,1,323,regulation of DNA metabolic process,BP,ID3
11697,GO:0046486,0.86368844435825,0.411955988513739,1,318,glycerolipid metabolic process,BP,PIGH
16865,GO:0098796,0.863720030830385,0.267555749731224,4,728,membrane protein complex,CC,RNF125;APC2;PIGH;COX7C
2940,GO:0006468,0.864612038705608,0.241502201211915,6,1319,protein phosphorylation,BP,HES5;DDIT4;RGS2;GDNF;HES1;SPDYE1
14544,GO:0070062,0.865972807067627,0.202890975321875,15,2036,extracellular exosome,CC,FCGBP;LGALS7B;SLC2A3;SNRPD2;RPL31;HIST1H4F;RPL23A;SPN;RPL28;JADE2;FXYD3;HIST1H4I;RHOF;HIST1H4D;RAB15
2938,GO:0006464,0.867094078878828,0.197959366084556,17,3079,cellular protein modification process,BP,HES5;DDIT4;RGS2;PPP1R3D;GDNF;HES1;MUC6;RNF125;ACTR5;SNAI2;NUPR1;HIST1H1D;PIGH;JADE2;SPDYE1;ARRDC3;MUC12
9516,GO:0036211,0.867094078878828,0.197959366084556,17,3079,protein modification process,BP,HES5;DDIT4;RGS2;PPP1R3D;GDNF;HES1;MUC6;RNF125;ACTR5;SNAI2;NUPR1;HIST1H1D;PIGH;JADE2;SPDYE1;ARRDC3;MUC12
14866,GO:0070646,0.867655356517088,0.40418879337907,1,258,protein modification by small protein removal,BP,ACTR5
7603,GO:0031982,0.868137816977559,0.19170747631333,21,3052,vesicle,CC,FCGBP;NRSN1;LRIG3;LGALS7B;SLC2A3;SNRPD2;DDIT3;RPL31;HIST1H4F;RPL23A;SPN;RPL28;TMSB4X;JADE2;FXYD3;GPR89A;HIST1H4I;RHOF;ARRDC3;HIST1H4D;RAB15
10398,GO:0043230,0.868498266412076,0.199558491088911,15,2045,extracellular organelle,CC,FCGBP;LGALS7B;SLC2A3;SNRPD2;RPL31;HIST1H4F;RPL23A;SPN;RPL28;JADE2;FXYD3;HIST1H4I;RHOF;HIST1H4D;RAB15
18466,GO:1903561,0.868498266412076,0.199558491088911,15,2045,extracellular vesicle,CC,FCGBP;LGALS7B;SLC2A3;SNRPD2;RPL31;HIST1H4F;RPL23A;SPN;RPL28;JADE2;FXYD3;HIST1H4I;RHOF;HIST1H4D;RAB15
6593,GO:0022604,0.868755044986189,0.401715879982039,1,337,regulation of cell morphogenesis,BP,RHOF
502,GO:0001558,0.869196402892767,0.400951023611491,1,289,regulation of cell growth,BP,MUC12
12220,GO:0048471,0.87085775000167,0.31332904411365,2,513,perinuclear region of cytoplasm,CC,APC2;RAB15
12959,GO:0051338,0.871584305349005,0.275964353752158,3,732,regulation of transferase activity,BP,RGS2;SPDYE1;ARRDC3
12868,GO:0051186,0.871920313689274,0.311545435654599,2,429,cofactor metabolic process,BP,DDIT4;SLC2A3
5742,GO:0016887,0.872258054750935,0.394525857719177,1,349,ATPase activity,MF,ABCB5
13680,GO:0060205,0.873717332978903,0.391916489504192,1,229,cytoplasmic vesicle lumen,CC,TMSB4X
4606,GO:0010720,0.873829245783974,0.391299724253455,1,341,positive regulation of cell development,BP,HES1
7604,GO:0031983,0.874322770813526,0.390656489824845,1,230,vesicle lumen,CC,TMSB4X
99,GO:0000209,0.874323975185136,0.390459375803265,1,276,protein polyubiquitination,BP,RNF125
6292,GO:0019900,0.875891035614906,0.304180829750124,2,586,kinase binding,MF,SPDYE1;RHOF
10882,GO:0044421,0.876707594291678,0.184026051078617,18,2509,extracellular region part,CC,FCGBP;LRIG3;LGALS7B;SLC2A3;SNRPD2;APC2;RPL31;HIST1H4F;RPL23A;SPN;RPL28;TMSB4X;JADE2;FXYD3;HIST1H4I;RHOF;HIST1H4D;RAB15
2381,GO:0005515,0.877078100692134,0.175331427142256,56,8305,protein binding,MF,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RIN2;RGS2;HOXA9;FCGBP;NRSN1;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;SMIM14;IFIT2;RNF125;ACTR5;SNRPD2;DDIT3;SNAI2;APC2;RPL31;NUPR1;OTX1;RNF113A;HIST1H4F;PHF12;RPL23A;SPC25;CNNM1;SPN;SALL2;RPL28;TMSB4X;JADE2;ZNF169;FAM110C;KIAA0753;HSP90AB4P;ZKSCAN3;TMEM139;HIST1H4I;SPDYE1;RHOF;CIART;ARRDC3;MAP7D3;RPS27;HIST1H4D;RAB15;BTN3A1;STAC2;MAP1A
12887,GO:0051222,0.877133771211261,0.38451885028701,1,300,positive regulation of protein transport,BP,HES1
3203,GO:0006839,0.878830265317125,0.381126207409381,1,250,mitochondrial transport,BP,HES1
11202,GO:0045333,0.879024832425495,0.381384993079777,1,154,cellular respiration,BP,COX7C
547,GO:0001666,0.879276919010591,0.380160885485879,1,255,response to hypoxia,BP,DDIT4
16778,GO:0098590,0.881820473486911,0.293289725552129,2,624,plasma membrane region,CC,SLC9A4;APC2
11436,GO:0045862,0.882517172442993,0.373162697804814,1,281,positive regulation of proteolysis,BP,RNF125
5679,GO:0016788,0.882818110416535,0.291507496534727,2,553,hydrolase activity, acting on ester bonds,MF,PPP1R3D;ZC3H12D
17254,GO:0120036,0.882913798358016,0.236937667971836,4,1024,plasma membrane bounded cell projection organization,BP,HES5;GDNF;HES1;MAP1A
9540,GO:0036293,0.884027282707159,0.369980740316686,1,263,response to decreased oxygen levels,BP,DDIT4
11400,GO:0045787,0.884341164432871,0.369169181135515,1,303,positive regulation of cell cycle,BP,HES1
2406,GO:0005576,0.885196898915766,0.170571788105189,20,2791,extracellular region,CC,FCGBP;LRIG3;GDNF;LGALS7B;MUC6;SLC2A3;SNRPD2;APC2;RPL31;HIST1H4F;RPL23A;SPN;RPL28;TMSB4X;JADE2;FXYD3;HIST1H4I;RHOF;HIST1H4D;RAB15
6634,GO:0022900,0.886308729464403,0.365904294582181,1,142,electron transport chain,BP,COX7C
3076,GO:0006644,0.886445347346314,0.364498418403756,1,345,phospholipid metabolic process,BP,PIGH
12958,GO:0051336,0.887746371696722,0.229110028554063,4,896,regulation of hydrolase activity,BP,RIN2;RGS2;APC2;TMSB4X
17687,GO:1901564,0.88831721508084,0.159139321003895,33,4902,organonitrogen compound metabolic process,BP,NR1D1;HES5;DDIT4;RGS2;RPL37;NME9;PPP1R3D;GDNF;HES1;ZC3H12D;MUC6;RNF125;ACTR5;DDIT3;SNAI2;APC2;RPL31;NUPR1;HIST1H4F;RPL23A;HIST1H1D;SPN;PIGH;RPL28;TMSB4X;JADE2;COX7C;HIST1H4I;SPDYE1;ARRDC3;RPS27;HIST1H4D;MUC12
4428,GO:0010256,0.888681950619755,0.359576239855754,1,358,endomembrane system organization,BP,GOLGA2P5
12613,GO:0050790,0.889026290623529,0.192358002540738,8,1614,regulation of catalytic activity,BP,TXNIP;RIN2;RGS2;GDNF;APC2;TMSB4X;SPDYE1;ARRDC3
12967,GO:0051346,0.889390160771353,0.35823439721381,1,277,negative regulation of hydrolase activity,BP,RGS2
10956,GO:0044703,0.889640627413038,0.278737073783596,2,548,multi-organism reproductive process,BP,RGS2;HOXA9
2971,GO:0006511,0.889899556648506,0.278284852346736,2,513,ubiquitin-dependent protein catabolic process,BP,RNF125;DDIT3
2619,GO:0005929,0.890427838729598,0.355763460879919,1,340,cilium,CC,RAB15
7834,GO:0032386,0.890616082250763,0.355395286065739,1,320,regulation of intracellular transport,BP,HES1
5446,GO:0016311,0.891173805876879,0.354065571529794,1,360,dephosphorylation,BP,PPP1R3D
13951,GO:0060627,0.891316821922561,0.353779844237895,1,345,regulation of vesicle-mediated transport,BP,RAB15
19486,GO:1990234,0.892303199321962,0.240631257651317,3,713,transferase complex,CC,SNRPD2;PIGH;JADE2
2433,GO:0005615,0.895760572680595,0.159943399656777,17,2400,extracellular space,CC,FCGBP;LRIG3;LGALS7B;SLC2A3;SNRPD2;RPL31;HIST1H4F;RPL23A;SPN;RPL28;TMSB4X;JADE2;FXYD3;HIST1H4I;RHOF;HIST1H4D;RAB15
6795,GO:0030234,0.896183958675772,0.233783724093981,3,733,enzyme regulator activity,MF,TXNIP;RIN2;RGS2
6309,GO:0019941,0.896266880829538,0.266094096372553,2,521,modification-dependent protein catabolic process,BP,RNF125;DDIT3
2548,GO:0005815,0.896943814184557,0.264699696648163,2,611,microtubule organizing center,CC,FAM110C;KIAA0753
11433,GO:0045859,0.897308928687299,0.264015629515823,2,583,regulation of protein kinase activity,BP,RGS2;SPDYE1
12803,GO:0051094,0.897995839208848,0.230515853864112,3,831,positive regulation of developmental process,BP,GDNF;HES1;SNAI2
10669,GO:0043900,0.898117127817026,0.338610800480095,1,283,regulation of multi-organism process,BP,RNF125
10909,GO:0044455,0.898532928656708,0.338316743180947,1,166,mitochondrial membrane part,CC,COX7C
12241,GO:0048514,0.898613066023685,0.337240439298746,1,378,blood vessel morphogenesis,BP,HES1
19073,GO:1904951,0.899500661318443,0.33529729646355,1,332,positive regulation of establishment of protein localization,BP,HES1
14777,GO:0070482,0.899510208100765,0.335412666892794,1,283,response to oxygen levels,BP,DDIT4
6893,GO:0030424,0.899593073247277,0.335020805771784,1,361,axon,CC,NRSN1
10900,GO:0044446,0.899886766598391,0.143770049240201,48,7071,intracellular organelle part,CC,TXNIP;NR1D1;HES5;RGS2;RPL37;LRIG3;HES1;ZC3H12D;GOLGA2P5;MUC6;SMIM14;SLC2A3;RNF125;ACTR5;SNRPD2;DDIT3;SNAI2;APC2;RPL31;FAM217B;RNF113A;HIST1H4F;PHF12;RPL23A;SPC25;HIST1H1D;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;JADE2;FAM110C;KIAA0753;GPR89A;IVNS1ABP;ZKSCAN3;COX7C;HIST1H4I;RHOF;CIART;MAP7D3;RPS27;HIST1H4D;RAB15;MUC12;MAP1A
2084,GO:0004842,0.900842991018994,0.332102979461533,1,377,ubiquitin-protein transferase activity,MF,RNF125
11192,GO:0045296,0.90259952235257,0.328203115098079,1,298,cadherin binding,MF,RPL23A
10634,GO:0043632,0.903061687110971,0.252804182947925,2,530,modification-dependent macromolecule catabolic process,BP,RNF125;DDIT3
5558,GO:0016567,0.903629638629901,0.220479191677452,3,706,protein ubiquitination,BP,RNF125;JADE2;ARRDC3
11399,GO:0045786,0.906070682079865,0.24681964844243,2,536,negative regulation of cell cycle,BP,DDIT3;NUPR1
5325,GO:0016049,0.906325415955491,0.319303386973247,1,349,cell growth,BP,MUC12
988,GO:0002443,0.908288783965474,0.242410592958646,2,501,leukocyte mediated immunity,BP,SLC2A3;RHOF
5445,GO:0016310,0.908836226798046,0.162735786267987,8,1644,phosphorylation,BP,HES5;DDIT4;RGS2;NME9;GDNF;HES1;COX7C;SPDYE1
711,GO:0001934,0.912128697784635,0.234519398975209,2,621,positive regulation of protein phosphorylation,BP,HES5;HES1
10310,GO:0043086,0.912484849052307,0.233866181078946,2,535,negative regulation of catalytic activity,BP,TXNIP;RGS2
2555,GO:0005829,0.91324117244813,0.129644206406015,25,4101,cytosol,CC,TXNIP;DDIT4;TSC22D3;RIN2;RGS2;TCHH;RPL37;IFIT2;SNRPD2;DDIT3;APC2;RPL31;FAM217B;NUPR1;RPL23A;SPC25;RPL28;TMSB4X;KIAA0753;IVNS1ABP;ZKSCAN3;RHOF;RPS27;STAC2;MAP1A
10801,GO:0044281,0.914587052128705,0.153940001181655,8,1503,small molecule metabolic process,BP,NR1D1;DDIT4;NME9;PPP1R3D;SLC2A3;SNAI2;TMSB4X;COX7C
15173,GO:0071310,0.914731606568941,0.149859799144883,9,1803,cellular response to organic substance,BP,NR1D1;HES5;DDIT4;HES1;ID3;IFIT2;DDIT3;SNAI2;TMSB4X
7600,GO:0031974,0.915724583940346,0.124993074205285,28,4305,membrane-enclosed lumen,CC,TXNIP;NR1D1;HES5;RGS2;HES1;ZC3H12D;MUC6;ACTR5;SNRPD2;DDIT3;SNAI2;FAM217B;HIST1H4F;PHF12;RPL23A;HIST1H1D;SPN;SALL2;HOXC5;TMSB4X;JADE2;IVNS1ABP;ZKSCAN3;HIST1H4I;CIART;RPS27;HIST1H4D;MUC12
10401,GO:0043233,0.915724583940346,0.124993074205285,28,4305,organelle lumen,CC,TXNIP;NR1D1;HES5;RGS2;HES1;ZC3H12D;MUC6;ACTR5;SNRPD2;DDIT3;SNAI2;FAM217B;HIST1H4F;PHF12;RPL23A;HIST1H1D;SPN;SALL2;HOXC5;TMSB4X;JADE2;IVNS1ABP;ZKSCAN3;HIST1H4I;CIART;RPS27;HIST1H4D;MUC12
14522,GO:0070013,0.915724583940346,0.124993074205285,28,4305,intracellular organelle lumen,CC,TXNIP;NR1D1;HES5;RGS2;HES1;ZC3H12D;MUC6;ACTR5;SNRPD2;DDIT3;SNAI2;FAM217B;HIST1H4F;PHF12;RPL23A;HIST1H1D;SPN;SALL2;HOXC5;TMSB4X;JADE2;IVNS1ABP;ZKSCAN3;HIST1H4I;CIART;RPS27;HIST1H4D;MUC12
14867,GO:0070647,0.915947685480405,0.181217378893779,4,946,protein modification by small protein conjugation or removal,BP,RNF125;ACTR5;JADE2;ARRDC3
10732,GO:0044089,0.915960093711957,0.295840645317356,1,383,positive regulation of cellular component biogenesis,BP,RGS2
4378,GO:0010008,0.916199442935801,0.29527465723722,1,367,endosome membrane,CC,RAB15
6237,GO:0019787,0.91712090488769,0.292918236284535,1,401,ubiquitin-like protein transferase activity,MF,RNF125
16853,GO:0098772,0.918593782229527,0.165824745372119,5,1128,molecular function regulator,MF,TXNIP;RIN2;RGS2;GDNF;FXYD3
10508,GO:0043412,0.919144690248484,0.127694999414651,17,3237,macromolecule modification,BP,HES5;DDIT4;RGS2;PPP1R3D;GDNF;HES1;MUC6;RNF125;ACTR5;SNAI2;NUPR1;HIST1H1D;PIGH;JADE2;SPDYE1;ARRDC3;MUC12
6221,GO:0019752,0.920591184001735,0.188991287639791,3,753,carboxylic acid metabolic process,BP,NR1D1;DDIT4;SLC2A3
10883,GO:0044422,0.920817697238301,0.116425513560168,48,7166,organelle part,CC,TXNIP;NR1D1;HES5;RGS2;RPL37;LRIG3;HES1;ZC3H12D;GOLGA2P5;MUC6;SMIM14;SLC2A3;RNF125;ACTR5;SNRPD2;DDIT3;SNAI2;APC2;RPL31;FAM217B;RNF113A;HIST1H4F;PHF12;RPL23A;SPC25;HIST1H1D;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;JADE2;FAM110C;KIAA0753;GPR89A;IVNS1ABP;ZKSCAN3;COX7C;HIST1H4I;RHOF;CIART;MAP7D3;RPS27;HIST1H4D;RAB15;MUC12;MAP1A
10585,GO:0043549,0.921817920241896,0.214382927387702,2,642,regulation of kinase activity,BP,RGS2;SPDYE1
13158,GO:0051726,0.922664909808939,0.169254454666333,4,1003,regulation of cell cycle,BP,HES1;ID3;DDIT3;NUPR1
3288,GO:0006979,0.922910848304805,0.278387241492361,1,324,response to oxidative stress,BP,TXNIP
82,GO:0000165,0.923873358732571,0.210044168908689,2,605,MAPK cascade,BP,RGS2;GDNF
9957,GO:0042327,0.924977048274271,0.207651724641055,2,655,positive regulation of phosphorylation,BP,HES5;HES1
15519,GO:0071900,0.925936984032804,0.270405270230308,1,392,regulation of protein serine/threonine kinase activity,BP,RGS2
5313,GO:0016020,0.926528714491847,0.108803944780436,35,5733,membrane,CC,RGS2;NRSN1;S1PR5;TCHH;LRIG3;SLC24A4;GOLGA2P5;MUC6;SMIM14;SLC2A3;RNF125;SLC9A4;DCHS1;APC2;RPL31;HIST1H4F;CNNM1;SPN;PIGH;RPL28;FXYD3;GPR89A;COX7C;TMEM139;HIST1H4I;RHOF;ARRDC3;MAP7D3;LOC441081;HIST1H4D;RAB15;BTN3A1;MUC12;STAC2;ABCB5
3663,GO:0008152,0.928449519693905,0.10784403666528,55,8257,metabolic process,BP,TXNIP;NR1D1;HES5;DDIT4;TSC22D3;RGS2;HOXA9;RPL37;NME9;PPP1R3D;GDNF;HES1;HOXC13;ID3;ZC3H12D;MUC6;SLC2A3;RNF125;ACTR5;SNRPD2;DDIT3;SNAI2;APC2;RPL31;NUPR1;OTX1;ZNF44;RNF113A;HIST1H4F;PHF12;RPL23A;ZNF160;HIST1H1D;ZNF766;SPN;SALL2;HOXC5;PIGH;RPL28;TMSB4X;JADE2;ZNF169;IVNS1ABP;ZNF799;ZKSCAN3;COX7C;HIST1H4I;SPDYE1;CIART;ARRDC3;RPS27;ZNF485;HIST1H4D;MUC12;ZNF57
2534,GO:0005789,0.929000418307336,0.172727700531452,3,797,endoplasmic reticulum membrane,CC,SMIM14;RNF125;PIGH
4385,GO:0010035,0.929316943558527,0.261573984664133,1,346,response to inorganic substance,BP,TXNIP
6636,GO:0023014,0.929327958570599,0.198273335694015,2,623,signal transduction by protein phosphorylation,BP,RGS2;GDNF
17688,GO:1901565,0.930267669215179,0.155450533616171,4,979,organonitrogen compound catabolic process,BP,NR1D1;RNF125;DDIT3;APC2
16884,GO:0098827,0.930484960103925,0.169809270404088,3,801,endoplasmic reticulum subcompartment,CC,SMIM14;RNF125;PIGH
10896,GO:0044440,0.931083930035462,0.256761465584664,1,394,endosomal part,CC,RAB15
12083,GO:0048037,0.933180184115628,0.251162429688676,1,355,cofactor binding,MF,NR1D1
9892,GO:0042175,0.934058951091985,0.162718451208617,3,812,nuclear outer membrane-endoplasmic reticulum membrane network,CC,SMIM14;RNF125;PIGH
7881,GO:0032446,0.934261016956787,0.162326000140062,3,786,protein modification by small protein conjugation,BP,RNF125;JADE2;ARRDC3
6673,GO:0030031,0.936121764194857,0.242967706898637,1,438,cell projection assembly,BP,FAM110C
7335,GO:0031344,0.936551017850761,0.241781836094495,1,436,regulation of cell projection organization,BP,FAM110C
2546,GO:0005813,0.940669993420563,0.230219324659392,1,440,centrosome,CC,KIAA0753
10521,GO:0043436,0.940796259677545,0.149095459598394,3,820,oxoacid metabolic process,BP,NR1D1;DDIT4;SLC2A3
18583,GO:1903827,0.940904211409477,0.229582891426035,1,417,regulation of cellular protein localization,BP,HES1
7605,GO:0031984,0.941074399756926,0.126461867119255,5,1277,organelle subcompartment,CC,GOLGA2P5;SMIM14;RNF125;PIGH;GPR89A
16776,GO:0098588,0.941634766065891,0.11923223642441,6,1518,bounding membrane of organelle,CC,GOLGA2P5;SLC2A3;RNF125;GPR89A;RHOF;RAB15
18013,GO:1902494,0.942604915391672,0.117581148682135,6,1230,catalytic complex,CC,ACTR5;SNRPD2;PHF12;SALL2;PIGH;JADE2
3177,GO:0006796,0.943227307119818,0.100826193853437,11,2288,phosphate-containing compound metabolic process,BP,HES5;DDIT4;RGS2;NME9;PPP1R3D;GDNF;HES1;PIGH;TMSB4X;COX7C;SPDYE1
2710,GO:0006082,0.943235265015784,0.144072397245578,3,827,organic acid metabolic process,BP,NR1D1;DDIT4;SLC2A3
12644,GO:0050839,0.943597977297674,0.221887785076659,1,394,cell adhesion molecule binding,MF,RPL23A
12828,GO:0051130,0.944112034378823,0.14222815838059,3,909,positive regulation of cellular component organization,BP,RGS2;HES1;SNAI2
3240,GO:0006897,0.944396774264447,0.219496088732336,1,452,endocytosis,BP,RIN2
3303,GO:0007005,0.944747320316016,0.163612369431317,2,487,mitochondrion organization,BP,HES1;IFIT2
4808,GO:0012505,0.944901680427339,0.0915794866832005,16,3161,endomembrane system,CC,NRSN1;GOLGA2P5;MUC6;SMIM14;SLC2A3;IFIT2;RNF125;DDIT3;APC2;PIGH;TMSB4X;GPR89A;RHOF;ARRDC3;RAB15;MUC12
3252,GO:0006914,0.949757027246873,0.203666281840399,1,428,autophagy,BP,ZKSCAN3
14489,GO:0061919,0.949757027246873,0.203666281840399,1,428,process utilizing autophagic mechanism,BP,ZKSCAN3
6074,GO:0019221,0.951063569912275,0.148574860219233,2,530,cytokine-mediated signaling pathway,BP,IFIT2;TMSB4X
10505,GO:0043408,0.951074736447137,0.199629073255898,1,475,regulation of MAPK cascade,BP,RGS2
2617,GO:0005925,0.952814899333963,0.194464869038381,1,355,focal adhesion,CC,RPL31
2616,GO:0005924,0.953338672045477,0.192848600531698,1,356,cell-substrate adherens junction,CC,RPL31
6689,GO:0030055,0.954228026486563,0.190086493005909,1,360,cell-substrate junction,CC,RPL31
3176,GO:0006793,0.956536864572636,0.0796219793830215,11,2359,phosphorus metabolic process,BP,HES5;DDIT4;RGS2;NME9;PPP1R3D;GDNF;HES1;PIGH;TMSB4X;COX7C;SPDYE1
13536,GO:0055114,0.956704733047814,0.115407433918741,3,719,oxidation-reduction process,BP,NR1D1;PPP1R3D;COX7C
9789,GO:0040008,0.956799384461802,0.181901151462328,1,450,regulation of growth,BP,MUC12
12968,GO:0051347,0.957707660953429,0.178983209997983,1,483,positive regulation of transferase activity,BP,ARRDC3
2213,GO:0005102,0.958939275881594,0.110410059639201,3,879,signaling receptor binding,MF,GDNF;ARRDC3;BTN3A1
4266,GO:0009611,0.959525804536836,0.173213322590923,1,417,response to wounding,BP,ID3
16873,GO:0098805,0.959526391039026,0.0986924121743332,4,1197,whole membrane,CC,SLC2A3;GPR89A;RHOF;RAB15
15485,GO:0071840,0.960681578546755,0.0624241466525174,29,4803,cellular component organization or biogenesis,BP,HES5;RGS2;RPL37;GDNF;HES1;GOLGA2P5;IFIT2;SNRPD2;DDIT3;SNAI2;APC2;RPL31;HIST1H4F;RPL23A;SPC25;HIST1H1D;RPL28;TMSB4X;JADE2;FAM110C;KIAA0753;ZKSCAN3;HIST1H4I;RHOF;MAP7D3;RPS27;HIST1H4D;MUC12;MAP1A
9902,GO:0042221,0.961015161269979,0.0688052528725653,14,2777,response to chemical,BP,TXNIP;NR1D1;HES5;DDIT4;GDNF;HES1;ID3;IFIT2;DDIT3;SNAI2;NUPR1;SPN;TMSB4X;ABCB5
4383,GO:0010033,0.963549166354315,0.0695941876400726,10,2167,response to organic substance,BP,TXNIP;NR1D1;HES5;DDIT4;HES1;ID3;IFIT2;DDIT3;SNAI2;TMSB4X
3065,GO:0006629,0.963814820268311,0.099399401501567,3,975,lipid metabolic process,BP,NR1D1;SNAI2;PIGH
9244,GO:0035639,0.967900976941803,0.0810779713821005,4,1403,purine ribonucleoside triphosphate binding,MF,HSP90AB4P;RHOF;RAB15;ABCB5
16867,GO:0098798,0.9679336383975,0.145463640542633,1,218,mitochondrial protein complex,CC,COX7C
160,GO:0000323,0.969039102155166,0.141102296356391,1,518,lytic vacuole,CC,ARRDC3
2512,GO:0005764,0.969039102155166,0.141102296356391,1,518,lysosome,CC,ARRDC3
10891,GO:0044432,0.969058647332103,0.0872346036836229,3,964,endoplasmic reticulum part,CC,SMIM14;RNF125;PIGH
5322,GO:0016043,0.969152989055274,0.0505675415043301,26,4594,cellular component organization,BP,HES5;RGS2;GDNF;HES1;GOLGA2P5;IFIT2;SNRPD2;DDIT3;SNAI2;APC2;HIST1H4F;RPL23A;SPC25;HIST1H1D;TMSB4X;JADE2;FAM110C;KIAA0753;ZKSCAN3;HIST1H4I;RHOF;MAP7D3;RPS27;HIST1H4D;MUC12;MAP1A
13109,GO:0051640,0.969323522862102,0.140099972261091,1,522,organelle localization,BP,RAB15
7958,GO:0032555,0.970229399080483,0.0760424871157434,4,1422,purine ribonucleotide binding,MF,HSP90AB4P;RHOF;RAB15;ABCB5
7956,GO:0032553,0.971519230813688,0.0732229347564376,4,1433,ribonucleotide binding,MF,HSP90AB4P;RHOF;RAB15;ABCB5
5816,GO:0017076,0.972381877980149,0.0713249955148201,4,1436,purine nucleotide binding,MF,HSP90AB4P;RHOF;RAB15;ABCB5
9474,GO:0036094,0.972977129182289,0.0613059834277246,6,1809,small molecule binding,MF,ID3;SLC2A3;HSP90AB4P;RHOF;RAB15;ABCB5
2609,GO:0005912,0.973245331708918,0.126082998156179,1,447,adherens junction,CC,RPL31
5440,GO:0016301,0.97355372863103,0.124837344318335,1,635,kinase activity,MF,NME9
5380,GO:0016192,0.973954509966305,0.062897306270829,5,1437,vesicle-mediated transport,BP,RIN2;SLC2A3;TMSB4X;RHOF;RAB15
14598,GO:0070161,0.975361682897771,0.118230613975774,1,464,anchoring junction,CC,RPL31
2520,GO:0005773,0.981922470910541,0.0925760808968264,1,601,vacuole,CC,ARRDC3
14975,GO:0070887,0.981965048752242,0.03817601566993,9,2119,cellular response to chemical stimulus,BP,NR1D1;HES5;DDIT4;HES1;ID3;IFIT2;DDIT3;SNAI2;TMSB4X
6688,GO:0030054,0.985233867041864,0.0556832457418698,2,871,cell junction,CC,RPL31;HOXC5
2969,GO:0006508,0.985670343488545,0.0405298419629891,4,1252,proteolysis,BP,NR1D1;RNF125;ACTR5;DDIT3
15196,GO:0071345,0.985916217134857,0.0535412434115357,2,745,cellular response to cytokine stimulus,BP,IFIT2;TMSB4X
3482,GO:0007346,0.986778633170393,0.0720846491410122,1,578,regulation of mitotic cell cycle,BP,HES1
6745,GO:0030162,0.987085590749124,0.0707566019583105,1,518,regulation of proteolysis,BP,RNF125
10355,GO:0043168,0.987292935522137,0.0315572724709771,6,1997,anion binding,MF,ID3;PHF12;HSP90AB4P;RHOF;RAB15;ABCB5
9788,GO:0040007,0.987321802278384,0.0696626897067836,1,653,growth,BP,MUC12
16574,GO:0097367,0.987642644223237,0.0356118968588226,4,1581,carbohydrate derivative binding,MF,HSP90AB4P;RHOF;RAB15;ABCB5
133,GO:0000278,0.988973529099889,0.0435487653505821,2,914,mitotic cell cycle,BP,HES1;SPC25
2491,GO:0005737,0.989112516837146,0.019198975022979,52,8352,cytoplasm,CC,TXNIP;NR1D1;DDIT4;TSC22D3;RIN2;RGS2;HOXA9;NRSN1;TCHH;RPL37;LRIG3;NME9;PPP1R3D;HES1;ID3;SLC24A4;ZC3H12D;GOLGA2P5;LGALS7B;MUC6;SMIM14;SLC2A3;IFIT2;RNF125;ACTR5;SNRPD2;DDIT3;SNAI2;APC2;RPL31;FAM217B;NUPR1;RPL23A;SPC25;PIGH;RPL28;TMSB4X;FAM110C;KIAA0753;GPR89A;IVNS1ABP;HSP90AB4P;ZKSCAN3;COX7C;RHOF;ARRDC3;MAP7D3;RPS27;RAB15;MUC12;STAC2;MAP1A
2389,GO:0005524,0.989656021965178,0.0412363475068757,2,1150,ATP binding,MF,HSP90AB4P;ABCB5
2528,GO:0005783,0.989752008539924,0.0302511571342795,4,1324,endoplasmic reticulum,CC,SMIM14;IFIT2;RNF125;PIGH
8593,GO:0034097,0.990217934631019,0.0393637758826543,2,812,response to cytokine,BP,IFIT2;TMSB4X
83,GO:0000166,0.990581007576188,0.0280844677666627,4,1627,nucleotide binding,MF,HSP90AB4P;RHOF;RAB15;ABCB5
14149,GO:0061024,0.990684298557447,0.0542297061011654,1,662,membrane organization,BP,GDNF
7962,GO:0032559,0.990720629042382,0.0376070111913749,2,1169,adenyl ribonucleotide binding,MF,HSP90AB4P;ABCB5
17603,GO:1901265,0.99073620408649,0.0276782238440645,4,1628,nucleoside phosphate binding,MF,HSP90AB4P;RHOF;RAB15;ABCB5
6947,GO:0030554,0.991473483408483,0.0349959274001174,2,1181,adenyl nucleotide binding,MF,HSP90AB4P;ABCB5
2493,GO:0005740,0.99156250502193,0.0347500846475481,2,617,mitochondrial envelope,CC,TXNIP;COX7C
2487,GO:0005730,0.992278454379706,0.0321877616101806,2,834,nucleolus,CC,RGS2;RPL23A
5665,GO:0016772,0.992355146964817,0.0460907819954172,1,778,transferase activity, transferring phosphorus-containing groups,MF,NME9
10197,GO:0042802,0.992436438956006,0.0261628509826017,3,1164,identical protein binding,MF,GDNF;HES1;DDIT3
2496,GO:0005743,0.993724816670675,0.0392470776233895,1,407,mitochondrial inner membrane,CC,COX7C
10788,GO:0044255,0.993950996158734,0.0379816315516815,1,758,cellular lipid metabolic process,BP,PIGH
5523,GO:0016491,0.994691373142448,0.0341146179785333,1,529,oxidoreductase activity,MF,COX7C
6274,GO:0019866,0.995438422159074,0.0300780623639724,1,451,organelle inner membrane,CC,COX7C
3660,GO:0008144,0.995444661867432,0.0204370855166127,2,1266,drug binding,MF,HSP90AB4P;ABCB5
5678,GO:0016787,0.995994605926665,0.012041416872458,5,1813,hydrolase activity,MF,PPP1R3D;ZC3H12D;RHOF;RAB15;ABCB5
18240,GO:1903047,0.996375437942431,0.024746625336165,1,761,mitotic cell cycle process,BP,SPC25
7202,GO:0031090,0.99677698989724,0.00833695085592847,8,2223,organelle membrane,CC,LRIG3;GOLGA2P5;SLC2A3;RNF125;GPR89A;COX7C;RHOF;RAB15
10898,GO:0044444,0.997682037244016,0.00445337781389629,41,7167,cytoplasmic part,CC,TXNIP;DDIT4;TSC22D3;RIN2;RGS2;NRSN1;TCHH;RPL37;LRIG3;PPP1R3D;ZC3H12D;GOLGA2P5;MUC6;SMIM14;SLC2A3;IFIT2;RNF125;SNRPD2;DDIT3;APC2;RPL31;FAM217B;NUPR1;RPL23A;SPC25;PIGH;RPL28;TMSB4X;FAM110C;KIAA0753;GPR89A;IVNS1ABP;ZKSCAN3;COX7C;RHOF;ARRDC3;RPS27;RAB15;MUC12;STAC2;MAP1A
7596,GO:0031966,0.998372275106879,0.0125344834651275,1,578,mitochondrial membrane,CC,COX7C
10888,GO:0044429,0.998510239533433,0.00770997612675903,2,851,mitochondrial part,CC,TXNIP;COX7C
5648,GO:0016740,0.998753720840493,0.00462891389810028,4,1894,transferase activity,MF,NME9;RNF125;PIGH;JADE2
7597,GO:0031967,0.999145376238748,0.00471190144896079,2,972,organelle envelope,CC,TXNIP;COX7C
7601,GO:0031975,0.999145376238748,0.00471190144896079,2,972,envelope,CC,TXNIP;COX7C
2492,GO:0005739,0.999479846147934,0.00209667466426828,4,1425,mitochondrion,CC,TXNIP;DDIT4;RGS2;COX7C
17301,GO:0140096,0.999815139076331,0.00119133963702984,2,1699,catalytic activity, acting on a protein,MF,PPP1R3D;RNF125
1489,GO:0003824,0.999999829019525,7.38484952419013e-07,10,4344,catalytic activity,MF,NME9;PPP1R3D;ZC3H12D;RNF125;PIGH;JADE2;COX7C;RHOF;RAB15;ABCB5
16103,GO:0090085,0.999999999999988,0.914143683723959,0,11,regulation of protein deubiquitination,BP,
12311,GO:0048662,0.999999999999988,0.830689419909023,0,27,negative regulation of smooth muscle cell proliferation,BP,
1114,GO:0002701,0.999999999999989,0.861207319124769,0,20,negative regulation of production of molecular mediator of immune response,BP,
18037,GO:1902555,0.99999999999999,0.767458679841328,0,29,endoribonuclease complex,CC,
19227,GO:1905348,0.99999999999999,0.767458679841328,0,29,endonuclease complex,CC,
20206,GO:2001057,0.999999999999999,0.708995081881863,0,51,reactive nitrogen species metabolic process,BP,
7790,GO:0032329,1,0.957142402904508,0,8,serine transport,BP,
1,GO:0000002,1,0.855659547487472,0,24,mitochondrial genome maintenance,BP,
3,GO:0000009,1,0.995112892559295,0,1,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.985685010370341,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000011,1,0.995366574475227,0,1,vacuole inheritance,BP,
6,GO:0000012,1,0.961061512498834,0,8,single strand break repair,BP,
7,GO:0000014,1,0.96615930268123,0,7,single-stranded DNA endodeoxyribonuclease activity,MF,
8,GO:0000015,1,0.992389343356341,0,1,phosphopyruvate hydratase complex,CC,
9,GO:0000018,1,0.710155424729698,0,58,regulation of DNA recombination,BP,
10,GO:0000019,1,0.986040922533577,0,3,regulation of mitotic recombination,BP,
11,GO:0000022,1,0.943888606951221,0,10,mitotic spindle elongation,BP,
12,GO:0000023,1,0.986164509990694,0,3,maltose metabolic process,BP,
13,GO:0000026,1,0.986093965308321,0,3,alpha-1,2-mannosyltransferase activity,MF,
16,GO:0000030,1,0.820027880244964,0,22,mannosyltransferase activity,MF,
17,GO:0000032,1,0.991967176450215,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.975760022376662,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.944033747523661,0,2,acyl binding,MF,
20,GO:0000036,1,0.944033747523661,0,2,acyl carrier activity,MF,
21,GO:0000038,1,0.869679104819757,0,23,very long-chain fatty acid metabolic process,BP,
22,GO:0000041,1,0.525517473476293,0,74,transition metal ion transport,BP,
23,GO:0000045,1,0.589634693729908,0,84,autophagosome assembly,BP,
24,GO:0000048,1,0.995094192629849,0,1,peptidyltransferase activity,MF,
25,GO:0000049,1,0.692824500379659,0,54,tRNA binding,MF,
26,GO:0000050,1,0.931717392877981,0,10,urea cycle,BP,
27,GO:0000052,1,0.95600475044489,0,7,citrulline metabolic process,BP,
28,GO:0000053,1,0.992456122944064,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.854338174797629,0,13,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.91431612575551,0,8,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.91702289088755,0,7,ribosomal small subunit export from nucleus,BP,
32,GO:0000060,1,0.746050322574427,0,37,protein import into nucleus, translocation,BP,
33,GO:0000062,1,0.873545957169446,0,17,fatty-acyl-CoA binding,MF,
34,GO:0000064,1,0.979094535730536,0,4,L-ornithine transmembrane transporter activity,MF,
35,GO:0000070,1,0.383093797133062,0,142,mitotic sister chromatid segregation,BP,
36,GO:0000075,1,0.247353815276065,0,208,cell cycle checkpoint,BP,
37,GO:0000076,1,0.905740034769558,0,16,DNA replication checkpoint,BP,
38,GO:0000077,1,0.3792747451827,0,147,DNA damage checkpoint,BP,
39,GO:0000079,1,0.581392961935984,0,72,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
40,GO:0000082,1,0.195953034800518,0,222,G1/S transition of mitotic cell cycle,BP,
41,GO:0000083,1,0.853838287538655,0,25,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
42,GO:0000086,1,0.161360451864926,0,225,G2/M transition of mitotic cell cycle,BP,
43,GO:0000095,1,0.994758631763274,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
44,GO:0000096,1,0.833288836404165,0,30,sulfur amino acid metabolic process,BP,
45,GO:0000097,1,0.915416283662626,0,14,sulfur amino acid biosynthetic process,BP,
46,GO:0000098,1,0.964159146155481,0,7,sulfur amino acid catabolic process,BP,
47,GO:0000099,1,0.981594237657353,0,4,sulfur amino acid transmembrane transporter activity,MF,
48,GO:0000101,1,0.986163876951633,0,3,sulfur amino acid transport,BP,
49,GO:0000103,1,0.974869291576925,0,3,sulfate assimilation,BP,
50,GO:0000104,1,0.955516278776553,0,5,succinate dehydrogenase activity,MF,
51,GO:0000105,1,0.990473497453471,0,2,histidine biosynthetic process,BP,
52,GO:0000109,1,0.933412353697953,0,10,nucleotide-excision repair complex,CC,
53,GO:0000110,1,0.980630622897712,0,3,nucleotide-excision repair factor 1 complex,CC,
54,GO:0000111,1,0.995366971511603,0,1,nucleotide-excision repair factor 2 complex,CC,
55,GO:0000117,1,0.995366990826138,0,1,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
57,GO:0000120,1,0.963245935217186,0,5,RNA polymerase I transcription factor complex,CC,
58,GO:0000121,1,0.995366787173025,0,1,glycerol-1-phosphatase activity,MF,
61,GO:0000124,1,0.891346554012453,0,13,SAGA complex,CC,
62,GO:0000125,1,0.940251597754034,0,5,PCAF complex,CC,
63,GO:0000126,1,0.990755181667343,0,2,transcription factor TFIIIB complex,CC,
64,GO:0000127,1,0.955764882199977,0,6,transcription factor TFIIIC complex,CC,
65,GO:0000132,1,0.888960785711967,0,18,establishment of mitotic spindle orientation,BP,
67,GO:0000138,1,0.947431257104448,0,6,Golgi trans cisterna,CC,
69,GO:0000145,1,0.922396040859307,0,16,exocyst,CC,
70,GO:0000146,1,0.93703419079087,0,14,microfilament motor activity,MF,
71,GO:0000147,1,0.986164531023741,0,3,actin cortical patch assembly,BP,
72,GO:0000149,1,0.545735026479628,0,93,SNARE binding,MF,
73,GO:0000150,1,0.945522408372477,0,8,recombinase activity,MF,
74,GO:0000151,1,0.177916538598302,0,266,ubiquitin ligase complex,CC,
75,GO:0000152,1,0.706461351045043,0,40,nuclear ubiquitin ligase complex,CC,
76,GO:0000153,1,0.909318133204148,0,11,cytoplasmic ubiquitin ligase complex,CC,
77,GO:0000154,1,0.71890974610949,0,34,rRNA modification,BP,
78,GO:0000155,1,0.99536699082602,0,1,phosphorelay sensor kinase activity,MF,
79,GO:0000159,1,0.900302366147207,0,20,protein phosphatase type 2A complex,CC,
80,GO:0000160,1,0.990755190943487,0,2,phosphorelay signal transduction system,BP,
81,GO:0000164,1,0.936469523237135,0,11,protein phosphatase type 1 complex,CC,
84,GO:0000171,1,0.990646342000713,0,2,ribonuclease MRP activity,MF,
85,GO:0000172,1,0.933797105224362,0,6,ribonuclease MRP complex,CC,
86,GO:0000173,1,0.990613200183143,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
87,GO:0000175,1,0.787873361192012,0,30,3'-5'-exoribonuclease activity,MF,
88,GO:0000176,1,0.836477098529112,0,13,nuclear exosome (RNase complex),CC,
89,GO:0000177,1,0.861548356110643,0,15,cytoplasmic exosome (RNase complex),CC,
90,GO:0000178,1,0.80207285078509,0,22,exosome (RNase complex),CC,
91,GO:0000179,1,0.968244618581753,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
92,GO:0000182,1,0.949178939208767,0,10,rDNA binding,MF,
95,GO:0000185,1,0.906580312645607,0,16,activation of MAPKKK activity,BP,
96,GO:0000186,1,0.798043118950187,0,45,activation of MAPKK activity,BP,
97,GO:0000187,1,0.519011926313342,0,104,activation of MAPK activity,BP,
98,GO:0000188,1,0.867831593022719,0,22,inactivation of MAPK activity,BP,
100,GO:0000210,1,0.995366946678943,0,1,NAD+ diphosphatase activity,MF,
101,GO:0000212,1,0.948388664070734,0,10,meiotic spindle organization,BP,
102,GO:0000213,1,0.976344171173168,0,4,tRNA-intron endonuclease activity,MF,
103,GO:0000214,1,0.97461912747536,0,4,tRNA-intron endonuclease complex,CC,
104,GO:0000215,1,0.975081501343651,0,2,tRNA 2'-phosphotransferase activity,MF,
105,GO:0000217,1,0.875434597915966,0,23,DNA secondary structure binding,MF,
106,GO:0000220,1,0.947854395933805,0,5,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
107,GO:0000221,1,0.985101168985794,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
108,GO:0000224,1,0.995303116056287,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
109,GO:0000225,1,0.982609909390169,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
112,GO:0000229,1,0.98991388349424,0,1,cytoplasmic chromosome,CC,
113,GO:0000235,1,0.962887324630706,0,8,astral microtubule,CC,
114,GO:0000242,1,0.909752797964889,0,19,pericentriolar material,CC,
115,GO:0000243,1,0.920905398907225,0,8,commitment complex,CC,
116,GO:0000244,1,0.944689199177543,0,12,spliceosomal tri-snRNP complex assembly,BP,
118,GO:0000246,1,0.995366990826152,0,1,delta24(24-1) sterol reductase activity,MF,
119,GO:0000247,1,0.982649015560594,0,1,C-8 sterol isomerase activity,MF,
120,GO:0000248,1,0.990754785405327,0,2,C-5 sterol desaturase activity,MF,
121,GO:0000250,1,0.995366990826153,0,1,lanosterol synthase activity,MF,
122,GO:0000252,1,0.989979106038821,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
123,GO:0000253,1,0.946628215235726,0,4,3-keto sterol reductase activity,MF,
124,GO:0000254,1,0.990754370961523,0,2,C-4 methylsterol oxidase activity,MF,
125,GO:0000255,1,0.986164531023753,0,3,allantoin metabolic process,BP,
126,GO:0000257,1,0.986452775796898,0,1,nitrilase activity,MF,
127,GO:0000262,1,0.98991388349424,0,1,mitochondrial chromosome,CC,
128,GO:0000266,1,0.825131801563254,0,33,mitochondrial fission,BP,
129,GO:0000268,1,0.974710045691284,0,4,peroxisome targeting sequence binding,MF,
130,GO:0000270,1,0.975701813833231,0,2,peptidoglycan metabolic process,BP,
134,GO:0000280,1,0.124246909604239,0,318,nuclear division,BP,
135,GO:0000281,1,0.685707387121466,0,60,mitotic cytokinesis,BP,
136,GO:0000285,1,0.97766122396391,0,3,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
137,GO:0000287,1,0.363181170673737,0,156,magnesium ion binding,MF,
138,GO:0000288,1,0.544636833514245,0,72,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
139,GO:0000289,1,0.819725204419045,0,35,nuclear-transcribed mRNA poly(A) tail shortening,BP,
140,GO:0000290,1,0.933836421611669,0,9,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
141,GO:0000291,1,0.657979417719296,0,35,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
142,GO:0000293,1,0.986157979137212,0,3,ferric-chelate reductase activity,MF,
143,GO:0000294,1,0.990751739133439,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
144,GO:0000295,1,0.931742506627427,0,11,adenine nucleotide transmembrane transporter activity,MF,
145,GO:0000296,1,0.994932015741758,0,1,spermine transport,BP,
146,GO:0000298,1,0.970671105713102,0,4,endopolyphosphatase activity,MF,
147,GO:0000301,1,0.986163283475605,0,3,retrograde transport, vesicle recycling within Golgi,BP,
149,GO:0000303,1,0.803476242547405,0,20,response to superoxide,BP,
151,GO:0000306,1,0.981009862646559,0,4,extrinsic component of vacuolar membrane,CC,
152,GO:0000307,1,0.757324434771467,0,37,cyclin-dependent protein kinase holoenzyme complex,CC,
153,GO:0000308,1,0.990755199725676,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
154,GO:0000309,1,0.990755195663627,0,2,nicotinamide-nucleotide adenylyltransferase activity,MF,
155,GO:0000313,1,0.237482900466205,0,84,organellar ribosome,CC,
156,GO:0000314,1,0.630452970988911,0,28,organellar small ribosomal subunit,CC,
157,GO:0000315,1,0.417130885079282,0,51,organellar large ribosomal subunit,CC,
158,GO:0000320,1,0.99075519984928,0,2,re-entry into mitotic cell cycle,BP,
159,GO:0000322,1,0.976974356870103,0,3,storage vacuole,CC,
161,GO:0000332,1,0.966519617466378,0,1,template for synthesis of G-rich strand of telomere DNA activity,MF,
162,GO:0000333,1,0.96203997556098,0,2,telomerase catalytic core complex,CC,
163,GO:0000338,1,0.926204661366935,0,10,protein deneddylation,BP,
164,GO:0000339,1,0.878109295887753,0,17,RNA cap binding,MF,
165,GO:0000340,1,0.951128137161368,0,9,RNA 7-methylguanosine cap binding,MF,
166,GO:0000346,1,0.902883137054633,0,13,transcription export complex,CC,
167,GO:0000347,1,0.944843552089604,0,6,THO complex,CC,
168,GO:0000349,1,0.990444666209682,0,2,generation of catalytic spliceosome for first transesterification step,BP,
169,GO:0000350,1,0.977729115846517,0,3,generation of catalytic spliceosome for second transesterification step,BP,
170,GO:0000354,1,0.990755080820589,0,2,cis assembly of pre-catalytic spliceosome,BP,
173,GO:0000379,1,0.982782028966238,0,3,tRNA-type intron splice site recognition and cleavage,BP,
174,GO:0000380,1,0.756493080075494,0,46,alternative mRNA splicing, via spliceosome,BP,
175,GO:0000381,1,0.817569998700422,0,34,regulation of alternative mRNA splicing, via spliceosome,BP,
176,GO:0000384,1,0.980955368156207,0,2,first spliceosomal transesterification activity,MF,
177,GO:0000386,1,0.982124958252712,0,3,second spliceosomal transesterification activity,MF,
179,GO:0000389,1,0.964497845691415,0,6,mRNA 3'-splice site recognition,BP,
180,GO:0000390,1,0.978939221861325,0,2,spliceosomal complex disassembly,BP,
181,GO:0000393,1,0.968384176237683,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
182,GO:0000394,1,0.852104672398966,0,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,
183,GO:0000395,1,0.960841680156432,0,6,mRNA 5'-splice site recognition,BP,
185,GO:0000400,1,0.904583769657339,0,16,four-way junction DNA binding,MF,
186,GO:0000403,1,0.972517383192804,0,6,Y-form DNA binding,MF,
187,GO:0000404,1,0.986164325310999,0,3,heteroduplex DNA loop binding,MF,
188,GO:0000405,1,0.967812706416444,0,7,bubble DNA binding,MF,
189,GO:0000406,1,0.990755012416021,0,2,double-strand/single-strand DNA junction binding,MF,
190,GO:0000407,1,0.850604684585062,0,32,phagophore assembly site,CC,
191,GO:0000408,1,0.946971167093144,0,5,EKC/KEOPS complex,CC,
192,GO:0000409,1,0.995366990826073,0,1,regulation of transcription by galactose,BP,
193,GO:0000411,1,0.995366990826073,0,1,positive regulation of transcription by galactose,BP,
194,GO:0000412,1,0.995366568931835,0,1,histone peptidyl-prolyl isomerization,BP,
195,GO:0000413,1,0.71680689443192,0,30,protein peptidyl-prolyl isomerization,BP,
196,GO:0000414,1,0.981594584392806,0,4,regulation of histone H3-K36 methylation,BP,
197,GO:0000415,1,0.995366990826099,0,1,negative regulation of histone H3-K36 methylation,BP,
198,GO:0000416,1,0.995366983252891,0,1,positive regulation of histone H3-K36 methylation,BP,
199,GO:0000417,1,0.995366990826125,0,1,HIR complex,CC,
201,GO:0000422,1,0.552667328058695,0,77,autophagy of mitochondrion,BP,
202,GO:0000423,1,0.890153037431748,0,19,mitophagy,BP,
203,GO:0000428,1,0.346829345492209,0,128,DNA-directed RNA polymerase complex,CC,
204,GO:0000429,1,0.97775991025226,0,3,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
205,GO:0000430,1,0.982311903073977,0,2,regulation of transcription from RNA polymerase II promoter by glucose,BP,
206,GO:0000431,1,0.995366990826073,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
207,GO:0000432,1,0.982311903073977,0,2,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
208,GO:0000435,1,0.995366990826073,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
209,GO:0000436,1,0.97775991025226,0,3,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
210,GO:0000438,1,0.973942410610836,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
211,GO:0000439,1,0.945386638637564,0,9,core TFIIH complex,CC,
212,GO:0000444,1,0.966962845373489,0,4,MIS12/MIND type complex,CC,
213,GO:0000445,1,0.944843552089604,0,6,THO complex part of transcription export complex,CC,
214,GO:0000447,1,0.91220653817331,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
215,GO:0000448,1,0.990515860791857,0,2,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
216,GO:0000451,1,0.987905776726319,0,2,rRNA 2'-O-methylation,BP,
217,GO:0000453,1,0.987905776726319,0,2,enzyme-directed rRNA 2'-O-methylation,BP,
218,GO:0000454,1,0.943820944363871,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
219,GO:0000455,1,0.986610692391086,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
220,GO:0000459,1,0.929813107199659,0,7,exonucleolytic trimming involved in rRNA processing,BP,
221,GO:0000460,1,0.726313400593371,0,33,maturation of 5.8S rRNA,BP,
222,GO:0000461,1,0.947816666197795,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
223,GO:0000462,1,0.668128235329597,0,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
224,GO:0000463,1,0.883158475969332,0,10,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000466,1,0.823802887978145,0,22,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000467,1,0.929813107199659,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000469,1,0.782392682205634,0,26,cleavage involved in rRNA processing,BP,
228,GO:0000470,1,0.747989871699813,0,24,maturation of LSU-rRNA,BP,
229,GO:0000472,1,0.985626737796644,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
230,GO:0000478,1,0.88676115646031,0,15,endonucleolytic cleavage involved in rRNA processing,BP,
231,GO:0000479,1,0.89103044529435,0,14,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
232,GO:0000480,1,0.97100958819311,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
233,GO:0000481,1,0.99536697108092,0,1,maturation of 5S rRNA,BP,
234,GO:0000491,1,0.924480570843827,0,9,small nucleolar ribonucleoprotein complex assembly,BP,
235,GO:0000492,1,0.936333191322921,0,7,box C/D snoRNP assembly,BP,
236,GO:0000493,1,0.987350954912411,0,2,box H/ACA snoRNP assembly,BP,
237,GO:0000494,1,0.982902032395413,0,1,box C/D snoRNA 3'-end processing,BP,
238,GO:0000495,1,0.995327122950758,0,1,box H/ACA snoRNA 3'-end processing,BP,
239,GO:0000496,1,0.966519617466378,0,1,base pairing,MF,
240,GO:0000497,1,0.966519617466378,0,1,base pairing with DNA,MF,
241,GO:0000502,1,0.45149774399288,0,63,proteasome complex,CC,
243,GO:0000578,1,0.890160886660536,0,22,embryonic axis specification,BP,
244,GO:0000700,1,0.969542096255463,0,4,mismatch base pair DNA N-glycosylase activity,MF,
245,GO:0000701,1,0.978709441670647,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
246,GO:0000702,1,0.93388755964985,0,5,oxidized base lesion DNA N-glycosylase activity,MF,
247,GO:0000703,1,0.970669622016928,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
248,GO:0000706,1,0.990754785405328,0,2,meiotic DNA double-strand break processing,BP,
249,GO:0000707,1,0.945793701726735,0,8,meiotic DNA recombinase assembly,BP,
250,GO:0000710,1,0.981594601324194,0,4,meiotic mismatch repair,BP,
251,GO:0000712,1,0.949403225098565,0,9,resolution of meiotic recombination intermediates,BP,
252,GO:0000715,1,0.797782898236825,0,23,nucleotide-excision repair, DNA damage recognition,BP,
253,GO:0000717,1,0.814300622667293,0,22,nucleotide-excision repair, DNA duplex unwinding,BP,
254,GO:0000718,1,0.991485701225143,0,1,nucleotide-excision repair, DNA damage removal,BP,
255,GO:0000720,1,0.976221743147952,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
256,GO:0000722,1,0.903956374941061,0,14,telomere maintenance via recombination,BP,
258,GO:0000724,1,0.556915200467275,0,101,double-strand break repair via homologous recombination,BP,
259,GO:0000725,1,0.55431734443539,0,102,recombinational repair,BP,
261,GO:0000727,1,0.962748030215399,0,5,double-strand break repair via break-induced replication,BP,
262,GO:0000729,1,0.894664863088137,0,22,DNA double-strand break processing,BP,
263,GO:0000730,1,0.937036705274744,0,10,DNA recombinase assembly,BP,
264,GO:0000731,1,0.609733244569099,0,68,DNA synthesis involved in DNA repair,BP,
265,GO:0000732,1,0.873275349961216,0,25,strand displacement,BP,
266,GO:0000733,1,0.951114134316089,0,9,DNA strand renaturation,BP,
267,GO:0000737,1,0.866720327856583,0,21,DNA catabolic process, endonucleolytic,BP,
268,GO:0000738,1,0.964880536008256,0,4,DNA catabolic process, exonucleolytic,BP,
269,GO:0000741,1,0.991695739399954,0,1,karyogamy,BP,
270,GO:0000768,1,0.838250678952122,0,28,syncytium formation by plasma membrane fusion,BP,
271,GO:0000773,1,0.979334613632256,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
272,GO:0000774,1,0.918247861255209,0,11,adenyl-nucleotide exchange factor activity,MF,
276,GO:0000778,1,0.932148188502097,0,12,condensed nuclear chromosome kinetochore,CC,
278,GO:0000780,1,0.887552488343146,0,20,condensed nuclear chromosome, centromeric region,CC,
280,GO:0000782,1,0.950026334016132,0,10,telomere cap complex,CC,
281,GO:0000783,1,0.950026334016132,0,10,nuclear telomere cap complex,CC,
288,GO:0000792,1,0.648756409046637,0,66,heterochromatin,CC,
290,GO:0000794,1,0.690585768112421,0,66,condensed nuclear chromosome,CC,
291,GO:0000795,1,0.905844070699634,0,17,synaptonemal complex,CC,
292,GO:0000796,1,0.968011171225868,0,7,condensin complex,CC,
293,GO:0000797,1,0.995366990826165,0,1,condensin core heterodimer,CC,
294,GO:0000798,1,0.985743319668478,0,3,nuclear cohesin complex,CC,
295,GO:0000799,1,0.986164531023741,0,3,nuclear condensin complex,CC,
296,GO:0000800,1,0.967043109320251,0,7,lateral element,CC,
297,GO:0000801,1,0.995366990826138,0,1,central element,CC,
298,GO:0000803,1,0.862104563049112,0,25,sex chromosome,CC,
299,GO:0000805,1,0.964635508217847,0,7,X chromosome,CC,
300,GO:0000806,1,0.990193479243105,0,2,Y chromosome,CC,
301,GO:0000808,1,0.958401071092065,0,9,origin recognition complex,CC,
302,GO:0000811,1,0.974023940249543,0,3,GINS complex,CC,
303,GO:0000812,1,0.920982427898706,0,10,Swr1 complex,CC,
304,GO:0000813,1,0.942340198427308,0,8,ESCRT I complex,CC,
305,GO:0000814,1,0.961177074055052,0,3,ESCRT II complex,CC,
306,GO:0000815,1,0.910211523422619,0,12,ESCRT III complex,CC,
307,GO:0000818,1,0.990130658268814,0,2,nuclear MIS12/MIND complex,CC,
309,GO:0000820,1,0.985679613806146,0,3,regulation of glutamine family amino acid metabolic process,BP,
310,GO:0000821,1,0.99026805126493,0,2,regulation of arginine metabolic process,BP,
311,GO:0000822,1,0.98616401804269,0,3,inositol hexakisphosphate binding,MF,
312,GO:0000823,1,0.992159402018252,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
313,GO:0000824,1,0.992159402018252,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
314,GO:0000825,1,0.992159402018252,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
315,GO:0000827,1,0.972291517048722,0,4,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
316,GO:0000828,1,0.972291517048722,0,4,inositol hexakisphosphate kinase activity,MF,
317,GO:0000829,1,0.972291517048722,0,4,inositol heptakisphosphate kinase activity,MF,
318,GO:0000832,1,0.972291517048722,0,4,inositol hexakisphosphate 5-kinase activity,MF,
319,GO:0000835,1,0.96736515067362,0,6,ER ubiquitin ligase complex,CC,
320,GO:0000836,1,0.971869308105937,0,5,Hrd1p ubiquitin ligase complex,CC,
321,GO:0000839,1,0.98094087574717,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
322,GO:0000900,1,0.949099953221412,0,10,translation repressor activity, mRNA regulatory element binding,MF,
326,GO:0000912,1,0.971834237660555,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
327,GO:0000915,1,0.971834237660555,0,6,actomyosin contractile ring assembly,BP,
328,GO:0000916,1,0.994600178827652,0,1,actomyosin contractile ring contraction,BP,
329,GO:0000917,1,0.992650471036551,0,1,division septum assembly,BP,
330,GO:0000920,1,0.867649039179179,0,17,cell separation after cytokinesis,BP,
331,GO:0000921,1,0.954542103963001,0,10,septin ring assembly,BP,
333,GO:0000923,1,0.972517494722165,0,6,equatorial microtubule organizing center,CC,
334,GO:0000928,1,0.995366574475227,0,1,gamma-tubulin small complex, spindle pole body,CC,
335,GO:0000930,1,0.887529976957636,0,19,gamma-tubulin complex,CC,
336,GO:0000931,1,0.96352323015997,0,8,gamma-tubulin large complex,CC,
338,GO:0000938,1,0.981594140917278,0,4,GARP complex,CC,
339,GO:0000939,1,0.977188126184606,0,3,condensed chromosome inner kinetochore,CC,
340,GO:0000940,1,0.936163778587248,0,13,condensed chromosome outer kinetochore,CC,
341,GO:0000941,1,0.994836070997394,0,1,condensed nuclear chromosome inner kinetochore,CC,
342,GO:0000942,1,0.978939283534924,0,4,condensed nuclear chromosome outer kinetochore,CC,
344,GO:0000957,1,0.976938885057178,0,5,mitochondrial RNA catabolic process,BP,
345,GO:0000958,1,0.986056661017944,0,3,mitochondrial mRNA catabolic process,BP,
346,GO:0000959,1,0.772717892765694,0,41,mitochondrial RNA metabolic process,BP,
347,GO:0000960,1,0.98148710224806,0,4,regulation of mitochondrial RNA catabolic process,BP,
348,GO:0000961,1,0.990754785405249,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
349,GO:0000962,1,0.990646833488123,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
350,GO:0000963,1,0.899444113510524,0,16,mitochondrial RNA processing,BP,
351,GO:0000964,1,0.964853802284647,0,4,mitochondrial RNA 5'-end processing,BP,
352,GO:0000965,1,0.959847158218837,0,5,mitochondrial RNA 3'-end processing,BP,
353,GO:0000966,1,0.801366844330258,0,21,RNA 5'-end processing,BP,
354,GO:0000967,1,0.985626737796644,0,3,rRNA 5'-end processing,BP,
355,GO:0000972,1,0.960635805949759,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
356,GO:0000973,1,0.982168366091655,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
357,GO:0000974,1,0.917870263420356,0,13,Prp19 complex,CC,
361,GO:0000979,1,0.820535735467883,0,29,RNA polymerase II core promoter sequence-specific DNA binding,MF,
362,GO:0000980,1,0.725366737786842,0,51,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
365,GO:0000983,1,0.914362498560275,0,15,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,
369,GO:0000990,1,0.946871091958205,0,9,transcription factor activity, core RNA polymerase binding,MF,
370,GO:0000991,1,0.983324141330388,0,2,transcription factor activity, core RNA polymerase II binding,MF,
371,GO:0000992,1,0.990591229204623,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
372,GO:0000993,1,0.841916665661412,0,27,RNA polymerase II core binding,MF,
373,GO:0000994,1,0.992006217542426,0,1,RNA polymerase III core binding,MF,
374,GO:0000995,1,0.98159451510237,0,4,transcription factor activity, core RNA polymerase III binding,MF,
375,GO:0001002,1,0.990591229204623,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
376,GO:0001003,1,0.990591229204623,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
377,GO:0001007,1,0.979833700368846,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
379,GO:0001011,1,0.995366990826007,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
381,GO:0001013,1,0.948494984798161,0,8,RNA polymerase I regulatory region DNA binding,MF,
382,GO:0001016,1,0.94208582331642,0,7,RNA polymerase III regulatory region DNA binding,MF,
383,GO:0001018,1,0.988725019891798,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
384,GO:0001025,1,0.986164531023246,0,3,RNA polymerase III transcription factor binding,MF,
385,GO:0001026,1,0.990755181667343,0,2,TFIIIB-type transcription factor activity,MF,
386,GO:0001030,1,0.973585373272598,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
387,GO:0001031,1,0.973585373272598,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
388,GO:0001032,1,0.976524796017234,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
389,GO:0001034,1,0.992257363154463,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
390,GO:0001042,1,0.967453802610027,0,6,RNA polymerase I core binding,MF,
393,GO:0001054,1,0.866596028259335,0,11,RNA polymerase I activity,MF,
394,GO:0001055,1,0.872651122259883,0,11,RNA polymerase II activity,MF,
395,GO:0001056,1,0.847953672105514,0,15,RNA polymerase III activity,MF,
397,GO:0001069,1,0.990755199849293,0,2,regulatory region RNA binding,MF,
398,GO:0001074,1,0.995332155378915,0,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,
399,GO:0001075,1,0.960967341262635,0,6,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
403,GO:0001083,1,0.973959040466971,0,5,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
404,GO:0001084,1,0.995332155378915,0,1,transcription factor activity, TFIID-class binding,MF,
406,GO:0001087,1,0.995366990826007,0,1,transcription factor activity, TFIIB-class binding,MF,
407,GO:0001091,1,0.897177107979229,0,16,RNA polymerase II basal transcription factor binding,MF,
408,GO:0001093,1,0.983083324857248,0,3,TFIIB-class transcription factor binding,MF,
409,GO:0001094,1,0.935615988285416,0,9,TFIID-class transcription factor binding,MF,
410,GO:0001096,1,0.995366978654065,0,1,TFIIF-class transcription factor binding,MF,
411,GO:0001097,1,0.979994244821786,0,3,TFIIH-class transcription factor binding,MF,
412,GO:0001098,1,0.749853439708969,0,42,basal transcription machinery binding,MF,
413,GO:0001099,1,0.749853439708969,0,42,basal RNA polymerase II transcription machinery binding,MF,
415,GO:0001102,1,0.789469623074202,0,35,RNA polymerase II activating transcription factor binding,MF,
416,GO:0001103,1,0.833327661575194,0,29,RNA polymerase II repressing transcription factor binding,MF,
418,GO:0001105,1,0.809927333624462,0,33,RNA polymerase II transcription coactivator activity,MF,
420,GO:0001112,1,0.995366709827893,0,1,DNA-templated transcriptional open complex formation,BP,
421,GO:0001113,1,0.995366709827893,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
422,GO:0001120,1,0.995366709827893,0,1,protein-DNA complex remodeling,BP,
423,GO:0001128,1,0.986148574413958,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
424,GO:0001129,1,0.983083324857325,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
425,GO:0001132,1,0.983083324857325,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
428,GO:0001135,1,0.968007458642143,0,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
429,GO:0001147,1,0.990755148372361,0,2,transcription termination site sequence-specific DNA binding,MF,
430,GO:0001156,1,0.986164531023246,0,3,TFIIIC-class transcription factor binding,MF,
431,GO:0001158,1,0.673594746678866,0,64,enhancer sequence-specific DNA binding,MF,
432,GO:0001160,1,0.990755148372361,0,2,transcription termination site DNA binding,MF,
433,GO:0001161,1,0.942717169835167,0,10,intronic transcription regulatory region sequence-specific DNA binding,MF,
434,GO:0001162,1,0.951518819511137,0,8,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
435,GO:0001163,1,0.948494984798161,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
436,GO:0001164,1,0.948494984798161,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
437,GO:0001165,1,0.995366990826165,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
438,GO:0001172,1,0.957356132398807,0,2,transcription, RNA-templated,BP,
439,GO:0001179,1,0.992750500403717,0,1,RNA polymerase I transcription factor binding,MF,
440,GO:0001181,1,0.985596825549938,0,2,transcription factor activity, core RNA polymerase I binding,MF,
441,GO:0001188,1,0.948494984798161,0,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,
442,GO:0001190,1,0.754878174113276,0,47,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,
444,GO:0001192,1,0.97668444853412,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
445,GO:0001193,1,0.97668444853412,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
446,GO:0001205,1,0.894608338702621,0,20,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
447,GO:0001206,1,0.977046177790153,0,5,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
450,GO:0001223,1,0.901732143645176,0,16,transcription coactivator binding,MF,
451,GO:0001224,1,0.986164418161912,0,3,RNA polymerase II transcription cofactor binding,MF,
452,GO:0001225,1,0.990755199849071,0,2,RNA polymerase II transcription coactivator binding,MF,
453,GO:0001226,1,0.995366876923498,0,1,RNA polymerase II transcription corepressor binding,MF,
456,GO:0001300,1,0.990754815931092,0,2,chronological cell aging,BP,
457,GO:0001302,1,0.942164286017479,0,6,replicative cell aging,BP,
458,GO:0001306,1,0.979969782766415,0,1,age-dependent response to oxidative stress,BP,
459,GO:0001315,1,0.979969782766415,0,1,age-dependent response to reactive oxygen species,BP,
460,GO:0001325,1,0.932661379471688,0,15,formation of extrachromosomal circular DNA,BP,
461,GO:0001401,1,0.987282316428568,0,2,mitochondrial sorting and assembly machinery complex,CC,
462,GO:0001405,1,0.962591609900563,0,5,presequence translocase-associated import motor,CC,
464,GO:0001502,1,0.942539311084798,0,11,cartilage condensation,BP,
468,GO:0001508,1,0.677271445016049,0,67,action potential,BP,
469,GO:0001510,1,0.657132242371501,0,61,RNA methylation,BP,
470,GO:0001512,1,0.982374270715085,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
471,GO:0001514,1,0.957836721866307,0,7,selenocysteine incorporation,BP,
472,GO:0001515,1,0.993594133013948,0,1,opioid peptide activity,MF,
473,GO:0001516,1,0.847776472196214,0,17,prostaglandin biosynthetic process,BP,
474,GO:0001517,1,0.976658937808758,0,5,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
475,GO:0001518,1,0.972518303431659,0,6,voltage-gated sodium channel complex,CC,
476,GO:0001519,1,0.995366983442151,0,1,peptide amidation,BP,
477,GO:0001520,1,0.990754901124171,0,2,outer dense fiber,CC,
478,GO:0001522,1,0.818898472163333,0,18,pseudouridine synthesis,BP,
479,GO:0001523,1,0.753323752187993,0,43,retinoid metabolic process,BP,
480,GO:0001525,1,0.140040872342731,0,322,angiogenesis,BP,
481,GO:0001527,1,0.948809607268833,0,8,microfibril,CC,
482,GO:0001530,1,0.904693795561252,0,10,lipopolysaccharide binding,MF,
484,GO:0001534,1,0.99536698602807,0,1,radial spoke,CC,
485,GO:0001536,1,0.99536698602807,0,1,radial spoke stalk,CC,
486,GO:0001537,1,0.990031010243329,0,2,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
487,GO:0001539,1,0.926127783957209,0,15,cilium or flagellum-dependent cell motility,BP,
488,GO:0001540,1,0.734458853356095,0,42,amyloid-beta binding,MF,
489,GO:0001541,1,0.745556071200321,0,42,ovarian follicle development,BP,
490,GO:0001542,1,0.972392394858458,0,6,ovulation from ovarian follicle,BP,
491,GO:0001543,1,0.995366990826045,0,1,ovarian follicle rupture,BP,
492,GO:0001544,1,0.995366990826047,0,1,initiation of primordial ovarian follicle growth,BP,
493,GO:0001545,1,0.995366990826125,0,1,primary ovarian follicle growth,BP,
494,GO:0001546,1,0.990619251145234,0,1,preantral ovarian follicle growth,BP,
495,GO:0001547,1,0.96873349022527,0,5,antral ovarian follicle growth,BP,
496,GO:0001550,1,0.99075519984928,0,2,ovarian cumulus expansion,BP,
497,GO:0001552,1,0.993355448947599,0,1,ovarian follicle atresia,BP,
498,GO:0001553,1,0.976257059972721,0,5,luteinization,BP,
499,GO:0001554,1,0.977046050202277,0,5,luteolysis,BP,
500,GO:0001555,1,0.990754391488978,0,2,oocyte growth,BP,
501,GO:0001556,1,0.901029532982213,0,17,oocyte maturation,BP,
503,GO:0001560,1,0.990755199849187,0,2,regulation of cell growth by extracellular stimulus,BP,
504,GO:0001561,1,0.963772050180962,0,6,fatty acid alpha-oxidation,BP,
505,GO:0001562,1,0.926832021141248,0,9,response to protozoan,BP,
507,GO:0001569,1,0.88416187220586,0,23,branching involved in blood vessel morphogenesis,BP,
508,GO:0001570,1,0.772588235288202,0,49,vasculogenesis,BP,
509,GO:0001572,1,0.995366990826165,0,1,lactosylceramide biosynthetic process,BP,
510,GO:0001573,1,0.945969462652676,0,10,ganglioside metabolic process,BP,
511,GO:0001574,1,0.976682604439722,0,4,ganglioside biosynthetic process,BP,
512,GO:0001575,1,0.987346868122231,0,2,globoside metabolic process,BP,
513,GO:0001576,1,0.994214827713524,0,1,globoside biosynthetic process,BP,
514,GO:0001578,1,0.77322106593621,0,45,microtubule bundle formation,BP,
515,GO:0001579,1,0.990754820054082,0,2,medium-chain fatty acid transport,BP,
516,GO:0001580,1,0.926184554711598,0,5,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
517,GO:0001582,1,0.995316512568758,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
518,GO:0001588,1,0.968775579355818,0,2,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
519,GO:0001595,1,0.983172215556849,0,1,angiotensin receptor activity,MF,
520,GO:0001605,1,0.995366990826164,0,1,adrenomedullin receptor activity,MF,
521,GO:0001608,1,0.968836901742352,0,5,G-protein coupled nucleotide receptor activity,MF,
522,GO:0001609,1,0.981948953045568,0,3,G-protein coupled adenosine receptor activity,MF,
523,GO:0001614,1,0.96295070366992,0,6,purinergic nucleotide receptor activity,MF,
524,GO:0001618,1,0.766604821304032,0,44,virus receptor activity,MF,
525,GO:0001631,1,0.984027790130879,0,2,cysteinyl leukotriene receptor activity,MF,
526,GO:0001632,1,0.984027790130879,0,2,leukotriene B4 receptor activity,MF,
527,GO:0001635,1,0.968377274883745,0,3,calcitonin gene-related peptide receptor activity,MF,
528,GO:0001637,1,0.971385540508689,0,6,G-protein coupled chemoattractant receptor activity,MF,
529,GO:0001640,1,0.995366990826112,0,1,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
530,GO:0001642,1,0.995366990826112,0,1,group III metabotropic glutamate receptor activity,MF,
532,GO:0001650,1,0.449728645257955,0,118,fibrillar center,CC,
533,GO:0001651,1,0.978346928301566,0,2,dense fibrillar component,CC,
534,GO:0001652,1,0.968682451556373,0,4,granular component,CC,
535,GO:0001653,1,0.811787018373396,0,28,peptide receptor activity,MF,
542,GO:0001660,1,0.953811938896367,0,7,fever generation,BP,
543,GO:0001661,1,0.989893913849978,0,2,conditioned taste aversion,BP,
544,GO:0001662,1,0.870027841837147,0,18,behavioral fear response,BP,
546,GO:0001665,1,0.974181020857117,0,4,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
549,GO:0001669,1,0.695508179673221,0,52,acrosomal vesicle,CC,
550,GO:0001671,1,0.857398548268705,0,22,ATPase activator activity,MF,
551,GO:0001672,1,0.963237819592225,0,7,regulation of chromatin assembly or disassembly,BP,
552,GO:0001673,1,0.933006017422038,0,10,male germ cell nucleus,CC,
553,GO:0001674,1,0.990174093236749,0,2,female germ cell nucleus,CC,
554,GO:0001675,1,0.95410814175434,0,8,acrosome assembly,BP,
555,GO:0001676,1,0.656871995237473,0,61,long-chain fatty acid metabolic process,BP,
557,GO:0001680,1,0.994896215629768,0,1,tRNA 3'-terminal CCA addition,BP,
558,GO:0001681,1,0.995366516811088,0,1,sialate O-acetylesterase activity,MF,
559,GO:0001682,1,0.859199160739578,0,12,tRNA 5'-leader removal,BP,
560,GO:0001692,1,0.977398407059126,0,1,histamine metabolic process,BP,
561,GO:0001695,1,0.977398407059126,0,1,histamine catabolic process,BP,
564,GO:0001702,1,0.919140126129299,0,18,gastrulation with mouth forming second,BP,
565,GO:0001704,1,0.664275407307054,0,79,formation of primary germ layer,BP,
566,GO:0001705,1,0.990755185920954,0,2,ectoderm formation,BP,
567,GO:0001706,1,0.804762943520896,0,41,endoderm formation,BP,
568,GO:0001707,1,0.816764427355159,0,39,mesoderm formation,BP,
571,GO:0001710,1,0.966237805836768,0,6,mesodermal cell fate commitment,BP,
572,GO:0001711,1,0.940859337179542,0,10,endodermal cell fate commitment,BP,
573,GO:0001712,1,0.990755185920954,0,2,ectodermal cell fate commitment,BP,
574,GO:0001714,1,0.969215955586845,0,4,endodermal cell fate specification,BP,
575,GO:0001715,1,0.995366989216536,0,1,ectodermal cell fate specification,BP,
576,GO:0001725,1,0.77158757551295,0,43,stress fiber,CC,
577,GO:0001726,1,0.430908954827963,0,138,ruffle,CC,
578,GO:0001727,1,0.974508794760756,0,5,lipid kinase activity,MF,
579,GO:0001729,1,0.990754830878469,0,2,ceramide kinase activity,MF,
580,GO:0001730,1,0.971720180503004,0,4,2'-5'-oligoadenylate synthetase activity,MF,
581,GO:0001731,1,0.950597995040957,0,8,formation of translation preinitiation complex,BP,
582,GO:0001732,1,0.98886755680119,0,2,formation of cytoplasmic translation initiation complex,BP,
583,GO:0001733,1,0.995303116056287,0,1,galactosylceramide sulfotransferase activity,MF,
584,GO:0001735,1,0.990700741536844,0,2,prenylcysteine oxidase activity,MF,
585,GO:0001736,1,0.361121665842501,0,109,establishment of planar polarity,BP,
586,GO:0001738,1,0.340714797316875,0,121,morphogenesis of a polarized epithelium,BP,
587,GO:0001739,1,0.96606787212023,0,6,sex chromatin,CC,
588,GO:0001740,1,0.98328382811267,0,3,Barr body,CC,
589,GO:0001741,1,0.927477207666269,0,11,XY body,CC,
590,GO:0001743,1,0.990755129988,0,2,optic placode formation,BP,
591,GO:0001750,1,0.816410646356396,0,35,photoreceptor outer segment,CC,
592,GO:0001754,1,0.915046136853956,0,18,eye photoreceptor cell differentiation,BP,
594,GO:0001756,1,0.822864974441195,0,39,somitogenesis,BP,
595,GO:0001757,1,0.990755097221945,0,2,somite specification,BP,
596,GO:0001758,1,0.985087611050714,0,3,retinal dehydrogenase activity,MF,
600,GO:0001765,1,0.936454807539182,0,9,membrane raft assembly,BP,
601,GO:0001766,1,0.953706279339746,0,6,membrane raft polarization,BP,
602,GO:0001767,1,0.972499493295739,0,6,establishment of lymphocyte polarity,BP,
603,GO:0001768,1,0.977027281084811,0,5,establishment of T cell polarity,BP,
604,GO:0001770,1,0.99536699082606,0,1,establishment of natural killer cell polarity,BP,
605,GO:0001771,1,0.963737566272312,0,6,immunological synapse formation,BP,
606,GO:0001772,1,0.883325541330913,0,20,immunological synapse,CC,
607,GO:0001773,1,0.878981391415145,0,14,myeloid dendritic cell activation,BP,
608,GO:0001774,1,0.932592758111472,0,13,microglial cell activation,BP,
611,GO:0001777,1,0.97527649662577,0,1,T cell homeostatic proliferation,BP,
612,GO:0001778,1,0.981594888733415,0,4,plasma membrane repair,BP,
613,GO:0001779,1,0.891250794237213,0,15,natural killer cell differentiation,BP,
614,GO:0001780,1,0.951147399715816,0,9,neutrophil homeostasis,BP,
615,GO:0001781,1,0.968988270793699,0,5,neutrophil apoptotic process,BP,
616,GO:0001782,1,0.844537421288612,0,22,B cell homeostasis,BP,
617,GO:0001783,1,0.832990422005457,0,22,B cell apoptotic process,BP,
618,GO:0001784,1,0.873068440394355,0,27,phosphotyrosine residue binding,MF,
619,GO:0001786,1,0.868342735575002,0,27,phosphatidylserine binding,MF,
620,GO:0001787,1,0.945915724162462,0,5,natural killer cell proliferation,BP,
621,GO:0001792,1,0.995366990826152,0,1,polymeric immunoglobulin receptor activity,MF,
622,GO:0001794,1,0.995366990826151,0,1,type IIa hypersensitivity,BP,
623,GO:0001796,1,0.995366990826151,0,1,regulation of type IIa hypersensitivity,BP,
624,GO:0001798,1,0.995366990826151,0,1,positive regulation of type IIa hypersensitivity,BP,
625,GO:0001806,1,0.976408122094414,0,3,type IV hypersensitivity,BP,
626,GO:0001807,1,0.980954142270248,0,2,regulation of type IV hypersensitivity,BP,
627,GO:0001808,1,0.993975897692884,0,1,negative regulation of type IV hypersensitivity,BP,
628,GO:0001809,1,0.986900227879662,0,1,positive regulation of type IV hypersensitivity,BP,
633,GO:0001820,1,0.97383270750247,0,3,serotonin secretion,BP,
634,GO:0001821,1,0.915309841913937,0,8,histamine secretion,BP,
637,GO:0001824,1,0.711257714019577,0,48,blastocyst development,BP,
638,GO:0001825,1,0.853414202480275,0,22,blastocyst formation,BP,
639,GO:0001826,1,0.977032367670558,0,5,inner cell mass cell differentiation,BP,
640,GO:0001827,1,0.99075519984928,0,2,inner cell mass cell fate commitment,BP,
641,GO:0001828,1,0.99075519984928,0,2,inner cell mass cellular morphogenesis,BP,
642,GO:0001829,1,0.936469741257763,0,10,trophectodermal cell differentiation,BP,
643,GO:0001831,1,0.995366990826074,0,1,trophectodermal cellular morphogenesis,BP,
644,GO:0001832,1,0.92277007238518,0,15,blastocyst growth,BP,
645,GO:0001833,1,0.948992246419055,0,10,inner cell mass cell proliferation,BP,
646,GO:0001834,1,0.990754785405222,0,2,trophectodermal cell proliferation,BP,
647,GO:0001835,1,0.995366857802029,0,1,blastocyst hatching,BP,
648,GO:0001836,1,0.587831950224409,0,50,release of cytochrome c from mitochondria,BP,
651,GO:0001839,1,0.974688764734923,0,5,neural plate morphogenesis,BP,
652,GO:0001840,1,0.961199468151164,0,8,neural plate development,BP,
653,GO:0001841,1,0.600928460024577,0,87,neural tube formation,BP,
654,GO:0001842,1,0.960568013533147,0,5,neural fold formation,BP,
655,GO:0001843,1,0.650461011877898,0,75,neural tube closure,BP,
656,GO:0001844,1,0.7816106223443,0,30,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
657,GO:0001845,1,0.932479483775706,0,9,phagolysosome assembly,BP,
658,GO:0001846,1,0.954404826620014,0,5,opsonin binding,MF,
659,GO:0001848,1,0.954404826619987,0,5,complement binding,MF,
660,GO:0001849,1,0.976110748265065,0,2,complement component C1q binding,MF,
661,GO:0001850,1,0.992469358211902,0,1,complement component C3a binding,MF,
662,GO:0001851,1,0.992469358211902,0,1,complement component C3b binding,MF,
663,GO:0001855,1,0.989775506352291,0,1,complement component C4b binding,MF,
664,GO:0001865,1,0.981594888732018,0,4,NK T cell differentiation,BP,
665,GO:0001866,1,0.950321145499584,0,4,NK T cell proliferation,BP,
666,GO:0001867,1,0.973621765605031,0,4,complement activation, lectin pathway,BP,
667,GO:0001868,1,0.993001353707462,0,1,regulation of complement activation, lectin pathway,BP,
668,GO:0001869,1,0.993001353707462,0,1,negative regulation of complement activation, lectin pathway,BP,
669,GO:0001871,1,0.971821245903791,0,6,pattern binding,MF,
670,GO:0001875,1,0.986157362235857,0,3,lipopolysaccharide receptor activity,MF,
671,GO:0001878,1,0.994975311334276,0,1,response to yeast,BP,
672,GO:0001880,1,0.990755181323698,0,2,Mullerian duct regression,BP,
673,GO:0001881,1,0.841050356879344,0,28,receptor recycling,BP,
676,GO:0001884,1,0.990696298557805,0,2,pyrimidine nucleoside binding,MF,
677,GO:0001885,1,0.772957163195247,0,44,endothelial cell development,BP,
678,GO:0001886,1,0.954555584314775,0,7,endothelial cell morphogenesis,BP,
679,GO:0001887,1,0.980938349821716,0,4,selenium compound metabolic process,BP,
680,GO:0001888,1,0.990754758472348,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
683,GO:0001891,1,0.908437450880896,0,16,phagocytic cup,CC,
685,GO:0001893,1,0.862220726521277,0,26,maternal placenta development,BP,
687,GO:0001895,1,0.784672065763139,0,33,retina homeostasis,BP,
688,GO:0001905,1,0.990755199849163,0,2,activation of membrane attack complex,BP,
689,GO:0001906,1,0.498596249097745,0,67,cell killing,BP,
690,GO:0001907,1,0.962822652183045,0,3,killing by symbiont of host cells,BP,
691,GO:0001909,1,0.633700903523706,0,53,leukocyte mediated cytotoxicity,BP,
692,GO:0001910,1,0.788395831449687,0,30,regulation of leukocyte mediated cytotoxicity,BP,
693,GO:0001911,1,0.932440171567444,0,10,negative regulation of leukocyte mediated cytotoxicity,BP,
694,GO:0001912,1,0.863621666557631,0,17,positive regulation of leukocyte mediated cytotoxicity,BP,
695,GO:0001913,1,0.832083118053496,0,20,T cell mediated cytotoxicity,BP,
696,GO:0001914,1,0.890196513325866,0,13,regulation of T cell mediated cytotoxicity,BP,
697,GO:0001915,1,0.983087662931881,0,3,negative regulation of T cell mediated cytotoxicity,BP,
698,GO:0001916,1,0.924592766153238,0,8,positive regulation of T cell mediated cytotoxicity,BP,
699,GO:0001917,1,0.880379795802376,0,23,photoreceptor inner segment,CC,
700,GO:0001918,1,0.995366414610003,0,1,farnesylated protein binding,MF,
701,GO:0001919,1,0.900225507874037,0,20,regulation of receptor recycling,BP,
702,GO:0001920,1,0.986164039110392,0,3,negative regulation of receptor recycling,BP,
703,GO:0001921,1,0.936101512031436,0,13,positive regulation of receptor recycling,BP,
704,GO:0001922,1,0.986164531021556,0,3,B-1 B cell homeostasis,BP,
705,GO:0001923,1,0.97625687283149,0,3,B-1 B cell differentiation,BP,
706,GO:0001927,1,0.98564965614793,0,3,exocyst assembly,BP,
707,GO:0001928,1,0.994847366738983,0,1,regulation of exocyst assembly,BP,
712,GO:0001935,1,0.544488831150527,0,89,endothelial cell proliferation,BP,
713,GO:0001936,1,0.577358202405777,0,78,regulation of endothelial cell proliferation,BP,
714,GO:0001937,1,0.884278296666324,0,20,negative regulation of endothelial cell proliferation,BP,
715,GO:0001938,1,0.6472398192328,0,60,positive regulation of endothelial cell proliferation,BP,
716,GO:0001939,1,0.969136357987981,0,6,female pronucleus,CC,
717,GO:0001940,1,0.973648712616182,0,5,male pronucleus,CC,
721,GO:0001945,1,0.897156142609093,0,18,lymph vessel development,BP,
722,GO:0001946,1,0.957907795553326,0,9,lymphangiogenesis,BP,
723,GO:0001947,1,0.830858780006956,0,35,heart looping,BP,
724,GO:0001951,1,0.986164326333803,0,3,intestinal D-glucose absorption,BP,
725,GO:0001952,1,0.611665613620363,0,82,regulation of cell-matrix adhesion,BP,
726,GO:0001953,1,0.866973756869325,0,27,negative regulation of cell-matrix adhesion,BP,
727,GO:0001954,1,0.775378319495723,0,38,positive regulation of cell-matrix adhesion,BP,
729,GO:0001956,1,0.950660741495836,0,9,positive regulation of neurotransmitter secretion,BP,
730,GO:0001957,1,0.977530126240215,0,4,intramembranous ossification,BP,
731,GO:0001958,1,0.909217201553757,0,16,endochondral ossification,BP,
732,GO:0001959,1,0.406366034326791,0,127,regulation of cytokine-mediated signaling pathway,BP,
733,GO:0001960,1,0.73267723987274,0,38,negative regulation of cytokine-mediated signaling pathway,BP,
734,GO:0001961,1,0.811879104820528,0,33,positive regulation of cytokine-mediated signaling pathway,BP,
736,GO:0001964,1,0.967771975658401,0,7,startle response,BP,
738,GO:0001966,1,0.986385579863497,0,1,thigmotaxis,BP,
739,GO:0001967,1,0.955082463477471,0,7,suckling behavior,BP,
740,GO:0001968,1,0.919718951724633,0,17,fibronectin binding,MF,
741,GO:0001969,1,0.990755199849163,0,2,regulation of activation of membrane attack complex,BP,
742,GO:0001970,1,0.995366990826151,0,1,positive regulation of activation of membrane attack complex,BP,
743,GO:0001971,1,0.995366990826034,0,1,negative regulation of activation of membrane attack complex,BP,
744,GO:0001972,1,0.942372760453738,0,9,retinoic acid binding,MF,
745,GO:0001973,1,0.966016733409363,0,5,adenosine receptor signaling pathway,BP,
746,GO:0001974,1,0.844719739347994,0,25,blood vessel remodeling,BP,
747,GO:0001975,1,0.912934970693796,0,13,response to amphetamine,BP,
748,GO:0001976,1,0.965668838557833,0,4,neurological system process involved in regulation of systemic arterial blood pressure,BP,
749,GO:0001977,1,0.934536303361425,0,9,renal system process involved in regulation of blood volume,BP,
750,GO:0001978,1,0.994605617896706,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
751,GO:0001983,1,0.994605617896706,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
752,GO:0001985,1,0.994605617896706,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
753,GO:0001990,1,0.894198604820461,0,16,regulation of systemic arterial blood pressure by hormone,BP,
754,GO:0001991,1,0.955620031763974,0,8,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,
755,GO:0001992,1,0.995366990826152,0,1,regulation of systemic arterial blood pressure by vasopressin,BP,
756,GO:0001993,1,0.976251971971898,0,4,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
757,GO:0001994,1,0.994605617896706,0,1,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
758,GO:0001996,1,0.982196771509276,0,3,positive regulation of heart rate by epinephrine-norepinephrine,BP,
759,GO:0001997,1,0.994605617896706,0,1,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
760,GO:0001998,1,0.993199557245985,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
761,GO:0001999,1,0.98159419777667,0,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
762,GO:0002001,1,0.98159419777667,0,4,renin secretion into blood stream,BP,
763,GO:0002002,1,0.973544382267014,0,4,regulation of angiotensin levels in blood,BP,
764,GO:0002003,1,0.973544382267014,0,4,angiotensin maturation,BP,
766,GO:0002011,1,0.782425738900441,0,44,morphogenesis of an epithelial sheet,BP,
767,GO:0002016,1,0.972420652557464,0,1,regulation of blood volume by renin-angiotensin,BP,
768,GO:0002017,1,0.992903818990308,0,1,regulation of blood volume by renal aldosterone,BP,
769,GO:0002019,1,0.972420652557464,0,1,regulation of renal output by angiotensin,BP,
770,GO:0002020,1,0.495412687438379,0,89,protease binding,MF,
771,GO:0002021,1,0.923734887964933,0,10,response to dietary excess,BP,
772,GO:0002024,1,0.973478277537909,0,5,diet induced thermogenesis,BP,
773,GO:0002025,1,0.99394869310473,0,1,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
774,GO:0002026,1,0.918874989465563,0,14,regulation of the force of heart contraction,BP,
775,GO:0002027,1,0.740906949779911,0,44,regulation of heart rate,BP,
777,GO:0002029,1,0.919135992419286,0,12,desensitization of G-protein coupled receptor protein signaling pathway,BP,
778,GO:0002031,1,0.9303921328761,0,10,G-protein coupled receptor internalization,BP,
779,GO:0002032,1,0.98708627619478,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
780,GO:0002034,1,0.993199557245985,0,1,regulation of blood vessel diameter by renin-angiotensin,BP,
781,GO:0002036,1,0.980122298094146,0,4,regulation of L-glutamate import across plasma membrane,BP,
782,GO:0002037,1,0.994373782975589,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
783,GO:0002038,1,0.994866746349447,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
785,GO:0002040,1,0.669240989294006,0,72,sprouting angiogenesis,BP,
786,GO:0002041,1,0.994934500946605,0,1,intussusceptive angiogenesis,BP,
787,GO:0002042,1,0.802221847388501,0,37,cell migration involved in sprouting angiogenesis,BP,
788,GO:0002043,1,0.933334248171461,0,10,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
789,GO:0002046,1,0.978949157649859,0,1,opsin binding,MF,
790,GO:0002051,1,0.981594551581826,0,4,osteoblast fate commitment,BP,
791,GO:0002052,1,0.940569877670545,0,12,positive regulation of neuroblast proliferation,BP,
792,GO:0002053,1,0.913148330181988,0,18,positive regulation of mesenchymal cell proliferation,BP,
793,GO:0002054,1,0.96441210768522,0,3,nucleobase binding,MF,
794,GO:0002055,1,0.973603815647657,0,1,adenine binding,MF,
795,GO:0002060,1,0.96441210768522,0,3,purine nucleobase binding,MF,
797,GO:0002063,1,0.922132545191856,0,17,chondrocyte development,BP,
800,GO:0002066,1,0.782894750583599,0,38,columnar/cuboidal epithelial cell development,BP,
802,GO:0002068,1,0.906300928541766,0,17,glandular epithelial cell development,BP,
803,GO:0002069,1,0.957151525795438,0,6,columnar/cuboidal epithelial cell maturation,BP,
804,GO:0002070,1,0.931600634768054,0,11,epithelial cell maturation,BP,
805,GO:0002071,1,0.99075457856485,0,2,glandular epithelial cell maturation,BP,
806,GO:0002072,1,0.972518156730441,0,6,optic cup morphogenesis involved in camera-type eye development,BP,
807,GO:0002074,1,0.985582686599884,0,3,extraocular skeletal muscle development,BP,
808,GO:0002076,1,0.941826057493307,0,11,osteoblast development,BP,
809,GO:0002079,1,0.990755063283655,0,2,inner acrosomal membrane,CC,
810,GO:0002080,1,0.94820333918558,0,10,acrosomal membrane,CC,
811,GO:0002081,1,0.99536699082602,0,1,outer acrosomal membrane,CC,
812,GO:0002082,1,0.906846254001924,0,14,regulation of oxidative phosphorylation,BP,
813,GO:0002083,1,0.990497377587918,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
814,GO:0002084,1,0.948414514380506,0,9,protein depalmitoylation,BP,
816,GO:0002086,1,0.995366969599153,0,1,diaphragm contraction,BP,
817,GO:0002087,1,0.977042449744594,0,5,regulation of respiratory gaseous exchange by neurological system process,BP,
818,GO:0002088,1,0.785472061842139,0,43,lens development in camera-type eye,BP,
819,GO:0002089,1,0.942633752068102,0,12,lens morphogenesis in camera-type eye,BP,
820,GO:0002090,1,0.860409876137146,0,25,regulation of receptor internalization,BP,
821,GO:0002091,1,0.961629968836471,0,7,negative regulation of receptor internalization,BP,
822,GO:0002092,1,0.914433016478823,0,15,positive regulation of receptor internalization,BP,
823,GO:0002093,1,0.95025015640342,0,7,auditory receptor cell morphogenesis,BP,
824,GO:0002094,1,0.985907782559952,0,2,polyprenyltransferase activity,MF,
825,GO:0002097,1,0.903427041167376,0,16,tRNA wobble base modification,BP,
826,GO:0002098,1,0.927640379692267,0,12,tRNA wobble uridine modification,BP,
827,GO:0002100,1,0.995366990826099,0,1,tRNA wobble adenosine to inosine editing,BP,
828,GO:0002101,1,0.978454501531296,0,3,tRNA wobble cytosine modification,BP,
829,GO:0002102,1,0.867833266335785,0,27,podosome,CC,
830,GO:0002114,1,0.995366987966522,0,1,interleukin-33 receptor activity,MF,
831,GO:0002115,1,0.926715867068864,0,13,store-operated calcium entry,BP,
832,GO:0002116,1,0.95450977682631,0,10,semaphorin receptor complex,CC,
833,GO:0002118,1,0.995366930727727,0,1,aggressive behavior,BP,
834,GO:0002121,1,0.995366930727727,0,1,inter-male aggressive behavior,BP,
835,GO:0002127,1,0.987621788846115,0,1,tRNA wobble base cytosine methylation,BP,
836,GO:0002133,1,0.990755199848925,0,2,polycystin complex,CC,
837,GO:0002134,1,0.990696298557805,0,2,UTP binding,MF,
838,GO:0002135,1,0.99530781851319,0,1,CTP binding,MF,
839,GO:0002138,1,0.959226303214666,0,5,retinoic acid biosynthetic process,BP,
840,GO:0002143,1,0.974495158020997,0,4,tRNA wobble position uridine thiolation,BP,
841,GO:0002144,1,0.994284878633953,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
842,GO:0002151,1,0.969899134740358,0,6,G-quadruplex RNA binding,MF,
843,GO:0002153,1,0.995182664546486,0,1,steroid receptor RNA activator RNA binding,MF,
844,GO:0002154,1,0.976101730682346,0,5,thyroid hormone mediated signaling pathway,BP,
845,GO:0002155,1,0.985211371365079,0,3,regulation of thyroid hormone mediated signaling pathway,BP,
846,GO:0002158,1,0.971071432518081,0,3,osteoclast proliferation,BP,
847,GO:0002159,1,0.981594308556848,0,4,desmosome assembly,BP,
848,GO:0002161,1,0.939282379298053,0,11,aminoacyl-tRNA editing activity,MF,
849,GO:0002162,1,0.968011171319702,0,7,dystroglycan binding,MF,
850,GO:0002169,1,0.990697580587754,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
851,GO:0002175,1,0.981594488333483,0,4,protein localization to paranode region of axon,BP,
852,GO:0002176,1,0.952801904146773,0,3,male germ cell proliferation,BP,
853,GO:0002177,1,0.970929366900988,0,3,manchette,CC,
854,GO:0002178,1,0.934782860116118,0,11,palmitoyltransferase complex,CC,
856,GO:0002182,1,0.94562751263946,0,11,cytoplasmic translational elongation,BP,
857,GO:0002183,1,0.870561475884817,0,18,cytoplasmic translational initiation,BP,
858,GO:0002184,1,0.990754724402147,0,2,cytoplasmic translational termination,BP,
859,GO:0002188,1,0.986164277874282,0,3,translation reinitiation,BP,
860,GO:0002189,1,0.995302770854769,0,1,ribose phosphate diphosphokinase complex,CC,
861,GO:0002190,1,0.94975458344845,0,5,cap-independent translational initiation,BP,
862,GO:0002191,1,0.982091283242686,0,3,cap-dependent translational initiation,BP,
863,GO:0002192,1,0.967067919405611,0,2,IRES-dependent translational initiation of linear mRNA,BP,
864,GO:0002193,1,0.985881380494562,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
865,GO:0002196,1,0.993047243179903,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
866,GO:0002199,1,0.959732373102802,0,7,zona pellucida receptor complex,CC,
867,GO:0002200,1,0.735379352488437,0,54,somatic diversification of immune receptors,BP,
868,GO:0002204,1,0.827702050057587,0,33,somatic recombination of immunoglobulin genes involved in immune response,BP,
869,GO:0002208,1,0.827702050057587,0,33,somatic diversification of immunoglobulins involved in immune response,BP,
870,GO:0002209,1,0.870027841837147,0,18,behavioral defense response,BP,
876,GO:0002225,1,0.980836257753173,0,2,positive regulation of antimicrobial peptide production,BP,
877,GO:0002227,1,0.737016498280829,0,10,innate immune response in mucosa,BP,
878,GO:0002228,1,0.738170159364676,0,36,natural killer cell mediated immunity,BP,
879,GO:0002230,1,0.873424382185165,0,17,positive regulation of defense response to virus by host,BP,
881,GO:0002238,1,0.995366990826164,0,1,response to molecule of fungal origin,BP,
883,GO:0002246,1,0.956887931647283,0,6,wound healing involved in inflammatory response,BP,
884,GO:0002248,1,0.967233971331604,0,5,connective tissue replacement involved in inflammatory response wound healing,BP,
885,GO:0002249,1,0.990755199849163,0,2,lymphocyte anergy,BP,
887,GO:0002251,1,0.723404135193546,0,14,organ or tissue specific immune response,BP,
890,GO:0002254,1,0.98868160419487,0,2,kinin cascade,BP,
892,GO:0002262,1,0.466445706650233,0,106,myeloid cell homeostasis,BP,
894,GO:0002265,1,0.986164484016444,0,3,astrocyte activation involved in immune response,BP,
895,GO:0002266,1,0.988199300052381,0,2,follicular dendritic cell activation,BP,
896,GO:0002268,1,0.988199300052381,0,2,follicular dendritic cell differentiation,BP,
899,GO:0002276,1,0.989707361047725,0,2,basophil activation involved in immune response,BP,
900,GO:0002277,1,0.977176262583746,0,1,myeloid dendritic cell activation involved in immune response,BP,
901,GO:0002278,1,0.972365857147723,0,4,eosinophil activation involved in immune response,BP,
902,GO:0002279,1,0.82816887935246,0,26,mast cell activation involved in immune response,BP,
903,GO:0002281,1,0.976687624664953,0,5,macrophage activation involved in immune response,BP,
908,GO:0002291,1,0.977662848905832,0,3,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
914,GO:0002299,1,0.989465780365335,0,1,alpha-beta intraepithelial T cell differentiation,BP,
915,GO:0002300,1,0.989465780365335,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
916,GO:0002304,1,0.989465780365335,0,1,gamma-delta intraepithelial T cell differentiation,BP,
917,GO:0002305,1,0.989465780365335,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
918,GO:0002309,1,0.975734104972131,0,1,T cell proliferation involved in immune response,BP,
919,GO:0002312,1,0.728948091866001,0,50,B cell activation involved in immune response,BP,
920,GO:0002313,1,0.889163579181816,0,15,mature B cell differentiation involved in immune response,BP,
921,GO:0002314,1,0.98429141302437,0,2,germinal center B cell differentiation,BP,
922,GO:0002315,1,0.959099315222707,0,8,marginal zone B cell differentiation,BP,
923,GO:0002316,1,0.995366990826152,0,1,follicular B cell differentiation,BP,
924,GO:0002317,1,0.953910655371775,0,3,plasma cell differentiation,BP,
925,GO:0002318,1,0.985629604513948,0,3,myeloid progenitor cell differentiation,BP,
927,GO:0002322,1,0.990755199849241,0,2,B cell proliferation involved in immune response,BP,
928,GO:0002323,1,0.923062254968323,0,9,natural killer cell activation involved in immune response,BP,
929,GO:0002325,1,0.983037423653184,0,1,natural killer cell differentiation involved in immune response,BP,
930,GO:0002326,1,0.986164529414991,0,3,B cell lineage commitment,BP,
931,GO:0002327,1,0.972518303431738,0,6,immature B cell differentiation,BP,
933,GO:0002329,1,0.981594888733208,0,4,pre-B cell differentiation,BP,
934,GO:0002331,1,0.990755199848952,0,2,pre-B cell allelic exclusion,BP,
935,GO:0002332,1,0.995366990826138,0,1,transitional stage B cell differentiation,BP,
936,GO:0002333,1,0.995366990826138,0,1,transitional one stage B cell differentiation,BP,
937,GO:0002335,1,0.863995777805339,0,19,mature B cell differentiation,BP,
938,GO:0002337,1,0.980801948641291,0,2,B-1a B cell differentiation,BP,
939,GO:0002339,1,0.970050416182903,0,2,B cell selection,BP,
941,GO:0002349,1,0.95502721295011,0,5,histamine production involved in inflammatory response,BP,
942,GO:0002351,1,0.995366990826164,0,1,serotonin production involved in inflammatory response,BP,
943,GO:0002352,1,0.970050416182903,0,2,B cell negative selection,BP,
944,GO:0002353,1,0.98868160419487,0,2,plasma kallikrein-kinin cascade,BP,
945,GO:0002357,1,0.995366087105313,0,1,defense response to tumor cell,BP,
946,GO:0002358,1,0.97527649662577,0,1,B cell homeostatic proliferation,BP,
951,GO:0002368,1,0.994993592016332,0,1,B cell cytokine production,BP,
952,GO:0002369,1,0.873553062332245,0,19,T cell cytokine production,BP,
953,GO:0002370,1,0.972603094546745,0,3,natural killer cell cytokine production,BP,
954,GO:0002371,1,0.96461012135318,0,4,dendritic cell cytokine production,BP,
955,GO:0002373,1,0.97814692190544,0,1,plasmacytoid dendritic cell cytokine production,BP,
956,GO:0002374,1,0.933374115510646,0,12,cytokine secretion involved in immune response,BP,
958,GO:0002377,1,0.67852107379904,0,64,immunoglobulin production,BP,
959,GO:0002378,1,0.995366990826164,0,1,immunoglobulin biosynthetic process,BP,
960,GO:0002380,1,0.995366990826164,0,1,immunoglobulin secretion involved in immune response,BP,
961,GO:0002381,1,0.810621779986349,0,35,immunoglobulin production involved in immunoglobulin mediated immune response,BP,
962,GO:0002384,1,0.995366990826138,0,1,hepatic immune response,BP,
963,GO:0002385,1,0.726783669588586,0,13,mucosal immune response,BP,
964,GO:0002386,1,0.995366990826152,0,1,immune response in mucosal-associated lymphoid tissue,BP,
965,GO:0002396,1,0.993170376688421,0,1,MHC protein complex assembly,BP,
966,GO:0002397,1,0.993170376688421,0,1,MHC class I protein complex assembly,BP,
967,GO:0002407,1,0.922140816427555,0,11,dendritic cell chemotaxis,BP,
968,GO:0002408,1,0.995366990826139,0,1,myeloid dendritic cell chemotaxis,BP,
969,GO:0002414,1,0.987257559912667,0,2,immunoglobulin transcytosis in epithelial cells,BP,
970,GO:0002415,1,0.995366990826152,0,1,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
971,GO:0002416,1,0.99185325693685,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
972,GO:0002418,1,0.954268681726368,0,8,immune response to tumor cell,BP,
973,GO:0002420,1,0.98122270503833,0,4,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
974,GO:0002423,1,0.98122270503833,0,4,natural killer cell mediated immune response to tumor cell,BP,
975,GO:0002424,1,0.990383449345203,0,2,T cell mediated immune response to tumor cell,BP,
976,GO:0002428,1,0.965804018062509,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
978,GO:0002430,1,0.994930769572645,0,1,complement receptor mediated signaling pathway,BP,
979,GO:0002431,1,0.707094330086882,0,61,Fc receptor mediated stimulatory signaling pathway,BP,
980,GO:0002432,1,0.995366990826151,0,1,granuloma formation,BP,
981,GO:0002433,1,0.717615556658007,0,58,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,
982,GO:0002437,1,0.830662015339048,0,21,inflammatory response to antigenic stimulus,BP,
983,GO:0002438,1,0.934738842361423,0,8,acute inflammatory response to antigenic stimulus,BP,
984,GO:0002439,1,0.976266141926131,0,3,chronic inflammatory response to antigenic stimulus,BP,
985,GO:0002440,1,0.463085117664341,0,112,production of molecular mediator of immune response,BP,
986,GO:0002441,1,0.95502721295011,0,5,histamine secretion involved in inflammatory response,BP,
987,GO:0002442,1,0.995366990826164,0,1,serotonin secretion involved in inflammatory response,BP,
990,GO:0002445,1,0.995366990826151,0,1,type II hypersensitivity,BP,
992,GO:0002447,1,0.972365857147723,0,4,eosinophil mediated immunity,BP,
993,GO:0002448,1,0.824323643723833,0,27,mast cell mediated immunity,BP,
994,GO:0002449,1,0.385987308151767,0,134,lymphocyte mediated immunity,BP,
995,GO:0002455,1,0.874651460959837,0,18,humoral immune response mediated by circulating immunoglobulin,BP,
996,GO:0002456,1,0.672266205946414,0,54,T cell mediated immunity,BP,
997,GO:0002457,1,0.979644317103467,0,4,T cell antigen processing and presentation,BP,
999,GO:0002461,1,0.995006922237278,0,1,tolerance induction dependent upon immune response,BP,
1000,GO:0002467,1,0.946189667151093,0,10,germinal center formation,BP,
1001,GO:0002468,1,0.971940671868054,0,4,dendritic cell antigen processing and presentation,BP,
1002,GO:0002474,1,0.390743506434062,0,83,antigen processing and presentation of peptide antigen via MHC class I,BP,
1003,GO:0002475,1,0.952436350710355,0,6,antigen processing and presentation via MHC class Ib,BP,
1004,GO:0002476,1,0.986359303661125,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
1005,GO:0002477,1,0.979163696959576,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1006,GO:0002478,1,0.258133453325212,0,141,antigen processing and presentation of exogenous peptide antigen,BP,
1007,GO:0002479,1,0.442798424357907,0,66,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,
1008,GO:0002480,1,0.904646589206817,0,9,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1009,GO:0002481,1,0.979163696959576,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1010,GO:0002483,1,0.941750429168217,0,8,antigen processing and presentation of endogenous peptide antigen,BP,
1011,GO:0002488,1,0.995366990826125,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1012,GO:0002489,1,0.995366990826125,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1013,GO:0002495,1,0.572449726282977,0,76,antigen processing and presentation of peptide antigen via MHC class II,BP,
1014,GO:0002501,1,0.993170376688421,0,1,peptide antigen assembly with MHC protein complex,BP,
1015,GO:0002502,1,0.993170376688421,0,1,peptide antigen assembly with MHC class I protein complex,BP,
1016,GO:0002504,1,0.56978050711016,0,77,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1017,GO:0002507,1,0.933985524404771,0,12,tolerance induction,BP,
1018,GO:0002513,1,0.985474251618798,0,3,tolerance induction to self antigen,BP,
1019,GO:0002514,1,0.995366990826165,0,1,B cell tolerance induction,BP,
1020,GO:0002517,1,0.965888510946149,0,5,T cell tolerance induction,BP,
1021,GO:0002519,1,0.995006922237278,0,1,natural killer cell tolerance induction,BP,
1024,GO:0002523,1,0.923204566627267,0,5,leukocyte migration involved in inflammatory response,BP,
1025,GO:0002524,1,0.971883173492078,0,4,hypersensitivity,BP,
1027,GO:0002528,1,0.990754872428044,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
1028,GO:0002532,1,0.786401584773487,0,35,production of molecular mediator involved in inflammatory response,BP,
1029,GO:0002534,1,0.868262700186353,0,23,cytokine production involved in inflammatory response,BP,
1030,GO:0002536,1,0.971067018177993,0,2,respiratory burst involved in inflammatory response,BP,
1031,GO:0002537,1,0.995366990826045,0,1,nitric oxide production involved in inflammatory response,BP,
1032,GO:0002538,1,0.995366806405613,0,1,arachidonic acid metabolite production involved in inflammatory response,BP,
1033,GO:0002540,1,0.995366806405613,0,1,leukotriene production involved in inflammatory response,BP,
1034,GO:0002541,1,0.989158392609943,0,2,activation of plasma proteins involved in acute inflammatory response,BP,
1035,GO:0002542,1,0.994060612452411,0,1,Factor XII activation,BP,
1036,GO:0002543,1,0.990458402342698,0,2,activation of blood coagulation via clotting cascade,BP,
1037,GO:0002544,1,0.887390182176356,0,12,chronic inflammatory response,BP,
1038,GO:0002545,1,0.992919600986792,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1039,GO:0002548,1,0.836758614111199,0,19,monocyte chemotaxis,BP,
1040,GO:0002551,1,0.938566079274204,0,8,mast cell chemotaxis,BP,
1041,GO:0002553,1,0.95502721295011,0,5,histamine secretion by mast cell,BP,
1042,GO:0002554,1,0.995366990826164,0,1,serotonin secretion by platelet,BP,
1043,GO:0002560,1,0.995366990826139,0,1,basophil mediated immunity,BP,
1044,GO:0002561,1,0.995366990826139,0,1,basophil degranulation,BP,
1045,GO:0002562,1,0.768711868621299,0,45,somatic diversification of immune receptors via germline recombination within a single locus,BP,
1046,GO:0002566,1,0.921349830898805,0,15,somatic diversification of immune receptors via somatic mutation,BP,
1047,GO:0002568,1,0.977045670000279,0,5,somatic diversification of T cell receptor genes,BP,
1048,GO:0002572,1,0.990754949053881,0,2,pro-T cell differentiation,BP,
1049,GO:0002573,1,0.464056229649707,0,124,myeloid leukocyte differentiation,BP,
1051,GO:0002577,1,0.923706608457184,0,8,regulation of antigen processing and presentation,BP,
1052,GO:0002578,1,0.968087004599667,0,4,negative regulation of antigen processing and presentation,BP,
1053,GO:0002579,1,0.954173268600246,0,4,positive regulation of antigen processing and presentation,BP,
1054,GO:0002580,1,0.959597038681774,0,3,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1055,GO:0002581,1,0.98201489704299,0,2,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1056,GO:0002582,1,0.977176262583746,0,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1057,GO:0002583,1,0.950389252603171,0,4,regulation of antigen processing and presentation of peptide antigen,BP,
1058,GO:0002584,1,0.972594481692653,0,3,negative regulation of antigen processing and presentation of peptide antigen,BP,
1059,GO:0002585,1,0.977176262583746,0,1,positive regulation of antigen processing and presentation of peptide antigen,BP,
1060,GO:0002586,1,0.964065437314474,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1061,GO:0002587,1,0.986586469380563,0,1,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1062,GO:0002588,1,0.977176262583746,0,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1063,GO:0002589,1,0.985819960871684,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1064,GO:0002590,1,0.985819960871684,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1065,GO:0002604,1,0.971940671868054,0,4,regulation of dendritic cell antigen processing and presentation,BP,
1066,GO:0002605,1,0.995366990826125,0,1,negative regulation of dendritic cell antigen processing and presentation,BP,
1067,GO:0002606,1,0.976465885095227,0,3,positive regulation of dendritic cell antigen processing and presentation,BP,
1068,GO:0002625,1,0.993389805337357,0,1,regulation of T cell antigen processing and presentation,BP,
1069,GO:0002626,1,0.993389805337357,0,1,negative regulation of T cell antigen processing and presentation,BP,
1070,GO:0002634,1,0.970932258877854,0,5,regulation of germinal center formation,BP,
1071,GO:0002635,1,0.995366990825902,0,1,negative regulation of germinal center formation,BP,
1072,GO:0002636,1,0.989140067213088,0,1,positive regulation of germinal center formation,BP,
1073,GO:0002637,1,0.805994891802398,0,34,regulation of immunoglobulin production,BP,
1074,GO:0002638,1,0.976112536916281,0,5,negative regulation of immunoglobulin production,BP,
1075,GO:0002639,1,0.865866036766747,0,21,positive regulation of immunoglobulin production,BP,
1076,GO:0002643,1,0.947760913581061,0,9,regulation of tolerance induction,BP,
1077,GO:0002645,1,0.96588851094606,0,5,positive regulation of tolerance induction,BP,
1078,GO:0002649,1,0.995366990826165,0,1,regulation of tolerance induction to self antigen,BP,
1079,GO:0002651,1,0.995366990826165,0,1,positive regulation of tolerance induction to self antigen,BP,
1080,GO:0002652,1,0.995006922237278,0,1,regulation of tolerance induction dependent upon immune response,BP,
1081,GO:0002661,1,0.995366990826165,0,1,regulation of B cell tolerance induction,BP,
1082,GO:0002663,1,0.995366990826165,0,1,positive regulation of B cell tolerance induction,BP,
1083,GO:0002664,1,0.965888510946149,0,5,regulation of T cell tolerance induction,BP,
1084,GO:0002666,1,0.970385870663654,0,4,positive regulation of T cell tolerance induction,BP,
1085,GO:0002667,1,0.990755199849163,0,2,regulation of T cell anergy,BP,
1086,GO:0002669,1,0.995366990826099,0,1,positive regulation of T cell anergy,BP,
1087,GO:0002673,1,0.794652266196355,0,30,regulation of acute inflammatory response,BP,
1088,GO:0002674,1,0.961149634062988,0,4,negative regulation of acute inflammatory response,BP,
1089,GO:0002675,1,0.91395875580555,0,11,positive regulation of acute inflammatory response,BP,
1090,GO:0002676,1,0.944314987876055,0,6,regulation of chronic inflammatory response,BP,
1091,GO:0002677,1,0.985759960910738,0,2,negative regulation of chronic inflammatory response,BP,
1092,GO:0002678,1,0.973557599526923,0,3,positive regulation of chronic inflammatory response,BP,
1093,GO:0002679,1,0.966566540443924,0,3,respiratory burst involved in defense response,BP,
1094,GO:0002681,1,0.977045670000279,0,5,somatic recombination of T cell receptor gene segments,BP,
1099,GO:0002686,1,0.839058783407997,0,17,negative regulation of leukocyte migration,BP,
1101,GO:0002688,1,0.596591173921055,0,60,regulation of leukocyte chemotaxis,BP,
1102,GO:0002689,1,0.909704592745134,0,7,negative regulation of leukocyte chemotaxis,BP,
1103,GO:0002690,1,0.675949622950123,0,47,positive regulation of leukocyte chemotaxis,BP,
1104,GO:0002691,1,0.917767728786183,0,13,regulation of cellular extravasation,BP,
1105,GO:0002692,1,0.961847072167104,0,4,negative regulation of cellular extravasation,BP,
1106,GO:0002693,1,0.960686716538875,0,8,positive regulation of cellular extravasation,BP,
1112,GO:0002699,1,0.470339506925662,0,101,positive regulation of immune effector process,BP,
1113,GO:0002700,1,0.594632960622265,0,72,regulation of production of molecular mediator of immune response,BP,
1115,GO:0002702,1,0.710007708112201,0,46,positive regulation of production of molecular mediator of immune response,BP,
1116,GO:0002703,1,0.485291665497201,0,102,regulation of leukocyte mediated immunity,BP,
1117,GO:0002704,1,0.8290026374893,0,26,negative regulation of leukocyte mediated immunity,BP,
1118,GO:0002705,1,0.643610937839845,0,59,positive regulation of leukocyte mediated immunity,BP,
1119,GO:0002706,1,0.594355010492125,0,73,regulation of lymphocyte mediated immunity,BP,
1120,GO:0002707,1,0.872825530548371,0,20,negative regulation of lymphocyte mediated immunity,BP,
1121,GO:0002708,1,0.712602411564183,0,46,positive regulation of lymphocyte mediated immunity,BP,
1122,GO:0002709,1,0.786510650256314,0,32,regulation of T cell mediated immunity,BP,
1123,GO:0002710,1,0.943303470354147,0,8,negative regulation of T cell mediated immunity,BP,
1124,GO:0002711,1,0.859416812619547,0,20,positive regulation of T cell mediated immunity,BP,
1125,GO:0002712,1,0.847399672638694,0,27,regulation of B cell mediated immunity,BP,
1126,GO:0002713,1,0.980142394325626,0,4,negative regulation of B cell mediated immunity,BP,
1127,GO:0002714,1,0.885301742815543,0,19,positive regulation of B cell mediated immunity,BP,
1128,GO:0002715,1,0.872294731091372,0,18,regulation of natural killer cell mediated immunity,BP,
1129,GO:0002716,1,0.939717078798736,0,9,negative regulation of natural killer cell mediated immunity,BP,
1130,GO:0002717,1,0.919894413400216,0,10,positive regulation of natural killer cell mediated immunity,BP,
1131,GO:0002718,1,0.727469711846326,0,41,regulation of cytokine production involved in immune response,BP,
1132,GO:0002719,1,0.882313565731274,0,15,negative regulation of cytokine production involved in immune response,BP,
1133,GO:0002720,1,0.83632643187996,0,23,positive regulation of cytokine production involved in immune response,BP,
1134,GO:0002724,1,0.915819776482787,0,13,regulation of T cell cytokine production,BP,
1135,GO:0002725,1,0.976761600161292,0,3,negative regulation of T cell cytokine production,BP,
1136,GO:0002726,1,0.941991880458735,0,9,positive regulation of T cell cytokine production,BP,
1137,GO:0002727,1,0.972603094546745,0,3,regulation of natural killer cell cytokine production,BP,
1138,GO:0002728,1,0.995366990826164,0,1,negative regulation of natural killer cell cytokine production,BP,
1139,GO:0002729,1,0.977131355075901,0,2,positive regulation of natural killer cell cytokine production,BP,
1140,GO:0002730,1,0.96461012135318,0,4,regulation of dendritic cell cytokine production,BP,
1141,GO:0002731,1,0.973614010259962,0,2,negative regulation of dendritic cell cytokine production,BP,
1142,GO:0002732,1,0.995366990826164,0,1,positive regulation of dendritic cell cytokine production,BP,
1143,GO:0002736,1,0.97814692190544,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1144,GO:0002737,1,0.97814692190544,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1145,GO:0002739,1,0.942089574837617,0,10,regulation of cytokine secretion involved in immune response,BP,
1146,GO:0002740,1,0.981235238717318,0,2,negative regulation of cytokine secretion involved in immune response,BP,
1147,GO:0002741,1,0.964585165374548,0,7,positive regulation of cytokine secretion involved in immune response,BP,
1149,GO:0002755,1,0.855060724960884,0,24,MyD88-dependent toll-like receptor signaling pathway,BP,
1150,GO:0002756,1,0.834723086925492,0,26,MyD88-independent toll-like receptor signaling pathway,BP,
1153,GO:0002759,1,0.969047277995017,0,4,regulation of antimicrobial humoral response,BP,
1154,GO:0002760,1,0.980836257753173,0,2,positive regulation of antimicrobial humoral response,BP,
1155,GO:0002761,1,0.63736357899083,0,73,regulation of myeloid leukocyte differentiation,BP,
1156,GO:0002762,1,0.851170952454061,0,29,negative regulation of myeloid leukocyte differentiation,BP,
1157,GO:0002763,1,0.786270020071971,0,35,positive regulation of myeloid leukocyte differentiation,BP,
1159,GO:0002765,1,0.979207120200581,0,3,immune response-inhibiting signal transduction,BP,
1160,GO:0002767,1,0.985142739580329,0,2,immune response-inhibiting cell surface receptor signaling pathway,BP,
1162,GO:0002774,1,0.995366736535581,0,1,Fc receptor mediated inhibitory signaling pathway,BP,
1163,GO:0002775,1,0.976291011883559,0,3,antimicrobial peptide production,BP,
1164,GO:0002778,1,0.976291011883559,0,3,antibacterial peptide production,BP,
1165,GO:0002784,1,0.976291011883559,0,3,regulation of antimicrobial peptide production,BP,
1166,GO:0002785,1,0.99536697768676,0,1,negative regulation of antimicrobial peptide production,BP,
1167,GO:0002786,1,0.976291011883559,0,3,regulation of antibacterial peptide production,BP,
1168,GO:0002787,1,0.99536697768676,0,1,negative regulation of antibacterial peptide production,BP,
1172,GO:0002793,1,0.344312708711082,0,154,positive regulation of peptide secretion,BP,
1173,GO:0002803,1,0.980836257753173,0,2,positive regulation of antibacterial peptide production,BP,
1174,GO:0002819,1,0.578895331163728,0,81,regulation of adaptive immune response,BP,
1175,GO:0002820,1,0.894423809863366,0,19,negative regulation of adaptive immune response,BP,
1176,GO:0002821,1,0.698024269546398,0,50,positive regulation of adaptive immune response,BP,
1177,GO:0002822,1,0.613640878936985,0,73,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1178,GO:0002823,1,0.898592421537247,0,18,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1179,GO:0002824,1,0.724451928311736,0,46,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1180,GO:0002825,1,0.928800017031001,0,10,regulation of T-helper 1 type immune response,BP,
1181,GO:0002826,1,0.985577799041527,0,3,negative regulation of T-helper 1 type immune response,BP,
1182,GO:0002827,1,0.942400725962026,0,7,positive regulation of T-helper 1 type immune response,BP,
1183,GO:0002828,1,0.871253716664439,0,19,regulation of type 2 immune response,BP,
1184,GO:0002829,1,0.946681953611963,0,8,negative regulation of type 2 immune response,BP,
1185,GO:0002830,1,0.926413583916712,0,10,positive regulation of type 2 immune response,BP,
1188,GO:0002833,1,0.824187268794739,0,26,positive regulation of response to biotic stimulus,BP,
1189,GO:0002834,1,0.971784673288288,0,6,regulation of response to tumor cell,BP,
1190,GO:0002835,1,0.990396732467367,0,2,negative regulation of response to tumor cell,BP,
1191,GO:0002836,1,0.985777474222836,0,3,positive regulation of response to tumor cell,BP,
1192,GO:0002837,1,0.971784673288288,0,6,regulation of immune response to tumor cell,BP,
1193,GO:0002838,1,0.990396732467367,0,2,negative regulation of immune response to tumor cell,BP,
1194,GO:0002839,1,0.985777474222836,0,3,positive regulation of immune response to tumor cell,BP,
1195,GO:0002840,1,0.990383449345203,0,2,regulation of T cell mediated immune response to tumor cell,BP,
1196,GO:0002842,1,0.994993592016332,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
1197,GO:0002855,1,0.98122270503833,0,4,regulation of natural killer cell mediated immune response to tumor cell,BP,
1198,GO:0002856,1,0.990396732467367,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1199,GO:0002857,1,0.990738044191259,0,2,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1200,GO:0002858,1,0.98122270503833,0,4,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1201,GO:0002859,1,0.990396732467367,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1202,GO:0002860,1,0.990738044191259,0,2,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1203,GO:0002861,1,0.898227187734992,0,8,regulation of inflammatory response to antigenic stimulus,BP,
1204,GO:0002862,1,0.943641728776313,0,4,negative regulation of inflammatory response to antigenic stimulus,BP,
1205,GO:0002863,1,0.951904312131752,0,4,positive regulation of inflammatory response to antigenic stimulus,BP,
1206,GO:0002864,1,0.954958209132572,0,4,regulation of acute inflammatory response to antigenic stimulus,BP,
1207,GO:0002865,1,0.993975897692884,0,1,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1208,GO:0002866,1,0.960748510491219,0,3,positive regulation of acute inflammatory response to antigenic stimulus,BP,
1209,GO:0002870,1,0.990755199849163,0,2,T cell anergy,BP,
1210,GO:0002874,1,0.981235238717318,0,2,regulation of chronic inflammatory response to antigenic stimulus,BP,
1211,GO:0002875,1,0.990348766719998,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1212,GO:0002876,1,0.990798677411377,0,1,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1213,GO:0002880,1,0.992919600986792,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1214,GO:0002882,1,0.992919600986792,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1215,GO:0002883,1,0.976408369264913,0,3,regulation of hypersensitivity,BP,
1216,GO:0002884,1,0.993975897692884,0,1,negative regulation of hypersensitivity,BP,
1217,GO:0002885,1,0.982327218320177,0,2,positive regulation of hypersensitivity,BP,
1218,GO:0002886,1,0.833328306994015,0,27,regulation of myeloid leukocyte mediated immunity,BP,
1219,GO:0002887,1,0.975618209774723,0,4,negative regulation of myeloid leukocyte mediated immunity,BP,
1220,GO:0002888,1,0.90354144217466,0,13,positive regulation of myeloid leukocyte mediated immunity,BP,
1221,GO:0002889,1,0.847399672638694,0,27,regulation of immunoglobulin mediated immune response,BP,
1222,GO:0002890,1,0.980142394325626,0,4,negative regulation of immunoglobulin mediated immune response,BP,
1223,GO:0002891,1,0.885301742815543,0,19,positive regulation of immunoglobulin mediated immune response,BP,
1224,GO:0002892,1,0.995366990826151,0,1,regulation of type II hypersensitivity,BP,
1225,GO:0002894,1,0.995366990826151,0,1,positive regulation of type II hypersensitivity,BP,
1226,GO:0002901,1,0.940553478897487,0,4,mature B cell apoptotic process,BP,
1227,GO:0002902,1,0.853227124874325,0,17,regulation of B cell apoptotic process,BP,
1228,GO:0002903,1,0.895838643871473,0,12,negative regulation of B cell apoptotic process,BP,
1229,GO:0002904,1,0.961384562549655,0,3,positive regulation of B cell apoptotic process,BP,
1230,GO:0002905,1,0.940553478897487,0,4,regulation of mature B cell apoptotic process,BP,
1231,GO:0002906,1,0.940553478897487,0,4,negative regulation of mature B cell apoptotic process,BP,
1232,GO:0002911,1,0.990755199849163,0,2,regulation of lymphocyte anergy,BP,
1233,GO:0002913,1,0.995366990826099,0,1,positive regulation of lymphocyte anergy,BP,
1234,GO:0002920,1,0.856062531312625,0,22,regulation of humoral immune response,BP,
1235,GO:0002921,1,0.974211408564556,0,5,negative regulation of humoral immune response,BP,
1236,GO:0002922,1,0.947436321225342,0,6,positive regulation of humoral immune response,BP,
1237,GO:0002923,1,0.985690130546178,0,2,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1238,GO:0002924,1,0.99484455799053,0,1,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1239,GO:0002925,1,0.990798677411377,0,1,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1240,GO:0002930,1,0.995366990826151,0,1,trabecular meshwork development,BP,
1241,GO:0002931,1,0.841534257599217,0,27,response to ischemia,BP,
1242,GO:0002933,1,0.98672548679614,0,2,lipid hydroxylation,BP,
1244,GO:0002940,1,0.990016532794426,0,2,tRNA N2-guanine methylation,BP,
1245,GO:0002943,1,0.975026782510007,0,4,tRNA dihydrouridine synthesis,BP,
1246,GO:0002944,1,0.990280018192652,0,2,cyclin K-CDK12 complex,CC,
1247,GO:0002945,1,0.990280018192718,0,2,cyclin K-CDK13 complex,CC,
1248,GO:0002946,1,0.987621788846115,0,1,tRNA C5-cytosine methylation,BP,
1249,GO:0002947,1,0.995366990826138,0,1,tumor necrosis factor receptor superfamily complex,CC,
1250,GO:0002949,1,0.977044837189197,0,3,tRNA threonylcarbamoyladenosine modification,BP,
1251,GO:0002950,1,0.979497000431467,0,3,ceramide phosphoethanolamine synthase activity,MF,
1252,GO:0002951,1,0.995094192629849,0,1,leukotriene-C(4) hydrolase,MF,
1257,GO:0003009,1,0.835687808141218,0,18,skeletal muscle contraction,BP,
1258,GO:0003010,1,0.975113534379124,0,2,voluntary skeletal muscle contraction,BP,
1259,GO:0003011,1,0.990755178719503,0,2,involuntary skeletal muscle contraction,BP,
1262,GO:0003014,1,0.717608083562315,0,58,renal system process,BP,
1264,GO:0003016,1,0.908252577575065,0,17,respiratory system process,BP,
1265,GO:0003017,1,0.995366990825969,0,1,lymph circulation,BP,
1267,GO:0003025,1,0.989997314180147,0,2,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1268,GO:0003032,1,0.99023218472994,0,2,detection of oxygen,BP,
1269,GO:0003044,1,0.855424033360001,0,21,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
1270,GO:0003050,1,0.995366824985815,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1271,GO:0003056,1,0.974916177452363,0,5,regulation of vascular smooth muscle contraction,BP,
1272,GO:0003057,1,0.98527352294077,0,3,regulation of the force of heart contraction by chemical signal,BP,
1273,GO:0003062,1,0.975673023528541,0,4,regulation of heart rate by chemical signal,BP,
1274,GO:0003064,1,0.992599516499081,0,1,regulation of heart rate by hormone,BP,
1275,GO:0003065,1,0.992121550627632,0,1,positive regulation of heart rate by epinephrine,BP,
1276,GO:0003068,1,0.979969782766415,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1277,GO:0003069,1,0.979969782766415,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1278,GO:0003070,1,0.979969782766415,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
1279,GO:0003071,1,0.923872102340629,0,11,renal system process involved in regulation of systemic arterial blood pressure,BP,
1280,GO:0003072,1,0.993199557245985,0,1,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1281,GO:0003073,1,0.772107810214677,0,41,regulation of systemic arterial blood pressure,BP,
1282,GO:0003081,1,0.922926479315295,0,10,regulation of systemic arterial blood pressure by renin-angiotensin,BP,
1283,GO:0003083,1,0.972420652557464,0,1,negative regulation of renal output by angiotensin,BP,
1284,GO:0003084,1,0.944951736286523,0,6,positive regulation of systemic arterial blood pressure,BP,
1285,GO:0003085,1,0.941311069444845,0,9,negative regulation of systemic arterial blood pressure,BP,
1286,GO:0003091,1,0.899851255176711,0,20,renal water homeostasis,BP,
1287,GO:0003093,1,0.941220006404192,0,8,regulation of glomerular filtration,BP,
1288,GO:0003094,1,0.950102860297439,0,11,glomerular filtration,BP,
1289,GO:0003096,1,0.97871740863725,0,4,renal sodium ion transport,BP,
1290,GO:0003097,1,0.978015352880813,0,4,renal water transport,BP,
1291,GO:0003099,1,0.994605617896706,0,1,positive regulation of the force of heart contraction by chemical signal,BP,
1292,GO:0003100,1,0.97823604122435,0,4,regulation of systemic arterial blood pressure by endothelin,BP,
1293,GO:0003104,1,0.981507296452853,0,4,positive regulation of glomerular filtration,BP,
1294,GO:0003105,1,0.96342776220398,0,3,negative regulation of glomerular filtration,BP,
1295,GO:0003106,1,0.972420652557464,0,1,negative regulation of glomerular filtration by angiotensin,BP,
1296,GO:0003127,1,0.995366990826164,0,1,detection of nodal flow,BP,
1297,GO:0003128,1,0.966271444846127,0,5,heart field specification,BP,
1298,GO:0003129,1,0.979797455836734,0,3,heart induction,BP,
1299,GO:0003130,1,0.987457787134543,0,2,BMP signaling pathway involved in heart induction,BP,
1300,GO:0003131,1,0.995366499145455,0,1,mesodermal-endodermal cell signaling,BP,
1301,GO:0003133,1,0.987457787134543,0,2,endodermal-mesodermal cell signaling,BP,
1302,GO:0003134,1,0.987457787134543,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
1303,GO:0003139,1,0.973827237726412,0,4,secondary heart field specification,BP,
1304,GO:0003140,1,0.974589623338925,0,4,determination of left/right asymmetry in lateral mesoderm,BP,
1306,GO:0003148,1,0.91872868312809,0,16,outflow tract septum morphogenesis,BP,
1307,GO:0003149,1,0.943279166696496,0,9,membranous septum morphogenesis,BP,
1308,GO:0003150,1,0.979858784276573,0,4,muscular septum morphogenesis,BP,
1311,GO:0003157,1,0.957198319531202,0,8,endocardium development,BP,
1312,GO:0003158,1,0.63900417274808,0,75,endothelium development,BP,
1313,GO:0003159,1,0.929217021766983,0,11,morphogenesis of an endothelium,BP,
1314,GO:0003160,1,0.97993379448307,0,3,endocardium morphogenesis,BP,
1315,GO:0003161,1,0.944986965504902,0,10,cardiac conduction system development,BP,
1316,GO:0003162,1,0.990755199849071,0,2,atrioventricular node development,BP,
1317,GO:0003163,1,0.990755199849279,0,2,sinoatrial node development,BP,
1318,GO:0003164,1,0.977265211515363,0,3,His-Purkinje system development,BP,
1319,GO:0003165,1,0.995366990826138,0,1,Purkinje myocyte development,BP,
1320,GO:0003166,1,0.981814927735879,0,2,bundle of His development,BP,
1321,GO:0003167,1,0.995366990826165,0,1,atrioventricular bundle cell differentiation,BP,
1322,GO:0003169,1,0.990755163210557,0,2,coronary vein morphogenesis,BP,
1326,GO:0003175,1,0.98159473609598,0,4,tricuspid valve development,BP,
1327,GO:0003176,1,0.972101921611012,0,4,aortic valve development,BP,
1328,GO:0003177,1,0.969280907192513,0,6,pulmonary valve development,BP,
1330,GO:0003180,1,0.972101921611012,0,4,aortic valve morphogenesis,BP,
1333,GO:0003184,1,0.969280907192513,0,6,pulmonary valve morphogenesis,BP,
1334,GO:0003186,1,0.98159473609598,0,4,tricuspid valve morphogenesis,BP,
1338,GO:0003193,1,0.995366807366016,0,1,pulmonary valve formation,BP,
1339,GO:0003195,1,0.99536685468278,0,1,tricuspid valve formation,BP,
1342,GO:0003199,1,0.989034172764745,0,1,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
1346,GO:0003207,1,0.977363796967054,0,4,cardiac chamber formation,BP,
1347,GO:0003208,1,0.810564203774185,0,40,cardiac ventricle morphogenesis,BP,
1348,GO:0003209,1,0.920880957189068,0,17,cardiac atrium morphogenesis,BP,
1349,GO:0003211,1,0.977363796967054,0,4,cardiac ventricle formation,BP,
1350,GO:0003213,1,0.990755199849057,0,2,cardiac right atrium morphogenesis,BP,
1351,GO:0003214,1,0.971337988319223,0,6,cardiac left ventricle morphogenesis,BP,
1352,GO:0003215,1,0.941700586895656,0,12,cardiac right ventricle morphogenesis,BP,
1353,GO:0003219,1,0.986485077492125,0,2,cardiac right ventricle formation,BP,
1354,GO:0003220,1,0.995366990825981,0,1,left ventricular cardiac muscle tissue morphogenesis,BP,
1355,GO:0003221,1,0.995366990825915,0,1,right ventricular cardiac muscle tissue morphogenesis,BP,
1356,GO:0003222,1,0.949680627938177,0,11,ventricular trabecula myocardium morphogenesis,BP,
1357,GO:0003223,1,0.970172315482096,0,6,ventricular compact myocardium morphogenesis,BP,
1358,GO:0003226,1,0.995366990825915,0,1,right ventricular compact myocardium morphogenesis,BP,
1359,GO:0003228,1,0.983205757900744,0,3,atrial cardiac muscle tissue development,BP,
1360,GO:0003229,1,0.838099789448824,0,32,ventricular cardiac muscle tissue development,BP,
1361,GO:0003230,1,0.900406886916162,0,21,cardiac atrium development,BP,
1363,GO:0003241,1,0.981302586613004,0,3,growth involved in heart morphogenesis,BP,
1364,GO:0003245,1,0.985870882427121,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1365,GO:0003247,1,0.990460465789248,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1366,GO:0003249,1,0.990755199848823,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1367,GO:0003250,1,0.990755199848823,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1368,GO:0003251,1,0.995366990825981,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1369,GO:0003252,1,0.995366990825863,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1370,GO:0003253,1,0.977750921156406,0,4,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1371,GO:0003254,1,0.809457568154718,0,27,regulation of membrane depolarization,BP,
1372,GO:0003256,1,0.985881380494589,0,3,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1373,GO:0003257,1,0.995366990826152,0,1,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1377,GO:0003270,1,0.995366990825967,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1380,GO:0003274,1,0.986164187987096,0,3,endocardial cushion fusion,BP,
1381,GO:0003275,1,0.990755143581362,0,2,apoptotic process involved in outflow tract morphogenesis,BP,
1382,GO:0003278,1,0.985735937986394,0,3,apoptotic process involved in heart morphogenesis,BP,
1385,GO:0003283,1,0.932987933443756,0,14,atrial septum development,BP,
1386,GO:0003284,1,0.981594366317648,0,4,septum primum development,BP,
1387,GO:0003289,1,0.986164187987096,0,3,atrial septum primum morphogenesis,BP,
1388,GO:0003292,1,0.995366990826125,0,1,cardiac septum cell differentiation,BP,
1389,GO:0003294,1,0.990754809696829,0,2,atrial ventricular junction remodeling,BP,
1390,GO:0003298,1,0.924251927535037,0,13,physiological muscle hypertrophy,BP,
1391,GO:0003299,1,0.945765455207562,0,12,muscle hypertrophy in response to stress,BP,
1393,GO:0003301,1,0.924251927535037,0,13,physiological cardiac muscle hypertrophy,BP,
1394,GO:0003306,1,0.969187033735809,0,6,Wnt signaling pathway involved in heart development,BP,
1395,GO:0003307,1,0.982787117552343,0,3,regulation of Wnt signaling pathway involved in heart development,BP,
1396,GO:0003308,1,0.987645815705612,0,2,negative regulation of Wnt signaling pathway involved in heart development,BP,
1397,GO:0003309,1,0.914766638474613,0,15,type B pancreatic cell differentiation,BP,
1399,GO:0003321,1,0.982196771509276,0,3,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1400,GO:0003323,1,0.919029339065097,0,14,type B pancreatic cell development,BP,
1401,GO:0003333,1,0.760623021255885,0,48,amino acid transmembrane transport,BP,
1402,GO:0003334,1,0.938969965690224,0,11,keratinocyte development,BP,
1403,GO:0003335,1,0.995306499618449,0,1,corneocyte development,BP,
1404,GO:0003336,1,0.995306499618449,0,1,corneocyte desquamation,BP,
1408,GO:0003340,1,0.990755111984189,0,2,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1409,GO:0003341,1,0.81759773558259,0,25,cilium movement,BP,
1410,GO:0003342,1,0.995366698642032,0,1,proepicardium development,BP,
1411,GO:0003343,1,0.995366698642032,0,1,septum transversum development,BP,
1412,GO:0003344,1,0.972518302443434,0,6,pericardium morphogenesis,BP,
1413,GO:0003345,1,0.995366989815066,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1414,GO:0003348,1,0.981352402472518,0,4,cardiac endothelial cell differentiation,BP,
1415,GO:0003350,1,0.990171071729593,0,2,pulmonary myocardium development,BP,
1416,GO:0003351,1,0.897518532788531,0,10,epithelial cilium movement,BP,
1417,GO:0003352,1,0.976924576704834,0,5,regulation of cilium movement,BP,
1418,GO:0003356,1,0.976924576704834,0,5,regulation of cilium beat frequency,BP,
1419,GO:0003357,1,0.990755199849124,0,2,noradrenergic neuron differentiation,BP,
1420,GO:0003360,1,0.985064837748889,0,3,brainstem development,BP,
1421,GO:0003363,1,0.995366990826113,0,1,lamellipodium assembly involved in ameboidal cell migration,BP,
1422,GO:0003365,1,0.986164531023507,0,3,establishment of cell polarity involved in ameboidal cell migration,BP,
1423,GO:0003366,1,0.995366990826112,0,1,cell-matrix adhesion involved in ameboidal cell migration,BP,
1424,GO:0003373,1,0.963523651991315,0,8,dynamin family protein polymerization involved in membrane fission,BP,
1425,GO:0003374,1,0.963523651991315,0,8,dynamin family protein polymerization involved in mitochondrial fission,BP,
1427,GO:0003382,1,0.867214593941575,0,22,epithelial cell morphogenesis,BP,
1428,GO:0003383,1,0.986164531023624,0,3,apical constriction,BP,
1429,GO:0003400,1,0.994551950924641,0,1,regulation of COPII vesicle coating,BP,
1430,GO:0003401,1,0.883796204753235,0,23,axis elongation,BP,
1431,GO:0003402,1,0.981594888733455,0,4,planar cell polarity pathway involved in axis elongation,BP,
1432,GO:0003404,1,0.995366881964039,0,1,optic vesicle morphogenesis,BP,
1433,GO:0003406,1,0.986163637981095,0,3,retinal pigment epithelium development,BP,
1434,GO:0003407,1,0.849190203836025,0,31,neural retina development,BP,
1435,GO:0003408,1,0.99075519984911,0,2,optic cup formation involved in camera-type eye development,BP,
1436,GO:0003409,1,0.995366881964039,0,1,optic cup structural organization,BP,
1437,GO:0003413,1,0.96665953696606,0,7,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
1438,GO:0003415,1,0.981594410148911,0,4,chondrocyte hypertrophy,BP,
1439,GO:0003416,1,0.940008351046506,0,13,endochondral bone growth,BP,
1440,GO:0003417,1,0.962765998264752,0,8,growth plate cartilage development,BP,
1441,GO:0003418,1,0.98090754397524,0,4,growth plate cartilage chondrocyte differentiation,BP,
1442,GO:0003419,1,0.990669227020082,0,2,growth plate cartilage chondrocyte proliferation,BP,
1443,GO:0003420,1,0.990669227020082,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1444,GO:0003430,1,0.990754717141176,0,2,growth plate cartilage chondrocyte growth,BP,
1445,GO:0003431,1,0.98090754397524,0,4,growth plate cartilage chondrocyte development,BP,
1446,GO:0003433,1,0.975682073485043,0,5,chondrocyte development involved in endochondral bone morphogenesis,BP,
1450,GO:0003678,1,0.782975002614683,0,46,DNA helicase activity,MF,
1451,GO:0003680,1,0.969604446898695,0,6,AT DNA binding,MF,
1453,GO:0003684,1,0.652463608800276,0,66,damaged DNA binding,MF,
1454,GO:0003688,1,0.934488234353449,0,14,DNA replication origin binding,MF,
1455,GO:0003689,1,0.948115364159602,0,8,DNA clamp loader activity,MF,
1457,GO:0003691,1,0.95119138009084,0,9,double-stranded telomeric DNA binding,MF,
1458,GO:0003696,1,0.979686533734305,0,4,satellite DNA binding,MF,
1459,GO:0003697,1,0.534959686155562,0,96,single-stranded DNA binding,MF,
1463,GO:0003708,1,0.981593885004501,0,4,retinoic acid receptor activity,MF,
1467,GO:0003720,1,0.928765940721069,0,8,telomerase activity,MF,
1468,GO:0003721,1,0.966519617466378,0,1,telomerase RNA reverse transcriptase activity,MF,
1470,GO:0003724,1,0.737144200365903,0,61,RNA helicase activity,MF,
1471,GO:0003725,1,0.714389160323299,0,63,double-stranded RNA binding,MF,
1472,GO:0003726,1,0.990755199849227,0,2,double-stranded RNA adenosine deaminase activity,MF,
1473,GO:0003727,1,0.652717255456019,0,71,single-stranded RNA binding,MF,
1474,GO:0003729,1,0.247233003603789,0,180,mRNA binding,MF,
1475,GO:0003730,1,0.714623305474636,0,54,mRNA 3'-UTR binding,MF,
1477,GO:0003743,1,0.658352827406138,0,49,translation initiation factor activity,MF,
1478,GO:0003746,1,0.884717660854372,0,16,translation elongation factor activity,MF,
1479,GO:0003747,1,0.966734318257691,0,6,translation release factor activity,MF,
1480,GO:0003755,1,0.71680689443192,0,30,peptidyl-prolyl cis-trans isomerase activity,MF,
1481,GO:0003756,1,0.903989334809991,0,17,protein disulfide isomerase activity,MF,
1482,GO:0003774,1,0.548119014957101,0,94,motor activity,MF,
1483,GO:0003777,1,0.631945985016044,0,82,microtubule motor activity,MF,
1486,GO:0003796,1,0.988812377962012,0,1,lysozyme activity,MF,
1487,GO:0003810,1,0.986163223806496,0,3,protein-glutamine gamma-glutamyltransferase activity,MF,
1488,GO:0003823,1,0.833026705468777,0,24,antigen binding,MF,
1490,GO:0003826,1,0.987368327281576,0,2,alpha-ketoacid dehydrogenase activity,MF,
1491,GO:0003827,1,0.990754354860747,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1492,GO:0003828,1,0.990755199849058,0,2,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
1493,GO:0003829,1,0.990755140026109,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1494,GO:0003831,1,0.956444446305202,0,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1495,GO:0003835,1,0.990755199849201,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1496,GO:0003836,1,0.966871090599843,0,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1497,GO:0003839,1,0.952303237123987,0,4,gamma-glutamylcyclotransferase activity,MF,
1498,GO:0003841,1,0.903448435597346,0,19,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
1499,GO:0003842,1,0.995366857802029,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1500,GO:0003844,1,0.995366771002472,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1501,GO:0003845,1,0.980210165147934,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
1502,GO:0003846,1,0.990615781820795,0,2,2-acylglycerol O-acyltransferase activity,MF,
1503,GO:0003847,1,0.952789391055726,0,4,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1504,GO:0003854,1,0.98009068626676,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
1505,GO:0003857,1,0.918468686478134,0,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,
1506,GO:0003858,1,0.990754747160784,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1507,GO:0003860,1,0.993274926253489,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1508,GO:0003863,1,0.987368327281576,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1509,GO:0003865,1,0.990237557770863,0,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1510,GO:0003867,1,0.995366990826165,0,1,4-aminobutyrate transaminase activity,MF,
1511,GO:0003868,1,0.992178217166212,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1512,GO:0003870,1,0.995042957705271,0,1,5-aminolevulinate synthase activity,MF,
1513,GO:0003872,1,0.986145685610171,0,3,6-phosphofructokinase activity,MF,
1514,GO:0003873,1,0.986164487524587,0,3,6-phosphofructo-2-kinase activity,MF,
1515,GO:0003874,1,0.978037514283719,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
1516,GO:0003875,1,0.995366932828873,0,1,ADP-ribosylarginine hydrolase activity,MF,
1517,GO:0003876,1,0.990755193597515,0,2,AMP deaminase activity,MF,
1518,GO:0003877,1,0.994314330594104,0,1,ATP adenylyltransferase activity,MF,
1519,GO:0003878,1,0.995366990826152,0,1,ATP citrate synthase activity,MF,
1520,GO:0003880,1,0.976107244894574,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
1521,GO:0003881,1,0.992856067074568,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1522,GO:0003882,1,0.995222218045383,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1523,GO:0003883,1,0.990754785276736,0,2,CTP synthase activity,MF,
1524,GO:0003886,1,0.98616453094333,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1525,GO:0003887,1,0.82942284977099,0,26,DNA-directed DNA polymerase activity,MF,
1526,GO:0003896,1,0.978493620148548,0,3,DNA primase activity,MF,
1527,GO:0003899,1,0.663062635054222,0,41,DNA-directed 5'-3' RNA polymerase activity,MF,
1528,GO:0003905,1,0.981272802792047,0,1,alkylbase DNA N-glycosylase activity,MF,
1529,GO:0003906,1,0.885346478335422,0,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
1530,GO:0003908,1,0.984723310341429,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1531,GO:0003909,1,0.964317410167102,0,7,DNA ligase activity,MF,
1532,GO:0003910,1,0.969818249645742,0,6,DNA ligase (ATP) activity,MF,
1533,GO:0003916,1,0.970371327134134,0,6,DNA topoisomerase activity,MF,
1534,GO:0003917,1,0.979428105311225,0,4,DNA topoisomerase type I activity,MF,
1535,GO:0003918,1,0.990755199849254,0,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
1536,GO:0003919,1,0.993565389060168,0,1,FMN adenylyltransferase activity,MF,
1537,GO:0003920,1,0.992919600986792,0,1,GMP reductase activity,MF,
1538,GO:0003921,1,0.995238290092221,0,1,GMP synthase activity,MF,
1539,GO:0003922,1,0.995238290092221,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1540,GO:0003923,1,0.972508262761642,0,5,GPI-anchor transamidase activity,MF,
1542,GO:0003933,1,0.993440604030376,0,1,GTP cyclohydrolase activity,MF,
1543,GO:0003934,1,0.993440604030376,0,1,GTP cyclohydrolase I activity,MF,
1544,GO:0003937,1,0.994257209385536,0,1,IMP cyclohydrolase activity,MF,
1545,GO:0003938,1,0.986459521513766,0,2,IMP dehydrogenase activity,MF,
1546,GO:0003939,1,0.995296708755865,0,1,L-iditol 2-dehydrogenase activity,MF,
1547,GO:0003940,1,0.994646465207342,0,1,L-iduronidase activity,MF,
1548,GO:0003941,1,0.982361889454045,0,2,L-serine ammonia-lyase activity,MF,
1549,GO:0003943,1,0.990493511598362,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1550,GO:0003944,1,0.99469084979292,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1551,GO:0003945,1,0.978209058008563,0,4,N-acetyllactosamine synthase activity,MF,
1552,GO:0003948,1,0.994214827713524,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1553,GO:0003950,1,0.916552731938039,0,17,NAD+ ADP-ribosyltransferase activity,MF,
1554,GO:0003951,1,0.938951109003697,0,13,NAD+ kinase activity,MF,
1555,GO:0003952,1,0.995213700845504,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1556,GO:0003953,1,0.988505615591278,0,1,NAD+ nucleosidase activity,MF,
1557,GO:0003954,1,0.406828091951816,0,40,NADH dehydrogenase activity,MF,
1558,GO:0003955,1,0.973187849698202,0,3,NAD(P)H dehydrogenase (quinone) activity,MF,
1559,GO:0003956,1,0.990460465789248,0,1,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1560,GO:0003957,1,0.995366990826165,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1561,GO:0003958,1,0.976835245948536,0,5,NADPH-hemoprotein reductase activity,MF,
1562,GO:0003960,1,0.973962371423861,0,3,NADPH:quinone reductase activity,MF,
1563,GO:0003962,1,0.991669902477171,0,1,cystathionine gamma-synthase activity,MF,
1564,GO:0003963,1,0.989962174366742,0,2,RNA-3'-phosphate cyclase activity,MF,
1565,GO:0003964,1,0.928765940721069,0,8,RNA-directed DNA polymerase activity,MF,
1566,GO:0003968,1,0.957356132398807,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1567,GO:0003972,1,0.995366574475227,0,1,RNA ligase (ATP) activity,MF,
1568,GO:0003973,1,0.995366990826112,0,1,(S)-2-hydroxy-acid oxidase activity,MF,
1569,GO:0003974,1,0.990146644135533,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1570,GO:0003975,1,0.994461746266255,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1571,GO:0003976,1,0.974459670155231,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1572,GO:0003977,1,0.990416004232814,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1573,GO:0003978,1,0.990146644135533,0,1,UDP-glucose 4-epimerase activity,MF,
1574,GO:0003979,1,0.995366827364554,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1575,GO:0003980,1,0.990755199849032,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1576,GO:0003983,1,0.994457680249057,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1577,GO:0003985,1,0.97928550659452,0,3,acetyl-CoA C-acetyltransferase activity,MF,
1578,GO:0003986,1,0.954528997659864,0,3,acetyl-CoA hydrolase activity,MF,
1579,GO:0003987,1,0.990754884941477,0,2,acetate-CoA ligase activity,MF,
1580,GO:0003988,1,0.960246034754228,0,6,acetyl-CoA C-acyltransferase activity,MF,
1581,GO:0003989,1,0.990755199848888,0,2,acetyl-CoA carboxylase activity,MF,
1582,GO:0003990,1,0.995213700845504,0,1,acetylcholinesterase activity,MF,
1583,GO:0003991,1,0.994136844408377,0,1,acetylglutamate kinase activity,MF,
1584,GO:0003993,1,0.951226873469042,0,6,acid phosphatase activity,MF,
1585,GO:0003994,1,0.990753940423994,0,2,aconitate hydratase activity,MF,
1586,GO:0003995,1,0.922708437436266,0,13,acyl-CoA dehydrogenase activity,MF,
1587,GO:0003996,1,0.994824612585235,0,1,acyl-CoA ligase activity,MF,
1588,GO:0003997,1,0.983266655631371,0,3,acyl-CoA oxidase activity,MF,
1589,GO:0003998,1,0.955673602192236,0,2,acylphosphatase activity,MF,
1590,GO:0003999,1,0.973603815647657,0,1,adenine phosphoribosyltransferase activity,MF,
1591,GO:0004000,1,0.966387595781954,0,6,adenosine deaminase activity,MF,
1592,GO:0004001,1,0.994044997930392,0,1,adenosine kinase activity,MF,
1594,GO:0004004,1,0.740587426529876,0,60,ATP-dependent RNA helicase activity,MF,
1595,GO:0004008,1,0.990755199849071,0,2,copper-exporting ATPase activity,MF,
1596,GO:0004012,1,0.941398726561773,0,13,phospholipid-translocating ATPase activity,MF,
1597,GO:0004013,1,0.98573844705399,0,3,adenosylhomocysteinase activity,MF,
1598,GO:0004014,1,0.995366864645357,0,1,adenosylmethionine decarboxylase activity,MF,
1599,GO:0004016,1,0.972518249038166,0,6,adenylate cyclase activity,MF,
1600,GO:0004017,1,0.97611771512319,0,5,adenylate kinase activity,MF,
1601,GO:0004018,1,0.988297151840119,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1602,GO:0004019,1,0.995366064575819,0,1,adenylosuccinate synthase activity,MF,
1603,GO:0004020,1,0.990698230093962,0,2,adenylylsulfate kinase activity,MF,
1604,GO:0004021,1,0.995366990515785,0,1,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1605,GO:0004022,1,0.995351917877958,0,1,alcohol dehydrogenase (NAD) activity,MF,
1606,GO:0004027,1,0.984024144473683,0,1,alcohol sulfotransferase activity,MF,
1607,GO:0004028,1,0.966827294950665,0,7,3-chloroallyl aldehyde dehydrogenase activity,MF,
1608,GO:0004029,1,0.940076800894771,0,13,aldehyde dehydrogenase (NAD) activity,MF,
1609,GO:0004030,1,0.976803567929493,0,5,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1610,GO:0004031,1,0.995366990826165,0,1,aldehyde oxidase activity,MF,
1611,GO:0004032,1,0.938568532691227,0,5,alditol:NADP+ 1-oxidoreductase activity,MF,
1612,GO:0004033,1,0.847853641200579,0,16,aldo-keto reductase (NADP) activity,MF,
1613,GO:0004034,1,0.995258125840563,0,1,aldose 1-epimerase activity,MF,
1614,GO:0004040,1,0.989682589432362,0,2,amidase activity,MF,
1615,GO:0004042,1,0.994136844408377,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1616,GO:0004043,1,0.995366962748951,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1617,GO:0004044,1,0.99536698481134,0,1,amidophosphoribosyltransferase activity,MF,
1618,GO:0004045,1,0.937219608840558,0,4,aminoacyl-tRNA hydrolase activity,MF,
1619,GO:0004046,1,0.977584483511129,0,3,aminoacylase activity,MF,
1620,GO:0004047,1,0.982872051742901,0,2,aminomethyltransferase activity,MF,
1621,GO:0004052,1,0.990401424750049,0,2,arachidonate 12-lipoxygenase activity,MF,
1622,GO:0004053,1,0.981536093209012,0,2,arginase activity,MF,
1623,GO:0004055,1,0.992456122944064,0,1,argininosuccinate synthase activity,MF,
1624,GO:0004056,1,0.99369385881112,0,1,argininosuccinate lyase activity,MF,
1625,GO:0004057,1,0.994717235336064,0,1,arginyltransferase activity,MF,
1626,GO:0004060,1,0.9938363313509,0,1,arylamine N-acetyltransferase activity,MF,
1627,GO:0004061,1,0.991156461546762,0,1,arylformamidase activity,MF,
1628,GO:0004062,1,0.954384027874653,0,4,aryl sulfotransferase activity,MF,
1629,GO:0004064,1,0.976833384192142,0,3,arylesterase activity,MF,
1630,GO:0004065,1,0.965794595552293,0,7,arylsulfatase activity,MF,
1631,GO:0004066,1,0.990288135408812,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1632,GO:0004069,1,0.989649324267882,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1633,GO:0004070,1,0.990755199849162,0,2,aspartate carbamoyltransferase activity,MF,
1634,GO:0004074,1,0.957896059740807,0,2,biliverdin reductase activity,MF,
1635,GO:0004075,1,0.986107187032274,0,3,biotin carboxylase activity,MF,
1636,GO:0004077,1,0.995366990826113,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1637,GO:0004078,1,0.995366990826113,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1638,GO:0004079,1,0.995366990826113,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1639,GO:0004080,1,0.995366990826113,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1640,GO:0004081,1,0.974688971026775,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1641,GO:0004082,1,0.984800719828568,0,2,bisphosphoglycerate mutase activity,MF,
1642,GO:0004083,1,0.995366574475227,0,1,bisphosphoglycerate 2-phosphatase activity,MF,
1643,GO:0004084,1,0.98565363550537,0,2,branched-chain-amino-acid transaminase activity,MF,
1644,GO:0004085,1,0.99321405027932,0,1,butyryl-CoA dehydrogenase activity,MF,
1645,GO:0004087,1,0.990755199849162,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1646,GO:0004088,1,0.990755199849162,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1647,GO:0004089,1,0.972583771956169,0,5,carbonate dehydratase activity,MF,
1648,GO:0004090,1,0.928710791933497,0,4,carbonyl reductase (NADPH) activity,MF,
1649,GO:0004092,1,0.995366492331572,0,1,carnitine O-acetyltransferase activity,MF,
1650,GO:0004095,1,0.981588314934211,0,4,carnitine O-palmitoyltransferase activity,MF,
1651,GO:0004096,1,0.972611274114874,0,3,catalase activity,MF,
1652,GO:0004098,1,0.99308878469887,0,1,cerebroside-sulfatase activity,MF,
1653,GO:0004103,1,0.985828609632378,0,2,choline kinase activity,MF,
1654,GO:0004104,1,0.990596949126965,0,2,cholinesterase activity,MF,
1655,GO:0004105,1,0.985169494149382,0,2,choline-phosphate cytidylyltransferase activity,MF,
1656,GO:0004108,1,0.995366665188995,0,1,citrate (Si)-synthase activity,MF,
1657,GO:0004109,1,0.99066040539031,0,2,coproporphyrinogen oxidase activity,MF,
1658,GO:0004111,1,0.967451630164074,0,4,creatine kinase activity,MF,
1659,GO:0004112,1,0.932992348309569,0,12,cyclic-nucleotide phosphodiesterase activity,MF,
1660,GO:0004113,1,0.995366990826152,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1661,GO:0004114,1,0.937338278223065,0,11,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1662,GO:0004115,1,0.972517992405427,0,6,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1663,GO:0004117,1,0.995362644056522,0,1,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
1664,GO:0004118,1,0.995366990826139,0,1,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1665,GO:0004122,1,0.995337765554784,0,1,cystathionine beta-synthase activity,MF,
1666,GO:0004123,1,0.991669902477171,0,1,cystathionine gamma-lyase activity,MF,
1667,GO:0004126,1,0.931268839406234,0,7,cytidine deaminase activity,MF,
1668,GO:0004127,1,0.990754423903968,0,2,cytidylate kinase activity,MF,
1669,GO:0004128,1,0.953814889349814,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1671,GO:0004132,1,0.993912800421657,0,1,dCMP deaminase activity,MF,
1672,GO:0004133,1,0.995366990826059,0,1,glycogen debranching enzyme activity,MF,
1673,GO:0004134,1,0.995366990826059,0,1,4-alpha-glucanotransferase activity,MF,
1674,GO:0004135,1,0.995366990826059,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1675,GO:0004137,1,0.990727303966929,0,2,deoxycytidine kinase activity,MF,
1676,GO:0004138,1,0.979716819340251,0,1,deoxyguanosine kinase activity,MF,
1677,GO:0004139,1,0.991485701225143,0,1,deoxyribose-phosphate aldolase activity,MF,
1678,GO:0004140,1,0.988962965565852,0,2,dephospho-CoA kinase activity,MF,
1679,GO:0004142,1,0.979856596932639,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1680,GO:0004143,1,0.963523044460525,0,8,diacylglycerol kinase activity,MF,
1681,GO:0004144,1,0.990615781820795,0,2,diacylglycerol O-acyltransferase activity,MF,
1682,GO:0004145,1,0.961020311021029,0,2,diamine N-acetyltransferase activity,MF,
1683,GO:0004146,1,0.976441039757183,0,2,dihydrofolate reductase activity,MF,
1684,GO:0004148,1,0.99536696674851,0,1,dihydrolipoyl dehydrogenase activity,MF,
1685,GO:0004149,1,0.995366527560217,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1686,GO:0004151,1,0.990755199849162,0,2,dihydroorotase activity,MF,
1687,GO:0004152,1,0.994116813998554,0,1,dihydroorotate dehydrogenase activity,MF,
1688,GO:0004155,1,0.990619251145234,0,1,6,7-dihydropteridine reductase activity,MF,
1689,GO:0004157,1,0.995366990826164,0,1,dihydropyrimidinase activity,MF,
1690,GO:0004161,1,0.983821381198285,0,2,dimethylallyltranstransferase activity,MF,
1691,GO:0004163,1,0.992215627073062,0,1,diphosphomevalonate decarboxylase activity,MF,
1692,GO:0004164,1,0.992140513219086,0,1,diphthine synthase activity,MF,
1693,GO:0004165,1,0.986163705520746,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
1694,GO:0004167,1,0.941509980925824,0,2,dopachrome isomerase activity,MF,
1695,GO:0004168,1,0.994663759095586,0,1,dolichol kinase activity,MF,
1696,GO:0004169,1,0.930756434027214,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1697,GO:0004170,1,0.992848049037796,0,1,dUTP diphosphatase activity,MF,
1698,GO:0004174,1,0.990462101855826,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
1699,GO:0004175,1,0.181880179170213,0,228,endopeptidase activity,MF,
1700,GO:0004176,1,0.981313754015043,0,4,ATP-dependent peptidase activity,MF,
1701,GO:0004177,1,0.841345576890443,0,33,aminopeptidase activity,MF,
1702,GO:0004180,1,0.908859965186439,0,17,carboxypeptidase activity,MF,
1703,GO:0004181,1,0.961087035293446,0,8,metallocarboxypeptidase activity,MF,
1704,GO:0004185,1,0.956594714035282,0,8,serine-type carboxypeptidase activity,MF,
1705,GO:0004190,1,0.927014841130212,0,14,aspartic-type endopeptidase activity,MF,
1706,GO:0004197,1,0.592461690547116,0,75,cysteine-type endopeptidase activity,MF,
1707,GO:0004198,1,0.884715525695848,0,16,calcium-dependent cysteine-type endopeptidase activity,MF,
1708,GO:0004222,1,0.737258463614662,0,57,metalloendopeptidase activity,MF,
1709,GO:0004252,1,0.606871905679052,0,73,serine-type endopeptidase activity,MF,
1710,GO:0004298,1,0.706568218904565,0,18,threonine-type endopeptidase activity,MF,
1711,GO:0004300,1,0.935743955246181,0,8,enoyl-CoA hydratase activity,MF,
1712,GO:0004301,1,0.950722246200867,0,7,epoxide hydrolase activity,MF,
1713,GO:0004303,1,0.927622469174646,0,7,estradiol 17-beta-dehydrogenase activity,MF,
1714,GO:0004304,1,0.992044959517752,0,1,estrone sulfotransferase activity,MF,
1715,GO:0004305,1,0.976688445913669,0,4,ethanolamine kinase activity,MF,
1716,GO:0004306,1,0.992725726828404,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1717,GO:0004307,1,0.976051288885806,0,2,ethanolaminephosphotransferase activity,MF,
1718,GO:0004308,1,0.979747085200973,0,4,exo-alpha-sialidase activity,MF,
1719,GO:0004309,1,0.981092293978615,0,4,exopolyphosphatase activity,MF,
1720,GO:0004310,1,0.99430306699322,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1721,GO:0004311,1,0.985109516897726,0,3,farnesyltranstransferase activity,MF,
1722,GO:0004312,1,0.937095505788565,0,9,fatty acid synthase activity,MF,
1723,GO:0004313,1,0.995366990825994,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1724,GO:0004314,1,0.98880402311274,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
1725,GO:0004315,1,0.980358190243287,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
1726,GO:0004316,1,0.995366990825994,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1727,GO:0004317,1,0.995366990825994,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1728,GO:0004319,1,0.995366990825994,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
1729,GO:0004320,1,0.987212508658475,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
1730,GO:0004322,1,0.974906879059918,0,3,ferroxidase activity,MF,
1731,GO:0004324,1,0.9930434418814,0,1,ferredoxin-NADP+ reductase activity,MF,
1732,GO:0004325,1,0.99536699082606,0,1,ferrochelatase activity,MF,
1733,GO:0004326,1,0.995264882158447,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1734,GO:0004329,1,0.990755132621056,0,2,formate-tetrahydrofolate ligase activity,MF,
1735,GO:0004331,1,0.981594434777801,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1736,GO:0004332,1,0.979881922723,0,2,fructose-bisphosphate aldolase activity,MF,
1737,GO:0004333,1,0.992140513219086,0,1,fumarate hydratase activity,MF,
1738,GO:0004334,1,0.987932532673737,0,1,fumarylacetoacetase activity,MF,
1739,GO:0004335,1,0.981864938257796,0,2,galactokinase activity,MF,
1740,GO:0004336,1,0.995366592959221,0,1,galactosylceramidase activity,MF,
1741,GO:0004337,1,0.983821381198285,0,2,geranyltranstransferase activity,MF,
1742,GO:0004339,1,0.995366990826086,0,1,glucan 1,4-alpha-glucosidase activity,MF,
1743,GO:0004340,1,0.986164519277882,0,3,glucokinase activity,MF,
1744,GO:0004342,1,0.988177891355943,0,2,glucosamine-6-phosphate deaminase activity,MF,
1745,GO:0004343,1,0.99536699056711,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1746,GO:0004344,1,0.995366990825967,0,1,glucose dehydrogenase activity,MF,
1747,GO:0004345,1,0.99043569548866,0,2,glucose-6-phosphate dehydrogenase activity,MF,
1748,GO:0004346,1,0.990448126099904,0,1,glucose-6-phosphatase activity,MF,
1749,GO:0004347,1,0.994210053136302,0,1,glucose-6-phosphate isomerase activity,MF,
1750,GO:0004348,1,0.990547674810286,0,2,glucosylceramidase activity,MF,
1751,GO:0004349,1,0.995366942340392,0,1,glutamate 5-kinase activity,MF,
1752,GO:0004350,1,0.995366942340392,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1753,GO:0004351,1,0.990491736888787,0,2,glutamate decarboxylase activity,MF,
1754,GO:0004352,1,0.995366945430975,0,1,glutamate dehydrogenase (NAD+) activity,MF,
1755,GO:0004353,1,0.995366945430975,0,1,glutamate dehydrogenase [NAD(P)+] activity,MF,
1756,GO:0004356,1,0.995366990826152,0,1,glutamate-ammonia ligase activity,MF,
1757,GO:0004357,1,0.990754948172085,0,2,glutamate-cysteine ligase activity,MF,
1758,GO:0004359,1,0.985995000827547,0,3,glutaminase activity,MF,
1759,GO:0004360,1,0.995366990825994,0,1,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1760,GO:0004361,1,0.991323192844333,0,1,glutaryl-CoA dehydrogenase activity,MF,
1761,GO:0004362,1,0.994880289539658,0,1,glutathione-disulfide reductase activity,MF,
1762,GO:0004363,1,0.993111233617557,0,1,glutathione synthase activity,MF,
1763,GO:0004364,1,0.739976857489979,0,18,glutathione transferase activity,MF,
1764,GO:0004365,1,0.9855963679086,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1765,GO:0004366,1,0.977038714440316,0,5,glycerol-3-phosphate O-acyltransferase activity,MF,
1766,GO:0004367,1,0.995366990426746,0,1,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1767,GO:0004368,1,0.995366990826126,0,1,glycerol-3-phosphate dehydrogenase activity,MF,
1768,GO:0004370,1,0.990755185053954,0,2,glycerol kinase activity,MF,
1769,GO:0004371,1,0.995366574475227,0,1,glycerone kinase activity,MF,
1770,GO:0004372,1,0.990054307114572,0,2,glycine hydroxymethyltransferase activity,MF,
1771,GO:0004373,1,0.995366934880468,0,1,glycogen (starch) synthase activity,MF,
1772,GO:0004375,1,0.995366988609227,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1773,GO:0004376,1,0.980575926962558,0,4,glycolipid mannosyltransferase activity,MF,
1774,GO:0004377,1,0.995301025996207,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1775,GO:0004378,1,0.995366588660317,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1776,GO:0004379,1,0.990755199849292,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
1777,GO:0004382,1,0.989449591277573,0,2,guanosine-diphosphatase activity,MF,
1778,GO:0004383,1,0.972518249038166,0,6,guanylate cyclase activity,MF,
1779,GO:0004385,1,0.933436607783196,0,11,guanylate kinase activity,MF,
1780,GO:0004386,1,0.490889908833424,0,138,helicase activity,MF,
1781,GO:0004392,1,0.981039824698575,0,2,heme oxygenase (decyclizing) activity,MF,
1782,GO:0004394,1,0.995366990826138,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1783,GO:0004395,1,0.984741452522495,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1784,GO:0004396,1,0.986164519277882,0,3,hexokinase activity,MF,
1785,GO:0004397,1,0.995366801879365,0,1,histidine ammonia-lyase activity,MF,
1786,GO:0004402,1,0.732528194756814,0,51,histone acetyltransferase activity,MF,
1787,GO:0004407,1,0.782370355546316,0,42,histone deacetylase activity,MF,
1788,GO:0004408,1,0.994927016771324,0,1,holocytochrome-c synthase activity,MF,
1789,GO:0004415,1,0.972735694861644,0,5,hyalurononglucosaminidase activity,MF,
1790,GO:0004416,1,0.98492142716432,0,2,hydroxyacylglutathione hydrolase activity,MF,
1791,GO:0004418,1,0.988131164673001,0,1,hydroxymethylbilane synthase activity,MF,
1792,GO:0004419,1,0.98864527617743,0,1,hydroxymethylglutaryl-CoA lyase activity,MF,
1793,GO:0004420,1,0.995366990826164,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1794,GO:0004421,1,0.995366945682435,0,1,hydroxymethylglutaryl-CoA synthase activity,MF,
1795,GO:0004422,1,0.980683596853657,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
1796,GO:0004423,1,0.995366990826125,0,1,iduronate-2-sulfatase activity,MF,
1797,GO:0004427,1,0.966207652727422,0,3,inorganic diphosphatase activity,MF,
1798,GO:0004430,1,0.971814815355137,0,6,1-phosphatidylinositol 4-kinase activity,MF,
1799,GO:0004435,1,0.926311470169457,0,14,phosphatidylinositol phospholipase C activity,MF,
1800,GO:0004438,1,0.936753287811005,0,14,phosphatidylinositol-3-phosphatase activity,MF,
1801,GO:0004439,1,0.962941740865616,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1802,GO:0004441,1,0.994226706671134,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1803,GO:0004445,1,0.976490110372047,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
1804,GO:0004446,1,0.995366521608773,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1805,GO:0004448,1,0.961512705390621,0,5,isocitrate dehydrogenase activity,MF,
1806,GO:0004449,1,0.974533805360795,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1807,GO:0004450,1,0.98664257073037,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
1808,GO:0004452,1,0.980860339318578,0,2,isopentenyl-diphosphate delta-isomerase activity,MF,
1809,GO:0004454,1,0.995179134776111,0,1,ketohexokinase activity,MF,
1810,GO:0004457,1,0.968205404561572,0,4,lactate dehydrogenase activity,MF,
1811,GO:0004458,1,0.995333062328682,0,1,D-lactate dehydrogenase (cytochrome) activity,MF,
1812,GO:0004459,1,0.972746592759429,0,3,L-lactate dehydrogenase activity,MF,
1813,GO:0004461,1,0.989673485718902,0,2,lactose synthase activity,MF,
1814,GO:0004462,1,0.993992052374008,0,1,lactoylglutathione lyase activity,MF,
1815,GO:0004463,1,0.994141818374388,0,1,leukotriene-A4 hydrolase activity,MF,
1816,GO:0004464,1,0.947449771318894,0,2,leukotriene-C4 synthase activity,MF,
1817,GO:0004465,1,0.984959862532933,0,3,lipoprotein lipase activity,MF,
1818,GO:0004466,1,0.968825764404548,0,4,long-chain-acyl-CoA dehydrogenase activity,MF,
1819,GO:0004467,1,0.958618442524538,0,9,long-chain fatty acid-CoA ligase activity,MF,
1820,GO:0004468,1,0.981594395634532,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
1821,GO:0004470,1,0.970683844880158,0,4,malic enzyme activity,MF,
1822,GO:0004471,1,0.985618406571145,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1823,GO:0004473,1,0.985618406571145,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
1824,GO:0004475,1,0.99004389338632,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
1825,GO:0004476,1,0.991967176450215,0,1,mannose-6-phosphate isomerase activity,MF,
1826,GO:0004477,1,0.980744578975231,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1827,GO:0004478,1,0.995366489838277,0,1,methionine adenosyltransferase activity,MF,
1828,GO:0004479,1,0.995365609716794,0,1,methionyl-tRNA formyltransferase activity,MF,
1829,GO:0004482,1,0.995366990826112,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
1830,GO:0004483,1,0.990754370961523,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
1831,GO:0004484,1,0.995366990826164,0,1,mRNA guanylyltransferase activity,MF,
1832,GO:0004485,1,0.990697580587754,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
1833,GO:0004486,1,0.995366942603148,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
1834,GO:0004487,1,0.985310327432671,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
1835,GO:0004488,1,0.980744578975231,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
1836,GO:0004489,1,0.995366990826059,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
1837,GO:0004490,1,0.989861393139042,0,1,methylglutaconyl-CoA hydratase activity,MF,
1838,GO:0004491,1,0.994614625735962,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
1839,GO:0004492,1,0.994338830167555,0,1,methylmalonyl-CoA decarboxylase activity,MF,
1840,GO:0004493,1,0.976594577863242,0,1,methylmalonyl-CoA epimerase activity,MF,
1841,GO:0004494,1,0.995366647059697,0,1,methylmalonyl-CoA mutase activity,MF,
1842,GO:0004496,1,0.994139333069833,0,1,mevalonate kinase activity,MF,
1843,GO:0004497,1,0.773587396507325,0,43,monooxygenase activity,MF,
1844,GO:0004498,1,0.995264882158447,0,1,calcidiol 1-monooxygenase activity,MF,
1845,GO:0004499,1,0.994453602075062,0,1,N,N-dimethylaniline monooxygenase activity,MF,
1846,GO:0004500,1,0.995366720724551,0,1,dopamine beta-monooxygenase activity,MF,
1847,GO:0004504,1,0.995366983442151,0,1,peptidylglycine monooxygenase activity,MF,
1848,GO:0004505,1,0.974801290954034,0,2,phenylalanine 4-monooxygenase activity,MF,
1849,GO:0004506,1,0.995366675387586,0,1,squalene monooxygenase activity,MF,
1850,GO:0004511,1,0.993103767077917,0,1,tyrosine 3-monooxygenase activity,MF,
1851,GO:0004512,1,0.994861259427477,0,1,inositol-3-phosphate synthase activity,MF,
1852,GO:0004513,1,0.994979936267601,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
1853,GO:0004514,1,0.98013256884821,0,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
1854,GO:0004515,1,0.986164526857245,0,3,nicotinate-nucleotide adenylyltransferase activity,MF,
1855,GO:0004516,1,0.995366574475227,0,1,nicotinate phosphoribosyltransferase activity,MF,
1856,GO:0004517,1,0.990627088591634,0,2,nitric-oxide synthase activity,MF,
1859,GO:0004520,1,0.736204607250411,0,45,endodeoxyribonuclease activity,MF,
1860,GO:0004521,1,0.666989301583491,0,47,endoribonuclease activity,MF,
1861,GO:0004522,1,0.989513494299247,0,1,ribonuclease A activity,MF,
1862,GO:0004523,1,0.942524281582128,0,6,RNA-DNA hybrid ribonuclease activity,MF,
1863,GO:0004525,1,0.977953069118213,0,4,ribonuclease III activity,MF,
1864,GO:0004526,1,0.867423418268691,0,11,ribonuclease P activity,MF,
1865,GO:0004527,1,0.636833322795712,0,69,exonuclease activity,MF,
1866,GO:0004528,1,0.97304655314539,0,4,phosphodiesterase I activity,MF,
1867,GO:0004529,1,0.893443045407377,0,17,exodeoxyribonuclease activity,MF,
1868,GO:0004530,1,0.99075497450872,0,2,deoxyribonuclease I activity,MF,
1869,GO:0004531,1,0.993789777090272,0,1,deoxyribonuclease II activity,MF,
1870,GO:0004532,1,0.767809953777777,0,34,exoribonuclease activity,MF,
1871,GO:0004534,1,0.986164479782482,0,3,5'-3' exoribonuclease activity,MF,
1872,GO:0004535,1,0.945065572488271,0,12,poly(A)-specific ribonuclease activity,MF,
1873,GO:0004536,1,0.646346908664795,0,61,deoxyribonuclease activity,MF,
1874,GO:0004540,1,0.487937493629443,0,86,ribonuclease activity,MF,
1875,GO:0004549,1,0.842939595802423,0,16,tRNA-specific ribonuclease activity,MF,
1877,GO:0004551,1,0.880888470971731,0,12,nucleotide diphosphatase activity,MF,
1878,GO:0004553,1,0.715428774185443,0,62,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,
1879,GO:0004556,1,0.994611031178077,0,1,alpha-amylase activity,MF,
1880,GO:0004557,1,0.982793588221199,0,2,alpha-galactosidase activity,MF,
1881,GO:0004558,1,0.986164509990694,0,3,alpha-1,4-glucosidase activity,MF,
1882,GO:0004559,1,0.939345145942341,0,13,alpha-mannosidase activity,MF,
1883,GO:0004560,1,0.988627667282334,0,2,alpha-L-fucosidase activity,MF,
1884,GO:0004561,1,0.995366341499347,0,1,alpha-N-acetylglucosaminidase activity,MF,
1885,GO:0004563,1,0.974093940799943,0,5,beta-N-acetylhexosaminidase activity,MF,
1886,GO:0004565,1,0.981422802875737,0,4,beta-galactosidase activity,MF,
1887,GO:0004566,1,0.986882259318083,0,2,beta-glucuronidase activity,MF,
1888,GO:0004567,1,0.995366891169665,0,1,beta-mannosidase activity,MF,
1889,GO:0004568,1,0.990754908593028,0,2,chitinase activity,MF,
1890,GO:0004569,1,0.995366990826165,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
1891,GO:0004571,1,0.965900455526212,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
1892,GO:0004572,1,0.990755199849228,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
1893,GO:0004573,1,0.995364681891695,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
1894,GO:0004574,1,0.995366969599153,0,1,oligo-1,6-glucosidase activity,MF,
1895,GO:0004576,1,0.901156876579371,0,10,oligosaccharyl transferase activity,MF,
1896,GO:0004577,1,0.97611297675686,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
1897,GO:0004578,1,0.995366990652136,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
1898,GO:0004579,1,0.916803393169647,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
1899,GO:0004581,1,0.98295045495779,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
1900,GO:0004582,1,0.937475638075318,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
1901,GO:0004583,1,0.977627735608405,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
1902,GO:0004584,1,0.995089608720626,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
1903,GO:0004586,1,0.984925368459301,0,3,ornithine decarboxylase activity,MF,
1904,GO:0004587,1,0.993628847786826,0,1,ornithine-oxo-acid transaminase activity,MF,
1905,GO:0004588,1,0.995354796413888,0,1,orotate phosphoribosyltransferase activity,MF,
1906,GO:0004590,1,0.995354796413888,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
1907,GO:0004591,1,0.972163813980307,0,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
1908,GO:0004594,1,0.97812724267976,0,4,pantothenate kinase activity,MF,
1909,GO:0004595,1,0.994951632506514,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
1910,GO:0004596,1,0.920611183654373,0,10,peptide alpha-N-acetyltransferase activity,MF,
1911,GO:0004597,1,0.995366973505144,0,1,peptide-aspartate beta-dioxygenase activity,MF,
1912,GO:0004598,1,0.995366983442151,0,1,peptidylamidoglycolate lyase activity,MF,
1913,GO:0004601,1,0.664864288816709,0,28,peroxidase activity,MF,
1914,GO:0004602,1,0.76561040991211,0,15,glutathione peroxidase activity,MF,
1915,GO:0004605,1,0.986160213127068,0,3,phosphatidate cytidylyltransferase activity,MF,
1916,GO:0004607,1,0.986301259180679,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
1917,GO:0004608,1,0.979334613632256,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
1918,GO:0004609,1,0.989784834527142,0,2,phosphatidylserine decarboxylase activity,MF,
1919,GO:0004610,1,0.993736287234375,0,1,phosphoacetylglucosamine mutase activity,MF,
1920,GO:0004611,1,0.993533089308813,0,1,phosphoenolpyruvate carboxykinase activity,MF,
1921,GO:0004613,1,0.993533089308813,0,1,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
1922,GO:0004614,1,0.97987119824812,0,4,phosphoglucomutase activity,MF,
1923,GO:0004615,1,0.98018839221348,0,2,phosphomannomutase activity,MF,
1924,GO:0004616,1,0.982451195436697,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
1925,GO:0004617,1,0.993859261278676,0,1,phosphoglycerate dehydrogenase activity,MF,
1926,GO:0004618,1,0.995191633702289,0,1,phosphoglycerate kinase activity,MF,
1927,GO:0004619,1,0.984800719828568,0,2,phosphoglycerate mutase activity,MF,
1928,GO:0004620,1,0.702249336564865,0,60,phospholipase activity,MF,
1929,GO:0004621,1,0.994930769572645,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
1930,GO:0004622,1,0.918003116547866,0,16,lysophospholipase activity,MF,
1931,GO:0004623,1,0.877466815716014,0,20,phospholipase A2 activity,MF,
1932,GO:0004629,1,0.922015841444726,0,15,phospholipase C activity,MF,
1933,GO:0004630,1,0.970270775694086,0,5,phospholipase D activity,MF,
1934,GO:0004631,1,0.985314893645308,0,1,phosphomevalonate kinase activity,MF,
1935,GO:0004632,1,0.984696072088379,0,1,phosphopantothenate--cysteine ligase activity,MF,
1936,GO:0004633,1,0.994730166570405,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
1937,GO:0004634,1,0.992389343356341,0,1,phosphopyruvate hydratase activity,MF,
1938,GO:0004637,1,0.995366935313711,0,1,phosphoribosylamine-glycine ligase activity,MF,
1939,GO:0004638,1,0.995366900241,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
1940,GO:0004639,1,0.995366900241,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
1941,GO:0004641,1,0.995366935313711,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
1942,GO:0004642,1,0.995366990826153,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
1943,GO:0004643,1,0.994257209385536,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
1944,GO:0004644,1,0.995366935313711,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
1945,GO:0004645,1,0.977030013520125,0,4,phosphorylase activity,MF,
1946,GO:0004647,1,0.988135214018486,0,2,phosphoserine phosphatase activity,MF,
1947,GO:0004648,1,0.994358590243411,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
1948,GO:0004649,1,0.986496401216824,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
1949,GO:0004651,1,0.985920103013545,0,2,polynucleotide 5'-phosphatase activity,MF,
1950,GO:0004652,1,0.96306821851878,0,8,polynucleotide adenylyltransferase activity,MF,
1951,GO:0004653,1,0.9457771529031,0,12,polypeptide N-acetylgalactosaminyltransferase activity,MF,
1952,GO:0004654,1,0.995366990826165,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
1953,GO:0004655,1,0.99536682318669,0,1,porphobilinogen synthase activity,MF,
1954,GO:0004656,1,0.985572504042598,0,3,procollagen-proline 4-dioxygenase activity,MF,
1955,GO:0004657,1,0.994730166570405,0,1,proline dehydrogenase activity,MF,
1956,GO:0004658,1,0.987713806878004,0,2,propionyl-CoA carboxylase activity,MF,
1957,GO:0004659,1,0.908369692910263,0,15,prenyltransferase activity,MF,
1958,GO:0004660,1,0.985430248774086,0,2,protein farnesyltransferase activity,MF,
1959,GO:0004661,1,0.964036976926513,0,5,protein geranylgeranyltransferase activity,MF,
1960,GO:0004662,1,0.985428422373189,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
1961,GO:0004663,1,0.968528092837133,0,4,Rab geranylgeranyltransferase activity,MF,
1962,GO:0004666,1,0.990755199849292,0,2,prostaglandin-endoperoxide synthase activity,MF,
1963,GO:0004668,1,0.99536682795566,0,1,protein-arginine deiminase activity,MF,
1964,GO:0004671,1,0.995366990826165,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
1965,GO:0004672,1,0.0745510996932686,0,475,protein kinase activity,MF,
1966,GO:0004673,1,0.968904408683397,0,2,protein histidine kinase activity,MF,
1967,GO:0004674,1,0.118985725532355,0,397,protein serine/threonine kinase activity,MF,
1968,GO:0004675,1,0.94265207075884,0,12,transmembrane receptor protein serine/threonine kinase activity,MF,
1969,GO:0004676,1,0.99536699082606,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
1970,GO:0004677,1,0.986164043836256,0,3,DNA-dependent protein kinase activity,MF,
1971,GO:0004679,1,0.963842933114147,0,7,AMP-activated protein kinase activity,MF,
1972,GO:0004683,1,0.88565094401658,0,22,calmodulin-dependent protein kinase activity,MF,
1973,GO:0004686,1,0.995366990826047,0,1,elongation factor-2 kinase activity,MF,
1974,GO:0004687,1,0.990755199849032,0,2,myosin light chain kinase activity,MF,
1975,GO:0004689,1,0.969441919669049,0,5,phosphorylase kinase activity,MF,
1976,GO:0004690,1,0.964148737246506,0,7,cyclic nucleotide-dependent protein kinase activity,MF,
1977,GO:0004691,1,0.968638094389861,0,6,cAMP-dependent protein kinase activity,MF,
1978,GO:0004692,1,0.995366988401088,0,1,cGMP-dependent protein kinase activity,MF,
1979,GO:0004693,1,0.816939882820211,0,30,cyclin-dependent protein serine/threonine kinase activity,MF,
1980,GO:0004694,1,0.981590805112385,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
1981,GO:0004697,1,0.940449421508853,0,13,protein kinase C activity,MF,
1982,GO:0004698,1,0.995366990825981,0,1,calcium-dependent protein kinase C activity,MF,
1983,GO:0004699,1,0.986163924652167,0,3,calcium-independent protein kinase C activity,MF,
1984,GO:0004702,1,0.645368859706438,0,87,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,
1985,GO:0004703,1,0.990709690719688,0,2,G-protein coupled receptor kinase activity,MF,
1986,GO:0004704,1,0.965626384260921,0,5,NF-kappaB-inducing kinase activity,MF,
1987,GO:0004705,1,0.978231498499041,0,3,JUN kinase activity,MF,
1988,GO:0004706,1,0.986164448611511,0,3,JUN kinase kinase kinase activity,MF,
1989,GO:0004707,1,0.930103646897336,0,12,MAP kinase activity,MF,
1990,GO:0004708,1,0.937709032535035,0,12,MAP kinase kinase activity,MF,
1991,GO:0004709,1,0.788748441543291,0,51,MAP kinase kinase kinase activity,MF,
1992,GO:0004711,1,0.964750802335515,0,7,ribosomal protein S6 kinase activity,MF,
1993,GO:0004712,1,0.823555783782838,0,36,protein serine/threonine/tyrosine kinase activity,MF,
1994,GO:0004713,1,0.557128528337421,0,111,protein tyrosine kinase activity,MF,
1995,GO:0004714,1,0.823604588361635,0,38,transmembrane receptor protein tyrosine kinase activity,MF,
1996,GO:0004715,1,0.863407304957454,0,31,non-membrane spanning protein tyrosine kinase activity,MF,
1997,GO:0004716,1,0.972470426034332,0,6,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,
1998,GO:0004719,1,0.982413303427743,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
1999,GO:0004720,1,0.97677322965655,0,5,protein-lysine 6-oxidase activity,MF,
2002,GO:0004723,1,0.967313128426104,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
2003,GO:0004725,1,0.622100551320305,0,75,protein tyrosine phosphatase activity,MF,
2004,GO:0004726,1,0.95223397029452,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
2005,GO:0004727,1,0.994044997930392,0,1,prenylated protein tyrosine phosphatase activity,MF,
2006,GO:0004728,1,0.995333062328682,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
2007,GO:0004729,1,0.991680251628529,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
2008,GO:0004730,1,0.990810493933111,0,1,pseudouridylate synthase activity,MF,
2009,GO:0004731,1,0.990562489304417,0,2,purine-nucleoside phosphorylase activity,MF,
2010,GO:0004733,1,0.995366940743845,0,1,pyridoxamine-phosphate oxidase activity,MF,
2011,GO:0004735,1,0.984166259295039,0,2,pyrroline-5-carboxylate reductase activity,MF,
2012,GO:0004736,1,0.995366990826112,0,1,pyruvate carboxylase activity,MF,
2013,GO:0004738,1,0.97082501903759,0,5,pyruvate dehydrogenase activity,MF,
2014,GO:0004739,1,0.984458370816706,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2015,GO:0004740,1,0.985745750022463,0,3,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
2016,GO:0004741,1,0.986164528826947,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2017,GO:0004742,1,0.995366990826152,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2018,GO:0004743,1,0.995366574475227,0,1,pyruvate kinase activity,MF,
2019,GO:0004745,1,0.945934910972515,0,7,retinol dehydrogenase activity,MF,
2020,GO:0004747,1,0.983497046466413,0,1,ribokinase activity,MF,
2021,GO:0004748,1,0.986164288990761,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2022,GO:0004749,1,0.978117867393952,0,4,ribose phosphate diphosphokinase activity,MF,
2023,GO:0004750,1,0.994954042250768,0,1,ribulose-phosphate 3-epimerase activity,MF,
2024,GO:0004751,1,0.992547930287484,0,1,ribose-5-phosphate isomerase activity,MF,
2025,GO:0004753,1,0.995366990826125,0,1,saccharopine dehydrogenase activity,MF,
2026,GO:0004756,1,0.9902195563411,0,2,selenide, water dikinase activity,MF,
2027,GO:0004757,1,0.987947906318411,0,1,sepiapterin reductase activity,MF,
2028,GO:0004758,1,0.974623127353639,0,5,serine C-palmitoyltransferase activity,MF,
2029,GO:0004766,1,0.984922138755743,0,1,spermidine synthase activity,MF,
2030,GO:0004767,1,0.96871375928967,0,5,sphingomyelin phosphodiesterase activity,MF,
2031,GO:0004768,1,0.986130502895375,0,3,stearoyl-CoA 9-desaturase activity,MF,
2032,GO:0004769,1,0.982649015560594,0,1,steroid delta-isomerase activity,MF,
2033,GO:0004771,1,0.977030714824701,0,5,sterol esterase activity,MF,
2034,GO:0004772,1,0.995366921815792,0,1,sterol O-acyltransferase activity,MF,
2035,GO:0004773,1,0.995366990826099,0,1,steryl-sulfatase activity,MF,
2036,GO:0004774,1,0.977790562912438,0,3,succinate-CoA ligase activity,MF,
2037,GO:0004775,1,0.982629511933808,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
2038,GO:0004776,1,0.983144108121356,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
2039,GO:0004777,1,0.995366990826151,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2040,GO:0004779,1,0.990698230093962,0,2,sulfate adenylyltransferase activity,MF,
2041,GO:0004781,1,0.990698230093962,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2042,GO:0004782,1,0.995362644056522,0,1,sulfinoalanine decarboxylase activity,MF,
2043,GO:0004784,1,0.935626518488152,0,4,superoxide dismutase activity,MF,
2044,GO:0004790,1,0.99531532720628,0,1,thioether S-methyltransferase activity,MF,
2045,GO:0004791,1,0.935885743943681,0,6,thioredoxin-disulfide reductase activity,MF,
2046,GO:0004792,1,0.965846025521525,0,3,thiosulfate sulfurtransferase activity,MF,
2047,GO:0004793,1,0.990054307114572,0,2,threonine aldolase activity,MF,
2048,GO:0004794,1,0.987046983026989,0,1,L-threonine ammonia-lyase activity,MF,
2049,GO:0004795,1,0.994334404277009,0,1,threonine synthase activity,MF,
2050,GO:0004797,1,0.985353091065045,0,2,thymidine kinase activity,MF,
2051,GO:0004798,1,0.977743114261659,0,2,thymidylate kinase activity,MF,
2052,GO:0004799,1,0.989782138899612,0,1,thymidylate synthase activity,MF,
2053,GO:0004801,1,0.984357684555215,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2054,GO:0004802,1,0.994312084263515,0,1,transketolase activity,MF,
2055,GO:0004803,1,0.990755199849267,0,2,transposase activity,MF,
2056,GO:0004806,1,0.953080820662554,0,10,triglyceride lipase activity,MF,
2057,GO:0004807,1,0.987993933211803,0,1,triose-phosphate isomerase activity,MF,
2058,GO:0004809,1,0.983545048997106,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2059,GO:0004810,1,0.994896215629768,0,1,tRNA adenylyltransferase activity,MF,
2060,GO:0004812,1,0.780722738587706,0,44,aminoacyl-tRNA ligase activity,MF,
2061,GO:0004813,1,0.983865902025926,0,3,alanine-tRNA ligase activity,MF,
2062,GO:0004814,1,0.982004671907372,0,3,arginine-tRNA ligase activity,MF,
2063,GO:0004815,1,0.990420194681427,0,2,aspartate-tRNA ligase activity,MF,
2064,GO:0004816,1,0.990290053875948,0,2,asparagine-tRNA ligase activity,MF,
2065,GO:0004817,1,0.98822631276664,0,2,cysteine-tRNA ligase activity,MF,
2066,GO:0004818,1,0.990755199512449,0,2,glutamate-tRNA ligase activity,MF,
2067,GO:0004819,1,0.990607496364114,0,2,glutamine-tRNA ligase activity,MF,
2068,GO:0004820,1,0.985326027555134,0,2,glycine-tRNA ligase activity,MF,
2069,GO:0004821,1,0.988856312991786,0,2,histidine-tRNA ligase activity,MF,
2070,GO:0004822,1,0.990755171166203,0,2,isoleucine-tRNA ligase activity,MF,
2071,GO:0004823,1,0.990755199849279,0,2,leucine-tRNA ligase activity,MF,
2072,GO:0004824,1,0.994314330594104,0,1,lysine-tRNA ligase activity,MF,
2073,GO:0004825,1,0.990754399909387,0,2,methionine-tRNA ligase activity,MF,
2074,GO:0004826,1,0.971209610008157,0,5,phenylalanine-tRNA ligase activity,MF,
2075,GO:0004827,1,0.97276416411755,0,3,proline-tRNA ligase activity,MF,
2076,GO:0004828,1,0.987245692857529,0,2,serine-tRNA ligase activity,MF,
2077,GO:0004829,1,0.985925735787033,0,3,threonine-tRNA ligase activity,MF,
2078,GO:0004830,1,0.990748641298346,0,2,tryptophan-tRNA ligase activity,MF,
2079,GO:0004831,1,0.989909296431112,0,2,tyrosine-tRNA ligase activity,MF,
2080,GO:0004832,1,0.986164513530674,0,3,valine-tRNA ligase activity,MF,
2081,GO:0004833,1,0.989608297565847,0,1,tryptophan 2,3-dioxygenase activity,MF,
2082,GO:0004835,1,0.995366990826151,0,1,tubulin-tyrosine ligase activity,MF,
2083,GO:0004839,1,0.976918614480335,0,5,ubiquitin activating enzyme activity,MF,
2085,GO:0004843,1,0.656342994454947,0,70,thiol-dependent ubiquitin-specific protease activity,MF,
2086,GO:0004844,1,0.955691301810265,0,5,uracil DNA N-glycosylase activity,MF,
2087,GO:0004849,1,0.962537483889291,0,5,uridine kinase activity,MF,
2088,GO:0004850,1,0.992316997393354,0,1,uridine phosphorylase activity,MF,
2089,GO:0004852,1,0.986351894952717,0,1,uroporphyrinogen-III synthase activity,MF,
2090,GO:0004853,1,0.986851041569656,0,1,uroporphyrinogen decarboxylase activity,MF,
2091,GO:0004854,1,0.990755199849267,0,2,xanthine dehydrogenase activity,MF,
2092,GO:0004855,1,0.995366990826125,0,1,xanthine oxidase activity,MF,
2093,GO:0004856,1,0.995366980723973,0,1,xylulokinase activity,MF,
2095,GO:0004859,1,0.917394491168669,0,7,phospholipase inhibitor activity,MF,
2096,GO:0004860,1,0.619563286827495,0,71,protein kinase inhibitor activity,MF,
2097,GO:0004861,1,0.911008234944794,0,11,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,
2098,GO:0004862,1,0.955036597683141,0,7,cAMP-dependent protein kinase inhibitor activity,MF,
2099,GO:0004864,1,0.847386820842341,0,23,protein phosphatase inhibitor activity,MF,
2100,GO:0004865,1,0.930167988132867,0,6,protein serine/threonine phosphatase inhibitor activity,MF,
2101,GO:0004866,1,0.45765377485957,0,77,endopeptidase inhibitor activity,MF,
2102,GO:0004867,1,0.691300584049829,0,40,serine-type endopeptidase inhibitor activity,MF,
2103,GO:0004869,1,0.730861188910217,0,29,cysteine-type endopeptidase inhibitor activity,MF,
2105,GO:0004874,1,0.990755199849241,0,2,aryl hydrocarbon receptor activity,MF,
2107,GO:0004882,1,0.995366870768743,0,1,androgen receptor activity,MF,
2108,GO:0004883,1,0.995366990826085,0,1,glucocorticoid receptor activity,MF,
2109,GO:0004886,1,0.990754769831886,0,2,9-cis retinoic acid receptor activity,MF,
2110,GO:0004887,1,0.978323596250081,0,4,thyroid hormone receptor activity,MF,
2112,GO:0004890,1,0.995366801879365,0,1,GABA-A receptor activity,MF,
2113,GO:0004896,1,0.778347729230224,0,43,cytokine receptor activity,MF,
2114,GO:0004897,1,0.986164369641592,0,3,ciliary neurotrophic factor receptor activity,MF,
2115,GO:0004900,1,0.992667316171941,0,1,erythropoietin receptor activity,MF,
2116,GO:0004904,1,0.967512821669503,0,5,interferon receptor activity,MF,
2117,GO:0004905,1,0.982698138901223,0,2,type I interferon receptor activity,MF,
2118,GO:0004906,1,0.989134172970956,0,2,interferon-gamma receptor activity,MF,
2119,GO:0004908,1,0.967609351221799,0,5,interleukin-1 receptor activity,MF,
2120,GO:0004909,1,0.988945821519274,0,2,interleukin-1, Type I, activating receptor activity,MF,
2121,GO:0004910,1,0.98755889731644,0,1,interleukin-1, Type II, blocking receptor activity,MF,
2122,GO:0004913,1,0.99513483238456,0,1,interleukin-4 receptor activity,MF,
2123,GO:0004915,1,0.990755037724745,0,2,interleukin-6 receptor activity,MF,
2124,GO:0004917,1,0.992261977683044,0,1,interleukin-7 receptor activity,MF,
2125,GO:0004918,1,0.995255140810226,0,1,interleukin-8 receptor activity,MF,
2126,GO:0004920,1,0.977597633944882,0,4,interleukin-10 receptor activity,MF,
2127,GO:0004921,1,0.99536682795566,0,1,interleukin-11 receptor activity,MF,
2128,GO:0004923,1,0.990755037724537,0,2,leukemia inhibitory factor receptor activity,MF,
2129,GO:0004924,1,0.98616435419131,0,3,oncostatin-M receptor activity,MF,
2131,GO:0004931,1,0.993926676033175,0,1,extracellularly ATP-gated cation channel activity,MF,
2132,GO:0004935,1,0.988586580265476,0,2,adrenergic receptor activity,MF,
2133,GO:0004936,1,0.994605617896706,0,1,alpha-adrenergic receptor activity,MF,
2134,GO:0004937,1,0.994605617896706,0,1,alpha1-adrenergic receptor activity,MF,
2135,GO:0004939,1,0.99394869310473,0,1,beta-adrenergic receptor activity,MF,
2136,GO:0004941,1,0.99394869310473,0,1,beta2-adrenergic receptor activity,MF,
2137,GO:0004945,1,0.983172215556849,0,1,angiotensin type II receptor activity,MF,
2138,GO:0004947,1,0.980518917785836,0,2,bradykinin receptor activity,MF,
2139,GO:0004948,1,0.995366990826164,0,1,calcitonin receptor activity,MF,
2140,GO:0004950,1,0.971385540508689,0,6,chemokine receptor activity,MF,
2141,GO:0004952,1,0.968775579355818,0,2,dopamine neurotransmitter receptor activity,MF,
2142,GO:0004953,1,0.967356206697345,0,5,icosanoid receptor activity,MF,
2143,GO:0004954,1,0.983060923134813,0,3,prostanoid receptor activity,MF,
2144,GO:0004955,1,0.988121842933852,0,2,prostaglandin receptor activity,MF,
2145,GO:0004957,1,0.995366924770142,0,1,prostaglandin E receptor activity,MF,
2146,GO:0004960,1,0.994878946369531,0,1,thromboxane receptor activity,MF,
2147,GO:0004961,1,0.994878946369531,0,1,thromboxane A2 receptor activity,MF,
2148,GO:0004962,1,0.995366988506712,0,1,endothelin receptor activity,MF,
2149,GO:0004965,1,0.990755199849267,0,2,G-protein coupled GABA receptor activity,MF,
2150,GO:0004966,1,0.958967750218899,0,3,galanin receptor activity,MF,
2151,GO:0004968,1,0.995366990826099,0,1,gonadotropin-releasing hormone receptor activity,MF,
2152,GO:0004969,1,0.990754840953557,0,2,histamine receptor activity,MF,
2153,GO:0004970,1,0.990755199849279,0,2,ionotropic glutamate receptor activity,MF,
2154,GO:0004972,1,0.990755199849279,0,2,NMDA glutamate receptor activity,MF,
2155,GO:0004974,1,0.984027790130879,0,2,leukotriene receptor activity,MF,
2156,GO:0004977,1,0.98818310390562,0,2,melanocortin receptor activity,MF,
2157,GO:0004979,1,0.992783290737664,0,1,beta-endorphin receptor activity,MF,
2158,GO:0004980,1,0.995366759262696,0,1,melanocyte-stimulating hormone receptor activity,MF,
2159,GO:0004984,1,0.951904344073561,0,3,olfactory receptor activity,MF,
2160,GO:0004985,1,0.978188503658292,0,3,opioid receptor activity,MF,
2161,GO:0004990,1,0.995366990826152,0,1,oxytocin receptor activity,MF,
2162,GO:0004992,1,0.995366990826138,0,1,platelet activating factor receptor activity,MF,
2163,GO:0004993,1,0.973240272848599,0,3,G-protein coupled serotonin receptor activity,MF,
2164,GO:0004996,1,0.995366989784868,0,1,thyroid-stimulating hormone receptor activity,MF,
2165,GO:0004998,1,0.995366990826151,0,1,transferrin receptor activity,MF,
2166,GO:0004999,1,0.995366450921413,0,1,vasoactive intestinal polypeptide receptor activity,MF,
2167,GO:0005000,1,0.990755050869491,0,2,vasopressin receptor activity,MF,
2168,GO:0005001,1,0.95411191521076,0,10,transmembrane receptor protein tyrosine phosphatase activity,MF,
2169,GO:0005003,1,0.933947990089764,0,11,ephrin receptor activity,MF,
2170,GO:0005004,1,0.995366990826099,0,1,GPI-linked ephrin receptor activity,MF,
2171,GO:0005005,1,0.933947990089764,0,11,transmembrane-ephrin receptor activity,MF,
2172,GO:0005006,1,0.990704294244836,0,2,epidermal growth factor-activated receptor activity,MF,
2173,GO:0005007,1,0.977045681522577,0,5,fibroblast growth factor-activated receptor activity,MF,
2174,GO:0005008,1,0.995366990826085,0,1,hepatocyte growth factor-activated receptor activity,MF,
2175,GO:0005009,1,0.995366990825967,0,1,insulin-activated receptor activity,MF,
2176,GO:0005010,1,0.986164531023285,0,3,insulin-like growth factor-activated receptor activity,MF,
2177,GO:0005011,1,0.995366990826165,0,1,macrophage colony-stimulating factor receptor activity,MF,
2178,GO:0005021,1,0.990647811994308,0,2,vascular endothelial growth factor-activated receptor activity,MF,
2179,GO:0005024,1,0.968010834526226,0,7,transforming growth factor beta-activated receptor activity,MF,
2180,GO:0005025,1,0.986164187987018,0,3,transforming growth factor beta receptor activity, type I,MF,
2181,GO:0005026,1,0.995366990826165,0,1,transforming growth factor beta receptor activity, type II,MF,
2182,GO:0005030,1,0.995366990826072,0,1,neurotrophin receptor activity,MF,
2183,GO:0005031,1,0.88476136667711,0,17,tumor necrosis factor-activated receptor activity,MF,
2184,GO:0005034,1,0.995366803504279,0,1,osmosensor activity,MF,
2185,GO:0005035,1,0.88476136667711,0,17,death receptor activity,MF,
2186,GO:0005041,1,0.956733481056336,0,9,low-density lipoprotein particle receptor activity,MF,
2187,GO:0005042,1,0.995366990826164,0,1,netrin receptor activity,MF,
2188,GO:0005044,1,0.879772229456187,0,21,scavenger receptor activity,MF,
2189,GO:0005046,1,0.984817457230051,0,2,KDEL sequence binding,MF,
2190,GO:0005047,1,0.971072862239625,0,5,signal recognition particle binding,MF,
2191,GO:0005048,1,0.791842521729859,0,39,signal sequence binding,MF,
2192,GO:0005049,1,0.960454898528918,0,8,nuclear export signal receptor activity,MF,
2193,GO:0005052,1,0.990755004171381,0,2,peroxisome matrix targeting signal-1 binding,MF,
2194,GO:0005053,1,0.988386878097124,0,1,peroxisome matrix targeting signal-2 binding,MF,
2195,GO:0005055,1,0.977253211589571,0,2,laminin receptor activity,MF,
2196,GO:0005057,1,0.539334064999241,0,119,signal transducer activity, downstream of receptor,MF,
2197,GO:0005068,1,0.964872272028116,0,7,transmembrane receptor protein tyrosine kinase adaptor activity,MF,
2198,GO:0005070,1,0.834539025675697,0,35,SH3/SH2 adaptor activity,MF,
2199,GO:0005072,1,0.963332213553826,0,8,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2200,GO:0005078,1,0.968010796725127,0,7,MAP-kinase scaffold activity,MF,
2201,GO:0005080,1,0.786911814627172,0,35,protein kinase C binding,MF,
2203,GO:0005086,1,0.904792795501193,0,15,ARF guanyl-nucleotide exchange factor activity,MF,
2204,GO:0005087,1,0.955485158570531,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2206,GO:0005089,1,0.763407269268286,0,58,Rho guanyl-nucleotide exchange factor activity,MF,
2207,GO:0005090,1,0.994551950924641,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2208,GO:0005092,1,0.907376516223919,0,13,GDP-dissociation inhibitor activity,MF,
2209,GO:0005093,1,0.99034523096781,0,2,Rab GDP-dissociation inhibitor activity,MF,
2210,GO:0005094,1,0.97671147622898,0,2,Rho GDP-dissociation inhibitor activity,MF,
2211,GO:0005095,1,0.908675235568894,0,11,GTPase inhibitor activity,MF,
2214,GO:0005104,1,0.953381018958193,0,10,fibroblast growth factor receptor binding,MF,
2215,GO:0005105,1,0.994897526876748,0,1,type 1 fibroblast growth factor receptor binding,MF,
2216,GO:0005109,1,0.873372922813546,0,23,frizzled binding,MF,
2217,GO:0005112,1,0.924722778032877,0,15,Notch binding,MF,
2218,GO:0005113,1,0.975915156217398,0,5,patched binding,MF,
2219,GO:0005114,1,0.96350792723089,0,7,type II transforming growth factor beta receptor binding,MF,
2220,GO:0005115,1,0.995366990826125,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2221,GO:0005119,1,0.990755123954766,0,2,smoothened binding,MF,
2222,GO:0005123,1,0.923610321728195,0,14,death receptor binding,MF,
2223,GO:0005124,1,0.989506759323632,0,2,scavenger receptor binding,MF,
2224,GO:0005125,1,0.457991631934299,0,78,cytokine activity,MF,
2225,GO:0005126,1,0.304693011246325,0,135,cytokine receptor binding,MF,
2226,GO:0005127,1,0.983018675966304,0,3,ciliary neurotrophic factor receptor binding,MF,
2227,GO:0005128,1,0.995366867364672,0,1,erythropoietin receptor binding,MF,
2228,GO:0005129,1,0.974561039035535,0,1,granulocyte macrophage colony-stimulating factor receptor binding,MF,
2229,GO:0005131,1,0.98093128726376,0,4,growth hormone receptor binding,MF,
2230,GO:0005132,1,0.97058028410841,0,2,type I interferon receptor binding,MF,
2231,GO:0005134,1,0.984258744259905,0,3,interleukin-2 receptor binding,MF,
2232,GO:0005135,1,0.995366867364672,0,1,interleukin-3 receptor binding,MF,
2233,GO:0005136,1,0.995366780943412,0,1,interleukin-4 receptor binding,MF,
2234,GO:0005137,1,0.994548159528985,0,1,interleukin-5 receptor binding,MF,
2235,GO:0005138,1,0.959186313116309,0,5,interleukin-6 receptor binding,MF,
2236,GO:0005141,1,0.990348766719998,0,1,interleukin-10 receptor binding,MF,
2237,GO:0005142,1,0.995072680832062,0,1,interleukin-11 receptor binding,MF,
2238,GO:0005143,1,0.989049864390831,0,2,interleukin-12 receptor binding,MF,
2239,GO:0005146,1,0.986130913566835,0,2,leukemia inhibitory factor receptor binding,MF,
2240,GO:0005149,1,0.945874226176367,0,9,interleukin-1 receptor binding,MF,
2241,GO:0005150,1,0.987448363210578,0,2,interleukin-1, Type I receptor binding,MF,
2242,GO:0005151,1,0.98744838442157,0,2,interleukin-1, Type II receptor binding,MF,
2243,GO:0005152,1,0.982872451409122,0,3,interleukin-1 receptor antagonist activity,MF,
2244,GO:0005153,1,0.990754577179139,0,2,interleukin-8 receptor binding,MF,
2245,GO:0005154,1,0.844438470305427,0,26,epidermal growth factor receptor binding,MF,
2246,GO:0005157,1,0.995194333493049,0,1,macrophage colony-stimulating factor receptor binding,MF,
2247,GO:0005158,1,0.918247285737936,0,18,insulin receptor binding,MF,
2248,GO:0005159,1,0.923532618907529,0,13,insulin-like growth factor receptor binding,MF,
2249,GO:0005160,1,0.857941941452742,0,25,transforming growth factor beta receptor binding,MF,
2250,GO:0005161,1,0.954611569141872,0,10,platelet-derived growth factor receptor binding,MF,
2251,GO:0005164,1,0.845109334732346,0,21,tumor necrosis factor receptor binding,MF,
2252,GO:0005165,1,0.952434982839723,0,7,neurotrophin receptor binding,MF,
2253,GO:0005166,1,0.979355933200066,0,1,neurotrophin p75 receptor binding,MF,
2254,GO:0005167,1,0.952434982839723,0,7,neurotrophin TRK receptor binding,MF,
2255,GO:0005168,1,0.972518074472671,0,6,neurotrophin TRKA receptor binding,MF,
2256,GO:0005169,1,0.974817482965544,0,2,neurotrophin TRKB receptor binding,MF,
2257,GO:0005170,1,0.995366990826152,0,1,neurotrophin TRKC receptor binding,MF,
2258,GO:0005171,1,0.993986681444361,0,1,hepatocyte growth factor receptor binding,MF,
2259,GO:0005172,1,0.932116447125017,0,8,vascular endothelial growth factor receptor binding,MF,
2260,GO:0005173,1,0.986164531023636,0,3,stem cell factor receptor binding,MF,
2261,GO:0005174,1,0.994911790068004,0,1,CD40 receptor binding,MF,
2262,GO:0005175,1,0.972014659630343,0,1,CD27 receptor binding,MF,
2263,GO:0005176,1,0.977747050729698,0,2,ErbB-2 class receptor binding,MF,
2264,GO:0005178,1,0.656746982621075,0,77,integrin binding,MF,
2265,GO:0005179,1,0.834320907284036,0,20,hormone activity,MF,
2266,GO:0005183,1,0.991323192844333,0,1,gonadotropin hormone-releasing hormone activity,MF,
2267,GO:0005184,1,0.952401798404747,0,3,neuropeptide hormone activity,MF,
2269,GO:0005199,1,0.995366909861015,0,1,structural constituent of cell wall,MF,
2270,GO:0005200,1,0.605639232735667,0,79,structural constituent of cytoskeleton,MF,
2272,GO:0005212,1,0.962555277399298,0,3,structural constituent of eye lens,MF,
2275,GO:0005217,1,0.911963905131918,0,16,intracellular ligand-gated ion channel activity,MF,
2276,GO:0005219,1,0.974316150992228,0,2,ryanodine-sensitive calcium-release channel activity,MF,
2277,GO:0005220,1,0.986164531023026,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2278,GO:0005225,1,0.963524578379097,0,8,volume-sensitive anion channel activity,MF,
2279,GO:0005227,1,0.924372067382287,0,13,calcium activated cation channel activity,MF,
2280,GO:0005229,1,0.954536789652528,0,10,intracellular calcium activated chloride channel activity,MF,
2281,GO:0005230,1,0.956537729564183,0,9,extracellular ligand-gated ion channel activity,MF,
2282,GO:0005231,1,0.965467063833026,0,7,excitatory extracellular ligand-gated ion channel activity,MF,
2283,GO:0005234,1,0.995366990826164,0,1,extracellularly glutamate-gated ion channel activity,MF,
2284,GO:0005237,1,0.995366801879365,0,1,inhibitory extracellular ligand-gated ion channel activity,MF,
2285,GO:0005242,1,0.967169124886331,0,7,inward rectifier potassium channel activity,MF,
2286,GO:0005243,1,0.965437230606628,0,7,gap junction channel activity,MF,
2288,GO:0005245,1,0.926732661236748,0,13,voltage-gated calcium channel activity,MF,
2289,GO:0005246,1,0.870351207870904,0,18,calcium channel regulator activity,MF,
2290,GO:0005247,1,0.955159767685607,0,7,voltage-gated chloride channel activity,MF,
2291,GO:0005248,1,0.957079514913082,0,9,voltage-gated sodium channel activity,MF,
2292,GO:0005249,1,0.89280216837163,0,24,voltage-gated potassium channel activity,MF,
2293,GO:0005250,1,0.995366990826165,0,1,A-type (transient outward) potassium channel activity,MF,
2294,GO:0005251,1,0.96256331336492,0,8,delayed rectifier potassium channel activity,MF,
2299,GO:0005267,1,0.839576178428458,0,33,potassium channel activity,MF,
2300,GO:0005272,1,0.929968476820656,0,15,sodium channel activity,MF,
2301,GO:0005275,1,0.995366701249256,0,1,amine transmembrane transporter activity,MF,
2302,GO:0005280,1,0.986163398788234,0,3,amino acid:proton symporter activity,MF,
2303,GO:0005283,1,0.966411816439416,0,7,amino acid:sodium symporter activity,MF,
2304,GO:0005287,1,0.990486364538481,0,2,high-affinity basic amino acid transmembrane transporter activity,MF,
2305,GO:0005289,1,0.990486364538481,0,2,high-affinity arginine transmembrane transporter activity,MF,
2306,GO:0005290,1,0.990753980346804,0,2,L-histidine transmembrane transporter activity,MF,
2307,GO:0005292,1,0.990486364538481,0,2,high-affinity lysine transmembrane transporter activity,MF,
2308,GO:0005294,1,0.995366990825956,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2309,GO:0005295,1,0.995366841160869,0,1,neutral amino acid:sodium symporter activity,MF,
2310,GO:0005298,1,0.995366990826152,0,1,proline:sodium symporter activity,MF,
2311,GO:0005308,1,0.995366958730868,0,1,creatine transmembrane transporter activity,MF,
2312,GO:0005309,1,0.995366958730868,0,1,creatine:sodium symporter activity,MF,
2313,GO:0005310,1,0.906008876992696,0,20,dicarboxylic acid transmembrane transporter activity,MF,
2314,GO:0005313,1,0.972516431609792,0,6,L-glutamate transmembrane transporter activity,MF,
2315,GO:0005314,1,0.990754109618731,0,2,high-affinity glutamate transmembrane transporter activity,MF,
2316,GO:0005315,1,0.986164403438719,0,3,inorganic phosphate transmembrane transporter activity,MF,
2317,GO:0005316,1,0.995366875990631,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2318,GO:0005319,1,0.604899757055112,0,80,lipid transporter activity,MF,
2319,GO:0005324,1,0.990350085896595,0,2,long-chain fatty acid transporter activity,MF,
2320,GO:0005326,1,0.888362898062316,0,24,neurotransmitter transporter activity,MF,
2321,GO:0005328,1,0.953035820503316,0,10,neurotransmitter:sodium symporter activity,MF,
2322,GO:0005329,1,0.990755199849267,0,2,dopamine transmembrane transporter activity,MF,
2323,GO:0005330,1,0.995366990826164,0,1,dopamine:sodium symporter activity,MF,
2324,GO:0005332,1,0.993724238835064,0,1,gamma-aminobutyric acid:sodium symporter activity,MF,
2325,GO:0005335,1,0.995366990826164,0,1,serotonin:sodium symporter activity,MF,
2326,GO:0005337,1,0.970780444998013,0,6,nucleoside transmembrane transporter activity,MF,
2327,GO:0005338,1,0.926654058105089,0,11,nucleotide-sugar transmembrane transporter activity,MF,
2328,GO:0005342,1,0.603895361658123,0,91,organic acid transmembrane transporter activity,MF,
2329,GO:0005343,1,0.931246565110977,0,13,organic acid:sodium symporter activity,MF,
2330,GO:0005344,1,0.993417007491667,0,1,oxygen carrier activity,MF,
2331,GO:0005345,1,0.96059163059814,0,5,purine nucleobase transmembrane transporter activity,MF,
2332,GO:0005346,1,0.931742506627427,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2333,GO:0005347,1,0.947413122780303,0,8,ATP transmembrane transporter activity,MF,
2334,GO:0005350,1,0.990133704303109,0,2,pyrimidine nucleobase transmembrane transporter activity,MF,
2335,GO:0005351,1,0.959923801539685,0,8,carbohydrate:proton symporter activity,MF,
2337,GO:0005365,1,0.990755199848914,0,2,myo-inositol transmembrane transporter activity,MF,
2338,GO:0005366,1,0.995366990826072,0,1,myo-inositol:proton symporter activity,MF,
2339,GO:0005367,1,0.995366990825877,0,1,myo-inositol:sodium symporter activity,MF,
2340,GO:0005368,1,0.995366990826086,0,1,taurine transmembrane transporter activity,MF,
2341,GO:0005369,1,0.995366990826086,0,1,taurine:sodium symporter activity,MF,
2342,GO:0005372,1,0.971122735813377,0,4,water transmembrane transporter activity,MF,
2343,GO:0005375,1,0.942051906211817,0,6,copper ion transmembrane transporter activity,MF,
2344,GO:0005381,1,0.963076865852074,0,6,iron ion transmembrane transporter activity,MF,
2345,GO:0005384,1,0.981594779928026,0,4,manganese ion transmembrane transporter activity,MF,
2346,GO:0005385,1,0.928339093694065,0,15,zinc ion transmembrane transporter activity,MF,
2347,GO:0005388,1,0.96352458071028,0,8,calcium-transporting ATPase activity,MF,
2348,GO:0005391,1,0.972012654143761,0,5,sodium:potassium-exchanging ATPase activity,MF,
2349,GO:0005402,1,0.945695558328316,0,11,carbohydrate:cation symporter activity,MF,
2350,GO:0005412,1,0.989770833951074,0,2,glucose:sodium symporter activity,MF,
2351,GO:0005415,1,0.990017653996545,0,2,nucleoside:sodium symporter activity,MF,
2352,GO:0005416,1,0.957473966509998,0,9,amino acid:cation symporter activity,MF,
2353,GO:0005427,1,0.995366793948851,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2354,GO:0005432,1,0.985665732855109,0,3,calcium:sodium antiporter activity,MF,
2355,GO:0005436,1,0.99075507167731,0,2,sodium:phosphate symporter activity,MF,
2357,GO:0005452,1,0.939926254115583,0,13,inorganic anion exchanger activity,MF,
2358,GO:0005456,1,0.992344262488714,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2359,GO:0005457,1,0.99075504581397,0,2,GDP-fucose transmembrane transporter activity,MF,
2360,GO:0005459,1,0.974919957928035,0,2,UDP-galactose transmembrane transporter activity,MF,
2361,GO:0005461,1,0.9953669908261,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2362,GO:0005462,1,0.989882095953693,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2363,GO:0005464,1,0.995366990826074,0,1,UDP-xylose transmembrane transporter activity,MF,
2364,GO:0005471,1,0.970166902814952,0,3,ATP:ADP antiporter activity,MF,
2365,GO:0005476,1,0.988231782052303,0,2,carnitine:acyl carnitine antiporter activity,MF,
2366,GO:0005477,1,0.995366958127338,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2367,GO:0005483,1,0.983464459126231,0,3,soluble NSF attachment protein activity,MF,
2368,GO:0005484,1,0.763543510944548,0,34,SNAP receptor activity,MF,
2370,GO:0005496,1,0.674684486586356,0,55,steroid binding,MF,
2371,GO:0005497,1,0.968499195143836,0,2,androgen binding,MF,
2372,GO:0005499,1,0.989454805003334,0,2,vitamin D binding,MF,
2373,GO:0005501,1,0.896590767664905,0,12,retinoid binding,MF,
2374,GO:0005502,1,0.995366990826165,0,1,11-cis retinal binding,MF,
2375,GO:0005503,1,0.995366990826165,0,1,all-trans retinal binding,MF,
2377,GO:0005506,1,0.546705971836092,0,89,iron ion binding,MF,
2378,GO:0005507,1,0.666276060016078,0,36,copper ion binding,MF,
2380,GO:0005513,1,0.948521616654369,0,7,detection of calcium ion,BP,
2383,GO:0005518,1,0.797455298716655,0,42,collagen binding,MF,
2384,GO:0005519,1,0.995366990797053,0,1,cytoskeletal regulatory protein binding,MF,
2385,GO:0005520,1,0.889009364788356,0,16,insulin-like growth factor binding,MF,
2386,GO:0005521,1,0.909552623205303,0,14,lamin binding,MF,
2387,GO:0005522,1,0.949546011547032,0,10,profilin binding,MF,
2388,GO:0005523,1,0.912642139264198,0,7,tropomyosin binding,MF,
2391,GO:0005527,1,0.86691854766917,0,12,macrolide binding,MF,
2392,GO:0005528,1,0.86691854766917,0,12,FK506 binding,MF,
2393,GO:0005534,1,0.977314795287339,0,3,galactose binding,MF,
2395,GO:0005537,1,0.955837134359657,0,8,mannose binding,MF,
2396,GO:0005539,1,0.475884431055753,0,102,glycosaminoglycan binding,MF,
2397,GO:0005540,1,0.947275251714652,0,8,hyaluronic acid binding,MF,
2398,GO:0005542,1,0.930714948274554,0,6,folic acid binding,MF,
2400,GO:0005544,1,0.821242279724501,0,33,calcium-dependent phospholipid binding,MF,
2401,GO:0005545,1,0.94573338689487,0,12,1-phosphatidylinositol binding,MF,
2402,GO:0005546,1,0.75104756812381,0,43,phosphatidylinositol-4,5-bisphosphate binding,MF,
2403,GO:0005547,1,0.837203779521968,0,29,phosphatidylinositol-3,4,5-trisphosphate binding,MF,
2404,GO:0005548,1,0.791995883958596,0,42,phospholipid transporter activity,MF,
2407,GO:0005577,1,0.986127458890115,0,3,fibrinogen complex,CC,
2408,GO:0005578,1,0.326927566314172,0,187,proteinaceous extracellular matrix,CC,
2409,GO:0005579,1,0.995366990826139,0,1,membrane attack complex,CC,
2410,GO:0005581,1,0.833205538251722,0,35,collagen trimer,CC,
2411,GO:0005583,1,0.959058562281559,0,9,fibrillar collagen trimer,CC,
2412,GO:0005584,1,0.990755199849241,0,2,collagen type I trimer,CC,
2413,GO:0005586,1,0.995366990826138,0,1,collagen type III trimer,CC,
2414,GO:0005587,1,0.977046177790034,0,5,collagen type IV trimer,CC,
2415,GO:0005588,1,0.986164531023455,0,3,collagen type V trimer,CC,
2416,GO:0005589,1,0.983932605447962,0,2,collagen type VI trimer,CC,
2417,GO:0005590,1,0.995366990825969,0,1,collagen type VII trimer,CC,
2418,GO:0005591,1,0.995346606520723,0,1,collagen type VIII trimer,CC,
2419,GO:0005592,1,0.99536699082606,0,1,collagen type XI trimer,CC,
2420,GO:0005593,1,0.98151122668036,0,4,FACIT collagen trimer,CC,
2421,GO:0005594,1,0.990670766057018,0,2,collagen type IX trimer,CC,
2422,GO:0005595,1,0.99536699082594,0,1,collagen type XII trimer,CC,
2423,GO:0005597,1,0.995366990826138,0,1,collagen type XVI trimer,CC,
2424,GO:0005598,1,0.995346606520723,0,1,short-chain collagen trimer,CC,
2425,GO:0005600,1,0.995366732943209,0,1,collagen type XIII trimer,CC,
2426,GO:0005604,1,0.677782645496386,0,67,basement membrane,CC,
2427,GO:0005605,1,0.907705180077787,0,17,basal lamina,CC,
2428,GO:0005606,1,0.986164531023391,0,3,laminin-1 complex,CC,
2429,GO:0005607,1,0.990755199849254,0,2,laminin-2 complex,CC,
2430,GO:0005608,1,0.990755199849057,0,2,laminin-3 complex,CC,
2431,GO:0005610,1,0.986164531023326,0,3,laminin-5 complex,CC,
2432,GO:0005614,1,0.963524291926725,0,8,interstitial matrix,CC,
2437,GO:0005635,1,0.0753550932127731,0,375,nuclear envelope,CC,
2438,GO:0005637,1,0.736438136515503,0,45,nuclear inner membrane,CC,
2439,GO:0005638,1,0.977413535014091,0,4,lamin filament,CC,
2440,GO:0005639,1,0.962116871390546,0,8,integral component of nuclear inner membrane,CC,
2441,GO:0005640,1,0.893396808117126,0,17,nuclear outer membrane,CC,
2442,GO:0005641,1,0.964539720926844,0,7,nuclear envelope lumen,CC,
2443,GO:0005642,1,0.967401709567739,0,5,annulate lamellae,CC,
2444,GO:0005643,1,0.603178677718091,0,76,nuclear pore,CC,
2445,GO:0005652,1,0.949287933408392,0,9,nuclear lamina,CC,
2447,GO:0005655,1,0.879939270403362,0,8,nucleolar ribonuclease P complex,CC,
2448,GO:0005656,1,0.97813575272127,0,3,nuclear pre-replicative complex,CC,
2449,GO:0005657,1,0.632616796171936,0,68,replication fork,CC,
2450,GO:0005658,1,0.964851590627237,0,6,alpha DNA polymerase:primase complex,CC,
2451,GO:0005662,1,0.910471305111474,0,14,DNA replication factor A complex,CC,
2452,GO:0005663,1,0.948419821481798,0,6,DNA replication factor C complex,CC,
2453,GO:0005664,1,0.958401071092065,0,9,nuclear origin of replication recognition complex,CC,
2454,GO:0005665,1,0.815759727754668,0,17,DNA-directed RNA polymerase II, core complex,CC,
2455,GO:0005666,1,0.829558741152333,0,17,DNA-directed RNA polymerase III complex,CC,
2457,GO:0005668,1,0.979880330766269,0,2,RNA polymerase transcription factor SL1 complex,CC,
2458,GO:0005669,1,0.733292931805537,0,35,transcription factor TFIID complex,CC,
2459,GO:0005671,1,0.910662173503476,0,14,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2460,GO:0005672,1,0.957648749141818,0,4,transcription factor TFIIA complex,CC,
2461,GO:0005673,1,0.984556519875168,0,2,transcription factor TFIIE complex,CC,
2462,GO:0005674,1,0.98327426686207,0,2,transcription factor TFIIF complex,CC,
2463,GO:0005675,1,0.905910324692112,0,13,holo TFIIH complex,CC,
2464,GO:0005677,1,0.952852619001906,0,9,chromatin silencing complex,CC,
2465,GO:0005680,1,0.807061183129983,0,21,anaphase-promoting complex,CC,
2468,GO:0005683,1,0.879534308680935,0,7,U7 snRNP,CC,
2473,GO:0005688,1,0.867882239018362,0,8,U6 snRNP,CC,
2475,GO:0005690,1,0.990030596098877,0,2,U4atac snRNP,CC,
2476,GO:0005691,1,0.995366990826151,0,1,U6atac snRNP,CC,
2478,GO:0005697,1,0.792837867125581,0,22,telomerase holoenzyme complex,CC,
2479,GO:0005712,1,0.99063143040665,0,2,chiasma,CC,
2480,GO:0005713,1,0.99524265188522,0,1,recombination nodule,CC,
2481,GO:0005715,1,0.99524265188522,0,1,late recombination nodule,CC,
2483,GO:0005720,1,0.787536467154889,0,33,nuclear heterochromatin,CC,
2484,GO:0005721,1,0.906338518018929,0,18,pericentric heterochromatin,CC,
2485,GO:0005724,1,0.990460465789248,0,1,nuclear telomeric heterochromatin,CC,
2486,GO:0005726,1,0.981594845857726,0,4,perichromatin fibrils,CC,
2488,GO:0005731,1,0.991388705237635,0,1,nucleolus organizer region,CC,
2489,GO:0005732,1,0.671250068777696,0,24,small nucleolar ribonucleoprotein complex,CC,
2490,GO:0005736,1,0.862574480187176,0,12,DNA-directed RNA polymerase I complex,CC,
2494,GO:0005741,1,0.329590983498575,0,148,mitochondrial outer membrane,CC,
2495,GO:0005742,1,0.894338214681966,0,8,mitochondrial outer membrane translocase complex,CC,
2497,GO:0005744,1,0.8702096159441,0,13,mitochondrial inner membrane presequence translocase complex,CC,
2498,GO:0005745,1,0.990749819908531,0,2,m-AAA complex,CC,
2500,GO:0005747,1,0.387400343192498,0,42,mitochondrial respiratory chain complex I,CC,
2501,GO:0005749,1,0.955516278776553,0,5,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2502,GO:0005750,1,0.868956017492284,0,11,mitochondrial respiratory chain complex III,CC,
2504,GO:0005753,1,0.994653416395701,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
2505,GO:0005757,1,0.958129630040914,0,4,mitochondrial permeability transition pore complex,CC,
2507,GO:0005759,1,0.0172018175508085,0,393,mitochondrial matrix,CC,
2508,GO:0005760,1,0.990755199849293,0,2,gamma DNA polymerase complex,CC,
2509,GO:0005761,1,0.237482900466205,0,84,mitochondrial ribosome,CC,
2510,GO:0005762,1,0.417130885079282,0,51,mitochondrial large ribosomal subunit,CC,
2511,GO:0005763,1,0.630452970988911,0,28,mitochondrial small ribosomal subunit,CC,
2513,GO:0005765,1,0.146568987026419,0,298,lysosomal membrane,CC,
2514,GO:0005766,1,0.395288126508752,0,122,primary lysosome,CC,
2515,GO:0005767,1,0.909705281217102,0,10,secondary lysosome,CC,
2519,GO:0005771,1,0.791457518566396,0,25,multivesicular body,CC,
2521,GO:0005774,1,0.102356706713629,0,343,vacuolar membrane,CC,
2522,GO:0005775,1,0.42398081279349,0,126,vacuolar lumen,CC,
2523,GO:0005776,1,0.596179261434988,0,84,autophagosome,CC,
2524,GO:0005777,1,0.444974700514371,0,104,peroxisome,CC,
2525,GO:0005778,1,0.698494501671675,0,51,peroxisomal membrane,CC,
2526,GO:0005779,1,0.875577482602916,0,15,integral component of peroxisomal membrane,CC,
2527,GO:0005782,1,0.791067434513379,0,30,peroxisomal matrix,CC,
2529,GO:0005784,1,0.926286588424754,0,4,Sec61 translocon complex,CC,
2530,GO:0005785,1,0.93649621743918,0,7,signal recognition particle receptor complex,CC,
2531,GO:0005786,1,0.935506025889961,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2532,GO:0005787,1,0.934852699298953,0,5,signal peptidase complex,CC,
2533,GO:0005788,1,0.309012142605512,0,185,endoplasmic reticulum lumen,CC,
2535,GO:0005790,1,0.831299142391078,0,23,smooth endoplasmic reticulum,CC,
2536,GO:0005791,1,0.544973441919996,0,62,rough endoplasmic reticulum,CC,
2537,GO:0005793,1,0.493304722700167,0,102,endoplasmic reticulum-Golgi intermediate compartment,CC,
2541,GO:0005797,1,0.94303850948639,0,7,Golgi medial cisterna,CC,
2544,GO:0005802,1,0.323890301919327,0,168,trans-Golgi network,CC,
2545,GO:0005811,1,0.674159973608892,0,63,lipid droplet,CC,
2549,GO:0005816,1,0.968009961277736,0,7,spindle pole body,CC,
2550,GO:0005818,1,0.962887324630706,0,8,aster,CC,
2552,GO:0005826,1,0.97540985228884,0,5,actomyosin contractile ring,CC,
2553,GO:0005827,1,0.975121319549214,0,5,polar microtubule,CC,
2554,GO:0005828,1,0.967789613657119,0,7,kinetochore microtubule,CC,
2556,GO:0005832,1,0.946420982146874,0,10,chaperonin-containing T-complex,CC,
2557,GO:0005833,1,0.995366669851539,0,1,hemoglobin complex,CC,
2558,GO:0005834,1,0.87162354769466,0,19,heterotrimeric G-protein complex,CC,
2559,GO:0005838,1,0.817218897827572,0,21,proteasome regulatory particle,CC,
2560,GO:0005839,1,0.700211178254933,0,20,proteasome core complex,CC,
2563,GO:0005845,1,0.914077565525365,0,11,mRNA cap binding complex,CC,
2564,GO:0005846,1,0.989610685361649,0,2,nuclear cap binding complex,CC,
2565,GO:0005847,1,0.91383784065738,0,16,mRNA cleavage and polyadenylation specificity factor complex,CC,
2566,GO:0005849,1,0.902037876792793,0,18,mRNA cleavage factor complex,CC,
2567,GO:0005850,1,0.981562687217848,0,4,eukaryotic translation initiation factor 2 complex,CC,
2568,GO:0005851,1,0.957503782647418,0,6,eukaryotic translation initiation factor 2B complex,CC,
2569,GO:0005852,1,0.844824939480615,0,17,eukaryotic translation initiation factor 3 complex,CC,
2570,GO:0005853,1,0.960216217952181,0,3,eukaryotic translation elongation factor 1 complex,CC,
2571,GO:0005854,1,0.976967724578267,0,2,nascent polypeptide-associated complex,CC,
2573,GO:0005858,1,0.941188274345066,0,8,axonemal dynein complex,CC,
2574,GO:0005859,1,0.936715551089658,0,7,muscle myosin complex,CC,
2575,GO:0005861,1,0.949252268142836,0,3,troponin complex,CC,
2576,GO:0005862,1,0.966464457901375,0,4,muscle thin filament tropomyosin,CC,
2577,GO:0005863,1,0.995366982257957,0,1,striated muscle myosin thick filament,CC,
2578,GO:0005865,1,0.899583130151078,0,11,striated muscle thin filament,CC,
2579,GO:0005868,1,0.815185365296024,0,20,cytoplasmic dynein complex,CC,
2580,GO:0005869,1,0.926844448865505,0,8,dynactin complex,CC,
2581,GO:0005871,1,0.80887415821955,0,44,kinesin complex,CC,
2582,GO:0005873,1,0.986164118478089,0,3,plus-end kinesin complex,CC,
2585,GO:0005876,1,0.729242053945919,0,56,spindle microtubule,CC,
2586,GO:0005879,1,0.968457302993461,0,5,axonemal microtubule,CC,
2587,GO:0005880,1,0.987970937409156,0,1,nuclear microtubule,CC,
2589,GO:0005882,1,0.626388513894899,0,70,intermediate filament,CC,
2590,GO:0005883,1,0.967905278780344,0,7,neurofilament,CC,
2592,GO:0005885,1,0.896108494904561,0,10,Arp2/3 protein complex,CC,
2595,GO:0005889,1,0.990755149914914,0,2,potassium:proton exchanging ATPase complex,CC,
2596,GO:0005890,1,0.976538224454002,0,4,sodium:potassium-exchanging ATPase complex,CC,
2597,GO:0005891,1,0.932156478720413,0,10,voltage-gated calcium channel complex,CC,
2598,GO:0005892,1,0.975891050767289,0,5,acetylcholine-gated channel complex,CC,
2599,GO:0005895,1,0.994548159528985,0,1,interleukin-5 receptor complex,CC,
2600,GO:0005896,1,0.990755037724745,0,2,interleukin-6 receptor complex,CC,
2601,GO:0005898,1,0.995366990825404,0,1,interleukin-13 receptor complex,CC,
2602,GO:0005899,1,0.990755199848938,0,2,insulin receptor complex,CC,
2603,GO:0005900,1,0.99075502220337,0,2,oncostatin-M receptor complex,CC,
2604,GO:0005901,1,0.746903648027255,0,53,caveola,CC,
2606,GO:0005903,1,0.68863392839018,0,58,brush border,CC,
2607,GO:0005905,1,0.723291946143681,0,56,clathrin-coated pit,CC,
2608,GO:0005911,1,0.174632249469187,0,301,cell-cell junction,CC,
2610,GO:0005913,1,0.627530290605018,0,74,cell-cell adherens junction,CC,
2611,GO:0005915,1,0.972517737016628,0,6,zonula adherens,CC,
2612,GO:0005916,1,0.972517953843899,0,6,fascia adherens,CC,
2613,GO:0005921,1,0.914970683066403,0,16,gap junction,CC,
2614,GO:0005922,1,0.940846416797297,0,10,connexin complex,CC,
2615,GO:0005923,1,0.603914114656059,0,89,bicellular tight junction,CC,
2618,GO:0005927,1,0.989279801802513,0,1,muscle tendon junction,CC,
2620,GO:0005930,1,0.654241412937542,0,62,axoneme,CC,
2622,GO:0005940,1,0.958987243460415,0,9,septin ring,CC,
2623,GO:0005942,1,0.925342424351342,0,16,phosphatidylinositol 3-kinase complex,CC,
2624,GO:0005943,1,0.990755192002596,0,2,phosphatidylinositol 3-kinase complex, class IA,CC,
2625,GO:0005945,1,0.990754871236909,0,2,6-phosphofructokinase complex,CC,
2626,GO:0005947,1,0.963420013548633,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2627,GO:0005952,1,0.976690423345474,0,5,cAMP-dependent protein kinase complex,CC,
2628,GO:0005953,1,0.985428422373189,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2629,GO:0005954,1,0.995251076079664,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
2630,GO:0005955,1,0.981594408123428,0,4,calcineurin complex,CC,
2631,GO:0005956,1,0.977602998193498,0,2,protein kinase CK2 complex,CC,
2632,GO:0005958,1,0.981543654917579,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2633,GO:0005960,1,0.984093353125706,0,2,glycine cleavage complex,CC,
2634,GO:0005964,1,0.969441919669049,0,5,phosphorylase kinase complex,CC,
2635,GO:0005965,1,0.985430248774086,0,2,protein farnesyltransferase complex,CC,
2636,GO:0005967,1,0.985745750022555,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
2637,GO:0005968,1,0.973762263984507,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2638,GO:0005969,1,0.99536699082602,0,1,serine-pyruvate aminotransferase complex,CC,
2639,GO:0005971,1,0.986164288990761,0,3,ribonucleoside-diphosphate reductase complex,CC,
2647,GO:0005982,1,0.995366990826086,0,1,starch metabolic process,BP,
2648,GO:0005983,1,0.995366990826086,0,1,starch catabolic process,BP,
2649,GO:0005984,1,0.967309851499934,0,7,disaccharide metabolic process,BP,
2650,GO:0005985,1,0.995366969599153,0,1,sucrose metabolic process,BP,
2651,GO:0005988,1,0.990755187628362,0,2,lactose metabolic process,BP,
2652,GO:0005989,1,0.990755187628362,0,2,lactose biosynthetic process,BP,
2653,GO:0005991,1,0.995366641197951,0,1,trehalose metabolic process,BP,
2655,GO:0005997,1,0.950596865418975,0,4,xylulose metabolic process,BP,
2656,GO:0005998,1,0.995366980723973,0,1,xylulose catabolic process,BP,
2657,GO:0005999,1,0.978757730103141,0,2,xylulose biosynthetic process,BP,
2658,GO:0006000,1,0.930680418902615,0,11,fructose metabolic process,BP,
2659,GO:0006001,1,0.980337427374436,0,4,fructose catabolic process,BP,
2660,GO:0006002,1,0.958454230886296,0,6,fructose 6-phosphate metabolic process,BP,
2661,GO:0006003,1,0.981594434777801,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2662,GO:0006004,1,0.939374258390154,0,13,fucose metabolic process,BP,
2664,GO:0006007,1,0.860282660662761,0,21,glucose catabolic process,BP,
2665,GO:0006011,1,0.961767145209014,0,6,UDP-glucose metabolic process,BP,
2666,GO:0006012,1,0.923966603853116,0,11,galactose metabolic process,BP,
2667,GO:0006013,1,0.949987234182057,0,8,mannose metabolic process,BP,
2668,GO:0006014,1,0.960219006566891,0,3,D-ribose metabolic process,BP,
2669,GO:0006015,1,0.985250882739635,0,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2670,GO:0006020,1,0.947674481383928,0,10,inositol metabolic process,BP,
2671,GO:0006021,1,0.974462358648244,0,4,inositol biosynthetic process,BP,
2672,GO:0006022,1,0.524683832569483,0,118,aminoglycan metabolic process,BP,
2673,GO:0006023,1,0.62567499939459,0,87,aminoglycan biosynthetic process,BP,
2674,GO:0006024,1,0.645015733323992,0,82,glycosaminoglycan biosynthetic process,BP,
2675,GO:0006026,1,0.789843951838713,0,43,aminoglycan catabolic process,BP,
2676,GO:0006027,1,0.797233644398947,0,41,glycosaminoglycan catabolic process,BP,
2677,GO:0006029,1,0.73683665676245,0,59,proteoglycan metabolic process,BP,
2678,GO:0006030,1,0.990754908593028,0,2,chitin metabolic process,BP,
2679,GO:0006032,1,0.990754908593028,0,2,chitin catabolic process,BP,
2680,GO:0006040,1,0.840218159737024,0,27,amino sugar metabolic process,BP,
2681,GO:0006041,1,0.977436876384698,0,4,glucosamine metabolic process,BP,
2682,GO:0006043,1,0.988177891355943,0,2,glucosamine catabolic process,BP,
2683,GO:0006044,1,0.93054813648291,0,13,N-acetylglucosamine metabolic process,BP,
2684,GO:0006045,1,0.990755196341989,0,2,N-acetylglucosamine biosynthetic process,BP,
2685,GO:0006046,1,0.980800073366977,0,3,N-acetylglucosamine catabolic process,BP,
2686,GO:0006047,1,0.927408416500156,0,13,UDP-N-acetylglucosamine metabolic process,BP,
2687,GO:0006048,1,0.946504470429749,0,9,UDP-N-acetylglucosamine biosynthetic process,BP,
2688,GO:0006049,1,0.995366604622991,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2689,GO:0006050,1,0.989675502418522,0,1,mannosamine metabolic process,BP,
2690,GO:0006051,1,0.989675502418522,0,1,N-acetylmannosamine metabolic process,BP,
2691,GO:0006054,1,0.934852032082823,0,10,N-acetylneuraminate metabolic process,BP,
2692,GO:0006055,1,0.98426545667271,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2693,GO:0006056,1,0.991967176450215,0,1,mannoprotein metabolic process,BP,
2694,GO:0006057,1,0.991967176450215,0,1,mannoprotein biosynthetic process,BP,
2695,GO:0006059,1,0.969123669974867,0,3,hexitol metabolic process,BP,
2696,GO:0006060,1,0.982452342364271,0,2,sorbitol metabolic process,BP,
2697,GO:0006061,1,0.987095632384479,0,1,sorbitol biosynthetic process,BP,
2698,GO:0006062,1,0.995296708755865,0,1,sorbitol catabolic process,BP,
2699,GO:0006063,1,0.91199518657162,0,12,uronic acid metabolic process,BP,
2700,GO:0006064,1,0.944380803966037,0,5,glucuronate catabolic process,BP,
2701,GO:0006065,1,0.985263369475109,0,3,UDP-glucuronate biosynthetic process,BP,
2702,GO:0006066,1,0.206430473516709,0,234,alcohol metabolic process,BP,
2703,GO:0006067,1,0.929175879187646,0,11,ethanol metabolic process,BP,
2704,GO:0006068,1,0.947659069268836,0,7,ethanol catabolic process,BP,
2705,GO:0006069,1,0.971240417738145,0,6,ethanol oxidation,BP,
2706,GO:0006071,1,0.925758915444463,0,11,glycerol metabolic process,BP,
2707,GO:0006072,1,0.968004571419167,0,7,glycerol-3-phosphate metabolic process,BP,
2709,GO:0006081,1,0.666907514168545,0,56,cellular aldehyde metabolic process,BP,
2711,GO:0006083,1,0.98616421755837,0,3,acetate metabolic process,BP,
2712,GO:0006084,1,0.840013841176259,0,29,acetyl-CoA metabolic process,BP,
2713,GO:0006085,1,0.912006366626839,0,18,acetyl-CoA biosynthetic process,BP,
2714,GO:0006086,1,0.935003756273198,0,13,acetyl-CoA biosynthetic process from pyruvate,BP,
2715,GO:0006089,1,0.919735457967638,0,11,lactate metabolic process,BP,
2720,GO:0006097,1,0.98664257073037,0,2,glyoxylate cycle,BP,
2721,GO:0006098,1,0.87203837508709,0,16,pentose-phosphate shunt,BP,
2722,GO:0006099,1,0.803152800499334,0,28,tricarboxylic acid cycle,BP,
2723,GO:0006101,1,0.78833366853105,0,32,citrate metabolic process,BP,
2724,GO:0006102,1,0.961520725853934,0,5,isocitrate metabolic process,BP,
2725,GO:0006103,1,0.909785836858112,0,16,2-oxoglutarate metabolic process,BP,
2726,GO:0006104,1,0.968748305930682,0,5,succinyl-CoA metabolic process,BP,
2727,GO:0006105,1,0.92945130050906,0,11,succinate metabolic process,BP,
2728,GO:0006106,1,0.981870260805254,0,3,fumarate metabolic process,BP,
2729,GO:0006107,1,0.922553927573906,0,10,oxaloacetate metabolic process,BP,
2730,GO:0006108,1,0.949056545159402,0,6,malate metabolic process,BP,
2735,GO:0006113,1,0.995366574475227,0,1,fermentation,BP,
2736,GO:0006114,1,0.983390259455153,0,3,glycerol biosynthetic process,BP,
2737,GO:0006116,1,0.988929698068331,0,2,NADH oxidation,BP,
2738,GO:0006117,1,0.995327122950758,0,1,acetaldehyde metabolic process,BP,
2740,GO:0006120,1,0.380720458028581,0,45,mitochondrial electron transport, NADH to ubiquinone,BP,
2741,GO:0006121,1,0.961097181723772,0,4,mitochondrial electron transport, succinate to ubiquinone,BP,
2742,GO:0006122,1,0.857830913706994,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2744,GO:0006127,1,0.995366990826126,0,1,glycerophosphate shuttle,BP,
2747,GO:0006144,1,0.877608068905932,0,19,purine nucleobase metabolic process,BP,
2748,GO:0006145,1,0.981594683097789,0,4,purine nucleobase catabolic process,BP,
2749,GO:0006147,1,0.995366990826153,0,1,guanine catabolic process,BP,
2750,GO:0006148,1,0.995173393564846,0,1,inosine catabolic process,BP,
2751,GO:0006152,1,0.951718774714726,0,6,purine nucleoside catabolic process,BP,
2752,GO:0006154,1,0.984512987919473,0,2,adenosine catabolic process,BP,
2753,GO:0006157,1,0.989140067213088,0,1,deoxyadenosine catabolic process,BP,
2757,GO:0006166,1,0.944702948354382,0,5,purine ribonucleoside salvage,BP,
2758,GO:0006167,1,0.947564969237609,0,5,AMP biosynthetic process,BP,
2759,GO:0006168,1,0.954791584092673,0,3,adenine salvage,BP,
2760,GO:0006169,1,0.994044997930392,0,1,adenosine salvage,BP,
2761,GO:0006171,1,0.839455880766242,0,25,cAMP biosynthetic process,BP,
2762,GO:0006172,1,0.994919446641692,0,1,ADP biosynthetic process,BP,
2763,GO:0006175,1,0.994044997930392,0,1,dATP biosynthetic process,BP,
2764,GO:0006177,1,0.962793476523084,0,5,GMP biosynthetic process,BP,
2765,GO:0006178,1,0.980683596853657,0,2,guanine salvage,BP,
2766,GO:0006182,1,0.922058476708057,0,14,cGMP biosynthetic process,BP,
2768,GO:0006185,1,0.979270594786824,0,1,dGDP biosynthetic process,BP,
2769,GO:0006188,1,0.937142673649156,0,10,IMP biosynthetic process,BP,
2770,GO:0006189,1,0.964531793588782,0,6,'de novo' IMP biosynthetic process,BP,
2771,GO:0006193,1,0.981566547056908,0,1,ITP catabolic process,BP,
2772,GO:0006195,1,0.737693686962801,0,34,purine nucleotide catabolic process,BP,
2773,GO:0006196,1,0.990755199849254,0,2,AMP catabolic process,BP,
2774,GO:0006198,1,0.959058053667678,0,9,cAMP catabolic process,BP,
2775,GO:0006203,1,0.962549724596807,0,3,dGTP catabolic process,BP,
2776,GO:0006206,1,0.88395878146283,0,17,pyrimidine nucleobase metabolic process,BP,
2777,GO:0006207,1,0.971284148650771,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
2778,GO:0006208,1,0.990006073383965,0,2,pyrimidine nucleobase catabolic process,BP,
2779,GO:0006210,1,0.990006073383965,0,2,thymine catabolic process,BP,
2780,GO:0006211,1,0.986164531023092,0,3,5-methylcytosine catabolic process,BP,
2781,GO:0006212,1,0.99536678233859,0,1,uracil catabolic process,BP,
2783,GO:0006214,1,0.99536678233859,0,1,thymidine catabolic process,BP,
2784,GO:0006216,1,0.935691790528424,0,6,cytidine catabolic process,BP,
2785,GO:0006218,1,0.992316997393354,0,1,uridine catabolic process,BP,
2788,GO:0006222,1,0.940722013425988,0,9,UMP biosynthetic process,BP,
2789,GO:0006226,1,0.977116823954223,0,3,dUMP biosynthetic process,BP,
2790,GO:0006227,1,0.977743114261659,0,2,dUDP biosynthetic process,BP,
2792,GO:0006231,1,0.979064559849284,0,3,dTMP biosynthetic process,BP,
2793,GO:0006233,1,0.977743114261659,0,2,dTDP biosynthetic process,BP,
2794,GO:0006235,1,0.953890238630155,0,4,dTTP biosynthetic process,BP,
2795,GO:0006238,1,0.984376090933901,0,1,CMP salvage,BP,
2797,GO:0006244,1,0.889703487768303,0,12,pyrimidine nucleotide catabolic process,BP,
2798,GO:0006253,1,0.981877914626818,0,1,dCTP catabolic process,BP,
2799,GO:0006256,1,0.995366616056572,0,1,UDP catabolic process,BP,
2800,GO:0006258,1,0.980700980994807,0,2,UDP-glucose catabolic process,BP,
2803,GO:0006261,1,0.41506615430023,0,137,DNA-dependent DNA replication,BP,
2804,GO:0006264,1,0.944609786931315,0,10,mitochondrial DNA replication,BP,
2805,GO:0006265,1,0.949951272929738,0,9,DNA topological change,BP,
2806,GO:0006266,1,0.836774703254015,0,23,DNA ligation,BP,
2807,GO:0006267,1,0.97813575272127,0,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
2808,GO:0006268,1,0.965703387193536,0,7,DNA unwinding involved in DNA replication,BP,
2809,GO:0006269,1,0.969445310091893,0,5,DNA replication, synthesis of RNA primer,BP,
2810,GO:0006270,1,0.77209368533055,0,41,DNA replication initiation,BP,
2811,GO:0006271,1,0.859786566242793,0,20,DNA strand elongation involved in DNA replication,BP,
2812,GO:0006272,1,0.976886433401629,0,3,leading strand elongation,BP,
2813,GO:0006273,1,0.93008563456351,0,11,lagging strand elongation,BP,
2815,GO:0006278,1,0.628127142921579,0,66,RNA-dependent DNA biosynthetic process,BP,
2817,GO:0006282,1,0.604680672840465,0,83,regulation of DNA repair,BP,
2818,GO:0006283,1,0.50475236523184,0,73,transcription-coupled nucleotide-excision repair,BP,
2819,GO:0006284,1,0.732269397451455,0,41,base-excision repair,BP,
2820,GO:0006285,1,0.913011654578881,0,10,base-excision repair, AP site formation,BP,
2821,GO:0006286,1,0.973412567635792,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
2822,GO:0006287,1,0.966619127470974,0,5,base-excision repair, gap-filling,BP,
2823,GO:0006288,1,0.974655216907422,0,3,base-excision repair, DNA ligation,BP,
2824,GO:0006289,1,0.381560035493527,0,113,nucleotide-excision repair,BP,
2825,GO:0006290,1,0.945493721809175,0,7,pyrimidine dimer repair,BP,
2826,GO:0006293,1,0.855325109575291,0,21,nucleotide-excision repair, preincision complex stabilization,BP,
2827,GO:0006294,1,0.76217021381137,0,29,nucleotide-excision repair, preincision complex assembly,BP,
2828,GO:0006295,1,0.855325109575291,0,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,
2829,GO:0006296,1,0.717738238725356,0,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,
2830,GO:0006297,1,0.815894428179202,0,23,nucleotide-excision repair, DNA gap filling,BP,
2831,GO:0006298,1,0.814402245937287,0,31,mismatch repair,BP,
2832,GO:0006301,1,0.669726560925171,0,49,postreplication repair,BP,
2835,GO:0006304,1,0.580683683894451,0,79,DNA modification,BP,
2836,GO:0006305,1,0.794458490664868,0,44,DNA alkylation,BP,
2837,GO:0006306,1,0.794458490664868,0,44,DNA methylation,BP,
2838,GO:0006307,1,0.90860599633932,0,10,DNA dealkylation involved in DNA repair,BP,
2839,GO:0006308,1,0.808402806126627,0,29,DNA catabolic process,BP,
2840,GO:0006309,1,0.888065600619576,0,16,apoptotic DNA fragmentation,BP,
2842,GO:0006311,1,0.995366802530454,0,1,meiotic gene conversion,BP,
2843,GO:0006312,1,0.870421718554434,0,22,mitotic recombination,BP,
2844,GO:0006313,1,0.995366990826125,0,1,transposition, DNA-mediated,BP,
2851,GO:0006337,1,0.892836256517167,0,16,nucleosome disassembly,BP,
2854,GO:0006343,1,0.99536698911949,0,1,establishment of chromatin silencing,BP,
2855,GO:0006344,1,0.981576156963117,0,4,maintenance of chromatin silencing,BP,
2856,GO:0006346,1,0.929910132649802,0,15,methylation-dependent chromatin silencing,BP,
2857,GO:0006348,1,0.910583720330932,0,8,chromatin silencing at telomere,BP,
2858,GO:0006349,1,0.938124559480186,0,13,regulation of gene expression by genetic imprinting,BP,
2861,GO:0006353,1,0.394350346154627,0,107,DNA-templated transcription, termination,BP,
2862,GO:0006354,1,0.374237646566975,0,121,DNA-templated transcription, elongation,BP,
2864,GO:0006356,1,0.811319303228706,0,30,regulation of transcription by RNA polymerase I,BP,
2866,GO:0006359,1,0.860225923561817,0,24,regulation of transcription by RNA polymerase III,BP,
2867,GO:0006360,1,0.63243732569708,0,59,transcription by RNA polymerase I,BP,
2868,GO:0006361,1,0.720630712081902,0,35,transcription initiation from RNA polymerase I promoter,BP,
2869,GO:0006362,1,0.75442199244708,0,29,transcription elongation from RNA polymerase I promoter,BP,
2870,GO:0006363,1,0.75091527113642,0,30,termination of RNA polymerase I transcription,BP,
2874,GO:0006368,1,0.448669296068581,0,97,transcription elongation from RNA polymerase II promoter,BP,
2875,GO:0006369,1,0.561198321984369,0,69,termination of RNA polymerase II transcription,BP,
2876,GO:0006370,1,0.732762995027754,0,32,7-methylguanosine mRNA capping,BP,
2877,GO:0006376,1,0.85670775974885,0,26,mRNA splice site selection,BP,
2878,GO:0006378,1,0.793003283303074,0,39,mRNA polyadenylation,BP,
2879,GO:0006379,1,0.798792102509505,0,27,mRNA cleavage,BP,
2880,GO:0006382,1,0.975197373577254,0,5,adenosine to inosine editing,BP,
2882,GO:0006384,1,0.947878573721741,0,7,transcription initiation from RNA polymerase III promoter,BP,
2883,GO:0006386,1,0.974908146887066,0,1,termination of RNA polymerase III transcription,BP,
2884,GO:0006388,1,0.864237076016922,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
2885,GO:0006390,1,0.914592698851826,0,13,mitochondrial transcription,BP,
2886,GO:0006391,1,0.980877899968997,0,3,transcription initiation from mitochondrial promoter,BP,
2887,GO:0006393,1,0.990754370961523,0,2,termination of mitochondrial transcription,BP,
2890,GO:0006398,1,0.972457895820655,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
2891,GO:0006399,1,0.235206157223381,0,183,tRNA metabolic process,BP,
2892,GO:0006400,1,0.594205564444208,0,74,tRNA modification,BP,
2895,GO:0006403,1,0.217399994305244,0,209,RNA localization,BP,
2896,GO:0006404,1,0.967816164003893,0,3,RNA import into nucleus,BP,
2897,GO:0006405,1,0.375269030360022,0,133,RNA export from nucleus,BP,
2898,GO:0006406,1,0.499349325561795,0,103,mRNA export from nucleus,BP,
2899,GO:0006407,1,0.964195610360482,0,3,rRNA export from nucleus,BP,
2900,GO:0006408,1,0.986001277547425,0,2,snRNA export from nucleus,BP,
2901,GO:0006409,1,0.822619948894952,0,32,tRNA export from nucleus,BP,
2904,GO:0006414,1,0.171453628020607,0,125,translational elongation,BP,
2905,GO:0006415,1,0.210732833573269,0,100,translational termination,BP,
2907,GO:0006418,1,0.727790949763234,0,49,tRNA aminoacylation for protein translation,BP,
2908,GO:0006419,1,0.983865902025926,0,3,alanyl-tRNA aminoacylation,BP,
2909,GO:0006420,1,0.982004671907372,0,3,arginyl-tRNA aminoacylation,BP,
2910,GO:0006421,1,0.98570143209884,0,3,asparaginyl-tRNA aminoacylation,BP,
2911,GO:0006422,1,0.995030528519637,0,1,aspartyl-tRNA aminoacylation,BP,
2912,GO:0006423,1,0.98822631276664,0,2,cysteinyl-tRNA aminoacylation,BP,
2913,GO:0006424,1,0.990755199512449,0,2,glutamyl-tRNA aminoacylation,BP,
2914,GO:0006425,1,0.990607496364114,0,2,glutaminyl-tRNA aminoacylation,BP,
2915,GO:0006426,1,0.985326027555134,0,2,glycyl-tRNA aminoacylation,BP,
2916,GO:0006427,1,0.988856312991786,0,2,histidyl-tRNA aminoacylation,BP,
2917,GO:0006428,1,0.990755171166203,0,2,isoleucyl-tRNA aminoacylation,BP,
2918,GO:0006429,1,0.990755199849279,0,2,leucyl-tRNA aminoacylation,BP,
2919,GO:0006430,1,0.994314330594104,0,1,lysyl-tRNA aminoacylation,BP,
2920,GO:0006431,1,0.990754399909387,0,2,methionyl-tRNA aminoacylation,BP,
2921,GO:0006432,1,0.971209610008157,0,5,phenylalanyl-tRNA aminoacylation,BP,
2922,GO:0006433,1,0.97276416411755,0,3,prolyl-tRNA aminoacylation,BP,
2923,GO:0006434,1,0.987245692857529,0,2,seryl-tRNA aminoacylation,BP,
2924,GO:0006435,1,0.985925735787033,0,3,threonyl-tRNA aminoacylation,BP,
2925,GO:0006436,1,0.990748641298346,0,2,tryptophanyl-tRNA aminoacylation,BP,
2926,GO:0006437,1,0.989909296431112,0,2,tyrosyl-tRNA aminoacylation,BP,
2927,GO:0006438,1,0.986164513530674,0,3,valyl-tRNA aminoacylation,BP,
2928,GO:0006446,1,0.569318751223628,0,70,regulation of translational initiation,BP,
2929,GO:0006447,1,0.981637971621939,0,3,regulation of translational initiation by iron,BP,
2930,GO:0006448,1,0.901594338194361,0,17,regulation of translational elongation,BP,
2931,GO:0006449,1,0.957704939084257,0,7,regulation of translational termination,BP,
2932,GO:0006450,1,0.827619371471926,0,18,regulation of translational fidelity,BP,
2933,GO:0006451,1,0.957836721866307,0,7,translational readthrough,BP,
2934,GO:0006452,1,0.980977064995119,0,2,translational frameshifting,BP,
2936,GO:0006458,1,0.741368377237569,0,46,'de novo' protein folding,BP,
2937,GO:0006463,1,0.99536698447799,0,1,steroid hormone receptor complex assembly,BP,
2939,GO:0006465,1,0.859991633468987,0,16,signal peptide processing,BP,
2943,GO:0006471,1,0.87636758185888,0,24,protein ADP-ribosylation,BP,
2945,GO:0006474,1,0.903651237455854,0,14,N-terminal protein amino acid acetylation,BP,
2947,GO:0006476,1,0.585265429402591,0,91,protein deacetylation,BP,
2948,GO:0006477,1,0.973802228401964,0,5,protein sulfation,BP,
2949,GO:0006478,1,0.987466393968392,0,2,peptidyl-tyrosine sulfation,BP,
2951,GO:0006480,1,0.995366574475227,0,1,N-terminal protein amino acid methylation,BP,
2952,GO:0006481,1,0.976107244894574,0,3,C-terminal protein methylation,BP,
2953,GO:0006482,1,0.872584297905231,0,29,protein demethylation,BP,
2955,GO:0006487,1,0.537731176316766,0,78,protein N-linked glycosylation,BP,
2956,GO:0006488,1,0.875380454395672,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
2957,GO:0006489,1,0.962366521239479,0,7,dolichyl diphosphate biosynthetic process,BP,
2958,GO:0006490,1,0.871260767222449,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
2959,GO:0006491,1,0.91571070124282,0,16,N-glycan processing,BP,
2962,GO:0006498,1,0.976099616572389,0,5,N-terminal protein lipidation,BP,
2963,GO:0006499,1,0.981573340073907,0,4,N-terminal protein myristoylation,BP,
2964,GO:0006500,1,0.994424712951054,0,1,N-terminal protein palmitoylation,BP,
2965,GO:0006501,1,0.748760559932866,0,34,C-terminal protein lipidation,BP,
2968,GO:0006507,1,0.994930769572645,0,1,GPI anchor release,BP,
2970,GO:0006509,1,0.781725692365924,0,36,membrane protein ectodomain proteolysis,BP,
2972,GO:0006513,1,0.645453883222451,0,65,protein monoubiquitination,BP,
2973,GO:0006515,1,0.853165960518737,0,24,protein quality control for misfolded or incompletely synthesized proteins,BP,
2974,GO:0006516,1,0.896461826009702,0,15,glycoprotein catabolic process,BP,
2975,GO:0006517,1,0.800353559104988,0,32,protein deglycosylation,BP,
2977,GO:0006520,1,0.106226661722482,0,279,cellular amino acid metabolic process,BP,
2978,GO:0006521,1,0.510760508111417,0,52,regulation of cellular amino acid metabolic process,BP,
2979,GO:0006522,1,0.995366990515785,0,1,alanine metabolic process,BP,
2980,GO:0006524,1,0.995366990515785,0,1,alanine catabolic process,BP,
2981,GO:0006525,1,0.896117313092113,0,16,arginine metabolic process,BP,
2982,GO:0006526,1,0.971348076039647,0,5,arginine biosynthetic process,BP,
2983,GO:0006527,1,0.932311544301119,0,9,arginine catabolic process,BP,
2984,GO:0006528,1,0.97533721070378,0,3,asparagine metabolic process,BP,
2985,GO:0006529,1,0.990288135408812,0,2,asparagine biosynthetic process,BP,
2986,GO:0006531,1,0.968589980822261,0,6,aspartate metabolic process,BP,
2987,GO:0006532,1,0.989649324267882,0,2,aspartate biosynthetic process,BP,
2988,GO:0006533,1,0.989649324267882,0,2,aspartate catabolic process,BP,
2989,GO:0006534,1,0.9391586388879,0,11,cysteine metabolic process,BP,
2990,GO:0006535,1,0.995337765554784,0,1,cysteine biosynthetic process from serine,BP,
2991,GO:0006536,1,0.876649822763081,0,23,glutamate metabolic process,BP,
2992,GO:0006537,1,0.981577266548793,0,4,glutamate biosynthetic process,BP,
2993,GO:0006538,1,0.97117412510285,0,6,glutamate catabolic process,BP,
2994,GO:0006540,1,0.9904917368888,0,2,glutamate decarboxylation to succinate,BP,
2995,GO:0006541,1,0.913772143535985,0,17,glutamine metabolic process,BP,
2996,GO:0006542,1,0.995366990826152,0,1,glutamine biosynthetic process,BP,
2997,GO:0006543,1,0.98614688113955,0,3,glutamine catabolic process,BP,
2998,GO:0006544,1,0.949804321342156,0,8,glycine metabolic process,BP,
2999,GO:0006545,1,0.990054307114572,0,2,glycine biosynthetic process,BP,
3000,GO:0006546,1,0.978317490764968,0,3,glycine catabolic process,BP,
3001,GO:0006547,1,0.959131126034895,0,5,histidine metabolic process,BP,
3002,GO:0006548,1,0.968359602318785,0,3,histidine catabolic process,BP,
3003,GO:0006549,1,0.971106145472773,0,5,isoleucine metabolic process,BP,
3004,GO:0006550,1,0.984732782597571,0,2,isoleucine catabolic process,BP,
3005,GO:0006551,1,0.951171149923559,0,7,leucine metabolic process,BP,
3006,GO:0006552,1,0.965021324731539,0,5,leucine catabolic process,BP,
3007,GO:0006553,1,0.954564891211169,0,9,lysine metabolic process,BP,
3008,GO:0006554,1,0.959010569482421,0,8,lysine catabolic process,BP,
3009,GO:0006555,1,0.892794218633148,0,17,methionine metabolic process,BP,
3010,GO:0006556,1,0.989591123944043,0,2,S-adenosylmethionine biosynthetic process,BP,
3011,GO:0006557,1,0.995366864645357,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3012,GO:0006558,1,0.945267453218616,0,4,L-phenylalanine metabolic process,BP,
3013,GO:0006559,1,0.945267453218616,0,4,L-phenylalanine catabolic process,BP,
3014,GO:0006560,1,0.963744359255702,0,6,proline metabolic process,BP,
3015,GO:0006561,1,0.973363032356521,0,4,proline biosynthetic process,BP,
3016,GO:0006562,1,0.990121160059752,0,2,proline catabolic process,BP,
3017,GO:0006563,1,0.939788970195854,0,10,L-serine metabolic process,BP,
3018,GO:0006564,1,0.965761561751848,0,6,L-serine biosynthetic process,BP,
3019,GO:0006565,1,0.977758767177268,0,3,L-serine catabolic process,BP,
3020,GO:0006566,1,0.971410409373417,0,3,threonine metabolic process,BP,
3021,GO:0006567,1,0.976946874723707,0,2,threonine catabolic process,BP,
3022,GO:0006568,1,0.962751403824537,0,5,tryptophan metabolic process,BP,
3023,GO:0006569,1,0.975702689598349,0,3,tryptophan catabolic process,BP,
3024,GO:0006570,1,0.959821996211791,0,4,tyrosine metabolic process,BP,
3025,GO:0006572,1,0.966489734446565,0,3,tyrosine catabolic process,BP,
3026,GO:0006573,1,0.949057024453999,0,9,valine metabolic process,BP,
3027,GO:0006574,1,0.976389276994505,0,4,valine catabolic process,BP,
3028,GO:0006575,1,0.333331543927699,0,134,cellular modified amino acid metabolic process,BP,
3029,GO:0006576,1,0.773997292928041,0,30,cellular biogenic amine metabolic process,BP,
3030,GO:0006577,1,0.938147144977658,0,13,amino-acid betaine metabolic process,BP,
3031,GO:0006578,1,0.969944611021418,0,6,amino-acid betaine biosynthetic process,BP,
3032,GO:0006580,1,0.995361301061461,0,1,ethanolamine metabolic process,BP,
3033,GO:0006582,1,0.935900069478843,0,9,melanin metabolic process,BP,
3034,GO:0006584,1,0.831571971627122,0,26,catecholamine metabolic process,BP,
3035,GO:0006585,1,0.993103767077917,0,1,dopamine biosynthetic process from tyrosine,BP,
3036,GO:0006586,1,0.962751403824537,0,5,indolalkylamine metabolic process,BP,
3037,GO:0006589,1,0.995366720724551,0,1,octopamine biosynthetic process,BP,
3038,GO:0006590,1,0.956706499574781,0,9,thyroid hormone generation,BP,
3039,GO:0006591,1,0.956185160861437,0,7,ornithine metabolic process,BP,
3040,GO:0006592,1,0.995366942340392,0,1,ornithine biosynthetic process,BP,
3041,GO:0006595,1,0.8647151423051,0,14,polyamine metabolic process,BP,
3042,GO:0006596,1,0.898604170636171,0,12,polyamine biosynthetic process,BP,
3043,GO:0006597,1,0.986518868294737,0,2,spermine biosynthetic process,BP,
3044,GO:0006598,1,0.931078372981404,0,5,polyamine catabolic process,BP,
3045,GO:0006600,1,0.934598622194913,0,8,creatine metabolic process,BP,
3046,GO:0006601,1,0.979610981160659,0,1,creatine biosynthetic process,BP,
3049,GO:0006607,1,0.904170689391159,0,20,NLS-bearing protein import into nucleus,BP,
3050,GO:0006610,1,0.938707361506854,0,8,ribosomal protein import into nucleus,BP,
3051,GO:0006611,1,0.2787357549978,0,170,protein export from nucleus,BP,
3055,GO:0006616,1,0.913967703871591,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3056,GO:0006617,1,0.971899461901102,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3057,GO:0006620,1,0.931796542301263,0,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3058,GO:0006621,1,0.947177134951245,0,8,protein retention in ER lumen,BP,
3059,GO:0006622,1,0.891667919189852,0,21,protein targeting to lysosome,BP,
3060,GO:0006623,1,0.830084167298647,0,34,protein targeting to vacuole,BP,
3061,GO:0006624,1,0.96927308981605,0,2,vacuolar protein processing,BP,
3062,GO:0006625,1,0.90776480546654,0,17,protein targeting to peroxisome,BP,
3064,GO:0006627,1,0.940921569835109,0,6,protein processing involved in protein targeting to mitochondrion,BP,
3066,GO:0006631,1,0.154540327213032,0,259,fatty acid metabolic process,BP,
3067,GO:0006633,1,0.488828514346354,0,93,fatty acid biosynthetic process,BP,
3068,GO:0006635,1,0.640257846217919,0,61,fatty acid beta-oxidation,BP,
3069,GO:0006636,1,0.792109914904324,0,29,unsaturated fatty acid biosynthetic process,BP,
3070,GO:0006637,1,0.573848193281964,0,77,acyl-CoA metabolic process,BP,
3071,GO:0006638,1,0.639641381379694,0,67,neutral lipid metabolic process,BP,
3072,GO:0006639,1,0.642633998141528,0,66,acylglycerol metabolic process,BP,
3073,GO:0006641,1,0.69728846261677,0,53,triglyceride metabolic process,BP,
3074,GO:0006642,1,0.98590227315378,0,3,triglyceride mobilization,BP,
3077,GO:0006646,1,0.942366386858552,0,11,phosphatidylethanolamine biosynthetic process,BP,
3079,GO:0006651,1,0.97445536072427,0,2,diacylglycerol biosynthetic process,BP,
3080,GO:0006654,1,0.862460968404186,0,29,phosphatidic acid biosynthetic process,BP,
3081,GO:0006655,1,0.949849959258257,0,10,phosphatidylglycerol biosynthetic process,BP,
3082,GO:0006656,1,0.818564160314339,0,29,phosphatidylcholine biosynthetic process,BP,
3083,GO:0006657,1,0.951635993456844,0,7,CDP-choline pathway,BP,
3084,GO:0006658,1,0.896755000444873,0,21,phosphatidylserine metabolic process,BP,
3085,GO:0006659,1,0.980722520870497,0,4,phosphatidylserine biosynthetic process,BP,
3086,GO:0006660,1,0.992044959517752,0,1,phosphatidylserine catabolic process,BP,
3088,GO:0006662,1,0.906018495486522,0,9,glycerol ether metabolic process,BP,
3089,GO:0006663,1,0.980431349220963,0,3,platelet activating factor biosynthetic process,BP,
3091,GO:0006665,1,0.460753887475903,0,129,sphingolipid metabolic process,BP,
3092,GO:0006666,1,0.995366990826151,0,1,3-keto-sphinganine metabolic process,BP,
3093,GO:0006667,1,0.98829937207941,0,2,sphinganine metabolic process,BP,
3094,GO:0006668,1,0.990754751602199,0,2,sphinganine-1-phosphate metabolic process,BP,
3095,GO:0006669,1,0.995366648030241,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3096,GO:0006670,1,0.91530869918395,0,10,sphingosine metabolic process,BP,
3097,GO:0006671,1,0.995366990826151,0,1,phytosphingosine metabolic process,BP,
3098,GO:0006672,1,0.67436064684298,0,66,ceramide metabolic process,BP,
3099,GO:0006677,1,0.920551294222064,0,14,glycosylceramide metabolic process,BP,
3100,GO:0006678,1,0.960774134025994,0,7,glucosylceramide metabolic process,BP,
3101,GO:0006679,1,0.985809554866348,0,2,glucosylceramide biosynthetic process,BP,
3102,GO:0006680,1,0.985957388637181,0,3,glucosylceramide catabolic process,BP,
3103,GO:0006681,1,0.968406402539432,0,6,galactosylceramide metabolic process,BP,
3104,GO:0006682,1,0.984245320794923,0,3,galactosylceramide biosynthetic process,BP,
3105,GO:0006683,1,0.995366592959221,0,1,galactosylceramide catabolic process,BP,
3106,GO:0006684,1,0.907763555489085,0,13,sphingomyelin metabolic process,BP,
3107,GO:0006685,1,0.972974675007464,0,5,sphingomyelin catabolic process,BP,
3108,GO:0006686,1,0.948021386138611,0,6,sphingomyelin biosynthetic process,BP,
3109,GO:0006687,1,0.735455572794237,0,53,glycosphingolipid metabolic process,BP,
3110,GO:0006688,1,0.927752996720296,0,13,glycosphingolipid biosynthetic process,BP,
3111,GO:0006689,1,0.978155310503695,0,4,ganglioside catabolic process,BP,
3112,GO:0006690,1,0.613104018461579,0,61,icosanoid metabolic process,BP,
3113,GO:0006691,1,0.89288427908544,0,12,leukotriene metabolic process,BP,
3114,GO:0006692,1,0.787356396768844,0,27,prostanoid metabolic process,BP,
3115,GO:0006693,1,0.787356396768844,0,27,prostaglandin metabolic process,BP,
3117,GO:0006695,1,0.668348030192424,0,59,cholesterol biosynthetic process,BP,
3118,GO:0006696,1,0.988771562554042,0,2,ergosterol biosynthetic process,BP,
3120,GO:0006700,1,0.87415171938041,0,15,C21-steroid hormone biosynthetic process,BP,
3121,GO:0006701,1,0.974139603523929,0,4,progesterone biosynthetic process,BP,
3122,GO:0006702,1,0.976528585950267,0,5,androgen biosynthetic process,BP,
3123,GO:0006703,1,0.923312311104688,0,8,estrogen biosynthetic process,BP,
3124,GO:0006704,1,0.953264612179648,0,8,glucocorticoid biosynthetic process,BP,
3125,GO:0006705,1,0.981593243496628,0,4,mineralocorticoid biosynthetic process,BP,
3126,GO:0006706,1,0.902276444666168,0,13,steroid catabolic process,BP,
3127,GO:0006707,1,0.968185840085161,0,4,cholesterol catabolic process,BP,
3128,GO:0006710,1,0.992864068114836,0,1,androgen catabolic process,BP,
3129,GO:0006711,1,0.992044959517752,0,1,estrogen catabolic process,BP,
3130,GO:0006713,1,0.9921120416157,0,1,glucocorticoid catabolic process,BP,
3131,GO:0006720,1,0.599094646070023,0,72,isoprenoid metabolic process,BP,
3132,GO:0006721,1,0.707558349797735,0,54,terpenoid metabolic process,BP,
3133,GO:0006722,1,0.995162314705154,0,1,triterpenoid metabolic process,BP,
3135,GO:0006726,1,0.995366990826165,0,1,eye pigment biosynthetic process,BP,
3136,GO:0006729,1,0.922624564481377,0,7,tetrahydrobiopterin biosynthetic process,BP,
3137,GO:0006730,1,0.878257548467073,0,21,one-carbon metabolic process,BP,
3140,GO:0006734,1,0.833482444008683,0,26,NADH metabolic process,BP,
3141,GO:0006735,1,0.888886684987135,0,17,NADH regeneration,BP,
3142,GO:0006738,1,0.995173393564846,0,1,nicotinamide riboside catabolic process,BP,
3143,GO:0006739,1,0.802526719445479,0,27,NADP metabolic process,BP,
3144,GO:0006740,1,0.985513209288727,0,3,NADPH regeneration,BP,
3145,GO:0006741,1,0.977849829989954,0,4,NADP biosynthetic process,BP,
3146,GO:0006742,1,0.995366946678943,0,1,NADP catabolic process,BP,
3147,GO:0006743,1,0.873579602331925,0,15,ubiquinone metabolic process,BP,
3148,GO:0006744,1,0.877651868942666,0,14,ubiquinone biosynthetic process,BP,
3149,GO:0006747,1,0.993565389060168,0,1,FAD biosynthetic process,BP,
3150,GO:0006749,1,0.597160879268367,0,42,glutathione metabolic process,BP,
3151,GO:0006750,1,0.882888165609338,0,14,glutathione biosynthetic process,BP,
3152,GO:0006751,1,0.959713678507634,0,5,glutathione catabolic process,BP,
3156,GO:0006760,1,0.858247108613677,0,22,folic acid-containing compound metabolic process,BP,
3159,GO:0006768,1,0.935578514696281,0,11,biotin metabolic process,BP,
3160,GO:0006771,1,0.965265346222186,0,6,riboflavin metabolic process,BP,
3161,GO:0006772,1,0.992168818789806,0,1,thiamine metabolic process,BP,
3163,GO:0006776,1,0.968206049783965,0,3,vitamin A metabolic process,BP,
3164,GO:0006777,1,0.964383602340493,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3165,GO:0006778,1,0.771966646885613,0,31,porphyrin-containing compound metabolic process,BP,
3166,GO:0006779,1,0.845346813162308,0,21,porphyrin-containing compound biosynthetic process,BP,
3167,GO:0006780,1,0.980981083953561,0,2,uroporphyrinogen III biosynthetic process,BP,
3168,GO:0006781,1,0.994555730597015,0,1,succinyl-CoA pathway,BP,
3169,GO:0006782,1,0.940304195548065,0,7,protoporphyrinogen IX biosynthetic process,BP,
3170,GO:0006783,1,0.858007319091011,0,18,heme biosynthetic process,BP,
3171,GO:0006784,1,0.990754892204004,0,2,heme a biosynthetic process,BP,
3172,GO:0006787,1,0.930520355595146,0,6,porphyrin-containing compound catabolic process,BP,
3173,GO:0006788,1,0.981039824698575,0,2,heme oxidation,BP,
3174,GO:0006789,1,0.990211590228369,0,2,bilirubin conjugation,BP,
3175,GO:0006790,1,0.108355077014933,0,273,sulfur compound metabolic process,BP,
3178,GO:0006797,1,0.976545424953511,0,5,polyphosphate metabolic process,BP,
3179,GO:0006798,1,0.981092293978615,0,4,polyphosphate catabolic process,BP,
3180,GO:0006801,1,0.711433953350093,0,36,superoxide metabolic process,BP,
3181,GO:0006805,1,0.563168944679449,0,67,xenobiotic metabolic process,BP,
3183,GO:0006808,1,0.97075673338627,0,2,regulation of nitrogen utilization,BP,
3184,GO:0006809,1,0.729413968658559,0,45,nitric oxide biosynthetic process,BP,
3191,GO:0006817,1,0.933565164050046,0,12,phosphate ion transport,BP,
3194,GO:0006824,1,0.989789997967141,0,2,cobalt ion transport,BP,
3195,GO:0006825,1,0.819206729191647,0,18,copper ion transport,BP,
3196,GO:0006826,1,0.688716986600625,0,42,iron ion transport,BP,
3197,GO:0006828,1,0.986164530215354,0,3,manganese ion transport,BP,
3198,GO:0006829,1,0.919749339958182,0,17,zinc ion transport,BP,
3199,GO:0006833,1,0.968958444013492,0,6,water transport,BP,
3200,GO:0006835,1,0.762209838160617,0,46,dicarboxylic acid transport,BP,
3202,GO:0006837,1,0.958163284433379,0,6,serotonin transport,BP,
3204,GO:0006842,1,0.976318948512465,0,4,tricarboxylic acid transport,BP,
3205,GO:0006843,1,0.99001803076833,0,1,mitochondrial citrate transmembrane transport,BP,
3206,GO:0006844,1,0.987963623652385,0,2,acyl carnitine transport,BP,
3207,GO:0006848,1,0.986163673532741,0,3,pyruvate transport,BP,
3208,GO:0006850,1,0.990754370961523,0,2,mitochondrial pyruvate transmembrane transport,BP,
3209,GO:0006851,1,0.879930140861985,0,20,mitochondrial calcium ion transmembrane transport,BP,
3210,GO:0006853,1,0.950637131112122,0,10,carnitine shuttle,BP,
3212,GO:0006857,1,0.957561976045975,0,8,oligopeptide transport,BP,
3213,GO:0006858,1,0.974675030286107,0,3,extracellular transport,BP,
3214,GO:0006862,1,0.899223466806684,0,16,nucleotide transport,BP,
3215,GO:0006863,1,0.948673134684087,0,6,purine nucleobase transport,BP,
3216,GO:0006864,1,0.983446379709979,0,2,pyrimidine nucleotide transport,BP,
3217,GO:0006865,1,0.637945515387291,0,78,amino acid transport,BP,
3218,GO:0006867,1,0.995366330720897,0,1,asparagine transport,BP,
3219,GO:0006868,1,0.979513250238603,0,4,glutamine transport,BP,
3220,GO:0006869,1,0.288922101175995,0,199,lipid transport,BP,
3224,GO:0006878,1,0.865996691569622,0,13,cellular copper ion homeostasis,BP,
3225,GO:0006879,1,0.663977038489964,0,46,cellular iron ion homeostasis,BP,
3226,GO:0006880,1,0.954993229358273,0,3,intracellular sequestering of iron ion,BP,
3227,GO:0006882,1,0.781059373953581,0,21,cellular zinc ion homeostasis,BP,
3228,GO:0006883,1,0.958560031678551,0,8,cellular sodium ion homeostasis,BP,
3229,GO:0006884,1,0.902080057852772,0,17,cell volume homeostasis,BP,
3233,GO:0006888,1,0.291485942962091,0,170,ER to Golgi vesicle-mediated transport,BP,
3234,GO:0006890,1,0.604695762709703,0,77,retrograde vesicle-mediated transport, Golgi to ER,BP,
3235,GO:0006891,1,0.817056116315541,0,30,intra-Golgi vesicle-mediated transport,BP,
3236,GO:0006892,1,0.579755322768732,0,89,post-Golgi vesicle-mediated transport,BP,
3237,GO:0006893,1,0.760356523980825,0,45,Golgi to plasma membrane transport,BP,
3238,GO:0006895,1,0.911307151358738,0,19,Golgi to endosome transport,BP,
3239,GO:0006896,1,0.924804906855409,0,14,Golgi to vacuole transport,BP,
3241,GO:0006898,1,0.339664160045575,0,164,receptor-mediated endocytosis,BP,
3242,GO:0006900,1,0.535347249824062,0,86,vesicle budding from membrane,BP,
3243,GO:0006901,1,0.630130189044781,0,60,vesicle coating,BP,
3244,GO:0006903,1,0.575358742557216,0,77,vesicle targeting,BP,
3246,GO:0006906,1,0.46641760303909,0,121,vesicle fusion,BP,
3247,GO:0006907,1,0.903513346598008,0,16,pinocytosis,BP,
3248,GO:0006909,1,0.386813002979187,0,151,phagocytosis,BP,
3249,GO:0006910,1,0.970164376468183,0,6,phagocytosis, recognition,BP,
3250,GO:0006911,1,0.8555772847516,0,25,phagocytosis, engulfment,BP,
3254,GO:0006919,1,0.485324951358956,0,77,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
3255,GO:0006921,1,0.840701285604495,0,25,cellular component disassembly involved in execution phase of apoptosis,BP,
3257,GO:0006925,1,0.904643418822531,0,13,inflammatory cell apoptotic process,BP,
3260,GO:0006930,1,0.960480308303061,0,8,substrate-dependent cell migration, cell extension,BP,
3261,GO:0006931,1,0.971032831702418,0,3,substrate-dependent cell migration, cell attachment to substrate,BP,
3270,GO:0006949,1,0.834359083200098,0,29,syncytium formation,BP,
3273,GO:0006953,1,0.879326596617276,0,17,acute-phase response,BP,
3276,GO:0006956,1,0.894606098767955,0,17,complement activation,BP,
3277,GO:0006957,1,0.990755199849266,0,2,complement activation, alternative pathway,BP,
3278,GO:0006958,1,0.924747676058508,0,12,complement activation, classical pathway,BP,
3279,GO:0006959,1,0.336046301922829,0,82,humoral immune response,BP,
3282,GO:0006971,1,0.942903297449556,0,8,hypotonic response,BP,
3283,GO:0006972,1,0.928379626015553,0,14,hyperosmotic response,BP,
3285,GO:0006975,1,0.959700954677279,0,7,DNA damage induced protein phosphorylation,BP,
3286,GO:0006977,1,0.623180954184948,0,59,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,
3287,GO:0006978,1,0.857869684018224,0,18,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
3289,GO:0006982,1,0.969650536825389,0,2,response to lipid hydroperoxide,BP,
3293,GO:0006987,1,0.943319256574687,0,8,activation of signaling protein activity involved in unfolded protein response,BP,
3294,GO:0006990,1,0.980459631842004,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
3295,GO:0006991,1,0.955529443642138,0,9,response to sterol depletion,BP,
3296,GO:0006995,1,0.891827865135324,0,10,cellular response to nitrogen starvation,BP,
3298,GO:0006997,1,0.45195050613497,0,124,nucleus organization,BP,
3299,GO:0006998,1,0.597920622005943,0,80,nuclear envelope organization,BP,
3300,GO:0006999,1,0.913853629032428,0,15,nuclear pore organization,BP,
3301,GO:0007000,1,0.948794629583029,0,7,nucleolus organization,BP,
3302,GO:0007004,1,0.634322476430062,0,64,telomere maintenance via telomerase,BP,
3304,GO:0007006,1,0.414871411745506,0,99,mitochondrial membrane organization,BP,
3305,GO:0007007,1,0.781167385007027,0,22,inner mitochondrial membrane organization,BP,
3306,GO:0007008,1,0.995366914937935,0,1,outer mitochondrial membrane organization,BP,
3307,GO:0007009,1,0.698836470747244,0,60,plasma membrane organization,BP,
3309,GO:0007014,1,0.995366982257957,0,1,actin ubiquitination,BP,
3311,GO:0007016,1,0.963524416203158,0,8,cytoskeletal anchoring at plasma membrane,BP,
3313,GO:0007018,1,0.215792275312806,0,228,microtubule-based movement,BP,
3315,GO:0007020,1,0.862192877595368,0,26,microtubule nucleation,BP,
3316,GO:0007021,1,0.899310176228921,0,7,tubulin complex assembly,BP,
3317,GO:0007023,1,0.952197578548359,0,4,post-chaperonin tubulin folding pathway,BP,
3319,GO:0007028,1,0.959070646411895,0,8,cytoplasm organization,BP,
3320,GO:0007029,1,0.782810217958054,0,43,endoplasmic reticulum organization,BP,
3322,GO:0007031,1,0.809664117832918,0,28,peroxisome organization,BP,
3323,GO:0007032,1,0.635984026775714,0,69,endosome organization,BP,
3325,GO:0007034,1,0.46829984257516,0,119,vacuolar transport,BP,
3326,GO:0007035,1,0.840237077406185,0,19,vacuolar acidification,BP,
3327,GO:0007039,1,0.926924794503748,0,12,protein catabolic process in the vacuole,BP,
3329,GO:0007041,1,0.593985634669421,0,90,lysosomal transport,BP,
3330,GO:0007042,1,0.920936883252586,0,8,lysosomal lumen acidification,BP,
3332,GO:0007044,1,0.665819332606318,0,75,cell-substrate junction assembly,BP,
3333,GO:0007045,1,0.722651519597003,0,60,cell-substrate adherens junction assembly,BP,
3338,GO:0007056,1,0.989374502452399,0,2,spindle assembly involved in female meiosis,BP,
3339,GO:0007057,1,0.989374502452399,0,2,spindle assembly involved in female meiosis I,BP,
3341,GO:0007060,1,0.990631016014009,0,2,male meiosis chromosome segregation,BP,
3343,GO:0007063,1,0.875303105779666,0,21,regulation of sister chromatid cohesion,BP,
3344,GO:0007064,1,0.867086295226815,0,22,mitotic sister chromatid cohesion,BP,
3345,GO:0007066,1,0.97810318688549,0,1,female meiosis sister chromatid cohesion,BP,
3346,GO:0007072,1,0.991388705237635,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3347,GO:0007076,1,0.925605474055233,0,16,mitotic chromosome condensation,BP,
3348,GO:0007077,1,0.769673552849034,0,42,mitotic nuclear envelope disassembly,BP,
3349,GO:0007079,1,0.98616426827827,0,3,mitotic chromosome movement towards spindle pole,BP,
3350,GO:0007080,1,0.757599321232726,0,43,mitotic metaphase plate congression,BP,
3351,GO:0007084,1,0.924258763294436,0,10,mitotic nuclear envelope reassembly,BP,
3352,GO:0007088,1,0.3699924173344,0,141,regulation of mitotic nuclear division,BP,
3353,GO:0007089,1,0.977901709850049,0,4,traversing start control point of mitotic cell cycle,BP,
3354,GO:0007091,1,0.69816854868152,0,49,metaphase/anaphase transition of mitotic cell cycle,BP,
3355,GO:0007093,1,0.32857440288623,0,154,mitotic cell cycle checkpoint,BP,
3356,GO:0007094,1,0.822833833598206,0,29,mitotic spindle assembly checkpoint,BP,
3357,GO:0007095,1,0.905384229066657,0,19,mitotic G2 DNA damage checkpoint,BP,
3358,GO:0007096,1,0.89596289335411,0,15,regulation of exit from mitosis,BP,
3359,GO:0007097,1,0.926105623509878,0,16,nuclear migration,BP,
3362,GO:0007100,1,0.922338974967665,0,13,mitotic centrosome separation,BP,
3363,GO:0007113,1,0.968667184679526,0,3,endomitotic cell cycle,BP,
3364,GO:0007127,1,0.626982429473782,0,67,meiosis I,BP,
3365,GO:0007129,1,0.909135975037023,0,18,synapsis,BP,
3366,GO:0007130,1,0.965646669925385,0,7,synaptonemal complex assembly,BP,
3367,GO:0007131,1,0.791226510636562,0,36,reciprocal meiotic recombination,BP,
3368,GO:0007135,1,0.954890688681337,0,6,meiosis II,BP,
3369,GO:0007140,1,0.852336564843697,0,23,male meiotic nuclear division,BP,
3370,GO:0007141,1,0.897866140955201,0,12,male meiosis I,BP,
3371,GO:0007143,1,0.883896513503658,0,18,female meiotic nuclear division,BP,
3372,GO:0007144,1,0.953047236796276,0,6,female meiosis I,BP,
3373,GO:0007146,1,0.995366574475227,0,1,meiotic recombination nodule assembly,BP,
3374,GO:0007147,1,0.995366973171715,0,1,female meiosis II,BP,
3379,GO:0007158,1,0.972518059196639,0,6,neuron cell-cell adhesion,BP,
3381,GO:0007160,1,0.421311327669905,0,149,cell-matrix adhesion,BP,
3382,GO:0007161,1,0.981594535038454,0,4,calcium-independent cell-matrix adhesion,BP,
3385,GO:0007164,1,0.361121665842501,0,109,establishment of tissue polarity,BP,
3389,GO:0007168,1,0.990265309544443,0,2,receptor guanylyl cyclase signaling pathway,BP,
3391,GO:0007171,1,0.970891974193079,0,6,activation of transmembrane receptor protein tyrosine kinase activity,BP,
3392,GO:0007172,1,0.965456471982777,0,7,signal complex assembly,BP,
3393,GO:0007173,1,0.519530200942043,0,108,epidermal growth factor receptor signaling pathway,BP,
3394,GO:0007174,1,0.994774072587903,0,1,epidermal growth factor catabolic process,BP,
3395,GO:0007175,1,0.910306949879823,0,13,negative regulation of epidermal growth factor-activated receptor activity,BP,
3396,GO:0007176,1,0.855700868897457,0,22,regulation of epidermal growth factor-activated receptor activity,BP,
3398,GO:0007179,1,0.441438989208466,0,129,transforming growth factor beta receptor signaling pathway,BP,
3399,GO:0007181,1,0.982245542845905,0,2,transforming growth factor beta receptor complex assembly,BP,
3400,GO:0007182,1,0.968602370732654,0,6,common-partner SMAD protein phosphorylation,BP,
3401,GO:0007183,1,0.931256270109027,0,11,SMAD protein complex assembly,BP,
3402,GO:0007185,1,0.98159488873313,0,4,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3406,GO:0007189,1,0.791901507376703,0,38,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
3407,GO:0007190,1,0.930345776366679,0,14,activation of adenylate cyclase activity,BP,
3408,GO:0007191,1,0.966124418810999,0,6,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
3410,GO:0007194,1,0.951896662982526,0,7,negative regulation of adenylate cyclase activity,BP,
3411,GO:0007195,1,0.990596989103802,0,2,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3412,GO:0007196,1,0.995366990826112,0,1,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3413,GO:0007197,1,0.990753574477342,0,2,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
3414,GO:0007198,1,0.97836649519616,0,2,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
3415,GO:0007200,1,0.824165285200884,0,31,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
3416,GO:0007202,1,0.932826693867989,0,10,activation of phospholipase C activity,BP,
3418,GO:0007205,1,0.875402147512443,0,20,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,
3419,GO:0007206,1,0.995366990826153,0,1,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
3420,GO:0007207,1,0.989807287823776,0,2,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
3421,GO:0007210,1,0.973240272848599,0,3,serotonin receptor signaling pathway,BP,
3422,GO:0007212,1,0.839608587259873,0,26,dopamine receptor signaling pathway,BP,
3423,GO:0007213,1,0.92930647095975,0,10,G-protein coupled acetylcholine receptor signaling pathway,BP,
3424,GO:0007214,1,0.96785873890537,0,6,gamma-aminobutyric acid signaling pathway,BP,
3425,GO:0007215,1,0.835893837762347,0,32,glutamate receptor signaling pathway,BP,
3426,GO:0007216,1,0.969154738389869,0,5,G-protein coupled glutamate receptor signaling pathway,BP,
3427,GO:0007217,1,0.995321619947479,0,1,tachykinin receptor signaling pathway,BP,
3428,GO:0007218,1,0.824458166488606,0,17,neuropeptide signaling pathway,BP,
3430,GO:0007220,1,0.903298294583442,0,15,Notch receptor processing,BP,
3431,GO:0007221,1,0.927202997168448,0,16,positive regulation of transcription of Notch receptor target,BP,
3432,GO:0007223,1,0.857573384463826,0,32,Wnt signaling pathway, calcium modulating pathway,BP,
3434,GO:0007225,1,0.995366990826165,0,1,patched ligand maturation,BP,
3435,GO:0007227,1,0.986164524479923,0,3,signal transduction downstream of smoothened,BP,
3436,GO:0007228,1,0.990755193394123,0,2,positive regulation of hh target transcription factor activity,BP,
3437,GO:0007229,1,0.700863161316214,0,62,integrin-mediated signaling pathway,BP,
3438,GO:0007231,1,0.986022997562283,0,2,osmosensory signaling pathway,BP,
3440,GO:0007250,1,0.919480074304831,0,16,activation of NF-kappaB-inducing kinase activity,BP,
3441,GO:0007252,1,0.91423243546003,0,13,I-kappaB phosphorylation,BP,
3443,GO:0007254,1,0.374228743150105,0,155,JNK cascade,BP,
3444,GO:0007256,1,0.972518222147103,0,6,activation of JNKK activity,BP,
3445,GO:0007257,1,0.877213306625189,0,28,activation of JUN kinase activity,BP,
3446,GO:0007258,1,0.973697941216453,0,4,JUN phosphorylation,BP,
3449,GO:0007263,1,0.942425640562902,0,8,nitric oxide mediated signal transduction,BP,
3455,GO:0007269,1,0.641579635124646,0,75,neurotransmitter secretion,BP,
3456,GO:0007270,1,0.961959247028943,0,6,neuron-neuron synaptic transmission,BP,
3457,GO:0007271,1,0.941622339058806,0,10,synaptic transmission, cholinergic,BP,
3459,GO:0007274,1,0.95873958667644,0,9,neuromuscular synaptic transmission,BP,
3462,GO:0007281,1,0.414634521415333,0,133,germ cell development,BP,
3464,GO:0007284,1,0.990755199849267,0,2,spermatogonial cell division,BP,
3465,GO:0007286,1,0.615652385911808,0,69,spermatid development,BP,
3466,GO:0007288,1,0.947017634494384,0,10,sperm axoneme assembly,BP,
3467,GO:0007289,1,0.923950926934257,0,11,spermatid nucleus differentiation,BP,
3468,GO:0007290,1,0.995366990826165,0,1,spermatid nucleus elongation,BP,
3469,GO:0007292,1,0.627146765427513,0,75,female gamete generation,BP,
3470,GO:0007296,1,0.977100719552722,0,4,vitellogenesis,BP,
3471,GO:0007308,1,0.995323773158493,0,1,oocyte construction,BP,
3472,GO:0007309,1,0.995323773158493,0,1,oocyte axis specification,BP,
3473,GO:0007314,1,0.995323773158493,0,1,oocyte anterior/posterior axis specification,BP,
3474,GO:0007315,1,0.995323773158493,0,1,pole plasm assembly,BP,
3475,GO:0007320,1,0.981091990212034,0,4,insemination,BP,
3478,GO:0007340,1,0.896946810903885,0,12,acrosome reaction,BP,
3479,GO:0007341,1,0.981948067486343,0,3,penetration of zona pellucida,BP,
3480,GO:0007342,1,0.943760092052474,0,4,fusion of sperm to egg plasma membrane involved in single fertilization,BP,
3481,GO:0007344,1,0.991695739399954,0,1,pronuclear fusion,BP,
3483,GO:0007350,1,0.940138825705622,0,12,blastoderm segmentation,BP,
3484,GO:0007351,1,0.953439318203603,0,9,tripartite regional subdivision,BP,
3485,GO:0007352,1,0.995366990825915,0,1,zygotic specification of dorsal/ventral axis,BP,
3486,GO:0007354,1,0.982910546454174,0,3,zygotic determination of anterior/posterior axis, embryo,BP,
3487,GO:0007356,1,0.987486348809159,0,2,thorax and anterior abdomen determination,BP,
3488,GO:0007368,1,0.660935087565219,0,69,determination of left/right symmetry,BP,
3489,GO:0007369,1,0.525159038930936,0,122,gastrulation,BP,
3490,GO:0007371,1,0.995366984341286,0,1,ventral midline determination,BP,
3492,GO:0007386,1,0.97560680847045,0,5,compartment pattern specification,BP,
3493,GO:0007387,1,0.995363193684474,0,1,anterior compartment pattern formation,BP,
3494,GO:0007388,1,0.995363193684474,0,1,posterior compartment specification,BP,
3496,GO:0007398,1,0.932262367319214,0,15,ectoderm development,BP,
3498,GO:0007402,1,0.979355933200066,0,1,ganglion mother cell fate determination,BP,
3499,GO:0007403,1,0.995366929196251,0,1,glial cell fate determination,BP,
3500,GO:0007405,1,0.849712194633969,0,33,neuroblast proliferation,BP,
3501,GO:0007406,1,0.98090775445471,0,4,negative regulation of neuroblast proliferation,BP,
3504,GO:0007412,1,0.977546200956744,0,2,axon target recognition,BP,
3505,GO:0007413,1,0.934503594679803,0,14,axonal fasciculation,BP,
3506,GO:0007416,1,0.68423818520716,0,76,synapse assembly,BP,
3508,GO:0007418,1,0.990755193394043,0,2,ventral midline development,BP,
3514,GO:0007439,1,0.995366648998949,0,1,ectodermal digestive tract development,BP,
3515,GO:0007440,1,0.97251824320016,0,6,foregut morphogenesis,BP,
3516,GO:0007442,1,0.981594418824009,0,4,hindgut morphogenesis,BP,
3517,GO:0007468,1,0.994023985838802,0,1,regulation of rhodopsin gene expression,BP,
3518,GO:0007492,1,0.742872835290358,0,57,endoderm development,BP,
3519,GO:0007494,1,0.96796347123657,0,7,midgut development,BP,
3520,GO:0007495,1,0.995366820767689,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3521,GO:0007497,1,0.995366990826165,0,1,posterior midgut development,BP,
3522,GO:0007498,1,0.667660065850962,0,71,mesoderm development,BP,
3523,GO:0007499,1,0.995366990826165,0,1,ectoderm and mesoderm interaction,BP,
3524,GO:0007500,1,0.987457606313135,0,2,mesodermal cell fate determination,BP,
3525,GO:0007501,1,0.983069562318622,0,3,mesodermal cell fate specification,BP,
3527,GO:0007509,1,0.995366990826086,0,1,mesoderm migration involved in gastrulation,BP,
3528,GO:0007512,1,0.967700571944441,0,5,adult heart development,BP,
3530,GO:0007518,1,0.995101421136794,0,1,myoblast fate determination,BP,
3532,GO:0007520,1,0.87696505383629,0,20,myoblast fusion,BP,
3533,GO:0007525,1,0.990721426750807,0,2,somatic muscle development,BP,
3534,GO:0007528,1,0.866007103851187,0,29,neuromuscular junction development,BP,
3535,GO:0007529,1,0.990755196861517,0,2,establishment of synaptic specificity at neuromuscular junction,BP,
3536,GO:0007530,1,0.942746388472325,0,11,sex determination,BP,
3537,GO:0007538,1,0.990755199558037,0,2,primary sex determination,BP,
3538,GO:0007542,1,0.990755199558037,0,2,primary sex determination, germ-line,BP,
3540,GO:0007549,1,0.933921241110797,0,12,dosage compensation,BP,
3541,GO:0007565,1,0.441051208271436,0,122,female pregnancy,BP,
3542,GO:0007566,1,0.74214493788769,0,35,embryo implantation,BP,
3543,GO:0007567,1,0.949221516949159,0,9,parturition,BP,
3546,GO:0007571,1,0.979969782766415,0,1,age-dependent general metabolic decline,BP,
3547,GO:0007576,1,0.995308470634076,0,1,nucleolar fragmentation,BP,
3549,GO:0007585,1,0.750199547166389,0,39,respiratory gaseous exchange,BP,
3551,GO:0007588,1,0.85959850217203,0,20,excretion,BP,
3552,GO:0007589,1,0.698270559472603,0,52,body fluid secretion,BP,
3553,GO:0007595,1,0.819160246180675,0,32,lactation,BP,
3554,GO:0007596,1,0.181304687826012,0,213,blood coagulation,BP,
3555,GO:0007597,1,0.960329996141524,0,5,blood coagulation, intrinsic pathway,BP,
3556,GO:0007598,1,0.995068827668363,0,1,blood coagulation, extrinsic pathway,BP,
3557,GO:0007599,1,0.178334411689777,0,216,hemostasis,BP,
3559,GO:0007601,1,0.627706352282457,0,82,visual perception,BP,
3560,GO:0007602,1,0.880070430254096,0,23,phototransduction,BP,
3561,GO:0007603,1,0.917084499966884,0,16,phototransduction, visible light,BP,
3566,GO:0007611,1,0.441008665742151,0,134,learning or memory,BP,
3567,GO:0007612,1,0.650604876057111,0,75,learning,BP,
3568,GO:0007613,1,0.668065938066062,0,64,memory,BP,
3569,GO:0007614,1,0.947616547065973,0,6,short-term memory,BP,
3570,GO:0007616,1,0.879363755876169,0,21,long-term memory,BP,
3571,GO:0007617,1,0.944830914366547,0,11,mating behavior,BP,
3572,GO:0007618,1,0.884852347115887,0,18,mating,BP,
3573,GO:0007619,1,0.983754539306632,0,3,courtship behavior,BP,
3574,GO:0007620,1,0.931739114536823,0,8,copulation,BP,
3575,GO:0007621,1,0.995366990826047,0,1,negative regulation of female receptivity,BP,
3578,GO:0007624,1,0.995366990826138,0,1,ultradian rhythm,BP,
3579,GO:0007625,1,0.924586416599264,0,6,grooming behavior,BP,
3581,GO:0007628,1,0.92773607478815,0,12,adult walking behavior,BP,
3582,GO:0007631,1,0.754065958648807,0,35,feeding behavior,BP,
3583,GO:0007632,1,0.803676121802882,0,35,visual behavior,BP,
3584,GO:0007634,1,0.995209950234741,0,1,optokinetic behavior,BP,
3585,GO:0007635,1,0.972517817106371,0,6,chemosensory behavior,BP,
3586,GO:0007638,1,0.963524658269653,0,8,mechanosensory behavior,BP,
3587,GO:0008009,1,0.813328453952402,0,14,chemokine activity,MF,
3592,GO:0008020,1,0.990735732835999,0,2,G-protein coupled photoreceptor activity,MF,
3594,GO:0008022,1,0.338016713982444,0,161,protein C-terminus binding,MF,
3595,GO:0008023,1,0.752361829857128,0,46,transcription elongation factor complex,CC,
3596,GO:0008024,1,0.962018259087792,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3597,GO:0008026,1,0.639563806693508,0,88,ATP-dependent helicase activity,MF,
3598,GO:0008028,1,0.865200470874841,0,26,monocarboxylic acid transmembrane transporter activity,MF,
3599,GO:0008033,1,0.381510499546392,0,120,tRNA processing,BP,
3600,GO:0008035,1,0.981195610707158,0,4,high-density lipoprotein particle binding,MF,
3601,GO:0008037,1,0.664656820467951,0,62,cell recognition,BP,
3602,GO:0008038,1,0.900390798766328,0,22,neuron recognition,BP,
3603,GO:0008043,1,0.960992352400417,0,2,intracellular ferritin complex,CC,
3604,GO:0008045,1,0.920267449683609,0,14,motor neuron axon guidance,BP,
3605,GO:0008046,1,0.981594888733428,0,4,axon guidance receptor activity,MF,
3607,GO:0008048,1,0.994874902021167,0,1,calcium sensitive guanylate cyclase activator activity,MF,
3608,GO:0008049,1,0.993118683747675,0,1,male courtship behavior,BP,
3609,GO:0008050,1,0.990571717822835,0,2,female courtship behavior,BP,
3610,GO:0008052,1,0.979355933200066,0,1,sensory organ boundary specification,BP,
3611,GO:0008053,1,0.835406498264886,0,20,mitochondrial fusion,BP,
3612,GO:0008057,1,0.995366990826047,0,1,eye pigment granule organization,BP,
3613,GO:0008061,1,0.990754908593028,0,2,chitin binding,MF,
3614,GO:0008063,1,0.981496479723707,0,4,Toll signaling pathway,BP,
3616,GO:0008065,1,0.99075513600897,0,2,establishment of blood-nerve barrier,BP,
3617,GO:0008066,1,0.986164531023701,0,3,glutamate receptor activity,MF,
3618,GO:0008073,1,0.975749057395819,0,2,ornithine decarboxylase inhibitor activity,MF,
3619,GO:0008074,1,0.972518249038166,0,6,guanylate cyclase complex, soluble,CC,
3620,GO:0008076,1,0.855608682541838,0,29,voltage-gated potassium channel complex,CC,
3621,GO:0008078,1,0.995366990826086,0,1,mesodermal cell migration,BP,
3622,GO:0008079,1,0.966734318257691,0,6,translation termination factor activity,MF,
3623,GO:0008080,1,0.604157901668515,0,72,N-acetyltransferase activity,MF,
3624,GO:0008081,1,0.71352555697706,0,57,phosphoric diester hydrolase activity,MF,
3626,GO:0008088,1,0.709812288203789,0,48,axo-dendritic transport,BP,
3627,GO:0008089,1,0.771672617150529,0,34,anterograde axonal transport,BP,
3628,GO:0008090,1,0.937035901401161,0,7,retrograde axonal transport,BP,
3629,GO:0008091,1,0.972518255529537,0,6,spectrin,CC,
3631,GO:0008093,1,0.944250209670743,0,11,cytoskeletal adaptor activity,MF,
3632,GO:0008094,1,0.631526158893766,0,79,DNA-dependent ATPase activity,MF,
3633,GO:0008097,1,0.854183756236335,0,10,5S rRNA binding,MF,
3635,GO:0008106,1,0.888027524219684,0,12,alcohol dehydrogenase (NADP+) activity,MF,
3636,GO:0008107,1,0.99075496636133,0,2,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3637,GO:0008108,1,0.986011881134435,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
3638,GO:0008109,1,0.990755140026121,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3639,GO:0008111,1,0.993578202154248,0,1,alpha-methylacyl-CoA racemase activity,MF,
3640,GO:0008112,1,0.989662095655057,0,1,nicotinamide N-methyltransferase activity,MF,
3641,GO:0008113,1,0.974464294169397,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
3642,GO:0008116,1,0.995366990826138,0,1,prostaglandin-I synthase activity,MF,
3643,GO:0008117,1,0.995366990826125,0,1,sphinganine-1-phosphate aldolase activity,MF,
3644,GO:0008118,1,0.99474766508198,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3645,GO:0008119,1,0.995366857285493,0,1,thiopurine S-methyltransferase activity,MF,
3646,GO:0008120,1,0.990398588884564,0,1,ceramide glucosyltransferase activity,MF,
3647,GO:0008121,1,0.896522283940885,0,7,ubiquinol-cytochrome-c reductase activity,MF,
3648,GO:0008124,1,0.974801290954034,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
3649,GO:0008126,1,0.995366516811088,0,1,acetylesterase activity,MF,
3650,GO:0008127,1,0.985332589258062,0,1,quercetin 2,3-dioxygenase activity,MF,
3651,GO:0008131,1,0.986142717835454,0,3,primary amine oxidase activity,MF,
3653,GO:0008135,1,0.532334805667439,0,81,translation factor activity, RNA binding,MF,
3654,GO:0008137,1,0.412908395982214,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3655,GO:0008138,1,0.77679088391805,0,34,protein tyrosine/serine/threonine phosphatase activity,MF,
3656,GO:0008139,1,0.891093011876658,0,23,nuclear localization sequence binding,MF,
3658,GO:0008142,1,0.978308763567377,0,4,oxysterol binding,MF,
3659,GO:0008143,1,0.924046114598052,0,14,poly(A) binding,MF,
3661,GO:0008146,1,0.834510794085404,0,28,sulfotransferase activity,MF,
3665,GO:0008156,1,0.809637196437378,0,33,negative regulation of DNA replication,BP,
3666,GO:0008157,1,0.915295485971357,0,14,protein phosphatase 1 binding,MF,
3667,GO:0008158,1,0.973417811818557,0,2,hedgehog receptor activity,MF,
3668,GO:0008160,1,0.995343082616693,0,1,protein tyrosine phosphatase activator activity,MF,
3669,GO:0008168,1,0.307527867506021,0,177,methyltransferase activity,MF,
3670,GO:0008169,1,0.975631851088385,0,3,C-methyltransferase activity,MF,
3671,GO:0008170,1,0.613025764023629,0,76,N-methyltransferase activity,MF,
3672,GO:0008171,1,0.864630089242829,0,21,O-methyltransferase activity,MF,
3673,GO:0008172,1,0.964926571564701,0,5,S-methyltransferase activity,MF,
3674,GO:0008173,1,0.690540949500861,0,55,RNA methyltransferase activity,MF,
3675,GO:0008174,1,0.953571346433272,0,9,mRNA methyltransferase activity,MF,
3676,GO:0008175,1,0.850952504803233,0,28,tRNA methyltransferase activity,MF,
3677,GO:0008176,1,0.976362096561499,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3678,GO:0008177,1,0.955516278776553,0,5,succinate dehydrogenase (ubiquinone) activity,MF,
3679,GO:0008179,1,0.94321414008552,0,10,adenylate cyclase binding,MF,
3680,GO:0008180,1,0.823734886516963,0,27,COP9 signalosome,CC,
3681,GO:0008184,1,0.990754685232654,0,2,glycogen phosphorylase activity,MF,
3682,GO:0008186,1,0.737144397917192,0,61,RNA-dependent ATPase activity,MF,
3683,GO:0008187,1,0.901050458384598,0,20,poly-pyrimidine tract binding,MF,
3684,GO:0008188,1,0.947630526992202,0,5,neuropeptide receptor activity,MF,
3685,GO:0008190,1,0.923306519067253,0,8,eukaryotic initiation factor 4E binding,MF,
3686,GO:0008191,1,0.921660583174908,0,7,metalloendopeptidase inhibitor activity,MF,
3687,GO:0008192,1,0.976326762821458,0,3,RNA guanylyltransferase activity,MF,
3688,GO:0008193,1,0.980872160269281,0,2,tRNA guanylyltransferase activity,MF,
3690,GO:0008195,1,0.959056350584279,0,9,phosphatidate phosphatase activity,MF,
3691,GO:0008198,1,0.862516864421728,0,17,ferrous iron binding,MF,
3692,GO:0008199,1,0.940188262204571,0,5,ferric iron binding,MF,
3693,GO:0008200,1,0.804461805316682,0,24,ion channel inhibitor activity,MF,
3694,GO:0008201,1,0.56347959225892,0,76,heparin binding,MF,
3696,GO:0008203,1,0.512056509939863,0,100,cholesterol metabolic process,BP,
3697,GO:0008204,1,0.988771562554042,0,2,ergosterol metabolic process,BP,
3699,GO:0008207,1,0.844293105470938,0,19,C21-steroid hormone metabolic process,BP,
3700,GO:0008209,1,0.916381987970661,0,13,androgen metabolic process,BP,
3701,GO:0008210,1,0.872234717418677,0,17,estrogen metabolic process,BP,
3702,GO:0008211,1,0.903984184242983,0,13,glucocorticoid metabolic process,BP,
3703,GO:0008212,1,0.981593243496628,0,4,mineralocorticoid metabolic process,BP,
3705,GO:0008214,1,0.872584297905231,0,29,protein dealkylation,BP,
3706,GO:0008215,1,0.93415848074043,0,6,spermine metabolic process,BP,
3707,GO:0008216,1,0.913254180094758,0,7,spermidine metabolic process,BP,
3708,GO:0008217,1,0.580871874660291,0,83,regulation of blood pressure,BP,
3709,GO:0008218,1,0.995366945682435,0,1,bioluminescence,BP,
3711,GO:0008227,1,0.948809545161991,0,8,G-protein coupled amine receptor activity,MF,
3712,GO:0008228,1,0.990755199849162,0,2,opsonization,BP,
3713,GO:0008233,1,0.0688662644972324,0,374,peptidase activity,MF,
3714,GO:0008234,1,0.364656234825592,0,150,cysteine-type peptidase activity,MF,
3715,GO:0008235,1,0.860450408447451,0,31,metalloexopeptidase activity,MF,
3716,GO:0008236,1,0.520297745894518,0,91,serine-type peptidase activity,MF,
3717,GO:0008237,1,0.587694599173865,0,98,metallopeptidase activity,MF,
3718,GO:0008238,1,0.70080799449265,0,64,exopeptidase activity,MF,
3719,GO:0008239,1,0.966790443224706,0,6,dipeptidyl-peptidase activity,MF,
3720,GO:0008240,1,0.99075516750132,0,2,tripeptidyl-peptidase activity,MF,
3721,GO:0008242,1,0.94377886770345,0,8,omega peptidase activity,MF,
3722,GO:0008250,1,0.855319760972786,0,12,oligosaccharyltransferase complex,CC,
3723,GO:0008251,1,0.990753053613083,0,2,tRNA-specific adenosine deaminase activity,MF,
3724,GO:0008252,1,0.936229007642433,0,10,nucleotidase activity,MF,
3725,GO:0008253,1,0.945095125723389,0,8,5'-nucleotidase activity,MF,
3726,GO:0008254,1,0.995366990826059,0,1,3'-nucleotidase activity,MF,
3727,GO:0008260,1,0.995366963653428,0,1,3-oxoacid CoA-transferase activity,MF,
3728,GO:0008263,1,0.990635538549989,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
3729,GO:0008265,1,0.995365006131273,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
3730,GO:0008266,1,0.917962878792121,0,16,poly(U) RNA binding,MF,
3731,GO:0008267,1,0.99536699082602,0,1,poly-glutamine tract binding,MF,
3732,GO:0008269,1,0.994694186358932,0,1,JAK pathway signal transduction adaptor activity,MF,
3734,GO:0008271,1,0.977033401398438,0,5,secondary active sulfate transmembrane transporter activity,MF,
3735,GO:0008272,1,0.965678317753718,0,7,sulfate transport,BP,
3737,GO:0008274,1,0.96352323015997,0,8,gamma-tubulin ring complex,CC,
3738,GO:0008275,1,0.981594324989473,0,4,gamma-tubulin small complex,CC,
3739,GO:0008276,1,0.628801383827955,0,72,protein methyltransferase activity,MF,
3741,GO:0008278,1,0.963073310281446,0,8,cohesin complex,CC,
3742,GO:0008281,1,0.995366990826165,0,1,sulfonylurea receptor activity,MF,
3743,GO:0008282,1,0.990754957251611,0,2,inward rectifying potassium channel,CC,
3747,GO:0008286,1,0.516145082385373,0,101,insulin receptor signaling pathway,BP,
3748,GO:0008287,1,0.772751650142181,0,46,protein serine/threonine phosphatase complex,CC,
3750,GO:0008290,1,0.96094078912384,0,6,F-actin capping protein complex,CC,
3751,GO:0008291,1,0.995352427354762,0,1,acetylcholine metabolic process,BP,
3752,GO:0008292,1,0.995352427354762,0,1,acetylcholine biosynthetic process,BP,
3753,GO:0008294,1,0.995366990825837,0,1,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
3754,GO:0008295,1,0.966496066005976,0,4,spermidine biosynthetic process,BP,
3755,GO:0008296,1,0.934479170128592,0,8,3'-5'-exodeoxyribonuclease activity,MF,
3756,GO:0008297,1,0.956049475143664,0,6,single-stranded DNA exodeoxyribonuclease activity,MF,
3757,GO:0008298,1,0.921457766152741,0,12,intracellular mRNA localization,BP,
3758,GO:0008299,1,0.853176976297252,0,21,isoprenoid biosynthetic process,BP,
3759,GO:0008300,1,0.990743712830173,0,2,isoprenoid catabolic process,BP,
3760,GO:0008301,1,0.932128145502559,0,13,DNA binding, bending,MF,
3761,GO:0008305,1,0.923870428615986,0,17,integrin complex,CC,
3762,GO:0008306,1,0.78912830384229,0,40,associative learning,BP,
3763,GO:0008307,1,0.816658480626189,0,25,structural constituent of muscle,MF,
3765,GO:0008309,1,0.972496455895159,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
3766,GO:0008310,1,0.964974672250901,0,4,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
3767,GO:0008311,1,0.982128417220116,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
3768,GO:0008312,1,0.930506906313739,0,7,7S RNA binding,MF,
3769,GO:0008318,1,0.95512042865833,0,7,protein prenyltransferase activity,MF,
3770,GO:0008320,1,0.82788945590372,0,13,protein transmembrane transporter activity,MF,
3771,GO:0008321,1,0.990755199849228,0,2,Ral guanyl-nucleotide exchange factor activity,MF,
3773,GO:0008327,1,0.89953269708887,0,16,methyl-CpG binding,MF,
3774,GO:0008328,1,0.907891234456268,0,17,ionotropic glutamate receptor complex,CC,
3775,GO:0008329,1,0.953120506014628,0,7,signaling pattern recognition receptor activity,MF,
3776,GO:0008330,1,0.975157702757269,0,4,protein tyrosine/threonine phosphatase activity,MF,
3777,GO:0008331,1,0.983401087289801,0,3,high voltage-gated calcium channel activity,MF,
3778,GO:0008332,1,0.993313699578051,0,1,low voltage-gated calcium channel activity,MF,
3779,GO:0008333,1,0.750636713620899,0,48,endosome to lysosome transport,BP,
3780,GO:0008334,1,0.77515602535188,0,24,histone mRNA metabolic process,BP,
3781,GO:0008336,1,0.992982056220991,0,1,gamma-butyrobetaine dioxygenase activity,MF,
3782,GO:0008340,1,0.959024561689505,0,9,determination of adult lifespan,BP,
3783,GO:0008343,1,0.99536699082602,0,1,adult feeding behavior,BP,
3785,GO:0008347,1,0.816866181935408,0,33,glial cell migration,BP,
3786,GO:0008348,1,0.99536697768676,0,1,negative regulation of antimicrobial humoral response,BP,
3787,GO:0008349,1,0.953751749865963,0,10,MAP kinase kinase kinase kinase activity,MF,
3788,GO:0008352,1,0.995355663539428,0,1,katanin complex,CC,
3789,GO:0008353,1,0.887439600166519,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
3790,GO:0008354,1,0.967215071701719,0,7,germ cell migration,BP,
3791,GO:0008355,1,0.995366990826151,0,1,olfactory learning,BP,
3792,GO:0008356,1,0.920627099984326,0,13,asymmetric cell division,BP,
3793,GO:0008358,1,0.995323773158493,0,1,maternal determination of anterior/posterior axis, embryo,BP,
3795,GO:0008361,1,0.490463632701483,0,123,regulation of cell size,BP,
3797,GO:0008373,1,0.924550317277552,0,14,sialyltransferase activity,MF,
3798,GO:0008374,1,0.817906892355993,0,38,O-acyltransferase activity,MF,
3800,GO:0008376,1,0.840365676187233,0,34,acetylgalactosaminyltransferase activity,MF,
3801,GO:0008378,1,0.85805607275524,0,27,galactosyltransferase activity,MF,
3802,GO:0008379,1,0.904963891009247,0,5,thioredoxin peroxidase activity,MF,
3804,GO:0008381,1,0.986163932868119,0,3,mechanosensitive ion channel activity,MF,
3805,GO:0008384,1,0.986164380670185,0,3,IkappaB kinase activity,MF,
3806,GO:0008385,1,0.934903614834496,0,9,IkappaB kinase complex,CC,
3807,GO:0008391,1,0.988121454245557,0,2,arachidonic acid monooxygenase activity,MF,
3808,GO:0008392,1,0.988121454245557,0,2,arachidonic acid epoxygenase activity,MF,
3809,GO:0008395,1,0.951855954816178,0,8,steroid hydroxylase activity,MF,
3810,GO:0008396,1,0.995146103438213,0,1,oxysterol 7-alpha-hydroxylase activity,MF,
3811,GO:0008398,1,0.995366744787704,0,1,sterol 14-demethylase activity,MF,
3812,GO:0008401,1,0.990734108297097,0,2,retinoic acid 4-hydroxylase activity,MF,
3813,GO:0008403,1,0.995366813683676,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
3814,GO:0008404,1,0.992742259796257,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
3815,GO:0008405,1,0.992742259796257,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
3817,GO:0008408,1,0.718778046901295,0,46,3'-5' exonuclease activity,MF,
3818,GO:0008409,1,0.925726931064375,0,16,5'-3' exonuclease activity,MF,
3819,GO:0008410,1,0.983266675722267,0,3,CoA-transferase activity,MF,
3820,GO:0008413,1,0.967031870698066,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
3821,GO:0008417,1,0.952694863290913,0,10,fucosyltransferase activity,MF,
3822,GO:0008418,1,0.981837892686248,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
3823,GO:0008419,1,0.995353648504055,0,1,RNA lariat debranching enzyme activity,MF,
3824,GO:0008420,1,0.947939251760539,0,8,CTD phosphatase activity,MF,
3825,GO:0008422,1,0.990755181185011,0,2,beta-glucosidase activity,MF,
3826,GO:0008424,1,0.995366876923498,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
3827,GO:0008425,1,0.984741452522495,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
3828,GO:0008426,1,0.958582625130555,0,3,protein kinase C inhibitor activity,MF,
3829,GO:0008427,1,0.974175187661214,0,2,calcium-dependent protein kinase inhibitor activity,MF,
3830,GO:0008428,1,0.983854429432845,0,3,ribonuclease inhibitor activity,MF,
3831,GO:0008429,1,0.919045216747763,0,8,phosphatidylethanolamine binding,MF,
3832,GO:0008430,1,0.991828160816106,0,1,selenium binding,MF,
3833,GO:0008431,1,0.995366726065616,0,1,vitamin E binding,MF,
3834,GO:0008432,1,0.934340678382708,0,8,JUN kinase binding,MF,
3835,GO:0008434,1,0.995366990826165,0,1,calcitriol receptor activity,MF,
3836,GO:0008440,1,0.978431101848634,0,4,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
3837,GO:0008441,1,0.990624879924434,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
3838,GO:0008442,1,0.99360680946988,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
3839,GO:0008443,1,0.972499672919945,0,6,phosphofructokinase activity,MF,
3840,GO:0008444,1,0.994646465207342,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
3841,GO:0008446,1,0.990927654909145,0,1,GDP-mannose 4,6-dehydratase activity,MF,
3842,GO:0008448,1,0.99253493458708,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
3843,GO:0008449,1,0.99075519984928,0,2,N-acetylglucosamine-6-sulfatase activity,MF,
3844,GO:0008452,1,0.995366574475227,0,1,RNA ligase activity,MF,
3845,GO:0008453,1,0.995366574475227,0,1,alanine-glyoxylate transaminase activity,MF,
3846,GO:0008454,1,0.990749006049873,0,2,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
3847,GO:0008455,1,0.995362644056522,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
3848,GO:0008456,1,0.995366983404551,0,1,alpha-N-acetylgalactosaminidase activity,MF,
3849,GO:0008457,1,0.995366990826138,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
3850,GO:0008458,1,0.995366858317226,0,1,carnitine O-octanoyltransferase activity,MF,
3851,GO:0008459,1,0.990362998750008,0,2,chondroitin 6-sulfotransferase activity,MF,
3852,GO:0008460,1,0.993118683747675,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
3853,GO:0008465,1,0.984246971983521,0,1,glycerate dehydrogenase activity,MF,
3854,GO:0008466,1,0.992280390272765,0,1,glycogenin glucosyltransferase activity,MF,
3855,GO:0008467,1,0.980912844664957,0,3,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
3856,GO:0008469,1,0.954764900343378,0,8,histone-arginine N-methyltransferase activity,MF,
3857,GO:0008470,1,0.995366990826165,0,1,isovaleryl-CoA dehydrogenase activity,MF,
3858,GO:0008474,1,0.940640387161152,0,10,palmitoyl-(protein) hydrolase activity,MF,
3859,GO:0008475,1,0.986163924488993,0,3,procollagen-lysine 5-dioxygenase activity,MF,
3860,GO:0008476,1,0.987466393968392,0,2,protein-tyrosine sulfotransferase activity,MF,
3861,GO:0008478,1,0.995366990826047,0,1,pyridoxal kinase activity,MF,
3862,GO:0008479,1,0.952260235714353,0,4,queuine tRNA-ribosyltransferase activity,MF,
3863,GO:0008481,1,0.988182993466766,0,2,sphinganine kinase activity,MF,
3864,GO:0008482,1,0.99503262177923,0,1,sulfite oxidase activity,MF,
3865,GO:0008483,1,0.935519389541503,0,12,transaminase activity,MF,
3866,GO:0008484,1,0.94336696052599,0,12,sulfuric ester hydrolase activity,MF,
3867,GO:0008486,1,0.970671105713102,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
3868,GO:0008488,1,0.995366812118089,0,1,gamma-glutamyl carboxylase activity,MF,
3869,GO:0008489,1,0.995366584873465,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
3870,GO:0008493,1,0.992771026591583,0,1,tetracycline transmembrane transporter activity,MF,
3871,GO:0008494,1,0.934462562629079,0,7,translation activator activity,MF,
3872,GO:0008495,1,0.995366681765408,0,1,protoheme IX farnesyltransferase activity,MF,
3873,GO:0008496,1,0.995366990826153,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
3874,GO:0008499,1,0.937082300880048,0,11,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
3875,GO:0008503,1,0.96955784309338,0,2,benzodiazepine receptor activity,MF,
3876,GO:0008504,1,0.979354833118079,0,4,monoamine transmembrane transporter activity,MF,
3877,GO:0008506,1,0.990755046992583,0,2,sucrose:proton symporter activity,MF,
3878,GO:0008507,1,0.995366966416867,0,1,sodium:iodide symporter activity,MF,
3879,GO:0008508,1,0.981698849312712,0,2,bile acid:sodium symporter activity,MF,
3881,GO:0008510,1,0.977046177790384,0,5,sodium:bicarbonate symporter activity,MF,
3882,GO:0008511,1,0.995366990826073,0,1,sodium:potassium:chloride symporter activity,MF,
3883,GO:0008513,1,0.994649946419088,0,1,secondary active organic cation transmembrane transporter activity,MF,
3885,GO:0008515,1,0.990755046992583,0,2,sucrose transmembrane transporter activity,MF,
3886,GO:0008517,1,0.981594116619114,0,4,folic acid transmembrane transporter activity,MF,
3887,GO:0008518,1,0.995366511980814,0,1,reduced folate carrier activity,MF,
3888,GO:0008519,1,0.909882192279344,0,18,ammonium transmembrane transporter activity,MF,
3889,GO:0008520,1,0.995366990826073,0,1,L-ascorbate:sodium symporter activity,MF,
3890,GO:0008521,1,0.995355450952031,0,1,acetyl-CoA transmembrane transporter activity,MF,
3891,GO:0008523,1,0.995366883536079,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
3892,GO:0008525,1,0.967352675308214,0,6,phosphatidylcholine transporter activity,MF,
3893,GO:0008526,1,0.961710257163645,0,8,phosphatidylinositol transporter activity,MF,
3894,GO:0008527,1,0.926137546232823,0,5,taste receptor activity,MF,
3895,GO:0008528,1,0.815574488634027,0,27,G-protein coupled peptide receptor activity,MF,
3896,GO:0008531,1,0.995362644056522,0,1,riboflavin kinase activity,MF,
3897,GO:0008532,1,0.941442730324058,0,10,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
3898,GO:0008534,1,0.943739368246768,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
3899,GO:0008535,1,0.788849008325118,0,24,respiratory chain complex IV assembly,BP,
3900,GO:0008536,1,0.797048750003764,0,32,Ran GTPase binding,MF,
3901,GO:0008537,1,0.953126776745455,0,3,proteasome activator complex,CC,
3902,GO:0008540,1,0.892752332418792,0,12,proteasome regulatory particle, base subcomplex,CC,
3903,GO:0008541,1,0.937616258389989,0,7,proteasome regulatory particle, lid subcomplex,CC,
3904,GO:0008542,1,0.838382143075957,0,31,visual learning,BP,
3905,GO:0008543,1,0.55328136690575,0,84,fibroblast growth factor receptor signaling pathway,BP,
3907,GO:0008545,1,0.990755116116808,0,2,JUN kinase kinase activity,MF,
3908,GO:0008553,1,0.939103337783357,0,9,proton-exporting ATPase activity, phosphorylative mechanism,MF,
3909,GO:0008555,1,0.995366990826152,0,1,chloride-transporting ATPase activity,MF,
3910,GO:0008556,1,0.972012654143761,0,5,potassium-transporting ATPase activity,MF,
3912,GO:0008565,1,0.523941852801925,0,71,protein transporter activity,MF,
3913,GO:0008568,1,0.947732756274722,0,10,microtubule-severing ATPase activity,MF,
3914,GO:0008569,1,0.940718056228624,0,11,ATP-dependent microtubule motor activity, minus-end-directed,MF,
3915,GO:0008574,1,0.864384911203838,0,23,ATP-dependent microtubule motor activity, plus-end-directed,MF,
3916,GO:0008579,1,0.995366990826152,0,1,JUN kinase phosphatase activity,MF,
3917,GO:0008582,1,0.990755199849137,0,2,regulation of synaptic growth at neuromuscular junction,BP,
3920,GO:0008589,1,0.746600695199148,0,54,regulation of smoothened signaling pathway,BP,
3921,GO:0008591,1,0.992243492218644,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
3922,GO:0008592,1,0.995366851515136,0,1,regulation of Toll signaling pathway,BP,
3924,GO:0008594,1,0.990755199849187,0,2,photoreceptor cell morphogenesis,BP,
3925,GO:0008595,1,0.953439318203603,0,9,anterior/posterior axis specification, embryo,BP,
3926,GO:0008597,1,0.98635580390105,0,2,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
3927,GO:0008603,1,0.972873499451219,0,5,cAMP-dependent protein kinase regulator activity,MF,
3928,GO:0008607,1,0.980431382459459,0,3,phosphorylase kinase regulator activity,MF,
3929,GO:0008608,1,0.856465529248952,0,28,attachment of spindle microtubules to kinetochore,BP,
3930,GO:0008609,1,0.995366990826034,0,1,alkylglycerone-phosphate synthase activity,MF,
3932,GO:0008611,1,0.961690883943986,0,5,ether lipid biosynthetic process,BP,
3933,GO:0008612,1,0.957761636425763,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
3934,GO:0008614,1,0.989751368173323,0,2,pyridoxine metabolic process,BP,
3935,GO:0008615,1,0.989751368173323,0,2,pyridoxine biosynthetic process,BP,
3936,GO:0008616,1,0.965774965232723,0,3,queuosine biosynthetic process,BP,
3937,GO:0008617,1,0.979716819340251,0,1,guanosine metabolic process,BP,
3938,GO:0008622,1,0.950200546646349,0,5,epsilon DNA polymerase complex,CC,
3939,GO:0008623,1,0.990580645898045,0,2,CHRAC,CC,
3940,GO:0008625,1,0.620949295293467,0,66,extrinsic apoptotic signaling pathway via death domain receptors,BP,
3941,GO:0008626,1,0.979893748690592,0,3,granzyme-mediated apoptotic signaling pathway,BP,
3942,GO:0008627,1,0.954434394114607,0,7,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
3944,GO:0008631,1,0.746146969772179,0,39,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
3945,GO:0008635,1,0.934844962255144,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
3947,GO:0008641,1,0.95054551766516,0,10,ubiquitin-like modifier activating enzyme activity,MF,
3950,GO:0008649,1,0.862884158299057,0,16,rRNA methyltransferase activity,MF,
3951,GO:0008650,1,0.995366964362857,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
3952,GO:0008652,1,0.699773810599139,0,58,cellular amino acid biosynthetic process,BP,
3954,GO:0008655,1,0.899213131338934,0,12,pyrimidine-containing compound salvage,BP,
3955,GO:0008656,1,0.874766762543121,0,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
3956,GO:0008670,1,0.974510605741473,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
3957,GO:0008689,1,0.984741452522495,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
3958,GO:0008700,1,0.995366574475227,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
3959,GO:0008705,1,0.995366990825916,0,1,methionine synthase activity,MF,
3960,GO:0008709,1,0.978419412737323,0,1,cholate 7-alpha-dehydrogenase activity,MF,
3961,GO:0008721,1,0.995254133737912,0,1,D-serine ammonia-lyase activity,MF,
3962,GO:0008725,1,0.981272802792047,0,1,DNA-3-methyladenine glycosylase activity,MF,
3963,GO:0008732,1,0.990054307114572,0,2,L-allo-threonine aldolase activity,MF,
3964,GO:0008745,1,0.975701813833231,0,2,N-acetylmuramoyl-L-alanine amidase activity,MF,
3965,GO:0008746,1,0.995366990826165,0,1,NAD(P)+ transhydrogenase activity,MF,
3966,GO:0008747,1,0.989431571910184,0,1,N-acetylneuraminate lyase activity,MF,
3967,GO:0008750,1,0.995366990826165,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
3968,GO:0008753,1,0.995366937165233,0,1,NADPH dehydrogenase (quinone) activity,MF,
3969,GO:0008757,1,0.411961198053753,0,132,S-adenosylmethionine-dependent methyltransferase activity,MF,
3970,GO:0008761,1,0.995366990826152,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
3971,GO:0008768,1,0.976504570662288,0,1,UDP-sugar diphosphatase activity,MF,
3972,GO:0008775,1,0.992442847539249,0,1,acetate CoA-transferase activity,MF,
3973,GO:0008781,1,0.976049626843757,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
3974,GO:0008783,1,0.994660322715859,0,1,agmatinase activity,MF,
3975,GO:0008785,1,0.989513494299247,0,1,alkyl hydroperoxide reductase activity,MF,
3976,GO:0008792,1,0.995366574475227,0,1,arginine decarboxylase activity,MF,
3977,GO:0008794,1,0.97753126426181,0,1,arsenate reductase (glutaredoxin) activity,MF,
3978,GO:0008796,1,0.974688971026775,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
3979,GO:0008798,1,0.995366990826125,0,1,beta-aspartyl-peptidase activity,MF,
3980,GO:0008802,1,0.995366962748951,0,1,betaine-aldehyde dehydrogenase activity,MF,
3981,GO:0008803,1,0.979227865558499,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
3982,GO:0008808,1,0.995366987635455,0,1,cardiolipin synthase activity,MF,
3983,GO:0008817,1,0.995366990826138,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
3984,GO:0008821,1,0.933017713376196,0,9,crossover junction endodeoxyribonuclease activity,MF,
3985,GO:0008823,1,0.967418600203968,0,5,cupric reductase activity,MF,
3986,GO:0008832,1,0.995366829720426,0,1,dGTPase activity,MF,
3987,GO:0008841,1,0.995264882158447,0,1,dihydrofolate synthase activity,MF,
3988,GO:0008852,1,0.995366504674048,0,1,exodeoxyribonuclease I activity,MF,
3989,GO:0008853,1,0.980499403794337,0,3,exodeoxyribonuclease III activity,MF,
3990,GO:0008859,1,0.978517146486943,0,1,exoribonuclease II activity,MF,
3991,GO:0008865,1,0.986164519277882,0,3,fructokinase activity,MF,
3992,GO:0008887,1,0.995366850982475,0,1,glycerate kinase activity,MF,
3993,GO:0008889,1,0.986163995238848,0,3,glycerophosphodiester phosphodiesterase activity,MF,
3994,GO:0008890,1,0.989768869500158,0,1,glycine C-acetyltransferase activity,MF,
3995,GO:0008892,1,0.995366990826153,0,1,guanine deaminase activity,MF,
3996,GO:0008893,1,0.980367239166016,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
3997,GO:0008894,1,0.995365060447133,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
3998,GO:0008897,1,0.995366539311692,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
3999,GO:0008900,1,0.995366965913712,0,1,potassium:proton exchanging ATPase activity,MF,
4000,GO:0008903,1,0.981737636930887,0,1,hydroxypyruvate isomerase activity,MF,
4001,GO:0008905,1,0.99004389338632,0,1,mannose-phosphate guanylyltransferase activity,MF,
4002,GO:0008934,1,0.9749576470753,0,4,inositol monophosphate 1-phosphatase activity,MF,
4003,GO:0008940,1,0.986163705932677,0,3,nitrate reductase activity,MF,
4004,GO:0008941,1,0.988728668854718,0,2,nitric oxide dioxygenase activity,MF,
4005,GO:0008948,1,0.976709348818889,0,4,oxaloacetate decarboxylase activity,MF,
4006,GO:0008962,1,0.989108130149428,0,2,phosphatidylglycerophosphatase activity,MF,
4007,GO:0008963,1,0.994461746266255,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
4008,GO:0008967,1,0.989254173657726,0,2,phosphoglycolate phosphatase activity,MF,
4009,GO:0008970,1,0.96672350694571,0,7,phosphatidylcholine 1-acylhydrolase activity,MF,
4010,GO:0008973,1,0.995366855727884,0,1,phosphopentomutase activity,MF,
4011,GO:0008988,1,0.990754370961523,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
4012,GO:0008995,1,0.995333062328682,0,1,ribonuclease E activity,MF,
4013,GO:0009000,1,0.995239389996524,0,1,selenocysteine lyase activity,MF,
4014,GO:0009007,1,0.99536697875851,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4015,GO:0009008,1,0.96659617814314,0,5,DNA-methyltransferase activity,MF,
4016,GO:0009013,1,0.995366990826151,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4017,GO:0009019,1,0.981593656766451,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4018,GO:0009020,1,0.993477298997412,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4019,GO:0009032,1,0.990739321890347,0,1,thymidine phosphorylase activity,MF,
4020,GO:0009041,1,0.973211602714522,0,3,uridylate kinase activity,MF,
4021,GO:0009048,1,0.945404656321652,0,10,dosage compensation by inactivation of X chromosome,BP,
4022,GO:0009051,1,0.968839579524403,0,3,pentose-phosphate shunt, oxidative branch,BP,
4023,GO:0009052,1,0.962078756073524,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4030,GO:0009061,1,0.995147683086322,0,1,anaerobic respiration,BP,
4031,GO:0009062,1,0.53164285791352,0,88,fatty acid catabolic process,BP,
4032,GO:0009063,1,0.593280767597462,0,75,cellular amino acid catabolic process,BP,
4033,GO:0009064,1,0.73861275797772,0,49,glutamine family amino acid metabolic process,BP,
4034,GO:0009065,1,0.884026502260999,0,20,glutamine family amino acid catabolic process,BP,
4035,GO:0009066,1,0.771043551935919,0,41,aspartate family amino acid metabolic process,BP,
4036,GO:0009067,1,0.884426941113155,0,21,aspartate family amino acid biosynthetic process,BP,
4037,GO:0009068,1,0.927187153965132,0,12,aspartate family amino acid catabolic process,BP,
4038,GO:0009069,1,0.827821048650224,0,31,serine family amino acid metabolic process,BP,
4039,GO:0009070,1,0.926048078787412,0,14,serine family amino acid biosynthetic process,BP,
4040,GO:0009071,1,0.951130876519361,0,7,serine family amino acid catabolic process,BP,
4041,GO:0009072,1,0.896675516061605,0,11,aromatic amino acid family metabolic process,BP,
4042,GO:0009074,1,0.915064753647632,0,8,aromatic amino acid family catabolic process,BP,
4043,GO:0009078,1,0.995366990515785,0,1,pyruvate family amino acid metabolic process,BP,
4044,GO:0009080,1,0.995366990515785,0,1,pyruvate family amino acid catabolic process,BP,
4045,GO:0009081,1,0.858741377414245,0,23,branched-chain amino acid metabolic process,BP,
4046,GO:0009082,1,0.98565363550537,0,2,branched-chain amino acid biosynthetic process,BP,
4047,GO:0009083,1,0.870808503228624,0,20,branched-chain amino acid catabolic process,BP,
4048,GO:0009084,1,0.923733249675386,0,14,glutamine family amino acid biosynthetic process,BP,
4049,GO:0009085,1,0.990754750402817,0,2,lysine biosynthetic process,BP,
4050,GO:0009086,1,0.928953887003837,0,11,methionine biosynthetic process,BP,
4051,GO:0009088,1,0.994334404277009,0,1,threonine biosynthetic process,BP,
4052,GO:0009092,1,0.97089096804876,0,4,homoserine metabolic process,BP,
4053,GO:0009093,1,0.995337765554784,0,1,cysteine catabolic process,BP,
4054,GO:0009098,1,0.98565363550537,0,2,leucine biosynthetic process,BP,
4055,GO:0009099,1,0.98565363550537,0,2,valine biosynthetic process,BP,
4058,GO:0009106,1,0.986318796128997,0,2,lipoate metabolic process,BP,
4059,GO:0009107,1,0.990910197408557,0,1,lipoate biosynthetic process,BP,
4061,GO:0009109,1,0.897215631167651,0,11,coenzyme catabolic process,BP,
4063,GO:0009111,1,0.931061069389728,0,8,vitamin catabolic process,BP,
4064,GO:0009112,1,0.779246323765631,0,35,nucleobase metabolic process,BP,
4065,GO:0009113,1,0.904664720581546,0,13,purine nucleobase biosynthetic process,BP,
4066,GO:0009115,1,0.990755199849267,0,2,xanthine catabolic process,BP,
4070,GO:0009120,1,0.942352048462867,0,6,deoxyribonucleoside metabolic process,BP,
4073,GO:0009125,1,0.934776567541804,0,9,nucleoside monophosphate catabolic process,BP,
4076,GO:0009128,1,0.939131101938376,0,8,purine nucleoside monophosphate catabolic process,BP,
4077,GO:0009129,1,0.905436302677672,0,14,pyrimidine nucleoside monophosphate metabolic process,BP,
4078,GO:0009130,1,0.905436302677672,0,14,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4080,GO:0009133,1,0.952603008718842,0,4,nucleoside diphosphate biosynthetic process,BP,
4081,GO:0009134,1,0.943201591443243,0,7,nucleoside diphosphate catabolic process,BP,
4083,GO:0009136,1,0.974294164229105,0,2,purine nucleoside diphosphate biosynthetic process,BP,
4084,GO:0009137,1,0.967821316976916,0,4,purine nucleoside diphosphate catabolic process,BP,
4085,GO:0009138,1,0.973211684642623,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
4086,GO:0009139,1,0.977743114261659,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4087,GO:0009140,1,0.995366616056572,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4090,GO:0009143,1,0.893583586302032,0,11,nucleoside triphosphate catabolic process,BP,
4093,GO:0009146,1,0.930198768564723,0,6,purine nucleoside triphosphate catabolic process,BP,
4096,GO:0009149,1,0.974854103960284,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4098,GO:0009151,1,0.893691878407254,0,9,purine deoxyribonucleotide metabolic process,BP,
4100,GO:0009153,1,0.973437638461374,0,2,purine deoxyribonucleotide biosynthetic process,BP,
4101,GO:0009154,1,0.827413934356401,0,23,purine ribonucleotide catabolic process,BP,
4102,GO:0009155,1,0.937124280846122,0,6,purine deoxyribonucleotide catabolic process,BP,
4104,GO:0009157,1,0.924829712098498,0,9,deoxyribonucleoside monophosphate biosynthetic process,BP,
4105,GO:0009158,1,0.939131101938376,0,8,ribonucleoside monophosphate catabolic process,BP,
4106,GO:0009159,1,0.995366574475227,0,1,deoxyribonucleoside monophosphate catabolic process,BP,
4108,GO:0009162,1,0.901440542543294,0,11,deoxyribonucleoside monophosphate metabolic process,BP,
4110,GO:0009164,1,0.833354997427269,0,20,nucleoside catabolic process,BP,
4115,GO:0009169,1,0.939131101938376,0,8,purine ribonucleoside monophosphate catabolic process,BP,
4116,GO:0009170,1,0.979270594786824,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4117,GO:0009173,1,0.940722013425988,0,9,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4118,GO:0009174,1,0.940722013425988,0,9,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4119,GO:0009176,1,0.96251666469273,0,5,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4120,GO:0009177,1,0.96251666469273,0,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4122,GO:0009180,1,0.974294164229105,0,2,purine ribonucleoside diphosphate biosynthetic process,BP,
4123,GO:0009181,1,0.967821316976916,0,4,purine ribonucleoside diphosphate catabolic process,BP,
4124,GO:0009182,1,0.968368706229188,0,2,purine deoxyribonucleoside diphosphate metabolic process,BP,
4125,GO:0009183,1,0.979270594786824,0,1,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
4126,GO:0009184,1,0.988869993719741,0,1,purine deoxyribonucleoside diphosphate catabolic process,BP,
4128,GO:0009186,1,0.946807984136239,0,4,deoxyribonucleoside diphosphate metabolic process,BP,
4129,GO:0009187,1,0.705787655163571,0,58,cyclic nucleotide metabolic process,BP,
4130,GO:0009188,1,0.974294164229105,0,2,ribonucleoside diphosphate biosynthetic process,BP,
4131,GO:0009189,1,0.957469909568894,0,3,deoxyribonucleoside diphosphate biosynthetic process,BP,
4132,GO:0009190,1,0.78845172259657,0,35,cyclic nucleotide biosynthetic process,BP,
4133,GO:0009191,1,0.947595034328811,0,6,ribonucleoside diphosphate catabolic process,BP,
4134,GO:0009192,1,0.988869993719741,0,1,deoxyribonucleoside diphosphate catabolic process,BP,
4135,GO:0009193,1,0.995366616056572,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4136,GO:0009195,1,0.995366616056572,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4137,GO:0009196,1,0.977743114261659,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4138,GO:0009197,1,0.977743114261659,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4140,GO:0009200,1,0.836428548560084,0,15,deoxyribonucleoside triphosphate metabolic process,BP,
4142,GO:0009202,1,0.94820674820952,0,5,deoxyribonucleoside triphosphate biosynthetic process,BP,
4143,GO:0009203,1,0.981566547056908,0,1,ribonucleoside triphosphate catabolic process,BP,
4144,GO:0009204,1,0.923833689774197,0,7,deoxyribonucleoside triphosphate catabolic process,BP,
4147,GO:0009207,1,0.981566547056908,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4150,GO:0009211,1,0.929890995971761,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4151,GO:0009212,1,0.953890238630155,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4152,GO:0009213,1,0.974854103960284,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4153,GO:0009214,1,0.950187494824554,0,11,cyclic nucleotide catabolic process,BP,
4154,GO:0009215,1,0.903762368272626,0,8,purine deoxyribonucleoside triphosphate metabolic process,BP,
4155,GO:0009216,1,0.994044997930392,0,1,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4156,GO:0009217,1,0.947678413145053,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4158,GO:0009219,1,0.835042038985455,0,18,pyrimidine deoxyribonucleotide metabolic process,BP,
4160,GO:0009221,1,0.927602486429267,0,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4161,GO:0009222,1,0.995366616056572,0,1,pyrimidine ribonucleotide catabolic process,BP,
4162,GO:0009223,1,0.893850378093046,0,11,pyrimidine deoxyribonucleotide catabolic process,BP,
4163,GO:0009224,1,0.984376090933901,0,1,CMP biosynthetic process,BP,
4164,GO:0009225,1,0.785627936006824,0,33,nucleotide-sugar metabolic process,BP,
4165,GO:0009226,1,0.854649383546359,0,21,nucleotide-sugar biosynthetic process,BP,
4166,GO:0009227,1,0.976155988882264,0,3,nucleotide-sugar catabolic process,BP,
4167,GO:0009231,1,0.995362644056522,0,1,riboflavin biosynthetic process,BP,
4168,GO:0009233,1,0.990755019436318,0,2,menaquinone metabolic process,BP,
4169,GO:0009234,1,0.995366975722356,0,1,menaquinone biosynthetic process,BP,
4170,GO:0009235,1,0.909568738518073,0,12,cobalamin metabolic process,BP,
4171,GO:0009236,1,0.986164066094812,0,3,cobalamin biosynthetic process,BP,
4172,GO:0009237,1,0.99536660776398,0,1,siderophore metabolic process,BP,
4173,GO:0009240,1,0.953304313213794,0,5,isopentenyl diphosphate biosynthetic process,BP,
4174,GO:0009245,1,0.944033747523661,0,2,lipid A biosynthetic process,BP,
4176,GO:0009249,1,0.885247130430416,0,7,protein lipoylation,BP,
4179,GO:0009253,1,0.975701813833231,0,2,peptidoglycan catabolic process,BP,
4180,GO:0009256,1,0.98131574210358,0,4,10-formyltetrahydrofolate metabolic process,BP,
4181,GO:0009257,1,0.990755132621056,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4182,GO:0009258,1,0.995366990826045,0,1,10-formyltetrahydrofolate catabolic process,BP,
4185,GO:0009261,1,0.823571856553538,0,24,ribonucleotide catabolic process,BP,
4186,GO:0009262,1,0.729452959807148,0,31,deoxyribonucleotide metabolic process,BP,
4187,GO:0009263,1,0.890434784870552,0,13,deoxyribonucleotide biosynthetic process,BP,
4188,GO:0009264,1,0.830432962411358,0,18,deoxyribonucleotide catabolic process,BP,
4189,GO:0009265,1,0.902942214942224,0,10,2'-deoxyribonucleotide biosynthetic process,BP,
4190,GO:0009266,1,0.317044610030889,0,177,response to temperature stimulus,BP,
4191,GO:0009267,1,0.506598748002448,0,115,cellular response to starvation,BP,
4192,GO:0009268,1,0.876474522977737,0,22,response to pH,BP,
4193,GO:0009295,1,0.762426481395179,0,40,nucleoid,CC,
4194,GO:0009298,1,0.962629355571262,0,4,GDP-mannose biosynthetic process,BP,
4196,GO:0009301,1,0.572689265259763,0,67,snRNA transcription,BP,
4197,GO:0009303,1,0.81102925082185,0,27,rRNA transcription,BP,
4198,GO:0009304,1,0.951334494888182,0,7,tRNA transcription,BP,
4199,GO:0009305,1,0.995366990826113,0,1,protein biotinylation,BP,
4201,GO:0009308,1,0.375453116377597,0,92,amine metabolic process,BP,
4202,GO:0009309,1,0.894435571882698,0,13,amine biosynthetic process,BP,
4203,GO:0009310,1,0.875581901809444,0,12,amine catabolic process,BP,
4204,GO:0009311,1,0.717958903672251,0,54,oligosaccharide metabolic process,BP,
4205,GO:0009312,1,0.834868596625991,0,26,oligosaccharide biosynthetic process,BP,
4206,GO:0009313,1,0.955696692712528,0,9,oligosaccharide catabolic process,BP,
4208,GO:0009328,1,0.978452439719408,0,4,phenylalanine-tRNA ligase complex,CC,
4209,GO:0009330,1,0.990755193730692,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
4210,GO:0009331,1,0.990755199451673,0,2,glycerol-3-phosphate dehydrogenase complex,CC,
4211,GO:0009346,1,0.995366990826152,0,1,citrate lyase complex,CC,
4212,GO:0009353,1,0.985805137433146,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4213,GO:0009360,1,0.995361977224151,0,1,DNA polymerase III complex,CC,
4214,GO:0009368,1,0.977757151223269,0,2,endopeptidase Clp complex,CC,
4215,GO:0009372,1,0.995366872685533,0,1,quorum sensing,BP,
4216,GO:0009374,1,0.976868869006528,0,5,biotin binding,MF,
4217,GO:0009378,1,0.977046155410585,0,5,four-way junction helicase activity,MF,
4218,GO:0009383,1,0.990750872988759,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4219,GO:0009384,1,0.995366990826152,0,1,N-acylmannosamine kinase activity,MF,
4220,GO:0009386,1,0.994975311334276,0,1,translational attenuation,BP,
4221,GO:0009394,1,0.746096648401416,0,27,2'-deoxyribonucleotide metabolic process,BP,
4222,GO:0009395,1,0.830333434004848,0,28,phospholipid catabolic process,BP,
4223,GO:0009396,1,0.924734003661543,0,9,folic acid-containing compound biosynthetic process,BP,
4224,GO:0009397,1,0.967874785524035,0,3,folic acid-containing compound catabolic process,BP,
4225,GO:0009398,1,0.995362644056522,0,1,FMN biosynthetic process,BP,
4226,GO:0009400,1,0.995366520412405,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
4227,GO:0009403,1,0.966391140581663,0,5,toxin biosynthetic process,BP,
4228,GO:0009404,1,0.869167866897231,0,17,toxin metabolic process,BP,
4229,GO:0009405,1,0.990755199849241,0,2,pathogenesis,BP,
4230,GO:0009407,1,0.951721085369285,0,4,toxin catabolic process,BP,
4231,GO:0009408,1,0.420044146418043,0,140,response to heat,BP,
4232,GO:0009409,1,0.818650320813425,0,31,response to cold,BP,
4235,GO:0009414,1,0.950422462252945,0,6,response to water deprivation,BP,
4236,GO:0009415,1,0.929955093506186,0,10,response to water,BP,
4238,GO:0009435,1,0.810859459580396,0,34,NAD biosynthetic process,BP,
4239,GO:0009436,1,0.995366574475227,0,1,glyoxylate catabolic process,BP,
4240,GO:0009437,1,0.942516837185652,0,12,carnitine metabolic process,BP,
4241,GO:0009438,1,0.951949910250793,0,5,methylglyoxal metabolic process,BP,
4242,GO:0009439,1,0.970480917774577,0,2,cyanate metabolic process,BP,
4243,GO:0009440,1,0.970480917774577,0,2,cyanate catabolic process,BP,
4244,GO:0009441,1,0.973505103848138,0,2,glycolate metabolic process,BP,
4245,GO:0009443,1,0.995366990826047,0,1,pyridoxal 5'-phosphate salvage,BP,
4246,GO:0009445,1,0.93313772373145,0,7,putrescine metabolic process,BP,
4247,GO:0009446,1,0.970999520160661,0,5,putrescine biosynthetic process,BP,
4248,GO:0009447,1,0.952517634395965,0,3,putrescine catabolic process,BP,
4249,GO:0009448,1,0.981333819567178,0,4,gamma-aminobutyric acid metabolic process,BP,
4250,GO:0009449,1,0.98590226047374,0,3,gamma-aminobutyric acid biosynthetic process,BP,
4251,GO:0009450,1,0.990755199849292,0,2,gamma-aminobutyric acid catabolic process,BP,
4252,GO:0009451,1,0.380894869707651,0,131,RNA modification,BP,
4253,GO:0009452,1,0.729355949724698,0,33,7-methylguanosine RNA capping,BP,
4255,GO:0009581,1,0.763973307979905,0,47,detection of external stimulus,BP,
4256,GO:0009582,1,0.760422835282856,0,48,detection of abiotic stimulus,BP,
4257,GO:0009583,1,0.852242117509982,0,28,detection of light stimulus,BP,
4258,GO:0009584,1,0.883961960765677,0,22,detection of visible light,BP,
4259,GO:0009593,1,0.80138018091899,0,24,detection of chemical stimulus,BP,
4260,GO:0009595,1,0.944474686953523,0,9,detection of biotic stimulus,BP,
4261,GO:0009597,1,0.974266020978015,0,5,detection of virus,BP,
4264,GO:0009608,1,0.975741178835036,0,2,response to symbiont,BP,
4265,GO:0009609,1,0.975741178835036,0,2,response to symbiotic bacterium,BP,
4270,GO:0009620,1,0.814306527385442,0,20,response to fungus,BP,
4271,GO:0009624,1,0.995340515049184,0,1,response to nematode,BP,
4273,GO:0009629,1,0.966184249004937,0,6,response to gravity,BP,
4274,GO:0009631,1,0.995366990826164,0,1,cold acclimation,BP,
4275,GO:0009635,1,0.930674880464231,0,12,response to herbicide,BP,
4277,GO:0009637,1,0.990755074494105,0,2,response to blue light,BP,
4278,GO:0009642,1,0.966448192160244,0,7,response to light intensity,BP,
4279,GO:0009644,1,0.989594016454856,0,2,response to high light intensity,BP,
4280,GO:0009645,1,0.995366945682435,0,1,response to low light intensity stimulus,BP,
4281,GO:0009646,1,0.995366878313285,0,1,response to absence of light,BP,
4282,GO:0009648,1,0.859799912927046,0,22,photoperiodism,BP,
4283,GO:0009649,1,0.862134704270641,0,24,entrainment of circadian clock,BP,
4284,GO:0009650,1,0.923429453959293,0,12,UV protection,BP,
4285,GO:0009651,1,0.898444862414899,0,15,response to salt stress,BP,
4287,GO:0009669,1,0.990755046992583,0,2,sucrose:cation symporter activity,MF,
4288,GO:0009674,1,0.995366990826073,0,1,potassium:sodium symporter activity,MF,
4289,GO:0009692,1,0.995340515049184,0,1,ethylene metabolic process,BP,
4290,GO:0009698,1,0.995340515049184,0,1,phenylpropanoid metabolic process,BP,
4291,GO:0009712,1,0.831571971627122,0,26,catechol-containing compound metabolic process,BP,
4292,GO:0009713,1,0.934037624309531,0,10,catechol-containing compound biosynthetic process,BP,
4294,GO:0009720,1,0.995366668457488,0,1,detection of hormone stimulus,BP,
4296,GO:0009726,1,0.990754878957138,0,2,detection of endogenous stimulus,BP,
4297,GO:0009737,1,0.995366990826152,0,1,response to abscisic acid,BP,
4298,GO:0009738,1,0.995366990826152,0,1,abscisic acid-activated signaling pathway,BP,
4300,GO:0009744,1,0.985978289781304,0,3,response to sucrose,BP,
4303,GO:0009750,1,0.978348938502199,0,4,response to fructose,BP,
4304,GO:0009753,1,0.975408435411332,0,2,response to jasmonic acid,BP,
4306,GO:0009756,1,0.948602049282227,0,6,carbohydrate mediated signaling,BP,
4307,GO:0009757,1,0.953191779578825,0,5,hexose mediated signaling,BP,
4308,GO:0009758,1,0.995366990825981,0,1,carbohydrate utilization,BP,
4309,GO:0009785,1,0.990755074494105,0,2,blue light signaling pathway,BP,
4310,GO:0009786,1,0.982473301233166,0,2,regulation of asymmetric cell division,BP,
4311,GO:0009787,1,0.995366990826152,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4312,GO:0009789,1,0.995366990826152,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4314,GO:0009791,1,0.636344143426378,0,76,post-embryonic development,BP,
4319,GO:0009804,1,0.995340515049184,0,1,coumarin metabolic process,BP,
4320,GO:0009810,1,0.994694186358932,0,1,stilbene metabolic process,BP,
4321,GO:0009812,1,0.939959767427123,0,9,flavonoid metabolic process,BP,
4322,GO:0009814,1,0.994670598384778,0,1,defense response, incompatible interaction,BP,
4323,GO:0009817,1,0.994670598384778,0,1,defense response to fungus, incompatible interaction,BP,
4324,GO:0009820,1,0.975254217916966,0,4,alkaloid metabolic process,BP,
4325,GO:0009822,1,0.991345105512178,0,1,alkaloid catabolic process,BP,
4326,GO:0009826,1,0.988051122475992,0,2,unidimensional cell growth,BP,
4327,GO:0009838,1,0.962250605282255,0,5,abscission,BP,
4328,GO:0009841,1,0.995082167891364,0,1,mitochondrial endopeptidase Clp complex,CC,
4329,GO:0009850,1,0.992442847539249,0,1,auxin metabolic process,BP,
4330,GO:0009852,1,0.992442847539249,0,1,auxin catabolic process,BP,
4332,GO:0009880,1,0.833947258601185,0,36,embryonic pattern specification,BP,
4333,GO:0009881,1,0.981575475445048,0,4,photoreceptor activity,MF,
4334,GO:0009882,1,0.990755074494105,0,2,blue light photoreceptor activity,MF,
4335,GO:0009886,1,0.91007410554003,0,10,post-embryonic animal morphogenesis,BP,
4351,GO:0009918,1,0.995354459595608,0,1,sterol delta7 reductase activity,MF,
4352,GO:0009922,1,0.970177743393844,0,5,fatty acid elongase activity,MF,
4353,GO:0009925,1,0.891230098810823,0,21,basal plasma membrane,CC,
4354,GO:0009931,1,0.965575686797391,0,7,calcium-dependent protein serine/threonine kinase activity,MF,
4356,GO:0009950,1,0.938746821288871,0,11,dorsal/ventral axis specification,BP,
4360,GO:0009955,1,0.994680773914287,0,1,adaxial/abaxial pattern specification,BP,
4361,GO:0009956,1,0.995366990410423,0,1,radial pattern formation,BP,
4362,GO:0009957,1,0.990470746392785,0,2,epidermal cell fate specification,BP,
4366,GO:0009972,1,0.935691790528424,0,6,cytidine deamination,BP,
4367,GO:0009975,1,0.958290362724336,0,9,cyclase activity,MF,
4368,GO:0009982,1,0.902222996513573,0,13,pseudouridine synthase activity,MF,
4371,GO:0009988,1,0.80224330221587,0,26,cell-cell recognition,BP,
4373,GO:0009992,1,0.9945947139099,0,1,cellular water homeostasis,BP,
4374,GO:0009994,1,0.844822630555128,0,29,oocyte differentiation,BP,
4375,GO:0009996,1,0.987646006170635,0,2,negative regulation of cell fate specification,BP,
4377,GO:0010002,1,0.963006650449186,0,8,cardioblast differentiation,BP,
4379,GO:0010009,1,0.976898856966157,0,5,cytoplasmic side of endosome membrane,CC,
4380,GO:0010015,1,0.974537838279069,0,1,root morphogenesis,BP,
4381,GO:0010025,1,0.989664330656425,0,2,wax biosynthetic process,BP,
4382,GO:0010032,1,0.977046177790461,0,5,meiotic chromosome condensation,BP,
4384,GO:0010034,1,0.995366957924487,0,1,response to acetate,BP,
4387,GO:0010039,1,0.846567388638524,0,24,response to iron ion,BP,
4388,GO:0010040,1,0.96393488737612,0,4,response to iron(II) ion,BP,
4389,GO:0010041,1,0.959698711197316,0,5,response to iron(III) ion,BP,
4390,GO:0010042,1,0.912740013566564,0,12,response to manganese ion,BP,
4391,GO:0010043,1,0.747123702060841,0,26,response to zinc ion,BP,
4392,GO:0010044,1,0.976042849810186,0,4,response to aluminum ion,BP,
4393,GO:0010046,1,0.977856034863266,0,4,response to mycotoxin,BP,
4394,GO:0010053,1,0.974537838279069,0,1,root epidermal cell differentiation,BP,
4395,GO:0010054,1,0.974537838279069,0,1,trichoblast differentiation,BP,
4396,GO:0010070,1,0.995174839715213,0,1,zygote asymmetric cell division,BP,
4398,GO:0010106,1,0.993389805337357,0,1,cellular response to iron ion starvation,BP,
4399,GO:0010107,1,0.915031941350856,0,18,potassium ion import,BP,
4400,GO:0010121,1,0.993628847786826,0,1,arginine catabolic process to proline via ornithine,BP,
4401,GO:0010124,1,0.992442847539249,0,1,phenylacetate catabolic process,BP,
4402,GO:0010133,1,0.990121160059752,0,2,proline catabolic process to glutamate,BP,
4403,GO:0010138,1,0.964115338892373,0,4,pyrimidine ribonucleotide salvage,BP,
4404,GO:0010139,1,0.990184886160895,0,1,pyrimidine deoxyribonucleotide salvage,BP,
4405,GO:0010142,1,0.995366945682435,0,1,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
4407,GO:0010157,1,0.995366990826033,0,1,response to chlorate,BP,
4408,GO:0010159,1,0.982882283530553,0,3,specification of animal organ position,BP,
4409,GO:0010160,1,0.979355933200066,0,1,formation of animal organ boundary,BP,
4410,GO:0010164,1,0.990184886160895,0,1,response to cesium ion,BP,
4411,GO:0010165,1,0.834880941803007,0,33,response to X-ray,BP,
4412,GO:0010166,1,0.989664330656425,0,2,wax metabolic process,BP,
4413,GO:0010171,1,0.779632861013034,0,42,body morphogenesis,BP,
4414,GO:0010172,1,0.950194859212126,0,10,embryonic body morphogenesis,BP,
4415,GO:0010181,1,0.948099405823378,0,10,FMN binding,MF,
4416,GO:0010182,1,0.953191779578825,0,5,sugar mediated signaling pathway,BP,
4417,GO:0010189,1,0.990933464906061,0,1,vitamin E biosynthetic process,BP,
4418,GO:0010193,1,0.989256417433987,0,2,response to ozone,BP,
4420,GO:0010216,1,0.972518071349943,0,6,maintenance of DNA methylation,BP,
4421,GO:0010224,1,0.921881681561634,0,14,response to UV-B,BP,
4422,GO:0010225,1,0.908179320049198,0,13,response to UV-C,BP,
4423,GO:0010226,1,0.910391563629184,0,15,response to lithium ion,BP,
4424,GO:0010232,1,0.99536678233859,0,1,vascular transport,BP,
4425,GO:0010243,1,0.011515864035073,0,653,response to organonitrogen compound,BP,
4426,GO:0010248,1,0.947283432946231,0,6,establishment or maintenance of transmembrane electrochemical gradient,BP,
4427,GO:0010255,1,0.953191779578825,0,5,glucose mediated signaling pathway,BP,
4429,GO:0010257,1,0.352173061641542,0,55,NADH dehydrogenase complex assembly,BP,
4430,GO:0010259,1,0.876797151135471,0,21,multicellular organism aging,BP,
4431,GO:0010260,1,0.995366574475227,0,1,animal organ senescence,BP,
4432,GO:0010265,1,0.945798066272794,0,6,SCF complex assembly,BP,
4433,GO:0010266,1,0.965064300379103,0,3,response to vitamin B1,BP,
4434,GO:0010269,1,0.963872647400814,0,3,response to selenium ion,BP,
4435,GO:0010273,1,0.878386761028899,0,5,detoxification of copper ion,BP,
4436,GO:0010286,1,0.95191702965273,0,5,heat acclimation,BP,
4437,GO:0010288,1,0.873721148406045,0,20,response to lead ion,BP,
4438,GO:0010309,1,0.990892698675113,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4439,GO:0010310,1,0.933345089105422,0,10,regulation of hydrogen peroxide metabolic process,BP,
4440,GO:0010314,1,0.936029740413452,0,10,phosphatidylinositol-5-phosphate binding,MF,
4441,GO:0010324,1,0.752077848185881,0,42,membrane invagination,BP,
4442,GO:0010332,1,0.685559029681506,0,50,response to gamma radiation,BP,
4443,GO:0010335,1,0.995366990826164,0,1,response to non-ionic osmotic stress,BP,
4444,GO:0010340,1,0.954490710040051,0,7,carboxyl-O-methyltransferase activity,MF,
4445,GO:0010348,1,0.995366574475227,0,1,lithium:proton antiporter activity,MF,
4446,GO:0010359,1,0.972514856790114,0,6,regulation of anion channel activity,BP,
4447,GO:0010360,1,0.986163705932692,0,3,negative regulation of anion channel activity,BP,
4448,GO:0010369,1,0.918259265903524,0,13,chromocenter,CC,
4449,GO:0010370,1,0.989214279641037,0,2,perinucleolar chromocenter,CC,
4450,GO:0010385,1,0.974938784892183,0,5,double-stranded methylated DNA binding,MF,
4451,GO:0010387,1,0.994936976655377,0,1,COP9 signalosome assembly,BP,
4452,GO:0010389,1,0.215620232435793,0,180,regulation of G2/M transition of mitotic cell cycle,BP,
4453,GO:0010390,1,0.842897343263294,0,29,histone monoubiquitination,BP,
4454,GO:0010412,1,0.995366891169665,0,1,mannan metabolic process,BP,
4455,GO:0010420,1,0.984741452522495,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4456,GO:0010421,1,0.909025302093388,0,11,hydrogen peroxide-mediated programmed cell death,BP,
4457,GO:0010428,1,0.995366990826125,0,1,methyl-CpNpG binding,MF,
4458,GO:0010430,1,0.995366990826165,0,1,fatty acid omega-oxidation,BP,
4459,GO:0010447,1,0.934982322910628,0,11,response to acidic pH,BP,
4460,GO:0010452,1,0.953318512057872,0,9,histone H3-K36 methylation,BP,
4461,GO:0010453,1,0.919293162216894,0,13,regulation of cell fate commitment,BP,
4462,GO:0010454,1,0.983069375908939,0,3,negative regulation of cell fate commitment,BP,
4463,GO:0010455,1,0.964817572570317,0,4,positive regulation of cell fate commitment,BP,
4464,GO:0010457,1,0.949275858694175,0,11,centriole-centriole cohesion,BP,
4465,GO:0010458,1,0.816194882944764,0,26,exit from mitosis,BP,
4466,GO:0010459,1,0.962610171711003,0,4,negative regulation of heart rate,BP,
4467,GO:0010460,1,0.915984509044484,0,10,positive regulation of heart rate,BP,
4469,GO:0010464,1,0.88919320037266,0,23,regulation of mesenchymal cell proliferation,BP,
4470,GO:0010465,1,0.995366990826072,0,1,nerve growth factor receptor activity,MF,
4471,GO:0010466,1,0.282625730390465,0,137,negative regulation of peptidase activity,BP,
4475,GO:0010470,1,0.887591638845208,0,23,regulation of gastrulation,BP,
4476,GO:0010477,1,0.995366856248422,0,1,response to sulfur dioxide,BP,
4477,GO:0010481,1,0.976430778461352,0,3,epidermal cell division,BP,
4478,GO:0010482,1,0.976430778461352,0,3,regulation of epidermal cell division,BP,
4479,GO:0010484,1,0.981594538611598,0,4,H3 histone acetyltransferase activity,MF,
4480,GO:0010485,1,0.9127516925163,0,18,H4 histone acetyltransferase activity,MF,
4481,GO:0010494,1,0.803397761055794,0,40,cytoplasmic stress granule,CC,
4483,GO:0010499,1,0.693682358938159,0,22,proteasomal ubiquitin-independent protein catabolic process,BP,
4484,GO:0010501,1,0.805453204976123,0,42,RNA secondary structure unwinding,BP,
4487,GO:0010508,1,0.555871609728065,0,98,positive regulation of autophagy,BP,
4488,GO:0010509,1,0.995366990826138,0,1,polyamine homeostasis,BP,
4489,GO:0010510,1,0.94373498246795,0,11,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4490,GO:0010511,1,0.972650819579273,0,4,regulation of phosphatidylinositol biosynthetic process,BP,
4491,GO:0010512,1,0.990754003408654,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
4492,GO:0010513,1,0.981729807630035,0,2,positive regulation of phosphatidylinositol biosynthetic process,BP,
4494,GO:0010518,1,0.855541381461306,0,25,positive regulation of phospholipase activity,BP,
4496,GO:0010520,1,0.990736109557268,0,2,regulation of reciprocal meiotic recombination,BP,
4497,GO:0010521,1,0.971435571786175,0,3,telomerase inhibitor activity,MF,
4498,GO:0010522,1,0.676720871555079,0,55,regulation of calcium ion transport into cytosol,BP,
4499,GO:0010523,1,0.886481220852338,0,13,negative regulation of calcium ion transport into cytosol,BP,
4500,GO:0010524,1,0.817578652000471,0,27,positive regulation of calcium ion transport into cytosol,BP,
4501,GO:0010528,1,0.929846710498003,0,11,regulation of transposition,BP,
4502,GO:0010529,1,0.929846710498003,0,11,negative regulation of transposition,BP,
4503,GO:0010533,1,0.948953789351674,0,3,regulation of activation of Janus kinase activity,BP,
4504,GO:0010536,1,0.964623914405762,0,2,positive regulation of activation of Janus kinase activity,BP,
4505,GO:0010543,1,0.8849090523261,0,21,regulation of platelet activation,BP,
4506,GO:0010544,1,0.91419719355908,0,14,negative regulation of platelet activation,BP,
4510,GO:0010559,1,0.833524987207025,0,28,regulation of glycoprotein biosynthetic process,BP,
4511,GO:0010560,1,0.914564105054405,0,14,positive regulation of glycoprotein biosynthetic process,BP,
4512,GO:0010561,1,0.925825663705641,0,11,negative regulation of glycoprotein biosynthetic process,BP,
4515,GO:0010564,1,0.0101960527210793,0,623,regulation of cell cycle process,BP,
4517,GO:0010566,1,0.953233270504319,0,8,regulation of ketone biosynthetic process,BP,
4518,GO:0010569,1,0.861824014956957,0,25,regulation of double-strand break repair via homologous recombination,BP,
4519,GO:0010571,1,0.972517658564494,0,6,positive regulation of nuclear cell cycle DNA replication,BP,
4520,GO:0010572,1,0.990751742953595,0,2,positive regulation of platelet activation,BP,
4521,GO:0010573,1,0.863574796808829,0,23,vascular endothelial growth factor production,BP,
4522,GO:0010574,1,0.867601331710299,0,22,regulation of vascular endothelial growth factor production,BP,
4523,GO:0010575,1,0.899597682196287,0,19,positive regulation of vascular endothelial growth factor production,BP,
4524,GO:0010585,1,0.993257142109047,0,1,glutamine secretion,BP,
4525,GO:0010586,1,0.873106175356957,0,21,miRNA metabolic process,BP,
4526,GO:0010587,1,0.977042318746166,0,5,miRNA catabolic process,BP,
4527,GO:0010591,1,0.86548981341248,0,25,regulation of lamellipodium assembly,BP,
4528,GO:0010592,1,0.917256465480649,0,14,positive regulation of lamellipodium assembly,BP,
4529,GO:0010593,1,0.99075519984924,0,2,negative regulation of lamellipodium assembly,BP,
4532,GO:0010596,1,0.805422373973448,0,34,negative regulation of endothelial cell migration,BP,
4533,GO:0010603,1,0.968011057511372,0,7,regulation of cytoplasmic mRNA processing body assembly,BP,
4536,GO:0010606,1,0.97704606596021,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4538,GO:0010609,1,0.990431420154952,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4540,GO:0010612,1,0.972517906633748,0,6,regulation of cardiac muscle adaptation,BP,
4541,GO:0010613,1,0.894036449084271,0,20,positive regulation of cardiac muscle hypertrophy,BP,
4543,GO:0010615,1,0.995366990826165,0,1,positive regulation of cardiac muscle adaptation,BP,
4544,GO:0010616,1,0.977045779165895,0,5,negative regulation of cardiac muscle adaptation,BP,
4545,GO:0010621,1,0.981536269547348,0,1,negative regulation of transcription by transcription factor localization,BP,
4546,GO:0010623,1,0.942008861498649,0,7,programmed cell death involved in cell development,BP,
4547,GO:0010624,1,0.981594476766943,0,4,regulation of Schwann cell proliferation,BP,
4548,GO:0010626,1,0.981594476766943,0,4,negative regulation of Schwann cell proliferation,BP,
4553,GO:0010633,1,0.740858470518169,0,49,negative regulation of epithelial cell migration,BP,
4555,GO:0010635,1,0.955138297013207,0,8,regulation of mitochondrial fusion,BP,
4556,GO:0010636,1,0.990712180127463,0,2,positive regulation of mitochondrial fusion,BP,
4557,GO:0010637,1,0.968588991189628,0,5,negative regulation of mitochondrial fusion,BP,
4560,GO:0010640,1,0.922735612084182,0,16,regulation of platelet-derived growth factor receptor signaling pathway,BP,
4561,GO:0010641,1,0.981300804010065,0,4,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4562,GO:0010642,1,0.944711139445293,0,11,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,
4563,GO:0010643,1,0.986163844861884,0,3,cell communication by chemical coupling,BP,
4564,GO:0010644,1,0.886611556450772,0,19,cell communication by electrical coupling,BP,
4565,GO:0010645,1,0.990754809696829,0,2,regulation of cell communication by chemical coupling,BP,
4569,GO:0010649,1,0.947419596706646,0,9,regulation of cell communication by electrical coupling,BP,
4570,GO:0010650,1,0.995366990825942,0,1,positive regulation of cell communication by electrical coupling,BP,
4571,GO:0010652,1,0.990754809696829,0,2,positive regulation of cell communication by chemical coupling,BP,
4572,GO:0010656,1,0.87692442255096,0,23,negative regulation of muscle cell apoptotic process,BP,
4573,GO:0010657,1,0.788487372772049,0,41,muscle cell apoptotic process,BP,
4574,GO:0010658,1,0.88407506218575,0,22,striated muscle cell apoptotic process,BP,
4575,GO:0010659,1,0.892377032648848,0,20,cardiac muscle cell apoptotic process,BP,
4576,GO:0010660,1,0.799578797300666,0,38,regulation of muscle cell apoptotic process,BP,
4577,GO:0010661,1,0.911926266069837,0,15,positive regulation of muscle cell apoptotic process,BP,
4578,GO:0010662,1,0.892335497117519,0,20,regulation of striated muscle cell apoptotic process,BP,
4579,GO:0010663,1,0.966391011259709,0,6,positive regulation of striated muscle cell apoptotic process,BP,
4580,GO:0010664,1,0.919115953082741,0,15,negative regulation of striated muscle cell apoptotic process,BP,
4581,GO:0010665,1,0.90071413433094,0,18,regulation of cardiac muscle cell apoptotic process,BP,
4582,GO:0010666,1,0.966391011259709,0,6,positive regulation of cardiac muscle cell apoptotic process,BP,
4583,GO:0010667,1,0.932064852772432,0,12,negative regulation of cardiac muscle cell apoptotic process,BP,
4584,GO:0010668,1,0.977045748953828,0,5,ectodermal cell differentiation,BP,
4587,GO:0010676,1,0.823084971825003,0,35,positive regulation of cellular carbohydrate metabolic process,BP,
4589,GO:0010692,1,0.958680363744319,0,8,regulation of alkaline phosphatase activity,BP,
4590,GO:0010693,1,0.981637971621967,0,3,negative regulation of alkaline phosphatase activity,BP,
4591,GO:0010694,1,0.976617894382936,0,5,positive regulation of alkaline phosphatase activity,BP,
4592,GO:0010698,1,0.96480540318041,0,2,acetyltransferase activator activity,MF,
4593,GO:0010700,1,0.995366765183482,0,1,negative regulation of norepinephrine secretion,BP,
4594,GO:0010701,1,0.989691641940341,0,2,positive regulation of norepinephrine secretion,BP,
4595,GO:0010705,1,0.995366990826165,0,1,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4596,GO:0010710,1,0.965410196319121,0,3,regulation of collagen catabolic process,BP,
4597,GO:0010711,1,0.974421722805744,0,1,negative regulation of collagen catabolic process,BP,
4598,GO:0010712,1,0.853486340975898,0,23,regulation of collagen metabolic process,BP,
4599,GO:0010713,1,0.945166920897398,0,6,negative regulation of collagen metabolic process,BP,
4600,GO:0010714,1,0.911496437268618,0,15,positive regulation of collagen metabolic process,BP,
4601,GO:0010715,1,0.929527489640403,0,11,regulation of extracellular matrix disassembly,BP,
4602,GO:0010716,1,0.964734531629913,0,3,negative regulation of extracellular matrix disassembly,BP,
4603,GO:0010717,1,0.694083346671298,0,62,regulation of epithelial to mesenchymal transition,BP,
4604,GO:0010718,1,0.817004777919451,0,38,positive regulation of epithelial to mesenchymal transition,BP,
4605,GO:0010719,1,0.874815764427753,0,18,negative regulation of epithelial to mesenchymal transition,BP,
4608,GO:0010722,1,0.995366990826059,0,1,regulation of ferrochelatase activity,BP,
4609,GO:0010724,1,0.986163983579123,0,3,regulation of definitive erythrocyte differentiation,BP,
4610,GO:0010726,1,0.989282406274496,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
4611,GO:0010727,1,0.981120119671219,0,4,negative regulation of hydrogen peroxide metabolic process,BP,
4612,GO:0010728,1,0.979661663049083,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
4613,GO:0010729,1,0.993887600473704,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
4614,GO:0010730,1,0.985687577174559,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
4615,GO:0010731,1,0.995046016333527,0,1,protein glutathionylation,BP,
4616,GO:0010732,1,0.995046016333527,0,1,regulation of protein glutathionylation,BP,
4617,GO:0010734,1,0.995046016333527,0,1,negative regulation of protein glutathionylation,BP,
4618,GO:0010735,1,0.986164530750804,0,3,positive regulation of transcription via serum response element binding,BP,
4619,GO:0010736,1,0.995366990826152,0,1,serum response element binding,MF,
4620,GO:0010737,1,0.852837760995937,0,18,protein kinase A signaling,BP,
4621,GO:0010738,1,0.907328872265262,0,12,regulation of protein kinase A signaling,BP,
4622,GO:0010739,1,0.948377275279902,0,5,positive regulation of protein kinase A signaling,BP,
4623,GO:0010742,1,0.866071156364167,0,20,macrophage derived foam cell differentiation,BP,
4624,GO:0010743,1,0.882952494761605,0,16,regulation of macrophage derived foam cell differentiation,BP,
4625,GO:0010744,1,0.935304591821069,0,7,positive regulation of macrophage derived foam cell differentiation,BP,
4626,GO:0010745,1,0.944068472505135,0,9,negative regulation of macrophage derived foam cell differentiation,BP,
4627,GO:0010746,1,0.98159444683363,0,4,regulation of plasma membrane long-chain fatty acid transport,BP,
4628,GO:0010748,1,0.98159444683363,0,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,
4629,GO:0010749,1,0.986116241601238,0,3,regulation of nitric oxide mediated signal transduction,BP,
4630,GO:0010750,1,0.995318255982901,0,1,positive regulation of nitric oxide mediated signal transduction,BP,
4631,GO:0010751,1,0.990755199849084,0,2,negative regulation of nitric oxide mediated signal transduction,BP,
4632,GO:0010752,1,0.990755199849254,0,2,regulation of cGMP-mediated signaling,BP,
4633,GO:0010754,1,0.995366990826125,0,1,negative regulation of cGMP-mediated signaling,BP,
4634,GO:0010755,1,0.956809421091605,0,7,regulation of plasminogen activation,BP,
4635,GO:0010756,1,0.981923078195284,0,3,positive regulation of plasminogen activation,BP,
4636,GO:0010757,1,0.974429307487982,0,4,negative regulation of plasminogen activation,BP,
4637,GO:0010758,1,0.873407930571903,0,14,regulation of macrophage chemotaxis,BP,
4638,GO:0010759,1,0.953387831134473,0,7,positive regulation of macrophage chemotaxis,BP,
4639,GO:0010760,1,0.929313181928637,0,4,negative regulation of macrophage chemotaxis,BP,
4640,GO:0010761,1,0.849232347719972,0,33,fibroblast migration,BP,
4641,GO:0010762,1,0.888328753143686,0,24,regulation of fibroblast migration,BP,
4642,GO:0010763,1,0.957651453019592,0,9,positive regulation of fibroblast migration,BP,
4643,GO:0010764,1,0.9672887239329,0,6,negative regulation of fibroblast migration,BP,
4644,GO:0010765,1,0.890800797113964,0,21,positive regulation of sodium ion transport,BP,
4645,GO:0010766,1,0.931112433194033,0,10,negative regulation of sodium ion transport,BP,
4646,GO:0010767,1,0.986157582135617,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4647,GO:0010768,1,0.99075519984911,0,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4648,GO:0010769,1,0.307309714831529,0,197,regulation of cell morphogenesis involved in differentiation,BP,
4649,GO:0010770,1,0.506279664229231,0,110,positive regulation of cell morphogenesis involved in differentiation,BP,
4650,GO:0010771,1,0.700638639261576,0,64,negative regulation of cell morphogenesis involved in differentiation,BP,
4651,GO:0010792,1,0.972509199826242,0,6,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4652,GO:0010793,1,0.976066387144183,0,5,regulation of mRNA export from nucleus,BP,
4653,GO:0010795,1,0.984741452522495,0,1,regulation of ubiquinone biosynthetic process,BP,
4654,GO:0010796,1,0.971302009788861,0,3,regulation of multivesicular body size,BP,
4655,GO:0010797,1,0.983780658376657,0,1,regulation of multivesicular body size involved in endosome transport,BP,
4657,GO:0010800,1,0.893777198626019,0,21,positive regulation of peptidyl-threonine phosphorylation,BP,
4659,GO:0010803,1,0.647887929769775,0,52,regulation of tumor necrosis factor-mediated signaling pathway,BP,
4660,GO:0010804,1,0.858954218752197,0,14,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
4661,GO:0010807,1,0.968813800173196,0,6,regulation of synaptic vesicle priming,BP,
4662,GO:0010808,1,0.995366990826099,0,1,positive regulation of synaptic vesicle priming,BP,
4663,GO:0010810,1,0.427243993170985,0,139,regulation of cell-substrate adhesion,BP,
4664,GO:0010811,1,0.611004667233254,0,77,positive regulation of cell-substrate adhesion,BP,
4665,GO:0010812,1,0.773584505099649,0,45,negative regulation of cell-substrate adhesion,BP,
4666,GO:0010813,1,0.983635369146959,0,2,neuropeptide catabolic process,BP,
4667,GO:0010814,1,0.995366990826151,0,1,substance P catabolic process,BP,
4668,GO:0010815,1,0.974431581251585,0,4,bradykinin catabolic process,BP,
4669,GO:0010816,1,0.995366990826151,0,1,calcitonin catabolic process,BP,
4671,GO:0010818,1,0.940905805646156,0,9,T cell chemotaxis,BP,
4672,GO:0010819,1,0.959645803499405,0,6,regulation of T cell chemotaxis,BP,
4673,GO:0010820,1,0.959645803499405,0,6,positive regulation of T cell chemotaxis,BP,
4676,GO:0010823,1,0.733223674566151,0,41,negative regulation of mitochondrion organization,BP,
4677,GO:0010824,1,0.797656099378361,0,37,regulation of centrosome duplication,BP,
4678,GO:0010825,1,0.971837539860614,0,6,positive regulation of centrosome duplication,BP,
4679,GO:0010826,1,0.910080770577237,0,12,negative regulation of centrosome duplication,BP,
4680,GO:0010827,1,0.76400602734648,0,51,regulation of glucose transmembrane transport,BP,
4681,GO:0010828,1,0.867407135406124,0,29,positive regulation of glucose transmembrane transport,BP,
4682,GO:0010829,1,0.926708116676483,0,12,negative regulation of glucose transmembrane transport,BP,
4683,GO:0010830,1,0.8193993233738,0,31,regulation of myotube differentiation,BP,
4684,GO:0010831,1,0.882799951654262,0,18,positive regulation of myotube differentiation,BP,
4685,GO:0010832,1,0.95517079774621,0,7,negative regulation of myotube differentiation,BP,
4686,GO:0010833,1,0.604842069685842,0,74,telomere maintenance via telomere lengthening,BP,
4687,GO:0010835,1,0.961725512601458,0,7,regulation of protein ADP-ribosylation,BP,
4688,GO:0010836,1,0.979768758074032,0,3,negative regulation of protein ADP-ribosylation,BP,
4690,GO:0010838,1,0.977045457799649,0,5,positive regulation of keratinocyte proliferation,BP,
4692,GO:0010842,1,0.923395557936373,0,15,retina layer formation,BP,
4693,GO:0010845,1,0.995348000986484,0,1,positive regulation of reciprocal meiotic recombination,BP,
4694,GO:0010847,1,0.976755443940227,0,4,regulation of chromatin assembly,BP,
4695,GO:0010848,1,0.99536687124987,0,1,regulation of chromatin disassembly,BP,
4696,GO:0010849,1,0.994653416395701,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
4697,GO:0010851,1,0.994874902021167,0,1,cyclase regulator activity,MF,
4698,GO:0010853,1,0.994874902021167,0,1,cyclase activator activity,MF,
4699,GO:0010856,1,0.995366874581822,0,1,adenylate cyclase activator activity,MF,
4700,GO:0010857,1,0.961089622729926,0,8,calcium-dependent protein kinase activity,MF,
4701,GO:0010858,1,0.974175187661214,0,2,calcium-dependent protein kinase regulator activity,MF,
4702,GO:0010859,1,0.995366990826151,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
4703,GO:0010862,1,0.858485719217006,0,25,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,
4704,GO:0010863,1,0.911397794463157,0,15,positive regulation of phospholipase C activity,BP,
4705,GO:0010866,1,0.918255043971439,0,13,regulation of triglyceride biosynthetic process,BP,
4706,GO:0010867,1,0.951603113314033,0,9,positive regulation of triglyceride biosynthetic process,BP,
4707,GO:0010868,1,0.9907551932561,0,2,negative regulation of triglyceride biosynthetic process,BP,
4709,GO:0010870,1,0.926775913053911,0,10,positive regulation of receptor biosynthetic process,BP,
4711,GO:0010872,1,0.936863946727195,0,5,regulation of cholesterol esterification,BP,
4712,GO:0010873,1,0.945612232908567,0,3,positive regulation of cholesterol esterification,BP,
4713,GO:0010874,1,0.909359557518647,0,14,regulation of cholesterol efflux,BP,
4714,GO:0010875,1,0.917853655101723,0,12,positive regulation of cholesterol efflux,BP,
4715,GO:0010876,1,0.245032062461638,0,222,lipid localization,BP,
4716,GO:0010877,1,0.978047801938611,0,2,lipid transport involved in lipid storage,BP,
4717,GO:0010878,1,0.940365682949465,0,11,cholesterol storage,BP,
4718,GO:0010879,1,0.994866746349447,0,1,cholesterol transport involved in cholesterol storage,BP,
4719,GO:0010880,1,0.878854409246317,0,15,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
4720,GO:0010881,1,0.896803687149213,0,11,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
4721,GO:0010882,1,0.878092473846198,0,15,regulation of cardiac muscle contraction by calcium ion signaling,BP,
4722,GO:0010883,1,0.825581155730296,0,29,regulation of lipid storage,BP,
4723,GO:0010884,1,0.928593792952377,0,12,positive regulation of lipid storage,BP,
4724,GO:0010885,1,0.949623179202914,0,9,regulation of cholesterol storage,BP,
4725,GO:0010886,1,0.98615738021673,0,3,positive regulation of cholesterol storage,BP,
4726,GO:0010887,1,0.962958811150325,0,6,negative regulation of cholesterol storage,BP,
4727,GO:0010888,1,0.917469532587099,0,13,negative regulation of lipid storage,BP,
4728,GO:0010889,1,0.947929383073624,0,7,regulation of sequestering of triglyceride,BP,
4729,GO:0010890,1,0.973982538801175,0,2,positive regulation of sequestering of triglyceride,BP,
4730,GO:0010891,1,0.973258893342552,0,5,negative regulation of sequestering of triglyceride,BP,
4733,GO:0010896,1,0.9845286609138,0,3,regulation of triglyceride catabolic process,BP,
4734,GO:0010897,1,0.994930769572645,0,1,negative regulation of triglyceride catabolic process,BP,
4735,GO:0010898,1,0.989545501294286,0,2,positive regulation of triglyceride catabolic process,BP,
4736,GO:0010899,1,0.957896073898361,0,3,regulation of phosphatidylcholine catabolic process,BP,
4737,GO:0010900,1,0.96684470366738,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
4738,GO:0010904,1,0.994614625735962,0,1,regulation of UDP-glucose catabolic process,BP,
4739,GO:0010905,1,0.994614625735962,0,1,negative regulation of UDP-glucose catabolic process,BP,
4741,GO:0010907,1,0.892527814317778,0,23,positive regulation of glucose metabolic process,BP,
4742,GO:0010908,1,0.986164057392432,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4743,GO:0010909,1,0.986164057392432,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4744,GO:0010911,1,0.966529611873348,0,7,regulation of isomerase activity,BP,
4745,GO:0010912,1,0.966529611873348,0,7,positive regulation of isomerase activity,BP,
4746,GO:0010915,1,0.956806715154637,0,2,regulation of very-low-density lipoprotein particle clearance,BP,
4747,GO:0010916,1,0.956806715154637,0,2,negative regulation of very-low-density lipoprotein particle clearance,BP,
4748,GO:0010917,1,0.933141582129035,0,8,negative regulation of mitochondrial membrane potential,BP,
4749,GO:0010918,1,0.943813715826266,0,7,positive regulation of mitochondrial membrane potential,BP,
4750,GO:0010919,1,0.968010371386836,0,7,regulation of inositol phosphate biosynthetic process,BP,
4751,GO:0010921,1,0.450717520294473,0,134,regulation of phosphatase activity,BP,
4752,GO:0010922,1,0.885095033108812,0,23,positive regulation of phosphatase activity,BP,
4753,GO:0010923,1,0.636346493322016,0,74,negative regulation of phosphatase activity,BP,
4754,GO:0010927,1,0.711600423691365,0,60,cellular component assembly involved in morphogenesis,BP,
4755,GO:0010931,1,0.995366990826007,0,1,macrophage tolerance induction,BP,
4756,GO:0010932,1,0.995366990826007,0,1,regulation of macrophage tolerance induction,BP,
4757,GO:0010933,1,0.995366990826007,0,1,positive regulation of macrophage tolerance induction,BP,
4758,GO:0010934,1,0.933224434578246,0,10,macrophage cytokine production,BP,
4759,GO:0010935,1,0.942021526269688,0,8,regulation of macrophage cytokine production,BP,
4760,GO:0010936,1,0.964735057561102,0,5,negative regulation of macrophage cytokine production,BP,
4761,GO:0010939,1,0.807914047598526,0,24,regulation of necrotic cell death,BP,
4762,GO:0010940,1,0.938216889162523,0,5,positive regulation of necrotic cell death,BP,
4765,GO:0010944,1,0.941473737366957,0,6,negative regulation of transcription by competitive promoter binding,BP,
4766,GO:0010948,1,0.0887176253230976,0,295,negative regulation of cell cycle process,BP,
4767,GO:0010950,1,0.300122667010466,0,135,positive regulation of endopeptidase activity,BP,
4768,GO:0010951,1,0.288844966927922,0,135,negative regulation of endopeptidase activity,BP,
4769,GO:0010952,1,0.270080444030449,0,151,positive regulation of peptidase activity,BP,
4770,GO:0010954,1,0.934566187861262,0,12,positive regulation of protein processing,BP,
4771,GO:0010955,1,0.812146220528226,0,26,negative regulation of protein processing,BP,
4772,GO:0010956,1,0.990653558860613,0,2,negative regulation of calcidiol 1-monooxygenase activity,BP,
4774,GO:0010958,1,0.980122298094146,0,4,regulation of amino acid import across plasma membrane,BP,
4776,GO:0010960,1,0.967963760690972,0,7,magnesium ion homeostasis,BP,
4777,GO:0010961,1,0.990755199849188,0,2,cellular magnesium ion homeostasis,BP,
4779,GO:0010963,1,0.987839962517201,0,1,regulation of L-arginine import,BP,
4780,GO:0010965,1,0.679234699411608,0,50,regulation of mitotic sister chromatid separation,BP,
4781,GO:0010966,1,0.98616453102361,0,3,regulation of phosphate transport,BP,
4782,GO:0010967,1,0.991156461546762,0,1,regulation of polyamine biosynthetic process,BP,
4783,GO:0010968,1,0.952544601658205,0,6,regulation of microtubule nucleation,BP,
4784,GO:0010970,1,0.3905865551553,0,131,transport along microtubule,BP,
4785,GO:0010971,1,0.882065897050227,0,19,positive regulation of G2/M transition of mitotic cell cycle,BP,
4786,GO:0010972,1,0.396478959825344,0,87,negative regulation of G2/M transition of mitotic cell cycle,BP,
4787,GO:0010975,1,0.141089710621365,0,317,regulation of neuron projection development,BP,
4788,GO:0010976,1,0.322270398675949,0,187,positive regulation of neuron projection development,BP,
4789,GO:0010977,1,0.509142444599606,0,103,negative regulation of neuron projection development,BP,
4790,GO:0010979,1,0.990653558860639,0,2,regulation of vitamin D 24-hydroxylase activity,BP,
4791,GO:0010980,1,0.990653558860639,0,2,positive regulation of vitamin D 24-hydroxylase activity,BP,
4792,GO:0010982,1,0.990320976584222,0,2,regulation of high-density lipoprotein particle clearance,BP,
4793,GO:0010983,1,0.990320976584222,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
4794,GO:0010984,1,0.901882276443755,0,11,regulation of lipoprotein particle clearance,BP,
4795,GO:0010985,1,0.943463266309015,0,5,negative regulation of lipoprotein particle clearance,BP,
4796,GO:0010986,1,0.976321241618154,0,4,positive regulation of lipoprotein particle clearance,BP,
4797,GO:0010988,1,0.956275150365717,0,6,regulation of low-density lipoprotein particle clearance,BP,
4798,GO:0010989,1,0.98606120949552,0,3,negative regulation of low-density lipoprotein particle clearance,BP,
4799,GO:0010990,1,0.986164531020309,0,3,regulation of SMAD protein complex assembly,BP,
4800,GO:0010991,1,0.990755199849149,0,2,negative regulation of SMAD protein complex assembly,BP,
4801,GO:0010992,1,0.936354858477347,0,7,ubiquitin recycling,BP,
4802,GO:0010994,1,0.945097749079578,0,5,free ubiquitin chain polymerization,BP,
4803,GO:0010996,1,0.936067138019178,0,12,response to auditory stimulus,BP,
4804,GO:0010997,1,0.971924284740228,0,5,anaphase-promoting complex binding,MF,
4805,GO:0010998,1,0.943590807121966,0,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
4806,GO:0010999,1,0.995366990826164,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
4810,GO:0012507,1,0.705608901206391,0,46,ER to Golgi transport vesicle membrane,CC,
4811,GO:0012510,1,0.894807924998177,0,13,trans-Golgi network transport vesicle membrane,CC,
4812,GO:0014002,1,0.85608678447201,0,19,astrocyte development,BP,
4814,GO:0014004,1,0.990755082260773,0,2,microglia differentiation,BP,
4815,GO:0014005,1,0.990755082260773,0,2,microglia development,BP,
4817,GO:0014010,1,0.977045767711031,0,5,Schwann cell proliferation,BP,
4818,GO:0014011,1,0.995366574475227,0,1,Schwann cell proliferation involved in axon regeneration,BP,
4819,GO:0014012,1,0.960591060242474,0,4,peripheral nervous system axon regeneration,BP,
4823,GO:0014016,1,0.995213700845504,0,1,neuroblast differentiation,BP,
4824,GO:0014020,1,0.624687382517647,0,80,primary neural tube formation,BP,
4825,GO:0014022,1,0.986163877188497,0,3,neural plate elongation,BP,
4826,GO:0014028,1,0.989034172764745,0,1,notochord formation,BP,
4827,GO:0014029,1,0.932734386753124,0,10,neural crest formation,BP,
4831,GO:0014034,1,0.990755199558051,0,2,neural crest cell fate commitment,BP,
4832,GO:0014036,1,0.99536699053359,0,1,neural crest cell fate specification,BP,
4833,GO:0014037,1,0.832875098652502,0,31,Schwann cell differentiation,BP,
4834,GO:0014038,1,0.98248747492564,0,3,regulation of Schwann cell differentiation,BP,
4835,GO:0014040,1,0.990715514576797,0,2,positive regulation of Schwann cell differentiation,BP,
4836,GO:0014041,1,0.950796297652713,0,7,regulation of neuron maturation,BP,
4837,GO:0014042,1,0.981594887132316,0,4,positive regulation of neuron maturation,BP,
4838,GO:0014043,1,0.987655217153249,0,2,negative regulation of neuron maturation,BP,
4839,GO:0014044,1,0.863675315790582,0,24,Schwann cell development,BP,
4840,GO:0014045,1,0.977616962210817,0,4,establishment of endothelial blood-brain barrier,BP,
4842,GO:0014047,1,0.897545863296054,0,19,glutamate secretion,BP,
4843,GO:0014048,1,0.963822033339267,0,5,regulation of glutamate secretion,BP,
4844,GO:0014049,1,0.968310057143052,0,4,positive regulation of glutamate secretion,BP,
4845,GO:0014051,1,0.977046177790126,0,5,gamma-aminobutyric acid secretion,BP,
4846,GO:0014052,1,0.986164531023741,0,3,regulation of gamma-aminobutyric acid secretion,BP,
4847,GO:0014053,1,0.995366990826165,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
4848,GO:0014054,1,0.995366990826138,0,1,positive regulation of gamma-aminobutyric acid secretion,BP,
4850,GO:0014061,1,0.985105621377088,0,3,regulation of norepinephrine secretion,BP,
4851,GO:0014062,1,0.978366626990994,0,2,regulation of serotonin secretion,BP,
4852,GO:0014063,1,0.982921410541073,0,1,negative regulation of serotonin secretion,BP,
4853,GO:0014064,1,0.995366990826164,0,1,positive regulation of serotonin secretion,BP,
4854,GO:0014065,1,0.61745339928839,0,85,phosphatidylinositol 3-kinase signaling,BP,
4855,GO:0014066,1,0.698820759175075,0,62,regulation of phosphatidylinositol 3-kinase signaling,BP,
4856,GO:0014067,1,0.955772580147724,0,9,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
4857,GO:0014068,1,0.803655072783983,0,36,positive regulation of phosphatidylinositol 3-kinase signaling,BP,
4858,GO:0014069,1,0.454224439830651,0,147,postsynaptic density,CC,
4860,GO:0014072,1,0.895074830885665,0,17,response to isoquinoline alkaloid,BP,
4861,GO:0014074,1,0.553747981793904,0,93,response to purine-containing compound,BP,
4862,GO:0014075,1,0.83873686113279,0,23,response to amine,BP,
4863,GO:0014701,1,0.981594866255689,0,4,junctional sarcoplasmic reticulum membrane,CC,
4864,GO:0014704,1,0.839850436222715,0,32,intercalated disc,CC,
4866,GO:0014717,1,0.982327083940068,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4867,GO:0014718,1,0.982327083940068,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4868,GO:0014719,1,0.973812658007412,0,3,skeletal muscle satellite cell activation,BP,
4869,GO:0014721,1,0.975113534379124,0,2,twitch skeletal muscle contraction,BP,
4870,GO:0014722,1,0.952170836716292,0,4,regulation of skeletal muscle contraction by calcium ion signaling,BP,
4871,GO:0014731,1,0.969912213651708,0,6,spectrin-associated cytoskeleton,CC,
4872,GO:0014732,1,0.980266681323784,0,3,skeletal muscle atrophy,BP,
4873,GO:0014733,1,0.948307970371464,0,8,regulation of skeletal muscle adaptation,BP,
4874,GO:0014734,1,0.995366990825981,0,1,skeletal muscle hypertrophy,BP,
4875,GO:0014735,1,0.982163499078827,0,2,regulation of muscle atrophy,BP,
4876,GO:0014736,1,0.982163499078827,0,2,negative regulation of muscle atrophy,BP,
4877,GO:0014738,1,0.986036300843427,0,3,regulation of muscle hyperplasia,BP,
4878,GO:0014739,1,0.995366654294266,0,1,positive regulation of muscle hyperplasia,BP,
4879,GO:0014740,1,0.990626714561237,0,2,negative regulation of muscle hyperplasia,BP,
4881,GO:0014742,1,0.894036449084271,0,20,positive regulation of muscle hypertrophy,BP,
4883,GO:0014744,1,0.9861641975675,0,3,positive regulation of muscle adaptation,BP,
4884,GO:0014745,1,0.950615092552785,0,9,negative regulation of muscle adaptation,BP,
4885,GO:0014802,1,0.978892865790905,0,2,terminal cisterna,CC,
4886,GO:0014805,1,0.946510940076712,0,4,smooth muscle adaptation,BP,
4887,GO:0014806,1,0.984596171114396,0,2,smooth muscle hyperplasia,BP,
4888,GO:0014807,1,0.967283476652952,0,6,regulation of somitogenesis,BP,
4889,GO:0014808,1,0.867179905197442,0,16,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
4890,GO:0014809,1,0.9566054805278,0,3,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
4891,GO:0014810,1,0.974630596415014,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
4892,GO:0014812,1,0.725981226705386,0,54,muscle cell migration,BP,
4893,GO:0014816,1,0.990755199849097,0,2,skeletal muscle satellite cell differentiation,BP,
4894,GO:0014819,1,0.922475625785221,0,5,regulation of skeletal muscle contraction,BP,
4895,GO:0014820,1,0.951878605805615,0,6,tonic smooth muscle contraction,BP,
4897,GO:0014823,1,0.763706154273178,0,40,response to activity,BP,
4898,GO:0014824,1,0.980467491802627,0,4,artery smooth muscle contraction,BP,
4899,GO:0014825,1,0.975368272283632,0,1,stomach fundus smooth muscle contraction,BP,
4900,GO:0014826,1,0.994254882565581,0,1,vein smooth muscle contraction,BP,
4901,GO:0014827,1,0.994761741131567,0,1,intestine smooth muscle contraction,BP,
4902,GO:0014829,1,0.942636360933124,0,12,vascular smooth muscle contraction,BP,
4903,GO:0014831,1,0.961284644258928,0,4,gastro-intestinal system smooth muscle contraction,BP,
4904,GO:0014832,1,0.986164342833301,0,3,urinary bladder smooth muscle contraction,BP,
4905,GO:0014834,1,0.977599296721362,0,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
4906,GO:0014835,1,0.995366990826152,0,1,myoblast differentiation involved in skeletal muscle regeneration,BP,
4907,GO:0014839,1,0.979904052838873,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
4908,GO:0014841,1,0.966178733078053,0,7,skeletal muscle satellite cell proliferation,BP,
4909,GO:0014842,1,0.966178733078053,0,7,regulation of skeletal muscle satellite cell proliferation,BP,
4910,GO:0014843,1,0.995366990826074,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
4911,GO:0014846,1,0.995366990826153,0,1,esophagus smooth muscle contraction,BP,
4912,GO:0014847,1,0.975368272283632,0,1,proximal stomach smooth muscle contraction,BP,
4913,GO:0014848,1,0.986164342833301,0,3,urinary tract smooth muscle contraction,BP,
4914,GO:0014850,1,0.900828762160415,0,14,response to muscle activity,BP,
4915,GO:0014852,1,0.995366545689463,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
4916,GO:0014853,1,0.995366545689463,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
4917,GO:0014854,1,0.949594022807305,0,8,response to inactivity,BP,
4918,GO:0014855,1,0.833871369406301,0,37,striated muscle cell proliferation,BP,
4919,GO:0014856,1,0.966178733078053,0,7,skeletal muscle cell proliferation,BP,
4920,GO:0014857,1,0.966178733078053,0,7,regulation of skeletal muscle cell proliferation,BP,
4921,GO:0014858,1,0.990755199849279,0,2,positive regulation of skeletal muscle cell proliferation,BP,
4922,GO:0014859,1,0.995366893701033,0,1,negative regulation of skeletal muscle cell proliferation,BP,
4923,GO:0014866,1,0.984298671450608,0,3,skeletal myofibril assembly,BP,
4924,GO:0014870,1,0.963699170040598,0,6,response to muscle inactivity,BP,
4925,GO:0014874,1,0.950911433574932,0,7,response to stimulus involved in regulation of muscle adaptation,BP,
4926,GO:0014876,1,0.986735755245429,0,1,response to injury involved in regulation of muscle adaptation,BP,
4927,GO:0014877,1,0.968186859349939,0,5,response to muscle inactivity involved in regulation of muscle adaptation,BP,
4928,GO:0014878,1,0.995366990826152,0,1,response to electrical stimulus involved in regulation of muscle adaptation,BP,
4929,GO:0014883,1,0.96609620365023,0,4,transition between fast and slow fiber,BP,
4930,GO:0014886,1,0.990755073998398,0,2,transition between slow and fast fiber,BP,
4931,GO:0014887,1,0.945765455207562,0,12,cardiac muscle adaptation,BP,
4932,GO:0014888,1,0.883222636728425,0,22,striated muscle adaptation,BP,
4933,GO:0014889,1,0.951976009377554,0,7,muscle atrophy,BP,
4934,GO:0014891,1,0.975722083105805,0,4,striated muscle atrophy,BP,
4935,GO:0014894,1,0.968186859349939,0,5,response to denervation involved in regulation of muscle adaptation,BP,
4936,GO:0014895,1,0.972420652557464,0,1,smooth muscle hypertrophy,BP,
4939,GO:0014898,1,0.945765455207562,0,12,cardiac muscle hypertrophy in response to stress,BP,
4940,GO:0014900,1,0.975491458279629,0,4,muscle hyperplasia,BP,
4941,GO:0014901,1,0.982327083940068,0,2,satellite cell activation involved in skeletal muscle regeneration,BP,
4942,GO:0014902,1,0.705149719146856,0,56,myotube differentiation,BP,
4943,GO:0014904,1,0.905976483802443,0,16,myotube cell development,BP,
4944,GO:0014908,1,0.995366990826099,0,1,myotube differentiation involved in skeletal muscle regeneration,BP,
4945,GO:0014909,1,0.768133431286037,0,46,smooth muscle cell migration,BP,
4946,GO:0014910,1,0.79014492848736,0,41,regulation of smooth muscle cell migration,BP,
4947,GO:0014911,1,0.891911935785569,0,22,positive regulation of smooth muscle cell migration,BP,
4948,GO:0014912,1,0.902743424472099,0,15,negative regulation of smooth muscle cell migration,BP,
4949,GO:0014916,1,0.984255750978692,0,3,regulation of lung blood pressure,BP,
4951,GO:0015012,1,0.902906017795019,0,20,heparan sulfate proteoglycan biosynthetic process,BP,
4952,GO:0015014,1,0.981594800826998,0,4,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
4953,GO:0015015,1,0.980152336036484,0,4,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
4954,GO:0015016,1,0.990755199847281,0,2,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
4955,GO:0015018,1,0.987700056459455,0,1,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
4956,GO:0015019,1,0.995366990826152,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
4957,GO:0015020,1,0.927632267364416,0,14,glucuronosyltransferase activity,MF,
4958,GO:0015026,1,0.894715697478478,0,20,coreceptor activity,MF,
4959,GO:0015030,1,0.633005745891393,0,51,Cajal body,CC,
4961,GO:0015035,1,0.768952416091013,0,20,protein disulfide oxidoreductase activity,MF,
4962,GO:0015036,1,0.691565576098534,0,34,disulfide oxidoreductase activity,MF,
4963,GO:0015037,1,0.86216818183222,0,12,peptide disulfide oxidoreductase activity,MF,
4964,GO:0015038,1,0.924192006516148,0,5,glutathione disulfide oxidoreductase activity,MF,
4965,GO:0015039,1,0.9930434418814,0,1,NADPH-adrenodoxin reductase activity,MF,
4966,GO:0015057,1,0.986068436083405,0,3,thrombin-activated receptor activity,MF,
4967,GO:0015074,1,0.947903566045655,0,10,DNA integration,BP,
4974,GO:0015086,1,0.995366990826139,0,1,cadmium ion transmembrane transporter activity,MF,
4975,GO:0015087,1,0.995366990826139,0,1,cobalt ion transmembrane transporter activity,MF,
4976,GO:0015091,1,0.995366990826151,0,1,ferric iron transmembrane transporter activity,MF,
4977,GO:0015093,1,0.99075519984928,0,2,ferrous iron transmembrane transporter activity,MF,
4978,GO:0015094,1,0.995366990826139,0,1,lead ion transmembrane transporter activity,MF,
4979,GO:0015095,1,0.910570644992814,0,17,magnesium ion transmembrane transporter activity,MF,
4980,GO:0015098,1,0.993047243179903,0,1,molybdate ion transmembrane transporter activity,MF,
4981,GO:0015101,1,0.911254141882126,0,18,organic cation transmembrane transporter activity,MF,
4983,GO:0015105,1,0.98504781901311,0,1,arsenite transmembrane transporter activity,MF,
4984,GO:0015106,1,0.950175558293624,0,11,bicarbonate transmembrane transporter activity,MF,
4986,GO:0015111,1,0.986164506837548,0,3,iodide transmembrane transporter activity,MF,
4987,GO:0015112,1,0.995353883872325,0,1,nitrate transmembrane transporter activity,MF,
4988,GO:0015114,1,0.966971412417692,0,7,phosphate ion transmembrane transporter activity,MF,
4989,GO:0015116,1,0.970174807004726,0,6,sulfate transmembrane transporter activity,MF,
4990,GO:0015117,1,0.992982056220991,0,1,thiosulfate transmembrane transporter activity,MF,
4991,GO:0015119,1,0.985105626422284,0,3,hexose phosphate transmembrane transporter activity,MF,
4992,GO:0015125,1,0.972621240088032,0,4,bile acid transmembrane transporter activity,MF,
4993,GO:0015127,1,0.995366990826164,0,1,bilirubin transmembrane transporter activity,MF,
4994,GO:0015129,1,0.984742822954948,0,3,lactate transmembrane transporter activity,MF,
4995,GO:0015130,1,0.995366990826138,0,1,mevalonate transmembrane transporter activity,MF,
4996,GO:0015131,1,0.992982056220991,0,1,oxaloacetate transmembrane transporter activity,MF,
4997,GO:0015136,1,0.995366889887653,0,1,sialic acid transmembrane transporter activity,MF,
4998,GO:0015137,1,0.976318948512465,0,4,citrate transmembrane transporter activity,MF,
4999,GO:0015140,1,0.985063007436895,0,2,malate transmembrane transporter activity,MF,
5000,GO:0015141,1,0.983801244923613,0,3,succinate transmembrane transporter activity,MF,
5001,GO:0015142,1,0.976318948512465,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5002,GO:0015143,1,0.992807703284488,0,1,urate transmembrane transporter activity,MF,
5006,GO:0015152,1,0.994298539157786,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
5007,GO:0015154,1,0.990755046992583,0,2,disaccharide transmembrane transporter activity,MF,
5008,GO:0015157,1,0.990755046992583,0,2,oligosaccharide transmembrane transporter activity,MF,
5009,GO:0015165,1,0.935307957133895,0,9,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5010,GO:0015166,1,0.978675348442802,0,4,polyol transmembrane transporter activity,MF,
5011,GO:0015168,1,0.9878087278569,0,2,glycerol transmembrane transporter activity,MF,
5012,GO:0015171,1,0.759681216183247,0,49,amino acid transmembrane transporter activity,MF,
5013,GO:0015172,1,0.972516431609792,0,6,acidic amino acid transmembrane transporter activity,MF,
5014,GO:0015173,1,0.99524265188522,0,1,aromatic amino acid transmembrane transporter activity,MF,
5015,GO:0015174,1,0.955389180987882,0,9,basic amino acid transmembrane transporter activity,MF,
5016,GO:0015175,1,0.863449906345806,0,24,neutral amino acid transmembrane transporter activity,MF,
5017,GO:0015179,1,0.804550901797662,0,38,L-amino acid transmembrane transporter activity,MF,
5018,GO:0015180,1,0.976923392602681,0,5,L-alanine transmembrane transporter activity,MF,
5019,GO:0015181,1,0.974163082262148,0,5,arginine transmembrane transporter activity,MF,
5020,GO:0015182,1,0.995366330720897,0,1,L-asparagine transmembrane transporter activity,MF,
5021,GO:0015183,1,0.986163718475862,0,3,L-aspartate transmembrane transporter activity,MF,
5022,GO:0015184,1,0.990755199849267,0,2,L-cystine transmembrane transporter activity,MF,
5023,GO:0015185,1,0.993724238835064,0,1,gamma-aminobutyric acid transmembrane transporter activity,MF,
5024,GO:0015186,1,0.979513250238603,0,4,L-glutamine transmembrane transporter activity,MF,
5025,GO:0015187,1,0.974479828205199,0,5,glycine transmembrane transporter activity,MF,
5026,GO:0015189,1,0.974163082262148,0,5,L-lysine transmembrane transporter activity,MF,
5027,GO:0015190,1,0.995366330720897,0,1,L-leucine transmembrane transporter activity,MF,
5028,GO:0015191,1,0.995366330720897,0,1,L-methionine transmembrane transporter activity,MF,
5029,GO:0015193,1,0.976924040616043,0,5,L-proline transmembrane transporter activity,MF,
5030,GO:0015194,1,0.961636370683131,0,7,L-serine transmembrane transporter activity,MF,
5031,GO:0015195,1,0.995366990826152,0,1,L-threonine transmembrane transporter activity,MF,
5032,GO:0015196,1,0.99524265188522,0,1,L-tryptophan transmembrane transporter activity,MF,
5033,GO:0015203,1,0.995366574475227,0,1,polyamine transmembrane transporter activity,MF,
5034,GO:0015204,1,0.983231555433434,0,3,urea transmembrane transporter activity,MF,
5035,GO:0015205,1,0.956139144898755,0,6,nucleobase transmembrane transporter activity,MF,
5036,GO:0015207,1,0.970166902814952,0,3,adenine transmembrane transporter activity,MF,
5037,GO:0015211,1,0.99525004465248,0,1,purine nucleoside transmembrane transporter activity,MF,
5038,GO:0015215,1,0.903414070415716,0,15,nucleotide transmembrane transporter activity,MF,
5039,GO:0015216,1,0.931742506627427,0,11,purine nucleotide transmembrane transporter activity,MF,
5040,GO:0015217,1,0.942965545906914,0,9,ADP transmembrane transporter activity,MF,
5041,GO:0015218,1,0.983446379709979,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5042,GO:0015220,1,0.976772694482587,0,5,choline transmembrane transporter activity,MF,
5043,GO:0015222,1,0.988494893575857,0,2,serotonin transmembrane transporter activity,MF,
5044,GO:0015226,1,0.978388964285449,0,4,carnitine transmembrane transporter activity,MF,
5045,GO:0015227,1,0.987963623652385,0,2,acyl carnitine transmembrane transporter activity,MF,
5046,GO:0015228,1,0.985610701784583,0,3,coenzyme A transmembrane transporter activity,MF,
5047,GO:0015229,1,0.995366990826073,0,1,L-ascorbic acid transmembrane transporter activity,MF,
5048,GO:0015230,1,0.990256961073357,0,2,FAD transmembrane transporter activity,MF,
5049,GO:0015232,1,0.967795628045315,0,7,heme transporter activity,MF,
5050,GO:0015234,1,0.985944456543045,0,2,thiamine transmembrane transporter activity,MF,
5052,GO:0015245,1,0.976060999358876,0,5,fatty acid transmembrane transporter activity,MF,
5053,GO:0015247,1,0.986164531023728,0,3,aminophospholipid transmembrane transporter activity,MF,
5054,GO:0015248,1,0.84219597292503,0,20,sterol transporter activity,MF,
5055,GO:0015250,1,0.971122735813377,0,4,water channel activity,MF,
5056,GO:0015252,1,0.995366775300441,0,1,proton channel activity,MF,
5057,GO:0015254,1,0.9878087278569,0,2,glycerol channel activity,MF,
5058,GO:0015265,1,0.995366701249256,0,1,urea channel activity,MF,
5060,GO:0015269,1,0.952476179462427,0,7,calcium-activated potassium channel activity,MF,
5061,GO:0015271,1,0.981594875110526,0,4,outward rectifier potassium channel activity,MF,
5062,GO:0015272,1,0.995366747112218,0,1,ATP-activated inward rectifier potassium channel activity,MF,
5063,GO:0015275,1,0.990755013385102,0,2,stretch-activated, cation-selective, calcium channel activity,MF,
5064,GO:0015276,1,0.812773575090212,0,40,ligand-gated ion channel activity,MF,
5065,GO:0015278,1,0.911963905131918,0,16,calcium-release channel activity,MF,
5066,GO:0015279,1,0.969644810294109,0,5,store-operated calcium channel activity,MF,
5067,GO:0015280,1,0.986164025112791,0,3,ligand-gated sodium channel activity,MF,
5068,GO:0015288,1,0.951519794304438,0,6,porin activity,MF,
5070,GO:0015292,1,0.995366574475227,0,1,uniporter activity,MF,
5072,GO:0015294,1,0.759625656639249,0,53,solute:cation symporter activity,MF,
5073,GO:0015295,1,0.905334204755586,0,18,solute:proton symporter activity,MF,
5074,GO:0015296,1,0.968011005550293,0,7,anion:cation symporter activity,MF,
5078,GO:0015301,1,0.900820550049768,0,18,anion:anion antiporter activity,MF,
5079,GO:0015307,1,0.984661162590556,0,2,drug:proton antiporter activity,MF,
5080,GO:0015315,1,0.985105626422284,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5081,GO:0015317,1,0.990997071763438,0,1,phosphate:proton symporter activity,MF,
5083,GO:0015319,1,0.99075507167731,0,2,sodium:inorganic phosphate symporter activity,MF,
5084,GO:0015321,1,0.99075507167731,0,2,sodium-dependent phosphate transmembrane transporter activity,MF,
5085,GO:0015322,1,0.995366793948851,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
5086,GO:0015327,1,0.995366990825956,0,1,cystine:glutamate antiporter activity,MF,
5087,GO:0015328,1,0.995366990825956,0,1,cystine secondary active transmembrane transporter activity,MF,
5088,GO:0015333,1,0.986163776101062,0,3,peptide:proton symporter activity,MF,
5089,GO:0015347,1,0.957570636084972,0,9,sodium-independent organic anion transmembrane transporter activity,MF,
5090,GO:0015349,1,0.990754573242026,0,2,thyroid hormone transmembrane transporter activity,MF,
5091,GO:0015350,1,0.99075472319709,0,2,methotrexate transmembrane transporter activity,MF,
5092,GO:0015355,1,0.97101564998795,0,4,secondary active monocarboxylate transmembrane transporter activity,MF,
5093,GO:0015362,1,0.995366990826138,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5094,GO:0015367,1,0.992025625849247,0,1,oxoglutarate:malate antiporter activity,MF,
5096,GO:0015369,1,0.995366990826139,0,1,calcium:proton antiporter activity,MF,
5097,GO:0015370,1,0.854987935736989,0,31,solute:sodium symporter activity,MF,
5098,GO:0015373,1,0.990755175551706,0,2,anion:sodium symporter activity,MF,
5099,GO:0015375,1,0.995366841160869,0,1,glycine:sodium symporter activity,MF,
5100,GO:0015377,1,0.972518160754668,0,6,cation:chloride symporter activity,MF,
5101,GO:0015378,1,0.995366990826073,0,1,sodium:chloride symporter activity,MF,
5102,GO:0015379,1,0.972518160754668,0,6,potassium:chloride symporter activity,MF,
5105,GO:0015389,1,0.994742924991196,0,1,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5106,GO:0015390,1,0.994742924991196,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5107,GO:0015391,1,0.994742924991196,0,1,nucleobase:cation symporter activity,MF,
5110,GO:0015410,1,0.986164421717515,0,3,manganese-transporting ATPase activity,MF,
5111,GO:0015420,1,0.995366990826099,0,1,cobalamin-transporting ATPase activity,MF,
5112,GO:0015421,1,0.995366957310922,0,1,oligopeptide-transporting ATPase activity,MF,
5113,GO:0015431,1,0.995366990826099,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5114,GO:0015432,1,0.995366958228449,0,1,bile acid-exporting ATPase activity,MF,
5115,GO:0015433,1,0.990755159493975,0,2,peptide antigen-transporting ATPase activity,MF,
5116,GO:0015439,1,0.995366668922624,0,1,heme-transporting ATPase activity,MF,
5117,GO:0015440,1,0.981594470844527,0,4,peptide-transporting ATPase activity,MF,
5118,GO:0015450,1,0.886102153587309,0,7,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5119,GO:0015459,1,0.86064769357186,0,25,potassium channel regulator activity,MF,
5120,GO:0015464,1,0.964092008084076,0,7,acetylcholine receptor activity,MF,
5121,GO:0015467,1,0.990754338152661,0,2,G-protein activated inward rectifier potassium channel activity,MF,
5122,GO:0015485,1,0.78914960891211,0,30,cholesterol binding,MF,
5123,GO:0015489,1,0.995366574475227,0,1,putrescine transmembrane transporter activity,MF,
5125,GO:0015499,1,0.995354459595608,0,1,formate transmembrane transporter activity,MF,
5126,GO:0015501,1,0.990754109618731,0,2,glutamate:sodium symporter activity,MF,
5127,GO:0015526,1,0.985105626422284,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5128,GO:0015538,1,0.995366889887653,0,1,sialic acid:proton symporter activity,MF,
5129,GO:0015556,1,0.962447232726832,0,7,C4-dicarboxylate transmembrane transporter activity,MF,
5131,GO:0015578,1,0.995226939657047,0,1,mannose transmembrane transporter activity,MF,
5132,GO:0015605,1,0.873528539857183,0,22,organophosphate ester transmembrane transporter activity,MF,
5133,GO:0015616,1,0.981594626384709,0,4,DNA translocase activity,MF,
5137,GO:0015643,1,0.96108491367939,0,7,toxic substance binding,MF,
5138,GO:0015645,1,0.953755423868033,0,10,fatty acid ligase activity,MF,
5139,GO:0015651,1,0.969078594555494,0,6,quaternary ammonium group transmembrane transporter activity,MF,
5140,GO:0015658,1,0.995366330720897,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5141,GO:0015660,1,0.995354459595608,0,1,formate efflux transmembrane transporter activity,MF,
5142,GO:0015662,1,0.879472481392131,0,22,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,
5143,GO:0015669,1,0.979463036851953,0,3,gas transport,BP,
5144,GO:0015670,1,0.990822292232329,0,1,carbon dioxide transport,BP,
5145,GO:0015671,1,0.988536735234692,0,2,oxygen transport,BP,
5147,GO:0015677,1,0.954028836326667,0,8,copper ion import,BP,
5148,GO:0015679,1,0.990755199849136,0,2,plasma membrane copper ion transport,BP,
5149,GO:0015680,1,0.943957753075916,0,3,intracellular copper ion transport,BP,
5150,GO:0015682,1,0.75051384639467,0,32,ferric iron transport,BP,
5151,GO:0015684,1,0.99075519984928,0,2,ferrous iron transport,BP,
5152,GO:0015688,1,0.970315133944793,0,2,iron chelate transport,BP,
5153,GO:0015689,1,0.993047243179903,0,1,molybdate ion transport,BP,
5154,GO:0015691,1,0.984636275228886,0,3,cadmium ion transport,BP,
5155,GO:0015692,1,0.995366990826139,0,1,lead ion transport,BP,
5156,GO:0015693,1,0.910570644992814,0,17,magnesium ion transport,BP,
5157,GO:0015694,1,0.995366990826164,0,1,mercury ion transport,BP,
5158,GO:0015695,1,0.85958066118269,0,28,organic cation transport,BP,
5160,GO:0015697,1,0.954661422210778,0,9,quaternary ammonium group transport,BP,
5162,GO:0015700,1,0.98504781901311,0,1,arsenite transport,BP,
5163,GO:0015701,1,0.898112354001917,0,19,bicarbonate transport,BP,
5164,GO:0015705,1,0.981594864657992,0,4,iodide transport,BP,
5165,GO:0015706,1,0.995353883872325,0,1,nitrate transport,BP,
5166,GO:0015709,1,0.992982056220991,0,1,thiosulfate transport,BP,
5168,GO:0015712,1,0.97569440502641,0,4,hexose phosphate transport,BP,
5169,GO:0015718,1,0.595879819981688,0,87,monocarboxylic acid transport,BP,
5170,GO:0015721,1,0.91531560267118,0,13,bile acid and bile salt transport,BP,
5171,GO:0015722,1,0.986164211793717,0,3,canalicular bile acid transport,BP,
5172,GO:0015723,1,0.995366990826164,0,1,bilirubin transport,BP,
5173,GO:0015724,1,0.995354459595608,0,1,formate transport,BP,
5174,GO:0015727,1,0.980179693131654,0,4,lactate transport,BP,
5175,GO:0015728,1,0.995366990826138,0,1,mevalonate transport,BP,
5176,GO:0015729,1,0.992982056220991,0,1,oxaloacetate transport,BP,
5177,GO:0015732,1,0.929501154936261,0,8,prostaglandin transport,BP,
5178,GO:0015734,1,0.995366990826086,0,1,taurine transport,BP,
5179,GO:0015739,1,0.995366889887653,0,1,sialic acid transport,BP,
5180,GO:0015740,1,0.956758892986479,0,9,C4-dicarboxylate transport,BP,
5181,GO:0015742,1,0.992025625849247,0,1,alpha-ketoglutarate transport,BP,
5182,GO:0015743,1,0.992982056220991,0,1,malate transport,BP,
5183,GO:0015744,1,0.983801244923613,0,3,succinate transport,BP,
5184,GO:0015746,1,0.976318948512465,0,4,citrate transport,BP,
5185,GO:0015747,1,0.988160936427782,0,2,urate transport,BP,
5186,GO:0015748,1,0.635539719659346,0,67,organophosphate ester transport,BP,
5188,GO:0015760,1,0.97569440502641,0,4,glucose-6-phosphate transport,BP,
5189,GO:0015761,1,0.995226939657047,0,1,mannose transmembrane transport,BP,
5190,GO:0015766,1,0.990755046992583,0,2,disaccharide transport,BP,
5191,GO:0015770,1,0.990755046992583,0,2,sucrose transport,BP,
5192,GO:0015772,1,0.990755046992583,0,2,oligosaccharide transport,BP,
5193,GO:0015780,1,0.921905705630108,0,12,nucleotide-sugar transmembrane transport,BP,
5194,GO:0015782,1,0.992344262488714,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
5195,GO:0015783,1,0.99075504581397,0,2,GDP-fucose transmembrane transport,BP,
5196,GO:0015786,1,0.994880289539658,0,1,UDP-glucose transmembrane transport,BP,
5197,GO:0015787,1,0.9953669908261,0,1,UDP-glucuronic acid transmembrane transport,BP,
5198,GO:0015790,1,0.995366990826074,0,1,UDP-xylose transmembrane transport,BP,
5199,GO:0015791,1,0.969613240701883,0,6,polyol transport,BP,
5200,GO:0015793,1,0.9878087278569,0,2,glycerol transport,BP,
5201,GO:0015797,1,0.995354459595608,0,1,mannitol transport,BP,
5202,GO:0015798,1,0.986164531023128,0,3,myo-inositol transport,BP,
5203,GO:0015800,1,0.838375033976517,0,31,acidic amino acid transport,BP,
5204,GO:0015801,1,0.990130813067836,0,2,aromatic amino acid transport,BP,
5205,GO:0015802,1,0.946248235999459,0,9,basic amino acid transport,BP,
5206,GO:0015803,1,0.985665491449322,0,3,branched-chain amino acid transport,BP,
5207,GO:0015804,1,0.855421193002423,0,26,neutral amino acid transport,BP,
5208,GO:0015805,1,0.994758631763274,0,1,S-adenosyl-L-methionine transport,BP,
5209,GO:0015807,1,0.772256127190311,0,43,L-amino acid transport,BP,
5210,GO:0015808,1,0.976923392602681,0,5,L-alanine transport,BP,
5211,GO:0015809,1,0.960371974059122,0,6,arginine transport,BP,
5212,GO:0015810,1,0.990755040644171,0,2,aspartate transmembrane transport,BP,
5213,GO:0015811,1,0.990755199849267,0,2,L-cystine transport,BP,
5214,GO:0015812,1,0.970912833411612,0,6,gamma-aminobutyric acid transport,BP,
5215,GO:0015813,1,0.929822805655754,0,13,L-glutamate transmembrane transport,BP,
5216,GO:0015816,1,0.969963710949771,0,6,glycine transport,BP,
5217,GO:0015817,1,0.995366425817292,0,1,histidine transport,BP,
5218,GO:0015819,1,0.992966543040724,0,1,lysine transport,BP,
5219,GO:0015820,1,0.990254520676882,0,2,leucine transport,BP,
5220,GO:0015821,1,0.995366330720897,0,1,methionine transport,BP,
5221,GO:0015822,1,0.981328510625889,0,4,ornithine transport,BP,
5222,GO:0015824,1,0.972396725791282,0,6,proline transport,BP,
5223,GO:0015825,1,0.961636370683131,0,7,L-serine transport,BP,
5224,GO:0015826,1,0.995366990826152,0,1,threonine transport,BP,
5225,GO:0015827,1,0.990130813067836,0,2,tryptophan transport,BP,
5228,GO:0015838,1,0.963834873059287,0,7,amino-acid betaine transport,BP,
5229,GO:0015840,1,0.983231555433434,0,3,urea transport,BP,
5230,GO:0015842,1,0.986247117136137,0,2,aminergic neurotransmitter loading into synaptic vesicle,BP,
5232,GO:0015846,1,0.957366125766767,0,6,polyamine transport,BP,
5233,GO:0015847,1,0.995366574475227,0,1,putrescine transport,BP,
5234,GO:0015849,1,0.349588797444463,0,176,organic acid transport,BP,
5236,GO:0015851,1,0.944275263043944,0,7,nucleobase transport,BP,
5237,GO:0015853,1,0.958130966194615,0,4,adenine transport,BP,
5238,GO:0015855,1,0.990133704303109,0,2,pyrimidine nucleobase transport,BP,
5239,GO:0015858,1,0.970780444998013,0,6,nucleoside transport,BP,
5240,GO:0015860,1,0.990017653996545,0,2,purine nucleoside transmembrane transport,BP,
5241,GO:0015862,1,0.995026315780825,0,1,uridine transport,BP,
5242,GO:0015864,1,0.989795087895744,0,2,pyrimidine nucleoside transport,BP,
5243,GO:0015865,1,0.927422030679828,0,12,purine nucleotide transport,BP,
5244,GO:0015866,1,0.942965545906914,0,9,ADP transport,BP,
5245,GO:0015867,1,0.943020825221884,0,9,ATP transport,BP,
5246,GO:0015868,1,0.927422030679828,0,12,purine ribonucleotide transport,BP,
5247,GO:0015870,1,0.995352427354762,0,1,acetylcholine transport,BP,
5248,GO:0015871,1,0.967740188099281,0,7,choline transport,BP,
5250,GO:0015874,1,0.975996770515541,0,5,norepinephrine transport,BP,
5251,GO:0015876,1,0.995355450952031,0,1,acetyl-CoA transport,BP,
5252,GO:0015878,1,0.995366883536079,0,1,biotin transport,BP,
5253,GO:0015879,1,0.972831348167736,0,5,carnitine transport,BP,
5254,GO:0015880,1,0.985610701784583,0,3,coenzyme A transport,BP,
5255,GO:0015881,1,0.995366958730868,0,1,creatine transmembrane transport,BP,
5256,GO:0015882,1,0.995366990826073,0,1,L-ascorbic acid transmembrane transport,BP,
5257,GO:0015884,1,0.958104716255435,0,5,folic acid transport,BP,
5258,GO:0015886,1,0.967795628045315,0,7,heme transport,BP,
5259,GO:0015887,1,0.995366883536079,0,1,pantothenate transmembrane transport,BP,
5260,GO:0015888,1,0.990754769589111,0,2,thiamine transport,BP,
5261,GO:0015889,1,0.97872128464155,0,2,cobalamin transport,BP,
5262,GO:0015891,1,0.970315133944793,0,2,siderophore transport,BP,
5264,GO:0015904,1,0.992771026591583,0,1,tetracycline transport,BP,
5265,GO:0015908,1,0.733945913924099,0,52,fatty acid transport,BP,
5266,GO:0015909,1,0.79561859255444,0,37,long-chain fatty acid transport,BP,
5267,GO:0015910,1,0.990350085896595,0,2,peroxisomal long-chain fatty acid import,BP,
5268,GO:0015911,1,0.97678587904784,0,5,plasma membrane long-chain fatty acid transport,BP,
5269,GO:0015914,1,0.728141570871738,0,46,phospholipid transport,BP,
5270,GO:0015916,1,0.995355450952031,0,1,fatty-acyl-CoA transport,BP,
5271,GO:0015917,1,0.981594888733454,0,4,aminophospholipid transport,BP,
5272,GO:0015918,1,0.665040358108597,0,55,sterol transport,BP,
5273,GO:0015919,1,0.916051977031982,0,16,peroxisomal membrane transport,BP,
5274,GO:0015920,1,0.995359826602095,0,1,lipopolysaccharide transport,BP,
5275,GO:0015923,1,0.934989921645532,0,14,mannosidase activity,MF,
5276,GO:0015924,1,0.956967340478066,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5277,GO:0015925,1,0.964532424055908,0,6,galactosidase activity,MF,
5278,GO:0015926,1,0.963522412456626,0,8,glucosidase activity,MF,
5279,GO:0015928,1,0.988627667282334,0,2,fucosidase activity,MF,
5280,GO:0015929,1,0.938124155635025,0,12,hexosaminidase activity,MF,
5281,GO:0015931,1,0.231563492115657,0,208,nucleobase-containing compound transport,BP,
5282,GO:0015932,1,0.808795672911334,0,33,nucleobase-containing compound transmembrane transporter activity,MF,
5285,GO:0015936,1,0.896146055956358,0,15,coenzyme A metabolic process,BP,
5286,GO:0015937,1,0.931883613537623,0,10,coenzyme A biosynthetic process,BP,
5287,GO:0015938,1,0.979716819340251,0,1,coenzyme A catabolic process,BP,
5288,GO:0015939,1,0.962893169796558,0,5,pantothenate metabolic process,BP,
5289,GO:0015942,1,0.967874582950149,0,3,formate metabolic process,BP,
5290,GO:0015949,1,0.743298334883087,0,27,nucleobase-containing small molecule interconversion,BP,
5291,GO:0015950,1,0.992919600986792,0,1,purine nucleotide interconversion,BP,
5292,GO:0015951,1,0.992919600986792,0,1,purine ribonucleotide interconversion,BP,
5293,GO:0015959,1,0.956223034056562,0,7,diadenosine polyphosphate metabolic process,BP,
5294,GO:0015960,1,0.985120440910021,0,3,diadenosine polyphosphate biosynthetic process,BP,
5295,GO:0015961,1,0.970671105713102,0,4,diadenosine polyphosphate catabolic process,BP,
5296,GO:0015965,1,0.985120440910021,0,3,diadenosine tetraphosphate metabolic process,BP,
5297,GO:0015966,1,0.985120440910021,0,3,diadenosine tetraphosphate biosynthetic process,BP,
5299,GO:0015985,1,0.908492078587656,0,8,energy coupled proton transport, down electrochemical gradient,BP,
5300,GO:0015986,1,0.908492078587656,0,8,ATP synthesis coupled proton transport,BP,
5301,GO:0015988,1,0.794018619045771,0,21,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5302,GO:0015990,1,0.974769508101221,0,1,electron transport coupled proton transport,BP,
5303,GO:0015991,1,0.814619582745799,0,20,ATP hydrolysis coupled proton transport,BP,
5304,GO:0016004,1,0.942688557455344,0,8,phospholipase activator activity,MF,
5305,GO:0016005,1,0.990720977373619,0,2,phospholipase A2 activator activity,MF,
5306,GO:0016010,1,0.931868713201262,0,12,dystrophin-associated glycoprotein complex,CC,
5307,GO:0016011,1,0.982179405298721,0,3,dystroglycan complex,CC,
5308,GO:0016012,1,0.986751736027584,0,2,sarcoglycan complex,CC,
5309,GO:0016013,1,0.990440727092653,0,2,syntrophin complex,CC,
5310,GO:0016015,1,0.985503830957101,0,2,morphogen activity,MF,
5311,GO:0016018,1,0.911619070981163,0,10,cyclosporin A binding,MF,
5312,GO:0016019,1,0.975701813833231,0,2,peptidoglycan receptor activity,MF,
5315,GO:0016024,1,0.93401149180175,0,13,CDP-diacylglycerol biosynthetic process,BP,
5316,GO:0016031,1,0.995366914937935,0,1,tRNA import into mitochondrion,BP,
5318,GO:0016034,1,0.986011881134435,0,1,maleylacetoacetate isomerase activity,MF,
5319,GO:0016035,1,0.97777291310185,0,2,zeta DNA polymerase complex,CC,
5320,GO:0016036,1,0.994878946369531,0,1,cellular response to phosphate starvation,BP,
5321,GO:0016042,1,0.239408005566638,0,201,lipid catabolic process,BP,
5323,GO:0016045,1,0.953299392173003,0,7,detection of bacterium,BP,
5324,GO:0016048,1,0.949709237887156,0,7,detection of temperature stimulus,BP,
5326,GO:0016050,1,0.117952114387408,0,319,vesicle organization,BP,
5330,GO:0016054,1,0.257066755665019,0,190,organic acid catabolic process,BP,
5332,GO:0016056,1,0.935827779210086,0,13,rhodopsin mediated signaling pathway,BP,
5333,GO:0016062,1,0.995320516658041,0,1,adaptation of rhodopsin mediated signaling,BP,
5334,GO:0016064,1,0.692171623069803,0,58,immunoglobulin mediated immune response,BP,
5338,GO:0016073,1,0.461039882280612,0,84,snRNA metabolic process,BP,
5340,GO:0016075,1,0.859553829131378,0,15,rRNA catabolic process,BP,
5341,GO:0016077,1,0.995366990826113,0,1,snoRNA catabolic process,BP,
5342,GO:0016078,1,0.934236361999706,0,6,tRNA catabolic process,BP,
5343,GO:0016079,1,0.747908002580777,0,50,synaptic vesicle exocytosis,BP,
5344,GO:0016080,1,0.986164496992487,0,3,synaptic vesicle targeting,BP,
5345,GO:0016081,1,0.971473340568711,0,6,synaptic vesicle docking,BP,
5346,GO:0016082,1,0.945738000530238,0,11,synaptic vesicle priming,BP,
5347,GO:0016093,1,0.951262497211093,0,6,polyprenol metabolic process,BP,
5348,GO:0016094,1,0.986152988082272,0,3,polyprenol biosynthetic process,BP,
5349,GO:0016095,1,0.995355450952031,0,1,polyprenol catabolic process,BP,
5350,GO:0016098,1,0.995366784419756,0,1,monoterpenoid metabolic process,BP,
5351,GO:0016101,1,0.733711593342552,0,48,diterpenoid metabolic process,BP,
5352,GO:0016102,1,0.959226303214666,0,5,diterpenoid biosynthetic process,BP,
5353,GO:0016103,1,0.995366990826164,0,1,diterpenoid catabolic process,BP,
5354,GO:0016114,1,0.939324860939067,0,8,terpenoid biosynthetic process,BP,
5355,GO:0016115,1,0.995366990826164,0,1,terpenoid catabolic process,BP,
5356,GO:0016125,1,0.464035467045282,0,110,sterol metabolic process,BP,
5357,GO:0016126,1,0.643178720952833,0,64,sterol biosynthetic process,BP,
5358,GO:0016127,1,0.968185840085161,0,4,sterol catabolic process,BP,
5359,GO:0016128,1,0.984177587665972,0,3,phytosteroid metabolic process,BP,
5360,GO:0016129,1,0.984177587665972,0,3,phytosteroid biosynthetic process,BP,
5361,GO:0016131,1,0.995354459595608,0,1,brassinosteroid metabolic process,BP,
5362,GO:0016132,1,0.995354459595608,0,1,brassinosteroid biosynthetic process,BP,
5363,GO:0016137,1,0.899337169931297,0,13,glycoside metabolic process,BP,
5364,GO:0016139,1,0.957951493629495,0,7,glycoside catabolic process,BP,
5365,GO:0016149,1,0.995366980158686,0,1,translation release factor activity, codon specific,MF,
5366,GO:0016150,1,0.990222969763118,0,1,translation release factor activity, codon nonspecific,MF,
5367,GO:0016154,1,0.990739321890347,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
5368,GO:0016155,1,0.995366990826045,0,1,formyltetrahydrofolate dehydrogenase activity,MF,
5369,GO:0016160,1,0.990002702667537,0,2,amylase activity,MF,
5370,GO:0016165,1,0.990464429696304,0,2,linoleate 13S-lipoxygenase activity,MF,
5371,GO:0016174,1,0.980423369126804,0,4,NAD(P)H oxidase activity,MF,
5372,GO:0016175,1,0.967590751472488,0,2,superoxide-generating NADPH oxidase activity,MF,
5373,GO:0016176,1,0.964141068121231,0,5,superoxide-generating NADPH oxidase activator activity,MF,
5374,GO:0016180,1,0.830001821921961,0,22,snRNA processing,BP,
5375,GO:0016182,1,0.995366990826165,0,1,synaptic vesicle budding from endosome,BP,
5376,GO:0016185,1,0.981594330553606,0,4,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
5377,GO:0016188,1,0.962135014906618,0,5,synaptic vesicle maturation,BP,
5378,GO:0016189,1,0.99536699082602,0,1,synaptic vesicle to endosome fusion,BP,
5379,GO:0016191,1,0.981447335220154,0,4,synaptic vesicle uncoating,BP,
5381,GO:0016197,1,0.314215901186893,0,175,endosomal transport,BP,
5382,GO:0016198,1,0.977045982621535,0,5,axon choice point recognition,BP,
5383,GO:0016199,1,0.981594841941891,0,4,axon midline choice point recognition,BP,
5385,GO:0016206,1,0.990269130155397,0,2,catechol O-methyltransferase activity,MF,
5386,GO:0016208,1,0.914791075747062,0,9,AMP binding,MF,
5387,GO:0016209,1,0.498070990836941,0,53,antioxidant activity,MF,
5388,GO:0016211,1,0.995366990826152,0,1,ammonia ligase activity,MF,
5389,GO:0016212,1,0.989995873772845,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5390,GO:0016213,1,0.995366802530454,0,1,linoleoyl-CoA desaturase activity,MF,
5391,GO:0016215,1,0.986130502895375,0,3,acyl-CoA desaturase activity,MF,
5392,GO:0016222,1,0.990717736856032,0,2,procollagen-proline 4-dioxygenase complex,CC,
5393,GO:0016226,1,0.787663635849271,0,20,iron-sulfur cluster assembly,BP,
5394,GO:0016229,1,0.834008105529086,0,19,steroid dehydrogenase activity,MF,
5395,GO:0016230,1,0.982327190425719,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5396,GO:0016231,1,0.995366990826151,0,1,beta-N-acetylglucosaminidase activity,MF,
5397,GO:0016232,1,0.995366483568691,0,1,HNK-1 sulfotransferase activity,MF,
5399,GO:0016234,1,0.683299939747247,0,68,inclusion body,CC,
5400,GO:0016235,1,0.838046240707535,0,34,aggresome,CC,
5401,GO:0016236,1,0.146429578453445,0,270,macroautophagy,BP,
5402,GO:0016237,1,0.995366990826165,0,1,lysosomal microautophagy,BP,
5403,GO:0016239,1,0.709303267339737,0,58,positive regulation of macroautophagy,BP,
5404,GO:0016240,1,0.960152205529464,0,4,autophagosome membrane docking,BP,
5405,GO:0016241,1,0.377693434935965,0,151,regulation of macroautophagy,BP,
5406,GO:0016242,1,0.848329084782737,0,29,negative regulation of macroautophagy,BP,
5407,GO:0016243,1,0.99536699082396,0,1,regulation of autophagosome size,BP,
5408,GO:0016246,1,0.885175800975212,0,15,RNA interference,BP,
5410,GO:0016248,1,0.800725401623013,0,25,channel inhibitor activity,MF,
5411,GO:0016250,1,0.995366168694732,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5413,GO:0016255,1,0.956060123368365,0,7,attachment of GPI anchor to protein,BP,
5414,GO:0016256,1,0.979887801530949,0,2,N-glycan processing to lysosome,BP,
5415,GO:0016259,1,0.978796022913773,0,4,selenocysteine metabolic process,BP,
5416,GO:0016260,1,0.9902195563411,0,2,selenocysteine biosynthetic process,BP,
5417,GO:0016262,1,0.983652260281498,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5418,GO:0016263,1,0.985658787121323,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5419,GO:0016264,1,0.967662064553203,0,7,gap junction assembly,BP,
5421,GO:0016267,1,0.985658787121323,0,2,O-glycan processing, core 1,BP,
5422,GO:0016269,1,0.995266759510814,0,1,O-glycan processing, core 3,BP,
5423,GO:0016272,1,0.86864827709175,0,7,prefoldin complex,CC,
5424,GO:0016273,1,0.941323912528098,0,11,arginine N-methyltransferase activity,MF,
5425,GO:0016274,1,0.941323912528098,0,11,protein-arginine N-methyltransferase activity,MF,
5426,GO:0016277,1,0.995158529651144,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5427,GO:0016278,1,0.755869746047481,0,48,lysine N-methyltransferase activity,MF,
5428,GO:0016279,1,0.759399522459326,0,47,protein-lysine N-methyltransferase activity,MF,
5429,GO:0016281,1,0.932126467938923,0,9,eukaryotic translation initiation factor 4F complex,CC,
5430,GO:0016282,1,0.995366990826164,0,1,eukaryotic 43S preinitiation complex,CC,
5431,GO:0016286,1,0.995280530105183,0,1,small conductance calcium-activated potassium channel activity,MF,
5432,GO:0016287,1,0.995360699477738,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5433,GO:0016289,1,0.894462223639788,0,13,CoA hydrolase activity,MF,
5434,GO:0016290,1,0.940223015263847,0,7,palmitoyl-CoA hydrolase activity,MF,
5435,GO:0016295,1,0.987212508658475,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5436,GO:0016296,1,0.987212508658475,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5437,GO:0016297,1,0.987212508658475,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
5438,GO:0016298,1,0.653015273892746,0,75,lipase activity,MF,
5439,GO:0016300,1,0.986163936060765,0,3,tRNA (uracil) methyltransferase activity,MF,
5441,GO:0016303,1,0.886193535125631,0,26,1-phosphatidylinositol-3-kinase activity,MF,
5442,GO:0016307,1,0.920042839115095,0,14,phosphatidylinositol phosphate kinase activity,MF,
5443,GO:0016308,1,0.963198821047467,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5444,GO:0016309,1,0.98616432083291,0,3,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5447,GO:0016312,1,0.980470054616539,0,4,inositol bisphosphate phosphatase activity,MF,
5448,GO:0016314,1,0.99075519984928,0,2,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5449,GO:0016316,1,0.990755199849188,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5450,GO:0016320,1,0.980259433061035,0,2,endoplasmic reticulum membrane fusion,BP,
5451,GO:0016321,1,0.985255853376096,0,3,female meiosis chromosome segregation,BP,
5452,GO:0016322,1,0.971699290918409,0,6,neuron remodeling,BP,
5455,GO:0016327,1,0.922869299290779,0,13,apicolateral plasma membrane,CC,
5456,GO:0016328,1,0.760747940778575,0,45,lateral plasma membrane,CC,
5458,GO:0016332,1,0.995366990404888,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
5459,GO:0016333,1,0.995366624735375,0,1,morphogenesis of follicular epithelium,BP,
5460,GO:0016334,1,0.995366624735375,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5461,GO:0016338,1,0.922341057502604,0,9,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,
5463,GO:0016340,1,0.990755199849162,0,2,calcium-dependent cell-matrix adhesion,BP,
5465,GO:0016344,1,0.990752076932555,0,2,meiotic chromosome movement towards spindle pole,BP,
5467,GO:0016361,1,0.987476769604087,0,2,activin receptor activity, type I,MF,
5468,GO:0016362,1,0.990755199848718,0,2,activin receptor activity, type II,MF,
5469,GO:0016363,1,0.570753231413772,0,94,nuclear matrix,CC,
5470,GO:0016401,1,0.98784444996805,0,2,palmitoyl-CoA oxidase activity,MF,
5471,GO:0016402,1,0.995366526967352,0,1,pristanoyl-CoA oxidase activity,MF,
5472,GO:0016403,1,0.981340295845501,0,2,dimethylargininase activity,MF,
5473,GO:0016404,1,0.995366990826164,0,1,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5474,GO:0016405,1,0.935681064976805,0,14,CoA-ligase activity,MF,
5475,GO:0016406,1,0.972511173045854,0,6,carnitine O-acyltransferase activity,MF,
5476,GO:0016407,1,0.535106279759637,0,88,acetyltransferase activity,MF,
5477,GO:0016408,1,0.914588930695002,0,13,C-acyltransferase activity,MF,
5478,GO:0016409,1,0.816496374107264,0,33,palmitoyltransferase activity,MF,
5479,GO:0016410,1,0.581803264092786,0,80,N-acyltransferase activity,MF,
5480,GO:0016411,1,0.885591657649999,0,23,acylglycerol O-acyltransferase activity,MF,
5481,GO:0016413,1,0.970372072505511,0,6,O-acetyltransferase activity,MF,
5482,GO:0016414,1,0.995366858317226,0,1,O-octanoyltransferase activity,MF,
5483,GO:0016415,1,0.995366858317226,0,1,octanoyltransferase activity,MF,
5484,GO:0016416,1,0.981588314934211,0,4,O-palmitoyltransferase activity,MF,
5485,GO:0016417,1,0.840051847187848,0,27,S-acyltransferase activity,MF,
5486,GO:0016418,1,0.990755199849124,0,2,S-acetyltransferase activity,MF,
5487,GO:0016419,1,0.98880402311274,0,2,S-malonyltransferase activity,MF,
5488,GO:0016420,1,0.98880402311274,0,2,malonyltransferase activity,MF,
5489,GO:0016421,1,0.96947585895347,0,6,CoA carboxylase activity,MF,
5490,GO:0016422,1,0.983259390368524,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5491,GO:0016423,1,0.923085624629699,0,13,tRNA (guanine) methyltransferase activity,MF,
5492,GO:0016426,1,0.97886431332423,0,4,tRNA (adenine) methyltransferase activity,MF,
5493,GO:0016427,1,0.953253481235556,0,8,tRNA (cytosine) methyltransferase activity,MF,
5494,GO:0016428,1,0.973790314301262,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5495,GO:0016429,1,0.983421801328675,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
5496,GO:0016430,1,0.995366574475227,0,1,tRNA (adenine-N6-)-methyltransferase activity,MF,
5497,GO:0016433,1,0.95662138514626,0,6,rRNA (adenine) methyltransferase activity,MF,
5498,GO:0016434,1,0.986159811438356,0,3,rRNA (cytosine) methyltransferase activity,MF,
5499,GO:0016435,1,0.953565982258722,0,4,rRNA (guanine) methyltransferase activity,MF,
5500,GO:0016436,1,0.990754897163918,0,2,rRNA (uridine) methyltransferase activity,MF,
5502,GO:0016442,1,0.942982592313624,0,11,RISC complex,CC,
5503,GO:0016444,1,0.768711868621299,0,45,somatic cell DNA recombination,BP,
5504,GO:0016445,1,0.772526471756349,0,45,somatic diversification of immunoglobulins,BP,
5505,GO:0016446,1,0.92564215311775,0,14,somatic hypermutation of immunoglobulin genes,BP,
5506,GO:0016447,1,0.803771961099179,0,37,somatic recombination of immunoglobulin gene segments,BP,
5507,GO:0016453,1,0.969263912318684,0,4,C-acetyltransferase activity,MF,
5508,GO:0016454,1,0.974623127353639,0,5,C-palmitoyltransferase activity,MF,
5510,GO:0016459,1,0.776239753456706,0,35,myosin complex,CC,
5511,GO:0016460,1,0.89594280461433,0,13,myosin II complex,CC,
5512,GO:0016461,1,0.922869363258267,0,7,unconventional myosin complex,CC,
5514,GO:0016469,1,0.774704306299042,0,24,proton-transporting two-sector ATPase complex,CC,
5515,GO:0016471,1,0.906755438826141,0,11,vacuolar proton-transporting V-type ATPase complex,CC,
5516,GO:0016476,1,0.986091149655823,0,3,regulation of embryonic cell shape,BP,
5518,GO:0016479,1,0.983283828112682,0,3,negative regulation of transcription by RNA polymerase I,BP,
5519,GO:0016480,1,0.961639630930975,0,3,negative regulation of transcription by RNA polymerase III,BP,
5520,GO:0016482,1,0.441730210227992,0,131,cytosolic transport,BP,
5521,GO:0016485,1,0.327472499817052,0,153,protein processing,BP,
5522,GO:0016486,1,0.891088206497353,0,17,peptide hormone processing,BP,
5524,GO:0016492,1,0.995366990826138,0,1,G-protein coupled neurotensin receptor activity,MF,
5525,GO:0016493,1,0.989713959852849,0,2,C-C chemokine receptor activity,MF,
5526,GO:0016494,1,0.986052823532223,0,3,C-X-C chemokine receptor activity,MF,
5527,GO:0016500,1,0.971583071962708,0,6,protein-hormone receptor activity,MF,
5528,GO:0016502,1,0.96295070366992,0,6,nucleotide receptor activity,MF,
5529,GO:0016503,1,0.985473658520872,0,1,pheromone receptor activity,MF,
5530,GO:0016504,1,0.754809755138548,0,32,peptidase activator activity,MF,
5531,GO:0016505,1,0.861509077357347,0,16,peptidase activator activity involved in apoptotic process,MF,
5532,GO:0016507,1,0.995366725657291,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5533,GO:0016508,1,0.986158170305729,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5534,GO:0016509,1,0.985403502597504,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5535,GO:0016514,1,0.930710214051492,0,13,SWI/SNF complex,CC,
5536,GO:0016517,1,0.993653808561672,0,1,interleukin-12 receptor activity,MF,
5537,GO:0016519,1,0.993926676033175,0,1,gastric inhibitory peptide receptor activity,MF,
5538,GO:0016520,1,0.995366990826165,0,1,growth hormone-releasing hormone receptor activity,MF,
5539,GO:0016524,1,0.990754370961523,0,2,latrotoxin receptor activity,MF,
5540,GO:0016525,1,0.71300049359369,0,61,negative regulation of angiogenesis,BP,
5541,GO:0016528,1,0.756533134567018,0,43,sarcoplasm,CC,
5542,GO:0016529,1,0.784023956550795,0,37,sarcoplasmic reticulum,CC,
5543,GO:0016530,1,0.887536273501233,0,6,metallochaperone activity,MF,
5544,GO:0016531,1,0.891672834950977,0,5,copper chaperone activity,MF,
5545,GO:0016532,1,0.954224176842241,0,3,superoxide dismutase copper chaperone activity,MF,
5546,GO:0016533,1,0.977988314407118,0,2,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
5547,GO:0016534,1,0.995366989296734,0,1,cyclin-dependent protein kinase 5 activator activity,MF,
5548,GO:0016538,1,0.780539439291941,0,28,cyclin-dependent protein serine/threonine kinase regulator activity,MF,
5549,GO:0016540,1,0.943741390294351,0,9,protein autoprocessing,BP,
5550,GO:0016553,1,0.928086998654144,0,11,base conversion or substitution editing,BP,
5551,GO:0016554,1,0.951705067201418,0,6,cytidine to uridine editing,BP,
5552,GO:0016556,1,0.915848999300172,0,15,mRNA modification,BP,
5553,GO:0016557,1,0.970894737259929,0,3,peroxisome membrane biogenesis,BP,
5554,GO:0016558,1,0.933242643498575,0,12,protein import into peroxisome matrix,BP,
5555,GO:0016559,1,0.916518680832827,0,7,peroxisome fission,BP,
5556,GO:0016560,1,0.979520734676563,0,4,protein import into peroxisome matrix, docking,BP,
5557,GO:0016561,1,0.988662068486678,0,2,protein import into peroxisome matrix, translocation,BP,
5562,GO:0016572,1,0.844699055584762,0,29,histone phosphorylation,BP,
5564,GO:0016574,1,0.773733409103158,0,45,histone ubiquitination,BP,
5565,GO:0016575,1,0.626920207826597,0,80,histone deacetylation,BP,
5566,GO:0016576,1,0.983627960767198,0,3,histone dephosphorylation,BP,
5567,GO:0016577,1,0.882024897192243,0,27,histone demethylation,BP,
5568,GO:0016578,1,0.860862693862461,0,21,histone deubiquitination,BP,
5573,GO:0016586,1,0.990755199849175,0,2,RSC-type complex,CC,
5574,GO:0016589,1,0.9468362938377,0,7,NURF complex,CC,
5575,GO:0016590,1,0.995366990826113,0,1,ACF complex,CC,
5576,GO:0016591,1,0.4237171054162,0,103,DNA-directed RNA polymerase II, holoenzyme,CC,
5577,GO:0016592,1,0.746363911487721,0,35,mediator complex,CC,
5578,GO:0016593,1,0.950209837503646,0,8,Cdc73/Paf1 complex,CC,
5579,GO:0016594,1,0.979258511506429,0,4,glycine binding,MF,
5580,GO:0016595,1,0.972259206545176,0,6,glutamate binding,MF,
5581,GO:0016596,1,0.995366574475227,0,1,thienylcyclohexylpiperidine binding,MF,
5582,GO:0016597,1,0.817590684989641,0,33,amino acid binding,MF,
5583,GO:0016598,1,0.987278187736184,0,2,protein arginylation,BP,
5584,GO:0016600,1,0.960769698722194,0,8,flotillin complex,CC,
5585,GO:0016601,1,0.806405377141219,0,34,Rac protein signal transduction,BP,
5586,GO:0016602,1,0.96712381873067,0,4,CCAAT-binding factor complex,CC,
5587,GO:0016603,1,0.985816946075487,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5590,GO:0016607,1,0.101164456959535,0,340,nuclear speck,CC,
5591,GO:0016614,1,0.449616918932389,0,93,oxidoreductase activity, acting on CH-OH group of donors,MF,
5592,GO:0016615,1,0.95070149249619,0,6,malate dehydrogenase activity,MF,
5593,GO:0016616,1,0.48592521017119,0,83,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
5594,GO:0016618,1,0.974920202356939,0,3,hydroxypyruvate reductase activity,MF,
5595,GO:0016620,1,0.869009771972951,0,26,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,
5596,GO:0016623,1,0.995366990826165,0,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
5597,GO:0016624,1,0.944954731745515,0,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
5598,GO:0016627,1,0.689969545392693,0,49,oxidoreductase activity, acting on the CH-CH group of donors,MF,
5599,GO:0016628,1,0.82197167771877,0,21,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,
5600,GO:0016634,1,0.965975013101122,0,6,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
5601,GO:0016635,1,0.949891866123199,0,6,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
5602,GO:0016638,1,0.945105550992506,0,12,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,
5603,GO:0016639,1,0.995366945430975,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
5604,GO:0016641,1,0.953929260722723,0,10,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,
5605,GO:0016642,1,0.995366988609227,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
5606,GO:0016645,1,0.868545576814681,0,19,oxidoreductase activity, acting on the CH-NH group of donors,MF,
5607,GO:0016646,1,0.894701322769087,0,14,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,
5608,GO:0016647,1,0.985347032142105,0,2,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
5609,GO:0016649,1,0.990462101855826,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
5610,GO:0016651,1,0.27475876509276,0,83,oxidoreductase activity, acting on NAD(P)H,MF,
5611,GO:0016652,1,0.995366990826165,0,1,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
5612,GO:0016653,1,0.931788706533894,0,12,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,
5613,GO:0016655,1,0.360622862163398,0,49,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,
5614,GO:0016657,1,0.992919600986792,0,1,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
5615,GO:0016661,1,0.964260771041857,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
5616,GO:0016662,1,0.995337765554784,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
5617,GO:0016667,1,0.620327507040564,0,50,oxidoreductase activity, acting on a sulfur group of donors,MF,
5618,GO:0016668,1,0.907275880085709,0,11,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,
5619,GO:0016670,1,0.967431100561903,0,7,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5620,GO:0016671,1,0.887329061636349,0,12,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
5621,GO:0016672,1,0.963438939267324,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
5624,GO:0016679,1,0.892339715556945,0,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5625,GO:0016681,1,0.896522283940885,0,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5626,GO:0016684,1,0.640066741561307,0,32,oxidoreductase activity, acting on peroxide as acceptor,MF,
5627,GO:0016701,1,0.898943378738203,0,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,
5628,GO:0016702,1,0.898943378738203,0,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,
5629,GO:0016705,1,0.577477252887555,0,95,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,
5630,GO:0016706,1,0.806366224233295,0,39,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,
5631,GO:0016708,1,0.988728668854718,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
5632,GO:0016709,1,0.890809638471663,0,20,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,
5633,GO:0016711,1,0.995340515049184,0,1,flavonoid 3'-monooxygenase activity,MF,
5634,GO:0016712,1,0.942467751313454,0,10,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
5635,GO:0016714,1,0.968076871303115,0,3,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
5636,GO:0016715,1,0.990754923634616,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
5637,GO:0016717,1,0.977012051940802,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
5638,GO:0016721,1,0.935626518488152,0,4,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
5639,GO:0016722,1,0.916919673694707,0,14,oxidoreductase activity, oxidizing metal ions,MF,
5640,GO:0016723,1,0.945197430998966,0,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,
5641,GO:0016724,1,0.974906879059918,0,3,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
5642,GO:0016725,1,0.972517862988133,0,6,oxidoreductase activity, acting on CH or CH2 groups,MF,
5643,GO:0016726,1,0.990755199849267,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
5644,GO:0016727,1,0.995366990826125,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
5645,GO:0016728,1,0.986164288990761,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
5646,GO:0016730,1,0.9930434418814,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
5647,GO:0016731,1,0.9930434418814,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
5649,GO:0016741,1,0.295612648509699,0,185,transferase activity, transferring one-carbon groups,MF,
5650,GO:0016742,1,0.970744927406132,0,6,hydroxymethyl-, formyl- and related transferase activity,MF,
5651,GO:0016743,1,0.990755199849162,0,2,carboxyl- or carbamoyltransferase activity,MF,
5652,GO:0016744,1,0.978757730103141,0,2,transferase activity, transferring aldehyde or ketonic groups,MF,
5653,GO:0016746,1,0.289861112369413,0,190,transferase activity, transferring acyl groups,MF,
5654,GO:0016747,1,0.320179416781228,0,172,transferase activity, transferring acyl groups other than amino-acyl groups,MF,
5655,GO:0016748,1,0.990432189874116,0,2,succinyltransferase activity,MF,
5656,GO:0016749,1,0.995042957705271,0,1,N-succinyltransferase activity,MF,
5657,GO:0016751,1,0.995366527560217,0,1,S-succinyltransferase activity,MF,
5658,GO:0016755,1,0.953339034081502,0,9,transferase activity, transferring amino-acyl groups,MF,
5661,GO:0016763,1,0.75786837665145,0,40,transferase activity, transferring pentosyl groups,MF,
5662,GO:0016765,1,0.594439517122402,0,47,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
5663,GO:0016768,1,0.991111291885465,0,1,spermine synthase activity,MF,
5664,GO:0016769,1,0.922034266034057,0,13,transferase activity, transferring nitrogenous groups,MF,
5666,GO:0016773,1,0.0404614188074865,0,582,phosphotransferase activity, alcohol group as acceptor,MF,
5667,GO:0016774,1,0.984772037750273,0,3,phosphotransferase activity, carboxyl group as acceptor,MF,
5668,GO:0016775,1,0.937356910037752,0,6,phosphotransferase activity, nitrogenous group as acceptor,MF,
5670,GO:0016778,1,0.978117867393952,0,4,diphosphotransferase activity,MF,
5671,GO:0016779,1,0.350564719875178,0,126,nucleotidyltransferase activity,MF,
5672,GO:0016780,1,0.88111048840658,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
5673,GO:0016781,1,0.9902195563411,0,2,phosphotransferase activity, paired acceptors,MF,
5674,GO:0016782,1,0.698086352095382,0,46,transferase activity, transferring sulfur-containing groups,MF,
5675,GO:0016783,1,0.87611091168388,0,12,sulfurtransferase activity,MF,
5676,GO:0016784,1,0.988214398421963,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
5677,GO:0016785,1,0.995366990826138,0,1,transferase activity, transferring selenium-containing groups,MF,
5680,GO:0016790,1,0.804427725860761,0,28,thiolester hydrolase activity,MF,
5682,GO:0016793,1,0.995366829720426,0,1,triphosphoric monoester hydrolase activity,MF,
5683,GO:0016794,1,0.980367239166016,0,1,diphosphoric monoester hydrolase activity,MF,
5684,GO:0016796,1,0.712536659795543,0,48,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
5685,GO:0016798,1,0.577633585774649,0,84,hydrolase activity, acting on glycosyl bonds,MF,
5686,GO:0016799,1,0.827987305177217,0,20,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,
5687,GO:0016801,1,0.920526239668451,0,13,hydrolase activity, acting on ether bonds,MF,
5688,GO:0016802,1,0.98573844705399,0,3,trialkylsulfonium hydrolase activity,MF,
5689,GO:0016803,1,0.93385488793491,0,10,ether hydrolase activity,MF,
5690,GO:0016805,1,0.961565926286105,0,7,dipeptidase activity,MF,
5691,GO:0016807,1,0.995366574475227,0,1,cysteine-type carboxypeptidase activity,MF,
5692,GO:0016810,1,0.465208064638115,0,110,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,
5693,GO:0016811,1,0.609301809919886,0,70,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,
5694,GO:0016812,1,0.977046147823502,0,5,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
5695,GO:0016813,1,0.953630465248855,0,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
5696,GO:0016814,1,0.85442933737528,0,23,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,
5697,GO:0016815,1,0.986452775796898,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
5700,GO:0016822,1,0.979002801311927,0,2,hydrolase activity, acting on acid carbon-carbon bonds,MF,
5701,GO:0016823,1,0.979002801311927,0,2,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
5702,GO:0016826,1,0.995366168694732,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
5703,GO:0016829,1,0.366504371941893,0,129,lyase activity,MF,
5704,GO:0016830,1,0.760091854191312,0,41,carbon-carbon lyase activity,MF,
5705,GO:0016831,1,0.833000760606435,0,28,carboxy-lyase activity,MF,
5706,GO:0016832,1,0.952974506195398,0,7,aldehyde-lyase activity,MF,
5707,GO:0016833,1,0.964431921818758,0,5,oxo-acid-lyase activity,MF,
5708,GO:0016835,1,0.65487520458227,0,53,carbon-oxygen lyase activity,MF,
5709,GO:0016836,1,0.759286383865945,0,36,hydro-lyase activity,MF,
5710,GO:0016838,1,0.972494940506124,0,2,carbon-oxygen lyase activity, acting on phosphates,MF,
5711,GO:0016840,1,0.90598164830699,0,11,carbon-nitrogen lyase activity,MF,
5712,GO:0016841,1,0.97780948199807,0,3,ammonia-lyase activity,MF,
5713,GO:0016842,1,0.930877016543291,0,7,amidine-lyase activity,MF,
5714,GO:0016843,1,0.995366574475227,0,1,amine-lyase activity,MF,
5715,GO:0016844,1,0.995366574475227,0,1,strictosidine synthase activity,MF,
5716,GO:0016846,1,0.908820255010649,0,7,carbon-sulfur lyase activity,MF,
5717,GO:0016849,1,0.952444405202962,0,9,phosphorus-oxygen lyase activity,MF,
5718,GO:0016853,1,0.348524253355396,0,120,isomerase activity,MF,
5719,GO:0016854,1,0.895879753733752,0,13,racemase and epimerase activity,MF,
5720,GO:0016855,1,0.995254133737912,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
5721,GO:0016857,1,0.927713550217165,0,10,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
5722,GO:0016859,1,0.706742050265819,0,31,cis-trans isomerase activity,MF,
5723,GO:0016860,1,0.690750467258514,0,40,intramolecular oxidoreductase activity,MF,
5724,GO:0016861,1,0.933867499857844,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
5725,GO:0016862,1,0.941509980925824,0,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
5726,GO:0016863,1,0.862640960694293,0,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
5727,GO:0016864,1,0.903989334809991,0,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
5728,GO:0016866,1,0.840502808862566,0,24,intramolecular transferase activity,MF,
5729,GO:0016868,1,0.945848949846976,0,8,intramolecular transferase activity, phosphotransferases,MF,
5730,GO:0016872,1,0.994861259427477,0,1,intramolecular lyase activity,MF,
5731,GO:0016874,1,0.455346725070747,0,135,ligase activity,MF,
5732,GO:0016875,1,0.780722738587706,0,44,ligase activity, forming carbon-oxygen bonds,MF,
5733,GO:0016877,1,0.865558633230998,0,28,ligase activity, forming carbon-sulfur bonds,MF,
5734,GO:0016878,1,0.910641343833959,0,18,acid-thiol ligase activity,MF,
5735,GO:0016879,1,0.757074939797831,0,43,ligase activity, forming carbon-nitrogen bonds,MF,
5736,GO:0016880,1,0.990754785405313,0,2,acid-ammonia (or amide) ligase activity,MF,
5737,GO:0016881,1,0.912572867344316,0,16,acid-amino acid ligase activity,MF,
5738,GO:0016882,1,0.972381230283702,0,2,cyclo-ligase activity,MF,
5739,GO:0016884,1,0.92531923390261,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
5740,GO:0016885,1,0.959612429426412,0,8,ligase activity, forming carbon-carbon bonds,MF,
5741,GO:0016886,1,0.950208136719917,0,10,ligase activity, forming phosphoric ester bonds,MF,
5743,GO:0016888,1,0.935349833690535,0,11,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
5744,GO:0016889,1,0.84283830515244,0,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
5745,GO:0016890,1,0.98388104975641,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
5746,GO:0016891,1,0.776918483456513,0,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
5747,GO:0016892,1,0.951073729481421,0,6,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
5748,GO:0016893,1,0.737197355244055,0,35,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
5749,GO:0016894,1,0.801522327275399,0,26,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
5750,GO:0016895,1,0.893443045407377,0,17,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
5751,GO:0016896,1,0.780569699472341,0,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,
5752,GO:0016898,1,0.995333062328682,0,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
5753,GO:0016899,1,0.990755194988544,0,2,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
5754,GO:0016900,1,0.960972795160988,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
5755,GO:0016901,1,0.995366990826126,0,1,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
5756,GO:0016903,1,0.819481042123506,0,34,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,
5757,GO:0016907,1,0.990753574477342,0,2,G-protein coupled acetylcholine receptor activity,MF,
5758,GO:0016909,1,0.978231498499041,0,3,SAP kinase activity,MF,
5759,GO:0016917,1,0.986164343803861,0,3,GABA receptor activity,MF,
5760,GO:0016918,1,0.926805592573913,0,5,retinal binding,MF,
5761,GO:0016920,1,0.99536699082606,0,1,pyroglutamyl-peptidase activity,MF,
5762,GO:0016922,1,0.903818738180198,0,18,ligand-dependent nuclear receptor binding,MF,
5763,GO:0016925,1,0.584657542215327,0,85,protein sumoylation,BP,
5764,GO:0016926,1,0.963580256723345,0,7,protein desumoylation,BP,
5765,GO:0016929,1,0.972416498824601,0,6,SUMO-specific protease activity,MF,
5766,GO:0016936,1,0.982710283003056,0,2,galactoside binding,MF,
5767,GO:0016938,1,0.995366636758172,0,1,kinesin I complex,CC,
5768,GO:0016939,1,0.986164233666898,0,3,kinesin II complex,CC,
5769,GO:0016941,1,0.995366935169542,0,1,natriuretic peptide receptor activity,MF,
5770,GO:0016942,1,0.969659916861236,0,3,insulin-like growth factor binding protein complex,CC,
5771,GO:0016964,1,0.995366990825772,0,1,alpha-2 macroglobulin receptor activity,MF,
5772,GO:0016971,1,0.985959132507408,0,3,flavin-linked sulfhydryl oxidase activity,MF,
5773,GO:0016972,1,0.98139043108661,0,4,thiol oxidase activity,MF,
5774,GO:0016973,1,0.926039159099402,0,10,poly(A)+ mRNA export from nucleus,BP,
5775,GO:0016979,1,0.987256819618231,0,1,lipoate-protein ligase activity,MF,
5776,GO:0016992,1,0.990910197408557,0,1,lipoate synthase activity,MF,
5777,GO:0016997,1,0.979747085200973,0,4,alpha-sialidase activity,MF,
5778,GO:0016998,1,0.984230511046271,0,2,cell wall macromolecule catabolic process,BP,
5779,GO:0016999,1,0.441091009423348,0,97,antibiotic metabolic process,BP,
5780,GO:0017000,1,0.898267302684996,0,14,antibiotic biosynthetic process,BP,
5781,GO:0017001,1,0.766754020262768,0,28,antibiotic catabolic process,BP,
5782,GO:0017002,1,0.973812594816352,0,5,activin-activated receptor activity,MF,
5783,GO:0017003,1,0.994927016771324,0,1,protein-heme linkage,BP,
5784,GO:0017004,1,0.717170239375174,0,34,cytochrome complex assembly,BP,
5785,GO:0017005,1,0.995366975109459,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
5786,GO:0017006,1,0.994927016771324,0,1,protein-tetrapyrrole linkage,BP,
5787,GO:0017014,1,0.892833149029773,0,10,protein nitrosylation,BP,
5788,GO:0017015,1,0.606321525456709,0,80,regulation of transforming growth factor beta receptor signaling pathway,BP,
5790,GO:0017017,1,0.937374395098642,0,11,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,
5791,GO:0017018,1,0.990755199849254,0,2,myosin phosphatase activity,MF,
5792,GO:0017020,1,0.995366545689463,0,1,myosin phosphatase regulator activity,MF,
5793,GO:0017022,1,0.739472331822124,0,43,myosin binding,MF,
5794,GO:0017024,1,0.977176262583746,0,1,myosin I binding,MF,
5795,GO:0017025,1,0.830220297235646,0,23,TBP-class protein binding,MF,
5796,GO:0017034,1,0.974481338788326,0,5,Rap guanyl-nucleotide exchange factor activity,MF,
5798,GO:0017040,1,0.95756448501141,0,4,N-acylsphingosine amidohydrolase activity,MF,
5799,GO:0017046,1,0.913794199964287,0,15,peptide hormone binding,MF,
5800,GO:0017048,1,0.482739492070786,0,139,Rho GTPase binding,MF,
5801,GO:0017049,1,0.881636180621311,0,21,GTP-Rho binding,MF,
5802,GO:0017050,1,0.988182993466766,0,2,D-erythro-sphingosine kinase activity,MF,
5804,GO:0017055,1,0.99057165586969,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
5805,GO:0017056,1,0.869422911106138,0,25,structural constituent of nuclear pore,MF,
5806,GO:0017057,1,0.97561639740272,0,2,6-phosphogluconolactonase activity,MF,
5807,GO:0017059,1,0.950053475112968,0,8,serine C-palmitoyltransferase complex,CC,
5808,GO:0017060,1,0.990101671265037,0,2,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
5809,GO:0017061,1,0.995366990826165,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
5810,GO:0017062,1,0.930038415676109,0,9,respiratory chain complex III assembly,BP,
5811,GO:0017064,1,0.994289444996161,0,1,fatty acid amide hydrolase activity,MF,
5812,GO:0017065,1,0.989567769752856,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
5813,GO:0017069,1,0.689275217612714,0,38,snRNA binding,MF,
5814,GO:0017070,1,0.88573044075016,0,11,U6 snRNA binding,MF,
5815,GO:0017075,1,0.933308788882664,0,14,syntaxin-1 binding,MF,
5818,GO:0017081,1,0.897802643609199,0,12,chloride channel regulator activity,MF,
5819,GO:0017082,1,0.995366574475227,0,1,mineralocorticoid receptor activity,MF,
5820,GO:0017084,1,0.995366942340392,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
5821,GO:0017085,1,0.92391066620596,0,15,response to insecticide,BP,
5822,GO:0017087,1,0.995366990550685,0,1,mitochondrial processing peptidase complex,CC,
5823,GO:0017089,1,0.988731341973396,0,2,glycolipid transporter activity,MF,
5824,GO:0017091,1,0.858556662504405,0,21,AU-rich element binding,MF,
5825,GO:0017095,1,0.990755199720701,0,2,heparan sulfate 6-O-sulfotransferase activity,MF,
5826,GO:0017098,1,0.99530781851319,0,1,sulfonylurea receptor binding,MF,
5827,GO:0017099,1,0.968825764404548,0,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,
5828,GO:0017101,1,0.914419657901327,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
5829,GO:0017102,1,0.990717987409033,0,2,methionyl glutamyl tRNA synthetase complex,CC,
5830,GO:0017108,1,0.971966624504185,0,6,5'-flap endonuclease activity,MF,
5831,GO:0017109,1,0.990754948172085,0,2,glutamate-cysteine ligase complex,CC,
5832,GO:0017110,1,0.914657635316185,0,13,nucleoside-diphosphatase activity,MF,
5835,GO:0017113,1,0.99536678233859,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
5836,GO:0017116,1,0.986153844425289,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
5837,GO:0017119,1,0.942955305939895,0,12,Golgi transport complex,CC,
5838,GO:0017121,1,0.962913825050701,0,7,phospholipid scrambling,BP,
5839,GO:0017124,1,0.560495736792862,0,96,SH3 domain binding,MF,
5840,GO:0017125,1,0.995366990826165,0,1,deoxycytidyl transferase activity,MF,
5841,GO:0017126,1,0.995366990826152,0,1,nucleologenesis,BP,
5842,GO:0017127,1,0.896394467959073,0,10,cholesterol transporter activity,MF,
5843,GO:0017128,1,0.968235599335905,0,6,phospholipid scramblase activity,MF,
5844,GO:0017130,1,0.995366990826074,0,1,poly(C) RNA binding,MF,
5845,GO:0017133,1,0.995072680832062,0,1,mitochondrial electron transfer flavoprotein complex,CC,
5846,GO:0017134,1,0.847008646499726,0,18,fibroblast growth factor binding,MF,
5847,GO:0017136,1,0.913219414194203,0,16,NAD-dependent histone deacetylase activity,MF,
5849,GO:0017143,1,0.990719445766573,0,2,insecticide metabolic process,BP,
5851,GO:0017145,1,0.860307810874479,0,26,stem cell division,BP,
5852,GO:0017146,1,0.986164531023728,0,3,NMDA selective glutamate receptor complex,CC,
5853,GO:0017147,1,0.902230628113512,0,21,Wnt-protein binding,MF,
5855,GO:0017150,1,0.975026782510007,0,4,tRNA dihydrouridine synthase activity,MF,
5856,GO:0017151,1,0.963040275758738,0,7,DEAD/H-box RNA helicase binding,MF,
5857,GO:0017153,1,0.981593659469666,0,4,sodium:dicarboxylate symporter activity,MF,
5858,GO:0017154,1,0.95450977682631,0,10,semaphorin receptor activity,MF,
5859,GO:0017156,1,0.679608678319314,0,67,calcium ion regulated exocytosis,BP,
5861,GO:0017158,1,0.781374289035608,0,43,regulation of calcium ion-dependent exocytosis,BP,
5862,GO:0017160,1,0.910647841362127,0,14,Ral GTPase binding,MF,
5863,GO:0017161,1,0.990755199849188,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
5864,GO:0017162,1,0.949630331878357,0,8,aryl hydrocarbon receptor binding,MF,
5865,GO:0017166,1,0.954580322219589,0,10,vinculin binding,MF,
5866,GO:0017168,1,0.995366990826125,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
5867,GO:0017169,1,0.944879624002194,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
5868,GO:0017171,1,0.513045082997364,0,94,serine hydrolase activity,MF,
5870,GO:0017177,1,0.995366990346783,0,1,glucosidase II complex,CC,
5871,GO:0017178,1,0.995366574475227,0,1,diphthine-ammonia ligase activity,MF,
5872,GO:0017182,1,0.95445599099278,0,9,peptidyl-diphthamide metabolic process,BP,
5873,GO:0017183,1,0.95445599099278,0,9,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
5874,GO:0017185,1,0.963511058512912,0,8,peptidyl-lysine hydroxylation,BP,
5875,GO:0017186,1,0.985816946075487,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
5876,GO:0017187,1,0.95208455365243,0,4,peptidyl-glutamic acid carboxylation,BP,
5877,GO:0017196,1,0.955558157598241,0,6,N-terminal peptidyl-methionine acetylation,BP,
5878,GO:0017198,1,0.976975576064918,0,1,N-terminal peptidyl-serine acetylation,BP,
5879,GO:0018002,1,0.976975576064918,0,1,N-terminal peptidyl-glutamic acid acetylation,BP,
5880,GO:0018008,1,0.990755199849292,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
5881,GO:0018009,1,0.994424712951054,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
5882,GO:0018011,1,0.995366574475227,0,1,N-terminal peptidyl-alanine methylation,BP,
5883,GO:0018012,1,0.995366574475227,0,1,N-terminal peptidyl-alanine trimethylation,BP,
5884,GO:0018013,1,0.995366574475227,0,1,N-terminal peptidyl-glycine methylation,BP,
5885,GO:0018016,1,0.995366574475227,0,1,N-terminal peptidyl-proline dimethylation,BP,
5888,GO:0018024,1,0.785624583811462,0,40,histone-lysine N-methyltransferase activity,MF,
5889,GO:0018025,1,0.995366574475227,0,1,calmodulin-lysine N-methyltransferase activity,MF,
5890,GO:0018026,1,0.952868941517026,0,9,peptidyl-lysine monomethylation,BP,
5891,GO:0018027,1,0.917250524855,0,14,peptidyl-lysine dimethylation,BP,
5892,GO:0018032,1,0.995366983442151,0,1,protein amidation,BP,
5893,GO:0018057,1,0.986163912168205,0,3,peptidyl-lysine oxidation,BP,
5894,GO:0018063,1,0.994927016771324,0,1,cytochrome c-heme linkage,BP,
5895,GO:0018065,1,0.849018686528258,0,11,protein-cofactor linkage,BP,
5896,GO:0018076,1,0.981594888733195,0,4,N-terminal peptidyl-lysine acetylation,BP,
5897,GO:0018094,1,0.995366923794929,0,1,protein polyglycylation,BP,
5898,GO:0018095,1,0.960712505982898,0,8,protein polyglutamylation,BP,
5899,GO:0018101,1,0.99536682795566,0,1,protein citrullination,BP,
5900,GO:0018103,1,0.944289021785292,0,6,protein C-linked glycosylation,BP,
5902,GO:0018106,1,0.973415645171836,0,1,peptidyl-histidine phosphorylation,BP,
5905,GO:0018114,1,0.995254133737912,0,1,threonine racemase activity,MF,
5906,GO:0018117,1,0.990595020269879,0,1,protein adenylylation,BP,
5907,GO:0018119,1,0.892833149029773,0,10,peptidyl-cysteine S-nitrosylation,BP,
5908,GO:0018125,1,0.97767766341363,0,3,peptidyl-cysteine methylation,BP,
5909,GO:0018126,1,0.909761925841772,0,20,protein hydroxylation,BP,
5911,GO:0018146,1,0.884234753586028,0,22,keratan sulfate biosynthetic process,BP,
5912,GO:0018149,1,0.656855788580993,0,29,peptide cross-linking,BP,
5913,GO:0018153,1,0.989795928712644,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
5914,GO:0018158,1,0.916541987000917,0,9,protein oxidation,BP,
5915,GO:0018160,1,0.988131164673001,0,1,peptidyl-pyrromethane cofactor linkage,BP,
5916,GO:0018166,1,0.995366990826151,0,1,C-terminal protein-tyrosinylation,BP,
5917,GO:0018171,1,0.952532605475035,0,4,peptidyl-cysteine oxidation,BP,
5918,GO:0018175,1,0.990595020269879,0,1,protein nucleotidylation,BP,
5919,GO:0018192,1,0.995225769074058,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
5921,GO:0018194,1,0.995366574475227,0,1,peptidyl-alanine modification,BP,
5922,GO:0018195,1,0.875608863934243,0,17,peptidyl-arginine modification,BP,
5923,GO:0018196,1,0.703943521859847,0,39,peptidyl-asparagine modification,BP,
5924,GO:0018197,1,0.986164513858802,0,3,peptidyl-aspartic acid modification,BP,
5925,GO:0018198,1,0.716138527118435,0,38,peptidyl-cysteine modification,BP,
5926,GO:0018199,1,0.975755953733042,0,4,peptidyl-glutamine modification,BP,
5927,GO:0018200,1,0.881198576214116,0,16,peptidyl-glutamic acid modification,BP,
5928,GO:0018201,1,0.986164118478142,0,3,peptidyl-glycine modification,BP,
5929,GO:0018202,1,0.924760966480013,0,11,peptidyl-histidine modification,BP,
5931,GO:0018206,1,0.925968172860044,0,10,peptidyl-methionine modification,BP,
5932,GO:0018208,1,0.676687149409044,0,42,peptidyl-proline modification,BP,
5935,GO:0018211,1,0.944289021785292,0,6,peptidyl-tryptophan modification,BP,
5937,GO:0018214,1,0.95208455365243,0,4,protein carboxylation,BP,
5938,GO:0018216,1,0.932615128910918,0,13,peptidyl-arginine methylation,BP,
5939,GO:0018217,1,0.99536699082396,0,1,peptidyl-aspartic acid phosphorylation,BP,
5940,GO:0018230,1,0.881132111158908,0,18,peptidyl-L-cysteine S-palmitoylation,BP,
5941,GO:0018231,1,0.881132111158908,0,18,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
5942,GO:0018242,1,0.941392151145545,0,13,protein O-linked glycosylation via serine,BP,
5943,GO:0018243,1,0.9457771529031,0,12,protein O-linked glycosylation via threonine,BP,
5944,GO:0018262,1,0.989795928712644,0,2,isopeptide cross-linking,BP,
5945,GO:0018271,1,0.995366990826113,0,1,biotin-protein ligase activity,MF,
5946,GO:0018272,1,0.991669902477171,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
5947,GO:0018277,1,0.995089608720626,0,1,protein deamination,BP,
5948,GO:0018279,1,0.707233198380071,0,38,protein N-linked glycosylation via asparagine,BP,
5949,GO:0018282,1,0.990507422550999,0,2,metal incorporation into metallo-sulfur cluster,BP,
5950,GO:0018283,1,0.990507422550999,0,2,iron incorporation into metallo-sulfur cluster,BP,
5951,GO:0018293,1,0.98362975183161,0,1,protein-FAD linkage,BP,
5952,GO:0018298,1,0.986145288718558,0,3,protein-chromophore linkage,BP,
5953,GO:0018307,1,0.973366948791672,0,2,enzyme active site formation,BP,
5954,GO:0018312,1,0.98828357828177,0,2,peptidyl-serine ADP-ribosylation,BP,
5955,GO:0018315,1,0.995366990826152,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
5956,GO:0018317,1,0.944289021785292,0,6,protein C-linked glycosylation via tryptophan,BP,
5957,GO:0018322,1,0.995366990826151,0,1,protein tyrosinylation,BP,
5958,GO:0018323,1,0.978037514283719,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
5959,GO:0018335,1,0.981594201733171,0,4,protein succinylation,BP,
5960,GO:0018342,1,0.94628533178592,0,9,protein prenylation,BP,
5961,GO:0018343,1,0.980863403464777,0,3,protein farnesylation,BP,
5962,GO:0018344,1,0.959568704706833,0,6,protein geranylgeranylation,BP,
5963,GO:0018345,1,0.841136047354593,0,27,protein palmitoylation,BP,
5964,GO:0018352,1,0.986812549814159,0,2,protein-pyridoxal-5-phosphate linkage,BP,
5965,GO:0018364,1,0.953152650151897,0,2,peptidyl-glutamine methylation,BP,
5966,GO:0018377,1,0.981573340073907,0,4,protein myristoylation,BP,
5969,GO:0018395,1,0.995366972215419,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
5970,GO:0018400,1,0.995366990826085,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
5971,GO:0018401,1,0.976001148766393,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
5972,GO:0018406,1,0.944289021785292,0,6,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
5973,GO:0018410,1,0.72403124541204,0,39,C-terminal protein amino acid modification,BP,
5974,GO:0018423,1,0.980651632106564,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
5975,GO:0018444,1,0.986164047184395,0,3,translation release factor complex,CC,
5976,GO:0018455,1,0.984976082722581,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
5977,GO:0018467,1,0.995351917877958,0,1,formaldehyde dehydrogenase activity,MF,
5978,GO:0018478,1,0.994614625735962,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
5979,GO:0018479,1,0.994280299393438,0,1,benzaldehyde dehydrogenase (NAD+) activity,MF,
5980,GO:0018585,1,0.994530952688334,0,1,fluorene oxygenase activity,MF,
5981,GO:0018636,1,0.975408435411332,0,2,phenanthrene 9,10-monooxygenase activity,MF,
5982,GO:0018738,1,0.983439984649338,0,1,S-formylglutathione hydrolase activity,MF,
5983,GO:0018773,1,0.990962446047837,0,1,acetylpyruvate hydrolase activity,MF,
5984,GO:0018812,1,0.981593246111093,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
5985,GO:0018872,1,0.995243726634004,0,1,arsonoacetate metabolic process,BP,
5986,GO:0018879,1,0.985041070002492,0,3,biphenyl metabolic process,BP,
5987,GO:0018894,1,0.986128736198307,0,3,dibenzo-p-dioxin metabolic process,BP,
5988,GO:0018904,1,0.882342870126716,0,13,ether metabolic process,BP,
5989,GO:0018916,1,0.951125416809324,0,4,nitrobenzene metabolic process,BP,
5990,GO:0018917,1,0.994530952688334,0,1,fluorene metabolic process,BP,
5991,GO:0018931,1,0.987095632384479,0,1,naphthalene metabolic process,BP,
5992,GO:0018958,1,0.733657522886391,0,47,phenol-containing compound metabolic process,BP,
5993,GO:0018963,1,0.988492963581318,0,2,phthalate metabolic process,BP,
5994,GO:0018992,1,0.990755199558037,0,2,germ-line sex determination,BP,
5995,GO:0018993,1,0.995366595097125,0,1,somatic sex determination,BP,
5996,GO:0018995,1,0.657094638099913,0,61,host,CC,
5998,GO:0019002,1,0.985735057808546,0,2,GMP binding,MF,
6000,GO:0019005,1,0.682663303956145,0,52,SCF ubiquitin ligase complex,CC,
6001,GO:0019008,1,0.982856930589978,0,2,molybdopterin synthase complex,CC,
6002,GO:0019034,1,0.990755199849292,0,2,viral replication complex,CC,
6003,GO:0019035,1,0.995366990826125,0,1,viral integration complex,CC,
6004,GO:0019042,1,0.928365823645265,0,11,viral latency,BP,
6005,GO:0019043,1,0.937034986156261,0,9,establishment of viral latency,BP,
6006,GO:0019045,1,0.990755199849071,0,2,latent virus replication,BP,
6007,GO:0019046,1,0.990755199849071,0,2,release from viral latency,BP,
6008,GO:0019048,1,0.836127172561472,0,30,modulation by virus of host morphology or physiology,BP,
6009,GO:0019049,1,0.98090394114415,0,4,evasion or tolerance of host defenses by virus,BP,
6010,GO:0019050,1,0.972238424313704,0,3,suppression by virus of host apoptotic process,BP,
6011,GO:0019054,1,0.885797581451526,0,20,modulation by virus of host process,BP,
6012,GO:0019058,1,0.161180398678244,0,255,viral life cycle,BP,
6013,GO:0019060,1,0.965485926441435,0,2,intracellular transport of viral protein in host cell,BP,
6014,GO:0019061,1,0.994893585807468,0,1,uncoating of virus,BP,
6015,GO:0019062,1,0.974770489388966,0,4,virion attachment to host cell,BP,
6016,GO:0019064,1,0.984943925803592,0,3,fusion of virus membrane with host plasma membrane,BP,
6017,GO:0019065,1,0.986155199424776,0,3,receptor-mediated endocytosis of virus by host cell,BP,
6018,GO:0019068,1,0.740261474844349,0,36,virion assembly,BP,
6019,GO:0019072,1,0.990755199849186,0,2,viral genome packaging,BP,
6020,GO:0019074,1,0.990755199849186,0,2,viral RNA genome packaging,BP,
6021,GO:0019075,1,0.990754370961523,0,2,virus maturation,BP,
6022,GO:0019076,1,0.825005486354476,0,33,viral release from host cell,BP,
6023,GO:0019079,1,0.474639588884515,0,97,viral genome replication,BP,
6025,GO:0019081,1,0.906669460075386,0,14,viral translation,BP,
6026,GO:0019082,1,0.995366990826139,0,1,viral protein processing,BP,
6028,GO:0019085,1,0.990755095916651,0,2,early viral transcription,BP,
6029,GO:0019086,1,0.973228666747866,0,4,late viral transcription,BP,
6030,GO:0019087,1,0.979969407400086,0,3,transformation of host cell by virus,BP,
6031,GO:0019088,1,0.989782138899612,0,1,immortalization of host cell by virus,BP,
6032,GO:0019089,1,0.995366990826099,0,1,transmission of virus,BP,
6033,GO:0019098,1,0.916398437489723,0,17,reproductive behavior,BP,
6034,GO:0019100,1,0.990755199558037,0,2,male germ-line sex determination,BP,
6035,GO:0019101,1,0.995366595097125,0,1,female somatic sex determination,BP,
6036,GO:0019103,1,0.939470992278284,0,6,pyrimidine nucleotide binding,MF,
6037,GO:0019104,1,0.853370061049432,0,15,DNA N-glycosylase activity,MF,
6038,GO:0019107,1,0.990755199849292,0,2,myristoyltransferase activity,MF,
6039,GO:0019118,1,0.986452775796898,0,1,phenanthrene-epoxide hydrolase activity,MF,
6040,GO:0019119,1,0.986452775796898,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6041,GO:0019135,1,0.992954864200654,0,1,deoxyhypusine monooxygenase activity,MF,
6042,GO:0019136,1,0.960862235942364,0,4,deoxynucleoside kinase activity,MF,
6043,GO:0019144,1,0.972934481020023,0,2,ADP-sugar diphosphatase activity,MF,
6044,GO:0019145,1,0.995278400885571,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6045,GO:0019150,1,0.994068373423914,0,1,D-ribulokinase activity,MF,
6046,GO:0019153,1,0.989953069159443,0,1,protein-disulfide reductase (glutathione) activity,MF,
6047,GO:0019158,1,0.986164519277882,0,3,mannokinase activity,MF,
6048,GO:0019166,1,0.977942633307322,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
6049,GO:0019171,1,0.995366990825994,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6050,GO:0019184,1,0.874714023936649,0,16,nonribosomal peptide biosynthetic process,BP,
6051,GO:0019185,1,0.990743712830187,0,2,snRNA-activating protein complex,CC,
6052,GO:0019187,1,0.995366990652136,0,1,beta-1,4-mannosyltransferase activity,MF,
6053,GO:0019198,1,0.95411191521076,0,10,transmembrane receptor protein phosphatase activity,MF,
6054,GO:0019199,1,0.776269822121372,0,50,transmembrane receptor protein kinase activity,MF,
6055,GO:0019200,1,0.888790606666115,0,19,carbohydrate kinase activity,MF,
6056,GO:0019201,1,0.879133152608937,0,20,nucleotide kinase activity,MF,
6057,GO:0019202,1,0.995366942340392,0,1,amino acid kinase activity,MF,
6058,GO:0019203,1,0.972216373464182,0,5,carbohydrate phosphatase activity,MF,
6060,GO:0019206,1,0.919337309163537,0,10,nucleoside kinase activity,MF,
6061,GO:0019207,1,0.330842287195187,0,162,kinase regulator activity,MF,
6062,GO:0019208,1,0.636505603699867,0,72,phosphatase regulator activity,MF,
6063,GO:0019209,1,0.677759147278339,0,58,kinase activator activity,MF,
6064,GO:0019210,1,0.613800242242879,0,73,kinase inhibitor activity,MF,
6065,GO:0019211,1,0.936978774272769,0,10,phosphatase activator activity,MF,
6066,GO:0019212,1,0.84345331027538,0,24,phosphatase inhibitor activity,MF,
6067,GO:0019213,1,0.72174014845984,0,51,deacetylase activity,MF,
6068,GO:0019215,1,0.927918685547014,0,11,intermediate filament binding,MF,
6070,GO:0019217,1,0.708245572564839,0,57,regulation of fatty acid metabolic process,BP,
6076,GO:0019226,1,0.830719736670472,0,27,transmission of nerve impulse,BP,
6077,GO:0019227,1,0.969800787626915,0,3,neuronal action potential propagation,BP,
6078,GO:0019228,1,0.928790701543285,0,13,neuronal action potential,BP,
6079,GO:0019229,1,0.8569475738778,0,28,regulation of vasoconstriction,BP,
6080,GO:0019230,1,0.990755199849149,0,2,proprioception,BP,
6081,GO:0019233,1,0.743794774109194,0,40,sensory perception of pain,BP,
6082,GO:0019236,1,0.980907183348683,0,2,response to pheromone,BP,
6083,GO:0019237,1,0.972516425858907,0,6,centromeric DNA binding,MF,
6084,GO:0019238,1,0.968713118908804,0,6,cyclohydrolase activity,MF,
6085,GO:0019239,1,0.833072402613661,0,24,deaminase activity,MF,
6086,GO:0019240,1,0.98159484091074,0,4,citrulline biosynthetic process,BP,
6087,GO:0019242,1,0.994210053136302,0,1,methylglyoxal biosynthetic process,BP,
6088,GO:0019243,1,0.98492142716432,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6089,GO:0019249,1,0.968993050730567,0,3,lactate biosynthetic process,BP,
6090,GO:0019254,1,0.990730192830769,0,2,carnitine metabolic process, CoA-linked,BP,
6091,GO:0019255,1,0.988228285633033,0,2,glucose 1-phosphate metabolic process,BP,
6092,GO:0019262,1,0.960409601195078,0,5,N-acetylneuraminate catabolic process,BP,
6093,GO:0019264,1,0.990054307114572,0,2,glycine biosynthetic process from serine,BP,
6094,GO:0019276,1,0.99536654741837,0,1,UDP-N-acetylgalactosamine metabolic process,BP,
6095,GO:0019285,1,0.995366962748951,0,1,glycine betaine biosynthetic process from choline,BP,
6096,GO:0019287,1,0.97191241100719,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
6097,GO:0019290,1,0.99536660776398,0,1,siderophore biosynthetic process,BP,
6098,GO:0019303,1,0.967431098937187,0,2,D-ribose catabolic process,BP,
6099,GO:0019317,1,0.97251768800849,0,6,fucose catabolic process,BP,
6102,GO:0019320,1,0.774927407190604,0,38,hexose catabolic process,BP,
6103,GO:0019321,1,0.892321436812818,0,11,pentose metabolic process,BP,
6104,GO:0019322,1,0.967454774175245,0,4,pentose biosynthetic process,BP,
6105,GO:0019323,1,0.958086174545269,0,4,pentose catabolic process,BP,
6106,GO:0019336,1,0.970013280511435,0,5,phenol-containing compound catabolic process,BP,
6107,GO:0019341,1,0.995340515049184,0,1,dibenzo-p-dioxin catabolic process,BP,
6108,GO:0019343,1,0.987046060704624,0,2,cysteine biosynthetic process via cystathionine,BP,
6109,GO:0019344,1,0.982203077352637,0,3,cysteine biosynthetic process,BP,
6110,GO:0019346,1,0.97089096804876,0,4,transsulfuration,BP,
6111,GO:0019348,1,0.955692639437433,0,5,dolichol metabolic process,BP,
6112,GO:0019353,1,0.995362950957149,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
6113,GO:0019355,1,0.990755195663627,0,2,nicotinamide nucleotide biosynthetic process from aspartate,BP,
6114,GO:0019357,1,0.995366574475227,0,1,nicotinate nucleotide biosynthetic process,BP,
6115,GO:0019358,1,0.995366574475227,0,1,nicotinate nucleotide salvage,BP,
6119,GO:0019364,1,0.995366946678943,0,1,pyridine nucleotide catabolic process,BP,
6120,GO:0019365,1,0.995366574475227,0,1,pyridine nucleotide salvage,BP,
6121,GO:0019367,1,0.970177743393844,0,5,fatty acid elongation, saturated fatty acid,BP,
6122,GO:0019368,1,0.970177743393844,0,5,fatty acid elongation, unsaturated fatty acid,BP,
6123,GO:0019369,1,0.860326885335997,0,26,arachidonic acid metabolic process,BP,
6124,GO:0019370,1,0.924244761485711,0,7,leukotriene biosynthetic process,BP,
6125,GO:0019371,1,0.946688679145987,0,7,cyclooxygenase pathway,BP,
6126,GO:0019372,1,0.92325626655991,0,9,lipoxygenase pathway,BP,
6127,GO:0019373,1,0.969250689129925,0,6,epoxygenase P450 pathway,BP,
6128,GO:0019374,1,0.968406402539432,0,6,galactolipid metabolic process,BP,
6129,GO:0019375,1,0.984245320794923,0,3,galactolipid biosynthetic process,BP,
6130,GO:0019376,1,0.995366592959221,0,1,galactolipid catabolic process,BP,
6131,GO:0019377,1,0.938084546843061,0,11,glycolipid catabolic process,BP,
6132,GO:0019388,1,0.940640099070744,0,8,galactose catabolic process,BP,
6133,GO:0019389,1,0.995351130689079,0,1,glucuronoside metabolic process,BP,
6134,GO:0019391,1,0.995351130689079,0,1,glucuronoside catabolic process,BP,
6135,GO:0019395,1,0.582765212969028,0,78,fatty acid oxidation,BP,
6136,GO:0019400,1,0.897149937131141,0,14,alditol metabolic process,BP,
6137,GO:0019401,1,0.970697803616423,0,4,alditol biosynthetic process,BP,
6138,GO:0019402,1,0.986435998580041,0,1,galactitol metabolic process,BP,
6139,GO:0019405,1,0.965243979343641,0,6,alditol catabolic process,BP,
6140,GO:0019406,1,0.987095632384479,0,1,hexitol biosynthetic process,BP,
6141,GO:0019407,1,0.995296708755865,0,1,hexitol catabolic process,BP,
6142,GO:0019408,1,0.990743712830187,0,2,dolichol biosynthetic process,BP,
6143,GO:0019413,1,0.990754884941477,0,2,acetate biosynthetic process,BP,
6144,GO:0019417,1,0.990755165491267,0,2,sulfur oxidation,BP,
6145,GO:0019418,1,0.937880780515728,0,4,sulfide oxidation,BP,
6146,GO:0019427,1,0.990754884941477,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6147,GO:0019430,1,0.833261753894476,0,17,removal of superoxide radicals,BP,
6148,GO:0019432,1,0.86681313007642,0,25,triglyceride biosynthetic process,BP,
6149,GO:0019433,1,0.914641154075845,0,11,triglyceride catabolic process,BP,
6152,GO:0019441,1,0.975702689598349,0,3,tryptophan catabolic process to kynurenine,BP,
6153,GO:0019448,1,0.995337765554784,0,1,L-cysteine catabolic process,BP,
6154,GO:0019464,1,0.978317490764968,0,3,glycine decarboxylation via glycine cleavage system,BP,
6155,GO:0019470,1,0.980824704919102,0,4,4-hydroxyproline catabolic process,BP,
6156,GO:0019471,1,0.927354225047031,0,12,4-hydroxyproline metabolic process,BP,
6157,GO:0019474,1,0.985550406988491,0,3,L-lysine catabolic process to acetyl-CoA,BP,
6158,GO:0019477,1,0.985550406988491,0,3,L-lysine catabolic process,BP,
6159,GO:0019482,1,0.990754965268371,0,2,beta-alanine metabolic process,BP,
6160,GO:0019483,1,0.99536678233859,0,1,beta-alanine biosynthetic process,BP,
6161,GO:0019493,1,0.993628847786826,0,1,arginine catabolic process to proline,BP,
6162,GO:0019509,1,0.960663748625089,0,5,L-methionine salvage from methylthioadenosine,BP,
6163,GO:0019510,1,0.994936976655377,0,1,S-adenosylhomocysteine catabolic process,BP,
6164,GO:0019511,1,0.94863592240577,0,11,peptidyl-proline hydroxylation,BP,
6165,GO:0019516,1,0.995333062328682,0,1,lactate oxidation,BP,
6166,GO:0019518,1,0.989768869500158,0,1,L-threonine catabolic process to glycine,BP,
6167,GO:0019519,1,0.995296708755865,0,1,pentitol metabolic process,BP,
6168,GO:0019520,1,0.988773024196616,0,2,aldonic acid metabolic process,BP,
6169,GO:0019521,1,0.988773024196616,0,2,D-gluconate metabolic process,BP,
6170,GO:0019527,1,0.995296708755865,0,1,pentitol catabolic process,BP,
6171,GO:0019530,1,0.981590601421264,0,4,taurine metabolic process,BP,
6172,GO:0019531,1,0.977033401398438,0,5,oxalate transmembrane transporter activity,MF,
6173,GO:0019532,1,0.977033401398438,0,5,oxalate transport,BP,
6174,GO:0019534,1,0.98159455850844,0,4,toxin transmembrane transporter activity,MF,
6176,GO:0019541,1,0.984347078059097,0,3,propionate metabolic process,BP,
6177,GO:0019542,1,0.990754884941477,0,2,propionate biosynthetic process,BP,
6178,GO:0019543,1,0.993533089308813,0,1,propionate catabolic process,BP,
6179,GO:0019544,1,0.993628847786826,0,1,arginine catabolic process to glutamate,BP,
6180,GO:0019547,1,0.981536093209012,0,2,arginine catabolic process to ornithine,BP,
6181,GO:0019550,1,0.989649324267882,0,2,glutamate catabolic process to aspartate,BP,
6182,GO:0019551,1,0.989649324267882,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6183,GO:0019556,1,0.995366801879365,0,1,histidine catabolic process to glutamate and formamide,BP,
6184,GO:0019557,1,0.995366801879365,0,1,histidine catabolic process to glutamate and formate,BP,
6185,GO:0019563,1,0.969806871556361,0,5,glycerol catabolic process,BP,
6186,GO:0019585,1,0.91199518657162,0,12,glucuronate metabolic process,BP,
6187,GO:0019605,1,0.99321405027932,0,1,butyrate metabolic process,BP,
6188,GO:0019614,1,0.970013280511435,0,5,catechol-containing compound catabolic process,BP,
6189,GO:0019626,1,0.943040776505418,0,7,short-chain fatty acid catabolic process,BP,
6190,GO:0019627,1,0.931717392877981,0,10,urea metabolic process,BP,
6192,GO:0019640,1,0.944380803966037,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6194,GO:0019659,1,0.995366574475227,0,1,glucose catabolic process to lactate,BP,
6195,GO:0019660,1,0.995366574475227,0,1,glycolytic fermentation,BP,
6196,GO:0019661,1,0.995366574475227,0,1,glucose catabolic process to lactate via pyruvate,BP,
6197,GO:0019666,1,0.995366574475227,0,1,nitrogenous compound fermentation,BP,
6198,GO:0019673,1,0.921443649169266,0,7,GDP-mannose metabolic process,BP,
6199,GO:0019674,1,0.730955788972477,0,48,NAD metabolic process,BP,
6200,GO:0019676,1,0.995366990826152,0,1,ammonia assimilation cycle,BP,
6201,GO:0019677,1,0.995366946678943,0,1,NAD catabolic process,BP,
6202,GO:0019682,1,0.854865085640318,0,20,glyceraldehyde-3-phosphate metabolic process,BP,
6203,GO:0019692,1,0.736283741239009,0,29,deoxyribose phosphate metabolic process,BP,
6205,GO:0019694,1,0.981590601421264,0,4,alkanesulfonate metabolic process,BP,
6206,GO:0019695,1,0.981438056761724,0,4,choline metabolic process,BP,
6207,GO:0019706,1,0.857523523632903,0,23,protein-cysteine S-palmitoyltransferase activity,MF,
6208,GO:0019707,1,0.857523523632903,0,23,protein-cysteine S-acyltransferase activity,MF,
6209,GO:0019720,1,0.964383602340493,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6210,GO:0019722,1,0.517382829773858,0,93,calcium-mediated signaling,BP,
6211,GO:0019724,1,0.692171623069803,0,58,B cell mediated immunity,BP,
6213,GO:0019730,1,0.464539476382018,0,39,antimicrobial humoral response,BP,
6214,GO:0019731,1,0.680464515596887,0,17,antibacterial humoral response,BP,
6215,GO:0019732,1,0.990754408240157,0,2,antifungal humoral response,BP,
6216,GO:0019740,1,0.966257677225969,0,3,nitrogen utilization,BP,
6217,GO:0019742,1,0.995162314705154,0,1,pentacyclic triterpenoid metabolic process,BP,
6218,GO:0019747,1,0.977220762612495,0,1,regulation of isoprenoid metabolic process,BP,
6219,GO:0019748,1,0.746597501690461,0,36,secondary metabolic process,BP,
6220,GO:0019751,1,0.563853909807483,0,86,polyol metabolic process,BP,
6222,GO:0019755,1,0.974205996904746,0,4,one-carbon compound transport,BP,
6223,GO:0019763,1,0.987257559912667,0,2,immunoglobulin receptor activity,MF,
6224,GO:0019770,1,0.99185325693685,0,1,IgG receptor activity,MF,
6225,GO:0019773,1,0.87760487262372,0,7,proteasome core complex, alpha-subunit complex,CC,
6226,GO:0019774,1,0.809360603103486,0,10,proteasome core complex, beta-subunit complex,CC,
6227,GO:0019776,1,0.975310394675737,0,3,Atg8 ligase activity,MF,
6228,GO:0019777,1,0.9795671034642,0,2,Atg12 transferase activity,MF,
6229,GO:0019778,1,0.995366990826165,0,1,Atg12 activating enzyme activity,MF,
6230,GO:0019779,1,0.995366990826165,0,1,Atg8 activating enzyme activity,MF,
6231,GO:0019780,1,0.9953669908261,0,1,FAT10 activating enzyme activity,MF,
6232,GO:0019781,1,0.986812784389013,0,2,NEDD8 activating enzyme activity,MF,
6233,GO:0019782,1,0.995366894950483,0,1,ISG15 activating enzyme activity,MF,
6234,GO:0019783,1,0.549352953160163,0,97,ubiquitin-like protein-specific protease activity,MF,
6235,GO:0019784,1,0.934384188484793,0,7,NEDD8-specific protease activity,MF,
6236,GO:0019785,1,0.989354272203577,0,2,ISG15-specific protease activity,MF,
6238,GO:0019788,1,0.925214389102993,0,6,NEDD8 transferase activity,MF,
6239,GO:0019789,1,0.895045289494837,0,16,SUMO transferase activity,MF,
6240,GO:0019797,1,0.986163293387401,0,3,procollagen-proline 3-dioxygenase activity,MF,
6241,GO:0019798,1,0.971933155406407,0,6,procollagen-proline dioxygenase activity,MF,
6242,GO:0019799,1,0.995366574475227,0,1,tubulin N-acetyltransferase activity,MF,
6243,GO:0019800,1,0.988513002501939,0,1,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
6244,GO:0019808,1,0.956565743739604,0,3,polyamine binding,MF,
6245,GO:0019809,1,0.961020311021029,0,2,spermidine binding,MF,
6246,GO:0019810,1,0.995366864645357,0,1,putrescine binding,MF,
6247,GO:0019811,1,0.995366990826164,0,1,cocaine binding,MF,
6248,GO:0019814,1,0.995366990826164,0,1,immunoglobulin complex,CC,
6249,GO:0019815,1,0.995366990826164,0,1,B cell receptor complex,CC,
6250,GO:0019825,1,0.940529078048735,0,11,oxygen binding,MF,
6251,GO:0019826,1,0.989736141421502,0,2,oxygen sensor activity,MF,
6253,GO:0019828,1,0.9855963679086,0,1,aspartic-type endopeptidase inhibitor activity,MF,
6254,GO:0019829,1,0.755222625458571,0,34,cation-transporting ATPase activity,MF,
6255,GO:0019834,1,0.968223370246857,0,3,phospholipase A2 inhibitor activity,MF,
6256,GO:0019835,1,0.81959151795963,0,17,cytolysis,BP,
6257,GO:0019838,1,0.557155041416273,0,86,growth factor binding,MF,
6258,GO:0019840,1,0.892429543493122,0,13,isoprenoid binding,MF,
6259,GO:0019841,1,0.93112313888562,0,4,retinol binding,MF,
6260,GO:0019842,1,0.551702632571043,0,84,vitamin binding,MF,
6263,GO:0019853,1,0.988214398421963,0,1,L-ascorbic acid biosynthetic process,BP,
6264,GO:0019855,1,0.922192243763175,0,8,calcium channel inhibitor activity,MF,
6265,GO:0019856,1,0.971284148650771,0,6,pyrimidine nucleobase biosynthetic process,BP,
6266,GO:0019857,1,0.986164531023092,0,3,5-methylcytosine metabolic process,BP,
6267,GO:0019858,1,0.974004122820123,0,2,cytosine metabolic process,BP,
6268,GO:0019859,1,0.990006073383965,0,2,thymine metabolic process,BP,
6269,GO:0019860,1,0.985195722140128,0,2,uracil metabolic process,BP,
6270,GO:0019862,1,0.989554226404695,0,1,IgA binding,MF,
6271,GO:0019863,1,0.987144146680788,0,1,IgE binding,MF,
6272,GO:0019864,1,0.99185325693685,0,1,IgG binding,MF,
6273,GO:0019865,1,0.968871016362596,0,3,immunoglobulin binding,MF,
6275,GO:0019867,1,0.294038552669074,0,165,outer membrane,CC,
6276,GO:0019869,1,0.921239336886607,0,7,chloride channel inhibitor activity,MF,
6277,GO:0019870,1,0.966453190885584,0,5,potassium channel inhibitor activity,MF,
6278,GO:0019871,1,0.974379075075107,0,5,sodium channel inhibitor activity,MF,
6279,GO:0019878,1,0.990754750402817,0,2,lysine biosynthetic process via aminoadipic acid,BP,
6280,GO:0019882,1,0.206877864774625,0,171,antigen processing and presentation,BP,
6281,GO:0019883,1,0.919571928550429,0,11,antigen processing and presentation of endogenous antigen,BP,
6282,GO:0019884,1,0.254506353341822,0,144,antigen processing and presentation of exogenous antigen,BP,
6283,GO:0019885,1,0.950355329122442,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6284,GO:0019886,1,0.58864738849644,0,74,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,
6285,GO:0019887,1,0.36570134851155,0,146,protein kinase regulator activity,MF,
6286,GO:0019888,1,0.670066215420585,0,61,protein phosphatase regulator activity,MF,
6287,GO:0019894,1,0.847386356734548,0,34,kinesin binding,MF,
6288,GO:0019896,1,0.933597892449317,0,11,axonal transport of mitochondrion,BP,
6294,GO:0019902,1,0.459225216926687,0,142,phosphatase binding,MF,
6295,GO:0019903,1,0.572766582002992,0,99,protein phosphatase binding,MF,
6297,GO:0019905,1,0.690918105473644,0,63,syntaxin binding,MF,
6298,GO:0019907,1,0.947762141872993,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6299,GO:0019908,1,0.900587532213453,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6300,GO:0019911,1,0.944405402237527,0,8,structural constituent of myelin sheath,MF,
6301,GO:0019912,1,0.989726083738468,0,2,cyclin-dependent protein kinase activating kinase activity,MF,
6302,GO:0019915,1,0.747021210034935,0,45,lipid storage,BP,
6303,GO:0019918,1,0.981231725778713,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6304,GO:0019919,1,0.959364317321788,0,7,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6307,GO:0019934,1,0.964997771592395,0,5,cGMP-mediated signaling,BP,
6310,GO:0019948,1,0.990617567103177,0,2,SUMO activating enzyme activity,MF,
6312,GO:0019955,1,0.68677605388311,0,58,cytokine binding,MF,
6313,GO:0019956,1,0.932329256589025,0,11,chemokine binding,MF,
6314,GO:0019957,1,0.987049117459776,0,2,C-C chemokine binding,MF,
6315,GO:0019958,1,0.986053229107992,0,3,C-X-C chemokine binding,MF,
6316,GO:0019959,1,0.995255140810226,0,1,interleukin-8 binding,MF,
6317,GO:0019960,1,0.986164526042669,0,3,C-X3-C chemokine binding,MF,
6318,GO:0019961,1,0.990755150795232,0,2,interferon binding,MF,
6319,GO:0019962,1,0.995366990826112,0,1,type I interferon binding,MF,
6320,GO:0019964,1,0.995366941546433,0,1,interferon-gamma binding,MF,
6321,GO:0019966,1,0.943978980148385,0,7,interleukin-1 binding,MF,
6322,GO:0019970,1,0.99536682795566,0,1,interleukin-11 binding,MF,
6323,GO:0019981,1,0.990755037724745,0,2,interleukin-6 binding,MF,
6324,GO:0019985,1,0.719449605041388,0,39,translesion synthesis,BP,
6325,GO:0019988,1,0.995365609716794,0,1,charged-tRNA amino acid modification,BP,
6326,GO:0019992,1,0.951246232106698,0,8,diacylglycerol binding,MF,
6327,GO:0020003,1,0.995366574475227,0,1,symbiont-containing vacuole,CC,
6328,GO:0020012,1,0.990751078558827,0,2,evasion or tolerance of host immune response,BP,
6329,GO:0020016,1,0.98616447848673,0,3,ciliary pocket,CC,
6330,GO:0020018,1,0.98616447848673,0,3,ciliary pocket membrane,CC,
6331,GO:0020021,1,0.989782138899612,0,1,immortalization of host cell,BP,
6332,GO:0020027,1,0.954056410258091,0,8,hemoglobin metabolic process,BP,
6334,GO:0021501,1,0.994200464464166,0,1,prechordal plate formation,BP,
6335,GO:0021502,1,0.990755199847072,0,2,neural fold elevation formation,BP,
6336,GO:0021503,1,0.995366990826008,0,1,neural fold bending,BP,
6337,GO:0021508,1,0.995366990826074,0,1,floor plate formation,BP,
6338,GO:0021510,1,0.783708794100295,0,47,spinal cord development,BP,
6339,GO:0021511,1,0.963476236874436,0,8,spinal cord patterning,BP,
6340,GO:0021512,1,0.995366990826153,0,1,spinal cord anterior/posterior patterning,BP,
6341,GO:0021513,1,0.967962497649343,0,7,spinal cord dorsal/ventral patterning,BP,
6342,GO:0021514,1,0.98159488873335,0,4,ventral spinal cord interneuron differentiation,BP,
6343,GO:0021515,1,0.91418483036569,0,17,cell differentiation in spinal cord,BP,
6344,GO:0021516,1,0.990751420099281,0,2,dorsal spinal cord development,BP,
6345,GO:0021517,1,0.914184811197831,0,17,ventral spinal cord development,BP,
6346,GO:0021520,1,0.967552213135645,0,6,spinal cord motor neuron cell fate specification,BP,
6347,GO:0021521,1,0.986164531023532,0,3,ventral spinal cord interneuron specification,BP,
6348,GO:0021522,1,0.918444157792335,0,16,spinal cord motor neuron differentiation,BP,
6349,GO:0021523,1,0.986600671710982,0,2,somatic motor neuron differentiation,BP,
6350,GO:0021524,1,0.987605266899605,0,2,visceral motor neuron differentiation,BP,
6351,GO:0021526,1,0.992831961903632,0,1,medial motor column neuron differentiation,BP,
6352,GO:0021527,1,0.995366990826153,0,1,spinal cord association neuron differentiation,BP,
6354,GO:0021533,1,0.952211148290681,0,9,cell differentiation in hindbrain,BP,
6355,GO:0021534,1,0.962825011209782,0,5,cell proliferation in hindbrain,BP,
6356,GO:0021535,1,0.953786290832742,0,10,cell migration in hindbrain,BP,
6359,GO:0021538,1,0.995366956481041,0,1,epithalamus development,BP,
6360,GO:0021539,1,0.984588621776052,0,2,subthalamus development,BP,
6361,GO:0021540,1,0.955416726533592,0,4,corpus callosum morphogenesis,BP,
6362,GO:0021541,1,0.995366990826153,0,1,ammon gyrus development,BP,
6363,GO:0021542,1,0.94594738853756,0,8,dentate gyrus development,BP,
6364,GO:0021543,1,0.492355325364263,0,113,pallium development,BP,
6365,GO:0021544,1,0.91918708458711,0,16,subpallium development,BP,
6367,GO:0021546,1,0.985353005276201,0,2,rhombomere development,BP,
6368,GO:0021547,1,0.994200464464166,0,1,midbrain-hindbrain boundary initiation,BP,
6369,GO:0021548,1,0.971536879665535,0,5,pons development,BP,
6370,GO:0021549,1,0.724832912463776,0,56,cerebellum development,BP,
6371,GO:0021553,1,0.995366990825915,0,1,olfactory nerve development,BP,
6372,GO:0021554,1,0.953040489138901,0,6,optic nerve development,BP,
6376,GO:0021559,1,0.972409064745484,0,6,trigeminal nerve development,BP,
6377,GO:0021560,1,0.990598792296535,0,2,abducens nerve development,BP,
6378,GO:0021561,1,0.967109604788291,0,6,facial nerve development,BP,
6379,GO:0021562,1,0.981488482422003,0,4,vestibulocochlear nerve development,BP,
6380,GO:0021563,1,0.990755068968709,0,2,glossopharyngeal nerve development,BP,
6381,GO:0021564,1,0.98454279703211,0,2,vagus nerve development,BP,
6382,GO:0021566,1,0.995366990826165,0,1,hypoglossal nerve development,BP,
6383,GO:0021569,1,0.989940024638352,0,1,rhombomere 3 development,BP,
6384,GO:0021570,1,0.989940024638352,0,1,rhombomere 4 development,BP,
6385,GO:0021571,1,0.995366904175501,0,1,rhombomere 5 development,BP,
6386,GO:0021572,1,0.995366904175501,0,1,rhombomere 6 development,BP,
6388,GO:0021577,1,0.995366990774029,0,1,hindbrain structural organization,BP,
6389,GO:0021578,1,0.986164528741871,0,3,hindbrain maturation,BP,
6390,GO:0021586,1,0.995366989296734,0,1,pons maturation,BP,
6391,GO:0021587,1,0.875592346059906,0,24,cerebellum morphogenesis,BP,
6392,GO:0021589,1,0.995366990774029,0,1,cerebellum structural organization,BP,
6393,GO:0021590,1,0.990755199079322,0,2,cerebellum maturation,BP,
6394,GO:0021591,1,0.864877016943121,0,17,ventricular system development,BP,
6395,GO:0021592,1,0.995366990826152,0,1,fourth ventricle development,BP,
6396,GO:0021598,1,0.990598792296535,0,2,abducens nerve morphogenesis,BP,
6397,GO:0021599,1,0.990598792296535,0,2,abducens nerve formation,BP,
6398,GO:0021602,1,0.921533975529658,0,15,cranial nerve morphogenesis,BP,
6399,GO:0021603,1,0.981439803416832,0,4,cranial nerve formation,BP,
6400,GO:0021604,1,0.971612586055688,0,5,cranial nerve structural organization,BP,
6401,GO:0021610,1,0.967109604788291,0,6,facial nerve morphogenesis,BP,
6402,GO:0021612,1,0.971612586055688,0,5,facial nerve structural organization,BP,
6403,GO:0021615,1,0.995366859343621,0,1,glossopharyngeal nerve morphogenesis,BP,
6404,GO:0021618,1,0.995366990826165,0,1,hypoglossal nerve morphogenesis,BP,
6405,GO:0021622,1,0.995366881964039,0,1,oculomotor nerve morphogenesis,BP,
6406,GO:0021623,1,0.995366881964039,0,1,oculomotor nerve formation,BP,
6407,GO:0021626,1,0.986164528741871,0,3,central nervous system maturation,BP,
6408,GO:0021631,1,0.986164531023597,0,3,optic nerve morphogenesis,BP,
6409,GO:0021636,1,0.98148844792764,0,4,trigeminal nerve morphogenesis,BP,
6410,GO:0021637,1,0.98148844792764,0,4,trigeminal nerve structural organization,BP,
6411,GO:0021644,1,0.989126001962687,0,1,vagus nerve morphogenesis,BP,
6412,GO:0021648,1,0.990647811994283,0,2,vestibulocochlear nerve morphogenesis,BP,
6413,GO:0021649,1,0.995259108849138,0,1,vestibulocochlear nerve structural organization,BP,
6414,GO:0021650,1,0.995366990826125,0,1,vestibulocochlear nerve formation,BP,
6415,GO:0021670,1,0.93994200305844,0,8,lateral ventricle development,BP,
6417,GO:0021678,1,0.94024438222838,0,3,third ventricle development,BP,
6418,GO:0021679,1,0.990754838117631,0,2,cerebellar molecular layer development,BP,
6419,GO:0021680,1,0.925775920360783,0,15,cerebellar Purkinje cell layer development,BP,
6420,GO:0021681,1,0.946020430381452,0,7,cerebellar granular layer development,BP,
6421,GO:0021682,1,0.995366990826138,0,1,nerve maturation,BP,
6422,GO:0021683,1,0.972588141774126,0,5,cerebellar granular layer morphogenesis,BP,
6423,GO:0021684,1,0.982168557571498,0,3,cerebellar granular layer formation,BP,
6424,GO:0021685,1,0.99536699082606,0,1,cerebellar granular layer structural organization,BP,
6425,GO:0021687,1,0.990754838117631,0,2,cerebellar molecular layer morphogenesis,BP,
6426,GO:0021688,1,0.995366887726606,0,1,cerebellar molecular layer formation,BP,
6427,GO:0021691,1,0.990755199079322,0,2,cerebellar Purkinje cell layer maturation,BP,
6428,GO:0021692,1,0.962861708354071,0,8,cerebellar Purkinje cell layer morphogenesis,BP,
6429,GO:0021693,1,0.990755097221854,0,2,cerebellar Purkinje cell layer structural organization,BP,
6430,GO:0021694,1,0.976374103407934,0,5,cerebellar Purkinje cell layer formation,BP,
6431,GO:0021695,1,0.824251183768374,0,31,cerebellar cortex development,BP,
6432,GO:0021696,1,0.89713048189298,0,19,cerebellar cortex morphogenesis,BP,
6433,GO:0021697,1,0.929132494599716,0,12,cerebellar cortex formation,BP,
6434,GO:0021698,1,0.990755097221854,0,2,cerebellar cortex structural organization,BP,
6435,GO:0021699,1,0.990755199079322,0,2,cerebellar cortex maturation,BP,
6437,GO:0021702,1,0.976374103407934,0,5,cerebellar Purkinje cell differentiation,BP,
6438,GO:0021707,1,0.982168557571498,0,3,cerebellar granule cell differentiation,BP,
6439,GO:0021718,1,0.995366989296734,0,1,superior olivary nucleus development,BP,
6440,GO:0021722,1,0.995366989296734,0,1,superior olivary nucleus maturation,BP,
6441,GO:0021730,1,0.995366990826007,0,1,trigeminal sensory nucleus development,BP,
6442,GO:0021740,1,0.995366990826007,0,1,principal sensory nucleus of trigeminal nerve development,BP,
6443,GO:0021747,1,0.98616452941534,0,3,cochlear nucleus development,BP,
6444,GO:0021756,1,0.932913960639921,0,13,striatum development,BP,
6445,GO:0021757,1,0.995366975109459,0,1,caudate nucleus development,BP,
6446,GO:0021758,1,0.995366975109459,0,1,putamen development,BP,
6447,GO:0021761,1,0.653076247291252,0,64,limbic system development,BP,
6448,GO:0021762,1,0.779160800446328,0,31,substantia nigra development,BP,
6449,GO:0021763,1,0.99478017495951,0,1,subthalamic nucleus development,BP,
6450,GO:0021764,1,0.990755199848915,0,2,amygdala development,BP,
6451,GO:0021766,1,0.728851578394336,0,49,hippocampus development,BP,
6452,GO:0021768,1,0.995366949580277,0,1,nucleus accumbens development,BP,
6453,GO:0021769,1,0.984426695132125,0,3,orbitofrontal cortex development,BP,
6454,GO:0021771,1,0.995366990826125,0,1,lateral geniculate nucleus development,BP,
6455,GO:0021772,1,0.907502484040554,0,17,olfactory bulb development,BP,
6456,GO:0021773,1,0.985368140964064,0,3,striatal medium spiny neuron differentiation,BP,
6457,GO:0021775,1,0.986164531023532,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6458,GO:0021776,1,0.986164531023532,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6459,GO:0021778,1,0.99536699082598,0,1,oligodendrocyte cell fate specification,BP,
6460,GO:0021779,1,0.99536699082598,0,1,oligodendrocyte cell fate commitment,BP,
6461,GO:0021780,1,0.99536699082598,0,1,glial cell fate specification,BP,
6466,GO:0021785,1,0.9724128356169,0,6,branchiomotor neuron axon guidance,BP,
6467,GO:0021794,1,0.962060320352396,0,7,thalamus development,BP,
6468,GO:0021795,1,0.854609162683321,0,30,cerebral cortex cell migration,BP,
6469,GO:0021796,1,0.986163589467794,0,3,cerebral cortex regionalization,BP,
6470,GO:0021797,1,0.995366920643499,0,1,forebrain anterior/posterior pattern specification,BP,
6471,GO:0021798,1,0.990755199849149,0,2,forebrain dorsal/ventral pattern formation,BP,
6472,GO:0021799,1,0.893228958560883,0,21,cerebral cortex radially oriented cell migration,BP,
6473,GO:0021800,1,0.976940258920237,0,5,cerebral cortex tangential migration,BP,
6474,GO:0021801,1,0.910211139574778,0,17,cerebral cortex radial glia guided migration,BP,
6475,GO:0021812,1,0.995366990826125,0,1,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6476,GO:0021814,1,0.967112218914946,0,7,cell motility involved in cerebral cortex radial glia guided migration,BP,
6477,GO:0021815,1,0.977045761415218,0,5,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6478,GO:0021816,1,0.990754785405289,0,2,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,BP,
6479,GO:0021817,1,0.986164523353063,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6480,GO:0021819,1,0.940458111877462,0,10,layer formation in cerebral cortex,BP,
6481,GO:0021822,1,0.99444335333573,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
6482,GO:0021823,1,0.990755199849174,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6483,GO:0021824,1,0.990647811994295,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6484,GO:0021825,1,0.981488482421937,0,4,substrate-dependent cerebral cortex tangential migration,BP,
6485,GO:0021826,1,0.990510734687873,0,2,substrate-independent telencephalic tangential migration,BP,
6486,GO:0021827,1,0.990755199849174,0,2,postnatal olfactory bulb interneuron migration,BP,
6487,GO:0021828,1,0.990647811994295,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6488,GO:0021830,1,0.990510734687873,0,2,interneuron migration from the subpallium to the cortex,BP,
6489,GO:0021836,1,0.990755199849174,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6490,GO:0021840,1,0.995121487827804,0,1,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6491,GO:0021842,1,0.995121487827804,0,1,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
6492,GO:0021843,1,0.990510734687873,0,2,substrate-independent telencephalic tangential interneuron migration,BP,
6493,GO:0021846,1,0.933234372226322,0,14,cell proliferation in forebrain,BP,
6494,GO:0021847,1,0.990755199849241,0,2,ventricular zone neuroblast division,BP,
6495,GO:0021849,1,0.99075514331248,0,2,neuroblast division in subventricular zone,BP,
6496,GO:0021854,1,0.909203270733277,0,11,hypothalamus development,BP,
6497,GO:0021855,1,0.98547624482171,0,3,hypothalamus cell migration,BP,
6498,GO:0021856,1,0.990647811994295,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
6499,GO:0021859,1,0.971536882743324,0,5,pyramidal neuron differentiation,BP,
6500,GO:0021860,1,0.971536882743324,0,5,pyramidal neuron development,BP,
6502,GO:0021869,1,0.98616453102369,0,3,forebrain ventricular zone progenitor cell division,BP,
6503,GO:0021870,1,0.995366990826112,0,1,Cajal-Retzius cell differentiation,BP,
6504,GO:0021871,1,0.946486103625356,0,11,forebrain regionalization,BP,
6506,GO:0021873,1,0.972518208074278,0,6,forebrain neuroblast division,BP,
6507,GO:0021877,1,0.976187211235881,0,5,forebrain neuron fate commitment,BP,
6509,GO:0021881,1,0.995366920643499,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
6510,GO:0021882,1,0.989884390067244,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6511,GO:0021884,1,0.893057074585293,0,16,forebrain neuron development,BP,
6512,GO:0021885,1,0.827017447612489,0,37,forebrain cell migration,BP,
6513,GO:0021886,1,0.96962086821756,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6514,GO:0021888,1,0.96962086821756,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
6515,GO:0021889,1,0.964197793086151,0,6,olfactory bulb interneuron differentiation,BP,
6516,GO:0021891,1,0.976536009221646,0,5,olfactory bulb interneuron development,BP,
6517,GO:0021892,1,0.970817250063981,0,3,cerebral cortex GABAergic interneuron differentiation,BP,
6518,GO:0021893,1,0.989884390067244,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
6519,GO:0021894,1,0.980740240973417,0,1,cerebral cortex GABAergic interneuron development,BP,
6520,GO:0021895,1,0.93214983409739,0,10,cerebral cortex neuron differentiation,BP,
6521,GO:0021896,1,0.990755199848965,0,2,forebrain astrocyte differentiation,BP,
6522,GO:0021897,1,0.990755199848965,0,2,forebrain astrocyte development,BP,
6523,GO:0021898,1,0.985297640482974,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
6524,GO:0021902,1,0.990755199849162,0,2,commitment of neuronal cell to specific neuron type in forebrain,BP,
6526,GO:0021904,1,0.911754589732779,0,18,dorsal/ventral neural tube patterning,BP,
6527,GO:0021910,1,0.972469536749486,0,6,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6528,GO:0021914,1,0.990705535728344,0,2,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6530,GO:0021924,1,0.962825011209782,0,5,cell proliferation in external granule layer,BP,
6531,GO:0021930,1,0.962825011209782,0,5,cerebellar granule cell precursor proliferation,BP,
6532,GO:0021932,1,0.967172725796358,0,7,hindbrain radial glia guided cell migration,BP,
6533,GO:0021934,1,0.990755199848992,0,2,hindbrain tangential cell migration,BP,
6534,GO:0021935,1,0.990755199848992,0,2,cerebellar granule cell precursor tangential migration,BP,
6535,GO:0021936,1,0.986164524598082,0,3,regulation of cerebellar granule cell precursor proliferation,BP,
6536,GO:0021937,1,0.990755193394043,0,2,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6537,GO:0021938,1,0.990755193394043,0,2,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6538,GO:0021940,1,0.990755193394043,0,2,positive regulation of cerebellar granule cell precursor proliferation,BP,
6539,GO:0021941,1,0.995366990826164,0,1,negative regulation of cerebellar granule cell precursor proliferation,BP,
6540,GO:0021942,1,0.985310675463283,0,3,radial glia guided migration of Purkinje cell,BP,
6541,GO:0021943,1,0.981594757709678,0,4,formation of radial glial scaffolds,BP,
6542,GO:0021952,1,0.907801301632914,0,15,central nervous system projection neuron axonogenesis,BP,
6544,GO:0021954,1,0.752595440380374,0,42,central nervous system neuron development,BP,
6545,GO:0021955,1,0.885264974474613,0,20,central nervous system neuron axonogenesis,BP,
6546,GO:0021956,1,0.993724238835064,0,1,central nervous system interneuron axonogenesis,BP,
6547,GO:0021957,1,0.981594874308438,0,4,corticospinal tract morphogenesis,BP,
6548,GO:0021960,1,0.986160223982028,0,3,anterior commissure morphogenesis,BP,
6549,GO:0021965,1,0.990755199849213,0,2,spinal cord ventral commissure morphogenesis,BP,
6550,GO:0021966,1,0.995366990826165,0,1,corticospinal neuron axon guidance,BP,
6551,GO:0021972,1,0.995366990826165,0,1,corticospinal neuron axon guidance through spinal cord,BP,
6552,GO:0021978,1,0.973792942143537,0,5,telencephalon regionalization,BP,
6553,GO:0021979,1,0.965127014035082,0,4,hypothalamus cell differentiation,BP,
6556,GO:0021986,1,0.995366956481041,0,1,habenula development,BP,
6557,GO:0021987,1,0.60060107913188,0,82,cerebral cortex development,BP,
6558,GO:0021988,1,0.903293236929494,0,18,olfactory lobe development,BP,
6559,GO:0021993,1,0.995366990826152,0,1,initiation of neural tube closure,BP,
6560,GO:0021997,1,0.99075519984911,0,2,neural plate axis specification,BP,
6561,GO:0021998,1,0.995366972215419,0,1,neural plate mediolateral regionalization,BP,
6562,GO:0021999,1,0.969042685290851,0,5,neural plate anterior/posterior regionalization,BP,
6563,GO:0022007,1,0.986163877188497,0,3,convergent extension involved in neural plate elongation,BP,
6565,GO:0022009,1,0.977616962210817,0,4,central nervous system vasculogenesis,BP,
6567,GO:0022011,1,0.887258576027411,0,21,myelination in peripheral nervous system,BP,
6568,GO:0022012,1,0.995366990826007,0,1,subpallium cell proliferation in forebrain,BP,
6569,GO:0022018,1,0.995366990826007,0,1,lateral ganglionic eminence cell proliferation,BP,
6570,GO:0022027,1,0.981594888732948,0,4,interkinetic nuclear migration,BP,
6571,GO:0022028,1,0.981594888733467,0,4,tangential migration from the subventricular zone to the olfactory bulb,BP,
6572,GO:0022029,1,0.838644341350789,0,34,telencephalon cell migration,BP,
6573,GO:0022030,1,0.910211139574778,0,17,telencephalon glial cell migration,BP,
6575,GO:0022038,1,0.902457416066822,0,13,corpus callosum development,BP,
6576,GO:0022400,1,0.944610144356103,0,11,regulation of rhodopsin mediated signaling pathway,BP,
6577,GO:0022401,1,0.919135992419286,0,12,negative adaptation of signaling pathway,BP,
6585,GO:0022410,1,0.894637623063723,0,9,circadian sleep/wake cycle process,BP,
6587,GO:0022412,1,0.29582339643354,0,186,cellular process involved in reproduction in multicellular organism,BP,
6589,GO:0022417,1,0.898236467488978,0,9,protein maturation by protein folding,BP,
6591,GO:0022602,1,0.871026318099498,0,26,ovulation cycle process,BP,
6594,GO:0022605,1,0.957639123891643,0,4,mammalian oogenesis stage,BP,
6599,GO:0022614,1,0.981594559459741,0,4,membrane to membrane docking,BP,
6600,GO:0022615,1,0.970253523807304,0,4,protein to membrane docking,BP,
6601,GO:0022616,1,0.840017195450865,0,25,DNA strand elongation,BP,
6602,GO:0022617,1,0.68602647375053,0,57,extracellular matrix disassembly,BP,
6604,GO:0022622,1,0.974537838279069,0,1,root system development,BP,
6605,GO:0022624,1,0.778826583947108,0,24,proteasome accessory complex,CC,
6612,GO:0022824,1,0.966866420513809,0,7,transmitter-gated ion channel activity,MF,
6613,GO:0022829,1,0.91861414833824,0,13,wide pore channel activity,MF,
6615,GO:0022834,1,0.812773575090212,0,40,ligand-gated channel activity,MF,
6616,GO:0022835,1,0.966866420513809,0,7,transmitter-gated channel activity,MF,
6620,GO:0022840,1,0.977410548076676,0,4,leak channel activity,MF,
6621,GO:0022841,1,0.98196180481487,0,3,potassium ion leak channel activity,MF,
6622,GO:0022842,1,0.977410548076676,0,4,narrow pore channel activity,MF,
6623,GO:0022843,1,0.823465272162995,0,38,voltage-gated cation channel activity,MF,
6624,GO:0022848,1,0.980434445753076,0,4,acetylcholine-gated cation-selective channel activity,MF,
6625,GO:0022849,1,0.995366990826164,0,1,glutamate-gated calcium ion channel activity,MF,
6626,GO:0022851,1,0.995366801879365,0,1,GABA-gated chloride ion channel activity,MF,
6627,GO:0022853,1,0.751712371212262,0,35,active ion transmembrane transporter activity,MF,
6629,GO:0022858,1,0.976923392602681,0,5,alanine transmembrane transporter activity,MF,
6630,GO:0022884,1,0.824045517597424,0,14,macromolecule transmembrane transporter activity,MF,
6631,GO:0022889,1,0.961636370683131,0,7,serine transmembrane transporter activity,MF,
6637,GO:0023016,1,0.990755084605851,0,2,signal transduction by trans-phosphorylation,BP,
6638,GO:0023019,1,0.947905586128346,0,9,signal transduction involved in regulation of gene expression,BP,
6639,GO:0023021,1,0.98560933014223,0,3,termination of signal transduction,BP,
6640,GO:0023023,1,0.914978921120777,0,12,MHC protein complex binding,MF,
6641,GO:0023024,1,0.995366827364554,0,1,MHC class I protein complex binding,MF,
6642,GO:0023025,1,0.990071963363009,0,2,MHC class Ib protein complex binding,MF,
6643,GO:0023026,1,0.924162329867634,0,10,MHC class II protein complex binding,MF,
6644,GO:0023029,1,0.980917552556291,0,4,MHC class Ib protein binding,MF,
6645,GO:0023030,1,0.990071963363009,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
6646,GO:0023035,1,0.966810138611709,0,6,CD40 signaling pathway,BP,
6647,GO:0023041,1,0.982189492353408,0,3,neuronal signal transduction,BP,
6652,GO:0023058,1,0.914830741246638,0,13,adaptation of signaling pathway,BP,
6655,GO:0030002,1,0.963359996129029,0,6,cellular anion homeostasis,BP,
6658,GO:0030007,1,0.963023663638406,0,7,cellular potassium ion homeostasis,BP,
6659,GO:0030008,1,0.841896394247887,0,13,TRAPP complex,CC,
6661,GO:0030011,1,0.946827028217454,0,9,maintenance of cell polarity,BP,
6662,GO:0030014,1,0.925937117101609,0,15,CCR4-NOT complex,CC,
6663,GO:0030015,1,0.97652503540177,0,5,CCR4-NOT core complex,CC,
6664,GO:0030016,1,0.411360953929779,0,124,myofibril,CC,
6665,GO:0030017,1,0.457750336149377,0,107,sarcomere,CC,
6666,GO:0030018,1,0.61027979720546,0,70,Z disc,CC,
6667,GO:0030020,1,0.986080483976358,0,3,extracellular matrix structural constituent conferring tensile strength,MF,
6668,GO:0030021,1,0.995366748653732,0,1,extracellular matrix structural constituent conferring compression resistance,MF,
6669,GO:0030023,1,0.986164531023154,0,3,extracellular matrix constituent conferring elasticity,MF,
6674,GO:0030032,1,0.758588964339688,0,49,lamellipodium assembly,BP,
6675,GO:0030033,1,0.914400373174502,0,15,microvillus assembly,BP,
6676,GO:0030035,1,0.986163828127921,0,3,microspike assembly,BP,
6678,GO:0030037,1,0.995366990826165,0,1,actin filament reorganization involved in cell cycle,BP,
6679,GO:0030038,1,0.681881025387434,0,68,contractile actin filament bundle assembly,BP,
6681,GO:0030042,1,0.820468952081031,0,35,actin filament depolymerization,BP,
6682,GO:0030043,1,0.966584100417305,0,4,actin filament fragmentation,BP,
6683,GO:0030046,1,0.986164367940146,0,3,parallel actin filament bundle assembly,BP,
6684,GO:0030047,1,0.98616425653681,0,3,actin modification,BP,
6685,GO:0030048,1,0.652619275209127,0,69,actin filament-based movement,BP,
6686,GO:0030049,1,0.851342279371974,0,14,muscle filament sliding,BP,
6687,GO:0030050,1,0.972517881910656,0,6,vesicle transport along actin filament,BP,
6690,GO:0030056,1,0.972518303431172,0,6,hemidesmosome,CC,
6691,GO:0030057,1,0.89441852602889,0,24,desmosome,CC,
6692,GO:0030060,1,0.964579393679803,0,3,L-malate dehydrogenase activity,MF,
6693,GO:0030061,1,0.972445895131808,0,5,mitochondrial crista,CC,
6694,GO:0030062,1,0.958674585192416,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
6695,GO:0030070,1,0.985995686662734,0,3,insulin processing,BP,
6696,GO:0030071,1,0.708003277232891,0,46,regulation of mitotic metaphase/anaphase transition,BP,
6699,GO:0030091,1,0.912179721770829,0,7,protein repair,BP,
6703,GO:0030100,1,0.338091856101184,0,157,regulation of endocytosis,BP,
6704,GO:0030101,1,0.710155956914621,0,40,natural killer cell activation,BP,
6705,GO:0030103,1,0.995366803504279,0,1,vasopressin secretion,BP,
6706,GO:0030104,1,0.77094394185151,0,48,water homeostasis,BP,
6707,GO:0030108,1,0.988214398421963,0,1,HLA-A specific activating MHC class I receptor activity,MF,
6709,GO:0030117,1,0.533771999900872,0,92,membrane coat,CC,
6711,GO:0030119,1,0.77389975600227,0,43,AP-type membrane coat adaptor complex,CC,
6712,GO:0030120,1,0.685969135000323,0,52,vesicle coat,CC,
6713,GO:0030121,1,0.962658959187743,0,6,AP-1 adaptor complex,CC,
6714,GO:0030122,1,0.925260486698311,0,12,AP-2 adaptor complex,CC,
6715,GO:0030123,1,0.949161027621729,0,9,AP-3 adaptor complex,CC,
6716,GO:0030124,1,0.972326728825671,0,4,AP-4 adaptor complex,CC,
6717,GO:0030125,1,0.842828407272351,0,24,clathrin vesicle coat,CC,
6718,GO:0030126,1,0.887734901683976,0,15,COPI vesicle coat,CC,
6719,GO:0030127,1,0.913041540611377,0,14,COPII vesicle coat,CC,
6720,GO:0030128,1,0.920969916614755,0,13,clathrin coat of endocytic vesicle,CC,
6721,GO:0030130,1,0.916754183899825,0,11,clathrin coat of trans-Golgi network vesicle,CC,
6722,GO:0030131,1,0.844730553440149,0,28,clathrin adaptor complex,CC,
6723,GO:0030132,1,0.88111900551966,0,17,clathrin coat of coated pit,CC,
6725,GO:0030134,1,0.584775338691085,0,68,COPII-coated ER to Golgi transport vesicle,CC,
6726,GO:0030135,1,0.23461041697899,0,208,coated vesicle,CC,
6727,GO:0030136,1,0.44924552734962,0,124,clathrin-coated vesicle,CC,
6728,GO:0030137,1,0.837266525477557,0,23,COPI-coated vesicle,CC,
6729,GO:0030139,1,0.225765587934739,0,208,endocytic vesicle,CC,
6730,GO:0030140,1,0.805170563595112,0,28,trans-Golgi network transport vesicle,CC,
6732,GO:0030144,1,0.985876353930532,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
6733,GO:0030145,1,0.776423825775415,0,41,manganese ion binding,MF,
6734,GO:0030148,1,0.621854715413975,0,78,sphingolipid biosynthetic process,BP,
6735,GO:0030149,1,0.872572213246131,0,19,sphingolipid catabolic process,BP,
6736,GO:0030150,1,0.82609127794429,0,18,protein import into mitochondrial matrix,BP,
6737,GO:0030151,1,0.981262315431229,0,4,molybdenum ion binding,MF,
6740,GO:0030156,1,0.973580318672233,0,1,benzodiazepine receptor binding,MF,
6741,GO:0030157,1,0.965526004280869,0,6,pancreatic juice secretion,BP,
6742,GO:0030158,1,0.986164092081947,0,3,protein xylosyltransferase activity,MF,
6743,GO:0030159,1,0.90848427352592,0,19,receptor signaling complex scaffold activity,MF,
6744,GO:0030160,1,0.983762841272052,0,3,GKAP/Homer scaffold activity,MF,
6747,GO:0030165,1,0.72721684852019,0,60,PDZ domain binding,MF,
6748,GO:0030166,1,0.799959400907252,0,44,proteoglycan biosynthetic process,BP,
6749,GO:0030167,1,0.982706838940314,0,3,proteoglycan catabolic process,BP,
6750,GO:0030168,1,0.521602306319619,0,103,platelet activation,BP,
6751,GO:0030169,1,0.972511284218005,0,6,low-density lipoprotein particle binding,MF,
6752,GO:0030170,1,0.834163081114893,0,33,pyridoxal phosphate binding,MF,
6753,GO:0030173,1,0.793106212390394,0,36,integral component of Golgi membrane,CC,
6754,GO:0030174,1,0.966097597265573,0,6,regulation of DNA-dependent DNA replication initiation,BP,
6755,GO:0030175,1,0.690909869045454,0,68,filopodium,CC,
6756,GO:0030176,1,0.430663214582187,0,123,integral component of endoplasmic reticulum membrane,CC,
6757,GO:0030177,1,0.313849344598026,0,135,positive regulation of Wnt signaling pathway,BP,
6760,GO:0030183,1,0.596125059271009,0,79,B cell differentiation,BP,
6761,GO:0030185,1,0.994254882565581,0,1,nitric oxide transport,BP,
6762,GO:0030193,1,0.74692125008823,0,46,regulation of blood coagulation,BP,
6763,GO:0030194,1,0.904708410993616,0,14,positive regulation of blood coagulation,BP,
6764,GO:0030195,1,0.829672065719822,0,30,negative regulation of blood coagulation,BP,
6765,GO:0030198,1,0.300456230138513,0,213,extracellular matrix organization,BP,
6766,GO:0030199,1,0.872725508096457,0,28,collagen fibril organization,BP,
6767,GO:0030200,1,0.982706838940314,0,3,heparan sulfate proteoglycan catabolic process,BP,
6768,GO:0030201,1,0.883157282876506,0,24,heparan sulfate proteoglycan metabolic process,BP,
6769,GO:0030202,1,0.981594862456498,0,4,heparin metabolic process,BP,
6770,GO:0030203,1,0.546019337806955,0,111,glycosaminoglycan metabolic process,BP,
6771,GO:0030204,1,0.863567797434424,0,27,chondroitin sulfate metabolic process,BP,
6772,GO:0030205,1,0.949846775660619,0,9,dermatan sulfate metabolic process,BP,
6773,GO:0030206,1,0.911901878314979,0,18,chondroitin sulfate biosynthetic process,BP,
6774,GO:0030207,1,0.947831046605939,0,9,chondroitin sulfate catabolic process,BP,
6775,GO:0030208,1,0.954961904917724,0,8,dermatan sulfate biosynthetic process,BP,
6776,GO:0030209,1,0.994646465207342,0,1,dermatan sulfate catabolic process,BP,
6777,GO:0030210,1,0.981594862456498,0,4,heparin biosynthetic process,BP,
6778,GO:0030212,1,0.873646576510966,0,25,hyaluronan metabolic process,BP,
6779,GO:0030213,1,0.941426973375397,0,11,hyaluronan biosynthetic process,BP,
6780,GO:0030214,1,0.9339481781904,0,13,hyaluronan catabolic process,BP,
6781,GO:0030215,1,0.924026795494282,0,17,semaphorin receptor binding,MF,
6784,GO:0030218,1,0.587563400055393,0,82,erythrocyte differentiation,BP,
6786,GO:0030220,1,0.91754803257045,0,14,platelet formation,BP,
6787,GO:0030222,1,0.995366972901915,0,1,eosinophil differentiation,BP,
6788,GO:0030223,1,0.946063918563754,0,6,neutrophil differentiation,BP,
6789,GO:0030224,1,0.849756962403429,0,24,monocyte differentiation,BP,
6790,GO:0030225,1,0.875291429891789,0,24,macrophage differentiation,BP,
6791,GO:0030226,1,0.986164531023053,0,3,apolipoprotein receptor activity,MF,
6792,GO:0030228,1,0.952291811105999,0,10,lipoprotein particle receptor activity,MF,
6793,GO:0030229,1,0.986164510364449,0,3,very-low-density lipoprotein particle receptor activity,MF,
6794,GO:0030233,1,0.990534128227314,0,1,deoxynucleotide transmembrane transporter activity,MF,
6796,GO:0030235,1,0.946621927578641,0,7,nitric-oxide synthase regulator activity,MF,
6797,GO:0030237,1,0.990754805418475,0,2,female sex determination,BP,
6798,GO:0030238,1,0.968565963658897,0,6,male sex determination,BP,
6799,GO:0030239,1,0.850994536466493,0,27,myofibril assembly,BP,
6800,GO:0030240,1,0.995366990827437,0,1,skeletal muscle thin filament assembly,BP,
6801,GO:0030241,1,0.99075519985048,0,2,skeletal muscle myosin thick filament assembly,BP,
6802,GO:0030242,1,0.977045533901586,0,5,autophagy of peroxisome,BP,
6804,GO:0030247,1,0.971821245903791,0,6,polysaccharide binding,MF,
6805,GO:0030249,1,0.994874902021167,0,1,guanylate cyclase regulator activity,MF,
6806,GO:0030250,1,0.994874902021167,0,1,guanylate cyclase activator activity,MF,
6807,GO:0030252,1,0.967941727011145,0,7,growth hormone secretion,BP,
6808,GO:0030258,1,0.300151008027295,0,195,lipid modification,BP,
6809,GO:0030259,1,0.976050747923629,0,4,lipid glycosylation,BP,
6810,GO:0030260,1,0.495323976223882,0,94,entry into host cell,BP,
6811,GO:0030261,1,0.867326149841257,0,28,chromosome condensation,BP,
6812,GO:0030262,1,0.851846136524783,0,23,apoptotic nuclear changes,BP,
6813,GO:0030263,1,0.98159419840258,0,4,apoptotic chromosome condensation,BP,
6814,GO:0030264,1,0.995366574475227,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
6815,GO:0030267,1,0.974920202356939,0,3,glyoxylate reductase (NADP) activity,MF,
6816,GO:0030272,1,0.976908522875979,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
6817,GO:0030274,1,0.980851047433632,0,4,LIM domain binding,MF,
6819,GO:0030276,1,0.75687412441141,0,47,clathrin binding,MF,
6823,GO:0030280,1,0.880532468118078,0,11,structural constituent of epidermis,MF,
6824,GO:0030282,1,0.739011068057048,0,55,bone mineralization,BP,
6825,GO:0030283,1,0.978419412737323,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
6826,GO:0030284,1,0.976911518032957,0,5,estrogen receptor activity,MF,
6827,GO:0030285,1,0.96615280487903,0,7,integral component of synaptic vesicle membrane,CC,
6828,GO:0030286,1,0.754144125514059,0,34,dynein complex,CC,
6829,GO:0030289,1,0.965083705309832,0,4,protein phosphatase 4 complex,CC,
6830,GO:0030290,1,0.995366965574457,0,1,sphingolipid activator protein activity,MF,
6831,GO:0030291,1,0.783978092019792,0,30,protein serine/threonine kinase inhibitor activity,MF,
6832,GO:0030292,1,0.982912750435757,0,3,protein tyrosine kinase inhibitor activity,MF,
6833,GO:0030294,1,0.99469585051582,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
6834,GO:0030295,1,0.697010455214886,0,52,protein kinase activator activity,MF,
6835,GO:0030296,1,0.938262845313352,0,11,protein tyrosine kinase activator activity,MF,
6836,GO:0030297,1,0.985921271847078,0,3,transmembrane receptor protein tyrosine kinase activator activity,MF,
6837,GO:0030298,1,0.983986825901894,0,1,receptor signaling protein tyrosine kinase activator activity,MF,
6838,GO:0030299,1,0.982179937222984,0,2,intestinal cholesterol absorption,BP,
6839,GO:0030301,1,0.687114325776112,0,48,cholesterol transport,BP,
6840,GO:0030302,1,0.990534128227314,0,1,deoxynucleotide transport,BP,
6841,GO:0030305,1,0.991878234510235,0,1,heparanase activity,MF,
6842,GO:0030306,1,0.972518113843703,0,6,ADP-ribosylation factor binding,MF,
6843,GO:0030307,1,0.41628250359917,0,119,positive regulation of cell growth,BP,
6844,GO:0030308,1,0.432301509774065,0,122,negative regulation of cell growth,BP,
6845,GO:0030309,1,0.945827961030613,0,9,poly-N-acetyllactosamine metabolic process,BP,
6846,GO:0030311,1,0.945827961030613,0,9,poly-N-acetyllactosamine biosynthetic process,BP,
6847,GO:0030314,1,0.98616450844266,0,3,junctional membrane complex,CC,
6848,GO:0030315,1,0.864904046738589,0,30,T-tubule,CC,
6849,GO:0030316,1,0.70292648279687,0,60,osteoclast differentiation,BP,
6850,GO:0030317,1,0.81198456969655,0,28,flagellated sperm motility,BP,
6851,GO:0030318,1,0.935483074237335,0,13,melanocyte differentiation,BP,
6852,GO:0030320,1,0.963359996129029,0,6,cellular monovalent inorganic anion homeostasis,BP,
6853,GO:0030321,1,0.990742726014274,0,2,transepithelial chloride transport,BP,
6854,GO:0030322,1,0.989895019947078,0,2,stabilization of membrane potential,BP,
6857,GO:0030325,1,0.90981740215476,0,11,adrenal gland development,BP,
6859,GO:0030327,1,0.986110136876209,0,3,prenylated protein catabolic process,BP,
6860,GO:0030328,1,0.990700741536844,0,2,prenylcysteine catabolic process,BP,
6861,GO:0030329,1,0.990700741536844,0,2,prenylcysteine metabolic process,BP,
6863,GO:0030331,1,0.81426611533251,0,33,estrogen receptor binding,MF,
6864,GO:0030332,1,0.862993875827097,0,24,cyclin binding,MF,
6867,GO:0030336,1,0.33304267939341,0,165,negative regulation of cell migration,BP,
6868,GO:0030337,1,0.981433995889044,0,2,DNA polymerase processivity factor activity,MF,
6869,GO:0030342,1,0.995366813683676,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
6870,GO:0030343,1,0.990184886160895,0,1,vitamin D3 25-hydroxylase activity,MF,
6871,GO:0030345,1,0.995366748653732,0,1,structural constituent of tooth enamel,MF,
6872,GO:0030346,1,0.942839771550612,0,6,protein phosphatase 2B binding,MF,
6873,GO:0030348,1,0.988446077268329,0,2,syntaxin-3 binding,MF,
6874,GO:0030350,1,0.990755171534975,0,2,iron-responsive element binding,MF,
6875,GO:0030351,1,0.995366521608773,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
6876,GO:0030366,1,0.978162209586567,0,2,molybdopterin synthase activity,MF,
6877,GO:0030368,1,0.97237036939131,0,6,interleukin-17 receptor activity,MF,
6878,GO:0030371,1,0.862128972344278,0,20,translation repressor activity,MF,
6879,GO:0030372,1,0.995366990826165,0,1,high molecular weight B cell growth factor receptor binding,MF,
6881,GO:0030375,1,0.986164162729704,0,3,thyroid hormone receptor coactivator activity,MF,
6882,GO:0030377,1,0.987668795739317,0,1,urokinase plasminogen activator receptor activity,MF,
6883,GO:0030378,1,0.995254133737912,0,1,serine racemase activity,MF,
6884,GO:0030379,1,0.995366990826072,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
6885,GO:0030388,1,0.970820423007758,0,4,fructose 1,6-bisphosphate metabolic process,BP,
6886,GO:0030389,1,0.972277569087145,0,1,fructosamine metabolic process,BP,
6887,GO:0030395,1,0.969199532235046,0,1,lactose binding,MF,
6888,GO:0030397,1,0.754526623869448,0,46,membrane disassembly,BP,
6889,GO:0030414,1,0.45765377485957,0,77,peptidase inhibitor activity,MF,
6890,GO:0030421,1,0.977220762612495,0,1,defecation,BP,
6891,GO:0030422,1,0.913590130738415,0,9,production of siRNA involved in RNA interference,BP,
6892,GO:0030423,1,0.970561650857478,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
6897,GO:0030430,1,0.978034067894662,0,4,host cell cytoplasm,CC,
6898,GO:0030431,1,0.861689741393054,0,14,sleep,BP,
6900,GO:0030433,1,0.632549437600602,0,68,ubiquitin-dependent ERAD pathway,BP,
6901,GO:0030449,1,0.912429775243411,0,14,regulation of complement activation,BP,
6902,GO:0030473,1,0.97704616938046,0,5,nuclear migration along microtubule,BP,
6903,GO:0030474,1,0.995366574475227,0,1,spindle pole body duplication,BP,
6904,GO:0030478,1,0.981592903635798,0,4,actin cap,CC,
6905,GO:0030479,1,0.977046177790409,0,5,actin cortical patch,CC,
6906,GO:0030485,1,0.985022883469098,0,2,smooth muscle contractile fiber,CC,
6907,GO:0030488,1,0.799494248733815,0,32,tRNA methylation,BP,
6908,GO:0030490,1,0.58525754977538,0,53,maturation of SSU-rRNA,BP,
6910,GO:0030497,1,0.93605897089619,0,10,fatty acid elongation,BP,
6911,GO:0030500,1,0.813394999589009,0,37,regulation of bone mineralization,BP,
6912,GO:0030501,1,0.873993875985223,0,22,positive regulation of bone mineralization,BP,
6913,GO:0030502,1,0.97067796874008,0,6,negative regulation of bone mineralization,BP,
6914,GO:0030504,1,0.995366990826007,0,1,inorganic diphosphate transmembrane transporter activity,MF,
6915,GO:0030505,1,0.990755199849032,0,2,inorganic diphosphate transport,BP,
6916,GO:0030506,1,0.932964715898304,0,13,ankyrin binding,MF,
6917,GO:0030507,1,0.918496120420474,0,17,spectrin binding,MF,
6920,GO:0030511,1,0.873405220215798,0,22,positive regulation of transforming growth factor beta receptor signaling pathway,BP,
6921,GO:0030512,1,0.709359164828552,0,53,negative regulation of transforming growth factor beta receptor signaling pathway,BP,
6923,GO:0030514,1,0.868569690695065,0,27,negative regulation of BMP signaling pathway,BP,
6924,GO:0030515,1,0.721880496523592,0,30,snoRNA binding,MF,
6925,GO:0030516,1,0.689741838798766,0,67,regulation of axon extension,BP,
6926,GO:0030517,1,0.862339127806829,0,27,negative regulation of axon extension,BP,
6927,GO:0030518,1,0.505564525203621,0,114,intracellular steroid hormone receptor signaling pathway,BP,
6928,GO:0030520,1,0.779272758114691,0,46,intracellular estrogen receptor signaling pathway,BP,
6929,GO:0030521,1,0.686826462412389,0,58,androgen receptor signaling pathway,BP,
6931,GO:0030523,1,0.995366990826152,0,1,dihydrolipoamide S-acyltransferase activity,MF,
6934,GO:0030538,1,0.990754725605271,0,2,embryonic genitalia morphogenesis,BP,
6935,GO:0030539,1,0.963031925153526,0,8,male genitalia development,BP,
6936,GO:0030540,1,0.93417756033926,0,10,female genitalia development,BP,
6939,GO:0030546,1,0.955298274852926,0,7,receptor activator activity,MF,
6940,GO:0030547,1,0.889283868110175,0,15,receptor inhibitor activity,MF,
6941,GO:0030548,1,0.937522993410013,0,6,acetylcholine receptor regulator activity,MF,
6942,GO:0030549,1,0.982541358488628,0,1,acetylcholine receptor activator activity,MF,
6943,GO:0030550,1,0.973899771656018,0,3,acetylcholine receptor inhibitor activity,MF,
6944,GO:0030551,1,0.908717021261948,0,16,cyclic nucleotide binding,MF,
6945,GO:0030552,1,0.949880734223883,0,11,cAMP binding,MF,
6946,GO:0030553,1,0.98616452862076,0,3,cGMP binding,MF,
6948,GO:0030572,1,0.995366987635455,0,1,phosphatidyltransferase activity,MF,
6949,GO:0030574,1,0.805812648514458,0,39,collagen catabolic process,BP,
6950,GO:0030575,1,0.950737376896285,0,9,nuclear body organization,BP,
6951,GO:0030576,1,0.985045945471528,0,3,Cajal body organization,BP,
6952,GO:0030578,1,0.97418571028573,0,4,PML body organization,BP,
6953,GO:0030579,1,0.968798134335266,0,5,ubiquitin-dependent SMAD protein catabolic process,BP,
6954,GO:0030580,1,0.984741452522495,0,1,quinone cofactor methyltransferase activity,MF,
6955,GO:0030581,1,0.965485926441435,0,2,symbiont intracellular protein transport in host,BP,
6956,GO:0030586,1,0.995366878313285,0,1,[methionine synthase] reductase activity,MF,
6957,GO:0030593,1,0.660801852967298,0,36,neutrophil chemotaxis,BP,
6958,GO:0030594,1,0.849262949942144,0,21,neurotransmitter receptor activity,MF,
6959,GO:0030595,1,0.395297714184529,0,102,leukocyte chemotaxis,BP,
6960,GO:0030611,1,0.97753126426181,0,1,arsenate reductase activity,MF,
6961,GO:0030613,1,0.941782560910802,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
6962,GO:0030614,1,0.941782560910802,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
6963,GO:0030616,1,0.995366990825981,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
6964,GO:0030617,1,0.995366752479038,0,1,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
6965,GO:0030618,1,0.981594551581696,0,4,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
6966,GO:0030619,1,0.933855858294678,0,7,U1 snRNA binding,MF,
6967,GO:0030620,1,0.920336167054331,0,6,U2 snRNA binding,MF,
6968,GO:0030621,1,0.971804839433752,0,6,U4 snRNA binding,MF,
6969,GO:0030622,1,0.985443246299564,0,3,U4atac snRNA binding,MF,
6970,GO:0030623,1,0.995366990826047,0,1,U5 snRNA binding,MF,
6971,GO:0030624,1,0.995366990826151,0,1,U6atac snRNA binding,MF,
6972,GO:0030626,1,0.988404225249174,0,2,U12 snRNA binding,MF,
6973,GO:0030627,1,0.97886343785607,0,2,pre-mRNA 5'-splice site binding,MF,
6974,GO:0030628,1,0.929308785401712,0,6,pre-mRNA 3'-splice site binding,MF,
6975,GO:0030629,1,0.995366574475227,0,1,U6 snRNA 3'-end binding,MF,
6976,GO:0030638,1,0.945365762040839,0,5,polyketide metabolic process,BP,
6978,GO:0030643,1,0.980010083717636,0,4,cellular phosphate ion homeostasis,BP,
6979,GO:0030644,1,0.98301420298375,0,2,cellular chloride ion homeostasis,BP,
6980,GO:0030647,1,0.945365762040839,0,5,aminoglycoside antibiotic metabolic process,BP,
6981,GO:0030653,1,0.995366990826164,0,1,beta-lactam antibiotic metabolic process,BP,
6983,GO:0030658,1,0.418072262605727,0,126,transport vesicle membrane,CC,
6986,GO:0030662,1,0.394115055687399,0,127,coated vesicle membrane,CC,
6987,GO:0030663,1,0.862693981816598,0,18,COPI-coated vesicle membrane,CC,
6988,GO:0030665,1,0.62321658039093,0,67,clathrin-coated vesicle membrane,CC,
6989,GO:0030666,1,0.404146690594093,0,112,endocytic vesicle membrane,CC,
6991,GO:0030669,1,0.830774223829298,0,25,clathrin-coated endocytic vesicle membrane,CC,
6992,GO:0030670,1,0.582100991552468,0,62,phagocytic vesicle membrane,CC,
6993,GO:0030672,1,0.6976789447631,0,52,synaptic vesicle membrane,CC,
6994,GO:0030673,1,0.954164077347695,0,10,axolemma,CC,
6995,GO:0030674,1,0.458576565224164,0,128,protein binding, bridging,MF,
6996,GO:0030676,1,0.94999016221636,0,11,Rac guanyl-nucleotide exchange factor activity,MF,
6997,GO:0030677,1,0.844734058279339,0,13,ribonuclease P complex,CC,
6998,GO:0030678,1,0.969346398247442,0,3,mitochondrial ribonuclease P complex,CC,
6999,GO:0030681,1,0.871489868097559,0,10,multimeric ribonuclease P complex,CC,
7000,GO:0030682,1,0.990751078558827,0,2,evasion or tolerance of host defense response,BP,
7001,GO:0030683,1,0.990751078558827,0,2,evasion or tolerance by virus of host immune response,BP,
7002,GO:0030684,1,0.561108908905311,0,74,preribosome,CC,
7003,GO:0030686,1,0.791986571213864,0,32,90S preribosome,CC,
7004,GO:0030687,1,0.815635684779717,0,24,preribosome, large subunit precursor,CC,
7005,GO:0030688,1,0.929308357554745,0,12,preribosome, small subunit precursor,CC,
7006,GO:0030689,1,0.981350707236135,0,3,Noc complex,CC,
7007,GO:0030690,1,0.995366479781941,0,1,Noc1p-Noc2p complex,CC,
7008,GO:0030691,1,0.995366479781941,0,1,Noc2p-Noc3p complex,CC,
7009,GO:0030692,1,0.98591973074003,0,2,Noc4p-Nop14p complex,CC,
7011,GO:0030696,1,0.99536680672612,0,1,tRNA (m5U54) methyltransferase activity,MF,
7012,GO:0030697,1,0.99536680672612,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7013,GO:0030702,1,0.995366990826125,0,1,chromatin silencing at centromere,BP,
7014,GO:0030705,1,0.348732605561998,0,152,cytoskeleton-dependent intracellular transport,BP,
7015,GO:0030718,1,0.995366988852198,0,1,germ-line stem cell population maintenance,BP,
7016,GO:0030719,1,0.995323773158493,0,1,P granule organization,BP,
7017,GO:0030728,1,0.938519751101466,0,12,ovulation,BP,
7018,GO:0030729,1,0.995366896599679,0,1,acetoacetate-CoA ligase activity,MF,
7019,GO:0030730,1,0.924176299981083,0,10,sequestering of triglyceride,BP,
7020,GO:0030731,1,0.979610981160659,0,1,guanidinoacetate N-methyltransferase activity,MF,
7021,GO:0030735,1,0.995366574475227,0,1,carnosine N-methyltransferase activity,MF,
7022,GO:0030742,1,0.854981591774464,0,20,GTP-dependent protein binding,MF,
7023,GO:0030748,1,0.99531532720628,0,1,amine N-methyltransferase activity,MF,
7024,GO:0030760,1,0.989662095655057,0,1,pyridine N-methyltransferase activity,MF,
7025,GO:0030791,1,0.995243726634004,0,1,arsenite methyltransferase activity,MF,
7026,GO:0030792,1,0.995243726634004,0,1,methylarsonite methyltransferase activity,MF,
7027,GO:0030799,1,0.76444372099444,0,41,regulation of cyclic nucleotide metabolic process,BP,
7028,GO:0030800,1,0.938718426076468,0,10,negative regulation of cyclic nucleotide metabolic process,BP,
7029,GO:0030801,1,0.857246270474405,0,20,positive regulation of cyclic nucleotide metabolic process,BP,
7030,GO:0030802,1,0.828996790354573,0,26,regulation of cyclic nucleotide biosynthetic process,BP,
7031,GO:0030803,1,0.947483532211976,0,8,negative regulation of cyclic nucleotide biosynthetic process,BP,
7032,GO:0030804,1,0.887312458580639,0,15,positive regulation of cyclic nucleotide biosynthetic process,BP,
7033,GO:0030805,1,0.986164121750422,0,3,regulation of cyclic nucleotide catabolic process,BP,
7034,GO:0030806,1,0.990754788692713,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7035,GO:0030807,1,0.995366990826113,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7041,GO:0030813,1,0.944536242730335,0,12,positive regulation of nucleotide catabolic process,BP,
7042,GO:0030814,1,0.826319166220963,0,28,regulation of cAMP metabolic process,BP,
7043,GO:0030815,1,0.938718426076468,0,10,negative regulation of cAMP metabolic process,BP,
7044,GO:0030816,1,0.905251647145745,0,12,positive regulation of cAMP metabolic process,BP,
7045,GO:0030817,1,0.869833217262848,0,19,regulation of cAMP biosynthetic process,BP,
7046,GO:0030818,1,0.947483532211976,0,8,negative regulation of cAMP biosynthetic process,BP,
7047,GO:0030819,1,0.92666971932073,0,9,positive regulation of cAMP biosynthetic process,BP,
7048,GO:0030820,1,0.986164121750422,0,3,regulation of cAMP catabolic process,BP,
7049,GO:0030821,1,0.990754788692713,0,2,negative regulation of cAMP catabolic process,BP,
7050,GO:0030822,1,0.995366990826113,0,1,positive regulation of cAMP catabolic process,BP,
7051,GO:0030823,1,0.925277154891098,0,13,regulation of cGMP metabolic process,BP,
7052,GO:0030825,1,0.947029141398808,0,8,positive regulation of cGMP metabolic process,BP,
7053,GO:0030826,1,0.953126012633538,0,7,regulation of cGMP biosynthetic process,BP,
7054,GO:0030828,1,0.957564629449724,0,6,positive regulation of cGMP biosynthetic process,BP,
7057,GO:0030834,1,0.832004416029281,0,32,regulation of actin filament depolymerization,BP,
7058,GO:0030835,1,0.878445579393584,0,24,negative regulation of actin filament depolymerization,BP,
7059,GO:0030836,1,0.951654428220623,0,7,positive regulation of actin filament depolymerization,BP,
7061,GO:0030838,1,0.598092802491538,0,71,positive regulation of actin filament polymerization,BP,
7062,GO:0030846,1,0.995366990825889,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7063,GO:0030849,1,0.995366990826151,0,1,autosome,CC,
7064,GO:0030850,1,0.815470659827041,0,36,prostate gland development,BP,
7065,GO:0030851,1,0.885489243229254,0,16,granulocyte differentiation,BP,
7066,GO:0030852,1,0.94420789932621,0,9,regulation of granulocyte differentiation,BP,
7067,GO:0030853,1,0.97704600930002,0,5,negative regulation of granulocyte differentiation,BP,
7068,GO:0030854,1,0.961920136151157,0,5,positive regulation of granulocyte differentiation,BP,
7073,GO:0030859,1,0.928268821920796,0,15,polarized epithelial cell differentiation,BP,
7074,GO:0030860,1,0.99065909568867,0,2,regulation of polarized epithelial cell differentiation,BP,
7075,GO:0030862,1,0.995366990826138,0,1,positive regulation of polarized epithelial cell differentiation,BP,
7076,GO:0030863,1,0.654634227940695,0,79,cortical cytoskeleton,CC,
7077,GO:0030864,1,0.722166870998419,0,59,cortical actin cytoskeleton,CC,
7078,GO:0030865,1,0.788785562802732,0,42,cortical cytoskeleton organization,BP,
7079,GO:0030866,1,0.825153568170848,0,34,cortical actin cytoskeleton organization,BP,
7080,GO:0030867,1,0.72395408697916,0,25,rough endoplasmic reticulum membrane,CC,
7081,GO:0030868,1,0.975521369696752,0,3,smooth endoplasmic reticulum membrane,CC,
7082,GO:0030870,1,0.976027621418549,0,5,Mre11 complex,CC,
7083,GO:0030874,1,0.991388705237635,0,1,nucleolar chromatin,CC,
7085,GO:0030878,1,0.915492208903108,0,15,thyroid gland development,BP,
7087,GO:0030880,1,0.331862467857301,0,130,RNA polymerase complex,CC,
7088,GO:0030881,1,0.954177549134071,0,6,beta-2-microglobulin binding,MF,
7089,GO:0030882,1,0.995366986774077,0,1,lipid antigen binding,MF,
7090,GO:0030883,1,0.995366986774077,0,1,endogenous lipid antigen binding,MF,
7091,GO:0030884,1,0.995366986774077,0,1,exogenous lipid antigen binding,MF,
7092,GO:0030885,1,0.965992308280766,0,3,regulation of myeloid dendritic cell activation,BP,
7093,GO:0030886,1,0.985403328043022,0,2,negative regulation of myeloid dendritic cell activation,BP,
7094,GO:0030888,1,0.774780580116219,0,35,regulation of B cell proliferation,BP,
7095,GO:0030889,1,0.947909682490932,0,10,negative regulation of B cell proliferation,BP,
7096,GO:0030890,1,0.825457552758486,0,23,positive regulation of B cell proliferation,BP,
7097,GO:0030891,1,0.954909003726262,0,4,VCB complex,CC,
7098,GO:0030893,1,0.985743325060828,0,3,meiotic cohesin complex,CC,
7099,GO:0030894,1,0.827545194342431,0,26,replisome,CC,
7100,GO:0030895,1,0.99536548932354,0,1,apolipoprotein B mRNA editing enzyme complex,CC,
7101,GO:0030896,1,0.972790991587151,0,5,checkpoint clamp complex,CC,
7102,GO:0030897,1,0.936286313093283,0,14,HOPS complex,CC,
7103,GO:0030898,1,0.942336115568419,0,8,actin-dependent ATPase activity,MF,
7104,GO:0030899,1,0.97965334708135,0,1,calcium-dependent ATPase activity,MF,
7109,GO:0030904,1,0.882033512941214,0,20,retromer complex,CC,
7110,GO:0030905,1,0.979363382394074,0,4,retromer, tubulation complex,CC,
7111,GO:0030906,1,0.967825061086655,0,4,retromer, cargo-selective complex,CC,
7112,GO:0030910,1,0.990755129988027,0,2,olfactory placode formation,BP,
7113,GO:0030911,1,0.958287902216201,0,8,TPR domain binding,MF,
7114,GO:0030913,1,0.957096781480526,0,7,paranodal junction assembly,BP,
7115,GO:0030914,1,0.899841263376045,0,12,STAGA complex,CC,
7116,GO:0030915,1,0.927560456051844,0,7,Smc5-Smc6 complex,CC,
7117,GO:0030916,1,0.986164530733697,0,3,otic vesicle formation,BP,
7119,GO:0030920,1,0.976975576064918,0,1,peptidyl-serine acetylation,BP,
7120,GO:0030934,1,0.990755199848874,0,2,anchoring collagen complex,CC,
7121,GO:0030935,1,0.995346606520723,0,1,sheet-forming collagen trimer,CC,
7122,GO:0030936,1,0.995366732943209,0,1,transmembrane collagen trimer,CC,
7123,GO:0030942,1,0.972376610068196,0,3,endoplasmic reticulum signal peptide binding,MF,
7124,GO:0030943,1,0.981677094070378,0,3,mitochondrion targeting sequence binding,MF,
7125,GO:0030947,1,0.880763090780966,0,19,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7126,GO:0030948,1,0.950846920669104,0,8,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7127,GO:0030949,1,0.961422059867872,0,7,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7129,GO:0030951,1,0.981593873000916,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7131,GO:0030953,1,0.967789871223303,0,7,astral microtubule organization,BP,
7133,GO:0030956,1,0.956635539619049,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7134,GO:0030957,1,0.930875397978392,0,10,Tat protein binding,MF,
7135,GO:0030961,1,0.995366574475227,0,1,peptidyl-arginine hydroxylation,BP,
7136,GO:0030964,1,0.387400343192498,0,42,NADH dehydrogenase complex,CC,
7138,GO:0030969,1,0.985985098180598,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
7139,GO:0030970,1,0.832840612003442,0,25,retrograde protein transport, ER to cytosol,BP,
7140,GO:0030971,1,0.770896506618299,0,45,receptor tyrosine kinase binding,MF,
7141,GO:0030974,1,0.985930046197506,0,2,thiamine pyrophosphate transmembrane transport,BP,
7142,GO:0030976,1,0.975278098174099,0,5,thiamine pyrophosphate binding,MF,
7143,GO:0030981,1,0.986143536080177,0,3,cortical microtubule cytoskeleton,CC,
7144,GO:0030983,1,0.928399198323616,0,13,mismatched DNA binding,MF,
7145,GO:0030984,1,0.978269650035344,0,2,kininogen binding,MF,
7146,GO:0030990,1,0.819842612821541,0,30,intraciliary transport particle,CC,
7147,GO:0030991,1,0.963475969803853,0,8,intraciliary transport particle A,CC,
7148,GO:0030992,1,0.87021099937194,0,19,intraciliary transport particle B,CC,
7149,GO:0030997,1,0.985218353936704,0,3,regulation of centriole-centriole cohesion,BP,
7150,GO:0031000,1,0.922212519851536,0,12,response to caffeine,BP,
7151,GO:0031005,1,0.952130576460989,0,10,filamin binding,MF,
7152,GO:0031010,1,0.933563565107292,0,10,ISWI-type complex,CC,
7154,GO:0031012,1,0.214368624791614,0,240,extracellular matrix,CC,
7155,GO:0031013,1,0.991156461546762,0,1,troponin I binding,MF,
7156,GO:0031014,1,0.953673047098148,0,2,troponin T binding,MF,
7158,GO:0031017,1,0.957821582873627,0,4,exocrine pancreas development,BP,
7160,GO:0031021,1,0.963072675358764,0,3,interphase microtubule organizing center,CC,
7161,GO:0031022,1,0.990755199530915,0,2,nuclear migration along microfilament,BP,
7163,GO:0031032,1,0.507895998781224,0,123,actomyosin structure organization,BP,
7164,GO:0031033,1,0.976001603846165,0,5,myosin filament organization,BP,
7165,GO:0031034,1,0.98159487844795,0,4,myosin filament assembly,BP,
7166,GO:0031038,1,0.99430306699322,0,1,myosin II filament organization,BP,
7167,GO:0031045,1,0.95622004839031,0,6,dense core granule,CC,
7169,GO:0031048,1,0.990754785405328,0,2,chromatin silencing by small RNA,BP,
7170,GO:0031049,1,0.995366499145455,0,1,programmed DNA elimination,BP,
7171,GO:0031050,1,0.778551132066429,0,41,dsRNA fragmentation,BP,
7172,GO:0031052,1,0.995366499145455,0,1,chromosome breakage,BP,
7173,GO:0031053,1,0.949269623705123,0,10,primary miRNA processing,BP,
7174,GO:0031054,1,0.928078661986455,0,13,pre-miRNA processing,BP,
7177,GO:0031057,1,0.843631313648617,0,32,negative regulation of histone modification,BP,
7179,GO:0031060,1,0.747592451666593,0,51,regulation of histone methylation,BP,
7180,GO:0031061,1,0.911874889233119,0,16,negative regulation of histone methylation,BP,
7181,GO:0031062,1,0.838959469441448,0,30,positive regulation of histone methylation,BP,
7182,GO:0031063,1,0.87068161414458,0,22,regulation of histone deacetylation,BP,
7183,GO:0031064,1,0.990755199849006,0,2,negative regulation of histone deacetylation,BP,
7184,GO:0031065,1,0.913904033927177,0,16,positive regulation of histone deacetylation,BP,
7185,GO:0031069,1,0.91679307903984,0,17,hair follicle morphogenesis,BP,
7186,GO:0031071,1,0.995118073433264,0,1,cysteine desulfurase activity,MF,
7188,GO:0031074,1,0.971895629464556,0,3,nucleocytoplasmic transport complex,CC,
7189,GO:0031076,1,0.887727771164928,0,25,embryonic camera-type eye development,BP,
7190,GO:0031077,1,0.93821599742628,0,7,post-embryonic camera-type eye development,BP,
7191,GO:0031078,1,0.94496786084174,0,11,histone deacetylase activity (H3-K14 specific),MF,
7192,GO:0031080,1,0.936089782731829,0,10,nuclear pore outer ring,CC,
7193,GO:0031081,1,0.990754785405313,0,2,nuclear pore distribution,BP,
7194,GO:0031082,1,0.863988739196022,0,18,BLOC complex,CC,
7195,GO:0031083,1,0.884337283875701,0,13,BLOC-1 complex,CC,
7196,GO:0031084,1,0.986148815843258,0,3,BLOC-2 complex,CC,
7197,GO:0031085,1,0.990746692646569,0,2,BLOC-3 complex,CC,
7198,GO:0031086,1,0.95771087526524,0,8,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7199,GO:0031087,1,0.962170881054875,0,7,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7200,GO:0031088,1,0.952641783422202,0,5,platelet dense granule membrane,CC,
7201,GO:0031089,1,0.970520117240721,0,5,platelet dense granule lumen,CC,
7204,GO:0031092,1,0.934948445742907,0,11,platelet alpha granule membrane,CC,
7206,GO:0031094,1,0.963524230568317,0,8,platelet dense tubular network,CC,
7207,GO:0031095,1,0.968010715166923,0,7,platelet dense tubular network membrane,CC,
7208,GO:0031098,1,0.24205508737174,0,227,stress-activated protein kinase signaling cascade,BP,
7209,GO:0031099,1,0.438069966554399,0,119,regeneration,BP,
7210,GO:0031100,1,0.665611012213111,0,57,animal organ regeneration,BP,
7211,GO:0031102,1,0.772071371182867,0,38,neuron projection regeneration,BP,
7212,GO:0031103,1,0.810229598699061,0,32,axon regeneration,BP,
7213,GO:0031104,1,0.995366990826138,0,1,dendrite regeneration,BP,
7214,GO:0031105,1,0.958987243460415,0,9,septin complex,CC,
7215,GO:0031106,1,0.945047548639939,0,12,septin ring organization,BP,
7222,GO:0031115,1,0.953032221866813,0,9,negative regulation of microtubule polymerization,BP,
7224,GO:0031117,1,0.990743737982056,0,2,positive regulation of microtubule depolymerization,BP,
7225,GO:0031118,1,0.891391286702638,0,8,rRNA pseudouridine synthesis,BP,
7226,GO:0031119,1,0.93762741483302,0,7,tRNA pseudouridine synthesis,BP,
7227,GO:0031120,1,0.927266765992261,0,4,snRNA pseudouridine synthesis,BP,
7228,GO:0031122,1,0.759855631227377,0,51,cytoplasmic microtubule organization,BP,
7229,GO:0031123,1,0.413062181990309,0,119,RNA 3'-end processing,BP,
7230,GO:0031124,1,0.560999846703509,0,88,mRNA 3'-end processing,BP,
7231,GO:0031125,1,0.835747272715264,0,12,rRNA 3'-end processing,BP,
7232,GO:0031126,1,0.906654943911489,0,7,snoRNA 3'-end processing,BP,
7233,GO:0031127,1,0.99075496636133,0,2,alpha-(1,2)-fucosyltransferase activity,MF,
7235,GO:0031133,1,0.986740815190189,0,2,regulation of axon diameter,BP,
7236,GO:0031134,1,0.983345031575023,0,3,sister chromatid biorientation,BP,
7237,GO:0031143,1,0.92933204834522,0,12,pseudopodium,CC,
7238,GO:0031145,1,0.38543160087218,0,77,anaphase-promoting complex-dependent catabolic process,BP,
7239,GO:0031146,1,0.443351970574521,0,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
7240,GO:0031151,1,0.995366990826047,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7241,GO:0031161,1,0.995366795951877,0,1,phosphatidylinositol catabolic process,BP,
7242,GO:0031163,1,0.787663635849271,0,20,metallo-sulfur cluster assembly,BP,
7243,GO:0031166,1,0.986164159677235,0,3,integral component of vacuolar membrane,CC,
7244,GO:0031167,1,0.82842615824568,0,21,rRNA methylation,BP,
7246,GO:0031177,1,0.939657142768919,0,3,phosphopantetheine binding,MF,
7247,GO:0031179,1,0.995366983442151,0,1,peptide modification,BP,
7248,GO:0031201,1,0.728417984959608,0,43,SNARE complex,CC,
7249,GO:0031204,1,0.960357963481426,0,3,posttranslational protein targeting to membrane, translocation,BP,
7250,GO:0031205,1,0.96482986461555,0,2,endoplasmic reticulum Sec complex,CC,
7251,GO:0031208,1,0.990709489889093,0,2,POZ domain binding,MF,
7252,GO:0031209,1,0.963524042401696,0,8,SCAR complex,CC,
7253,GO:0031210,1,0.892206880041224,0,12,phosphatidylcholine binding,MF,
7254,GO:0031211,1,0.950053475112968,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7255,GO:0031213,1,0.990755198771744,0,2,RSF complex,CC,
7256,GO:0031214,1,0.679544881397642,0,69,biomineral tissue development,BP,
7257,GO:0031223,1,0.972518273893702,0,6,auditory behavior,BP,
7259,GO:0031225,1,0.542400419595006,0,70,anchored component of membrane,CC,
7261,GO:0031227,1,0.424644312175876,0,126,intrinsic component of endoplasmic reticulum membrane,CC,
7262,GO:0031228,1,0.776706355237175,0,40,intrinsic component of Golgi membrane,CC,
7263,GO:0031229,1,0.962116871390546,0,8,intrinsic component of nuclear inner membrane,CC,
7264,GO:0031231,1,0.875577482602916,0,15,intrinsic component of peroxisomal membrane,CC,
7265,GO:0031232,1,0.977531728507445,0,3,extrinsic component of external side of plasma membrane,CC,
7266,GO:0031233,1,0.905252545301048,0,13,intrinsic component of external side of plasma membrane,CC,
7267,GO:0031234,1,0.68077403439145,0,66,extrinsic component of cytoplasmic side of plasma membrane,CC,
7268,GO:0031235,1,0.950162828585804,0,11,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
7269,GO:0031247,1,0.989143343258297,0,2,actin rod assembly,BP,
7271,GO:0031249,1,0.995186149668059,0,1,denatured protein binding,MF,
7272,GO:0031251,1,0.990755199849254,0,2,PAN complex,CC,
7278,GO:0031260,1,0.981211734118484,0,1,pseudopodium membrane,CC,
7279,GO:0031261,1,0.962942125048616,0,5,DNA replication preinitiation complex,CC,
7281,GO:0031264,1,0.947783166470041,0,9,death-inducing signaling complex,CC,
7282,GO:0031265,1,0.967967762891537,0,6,CD95 death-inducing signaling complex,CC,
7284,GO:0031268,1,0.91156979926418,0,12,pseudopodium organization,BP,
7285,GO:0031269,1,0.929039446894317,0,11,pseudopodium assembly,BP,
7286,GO:0031272,1,0.937715219715463,0,9,regulation of pseudopodium assembly,BP,
7287,GO:0031274,1,0.937715219715463,0,9,positive regulation of pseudopodium assembly,BP,
7288,GO:0031279,1,0.892180338529107,0,18,regulation of cyclase activity,BP,
7289,GO:0031280,1,0.951896662982526,0,7,negative regulation of cyclase activity,BP,
7290,GO:0031281,1,0.946053000293406,0,9,positive regulation of cyclase activity,BP,
7291,GO:0031282,1,0.978570228454013,0,4,regulation of guanylate cyclase activity,BP,
7292,GO:0031284,1,0.978570228454013,0,4,positive regulation of guanylate cyclase activity,BP,
7293,GO:0031289,1,0.995366722375531,0,1,actin phosphorylation,BP,
7294,GO:0031290,1,0.933951808240736,0,14,retinal ganglion cell axon guidance,BP,
7295,GO:0031291,1,0.966665639025932,0,3,Ran protein signal transduction,BP,
7296,GO:0031293,1,0.868239030107472,0,23,membrane protein intracellular domain proteolysis,BP,
7297,GO:0031294,1,0.800238196275055,0,34,lymphocyte costimulation,BP,
7298,GO:0031295,1,0.81388008251777,0,33,T cell costimulation,BP,
7299,GO:0031296,1,0.983277700304156,0,1,B cell costimulation,BP,
7300,GO:0031297,1,0.866915819435514,0,26,replication fork processing,BP,
7301,GO:0031298,1,0.933341186995996,0,9,replication fork protection complex,CC,
7302,GO:0031300,1,0.330770054113918,0,154,intrinsic component of organelle membrane,CC,
7303,GO:0031301,1,0.363120306685015,0,140,integral component of organelle membrane,CC,
7304,GO:0031302,1,0.995366990826151,0,1,intrinsic component of endosome membrane,CC,
7305,GO:0031304,1,0.724353750715338,0,36,intrinsic component of mitochondrial inner membrane,CC,
7306,GO:0031305,1,0.724353750715338,0,36,integral component of mitochondrial inner membrane,CC,
7307,GO:0031306,1,0.835474697296785,0,22,intrinsic component of mitochondrial outer membrane,CC,
7308,GO:0031307,1,0.839371341265457,0,21,integral component of mitochondrial outer membrane,CC,
7309,GO:0031310,1,0.986164159677235,0,3,intrinsic component of vacuolar membrane,CC,
7310,GO:0031312,1,0.851020974529632,0,28,extrinsic component of organelle membrane,CC,
7311,GO:0031313,1,0.958972183974814,0,7,extrinsic component of endosome membrane,CC,
7312,GO:0031314,1,0.977044542692723,0,5,extrinsic component of mitochondrial inner membrane,CC,
7313,GO:0031315,1,0.995366990826072,0,1,extrinsic component of mitochondrial outer membrane,CC,
7314,GO:0031320,1,0.995296708755865,0,1,hexitol dehydrogenase activity,MF,
7324,GO:0031332,1,0.942982592313624,0,11,RNAi effector complex,CC,
7327,GO:0031335,1,0.994878946369531,0,1,regulation of sulfur amino acid metabolic process,BP,
7328,GO:0031337,1,0.994878946369531,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7329,GO:0031338,1,0.768876590679057,0,49,regulation of vesicle fusion,BP,
7330,GO:0031339,1,0.981142524843291,0,3,negative regulation of vesicle fusion,BP,
7331,GO:0031340,1,0.959735404847019,0,6,positive regulation of vesicle fusion,BP,
7332,GO:0031341,1,0.737019986820513,0,36,regulation of cell killing,BP,
7333,GO:0031342,1,0.928061474795901,0,11,negative regulation of cell killing,BP,
7334,GO:0031343,1,0.811216172391458,0,22,positive regulation of cell killing,BP,
7336,GO:0031345,1,0.448496357629405,0,124,negative regulation of cell projection organization,BP,
7337,GO:0031346,1,0.205269104734561,0,258,positive regulation of cell projection organization,BP,
7341,GO:0031362,1,0.936703114595745,0,9,anchored component of external side of plasma membrane,CC,
7342,GO:0031365,1,0.850723589078218,0,24,N-terminal protein amino acid modification,BP,
7343,GO:0031369,1,0.781359522947606,0,28,translation initiation factor binding,MF,
7344,GO:0031370,1,0.995366990826165,0,1,eukaryotic initiation factor 4G binding,MF,
7345,GO:0031371,1,0.94862973523823,0,8,ubiquitin conjugating enzyme complex,CC,
7346,GO:0031372,1,0.984260567565832,0,2,UBC13-MMS2 complex,CC,
7347,GO:0031379,1,0.95735602413449,0,2,RNA-directed RNA polymerase complex,CC,
7348,GO:0031380,1,0.995366878313285,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7349,GO:0031386,1,0.833083409775564,0,12,protein tag,MF,
7350,GO:0031389,1,0.995366579969841,0,1,Rad17 RFC-like complex,CC,
7351,GO:0031390,1,0.948115352434069,0,8,Ctf18 RFC-like complex,CC,
7352,GO:0031392,1,0.973500239703994,0,4,regulation of prostaglandin biosynthetic process,BP,
7353,GO:0031393,1,0.990754989229003,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7354,GO:0031394,1,0.982586087238914,0,2,positive regulation of prostaglandin biosynthetic process,BP,
7356,GO:0031397,1,0.586849406243657,0,58,negative regulation of protein ubiquitination,BP,
7362,GO:0031403,1,0.990755130155478,0,2,lithium ion binding,MF,
7363,GO:0031404,1,0.973290437466811,0,3,chloride ion binding,MF,
7364,GO:0031405,1,0.995366990825903,0,1,lipoic acid binding,MF,
7366,GO:0031407,1,0.995095103294964,0,1,oxylipin metabolic process,BP,
7368,GO:0031414,1,0.924900571926569,0,9,N-terminal protein acetyltransferase complex,CC,
7369,GO:0031415,1,0.960674780388836,0,4,NatA complex,CC,
7370,GO:0031416,1,0.976297968751772,0,2,NatB complex,CC,
7371,GO:0031417,1,0.986155802838804,0,3,NatC complex,CC,
7372,GO:0031418,1,0.90706513836871,0,18,L-ascorbic acid binding,MF,
7373,GO:0031419,1,0.96034639257168,0,6,cobalamin binding,MF,
7376,GO:0031427,1,0.985820642726931,0,3,response to methotrexate,BP,
7377,GO:0031428,1,0.955853251684852,0,5,box C/D snoRNP complex,CC,
7378,GO:0031429,1,0.910844924532281,0,5,box H/ACA snoRNP complex,CC,
7379,GO:0031430,1,0.90345983198472,0,13,M band,CC,
7380,GO:0031431,1,0.990754688861831,0,2,Dbf4-dependent protein kinase complex,CC,
7381,GO:0031432,1,0.945419207998774,0,8,titin binding,MF,
7382,GO:0031433,1,0.995366990827437,0,1,telethonin binding,MF,
7383,GO:0031434,1,0.808591053821904,0,42,mitogen-activated protein kinase kinase binding,MF,
7384,GO:0031435,1,0.925654850106906,0,16,mitogen-activated protein kinase kinase kinase binding,MF,
7385,GO:0031436,1,0.990725292331556,0,2,BRCA1-BARD1 complex,CC,
7386,GO:0031437,1,0.985985098180639,0,3,regulation of mRNA cleavage,BP,
7387,GO:0031438,1,0.995366744009593,0,1,negative regulation of mRNA cleavage,BP,
7388,GO:0031439,1,0.9905751869819,0,2,positive regulation of mRNA cleavage,BP,
7389,GO:0031440,1,0.893361938024036,0,22,regulation of mRNA 3'-end processing,BP,
7390,GO:0031441,1,0.958873004508147,0,9,negative regulation of mRNA 3'-end processing,BP,
7391,GO:0031442,1,0.954297618441287,0,9,positive regulation of mRNA 3'-end processing,BP,
7392,GO:0031443,1,0.995366990826073,0,1,fast-twitch skeletal muscle fiber contraction,BP,
7393,GO:0031444,1,0.97965334708135,0,1,slow-twitch skeletal muscle fiber contraction,BP,
7394,GO:0031445,1,0.985871148345683,0,2,regulation of heterochromatin assembly,BP,
7395,GO:0031453,1,0.985871148345683,0,2,positive regulation of heterochromatin assembly,BP,
7396,GO:0031455,1,0.995366962748951,0,1,glycine betaine metabolic process,BP,
7397,GO:0031456,1,0.995366962748951,0,1,glycine betaine biosynthetic process,BP,
7398,GO:0031460,1,0.995366990826165,0,1,glycine betaine transport,BP,
7399,GO:0031461,1,0.347879536610994,0,157,cullin-RING ubiquitin ligase complex,CC,
7400,GO:0031462,1,0.893110617225664,0,12,Cul2-RING ubiquitin ligase complex,CC,
7401,GO:0031463,1,0.738948450807538,0,51,Cul3-RING ubiquitin ligase complex,CC,
7402,GO:0031464,1,0.916008504029593,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7403,GO:0031465,1,0.947920088357667,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
7404,GO:0031466,1,0.949644412664136,0,4,Cul5-RING ubiquitin ligase complex,CC,
7405,GO:0031467,1,0.94496334868581,0,5,Cul7-RING ubiquitin ligase complex,CC,
7406,GO:0031468,1,0.867462369359992,0,18,nuclear envelope reassembly,BP,
7407,GO:0031475,1,0.988884356636556,0,1,myosin V complex,CC,
7408,GO:0031489,1,0.905710573243909,0,13,myosin V binding,MF,
7410,GO:0031491,1,0.452076727283442,0,66,nucleosome binding,MF,
7411,GO:0031492,1,0.52037665216758,0,42,nucleosomal DNA binding,MF,
7412,GO:0031493,1,0.982135495254333,0,3,nucleosomal histone binding,MF,
7414,GO:0031498,1,0.888694239184925,0,17,chromatin disassembly,BP,
7415,GO:0031501,1,0.932868858991587,0,4,mannosyltransferase complex,CC,
7416,GO:0031503,1,0.211788383843516,0,219,protein-containing complex localization,BP,
7417,GO:0031506,1,0.991967176450215,0,1,cell wall glycoprotein biosynthetic process,BP,
7418,GO:0031507,1,0.92430138822378,0,10,heterochromatin assembly,BP,
7419,GO:0031508,1,0.978250497042268,0,2,pericentric heterochromatin assembly,BP,
7420,GO:0031509,1,0.990460465789248,0,1,telomeric heterochromatin assembly,BP,
7421,GO:0031510,1,0.978585646236027,0,3,SUMO activating enzyme complex,CC,
7422,GO:0031514,1,0.59205254154633,0,76,motile cilium,CC,
7423,GO:0031515,1,0.983055461393127,0,3,tRNA (m1A) methyltransferase complex,CC,
7424,GO:0031519,1,0.751284915346911,0,47,PcG protein complex,CC,
7425,GO:0031523,1,0.990752312792547,0,2,Myb complex,CC,
7426,GO:0031526,1,0.870539447622422,0,25,brush border membrane,CC,
7427,GO:0031527,1,0.949499266247561,0,11,filopodium membrane,CC,
7428,GO:0031528,1,0.906749764692229,0,14,microvillus membrane,CC,
7429,GO:0031529,1,0.788408288692986,0,38,ruffle organization,BP,
7430,GO:0031530,1,0.991323192844333,0,1,gonadotropin-releasing hormone receptor binding,MF,
7431,GO:0031531,1,0.985805137433146,0,1,thyrotropin-releasing hormone receptor binding,MF,
7432,GO:0031532,1,0.587718313583942,0,77,actin cytoskeleton reorganization,BP,
7433,GO:0031533,1,0.995366990826112,0,1,mRNA cap methyltransferase complex,CC,
7434,GO:0031536,1,0.952900737901683,0,4,positive regulation of exit from mitosis,BP,
7435,GO:0031543,1,0.953053874545381,0,10,peptidyl-proline dioxygenase activity,MF,
7436,GO:0031544,1,0.981593375402722,0,4,peptidyl-proline 3-dioxygenase activity,MF,
7437,GO:0031545,1,0.970931473254494,0,6,peptidyl-proline 4-dioxygenase activity,MF,
7438,GO:0031547,1,0.990755199849213,0,2,brain-derived neurotrophic factor receptor signaling pathway,BP,
7439,GO:0031554,1,0.995366990825889,0,1,regulation of DNA-templated transcription, termination,BP,
7440,GO:0031559,1,0.995366990826153,0,1,oxidosqualene cyclase activity,MF,
7441,GO:0031570,1,0.359698111204696,0,157,DNA integrity checkpoint,BP,
7442,GO:0031571,1,0.586641428900084,0,68,mitotic G1 DNA damage checkpoint,BP,
7443,GO:0031572,1,0.847607338373619,0,33,G2 DNA damage checkpoint,BP,
7444,GO:0031573,1,0.910799536618923,0,14,intra-S DNA damage checkpoint,BP,
7445,GO:0031577,1,0.802337508052822,0,32,spindle checkpoint,BP,
7446,GO:0031579,1,0.876349414434031,0,19,membrane raft organization,BP,
7447,GO:0031580,1,0.953706279339746,0,6,membrane raft distribution,BP,
7448,GO:0031581,1,0.93893171314818,0,11,hemidesmosome assembly,BP,
7449,GO:0031583,1,0.994254882565581,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
7450,GO:0031584,1,0.961259699092551,0,5,activation of phospholipase D activity,BP,
7451,GO:0031585,1,0.981594888010538,0,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7452,GO:0031587,1,0.986164530297691,0,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7453,GO:0031588,1,0.954841527791794,0,9,nucleotide-activated protein kinase complex,CC,
7454,GO:0031589,1,0.257661766729132,0,224,cell-substrate adhesion,BP,
7455,GO:0031590,1,0.990754391488978,0,2,wybutosine metabolic process,BP,
7456,GO:0031591,1,0.990754391488978,0,2,wybutosine biosynthetic process,BP,
7457,GO:0031592,1,0.99536699082602,0,1,centrosomal corona,CC,
7458,GO:0031593,1,0.812987030724174,0,37,polyubiquitin modification-dependent protein binding,MF,
7459,GO:0031594,1,0.810128646514186,0,37,neuromuscular junction,CC,
7460,GO:0031595,1,0.921528798184414,0,8,nuclear proteasome complex,CC,
7461,GO:0031597,1,0.900368516964204,0,12,cytosolic proteasome complex,CC,
7462,GO:0031616,1,0.922443604796732,0,9,spindle pole centrosome,CC,
7463,GO:0031618,1,0.952495947985281,0,8,nuclear pericentric heterochromatin,CC,
7464,GO:0031620,1,0.970438829734308,0,4,regulation of fever generation,BP,
7465,GO:0031622,1,0.970438829734308,0,4,positive regulation of fever generation,BP,
7466,GO:0031623,1,0.684761049378111,0,59,receptor internalization,BP,
7469,GO:0031626,1,0.995366990826151,0,1,beta-endorphin binding,MF,
7470,GO:0031627,1,0.986163740997937,0,3,telomeric loop formation,BP,
7471,GO:0031628,1,0.979082979702906,0,4,opioid receptor binding,MF,
7472,GO:0031629,1,0.930221311169305,0,10,synaptic vesicle fusion to presynaptic active zone membrane,BP,
7473,GO:0031630,1,0.995366990482937,0,1,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
7474,GO:0031635,1,0.992783290737664,0,1,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7475,GO:0031638,1,0.80144112429293,0,31,zymogen activation,BP,
7476,GO:0031639,1,0.934600549232898,0,12,plasminogen activation,BP,
7477,GO:0031640,1,0.771173687481274,0,16,killing of cells of other organism,BP,
7479,GO:0031642,1,0.952692587267737,0,6,negative regulation of myelination,BP,
7480,GO:0031643,1,0.958820904986688,0,9,positive regulation of myelination,BP,
7481,GO:0031644,1,0.800590466819731,0,33,regulation of neurological system process,BP,
7482,GO:0031645,1,0.943492836588508,0,7,negative regulation of neurological system process,BP,
7483,GO:0031646,1,0.917774301641944,0,14,positive regulation of neurological system process,BP,
7484,GO:0031647,1,0.205924434984886,0,213,regulation of protein stability,BP,
7485,GO:0031648,1,0.777842617960986,0,38,protein destabilization,BP,
7489,GO:0031652,1,0.933423082096697,0,8,positive regulation of heat generation,BP,
7490,GO:0031657,1,0.912570157813201,0,12,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7491,GO:0031658,1,0.934072496275192,0,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7492,GO:0031659,1,0.97699786252486,0,5,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7493,GO:0031663,1,0.752704870258602,0,37,lipopolysaccharide-mediated signaling pathway,BP,
7494,GO:0031664,1,0.877091912043475,0,15,regulation of lipopolysaccharide-mediated signaling pathway,BP,
7495,GO:0031665,1,0.930564029697277,0,8,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
7496,GO:0031666,1,0.955815512020779,0,4,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
7501,GO:0031672,1,0.877096426104066,0,19,A band,CC,
7502,GO:0031673,1,0.995366990825692,0,1,H zone,CC,
7503,GO:0031674,1,0.584741379927687,0,76,I band,CC,
7504,GO:0031681,1,0.974509000147255,0,5,G-protein beta-subunit binding,MF,
7505,GO:0031682,1,0.99536671531213,0,1,G-protein gamma-subunit binding,MF,
7506,GO:0031683,1,0.922567533966704,0,12,G-protein beta/gamma-subunit complex binding,MF,
7507,GO:0031685,1,0.990754975240073,0,2,adenosine receptor binding,MF,
7508,GO:0031686,1,0.995366765183482,0,1,A1 adenosine receptor binding,MF,
7510,GO:0031691,1,0.987808319659065,0,2,alpha-1A adrenergic receptor binding,MF,
7511,GO:0031692,1,0.987808319659065,0,2,alpha-1B adrenergic receptor binding,MF,
7512,GO:0031694,1,0.982097209269804,0,1,alpha-2A adrenergic receptor binding,MF,
7513,GO:0031697,1,0.981447334638263,0,4,beta-1 adrenergic receptor binding,MF,
7514,GO:0031698,1,0.977680529646016,0,4,beta-2 adrenergic receptor binding,MF,
7516,GO:0031700,1,0.987808981028745,0,1,adrenomedullin receptor binding,MF,
7517,GO:0031701,1,0.960657689798712,0,8,angiotensin receptor binding,MF,
7518,GO:0031702,1,0.965801968198774,0,7,type 1 angiotensin receptor binding,MF,
7519,GO:0031704,1,0.995366841160869,0,1,apelin receptor binding,MF,
7520,GO:0031705,1,0.994254882565581,0,1,bombesin receptor binding,MF,
7521,GO:0031707,1,0.994254882565581,0,1,endothelin A receptor binding,MF,
7522,GO:0031708,1,0.994254882565581,0,1,endothelin B receptor binding,MF,
7523,GO:0031714,1,0.995366990826151,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
7524,GO:0031715,1,0.995366990826151,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
7525,GO:0031726,1,0.983986825901894,0,1,CCR1 chemokine receptor binding,MF,
7526,GO:0031729,1,0.983986825901894,0,1,CCR4 chemokine receptor binding,MF,
7527,GO:0031730,1,0.941988971252471,0,5,CCR5 chemokine receptor binding,MF,
7528,GO:0031731,1,0.943583561852032,0,2,CCR6 chemokine receptor binding,MF,
7529,GO:0031748,1,0.972499331271789,0,5,D1 dopamine receptor binding,MF,
7530,GO:0031749,1,0.990755050964417,0,2,D2 dopamine receptor binding,MF,
7531,GO:0031752,1,0.990755199849228,0,2,D5 dopamine receptor binding,MF,
7532,GO:0031753,1,0.995366425817292,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
7533,GO:0031755,1,0.995366425817292,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
7534,GO:0031762,1,0.987808319659065,0,2,follicle-stimulating hormone receptor binding,MF,
7535,GO:0031763,1,0.974537838279069,0,1,galanin receptor binding,MF,
7536,GO:0031764,1,0.974537838279069,0,1,type 1 galanin receptor binding,MF,
7537,GO:0031765,1,0.974537838279069,0,1,type 2 galanin receptor binding,MF,
7538,GO:0031766,1,0.974537838279069,0,1,type 3 galanin receptor binding,MF,
7539,GO:0031775,1,0.995366990826007,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
7540,GO:0031798,1,0.995366990826034,0,1,type 1 metabotropic glutamate receptor binding,MF,
7541,GO:0031802,1,0.984963008044317,0,3,type 5 metabotropic glutamate receptor binding,MF,
7542,GO:0031811,1,0.99536699023616,0,1,G-protein coupled nucleotide receptor binding,MF,
7543,GO:0031812,1,0.99536699023616,0,1,P2Y1 nucleotide receptor binding,MF,
7544,GO:0031821,1,0.964219905775824,0,6,G-protein coupled serotonin receptor binding,MF,
7545,GO:0031826,1,0.97775112970173,0,3,type 2A serotonin receptor binding,MF,
7546,GO:0031839,1,0.975368272283632,0,1,type 1 neuromedin U receptor binding,MF,
7547,GO:0031840,1,0.975368272283632,0,1,type 2 neuromedin U receptor binding,MF,
7548,GO:0031848,1,0.95139707472083,0,10,protection from non-homologous end joining at telomere,BP,
7549,GO:0031849,1,0.99536698538156,0,1,olfactory receptor binding,MF,
7550,GO:0031852,1,0.979082979702906,0,4,mu-type opioid receptor binding,MF,
7551,GO:0031859,1,0.993096284110959,0,1,platelet activating factor receptor binding,MF,
7552,GO:0031860,1,0.986164515816988,0,3,telomeric 3' overhang formation,BP,
7553,GO:0031862,1,0.990755197990869,0,2,prostanoid receptor binding,MF,
7554,GO:0031867,1,0.995366988959226,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
7555,GO:0031870,1,0.995366990826112,0,1,thromboxane A2 receptor binding,MF,
7556,GO:0031871,1,0.983293325708991,0,3,proteinase activated receptor binding,MF,
7557,GO:0031883,1,0.994271102205394,0,1,taste receptor binding,MF,
7558,GO:0031893,1,0.994675698636431,0,1,vasopressin receptor binding,MF,
7559,GO:0031896,1,0.994675698636431,0,1,V2 vasopressin receptor binding,MF,
7560,GO:0031901,1,0.518982590380435,0,107,early endosome membrane,CC,
7561,GO:0031902,1,0.47454730323443,0,105,late endosome membrane,CC,
7562,GO:0031903,1,0.698494501671675,0,51,microbody membrane,CC,
7563,GO:0031904,1,0.869707825483561,0,17,endosome lumen,CC,
7564,GO:0031905,1,0.969538731446928,0,3,early endosome lumen,CC,
7565,GO:0031906,1,0.983635241959161,0,2,late endosome lumen,CC,
7566,GO:0031907,1,0.791067434513379,0,30,microbody lumen,CC,
7567,GO:0031914,1,0.973268160343776,0,3,negative regulation of synaptic plasticity,BP,
7568,GO:0031915,1,0.972547555849095,0,5,positive regulation of synaptic plasticity,BP,
7570,GO:0031930,1,0.98802453931829,0,1,mitochondria-nucleus signaling pathway,BP,
7571,GO:0031931,1,0.961809756286099,0,7,TORC1 complex,CC,
7573,GO:0031933,1,0.980632854440463,0,3,telomeric heterochromatin,CC,
7574,GO:0031935,1,0.903118780781416,0,20,regulation of chromatin silencing,BP,
7575,GO:0031936,1,0.961717820403109,0,8,negative regulation of chromatin silencing,BP,
7576,GO:0031937,1,0.958773031074032,0,8,positive regulation of chromatin silencing,BP,
7577,GO:0031938,1,0.983752805581138,0,2,regulation of chromatin silencing at telomere,BP,
7578,GO:0031940,1,0.990460465789248,0,1,positive regulation of chromatin silencing at telomere,BP,
7580,GO:0031943,1,0.938280285206705,0,8,regulation of glucocorticoid metabolic process,BP,
7581,GO:0031944,1,0.981593238575465,0,4,negative regulation of glucocorticoid metabolic process,BP,
7582,GO:0031945,1,0.995366990309484,0,1,positive regulation of glucocorticoid metabolic process,BP,
7583,GO:0031946,1,0.972516667853469,0,6,regulation of glucocorticoid biosynthetic process,BP,
7584,GO:0031947,1,0.981593238575465,0,4,negative regulation of glucocorticoid biosynthetic process,BP,
7585,GO:0031948,1,0.995366990309484,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
7586,GO:0031952,1,0.847410097604478,0,33,regulation of protein autophosphorylation,BP,
7587,GO:0031953,1,0.954528916849921,0,10,negative regulation of protein autophosphorylation,BP,
7588,GO:0031954,1,0.90030960720286,0,20,positive regulation of protein autophosphorylation,BP,
7589,GO:0031956,1,0.981594634352019,0,4,medium-chain fatty acid-CoA ligase activity,MF,
7590,GO:0031957,1,0.967141653469926,0,7,very long-chain fatty acid-CoA ligase activity,MF,
7591,GO:0031958,1,0.919429952851174,0,16,corticosteroid receptor signaling pathway,BP,
7592,GO:0031959,1,0.990754785405313,0,2,mineralocorticoid receptor signaling pathway,BP,
7594,GO:0031962,1,0.995366990826126,0,1,mineralocorticoid receptor binding,MF,
7595,GO:0031965,1,0.200407998322094,0,251,nuclear membrane,CC,
7598,GO:0031968,1,0.296821079145974,0,163,organelle outer membrane,CC,
7608,GO:0031990,1,0.990398960750165,0,2,mRNA export from nucleus in response to heat stress,BP,
7609,GO:0031994,1,0.934956160292945,0,9,insulin-like growth factor I binding,MF,
7610,GO:0031995,1,0.948081306162621,0,6,insulin-like growth factor II binding,MF,
7611,GO:0031996,1,0.950638201173173,0,10,thioesterase binding,MF,
7612,GO:0031997,1,0.975784811899562,0,3,N-terminal myristoylation domain binding,MF,
7613,GO:0031998,1,0.949496225962845,0,11,regulation of fatty acid beta-oxidation,BP,
7614,GO:0031999,1,0.99075475387298,0,2,negative regulation of fatty acid beta-oxidation,BP,
7615,GO:0032000,1,0.977046177700911,0,5,positive regulation of fatty acid beta-oxidation,BP,
7616,GO:0032002,1,0.988724815480875,0,2,interleukin-28 receptor complex,CC,
7619,GO:0032008,1,0.835583529020665,0,30,positive regulation of TOR signaling,BP,
7620,GO:0032009,1,0.959779594995976,0,7,early phagosome,CC,
7621,GO:0032010,1,0.985775830181779,0,3,phagolysosome,CC,
7622,GO:0032011,1,0.829650769519489,0,40,ARF protein signal transduction,BP,
7623,GO:0032012,1,0.829650769519489,0,40,regulation of ARF protein signal transduction,BP,
7624,GO:0032020,1,0.928611442168939,0,6,ISG15-protein conjugation,BP,
7625,GO:0032021,1,0.981593246111093,0,4,NELF complex,CC,
7626,GO:0032024,1,0.744133443992861,0,45,positive regulation of insulin secretion,BP,
7627,GO:0032025,1,0.93920914473526,0,10,response to cobalt ion,BP,
7628,GO:0032026,1,0.963522643634572,0,8,response to magnesium ion,BP,
7629,GO:0032027,1,0.982526831862115,0,3,myosin light chain binding,MF,
7630,GO:0032028,1,0.994298539157786,0,1,myosin head/neck binding,MF,
7631,GO:0032029,1,0.995366990825863,0,1,myosin tail binding,MF,
7632,GO:0032036,1,0.955036953855608,0,5,myosin heavy chain binding,MF,
7633,GO:0032039,1,0.937066044613681,0,13,integrator complex,CC,
7634,GO:0032040,1,0.772068299273655,0,33,small-subunit processome,CC,
7635,GO:0032041,1,0.94496786084174,0,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
7636,GO:0032042,1,0.922128734829995,0,14,mitochondrial DNA metabolic process,BP,
7637,GO:0032044,1,0.983851493919592,0,2,DSIF complex,CC,
7638,GO:0032045,1,0.951218818529924,0,8,guanyl-nucleotide exchange factor complex,CC,
7639,GO:0032048,1,0.921947821976036,0,14,cardiolipin metabolic process,BP,
7640,GO:0032049,1,0.958721198572952,0,8,cardiolipin biosynthetic process,BP,
7641,GO:0032050,1,0.943525521669271,0,7,clathrin heavy chain binding,MF,
7642,GO:0032051,1,0.977045769015563,0,5,clathrin light chain binding,MF,
7643,GO:0032052,1,0.952395282906349,0,5,bile acid binding,MF,
7644,GO:0032053,1,0.990754785405249,0,2,ciliary basal body organization,BP,
7645,GO:0032055,1,0.96390855922043,0,6,negative regulation of translation in response to stress,BP,
7646,GO:0032056,1,0.969710999943256,0,6,positive regulation of translation in response to stress,BP,
7647,GO:0032057,1,0.977665662231633,0,4,negative regulation of translational initiation in response to stress,BP,
7648,GO:0032058,1,0.981351058764971,0,4,positive regulation of translational initiation in response to stress,BP,
7649,GO:0032059,1,0.963698423215428,0,7,bleb,CC,
7650,GO:0032060,1,0.929049753506904,0,10,bleb assembly,BP,
7651,GO:0032069,1,0.807194370236497,0,29,regulation of nuclease activity,BP,
7652,GO:0032070,1,0.923180036971041,0,9,regulation of deoxyribonuclease activity,BP,
7653,GO:0032071,1,0.940659400554912,0,7,regulation of endodeoxyribonuclease activity,BP,
7654,GO:0032072,1,0.99536692857644,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
7655,GO:0032074,1,0.970220631990108,0,6,negative regulation of nuclease activity,BP,
7656,GO:0032075,1,0.876142634844787,0,16,positive regulation of nuclease activity,BP,
7657,GO:0032076,1,0.995363424876141,0,1,negative regulation of deoxyribonuclease activity,BP,
7658,GO:0032077,1,0.948977033937419,0,5,positive regulation of deoxyribonuclease activity,BP,
7659,GO:0032079,1,0.96245407805223,0,4,positive regulation of endodeoxyribonuclease activity,BP,
7661,GO:0032089,1,0.990754797374331,0,2,NACHT domain binding,MF,
7662,GO:0032090,1,0.972647764102277,0,2,Pyrin domain binding,MF,
7664,GO:0032092,1,0.612779697023088,0,73,positive regulation of protein binding,BP,
7665,GO:0032093,1,0.995366574475227,0,1,SAM domain binding,MF,
7666,GO:0032094,1,0.886204665890409,0,18,response to food,BP,
7667,GO:0032095,1,0.931006652124437,0,8,regulation of response to food,BP,
7668,GO:0032096,1,0.942147274415759,0,6,negative regulation of response to food,BP,
7669,GO:0032097,1,0.992783290737664,0,1,positive regulation of response to food,BP,
7670,GO:0032098,1,0.931006652124573,0,8,regulation of appetite,BP,
7671,GO:0032099,1,0.942147274415759,0,6,negative regulation of appetite,BP,
7672,GO:0032100,1,0.992783290737664,0,1,positive regulation of appetite,BP,
7678,GO:0032106,1,0.982555774036207,0,3,positive regulation of response to extracellular stimulus,BP,
7681,GO:0032109,1,0.982555774036207,0,3,positive regulation of response to nutrient levels,BP,
7682,GO:0032116,1,0.990754785405091,0,2,SMC loading complex,CC,
7683,GO:0032119,1,0.907998051295673,0,8,sequestering of zinc ion,BP,
7684,GO:0032127,1,0.995366798601386,0,1,dense core granule membrane,CC,
7685,GO:0032129,1,0.985871146655313,0,2,histone deacetylase activity (H3-K9 specific),MF,
7686,GO:0032133,1,0.969654348967702,0,4,chromosome passenger complex,CC,
7687,GO:0032135,1,0.963366476150849,0,6,DNA insertion or deletion binding,MF,
7688,GO:0032137,1,0.986041141949882,0,3,guanine/thymine mispair binding,MF,
7689,GO:0032138,1,0.98159423488856,0,4,single base insertion or deletion binding,MF,
7690,GO:0032139,1,0.976886248562445,0,3,dinucleotide insertion or deletion binding,MF,
7691,GO:0032142,1,0.986164344449021,0,3,single guanine insertion binding,MF,
7692,GO:0032143,1,0.990755012416008,0,2,single thymine insertion binding,MF,
7693,GO:0032144,1,0.995366990826165,0,1,4-aminobutyrate transaminase complex,CC,
7694,GO:0032145,1,0.995366990826165,0,1,succinate-semialdehyde dehydrogenase binding,MF,
7695,GO:0032147,1,0.226378752721526,0,238,activation of protein kinase activity,BP,
7696,GO:0032148,1,0.820217215203606,0,24,activation of protein kinase B activity,BP,
7698,GO:0032154,1,0.752897044856326,0,48,cleavage furrow,CC,
7699,GO:0032155,1,0.717407749834667,0,58,cell division site part,CC,
7700,GO:0032156,1,0.954542103962978,0,10,septin cytoskeleton,CC,
7701,GO:0032160,1,0.958987243460415,0,9,septin filament array,CC,
7702,GO:0032173,1,0.995366682217646,0,1,septin collar,CC,
7703,GO:0032181,1,0.990755012416021,0,2,dinucleotide repeat insertion binding,MF,
7704,GO:0032182,1,0.567518387226515,0,82,ubiquitin-like protein binding,MF,
7705,GO:0032183,1,0.941339620363256,0,13,SUMO binding,MF,
7706,GO:0032184,1,0.981594123450584,0,4,SUMO polymer binding,MF,
7707,GO:0032185,1,0.94066589090295,0,13,septin cytoskeleton organization,BP,
7708,GO:0032190,1,0.974697815102304,0,2,acrosin binding,MF,
7709,GO:0032194,1,0.995366975722356,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
7710,GO:0032196,1,0.916971082663882,0,14,transposition,BP,
7711,GO:0032197,1,0.995366990590503,0,1,transposition, RNA-mediated,BP,
7713,GO:0032201,1,0.8043073102761,0,27,telomere maintenance via semi-conservative replication,BP,
7714,GO:0032202,1,0.976204990669164,0,4,telomere assembly,BP,
7715,GO:0032203,1,0.99272158279163,0,1,telomere formation via telomerase,BP,
7716,GO:0032204,1,0.652892914264057,0,76,regulation of telomere maintenance,BP,
7717,GO:0032205,1,0.830753302046748,0,35,negative regulation of telomere maintenance,BP,
7718,GO:0032206,1,0.75659142439096,0,49,positive regulation of telomere maintenance,BP,
7719,GO:0032207,1,0.99536658106292,0,1,regulation of telomere maintenance via recombination,BP,
7720,GO:0032208,1,0.99536658106292,0,1,negative regulation of telomere maintenance via recombination,BP,
7721,GO:0032210,1,0.742503164954162,0,51,regulation of telomere maintenance via telomerase,BP,
7722,GO:0032211,1,0.896812741787544,0,19,negative regulation of telomere maintenance via telomerase,BP,
7723,GO:0032212,1,0.82098271825806,0,33,positive regulation of telomere maintenance via telomerase,BP,
7724,GO:0032213,1,0.990754421464855,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
7725,GO:0032214,1,0.990754421464855,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
7726,GO:0032216,1,0.99483036219762,0,1,glucosaminyl-phosphotidylinositol O-acyltransferase activity,MF,
7727,GO:0032217,1,0.990754370961523,0,2,riboflavin transmembrane transporter activity,MF,
7728,GO:0032218,1,0.990754370961523,0,2,riboflavin transport,BP,
7729,GO:0032222,1,0.995366990825943,0,1,regulation of synaptic transmission, cholinergic,BP,
7730,GO:0032224,1,0.995366990825943,0,1,positive regulation of synaptic transmission, cholinergic,BP,
7732,GO:0032226,1,0.96607623529491,0,5,positive regulation of synaptic transmission, dopaminergic,BP,
7733,GO:0032227,1,0.986164352388629,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
7734,GO:0032228,1,0.916108187088947,0,15,regulation of synaptic transmission, GABAergic,BP,
7735,GO:0032229,1,0.978366626653561,0,2,negative regulation of synaptic transmission, GABAergic,BP,
7736,GO:0032230,1,0.962852623759826,0,7,positive regulation of synaptic transmission, GABAergic,BP,
7737,GO:0032231,1,0.682194056339596,0,66,regulation of actin filament bundle assembly,BP,
7738,GO:0032232,1,0.912034052356146,0,14,negative regulation of actin filament bundle assembly,BP,
7739,GO:0032233,1,0.764432344708454,0,43,positive regulation of actin filament bundle assembly,BP,
7740,GO:0032237,1,0.981594478077664,0,4,activation of store-operated calcium channel activity,BP,
7741,GO:0032239,1,0.926354976506773,0,16,regulation of nucleobase-containing compound transport,BP,
7742,GO:0032240,1,0.990755199849057,0,2,negative regulation of nucleobase-containing compound transport,BP,
7743,GO:0032241,1,0.966886006750189,0,7,positive regulation of nucleobase-containing compound transport,BP,
7744,GO:0032252,1,0.986164118477829,0,3,secretory granule localization,BP,
7745,GO:0032253,1,0.995366574475227,0,1,dense core granule localization,BP,
7746,GO:0032258,1,0.989873743520105,0,2,protein localization by the Cvt pathway,BP,
7748,GO:0032261,1,0.930104249488222,0,7,purine nucleotide salvage,BP,
7749,GO:0032262,1,0.954648487387943,0,5,pyrimidine nucleotide salvage,BP,
7750,GO:0032263,1,0.980683596853657,0,2,GMP salvage,BP,
7751,GO:0032264,1,0.971615341096175,0,4,IMP salvage,BP,
7752,GO:0032266,1,0.847750585121796,0,30,phosphatidylinositol-3-phosphate binding,MF,
7759,GO:0032274,1,0.966734610859837,0,7,gonadotropin secretion,BP,
7760,GO:0032275,1,0.976546552512236,0,5,luteinizing hormone secretion,BP,
7761,GO:0032276,1,0.985367749164965,0,3,regulation of gonadotropin secretion,BP,
7762,GO:0032277,1,0.994563254844199,0,1,negative regulation of gonadotropin secretion,BP,
7763,GO:0032278,1,0.985367749164965,0,3,positive regulation of gonadotropin secretion,BP,
7764,GO:0032279,1,0.449986266722061,0,149,asymmetric synapse,CC,
7765,GO:0032280,1,0.981594888733389,0,4,symmetric synapse,CC,
7766,GO:0032281,1,0.937915877034195,0,10,AMPA glutamate receptor complex,CC,
7767,GO:0032286,1,0.986163652363979,0,3,central nervous system myelin maintenance,BP,
7768,GO:0032287,1,0.947375095544099,0,8,peripheral nervous system myelin maintenance,BP,
7769,GO:0032288,1,0.897397095031826,0,20,myelin assembly,BP,
7770,GO:0032289,1,0.985337557935628,0,3,central nervous system myelin formation,BP,
7771,GO:0032290,1,0.981594478077005,0,4,peripheral nervous system myelin formation,BP,
7773,GO:0032292,1,0.887258576027411,0,21,peripheral nervous system axon ensheathment,BP,
7774,GO:0032296,1,0.977953069118213,0,4,double-stranded RNA-specific ribonuclease activity,MF,
7775,GO:0032298,1,0.994802685576982,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
7776,GO:0032299,1,0.967774598844373,0,3,ribonuclease H2 complex,CC,
7777,GO:0032300,1,0.945642349311063,0,12,mismatch repair complex,CC,
7778,GO:0032301,1,0.990755012416008,0,2,MutSalpha complex,CC,
7779,GO:0032302,1,0.990755012416021,0,2,MutSbeta complex,CC,
7780,GO:0032303,1,0.925190974382273,0,9,regulation of icosanoid secretion,BP,
7781,GO:0032304,1,0.995366990826164,0,1,negative regulation of icosanoid secretion,BP,
7782,GO:0032305,1,0.929500977455578,0,8,positive regulation of icosanoid secretion,BP,
7783,GO:0032306,1,0.942550600528909,0,5,regulation of prostaglandin secretion,BP,
7784,GO:0032308,1,0.942550600528909,0,5,positive regulation of prostaglandin secretion,BP,
7785,GO:0032309,1,0.884018808756952,0,17,icosanoid secretion,BP,
7786,GO:0032310,1,0.938180789174982,0,6,prostaglandin secretion,BP,
7787,GO:0032311,1,0.972172618992018,0,2,angiogenin-PRI complex,CC,
7788,GO:0032324,1,0.955327370184117,0,7,molybdopterin cofactor biosynthetic process,BP,
7789,GO:0032328,1,0.972396080746611,0,6,alanine transport,BP,
7793,GO:0032332,1,0.954492136277335,0,10,positive regulation of chondrocyte differentiation,BP,
7794,GO:0032341,1,0.981593243496628,0,4,aldosterone metabolic process,BP,
7795,GO:0032342,1,0.981593243496628,0,4,aldosterone biosynthetic process,BP,
7796,GO:0032344,1,0.981593243496628,0,4,regulation of aldosterone metabolic process,BP,
7797,GO:0032345,1,0.986162878727752,0,3,negative regulation of aldosterone metabolic process,BP,
7798,GO:0032346,1,0.995366990309484,0,1,positive regulation of aldosterone metabolic process,BP,
7799,GO:0032347,1,0.981593243496628,0,4,regulation of aldosterone biosynthetic process,BP,
7800,GO:0032348,1,0.986162878727752,0,3,negative regulation of aldosterone biosynthetic process,BP,
7801,GO:0032349,1,0.995366990309484,0,1,positive regulation of aldosterone biosynthetic process,BP,
7802,GO:0032350,1,0.862833719982105,0,23,regulation of hormone metabolic process,BP,
7803,GO:0032351,1,0.967910209237781,0,7,negative regulation of hormone metabolic process,BP,
7804,GO:0032352,1,0.948073695944779,0,9,positive regulation of hormone metabolic process,BP,
7805,GO:0032353,1,0.967910209237781,0,7,negative regulation of hormone biosynthetic process,BP,
7806,GO:0032354,1,0.944115722978229,0,12,response to follicle-stimulating hormone,BP,
7808,GO:0032356,1,0.930357441185504,0,10,oxidized DNA binding,MF,
7809,GO:0032357,1,0.935666752549661,0,9,oxidized purine DNA binding,MF,
7810,GO:0032358,1,0.975961703099268,0,1,oxidized pyrimidine DNA binding,MF,
7811,GO:0032361,1,0.993748276642859,0,1,pyridoxal phosphate catabolic process,BP,
7812,GO:0032364,1,0.960842710099109,0,5,oxygen homeostasis,BP,
7813,GO:0032365,1,0.834239989289409,0,29,intracellular lipid transport,BP,
7814,GO:0032366,1,0.887380743670225,0,17,intracellular sterol transport,BP,
7815,GO:0032367,1,0.887380743670225,0,17,intracellular cholesterol transport,BP,
7816,GO:0032368,1,0.645592962658254,0,54,regulation of lipid transport,BP,
7817,GO:0032369,1,0.903615719987127,0,14,negative regulation of lipid transport,BP,
7818,GO:0032370,1,0.760616286778896,0,32,positive regulation of lipid transport,BP,
7819,GO:0032371,1,0.798431820507674,0,26,regulation of sterol transport,BP,
7820,GO:0032372,1,0.953462792980077,0,4,negative regulation of sterol transport,BP,
7821,GO:0032373,1,0.889293887887302,0,16,positive regulation of sterol transport,BP,
7822,GO:0032374,1,0.798431820507674,0,26,regulation of cholesterol transport,BP,
7823,GO:0032375,1,0.953462792980077,0,4,negative regulation of cholesterol transport,BP,
7824,GO:0032376,1,0.889293887887302,0,16,positive regulation of cholesterol transport,BP,
7825,GO:0032377,1,0.948095724166676,0,7,regulation of intracellular lipid transport,BP,
7826,GO:0032378,1,0.995366974859718,0,1,negative regulation of intracellular lipid transport,BP,
7827,GO:0032379,1,0.973425626014806,0,3,positive regulation of intracellular lipid transport,BP,
7828,GO:0032380,1,0.948095724166676,0,7,regulation of intracellular sterol transport,BP,
7829,GO:0032381,1,0.995366974859718,0,1,negative regulation of intracellular sterol transport,BP,
7830,GO:0032382,1,0.973425626014806,0,3,positive regulation of intracellular sterol transport,BP,
7831,GO:0032383,1,0.948095724166676,0,7,regulation of intracellular cholesterol transport,BP,
7832,GO:0032384,1,0.995366974859718,0,1,negative regulation of intracellular cholesterol transport,BP,
7833,GO:0032385,1,0.973425626014806,0,3,positive regulation of intracellular cholesterol transport,BP,
7835,GO:0032387,1,0.700973195822381,0,42,negative regulation of intracellular transport,BP,
7837,GO:0032389,1,0.96788846941773,0,7,MutLalpha complex,CC,
7838,GO:0032391,1,0.856607668807579,0,24,photoreceptor connecting cilium,CC,
7839,GO:0032392,1,0.591737994900843,0,81,DNA geometric change,BP,
7840,GO:0032393,1,0.97309777474819,0,2,MHC class I receptor activity,MF,
7841,GO:0032395,1,0.960741158514633,0,3,MHC class II receptor activity,MF,
7842,GO:0032397,1,0.988214398421963,0,1,activating MHC class I receptor activity,MF,
7843,GO:0032398,1,0.990950867365765,0,1,MHC class Ib protein complex,CC,
7844,GO:0032400,1,0.877976446435756,0,22,melanosome localization,BP,
7845,GO:0032401,1,0.886214847352941,0,20,establishment of melanosome localization,BP,
7846,GO:0032402,1,0.890345338119909,0,19,melanosome transport,BP,
7847,GO:0032404,1,0.947150748031772,0,8,mismatch repair complex binding,MF,
7848,GO:0032405,1,0.963240610613233,0,5,MutLalpha complex binding,MF,
7849,GO:0032407,1,0.969568997958976,0,5,MutSalpha complex binding,MF,
7851,GO:0032410,1,0.758742450162001,0,42,negative regulation of transporter activity,BP,
7854,GO:0032413,1,0.780806941545906,0,36,negative regulation of ion transmembrane transporter activity,BP,
7856,GO:0032415,1,0.984572020696637,0,3,regulation of sodium:proton antiporter activity,BP,
7857,GO:0032416,1,0.993760207203912,0,1,negative regulation of sodium:proton antiporter activity,BP,
7858,GO:0032417,1,0.99075478496345,0,2,positive regulation of sodium:proton antiporter activity,BP,
7859,GO:0032418,1,0.708012557893603,0,48,lysosome localization,BP,
7860,GO:0032419,1,0.994774072587903,0,1,extrinsic component of lysosome membrane,CC,
7861,GO:0032420,1,0.852757921702669,0,24,stereocilium,CC,
7862,GO:0032421,1,0.832109068490407,0,28,stereocilium bundle,CC,
7863,GO:0032422,1,0.985265270485251,0,3,purine-rich negative regulatory element binding,MF,
7864,GO:0032423,1,0.99536692857644,0,1,regulation of mismatch repair,BP,
7865,GO:0032425,1,0.99536692857644,0,1,positive regulation of mismatch repair,BP,
7866,GO:0032426,1,0.963848252588718,0,7,stereocilium tip,CC,
7867,GO:0032427,1,0.989943893016384,0,2,GBD domain binding,MF,
7868,GO:0032428,1,0.995366965574457,0,1,beta-N-acetylgalactosaminidase activity,MF,
7869,GO:0032429,1,0.942881311117026,0,7,regulation of phospholipase A2 activity,BP,
7870,GO:0032430,1,0.96989185567522,0,3,positive regulation of phospholipase A2 activity,BP,
7871,GO:0032431,1,0.974407638173524,0,2,activation of phospholipase A2 activity,BP,
7872,GO:0032432,1,0.739849097696802,0,47,actin filament bundle,CC,
7873,GO:0032433,1,0.929998687067608,0,12,filopodium tip,CC,
7875,GO:0032435,1,0.803271394751705,0,26,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
7877,GO:0032437,1,0.980132978899134,0,3,cuticular plate,CC,
7878,GO:0032438,1,0.823099588172087,0,22,melanosome organization,BP,
7879,GO:0032440,1,0.984486253799563,0,1,2-alkenal reductase [NAD(P)] activity,MF,
7880,GO:0032444,1,0.990755199848874,0,2,activin responsive factor complex,CC,
7882,GO:0032447,1,0.995225769074058,0,1,protein urmylation,BP,
7883,GO:0032449,1,0.965110806275812,0,5,CBM complex,CC,
7884,GO:0032450,1,0.986164509990694,0,3,maltose alpha-glucosidase activity,MF,
7885,GO:0032451,1,0.829252430171116,0,35,demethylase activity,MF,
7886,GO:0032452,1,0.890323380925534,0,25,histone demethylase activity,MF,
7887,GO:0032453,1,0.972518070521031,0,6,histone demethylase activity (H3-K4 specific),MF,
7888,GO:0032454,1,0.945782428089366,0,12,histone demethylase activity (H3-K9 specific),MF,
7889,GO:0032455,1,0.986164342717025,0,3,nerve growth factor processing,BP,
7890,GO:0032456,1,0.83259115946577,0,33,endocytic recycling,BP,
7891,GO:0032458,1,0.995366989864108,0,1,slow endocytic recycling,BP,
7892,GO:0032459,1,0.777866921503186,0,30,regulation of protein oligomerization,BP,
7893,GO:0032460,1,0.910143330205035,0,13,negative regulation of protein oligomerization,BP,
7894,GO:0032461,1,0.869531586420997,0,16,positive regulation of protein oligomerization,BP,
7895,GO:0032462,1,0.858350957514494,0,17,regulation of protein homooligomerization,BP,
7896,GO:0032463,1,0.918644277206485,0,11,negative regulation of protein homooligomerization,BP,
7897,GO:0032464,1,0.946099443249079,0,6,positive regulation of protein homooligomerization,BP,
7898,GO:0032465,1,0.658046325393857,0,68,regulation of cytokinesis,BP,
7899,GO:0032466,1,0.95779091117675,0,6,negative regulation of cytokinesis,BP,
7900,GO:0032467,1,0.8478394367019,0,25,positive regulation of cytokinesis,BP,
7901,GO:0032468,1,0.9953669493435,0,1,Golgi calcium ion homeostasis,BP,
7902,GO:0032469,1,0.860785616582068,0,20,endoplasmic reticulum calcium ion homeostasis,BP,
7903,GO:0032470,1,0.995366990826007,0,1,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
7904,GO:0032471,1,0.921123303869951,0,7,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
7905,GO:0032472,1,0.98891993702039,0,2,Golgi calcium ion transport,BP,
7907,GO:0032475,1,0.995352427354762,0,1,otolith formation,BP,
7910,GO:0032481,1,0.642007571874398,0,63,positive regulation of type I interferon production,BP,
7912,GO:0032483,1,0.981594567986766,0,4,regulation of Rab protein signal transduction,BP,
7913,GO:0032484,1,0.986164406980453,0,3,Ral protein signal transduction,BP,
7914,GO:0032485,1,0.986164406980453,0,3,regulation of Ral protein signal transduction,BP,
7915,GO:0032486,1,0.937923452897067,0,13,Rap protein signal transduction,BP,
7916,GO:0032487,1,0.986164516177435,0,3,regulation of Rap protein signal transduction,BP,
7917,GO:0032488,1,0.933669633103655,0,11,Cdc42 protein signal transduction,BP,
7918,GO:0032489,1,0.969385924788842,0,4,regulation of Cdc42 protein signal transduction,BP,
7919,GO:0032490,1,0.98158775278371,0,4,detection of molecule of bacterial origin,BP,
7920,GO:0032493,1,0.982891875921994,0,3,response to bacterial lipoprotein,BP,
7921,GO:0032494,1,0.976972808706312,0,5,response to peptidoglycan,BP,
7922,GO:0032495,1,0.940173407637348,0,12,response to muramyl dipeptide,BP,
7924,GO:0032497,1,0.995359826602095,0,1,detection of lipopolysaccharide,BP,
7925,GO:0032498,1,0.995366990826164,0,1,detection of muramyl dipeptide,BP,
7926,GO:0032499,1,0.995366990826164,0,1,detection of peptidoglycan,BP,
7927,GO:0032500,1,0.995366990826164,0,1,muramyl dipeptide binding,MF,
7931,GO:0032506,1,0.880137286684912,0,23,cytokinetic process,BP,
7933,GO:0032508,1,0.62463772751759,0,71,DNA duplex unwinding,BP,
7934,GO:0032509,1,0.86476097922588,0,20,endosome transport via multivesicular body sorting pathway,BP,
7935,GO:0032510,1,0.970005126245366,0,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,
7936,GO:0032511,1,0.920279141528724,0,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
7937,GO:0032515,1,0.7740157148683,0,35,negative regulation of phosphoprotein phosphatase activity,BP,
7938,GO:0032516,1,0.925545637455703,0,14,positive regulation of phosphoprotein phosphatase activity,BP,
7939,GO:0032525,1,0.968458676904992,0,6,somite rostral/caudal axis specification,BP,
7940,GO:0032526,1,0.603857103216437,0,71,response to retinoic acid,BP,
7941,GO:0032527,1,0.78219774201581,0,34,protein exit from endoplasmic reticulum,BP,
7942,GO:0032528,1,0.897173590254164,0,18,microvillus organization,BP,
7943,GO:0032530,1,0.95420843170694,0,9,regulation of microvillus organization,BP,
7944,GO:0032532,1,0.981179583808506,0,3,regulation of microvillus length,BP,
7945,GO:0032534,1,0.972517438110824,0,6,regulation of microvillus assembly,BP,
7947,GO:0032536,1,0.963679921273982,0,6,regulation of cell projection size,BP,
7948,GO:0032541,1,0.960358123933256,0,5,cortical endoplasmic reticulum,CC,
7949,GO:0032542,1,0.990705491904275,0,2,sulfiredoxin activity,MF,
7950,GO:0032543,1,0.167700188211264,0,129,mitochondrial translation,BP,
7951,GO:0032545,1,0.974459102398674,0,3,CURI complex,CC,
7954,GO:0032551,1,0.990696298557805,0,2,pyrimidine ribonucleoside binding,MF,
7955,GO:0032552,1,0.936861910191922,0,6,deoxyribonucleotide binding,MF,
7957,GO:0032554,1,0.961038971749769,0,4,purine deoxyribonucleotide binding,MF,
7959,GO:0032556,1,0.974854103960284,0,2,pyrimidine deoxyribonucleotide binding,MF,
7960,GO:0032557,1,0.985204952756689,0,3,pyrimidine ribonucleotide binding,MF,
7961,GO:0032558,1,0.965514165172013,0,3,adenyl deoxyribonucleotide binding,MF,
7963,GO:0032560,1,0.995366829720426,0,1,guanyl deoxyribonucleotide binding,MF,
7965,GO:0032564,1,0.965514165172013,0,3,dATP binding,MF,
7966,GO:0032567,1,0.995366829720426,0,1,dGTP binding,MF,
7968,GO:0032571,1,0.990667722499669,0,2,response to vitamin K,BP,
7969,GO:0032574,1,0.995366990762182,0,1,5'-3' RNA helicase activity,MF,
7970,GO:0032575,1,0.995366990762182,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
7972,GO:0032581,1,0.992620824102658,0,1,ER-dependent peroxisome organization,BP,
7973,GO:0032584,1,0.986163688065816,0,3,growth cone membrane,CC,
7974,GO:0032585,1,0.921641490760915,0,10,multivesicular body membrane,CC,
7975,GO:0032587,1,0.652626218380489,0,72,ruffle membrane,CC,
7976,GO:0032588,1,0.650033696385675,0,65,trans-Golgi network membrane,CC,
7977,GO:0032589,1,0.88209408704937,0,24,neuron projection membrane,CC,
7978,GO:0032590,1,0.92430039770939,0,14,dendrite membrane,CC,
7979,GO:0032591,1,0.977045762581024,0,5,dendritic spine membrane,CC,
7980,GO:0032592,1,0.581005787940444,0,65,integral component of mitochondrial membrane,CC,
7981,GO:0032593,1,0.944988532112499,0,6,insulin-responsive compartment,CC,
7982,GO:0032594,1,0.879776533185863,0,21,protein transport within lipid bilayer,BP,
7983,GO:0032595,1,0.994581861569669,0,1,B cell receptor transport within lipid bilayer,BP,
7984,GO:0032596,1,0.972782221740091,0,5,protein transport into membrane raft,BP,
7985,GO:0032597,1,0.994581861569669,0,1,B cell receptor transport into membrane raft,BP,
7986,GO:0032599,1,0.994581861569669,0,1,protein transport out of membrane raft,BP,
7987,GO:0032600,1,0.994581861569669,0,1,chemokine receptor transport out of membrane raft,BP,
7989,GO:0032604,1,0.930277672731512,0,8,granulocyte macrophage colony-stimulating factor production,BP,
7991,GO:0032607,1,0.878253389288699,0,22,interferon-alpha production,BP,
7992,GO:0032608,1,0.77149850934,0,43,interferon-beta production,BP,
7994,GO:0032610,1,0.903389988221802,0,7,interleukin-1 alpha production,BP,
7995,GO:0032611,1,0.727744584131126,0,42,interleukin-1 beta production,BP,
7996,GO:0032612,1,0.623324859886384,0,55,interleukin-1 production,BP,
7997,GO:0032613,1,0.835877255604599,0,24,interleukin-10 production,BP,
7998,GO:0032615,1,0.800319032027184,0,32,interleukin-12 production,BP,
7999,GO:0032616,1,0.935466257328829,0,10,interleukin-13 production,BP,
8000,GO:0032618,1,0.983097568193123,0,2,interleukin-15 production,BP,
8001,GO:0032620,1,0.895413364795709,0,13,interleukin-17 production,BP,
8002,GO:0032621,1,0.967613643054261,0,6,interleukin-18 production,BP,
8003,GO:0032623,1,0.782309894187766,0,38,interleukin-2 production,BP,
8004,GO:0032625,1,0.995366962840291,0,1,interleukin-21 production,BP,
8005,GO:0032627,1,0.9556912200338,0,5,interleukin-23 production,BP,
8006,GO:0032632,1,0.99039678045234,0,2,interleukin-3 production,BP,
8007,GO:0032633,1,0.906617308861881,0,17,interleukin-4 production,BP,
8008,GO:0032634,1,0.962554043892517,0,8,interleukin-5 production,BP,
8009,GO:0032635,1,0.653283359204367,0,68,interleukin-6 production,BP,
8011,GO:0032639,1,0.990950867365765,0,1,TRAIL production,BP,
8013,GO:0032641,1,0.990751557578275,0,2,lymphotoxin A production,BP,
8015,GO:0032645,1,0.930277672731512,0,8,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8016,GO:0032647,1,0.889121050421408,0,21,regulation of interferon-alpha production,BP,
8017,GO:0032648,1,0.782098265785929,0,41,regulation of interferon-beta production,BP,
8018,GO:0032649,1,0.689169837212926,0,47,regulation of interferon-gamma production,BP,
8019,GO:0032650,1,0.930924452057377,0,6,regulation of interleukin-1 alpha production,BP,
8020,GO:0032651,1,0.761707015123698,0,36,regulation of interleukin-1 beta production,BP,
8021,GO:0032652,1,0.672429140650662,0,48,regulation of interleukin-1 production,BP,
8022,GO:0032653,1,0.843693085446864,0,22,regulation of interleukin-10 production,BP,
8023,GO:0032655,1,0.804054032059901,0,31,regulation of interleukin-12 production,BP,
8024,GO:0032656,1,0.952164481336509,0,9,regulation of interleukin-13 production,BP,
8025,GO:0032658,1,0.992064218688857,0,1,regulation of interleukin-15 production,BP,
8026,GO:0032660,1,0.913573850442932,0,11,regulation of interleukin-17 production,BP,
8027,GO:0032661,1,0.972118944187375,0,5,regulation of interleukin-18 production,BP,
8028,GO:0032663,1,0.825463206142512,0,32,regulation of interleukin-2 production,BP,
8029,GO:0032667,1,0.9556912200338,0,5,regulation of interleukin-23 production,BP,
8030,GO:0032672,1,0.99039678045234,0,2,regulation of interleukin-3 production,BP,
8031,GO:0032673,1,0.9196134413451,0,14,regulation of interleukin-4 production,BP,
8032,GO:0032674,1,0.962554043892517,0,8,regulation of interleukin-5 production,BP,
8033,GO:0032675,1,0.679558825283784,0,64,regulation of interleukin-6 production,BP,
8035,GO:0032679,1,0.990950867365765,0,1,regulation of TRAIL production,BP,
8037,GO:0032681,1,0.995363558172447,0,1,regulation of lymphotoxin A production,BP,
8038,GO:0032682,1,0.927583326983618,0,10,negative regulation of chemokine production,BP,
8039,GO:0032685,1,0.995366865390916,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8040,GO:0032687,1,0.964892678022597,0,5,negative regulation of interferon-alpha production,BP,
8041,GO:0032688,1,0.91102169154207,0,13,negative regulation of interferon-beta production,BP,
8042,GO:0032689,1,0.888415878794349,0,17,negative regulation of interferon-gamma production,BP,
8043,GO:0032690,1,0.98755889731644,0,1,negative regulation of interleukin-1 alpha production,BP,
8044,GO:0032691,1,0.906204873511823,0,11,negative regulation of interleukin-1 beta production,BP,
8045,GO:0032692,1,0.873913793275245,0,16,negative regulation of interleukin-1 production,BP,
8046,GO:0032693,1,0.917815153010537,0,10,negative regulation of interleukin-10 production,BP,
8047,GO:0032695,1,0.923827361947972,0,11,negative regulation of interleukin-12 production,BP,
8048,GO:0032696,1,0.984432880705155,0,3,negative regulation of interleukin-13 production,BP,
8049,GO:0032700,1,0.970331352424508,0,5,negative regulation of interleukin-17 production,BP,
8050,GO:0032701,1,0.985759836672366,0,2,negative regulation of interleukin-18 production,BP,
8051,GO:0032703,1,0.939992199267142,0,12,negative regulation of interleukin-2 production,BP,
8052,GO:0032707,1,0.995102315596589,0,1,negative regulation of interleukin-23 production,BP,
8053,GO:0032712,1,0.995006922237278,0,1,negative regulation of interleukin-3 production,BP,
8054,GO:0032713,1,0.981476775926801,0,4,negative regulation of interleukin-4 production,BP,
8055,GO:0032714,1,0.990755142216451,0,2,negative regulation of interleukin-5 production,BP,
8056,GO:0032715,1,0.898930731661898,0,19,negative regulation of interleukin-6 production,BP,
8058,GO:0032720,1,0.824583669478217,0,26,negative regulation of tumor necrosis factor production,BP,
8059,GO:0032722,1,0.78394181848039,0,33,positive regulation of chemokine production,BP,
8060,GO:0032725,1,0.934611215452793,0,7,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8061,GO:0032727,1,0.921502459349159,0,16,positive regulation of interferon-alpha production,BP,
8062,GO:0032728,1,0.865089475624186,0,26,positive regulation of interferon-beta production,BP,
8063,GO:0032729,1,0.800056141992313,0,29,positive regulation of interferon-gamma production,BP,
8064,GO:0032730,1,0.942660073453225,0,5,positive regulation of interleukin-1 alpha production,BP,
8065,GO:0032731,1,0.860249066660298,0,21,positive regulation of interleukin-1 beta production,BP,
8066,GO:0032732,1,0.794230189645449,0,28,positive regulation of interleukin-1 production,BP,
8067,GO:0032733,1,0.891439300668608,0,14,positive regulation of interleukin-10 production,BP,
8068,GO:0032735,1,0.87859561589976,0,18,positive regulation of interleukin-12 production,BP,
8069,GO:0032736,1,0.967227159529498,0,6,positive regulation of interleukin-13 production,BP,
8070,GO:0032738,1,0.992064218688857,0,1,positive regulation of interleukin-15 production,BP,
8071,GO:0032740,1,0.936505493723099,0,7,positive regulation of interleukin-17 production,BP,
8072,GO:0032741,1,0.99075512948395,0,2,positive regulation of interleukin-18 production,BP,
8073,GO:0032743,1,0.878240980222236,0,20,positive regulation of interleukin-2 production,BP,
8074,GO:0032747,1,0.965544969013873,0,3,positive regulation of interleukin-23 production,BP,
8075,GO:0032752,1,0.995366990826164,0,1,positive regulation of interleukin-3 production,BP,
8076,GO:0032753,1,0.936982274954195,0,10,positive regulation of interleukin-4 production,BP,
8077,GO:0032754,1,0.971538760650785,0,6,positive regulation of interleukin-5 production,BP,
8078,GO:0032755,1,0.761979265227146,0,43,positive regulation of interleukin-6 production,BP,
8080,GO:0032759,1,0.990950867365765,0,1,positive regulation of TRAIL production,BP,
8082,GO:0032761,1,0.995363558172447,0,1,positive regulation of lymphotoxin A production,BP,
8083,GO:0032762,1,0.980160214929887,0,3,mast cell cytokine production,BP,
8084,GO:0032763,1,0.980160214929887,0,3,regulation of mast cell cytokine production,BP,
8085,GO:0032764,1,0.984723477737869,0,2,negative regulation of mast cell cytokine production,BP,
8086,GO:0032765,1,0.995366764448965,0,1,positive regulation of mast cell cytokine production,BP,
8087,GO:0032767,1,0.958569942212348,0,3,copper-dependent protein binding,MF,
8089,GO:0032769,1,0.94681509523215,0,7,negative regulation of monooxygenase activity,BP,
8091,GO:0032771,1,0.995366990826152,0,1,regulation of monophenol monooxygenase activity,BP,
8092,GO:0032773,1,0.995366990826152,0,1,positive regulation of monophenol monooxygenase activity,BP,
8094,GO:0032775,1,0.99536697875851,0,1,DNA methylation on adenine,BP,
8095,GO:0032776,1,0.98616453094333,0,3,DNA methylation on cytosine,BP,
8096,GO:0032777,1,0.976992956188071,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8097,GO:0032780,1,0.96093059850253,0,7,negative regulation of ATPase activity,BP,
8099,GO:0032782,1,0.9874685450119,0,2,bile acid secretion,BP,
8100,GO:0032783,1,0.966346072111258,0,4,ELL-EAF complex,CC,
8101,GO:0032784,1,0.783344432414264,0,40,regulation of DNA-templated transcription, elongation,BP,
8102,GO:0032785,1,0.934499455047554,0,11,negative regulation of DNA-templated transcription, elongation,BP,
8103,GO:0032786,1,0.850781076155107,0,24,positive regulation of DNA-templated transcription, elongation,BP,
8105,GO:0032790,1,0.946569089930475,0,8,ribosome disassembly,BP,
8107,GO:0032793,1,0.933818090321185,0,12,positive regulation of CREB transcription factor activity,BP,
8108,GO:0032794,1,0.921707655780892,0,14,GTPase activating protein binding,MF,
8109,GO:0032795,1,0.981109730811077,0,1,heterotrimeric G-protein binding,MF,
8110,GO:0032796,1,0.985710084085783,0,2,uropod organization,BP,
8111,GO:0032797,1,0.915347813142031,0,11,SMN complex,CC,
8112,GO:0032798,1,0.990754370961523,0,2,Swi5-Sfr1 complex,CC,
8113,GO:0032799,1,0.85655725619471,0,19,low-density lipoprotein receptor particle metabolic process,BP,
8115,GO:0032801,1,0.805235275299543,0,32,receptor catabolic process,BP,
8116,GO:0032802,1,0.89363126247757,0,13,low-density lipoprotein particle receptor catabolic process,BP,
8117,GO:0032803,1,0.960233028463583,0,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,
8118,GO:0032804,1,0.985865008984749,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
8119,GO:0032805,1,0.978539669590862,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
8120,GO:0032806,1,0.851045930667497,0,25,carboxy-terminal domain protein kinase complex,CC,
8121,GO:0032807,1,0.97591921836666,0,4,DNA ligase IV complex,CC,
8122,GO:0032808,1,0.981594832691263,0,4,lacrimal gland development,BP,
8123,GO:0032809,1,0.967794315263463,0,7,neuronal cell body membrane,CC,
8124,GO:0032810,1,0.984860600647127,0,2,sterol response element binding,MF,
8125,GO:0032813,1,0.78988940284996,0,33,tumor necrosis factor receptor superfamily binding,MF,
8126,GO:0032814,1,0.854722448876991,0,18,regulation of natural killer cell activation,BP,
8127,GO:0032815,1,0.952449534320538,0,5,negative regulation of natural killer cell activation,BP,
8128,GO:0032816,1,0.901630530736222,0,12,positive regulation of natural killer cell activation,BP,
8129,GO:0032817,1,0.95032114549961,0,4,regulation of natural killer cell proliferation,BP,
8130,GO:0032819,1,0.95032114549961,0,4,positive regulation of natural killer cell proliferation,BP,
8131,GO:0032823,1,0.928927366452427,0,9,regulation of natural killer cell differentiation,BP,
8132,GO:0032824,1,0.983037423653184,0,1,negative regulation of natural killer cell differentiation,BP,
8133,GO:0032825,1,0.949367817864939,0,7,positive regulation of natural killer cell differentiation,BP,
8134,GO:0032826,1,0.983037423653184,0,1,regulation of natural killer cell differentiation involved in immune response,BP,
8135,GO:0032827,1,0.983037423653184,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
8137,GO:0032836,1,0.952724245238438,0,7,glomerular basement membrane development,BP,
8138,GO:0032838,1,0.415251007928023,0,122,plasma membrane bounded cell projection cytoplasm,CC,
8139,GO:0032839,1,0.874405921929871,0,22,dendrite cytoplasm,CC,
8140,GO:0032847,1,0.986231315850291,0,2,regulation of cellular pH reduction,BP,
8141,GO:0032848,1,0.995366989202906,0,1,negative regulation of cellular pH reduction,BP,
8142,GO:0032849,1,0.990822292232329,0,1,positive regulation of cellular pH reduction,BP,
8143,GO:0032868,1,0.287416662396429,0,193,response to insulin,BP,
8144,GO:0032869,1,0.364486594529227,0,158,cellular response to insulin stimulus,BP,
8146,GO:0032872,1,0.374719340523563,0,160,regulation of stress-activated MAPK cascade,BP,
8147,GO:0032873,1,0.799369945584046,0,37,negative regulation of stress-activated MAPK cascade,BP,
8148,GO:0032874,1,0.523347727222422,0,107,positive regulation of stress-activated MAPK cascade,BP,
8149,GO:0032875,1,0.968011002595785,0,7,regulation of DNA endoreduplication,BP,
8150,GO:0032876,1,0.98159488220038,0,4,negative regulation of DNA endoreduplication,BP,
8151,GO:0032877,1,0.990755191845471,0,2,positive regulation of DNA endoreduplication,BP,
8152,GO:0032878,1,0.910272111716269,0,20,regulation of establishment or maintenance of cell polarity,BP,
8158,GO:0032887,1,0.995366990826059,0,1,regulation of spindle elongation,BP,
8159,GO:0032888,1,0.995366990826059,0,1,regulation of mitotic spindle elongation,BP,
8160,GO:0032889,1,0.995294480592495,0,1,regulation of vacuole fusion, non-autophagic,BP,
8161,GO:0032890,1,0.835636226587679,0,26,regulation of organic acid transport,BP,
8162,GO:0032891,1,0.962562348857926,0,8,negative regulation of organic acid transport,BP,
8163,GO:0032892,1,0.895395178337004,0,13,positive regulation of organic acid transport,BP,
8164,GO:0032897,1,0.868579041960986,0,21,negative regulation of viral transcription,BP,
8165,GO:0032898,1,0.986164423322808,0,3,neurotrophin production,BP,
8166,GO:0032899,1,0.995366990093737,0,1,regulation of neurotrophin production,BP,
8167,GO:0032901,1,0.995366990093737,0,1,positive regulation of neurotrophin production,BP,
8168,GO:0032902,1,0.990755092381819,0,2,nerve growth factor production,BP,
8169,GO:0032905,1,0.969532278095155,0,6,transforming growth factor beta1 production,BP,
8170,GO:0032906,1,0.971522090401631,0,6,transforming growth factor beta2 production,BP,
8171,GO:0032907,1,0.985386577628472,0,3,transforming growth factor beta3 production,BP,
8172,GO:0032908,1,0.969532278095155,0,6,regulation of transforming growth factor beta1 production,BP,
8173,GO:0032909,1,0.971522090401631,0,6,regulation of transforming growth factor beta2 production,BP,
8174,GO:0032910,1,0.985386577628472,0,3,regulation of transforming growth factor beta3 production,BP,
8175,GO:0032911,1,0.985595046841467,0,3,negative regulation of transforming growth factor beta1 production,BP,
8176,GO:0032912,1,0.995366990826152,0,1,negative regulation of transforming growth factor beta2 production,BP,
8177,GO:0032913,1,0.994581861569669,0,1,negative regulation of transforming growth factor beta3 production,BP,
8178,GO:0032914,1,0.983705169816936,0,3,positive regulation of transforming growth factor beta1 production,BP,
8179,GO:0032915,1,0.994347643980756,0,1,positive regulation of transforming growth factor beta2 production,BP,
8180,GO:0032916,1,0.990755199849044,0,2,positive regulation of transforming growth factor beta3 production,BP,
8181,GO:0032917,1,0.961020311021029,0,2,polyamine acetylation,BP,
8182,GO:0032918,1,0.961020311021029,0,2,spermidine acetylation,BP,
8183,GO:0032919,1,0.978712031215829,0,1,spermine acetylation,BP,
8184,GO:0032920,1,0.978712031215829,0,1,putrescine acetylation,BP,
8186,GO:0032924,1,0.861457990586048,0,22,activin receptor signaling pathway,BP,
8187,GO:0032925,1,0.889465066815319,0,16,regulation of activin receptor signaling pathway,BP,
8188,GO:0032926,1,0.953308820516515,0,7,negative regulation of activin receptor signaling pathway,BP,
8189,GO:0032927,1,0.956431606807325,0,6,positive regulation of activin receptor signaling pathway,BP,
8190,GO:0032928,1,0.890769948487102,0,11,regulation of superoxide anion generation,BP,
8191,GO:0032929,1,0.984268200831979,0,2,negative regulation of superoxide anion generation,BP,
8192,GO:0032930,1,0.909240911979226,0,8,positive regulation of superoxide anion generation,BP,
8193,GO:0032933,1,0.959979372117669,0,8,SREBP signaling pathway,BP,
8194,GO:0032934,1,0.775589616472454,0,33,sterol binding,MF,
8195,GO:0032937,1,0.986123687221468,0,3,SREBP-SCAP-Insig complex,CC,
8197,GO:0032941,1,0.871046728312573,0,17,secretion by tissue,BP,
8202,GO:0032947,1,0.684942961986779,0,72,protein-containing complex scaffold activity,MF,
8203,GO:0032954,1,0.990755099159295,0,2,regulation of cytokinetic process,BP,
8205,GO:0032957,1,0.963523939515418,0,8,inositol trisphosphate metabolic process,BP,
8206,GO:0032958,1,0.912342889249691,0,17,inositol phosphate biosynthetic process,BP,
8207,GO:0032959,1,0.972517676008442,0,6,inositol trisphosphate biosynthetic process,BP,
8208,GO:0032960,1,0.981594255521572,0,4,regulation of inositol trisphosphate biosynthetic process,BP,
8209,GO:0032962,1,0.986163894897857,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,
8210,GO:0032963,1,0.652415235102212,0,73,collagen metabolic process,BP,
8211,GO:0032964,1,0.848713109153808,0,27,collagen biosynthetic process,BP,
8212,GO:0032965,1,0.88411008062799,0,20,regulation of collagen biosynthetic process,BP,
8213,GO:0032966,1,0.969986057941028,0,5,negative regulation of collagen biosynthetic process,BP,
8214,GO:0032967,1,0.911496437268618,0,15,positive regulation of collagen biosynthetic process,BP,
8215,GO:0032968,1,0.904320910910369,0,15,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8217,GO:0032976,1,0.97527649662577,0,1,release of matrix enzymes from mitochondria,BP,
8218,GO:0032977,1,0.995366990826164,0,1,membrane insertase activity,MF,
8219,GO:0032978,1,0.995366990826164,0,1,protein insertion into membrane from inner side,BP,
8220,GO:0032979,1,0.995366990826164,0,1,protein insertion into mitochondrial membrane from inner side,BP,
8221,GO:0032980,1,0.995177710302648,0,1,keratinocyte activation,BP,
8222,GO:0032981,1,0.352173061641542,0,55,mitochondrial respiratory chain complex I assembly,BP,
8223,GO:0032982,1,0.96801116298429,0,7,myosin filament,CC,
8225,GO:0032986,1,0.861523556885235,0,18,protein-DNA complex disassembly,BP,
8226,GO:0032988,1,0.913113453717964,0,13,ribonucleoprotein complex disassembly,BP,
8231,GO:0032994,1,0.833232143681234,0,18,protein-lipid complex,CC,
8232,GO:0032996,1,0.992799582895633,0,1,Bcl3-Bcl10 complex,CC,
8234,GO:0033003,1,0.87028891933563,0,21,regulation of mast cell activation,BP,
8235,GO:0033004,1,0.980160011098955,0,3,negative regulation of mast cell activation,BP,
8236,GO:0033005,1,0.935466151732967,0,9,positive regulation of mast cell activation,BP,
8237,GO:0033006,1,0.879017463571181,0,19,regulation of mast cell activation involved in immune response,BP,
8238,GO:0033007,1,0.980160011098955,0,3,negative regulation of mast cell activation involved in immune response,BP,
8239,GO:0033008,1,0.939839751977032,0,8,positive regulation of mast cell activation involved in immune response,BP,
8240,GO:0033010,1,0.962524836667047,0,6,paranodal junction,CC,
8241,GO:0033013,1,0.701958516292307,0,43,tetrapyrrole metabolic process,BP,
8242,GO:0033014,1,0.833628159873223,0,24,tetrapyrrole biosynthetic process,BP,
8243,GO:0033015,1,0.930520355595146,0,6,tetrapyrrole catabolic process,BP,
8244,GO:0033017,1,0.875182126020825,0,21,sarcoplasmic reticulum membrane,CC,
8245,GO:0033018,1,0.988568580853432,0,2,sarcoplasmic reticulum lumen,CC,
8246,GO:0033023,1,0.990755172082318,0,2,mast cell homeostasis,BP,
8247,GO:0033024,1,0.990755172082318,0,2,mast cell apoptotic process,BP,
8248,GO:0033025,1,0.990755172082318,0,2,regulation of mast cell apoptotic process,BP,
8249,GO:0033026,1,0.995366990826153,0,1,negative regulation of mast cell apoptotic process,BP,
8250,GO:0033028,1,0.847762820934738,0,21,myeloid cell apoptotic process,BP,
8251,GO:0033029,1,0.968988270793699,0,5,regulation of neutrophil apoptotic process,BP,
8252,GO:0033030,1,0.995366990826112,0,1,negative regulation of neutrophil apoptotic process,BP,
8253,GO:0033031,1,0.973499897299238,0,4,positive regulation of neutrophil apoptotic process,BP,
8254,GO:0033032,1,0.864184203145731,0,18,regulation of myeloid cell apoptotic process,BP,
8255,GO:0033033,1,0.924991337299434,0,8,negative regulation of myeloid cell apoptotic process,BP,
8256,GO:0033034,1,0.952207202000035,0,6,positive regulation of myeloid cell apoptotic process,BP,
8258,GO:0033037,1,0.995366990826125,0,1,polysaccharide localization,BP,
8259,GO:0033038,1,0.930499127946934,0,4,bitter taste receptor activity,MF,
8260,GO:0033041,1,0.995316512568758,0,1,sweet taste receptor activity,MF,
8263,GO:0033045,1,0.603484557741172,0,70,regulation of sister chromatid segregation,BP,
8264,GO:0033046,1,0.76407920039656,0,36,negative regulation of sister chromatid segregation,BP,
8265,GO:0033047,1,0.631334826825112,0,61,regulation of mitotic sister chromatid segregation,BP,
8266,GO:0033048,1,0.771230655613593,0,34,negative regulation of mitotic sister chromatid segregation,BP,
8267,GO:0033058,1,0.995366574475227,0,1,directional locomotion,BP,
8268,GO:0033059,1,0.711150929092749,0,44,cellular pigmentation,BP,
8269,GO:0033061,1,0.941408629347491,0,9,DNA recombinase mediator complex,CC,
8270,GO:0033063,1,0.950198962925919,0,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8271,GO:0033065,1,0.973543442340545,0,2,Rad51C-XRCC3 complex,CC,
8272,GO:0033076,1,0.993103767077917,0,1,isoquinoline alkaloid metabolic process,BP,
8273,GO:0033077,1,0.723690260239183,0,48,T cell differentiation in thymus,BP,
8274,GO:0033078,1,0.986697065192011,0,2,extrathymic T cell differentiation,BP,
8275,GO:0033079,1,0.969803405339239,0,5,immature T cell proliferation,BP,
8276,GO:0033080,1,0.982882412872457,0,3,immature T cell proliferation in thymus,BP,
8277,GO:0033081,1,0.893311701849985,0,15,regulation of T cell differentiation in thymus,BP,
8278,GO:0033082,1,0.995366990826165,0,1,regulation of extrathymic T cell differentiation,BP,
8279,GO:0033083,1,0.974318783957801,0,4,regulation of immature T cell proliferation,BP,
8280,GO:0033084,1,0.98745797916072,0,2,regulation of immature T cell proliferation in thymus,BP,
8281,GO:0033085,1,0.961900941251559,0,5,negative regulation of T cell differentiation in thymus,BP,
8282,GO:0033087,1,0.978888759061248,0,3,negative regulation of immature T cell proliferation,BP,
8283,GO:0033088,1,0.98745797916072,0,2,negative regulation of immature T cell proliferation in thymus,BP,
8284,GO:0033089,1,0.967902728966786,0,5,positive regulation of T cell differentiation in thymus,BP,
8285,GO:0033091,1,0.995332610883223,0,1,positive regulation of immature T cell proliferation,BP,
8286,GO:0033093,1,0.980497472677451,0,4,Weibel-Palade body,CC,
8287,GO:0033106,1,0.980039780470715,0,2,cis-Golgi network membrane,CC,
8288,GO:0033108,1,0.247841277817083,0,89,mitochondrial respiratory chain complex assembly,BP,
8289,GO:0033116,1,0.680612344474554,0,55,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,
8290,GO:0033119,1,0.836360212148887,0,23,negative regulation of RNA splicing,BP,
8291,GO:0033120,1,0.874568120598339,0,25,positive regulation of RNA splicing,BP,
8292,GO:0033121,1,0.986164121750422,0,3,regulation of purine nucleotide catabolic process,BP,
8293,GO:0033122,1,0.990754788692713,0,2,negative regulation of purine nucleotide catabolic process,BP,
8294,GO:0033123,1,0.995366990826113,0,1,positive regulation of purine nucleotide catabolic process,BP,
8295,GO:0033127,1,0.932848495029525,0,12,regulation of histone phosphorylation,BP,
8296,GO:0033128,1,0.988600446948838,0,2,negative regulation of histone phosphorylation,BP,
8297,GO:0033129,1,0.953378241976456,0,8,positive regulation of histone phosphorylation,BP,
8298,GO:0033130,1,0.970209893358026,0,6,acetylcholine receptor binding,MF,
8299,GO:0033131,1,0.93547540364054,0,6,regulation of glucokinase activity,BP,
8300,GO:0033132,1,0.977288069112851,0,2,negative regulation of glucokinase activity,BP,
8301,GO:0033133,1,0.95722664484402,0,4,positive regulation of glucokinase activity,BP,
8304,GO:0033138,1,0.645815547447762,0,60,positive regulation of peptidyl-serine phosphorylation,BP,
8305,GO:0033139,1,0.950220102276443,0,6,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8306,GO:0033140,1,0.988166440520025,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8307,GO:0033141,1,0.961604396331645,0,4,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8308,GO:0033142,1,0.99463595398037,0,1,progesterone receptor binding,MF,
8309,GO:0033143,1,0.684129115117857,0,62,regulation of intracellular steroid hormone receptor signaling pathway,BP,
8310,GO:0033144,1,0.87491200886245,0,25,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8311,GO:0033145,1,0.891118051686872,0,13,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8312,GO:0033146,1,0.834479809741429,0,32,regulation of intracellular estrogen receptor signaling pathway,BP,
8313,GO:0033147,1,0.946914883957009,0,10,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8314,GO:0033148,1,0.955378571945264,0,8,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8315,GO:0033149,1,0.990755187523121,0,2,FFAT motif binding,MF,
8316,GO:0033151,1,0.928879580476675,0,12,V(D)J recombination,BP,
8317,GO:0033152,1,0.971150449334233,0,4,immunoglobulin V(D)J recombination,BP,
8318,GO:0033153,1,0.977045670000279,0,5,T cell receptor V(D)J recombination,BP,
8320,GO:0033158,1,0.888763956785535,0,17,regulation of protein import into nucleus, translocation,BP,
8321,GO:0033159,1,0.986077562880259,0,3,negative regulation of protein import into nucleus, translocation,BP,
8322,GO:0033160,1,0.946933242691419,0,10,positive regulation of protein import into nucleus, translocation,BP,
8323,GO:0033162,1,0.94296934035846,0,6,melanosome membrane,CC,
8324,GO:0033167,1,0.995366990825929,0,1,ARC complex,CC,
8325,GO:0033168,1,0.995366990825929,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8326,GO:0033169,1,0.941355373599307,0,13,histone H3-K9 demethylation,BP,
8327,GO:0033170,1,0.948115364159602,0,8,protein-DNA loading ATPase activity,MF,
8328,GO:0033173,1,0.871410309976359,0,24,calcineurin-NFAT signaling cascade,BP,
8329,GO:0033176,1,0.805565980390113,0,20,proton-transporting V-type ATPase complex,CC,
8330,GO:0033177,1,0.901282166650064,0,9,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8331,GO:0033178,1,0.900478102868853,0,10,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8332,GO:0033179,1,0.913212574663673,0,8,proton-transporting V-type ATPase, V0 domain,CC,
8333,GO:0033180,1,0.919113725133913,0,8,proton-transporting V-type ATPase, V1 domain,CC,
8334,GO:0033181,1,0.990881009965908,0,1,plasma membrane proton-transporting V-type ATPase complex,CC,
8335,GO:0033182,1,0.953322091594391,0,10,regulation of histone ubiquitination,BP,
8336,GO:0033183,1,0.985951107933656,0,3,negative regulation of histone ubiquitination,BP,
8337,GO:0033184,1,0.976929082925269,0,5,positive regulation of histone ubiquitination,BP,
8338,GO:0033185,1,0.937475638075318,0,3,dolichol-phosphate-mannose synthase complex,CC,
8339,GO:0033186,1,0.985726000782885,0,3,CAF-1 complex,CC,
8340,GO:0033188,1,0.979497000431467,0,3,sphingomyelin synthase activity,MF,
8341,GO:0033189,1,0.934263738007363,0,11,response to vitamin A,BP,
8342,GO:0033192,1,0.976341995966847,0,5,calmodulin-dependent protein phosphatase activity,MF,
8343,GO:0033194,1,0.88835241882598,0,14,response to hydroperoxide,BP,
8344,GO:0033197,1,0.917903712527292,0,11,response to vitamin E,BP,
8345,GO:0033198,1,0.871260637976013,0,19,response to ATP,BP,
8347,GO:0033204,1,0.995257632091666,0,1,ribonuclease P RNA binding,MF,
8348,GO:0033206,1,0.98159166467717,0,4,meiotic cytokinesis,BP,
8350,GO:0033210,1,0.966960658288125,0,7,leptin-mediated signaling pathway,BP,
8351,GO:0033211,1,0.963149126232251,0,5,adiponectin-activated signaling pathway,BP,
8352,GO:0033216,1,0.961137673901506,0,5,ferric iron import,BP,
8353,GO:0033218,1,0.225066151926362,0,198,amide binding,MF,
8354,GO:0033220,1,0.981594470844527,0,4,amide-transporting ATPase activity,MF,
8355,GO:0033227,1,0.983362355758542,0,3,dsRNA transport,BP,
8356,GO:0033233,1,0.863902035372239,0,20,regulation of protein sumoylation,BP,
8357,GO:0033234,1,0.93270542689934,0,10,negative regulation of protein sumoylation,BP,
8358,GO:0033235,1,0.92628911015631,0,10,positive regulation of protein sumoylation,BP,
8359,GO:0033238,1,0.483627993336995,0,61,regulation of cellular amine metabolic process,BP,
8360,GO:0033239,1,0.981113342285287,0,4,negative regulation of cellular amine metabolic process,BP,
8361,GO:0033240,1,0.939005147235923,0,7,positive regulation of cellular amine metabolic process,BP,
8362,GO:0033241,1,0.99536699082598,0,1,regulation of cellular amine catabolic process,BP,
8363,GO:0033242,1,0.99536699082598,0,1,negative regulation of cellular amine catabolic process,BP,
8364,GO:0033256,1,0.959327139480701,0,7,I-kappaB/NF-kappaB complex,CC,
8365,GO:0033257,1,0.988199300052381,0,2,Bcl3/NF-kappaB2 complex,CC,
8366,GO:0033260,1,0.686762126353114,0,49,nuclear DNA replication,BP,
8367,GO:0033262,1,0.933555400625541,0,12,regulation of nuclear cell cycle DNA replication,BP,
8368,GO:0033263,1,0.981594556173623,0,4,CORVET complex,CC,
8369,GO:0033265,1,0.990596949126965,0,2,choline binding,MF,
8371,GO:0033268,1,0.958709341797075,0,9,node of Ranvier,CC,
8372,GO:0033269,1,0.990251784811603,0,2,internode region of axon,CC,
8373,GO:0033270,1,0.961057873463485,0,8,paranode region of axon,CC,
8375,GO:0033274,1,0.995366990826059,0,1,response to vitamin B2,BP,
8376,GO:0033275,1,0.851342279371974,0,14,actin-myosin filament sliding,BP,
8377,GO:0033276,1,0.892934864378852,0,14,transcription factor TFTC complex,CC,
8378,GO:0033277,1,0.990235159871094,0,2,abortive mitotic cell cycle,BP,
8379,GO:0033278,1,0.981594527441239,0,4,cell proliferation in midbrain,BP,
8381,GO:0033283,1,0.995366958228449,0,1,organic acid-transporting ATPase activity,MF,
8382,GO:0033284,1,0.995366958228449,0,1,carboxylic acid-transporting ATPase activity,MF,
8383,GO:0033285,1,0.995366958228449,0,1,monocarboxylic acid-transporting ATPase activity,MF,
8384,GO:0033290,1,0.995366990826138,0,1,eukaryotic 48S preinitiation complex,CC,
8385,GO:0033291,1,0.964645695375047,0,1,eukaryotic 80S initiation complex,CC,
8386,GO:0033292,1,0.990755199849006,0,2,T-tubule organization,BP,
8388,GO:0033299,1,0.969226257002838,0,5,secretion of lysosomal enzymes,BP,
8390,GO:0033301,1,0.995366982785536,0,1,cell cycle comprising mitosis without cytokinesis,BP,
8391,GO:0033306,1,0.988279614457848,0,2,phytol metabolic process,BP,
8392,GO:0033313,1,0.976088996633712,0,5,meiotic cell cycle checkpoint,BP,
8393,GO:0033314,1,0.955188675169063,0,8,mitotic DNA replication checkpoint,BP,
8394,GO:0033316,1,0.995366709403035,0,1,meiotic spindle assembly checkpoint,BP,
8395,GO:0033319,1,0.994233794717128,0,1,UDP-D-xylose metabolic process,BP,
8396,GO:0033320,1,0.994233794717128,0,1,UDP-D-xylose biosynthetic process,BP,
8397,GO:0033326,1,0.995366990826165,0,1,cerebrospinal fluid secretion,BP,
8398,GO:0033327,1,0.955195032766168,0,6,Leydig cell differentiation,BP,
8399,GO:0033328,1,0.995366971297062,0,1,peroxisome membrane targeting sequence binding,MF,
8400,GO:0033341,1,0.990682272031858,0,2,regulation of collagen binding,BP,
8401,GO:0033342,1,0.995293727447312,0,1,negative regulation of collagen binding,BP,
8402,GO:0033343,1,0.995366990826023,0,1,positive regulation of collagen binding,BP,
8403,GO:0033344,1,0.835463820744237,0,22,cholesterol efflux,BP,
8404,GO:0033353,1,0.981170645603503,0,4,S-adenosylmethionine cycle,BP,
8405,GO:0033363,1,0.858741690447773,0,21,secretory granule organization,BP,
8406,GO:0033364,1,0.995366990825813,0,1,mast cell secretory granule organization,BP,
8408,GO:0033383,1,0.983821381198285,0,2,geranyl diphosphate metabolic process,BP,
8409,GO:0033384,1,0.983821381198285,0,2,geranyl diphosphate biosynthetic process,BP,
8410,GO:0033385,1,0.995366477232087,0,1,geranylgeranyl diphosphate metabolic process,BP,
8411,GO:0033386,1,0.995366477232087,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
8412,GO:0033387,1,0.984925368459301,0,3,putrescine biosynthetic process from ornithine,BP,
8413,GO:0033388,1,0.994660322715859,0,1,putrescine biosynthetic process from arginine,BP,
8414,GO:0033391,1,0.972517544430708,0,6,chromatoid body,CC,
8415,GO:0033477,1,0.993699964490529,0,1,S-methylmethionine metabolic process,BP,
8416,GO:0033483,1,0.931567608154197,0,8,gas homeostasis,BP,
8417,GO:0033484,1,0.969545601636208,0,3,nitric oxide homeostasis,BP,
8418,GO:0033488,1,0.995366744787704,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
8419,GO:0033489,1,0.969038280004405,0,4,cholesterol biosynthetic process via desmosterol,BP,
8420,GO:0033490,1,0.969038280004405,0,4,cholesterol biosynthetic process via lathosterol,BP,
8421,GO:0033499,1,0.981335581427364,0,2,galactose catabolic process via UDP-galactose,BP,
8423,GO:0033503,1,0.978421793042501,0,4,HULC complex,CC,
8424,GO:0033504,1,0.986164531023676,0,3,floor plate development,BP,
8425,GO:0033505,1,0.995366990826074,0,1,floor plate morphogenesis,BP,
8426,GO:0033512,1,0.985550406988491,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
8427,GO:0033522,1,0.864056852771227,0,25,histone H2A ubiquitination,BP,
8428,GO:0033523,1,0.935704491814902,0,12,histone H2B ubiquitination,BP,
8429,GO:0033526,1,0.995362950957149,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
8430,GO:0033539,1,0.916703998610653,0,12,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
8431,GO:0033540,1,0.912446380441659,0,13,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
8432,GO:0033549,1,0.93302829964811,0,12,MAP kinase phosphatase activity,MF,
8433,GO:0033552,1,0.995332155378915,0,1,response to vitamin B3,BP,
8434,GO:0033553,1,0.97717937162717,0,4,rDNA heterochromatin,CC,
8436,GO:0033555,1,0.791127130815913,0,32,multicellular organismal response to stress,BP,
8437,GO:0033557,1,0.986163293387401,0,3,Slx1-Slx4 complex,CC,
8438,GO:0033558,1,0.778735230464131,0,43,protein deacetylase activity,MF,
8439,GO:0033559,1,0.619546114045686,0,62,unsaturated fatty acid metabolic process,BP,
8440,GO:0033560,1,0.995366990478057,0,1,folate reductase activity,MF,
8441,GO:0033561,1,0.877751826680104,0,23,regulation of water loss via skin,BP,
8442,GO:0033564,1,0.990755199849254,0,2,anterior/posterior axon guidance,BP,
8443,GO:0033565,1,0.986163823292714,0,3,ESCRT-0 complex,CC,
8444,GO:0033566,1,0.990569200645183,0,2,gamma-tubulin complex localization,BP,
8445,GO:0033567,1,0.959044797558336,0,5,DNA replication, Okazaki fragment processing,BP,
8446,GO:0033570,1,0.995366990826151,0,1,transferrin transmembrane transporter activity,MF,
8447,GO:0033572,1,0.77370764208582,0,29,transferrin transport,BP,
8448,GO:0033574,1,0.778062168066182,0,32,response to testosterone,BP,
8449,GO:0033577,1,0.990689136854387,0,2,protein glycosylation in endoplasmic reticulum,BP,
8450,GO:0033578,1,0.972886555188357,0,5,protein glycosylation in Golgi,BP,
8451,GO:0033588,1,0.971282457645309,0,5,Elongator holoenzyme complex,CC,
8452,GO:0033590,1,0.980589300381597,0,3,response to cobalamin,BP,
8453,GO:0033591,1,0.96467873219396,0,4,response to L-ascorbic acid,BP,
8454,GO:0033592,1,0.976967710561277,0,5,RNA strand annealing activity,MF,
8455,GO:0033593,1,0.995366990825876,0,1,BRCA2-MAGE-D1 complex,CC,
8456,GO:0033594,1,0.995318255982901,0,1,response to hydroxyisoflavone,BP,
8457,GO:0033596,1,0.986164507002049,0,3,TSC1-TSC2 complex,CC,
8458,GO:0033597,1,0.994495819134088,0,1,mitotic checkpoint complex,CC,
8459,GO:0033598,1,0.819886850998763,0,26,mammary gland epithelial cell proliferation,BP,
8460,GO:0033599,1,0.875073022056767,0,17,regulation of mammary gland epithelial cell proliferation,BP,
8461,GO:0033600,1,0.973901123716744,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
8462,GO:0033601,1,0.962291210905639,0,8,positive regulation of mammary gland epithelial cell proliferation,BP,
8463,GO:0033602,1,0.995366990826165,0,1,negative regulation of dopamine secretion,BP,
8465,GO:0033604,1,0.990754975240111,0,2,negative regulation of catecholamine secretion,BP,
8467,GO:0033606,1,0.994581861569669,0,1,chemokine receptor transport within lipid bilayer,BP,
8468,GO:0033608,1,0.995366574475227,0,1,formyl-CoA transferase activity,MF,
8469,GO:0033609,1,0.995366574475227,0,1,oxalate metabolic process,BP,
8470,GO:0033612,1,0.925777679645442,0,11,receptor serine/threonine kinase binding,MF,
8471,GO:0033613,1,0.696292071527218,0,54,activating transcription factor binding,MF,
8472,GO:0033615,1,0.981154352861537,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
8473,GO:0033617,1,0.814778008023222,0,20,mitochondrial respiratory chain complex IV assembly,BP,
8474,GO:0033619,1,0.696381354888969,0,55,membrane protein proteolysis,BP,
8475,GO:0033622,1,0.947572202471329,0,11,integrin activation,BP,
8476,GO:0033623,1,0.972517175730911,0,6,regulation of integrin activation,BP,
8477,GO:0033624,1,0.990755134095727,0,2,negative regulation of integrin activation,BP,
8478,GO:0033625,1,0.990754785405301,0,2,positive regulation of integrin activation,BP,
8482,GO:0033630,1,0.904791138601113,0,12,positive regulation of cell adhesion mediated by integrin,BP,
8483,GO:0033631,1,0.942154205096466,0,9,cell-cell adhesion mediated by integrin,BP,
8484,GO:0033632,1,0.959828219329922,0,5,regulation of cell-cell adhesion mediated by integrin,BP,
8485,GO:0033633,1,0.995366990826165,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
8486,GO:0033634,1,0.974887976087599,0,3,positive regulation of cell-cell adhesion mediated by integrin,BP,
8487,GO:0033643,1,0.955173996437901,0,9,host cell part,CC,
8488,GO:0033644,1,0.995366990826139,0,1,host cell membrane,CC,
8489,GO:0033646,1,0.964090563770119,0,7,host intracellular part,CC,
8490,GO:0033647,1,0.973089805125633,0,5,host intracellular organelle,CC,
8491,GO:0033648,1,0.973089805125633,0,5,host intracellular membrane-bounded organelle,CC,
8492,GO:0033650,1,0.991757258668049,0,1,host cell mitochondrion,CC,
8493,GO:0033655,1,0.978034067894662,0,4,host cell cytoplasm part,CC,
8494,GO:0033668,1,0.967732578473727,0,4,negative regulation by symbiont of host apoptotic process,BP,
8496,GO:0033674,1,0.0700179873310244,0,415,positive regulation of kinase activity,BP,
8497,GO:0033676,1,0.9871602880424,0,1,double-stranded DNA-dependent ATPase activity,MF,
8498,GO:0033677,1,0.986151338864968,0,3,DNA/RNA helicase activity,MF,
8499,GO:0033678,1,0.995356284780612,0,1,5'-3' DNA/RNA helicase activity,MF,
8500,GO:0033679,1,0.995366990826165,0,1,3'-5' DNA/RNA helicase activity,MF,
8501,GO:0033680,1,0.990744542839648,0,2,ATP-dependent DNA/RNA helicase activity,MF,
8502,GO:0033681,1,0.995366990826165,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
8503,GO:0033682,1,0.995356284780612,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
8504,GO:0033683,1,0.709499426381966,0,39,nucleotide-excision repair, DNA incision,BP,
8505,GO:0033684,1,0.990754805932606,0,2,regulation of luteinizing hormone secretion,BP,
8506,GO:0033686,1,0.990754805932606,0,2,positive regulation of luteinizing hormone secretion,BP,
8507,GO:0033687,1,0.9129148885767,0,17,osteoblast proliferation,BP,
8508,GO:0033688,1,0.931303285982732,0,14,regulation of osteoblast proliferation,BP,
8509,GO:0033689,1,0.972513848653099,0,6,negative regulation of osteoblast proliferation,BP,
8510,GO:0033690,1,0.968687326575414,0,6,positive regulation of osteoblast proliferation,BP,
8511,GO:0033691,1,0.990755199849162,0,2,sialic acid binding,MF,
8513,GO:0033693,1,0.986164082249524,0,3,neurofilament bundle assembly,BP,
8514,GO:0033695,1,0.995366784419756,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
8515,GO:0033699,1,0.993859261278676,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
8516,GO:0033700,1,0.93298983142922,0,6,phospholipid efflux,BP,
8517,GO:0033737,1,0.995278400885571,0,1,1-pyrroline dehydrogenase activity,MF,
8518,GO:0033743,1,0.969327476290468,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
8519,GO:0033745,1,0.983132961578813,0,3,L-methionine-(R)-S-oxide reductase activity,MF,
8520,GO:0033746,1,0.995366972215419,0,1,histone demethylase activity (H3-R2 specific),MF,
8521,GO:0033749,1,0.995366972215419,0,1,histone demethylase activity (H4-R3 specific),MF,
8522,GO:0033750,1,0.854338174797629,0,13,ribosome localization,BP,
8523,GO:0033754,1,0.989608297565847,0,1,indoleamine 2,3-dioxygenase activity,MF,
8524,GO:0033762,1,0.816431807408688,0,30,response to glucagon,BP,
8525,GO:0033764,1,0.846444531245834,0,16,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
8526,GO:0033765,1,0.990237557770863,0,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
8527,GO:0033768,1,0.990754588429412,0,2,SUMO-targeted ubiquitin ligase complex,CC,
8528,GO:0033787,1,0.995366521608773,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
8529,GO:0033814,1,0.987384680721447,0,1,propanoyl-CoA C-acyltransferase activity,MF,
8530,GO:0033823,1,0.995366672627586,0,1,procollagen glucosyltransferase activity,MF,
8531,GO:0033829,1,0.981327317482748,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
8532,GO:0033842,1,0.990755097114784,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
8533,GO:0033857,1,0.990755199849254,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
8534,GO:0033858,1,0.995366811174319,0,1,N-acetylgalactosamine kinase activity,MF,
8535,GO:0033860,1,0.946644193133695,0,3,regulation of NAD(P)H oxidase activity,BP,
8536,GO:0033862,1,0.995366669851539,0,1,UMP kinase activity,MF,
8537,GO:0033864,1,0.946644193133695,0,3,positive regulation of NAD(P)H oxidase activity,BP,
8538,GO:0033865,1,0.786139146472128,0,33,nucleoside bisphosphate metabolic process,BP,
8539,GO:0033866,1,0.903775652052644,0,16,nucleoside bisphosphate biosynthetic process,BP,
8540,GO:0033867,1,0.990546342570549,0,1,Fas-activated serine/threonine kinase activity,MF,
8541,GO:0033869,1,0.979716819340251,0,1,nucleoside bisphosphate catabolic process,BP,
8542,GO:0033871,1,0.993396629402146,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
8543,GO:0033872,1,0.993904432471042,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
8544,GO:0033875,1,0.786139146472128,0,33,ribonucleoside bisphosphate metabolic process,BP,
8545,GO:0033878,1,0.995366987986426,0,1,hormone-sensitive lipase activity,MF,
8546,GO:0033882,1,0.982707584867652,0,1,choloyl-CoA hydrolase activity,MF,
8547,GO:0033883,1,0.975857249642737,0,2,pyridoxal phosphatase activity,MF,
8548,GO:0033885,1,0.994694186358932,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
8549,GO:0033897,1,0.984449585383792,0,1,ribonuclease T2 activity,MF,
8550,GO:0033906,1,0.988086139800137,0,2,hyaluronoglucuronidase activity,MF,
8551,GO:0033919,1,0.995366990346783,0,1,glucan 1,3-alpha-glucosidase activity,MF,
8552,GO:0033925,1,0.995366990826164,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
8553,GO:0033961,1,0.991711183988345,0,1,cis-stilbene-oxide hydrolase activity,MF,
8554,GO:0033962,1,0.886670338446103,0,18,cytoplasmic mRNA processing body assembly,BP,
8555,GO:0033967,1,0.982902032395413,0,1,box C/D snoRNA metabolic process,BP,
8556,GO:0033979,1,0.995327122950758,0,1,box H/ACA snoRNA metabolic process,BP,
8557,GO:0033981,1,0.97134208794452,0,1,D-dopachrome decarboxylase activity,MF,
8558,GO:0033989,1,0.995360837019954,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
8560,GO:0034012,1,0.995366574475227,0,1,FAD-AMP lyase (cyclizing) activity,MF,
8561,GO:0034014,1,0.994930769572645,0,1,response to triglyceride,BP,
8562,GO:0034021,1,0.974561039035535,0,1,response to silicon dioxide,BP,
8563,GO:0034030,1,0.903775652052644,0,16,ribonucleoside bisphosphate biosynthetic process,BP,
8564,GO:0034031,1,0.979716819340251,0,1,ribonucleoside bisphosphate catabolic process,BP,
8565,GO:0034032,1,0.786139146472128,0,33,purine nucleoside bisphosphate metabolic process,BP,
8566,GO:0034033,1,0.903775652052644,0,16,purine nucleoside bisphosphate biosynthetic process,BP,
8567,GO:0034034,1,0.979716819340251,0,1,purine nucleoside bisphosphate catabolic process,BP,
8568,GO:0034035,1,0.877389272931141,0,18,purine ribonucleoside bisphosphate metabolic process,BP,
8569,GO:0034036,1,0.96986159577106,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
8570,GO:0034038,1,0.983268126230626,0,1,deoxyhypusine synthase activity,MF,
8571,GO:0034039,1,0.985820461182753,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
8572,GO:0034040,1,0.986164179301497,0,3,lipid-transporting ATPase activity,MF,
8573,GO:0034041,1,0.995366668457488,0,1,sterol-transporting ATPase activity,MF,
8574,GO:0034045,1,0.920714566164154,0,16,phagophore assembly site membrane,CC,
8575,GO:0034046,1,0.96483293579329,0,7,poly(G) binding,MF,
8576,GO:0034056,1,0.986029200802278,0,3,estrogen response element binding,MF,
8577,GO:0034057,1,0.990676481728063,0,2,RNA strand-exchange activity,MF,
8578,GO:0034058,1,0.953876662960873,0,10,endosomal vesicle fusion,BP,
8579,GO:0034059,1,0.985847496102022,0,3,response to anoxia,BP,
8580,GO:0034061,1,0.770217233030987,0,34,DNA polymerase activity,MF,
8581,GO:0034062,1,0.634354822282604,0,43,5'-3' RNA polymerase activity,MF,
8582,GO:0034063,1,0.940592091359643,0,13,stress granule assembly,BP,
8583,GO:0034066,1,0.980783951132031,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
8584,GO:0034067,1,0.890636105491152,0,21,protein localization to Golgi apparatus,BP,
8586,GO:0034085,1,0.965586193073814,0,7,establishment of sister chromatid cohesion,BP,
8587,GO:0034086,1,0.915077268038653,0,12,maintenance of sister chromatid cohesion,BP,
8588,GO:0034087,1,0.990755174028471,0,2,establishment of mitotic sister chromatid cohesion,BP,
8589,GO:0034088,1,0.915077268038653,0,12,maintenance of mitotic sister chromatid cohesion,BP,
8590,GO:0034091,1,0.93270092554247,0,8,regulation of maintenance of sister chromatid cohesion,BP,
8591,GO:0034092,1,0.96794122573717,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
8592,GO:0034093,1,0.963605888439177,0,5,positive regulation of maintenance of sister chromatid cohesion,BP,
8595,GO:0034101,1,0.529208338907276,0,89,erythrocyte homeostasis,BP,
8596,GO:0034103,1,0.744646525289496,0,42,regulation of tissue remodeling,BP,
8597,GO:0034104,1,0.913373674708961,0,11,negative regulation of tissue remodeling,BP,
8598,GO:0034105,1,0.862877608643474,0,19,positive regulation of tissue remodeling,BP,
8599,GO:0034109,1,0.681520994965809,0,55,homotypic cell-cell adhesion,BP,
8600,GO:0034110,1,0.861812196402425,0,21,regulation of homotypic cell-cell adhesion,BP,
8601,GO:0034111,1,0.937978115931937,0,11,negative regulation of homotypic cell-cell adhesion,BP,
8602,GO:0034112,1,0.940469105879004,0,5,positive regulation of homotypic cell-cell adhesion,BP,
8603,GO:0034113,1,0.839042056517936,0,30,heterotypic cell-cell adhesion,BP,
8604,GO:0034114,1,0.915089464942356,0,14,regulation of heterotypic cell-cell adhesion,BP,
8605,GO:0034115,1,0.959159941916282,0,7,negative regulation of heterotypic cell-cell adhesion,BP,
8606,GO:0034116,1,0.944861631595286,0,8,positive regulation of heterotypic cell-cell adhesion,BP,
8607,GO:0034117,1,0.969199532235046,0,1,erythrocyte aggregation,BP,
8608,GO:0034118,1,0.969199532235046,0,1,regulation of erythrocyte aggregation,BP,
8609,GO:0034120,1,0.969199532235046,0,1,positive regulation of erythrocyte aggregation,BP,
8612,GO:0034123,1,0.912803033084811,0,12,positive regulation of toll-like receptor signaling pathway,BP,
8613,GO:0034124,1,0.988990433357063,0,2,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
8614,GO:0034127,1,0.979840957648166,0,4,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
8615,GO:0034128,1,0.98615917351978,0,3,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
8616,GO:0034134,1,0.92679123355796,0,10,toll-like receptor 2 signaling pathway,BP,
8617,GO:0034135,1,0.946937915867205,0,6,regulation of toll-like receptor 2 signaling pathway,BP,
8618,GO:0034136,1,0.986164279057283,0,3,negative regulation of toll-like receptor 2 signaling pathway,BP,
8619,GO:0034137,1,0.960229542104555,0,3,positive regulation of toll-like receptor 2 signaling pathway,BP,
8620,GO:0034138,1,0.912557011990348,0,17,toll-like receptor 3 signaling pathway,BP,
8621,GO:0034139,1,0.957587755998384,0,8,regulation of toll-like receptor 3 signaling pathway,BP,
8622,GO:0034140,1,0.986164102976036,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
8623,GO:0034141,1,0.966526593040677,0,6,positive regulation of toll-like receptor 3 signaling pathway,BP,
8627,GO:0034145,1,0.968008195248415,0,5,positive regulation of toll-like receptor 4 signaling pathway,BP,
8628,GO:0034146,1,0.995366990826151,0,1,toll-like receptor 5 signaling pathway,BP,
8629,GO:0034147,1,0.995366990826151,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
8630,GO:0034148,1,0.995366990826151,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
8631,GO:0034150,1,0.995366990826125,0,1,toll-like receptor 6 signaling pathway,BP,
8632,GO:0034154,1,0.980882522678732,0,4,toll-like receptor 7 signaling pathway,BP,
8633,GO:0034155,1,0.995366952351628,0,1,regulation of toll-like receptor 7 signaling pathway,BP,
8634,GO:0034157,1,0.995366952351628,0,1,positive regulation of toll-like receptor 7 signaling pathway,BP,
8635,GO:0034162,1,0.93358983360592,0,14,toll-like receptor 9 signaling pathway,BP,
8636,GO:0034163,1,0.986164431220029,0,3,regulation of toll-like receptor 9 signaling pathway,BP,
8637,GO:0034164,1,0.995366990826085,0,1,negative regulation of toll-like receptor 9 signaling pathway,BP,
8638,GO:0034165,1,0.990755099586378,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
8639,GO:0034166,1,0.995366885975733,0,1,toll-like receptor 10 signaling pathway,BP,
8640,GO:0034182,1,0.93270092554247,0,8,regulation of maintenance of mitotic sister chromatid cohesion,BP,
8641,GO:0034183,1,0.96794122573717,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
8642,GO:0034184,1,0.963605888439177,0,5,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
8643,GO:0034185,1,0.936805624533556,0,12,apolipoprotein binding,MF,
8644,GO:0034186,1,0.97228119478257,0,4,apolipoprotein A-I binding,MF,
8645,GO:0034188,1,0.990755199848966,0,2,apolipoprotein A-I receptor activity,MF,
8646,GO:0034189,1,0.990755163201625,0,2,very-low-density lipoprotein particle binding,MF,
8647,GO:0034190,1,0.979568800648691,0,4,apolipoprotein receptor binding,MF,
8648,GO:0034191,1,0.984129135013225,0,3,apolipoprotein A-I receptor binding,MF,
8649,GO:0034196,1,0.995334827886526,0,1,acylglycerol transport,BP,
8650,GO:0034197,1,0.995334827886526,0,1,triglyceride transport,BP,
8651,GO:0034198,1,0.783333051655878,0,40,cellular response to amino acid starvation,BP,
8652,GO:0034199,1,0.954265612390747,0,10,activation of protein kinase A activity,BP,
8653,GO:0034201,1,0.963242127600927,0,5,response to oleic acid,BP,
8654,GO:0034203,1,0.995366990826164,0,1,glycolipid translocation,BP,
8655,GO:0034204,1,0.932689643943456,0,15,lipid translocation,BP,
8656,GO:0034205,1,0.862027437037412,0,22,amyloid-beta formation,BP,
8657,GO:0034212,1,0.677325832135891,0,60,peptide N-acetyltransferase activity,MF,
8658,GO:0034213,1,0.989279801802513,0,1,quinolinate catabolic process,BP,
8659,GO:0034214,1,0.966318913438889,0,7,protein hexamerization,BP,
8662,GO:0034224,1,0.994820273505461,0,1,cellular response to zinc ion starvation,BP,
8663,GO:0034227,1,0.96403852099373,0,5,tRNA thio-modification,BP,
8664,GO:0034235,1,0.968355716996193,0,6,GPI anchor binding,MF,
8665,GO:0034236,1,0.935984715443821,0,11,protein kinase A catalytic subunit binding,MF,
8666,GO:0034237,1,0.931382102949916,0,15,protein kinase A regulatory subunit binding,MF,
8667,GO:0034238,1,0.995366990812036,0,1,macrophage fusion,BP,
8668,GO:0034239,1,0.995366990812036,0,1,regulation of macrophage fusion,BP,
8669,GO:0034241,1,0.995366990812036,0,1,positive regulation of macrophage fusion,BP,
8670,GO:0034242,1,0.988880754375273,0,2,negative regulation of syncytium formation by plasma membrane fusion,BP,
8671,GO:0034243,1,0.856867058561008,0,25,regulation of transcription elongation from RNA polymerase II promoter,BP,
8672,GO:0034244,1,0.938852330070124,0,10,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
8673,GO:0034245,1,0.995366988218009,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
8677,GO:0034250,1,0.413821062651554,0,123,positive regulation of cellular amide metabolic process,BP,
8678,GO:0034260,1,0.789963171663563,0,36,negative regulation of GTPase activity,BP,
8679,GO:0034271,1,0.985287288404976,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
8680,GO:0034272,1,0.985287288404976,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
8681,GO:0034274,1,0.986164396124694,0,3,Atg12-Atg5-Atg16 complex,CC,
8682,GO:0034275,1,0.989608297565847,0,1,kynurenic acid metabolic process,BP,
8683,GO:0034276,1,0.989608297565847,0,1,kynurenic acid biosynthetic process,BP,
8685,GO:0034285,1,0.985978289781304,0,3,response to disaccharide,BP,
8686,GO:0034308,1,0.785984010386429,0,37,primary alcohol metabolic process,BP,
8687,GO:0034309,1,0.978037514283719,0,1,primary alcohol biosynthetic process,BP,
8688,GO:0034310,1,0.947659069268836,0,7,primary alcohol catabolic process,BP,
8689,GO:0034311,1,0.844417185190266,0,17,diol metabolic process,BP,
8690,GO:0034312,1,0.862614764554377,0,15,diol biosynthetic process,BP,
8691,GO:0034314,1,0.81610143377766,0,29,Arp2/3 complex-mediated actin nucleation,BP,
8692,GO:0034315,1,0.932288280973753,0,14,regulation of Arp2/3 complex-mediated actin nucleation,BP,
8693,GO:0034316,1,0.97840196521127,0,4,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
8696,GO:0034331,1,0.968010267539228,0,7,cell junction maintenance,BP,
8697,GO:0034332,1,0.611078036901433,0,92,adherens junction organization,BP,
8698,GO:0034333,1,0.692394384153732,0,69,adherens junction assembly,BP,
8699,GO:0034334,1,0.981594401463941,0,4,adherens junction maintenance,BP,
8700,GO:0034338,1,0.984920316143247,0,3,short-chain carboxylesterase activity,MF,
8702,GO:0034341,1,0.366163150058768,0,124,response to interferon-gamma,BP,
8703,GO:0034342,1,0.989774700299242,0,2,response to type III interferon,BP,
8704,GO:0034343,1,0.986164198893771,0,3,type III interferon production,BP,
8705,GO:0034344,1,0.986164198893771,0,3,regulation of type III interferon production,BP,
8706,GO:0034346,1,0.995366715731018,0,1,positive regulation of type III interferon production,BP,
8707,GO:0034349,1,0.937509656088895,0,13,glial cell apoptotic process,BP,
8708,GO:0034350,1,0.967482332521695,0,7,regulation of glial cell apoptotic process,BP,
8709,GO:0034351,1,0.967482332521695,0,7,negative regulation of glial cell apoptotic process,BP,
8710,GO:0034353,1,0.995366574475227,0,1,RNA pyrophosphohydrolase activity,MF,
8711,GO:0034355,1,0.995366574475227,0,1,NAD salvage,BP,
8712,GO:0034356,1,0.939678145218898,0,12,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,
8713,GO:0034358,1,0.841330044257854,0,16,plasma lipoprotein particle,CC,
8714,GO:0034361,1,0.914297206346296,0,7,very-low-density lipoprotein particle,CC,
8715,GO:0034362,1,0.942671158065091,0,6,low-density lipoprotein particle,CC,
8716,GO:0034363,1,0.983095265244906,0,1,intermediate-density lipoprotein particle,CC,
8717,GO:0034364,1,0.868446306261887,0,10,high-density lipoprotein particle,CC,
8718,GO:0034365,1,0.983095265244906,0,1,discoidal high-density lipoprotein particle,CC,
8719,GO:0034366,1,0.995366520412405,0,1,spherical high-density lipoprotein particle,CC,
8720,GO:0034367,1,0.900534876486215,0,10,protein-containing complex remodeling,BP,
8721,GO:0034368,1,0.904731579675612,0,9,protein-lipid complex remodeling,BP,
8722,GO:0034369,1,0.904731579675612,0,9,plasma lipoprotein particle remodeling,BP,
8723,GO:0034370,1,0.969625486398511,0,2,triglyceride-rich lipoprotein particle remodeling,BP,
8724,GO:0034371,1,0.983095265244906,0,1,chylomicron remodeling,BP,
8725,GO:0034372,1,0.969625486398511,0,2,very-low-density lipoprotein particle remodeling,BP,
8726,GO:0034374,1,0.970915602011478,0,3,low-density lipoprotein particle remodeling,BP,
8727,GO:0034375,1,0.911841439939698,0,8,high-density lipoprotein particle remodeling,BP,
8728,GO:0034377,1,0.879753001543244,0,16,plasma lipoprotein particle assembly,BP,
8729,GO:0034378,1,0.973968587304177,0,3,chylomicron assembly,BP,
8730,GO:0034379,1,0.942930618490169,0,6,very-low-density lipoprotein particle assembly,BP,
8731,GO:0034380,1,0.937388489452401,0,9,high-density lipoprotein particle assembly,BP,
8732,GO:0034381,1,0.757616414547295,0,33,plasma lipoprotein particle clearance,BP,
8733,GO:0034382,1,0.94167761399938,0,4,chylomicron remnant clearance,BP,
8734,GO:0034383,1,0.824914053644409,0,25,low-density lipoprotein particle clearance,BP,
8735,GO:0034384,1,0.964567766913706,0,5,high-density lipoprotein particle clearance,BP,
8736,GO:0034385,1,0.914297206346296,0,7,triglyceride-rich plasma lipoprotein particle,CC,
8737,GO:0034386,1,0.995366990826165,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
8738,GO:0034388,1,0.968994609796862,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
8739,GO:0034389,1,0.915309656159413,0,14,lipid particle organization,BP,
8740,GO:0034390,1,0.918853802433794,0,14,smooth muscle cell apoptotic process,BP,
8741,GO:0034391,1,0.918853802433794,0,14,regulation of smooth muscle cell apoptotic process,BP,
8742,GO:0034392,1,0.978260820332946,0,4,negative regulation of smooth muscle cell apoptotic process,BP,
8743,GO:0034393,1,0.943662632834706,0,9,positive regulation of smooth muscle cell apoptotic process,BP,
8744,GO:0034394,1,0.766740677953625,0,40,protein localization to cell surface,BP,
8745,GO:0034395,1,0.989307547814527,0,1,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
8746,GO:0034397,1,0.958907232539453,0,9,telomere localization,BP,
8747,GO:0034398,1,0.977032924576698,0,5,telomere tethering at nuclear periphery,BP,
8748,GO:0034399,1,0.49671142230685,0,119,nuclear periphery,CC,
8749,GO:0034402,1,0.990398960750346,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
8751,GO:0034405,1,0.824214842068023,0,30,response to fluid shear stress,BP,
8752,GO:0034414,1,0.990158878406517,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
8753,GO:0034416,1,0.990754318337248,0,2,bisphosphoglycerate phosphatase activity,MF,
8754,GO:0034417,1,0.995366521608773,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
8755,GO:0034418,1,0.989709186469082,0,2,urate biosynthetic process,BP,
8756,GO:0034421,1,0.985687494391731,0,3,post-translational protein acetylation,BP,
8757,GO:0034423,1,0.995348893266823,0,1,autophagosome lumen,CC,
8758,GO:0034427,1,0.881915418281848,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
8759,GO:0034431,1,0.970671105713102,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
8760,GO:0034432,1,0.970671105713102,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
8761,GO:0034433,1,0.919735620766187,0,7,steroid esterification,BP,
8762,GO:0034434,1,0.919735620766187,0,7,sterol esterification,BP,
8763,GO:0034435,1,0.919735620766187,0,7,cholesterol esterification,BP,
8764,GO:0034436,1,0.970214929893474,0,3,glycoprotein transport,BP,
8765,GO:0034437,1,0.990754858202786,0,2,glycoprotein transporter activity,MF,
8766,GO:0034440,1,0.578197887104908,0,79,lipid oxidation,BP,
8767,GO:0034441,1,0.992210966876435,0,1,plasma lipoprotein particle oxidation,BP,
8768,GO:0034446,1,0.665355662759284,0,67,substrate adhesion-dependent cell spreading,BP,
8769,GO:0034447,1,0.936263047074436,0,4,very-low-density lipoprotein particle clearance,BP,
8770,GO:0034448,1,0.96549974309766,0,4,EGO complex,CC,
8771,GO:0034450,1,0.897584488657132,0,12,ubiquitin-ubiquitin ligase activity,MF,
8773,GO:0034452,1,0.953518976896737,0,10,dynactin binding,MF,
8774,GO:0034453,1,0.887474284722636,0,23,microtubule anchoring,BP,
8775,GO:0034454,1,0.958969604744841,0,9,microtubule anchoring at centrosome,BP,
8776,GO:0034455,1,0.98603876752477,0,3,t-UTP complex,CC,
8777,GO:0034456,1,0.974459102398674,0,3,UTP-C complex,CC,
8778,GO:0034457,1,0.960498734310613,0,3,Mpp10 complex,CC,
8779,GO:0034458,1,0.990646833488123,0,2,3'-5' RNA helicase activity,MF,
8780,GO:0034459,1,0.995366990826165,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
8781,GO:0034462,1,0.994824612585235,0,1,small-subunit processome assembly,BP,
8782,GO:0034463,1,0.964645695375047,0,1,90S preribosome assembly,BP,
8783,GO:0034464,1,0.949805076723737,0,9,BBSome,CC,
8784,GO:0034465,1,0.960278853759535,0,4,response to carbon monoxide,BP,
8786,GO:0034471,1,0.808862805490431,0,19,ncRNA 5'-end processing,BP,
8787,GO:0034472,1,0.865464855756927,0,14,snRNA 3'-end processing,BP,
8788,GO:0034473,1,0.960520346427166,0,3,U1 snRNA 3'-end processing,BP,
8789,GO:0034474,1,0.995366990826072,0,1,U2 snRNA 3'-end processing,BP,
8790,GO:0034475,1,0.89015572893339,0,8,U4 snRNA 3'-end processing,BP,
8791,GO:0034476,1,0.960520346427166,0,3,U5 snRNA 3'-end processing,BP,
8792,GO:0034477,1,0.995366574475227,0,1,U6 snRNA 3'-end processing,BP,
8793,GO:0034481,1,0.979948693227638,0,4,chondroitin sulfotransferase activity,MF,
8794,GO:0034483,1,0.958392202285789,0,8,heparan sulfate sulfotransferase activity,MF,
8795,GO:0034485,1,0.981036692640174,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
8796,GO:0034497,1,0.940507094243295,0,12,protein localization to phagophore assembly site,BP,
8797,GO:0034498,1,0.952717567932976,0,8,early endosome to Golgi transport,BP,
8798,GO:0034499,1,0.990755199849202,0,2,late endosome to Golgi transport,BP,
8799,GO:0034501,1,0.908218080446989,0,16,protein localization to kinetochore,BP,
8800,GO:0034502,1,0.638001137230136,0,72,protein localization to chromosome,BP,
8802,GO:0034505,1,0.939200258215977,0,12,tooth mineralization,BP,
8803,GO:0034506,1,0.995366990826125,0,1,chromosome, centromeric core domain,CC,
8805,GO:0034511,1,0.95026719527015,0,6,U3 snoRNA binding,MF,
8806,GO:0034512,1,0.995366574475227,0,1,box C/D snoRNA binding,MF,
8807,GO:0034513,1,0.910844924532281,0,5,box H/ACA snoRNA binding,MF,
8808,GO:0034515,1,0.990754698428924,0,2,proteasome storage granule,CC,
8809,GO:0034518,1,0.909837882412674,0,12,RNA cap binding complex,CC,
8810,GO:0034545,1,0.990962446047837,0,1,fumarylpyruvate hydrolase activity,MF,
8811,GO:0034551,1,0.930038415676109,0,9,mitochondrial respiratory chain complex III assembly,BP,
8812,GO:0034552,1,0.95710113642512,0,4,respiratory chain complex II assembly,BP,
8813,GO:0034553,1,0.95710113642512,0,4,mitochondrial respiratory chain complex II assembly,BP,
8814,GO:0034584,1,0.995366988852198,0,1,piRNA binding,MF,
8815,GO:0034587,1,0.963480474644382,0,8,piRNA metabolic process,BP,
8816,GO:0034589,1,0.995366990826152,0,1,hydroxyproline transport,BP,
8817,GO:0034590,1,0.995366990826152,0,1,L-hydroxyproline transmembrane transporter activity,MF,
8818,GO:0034593,1,0.897829146063956,0,23,phosphatidylinositol bisphosphate phosphatase activity,MF,
8819,GO:0034594,1,0.976490538769035,0,5,phosphatidylinositol trisphosphate phosphatase activity,MF,
8820,GO:0034595,1,0.940828640362404,0,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,
8821,GO:0034596,1,0.96352428719573,0,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,
8822,GO:0034597,1,0.990755199849188,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
8823,GO:0034599,1,0.177597469214157,0,219,cellular response to oxidative stress,BP,
8824,GO:0034602,1,0.995366990826152,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
8825,GO:0034603,1,0.97082501903759,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
8826,GO:0034604,1,0.97082501903759,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
8827,GO:0034605,1,0.509149152487757,0,113,cellular response to heat,BP,
8830,GO:0034614,1,0.365755688826807,0,121,cellular response to reactive oxygen species,BP,
8831,GO:0034616,1,0.933180380096401,0,13,response to laminar fluid shear stress,BP,
8832,GO:0034617,1,0.983794754917518,0,3,tetrahydrobiopterin binding,MF,
8833,GO:0034618,1,0.979367119821565,0,4,arginine binding,MF,
8836,GO:0034625,1,0.970177743393844,0,5,fatty acid elongation, monounsaturated fatty acid,BP,
8837,GO:0034626,1,0.970177743393844,0,5,fatty acid elongation, polyunsaturated fatty acid,BP,
8838,GO:0034627,1,0.990755195663627,0,2,'de novo' NAD biosynthetic process,BP,
8839,GO:0034628,1,0.990755195663627,0,2,'de novo' NAD biosynthetic process from aspartate,BP,
8840,GO:0034629,1,0.869352795034469,0,22,cellular protein-containing complex localization,BP,
8841,GO:0034634,1,0.995366990826099,0,1,glutathione transmembrane transporter activity,MF,
8842,GO:0034635,1,0.989155775695929,0,2,glutathione transport,BP,
8844,GO:0034638,1,0.931557731072151,0,6,phosphatidylcholine catabolic process,BP,
8845,GO:0034640,1,0.995366845033235,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
8847,GO:0034642,1,0.995366988292302,0,1,mitochondrion migration along actin filament,BP,
8848,GO:0034643,1,0.863061078166207,0,19,establishment of mitochondrion localization, microtubule-mediated,BP,
8851,GO:0034647,1,0.990755199848965,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
8852,GO:0034648,1,0.981594653673785,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
8853,GO:0034649,1,0.995366990093737,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
8854,GO:0034650,1,0.977044540090309,0,5,cortisol metabolic process,BP,
8855,GO:0034651,1,0.977044540090309,0,5,cortisol biosynthetic process,BP,
8856,GO:0034653,1,0.995366990826164,0,1,retinoic acid catabolic process,BP,
8859,GO:0034656,1,0.735317549550394,0,35,nucleobase-containing small molecule catabolic process,BP,
8860,GO:0034657,1,0.97765300529508,0,4,GID complex,CC,
8862,GO:0034661,1,0.828144414858061,0,23,ncRNA catabolic process,BP,
8863,GO:0034663,1,0.925926558219422,0,9,endoplasmic reticulum chaperone complex,CC,
8864,GO:0034665,1,0.990755194845419,0,2,integrin alpha1-beta1 complex,CC,
8865,GO:0034666,1,0.986164274076237,0,3,integrin alpha2-beta1 complex,CC,
8866,GO:0034667,1,0.990755194845418,0,2,integrin alpha3-beta1 complex,CC,
8867,GO:0034669,1,0.995366990826112,0,1,integrin alpha4-beta7 complex,CC,
8868,GO:0034670,1,0.995366990825943,0,1,chemotaxis to arachidonic acid,BP,
8869,GO:0034673,1,0.990755199849227,0,2,inhibin-betaglycan-ActRII complex,CC,
8870,GO:0034676,1,0.995366990826125,0,1,integrin alpha6-beta4 complex,CC,
8871,GO:0034677,1,0.995366985799255,0,1,integrin alpha7-beta1 complex,CC,
8872,GO:0034678,1,0.990755194845418,0,2,integrin alpha8-beta1 complex,CC,
8873,GO:0034680,1,0.990755194845407,0,2,integrin alpha10-beta1 complex,CC,
8874,GO:0034681,1,0.995366985799255,0,1,integrin alpha11-beta1 complex,CC,
8875,GO:0034683,1,0.995366990826073,0,1,integrin alphav-beta3 complex,CC,
8876,GO:0034684,1,0.99075512359994,0,2,integrin alphav-beta5 complex,CC,
8877,GO:0034685,1,0.990552209199332,0,2,integrin alphav-beta6 complex,CC,
8878,GO:0034686,1,0.990755199849032,0,2,integrin alphav-beta8 complex,CC,
8879,GO:0034693,1,0.995236071262308,0,1,U11/U12 snRNP,CC,
8880,GO:0034694,1,0.90624830407877,0,18,response to prostaglandin,BP,
8881,GO:0034695,1,0.93074195733835,0,14,response to prostaglandin E,BP,
8882,GO:0034696,1,0.989614894378427,0,2,response to prostaglandin F,BP,
8883,GO:0034698,1,0.905117654316156,0,21,response to gonadotropin,BP,
8884,GO:0034699,1,0.986154645256051,0,3,response to luteinizing hormone,BP,
8885,GO:0034702,1,0.560043211765444,0,99,ion channel complex,CC,
8886,GO:0034703,1,0.655353013899031,0,73,cation channel complex,CC,
8887,GO:0034704,1,0.849141166757969,0,24,calcium channel complex,CC,
8888,GO:0034705,1,0.851637312248075,0,30,potassium channel complex,CC,
8889,GO:0034706,1,0.963524596291486,0,8,sodium channel complex,CC,
8890,GO:0034707,1,0.913831758364232,0,12,chloride channel complex,CC,
8893,GO:0034711,1,0.982107674733984,0,3,inhibin binding,MF,
8894,GO:0034713,1,0.952514566099734,0,8,type I transforming growth factor beta receptor binding,MF,
8895,GO:0034714,1,0.985474335023316,0,3,type III transforming growth factor beta receptor binding,MF,
8897,GO:0034718,1,0.995366990826153,0,1,SMN-Gemin2 complex,CC,
8899,GO:0034720,1,0.972518070521031,0,6,histone H3-K4 demethylation,BP,
8900,GO:0034721,1,0.990755199848965,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
8901,GO:0034722,1,0.988476027672701,0,1,gamma-glutamyl-peptidase activity,MF,
8904,GO:0034727,1,0.995366990826165,0,1,piecemeal microautophagy of the nucleus,BP,
8906,GO:0034729,1,0.974308785981241,0,3,histone H3-K79 methylation,BP,
8907,GO:0034736,1,0.995366921815792,0,1,cholesterol O-acyltransferase activity,MF,
8908,GO:0034739,1,0.984841549681216,0,2,histone deacetylase activity (H4-K16 specific),MF,
8909,GO:0034750,1,0.990755138501656,0,2,Scrib-APC-beta-catenin complex,CC,
8910,GO:0034751,1,0.97497801010919,0,3,aryl hydrocarbon receptor complex,CC,
8911,GO:0034752,1,0.995366990826099,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
8912,GO:0034753,1,0.995366990826099,0,1,nuclear aryl hydrocarbon receptor complex,CC,
8913,GO:0034754,1,0.610121078820274,0,63,cellular hormone metabolic process,BP,
8914,GO:0034755,1,0.934736727810959,0,12,iron ion transmembrane transport,BP,
8915,GO:0034756,1,0.968181764004653,0,3,regulation of iron ion transport,BP,
8916,GO:0034757,1,0.995366990825994,0,1,negative regulation of iron ion transport,BP,
8917,GO:0034759,1,0.995366990825994,0,1,regulation of iron ion transmembrane transport,BP,
8918,GO:0034760,1,0.995366990825994,0,1,negative regulation of iron ion transmembrane transport,BP,
8920,GO:0034763,1,0.637132833425844,0,66,negative regulation of transmembrane transport,BP,
8923,GO:0034766,1,0.708205464273445,0,51,negative regulation of ion transmembrane transport,BP,
8925,GO:0034770,1,0.956551272659457,0,9,histone H4-K20 methylation,BP,
8926,GO:0034773,1,0.969976439110532,0,6,histone H4-K20 trimethylation,BP,
8928,GO:0034775,1,0.995366990826099,0,1,glutathione transmembrane transport,BP,
8929,GO:0034776,1,0.990755199849254,0,2,response to histamine,BP,
8930,GO:0034777,1,0.994781693977294,0,1,recycling endosome lumen,CC,
8931,GO:0034875,1,0.995366784419756,0,1,caffeine oxidase activity,MF,
8932,GO:0034959,1,0.995366990826151,0,1,endothelin maturation,BP,
8933,GO:0034963,1,0.982902032395413,0,1,box C/D snoRNA processing,BP,
8934,GO:0034964,1,0.995327122950758,0,1,box H/ACA snoRNA processing,BP,
8936,GO:0034969,1,0.945933204022551,0,10,histone arginine methylation,BP,
8937,GO:0034970,1,0.990737716306076,0,2,histone H3-R2 methylation,BP,
8938,GO:0034971,1,0.995366661426623,0,1,histone H3-R17 methylation,BP,
8939,GO:0034975,1,0.93496097897962,0,14,protein folding in endoplasmic reticulum,BP,
8941,GO:0034979,1,0.908983864987829,0,17,NAD-dependent protein deacetylase activity,MF,
8942,GO:0034982,1,0.911885811922817,0,10,mitochondrial protein processing,BP,
8943,GO:0034983,1,0.970592179657393,0,6,peptidyl-lysine deacetylation,BP,
8944,GO:0034986,1,0.995366990826059,0,1,iron chaperone activity,MF,
8945,GO:0034987,1,0.995366990825994,0,1,immunoglobulin receptor binding,MF,
8946,GO:0034988,1,0.995366990825994,0,1,Fc-gamma receptor I complex binding,MF,
8947,GO:0034991,1,0.990332055690531,0,2,nuclear meiotic cohesin complex,CC,
8948,GO:0034992,1,0.97704576141478,0,5,microtubule organizing center attachment site,CC,
8949,GO:0034993,1,0.97704576141478,0,5,meiotic nuclear membrane microtubule tethering complex,CC,
8950,GO:0034998,1,0.995366574475227,0,1,oligosaccharyltransferase I complex,CC,
8951,GO:0035004,1,0.82432944419769,0,41,phosphatidylinositol 3-kinase activity,MF,
8952,GO:0035005,1,0.972518153779106,0,6,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
8953,GO:0035014,1,0.972517910689153,0,6,phosphatidylinositol 3-kinase regulator activity,MF,
8955,GO:0035020,1,0.910453059458205,0,15,regulation of Rac protein signal transduction,BP,
8956,GO:0035021,1,0.981073620982796,0,4,negative regulation of Rac protein signal transduction,BP,
8957,GO:0035022,1,0.95912682317572,0,4,positive regulation of Rac protein signal transduction,BP,
8958,GO:0035023,1,0.609388055121997,0,95,regulation of Rho protein signal transduction,BP,
8959,GO:0035024,1,0.914826062189653,0,17,negative regulation of Rho protein signal transduction,BP,
8960,GO:0035025,1,0.929355057295079,0,13,positive regulation of Rho protein signal transduction,BP,
8961,GO:0035026,1,0.990755098945299,0,2,leading edge cell differentiation,BP,
8962,GO:0035032,1,0.96935378161123,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
8963,GO:0035033,1,0.982785661616743,0,2,histone deacetylase regulator activity,MF,
8964,GO:0035034,1,0.989598621429955,0,2,histone acetyltransferase regulator activity,MF,
8965,GO:0035035,1,0.875477769511864,0,24,histone acetyltransferase binding,MF,
8966,GO:0035036,1,0.841014929972674,0,18,sperm-egg recognition,BP,
8967,GO:0035037,1,0.995366990826164,0,1,sperm entry,BP,
8970,GO:0035054,1,0.99536679727965,0,1,embryonic heart tube anterior/posterior pattern specification,BP,
8971,GO:0035061,1,0.981594478077586,0,4,interchromatin granule,CC,
8972,GO:0035063,1,0.995366980301936,0,1,nuclear speck organization,BP,
8973,GO:0035064,1,0.721938230920769,0,56,methylated histone binding,MF,
8976,GO:0035067,1,0.923845350095239,0,14,negative regulation of histone acetylation,BP,
8977,GO:0035068,1,0.951786695779417,0,9,micro-ribonucleoprotein complex,CC,
8978,GO:0035082,1,0.860896626812146,0,23,axoneme assembly,BP,
8979,GO:0035087,1,0.970561244765033,0,4,siRNA loading onto RISC involved in RNA interference,BP,
8980,GO:0035088,1,0.831646704687087,0,31,establishment or maintenance of apical/basal cell polarity,BP,
8981,GO:0035089,1,0.937027385653335,0,13,establishment of apical/basal cell polarity,BP,
8982,GO:0035090,1,0.966290888581135,0,5,maintenance of apical/basal cell polarity,BP,
8984,GO:0035092,1,0.986164531023637,0,3,sperm chromatin condensation,BP,
8985,GO:0035093,1,0.990755199849174,0,2,spermatogenesis, exchange of chromosomal proteins,BP,
8986,GO:0035094,1,0.875845900217825,0,22,response to nicotine,BP,
8987,GO:0035095,1,0.981268304249538,0,4,behavioral response to nicotine,BP,
8988,GO:0035097,1,0.640119430822594,0,70,histone methyltransferase complex,CC,
8989,GO:0035098,1,0.923197379929051,0,16,ESC/E(Z) complex,CC,
8990,GO:0035101,1,0.98616370593269,0,3,FACT complex,CC,
8991,GO:0035102,1,0.935089102824946,0,12,PRC1 complex,CC,
8994,GO:0035112,1,0.972517777586699,0,6,genitalia morphogenesis,BP,
8997,GO:0035116,1,0.898472873168856,0,17,embryonic hindlimb morphogenesis,BP,
8998,GO:0035120,1,0.995366990825889,0,1,post-embryonic appendage morphogenesis,BP,
8999,GO:0035127,1,0.995366990825889,0,1,post-embryonic limb morphogenesis,BP,
9000,GO:0035128,1,0.995366990825889,0,1,post-embryonic forelimb morphogenesis,BP,
9002,GO:0035137,1,0.881916136820079,0,21,hindlimb morphogenesis,BP,
9003,GO:0035145,1,0.875112299593967,0,21,exon-exon junction complex,CC,
9006,GO:0035162,1,0.922801558708726,0,14,embryonic hemopoiesis,BP,
9007,GO:0035166,1,0.986164056501689,0,3,post-embryonic hemopoiesis,BP,
9008,GO:0035173,1,0.917107859014348,0,14,histone kinase activity,MF,
9009,GO:0035174,1,0.957019825952131,0,6,histone serine kinase activity,MF,
9010,GO:0035175,1,0.991301205102377,0,1,histone kinase activity (H3-S10 specific),MF,
9011,GO:0035176,1,0.845202162396135,0,31,social behavior,BP,
9012,GO:0035184,1,0.977577550948209,0,4,histone threonine kinase activity,MF,
9013,GO:0035188,1,0.995366857802029,0,1,hatching,BP,
9014,GO:0035189,1,0.985435326500978,0,3,Rb-E2F complex,CC,
9017,GO:0035196,1,0.817120949122125,0,38,production of miRNAs involved in gene silencing by miRNA,BP,
9018,GO:0035197,1,0.950051966206312,0,9,siRNA binding,MF,
9019,GO:0035198,1,0.891713377218346,0,21,miRNA binding,MF,
9020,GO:0035226,1,0.995366745564184,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9021,GO:0035227,1,0.995366745564184,0,1,regulation of glutamate-cysteine ligase activity,BP,
9022,GO:0035229,1,0.995366745564184,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9023,GO:0035234,1,0.946396300406409,0,6,ectopic germ cell programmed cell death,BP,
9024,GO:0035235,1,0.954870050945021,0,8,ionotropic glutamate receptor signaling pathway,BP,
9026,GO:0035240,1,0.993103767077917,0,1,dopamine binding,MF,
9027,GO:0035241,1,0.985940489124738,0,3,protein-arginine omega-N monomethyltransferase activity,MF,
9028,GO:0035242,1,0.959364317321788,0,7,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9029,GO:0035243,1,0.981231725778713,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
9030,GO:0035246,1,0.941323912528098,0,11,peptidyl-arginine N-methylation,BP,
9031,GO:0035247,1,0.950338712422236,0,9,peptidyl-arginine omega-N-methylation,BP,
9032,GO:0035248,1,0.99536654741837,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9033,GO:0035249,1,0.831707604547687,0,31,synaptic transmission, glutamatergic,BP,
9034,GO:0035250,1,0.878700523240226,0,23,UDP-galactosyltransferase activity,MF,
9035,GO:0035251,1,0.948206782768315,0,7,UDP-glucosyltransferase activity,MF,
9036,GO:0035252,1,0.966514001703056,0,6,UDP-xylosyltransferase activity,MF,
9037,GO:0035253,1,0.952546568935216,0,9,ciliary rootlet,CC,
9039,GO:0035255,1,0.903682415911811,0,20,ionotropic glutamate receptor binding,MF,
9040,GO:0035256,1,0.963490023843971,0,6,G-protein coupled glutamate receptor binding,MF,
9041,GO:0035257,1,0.432026015864769,0,130,nuclear hormone receptor binding,MF,
9042,GO:0035258,1,0.625644190726581,0,75,steroid hormone receptor binding,MF,
9043,GO:0035259,1,0.932856030459841,0,12,glucocorticoid receptor binding,MF,
9044,GO:0035261,1,0.990755199848837,0,2,external genitalia morphogenesis,BP,
9045,GO:0035262,1,0.995366990825981,0,1,gonad morphogenesis,BP,
9046,GO:0035264,1,0.515545312619787,0,105,multicellular organism growth,BP,
9047,GO:0035265,1,0.613931827740794,0,93,organ growth,BP,
9048,GO:0035267,1,0.879181637212613,0,19,NuA4 histone acetyltransferase complex,CC,
9049,GO:0035268,1,0.849401058825519,0,17,protein mannosylation,BP,
9050,GO:0035269,1,0.873441584947574,0,11,protein O-linked mannosylation,BP,
9053,GO:0035276,1,0.995366990826138,0,1,ethanol binding,MF,
9054,GO:0035278,1,0.92436675818959,0,12,miRNA mediated inhibition of translation,BP,
9055,GO:0035279,1,0.99075476249019,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9056,GO:0035280,1,0.960672006508818,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9057,GO:0035281,1,0.976420634040698,0,2,pre-miRNA export from nucleus,BP,
9059,GO:0035283,1,0.995366904175501,0,1,central nervous system segmentation,BP,
9060,GO:0035284,1,0.995366904175501,0,1,brain segmentation,BP,
9061,GO:0035290,1,0.986057600400874,0,3,trunk segmentation,BP,
9064,GO:0035299,1,0.995366990826151,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9065,GO:0035303,1,0.394589358321973,0,158,regulation of dephosphorylation,BP,
9066,GO:0035304,1,0.525472027513015,0,101,regulation of protein dephosphorylation,BP,
9067,GO:0035305,1,0.61992645114572,0,79,negative regulation of dephosphorylation,BP,
9068,GO:0035306,1,0.799189533192316,0,39,positive regulation of dephosphorylation,BP,
9069,GO:0035307,1,0.835758022835895,0,30,positive regulation of protein dephosphorylation,BP,
9070,GO:0035308,1,0.761146591746922,0,38,negative regulation of protein dephosphorylation,BP,
9071,GO:0035312,1,0.971044207801415,0,6,5'-3' exodeoxyribonuclease activity,MF,
9072,GO:0035313,1,0.936664823845166,0,13,wound healing, spreading of epidermal cells,BP,
9074,GO:0035325,1,0.907065544310447,0,8,Toll-like receptor binding,MF,
9075,GO:0035326,1,0.639236392741578,0,75,enhancer binding,MF,
9076,GO:0035327,1,0.831315434396227,0,20,transcriptionally active chromatin,CC,
9078,GO:0035330,1,0.949538328821316,0,11,regulation of hippo signaling,BP,
9079,GO:0035331,1,0.962866239605953,0,8,negative regulation of hippo signaling,BP,
9080,GO:0035332,1,0.990755199849006,0,2,positive regulation of hippo signaling,BP,
9081,GO:0035333,1,0.915986441745384,0,12,Notch receptor processing, ligand-dependent,BP,
9082,GO:0035335,1,0.625033345175757,0,74,peptidyl-tyrosine dephosphorylation,BP,
9083,GO:0035336,1,0.889828196170679,0,19,long-chain fatty-acyl-CoA metabolic process,BP,
9084,GO:0035337,1,0.812357497174373,0,32,fatty-acyl-CoA metabolic process,BP,
9085,GO:0035338,1,0.922636337935483,0,13,long-chain fatty-acyl-CoA biosynthetic process,BP,
9086,GO:0035339,1,0.967874750741166,0,4,SPOTS complex,CC,
9087,GO:0035349,1,0.985610701784583,0,3,coenzyme A transmembrane transport,BP,
9088,GO:0035350,1,0.990256961073357,0,2,FAD transmembrane transport,BP,
9089,GO:0035352,1,0.994866746349447,0,1,NAD transmembrane transport,BP,
9090,GO:0035354,1,0.995366920137051,0,1,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9091,GO:0035355,1,0.995366990826125,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9092,GO:0035356,1,0.957383716946421,0,5,cellular triglyceride homeostasis,BP,
9093,GO:0035357,1,0.929874754721199,0,14,peroxisome proliferator activated receptor signaling pathway,BP,
9094,GO:0035358,1,0.963178854060446,0,7,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9095,GO:0035359,1,0.995366990826125,0,1,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9096,GO:0035360,1,0.972169278099224,0,5,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9097,GO:0035363,1,0.976381922551541,0,4,histone locus body,CC,
9098,GO:0035368,1,0.977270048868058,0,4,selenocysteine insertion sequence binding,MF,
9099,GO:0035370,1,0.990331657086012,0,2,UBC13-UEV1A complex,CC,
9100,GO:0035371,1,0.917402688983997,0,18,microtubule plus-end,CC,
9101,GO:0035372,1,0.939311796902322,0,13,protein localization to microtubule,BP,
9102,GO:0035373,1,0.990755199848874,0,2,chondroitin sulfate proteoglycan binding,MF,
9103,GO:0035374,1,0.970363784217605,0,6,chondroitin sulfate binding,MF,
9104,GO:0035376,1,0.966890890730654,0,5,sterol import,BP,
9105,GO:0035381,1,0.993926676033175,0,1,ATP-gated ion channel activity,MF,
9106,GO:0035383,1,0.573848193281964,0,77,thioester metabolic process,BP,
9107,GO:0035384,1,0.772394666055287,0,43,thioester biosynthetic process,BP,
9108,GO:0035385,1,0.965902632125851,0,7,Roundabout signaling pathway,BP,
9109,GO:0035400,1,0.995366990826152,0,1,histone tyrosine kinase activity,MF,
9110,GO:0035401,1,0.995366990826152,0,1,histone kinase activity (H3-Y41 specific),MF,
9111,GO:0035402,1,0.990747937157755,0,2,histone kinase activity (H3-T11 specific),MF,
9112,GO:0035403,1,0.995366990825981,0,1,histone kinase activity (H3-T6 specific),MF,
9113,GO:0035404,1,0.942824610354566,0,9,histone-serine phosphorylation,BP,
9114,GO:0035405,1,0.977577550948209,0,4,histone-threonine phosphorylation,BP,
9115,GO:0035406,1,0.995366990826152,0,1,histone-tyrosine phosphorylation,BP,
9116,GO:0035407,1,0.990747937157755,0,2,histone H3-T11 phosphorylation,BP,
9117,GO:0035408,1,0.995366990825981,0,1,histone H3-T6 phosphorylation,BP,
9118,GO:0035409,1,0.995366990826152,0,1,histone H3-Y41 phosphorylation,BP,
9119,GO:0035418,1,0.87020750492322,0,22,protein localization to synapse,BP,
9120,GO:0035425,1,0.982834063552562,0,3,autocrine signaling,BP,
9121,GO:0035426,1,0.981594532671817,0,4,extracellular matrix-cell signaling,BP,
9122,GO:0035434,1,0.942051906211817,0,6,copper ion transmembrane transport,BP,
9123,GO:0035435,1,0.960182645169838,0,8,phosphate ion transmembrane transport,BP,
9124,GO:0035437,1,0.934061007150699,0,11,maintenance of protein localization in endoplasmic reticulum,BP,
9125,GO:0035438,1,0.991077219946905,0,1,cyclic-di-GMP binding,MF,
9126,GO:0035441,1,0.995366990826008,0,1,cell migration involved in vasculogenesis,BP,
9127,GO:0035442,1,0.986218899932089,0,2,dipeptide transmembrane transport,BP,
9128,GO:0035443,1,0.995366990826099,0,1,tripeptide transmembrane transport,BP,
9129,GO:0035445,1,0.995366775300441,0,1,borate transmembrane transport,BP,
9131,GO:0035456,1,0.795611939924409,0,20,response to interferon-beta,BP,
9133,GO:0035458,1,0.908473506829432,0,12,cellular response to interferon-beta,BP,
9134,GO:0035459,1,0.903539357504198,0,20,cargo loading into vesicle,BP,
9135,GO:0035461,1,0.95883692685229,0,8,vitamin transmembrane transport,BP,
9136,GO:0035469,1,0.995366990826153,0,1,determination of pancreatic left/right asymmetry,BP,
9137,GO:0035470,1,0.992275793949614,0,1,positive regulation of vascular wound healing,BP,
9138,GO:0035473,1,0.985036296899256,0,2,lipase binding,MF,
9139,GO:0035482,1,0.966333131417304,0,2,gastric motility,BP,
9140,GO:0035483,1,0.975368272283632,0,1,gastric emptying,BP,
9141,GO:0035485,1,0.99260378678419,0,1,adenine/guanine mispair binding,MF,
9142,GO:0035490,1,0.995366806405613,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9143,GO:0035491,1,0.995366806405613,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
9144,GO:0035493,1,0.924635082259843,0,14,SNARE complex assembly,BP,
9145,GO:0035494,1,0.983463903639111,0,3,SNARE complex disassembly,BP,
9146,GO:0035497,1,0.943069466242274,0,11,cAMP response element binding,MF,
9147,GO:0035498,1,0.995366574475227,0,1,carnosine metabolic process,BP,
9148,GO:0035500,1,0.990754705531478,0,2,MH2 domain binding,MF,
9149,GO:0035501,1,0.995366499145455,0,1,MH1 domain binding,MF,
9150,GO:0035502,1,0.982910653080445,0,3,metanephric part of ureteric bud development,BP,
9151,GO:0035504,1,0.98859399216161,0,1,regulation of myosin light chain kinase activity,BP,
9152,GO:0035505,1,0.98859399216161,0,1,positive regulation of myosin light chain kinase activity,BP,
9153,GO:0035507,1,0.968053668613797,0,6,regulation of myosin-light-chain-phosphatase activity,BP,
9154,GO:0035508,1,0.995366990826138,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9155,GO:0035509,1,0.977089064455155,0,4,negative regulation of myosin-light-chain-phosphatase activity,BP,
9156,GO:0035510,1,0.823453087030868,0,25,DNA dealkylation,BP,
9157,GO:0035511,1,0.954679994365681,0,5,oxidative DNA demethylation,BP,
9158,GO:0035513,1,0.975905946450012,0,4,oxidative RNA demethylation,BP,
9159,GO:0035514,1,0.96362720729166,0,3,DNA demethylase activity,MF,
9160,GO:0035515,1,0.975905946450012,0,4,oxidative RNA demethylase activity,MF,
9161,GO:0035516,1,0.995366990826152,0,1,oxidative DNA demethylase activity,MF,
9162,GO:0035517,1,0.98616450829273,0,3,PR-DUB complex,CC,
9163,GO:0035518,1,0.899914839610492,0,17,histone H2A monoubiquitination,BP,
9164,GO:0035519,1,0.944351149665951,0,4,protein K29-linked ubiquitination,BP,
9165,GO:0035520,1,0.959030991131643,0,9,monoubiquitinated protein deubiquitination,BP,
9166,GO:0035521,1,0.981566514758871,0,4,monoubiquitinated histone deubiquitination,BP,
9167,GO:0035522,1,0.981566514758871,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9168,GO:0035523,1,0.977307422384167,0,4,protein K29-linked deubiquitination,BP,
9169,GO:0035524,1,0.976924040616043,0,5,proline transmembrane transport,BP,
9170,GO:0035525,1,0.995327122950758,0,1,NF-kappaB p50/p65 complex,CC,
9171,GO:0035526,1,0.990755199849292,0,2,retrograde transport, plasma membrane to Golgi,BP,
9172,GO:0035529,1,0.948872718380611,0,5,NADH pyrophosphatase activity,MF,
9173,GO:0035538,1,0.995366861633608,0,1,carbohydrate response element binding,MF,
9174,GO:0035539,1,0.967031870698066,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9175,GO:0035542,1,0.966082865449922,0,7,regulation of SNARE complex assembly,BP,
9176,GO:0035544,1,0.995366990826164,0,1,negative regulation of SNARE complex assembly,BP,
9177,GO:0035546,1,0.981594829456936,0,4,interferon-beta secretion,BP,
9178,GO:0035547,1,0.981594829456936,0,4,regulation of interferon-beta secretion,BP,
9179,GO:0035549,1,0.981594829456936,0,4,positive regulation of interferon-beta secretion,BP,
9180,GO:0035552,1,0.980449468136635,0,3,oxidative single-stranded DNA demethylation,BP,
9181,GO:0035553,1,0.980485099652353,0,3,oxidative single-stranded RNA demethylation,BP,
9183,GO:0035561,1,0.894559839268265,0,21,regulation of chromatin binding,BP,
9184,GO:0035562,1,0.963522505078498,0,8,negative regulation of chromatin binding,BP,
9185,GO:0035563,1,0.932781157703658,0,12,positive regulation of chromatin binding,BP,
9186,GO:0035567,1,0.329289861782585,0,132,non-canonical Wnt signaling pathway,BP,
9187,GO:0035568,1,0.995366574475227,0,1,N-terminal peptidyl-proline methylation,BP,
9188,GO:0035570,1,0.995366574475227,0,1,N-terminal peptidyl-serine methylation,BP,
9189,GO:0035572,1,0.995366574475227,0,1,N-terminal peptidyl-serine dimethylation,BP,
9190,GO:0035573,1,0.995366574475227,0,1,N-terminal peptidyl-serine trimethylation,BP,
9191,GO:0035574,1,0.990754785405274,0,2,histone H4-K20 demethylation,BP,
9192,GO:0035575,1,0.990754785405274,0,2,histone demethylase activity (H4-K20 specific),MF,
9193,GO:0035577,1,0.690141691112696,0,47,azurophil granule membrane,CC,
9194,GO:0035578,1,0.592325500801286,0,69,azurophil granule lumen,CC,
9196,GO:0035580,1,0.712135992423805,0,39,specific granule lumen,CC,
9197,GO:0035581,1,0.967362367179764,0,6,sequestering of extracellular ligand from receptor,BP,
9198,GO:0035582,1,0.980937216503082,0,3,sequestering of BMP in extracellular matrix,BP,
9199,GO:0035583,1,0.986164531023221,0,3,sequestering of TGFbeta in extracellular matrix,BP,
9200,GO:0035584,1,0.866728201036118,0,10,calcium-mediated signaling using intracellular calcium source,BP,
9201,GO:0035585,1,0.995366574475227,0,1,calcium-mediated signaling using extracellular calcium source,BP,
9202,GO:0035586,1,0.956129677719136,0,7,purinergic receptor activity,MF,
9203,GO:0035587,1,0.936250734940673,0,10,purinergic receptor signaling pathway,BP,
9204,GO:0035588,1,0.946362868794589,0,8,G-protein coupled purinergic receptor signaling pathway,BP,
9205,GO:0035589,1,0.968836901742352,0,5,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
9206,GO:0035590,1,0.958487407338012,0,7,purinergic nucleotide receptor signaling pathway,BP,
9207,GO:0035591,1,0.760336410874841,0,55,signaling adaptor activity,MF,
9208,GO:0035594,1,0.983980163592647,0,3,ganglioside binding,MF,
9209,GO:0035596,1,0.989276854192133,0,2,methylthiotransferase activity,MF,
9210,GO:0035597,1,0.993881961269183,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9211,GO:0035598,1,0.995366872208265,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9212,GO:0035600,1,0.989276854192133,0,2,tRNA methylthiolation,BP,
9213,GO:0035601,1,0.5548923176926,0,100,protein deacylation,BP,
9214,GO:0035602,1,0.995366990826138,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9215,GO:0035603,1,0.995366990826138,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9216,GO:0035604,1,0.995366990826138,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9217,GO:0035605,1,0.9855963679086,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9218,GO:0035606,1,0.955693980295639,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9219,GO:0035607,1,0.990755199849241,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9220,GO:0035608,1,0.990754728604039,0,2,protein deglutamylation,BP,
9221,GO:0035609,1,0.995366990826151,0,1,C-terminal protein deglutamylation,BP,
9222,GO:0035610,1,0.995366990826151,0,1,protein side chain deglutamylation,BP,
9223,GO:0035611,1,0.995366517412584,0,1,protein branching point deglutamylation,BP,
9224,GO:0035612,1,0.962854609836907,0,8,AP-2 adaptor complex binding,MF,
9225,GO:0035613,1,0.904048094432327,0,15,RNA stem-loop binding,MF,
9226,GO:0035614,1,0.969820084441848,0,3,snRNA stem-loop binding,MF,
9227,GO:0035615,1,0.928970231768087,0,11,clathrin adaptor activity,MF,
9228,GO:0035616,1,0.986164358269714,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9229,GO:0035617,1,0.985435308098181,0,3,stress granule disassembly,BP,
9230,GO:0035620,1,0.98177111640964,0,3,ceramide transporter activity,MF,
9231,GO:0035621,1,0.989021895295037,0,2,ER to Golgi ceramide transport,BP,
9232,GO:0035622,1,0.99536699053359,0,1,intrahepatic bile duct development,BP,
9233,GO:0035623,1,0.995366852576414,0,1,renal glucose absorption,BP,
9234,GO:0035624,1,0.990755172082187,0,2,receptor transactivation,BP,
9235,GO:0035625,1,0.995366962931429,0,1,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
9236,GO:0035627,1,0.966490257850382,0,6,ceramide transport,BP,
9237,GO:0035630,1,0.98616433924611,0,3,bone mineralization involved in bone maturation,BP,
9238,GO:0035631,1,0.943326659103238,0,11,CD40 receptor complex,CC,
9239,GO:0035633,1,0.990251784811628,0,2,maintenance of permeability of blood-brain barrier,BP,
9240,GO:0035634,1,0.975046510207496,0,1,response to stilbenoid,BP,
9241,GO:0035635,1,0.883182950642513,0,18,entry of bacterium into host cell,BP,
9243,GO:0035638,1,0.995366990826165,0,1,signal maturation,BP,
9245,GO:0035640,1,0.915284575232304,0,13,exploration behavior,BP,
9246,GO:0035641,1,0.944723577705891,0,7,locomotory exploration behavior,BP,
9247,GO:0035642,1,0.995366661426623,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9248,GO:0035646,1,0.920585540457074,0,10,endosome to melanosome transport,BP,
9249,GO:0035650,1,0.961909311358339,0,4,AP-1 adaptor complex binding,MF,
9250,GO:0035651,1,0.966388794333479,0,3,AP-3 adaptor complex binding,MF,
9251,GO:0035655,1,0.956618074264822,0,5,interleukin-18-mediated signaling pathway,BP,
9252,GO:0035658,1,0.98446649172461,0,3,Mon1-Ccz1 complex,CC,
9253,GO:0035659,1,0.99133415856859,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
9254,GO:0035662,1,0.928732087157678,0,3,Toll-like receptor 4 binding,MF,
9255,GO:0035663,1,0.987467555378304,0,2,Toll-like receptor 2 binding,MF,
9256,GO:0035664,1,0.992064218688857,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9257,GO:0035665,1,0.992064218688857,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9258,GO:0035666,1,0.842527401278172,0,24,TRIF-dependent toll-like receptor signaling pathway,BP,
9259,GO:0035668,1,0.995366990826138,0,1,TRAM-dependent toll-like receptor signaling pathway,BP,
9260,GO:0035669,1,0.995366990826138,0,1,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9261,GO:0035671,1,0.990237557770863,0,2,enone reductase activity,MF,
9262,GO:0035672,1,0.968064332004374,0,6,oligopeptide transmembrane transport,BP,
9263,GO:0035673,1,0.98159466149239,0,4,oligopeptide transmembrane transporter activity,MF,
9264,GO:0035674,1,0.985430590314736,0,2,tricarboxylic acid transmembrane transport,BP,
9265,GO:0035675,1,0.995352427354762,0,1,neuromast hair cell development,BP,
9266,GO:0035686,1,0.959792422147378,0,3,sperm fibrous sheath,CC,
9268,GO:0035691,1,0.985578879664716,0,1,macrophage migration inhibitory factor signaling pathway,BP,
9269,GO:0035692,1,0.98101192279148,0,2,macrophage migration inhibitory factor receptor complex,CC,
9270,GO:0035693,1,0.985578879664716,0,1,NOS2-CD74 complex,CC,
9271,GO:0035694,1,0.975411434905533,0,4,mitochondrial protein catabolic process,BP,
9272,GO:0035695,1,0.995366990826152,0,1,mitophagy by induced vacuole formation,BP,
9273,GO:0035697,1,0.985950783532134,0,2,CD8-positive, alpha-beta T cell extravasation,BP,
9274,GO:0035698,1,0.985950783532134,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
9275,GO:0035700,1,0.992035302004488,0,1,astrocyte chemotaxis,BP,
9276,GO:0035701,1,0.985645402153902,0,3,hematopoietic stem cell migration,BP,
9277,GO:0035709,1,0.994680773914287,0,1,memory T cell activation,BP,
9279,GO:0035711,1,0.99536692857644,0,1,T-helper 1 cell activation,BP,
9280,GO:0035712,1,0.995366868831338,0,1,T-helper 2 cell activation,BP,
9281,GO:0035718,1,0.974175348183462,0,2,macrophage migration inhibitory factor binding,MF,
9282,GO:0035720,1,0.98183455250238,0,3,intraciliary anterograde transport,BP,
9283,GO:0035721,1,0.895761564399027,0,12,intraciliary retrograde transport,BP,
9284,GO:0035722,1,0.673232401111365,0,40,interleukin-12-mediated signaling pathway,BP,
9285,GO:0035723,1,0.951407748426029,0,9,interleukin-15-mediated signaling pathway,BP,
9287,GO:0035726,1,0.960016401842039,0,4,common myeloid progenitor cell proliferation,BP,
9288,GO:0035727,1,0.990754478751397,0,2,lysophosphatidic acid binding,MF,
9289,GO:0035728,1,0.943010701745723,0,11,response to hepatocyte growth factor,BP,
9290,GO:0035729,1,0.952189910283324,0,9,cellular response to hepatocyte growth factor stimulus,BP,
9291,GO:0035730,1,0.978603858191516,0,1,S-nitrosoglutathione binding,MF,
9292,GO:0035731,1,0.978603858191516,0,1,dinitrosyl-iron complex binding,MF,
9293,GO:0035732,1,0.978603858191516,0,1,nitric oxide storage,BP,
9294,GO:0035733,1,0.979671154363353,0,4,hepatic stellate cell activation,BP,
9295,GO:0035735,1,0.743914762912092,0,39,intraciliary transport involved in cilium assembly,BP,
9296,GO:0035739,1,0.979870773529846,0,4,CD4-positive, alpha-beta T cell proliferation,BP,
9297,GO:0035740,1,0.986359274919087,0,2,CD8-positive, alpha-beta T cell proliferation,BP,
9298,GO:0035743,1,0.942624973463082,0,8,CD4-positive, alpha-beta T cell cytokine production,BP,
9299,GO:0035744,1,0.982472661537522,0,1,T-helper 1 cell cytokine production,BP,
9300,GO:0035745,1,0.96391765898924,0,6,T-helper 2 cell cytokine production,BP,
9301,GO:0035747,1,0.973107654309847,0,3,natural killer cell chemotaxis,BP,
9302,GO:0035748,1,0.971538771959852,0,6,myelin sheath abaxonal region,CC,
9303,GO:0035749,1,0.963950766618403,0,5,myelin sheath adaxonal region,CC,
9304,GO:0035750,1,0.995366990826152,0,1,protein localization to myelin sheath abaxonal region,BP,
9305,GO:0035751,1,0.903393538195012,0,11,regulation of lysosomal lumen pH,BP,
9306,GO:0035752,1,0.993092536461668,0,1,lysosomal lumen pH elevation,BP,
9307,GO:0035754,1,0.976011765739269,0,5,B cell chemotaxis,BP,
9308,GO:0035755,1,0.995323773158493,0,1,cardiolipin hydrolase activity,MF,
9309,GO:0035766,1,0.986164528494694,0,3,cell chemotaxis to fibroblast growth factor,BP,
9311,GO:0035768,1,0.986164528494694,0,3,endothelial cell chemotaxis to fibroblast growth factor,BP,
9313,GO:0035771,1,0.972762175659042,0,5,interleukin-4-mediated signaling pathway,BP,
9315,GO:0035774,1,0.861422317983037,0,19,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
9316,GO:0035787,1,0.986163340063353,0,3,cell migration involved in kidney development,BP,
9317,GO:0035788,1,0.990754003408654,0,2,cell migration involved in metanephros development,BP,
9318,GO:0035789,1,0.990754003408654,0,2,metanephric mesenchymal cell migration,BP,
9319,GO:0035790,1,0.995366989161553,0,1,platelet-derived growth factor receptor-alpha signaling pathway,BP,
9320,GO:0035791,1,0.955074141654139,0,9,platelet-derived growth factor receptor-beta signaling pathway,BP,
9321,GO:0035793,1,0.990754003408654,0,2,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
9322,GO:0035794,1,0.659539654255942,0,55,positive regulation of mitochondrial membrane permeability,BP,
9323,GO:0035795,1,0.938513075006544,0,5,negative regulation of mitochondrial membrane permeability,BP,
9324,GO:0035799,1,0.9861641614945,0,3,ureter maturation,BP,
9325,GO:0035800,1,0.982163498051361,0,2,deubiquitinase activator activity,MF,
9326,GO:0035801,1,0.98751485573925,0,2,adrenal cortex development,BP,
9327,GO:0035802,1,0.98751485573925,0,2,adrenal cortex formation,BP,
9328,GO:0035803,1,0.974697815102304,0,2,egg coat formation,BP,
9329,GO:0035809,1,0.946556824492701,0,8,regulation of urine volume,BP,
9330,GO:0035810,1,0.975295840997563,0,5,positive regulation of urine volume,BP,
9331,GO:0035811,1,0.995366990826099,0,1,negative regulation of urine volume,BP,
9332,GO:0035812,1,0.989162912827193,0,2,renal sodium excretion,BP,
9333,GO:0035813,1,0.989162912827193,0,2,regulation of renal sodium excretion,BP,
9334,GO:0035814,1,0.994878946369531,0,1,negative regulation of renal sodium excretion,BP,
9335,GO:0035815,1,0.994254882565581,0,1,positive regulation of renal sodium excretion,BP,
9336,GO:0035821,1,0.451212503377429,0,91,modification of morphology or physiology of other organism,BP,
9337,GO:0035822,1,0.990755012415958,0,2,gene conversion,BP,
9338,GO:0035825,1,0.791226510636562,0,36,homologous recombination,BP,
9339,GO:0035838,1,0.990755199849227,0,2,growing cell tip,CC,
9340,GO:0035841,1,0.995366990826112,0,1,new growing cell tip,CC,
9341,GO:0035844,1,0.982882413382707,0,3,cloaca development,BP,
9342,GO:0035845,1,0.951951379921397,0,7,photoreceptor cell outer segment organization,BP,
9344,GO:0035851,1,0.995366654772929,0,1,Krueppel-associated box domain binding,MF,
9345,GO:0035853,1,0.995366990826164,0,1,chromosome passenger complex localization to spindle midzone,BP,
9346,GO:0035855,1,0.944966862106362,0,12,megakaryocyte development,BP,
9347,GO:0035859,1,0.928353572397387,0,13,Seh1-associated complex,CC,
9348,GO:0035860,1,0.990754949088799,0,2,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
9349,GO:0035861,1,0.848665571808349,0,32,site of double-strand break,CC,
9350,GO:0035862,1,0.995366990826113,0,1,dITP metabolic process,BP,
9351,GO:0035863,1,0.995366990826113,0,1,dITP catabolic process,BP,
9352,GO:0035864,1,0.951519628639432,0,6,response to potassium ion,BP,
9353,GO:0035865,1,0.968812108254876,0,3,cellular response to potassium ion,BP,
9354,GO:0035866,1,0.990755199849032,0,2,alphav-beta3 integrin-PKCalpha complex,CC,
9355,GO:0035867,1,0.986164531023298,0,3,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
9356,GO:0035868,1,0.990755137884605,0,2,alphav-beta3 integrin-HMGB1 complex,CC,
9357,GO:0035869,1,0.703434014044286,0,50,ciliary transition zone,CC,
9358,GO:0035870,1,0.977017970004613,0,2,dITP diphosphatase activity,MF,
9359,GO:0035871,1,0.954868605889945,0,9,protein K11-linked deubiquitination,BP,
9360,GO:0035872,1,0.820772835803047,0,32,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
9361,GO:0035873,1,0.980179693131654,0,4,lactate transmembrane transport,BP,
9362,GO:0035877,1,0.970432604159956,0,4,death effector domain binding,MF,
9364,GO:0035879,1,0.984742855308729,0,3,plasma membrane lactate transport,BP,
9365,GO:0035880,1,0.990072121135937,0,2,embryonic nail plate morphogenesis,BP,
9366,GO:0035881,1,0.989884390067244,0,2,amacrine cell differentiation,BP,
9369,GO:0035887,1,0.991669902477171,0,1,aortic smooth muscle cell differentiation,BP,
9370,GO:0035890,1,0.825005486354476,0,33,exit from host,BP,
9371,GO:0035891,1,0.825005486354476,0,33,exit from host cell,BP,
9372,GO:0035897,1,0.97252897458588,0,5,proteolysis in other organism,BP,
9373,GO:0035898,1,0.98382026633655,0,3,parathyroid hormone secretion,BP,
9374,GO:0035900,1,0.93263604792793,0,6,response to isolation stress,BP,
9375,GO:0035902,1,0.897762138373146,0,17,response to immobilization stress,BP,
9378,GO:0035907,1,0.976765281794895,0,5,dorsal aorta development,BP,
9381,GO:0035912,1,0.981312818427544,0,4,dorsal aorta morphogenesis,BP,
9383,GO:0035915,1,0.993983990746379,0,1,pore formation in membrane of other organism,BP,
9385,GO:0035922,1,0.995366807366016,0,1,foramen ovale closure,BP,
9386,GO:0035924,1,0.828734145180104,0,29,cellular response to vascular endothelial growth factor stimulus,BP,
9387,GO:0035925,1,0.945815504890047,0,11,mRNA 3'-UTR AU-rich region binding,MF,
9388,GO:0035926,1,0.976548795242017,0,5,chemokine (C-C motif) ligand 2 secretion,BP,
9389,GO:0035927,1,0.952488222818516,0,4,RNA import into mitochondrion,BP,
9390,GO:0035928,1,0.956923972672022,0,3,rRNA import into mitochondrion,BP,
9391,GO:0035929,1,0.946978714559245,0,7,steroid hormone secretion,BP,
9392,GO:0035930,1,0.961047116131144,0,4,corticosteroid hormone secretion,BP,
9393,GO:0035931,1,0.995363424876141,0,1,mineralocorticoid secretion,BP,
9394,GO:0035932,1,0.995363424876141,0,1,aldosterone secretion,BP,
9395,GO:0035933,1,0.965525650958653,0,3,glucocorticoid secretion,BP,
9396,GO:0035935,1,0.995366870768743,0,1,androgen secretion,BP,
9397,GO:0035936,1,0.995366990826073,0,1,testosterone secretion,BP,
9398,GO:0035938,1,0.995366990826099,0,1,estradiol secretion,BP,
9399,GO:0035945,1,0.995258125840563,0,1,mitochondrial ncRNA surveillance,BP,
9400,GO:0035946,1,0.995258125840563,0,1,mitochondrial mRNA surveillance,BP,
9402,GO:0035948,1,0.98616411300348,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
9403,GO:0035962,1,0.995366989018618,0,1,response to interleukin-13,BP,
9404,GO:0035963,1,0.995366989018618,0,1,cellular response to interleukin-13,BP,
9405,GO:0035964,1,0.963254437777256,0,6,COPI-coated vesicle budding,BP,
9406,GO:0035965,1,0.973808822578819,0,5,cardiolipin acyl-chain remodeling,BP,
9409,GO:0035970,1,0.919714349710372,0,15,peptidyl-threonine dephosphorylation,BP,
9410,GO:0035971,1,0.983893305002902,0,1,peptidyl-histidine dephosphorylation,BP,
9411,GO:0035973,1,0.956314961881568,0,7,aggrephagy,BP,
9413,GO:0035977,1,0.979455305761291,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
9414,GO:0035978,1,0.995366499145455,0,1,histone H2A-S139 phosphorylation,BP,
9415,GO:0035981,1,0.98454279703237,0,2,tongue muscle cell differentiation,BP,
9416,GO:0035983,1,0.983717572978095,0,3,response to trichostatin A,BP,
9417,GO:0035984,1,0.983717572978095,0,3,cellular response to trichostatin A,BP,
9418,GO:0035985,1,0.964559334781095,0,4,senescence-associated heterochromatin focus,CC,
9419,GO:0035986,1,0.971863384273945,0,3,senescence-associated heterochromatin focus assembly,BP,
9420,GO:0035987,1,0.838524429146298,0,34,endodermal cell differentiation,BP,
9421,GO:0035988,1,0.96292771544323,0,7,chondrocyte proliferation,BP,
9422,GO:0035989,1,0.978327396459091,0,4,tendon development,BP,
9423,GO:0035990,1,0.987457566080295,0,2,tendon cell differentiation,BP,
9424,GO:0035992,1,0.987457566080295,0,2,tendon formation,BP,
9425,GO:0035993,1,0.98230246302215,0,3,deltoid tuberosity development,BP,
9426,GO:0035994,1,0.932901159014072,0,13,response to muscle stretch,BP,
9427,GO:0035995,1,0.995366990827437,0,1,detection of muscle stretch,BP,
9428,GO:0035998,1,0.993440604030376,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
9429,GO:0035999,1,0.939408119913665,0,8,tetrahydrofolate interconversion,BP,
9430,GO:0036002,1,0.780535282883737,0,32,pre-mRNA binding,MF,
9432,GO:0036004,1,0.984135791080892,0,1,GAF domain binding,MF,
9433,GO:0036005,1,0.972820020064164,0,5,response to macrophage colony-stimulating factor,BP,
9434,GO:0036006,1,0.972820020064164,0,5,cellular response to macrophage colony-stimulating factor stimulus,BP,
9435,GO:0036009,1,0.982902032395413,0,1,protein-glutamine N-methyltransferase activity,MF,
9436,GO:0036010,1,0.91871045940413,0,18,protein localization to endosome,BP,
9437,GO:0036015,1,0.956086813190866,0,3,response to interleukin-3,BP,
9438,GO:0036016,1,0.956086813190866,0,3,cellular response to interleukin-3,BP,
9439,GO:0036017,1,0.9160170132029,0,4,response to erythropoietin,BP,
9440,GO:0036018,1,0.9160170132029,0,4,cellular response to erythropoietin,BP,
9441,GO:0036019,1,0.891929471448553,0,16,endolysosome,CC,
9442,GO:0036020,1,0.913527776600025,0,12,endolysosome membrane,CC,
9443,GO:0036021,1,0.976381545463651,0,4,endolysosome lumen,CC,
9444,GO:0036022,1,0.987861999381116,0,2,limb joint morphogenesis,BP,
9445,GO:0036023,1,0.987861999381116,0,2,embryonic skeletal limb joint morphogenesis,BP,
9446,GO:0036033,1,0.981594888732987,0,4,mediator complex binding,MF,
9447,GO:0036034,1,0.99043877770067,0,2,mediator complex assembly,BP,
9448,GO:0036035,1,0.93572836435287,0,13,osteoclast development,BP,
9449,GO:0036037,1,0.956095537158021,0,7,CD8-positive, alpha-beta T cell activation,BP,
9450,GO:0036038,1,0.890584420859483,0,13,MKS complex,CC,
9451,GO:0036041,1,0.90912228154719,0,6,long-chain fatty acid binding,MF,
9452,GO:0036042,1,0.946340550321602,0,4,long-chain fatty acyl-CoA binding,MF,
9453,GO:0036046,1,0.995366799259991,0,1,protein demalonylation,BP,
9454,GO:0036047,1,0.995366799259991,0,1,peptidyl-lysine demalonylation,BP,
9455,GO:0036048,1,0.995366799259991,0,1,protein desuccinylation,BP,
9456,GO:0036049,1,0.995366799259991,0,1,peptidyl-lysine desuccinylation,BP,
9457,GO:0036054,1,0.995366799259991,0,1,protein-malonyllysine demalonylase activity,MF,
9458,GO:0036055,1,0.995366799259991,0,1,protein-succinyllysine desuccinylase activity,MF,
9459,GO:0036056,1,0.981594888733363,0,4,filtration diaphragm,CC,
9460,GO:0036057,1,0.981594888733363,0,4,slit diaphragm,CC,
9461,GO:0036064,1,0.561022891874629,0,93,ciliary basal body,CC,
9462,GO:0036065,1,0.891993779038341,0,23,fucosylation,BP,
9463,GO:0036066,1,0.931978138275057,0,14,protein O-linked fucosylation,BP,
9464,GO:0036071,1,0.995366876923498,0,1,N-glycan fucosylation,BP,
9465,GO:0036072,1,0.977530126240215,0,4,direct ossification,BP,
9466,GO:0036075,1,0.909217201553757,0,16,replacement ossification,BP,
9467,GO:0036080,1,0.99075504581397,0,2,purine nucleotide-sugar transmembrane transporter activity,MF,
9468,GO:0036085,1,0.995366836082149,0,1,GDP-fucose import into Golgi lumen,BP,
9469,GO:0036089,1,0.955107817242256,0,7,cleavage furrow formation,BP,
9470,GO:0036090,1,0.987688335570569,0,2,cleavage furrow ingression,BP,
9471,GO:0036091,1,0.97766382508979,0,4,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
9472,GO:0036092,1,0.85780613889863,0,33,phosphatidylinositol-3-phosphate biosynthetic process,BP,
9473,GO:0036093,1,0.952801904146773,0,3,germ cell proliferation,BP,
9475,GO:0036105,1,0.995366971297062,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
9476,GO:0036109,1,0.921301106992186,0,11,alpha-linolenic acid metabolic process,BP,
9477,GO:0036111,1,0.995360837019954,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
9478,GO:0036112,1,0.984445301372827,0,2,medium-chain fatty-acyl-CoA metabolic process,BP,
9479,GO:0036114,1,0.989034172764745,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
9480,GO:0036115,1,0.989034172764745,0,1,fatty-acyl-CoA catabolic process,BP,
9481,GO:0036116,1,0.989034172764745,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
9482,GO:0036117,1,0.989043116509549,0,2,hyaluranon cable,CC,
9483,GO:0036118,1,0.984460289876324,0,3,hyaluranon cable assembly,BP,
9484,GO:0036119,1,0.919295445929464,0,17,response to platelet-derived growth factor,BP,
9485,GO:0036120,1,0.923578627299795,0,16,cellular response to platelet-derived growth factor stimulus,BP,
9486,GO:0036122,1,0.98475628230393,0,3,BMP binding,MF,
9487,GO:0036123,1,0.962186376916595,0,5,histone H3-K9 dimethylation,BP,
9488,GO:0036124,1,0.922774667180354,0,14,histone H3-K9 trimethylation,BP,
9489,GO:0036125,1,0.995366725657291,0,1,fatty acid beta-oxidation multienzyme complex,CC,
9490,GO:0036126,1,0.750178694485456,0,38,sperm flagellum,CC,
9491,GO:0036128,1,0.988710369818881,0,2,CatSper complex,CC,
9492,GO:0036132,1,0.975331428436983,0,3,13-prostaglandin reductase activity,MF,
9493,GO:0036135,1,0.990754785405222,0,2,Schwann cell migration,BP,
9494,GO:0036137,1,0.989995873772845,0,2,kynurenine aminotransferase activity,MF,
9495,GO:0036138,1,0.995366990826073,0,1,peptidyl-histidine hydroxylation,BP,
9496,GO:0036139,1,0.995366990826073,0,1,peptidyl-histidine dioxygenase activity,MF,
9497,GO:0036140,1,0.995366990826073,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
9498,GO:0036145,1,0.992035302004488,0,1,dendritic cell homeostasis,BP,
9499,GO:0036146,1,0.98312368525898,0,3,cellular response to mycotoxin,BP,
9500,GO:0036148,1,0.948056208993004,0,11,phosphatidylglycerol acyl-chain remodeling,BP,
9501,GO:0036149,1,0.96580643375613,0,7,phosphatidylinositol acyl-chain remodeling,BP,
9502,GO:0036150,1,0.943256384200317,0,12,phosphatidylserine acyl-chain remodeling,BP,
9503,GO:0036151,1,0.892051601288171,0,18,phosphatidylcholine acyl-chain remodeling,BP,
9504,GO:0036152,1,0.928172789168359,0,15,phosphatidylethanolamine acyl-chain remodeling,BP,
9505,GO:0036153,1,0.995366474549927,0,1,triglyceride acyl-chain remodeling,BP,
9506,GO:0036155,1,0.975715176020853,0,5,acylglycerol acyl-chain remodeling,BP,
9507,GO:0036156,1,0.99075519984877,0,2,inner dynein arm,CC,
9508,GO:0036157,1,0.96330981233755,0,3,outer dynein arm,CC,
9509,GO:0036158,1,0.943513699568612,0,6,outer dynein arm assembly,BP,
9510,GO:0036159,1,0.966380620034163,0,5,inner dynein arm assembly,BP,
9511,GO:0036164,1,0.981536269547348,0,1,cell-abiotic substrate adhesion,BP,
9512,GO:0036166,1,0.98357152734779,0,3,phenotypic switching,BP,
9513,GO:0036179,1,0.995365850795172,0,1,osteoclast maturation,BP,
9514,GO:0036194,1,0.967947959258115,0,3,muscle cell projection,CC,
9515,GO:0036195,1,0.967947959258115,0,3,muscle cell projection membrane,CC,
9517,GO:0036213,1,0.994600178827652,0,1,contractile ring contraction,BP,
9518,GO:0036215,1,0.995366648998949,0,1,response to stem cell factor,BP,
9519,GO:0036216,1,0.995366648998949,0,1,cellular response to stem cell factor stimulus,BP,
9520,GO:0036219,1,0.973014325578977,0,1,GTP diphosphatase activity,MF,
9521,GO:0036220,1,0.981566547056908,0,1,ITP diphosphatase activity,MF,
9522,GO:0036222,1,0.981566547056908,0,1,XTP diphosphatase activity,MF,
9523,GO:0036228,1,0.990473545442115,0,2,protein localization to nuclear inner membrane,BP,
9525,GO:0036245,1,0.983702802004447,0,2,cellular response to menadione,BP,
9526,GO:0036250,1,0.993264267790991,0,1,peroxisome transport along microtubule,BP,
9527,GO:0036255,1,0.995366988609227,0,1,response to methylamine,BP,
9528,GO:0036257,1,0.792500198428864,0,30,multivesicular body organization,BP,
9529,GO:0036258,1,0.796199087728721,0,29,multivesicular body assembly,BP,
9530,GO:0036260,1,0.729355949724698,0,33,RNA capping,BP,
9531,GO:0036261,1,0.995366980816202,0,1,7-methylguanosine cap hypermethylation,BP,
9532,GO:0036265,1,0.942419107604375,0,4,RNA (guanine-N7)-methylation,BP,
9533,GO:0036266,1,0.995311345297819,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
9534,GO:0036269,1,0.989608297565847,0,1,swimming behavior,BP,
9535,GO:0036270,1,0.922212519851536,0,12,response to diuretic,BP,
9536,GO:0036284,1,0.984056992611974,0,2,tubulobulbar complex,CC,
9537,GO:0036289,1,0.968745540710478,0,6,peptidyl-serine autophosphorylation,BP,
9538,GO:0036290,1,0.995366990826125,0,1,protein trans-autophosphorylation,BP,
9539,GO:0036292,1,0.982586078321341,0,2,DNA rewinding,BP,
9541,GO:0036294,1,0.247911272503688,0,158,cellular response to decreased oxygen levels,BP,
9542,GO:0036295,1,0.917118302188147,0,13,cellular response to increased oxygen levels,BP,
9543,GO:0036296,1,0.848176527429191,0,24,response to increased oxygen levels,BP,
9544,GO:0036297,1,0.739265076404546,0,48,interstrand cross-link repair,BP,
9545,GO:0036301,1,0.985804011245847,0,3,macrophage colony-stimulating factor production,BP,
9546,GO:0036302,1,0.976765496182739,0,5,atrioventricular canal development,BP,
9547,GO:0036303,1,0.944647714107047,0,12,lymph vessel morphogenesis,BP,
9548,GO:0036309,1,0.990755199848613,0,2,protein localization to M-band,BP,
9549,GO:0036310,1,0.955576950848602,0,8,annealing helicase activity,MF,
9550,GO:0036312,1,0.95894743216629,0,9,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
9551,GO:0036313,1,0.990588442560083,0,2,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
9552,GO:0036314,1,0.904488071853457,0,19,response to sterol,BP,
9553,GO:0036315,1,0.940222067748045,0,13,cellular response to sterol,BP,
9554,GO:0036316,1,0.995363424876141,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
9555,GO:0036317,1,0.995366574475227,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
9556,GO:0036324,1,0.977723759312553,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
9557,GO:0036333,1,0.995348746602618,0,1,hepatocyte homeostasis,BP,
9558,GO:0036335,1,0.995366990826152,0,1,intestinal stem cell homeostasis,BP,
9559,GO:0036336,1,0.904410903068182,0,15,dendritic cell migration,BP,
9560,GO:0036337,1,0.981270765360763,0,4,Fas signaling pathway,BP,
9562,GO:0036343,1,0.968830365608074,0,1,psychomotor behavior,BP,
9563,GO:0036344,1,0.910470573919321,0,15,platelet morphogenesis,BP,
9564,GO:0036351,1,0.994993592016332,0,1,histone H2A-K13 ubiquitination,BP,
9565,GO:0036352,1,0.994993592016332,0,1,histone H2A-K15 ubiquitination,BP,
9566,GO:0036353,1,0.945095588131014,0,8,histone H2A-K119 monoubiquitination,BP,
9567,GO:0036361,1,0.995254133737912,0,1,racemase activity, acting on amino acids and derivatives,MF,
9568,GO:0036363,1,0.990696298557832,0,2,transforming growth factor beta activation,BP,
9569,GO:0036367,1,0.995320516658041,0,1,light adaption,BP,
9570,GO:0036369,1,0.990755199849058,0,2,transcription factor catabolic process,BP,
9571,GO:0036371,1,0.99536699082602,0,1,protein localization to T-tubule,BP,
9572,GO:0036372,1,0.978949157649859,0,1,opsin transport,BP,
9573,GO:0036374,1,0.985840800138348,0,3,glutathione hydrolase activity,MF,
9574,GO:0036376,1,0.963023663638429,0,7,sodium ion export across plasma membrane,BP,
9575,GO:0036378,1,0.985495713184629,0,2,calcitriol biosynthetic process from calciol,BP,
9576,GO:0036379,1,0.89541027885777,0,12,myofilament,CC,
9577,GO:0036387,1,0.97813575272127,0,3,pre-replicative complex,CC,
9578,GO:0036388,1,0.97813575272127,0,3,pre-replicative complex assembly,BP,
9579,GO:0036392,1,0.995366982257957,0,1,chemokine (C-C motif) ligand 20 production,BP,
9580,GO:0036396,1,0.979414612584991,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
9581,GO:0036398,1,0.995366872685533,0,1,TCR signalosome,CC,
9582,GO:0036399,1,0.995366872685533,0,1,TCR signalosome assembly,BP,
9583,GO:0036402,1,0.93334824078287,0,6,proteasome-activating ATPase activity,MF,
9584,GO:0036403,1,0.99534676482507,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
9585,GO:0036404,1,0.995366990825929,0,1,conversion of ds siRNA to ss siRNA,BP,
9586,GO:0036414,1,0.99536682795566,0,1,histone citrullination,BP,
9587,GO:0036435,1,0.976081077529126,0,3,K48-linked polyubiquitin modification-dependent protein binding,MF,
9588,GO:0036438,1,0.976864053827192,0,4,maintenance of lens transparency,BP,
9589,GO:0036440,1,0.995366665188995,0,1,citrate synthase activity,MF,
9590,GO:0036442,1,0.802775788313289,0,22,proton-exporting ATPase activity,MF,
9591,GO:0036444,1,0.963522301139345,0,8,calcium import into the mitochondrion,BP,
9592,GO:0036445,1,0.954612894822254,0,10,neuronal stem cell division,BP,
9593,GO:0036446,1,0.986164512093428,0,3,myofibroblast differentiation,BP,
9594,GO:0036449,1,0.968010361244079,0,7,microtubule minus-end,CC,
9595,GO:0036451,1,0.990754370961523,0,2,cap mRNA methylation,BP,
9596,GO:0036452,1,0.812888186518184,0,26,ESCRT complex,CC,
9597,GO:0036454,1,0.969659916861236,0,3,growth factor complex,CC,
9598,GO:0036455,1,0.982027585836281,0,1,iron-sulfur transferase activity,MF,
9599,GO:0036457,1,0.98159486157733,0,4,keratohyalin granule,CC,
9600,GO:0036458,1,0.994646465207342,0,1,hepatocyte growth factor binding,MF,
9601,GO:0036459,1,0.590181733903329,0,87,thiol-dependent ubiquitinyl hydrolase activity,MF,
9602,GO:0036461,1,0.970888453973991,0,2,BLOC-2 complex binding,MF,
9603,GO:0036462,1,0.943824032650292,0,7,TRAIL-activated apoptotic signaling pathway,BP,
9605,GO:0036465,1,0.820099254235113,0,37,synaptic vesicle recycling,BP,
9606,GO:0036466,1,0.990755199849292,0,2,synaptic vesicle recycling via endosome,BP,
9607,GO:0036470,1,0.978037514283719,0,1,tyrosine 3-monooxygenase activator activity,MF,
9608,GO:0036471,1,0.978037514283719,0,1,cellular response to glyoxal,BP,
9609,GO:0036473,1,0.627516096945699,0,64,cell death in response to oxidative stress,BP,
9610,GO:0036474,1,0.833663801849652,0,22,cell death in response to hydrogen peroxide,BP,
9611,GO:0036475,1,0.878109525826833,0,19,neuron death in response to oxidative stress,BP,
9612,GO:0036476,1,0.964095927649017,0,3,neuron death in response to hydrogen peroxide,BP,
9614,GO:0036478,1,0.978037514283719,0,1,L-dopa decarboxylase activator activity,MF,
9615,GO:0036480,1,0.95114175120155,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
9616,GO:0036481,1,0.944538229137348,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
9617,GO:0036482,1,0.973494227803959,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
9618,GO:0036483,1,0.995366990826164,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
9619,GO:0036484,1,0.986057600400874,0,3,trunk neural crest cell migration,BP,
9620,GO:0036486,1,0.986057600400874,0,3,ventral trunk neural crest cell migration,BP,
9621,GO:0036487,1,0.99536699082598,0,1,nitric-oxide synthase inhibitor activity,MF,
9623,GO:0036490,1,0.960743011566315,0,8,regulation of translation in response to endoplasmic reticulum stress,BP,
9624,GO:0036491,1,0.965216734559981,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
9625,GO:0036492,1,0.969951970740033,0,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
9626,GO:0036493,1,0.983562603517611,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
9627,GO:0036494,1,0.995366990826138,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
9628,GO:0036496,1,0.983353451557362,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
9629,GO:0036497,1,0.995119784570559,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
9630,GO:0036498,1,0.627489380734045,0,67,IRE1-mediated unfolded protein response,BP,
9633,GO:0036501,1,0.995366990826151,0,1,UFD1-NPL4 complex,CC,
9634,GO:0036502,1,0.995366787857488,0,1,Derlin-1-VIMP complex,CC,
9635,GO:0036503,1,0.551898611542809,0,86,ERAD pathway,BP,
9636,GO:0036505,1,0.995366637253323,0,1,prosaposin receptor activity,MF,
9637,GO:0036506,1,0.985036601018768,0,3,maintenance of unfolded protein,BP,
9638,GO:0036507,1,0.854414209658542,0,22,protein demannosylation,BP,
9639,GO:0036508,1,0.854414209658542,0,22,protein alpha-1,2-demannosylation,BP,
9640,GO:0036509,1,0.988595880089529,0,2,trimming of terminal mannose on B branch,BP,
9641,GO:0036510,1,0.984015102046885,0,3,trimming of terminal mannose on C branch,BP,
9642,GO:0036511,1,0.988595880089529,0,2,trimming of first mannose on A branch,BP,
9643,GO:0036512,1,0.988595880089529,0,2,trimming of second mannose on A branch,BP,
9644,GO:0036513,1,0.943203220801131,0,10,Derlin-1 retrotranslocation complex,CC,
9645,GO:0036514,1,0.977045822919231,0,5,dopaminergic neuron axon guidance,BP,
9646,GO:0036515,1,0.981594888339304,0,4,serotonergic neuron axon guidance,BP,
9647,GO:0036517,1,0.995366990826125,0,1,chemoattraction of serotonergic neuron axon,BP,
9648,GO:0036518,1,0.990754840454181,0,2,chemorepulsion of dopaminergic neuron axon,BP,
9649,GO:0036524,1,0.978037514283719,0,1,protein deglycase activity,MF,
9650,GO:0036525,1,0.978037514283719,0,1,protein deglycation,BP,
9651,GO:0036526,1,0.978037514283719,0,1,peptidyl-cysteine deglycation,BP,
9652,GO:0036527,1,0.978037514283719,0,1,peptidyl-arginine deglycation,BP,
9653,GO:0036528,1,0.978037514283719,0,1,peptidyl-lysine deglycation,BP,
9654,GO:0036529,1,0.978037514283719,0,1,protein deglycation, glyoxal removal,BP,
9655,GO:0036530,1,0.978037514283719,0,1,protein deglycation, methylglyoxal removal,BP,
9656,GO:0036531,1,0.978037514283719,0,1,glutathione deglycation,BP,
9657,GO:0038001,1,0.987409390755996,0,2,paracrine signaling,BP,
9658,GO:0038002,1,0.995366990826152,0,1,endocrine signaling,BP,
9659,GO:0038003,1,0.973655398824922,0,4,opioid receptor signaling pathway,BP,
9660,GO:0038007,1,0.986164118478142,0,3,netrin-activated signaling pathway,BP,
9661,GO:0038016,1,0.990387922168808,0,2,insulin receptor internalization,BP,
9662,GO:0038018,1,0.990755199849227,0,2,Wnt receptor catabolic process,BP,
9663,GO:0038021,1,0.995366990826152,0,1,leptin receptor activity,MF,
9665,GO:0038024,1,0.780019118011161,0,42,cargo receptor activity,MF,
9666,GO:0038025,1,0.990755179094921,0,2,reelin receptor activity,MF,
9667,GO:0038026,1,0.986164510364463,0,3,reelin-mediated signaling pathway,BP,
9668,GO:0038027,1,0.979457102780986,0,4,apolipoprotein A-I-mediated signaling pathway,BP,
9669,GO:0038028,1,0.981594133151394,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
9670,GO:0038030,1,0.972485011839303,0,6,non-canonical Wnt signaling pathway via MAPK cascade,BP,
9671,GO:0038031,1,0.977012733487946,0,5,non-canonical Wnt signaling pathway via JNK cascade,BP,
9672,GO:0038033,1,0.963652841346938,0,4,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
9675,GO:0038037,1,0.96838215409786,0,3,G-protein coupled receptor dimeric complex,CC,
9676,GO:0038039,1,0.995366990826152,0,1,G-protein coupled receptor heterodimeric complex,CC,
9677,GO:0038042,1,0.954843181085276,0,4,dimeric G-protein coupled receptor signaling pathway,BP,
9678,GO:0038044,1,0.981393753453939,0,4,transforming growth factor-beta secretion,BP,
9679,GO:0038047,1,0.992783290737664,0,1,morphine receptor activity,MF,
9680,GO:0038049,1,0.990755199848938,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
9681,GO:0038051,1,0.995366990826085,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
9682,GO:0038052,1,0.990619246962023,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
9684,GO:0038062,1,0.995366988898562,0,1,protein tyrosine kinase collagen receptor activity,MF,
9685,GO:0038063,1,0.968011169444662,0,7,collagen-activated tyrosine kinase receptor signaling pathway,BP,
9686,GO:0038064,1,0.990755197930382,0,2,collagen receptor activity,MF,
9687,GO:0038065,1,0.963524685671148,0,8,collagen-activated signaling pathway,BP,
9688,GO:0038066,1,0.836357895191898,0,28,p38MAPK cascade,BP,
9689,GO:0038083,1,0.862403500974256,0,31,peptidyl-tyrosine autophosphorylation,BP,
9690,GO:0038084,1,0.882609017053171,0,18,vascular endothelial growth factor signaling pathway,BP,
9691,GO:0038085,1,0.995259108849138,0,1,vascular endothelial growth factor binding,MF,
9692,GO:0038086,1,0.995366954019034,0,1,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
9693,GO:0038089,1,0.954740284076105,0,6,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
9694,GO:0038091,1,0.995366954019034,0,1,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
9695,GO:0038092,1,0.962381294203735,0,6,nodal signaling pathway,BP,
9696,GO:0038093,1,0.285850040936369,0,154,Fc receptor signaling pathway,BP,
9697,GO:0038094,1,0.711747064781414,0,59,Fc-gamma receptor signaling pathway,BP,
9698,GO:0038095,1,0.376370907361784,0,109,Fc-epsilon receptor signaling pathway,BP,
9699,GO:0038096,1,0.717615556658007,0,58,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
9700,GO:0038098,1,0.993945953317704,0,1,sequestering of BMP from receptor via BMP binding,BP,
9701,GO:0038101,1,0.99150704774668,0,1,sequestering of nodal from receptor via nodal binding,BP,
9702,GO:0038107,1,0.97912703402223,0,3,nodal signaling pathway involved in determination of left/right asymmetry,BP,
9703,GO:0038108,1,0.986042633160382,0,3,negative regulation of appetite by leptin-mediated signaling pathway,BP,
9704,GO:0038109,1,0.995366648998949,0,1,Kit signaling pathway,BP,
9705,GO:0038110,1,0.959523097674056,0,8,interleukin-2-mediated signaling pathway,BP,
9706,GO:0038111,1,0.603686032310768,0,26,interleukin-7-mediated signaling pathway,BP,
9707,GO:0038112,1,0.995255140810226,0,1,interleukin-8-mediated signaling pathway,BP,
9708,GO:0038113,1,0.99075519984928,0,2,interleukin-9-mediated signaling pathway,BP,
9709,GO:0038114,1,0.981594862458488,0,4,interleukin-21-mediated signaling pathway,BP,
9710,GO:0038123,1,0.995366920137051,0,1,toll-like receptor TLR1:TLR2 signaling pathway,BP,
9711,GO:0038124,1,0.990755129483909,0,2,toll-like receptor TLR6:TLR2 signaling pathway,BP,
9712,GO:0038127,1,0.473764159346645,0,125,ERBB signaling pathway,BP,
9713,GO:0038128,1,0.811648341404451,0,31,ERBB2 signaling pathway,BP,
9714,GO:0038129,1,0.990357033168651,0,2,ERBB3 signaling pathway,BP,
9715,GO:0038131,1,0.988561231490355,0,2,neuregulin receptor activity,MF,
9716,GO:0038132,1,0.981594776388792,0,4,neuregulin binding,MF,
9717,GO:0038145,1,0.981899723373917,0,3,macrophage colony-stimulating factor signaling pathway,BP,
9718,GO:0038154,1,0.99536682795566,0,1,interleukin-11-mediated signaling pathway,BP,
9719,GO:0038155,1,0.956133274330992,0,6,interleukin-23-mediated signaling pathway,BP,
9720,GO:0038158,1,0.986053206719409,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
9721,GO:0038161,1,0.995366574475227,0,1,prolactin signaling pathway,BP,
9722,GO:0038162,1,0.992667316171941,0,1,erythropoietin-mediated signaling pathway,BP,
9723,GO:0038163,1,0.979013623049402,0,1,thrombopoietin-mediated signaling pathway,BP,
9724,GO:0038165,1,0.98616435419131,0,3,oncostatin-M-mediated signaling pathway,BP,
9725,GO:0038166,1,0.960656445957015,0,5,angiotensin-activated signaling pathway,BP,
9726,GO:0038171,1,0.985941400661055,0,3,cannabinoid signaling pathway,BP,
9727,GO:0038172,1,0.995366987966522,0,1,interleukin-33-mediated signaling pathway,BP,
9729,GO:0038180,1,0.940713200066421,0,8,nerve growth factor signaling pathway,BP,
9730,GO:0038181,1,0.995366990826165,0,1,bile acid receptor activity,MF,
9731,GO:0038183,1,0.995366990826165,0,1,bile acid signaling pathway,BP,
9732,GO:0038186,1,0.995366990826165,0,1,lithocholic acid receptor activity,MF,
9733,GO:0038187,1,0.953120506014628,0,7,pattern recognition receptor activity,MF,
9734,GO:0038189,1,0.980684640981791,0,4,neuropilin signaling pathway,BP,
9735,GO:0038190,1,0.990647775359712,0,2,VEGF-activated neuropilin signaling pathway,BP,
9736,GO:0038191,1,0.924059593295842,0,17,neuropilin binding,MF,
9737,GO:0038192,1,0.993926676033175,0,1,gastric inhibitory peptide signaling pathway,BP,
9738,GO:0038193,1,0.994878946369531,0,1,thromboxane A2 signaling pathway,BP,
9739,GO:0038194,1,0.995366989784868,0,1,thyroid-stimulating hormone signaling pathway,BP,
9740,GO:0038195,1,0.987668795739317,0,1,urokinase plasminogen activator signaling pathway,BP,
9742,GO:0038202,1,0.824756695346089,0,31,TORC1 signaling,BP,
9743,GO:0038203,1,0.963943374048017,0,7,TORC2 signaling,BP,
9744,GO:0039003,1,0.995366989784868,0,1,pronephric field specification,BP,
9745,GO:0039007,1,0.995366990826138,0,1,pronephric nephron morphogenesis,BP,
9746,GO:0039008,1,0.995366990826138,0,1,pronephric nephron tubule morphogenesis,BP,
9747,GO:0039017,1,0.995366989784868,0,1,pattern specification involved in pronephros development,BP,
9748,GO:0039019,1,0.990755183830694,0,2,pronephric nephron development,BP,
9749,GO:0039020,1,0.995366990826138,0,1,pronephric nephron tubule development,BP,
9750,GO:0039022,1,0.995366990826138,0,1,pronephric duct development,BP,
9751,GO:0039023,1,0.995366990826138,0,1,pronephric duct morphogenesis,BP,
9752,GO:0039502,1,0.995366990826151,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
9753,GO:0039503,1,0.995366990826151,0,1,suppression by virus of host innate immune response,BP,
9754,GO:0039506,1,0.990754205178619,0,2,modulation by virus of host molecular function,BP,
9755,GO:0039507,1,0.990754205178619,0,2,suppression by virus of host molecular function,BP,
9756,GO:0039513,1,0.995365991578734,0,1,suppression by virus of host catalytic activity,BP,
9757,GO:0039514,1,0.995366990826151,0,1,suppression by virus of host JAK-STAT cascade,BP,
9758,GO:0039516,1,0.995365991578734,0,1,modulation by virus of host catalytic activity,BP,
9759,GO:0039519,1,0.99075519984928,0,2,modulation by virus of host autophagy,BP,
9760,GO:0039520,1,0.995366990826138,0,1,induction by virus of host autophagy,BP,
9761,GO:0039521,1,0.995366990826165,0,1,suppression by virus of host autophagy,BP,
9762,GO:0039526,1,0.972238424313704,0,3,modulation by virus of host apoptotic process,BP,
9765,GO:0039530,1,0.940336823713994,0,9,MDA-5 signaling pathway,BP,
9768,GO:0039533,1,0.96024015193119,0,6,regulation of MDA-5 signaling pathway,BP,
9769,GO:0039534,1,0.969203457197124,0,4,negative regulation of MDA-5 signaling pathway,BP,
9772,GO:0039552,1,0.995366990826139,0,1,RIG-I binding,MF,
9773,GO:0039562,1,0.995366990826151,0,1,suppression by virus of host STAT activity,BP,
9774,GO:0039563,1,0.995366990826151,0,1,suppression by virus of host STAT1 activity,BP,
9775,GO:0039564,1,0.995366990826151,0,1,suppression by virus of host STAT2 activity,BP,
9776,GO:0039650,1,0.995365991578734,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
9777,GO:0039656,1,0.987519651705794,0,2,modulation by virus of host gene expression,BP,
9778,GO:0039663,1,0.984943925803592,0,3,membrane fusion involved in viral entry into host cell,BP,
9779,GO:0039689,1,0.985310879484968,0,3,negative stranded viral RNA replication,BP,
9780,GO:0039692,1,0.937356294657744,0,10,single stranded viral RNA replication via double stranded DNA intermediate,BP,
9781,GO:0039694,1,0.873481420336246,0,24,viral RNA genome replication,BP,
9782,GO:0039695,1,0.995366990826165,0,1,DNA-templated viral transcription,BP,
9783,GO:0039702,1,0.847674053135629,0,20,viral budding via host ESCRT complex,BP,
9784,GO:0039706,1,0.964316940139196,0,6,co-receptor binding,MF,
9785,GO:0039713,1,0.995366933567247,0,1,viral factory,CC,
9786,GO:0039714,1,0.995366933567247,0,1,cytoplasmic viral factory,CC,
9787,GO:0040001,1,0.872417372524984,0,22,establishment of mitotic spindle localization,BP,
9790,GO:0040009,1,0.981168314684897,0,4,regulation of growth rate,BP,
9794,GO:0040014,1,0.74543425134454,0,45,regulation of multicellular organism growth,BP,
9795,GO:0040015,1,0.947784112318173,0,9,negative regulation of multicellular organism growth,BP,
9796,GO:0040016,1,0.963589782418067,0,7,embryonic cleavage,BP,
9798,GO:0040018,1,0.886846129284249,0,19,positive regulation of multicellular organism growth,BP,
9800,GO:0040020,1,0.917971375603258,0,16,regulation of meiotic nuclear division,BP,
9802,GO:0040030,1,0.995366987256686,0,1,regulation of molecular function, epigenetic,BP,
9803,GO:0040031,1,0.918685150767281,0,6,snRNA modification,BP,
9804,GO:0040032,1,0.993001353707462,0,1,post-embryonic body morphogenesis,BP,
9805,GO:0040033,1,0.92436675818959,0,12,negative regulation of translation, ncRNA-mediated,BP,
9807,GO:0040036,1,0.887917804490397,0,21,regulation of fibroblast growth factor receptor signaling pathway,BP,
9808,GO:0040037,1,0.94458014118002,0,11,negative regulation of fibroblast growth factor receptor signaling pathway,BP,
9809,GO:0040038,1,0.990755068968956,0,2,polar body extrusion after meiotic divisions,BP,
9810,GO:0042000,1,0.995175560072827,0,1,translocation of peptides or proteins into host,BP,
9811,GO:0042007,1,0.987352806559508,0,1,interleukin-18 binding,MF,
9812,GO:0042008,1,0.995366954780392,0,1,interleukin-18 receptor activity,MF,
9813,GO:0042015,1,0.984785612523561,0,3,interleukin-20 binding,MF,
9814,GO:0042019,1,0.993653808561672,0,1,interleukin-23 binding,MF,
9815,GO:0042020,1,0.993653808561672,0,1,interleukin-23 receptor activity,MF,
9816,GO:0042022,1,0.993653808561672,0,1,interleukin-12 receptor complex,CC,
9817,GO:0042023,1,0.963524116404842,0,8,DNA endoreduplication,BP,
9818,GO:0042025,1,0.98574695900067,0,3,host cell nucleus,CC,
9819,GO:0042026,1,0.849732276831893,0,24,protein refolding,BP,
9820,GO:0042030,1,0.990755199849188,0,2,ATPase inhibitor activity,MF,
9821,GO:0042033,1,0.925986608170931,0,9,chemokine biosynthetic process,BP,
9823,GO:0042036,1,0.893206173751058,0,18,negative regulation of cytokine biosynthetic process,BP,
9824,GO:0042040,1,0.995366990826152,0,1,metal incorporation into metallo-molybdopterin complex,BP,
9825,GO:0042043,1,0.956309771066175,0,9,neurexin family protein binding,MF,
9826,GO:0042044,1,0.921567364310278,0,12,fluid transport,BP,
9827,GO:0042045,1,0.955537536278721,0,5,epithelial fluid transport,BP,
9828,GO:0042048,1,0.977045689226513,0,5,olfactory behavior,BP,
9829,GO:0042053,1,0.929940550295537,0,10,regulation of dopamine metabolic process,BP,
9830,GO:0042054,1,0.733697396846023,0,50,histone methyltransferase activity,MF,
9831,GO:0042056,1,0.862584325873086,0,14,chemoattractant activity,MF,
9832,GO:0042058,1,0.642971165607742,0,69,regulation of epidermal growth factor receptor signaling pathway,BP,
9833,GO:0042059,1,0.762739694512844,0,39,negative regulation of epidermal growth factor receptor signaling pathway,BP,
9834,GO:0042060,1,0.0761164675242292,0,344,wound healing,BP,
9836,GO:0042069,1,0.929940550295537,0,10,regulation of catecholamine metabolic process,BP,
9837,GO:0042073,1,0.680825945144495,0,49,intraciliary transport,BP,
9838,GO:0042074,1,0.972513628688807,0,6,cell migration involved in gastrulation,BP,
9839,GO:0042078,1,0.977268136151108,0,2,germ-line stem cell division,BP,
9840,GO:0042083,1,0.989782138899612,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
9841,GO:0042084,1,0.995366990825916,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
9844,GO:0042090,1,0.97693872548574,0,5,interleukin-12 biosynthetic process,BP,
9845,GO:0042091,1,0.988199532244837,0,2,interleukin-10 biosynthetic process,BP,
9846,GO:0042092,1,0.84843522000319,0,23,type 2 immune response,BP,
9848,GO:0042094,1,0.924897486584918,0,11,interleukin-2 biosynthetic process,BP,
9849,GO:0042095,1,0.954694718704451,0,7,interferon-gamma biosynthetic process,BP,
9850,GO:0042097,1,0.990751647398477,0,2,interleukin-4 biosynthetic process,BP,
9852,GO:0042100,1,0.707241884449574,0,45,B cell proliferation,BP,
9853,GO:0042101,1,0.957381897596076,0,7,T cell receptor complex,CC,
9855,GO:0042104,1,0.841352586377927,0,17,positive regulation of activated T cell proliferation,BP,
9856,GO:0042105,1,0.99484455799053,0,1,alpha-beta T cell receptor complex,CC,
9859,GO:0042109,1,0.990751557578275,0,2,lymphotoxin A biosynthetic process,BP,
9861,GO:0042113,1,0.38583383328958,0,145,B cell activation,BP,
9862,GO:0042116,1,0.771110338937806,0,38,macrophage activation,BP,
9863,GO:0042117,1,0.976217819973493,0,5,monocyte activation,BP,
9866,GO:0042126,1,0.981179438426615,0,4,nitrate metabolic process,BP,
9868,GO:0042128,1,0.99503262177923,0,1,nitrate assimilation,BP,
9871,GO:0042133,1,0.593087014210932,0,81,neurotransmitter metabolic process,BP,
9872,GO:0042134,1,0.974318849292781,0,2,rRNA primary transcript binding,MF,
9873,GO:0042135,1,0.920773037435057,0,12,neurotransmitter catabolic process,BP,
9874,GO:0042136,1,0.687406427514317,0,57,neurotransmitter biosynthetic process,BP,
9875,GO:0042137,1,0.993096284110959,0,1,sequestering of neurotransmitter,BP,
9876,GO:0042138,1,0.995034706323137,0,1,meiotic DNA double-strand break formation,BP,
9877,GO:0042140,1,0.995366574475227,0,1,late meiotic recombination nodule assembly,BP,
9878,GO:0042144,1,0.990683021727618,0,2,vacuole fusion, non-autophagic,BP,
9879,GO:0042147,1,0.644489533803082,0,68,retrograde transport, endosome to Golgi,BP,
9880,GO:0042148,1,0.945794097573394,0,8,strand invasion,BP,
9881,GO:0042149,1,0.822454000560943,0,36,cellular response to glucose starvation,BP,
9884,GO:0042159,1,0.92374563170306,0,12,lipoprotein catabolic process,BP,
9885,GO:0042162,1,0.832972170328811,0,35,telomeric DNA binding,MF,
9886,GO:0042165,1,0.901619653879766,0,18,neurotransmitter binding,MF,
9887,GO:0042166,1,0.975889449502969,0,5,acetylcholine binding,MF,
9888,GO:0042167,1,0.930520355595146,0,6,heme catabolic process,BP,
9889,GO:0042168,1,0.794583764609087,0,25,heme metabolic process,BP,
9890,GO:0042169,1,0.887298583583784,0,25,SH2 domain binding,MF,
9891,GO:0042171,1,0.899257391008568,0,20,lysophosphatidic acid acyltransferase activity,MF,
9894,GO:0042177,1,0.442439127181418,0,97,negative regulation of protein catabolic process,BP,
9895,GO:0042178,1,0.902142037303168,0,10,xenobiotic catabolic process,BP,
9897,GO:0042181,1,0.826551990598683,0,25,ketone biosynthetic process,BP,
9898,GO:0042182,1,0.957969008081587,0,5,ketone catabolic process,BP,
9899,GO:0042214,1,0.993103767077917,0,1,terpene metabolic process,BP,
9900,GO:0042219,1,0.886700492433012,0,17,cellular modified amino acid catabolic process,BP,
9901,GO:0042220,1,0.856761853131159,0,26,response to cocaine,BP,
9903,GO:0042222,1,0.971427295038322,0,2,interleukin-1 biosynthetic process,BP,
9904,GO:0042223,1,0.995366990826164,0,1,interleukin-3 biosynthetic process,BP,
9905,GO:0042226,1,0.942189621173064,0,10,interleukin-6 biosynthetic process,BP,
9906,GO:0042228,1,0.960814828976004,0,7,interleukin-8 biosynthetic process,BP,
9907,GO:0042231,1,0.982472661537522,0,1,interleukin-13 biosynthetic process,BP,
9908,GO:0042241,1,0.995366851515136,0,1,interleukin-18 biosynthetic process,BP,
9909,GO:0042245,1,0.990719139278934,0,2,RNA repair,BP,
9910,GO:0042246,1,0.824650824229457,0,30,tissue regeneration,BP,
9911,GO:0042247,1,0.995366624735375,0,1,establishment of planar polarity of follicular epithelium,BP,
9912,GO:0042249,1,0.935371691207609,0,14,establishment of planar polarity of embryonic epithelium,BP,
9913,GO:0042253,1,0.977919933652126,0,2,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
9916,GO:0042256,1,0.945977753182075,0,5,mature ribosome assembly,BP,
9917,GO:0042262,1,0.923823010063783,0,5,DNA protection,BP,
9918,GO:0042264,1,0.990755182607526,0,2,peptidyl-aspartic acid hydroxylation,BP,
9919,GO:0042265,1,0.995366990826073,0,1,peptidyl-asparagine hydroxylation,BP,
9920,GO:0042267,1,0.745081675426189,0,34,natural killer cell mediated cytotoxicity,BP,
9921,GO:0042268,1,0.919689956748031,0,6,regulation of cytolysis,BP,
9922,GO:0042269,1,0.892721239380759,0,16,regulation of natural killer cell mediated cytotoxicity,BP,
9923,GO:0042270,1,0.977885532546115,0,3,protection from natural killer cell mediated cytotoxicity,BP,
9924,GO:0042271,1,0.990755199849254,0,2,susceptibility to natural killer cell mediated cytotoxicity,BP,
9925,GO:0042272,1,0.990755199849032,0,2,nuclear RNA export factor complex,CC,
9928,GO:0042275,1,0.988898703119942,0,1,error-free postreplication DNA repair,BP,
9929,GO:0042276,1,0.835531003310673,0,19,error-prone translesion synthesis,BP,
9930,GO:0042277,1,0.288267842518867,0,172,peptide binding,MF,
9932,GO:0042281,1,0.986751659728374,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
9933,GO:0042282,1,0.995366990826164,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
9934,GO:0042284,1,0.992684091688488,0,1,sphingolipid delta-4 desaturase activity,MF,
9935,GO:0042285,1,0.966514001703056,0,6,xylosyltransferase activity,MF,
9936,GO:0042287,1,0.903229119425861,0,16,MHC protein binding,MF,
9937,GO:0042288,1,0.948622177289887,0,9,MHC class I protein binding,MF,
9938,GO:0042289,1,0.975401587325946,0,2,MHC class II protein binding,MF,
9939,GO:0042292,1,0.995225769074058,0,1,URM1 activating enzyme activity,MF,
9940,GO:0042296,1,0.960094522880647,0,4,ISG15 transferase activity,MF,
9941,GO:0042297,1,0.9815948732312,0,4,vocal learning,BP,
9942,GO:0042301,1,0.971012833511036,0,6,phosphate ion binding,MF,
9944,GO:0042304,1,0.822041477250763,0,28,regulation of fatty acid biosynthetic process,BP,
9945,GO:0042306,1,0.763762518576961,0,42,regulation of protein import into nucleus,BP,
9946,GO:0042307,1,0.856883396115243,0,27,positive regulation of protein import into nucleus,BP,
9947,GO:0042308,1,0.957654607643343,0,7,negative regulation of protein import into nucleus,BP,
9948,GO:0042310,1,0.807217614811099,0,38,vasoconstriction,BP,
9950,GO:0042313,1,0.994254882565581,0,1,protein kinase C deactivation,BP,
9951,GO:0042316,1,0.995366990826164,0,1,penicillin metabolic process,BP,
9952,GO:0042320,1,0.995366990826125,0,1,regulation of circadian sleep/wake cycle, REM sleep,BP,
9953,GO:0042321,1,0.989140067213088,0,1,negative regulation of circadian sleep/wake cycle, sleep,BP,
9954,GO:0042323,1,0.989140067213088,0,1,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
9958,GO:0042328,1,0.986164442712667,0,3,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
9960,GO:0042335,1,0.985515864839241,0,3,cuticle development,BP,
9961,GO:0042339,1,0.861522124286018,0,27,keratan sulfate metabolic process,BP,
9962,GO:0042340,1,0.965277696109924,0,7,keratan sulfate catabolic process,BP,
9963,GO:0042350,1,0.972971983743807,0,3,GDP-L-fucose biosynthetic process,BP,
9964,GO:0042351,1,0.977501942272738,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
9965,GO:0042352,1,0.995366990542223,0,1,GDP-L-fucose salvage,BP,
9966,GO:0042354,1,0.97251768800849,0,6,L-fucose metabolic process,BP,
9967,GO:0042355,1,0.97251768800849,0,6,L-fucose catabolic process,BP,
9968,GO:0042356,1,0.986452775796898,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
9969,GO:0042357,1,0.992168818789806,0,1,thiamine diphosphate metabolic process,BP,
9971,GO:0042360,1,0.990933464906061,0,1,vitamin E metabolic process,BP,
9972,GO:0042361,1,0.99536682468685,0,1,menaquinone catabolic process,BP,
9974,GO:0042363,1,0.981493838209186,0,4,fat-soluble vitamin catabolic process,BP,
9975,GO:0042364,1,0.955624095959805,0,8,water-soluble vitamin biosynthetic process,BP,
9976,GO:0042365,1,0.966300276776356,0,3,water-soluble vitamin catabolic process,BP,
9978,GO:0042369,1,0.990653382547387,0,2,vitamin D catabolic process,BP,
9979,GO:0042371,1,0.995366975722356,0,1,vitamin K biosynthetic process,BP,
9980,GO:0042373,1,0.937148347182839,0,5,vitamin K metabolic process,BP,
9981,GO:0042374,1,0.977168119506396,0,2,phylloquinone metabolic process,BP,
9982,GO:0042376,1,0.977168119506396,0,2,phylloquinone catabolic process,BP,
9983,GO:0042377,1,0.99536682468685,0,1,vitamin K catabolic process,BP,
9984,GO:0042379,1,0.730938603352583,0,22,chemokine receptor binding,MF,
9985,GO:0042382,1,0.96993227124733,0,6,paraspeckles,CC,
9986,GO:0042383,1,0.630630441562024,0,77,sarcolemma,CC,
9988,GO:0042392,1,0.965390926848031,0,5,sphingosine-1-phosphate phosphatase activity,MF,
9990,GO:0042398,1,0.75277813552996,0,33,cellular modified amino acid biosynthetic process,BP,
9991,GO:0042401,1,0.894435571882698,0,13,cellular biogenic amine biosynthetic process,BP,
9992,GO:0042402,1,0.879663391156748,0,11,cellular biogenic amine catabolic process,BP,
9993,GO:0042403,1,0.95227175345188,0,10,thyroid hormone metabolic process,BP,
9994,GO:0042405,1,0.940697148452291,0,12,nuclear inclusion body,CC,
9995,GO:0042406,1,0.975766651741728,0,4,extrinsic component of endoplasmic reticulum membrane,CC,
9996,GO:0042407,1,0.867066962201744,0,15,cristae formation,BP,
9997,GO:0042412,1,0.995362644056522,0,1,taurine biosynthetic process,BP,
9998,GO:0042414,1,0.988502342268218,0,2,epinephrine metabolic process,BP,
9999,GO:0042415,1,0.957780282573651,0,7,norepinephrine metabolic process,BP,
10000,GO:0042416,1,0.942759630257335,0,8,dopamine biosynthetic process,BP,
10001,GO:0042417,1,0.886226973697929,0,18,dopamine metabolic process,BP,
10002,GO:0042418,1,0.993103767077917,0,1,epinephrine biosynthetic process,BP,
10003,GO:0042420,1,0.974529881049148,0,4,dopamine catabolic process,BP,
10004,GO:0042421,1,0.983921476600208,0,3,norepinephrine biosynthetic process,BP,
10005,GO:0042423,1,0.934037624309531,0,10,catecholamine biosynthetic process,BP,
10006,GO:0042424,1,0.970013280511435,0,5,catecholamine catabolic process,BP,
10007,GO:0042426,1,0.990755171900691,0,2,choline catabolic process,BP,
10008,GO:0042428,1,0.981093194590233,0,4,serotonin metabolic process,BP,
10009,GO:0042430,1,0.948940065368128,0,8,indole-containing compound metabolic process,BP,
10010,GO:0042436,1,0.975702689598349,0,3,indole-containing compound catabolic process,BP,
10011,GO:0042438,1,0.940259385303388,0,8,melanin biosynthetic process,BP,
10012,GO:0042439,1,0.969283915718837,0,6,ethanolamine-containing compound metabolic process,BP,
10013,GO:0042440,1,0.669277574072714,0,48,pigment metabolic process,BP,
10014,GO:0042441,1,0.995366990826165,0,1,eye pigment metabolic process,BP,
10015,GO:0042445,1,0.427825661160591,0,117,hormone metabolic process,BP,
10016,GO:0042446,1,0.706755912058696,0,45,hormone biosynthetic process,BP,
10017,GO:0042447,1,0.960838848585397,0,6,hormone catabolic process,BP,
10018,GO:0042448,1,0.940906305475074,0,8,progesterone metabolic process,BP,
10019,GO:0042450,1,0.99369385881112,0,1,arginine biosynthetic process via ornithine,BP,
10021,GO:0042454,1,0.879531131724778,0,14,ribonucleoside catabolic process,BP,
10023,GO:0042461,1,0.899969391658297,0,18,photoreceptor cell development,BP,
10024,GO:0042462,1,0.940954290319446,0,12,eye photoreceptor cell development,BP,
10025,GO:0042470,1,0.517334056808349,0,92,melanosome,CC,
10028,GO:0042473,1,0.961059799890571,0,6,outer ear morphogenesis,BP,
10029,GO:0042474,1,0.906484353876549,0,11,middle ear morphogenesis,BP,
10032,GO:0042481,1,0.944894235067426,0,11,regulation of odontogenesis,BP,
10033,GO:0042482,1,0.975101834113574,0,5,positive regulation of odontogenesis,BP,
10034,GO:0042483,1,0.995366990826099,0,1,negative regulation of odontogenesis,BP,
10035,GO:0042487,1,0.973372885271985,0,5,regulation of odontogenesis of dentin-containing tooth,BP,
10036,GO:0042488,1,0.995194333493049,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,
10039,GO:0042492,1,0.971252354044829,0,5,gamma-delta T cell differentiation,BP,
10041,GO:0042494,1,0.990755129483909,0,2,detection of bacterial lipoprotein,BP,
10042,GO:0042495,1,0.995366920137051,0,1,detection of triacyl bacterial lipopeptide,BP,
10043,GO:0042496,1,0.990755129483909,0,2,detection of diacyl bacterial lipopeptide,BP,
10044,GO:0042497,1,0.995366920137051,0,1,triacyl lipopeptide binding,MF,
10045,GO:0042500,1,0.967310513709341,0,6,aspartic endopeptidase activity, intramembrane cleaving,MF,
10046,GO:0042501,1,0.917819030326753,0,10,serine phosphorylation of STAT protein,BP,
10049,GO:0042532,1,0.934935933795473,0,11,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10053,GO:0042536,1,0.978660707579014,0,3,negative regulation of tumor necrosis factor biosynthetic process,BP,
10054,GO:0042537,1,0.89662183693252,0,13,benzene-containing compound metabolic process,BP,
10055,GO:0042538,1,0.968027662614841,0,5,hyperosmotic salinity response,BP,
10056,GO:0042539,1,0.990755013385272,0,2,hypotonic salinity response,BP,
10057,GO:0042541,1,0.963344135128542,0,6,hemoglobin biosynthetic process,BP,
10059,GO:0042543,1,0.96897816042569,0,1,protein N-linked glycosylation via arginine,BP,
10060,GO:0042546,1,0.991967176450215,0,1,cell wall biogenesis,BP,
10061,GO:0042551,1,0.869581460432726,0,25,neuron maturation,BP,
10063,GO:0042554,1,0.872844406217638,0,15,superoxide anion generation,BP,
10064,GO:0042555,1,0.950015053009329,0,11,MCM complex,CC,
10065,GO:0042558,1,0.796969052936072,0,28,pteridine-containing compound metabolic process,BP,
10066,GO:0042559,1,0.862767358646881,0,14,pteridine-containing compound biosynthetic process,BP,
10067,GO:0042560,1,0.967874785524035,0,3,pteridine-containing compound catabolic process,BP,
10068,GO:0042562,1,0.727096936078652,0,44,hormone binding,MF,
10069,GO:0042564,1,0.995366990826152,0,1,NLS-dependent protein nuclear import complex,CC,
10070,GO:0042565,1,0.976420634040698,0,2,RNA nuclear export complex,CC,
10071,GO:0042567,1,0.990731401144273,0,2,insulin-like growth factor ternary complex,CC,
10072,GO:0042568,1,0.978733636819718,0,1,insulin-like growth factor binary complex,CC,
10073,GO:0042572,1,0.897917652897548,0,18,retinol metabolic process,BP,
10074,GO:0042573,1,0.914826443628027,0,11,retinoic acid metabolic process,BP,
10075,GO:0042574,1,0.955137384062867,0,8,retinal metabolic process,BP,
10076,GO:0042575,1,0.84673929919251,0,16,DNA polymerase complex,CC,
10077,GO:0042577,1,0.967354479079164,0,7,lipid phosphatase activity,MF,
10079,GO:0042579,1,0.444974700514371,0,104,microbody,CC,
10081,GO:0042582,1,0.395288126508752,0,122,azurophil granule,CC,
10082,GO:0042583,1,0.974711158363389,0,5,chromaffin granule,CC,
10083,GO:0042584,1,0.979249586228691,0,4,chromaffin granule membrane,CC,
10084,GO:0042585,1,0.990174093236749,0,2,germinal vesicle,CC,
10085,GO:0042586,1,0.982649015560594,0,1,peptide deformylase activity,MF,
10087,GO:0042588,1,0.943574420405533,0,9,zymogen granule,CC,
10088,GO:0042589,1,0.954762974304484,0,7,zymogen granule membrane,CC,
10089,GO:0042590,1,0.431919976670791,0,68,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,
10093,GO:0042595,1,0.99536698911949,0,1,behavioral response to starvation,BP,
10094,GO:0042596,1,0.870027841837147,0,18,fear response,BP,
10095,GO:0042599,1,0.900907001193695,0,12,lamellar body,CC,
10096,GO:0042602,1,0.976324149726277,0,1,riboflavin reductase (NADPH) activity,MF,
10097,GO:0042605,1,0.888199370861114,0,14,peptide antigen binding,MF,
10098,GO:0042608,1,0.980390857158488,0,3,T cell receptor binding,MF,
10099,GO:0042609,1,0.961771918921373,0,5,CD4 receptor binding,MF,
10100,GO:0042610,1,0.994156659832839,0,1,CD8 receptor binding,MF,
10101,GO:0042611,1,0.856202980025873,0,12,MHC protein complex,CC,
10102,GO:0042612,1,0.894945960663808,0,9,MHC class I protein complex,CC,
10103,GO:0042613,1,0.956762958938545,0,3,MHC class II protein complex,CC,
10104,GO:0042622,1,0.969492567106583,0,6,photoreceptor outer segment membrane,CC,
10106,GO:0042624,1,0.972420652557464,0,1,ATPase activity, uncoupled,MF,
10107,GO:0042625,1,0.751712371212262,0,35,ATPase coupled ion transmembrane transporter activity,MF,
10109,GO:0042627,1,0.945494473495795,0,3,chylomicron,CC,
10110,GO:0042628,1,0.994857117983983,0,1,mating plug formation,BP,
10111,GO:0042629,1,0.913859141700169,0,10,mast cell granule,CC,
10112,GO:0042631,1,0.995366964973394,0,1,cellular response to water deprivation,BP,
10113,GO:0042632,1,0.78263503499675,0,36,cholesterol homeostasis,BP,
10115,GO:0042634,1,0.851214856207699,0,23,regulation of hair cycle,BP,
10116,GO:0042635,1,0.900097548369134,0,11,positive regulation of hair cycle,BP,
10117,GO:0042636,1,0.981594823658176,0,4,negative regulation of hair cycle,BP,
10118,GO:0042637,1,0.960387857455759,0,4,catagen,BP,
10119,GO:0042640,1,0.981594814986969,0,4,anagen,BP,
10120,GO:0042641,1,0.732250826337263,0,54,actomyosin,CC,
10121,GO:0042643,1,0.995366624735375,0,1,actomyosin, actin portion,CC,
10122,GO:0042645,1,0.762426481395179,0,40,mitochondrial nucleoid,CC,
10123,GO:0042658,1,0.985578879664716,0,1,MHC class II protein binding, via antigen binding groove,MF,
10124,GO:0042659,1,0.96494196079326,0,7,regulation of cell fate specification,BP,
10125,GO:0042660,1,0.995366990826074,0,1,positive regulation of cell fate specification,BP,
10126,GO:0042661,1,0.983069562318622,0,3,regulation of mesodermal cell fate specification,BP,
10127,GO:0042662,1,0.992243492218644,0,1,negative regulation of mesodermal cell fate specification,BP,
10128,GO:0042663,1,0.987614732171371,0,2,regulation of endodermal cell fate specification,BP,
10129,GO:0042665,1,0.995366989216536,0,1,regulation of ectodermal cell fate specification,BP,
10130,GO:0042666,1,0.995366989216536,0,1,negative regulation of ectodermal cell fate specification,BP,
10132,GO:0042670,1,0.985944089747538,0,3,retinal cone cell differentiation,BP,
10134,GO:0042693,1,0.963107957994644,0,6,muscle cell fate commitment,BP,
10135,GO:0042695,1,0.957829866382157,0,5,thelarche,BP,
10136,GO:0042698,1,0.795105100816197,0,39,ovulation cycle,BP,
10137,GO:0042699,1,0.987808319659065,0,2,follicle-stimulating hormone signaling pathway,BP,
10138,GO:0042700,1,0.995366990826165,0,1,luteinizing hormone signaling pathway,BP,
10139,GO:0042701,1,0.989955145161066,0,2,progesterone secretion,BP,
10140,GO:0042704,1,0.990755030569718,0,2,uterine wall breakdown,BP,
10141,GO:0042709,1,0.995076500585975,0,1,succinate-CoA ligase complex,CC,
10142,GO:0042711,1,0.969926724079898,0,6,maternal behavior,BP,
10143,GO:0042713,1,0.986164531023753,0,3,sperm ejaculation,BP,
10144,GO:0042719,1,0.923035902632308,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10145,GO:0042720,1,0.964136734695051,0,2,mitochondrial inner membrane peptidase complex,CC,
10146,GO:0042721,1,0.9361936908086,0,5,mitochondrial inner membrane protein insertion complex,CC,
10147,GO:0042723,1,0.978222095597199,0,3,thiamine-containing compound metabolic process,BP,
10148,GO:0042726,1,0.960791443453666,0,7,flavin-containing compound metabolic process,BP,
10149,GO:0042727,1,0.988957530759246,0,2,flavin-containing compound biosynthetic process,BP,
10150,GO:0042728,1,0.995366989784868,0,1,flavin-containing compound catabolic process,BP,
10151,GO:0042730,1,0.912883084001862,0,15,fibrinolysis,BP,
10152,GO:0042731,1,0.968895924733265,0,4,PH domain binding,MF,
10153,GO:0042732,1,0.97123492896487,0,2,D-xylose metabolic process,BP,
10154,GO:0042733,1,0.753970103908612,0,47,embryonic digit morphogenesis,BP,
10155,GO:0042734,1,0.827960414549716,0,39,presynaptic membrane,CC,
10156,GO:0042737,1,0.553012167541411,0,73,drug catabolic process,BP,
10157,GO:0042738,1,0.949279707365074,0,9,exogenous drug catabolic process,BP,
10159,GO:0042743,1,0.743864365247889,0,28,hydrogen peroxide metabolic process,BP,
10160,GO:0042744,1,0.870761132889036,0,12,hydrogen peroxide catabolic process,BP,
10161,GO:0042745,1,0.883955731523825,0,11,circadian sleep/wake cycle,BP,
10162,GO:0042747,1,0.960435941592769,0,4,circadian sleep/wake cycle, REM sleep,BP,
10163,GO:0042748,1,0.979994521529508,0,3,circadian sleep/wake cycle, non-REM sleep,BP,
10164,GO:0042749,1,0.931521789916191,0,5,regulation of circadian sleep/wake cycle,BP,
10166,GO:0042753,1,0.970558654439851,0,6,positive regulation of circadian rhythm,BP,
10167,GO:0042754,1,0.953053067307755,0,9,negative regulation of circadian rhythm,BP,
10168,GO:0042755,1,0.887709178273987,0,14,eating behavior,BP,
10169,GO:0042756,1,0.97364168247286,0,3,drinking behavior,BP,
10170,GO:0042758,1,0.973130118858288,0,4,long-chain fatty acid catabolic process,BP,
10171,GO:0042759,1,0.929313038241255,0,9,long-chain fatty acid biosynthetic process,BP,
10172,GO:0042760,1,0.976129570376748,0,5,very long-chain fatty acid catabolic process,BP,
10173,GO:0042761,1,0.93605897089619,0,10,very long-chain fatty acid biosynthetic process,BP,
10174,GO:0042762,1,0.925897488600046,0,15,regulation of sulfur metabolic process,BP,
10175,GO:0042765,1,0.972508262761642,0,5,GPI-anchor transamidase complex,CC,
10176,GO:0042766,1,0.995366990826007,0,1,nucleosome mobilization,BP,
10177,GO:0042769,1,0.6981907591867,0,37,DNA damage response, detection of DNA damage,BP,
10180,GO:0042772,1,0.842680370506801,0,19,DNA damage response, signal transduction resulting in transcription,BP,
10182,GO:0042774,1,0.995366574475227,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10184,GO:0042776,1,0.925577449058707,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
10185,GO:0042779,1,0.990158878406517,0,2,tRNA 3'-trailer cleavage,BP,
10186,GO:0042780,1,0.945883077644137,0,7,tRNA 3'-end processing,BP,
10187,GO:0042781,1,0.990158878406517,0,2,3'-tRNA processing endoribonuclease activity,MF,
10190,GO:0042790,1,0.928184805201298,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10191,GO:0042791,1,0.955764882199977,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10192,GO:0042795,1,0.572689265259763,0,67,snRNA transcription by RNA polymerase II,BP,
10193,GO:0042796,1,0.967341772398744,0,6,snRNA transcription by RNA polymerase III,BP,
10194,GO:0042797,1,0.955764882199977,0,6,tRNA transcription by RNA polymerase III,BP,
10195,GO:0042799,1,0.981593656766141,0,4,histone methyltransferase activity (H4-K20 specific),MF,
10196,GO:0042800,1,0.888213423234032,0,16,histone methyltransferase activity (H3-K4 specific),MF,
10199,GO:0042805,1,0.929624003086361,0,15,actinin binding,MF,
10200,GO:0042806,1,0.995366574475227,0,1,fucose binding,MF,
10201,GO:0042809,1,0.908722917969781,0,15,vitamin D receptor binding,MF,
10202,GO:0042813,1,0.926720930690429,0,16,Wnt-activated receptor activity,MF,
10203,GO:0042816,1,0.974468411473311,0,5,vitamin B6 metabolic process,BP,
10204,GO:0042819,1,0.985165297376668,0,3,vitamin B6 biosynthetic process,BP,
10205,GO:0042820,1,0.993748276642859,0,1,vitamin B6 catabolic process,BP,
10206,GO:0042822,1,0.98456056196054,0,3,pyridoxal phosphate metabolic process,BP,
10207,GO:0042823,1,0.990755149996257,0,2,pyridoxal phosphate biosynthetic process,BP,
10208,GO:0042824,1,0.979427937387771,0,4,MHC class I peptide loading complex,CC,
10209,GO:0042825,1,0.986164144420573,0,3,TAP complex,CC,
10211,GO:0042827,1,0.920255306151541,0,11,platelet dense granule,CC,
10212,GO:0042832,1,0.926832021141248,0,9,defense response to protozoan,BP,
10213,GO:0042834,1,0.946710596066669,0,7,peptidoglycan binding,MF,
10214,GO:0042835,1,0.995366990826165,0,1,BRE binding,MF,
10215,GO:0042839,1,0.988214398421963,0,1,D-glucuronate metabolic process,BP,
10216,GO:0042840,1,0.988214398421963,0,1,D-glucuronate catabolic process,BP,
10217,GO:0042851,1,0.995366990515785,0,1,L-alanine metabolic process,BP,
10218,GO:0042853,1,0.995366990515785,0,1,L-alanine catabolic process,BP,
10221,GO:0042887,1,0.766165338884553,0,29,amide transmembrane transporter activity,MF,
10222,GO:0042891,1,0.960283313371424,0,7,antibiotic transport,BP,
10223,GO:0042895,1,0.964754876243615,0,6,antibiotic transmembrane transporter activity,MF,
10224,GO:0042903,1,0.988793863189942,0,2,tubulin deacetylase activity,MF,
10225,GO:0042904,1,0.99072872487081,0,2,9-cis-retinoic acid biosynthetic process,BP,
10226,GO:0042905,1,0.99072872487081,0,2,9-cis-retinoic acid metabolic process,BP,
10229,GO:0042921,1,0.928017030219749,0,14,glucocorticoid receptor signaling pathway,BP,
10230,GO:0042922,1,0.975368272283632,0,1,neuromedin U receptor binding,MF,
10231,GO:0042923,1,0.98779904079453,0,2,neuropeptide binding,MF,
10232,GO:0042937,1,0.995366990826099,0,1,tripeptide transmembrane transporter activity,MF,
10233,GO:0042938,1,0.986218899932089,0,2,dipeptide transport,BP,
10234,GO:0042939,1,0.989155775695929,0,2,tripeptide transport,BP,
10235,GO:0042940,1,0.986126726075246,0,3,D-amino acid transport,BP,
10236,GO:0042942,1,0.99532885167189,0,1,D-serine transport,BP,
10237,GO:0042946,1,0.995366574475227,0,1,glucoside transport,BP,
10238,GO:0042947,1,0.995366574475227,0,1,glucoside transmembrane transporter activity,MF,
10239,GO:0042953,1,0.963572027992488,0,6,lipoprotein transport,BP,
10240,GO:0042954,1,0.977023249751067,0,5,lipoprotein transporter activity,MF,
10241,GO:0042974,1,0.903647344517827,0,20,retinoic acid receptor binding,MF,
10242,GO:0042975,1,0.953120800579705,0,9,peroxisome proliferator activated receptor binding,MF,
10243,GO:0042976,1,0.931477568264455,0,7,activation of Janus kinase activity,BP,
10244,GO:0042978,1,0.990754785405313,0,2,ornithine decarboxylase activator activity,MF,
10245,GO:0042979,1,0.966725512340532,0,4,ornithine decarboxylase regulator activity,MF,
10247,GO:0042982,1,0.762762792713784,0,42,amyloid precursor protein metabolic process,BP,
10248,GO:0042983,1,0.947369322937315,0,9,amyloid precursor protein biosynthetic process,BP,
10249,GO:0042984,1,0.947369322937315,0,9,regulation of amyloid precursor protein biosynthetic process,BP,
10250,GO:0042985,1,0.964159032759038,0,6,negative regulation of amyloid precursor protein biosynthetic process,BP,
10251,GO:0042986,1,0.988820809798336,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
10252,GO:0042987,1,0.816570917963638,0,30,amyloid precursor protein catabolic process,BP,
10253,GO:0042988,1,0.995366990826151,0,1,X11-like protein binding,MF,
10257,GO:0042996,1,0.976904178966458,0,5,regulation of Golgi to plasma membrane protein transport,BP,
10258,GO:0042997,1,0.986021222911647,0,3,negative regulation of Golgi to plasma membrane protein transport,BP,
10259,GO:0042998,1,0.990755199197377,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
10260,GO:0042999,1,0.995366990826165,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10261,GO:0043000,1,0.983193172251034,0,2,Golgi to plasma membrane CFTR protein transport,BP,
10262,GO:0043001,1,0.851142092814608,0,29,Golgi to plasma membrane protein transport,BP,
10263,GO:0043002,1,0.995366990826165,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10264,GO:0043004,1,0.995366990826165,0,1,cytoplasmic sequestering of CFTR protein,BP,
10266,GO:0043006,1,0.995318255982901,0,1,activation of phospholipase A2 activity by calcium-mediated signaling,BP,
10267,GO:0043008,1,0.962303760173651,0,8,ATP-dependent protein binding,MF,
10270,GO:0043011,1,0.935569206125524,0,9,myeloid dendritic cell differentiation,BP,
10272,GO:0043015,1,0.854003024991611,0,25,gamma-tubulin binding,MF,
10273,GO:0043016,1,0.995363558172447,0,1,regulation of lymphotoxin A biosynthetic process,BP,
10274,GO:0043017,1,0.995363558172447,0,1,positive regulation of lymphotoxin A biosynthetic process,BP,
10275,GO:0043020,1,0.950701102433695,0,3,NADPH oxidase complex,CC,
10276,GO:0043021,1,0.436107856150238,0,110,ribonucleoprotein complex binding,MF,
10277,GO:0043022,1,0.689662627029385,0,47,ribosome binding,MF,
10278,GO:0043023,1,0.903450701179107,0,11,ribosomal large subunit binding,MF,
10279,GO:0043024,1,0.894812299471213,0,14,ribosomal small subunit binding,MF,
10281,GO:0043027,1,0.888743786761284,0,17,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,
10282,GO:0043028,1,0.773690417677425,0,32,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,
10284,GO:0043030,1,0.844578116304975,0,23,regulation of macrophage activation,BP,
10285,GO:0043031,1,0.975543358673948,0,4,negative regulation of macrophage activation,BP,
10286,GO:0043032,1,0.931964307548806,0,11,positive regulation of macrophage activation,BP,
10287,GO:0043033,1,0.995366990826059,0,1,isoamylase complex,CC,
10288,GO:0043034,1,0.911552433295184,0,17,costamere,CC,
10289,GO:0043035,1,0.995366987256686,0,1,chromatin insulator sequence binding,MF,
10290,GO:0043038,1,0.692879297737454,0,53,amino acid activation,BP,
10291,GO:0043039,1,0.696117891684173,0,52,tRNA aminoacylation,BP,
10292,GO:0043041,1,0.995366963653428,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
10295,GO:0043045,1,0.969006571504619,0,6,DNA methylation involved in embryo development,BP,
10296,GO:0043046,1,0.966765485924836,0,7,DNA methylation involved in gamete generation,BP,
10297,GO:0043047,1,0.942892377108867,0,11,single-stranded telomeric DNA binding,MF,
10298,GO:0043048,1,0.994663759095586,0,1,dolichyl monophosphate biosynthetic process,BP,
10299,GO:0043060,1,0.99524265188522,0,1,meiotic metaphase I plate congression,BP,
10300,GO:0043062,1,0.244032981023501,0,242,extracellular structure organization,BP,
10306,GO:0043073,1,0.923831099533956,0,12,germ cell nucleus,CC,
10307,GO:0043083,1,0.981594804409639,0,4,synaptic cleft,CC,
10308,GO:0043084,1,0.975452922015183,0,4,penile erection,BP,
10312,GO:0043090,1,0.940834545383208,0,12,amino acid import,BP,
10313,GO:0043094,1,0.758410075152408,0,32,cellular metabolic compound salvage,BP,
10314,GO:0043095,1,0.972966983226676,0,1,regulation of GTP cyclohydrolase I activity,BP,
10315,GO:0043096,1,0.939996927618916,0,5,purine nucleobase salvage,BP,
10316,GO:0043097,1,0.908136408029299,0,11,pyrimidine nucleoside salvage,BP,
10317,GO:0043101,1,0.887855736027697,0,13,purine-containing compound salvage,BP,
10318,GO:0043102,1,0.954608748735379,0,6,amino acid salvage,BP,
10319,GO:0043103,1,0.97202799975835,0,3,hypoxanthine salvage,BP,
10320,GO:0043105,1,0.972966983226676,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
10321,GO:0043111,1,0.98048329479015,0,2,replication fork arrest,BP,
10323,GO:0043113,1,0.828670924475138,0,29,receptor clustering,BP,
10324,GO:0043114,1,0.916394591328828,0,17,regulation of vascular permeability,BP,
10325,GO:0043116,1,0.960658088593784,0,7,negative regulation of vascular permeability,BP,
10326,GO:0043117,1,0.985474317929501,0,3,positive regulation of vascular permeability,BP,
10327,GO:0043120,1,0.97869548251489,0,3,tumor necrosis factor binding,MF,
10328,GO:0043121,1,0.977046003645821,0,5,neurotrophin binding,MF,
10331,GO:0043124,1,0.80902215435794,0,35,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,
10332,GO:0043125,1,0.968705645217664,0,4,ErbB-3 class receptor binding,MF,
10333,GO:0043126,1,0.98859399216161,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
10334,GO:0043128,1,0.98859399216161,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
10335,GO:0043129,1,0.970023708956258,0,5,surfactant homeostasis,BP,
10336,GO:0043130,1,0.614469717109629,0,65,ubiquitin binding,MF,
10337,GO:0043131,1,0.995366990826151,0,1,erythrocyte enucleation,BP,
10338,GO:0043132,1,0.994866746349447,0,1,NAD transport,BP,
10339,GO:0043136,1,0.995366787173025,0,1,glycerol-3-phosphatase activity,MF,
10340,GO:0043137,1,0.963510872573573,0,4,DNA replication, removal of RNA primer,BP,
10341,GO:0043138,1,0.932124958495174,0,12,3'-5' DNA helicase activity,MF,
10342,GO:0043139,1,0.957285453166486,0,7,5'-3' DNA helicase activity,MF,
10343,GO:0043140,1,0.968011149144825,0,7,ATP-dependent 3'-5' DNA helicase activity,MF,
10344,GO:0043141,1,0.967032136071178,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
10345,GO:0043142,1,0.925798483791569,0,13,single-stranded DNA-dependent ATPase activity,MF,
10347,GO:0043149,1,0.681881025387434,0,68,stress fiber assembly,BP,
10348,GO:0043153,1,0.885653911288754,0,20,entrainment of circadian clock by photoperiod,BP,
10349,GO:0043154,1,0.563992463521849,0,71,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
10350,GO:0043159,1,0.99536696674851,0,1,acrosomal matrix,CC,
10352,GO:0043162,1,0.867639832412562,0,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
10353,GO:0043163,1,0.990754590824662,0,2,cell envelope organization,BP,
10358,GO:0043171,1,0.874989046990103,0,23,peptide catabolic process,BP,
10359,GO:0043173,1,0.879668427704471,0,14,nucleotide salvage,BP,
10360,GO:0043174,1,0.85786514641468,0,16,nucleoside salvage,BP,
10361,GO:0043175,1,0.804183373759909,0,35,RNA polymerase core enzyme binding,MF,
10362,GO:0043176,1,0.973240272848599,0,3,amine binding,MF,
10364,GO:0043178,1,0.686249045988477,0,48,alcohol binding,MF,
10365,GO:0043179,1,0.994254882565581,0,1,rhythmic excitation,BP,
10366,GO:0043181,1,0.995366969599153,0,1,vacuolar sequestering,BP,
10367,GO:0043183,1,0.977387546967863,0,2,vascular endothelial growth factor receptor 1 binding,MF,
10368,GO:0043184,1,0.950010764432259,0,5,vascular endothelial growth factor receptor 2 binding,MF,
10369,GO:0043185,1,0.99417626142378,0,1,vascular endothelial growth factor receptor 3 binding,MF,
10370,GO:0043186,1,0.94300618628754,0,7,P granule,CC,
10371,GO:0043189,1,0.879181637212613,0,19,H4/H2A histone acetyltransferase complex,CC,
10372,GO:0043190,1,0.972517381113997,0,6,ATP-binding cassette (ABC) transporter complex,CC,
10373,GO:0043194,1,0.945730567839156,0,9,axon initial segment,CC,
10374,GO:0043195,1,0.755963679381284,0,41,terminal bouton,CC,
10375,GO:0043196,1,0.985241891382771,0,2,varicosity,CC,
10377,GO:0043198,1,0.89554518847129,0,21,dendritic shaft,CC,
10378,GO:0043199,1,0.979451724592177,0,3,sulfate binding,MF,
10379,GO:0043200,1,0.588504275652976,0,82,response to amino acid,BP,
10380,GO:0043201,1,0.953000817311802,0,10,response to leucine,BP,
10381,GO:0043202,1,0.642614306611953,0,71,lysosomal lumen,CC,
10382,GO:0043203,1,0.951687459826744,0,6,axon hillock,CC,
10383,GO:0043204,1,0.689466847552966,0,58,perikaryon,CC,
10385,GO:0043208,1,0.979420277090597,0,4,glycosphingolipid binding,MF,
10386,GO:0043209,1,0.357574262207492,0,139,myelin sheath,CC,
10387,GO:0043217,1,0.929926959155304,0,12,myelin maintenance,BP,
10388,GO:0043218,1,0.921608794242942,0,12,compact myelin,CC,
10389,GO:0043219,1,0.971316880503446,0,4,lateral loop,CC,
10390,GO:0043220,1,0.944514249288705,0,9,Schmidt-Lanterman incisure,CC,
10391,GO:0043221,1,0.995366989679833,0,1,SMC family protein binding,MF,
10392,GO:0043224,1,0.958509941346022,0,2,nuclear SCF ubiquitin ligase complex,CC,
10393,GO:0043225,1,0.963524655653009,0,8,ATPase-coupled anion transmembrane transporter activity,MF,
10402,GO:0043235,1,0.372752349396859,0,183,receptor complex,CC,
10403,GO:0043236,1,0.869859521893226,0,21,laminin binding,MF,
10404,GO:0043237,1,0.981594869823387,0,4,laminin-1 binding,MF,
10405,GO:0043240,1,0.946462144706432,0,11,Fanconi anaemia nuclear complex,CC,
10407,GO:0043243,1,0.86377572965718,0,23,positive regulation of protein complex disassembly,BP,
10409,GO:0043247,1,0.931712787733744,0,13,telomere maintenance in response to DNA damage,BP,
10410,GO:0043248,1,0.856864659385674,0,12,proteasome assembly,BP,
10411,GO:0043249,1,0.952376191915461,0,9,erythrocyte maturation,BP,
10412,GO:0043250,1,0.98863796205148,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
10413,GO:0043251,1,0.98863796205148,0,1,sodium-dependent organic anion transport,BP,
10414,GO:0043252,1,0.946238026022132,0,11,sodium-independent organic anion transport,BP,
10417,GO:0043256,1,0.963524687537387,0,8,laminin complex,CC,
10418,GO:0043257,1,0.995366990826125,0,1,laminin-8 complex,CC,
10419,GO:0043259,1,0.986164531023312,0,3,laminin-10 complex,CC,
10420,GO:0043260,1,0.986164531023312,0,3,laminin-11 complex,CC,
10421,GO:0043262,1,0.979945425867477,0,3,adenosine-diphosphatase activity,MF,
10422,GO:0043266,1,0.779337879186628,0,41,regulation of potassium ion transport,BP,
10423,GO:0043267,1,0.930418748789207,0,13,negative regulation of potassium ion transport,BP,
10424,GO:0043268,1,0.908308370889815,0,15,positive regulation of potassium ion transport,BP,
10427,GO:0043271,1,0.631360555995456,0,71,negative regulation of ion transport,BP,
10428,GO:0043273,1,0.995366990826153,0,1,CTPase activity,MF,
10429,GO:0043274,1,0.949230291674087,0,11,phospholipase binding,MF,
10431,GO:0043277,1,0.845238169489699,0,27,apoptotic cell clearance,BP,
10432,GO:0043278,1,0.895074830885665,0,17,response to morphine,BP,
10433,GO:0043279,1,0.665235325433067,0,66,response to alkaloid,BP,
10434,GO:0043280,1,0.367085558005841,0,109,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
10435,GO:0043281,1,0.20822016101996,0,176,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
10436,GO:0043291,1,0.99075519984877,0,2,RAVE complex,CC,
10437,GO:0043292,1,0.371171251007391,0,133,contractile fiber,CC,
10438,GO:0043293,1,0.98727249195539,0,2,apoptosome,CC,
10439,GO:0043295,1,0.879130723826444,0,11,glutathione binding,MF,
10440,GO:0043296,1,0.564433420516547,0,103,apical junction complex,CC,
10443,GO:0043300,1,0.839640018870505,0,27,regulation of leukocyte degranulation,BP,
10444,GO:0043301,1,0.971096831543908,0,5,negative regulation of leukocyte degranulation,BP,
10445,GO:0043302,1,0.910378425241024,0,13,positive regulation of leukocyte degranulation,BP,
10446,GO:0043303,1,0.82816887935246,0,26,mast cell degranulation,BP,
10447,GO:0043304,1,0.879017463571181,0,19,regulation of mast cell degranulation,BP,
10448,GO:0043305,1,0.984723387198458,0,2,negative regulation of mast cell degranulation,BP,
10449,GO:0043306,1,0.939839751977032,0,8,positive regulation of mast cell degranulation,BP,
10450,GO:0043307,1,0.972365857147723,0,4,eosinophil activation,BP,
10451,GO:0043308,1,0.972365857147723,0,4,eosinophil degranulation,BP,
10452,GO:0043309,1,0.982326791919221,0,2,regulation of eosinophil degranulation,BP,
10453,GO:0043311,1,0.982326791919221,0,2,positive regulation of eosinophil degranulation,BP,
10455,GO:0043313,1,0.981594888733481,0,4,regulation of neutrophil degranulation,BP,
10456,GO:0043314,1,0.990755199849201,0,2,negative regulation of neutrophil degranulation,BP,
10457,GO:0043315,1,0.995366990826138,0,1,positive regulation of neutrophil degranulation,BP,
10458,GO:0043316,1,0.990754626596024,0,2,cytotoxic T cell degranulation,BP,
10459,GO:0043317,1,0.995366942603148,0,1,regulation of cytotoxic T cell degranulation,BP,
10460,GO:0043318,1,0.995366942603148,0,1,negative regulation of cytotoxic T cell degranulation,BP,
10461,GO:0043320,1,0.967475037103336,0,6,natural killer cell degranulation,BP,
10462,GO:0043321,1,0.990695644567799,0,2,regulation of natural killer cell degranulation,BP,
10463,GO:0043323,1,0.990695644567799,0,2,positive regulation of natural killer cell degranulation,BP,
10464,GO:0043324,1,0.995366990826165,0,1,pigment metabolic process involved in developmental pigmentation,BP,
10465,GO:0043325,1,0.889403605537325,0,17,phosphatidylinositol-3,4-bisphosphate binding,MF,
10466,GO:0043328,1,0.941601378452933,0,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
10467,GO:0043330,1,0.833018059807279,0,26,response to exogenous dsRNA,BP,
10468,GO:0043331,1,0.62334613853699,0,73,response to dsRNA,BP,
10469,GO:0043335,1,0.982473283672232,0,2,protein unfolding,BP,
10470,GO:0043337,1,0.995366987635455,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
10471,GO:0043353,1,0.958340978778771,0,7,enucleate erythrocyte differentiation,BP,
10472,GO:0043354,1,0.995366990826151,0,1,enucleate erythrocyte maturation,BP,
10473,GO:0043366,1,0.988597693686492,0,2,beta selection,BP,
10477,GO:0043370,1,0.879866157380539,0,19,regulation of CD4-positive, alpha-beta T cell differentiation,BP,
10478,GO:0043371,1,0.94651736106286,0,10,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,
10479,GO:0043372,1,0.91321071920319,0,11,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,
10481,GO:0043374,1,0.971252304739831,0,5,CD8-positive, alpha-beta T cell differentiation,BP,
10482,GO:0043375,1,0.995366989202906,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
10483,GO:0043376,1,0.995366970935951,0,1,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
10484,GO:0043379,1,0.960621459218893,0,5,memory T cell differentiation,BP,
10485,GO:0043380,1,0.965094575878603,0,4,regulation of memory T cell differentiation,BP,
10486,GO:0043382,1,0.96958831310489,0,3,positive regulation of memory T cell differentiation,BP,
10487,GO:0043383,1,0.976465751507636,0,3,negative T cell selection,BP,
10488,GO:0043385,1,0.995365164953568,0,1,mycotoxin metabolic process,BP,
10489,GO:0043387,1,0.995365164953568,0,1,mycotoxin catabolic process,BP,
10493,GO:0043394,1,0.880933161336216,0,23,proteoglycan binding,MF,
10494,GO:0043395,1,0.943792664569613,0,10,heparan sulfate proteoglycan binding,MF,
10495,GO:0043396,1,0.995366841160869,0,1,corticotropin-releasing hormone secretion,BP,
10496,GO:0043397,1,0.995366841160869,0,1,regulation of corticotropin-releasing hormone secretion,BP,
10497,GO:0043398,1,0.974440711346821,0,3,HLH domain binding,MF,
10498,GO:0043400,1,0.970021460635656,0,2,cortisol secretion,BP,
10500,GO:0043402,1,0.986164118477724,0,3,glucocorticoid mediated signaling pathway,BP,
10501,GO:0043403,1,0.874559411945884,0,20,skeletal muscle tissue regeneration,BP,
10503,GO:0043406,1,0.294017245186831,0,197,positive regulation of MAP kinase activity,BP,
10507,GO:0043410,1,0.123115313968342,0,335,positive regulation of MAPK cascade,BP,
10511,GO:0043415,1,0.973243773988706,0,4,positive regulation of skeletal muscle tissue regeneration,BP,
10512,GO:0043416,1,0.973243773988706,0,4,regulation of skeletal muscle tissue regeneration,BP,
10513,GO:0043418,1,0.985957647219364,0,3,homocysteine catabolic process,BP,
10514,GO:0043422,1,0.926903054614999,0,11,protein kinase B binding,MF,
10515,GO:0043423,1,0.995366990826152,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
10519,GO:0043434,1,0.144776876195068,0,298,response to peptide hormone,BP,
10520,GO:0043435,1,0.990723365252667,0,2,response to corticotropin-releasing hormone,BP,
10522,GO:0043449,1,0.995340515049184,0,1,cellular alkene metabolic process,BP,
10523,GO:0043455,1,0.962191435070332,0,7,regulation of secondary metabolic process,BP,
10524,GO:0043456,1,0.980236916056115,0,3,regulation of pentose-phosphate shunt,BP,
10525,GO:0043457,1,0.88966009931335,0,16,regulation of cellular respiration,BP,
10526,GO:0043461,1,0.970728909834284,0,4,proton-transporting ATP synthase complex assembly,BP,
10528,GO:0043465,1,0.995366574475227,0,1,regulation of fermentation,BP,
10533,GO:0043474,1,0.995366990826165,0,1,pigment metabolic process involved in pigmentation,BP,
10534,GO:0043476,1,0.912066837361719,0,12,pigment accumulation,BP,
10535,GO:0043482,1,0.912066837361719,0,12,cellular pigment accumulation,BP,
10536,GO:0043484,1,0.534091235719051,0,101,regulation of RNA splicing,BP,
10537,GO:0043485,1,0.920585540457074,0,10,endosome to pigment granule transport,BP,
10542,GO:0043490,1,0.990755040644171,0,2,malate-aspartate shuttle,BP,
10545,GO:0043495,1,0.939573486559109,0,7,protein membrane anchor,MF,
10546,GO:0043496,1,0.847264677606377,0,20,regulation of protein homodimerization activity,BP,
10547,GO:0043497,1,0.934833423781517,0,9,regulation of protein heterodimerization activity,BP,
10549,GO:0043501,1,0.92958339185683,0,11,skeletal muscle adaptation,BP,
10551,GO:0043504,1,0.986164118474815,0,3,mitochondrial DNA repair,BP,
10552,GO:0043506,1,0.669734031717018,0,70,regulation of JUN kinase activity,BP,
10553,GO:0043507,1,0.73744064485156,0,57,positive regulation of JUN kinase activity,BP,
10554,GO:0043508,1,0.919803296586381,0,12,negative regulation of JUN kinase activity,BP,
10555,GO:0043509,1,0.994563254844199,0,1,activin A complex,CC,
10556,GO:0043511,1,0.994563254844199,0,1,inhibin complex,CC,
10557,GO:0043512,1,0.994563254844199,0,1,inhibin A complex,CC,
10558,GO:0043515,1,0.968745768062338,0,5,kinetochore binding,MF,
10560,GO:0043517,1,0.905673210056046,0,11,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
10562,GO:0043519,1,0.99430306699322,0,1,regulation of myosin II filament organization,BP,
10567,GO:0043527,1,0.959813581995863,0,5,tRNA methyltransferase complex,CC,
10568,GO:0043531,1,0.842396442160715,0,29,ADP binding,MF,
10569,GO:0043532,1,0.995366990826087,0,1,angiostatin binding,MF,
10570,GO:0043533,1,0.976702112470445,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
10574,GO:0043537,1,0.858925976256383,0,23,negative regulation of blood vessel endothelial cell migration,BP,
10575,GO:0043538,1,0.995366722375531,0,1,regulation of actin phosphorylation,BP,
10576,GO:0043539,1,0.817408872937857,0,27,protein serine/threonine kinase activator activity,MF,
10577,GO:0043541,1,0.990754925324407,0,2,UDP-N-acetylglucosamine transferase complex,CC,
10580,GO:0043544,1,0.99536696674851,0,1,lipoamide binding,MF,
10581,GO:0043545,1,0.955327370184117,0,7,molybdopterin cofactor metabolic process,BP,
10582,GO:0043546,1,0.972190709242474,0,6,molybdopterin cofactor binding,MF,
10584,GO:0043548,1,0.900256865749737,0,21,phosphatidylinositol 3-kinase binding,MF,
10586,GO:0043550,1,0.848050933139371,0,33,regulation of lipid kinase activity,BP,
10587,GO:0043551,1,0.880121673192334,0,27,regulation of phosphatidylinositol 3-kinase activity,BP,
10588,GO:0043552,1,0.917886416050226,0,18,positive regulation of phosphatidylinositol 3-kinase activity,BP,
10589,GO:0043553,1,0.985998306518645,0,3,negative regulation of phosphatidylinositol 3-kinase activity,BP,
10590,GO:0043555,1,0.894356102105578,0,18,regulation of translation in response to stress,BP,
10591,GO:0043558,1,0.915604927695475,0,14,regulation of translational initiation in response to stress,BP,
10592,GO:0043559,1,0.977046091952702,0,5,insulin binding,MF,
10593,GO:0043560,1,0.953651151368269,0,10,insulin receptor substrate binding,MF,
10594,GO:0043562,1,0.891827865135324,0,10,cellular response to nitrogen levels,BP,
10595,GO:0043564,1,0.989837783337399,0,2,Ku70:Ku80 complex,CC,
10597,GO:0043567,1,0.930620857823489,0,10,regulation of insulin-like growth factor receptor signaling pathway,BP,
10598,GO:0043568,1,0.976443590227413,0,5,positive regulation of insulin-like growth factor receptor signaling pathway,BP,
10599,GO:0043569,1,0.986164220286009,0,3,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
10600,GO:0043570,1,0.981594702994478,0,4,maintenance of DNA repeat elements,BP,
10601,GO:0043574,1,0.903554427242287,0,18,peroxisomal transport,BP,
10602,GO:0043576,1,0.936526374892352,0,13,regulation of respiratory gaseous exchange,BP,
10603,GO:0043578,1,0.98616452335288,0,3,nuclear matrix organization,BP,
10605,GO:0043584,1,0.946938721324552,0,10,nose development,BP,
10606,GO:0043585,1,0.990755199849122,0,2,nose morphogenesis,BP,
10610,GO:0043589,1,0.958799318154678,0,9,skin morphogenesis,BP,
10611,GO:0043596,1,0.7515803215722,0,41,nuclear replication fork,CC,
10612,GO:0043601,1,0.843903888329102,0,24,nuclear replisome,CC,
10613,GO:0043602,1,0.995280951782955,0,1,nitrate catabolic process,BP,
10616,GO:0043606,1,0.995366801879365,0,1,formamide metabolic process,BP,
10617,GO:0043610,1,0.995366990825981,0,1,regulation of carbohydrate utilization,BP,
10618,GO:0043614,1,0.990755199849267,0,2,multi-eIF complex,CC,
10619,GO:0043615,1,0.971526850046494,0,5,astrocyte cell migration,BP,
10622,GO:0043619,1,0.937140504469399,0,10,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
10624,GO:0043621,1,0.776180763345264,0,43,protein self-association,MF,
10625,GO:0043622,1,0.981594507467723,0,4,cortical microtubule organization,BP,
10627,GO:0043625,1,0.960747047122005,0,4,delta DNA polymerase complex,CC,
10628,GO:0043626,1,0.986003307534061,0,1,PCNA complex,CC,
10629,GO:0043627,1,0.724872488573918,0,49,response to estrogen,BP,
10630,GO:0043628,1,0.751754823882335,0,27,ncRNA 3'-end processing,BP,
10631,GO:0043629,1,0.99536699082602,0,1,ncRNA polyadenylation,BP,
10632,GO:0043630,1,0.99536699082602,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
10633,GO:0043631,1,0.785652502846713,0,41,RNA polyadenylation,BP,
10635,GO:0043633,1,0.925592249015877,0,8,polyadenylation-dependent RNA catabolic process,BP,
10636,GO:0043634,1,0.929904098630175,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
10637,GO:0043647,1,0.766797430362045,0,50,inositol phosphate metabolic process,BP,
10638,GO:0043648,1,0.595345036513383,0,78,dicarboxylic acid metabolic process,BP,
10639,GO:0043649,1,0.909149561028938,0,12,dicarboxylic acid catabolic process,BP,
10640,GO:0043650,1,0.962431514968661,0,8,dicarboxylic acid biosynthetic process,BP,
10641,GO:0043651,1,0.903485632689869,0,14,linoleic acid metabolic process,BP,
10642,GO:0043652,1,0.931331481322641,0,8,engulfment of apoptotic cell,BP,
10643,GO:0043653,1,0.906057290692493,0,8,mitochondrial fragmentation involved in apoptotic process,BP,
10644,GO:0043654,1,0.986157413837899,0,3,recognition of apoptotic cell,BP,
10645,GO:0043656,1,0.964090563770119,0,7,intracellular region of host,CC,
10646,GO:0043657,1,0.657094638099913,0,61,host cell,CC,
10647,GO:0043666,1,0.575248676801501,0,86,regulation of phosphoprotein phosphatase activity,BP,
10648,GO:0043679,1,0.645606283691303,0,66,axon terminus,CC,
10649,GO:0043682,1,0.990755199849071,0,2,copper-transporting ATPase activity,MF,
10650,GO:0043686,1,0.973461482112862,0,3,co-translational protein modification,BP,
10651,GO:0043687,1,0.0845525873036608,0,318,post-translational protein modification,BP,
10652,GO:0043691,1,0.942961669544141,0,8,reverse cholesterol transport,BP,
10653,GO:0043696,1,0.973641101016139,0,5,dedifferentiation,BP,
10654,GO:0043697,1,0.973641101016139,0,5,cell dedifferentiation,BP,
10655,GO:0043733,1,0.981272802792047,0,1,DNA-3-methylbase glycosylase activity,MF,
10656,GO:0043734,1,0.959125891691952,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
10657,GO:0043739,1,0.995366856248422,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
10658,GO:0043754,1,0.995366990825903,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
10659,GO:0043783,1,0.995072680832062,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
10660,GO:0043795,1,0.987095632384479,0,1,glyceraldehyde oxidoreductase activity,MF,
10661,GO:0043812,1,0.986164314476989,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
10662,GO:0043813,1,0.977045971039577,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
10663,GO:0043843,1,0.995316512568758,0,1,ADP-specific glucokinase activity,MF,
10664,GO:0043849,1,0.995366601992428,0,1,Ras palmitoyltransferase activity,MF,
10665,GO:0043865,1,0.995366330720897,0,1,methionine transmembrane transporter activity,MF,
10666,GO:0043874,1,0.9938189823179,0,1,acireductone synthase activity,MF,
10667,GO:0043890,1,0.995104098472142,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
10668,GO:0043891,1,0.9855963679086,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
10671,GO:0043902,1,0.315933479510784,0,142,positive regulation of multi-organism process,BP,
10672,GO:0043903,1,0.231520742547248,0,178,regulation of symbiosis, encompassing mutualism through parasitism,BP,
10673,GO:0043914,1,0.995366990550685,0,1,NADPH:sulfur oxidoreductase activity,MF,
10674,GO:0043916,1,0.981272802792047,0,1,DNA-7-methylguanine glycosylase activity,MF,
10675,GO:0043921,1,0.863130895154477,0,24,modulation by host of viral transcription,BP,
10676,GO:0043922,1,0.941775219360564,0,10,negative regulation by host of viral transcription,BP,
10677,GO:0043923,1,0.912324648902752,0,16,positive regulation by host of viral transcription,BP,
10678,GO:0043928,1,0.677444130989033,0,33,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
10680,GO:0043932,1,0.990061827879435,0,2,ossification involved in bone remodeling,BP,
10682,GO:0043946,1,0.991690581605567,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
10683,GO:0043947,1,0.991690581605567,0,1,positive regulation by host of symbiont catalytic activity,BP,
10685,GO:0043950,1,0.97489445483313,0,5,positive regulation of cAMP-mediated signaling,BP,
10687,GO:0043954,1,0.881344444084552,0,24,cellular component maintenance,BP,
10690,GO:0043968,1,0.894854727924373,0,16,histone H2A acetylation,BP,
10691,GO:0043969,1,0.995366990825981,0,1,histone H2B acetylation,BP,
10692,GO:0043970,1,0.929062275235774,0,12,histone H3-K9 acetylation,BP,
10693,GO:0043972,1,0.995366990826165,0,1,histone H3-K23 acetylation,BP,
10694,GO:0043973,1,0.994682460134404,0,1,histone H3-K4 acetylation,BP,
10695,GO:0043974,1,0.986164118123338,0,3,histone H3-K27 acetylation,BP,
10699,GO:0043984,1,0.902690590203054,0,19,histone H4-K16 acetylation,BP,
10700,GO:0043985,1,0.964413711896075,0,6,histone H4-R3 methylation,BP,
10701,GO:0043987,1,0.976461824289092,0,4,histone H3-S10 phosphorylation,BP,
10702,GO:0043988,1,0.975145730348077,0,3,histone H3-S28 phosphorylation,BP,
10703,GO:0043990,1,0.995366760008402,0,1,histone H2A-S1 phosphorylation,BP,
10704,GO:0043994,1,0.995366990826165,0,1,histone acetyltransferase activity (H3-K23 specific),MF,
10705,GO:0043995,1,0.952040824111063,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
10706,GO:0043996,1,0.952040824111063,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
10707,GO:0043997,1,0.995366781641782,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
10708,GO:0043998,1,0.995366897417136,0,1,H2A histone acetyltransferase activity,MF,
10709,GO:0044003,1,0.81263268356443,0,34,modification by symbiont of host morphology or physiology,BP,
10710,GO:0044004,1,0.962822652183045,0,3,disruption by symbiont of host cell,BP,
10711,GO:0044007,1,0.995366990826099,0,1,dissemination or transmission of symbiont from host,BP,
10712,GO:0044020,1,0.973415932177239,0,4,histone methyltransferase activity (H4-R3 specific),MF,
10713,GO:0044028,1,0.990755190784337,0,2,DNA hypomethylation,BP,
10714,GO:0044029,1,0.990755190784337,0,2,hypomethylation of CpG island,BP,
10715,GO:0044030,1,0.935127711216717,0,14,regulation of DNA methylation,BP,
10716,GO:0044033,1,0.963242543615818,0,6,multi-organism metabolic process,BP,
10717,GO:0044035,1,0.990454298177577,0,1,multi-organism catabolic process,BP,
10718,GO:0044036,1,0.976322923133385,0,3,cell wall macromolecule metabolic process,BP,
10719,GO:0044038,1,0.991967176450215,0,1,cell wall macromolecule biosynthetic process,BP,
10721,GO:0044053,1,0.995175560072827,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
10723,GO:0044058,1,0.915768099778201,0,12,regulation of digestive system process,BP,
10724,GO:0044060,1,0.883268765021891,0,20,regulation of endocrine process,BP,
10725,GO:0044062,1,0.982989969174265,0,3,regulation of excretion,BP,
10726,GO:0044065,1,0.958539313414582,0,8,regulation of respiratory system process,BP,
10727,GO:0044068,1,0.860923684010431,0,24,modulation by symbiont of host cellular process,BP,
10728,GO:0044070,1,0.719022360552714,0,48,regulation of anion transport,BP,
10731,GO:0044088,1,0.798584149981326,0,38,regulation of vacuole organization,BP,
10733,GO:0044090,1,0.939783706433176,0,12,positive regulation of vacuole organization,BP,
10734,GO:0044091,1,0.857499450182312,0,23,membrane biogenesis,BP,
10737,GO:0044094,1,0.98574695900067,0,3,host cell nuclear part,CC,
10738,GO:0044105,1,0.975756901341289,0,1,L-xylulose reductase (NAD+) activity,MF,
10739,GO:0044106,1,0.388677077339427,0,87,cellular amine metabolic process,BP,
10740,GO:0044107,1,0.974428286267577,0,4,cellular alcohol metabolic process,BP,
10741,GO:0044108,1,0.974428286267577,0,4,cellular alcohol biosynthetic process,BP,
10742,GO:0044110,1,0.948077999212292,0,6,growth involved in symbiotic interaction,BP,
10743,GO:0044111,1,0.985865008984697,0,2,development involved in symbiotic interaction,BP,
10744,GO:0044115,1,0.990454298177577,0,1,development of symbiont involved in interaction with host,BP,
10745,GO:0044116,1,0.948077999212292,0,6,growth of symbiont involved in interaction with host,BP,
10746,GO:0044117,1,0.948077999212292,0,6,growth of symbiont in host,BP,
10747,GO:0044126,1,0.964444195265448,0,5,regulation of growth of symbiont in host,BP,
10748,GO:0044128,1,0.995366990826164,0,1,positive regulation of growth of symbiont in host,BP,
10749,GO:0044130,1,0.968934907273407,0,4,negative regulation of growth of symbiont in host,BP,
10750,GO:0044144,1,0.964444195265448,0,5,modulation of growth of symbiont involved in interaction with host,BP,
10751,GO:0044145,1,0.990454298177577,0,1,modulation of development of symbiont involved in interaction with host,BP,
10752,GO:0044146,1,0.968934907273407,0,4,negative regulation of growth of symbiont involved in interaction with host,BP,
10753,GO:0044147,1,0.990454298177577,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
10754,GO:0044148,1,0.995366990826164,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
10755,GO:0044154,1,0.965227501154799,0,7,histone H3-K14 acetylation,BP,
10756,GO:0044183,1,0.781473186108195,0,33,protein binding involved in protein folding,MF,
10757,GO:0044190,1,0.991757258668049,0,1,host cell mitochondrial envelope,CC,
10758,GO:0044194,1,0.983768897271671,0,3,cytolytic granule,CC,
10759,GO:0044205,1,0.984913712537946,0,3,'de novo' UMP biosynthetic process,BP,
10760,GO:0044206,1,0.964115338892373,0,4,UMP salvage,BP,
10761,GO:0044207,1,0.995366990826138,0,1,translation initiation ternary complex,CC,
10762,GO:0044208,1,0.983716827972978,0,2,'de novo' AMP biosynthetic process,BP,
10763,GO:0044209,1,0.967804228456428,0,2,AMP salvage,BP,
10764,GO:0044210,1,0.990754785276736,0,2,'de novo' CTP biosynthetic process,BP,
10765,GO:0044211,1,0.97158247141106,0,3,CTP salvage,BP,
10767,GO:0044213,1,0.942717169835167,0,10,intronic transcription regulatory region DNA binding,MF,
10768,GO:0044214,1,0.986068867063528,0,3,spanning component of plasma membrane,CC,
10769,GO:0044215,1,0.657094638099913,0,61,other organism,CC,
10770,GO:0044216,1,0.657094638099913,0,61,other organism cell,CC,
10771,GO:0044217,1,0.657094638099913,0,61,other organism part,CC,
10772,GO:0044218,1,0.995366990826139,0,1,other organism cell membrane,CC,
10773,GO:0044220,1,0.995366990826165,0,1,host cell perinuclear region of cytoplasm,CC,
10774,GO:0044221,1,0.995366990826139,0,1,host cell synapse,CC,
10775,GO:0044224,1,0.97059247605278,0,6,juxtaparanode region of axon,CC,
10776,GO:0044228,1,0.995366990826165,0,1,host cell surface,CC,
10777,GO:0044231,1,0.995366990826139,0,1,host cell presynaptic membrane,CC,
10778,GO:0044232,1,0.893181947225519,0,18,organelle membrane contact site,CC,
10779,GO:0044233,1,0.923210738874411,0,12,ER-mitochondrion membrane contact site,CC,
10782,GO:0044241,1,0.982179937222984,0,2,lipid digestion,BP,
10783,GO:0044242,1,0.344166620594418,0,146,cellular lipid catabolic process,BP,
10784,GO:0044245,1,0.995366990826086,0,1,polysaccharide digestion,BP,
10797,GO:0044272,1,0.350661672950686,0,144,sulfur compound biosynthetic process,BP,
10798,GO:0044273,1,0.816628221572778,0,31,sulfur compound catabolic process,BP,
10800,GO:0044279,1,0.995366990826139,0,1,other organism membrane,CC,
10802,GO:0044282,1,0.110085909791805,0,302,small molecule catabolic process,BP,
10804,GO:0044284,1,0.977287446117353,0,1,mitochondrial crista junction,CC,
10805,GO:0044291,1,0.787499802364114,0,45,cell-cell contact zone,CC,
10806,GO:0044292,1,0.934589900719853,0,10,dendrite terminus,CC,
10807,GO:0044294,1,0.967860527508685,0,7,dendritic growth cone,CC,
10808,GO:0044295,1,0.888360482145101,0,20,axonal growth cone,CC,
10810,GO:0044298,1,0.967794315263463,0,7,cell body membrane,CC,
10811,GO:0044299,1,0.995366990826086,0,1,C-fiber,CC,
10812,GO:0044300,1,0.986164530439013,0,3,cerebellar mossy fiber,CC,
10813,GO:0044301,1,0.995366990826164,0,1,climbing fiber,CC,
10814,GO:0044302,1,0.986164238377748,0,3,dentate gyrus mossy fiber,CC,
10815,GO:0044304,1,0.815032873736053,0,39,main axon,CC,
10816,GO:0044305,1,0.995366990826099,0,1,calyx of Held,CC,
10817,GO:0044306,1,0.594193797342307,0,79,neuron projection terminus,CC,
10818,GO:0044307,1,0.995366990825837,0,1,dendritic branch,CC,
10819,GO:0044308,1,0.990755199849161,0,2,axonal spine,CC,
10821,GO:0044313,1,0.98616452519252,0,3,protein K6-linked deubiquitination,BP,
10822,GO:0044314,1,0.944351084468936,0,4,protein K27-linked ubiquitination,BP,
10823,GO:0044316,1,0.995366982705825,0,1,cone cell pedicle,CC,
10824,GO:0044317,1,0.986586469380563,0,1,rod spherule,CC,
10825,GO:0044319,1,0.859465077796592,0,25,wound healing, spreading of cells,BP,
10826,GO:0044320,1,0.95357322285528,0,10,cellular response to leptin stimulus,BP,
10828,GO:0044322,1,0.831678060500199,0,26,endoplasmic reticulum quality control compartment,CC,
10829,GO:0044323,1,0.990755099586534,0,2,retinoic acid-responsive element binding,MF,
10831,GO:0044325,1,0.576857062964935,0,81,ion channel binding,MF,
10832,GO:0044326,1,0.989155775695996,0,2,dendritic spine neck,CC,
10833,GO:0044327,1,0.952331218481236,0,8,dendritic spine head,CC,
10834,GO:0044328,1,0.995366574475227,0,1,canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration,BP,
10835,GO:0044329,1,0.995366574475227,0,1,canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion,BP,
10836,GO:0044330,1,0.995366574475227,0,1,canonical Wnt signaling pathway involved in positive regulation of wound healing,BP,
10837,GO:0044331,1,0.922728051520018,0,13,cell-cell adhesion mediated by cadherin,BP,
10838,GO:0044332,1,0.9770461777901,0,5,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
10839,GO:0044334,1,0.990755138482487,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
10840,GO:0044335,1,0.995366990825929,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
10841,GO:0044336,1,0.986163997885411,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
10842,GO:0044338,1,0.983954640592062,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
10843,GO:0044339,1,0.979395122625432,0,3,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
10844,GO:0044340,1,0.970338309534508,0,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
10845,GO:0044341,1,0.98616440343885,0,3,sodium-dependent phosphate transport,BP,
10847,GO:0044343,1,0.995366990826164,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
10849,GO:0044345,1,0.995366990826164,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
10850,GO:0044346,1,0.906242012119925,0,17,fibroblast apoptotic process,BP,
10851,GO:0044349,1,0.991485701225143,0,1,DNA excision,BP,
10852,GO:0044351,1,0.954655186224218,0,6,macropinocytosis,BP,
10853,GO:0044352,1,0.976749364590718,0,4,pinosome,CC,
10854,GO:0044354,1,0.976749364590718,0,4,macropinosome,CC,
10855,GO:0044355,1,0.987746831482751,0,1,clearance of foreign intracellular DNA,BP,
10856,GO:0044356,1,0.987746831482751,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
10857,GO:0044359,1,0.950305905604651,0,6,modulation of molecular function in other organism,BP,
10858,GO:0044362,1,0.954731538969798,0,5,negative regulation of molecular function in other organism,BP,
10859,GO:0044364,1,0.771173687481274,0,16,disruption of cells of other organism,BP,
10860,GO:0044375,1,0.972933679948966,0,2,regulation of peroxisome size,BP,
10861,GO:0044378,1,0.983522270329169,0,2,non-sequence-specific DNA binding, bending,MF,
10863,GO:0044381,1,0.937030329157158,0,14,glucose import in response to insulin stimulus,BP,
10864,GO:0044387,1,0.95654274680162,0,7,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,
10865,GO:0044388,1,0.941321906827029,0,5,small protein activating enzyme binding,MF,
10869,GO:0044393,1,0.986163628926489,0,3,microspike,CC,
10870,GO:0044395,1,0.995334827886526,0,1,protein targeting to vacuolar membrane,BP,
10871,GO:0044396,1,0.986164531023741,0,3,actin cortical patch organization,BP,
10873,GO:0044406,1,0.970246056357173,0,5,adhesion of symbiont to host,BP,
10874,GO:0044409,1,0.495323976223882,0,94,entry into host,BP,
10875,GO:0044413,1,0.98090394114415,0,4,avoidance of host defenses,BP,
10876,GO:0044414,1,0.995366990826151,0,1,suppression of host defenses,BP,
10877,GO:0044415,1,0.98090394114415,0,4,evasion or tolerance of host defenses,BP,
10878,GO:0044416,1,0.983074106908371,0,2,induction by symbiont of host defense response,BP,
10879,GO:0044417,1,0.931582605671115,0,9,translocation of molecules into host,BP,
10881,GO:0044420,1,0.613598169229601,0,85,extracellular matrix component,CC,
10893,GO:0044437,1,0.047211677587914,0,453,vacuolar part,CC,
10894,GO:0044438,1,0.574162657820616,0,73,microbody part,CC,
10895,GO:0044439,1,0.574162657820616,0,73,peroxisomal part,CC,
10897,GO:0044441,1,0.173515588231669,0,269,ciliary part,CC,
10901,GO:0044447,1,0.895239356203299,0,16,axoneme part,CC,
10902,GO:0044448,1,0.484168536154043,0,127,cell cortex part,CC,
10903,GO:0044449,1,0.414192652700813,0,120,contractile fiber part,CC,
10906,GO:0044452,1,0.274512979222853,0,163,nucleolar part,CC,
10907,GO:0044453,1,0.962116871390546,0,8,nuclear membrane part,CC,
10911,GO:0044458,1,0.916142936673208,0,12,motile cilium assembly,BP,
10915,GO:0044495,1,0.975368272283632,0,1,modulation of blood pressure in other organism,BP,
10916,GO:0044497,1,0.975368272283632,0,1,positive regulation of blood pressure in other organism,BP,
10917,GO:0044501,1,0.990755081298326,0,2,modulation of signal transduction in other organism,BP,
10918,GO:0044524,1,0.991669902477171,0,1,protein sulfhydration,BP,
10919,GO:0044528,1,0.97925729314447,0,4,regulation of mitochondrial mRNA stability,BP,
10920,GO:0044530,1,0.984925780492551,0,3,supraspliceosomal complex,CC,
10921,GO:0044531,1,0.949367195545761,0,6,modulation of programmed cell death in other organism,BP,
10922,GO:0044532,1,0.949367195545761,0,6,modulation of apoptotic process in other organism,BP,
10923,GO:0044533,1,0.962822652183045,0,3,positive regulation of apoptotic process in other organism,BP,
10924,GO:0044539,1,0.986164180237494,0,3,long-chain fatty acid import,BP,
10925,GO:0044540,1,0.991669902477171,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
10926,GO:0044545,1,0.974414575705395,0,5,NSL complex,CC,
10927,GO:0044546,1,0.957154638295987,0,9,NLRP3 inflammasome complex assembly,BP,
10928,GO:0044547,1,0.976191702278682,0,5,DNA topoisomerase binding,MF,
10929,GO:0044548,1,0.891571077064908,0,11,S100 protein binding,MF,
10930,GO:0044549,1,0.972966983226676,0,1,GTP cyclohydrolase binding,MF,
10931,GO:0044550,1,0.904421627344106,0,14,secondary metabolite biosynthetic process,BP,
10933,GO:0044565,1,0.983216058664754,0,2,dendritic cell proliferation,BP,
10934,GO:0044571,1,0.940210360055802,0,4,[2Fe-2S] cluster assembly,BP,
10935,GO:0044594,1,0.995360837019954,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
10936,GO:0044595,1,0.984741452522495,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
10937,GO:0044596,1,0.984741452522495,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
10938,GO:0044597,1,0.945365762040839,0,5,daunorubicin metabolic process,BP,
10939,GO:0044598,1,0.945365762040839,0,5,doxorubicin metabolic process,BP,
10940,GO:0044599,1,0.995366574475227,0,1,AP-5 adaptor complex,CC,
10941,GO:0044601,1,0.990595020269879,0,1,protein denucleotidylation,BP,
10942,GO:0044602,1,0.990595020269879,0,1,protein deadenylylation,BP,
10943,GO:0044603,1,0.990595020269879,0,1,protein adenylylhydrolase activity,MF,
10944,GO:0044609,1,0.989816823768807,0,2,DBIRD complex,CC,
10945,GO:0044610,1,0.994866746349447,0,1,FMN transmembrane transporter activity,MF,
10946,GO:0044611,1,0.986164531023676,0,3,nuclear pore inner ring,CC,
10947,GO:0044613,1,0.907668658716869,0,12,nuclear pore central transport channel,CC,
10948,GO:0044614,1,0.981594100109379,0,4,nuclear pore cytoplasmic filaments,CC,
10949,GO:0044615,1,0.954304992631262,0,9,nuclear pore nuclear basket,CC,
10950,GO:0044620,1,0.944033747523661,0,2,ACP phosphopantetheine attachment site binding,MF,
10951,GO:0044648,1,0.995366574475227,0,1,histone H3-K4 dimethylation,BP,
10952,GO:0044650,1,0.974770489388966,0,4,adhesion of symbiont to host cell,BP,
10953,GO:0044665,1,0.816009290463369,0,29,MLL1/2 complex,CC,
10954,GO:0044666,1,0.930759042384407,0,11,MLL3/4 complex,CC,
10955,GO:0044691,1,0.990755199840607,0,2,tooth eruption,BP,
10957,GO:0044706,1,0.410464447163208,0,136,multi-multicellular organism process,BP,
10958,GO:0044713,1,0.973014325578977,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
10959,GO:0044714,1,0.973014325578977,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
10960,GO:0044715,1,0.972717274000546,0,2,8-oxo-dGDP phosphatase activity,MF,
10961,GO:0044716,1,0.988869993719741,0,1,8-oxo-GDP phosphatase activity,MF,
10962,GO:0044717,1,0.988869993719741,0,1,8-hydroxy-dADP phosphatase activity,MF,
10963,GO:0044721,1,0.993264267790991,0,1,protein import into peroxisome matrix, substrate release,BP,
10964,GO:0044725,1,0.995366990825902,0,1,chromatin reprogramming in the zygote,BP,
10965,GO:0044727,1,0.995366990825902,0,1,DNA demethylation of male pronucleus,BP,
10966,GO:0044728,1,0.696828385130483,0,61,DNA methylation or demethylation,BP,
10967,GO:0044729,1,0.986164026114091,0,3,hemi-methylated DNA-binding,MF,
10968,GO:0044730,1,0.990454298177577,0,1,bone sialoprotein binding,MF,
10969,GO:0044732,1,0.995366574475227,0,1,mitotic spindle pole body,CC,
10970,GO:0044736,1,0.995366574475227,0,1,acid-sensing ion channel activity,MF,
10971,GO:0044743,1,0.686319259628473,0,38,protein transmembrane import into intracellular organelle,BP,
10972,GO:0044752,1,0.98581826631255,0,3,response to human chorionic gonadotropin,BP,
10973,GO:0044753,1,0.995366585415899,0,1,amphisome,CC,
10974,GO:0044754,1,0.9185092626547,0,8,autolysosome,CC,
10976,GO:0044766,1,0.606852469398732,0,68,multi-organism transport,BP,
10977,GO:0044769,1,0.822238090065844,0,18,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
10978,GO:0044770,1,0.0189177929469608,0,512,cell cycle phase transition,BP,
10979,GO:0044771,1,0.990754602974086,0,2,meiotic cell cycle phase transition,BP,
10980,GO:0044772,1,0.0227302910513293,0,485,mitotic cell cycle phase transition,BP,
10981,GO:0044773,1,0.488509584713465,0,99,mitotic DNA damage checkpoint,BP,
10982,GO:0044774,1,0.473159588971698,0,105,mitotic DNA integrity checkpoint,BP,
10983,GO:0044778,1,0.989785274289554,0,2,meiotic DNA integrity checkpoint,BP,
10984,GO:0044779,1,0.995366709403035,0,1,meiotic spindle checkpoint,BP,
10985,GO:0044782,1,0.156768887774136,0,291,cilium organization,BP,
10986,GO:0044783,1,0.583906773373265,0,69,G1 DNA damage checkpoint,BP,
10987,GO:0044784,1,0.69816854868152,0,49,metaphase/anaphase transition of cell cycle,BP,
10988,GO:0044785,1,0.995366709403035,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
10989,GO:0044786,1,0.661605234117953,0,57,cell cycle DNA replication,BP,
10990,GO:0044788,1,0.882973192546089,0,18,modulation by host of viral process,BP,
10991,GO:0044789,1,0.977045873856626,0,5,modulation by host of viral release from host cell,BP,
10992,GO:0044791,1,0.977045873856626,0,5,positive regulation by host of viral release from host cell,BP,
10993,GO:0044793,1,0.981120622869975,0,4,negative regulation by host of viral process,BP,
10994,GO:0044794,1,0.904179064472774,0,13,positive regulation by host of viral process,BP,
10995,GO:0044795,1,0.982668550668212,0,1,trans-Golgi network to recycling endosome transport,BP,
10996,GO:0044796,1,0.986003307534061,0,1,DNA polymerase processivity factor complex,CC,
10998,GO:0044800,1,0.984943925803592,0,3,multi-organism membrane fusion,BP,
10999,GO:0044803,1,0.980379874775064,0,4,multi-organism membrane organization,BP,
11000,GO:0044804,1,0.898030633436272,0,18,autophagy of nucleus,BP,
11001,GO:0044805,1,0.990755194399076,0,2,late nucleophagy,BP,
11002,GO:0044806,1,0.968000745515556,0,7,G-quadruplex DNA unwinding,BP,
11004,GO:0044818,1,0.868798993931023,0,26,mitotic G2/M transition checkpoint,BP,
11005,GO:0044819,1,0.586641428900084,0,68,mitotic G1/S transition checkpoint,BP,
11006,GO:0044821,1,0.981581574528167,0,4,meiotic telomere tethering at nuclear periphery,BP,
11007,GO:0044827,1,0.929430748292228,0,12,modulation by host of viral genome replication,BP,
11008,GO:0044828,1,0.981120622869975,0,4,negative regulation by host of viral genome replication,BP,
11009,GO:0044829,1,0.95173904007253,0,7,positive regulation by host of viral genome replication,BP,
11010,GO:0044830,1,0.990754798450848,0,2,modulation by host of viral RNA genome replication,BP,
11011,GO:0044837,1,0.966584782284955,0,7,actomyosin contractile ring organization,BP,
11012,GO:0044839,1,0.149042796636818,0,239,cell cycle G2/M phase transition,BP,
11013,GO:0044843,1,0.177732770797371,0,234,cell cycle G1/S phase transition,BP,
11014,GO:0044848,1,0.942703594561194,0,8,biological phase,BP,
11015,GO:0044849,1,0.935927833995774,0,9,estrous cycle,BP,
11016,GO:0044851,1,0.942703594561194,0,8,hair cycle phase,BP,
11017,GO:0044853,1,0.718755823331722,0,61,plasma membrane raft,CC,
11018,GO:0044854,1,0.977772250254877,0,4,plasma membrane raft assembly,BP,
11019,GO:0044855,1,0.995364978449716,0,1,plasma membrane raft distribution,BP,
11020,GO:0044856,1,0.995364978449716,0,1,plasma membrane raft localization,BP,
11021,GO:0044857,1,0.977772250254877,0,4,plasma membrane raft organization,BP,
11022,GO:0044858,1,0.995364978449716,0,1,plasma membrane raft polarization,BP,
11023,GO:0044860,1,0.979135441331812,0,4,protein localization to plasma membrane raft,BP,
11024,GO:0044861,1,0.988299372079488,0,2,protein transport into plasma membrane raft,BP,
11025,GO:0044868,1,0.9953669908261,0,1,modulation by host of viral molecular function,BP,
11026,GO:0044872,1,0.963572027992488,0,6,lipoprotein localization,BP,
11027,GO:0044877,1,0.00833829072263985,0,667,protein-containing complex binding,MF,
11028,GO:0044878,1,0.966731625206896,0,4,mitotic cytokinesis checkpoint,BP,
11029,GO:0045002,1,0.965861636160012,0,7,double-strand break repair via single-strand annealing,BP,
11030,GO:0045003,1,0.937036705274744,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11031,GO:0045004,1,0.990755150529795,0,2,DNA replication proofreading,BP,
11032,GO:0045005,1,0.829646071440956,0,32,DNA-dependent DNA replication maintenance of fidelity,BP,
11033,GO:0045006,1,0.886720361637768,0,10,DNA deamination,BP,
11034,GO:0045007,1,0.967355810959531,0,3,depurination,BP,
11035,GO:0045008,1,0.937388921870399,0,8,depyrimidination,BP,
11036,GO:0045009,1,0.94296934035846,0,6,chitosome,CC,
11037,GO:0045010,1,0.776490225145317,0,38,actin nucleation,BP,
11038,GO:0045016,1,0.995366901433591,0,1,mitochondrial magnesium ion transmembrane transport,BP,
11040,GO:0045019,1,0.916766548727228,0,10,negative regulation of nitric oxide biosynthetic process,BP,
11041,GO:0045022,1,0.778902425943954,0,38,early endosome to late endosome transport,BP,
11042,GO:0045023,1,0.772973656045852,0,42,G0 to G1 transition,BP,
11043,GO:0045025,1,0.990646833488123,0,2,mitochondrial degradosome,CC,
11044,GO:0045026,1,0.869734889573904,0,16,plasma membrane fusion,BP,
11045,GO:0045027,1,0.994271102205394,0,1,DNA end binding,MF,
11046,GO:0045028,1,0.968836901742352,0,5,G-protein coupled purinergic nucleotide receptor activity,MF,
11047,GO:0045031,1,0.988952020052884,0,2,ATP-activated adenosine receptor activity,MF,
11048,GO:0045032,1,0.995366765183482,0,1,ADP-activated adenosine receptor activity,MF,
11049,GO:0045039,1,0.905283504049453,0,6,protein import into mitochondrial inner membrane,BP,
11050,GO:0045040,1,0.91465967782745,0,6,protein import into mitochondrial outer membrane,BP,
11051,GO:0045041,1,0.983882870498234,0,2,protein import into mitochondrial intermembrane space,BP,
11052,GO:0045046,1,0.969810465539547,0,6,protein import into peroxisome membrane,BP,
11054,GO:0045048,1,0.969133422577407,0,5,protein insertion into ER membrane,BP,
11055,GO:0045053,1,0.977037701718068,0,5,protein retention in Golgi apparatus,BP,
11056,GO:0045054,1,0.981154441780961,0,3,constitutive secretory pathway,BP,
11058,GO:0045056,1,0.922860676336406,0,14,transcytosis,BP,
11060,GO:0045059,1,0.958948021345916,0,6,positive thymic T cell selection,BP,
11061,GO:0045060,1,0.976465751507636,0,3,negative thymic T cell selection,BP,
11062,GO:0045061,1,0.936925624117837,0,11,thymic T cell selection,BP,
11063,GO:0045062,1,0.991290183108913,0,1,extrathymic T cell selection,BP,
11065,GO:0045064,1,0.930895621581609,0,10,T-helper 2 cell differentiation,BP,
11066,GO:0045065,1,0.98617239533583,0,2,cytotoxic T cell differentiation,BP,
11067,GO:0045066,1,0.919682079485447,0,14,regulatory T cell differentiation,BP,
11068,GO:0045069,1,0.531500532737933,0,75,regulation of viral genome replication,BP,
11069,GO:0045070,1,0.802049724052626,0,31,positive regulation of viral genome replication,BP,
11070,GO:0045071,1,0.650941160897172,0,45,negative regulation of viral genome replication,BP,
11071,GO:0045072,1,0.971732161405039,0,6,regulation of interferon-gamma biosynthetic process,BP,
11072,GO:0045073,1,0.942517555016835,0,8,regulation of chemokine biosynthetic process,BP,
11073,GO:0045074,1,0.988199532244837,0,2,regulation of interleukin-10 biosynthetic process,BP,
11074,GO:0045075,1,0.97693872548574,0,5,regulation of interleukin-12 biosynthetic process,BP,
11075,GO:0045076,1,0.952058392015718,0,8,regulation of interleukin-2 biosynthetic process,BP,
11076,GO:0045077,1,0.994563254844199,0,1,negative regulation of interferon-gamma biosynthetic process,BP,
11077,GO:0045078,1,0.977045527689284,0,5,positive regulation of interferon-gamma biosynthetic process,BP,
11078,GO:0045079,1,0.990904369076813,0,1,negative regulation of chemokine biosynthetic process,BP,
11079,GO:0045080,1,0.95117403648417,0,7,positive regulation of chemokine biosynthetic process,BP,
11080,GO:0045081,1,0.995366971582776,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
11081,GO:0045082,1,0.992799582895633,0,1,positive regulation of interleukin-10 biosynthetic process,BP,
11082,GO:0045083,1,0.995366990826138,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
11083,GO:0045084,1,0.986056087473423,0,3,positive regulation of interleukin-12 biosynthetic process,BP,
11084,GO:0045085,1,0.991643945790632,0,1,negative regulation of interleukin-2 biosynthetic process,BP,
11085,GO:0045086,1,0.960084654404601,0,7,positive regulation of interleukin-2 biosynthetic process,BP,
11089,GO:0045091,1,0.94577372932913,0,9,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11090,GO:0045092,1,0.995366969447021,0,1,interleukin-18 receptor complex,CC,
11091,GO:0045095,1,0.822547086672561,0,26,keratin filament,CC,
11092,GO:0045098,1,0.990786842679304,0,1,type III intermediate filament,CC,
11093,GO:0045103,1,0.816509437531673,0,34,intermediate filament-based process,BP,
11094,GO:0045104,1,0.820318691877067,0,33,intermediate filament cytoskeleton organization,BP,
11095,GO:0045105,1,0.995366966583062,0,1,intermediate filament polymerization or depolymerization,BP,
11096,GO:0045109,1,0.915666304694078,0,16,intermediate filament organization,BP,
11097,GO:0045110,1,0.967710633103294,0,6,intermediate filament bundle assembly,BP,
11098,GO:0045111,1,0.495090807353946,0,102,intermediate filament cytoskeleton,CC,
11099,GO:0045112,1,0.960698052775369,0,3,integrin biosynthetic process,BP,
11100,GO:0045113,1,0.965171519314448,0,2,regulation of integrin biosynthetic process,BP,
11101,GO:0045116,1,0.832321231068681,0,14,protein neddylation,BP,
11102,GO:0045117,1,0.877349650637535,0,16,azole transport,BP,
11103,GO:0045120,1,0.940469241584577,0,12,pronucleus,CC,
11104,GO:0045121,1,0.309405812021828,0,202,membrane raft,CC,
11106,GO:0045124,1,0.893595018448645,0,21,regulation of bone resorption,BP,
11108,GO:0045127,1,0.989675502418522,0,1,N-acetylglucosamine kinase activity,MF,
11109,GO:0045128,1,0.995366802530454,0,1,negative regulation of reciprocal meiotic recombination,BP,
11110,GO:0045131,1,0.995366666125101,0,1,pre-mRNA branch point binding,MF,
11111,GO:0045132,1,0.74556427271257,0,49,meiotic chromosome segregation,BP,
11112,GO:0045134,1,0.980298943076579,0,4,uridine-diphosphatase activity,MF,
11113,GO:0045136,1,0.921202729076377,0,9,development of secondary sexual characteristics,BP,
11115,GO:0045141,1,0.963372464010595,0,8,meiotic telomere clustering,BP,
11116,GO:0045142,1,0.990755199699494,0,2,triplex DNA binding,MF,
11117,GO:0045143,1,0.851553082162642,0,27,homologous chromosome segregation,BP,
11118,GO:0045144,1,0.959337444504269,0,5,meiotic sister chromatid segregation,BP,
11119,GO:0045145,1,0.990754625620284,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
11120,GO:0045153,1,0.9837241633779,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
11121,GO:0045155,1,0.979165702541378,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
11122,GO:0045159,1,0.980007692036219,0,4,myosin II binding,MF,
11123,GO:0045161,1,0.964677868674746,0,7,neuronal ion channel clustering,BP,
11124,GO:0045162,1,0.981594641431119,0,4,clustering of voltage-gated sodium channels,BP,
11125,GO:0045163,1,0.99536699082594,0,1,clustering of voltage-gated potassium channels,BP,
11127,GO:0045167,1,0.99133415856859,0,1,asymmetric protein localization involved in cell fate determination,BP,
11130,GO:0045174,1,0.963438939267324,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
11131,GO:0045176,1,0.952822927249251,0,9,apical protein localization,BP,
11133,GO:0045178,1,0.819165261281564,0,36,basal part of cell,CC,
11134,GO:0045179,1,0.976061905589979,0,5,apical cortex,CC,
11135,GO:0045180,1,0.97704617779024,0,5,basal cortex,CC,
11136,GO:0045182,1,0.725111481009237,0,40,translation regulator activity,MF,
11137,GO:0045183,1,0.995366574475227,0,1,translation factor activity, non-nucleic acid binding,MF,
11140,GO:0045186,1,0.995366990826047,0,1,zonula adherens assembly,BP,
11141,GO:0045187,1,0.931521789916191,0,5,regulation of circadian sleep/wake cycle, sleep,BP,
11142,GO:0045188,1,0.984556797856351,0,2,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11143,GO:0045190,1,0.827702050057587,0,33,isotype switching,BP,
11144,GO:0045191,1,0.867773827906667,0,23,regulation of isotype switching,BP,
11145,GO:0045196,1,0.990755195915015,0,2,establishment or maintenance of neuroblast polarity,BP,
11146,GO:0045197,1,0.839423198272092,0,29,establishment or maintenance of epithelial cell apical/basal polarity,BP,
11147,GO:0045198,1,0.950181964897488,0,10,establishment of epithelial cell apical/basal polarity,BP,
11148,GO:0045199,1,0.966290888581135,0,5,maintenance of epithelial cell apical/basal polarity,BP,
11149,GO:0045200,1,0.990755195915015,0,2,establishment of neuroblast polarity,BP,
11151,GO:0045204,1,0.98616450392171,0,3,MAPK export from nucleus,BP,
11152,GO:0045208,1,0.995366963474111,0,1,MAPK phosphatase export from nucleus,BP,
11153,GO:0045209,1,0.995366963474111,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
11154,GO:0045210,1,0.990755199849241,0,2,FasL biosynthetic process,BP,
11155,GO:0045211,1,0.54986441748982,0,114,postsynaptic membrane,CC,
11156,GO:0045213,1,0.985187659725442,0,2,neurotransmitter receptor metabolic process,BP,
11157,GO:0045214,1,0.881724058463374,0,20,sarcomere organization,BP,
11159,GO:0045217,1,0.972517395491584,0,6,cell-cell junction maintenance,BP,
11160,GO:0045218,1,0.986164041511826,0,3,zonula adherens maintenance,BP,
11161,GO:0045219,1,0.995366990826139,0,1,regulation of FasL biosynthetic process,BP,
11162,GO:0045221,1,0.995366990826139,0,1,negative regulation of FasL biosynthetic process,BP,
11163,GO:0045222,1,0.982707584867652,0,1,CD4 biosynthetic process,BP,
11164,GO:0045223,1,0.982707584867652,0,1,regulation of CD4 biosynthetic process,BP,
11165,GO:0045225,1,0.982707584867652,0,1,negative regulation of CD4 biosynthetic process,BP,
11166,GO:0045226,1,0.990748319514917,0,2,extracellular polysaccharide biosynthetic process,BP,
11167,GO:0045229,1,0.990754590824662,0,2,external encapsulating structure organization,BP,
11168,GO:0045234,1,0.992083403503546,0,1,protein palmitoleylation,BP,
11169,GO:0045236,1,0.930816986742071,0,7,CXCR chemokine receptor binding,MF,
11170,GO:0045239,1,0.924981868611253,0,13,tricarboxylic acid cycle enzyme complex,CC,
11171,GO:0045240,1,0.936931712053256,0,11,dihydrolipoyl dehydrogenase complex,CC,
11172,GO:0045244,1,0.995076500585975,0,1,succinate-CoA ligase complex (GDP-forming),CC,
11173,GO:0045251,1,0.995072680832062,0,1,electron transfer flavoprotein complex,CC,
11174,GO:0045252,1,0.958708456136231,0,7,oxoglutarate dehydrogenase complex,CC,
11175,GO:0045254,1,0.961438314947196,0,7,pyruvate dehydrogenase complex,CC,
11176,GO:0045257,1,0.955516278776553,0,5,succinate dehydrogenase complex (ubiquinone),CC,
11177,GO:0045259,1,0.981671679150454,0,2,proton-transporting ATP synthase complex,CC,
11178,GO:0045263,1,0.986949280445354,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
11179,GO:0045271,1,0.387400343192498,0,42,respiratory chain complex I,CC,
11180,GO:0045272,1,0.948914313422571,0,3,plasma membrane respiratory chain complex I,CC,
11181,GO:0045273,1,0.955516278776553,0,5,respiratory chain complex II,CC,
11182,GO:0045274,1,0.995147683086322,0,1,plasma membrane respiratory chain complex II,CC,
11183,GO:0045275,1,0.868956017492284,0,11,respiratory chain complex III,CC,
11185,GO:0045281,1,0.955516278776553,0,5,succinate dehydrogenase complex,CC,
11186,GO:0045282,1,0.995147683086322,0,1,plasma membrane succinate dehydrogenase complex,CC,
11187,GO:0045283,1,0.955516278776553,0,5,fumarate reductase complex,CC,
11189,GO:0045293,1,0.979414612584991,0,3,mRNA editing complex,CC,
11190,GO:0045294,1,0.962561835398655,0,8,alpha-catenin binding,MF,
11193,GO:0045297,1,0.994857117983983,0,1,post-mating behavior,BP,
11194,GO:0045298,1,0.962230525026195,0,4,tubulin complex,CC,
11195,GO:0045309,1,0.820217986616562,0,36,protein phosphorylated amino acid binding,MF,
11197,GO:0045322,1,0.990754448025814,0,2,unmethylated CpG binding,MF,
11198,GO:0045323,1,0.982557333947098,0,3,interleukin-1 receptor complex,CC,
11199,GO:0045324,1,0.906726649597849,0,11,late endosome to vacuole transport,BP,
11200,GO:0045329,1,0.974460667865307,0,5,carnitine biosynthetic process,BP,
11201,GO:0045332,1,0.937034183963268,0,14,phospholipid translocation,BP,
11203,GO:0045334,1,0.765433789694364,0,37,clathrin-coated endocytic vesicle,CC,
11204,GO:0045335,1,0.456470825753406,0,105,phagocytic vesicle,CC,
11205,GO:0045337,1,0.979262429246834,0,3,farnesyl diphosphate biosynthetic process,BP,
11206,GO:0045338,1,0.973682295190844,0,4,farnesyl diphosphate metabolic process,BP,
11207,GO:0045340,1,0.978037514283719,0,1,mercury ion binding,MF,
11208,GO:0045341,1,0.98159436785105,0,4,MHC class I biosynthetic process,BP,
11209,GO:0045342,1,0.969099425448675,0,5,MHC class II biosynthetic process,BP,
11210,GO:0045343,1,0.98159436785105,0,4,regulation of MHC class I biosynthetic process,BP,
11211,GO:0045345,1,0.98159436785105,0,4,positive regulation of MHC class I biosynthetic process,BP,
11212,GO:0045346,1,0.969099425448675,0,5,regulation of MHC class II biosynthetic process,BP,
11213,GO:0045347,1,0.981192143859928,0,3,negative regulation of MHC class II biosynthetic process,BP,
11214,GO:0045348,1,0.978144495879633,0,3,positive regulation of MHC class II biosynthetic process,BP,
11215,GO:0045349,1,0.969736087762196,0,4,interferon-alpha biosynthetic process,BP,
11216,GO:0045350,1,0.96060361732227,0,6,interferon-beta biosynthetic process,BP,
11217,GO:0045351,1,0.945230777058667,0,8,type I interferon biosynthetic process,BP,
11218,GO:0045352,1,0.992044959517752,0,1,interleukin-1 Type I receptor antagonist activity,MF,
11219,GO:0045353,1,0.992044959517752,0,1,interleukin-1 Type II receptor antagonist activity,MF,
11220,GO:0045354,1,0.969736087762196,0,4,regulation of interferon-alpha biosynthetic process,BP,
11221,GO:0045355,1,0.978787270525663,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
11222,GO:0045356,1,0.990754926014142,0,2,positive regulation of interferon-alpha biosynthetic process,BP,
11223,GO:0045357,1,0.96060361732227,0,6,regulation of interferon-beta biosynthetic process,BP,
11224,GO:0045358,1,0.978625281382235,0,2,negative regulation of interferon-beta biosynthetic process,BP,
11225,GO:0045359,1,0.981589249150615,0,4,positive regulation of interferon-beta biosynthetic process,BP,
11226,GO:0045360,1,0.971427295038322,0,2,regulation of interleukin-1 biosynthetic process,BP,
11227,GO:0045362,1,0.971427295038322,0,2,positive regulation of interleukin-1 biosynthetic process,BP,
11228,GO:0045381,1,0.995366851515136,0,1,regulation of interleukin-18 biosynthetic process,BP,
11229,GO:0045399,1,0.995366990826164,0,1,regulation of interleukin-3 biosynthetic process,BP,
11230,GO:0045401,1,0.995366990826164,0,1,positive regulation of interleukin-3 biosynthetic process,BP,
11231,GO:0045402,1,0.990751647398477,0,2,regulation of interleukin-4 biosynthetic process,BP,
11232,GO:0045403,1,0.99536685468278,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
11233,GO:0045404,1,0.995363558172447,0,1,positive regulation of interleukin-4 biosynthetic process,BP,
11234,GO:0045408,1,0.946578110090264,0,9,regulation of interleukin-6 biosynthetic process,BP,
11235,GO:0045409,1,0.990755061176353,0,2,negative regulation of interleukin-6 biosynthetic process,BP,
11236,GO:0045410,1,0.962625633447354,0,6,positive regulation of interleukin-6 biosynthetic process,BP,
11237,GO:0045414,1,0.96528883837589,0,6,regulation of interleukin-8 biosynthetic process,BP,
11238,GO:0045415,1,0.9833487957253,0,3,negative regulation of interleukin-8 biosynthetic process,BP,
11239,GO:0045416,1,0.981637748331653,0,3,positive regulation of interleukin-8 biosynthetic process,BP,
11240,GO:0045423,1,0.995366990826164,0,1,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11241,GO:0045425,1,0.995366990826164,0,1,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11242,GO:0045428,1,0.790843540600019,0,35,regulation of nitric oxide biosynthetic process,BP,
11243,GO:0045429,1,0.862771810326145,0,25,positive regulation of nitric oxide biosynthetic process,BP,
11246,GO:0045446,1,0.677088475017829,0,66,endothelial cell differentiation,BP,
11248,GO:0045453,1,0.818462245444178,0,35,bone resorption,BP,
11250,GO:0045471,1,0.577920782814698,0,70,response to ethanol,BP,
11251,GO:0045472,1,0.957587519174365,0,7,response to ether,BP,
11253,GO:0045485,1,0.995366990826151,0,1,omega-6 fatty acid desaturase activity,MF,
11254,GO:0045494,1,0.899177815053948,0,20,photoreceptor cell maintenance,BP,
11255,GO:0045495,1,0.94300618628754,0,7,pole plasm,CC,
11256,GO:0045499,1,0.92383148639053,0,17,chemorepellent activity,MF,
11257,GO:0045503,1,0.928380111510168,0,15,dynein light chain binding,MF,
11258,GO:0045504,1,0.943716127662242,0,10,dynein heavy chain binding,MF,
11259,GO:0045505,1,0.821288093801339,0,21,dynein intermediate chain binding,MF,
11260,GO:0045509,1,0.990754912864058,0,2,interleukin-27 receptor activity,MF,
11261,GO:0045517,1,0.984135791080892,0,1,interleukin-20 receptor binding,MF,
11262,GO:0045518,1,0.984135791080892,0,1,interleukin-22 receptor binding,MF,
11263,GO:0045519,1,0.980325580791004,0,1,interleukin-23 receptor binding,MF,
11264,GO:0045540,1,0.764356066383522,0,41,regulation of cholesterol biosynthetic process,BP,
11265,GO:0045541,1,0.945371668120675,0,5,negative regulation of cholesterol biosynthetic process,BP,
11266,GO:0045542,1,0.976961385401325,0,5,positive regulation of cholesterol biosynthetic process,BP,
11267,GO:0045545,1,0.972818552982889,0,5,syndecan binding,MF,
11268,GO:0045569,1,0.969626653547677,0,4,TRAIL binding,MF,
11269,GO:0045575,1,0.989707361047725,0,2,basophil activation,BP,
11270,GO:0045576,1,0.816132085140899,0,29,mast cell activation,BP,
11271,GO:0045577,1,0.875905565556048,0,21,regulation of B cell differentiation,BP,
11272,GO:0045578,1,0.971950638122621,0,4,negative regulation of B cell differentiation,BP,
11273,GO:0045579,1,0.931909588048853,0,10,positive regulation of B cell differentiation,BP,
11274,GO:0045580,1,0.59153147743202,0,78,regulation of T cell differentiation,BP,
11275,GO:0045581,1,0.880733978699019,0,20,negative regulation of T cell differentiation,BP,
11276,GO:0045582,1,0.733743711114043,0,43,positive regulation of T cell differentiation,BP,
11277,GO:0045583,1,0.98617239533583,0,2,regulation of cytotoxic T cell differentiation,BP,
11278,GO:0045585,1,0.98617239533583,0,2,positive regulation of cytotoxic T cell differentiation,BP,
11279,GO:0045586,1,0.986164531023741,0,3,regulation of gamma-delta T cell differentiation,BP,
11280,GO:0045588,1,0.990755199849292,0,2,positive regulation of gamma-delta T cell differentiation,BP,
11281,GO:0045589,1,0.919682079485447,0,14,regulation of regulatory T cell differentiation,BP,
11282,GO:0045590,1,0.995366961824626,0,1,negative regulation of regulatory T cell differentiation,BP,
11283,GO:0045591,1,0.954517731012721,0,6,positive regulation of regulatory T cell differentiation,BP,
11290,GO:0045601,1,0.884806637885676,0,20,regulation of endothelial cell differentiation,BP,
11291,GO:0045602,1,0.963467151222985,0,5,negative regulation of endothelial cell differentiation,BP,
11292,GO:0045603,1,0.964788701082367,0,7,positive regulation of endothelial cell differentiation,BP,
11295,GO:0045606,1,0.851742061928596,0,20,positive regulation of epidermal cell differentiation,BP,
11298,GO:0045616,1,0.803523137281544,0,35,regulation of keratinocyte differentiation,BP,
11299,GO:0045617,1,0.97025363288149,0,6,negative regulation of keratinocyte differentiation,BP,
11300,GO:0045618,1,0.893625847933217,0,15,positive regulation of keratinocyte differentiation,BP,
11301,GO:0045619,1,0.51122617205514,0,99,regulation of lymphocyte differentiation,BP,
11302,GO:0045620,1,0.835946580137458,0,26,negative regulation of lymphocyte differentiation,BP,
11303,GO:0045621,1,0.682071579806431,0,53,positive regulation of lymphocyte differentiation,BP,
11304,GO:0045622,1,0.892334237109083,0,16,regulation of T-helper cell differentiation,BP,
11305,GO:0045623,1,0.950925618263608,0,9,negative regulation of T-helper cell differentiation,BP,
11306,GO:0045624,1,0.917575863584532,0,10,positive regulation of T-helper cell differentiation,BP,
11307,GO:0045625,1,0.96872927068867,0,5,regulation of T-helper 1 cell differentiation,BP,
11308,GO:0045626,1,0.990524104742717,0,2,negative regulation of T-helper 1 cell differentiation,BP,
11309,GO:0045627,1,0.977999050393529,0,3,positive regulation of T-helper 1 cell differentiation,BP,
11310,GO:0045628,1,0.942019707437715,0,8,regulation of T-helper 2 cell differentiation,BP,
11311,GO:0045629,1,0.978032805064588,0,3,negative regulation of T-helper 2 cell differentiation,BP,
11312,GO:0045630,1,0.963187251799046,0,5,positive regulation of T-helper 2 cell differentiation,BP,
11315,GO:0045634,1,0.970925261482413,0,5,regulation of melanocyte differentiation,BP,
11316,GO:0045636,1,0.986164529415223,0,3,positive regulation of melanocyte differentiation,BP,
11319,GO:0045639,1,0.681747629949958,0,59,positive regulation of myeloid cell differentiation,BP,
11320,GO:0045643,1,0.995366972901915,0,1,regulation of eosinophil differentiation,BP,
11321,GO:0045645,1,0.995366972901915,0,1,positive regulation of eosinophil differentiation,BP,
11322,GO:0045646,1,0.791797073953069,0,37,regulation of erythrocyte differentiation,BP,
11323,GO:0045647,1,0.950089322460471,0,8,negative regulation of erythrocyte differentiation,BP,
11324,GO:0045648,1,0.871919301803982,0,23,positive regulation of erythrocyte differentiation,BP,
11325,GO:0045649,1,0.929894971396823,0,12,regulation of macrophage differentiation,BP,
11326,GO:0045650,1,0.985845157246125,0,2,negative regulation of macrophage differentiation,BP,
11327,GO:0045651,1,0.943255518360202,0,10,positive regulation of macrophage differentiation,BP,
11330,GO:0045654,1,0.983478239375077,0,2,positive regulation of megakaryocyte differentiation,BP,
11331,GO:0045655,1,0.928580686996247,0,13,regulation of monocyte differentiation,BP,
11332,GO:0045656,1,0.975229202313727,0,5,negative regulation of monocyte differentiation,BP,
11333,GO:0045657,1,0.962784544987345,0,6,positive regulation of monocyte differentiation,BP,
11334,GO:0045658,1,0.984500608702224,0,3,regulation of neutrophil differentiation,BP,
11335,GO:0045659,1,0.990755182007153,0,2,negative regulation of neutrophil differentiation,BP,
11336,GO:0045660,1,0.993687738258579,0,1,positive regulation of neutrophil differentiation,BP,
11339,GO:0045663,1,0.937185691703788,0,10,positive regulation of myoblast differentiation,BP,
11342,GO:0045666,1,0.25293722877072,0,233,positive regulation of neuron differentiation,BP,
11345,GO:0045669,1,0.77807448375342,0,42,positive regulation of osteoblast differentiation,BP,
11346,GO:0045670,1,0.796150504342305,0,39,regulation of osteoclast differentiation,BP,
11347,GO:0045671,1,0.926806202606686,0,16,negative regulation of osteoclast differentiation,BP,
11348,GO:0045672,1,0.895787500284888,0,15,positive regulation of osteoclast differentiation,BP,
11351,GO:0045684,1,0.762436658928596,0,32,positive regulation of epidermis development,BP,
11355,GO:0045713,1,0.954122335376114,0,7,low-density lipoprotein particle receptor biosynthetic process,BP,
11356,GO:0045714,1,0.961120953459131,0,6,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
11357,GO:0045715,1,0.995366990826073,0,1,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
11358,GO:0045716,1,0.974609092451562,0,3,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
11359,GO:0045717,1,0.914696820833145,0,12,negative regulation of fatty acid biosynthetic process,BP,
11360,GO:0045719,1,0.976307356556496,0,5,negative regulation of glycogen biosynthetic process,BP,
11361,GO:0045721,1,0.965878824645081,0,7,negative regulation of gluconeogenesis,BP,
11362,GO:0045722,1,0.954940346257869,0,9,positive regulation of gluconeogenesis,BP,
11363,GO:0045723,1,0.942781985080685,0,9,positive regulation of fatty acid biosynthetic process,BP,
11364,GO:0045724,1,0.890073540863777,0,18,positive regulation of cilium assembly,BP,
11365,GO:0045725,1,0.959058326719999,0,9,positive regulation of glycogen biosynthetic process,BP,
11366,GO:0045726,1,0.995366990826151,0,1,positive regulation of integrin biosynthetic process,BP,
11367,GO:0045727,1,0.456559466631864,0,105,positive regulation of translation,BP,
11368,GO:0045730,1,0.872929679709193,0,14,respiratory burst,BP,
11370,GO:0045736,1,0.84176148021925,0,26,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
11371,GO:0045737,1,0.810087146152751,0,28,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
11372,GO:0045738,1,0.87375065101139,0,21,negative regulation of DNA repair,BP,
11373,GO:0045739,1,0.774784371188083,0,40,positive regulation of DNA repair,BP,
11374,GO:0045740,1,0.739372714209289,0,43,positive regulation of DNA replication,BP,
11375,GO:0045741,1,0.953663944160849,0,6,positive regulation of epidermal growth factor-activated receptor activity,BP,
11376,GO:0045742,1,0.83019025881883,0,25,positive regulation of epidermal growth factor receptor signaling pathway,BP,
11377,GO:0045743,1,0.964504461686316,0,5,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
11380,GO:0045746,1,0.799254307628377,0,32,negative regulation of Notch signaling pathway,BP,
11382,GO:0045751,1,0.995366851515136,0,1,negative regulation of Toll signaling pathway,BP,
11383,GO:0045759,1,0.983278044911785,0,2,negative regulation of action potential,BP,
11384,GO:0045760,1,0.971570633486255,0,6,positive regulation of action potential,BP,
11385,GO:0045761,1,0.934366068193223,0,11,regulation of adenylate cyclase activity,BP,
11386,GO:0045762,1,0.990755184934439,0,2,positive regulation of adenylate cyclase activity,BP,
11387,GO:0045763,1,0.990755199849122,0,2,negative regulation of cellular amino acid metabolic process,BP,
11388,GO:0045764,1,0.973027657523131,0,2,positive regulation of cellular amino acid metabolic process,BP,
11389,GO:0045765,1,0.329179716691247,0,175,regulation of angiogenesis,BP,
11390,GO:0045766,1,0.522928929419272,0,100,positive regulation of angiogenesis,BP,
11391,GO:0045769,1,0.995366990825903,0,1,negative regulation of asymmetric cell division,BP,
11392,GO:0045773,1,0.836921282277448,0,33,positive regulation of axon extension,BP,
11393,GO:0045776,1,0.86374771977275,0,24,negative regulation of blood pressure,BP,
11394,GO:0045777,1,0.880758261333037,0,14,positive regulation of blood pressure,BP,
11395,GO:0045778,1,0.711281203765853,0,55,positive regulation of ossification,BP,
11396,GO:0045779,1,0.96396627736827,0,6,negative regulation of bone resorption,BP,
11397,GO:0045780,1,0.94442174066332,0,11,positive regulation of bone resorption,BP,
11401,GO:0045792,1,0.964410736802711,0,7,negative regulation of cell size,BP,
11402,GO:0045793,1,0.950580464841203,0,9,positive regulation of cell size,BP,
11403,GO:0045794,1,0.981594888733389,0,4,negative regulation of cell volume,BP,
11404,GO:0045795,1,0.995366990826073,0,1,positive regulation of cell volume,BP,
11405,GO:0045799,1,0.985871148345683,0,2,positive regulation of chromatin assembly or disassembly,BP,
11406,GO:0045806,1,0.779216147909739,0,36,negative regulation of endocytosis,BP,
11407,GO:0045807,1,0.558430829639919,0,84,positive regulation of endocytosis,BP,
11408,GO:0045813,1,0.992243492218644,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
11411,GO:0045819,1,0.995366990612436,0,1,positive regulation of glycogen catabolic process,BP,
11413,GO:0045821,1,0.948935322457764,0,11,positive regulation of glycolytic process,BP,
11414,GO:0045822,1,0.936141289881424,0,10,negative regulation of heart contraction,BP,
11416,GO:0045824,1,0.794290400493202,0,34,negative regulation of innate immune response,BP,
11417,GO:0045829,1,0.985222521617251,0,3,negative regulation of isotype switching,BP,
11418,GO:0045830,1,0.901897263086795,0,16,positive regulation of isotype switching,BP,
11421,GO:0045835,1,0.971732334220385,0,6,negative regulation of meiotic nuclear division,BP,
11422,GO:0045836,1,0.969904816114429,0,6,positive regulation of meiotic nuclear division,BP,
11423,GO:0045837,1,0.933141582129035,0,8,negative regulation of membrane potential,BP,
11424,GO:0045838,1,0.92234184629905,0,10,positive regulation of membrane potential,BP,
11425,GO:0045839,1,0.717827297866557,0,42,negative regulation of mitotic nuclear division,BP,
11426,GO:0045840,1,0.746747203934725,0,39,positive regulation of mitotic nuclear division,BP,
11427,GO:0045841,1,0.819013078256825,0,30,negative regulation of mitotic metaphase/anaphase transition,BP,
11428,GO:0045842,1,0.934282788098058,0,8,positive regulation of mitotic metaphase/anaphase transition,BP,
11430,GO:0045844,1,0.795477148825963,0,41,positive regulation of striated muscle tissue development,BP,
11432,GO:0045852,1,0.98389847446117,0,3,pH elevation,BP,
11434,GO:0045860,1,0.0891991872813983,0,371,positive regulation of protein kinase activity,BP,
11435,GO:0045861,1,0.153044269831359,0,210,negative regulation of proteolysis,BP,
11437,GO:0045869,1,0.954603951232131,0,7,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11438,GO:0045870,1,0.995366990826125,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11439,GO:0045872,1,0.994023985838802,0,1,positive regulation of rhodopsin gene expression,BP,
11440,GO:0045875,1,0.958989061821305,0,5,negative regulation of sister chromatid cohesion,BP,
11441,GO:0045876,1,0.940945181746023,0,10,positive regulation of sister chromatid cohesion,BP,
11442,GO:0045879,1,0.906816001561508,0,20,negative regulation of smoothened signaling pathway,BP,
11443,GO:0045880,1,0.884317355166043,0,22,positive regulation of smoothened signaling pathway,BP,
11444,GO:0045887,1,0.995366990826047,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
11447,GO:0045898,1,0.903269006927277,0,13,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
11448,GO:0045899,1,0.91612425933363,0,10,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
11449,GO:0045900,1,0.971995430536845,0,4,negative regulation of translational elongation,BP,
11450,GO:0045901,1,0.976430869304163,0,3,positive regulation of translational elongation,BP,
11451,GO:0045903,1,0.951701635248227,0,3,positive regulation of translational fidelity,BP,
11452,GO:0045905,1,0.980977064995119,0,2,positive regulation of translational termination,BP,
11453,GO:0045906,1,0.965131278137601,0,6,negative regulation of vasoconstriction,BP,
11454,GO:0045907,1,0.918741121866011,0,16,positive regulation of vasoconstriction,BP,
11455,GO:0045910,1,0.90106964773944,0,21,negative regulation of DNA recombination,BP,
11456,GO:0045911,1,0.88938734078283,0,19,positive regulation of DNA recombination,BP,
11458,GO:0045913,1,0.780961953642737,0,46,positive regulation of carbohydrate metabolic process,BP,
11459,GO:0045914,1,0.99026921137323,0,2,negative regulation of catecholamine metabolic process,BP,
11460,GO:0045915,1,0.952267943166322,0,5,positive regulation of catecholamine metabolic process,BP,
11461,GO:0045916,1,0.983820064982066,0,3,negative regulation of complement activation,BP,
11462,GO:0045917,1,0.98787083921239,0,2,positive regulation of complement activation,BP,
11463,GO:0045918,1,0.956473054297395,0,2,negative regulation of cytolysis,BP,
11464,GO:0045919,1,0.961562209790443,0,4,positive regulation of cytolysis,BP,
11465,GO:0045920,1,0.901889355072162,0,18,negative regulation of exocytosis,BP,
11467,GO:0045922,1,0.901901181486871,0,15,negative regulation of fatty acid metabolic process,BP,
11468,GO:0045923,1,0.905294374144119,0,17,positive regulation of fatty acid metabolic process,BP,
11469,GO:0045924,1,0.990571717822835,0,2,regulation of female receptivity,BP,
11470,GO:0045925,1,0.995182664546486,0,1,positive regulation of female receptivity,BP,
11471,GO:0045926,1,0.308865626159212,0,166,negative regulation of growth,BP,
11472,GO:0045927,1,0.307675414761945,0,171,positive regulation of growth,BP,
11473,GO:0045930,1,0.102805563306202,0,275,negative regulation of mitotic cell cycle,BP,
11483,GO:0045943,1,0.884010205615679,0,21,positive regulation of transcription by RNA polymerase I,BP,
11485,GO:0045945,1,0.949506953793751,0,10,positive regulation of transcription by RNA polymerase III,BP,
11486,GO:0045947,1,0.85025898016422,0,18,negative regulation of translational initiation,BP,
11487,GO:0045948,1,0.854752382641765,0,23,positive regulation of translational initiation,BP,
11488,GO:0045950,1,0.990631022570731,0,2,negative regulation of mitotic recombination,BP,
11489,GO:0045953,1,0.944093967359034,0,8,negative regulation of natural killer cell mediated cytotoxicity,BP,
11490,GO:0045954,1,0.945620145058948,0,8,positive regulation of natural killer cell mediated cytotoxicity,BP,
11491,GO:0045955,1,0.965384719314355,0,7,negative regulation of calcium ion-dependent exocytosis,BP,
11492,GO:0045956,1,0.91923678687622,0,12,positive regulation of calcium ion-dependent exocytosis,BP,
11493,GO:0045963,1,0.99026921137323,0,2,negative regulation of dopamine metabolic process,BP,
11494,GO:0045964,1,0.952267943166322,0,5,positive regulation of dopamine metabolic process,BP,
11495,GO:0045967,1,0.990755199848823,0,2,negative regulation of growth rate,BP,
11496,GO:0045974,1,0.92436675818959,0,12,regulation of translation, ncRNA-mediated,BP,
11497,GO:0045976,1,0.990755138104075,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
11502,GO:0045987,1,0.889240821343994,0,18,positive regulation of smooth muscle contraction,BP,
11503,GO:0045988,1,0.984568993656784,0,3,negative regulation of striated muscle contraction,BP,
11505,GO:0045990,1,0.973228768862704,0,4,carbon catabolite regulation of transcription,BP,
11506,GO:0045991,1,0.973228768862704,0,4,carbon catabolite activation of transcription,BP,
11507,GO:0045992,1,0.904558741118114,0,19,negative regulation of embryonic development,BP,
11508,GO:0045993,1,0.995366990826164,0,1,negative regulation of translational initiation by iron,BP,
11509,GO:0045994,1,0.986207810804286,0,2,positive regulation of translational initiation by iron,BP,
11511,GO:0046006,1,0.79384343630293,0,26,regulation of activated T cell proliferation,BP,
11512,GO:0046007,1,0.9500646862562,0,8,negative regulation of activated T cell proliferation,BP,
11513,GO:0046015,1,0.968852866150937,0,4,regulation of transcription by glucose,BP,
11514,GO:0046016,1,0.977759910252335,0,3,positive regulation of transcription by glucose,BP,
11515,GO:0046030,1,0.948558743799271,0,11,inositol trisphosphate phosphatase activity,MF,
11517,GO:0046032,1,0.989090766060667,0,1,ADP catabolic process,BP,
11518,GO:0046033,1,0.930098999149427,0,9,AMP metabolic process,BP,
11520,GO:0046035,1,0.984376090933901,0,1,CMP metabolic process,BP,
11522,GO:0046037,1,0.884048804929828,0,19,GMP metabolic process,BP,
11523,GO:0046038,1,0.987320871589949,0,1,GMP catabolic process,BP,
11525,GO:0046040,1,0.928471658960255,0,12,IMP metabolic process,BP,
11526,GO:0046041,1,0.977002398929532,0,2,ITP metabolic process,BP,
11527,GO:0046048,1,0.995366616056572,0,1,UDP metabolic process,BP,
11528,GO:0046049,1,0.940722013425988,0,9,UMP metabolic process,BP,
11530,GO:0046054,1,0.979270594786824,0,1,dGMP metabolic process,BP,
11531,GO:0046056,1,0.988869993719741,0,1,dADP metabolic process,BP,
11532,GO:0046057,1,0.988869993719741,0,1,dADP catabolic process,BP,
11533,GO:0046058,1,0.785070177537534,0,39,cAMP metabolic process,BP,
11534,GO:0046060,1,0.9325243964248,0,5,dATP metabolic process,BP,
11535,GO:0046061,1,0.957983037585008,0,3,dATP catabolic process,BP,
11536,GO:0046065,1,0.981877914626818,0,1,dCTP metabolic process,BP,
11537,GO:0046066,1,0.968368706229188,0,2,dGDP metabolic process,BP,
11538,GO:0046067,1,0.988869993719741,0,1,dGDP catabolic process,BP,
11539,GO:0046068,1,0.886821595242068,0,22,cGMP metabolic process,BP,
11540,GO:0046069,1,0.990755199849186,0,2,cGMP catabolic process,BP,
11541,GO:0046070,1,0.94301770633876,0,4,dGTP metabolic process,BP,
11542,GO:0046072,1,0.977743114261659,0,2,dTDP metabolic process,BP,
11543,GO:0046073,1,0.979064559849284,0,3,dTMP metabolic process,BP,
11544,GO:0046075,1,0.953890238630155,0,4,dTTP metabolic process,BP,
11545,GO:0046077,1,0.977743114261659,0,2,dUDP metabolic process,BP,
11546,GO:0046078,1,0.967130139866716,0,4,dUMP metabolic process,BP,
11547,GO:0046080,1,0.992848049037796,0,1,dUTP metabolic process,BP,
11548,GO:0046081,1,0.992848049037796,0,1,dUTP catabolic process,BP,
11549,GO:0046083,1,0.954791584092673,0,3,adenine metabolic process,BP,
11550,GO:0046084,1,0.954791584092673,0,3,adenine biosynthetic process,BP,
11551,GO:0046085,1,0.965105344744565,0,6,adenosine metabolic process,BP,
11552,GO:0046086,1,0.989439262000097,0,2,adenosine biosynthetic process,BP,
11553,GO:0046087,1,0.935691790528424,0,6,cytidine metabolic process,BP,
11554,GO:0046090,1,0.989140067213088,0,1,deoxyadenosine metabolic process,BP,
11555,GO:0046092,1,0.995366990826164,0,1,deoxycytidine metabolic process,BP,
11556,GO:0046098,1,0.971615115246822,0,4,guanine metabolic process,BP,
11557,GO:0046099,1,0.980683596853657,0,2,guanine biosynthetic process,BP,
11558,GO:0046100,1,0.960189285068255,0,5,hypoxanthine metabolic process,BP,
11559,GO:0046101,1,0.966689437727798,0,4,hypoxanthine biosynthetic process,BP,
11560,GO:0046102,1,0.979760279352512,0,3,inosine metabolic process,BP,
11561,GO:0046103,1,0.984512987919473,0,2,inosine biosynthetic process,BP,
11562,GO:0046104,1,0.98078696164227,0,3,thymidine metabolic process,BP,
11563,GO:0046108,1,0.992316997393354,0,1,uridine metabolic process,BP,
11564,GO:0046110,1,0.979994521529677,0,3,xanthine metabolic process,BP,
11565,GO:0046111,1,0.989140067213088,0,1,xanthine biosynthetic process,BP,
11566,GO:0046112,1,0.878656952296726,0,19,nucleobase biosynthetic process,BP,
11567,GO:0046113,1,0.976307298847924,0,5,nucleobase catabolic process,BP,
11568,GO:0046116,1,0.965774965232723,0,3,queuosine metabolic process,BP,
11569,GO:0046121,1,0.976172290352829,0,3,deoxyribonucleoside catabolic process,BP,
11570,GO:0046122,1,0.96907467646531,0,2,purine deoxyribonucleoside metabolic process,BP,
11571,GO:0046124,1,0.989140067213088,0,1,purine deoxyribonucleoside catabolic process,BP,
11572,GO:0046125,1,0.98078696164227,0,3,pyrimidine deoxyribonucleoside metabolic process,BP,
11573,GO:0046127,1,0.99536678233859,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
11576,GO:0046130,1,0.951718774714726,0,6,purine ribonucleoside catabolic process,BP,
11579,GO:0046133,1,0.924191652573402,0,8,pyrimidine ribonucleoside catabolic process,BP,
11581,GO:0046135,1,0.883228410233076,0,13,pyrimidine nucleoside catabolic process,BP,
11582,GO:0046136,1,0.979496428396005,0,2,positive regulation of vitamin metabolic process,BP,
11584,GO:0046146,1,0.922624564481377,0,7,tetrahydrobiopterin metabolic process,BP,
11585,GO:0046148,1,0.726185425431223,0,40,pigment biosynthetic process,BP,
11586,GO:0046149,1,0.930520355595146,0,6,pigment catabolic process,BP,
11587,GO:0046160,1,0.990754892204004,0,2,heme a metabolic process,BP,
11588,GO:0046164,1,0.81936577517089,0,30,alcohol catabolic process,BP,
11589,GO:0046165,1,0.453147393035968,0,111,alcohol biosynthetic process,BP,
11590,GO:0046166,1,0.98237352926765,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
11591,GO:0046167,1,0.990755185053954,0,2,glycerol-3-phosphate biosynthetic process,BP,
11592,GO:0046168,1,0.995366990426746,0,1,glycerol-3-phosphate catabolic process,BP,
11593,GO:0046173,1,0.733362925417473,0,42,polyol biosynthetic process,BP,
11594,GO:0046174,1,0.897322646381151,0,18,polyol catabolic process,BP,
11595,GO:0046176,1,0.995366574475227,0,1,aldonic acid catabolic process,BP,
11596,GO:0046177,1,0.995366574475227,0,1,D-gluconate catabolic process,BP,
11597,GO:0046184,1,0.945431501434453,0,10,aldehyde biosynthetic process,BP,
11598,GO:0046185,1,0.932583444541368,0,9,aldehyde catabolic process,BP,
11599,GO:0046189,1,0.878195178468692,0,18,phenol-containing compound biosynthetic process,BP,
11600,GO:0046203,1,0.974570882022685,0,2,spermidine catabolic process,BP,
11601,GO:0046204,1,0.978712031215829,0,1,nor-spermidine metabolic process,BP,
11602,GO:0046208,1,0.967536731795036,0,3,spermine catabolic process,BP,
11603,GO:0046209,1,0.719223236006963,0,48,nitric oxide metabolic process,BP,
11604,GO:0046210,1,0.995280951782955,0,1,nitric oxide catabolic process,BP,
11605,GO:0046218,1,0.975702689598349,0,3,indolalkylamine catabolic process,BP,
11606,GO:0046222,1,0.995365164953568,0,1,aflatoxin metabolic process,BP,
11607,GO:0046223,1,0.995365164953568,0,1,aflatoxin catabolic process,BP,
11608,GO:0046272,1,0.994694186358932,0,1,stilbene catabolic process,BP,
11609,GO:0046292,1,0.974331783106416,0,3,formaldehyde metabolic process,BP,
11610,GO:0046293,1,0.995366990826165,0,1,formaldehyde biosynthetic process,BP,
11611,GO:0046294,1,0.978867999431272,0,2,formaldehyde catabolic process,BP,
11612,GO:0046295,1,0.978037514283719,0,1,glycolate biosynthetic process,BP,
11613,GO:0046305,1,0.995362644056522,0,1,alkanesulfonate biosynthetic process,BP,
11614,GO:0046316,1,0.995366574475227,0,1,gluconokinase activity,MF,
11615,GO:0046317,1,0.995366990826164,0,1,regulation of glucosylceramide biosynthetic process,BP,
11616,GO:0046318,1,0.995366990826164,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
11617,GO:0046320,1,0.924634296397685,0,16,regulation of fatty acid oxidation,BP,
11618,GO:0046321,1,0.96026367795076,0,8,positive regulation of fatty acid oxidation,BP,
11619,GO:0046322,1,0.980972353344049,0,4,negative regulation of fatty acid oxidation,BP,
11620,GO:0046323,1,0.75698682446641,0,52,glucose import,BP,
11621,GO:0046324,1,0.800763788751451,0,43,regulation of glucose import,BP,
11622,GO:0046325,1,0.948751583567315,0,9,negative regulation of glucose import,BP,
11623,GO:0046326,1,0.879595026035538,0,26,positive regulation of glucose import,BP,
11624,GO:0046327,1,0.993533089308813,0,1,glycerol biosynthetic process from pyruvate,BP,
11625,GO:0046328,1,0.45458379031692,0,129,regulation of JNK cascade,BP,
11626,GO:0046329,1,0.840094253406857,0,28,negative regulation of JNK cascade,BP,
11627,GO:0046330,1,0.576204195123916,0,91,positive regulation of JNK cascade,BP,
11629,GO:0046332,1,0.734508895165902,0,57,SMAD binding,MF,
11630,GO:0046333,1,0.995366720724551,0,1,octopamine metabolic process,BP,
11631,GO:0046337,1,0.925007144934071,0,15,phosphatidylethanolamine metabolic process,BP,
11632,GO:0046338,1,0.990752279635499,0,2,phosphatidylethanolamine catabolic process,BP,
11633,GO:0046339,1,0.929406223706518,0,12,diacylglycerol metabolic process,BP,
11634,GO:0046340,1,0.990752494964976,0,2,diacylglycerol catabolic process,BP,
11635,GO:0046341,1,0.927333749772052,0,14,CDP-diacylglycerol metabolic process,BP,
11636,GO:0046348,1,0.947115098925602,0,8,amino sugar catabolic process,BP,
11637,GO:0046349,1,0.937748701595754,0,11,amino sugar biosynthetic process,BP,
11638,GO:0046351,1,0.990755187628362,0,2,disaccharide biosynthetic process,BP,
11639,GO:0046355,1,0.995366891169665,0,1,mannan catabolic process,BP,
11640,GO:0046356,1,0.974265540024681,0,2,acetyl-CoA catabolic process,BP,
11641,GO:0046359,1,0.99321405027932,0,1,butyrate catabolic process,BP,
11642,GO:0046360,1,0.994334404277009,0,1,2-oxobutyrate biosynthetic process,BP,
11643,GO:0046361,1,0.994334404277009,0,1,2-oxobutyrate metabolic process,BP,
11645,GO:0046365,1,0.704203131664839,0,46,monosaccharide catabolic process,BP,
11646,GO:0046368,1,0.96846266629928,0,4,GDP-L-fucose metabolic process,BP,
11647,GO:0046370,1,0.982452342364271,0,2,fructose biosynthetic process,BP,
11648,GO:0046379,1,0.990748319514917,0,2,extracellular polysaccharide metabolic process,BP,
11649,GO:0046380,1,0.995366987302721,0,1,N-acetylneuraminate biosynthetic process,BP,
11650,GO:0046381,1,0.98426545667271,0,1,CMP-N-acetylneuraminate metabolic process,BP,
11651,GO:0046385,1,0.902942214942224,0,10,deoxyribose phosphate biosynthetic process,BP,
11652,GO:0046386,1,0.826577231837508,0,19,deoxyribose phosphate catabolic process,BP,
11654,GO:0046391,1,0.985250882739635,0,3,5-phosphoribose 1-diphosphate metabolic process,BP,
11656,GO:0046395,1,0.257066755665019,0,190,carboxylic acid catabolic process,BP,
11657,GO:0046398,1,0.985263369475109,0,3,UDP-glucuronate metabolic process,BP,
11658,GO:0046403,1,0.991485701225143,0,1,polynucleotide 3'-phosphatase activity,MF,
11659,GO:0046404,1,0.978695044188488,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
11660,GO:0046415,1,0.973504380164187,0,5,urate metabolic process,BP,
11661,GO:0046416,1,0.995254133737912,0,1,D-amino acid metabolic process,BP,
11663,GO:0046426,1,0.835174955818405,0,32,negative regulation of JAK-STAT cascade,BP,
11666,GO:0046437,1,0.995254133737912,0,1,D-amino acid biosynthetic process,BP,
11667,GO:0046439,1,0.976595196893448,0,5,L-cysteine metabolic process,BP,
11668,GO:0046440,1,0.985550406988491,0,3,L-lysine metabolic process,BP,
11669,GO:0046443,1,0.993565389060168,0,1,FAD metabolic process,BP,
11670,GO:0046444,1,0.995362644056522,0,1,FMN metabolic process,BP,
11671,GO:0046448,1,0.995213700845504,0,1,tropane alkaloid metabolic process,BP,
11672,GO:0046449,1,0.981594888733544,0,4,creatinine metabolic process,BP,
11673,GO:0046452,1,0.970832011566596,0,3,dihydrofolate metabolic process,BP,
11674,GO:0046456,1,0.772354491085909,0,27,icosanoid biosynthetic process,BP,
11675,GO:0046457,1,0.847776472196214,0,17,prostanoid biosynthetic process,BP,
11676,GO:0046459,1,0.910755915602896,0,12,short-chain fatty acid metabolic process,BP,
11677,GO:0046460,1,0.844634780127612,0,27,neutral lipid biosynthetic process,BP,
11678,GO:0046461,1,0.890437039974055,0,16,neutral lipid catabolic process,BP,
11679,GO:0046462,1,0.987447971345129,0,2,monoacylglycerol metabolic process,BP,
11680,GO:0046463,1,0.844634780127612,0,27,acylglycerol biosynthetic process,BP,
11681,GO:0046464,1,0.890437039974055,0,16,acylglycerol catabolic process,BP,
11682,GO:0046465,1,0.962366521239479,0,7,dolichyl diphosphate metabolic process,BP,
11683,GO:0046466,1,0.841980422863017,0,22,membrane lipid catabolic process,BP,
11685,GO:0046469,1,0.968284620616203,0,5,platelet activating factor metabolic process,BP,
11686,GO:0046470,1,0.670066200026656,0,56,phosphatidylcholine metabolic process,BP,
11687,GO:0046471,1,0.874011522298167,0,25,phosphatidylglycerol metabolic process,BP,
11688,GO:0046473,1,0.858458368875561,0,30,phosphatidic acid metabolic process,BP,
11690,GO:0046475,1,0.886351468233304,0,15,glycerophospholipid catabolic process,BP,
11691,GO:0046476,1,0.970275906455802,0,5,glycosylceramide biosynthetic process,BP,
11692,GO:0046477,1,0.964498511051982,0,6,glycosylceramide catabolic process,BP,
11693,GO:0046478,1,0.995366990826165,0,1,lactosylceramide metabolic process,BP,
11694,GO:0046479,1,0.943420664117603,0,10,glycosphingolipid catabolic process,BP,
11696,GO:0046485,1,0.949290111370165,0,7,ether lipid metabolic process,BP,
11698,GO:0046487,1,0.95751875591158,0,6,glyoxylate metabolic process,BP,
11700,GO:0046490,1,0.953304313213794,0,5,isopentenyl diphosphate metabolic process,BP,
11701,GO:0046491,1,0.976594577863242,0,1,L-methylmalonyl-CoA metabolic process,BP,
11702,GO:0046493,1,0.944033747523661,0,2,lipid A metabolic process,BP,
11703,GO:0046495,1,0.995173393564846,0,1,nicotinamide riboside metabolic process,BP,
11705,GO:0046497,1,0.995366574475227,0,1,nicotinate nucleotide metabolic process,BP,
11706,GO:0046498,1,0.941289516461387,0,6,S-adenosylhomocysteine metabolic process,BP,
11707,GO:0046499,1,0.995366864645357,0,1,S-adenosylmethioninamine metabolic process,BP,
11708,GO:0046500,1,0.921319628018553,0,10,S-adenosylmethionine metabolic process,BP,
11709,GO:0046501,1,0.931605138586966,0,9,protoporphyrinogen IX metabolic process,BP,
11710,GO:0046502,1,0.980981083953561,0,2,uroporphyrinogen III metabolic process,BP,
11711,GO:0046503,1,0.795457547928776,0,30,glycerolipid catabolic process,BP,
11712,GO:0046504,1,0.961690883943986,0,5,glycerol ether biosynthetic process,BP,
11713,GO:0046511,1,0.98829937207941,0,2,sphinganine biosynthetic process,BP,
11714,GO:0046512,1,0.935015606633025,0,8,sphingosine biosynthetic process,BP,
11715,GO:0046513,1,0.789005313154351,0,41,ceramide biosynthetic process,BP,
11716,GO:0046514,1,0.91609292670769,0,11,ceramide catabolic process,BP,
11717,GO:0046519,1,0.90683826814187,0,12,sphingoid metabolic process,BP,
11718,GO:0046520,1,0.930680325031116,0,9,sphingoid biosynthetic process,BP,
11719,GO:0046521,1,0.992783290737664,0,1,sphingoid catabolic process,BP,
11720,GO:0046523,1,0.995366768469134,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
11721,GO:0046525,1,0.991474999532875,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
11722,GO:0046526,1,0.995296708755865,0,1,D-xylulose reductase activity,MF,
11723,GO:0046527,1,0.913178138279984,0,14,glucosyltransferase activity,MF,
11724,GO:0046530,1,0.858288607894072,0,28,photoreceptor cell differentiation,BP,
11725,GO:0046532,1,0.976187279794508,0,5,regulation of photoreceptor cell differentiation,BP,
11726,GO:0046533,1,0.980732038049213,0,4,negative regulation of photoreceptor cell differentiation,BP,
11727,GO:0046534,1,0.995366990826164,0,1,positive regulation of photoreceptor cell differentiation,BP,
11728,GO:0046538,1,0.984800719828568,0,2,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
11729,GO:0046539,1,0.977398407059126,0,1,histamine N-methyltransferase activity,MF,
11731,GO:0046541,1,0.99536535797542,0,1,saliva secretion,BP,
11732,GO:0046543,1,0.948970151020618,0,7,development of secondary female sexual characteristics,BP,
11733,GO:0046544,1,0.995366990826164,0,1,development of secondary male sexual characteristics,BP,
11736,GO:0046548,1,0.986072659718788,0,3,retinal rod cell development,BP,
11737,GO:0046549,1,0.985944089747538,0,3,retinal cone cell development,BP,
11738,GO:0046554,1,0.985473658520872,0,1,malate dehydrogenase (NADP+) activity,MF,
11739,GO:0046570,1,0.984632399797541,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
11740,GO:0046573,1,0.990472787608466,0,1,lactonohydrolase activity,MF,
11741,GO:0046577,1,0.995366985943095,0,1,long-chain-alcohol oxidase activity,MF,
11742,GO:0046578,1,0.373898964257481,0,190,regulation of Ras protein signal transduction,BP,
11743,GO:0046579,1,0.83174240842707,0,29,positive regulation of Ras protein signal transduction,BP,
11744,GO:0046580,1,0.813746963427435,0,41,negative regulation of Ras protein signal transduction,BP,
11745,GO:0046581,1,0.984482343997446,0,3,intercellular canaliculus,CC,
11746,GO:0046586,1,0.972912749731271,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
11747,GO:0046587,1,0.995366690726578,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
11748,GO:0046588,1,0.977442728775064,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
11749,GO:0046592,1,0.985347032142105,0,2,polyamine oxidase activity,MF,
11750,GO:0046596,1,0.819034215281345,0,18,regulation of viral entry into host cell,BP,
11751,GO:0046597,1,0.875471106022539,0,12,negative regulation of viral entry into host cell,BP,
11752,GO:0046598,1,0.935624518468,0,6,positive regulation of viral entry into host cell,BP,
11753,GO:0046599,1,0.899241584435464,0,17,regulation of centriole replication,BP,
11754,GO:0046600,1,0.946105946002633,0,8,negative regulation of centriole replication,BP,
11755,GO:0046601,1,0.986164352915486,0,3,positive regulation of centriole replication,BP,
11756,GO:0046602,1,0.944800172157747,0,8,regulation of mitotic centrosome separation,BP,
11757,GO:0046604,1,0.96794115598161,0,3,positive regulation of mitotic centrosome separation,BP,
11758,GO:0046605,1,0.735343555987633,0,50,regulation of centrosome cycle,BP,
11759,GO:0046606,1,0.904989874148029,0,13,negative regulation of centrosome cycle,BP,
11760,GO:0046607,1,0.940671477039469,0,9,positive regulation of centrosome cycle,BP,
11761,GO:0046618,1,0.984661162590556,0,2,drug export,BP,
11762,GO:0046619,1,0.995366990826073,0,1,optic placode formation involved in camera-type eye formation,BP,
11763,GO:0046620,1,0.732194904596717,0,57,regulation of organ growth,BP,
11764,GO:0046621,1,0.899473817232807,0,22,negative regulation of organ growth,BP,
11765,GO:0046622,1,0.863649833439768,0,26,positive regulation of organ growth,BP,
11766,GO:0046623,1,0.995366990826099,0,1,sphingolipid-translocating ATPase activity,MF,
11767,GO:0046624,1,0.966933956389817,0,6,sphingolipid transporter activity,MF,
11768,GO:0046625,1,0.941228988826624,0,11,sphingolipid binding,MF,
11769,GO:0046626,1,0.777534225877952,0,42,regulation of insulin receptor signaling pathway,BP,
11770,GO:0046627,1,0.844128341461949,0,27,negative regulation of insulin receptor signaling pathway,BP,
11771,GO:0046628,1,0.957171504186934,0,9,positive regulation of insulin receptor signaling pathway,BP,
11772,GO:0046629,1,0.944701999646212,0,9,gamma-delta T cell activation,BP,
11775,GO:0046633,1,0.905717378873609,0,13,alpha-beta T cell proliferation,BP,
11776,GO:0046634,1,0.772794920840722,0,40,regulation of alpha-beta T cell activation,BP,
11777,GO:0046635,1,0.83967173071095,0,25,positive regulation of alpha-beta T cell activation,BP,
11778,GO:0046636,1,0.921317224959957,0,15,negative regulation of alpha-beta T cell activation,BP,
11779,GO:0046637,1,0.824023312883016,0,30,regulation of alpha-beta T cell differentiation,BP,
11780,GO:0046638,1,0.859263549841474,0,21,positive regulation of alpha-beta T cell differentiation,BP,
11781,GO:0046639,1,0.942129363660065,0,11,negative regulation of alpha-beta T cell differentiation,BP,
11782,GO:0046640,1,0.91794062822769,0,11,regulation of alpha-beta T cell proliferation,BP,
11783,GO:0046641,1,0.936811547891626,0,7,positive regulation of alpha-beta T cell proliferation,BP,
11784,GO:0046642,1,0.984432932405035,0,3,negative regulation of alpha-beta T cell proliferation,BP,
11785,GO:0046643,1,0.981594888733571,0,4,regulation of gamma-delta T cell activation,BP,
11786,GO:0046645,1,0.986164531023767,0,3,positive regulation of gamma-delta T cell activation,BP,
11789,GO:0046653,1,0.892929967442495,0,15,tetrahydrofolate metabolic process,BP,
11790,GO:0046654,1,0.951112362378198,0,7,tetrahydrofolate biosynthetic process,BP,
11791,GO:0046655,1,0.89229359499438,0,17,folic acid metabolic process,BP,
11792,GO:0046657,1,0.972381284528694,0,2,folic acid catabolic process,BP,
11793,GO:0046658,1,0.833537923992859,0,24,anchored component of plasma membrane,CC,
11796,GO:0046666,1,0.97075673338627,0,2,retinal cell programmed cell death,BP,
11797,GO:0046668,1,0.995366989202906,0,1,regulation of retinal cell programmed cell death,BP,
11798,GO:0046671,1,0.995366989202906,0,1,negative regulation of retinal cell programmed cell death,BP,
11799,GO:0046676,1,0.828975807825094,0,24,negative regulation of insulin secretion,BP,
11801,GO:0046680,1,0.994224337440378,0,1,response to DDT,BP,
11802,GO:0046683,1,0.579958831889141,0,85,response to organophosphorus,BP,
11803,GO:0046684,1,0.988502342268388,0,2,response to pyrethroid,BP,
11804,GO:0046685,1,0.80228411299586,0,29,response to arsenic-containing substance,BP,
11805,GO:0046686,1,0.644127973544759,0,44,response to cadmium ion,BP,
11806,GO:0046687,1,0.981445284486209,0,1,response to chromate,BP,
11807,GO:0046688,1,0.760313255372752,0,22,response to copper ion,BP,
11808,GO:0046689,1,0.955543370827571,0,5,response to mercury ion,BP,
11809,GO:0046690,1,0.995366945682435,0,1,response to tellurium ion,BP,
11810,GO:0046695,1,0.974364205256593,0,3,SLIK (SAGA-like) complex,CC,
11811,GO:0046696,1,0.99038328603006,0,2,lipopolysaccharide receptor complex,CC,
11812,GO:0046697,1,0.918270430261166,0,16,decidualization,BP,
11814,GO:0046703,1,0.869324216277533,0,9,natural killer cell lectin-like receptor binding,MF,
11815,GO:0046707,1,0.984507722529674,0,2,IDP metabolic process,BP,
11816,GO:0046709,1,0.984507722529674,0,2,IDP catabolic process,BP,
11817,GO:0046710,1,0.923039274759948,0,12,GDP metabolic process,BP,
11818,GO:0046711,1,0.979270594786824,0,1,GDP biosynthetic process,BP,
11819,GO:0046712,1,0.988869993719741,0,1,GDP catabolic process,BP,
11820,GO:0046713,1,0.995366775300441,0,1,borate transport,BP,
11821,GO:0046715,1,0.995366775300441,0,1,active borate transmembrane transporter activity,MF,
11822,GO:0046716,1,0.924092550987154,0,12,muscle cell cellular homeostasis,BP,
11824,GO:0046718,1,0.556075319253156,0,78,viral entry into host cell,BP,
11825,GO:0046719,1,0.943315034352566,0,7,regulation by virus of viral protein levels in host cell,BP,
11826,GO:0046724,1,0.995354459595608,0,1,oxalic acid secretion,BP,
11827,GO:0046725,1,0.995366964186677,0,1,negative regulation by virus of viral protein levels in host cell,BP,
11828,GO:0046726,1,0.981594442737631,0,4,positive regulation by virus of viral protein levels in host cell,BP,
11829,GO:0046730,1,0.983074106908371,0,2,induction of host immune response by virus,BP,
11830,GO:0046732,1,0.983074106908371,0,2,active induction of host immune response by virus,BP,
11831,GO:0046745,1,0.995366574475227,0,1,viral capsid secondary envelopment,BP,
11832,GO:0046755,1,0.830468554123728,0,23,viral budding,BP,
11833,GO:0046777,1,0.418353804784929,0,172,protein autophosphorylation,BP,
11834,GO:0046778,1,0.987519651705794,0,2,modification by virus of host mRNA processing,BP,
11835,GO:0046782,1,0.616742145427294,0,60,regulation of viral transcription,BP,
11836,GO:0046784,1,0.936102199878328,0,8,viral mRNA export from host cell nucleus,BP,
11838,GO:0046786,1,0.995366990826165,0,1,viral replication complex formation and maintenance,BP,
11839,GO:0046790,1,0.979514414597842,0,3,virion binding,MF,
11840,GO:0046794,1,0.668510453611653,0,55,transport of virus,BP,
11841,GO:0046811,1,0.995366990826138,0,1,histone deacetylase inhibitor activity,MF,
11842,GO:0046813,1,0.979366958014394,0,3,receptor-mediated virion attachment to host cell,BP,
11843,GO:0046817,1,0.983986825901894,0,1,chemokine receptor antagonist activity,MF,
11844,GO:0046822,1,0.54343698527076,0,92,regulation of nucleocytoplasmic transport,BP,
11845,GO:0046823,1,0.866268887252901,0,16,negative regulation of nucleocytoplasmic transport,BP,
11846,GO:0046824,1,0.73088365437791,0,52,positive regulation of nucleocytoplasmic transport,BP,
11847,GO:0046825,1,0.735679814966482,0,39,regulation of protein export from nucleus,BP,
11848,GO:0046826,1,0.913068436167517,0,7,negative regulation of protein export from nucleus,BP,
11849,GO:0046827,1,0.874026160708225,0,20,positive regulation of protein export from nucleus,BP,
11850,GO:0046831,1,0.930670349773248,0,15,regulation of RNA export from nucleus,BP,
11851,GO:0046832,1,0.990755199849057,0,2,negative regulation of RNA export from nucleus,BP,
11852,GO:0046833,1,0.966886006750189,0,7,positive regulation of RNA export from nucleus,BP,
11853,GO:0046834,1,0.668894470603273,0,76,lipid phosphorylation,BP,
11854,GO:0046835,1,0.858838299072065,0,24,carbohydrate phosphorylation,BP,
11855,GO:0046836,1,0.957269538265157,0,5,glycolipid transport,BP,
11856,GO:0046838,1,0.947069255069703,0,10,phosphorylated carbohydrate dephosphorylation,BP,
11857,GO:0046839,1,0.872822821597778,0,29,phospholipid dephosphorylation,BP,
11858,GO:0046847,1,0.826095958489804,0,40,filopodium assembly,BP,
11859,GO:0046848,1,0.986719226718782,0,1,hydroxyapatite binding,MF,
11860,GO:0046849,1,0.739332298726237,0,51,bone remodeling,BP,
11861,GO:0046850,1,0.869005521574728,0,27,regulation of bone remodeling,BP,
11862,GO:0046851,1,0.959498327756343,0,7,negative regulation of bone remodeling,BP,
11863,GO:0046852,1,0.94442174066332,0,11,positive regulation of bone remodeling,BP,
11864,GO:0046854,1,0.702663190101918,0,66,phosphatidylinositol phosphorylation,BP,
11865,GO:0046855,1,0.947069255069703,0,10,inositol phosphate dephosphorylation,BP,
11866,GO:0046856,1,0.906518990352698,0,21,phosphatidylinositol dephosphorylation,BP,
11867,GO:0046870,1,0.986037006573919,0,3,cadmium ion binding,MF,
11870,GO:0046874,1,0.989279801802513,0,1,quinolinate metabolic process,BP,
11871,GO:0046875,1,0.867017187515684,0,22,ephrin receptor binding,MF,
11873,GO:0046880,1,0.985367749164965,0,3,regulation of follicle-stimulating hormone secretion,BP,
11874,GO:0046881,1,0.985367749164965,0,3,positive regulation of follicle-stimulating hormone secretion,BP,
11875,GO:0046882,1,0.994563254844199,0,1,negative regulation of follicle-stimulating hormone secretion,BP,
11877,GO:0046884,1,0.98080175670752,0,4,follicle-stimulating hormone secretion,BP,
11878,GO:0046885,1,0.91337643445781,0,17,regulation of hormone biosynthetic process,BP,
11879,GO:0046886,1,0.956924986476866,0,7,positive regulation of hormone biosynthetic process,BP,
11880,GO:0046887,1,0.618740467804789,0,70,positive regulation of hormone secretion,BP,
11881,GO:0046888,1,0.787784646264291,0,33,negative regulation of hormone secretion,BP,
11884,GO:0046898,1,0.976708544637127,0,4,response to cycloheximide,BP,
11885,GO:0046899,1,0.990738997917484,0,2,nucleoside triphosphate adenylate kinase activity,MF,
11886,GO:0046900,1,0.983794854694908,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
11887,GO:0046901,1,0.995264882158447,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
11888,GO:0046902,1,0.593691688091616,0,66,regulation of mitochondrial membrane permeability,BP,
11892,GO:0046911,1,0.983095265244906,0,1,metal chelating activity,MF,
11893,GO:0046912,1,0.986164163631709,0,3,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
11895,GO:0046915,1,0.838251203444694,0,28,transition metal ion transmembrane transporter activity,MF,
11896,GO:0046916,1,0.468506154982458,0,77,cellular transition metal ion homeostasis,BP,
11897,GO:0046920,1,0.975083851516954,0,5,alpha-(1->3)-fucosyltransferase activity,MF,
11898,GO:0046921,1,0.995366876923498,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
11899,GO:0046922,1,0.990754875192275,0,2,peptide-O-fucosyltransferase activity,MF,
11900,GO:0046923,1,0.966139723967477,0,4,ER retention sequence binding,MF,
11901,GO:0046928,1,0.846222506964302,0,31,regulation of neurotransmitter secretion,BP,
11902,GO:0046929,1,0.95950433890894,0,8,negative regulation of neurotransmitter secretion,BP,
11903,GO:0046930,1,0.909566670200769,0,11,pore complex,CC,
11904,GO:0046931,1,0.901476680247855,0,15,pore complex assembly,BP,
11905,GO:0046933,1,0.950392855448711,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
11906,GO:0046934,1,0.85162175289889,0,34,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,
11907,GO:0046935,1,0.986164530900668,0,3,1-phosphatidylinositol-3-kinase regulator activity,MF,
11909,GO:0046940,1,0.968700800166197,0,4,nucleoside monophosphate phosphorylation,BP,
11910,GO:0046942,1,0.349588797444463,0,176,carboxylic acid transport,BP,
11911,GO:0046943,1,0.603895361658123,0,91,carboxylic acid transmembrane transporter activity,MF,
11912,GO:0046946,1,0.986163924488993,0,3,hydroxylysine metabolic process,BP,
11913,GO:0046947,1,0.986163924488993,0,3,hydroxylysine biosynthetic process,BP,
11914,GO:0046949,1,0.846274793456277,0,25,fatty-acyl-CoA biosynthetic process,BP,
11915,GO:0046950,1,0.960317505820771,0,7,cellular ketone body metabolic process,BP,
11916,GO:0046951,1,0.964789252426181,0,6,ketone body biosynthetic process,BP,
11917,GO:0046952,1,0.985243108092346,0,3,ketone body catabolic process,BP,
11918,GO:0046958,1,0.995366866873195,0,1,nonassociative learning,BP,
11919,GO:0046961,1,0.822238090065844,0,18,proton-transporting ATPase activity, rotational mechanism,MF,
11920,GO:0046963,1,0.988106137863915,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
11921,GO:0046964,1,0.988106137863915,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
11922,GO:0046965,1,0.939477760474146,0,12,retinoid X receptor binding,MF,
11923,GO:0046966,1,0.818499665409694,0,27,thyroid hormone receptor binding,MF,
11924,GO:0046967,1,0.990754851822421,0,2,cytosol to ER transport,BP,
11925,GO:0046968,1,0.995366990826125,0,1,peptide antigen transport,BP,
11926,GO:0046969,1,0.985871146655313,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
11927,GO:0046970,1,0.993396629402146,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
11928,GO:0046972,1,0.952040824111063,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
11929,GO:0046974,1,0.977043509018928,0,5,histone methyltransferase activity (H3-K9 specific),MF,
11930,GO:0046975,1,0.966698725509936,0,6,histone methyltransferase activity (H3-K36 specific),MF,
11931,GO:0046976,1,0.976354546799047,0,5,histone methyltransferase activity (H3-K27 specific),MF,
11932,GO:0046977,1,0.971451792630981,0,4,TAP binding,MF,
11933,GO:0046978,1,0.971451792630981,0,4,TAP1 binding,MF,
11934,GO:0046979,1,0.975974755883206,0,3,TAP2 binding,MF,
11935,GO:0046980,1,0.995366990826125,0,1,tapasin binding,MF,
11938,GO:0046984,1,0.97312205680684,0,4,regulation of hemoglobin biosynthetic process,BP,
11939,GO:0046985,1,0.977652707082771,0,3,positive regulation of hemoglobin biosynthetic process,BP,
11940,GO:0046986,1,0.995366990826164,0,1,negative regulation of hemoglobin biosynthetic process,BP,
11941,GO:0046996,1,0.995366574475227,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
11942,GO:0047006,1,0.986752269033518,0,1,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
11943,GO:0047012,1,0.989979106038821,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
11944,GO:0047015,1,0.978419412737323,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
11945,GO:0047016,1,0.994621780621837,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
11946,GO:0047017,1,0.995366574475227,0,1,prostaglandin-F synthase activity,MF,
11947,GO:0047021,1,0.984320832563559,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
11948,GO:0047023,1,0.975408435411332,0,2,androsterone dehydrogenase activity,MF,
11949,GO:0047025,1,0.974796208499423,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
11950,GO:0047035,1,0.979334613632256,0,1,testosterone dehydrogenase (NAD+) activity,MF,
11951,GO:0047042,1,0.986752269033518,0,1,androsterone dehydrogenase (B-specific) activity,MF,
11952,GO:0047045,1,0.984283928340559,0,1,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
11953,GO:0047057,1,0.960972795160988,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
11954,GO:0047066,1,0.978190619441799,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
11955,GO:0047086,1,0.975408435411332,0,2,ketosteroid monooxygenase activity,MF,
11956,GO:0047105,1,0.995278400885571,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
11957,GO:0047115,1,0.975408435411332,0,2,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
11958,GO:0047117,1,0.995366990825994,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
11959,GO:0047130,1,0.995366990826125,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
11960,GO:0047131,1,0.995366990826125,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
11961,GO:0047134,1,0.940593455822361,0,5,protein-disulfide reductase activity,MF,
11962,GO:0047144,1,0.956401680261784,0,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
11963,GO:0047150,1,0.993699964490529,0,1,betaine-homocysteine S-methyltransferase activity,MF,
11964,GO:0047159,1,0.99536699072066,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
11965,GO:0047166,1,0.993177696183732,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
11966,GO:0047179,1,0.964743982031934,0,2,platelet-activating factor acetyltransferase activity,MF,
11967,GO:0047184,1,0.971965674606711,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
11968,GO:0047186,1,0.995366990125433,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
11969,GO:0047191,1,0.99536699072066,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
11970,GO:0047192,1,0.983995245978108,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
11971,GO:0047220,1,0.99536638706212,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
11972,GO:0047223,1,0.986061567807328,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
11973,GO:0047224,1,0.995266759510814,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
11974,GO:0047237,1,0.990754750703541,0,2,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
11975,GO:0047238,1,0.981594522735386,0,4,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
11976,GO:0047256,1,0.995366990826138,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
11977,GO:0047263,1,0.995366584873465,0,1,N-acylsphingosine galactosyltransferase activity,MF,
11978,GO:0047273,1,0.995366888594687,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
11979,GO:0047275,1,0.995366958930375,0,1,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
11980,GO:0047277,1,0.993410230461435,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
11981,GO:0047280,1,0.995366990826165,0,1,nicotinamide phosphoribosyltransferase activity,MF,
11982,GO:0047288,1,0.987100763868505,0,2,monosialoganglioside sialyltransferase activity,MF,
11983,GO:0047290,1,0.990570717379245,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
11984,GO:0047291,1,0.994979936267601,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
11985,GO:0047293,1,0.990497377587918,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
11986,GO:0047298,1,0.995366990826165,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
11987,GO:0047322,1,0.990755199849097,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
11988,GO:0047323,1,0.994407934651307,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
11989,GO:0047325,1,0.9953668603647,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
11990,GO:0047326,1,0.992159402018252,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
11991,GO:0047341,1,0.995366928886859,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
11992,GO:0047369,1,0.995366574475227,0,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,
11993,GO:0047372,1,0.957840261514006,0,8,acylglycerol lipase activity,MF,
11994,GO:0047374,1,0.978882825254792,0,2,methylumbelliferyl-acetate deacetylase activity,MF,
11995,GO:0047389,1,0.990755030569708,0,2,glycerophosphocholine phosphodiesterase activity,MF,
11996,GO:0047391,1,0.987467354002107,0,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
11997,GO:0047395,1,0.995366620157594,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
11998,GO:0047408,1,0.987110992833189,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
11999,GO:0047409,1,0.987110992833189,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
12000,GO:0047429,1,0.90723175161474,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12001,GO:0047444,1,0.98426545667271,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12002,GO:0047451,1,0.995366990825994,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
12003,GO:0047464,1,0.995366990826164,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12004,GO:0047484,1,0.958911988217154,0,6,regulation of response to osmotic stress,BP,
12005,GO:0047485,1,0.495898421013521,0,96,protein N-terminus binding,MF,
12006,GO:0047493,1,0.979497000431467,0,3,ceramide cholinephosphotransferase activity,MF,
12007,GO:0047496,1,0.792551114769135,0,36,vesicle transport along microtubule,BP,
12008,GO:0047497,1,0.863061078166207,0,19,mitochondrion transport along microtubule,BP,
12009,GO:0047498,1,0.972476317670279,0,6,calcium-dependent phospholipase A2 activity,MF,
12010,GO:0047499,1,0.969519574335799,0,5,calcium-independent phospholipase A2 activity,MF,
12011,GO:0047522,1,0.975331428436983,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
12012,GO:0047536,1,0.99474766508198,0,1,2-aminoadipate transaminase activity,MF,
12013,GO:0047545,1,0.995366990826112,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
12014,GO:0047555,1,0.981594824848927,0,4,3',5'-cyclic-GMP phosphodiesterase activity,MF,
12015,GO:0047560,1,0.995366990826151,0,1,3-dehydrosphinganine reductase activity,MF,
12016,GO:0047578,1,0.995223408286427,0,1,4-hydroxyglutamate transaminase activity,MF,
12017,GO:0047598,1,0.995354459595608,0,1,7-dehydrocholesterol reductase activity,MF,
12018,GO:0047617,1,0.919187480958755,0,11,acyl-CoA hydrolase activity,MF,
12019,GO:0047620,1,0.995366620157594,0,1,acylglycerol kinase activity,MF,
12020,GO:0047621,1,0.990962446047837,0,1,acylpyruvate hydrolase activity,MF,
12021,GO:0047623,1,0.990755193597515,0,2,adenosine-phosphate deaminase activity,MF,
12022,GO:0047631,1,0.928401215920666,0,5,ADP-ribose diphosphatase activity,MF,
12023,GO:0047635,1,0.995366990515785,0,1,alanine-oxo-acid transaminase activity,MF,
12024,GO:0047658,1,0.991156461546762,0,1,alpha-amino-acid esterase activity,MF,
12025,GO:0047661,1,0.995254133737912,0,1,amino-acid racemase activity,MF,
12026,GO:0047676,1,0.995366990826151,0,1,arachidonate-CoA ligase activity,MF,
12027,GO:0047685,1,0.98868907566027,0,1,amine sulfotransferase activity,MF,
12028,GO:0047693,1,0.973014325578977,0,1,ATP diphosphatase activity,MF,
12029,GO:0047696,1,0.990709690719688,0,2,beta-adrenergic receptor kinase activity,MF,
12030,GO:0047708,1,0.994086362767229,0,1,biotinidase activity,MF,
12031,GO:0047710,1,0.981303299505924,0,1,bis(5'-adenosyl)-triphosphatase activity,MF,
12032,GO:0047718,1,0.986752269033518,0,1,indanol dehydrogenase activity,MF,
12033,GO:0047726,1,0.995280951782955,0,1,iron-cytochrome-c reductase activity,MF,
12034,GO:0047734,1,0.995366574475227,0,1,CDP-glycerol diphosphatase activity,MF,
12035,GO:0047747,1,0.995102315596589,0,1,cholate-CoA ligase activity,MF,
12036,GO:0047750,1,0.961980455332634,0,2,cholestenol delta-isomerase activity,MF,
12037,GO:0047751,1,0.990237557770863,0,2,cholestenone 5-alpha-reductase activity,MF,
12038,GO:0047756,1,0.98948552311486,0,2,chondroitin 4-sulfotransferase activity,MF,
12039,GO:0047757,1,0.990755199849057,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
12040,GO:0047760,1,0.995366896599679,0,1,butyrate-CoA ligase activity,MF,
12041,GO:0047800,1,0.995366982625587,0,1,cysteamine dioxygenase activity,MF,
12042,GO:0047801,1,0.994399471333418,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
12043,GO:0047840,1,0.981877914626818,0,1,dCTP diphosphatase activity,MF,
12044,GO:0047844,1,0.956137141543588,0,5,deoxycytidine deaminase activity,MF,
12045,GO:0047860,1,0.984850025092819,0,1,diiodophenylpyruvate reductase activity,MF,
12046,GO:0047874,1,0.994325514437845,0,1,dolichyldiphosphatase activity,MF,
12047,GO:0047888,1,0.993417007491667,0,1,fatty acid peroxidase activity,MF,
12048,GO:0047894,1,0.976725830020813,0,2,flavonol 3-sulfotransferase activity,MF,
12049,GO:0047915,1,0.990985548258812,0,1,ganglioside galactosyltransferase activity,MF,
12050,GO:0047933,1,0.995366990825994,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12051,GO:0047936,1,0.995366990825967,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
12052,GO:0047939,1,0.988214398421963,0,1,L-glucuronate reductase activity,MF,
12053,GO:0047977,1,0.995095103294964,0,1,hepoxilin-epoxide hydrolase activity,MF,
12054,GO:0047982,1,0.991669902477171,0,1,homocysteine desulfhydrase activity,MF,
12055,GO:0048002,1,0.238530467052264,0,149,antigen processing and presentation of peptide antigen,BP,
12056,GO:0048003,1,0.986164527007132,0,3,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12057,GO:0048006,1,0.995366986774077,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
12058,GO:0048007,1,0.986164527007132,0,3,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
12060,GO:0048009,1,0.880124676079877,0,22,insulin-like growth factor receptor signaling pathway,BP,
12061,GO:0048010,1,0.629499128926404,0,73,vascular endothelial growth factor receptor signaling pathway,BP,
12063,GO:0048012,1,0.938821451753434,0,11,hepatocyte growth factor receptor signaling pathway,BP,
12064,GO:0048013,1,0.611261757126543,0,72,ephrin receptor signaling pathway,BP,
12065,GO:0048014,1,0.995366990826152,0,1,Tie signaling pathway,BP,
12066,GO:0048015,1,0.558532888540263,0,104,phosphatidylinositol-mediated signaling,BP,
12067,GO:0048016,1,0.842546842423214,0,31,inositol phosphate-mediated signaling,BP,
12068,GO:0048017,1,0.550457824042105,0,107,inositol lipid-mediated signaling,BP,
12070,GO:0048019,1,0.924010627328151,0,10,receptor antagonist activity,MF,
12071,GO:0048020,1,0.884686166849452,0,8,CCR chemokine receptor binding,MF,
12072,GO:0048021,1,0.986164531023636,0,3,regulation of melanin biosynthetic process,BP,
12073,GO:0048022,1,0.990755199849175,0,2,negative regulation of melanin biosynthetic process,BP,
12074,GO:0048023,1,0.995366990826152,0,1,positive regulation of melanin biosynthetic process,BP,
12075,GO:0048024,1,0.686098618486788,0,64,regulation of mRNA splicing, via spliceosome,BP,
12076,GO:0048025,1,0.900756213336455,0,18,negative regulation of mRNA splicing, via spliceosome,BP,
12077,GO:0048026,1,0.929513902434229,0,12,positive regulation of mRNA splicing, via spliceosome,BP,
12078,GO:0048027,1,0.751057830858151,0,22,mRNA 5'-UTR binding,MF,
12080,GO:0048030,1,0.969199532235046,0,1,disaccharide binding,MF,
12081,GO:0048033,1,0.995366681765408,0,1,heme o metabolic process,BP,
12082,GO:0048034,1,0.995366681765408,0,1,heme O biosynthetic process,BP,
12084,GO:0048038,1,0.854318283540574,0,14,quinone binding,MF,
12085,GO:0048039,1,0.942070440105199,0,6,ubiquinone binding,MF,
12086,GO:0048040,1,0.994233794717128,0,1,UDP-glucuronate decarboxylase activity,MF,
12087,GO:0048041,1,0.722651519597003,0,60,focal adhesion assembly,BP,
12088,GO:0048048,1,0.888131571609718,0,22,embryonic eye morphogenesis,BP,
12089,GO:0048050,1,0.929363677902538,0,6,post-embryonic eye morphogenesis,BP,
12091,GO:0048066,1,0.815501841299654,0,30,developmental pigmentation,BP,
12092,GO:0048069,1,0.975659018260547,0,5,eye pigmentation,BP,
12093,GO:0048070,1,0.920848390385764,0,12,regulation of developmental pigmentation,BP,
12094,GO:0048073,1,0.99075519984928,0,2,regulation of eye pigmentation,BP,
12095,GO:0048075,1,0.995366990826152,0,1,positive regulation of eye pigmentation,BP,
12096,GO:0048087,1,0.948465844810429,0,7,positive regulation of developmental pigmentation,BP,
12097,GO:0048096,1,0.947618877669267,0,8,chromatin-mediated maintenance of transcription,BP,
12098,GO:0048102,1,0.951436723769616,0,7,autophagic cell death,BP,
12099,GO:0048103,1,0.924600259051907,0,16,somatic stem cell division,BP,
12100,GO:0048104,1,0.981594883945075,0,4,establishment of body hair or bristle planar orientation,BP,
12101,GO:0048105,1,0.981594883945075,0,4,establishment of body hair planar orientation,BP,
12102,GO:0048133,1,0.977268136151108,0,2,male germ-line stem cell asymmetric division,BP,
12103,GO:0048143,1,0.954468421937683,0,8,astrocyte activation,BP,
12106,GO:0048146,1,0.752238960051625,0,37,positive regulation of fibroblast proliferation,BP,
12108,GO:0048148,1,0.950611292723728,0,7,behavioral response to cocaine,BP,
12109,GO:0048149,1,0.979046530333116,0,4,behavioral response to ethanol,BP,
12110,GO:0048156,1,0.935868499825129,0,11,tau protein binding,MF,
12111,GO:0048160,1,0.995366990826165,0,1,primary follicle stage,BP,
12112,GO:0048162,1,0.990619251145234,0,1,multi-layer follicle stage,BP,
12113,GO:0048165,1,0.99075519984928,0,2,fused antrum stage,BP,
12114,GO:0048167,1,0.579463387467463,0,93,regulation of synaptic plasticity,BP,
12115,GO:0048168,1,0.8423395510889,0,29,regulation of neuronal synaptic plasticity,BP,
12116,GO:0048169,1,0.90183317574442,0,17,regulation of long-term neuronal synaptic plasticity,BP,
12117,GO:0048170,1,0.981131435903842,0,4,positive regulation of long-term neuronal synaptic plasticity,BP,
12118,GO:0048172,1,0.963324786526496,0,6,regulation of short-term neuronal synaptic plasticity,BP,
12119,GO:0048179,1,0.987476769604087,0,2,activin receptor complex,CC,
12120,GO:0048180,1,0.994563254844199,0,1,activin complex,CC,
12121,GO:0048185,1,0.926235212798277,0,11,activin binding,MF,
12122,GO:0048188,1,0.903444525059821,0,12,Set1C/COMPASS complex,CC,
12123,GO:0048193,1,0.121024121820756,0,309,Golgi vesicle transport,BP,
12124,GO:0048194,1,0.598571402351833,0,71,Golgi vesicle budding,BP,
12125,GO:0048199,1,0.617170396098358,0,64,vesicle targeting, to, from or within Golgi,BP,
12126,GO:0048200,1,0.963254437777256,0,6,Golgi transport vesicle coating,BP,
12127,GO:0048203,1,0.988682841593635,0,2,vesicle targeting, trans-Golgi to endosome,BP,
12128,GO:0048205,1,0.963254437777256,0,6,COPI coating of Golgi vesicle,BP,
12129,GO:0048207,1,0.647542406809163,0,56,vesicle targeting, rough ER to cis-Golgi,BP,
12130,GO:0048208,1,0.647542406809163,0,56,COPII vesicle coating,BP,
12131,GO:0048209,1,0.989943893016384,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
12132,GO:0048210,1,0.972821221161358,0,3,Golgi vesicle fusion to target membrane,BP,
12133,GO:0048211,1,0.990754630418634,0,2,Golgi vesicle docking,BP,
12134,GO:0048213,1,0.995366507117831,0,1,Golgi vesicle prefusion complex stabilization,BP,
12135,GO:0048227,1,0.937787316523434,0,8,plasma membrane to endosome transport,BP,
12137,GO:0048237,1,0.983935599665416,0,2,rough endoplasmic reticulum lumen,CC,
12138,GO:0048239,1,0.989722517080882,0,2,negative regulation of DNA recombination at telomere,BP,
12139,GO:0048240,1,0.931240883868729,0,7,sperm capacitation,BP,
12140,GO:0048243,1,0.980540829660401,0,4,norepinephrine secretion,BP,
12141,GO:0048244,1,0.990786842679304,0,1,phytanoyl-CoA dioxygenase activity,MF,
12142,GO:0048245,1,0.962334224613541,0,4,eosinophil chemotaxis,BP,
12143,GO:0048246,1,0.807666426668486,0,18,macrophage chemotaxis,BP,
12144,GO:0048247,1,0.810292068726937,0,21,lymphocyte chemotaxis,BP,
12145,GO:0048250,1,0.982197712049776,0,2,iron import into the mitochondrion,BP,
12146,GO:0048251,1,0.961706891424213,0,8,elastic fiber assembly,BP,
12147,GO:0048254,1,0.956932904770456,0,4,snoRNA localization,BP,
12149,GO:0048256,1,0.962783424145254,0,8,flap endonuclease activity,MF,
12150,GO:0048257,1,0.990554768516703,0,2,3'-flap endonuclease activity,MF,
12151,GO:0048259,1,0.686773985996207,0,56,regulation of receptor-mediated endocytosis,BP,
12152,GO:0048260,1,0.8040264051854,0,33,positive regulation of receptor-mediated endocytosis,BP,
12153,GO:0048261,1,0.897987527397553,0,14,negative regulation of receptor-mediated endocytosis,BP,
12156,GO:0048264,1,0.995366689838358,0,1,determination of ventral identity,BP,
12157,GO:0048265,1,0.940615882588472,0,8,response to pain,BP,
12158,GO:0048266,1,0.956139001906462,0,5,behavioral response to pain,BP,
12160,GO:0048269,1,0.989591123944043,0,2,methionine adenosyltransferase complex,CC,
12161,GO:0048270,1,0.994198059050158,0,1,methionine adenosyltransferase regulator activity,MF,
12162,GO:0048273,1,0.964214564665881,0,6,mitogen-activated protein kinase p38 binding,MF,
12164,GO:0048280,1,0.931821529227139,0,10,vesicle fusion with Golgi apparatus,BP,
12165,GO:0048284,1,0.374525250681213,0,146,organelle fusion,BP,
12166,GO:0048285,1,0.0969827763947294,0,355,organelle fission,BP,
12167,GO:0048286,1,0.881523208045002,0,23,lung alveolus development,BP,
12168,GO:0048289,1,0.978463548981646,0,4,isotype switching to IgE isotypes,BP,
12169,GO:0048290,1,0.970194193187992,0,6,isotype switching to IgA isotypes,BP,
12170,GO:0048291,1,0.957681699809115,0,8,isotype switching to IgG isotypes,BP,
12171,GO:0048293,1,0.978463548981646,0,4,regulation of isotype switching to IgE isotypes,BP,
12172,GO:0048294,1,0.990755143871178,0,2,negative regulation of isotype switching to IgE isotypes,BP,
12173,GO:0048295,1,0.987595030387619,0,2,positive regulation of isotype switching to IgE isotypes,BP,
12174,GO:0048296,1,0.974711460138009,0,5,regulation of isotype switching to IgA isotypes,BP,
12175,GO:0048297,1,0.994416348475733,0,1,negative regulation of isotype switching to IgA isotypes,BP,
12176,GO:0048298,1,0.980185734709725,0,4,positive regulation of isotype switching to IgA isotypes,BP,
12177,GO:0048302,1,0.962502497874011,0,7,regulation of isotype switching to IgG isotypes,BP,
12178,GO:0048304,1,0.971486824056281,0,5,positive regulation of isotype switching to IgG isotypes,BP,
12179,GO:0048305,1,0.923952935613646,0,11,immunoglobulin secretion,BP,
12180,GO:0048306,1,0.697219995902819,0,38,calcium-dependent protein binding,MF,
12181,GO:0048308,1,0.90614351132219,0,15,organelle inheritance,BP,
12182,GO:0048311,1,0.936893766262497,0,14,mitochondrion distribution,BP,
12183,GO:0048312,1,0.972517692093071,0,6,intracellular distribution of mitochondria,BP,
12184,GO:0048313,1,0.910366180736274,0,14,Golgi inheritance,BP,
12185,GO:0048318,1,0.944598720416344,0,5,axial mesoderm development,BP,
12186,GO:0048319,1,0.990755129988012,0,2,axial mesoderm morphogenesis,BP,
12187,GO:0048320,1,0.995366920643499,0,1,axial mesoderm formation,BP,
12188,GO:0048332,1,0.809196036512465,0,41,mesoderm morphogenesis,BP,
12189,GO:0048333,1,0.925914150150012,0,15,mesodermal cell differentiation,BP,
12190,GO:0048338,1,0.995366972215419,0,1,mesoderm structural organization,BP,
12191,GO:0048339,1,0.935655896169183,0,14,paraxial mesoderm development,BP,
12192,GO:0048340,1,0.968010666793873,0,7,paraxial mesoderm morphogenesis,BP,
12193,GO:0048341,1,0.981594395565695,0,4,paraxial mesoderm formation,BP,
12194,GO:0048352,1,0.995366972215419,0,1,paraxial mesoderm structural organization,BP,
12195,GO:0048364,1,0.974537838279069,0,1,root development,BP,
12196,GO:0048365,1,0.762110586168971,0,52,Rac GTPase binding,MF,
12197,GO:0048368,1,0.955855909813748,0,8,lateral mesoderm development,BP,
12198,GO:0048369,1,0.990755181323762,0,2,lateral mesoderm morphogenesis,BP,
12199,GO:0048370,1,0.990755181323762,0,2,lateral mesoderm formation,BP,
12200,GO:0048371,1,0.990755181323762,0,2,lateral mesodermal cell differentiation,BP,
12201,GO:0048372,1,0.990755181323762,0,2,lateral mesodermal cell fate commitment,BP,
12202,GO:0048377,1,0.990755181323762,0,2,lateral mesodermal cell fate specification,BP,
12203,GO:0048378,1,0.990755181323762,0,2,regulation of lateral mesodermal cell fate specification,BP,
12204,GO:0048382,1,0.990754890477935,0,2,mesendoderm development,BP,
12205,GO:0048384,1,0.877085016565126,0,21,retinoic acid receptor signaling pathway,BP,
12206,GO:0048385,1,0.927397471792231,0,11,regulation of retinoic acid receptor signaling pathway,BP,
12207,GO:0048386,1,0.980597675317606,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
12208,GO:0048387,1,0.971838886801087,0,5,negative regulation of retinoic acid receptor signaling pathway,BP,
12209,GO:0048388,1,0.983123383178411,0,2,endosomal lumen acidification,BP,
12210,GO:0048389,1,0.992054598406672,0,1,intermediate mesoderm development,BP,
12211,GO:0048390,1,0.992054598406672,0,1,intermediate mesoderm morphogenesis,BP,
12212,GO:0048391,1,0.992054598406672,0,1,intermediate mesoderm formation,BP,
12213,GO:0048392,1,0.992054598406672,0,1,intermediate mesodermal cell differentiation,BP,
12214,GO:0048403,1,0.995366990093737,0,1,brain-derived neurotrophic factor binding,MF,
12215,GO:0048406,1,0.981594714509859,0,4,nerve growth factor binding,MF,
12216,GO:0048407,1,0.963523523608765,0,8,platelet-derived growth factor binding,MF,
12217,GO:0048408,1,0.955859234145977,0,4,epidermal growth factor binding,MF,
12221,GO:0048475,1,0.533771999900872,0,92,coated membrane,CC,
12222,GO:0048476,1,0.950549502335309,0,5,Holliday junction resolvase complex,CC,
12223,GO:0048477,1,0.753710069696474,0,46,oogenesis,BP,
12224,GO:0048478,1,0.952641529226218,0,7,replication fork protection,BP,
12230,GO:0048488,1,0.854734459028693,0,29,synaptic vesicle endocytosis,BP,
12231,GO:0048489,1,0.630763796910383,0,76,synaptic vesicle transport,BP,
12232,GO:0048490,1,0.877100132942651,0,15,anterograde synaptic vesicle transport,BP,
12233,GO:0048495,1,0.97856859800613,0,4,Roundabout binding,MF,
12234,GO:0048496,1,0.985956462043399,0,3,maintenance of animal organ identity,BP,
12235,GO:0048499,1,0.972666505122364,0,3,synaptic vesicle membrane organization,BP,
12236,GO:0048500,1,0.910224482597807,0,9,signal recognition particle,CC,
12242,GO:0048515,1,0.591987842743873,0,73,spermatid differentiation,BP,
12245,GO:0048520,1,0.981594162375692,0,4,positive regulation of behavior,BP,
12249,GO:0048524,1,0.465723832062133,0,95,positive regulation of viral process,BP,
12250,GO:0048525,1,0.564626840817912,0,72,negative regulation of viral process,BP,
12251,GO:0048531,1,0.923633425566019,0,13,beta-1,3-galactosyltransferase activity,MF,
12252,GO:0048532,1,0.949302822898486,0,10,anatomical structure arrangement,BP,
12254,GO:0048535,1,0.923812410315392,0,12,lymph node development,BP,
12255,GO:0048536,1,0.868988332857693,0,24,spleen development,BP,
12256,GO:0048537,1,0.95461259270945,0,6,mucosal-associated lymphoid tissue development,BP,
12258,GO:0048539,1,0.976344197069015,0,4,bone marrow development,BP,
12259,GO:0048541,1,0.95461259270945,0,6,Peyer's patch development,BP,
12261,GO:0048546,1,0.869416299506863,0,26,digestive tract morphogenesis,BP,
12262,GO:0048548,1,0.951868016822165,0,9,regulation of pinocytosis,BP,
12263,GO:0048549,1,0.981300803572484,0,4,positive regulation of pinocytosis,BP,
12264,GO:0048550,1,0.970012782426077,0,5,negative regulation of pinocytosis,BP,
12265,GO:0048557,1,0.948504737032138,0,8,embryonic digestive tract morphogenesis,BP,
12266,GO:0048560,1,0.989364841942132,0,2,establishment of anatomical structure orientation,BP,
12267,GO:0048561,1,0.994736567310076,0,1,establishment of animal organ orientation,BP,
12269,GO:0048563,1,0.925054306752154,0,7,post-embryonic animal organ morphogenesis,BP,
12271,GO:0048566,1,0.90399092371829,0,16,embryonic digestive tract development,BP,
12273,GO:0048569,1,0.894398587410064,0,14,post-embryonic animal organ development,BP,
12274,GO:0048570,1,0.968486661346697,0,5,notochord morphogenesis,BP,
12278,GO:0048588,1,0.437377444660981,0,143,developmental cell growth,BP,
12279,GO:0048589,1,0.0967580095767904,0,396,developmental growth,BP,
12280,GO:0048592,1,0.601652786739209,0,86,eye morphogenesis,BP,
12281,GO:0048593,1,0.670964746631091,0,66,camera-type eye morphogenesis,BP,
12282,GO:0048596,1,0.930567220317859,0,15,embryonic camera-type eye morphogenesis,BP,
12283,GO:0048597,1,0.95581736904624,0,3,post-embryonic camera-type eye morphogenesis,BP,
12285,GO:0048599,1,0.848762732880193,0,28,oocyte development,BP,
12288,GO:0048611,1,0.995366648998949,0,1,embryonic ectodermal digestive tract development,BP,
12289,GO:0048617,1,0.977046117281465,0,5,embryonic foregut morphogenesis,BP,
12290,GO:0048619,1,0.995366514400037,0,1,embryonic hindgut morphogenesis,BP,
12291,GO:0048625,1,0.985901388540623,0,3,myoblast fate commitment,BP,
12292,GO:0048627,1,0.982327085228711,0,2,myoblast development,BP,
12293,GO:0048630,1,0.986164373144721,0,3,skeletal muscle tissue growth,BP,
12294,GO:0048631,1,0.986164373144721,0,3,regulation of skeletal muscle tissue growth,BP,
12295,GO:0048633,1,0.986164373144721,0,3,positive regulation of skeletal muscle tissue growth,BP,
12298,GO:0048636,1,0.795477148825963,0,41,positive regulation of muscle organ development,BP,
12299,GO:0048638,1,0.300241950100462,0,199,regulation of developmental growth,BP,
12300,GO:0048639,1,0.530782961422565,0,105,positive regulation of developmental growth,BP,
12301,GO:0048640,1,0.69362179500766,0,65,negative regulation of developmental growth,BP,
12304,GO:0048643,1,0.928506867820227,0,14,positive regulation of skeletal muscle tissue development,BP,
12305,GO:0048644,1,0.785315738037098,0,45,muscle organ morphogenesis,BP,
12314,GO:0048665,1,0.96306773370067,0,7,neuron fate specification,BP,
12317,GO:0048668,1,0.883835247961203,0,17,collateral sprouting,BP,
12318,GO:0048669,1,0.979395075937535,0,3,collateral sprouting in absence of injury,BP,
12319,GO:0048670,1,0.904623898425741,0,12,regulation of collateral sprouting,BP,
12320,GO:0048671,1,0.985901388559571,0,3,negative regulation of collateral sprouting,BP,
12321,GO:0048672,1,0.917573126484714,0,9,positive regulation of collateral sprouting,BP,
12322,GO:0048674,1,0.995212457382581,0,1,collateral sprouting of injured axon,BP,
12323,GO:0048675,1,0.626710176246896,0,87,axon extension,BP,
12324,GO:0048677,1,0.995366990826125,0,1,axon extension involved in regeneration,BP,
12325,GO:0048678,1,0.664074278167186,0,49,response to axon injury,BP,
12326,GO:0048679,1,0.883703792980077,0,18,regulation of axon regeneration,BP,
12327,GO:0048680,1,0.964927469535027,0,4,positive regulation of axon regeneration,BP,
12328,GO:0048681,1,0.928604957164639,0,11,negative regulation of axon regeneration,BP,
12329,GO:0048682,1,0.990601374201392,0,2,sprouting of injured axon,BP,
12330,GO:0048686,1,0.995212457382581,0,1,regulation of sprouting of injured axon,BP,
12331,GO:0048687,1,0.995212457382581,0,1,positive regulation of sprouting of injured axon,BP,
12332,GO:0048688,1,0.995212457382581,0,1,negative regulation of sprouting of injured axon,BP,
12333,GO:0048689,1,0.995212457382581,0,1,formation of growth cone in injured axon,BP,
12334,GO:0048693,1,0.995212457382581,0,1,regulation of collateral sprouting of injured axon,BP,
12335,GO:0048694,1,0.995212457382581,0,1,positive regulation of collateral sprouting of injured axon,BP,
12336,GO:0048696,1,0.988535139043986,0,1,regulation of collateral sprouting in absence of injury,BP,
12337,GO:0048697,1,0.988535139043986,0,1,positive regulation of collateral sprouting in absence of injury,BP,
12339,GO:0048701,1,0.839845290990166,0,32,embryonic cranial skeleton morphogenesis,BP,
12340,GO:0048702,1,0.967809637493951,0,7,embryonic neurocranium morphogenesis,BP,
12341,GO:0048703,1,0.961939670176267,0,7,embryonic viscerocranium morphogenesis,BP,
12342,GO:0048704,1,0.69234318107827,0,58,embryonic skeletal system morphogenesis,BP,
12343,GO:0048705,1,0.461658150678615,0,131,skeletal system morphogenesis,BP,
12351,GO:0048714,1,0.940931225950465,0,12,positive regulation of oligodendrocyte differentiation,BP,
12354,GO:0048730,1,0.908308418037268,0,19,epidermis morphogenesis,BP,
12357,GO:0048733,1,0.97651262516258,0,5,sebaceous gland development,BP,
12359,GO:0048738,1,0.491770639922384,0,126,cardiac muscle tissue development,BP,
12360,GO:0048739,1,0.969162948167407,0,6,cardiac muscle fiber development,BP,
12361,GO:0048741,1,0.924253944271335,0,13,skeletal muscle fiber development,BP,
12362,GO:0048742,1,0.976689416352308,0,5,regulation of skeletal muscle fiber development,BP,
12363,GO:0048743,1,0.990755197015169,0,2,positive regulation of skeletal muscle fiber development,BP,
12364,GO:0048745,1,0.938263731118378,0,13,smooth muscle tissue development,BP,
12365,GO:0048747,1,0.850441172595868,0,27,muscle fiber development,BP,
12367,GO:0048752,1,0.979825944205416,0,3,semicircular canal morphogenesis,BP,
12368,GO:0048753,1,0.819277624113804,0,23,pigment granule organization,BP,
12370,GO:0048755,1,0.976493787837684,0,5,branching morphogenesis of a nerve,BP,
12371,GO:0048757,1,0.920585540457074,0,10,pigment granule maturation,BP,
12373,GO:0048763,1,0.990755199848874,0,2,calcium-induced calcium release activity,MF,
12374,GO:0048764,1,0.974537838279069,0,1,trichoblast maturation,BP,
12375,GO:0048765,1,0.974537838279069,0,1,root hair cell differentiation,BP,
12376,GO:0048767,1,0.974537838279069,0,1,root hair elongation,BP,
12377,GO:0048769,1,0.990755199850429,0,2,sarcomerogenesis,BP,
12378,GO:0048770,1,0.517334056808349,0,92,pigment granule,CC,
12379,GO:0048771,1,0.536807649100824,0,96,tissue remodeling,BP,
12380,GO:0048786,1,0.914281667673339,0,19,presynaptic active zone,CC,
12381,GO:0048787,1,0.980541051642245,0,4,presynaptic active zone membrane,CC,
12382,GO:0048788,1,0.981594888732587,0,4,cytoskeleton of presynaptic active zone,CC,
12383,GO:0048791,1,0.910018739022331,0,18,calcium ion-regulated exocytosis of neurotransmitter,BP,
12384,GO:0048793,1,0.981594871834212,0,4,pronephros development,BP,
12386,GO:0048806,1,0.87633871062423,0,22,genitalia development,BP,
12387,GO:0048807,1,0.995366990826165,0,1,female genitalia morphogenesis,BP,
12389,GO:0048813,1,0.56724393136388,0,101,dendrite morphogenesis,BP,
12390,GO:0048814,1,0.717014362492665,0,57,regulation of dendrite morphogenesis,BP,
12391,GO:0048817,1,0.99075519984928,0,2,negative regulation of hair follicle maturation,BP,
12392,GO:0048818,1,0.960387857455733,0,4,positive regulation of hair follicle maturation,BP,
12393,GO:0048819,1,0.942703594561194,0,8,regulation of hair follicle maturation,BP,
12394,GO:0048820,1,0.91149956092397,0,15,hair follicle maturation,BP,
12395,GO:0048821,1,0.874528651317489,0,21,erythrocyte development,BP,
12396,GO:0048822,1,0.985205854397246,0,3,enucleate erythrocyte development,BP,
12399,GO:0048841,1,0.888230187548488,0,24,regulation of axon extension involved in axon guidance,BP,
12400,GO:0048842,1,0.972412833827586,0,6,positive regulation of axon extension involved in axon guidance,BP,
12401,GO:0048843,1,0.913356707137383,0,18,negative regulation of axon extension involved in axon guidance,BP,
12403,GO:0048845,1,0.960202706748037,0,8,venous blood vessel morphogenesis,BP,
12404,GO:0048846,1,0.871860047949063,0,28,axon extension involved in axon guidance,BP,
12405,GO:0048850,1,0.990755199849201,0,2,hypophysis morphogenesis,BP,
12409,GO:0048855,1,0.995366990826099,0,1,adenohypophysis morphogenesis,BP,
12411,GO:0048857,1,0.739191927826662,0,41,neural nucleus development,BP,
12413,GO:0048859,1,0.974817482965379,0,2,formation of anatomical boundary,BP,
12414,GO:0048861,1,0.977012710423916,0,4,leukemia inhibitory factor signaling pathway,BP,
12417,GO:0048865,1,0.970299822554581,0,3,stem cell fate commitment,BP,
12418,GO:0048866,1,0.99536699053359,0,1,stem cell fate specification,BP,
12419,GO:0048867,1,0.979355933200066,0,1,stem cell fate determination,BP,
12424,GO:0048873,1,0.861790700043268,0,19,homeostasis of number of cells within a tissue,BP,
12425,GO:0048874,1,0.995366872685533,0,1,homeostasis of number of cells in a free-living population,BP,
12426,GO:0048875,1,0.958711677638737,0,7,chemical homeostasis within a tissue,BP,
12428,GO:0048880,1,0.986146384995647,0,3,sensory system development,BP,
12429,GO:0048882,1,0.995352427354762,0,1,lateral line development,BP,
12430,GO:0048884,1,0.995352427354762,0,1,neuromast development,BP,
12431,GO:0048886,1,0.995352427354762,0,1,neuromast hair cell differentiation,BP,
12432,GO:0048925,1,0.995352427354762,0,1,lateral line system development,BP,
12433,GO:0048934,1,0.967499446315516,0,6,peripheral nervous system neuron differentiation,BP,
12434,GO:0048935,1,0.967499446315516,0,6,peripheral nervous system neuron development,BP,
12435,GO:0048936,1,0.984201699810904,0,3,peripheral nervous system neuron axonogenesis,BP,
12436,GO:0050000,1,0.673726035645642,0,67,chromosome localization,BP,
12437,GO:0050011,1,0.989861393139042,0,1,itaconyl-CoA hydratase activity,MF,
12438,GO:0050023,1,0.992758723783831,0,1,L-fuconate dehydratase activity,MF,
12439,GO:0050038,1,0.975756901341289,0,1,L-xylulose reductase (NADP+) activity,MF,
12440,GO:0050046,1,0.995366574475227,0,1,lathosterol oxidase activity,MF,
12441,GO:0050072,1,0.950420357985817,0,7,m7G(5')pppN diphosphatase activity,MF,
12442,GO:0050080,1,0.994642972742358,0,1,malonyl-CoA decarboxylase activity,MF,
12443,GO:0050104,1,0.988608664997433,0,1,L-gulonate 3-dehydrogenase activity,MF,
12444,GO:0050115,1,0.995366990826165,0,1,myosin-light-chain-phosphatase activity,MF,
12445,GO:0050119,1,0.990755199847281,0,2,N-acetylglucosamine deacetylase activity,MF,
12446,GO:0050124,1,0.995366987302721,0,1,N-acylneuraminate-9-phosphatase activity,MF,
12447,GO:0050135,1,0.988505615591278,0,1,NAD(P)+ nucleosidase activity,MF,
12448,GO:0050136,1,0.412908395982214,0,38,NADH dehydrogenase (quinone) activity,MF,
12449,GO:0050144,1,0.995366574475227,0,1,nucleoside deoxyribosyltransferase activity,MF,
12450,GO:0050145,1,0.968700800166197,0,4,nucleoside phosphate kinase activity,MF,
12451,GO:0050146,1,0.995366990826152,0,1,nucleoside phosphotransferase activity,MF,
12452,GO:0050152,1,0.984904130498575,0,1,omega-amidase activity,MF,
12453,GO:0050178,1,0.941509980925824,0,2,phenylpyruvate tautomerase activity,MF,
12454,GO:0050185,1,0.995366990825889,0,1,phosphatidylinositol deacylase activity,MF,
12455,GO:0050201,1,0.995366990542223,0,1,fucokinase activity,MF,
12456,GO:0050211,1,0.990754468664292,0,2,procollagen galactosyltransferase activity,MF,
12457,GO:0050220,1,0.95346082987144,0,4,prostaglandin-E synthase activity,MF,
12458,GO:0050221,1,0.984320832563559,0,1,prostaglandin-E2 9-reductase activity,MF,
12459,GO:0050252,1,0.990615781820795,0,2,retinol O-fatty-acyltransferase activity,MF,
12460,GO:0050253,1,0.990754001899285,0,2,retinyl-palmitate esterase activity,MF,
12461,GO:0050262,1,0.995366574475227,0,1,ribosylnicotinamide kinase activity,MF,
12462,GO:0050265,1,0.986164045667419,0,3,RNA uridylyltransferase activity,MF,
12463,GO:0050277,1,0.995366989018618,0,1,sedoheptulokinase activity,MF,
12464,GO:0050290,1,0.995366990826165,0,1,sphingomyelin phosphodiesterase D activity,MF,
12465,GO:0050291,1,0.977044133918776,0,5,sphingosine N-acyltransferase activity,MF,
12466,GO:0050294,1,0.961117622520343,0,3,steroid sulfotransferase activity,MF,
12467,GO:0050308,1,0.972216373464182,0,5,sugar-phosphatase activity,MF,
12468,GO:0050309,1,0.990448126099904,0,1,sugar-terminal-phosphatase activity,MF,
12469,GO:0050313,1,0.978712031215829,0,1,sulfur dioxygenase activity,MF,
12470,GO:0050321,1,0.924186113025623,0,12,tau-protein kinase activity,MF,
12471,GO:0050333,1,0.992168818789806,0,1,thiamin-triphosphatase activity,MF,
12472,GO:0050337,1,0.969885699161165,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
12473,GO:0050346,1,0.995366574475227,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
12474,GO:0050347,1,0.985685010370341,0,2,trans-octaprenyltranstransferase activity,MF,
12475,GO:0050353,1,0.995366534635254,0,1,trimethyllysine dioxygenase activity,MF,
12476,GO:0050354,1,0.995366574475227,0,1,triokinase activity,MF,
12477,GO:0050355,1,0.995366990826164,0,1,triphosphatase activity,MF,
12478,GO:0050379,1,0.995366990826164,0,1,UDP-glucuronate 5'-epimerase activity,MF,
12479,GO:0050405,1,0.990755199849097,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
12480,GO:0050421,1,0.995337765554784,0,1,nitrite reductase (NO-forming) activity,MF,
12481,GO:0050427,1,0.877389272931141,0,18,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,
12482,GO:0050428,1,0.96986159577106,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
12483,GO:0050431,1,0.93205913335006,0,15,transforming growth factor beta binding,MF,
12486,GO:0050434,1,0.71591901242277,0,40,positive regulation of viral transcription,BP,
12487,GO:0050435,1,0.833325674833095,0,29,amyloid-beta metabolic process,BP,
12488,GO:0050436,1,0.990755199418777,0,2,microfibril binding,MF,
12489,GO:0050444,1,0.995366878313285,0,1,aquacobalamin reductase (NADPH) activity,MF,
12490,GO:0050462,1,0.98426545667271,0,1,N-acetylneuraminate synthase activity,MF,
12491,GO:0050473,1,0.990735066487474,0,2,arachidonate 15-lipoxygenase activity,MF,
12492,GO:0050482,1,0.913359808354167,0,12,arachidonic acid secretion,BP,
12493,GO:0050497,1,0.989276854192133,0,2,transferase activity, transferring alkylthio groups,MF,
12494,GO:0050501,1,0.984460169684064,0,3,hyaluronan synthase activity,MF,
12495,GO:0050508,1,0.990755111131963,0,2,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
12496,GO:0050509,1,0.990755111131963,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
12497,GO:0050510,1,0.981594530384487,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
12498,GO:0050512,1,0.994214827713524,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
12499,GO:0050542,1,0.925038318452284,0,4,icosanoid binding,MF,
12500,GO:0050543,1,0.925038318452284,0,4,icosatetraenoic acid binding,MF,
12501,GO:0050544,1,0.925038318452284,0,4,arachidonic acid binding,MF,
12502,GO:0050560,1,0.995366906480586,0,1,aspartate-tRNA(Asn) ligase activity,MF,
12503,GO:0050561,1,0.995366990487764,0,1,glutamate-tRNA(Gln) ligase activity,MF,
12504,GO:0050567,1,0.956635539619049,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
12505,GO:0050577,1,0.986452775796898,0,1,GDP-L-fucose synthase activity,MF,
12506,GO:0050610,1,0.963438939267324,0,2,methylarsonate reductase activity,MF,
12507,GO:0050613,1,0.985261710575347,0,2,delta14-sterol reductase activity,MF,
12508,GO:0050614,1,0.995366990826152,0,1,delta24-sterol reductase activity,MF,
12509,GO:0050632,1,0.987384680721447,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
12510,GO:0050650,1,0.896495483455368,0,20,chondroitin sulfate proteoglycan biosynthetic process,BP,
12511,GO:0050651,1,0.938836900540813,0,10,dermatan sulfate proteoglycan biosynthetic process,BP,
12512,GO:0050652,1,0.995366983021542,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12513,GO:0050653,1,0.995366983021542,0,1,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12514,GO:0050654,1,0.859559762317278,0,28,chondroitin sulfate proteoglycan metabolic process,BP,
12515,GO:0050655,1,0.933807160228398,0,11,dermatan sulfate proteoglycan metabolic process,BP,
12516,GO:0050656,1,0.980273895907734,0,4,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
12517,GO:0050657,1,0.290049370258521,0,173,nucleic acid transport,BP,
12518,GO:0050658,1,0.290049370258521,0,173,RNA transport,BP,
12519,GO:0050659,1,0.990755199849267,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
12520,GO:0050660,1,0.707128879426367,0,60,flavin adenine dinucleotide binding,MF,
12521,GO:0050661,1,0.766045294125062,0,36,NADP binding,MF,
12522,GO:0050662,1,0.231508681153602,0,221,coenzyme binding,MF,
12524,GO:0050664,1,0.948641482193636,0,6,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
12525,GO:0050665,1,0.915127663130709,0,10,hydrogen peroxide biosynthetic process,BP,
12526,GO:0050666,1,0.994878946369531,0,1,regulation of homocysteine metabolic process,BP,
12527,GO:0050667,1,0.938785869257085,0,11,homocysteine metabolic process,BP,
12528,GO:0050668,1,0.994878946369531,0,1,positive regulation of homocysteine metabolic process,BP,
12534,GO:0050679,1,0.421409906716499,0,120,positive regulation of epithelial cell proliferation,BP,
12536,GO:0050681,1,0.78770154862067,0,39,androgen receptor binding,MF,
12537,GO:0050682,1,0.990194952337449,0,2,AF-2 domain binding,MF,
12538,GO:0050684,1,0.571152050917169,0,100,regulation of mRNA processing,BP,
12539,GO:0050685,1,0.886836579000517,0,21,positive regulation of mRNA processing,BP,
12540,GO:0050686,1,0.859658733513424,0,28,negative regulation of mRNA processing,BP,
12543,GO:0050689,1,0.961762044853631,0,5,negative regulation of defense response to virus by host,BP,
12544,GO:0050690,1,0.8566208426914,0,21,regulation of defense response to virus by virus,BP,
12545,GO:0050691,1,0.80794402384685,0,28,regulation of defense response to virus by host,BP,
12546,GO:0050692,1,0.988121908514529,0,2,DBD domain binding,MF,
12547,GO:0050693,1,0.97578367763387,0,4,LBD domain binding,MF,
12548,GO:0050694,1,0.995303116056287,0,1,galactose 3-O-sulfotransferase activity,MF,
12549,GO:0050698,1,0.995303116056287,0,1,proteoglycan sulfotransferase activity,MF,
12550,GO:0050699,1,0.846710857733593,0,22,WW domain binding,MF,
12551,GO:0050700,1,0.90692367224468,0,11,CARD domain binding,MF,
12552,GO:0050701,1,0.772884359541827,0,30,interleukin-1 secretion,BP,
12553,GO:0050702,1,0.843468781816025,0,24,interleukin-1 beta secretion,BP,
12554,GO:0050703,1,0.929987245434036,0,5,interleukin-1 alpha secretion,BP,
12555,GO:0050704,1,0.811454843919058,0,25,regulation of interleukin-1 secretion,BP,
12556,GO:0050705,1,0.958322818313103,0,4,regulation of interleukin-1 alpha secretion,BP,
12557,GO:0050706,1,0.859312271937309,0,20,regulation of interleukin-1 beta secretion,BP,
12562,GO:0050711,1,0.934671738662898,0,8,negative regulation of interleukin-1 secretion,BP,
12563,GO:0050712,1,0.98755889731644,0,1,negative regulation of interleukin-1 alpha secretion,BP,
12564,GO:0050713,1,0.955374540152537,0,5,negative regulation of interleukin-1 beta secretion,BP,
12565,GO:0050714,1,0.379365819864325,0,146,positive regulation of protein secretion,BP,
12566,GO:0050715,1,0.636459193584608,0,65,positive regulation of cytokine secretion,BP,
12567,GO:0050716,1,0.869795562182457,0,17,positive regulation of interleukin-1 secretion,BP,
12568,GO:0050717,1,0.970399796039709,0,3,positive regulation of interleukin-1 alpha secretion,BP,
12569,GO:0050718,1,0.905283521366635,0,14,positive regulation of interleukin-1 beta secretion,BP,
12570,GO:0050719,1,0.975950342566767,0,1,interleukin-1 alpha biosynthetic process,BP,
12571,GO:0050720,1,0.995366787173025,0,1,interleukin-1 beta biosynthetic process,BP,
12572,GO:0050721,1,0.975950342566767,0,1,regulation of interleukin-1 alpha biosynthetic process,BP,
12573,GO:0050722,1,0.995366787173025,0,1,regulation of interleukin-1 beta biosynthetic process,BP,
12574,GO:0050725,1,0.995366787173025,0,1,positive regulation of interleukin-1 beta biosynthetic process,BP,
12575,GO:0050726,1,0.975950342566767,0,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,
12577,GO:0050728,1,0.598350778249869,0,67,negative regulation of inflammatory response,BP,
12578,GO:0050729,1,0.582658523075362,0,63,positive regulation of inflammatory response,BP,
12581,GO:0050732,1,0.789546962412385,0,39,negative regulation of peptidyl-tyrosine phosphorylation,BP,
12582,GO:0050733,1,0.97367322710027,0,5,RS domain binding,MF,
12583,GO:0050746,1,0.939523662642125,0,8,regulation of lipoprotein metabolic process,BP,
12584,GO:0050747,1,0.952846316907518,0,5,positive regulation of lipoprotein metabolic process,BP,
12585,GO:0050748,1,0.995366990826073,0,1,negative regulation of lipoprotein metabolic process,BP,
12586,GO:0050750,1,0.894697285416815,0,17,low-density lipoprotein particle receptor binding,MF,
12587,GO:0050755,1,0.925986608170931,0,9,chemokine metabolic process,BP,
12588,GO:0050757,1,0.995350453326067,0,1,thymidylate synthase biosynthetic process,BP,
12589,GO:0050758,1,0.995350453326067,0,1,regulation of thymidylate synthase biosynthetic process,BP,
12590,GO:0050760,1,0.995350453326067,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
12591,GO:0050764,1,0.759041406763236,0,39,regulation of phagocytosis,BP,
12592,GO:0050765,1,0.94001764301491,0,9,negative regulation of phagocytosis,BP,
12593,GO:0050766,1,0.818961070416006,0,27,positive regulation of phagocytosis,BP,
12597,GO:0050770,1,0.498568688899693,0,121,regulation of axonogenesis,BP,
12598,GO:0050771,1,0.790755677910453,0,44,negative regulation of axonogenesis,BP,
12599,GO:0050772,1,0.671893542818655,0,66,positive regulation of axonogenesis,BP,
12600,GO:0050773,1,0.567903774234399,0,98,regulation of dendrite development,BP,
12601,GO:0050774,1,0.936631190344271,0,9,negative regulation of dendrite morphogenesis,BP,
12602,GO:0050775,1,0.887476122237269,0,25,positive regulation of dendrite morphogenesis,BP,
12604,GO:0050777,1,0.553368605920491,0,83,negative regulation of immune response,BP,
12607,GO:0050780,1,0.948634875411029,0,10,dopamine receptor binding,MF,
12608,GO:0050783,1,0.995213700845504,0,1,cocaine metabolic process,BP,
12609,GO:0050785,1,0.986063248057595,0,1,advanced glycation end-product receptor activity,MF,
12610,GO:0050786,1,0.837769137889618,0,7,RAGE receptor binding,MF,
12611,GO:0050787,1,0.973505103848241,0,2,detoxification of mercury ion,BP,
12614,GO:0050792,1,0.260395507715756,0,163,regulation of viral process,BP,
12621,GO:0050802,1,0.894637623063723,0,9,circadian sleep/wake cycle, sleep,BP,
12622,GO:0050803,1,0.564383412899503,0,101,regulation of synapse structure or activity,BP,
12624,GO:0050805,1,0.806477860886059,0,36,negative regulation of synaptic transmission,BP,
12625,GO:0050806,1,0.598512419756554,0,85,positive regulation of synaptic transmission,BP,
12626,GO:0050807,1,0.586060623348301,0,93,regulation of synapse organization,BP,
12629,GO:0050811,1,0.920855056034728,0,9,GABA receptor binding,MF,
12630,GO:0050812,1,0.939359564972812,0,12,regulation of acyl-CoA biosynthetic process,BP,
12631,GO:0050815,1,0.953408986317761,0,6,phosphoserine residue binding,MF,
12632,GO:0050816,1,0.970342035868748,0,3,phosphothreonine residue binding,MF,
12633,GO:0050817,1,0.18044806242017,0,214,coagulation,BP,
12634,GO:0050818,1,0.727027347689249,0,49,regulation of coagulation,BP,
12635,GO:0050819,1,0.811368565269365,0,32,negative regulation of coagulation,BP,
12636,GO:0050820,1,0.900512062298471,0,15,positive regulation of coagulation,BP,
12637,GO:0050821,1,0.366686927738324,0,134,protein stabilization,BP,
12638,GO:0050822,1,0.995366950285184,0,1,peptide stabilization,BP,
12639,GO:0050823,1,0.995366950285184,0,1,peptide antigen stabilization,BP,
12640,GO:0050829,1,0.722323200077371,0,21,defense response to Gram-negative bacterium,BP,
12641,GO:0050830,1,0.592838590227732,0,33,defense response to Gram-positive bacterium,BP,
12642,GO:0050832,1,0.838306678511592,0,14,defense response to fungus,BP,
12643,GO:0050833,1,0.986163673532741,0,3,pyruvate transmembrane transporter activity,MF,
12645,GO:0050840,1,0.808778316837273,0,34,extracellular matrix binding,MF,
12646,GO:0050847,1,0.963274351471345,0,7,progesterone receptor signaling pathway,BP,
12647,GO:0050848,1,0.71437707785422,0,45,regulation of calcium-mediated signaling,BP,
12648,GO:0050849,1,0.891235066047073,0,12,negative regulation of calcium-mediated signaling,BP,
12649,GO:0050850,1,0.821092197662443,0,23,positive regulation of calcium-mediated signaling,BP,
12652,GO:0050853,1,0.83959150668726,0,28,B cell receptor signaling pathway,BP,
12653,GO:0050854,1,0.801015454503948,0,34,regulation of antigen receptor-mediated signaling pathway,BP,
12654,GO:0050855,1,0.941660813421961,0,12,regulation of B cell receptor signaling pathway,BP,
12655,GO:0050856,1,0.842413730410611,0,24,regulation of T cell receptor signaling pathway,BP,
12656,GO:0050857,1,0.924462246697871,0,11,positive regulation of antigen receptor-mediated signaling pathway,BP,
12657,GO:0050858,1,0.895253563565209,0,16,negative regulation of antigen receptor-mediated signaling pathway,BP,
12658,GO:0050859,1,0.983254169451228,0,3,negative regulation of B cell receptor signaling pathway,BP,
12659,GO:0050860,1,0.905818075239546,0,14,negative regulation of T cell receptor signaling pathway,BP,
12660,GO:0050861,1,0.980211843797043,0,4,positive regulation of B cell receptor signaling pathway,BP,
12661,GO:0050862,1,0.94313765501348,0,7,positive regulation of T cell receptor signaling pathway,BP,
12663,GO:0050864,1,0.614846846505973,0,72,regulation of B cell activation,BP,
12668,GO:0050869,1,0.903467966959366,0,18,negative regulation of B cell activation,BP,
12670,GO:0050871,1,0.704113603030129,0,47,positive regulation of B cell activation,BP,
12674,GO:0050878,1,0.0986234261661512,0,307,regulation of body fluid levels,BP,
12675,GO:0050879,1,0.804302996674427,0,26,multicellular organismal movement,BP,
12677,GO:0050881,1,0.804302996674427,0,26,musculoskeletal movement,BP,
12678,GO:0050882,1,0.971504704387465,0,6,voluntary musculoskeletal movement,BP,
12679,GO:0050884,1,0.961658903525565,0,8,neuromuscular process controlling posture,BP,
12680,GO:0050885,1,0.86515114515661,0,27,neuromuscular process controlling balance,BP,
12681,GO:0050886,1,0.774721014837511,0,40,endocrine process,BP,
12682,GO:0050890,1,0.371147233119039,0,156,cognition,BP,
12683,GO:0050891,1,0.782399867889774,0,45,multicellular organismal water homeostasis,BP,
12684,GO:0050892,1,0.937574220185414,0,12,intestinal absorption,BP,
12685,GO:0050893,1,0.984476312461639,0,3,sensory processing,BP,
12687,GO:0050897,1,0.995366990826113,0,1,cobalt ion binding,MF,
12690,GO:0050904,1,0.990754859587679,0,2,diapedesis,BP,
12691,GO:0050905,1,0.778008165791487,0,46,neuromuscular process,BP,
12692,GO:0050906,1,0.786951818189703,0,26,detection of stimulus involved in sensory perception,BP,
12693,GO:0050907,1,0.8733945744877,0,10,detection of chemical stimulus involved in sensory perception,BP,
12694,GO:0050908,1,0.972934477786447,0,4,detection of light stimulus involved in visual perception,BP,
12695,GO:0050909,1,0.895496882142388,0,12,sensory perception of taste,BP,
12696,GO:0050910,1,0.990724878500155,0,2,detection of mechanical stimulus involved in sensory perception of sound,BP,
12697,GO:0050911,1,0.951904344073561,0,3,detection of chemical stimulus involved in sensory perception of smell,BP,
12698,GO:0050912,1,0.921842964641296,0,6,detection of chemical stimulus involved in sensory perception of taste,BP,
12699,GO:0050913,1,0.916603423549009,0,7,sensory perception of bitter taste,BP,
12700,GO:0050915,1,0.995366574475227,0,1,sensory perception of sour taste,BP,
12701,GO:0050916,1,0.985028696079238,0,3,sensory perception of sweet taste,BP,
12702,GO:0050917,1,0.990704952792613,0,2,sensory perception of umami taste,BP,
12703,GO:0050918,1,0.754828762552532,0,35,positive chemotaxis,BP,
12704,GO:0050919,1,0.875857610918748,0,28,negative chemotaxis,BP,
12707,GO:0050922,1,0.781900409289189,0,33,negative regulation of chemotaxis,BP,
12708,GO:0050923,1,0.98616453102361,0,3,regulation of negative chemotaxis,BP,
12709,GO:0050924,1,0.995366990826165,0,1,positive regulation of negative chemotaxis,BP,
12710,GO:0050925,1,0.990755199849149,0,2,negative regulation of negative chemotaxis,BP,
12711,GO:0050926,1,0.903666854705156,0,15,regulation of positive chemotaxis,BP,
12712,GO:0050927,1,0.907877735207773,0,14,positive regulation of positive chemotaxis,BP,
12713,GO:0050928,1,0.995366990826152,0,1,negative regulation of positive chemotaxis,BP,
12714,GO:0050929,1,0.995366990826165,0,1,induction of negative chemotaxis,BP,
12715,GO:0050930,1,0.93383399571187,0,8,induction of positive chemotaxis,BP,
12716,GO:0050931,1,0.861137463336578,0,23,pigment cell differentiation,BP,
12717,GO:0050932,1,0.961945407110399,0,7,regulation of pigment cell differentiation,BP,
12718,GO:0050942,1,0.977045358647488,0,5,positive regulation of pigment cell differentiation,BP,
12719,GO:0050951,1,0.94530661678009,0,8,sensory perception of temperature stimulus,BP,
12720,GO:0050953,1,0.624782545157161,0,83,sensory perception of light stimulus,BP,
12722,GO:0050955,1,0.995366990826138,0,1,thermoception,BP,
12723,GO:0050957,1,0.990755170938924,0,2,equilibrioception,BP,
12724,GO:0050960,1,0.995366990826138,0,1,detection of temperature stimulus involved in thermoception,BP,
12725,GO:0050961,1,0.949709237887156,0,7,detection of temperature stimulus involved in sensory perception,BP,
12726,GO:0050962,1,0.972934477786447,0,4,detection of light stimulus involved in sensory perception,BP,
12727,GO:0050965,1,0.949709237887156,0,7,detection of temperature stimulus involved in sensory perception of pain,BP,
12728,GO:0050966,1,0.989550412460412,0,2,detection of mechanical stimulus involved in sensory perception of pain,BP,
12729,GO:0050968,1,0.995366990826138,0,1,detection of chemical stimulus involved in sensory perception of pain,BP,
12730,GO:0050974,1,0.975328022727406,0,5,detection of mechanical stimulus involved in sensory perception,BP,
12731,GO:0050982,1,0.944119100965383,0,12,detection of mechanical stimulus,BP,
12732,GO:0050992,1,0.980860339318578,0,2,dimethylallyl diphosphate biosynthetic process,BP,
12733,GO:0050993,1,0.980860339318578,0,2,dimethylallyl diphosphate metabolic process,BP,
12734,GO:0050994,1,0.832906535179639,0,28,regulation of lipid catabolic process,BP,
12735,GO:0050995,1,0.914903395344541,0,10,negative regulation of lipid catabolic process,BP,
12736,GO:0050996,1,0.946955731268931,0,10,positive regulation of lipid catabolic process,BP,
12737,GO:0050997,1,0.892206880041224,0,12,quaternary ammonium group binding,MF,
12738,GO:0050998,1,0.937630193299162,0,11,nitric-oxide synthase binding,MF,
12739,GO:0050999,1,0.81663476945898,0,30,regulation of nitric-oxide synthase activity,BP,
12740,GO:0051000,1,0.931732151524566,0,12,positive regulation of nitric-oxide synthase activity,BP,
12741,GO:0051001,1,0.960203491985122,0,4,negative regulation of nitric-oxide synthase activity,BP,
12742,GO:0051004,1,0.918025246910935,0,10,regulation of lipoprotein lipase activity,BP,
12743,GO:0051005,1,0.955275344586741,0,3,negative regulation of lipoprotein lipase activity,BP,
12744,GO:0051006,1,0.974513001307793,0,4,positive regulation of lipoprotein lipase activity,BP,
12745,GO:0051010,1,0.941378245110194,0,13,microtubule plus-end binding,MF,
12746,GO:0051011,1,0.954612097912073,0,10,microtubule minus-end binding,MF,
12747,GO:0051012,1,0.986773473499469,0,2,microtubule sliding,BP,
12748,GO:0051013,1,0.966237358258191,0,6,microtubule severing,BP,
12749,GO:0051014,1,0.968194781943974,0,6,actin filament severing,BP,
12750,GO:0051015,1,0.484501279337924,0,121,actin filament binding,MF,
12751,GO:0051016,1,0.929791809239517,0,12,barbed-end actin filament capping,BP,
12753,GO:0051018,1,0.812042259350217,0,37,protein kinase A binding,MF,
12754,GO:0051019,1,0.867646573756593,0,26,mitogen-activated protein kinase binding,MF,
12756,GO:0051021,1,0.978394660390745,0,4,GDP-dissociation inhibitor binding,MF,
12757,GO:0051022,1,0.978394660390745,0,4,Rho GDP-dissociation inhibitor binding,MF,
12758,GO:0051023,1,0.932591026878538,0,9,regulation of immunoglobulin secretion,BP,
12759,GO:0051024,1,0.964791769277233,0,4,positive regulation of immunoglobulin secretion,BP,
12760,GO:0051025,1,0.995366744009593,0,1,negative regulation of immunoglobulin secretion,BP,
12761,GO:0051026,1,0.975693695435672,0,4,chiasma assembly,BP,
12762,GO:0051028,1,0.415251408717747,0,135,mRNA transport,BP,
12763,GO:0051029,1,0.922644915499652,0,6,rRNA transport,BP,
12764,GO:0051030,1,0.958706767557792,0,4,snRNA transport,BP,
12765,GO:0051031,1,0.818800113828109,0,33,tRNA transport,BP,
12766,GO:0051032,1,0.995366990652136,0,1,nucleic acid transmembrane transporter activity,MF,
12767,GO:0051033,1,0.995366990652136,0,1,RNA transmembrane transporter activity,MF,
12768,GO:0051036,1,0.962250114943923,0,5,regulation of endosome size,BP,
12769,GO:0051040,1,0.99536679727965,0,1,regulation of calcium-independent cell-cell adhesion,BP,
12770,GO:0051042,1,0.99536679727965,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
12771,GO:0051043,1,0.870736313824411,0,19,regulation of membrane protein ectodomain proteolysis,BP,
12772,GO:0051044,1,0.920495532472228,0,12,positive regulation of membrane protein ectodomain proteolysis,BP,
12773,GO:0051045,1,0.945993053395863,0,7,negative regulation of membrane protein ectodomain proteolysis,BP,
12781,GO:0051053,1,0.531325188313824,0,109,negative regulation of DNA metabolic process,BP,
12782,GO:0051054,1,0.315619253458754,0,181,positive regulation of DNA metabolic process,BP,
12785,GO:0051057,1,0.816401861886199,0,33,positive regulation of small GTPase mediated signal transduction,BP,
12786,GO:0051058,1,0.791302876226503,0,47,negative regulation of small GTPase mediated signal transduction,BP,
12787,GO:0051059,1,0.812933028049619,0,27,NF-kappaB binding,MF,
12788,GO:0051066,1,0.98412068585781,0,2,dihydrobiopterin metabolic process,BP,
12789,GO:0051068,1,0.99536696674851,0,1,dihydrolipoamide metabolic process,BP,
12790,GO:0051081,1,0.754526623869448,0,46,nuclear envelope disassembly,BP,
12792,GO:0051083,1,0.986828792312598,0,2,'de novo' cotranslational protein folding,BP,
12793,GO:0051084,1,0.823896693048463,0,31,'de novo' posttranslational protein folding,BP,
12794,GO:0051085,1,0.851580475012771,0,26,chaperone cofactor-dependent protein refolding,BP,
12795,GO:0051086,1,0.993516795857679,0,1,chaperone mediated protein folding independent of cofactor,BP,
12797,GO:0051088,1,0.986164503185052,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
12798,GO:0051089,1,0.995366990639516,0,1,constitutive protein ectodomain proteolysis,BP,
12801,GO:0051092,1,0.430729016268688,0,114,positive regulation of NF-kappaB transcription factor activity,BP,
12804,GO:0051095,1,0.933056820282404,0,9,regulation of helicase activity,BP,
12805,GO:0051096,1,0.948731414560061,0,6,positive regulation of helicase activity,BP,
12806,GO:0051097,1,0.983488279111597,0,3,negative regulation of helicase activity,BP,
12811,GO:0051102,1,0.995366990826125,0,1,DNA ligation involved in DNA recombination,BP,
12812,GO:0051103,1,0.925285640068976,0,11,DNA ligation involved in DNA repair,BP,
12813,GO:0051105,1,0.970674253642912,0,6,regulation of DNA ligation,BP,
12814,GO:0051106,1,0.975194043717144,0,5,positive regulation of DNA ligation,BP,
12815,GO:0051107,1,0.995366579969841,0,1,negative regulation of DNA ligation,BP,
12816,GO:0051117,1,0.657942562144046,0,54,ATPase binding,MF,
12818,GO:0051120,1,0.990484459712789,0,2,hepoxilin A3 synthase activity,MF,
12819,GO:0051121,1,0.981224307904154,0,4,hepoxilin metabolic process,BP,
12820,GO:0051122,1,0.981224307904154,0,4,hepoxilin biosynthetic process,BP,
12821,GO:0051123,1,0.798235327218301,0,28,RNA polymerase II transcriptional preinitiation complex assembly,BP,
12822,GO:0051124,1,0.972518257067788,0,6,synaptic growth at neuromuscular junction,BP,
12823,GO:0051125,1,0.893674052357822,0,22,regulation of actin nucleation,BP,
12824,GO:0051126,1,0.964416791201833,0,6,negative regulation of actin nucleation,BP,
12825,GO:0051127,1,0.945780529434696,0,12,positive regulation of actin nucleation,BP,
12829,GO:0051131,1,0.884349422561702,0,17,chaperone-mediated protein complex assembly,BP,
12830,GO:0051132,1,0.945915712786424,0,5,NK T cell activation,BP,
12831,GO:0051133,1,0.95867504264313,0,3,regulation of NK T cell activation,BP,
12832,GO:0051135,1,0.95867504264313,0,3,positive regulation of NK T cell activation,BP,
12833,GO:0051136,1,0.981594888732018,0,4,regulation of NK T cell differentiation,BP,
12834,GO:0051138,1,0.986164531022181,0,3,positive regulation of NK T cell differentiation,BP,
12835,GO:0051139,1,0.995366990826139,0,1,metal ion:proton antiporter activity,MF,
12836,GO:0051140,1,0.963139208908942,0,2,regulation of NK T cell proliferation,BP,
12837,GO:0051142,1,0.963139208908942,0,2,positive regulation of NK T cell proliferation,BP,
12839,GO:0051146,1,0.404754463976583,0,148,striated muscle cell differentiation,BP,
12840,GO:0051147,1,0.563494911132831,0,95,regulation of muscle cell differentiation,BP,
12841,GO:0051148,1,0.848400438179823,0,28,negative regulation of muscle cell differentiation,BP,
12842,GO:0051149,1,0.70352345524689,0,55,positive regulation of muscle cell differentiation,BP,
12843,GO:0051150,1,0.896479798310647,0,18,regulation of smooth muscle cell differentiation,BP,
12844,GO:0051151,1,0.957919532298568,0,7,negative regulation of smooth muscle cell differentiation,BP,
12845,GO:0051152,1,0.952200470335555,0,8,positive regulation of smooth muscle cell differentiation,BP,
12846,GO:0051153,1,0.690135737464375,0,60,regulation of striated muscle cell differentiation,BP,
12847,GO:0051154,1,0.889851434613469,0,20,negative regulation of striated muscle cell differentiation,BP,
12848,GO:0051155,1,0.80207369251265,0,33,positive regulation of striated muscle cell differentiation,BP,
12849,GO:0051156,1,0.846785523011586,0,21,glucose 6-phosphate metabolic process,BP,
12850,GO:0051160,1,0.995296708755865,0,1,L-xylitol catabolic process,BP,
12851,GO:0051164,1,0.995296708755865,0,1,L-xylitol metabolic process,BP,
12852,GO:0051167,1,0.944380803966037,0,5,xylulose 5-phosphate metabolic process,BP,
12853,GO:0051168,1,0.250808813967642,0,187,nuclear export,BP,
12860,GO:0051176,1,0.985679138841356,0,3,positive regulation of sulfur metabolic process,BP,
12861,GO:0051177,1,0.96431919657078,0,4,meiotic sister chromatid cohesion,BP,
12864,GO:0051181,1,0.817162623421083,0,29,cofactor transport,BP,
12865,GO:0051182,1,0.966864603569158,0,7,coenzyme transport,BP,
12866,GO:0051184,1,0.927058119124958,0,16,cofactor transmembrane transporter activity,MF,
12867,GO:0051185,1,0.971366563279355,0,6,coenzyme transmembrane transporter activity,MF,
12869,GO:0051187,1,0.693778275475756,0,35,cofactor catabolic process,BP,
12871,GO:0051189,1,0.955327370184117,0,7,prosthetic group metabolic process,BP,
12872,GO:0051192,1,0.944033747523661,0,2,prosthetic group binding,MF,
12874,GO:0051194,1,0.934404744742029,0,14,positive regulation of cofactor metabolic process,BP,
12877,GO:0051197,1,0.948935322457764,0,11,positive regulation of coenzyme metabolic process,BP,
12879,GO:0051204,1,0.767552734909571,0,32,protein insertion into mitochondrial membrane,BP,
12880,GO:0051205,1,0.730534675633154,0,40,protein insertion into membrane,BP,
12883,GO:0051213,1,0.633086527921187,0,73,dioxygenase activity,MF,
12885,GO:0051219,1,0.700086274521453,0,64,phosphoprotein binding,MF,
12891,GO:0051228,1,0.995366990826151,0,1,mitotic spindle disassembly,BP,
12892,GO:0051230,1,0.995366990826151,0,1,spindle disassembly,BP,
12893,GO:0051231,1,0.939271012288408,0,11,spindle elongation,BP,
12894,GO:0051232,1,0.995111149720051,0,1,meiotic spindle elongation,BP,
12895,GO:0051233,1,0.821786539139537,0,31,spindle midzone,CC,
12898,GO:0051236,1,0.285979074259446,0,176,establishment of RNA localization,BP,
12899,GO:0051238,1,0.867087804326551,0,11,sequestering of metal ion,BP,
12912,GO:0051255,1,0.943770795158414,0,10,spindle midzone assembly,BP,
12913,GO:0051256,1,0.952701271407843,0,8,mitotic spindle midzone assembly,BP,
12914,GO:0051257,1,0.99524265188522,0,1,meiotic spindle midzone assembly,BP,
12917,GO:0051260,1,0.206786136568952,0,214,protein homooligomerization,BP,
12920,GO:0051264,1,0.995366474549927,0,1,mono-olein transacylation activity,MF,
12921,GO:0051265,1,0.995366474549927,0,1,diolein transacylation activity,MF,
12922,GO:0051267,1,0.99536685468278,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
12924,GO:0051271,1,0.275168704777785,0,197,negative regulation of cellular component movement,BP,
12927,GO:0051279,1,0.704850478298023,0,47,regulation of release of sequestered calcium ion into cytosol,BP,
12928,GO:0051280,1,0.89893376154007,0,10,negative regulation of release of sequestered calcium ion into cytosol,BP,
12929,GO:0051281,1,0.830891184965103,0,24,positive regulation of release of sequestered calcium ion into cytosol,BP,
12932,GO:0051284,1,0.89893376154007,0,10,positive regulation of sequestering of calcium ion,BP,
12933,GO:0051286,1,0.97704598218437,0,5,cell tip,CC,
12934,GO:0051287,1,0.690408773152908,0,52,NAD binding,MF,
12935,GO:0051289,1,0.628394661014991,0,57,protein homotetramerization,BP,
12938,GO:0051292,1,0.94027222885824,0,10,nuclear pore complex assembly,BP,
12939,GO:0051293,1,0.840546355707776,0,30,establishment of spindle localization,BP,
12940,GO:0051294,1,0.868528330372999,0,23,establishment of spindle orientation,BP,
12941,GO:0051295,1,0.98616440074281,0,3,establishment of meiotic spindle localization,BP,
12943,GO:0051299,1,0.918061790784963,0,14,centrosome separation,BP,
12944,GO:0051300,1,0.995366574475227,0,1,spindle pole body organization,BP,
12947,GO:0051303,1,0.676876115495372,0,66,establishment of chromosome localization,BP,
12948,GO:0051304,1,0.612275121561274,0,69,chromosome separation,BP,
12949,GO:0051305,1,0.977042837249894,0,5,chromosome movement towards spindle pole,BP,
12950,GO:0051306,1,0.672753643467001,0,52,mitotic sister chromatid separation,BP,
12951,GO:0051307,1,0.936259318938839,0,12,meiotic chromosome separation,BP,
12952,GO:0051308,1,0.995366574475227,0,1,male meiosis chromosome separation,BP,
12953,GO:0051310,1,0.716028021741227,0,54,metaphase plate congression,BP,
12954,GO:0051311,1,0.99524265188522,0,1,meiotic metaphase plate congression,BP,
12955,GO:0051315,1,0.935045567359369,0,13,attachment of mitotic spindle microtubules to kinetochore,BP,
12956,GO:0051316,1,0.990226297525016,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
12957,GO:0051321,1,0.402435522210982,0,153,meiotic cell cycle,BP,
12960,GO:0051339,1,0.871658972029597,0,19,regulation of lyase activity,BP,
12961,GO:0051340,1,0.942319092825118,0,8,regulation of ligase activity,BP,
12963,GO:0051342,1,0.951418139655845,0,6,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
12964,GO:0051343,1,0.975784811899562,0,3,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
12965,GO:0051344,1,0.975035582769832,0,3,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
12970,GO:0051349,1,0.943824894218045,0,8,positive regulation of lyase activity,BP,
12971,GO:0051350,1,0.932213702504872,0,9,negative regulation of lyase activity,BP,
12972,GO:0051351,1,0.946708350787245,0,7,positive regulation of ligase activity,BP,
12973,GO:0051352,1,0.995366579969841,0,1,negative regulation of ligase activity,BP,
12975,GO:0051354,1,0.930033564458435,0,10,negative regulation of oxidoreductase activity,BP,
12976,GO:0051365,1,0.995366889457875,0,1,cellular response to potassium ion starvation,BP,
12977,GO:0051371,1,0.977046177791646,0,5,muscle alpha-actinin binding,MF,
12978,GO:0051377,1,0.986164268613574,0,3,mannose-ethanolamine phosphotransferase activity,MF,
12979,GO:0051378,1,0.973240272848599,0,3,serotonin binding,MF,
12980,GO:0051379,1,0.988932920164081,0,2,epinephrine binding,MF,
12981,GO:0051380,1,0.99394869310473,0,1,norepinephrine binding,MF,
12982,GO:0051382,1,0.916772125426743,0,14,kinetochore assembly,BP,
12983,GO:0051383,1,0.893104031421785,0,19,kinetochore organization,BP,
12985,GO:0051385,1,0.857251747468811,0,20,response to mineralocorticoid,BP,
12986,GO:0051386,1,0.966769220127002,0,7,regulation of neurotrophin TRK receptor signaling pathway,BP,
12987,GO:0051387,1,0.989487914616176,0,2,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
12988,GO:0051388,1,0.981591408538771,0,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
12989,GO:0051389,1,0.990755199849017,0,2,inactivation of MAPKK activity,BP,
12990,GO:0051391,1,0.995366990731326,0,1,tRNA acetylation,BP,
12991,GO:0051392,1,0.995366990731326,0,1,tRNA N-acetyltransferase activity,MF,
12992,GO:0051393,1,0.947103858206047,0,11,alpha-actinin binding,MF,
12993,GO:0051400,1,0.943226856273906,0,8,BH domain binding,MF,
12995,GO:0051403,1,0.273015194064299,0,204,stress-activated MAPK cascade,BP,
12997,GO:0051410,1,0.955096866822491,0,5,detoxification of nitrogen compound,BP,
12998,GO:0051412,1,0.946587622097536,0,10,response to corticosterone,BP,
12999,GO:0051413,1,0.995282624682745,0,1,response to cortisone,BP,
13000,GO:0051414,1,0.963645133841588,0,5,response to cortisol,BP,
13001,GO:0051415,1,0.972517494722165,0,6,microtubule nucleation by interphase microtubule organizing center,BP,
13002,GO:0051417,1,0.995366574475227,0,1,microtubule nucleation by spindle pole body,BP,
13003,GO:0051418,1,0.963523886221296,0,8,microtubule nucleation by microtubule organizing center,BP,
13004,GO:0051425,1,0.981594742172244,0,4,PTB domain binding,MF,
13005,GO:0051427,1,0.395929586354612,0,142,hormone receptor binding,MF,
13006,GO:0051428,1,0.930725785200344,0,9,peptide hormone receptor binding,MF,
13007,GO:0051429,1,0.976861385560188,0,3,corticotropin-releasing hormone receptor binding,MF,
13008,GO:0051430,1,0.988400397984819,0,2,corticotropin-releasing hormone receptor 1 binding,MF,
13009,GO:0051431,1,0.98832712450559,0,1,corticotropin-releasing hormone receptor 2 binding,MF,
13010,GO:0051433,1,0.995366990826164,0,1,BH2 domain binding,MF,
13011,GO:0051434,1,0.961649964653751,0,4,BH3 domain binding,MF,
13014,GO:0051444,1,0.828446032820654,0,13,negative regulation of ubiquitin-protein transferase activity,BP,
13015,GO:0051445,1,0.865076906116891,0,27,regulation of meiotic cell cycle,BP,
13016,GO:0051446,1,0.95568986636225,0,9,positive regulation of meiotic cell cycle,BP,
13017,GO:0051447,1,0.952395735002624,0,10,negative regulation of meiotic cell cycle,BP,
13018,GO:0051450,1,0.92289411498666,0,10,myoblast proliferation,BP,
13019,GO:0051451,1,0.94528558279039,0,8,myoblast migration,BP,
13022,GO:0051454,1,0.98389847446117,0,3,intracellular pH elevation,BP,
13023,GO:0051455,1,0.995366574475227,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
13024,GO:0051456,1,0.994836070997394,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
13025,GO:0051457,1,0.834103045408223,0,22,maintenance of protein location in nucleus,BP,
13026,GO:0051458,1,0.990755050869505,0,2,corticotropin secretion,BP,
13027,GO:0051459,1,0.990755050869505,0,2,regulation of corticotropin secretion,BP,
13028,GO:0051461,1,0.990755050869505,0,2,positive regulation of corticotropin secretion,BP,
13029,GO:0051462,1,0.970021460635656,0,2,regulation of cortisol secretion,BP,
13030,GO:0051463,1,0.995366990826099,0,1,negative regulation of cortisol secretion,BP,
13031,GO:0051464,1,0.974537838279069,0,1,positive regulation of cortisol secretion,BP,
13032,GO:0051466,1,0.995366841160869,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
13034,GO:0051481,1,0.981594888733106,0,4,negative regulation of cytosolic calcium ion concentration,BP,
13035,GO:0051482,1,0.924193322611141,0,11,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,
13036,GO:0051489,1,0.869505313523824,0,29,regulation of filopodium assembly,BP,
13037,GO:0051490,1,0.98217842864603,0,3,negative regulation of filopodium assembly,BP,
13038,GO:0051491,1,0.901989913479756,0,22,positive regulation of filopodium assembly,BP,
13039,GO:0051492,1,0.714800114724626,0,59,regulation of stress fiber assembly,BP,
13043,GO:0051496,1,0.813795012323917,0,37,positive regulation of stress fiber assembly,BP,
13044,GO:0051497,1,0.916283470287979,0,13,negative regulation of stress fiber assembly,BP,
13045,GO:0051499,1,0.981914762403397,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13046,GO:0051500,1,0.981914762403397,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
13047,GO:0051503,1,0.927422030679828,0,12,adenine nucleotide transport,BP,
13048,GO:0051525,1,0.990755199849058,0,2,NFAT protein binding,MF,
13049,GO:0051536,1,0.573102473904903,0,61,iron-sulfur cluster binding,MF,
13050,GO:0051537,1,0.805668430366909,0,19,2 iron, 2 sulfur cluster binding,MF,
13051,GO:0051538,1,0.973386822922273,0,3,3 iron, 4 sulfur cluster binding,MF,
13052,GO:0051539,1,0.710139958538485,0,41,4 iron, 4 sulfur cluster binding,MF,
13053,GO:0051540,1,0.573102473904903,0,61,metal cluster binding,MF,
13054,GO:0051541,1,0.960659257551711,0,4,elastin metabolic process,BP,
13055,GO:0051542,1,0.990469809262951,0,2,elastin biosynthetic process,BP,
13056,GO:0051543,1,0.995080287075418,0,1,regulation of elastin biosynthetic process,BP,
13057,GO:0051545,1,0.995080287075418,0,1,negative regulation of elastin biosynthetic process,BP,
13058,GO:0051546,1,0.930521639412135,0,13,keratinocyte migration,BP,
13059,GO:0051547,1,0.962941094151917,0,8,regulation of keratinocyte migration,BP,
13060,GO:0051548,1,0.990755199849161,0,2,negative regulation of keratinocyte migration,BP,
13061,GO:0051549,1,0.971929325522209,0,6,positive regulation of keratinocyte migration,BP,
13062,GO:0051552,1,0.99507839797967,0,1,flavone metabolic process,BP,
13063,GO:0051560,1,0.888260251571246,0,18,mitochondrial calcium ion homeostasis,BP,
13064,GO:0051561,1,0.926215407410473,0,9,positive regulation of mitochondrial calcium ion concentration,BP,
13065,GO:0051562,1,0.990754441275858,0,2,negative regulation of mitochondrial calcium ion concentration,BP,
13066,GO:0051563,1,0.99075515262606,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
13067,GO:0051567,1,0.854464172700144,0,26,histone H3-K9 methylation,BP,
13069,GO:0051569,1,0.883513598508451,0,21,regulation of histone H3-K4 methylation,BP,
13070,GO:0051570,1,0.891084759226327,0,17,regulation of histone H3-K9 methylation,BP,
13071,GO:0051571,1,0.924868569484015,0,14,positive regulation of histone H3-K4 methylation,BP,
13072,GO:0051572,1,0.984038424161681,0,3,negative regulation of histone H3-K4 methylation,BP,
13073,GO:0051573,1,0.944472017524718,0,9,negative regulation of histone H3-K9 methylation,BP,
13074,GO:0051574,1,0.947905894154266,0,7,positive regulation of histone H3-K9 methylation,BP,
13075,GO:0051575,1,0.976110122358225,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
13077,GO:0051581,1,0.985180222366523,0,3,negative regulation of neurotransmitter uptake,BP,
13078,GO:0051582,1,0.98418712226676,0,2,positive regulation of neurotransmitter uptake,BP,
13081,GO:0051585,1,0.995366810543291,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13082,GO:0051586,1,0.989265903628436,0,1,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13084,GO:0051589,1,0.924815324742499,0,13,negative regulation of neurotransmitter transport,BP,
13085,GO:0051590,1,0.889904630159078,0,17,positive regulation of neurotransmitter transport,BP,
13086,GO:0051591,1,0.693141650108013,0,61,response to cAMP,BP,
13088,GO:0051593,1,0.94556677242214,0,8,response to folic acid,BP,
13089,GO:0051595,1,0.960938795431781,0,3,response to methylglyoxal,BP,
13090,GO:0051596,1,0.98492142716432,0,2,methylglyoxal catabolic process,BP,
13091,GO:0051597,1,0.965158024199688,0,6,response to methylmercury,BP,
13092,GO:0051598,1,0.995366990826165,0,1,meiotic recombination checkpoint,BP,
13093,GO:0051599,1,0.978477434300601,0,4,response to hydrostatic pressure,BP,
13094,GO:0051601,1,0.961850070051928,0,7,exocyst localization,BP,
13095,GO:0051602,1,0.892598050759319,0,18,response to electrical stimulus,BP,
13097,GO:0051604,1,0.176315609592922,0,209,protein maturation,BP,
13098,GO:0051606,1,0.408103170428906,0,114,detection of stimulus,BP,
13100,GO:0051608,1,0.911064894001624,0,9,histamine transport,BP,
13101,GO:0051610,1,0.986164352388525,0,3,serotonin uptake,BP,
13102,GO:0051611,1,0.990755020392065,0,2,regulation of serotonin uptake,BP,
13103,GO:0051612,1,0.990755020392065,0,2,negative regulation of serotonin uptake,BP,
13104,GO:0051615,1,0.995366990826138,0,1,histamine uptake,BP,
13105,GO:0051620,1,0.995366810543291,0,1,norepinephrine uptake,BP,
13106,GO:0051621,1,0.995366810543291,0,1,regulation of norepinephrine uptake,BP,
13107,GO:0051622,1,0.995366810543291,0,1,negative regulation of norepinephrine uptake,BP,
13108,GO:0051639,1,0.961826187599699,0,8,actin filament network formation,BP,
13111,GO:0051642,1,0.877248857932815,0,22,centrosome localization,BP,
13112,GO:0051643,1,0.977045769015487,0,5,endoplasmic reticulum localization,BP,
13113,GO:0051645,1,0.932953055773603,0,12,Golgi localization,BP,
13114,GO:0051646,1,0.800900974565522,0,35,mitochondrion localization,BP,
13115,GO:0051647,1,0.916344547105673,0,18,nucleus localization,BP,
13116,GO:0051648,1,0.289692099786555,0,194,vesicle localization,BP,
13118,GO:0051650,1,0.29800682272726,0,188,establishment of vesicle localization,BP,
13120,GO:0051653,1,0.825042675679641,0,34,spindle localization,BP,
13121,GO:0051654,1,0.859055735271092,0,20,establishment of mitochondrion localization,BP,
13122,GO:0051656,1,0.0971867825912941,0,348,establishment of organelle localization,BP,
13123,GO:0051657,1,0.963523613452214,0,8,maintenance of organelle location,BP,
13124,GO:0051660,1,0.981594691159581,0,4,establishment of centrosome localization,BP,
13125,GO:0051661,1,0.977045497580169,0,5,maintenance of centrosome location,BP,
13126,GO:0051664,1,0.990754785405313,0,2,nuclear pore localization,BP,
13127,GO:0051665,1,0.949284803691973,0,7,membrane raft localization,BP,
13128,GO:0051666,1,0.986164531023741,0,3,actin cortical patch localization,BP,
13129,GO:0051668,1,0.607475477460402,0,83,localization within membrane,BP,
13130,GO:0051673,1,0.982543271240275,0,2,membrane disruption in other organism,BP,
13132,GO:0051683,1,0.954883311248284,0,7,establishment of Golgi localization,BP,
13133,GO:0051684,1,0.986164114638215,0,3,maintenance of Golgi location,BP,
13134,GO:0051685,1,0.995366574475227,0,1,maintenance of ER location,BP,
13135,GO:0051686,1,0.995366990825851,0,1,establishment of ER localization,BP,
13136,GO:0051693,1,0.890786364751225,0,21,actin filament capping,BP,
13137,GO:0051694,1,0.989749245021515,0,2,pointed-end actin filament capping,BP,
13138,GO:0051697,1,0.97537603700172,0,4,protein delipidation,BP,
13139,GO:0051701,1,0.323023269006207,0,159,interaction with host,BP,
13140,GO:0051702,1,0.684324982403804,0,52,interaction with symbiont,BP,
13141,GO:0051703,1,0.845202162396135,0,31,intraspecies interaction between organisms,BP,
13143,GO:0051705,1,0.807165799888636,0,38,multi-organism behavior,BP,
13145,GO:0051708,1,0.965485926441435,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
13146,GO:0051709,1,0.923682822761105,0,7,regulation of killing of cells of other organism,BP,
13147,GO:0051710,1,0.975701813833231,0,2,regulation of cytolysis in other organism,BP,
13148,GO:0051712,1,0.923682822761105,0,7,positive regulation of killing of cells of other organism,BP,
13149,GO:0051714,1,0.975701813833231,0,2,positive regulation of cytolysis in other organism,BP,
13150,GO:0051715,1,0.943294401595185,0,3,cytolysis in other organism,BP,
13152,GO:0051717,1,0.990754732781004,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
13153,GO:0051721,1,0.871392889648927,0,25,protein phosphatase 2A binding,MF,
13154,GO:0051722,1,0.995233826949388,0,1,protein C-terminal methylesterase activity,MF,
13155,GO:0051723,1,0.995233826949388,0,1,protein methylesterase activity,MF,
13156,GO:0051724,1,0.994866746349447,0,1,NAD transmembrane transporter activity,MF,
13157,GO:0051725,1,0.980105958731553,0,2,protein de-ADP-ribosylation,BP,
13159,GO:0051728,1,0.995366672627586,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
13160,GO:0051729,1,0.995366672627586,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
13161,GO:0051731,1,0.974159618837752,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
13162,GO:0051732,1,0.991695739399954,0,1,polyribonucleotide kinase activity,MF,
13163,GO:0051733,1,0.978695044188488,0,3,polydeoxyribonucleotide kinase activity,MF,
13164,GO:0051734,1,0.978695044188488,0,3,ATP-dependent polynucleotide kinase activity,MF,
13165,GO:0051736,1,0.991695739399954,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
13166,GO:0051747,1,0.968114156239837,0,2,cytosine C-5 DNA demethylase activity,MF,
13167,GO:0051748,1,0.994457680249057,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
13168,GO:0051750,1,0.984741452522495,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
13169,GO:0051754,1,0.985910986263058,0,3,meiotic sister chromatid cohesion, centromeric,BP,
13170,GO:0051764,1,0.949353985940249,0,11,actin crosslink formation,BP,
13171,GO:0051765,1,0.987562173281898,0,2,inositol tetrakisphosphate kinase activity,MF,
13172,GO:0051766,1,0.973896756616454,0,5,inositol trisphosphate kinase activity,MF,
13173,GO:0051767,1,0.919177406666589,0,10,nitric-oxide synthase biosynthetic process,BP,
13174,GO:0051769,1,0.919177406666589,0,10,regulation of nitric-oxide synthase biosynthetic process,BP,
13175,GO:0051770,1,0.949122073599462,0,7,positive regulation of nitric-oxide synthase biosynthetic process,BP,
13176,GO:0051771,1,0.96846875094808,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
13177,GO:0051775,1,0.904408058571488,0,10,response to redox state,BP,
13178,GO:0051780,1,0.995366990826138,0,1,behavioral response to nutrient,BP,
13179,GO:0051781,1,0.699891924618787,0,54,positive regulation of cell division,BP,
13181,GO:0051783,1,0.345100542083274,0,154,regulation of nuclear division,BP,
13182,GO:0051784,1,0.700719432385638,0,47,negative regulation of nuclear division,BP,
13183,GO:0051785,1,0.724199181287161,0,45,positive regulation of nuclear division,BP,
13184,GO:0051786,1,0.995366888594687,0,1,all-trans-retinol 13,14-reductase activity,MF,
13185,GO:0051787,1,0.87049366474682,0,23,misfolded protein binding,MF,
13186,GO:0051788,1,0.861988197430594,0,22,response to misfolded protein,BP,
13187,GO:0051790,1,0.970284712161535,0,4,short-chain fatty acid biosynthetic process,BP,
13188,GO:0051791,1,0.950494690363408,0,7,medium-chain fatty acid metabolic process,BP,
13189,GO:0051792,1,0.963894042783798,0,4,medium-chain fatty acid biosynthetic process,BP,
13190,GO:0051793,1,0.984896417112115,0,3,medium-chain fatty acid catabolic process,BP,
13191,GO:0051794,1,0.960387857455759,0,4,regulation of timing of catagen,BP,
13192,GO:0051795,1,0.96485989752649,0,3,positive regulation of timing of catagen,BP,
13193,GO:0051796,1,0.995366990826152,0,1,negative regulation of timing of catagen,BP,
13194,GO:0051797,1,0.871245159289658,0,18,regulation of hair follicle development,BP,
13195,GO:0051798,1,0.900097548369134,0,11,positive regulation of hair follicle development,BP,
13196,GO:0051799,1,0.986164524598146,0,3,negative regulation of hair follicle development,BP,
13197,GO:0051800,1,0.995366990826138,0,1,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
13198,GO:0051805,1,0.990751078558827,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
13199,GO:0051806,1,0.495323976223882,0,94,entry into cell of other organism involved in symbiotic interaction,BP,
13200,GO:0051807,1,0.990751078558827,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
13201,GO:0051808,1,0.995175560072827,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
13202,GO:0051817,1,0.594822593702114,0,77,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,
13203,GO:0051818,1,0.938138985336618,0,6,disruption of cells of other organism involved in symbiotic interaction,BP,
13204,GO:0051821,1,0.995366990826099,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
13205,GO:0051823,1,0.973940854115005,0,4,regulation of synapse structural plasticity,BP,
13206,GO:0051828,1,0.495323976223882,0,94,entry into other organism involved in symbiotic interaction,BP,
13207,GO:0051832,1,0.98090394114415,0,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,
13208,GO:0051833,1,0.995366990826151,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
13209,GO:0051834,1,0.98090394114415,0,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
13210,GO:0051835,1,0.978475710338613,0,3,positive regulation of synapse structural plasticity,BP,
13211,GO:0051836,1,0.931582605671115,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,
13212,GO:0051851,1,0.708246729078653,0,48,modification by host of symbiont morphology or physiology,BP,
13213,GO:0051852,1,0.960335545415822,0,4,disruption by host of symbiont cells,BP,
13214,GO:0051861,1,0.933377408222886,0,13,glycolipid binding,MF,
13215,GO:0051864,1,0.963523881174064,0,8,histone demethylase activity (H3-K36 specific),MF,
13216,GO:0051865,1,0.736654021024403,0,52,protein autoubiquitination,BP,
13217,GO:0051866,1,0.995366956481041,0,1,general adaptation syndrome,BP,
13218,GO:0051870,1,0.995366990478057,0,1,methotrexate binding,MF,
13219,GO:0051873,1,0.960335545415822,0,4,killing by host of symbiont cells,BP,
13220,GO:0051875,1,0.877976446435756,0,22,pigment granule localization,BP,
13221,GO:0051877,1,0.99072469715541,0,2,pigment granule aggregation in cell center,BP,
13222,GO:0051879,1,0.830647259352761,0,31,Hsp90 protein binding,MF,
13223,GO:0051880,1,0.968010946247555,0,7,G-quadruplex DNA binding,MF,
13224,GO:0051881,1,0.622129040039683,0,48,regulation of mitochondrial membrane potential,BP,
13225,GO:0051882,1,0.860716443453352,0,15,mitochondrial depolarization,BP,
13226,GO:0051883,1,0.938138985336618,0,6,killing of cells in other organism involved in symbiotic interaction,BP,
13227,GO:0051884,1,0.981594814986969,0,4,regulation of timing of anagen,BP,
13228,GO:0051885,1,0.995366990826125,0,1,positive regulation of timing of anagen,BP,
13229,GO:0051886,1,0.995366990826151,0,1,negative regulation of timing of anagen,BP,
13230,GO:0051890,1,0.99075519984928,0,2,regulation of cardioblast differentiation,BP,
13231,GO:0051891,1,0.995366990826151,0,1,positive regulation of cardioblast differentiation,BP,
13232,GO:0051892,1,0.995366990826153,0,1,negative regulation of cardioblast differentiation,BP,
13233,GO:0051893,1,0.78144707383559,0,44,regulation of focal adhesion assembly,BP,
13234,GO:0051894,1,0.889022162535416,0,20,positive regulation of focal adhesion assembly,BP,
13235,GO:0051895,1,0.943180101605345,0,12,negative regulation of focal adhesion assembly,BP,
13239,GO:0051899,1,0.694610981441759,0,51,membrane depolarization,BP,
13240,GO:0051900,1,0.881532136971427,0,13,regulation of mitochondrial depolarization,BP,
13241,GO:0051901,1,0.935877579123358,0,5,positive regulation of mitochondrial depolarization,BP,
13242,GO:0051902,1,0.957877538401898,0,5,negative regulation of mitochondrial depolarization,BP,
13243,GO:0051903,1,0.995351917877958,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
13244,GO:0051904,1,0.890345338119909,0,19,pigment granule transport,BP,
13245,GO:0051905,1,0.886214847352941,0,20,establishment of pigment granule localization,BP,
13246,GO:0051908,1,0.995366830305837,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
13247,GO:0051917,1,0.968040642902721,0,6,regulation of fibrinolysis,BP,
13248,GO:0051918,1,0.978360754682941,0,4,negative regulation of fibrinolysis,BP,
13249,GO:0051919,1,0.994060612452411,0,1,positive regulation of fibrinolysis,BP,
13250,GO:0051920,1,0.872882922567451,0,8,peroxiredoxin activity,MF,
13251,GO:0051923,1,0.936006822631774,0,9,sulfation,BP,
13252,GO:0051924,1,0.457074070182593,0,118,regulation of calcium ion transport,BP,
13253,GO:0051926,1,0.802672710341823,0,31,negative regulation of calcium ion transport,BP,
13254,GO:0051928,1,0.671931250818706,0,55,positive regulation of calcium ion transport,BP,
13255,GO:0051930,1,0.897398881185103,0,14,regulation of sensory perception of pain,BP,
13256,GO:0051931,1,0.897398881185103,0,14,regulation of sensory perception,BP,
13257,GO:0051932,1,0.88600062305031,0,19,synaptic transmission, GABAergic,BP,
13258,GO:0051933,1,0.995366990826099,0,1,amino acid neurotransmitter reuptake,BP,
13260,GO:0051935,1,0.995366990826099,0,1,glutamate reuptake,BP,
13262,GO:0051938,1,0.971059159911143,0,6,L-glutamate import,BP,
13264,GO:0051941,1,0.995366990826099,0,1,regulation of amino acid uptake involved in synaptic transmission,BP,
13265,GO:0051944,1,0.989265903628436,0,1,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
13266,GO:0051945,1,0.995366810543291,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
13267,GO:0051946,1,0.995366990826099,0,1,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
13269,GO:0051953,1,0.976070531536922,0,5,negative regulation of amine transport,BP,
13271,GO:0051955,1,0.920239857684193,0,13,regulation of amino acid transport,BP,
13272,GO:0051956,1,0.985180286223377,0,3,negative regulation of amino acid transport,BP,
13273,GO:0051957,1,0.958872570544856,0,6,positive regulation of amino acid transport,BP,
13274,GO:0051958,1,0.99075472319709,0,2,methotrexate transport,BP,
13275,GO:0051959,1,0.855972950566432,0,23,dynein light intermediate chain binding,MF,
13279,GO:0051963,1,0.805820207728328,0,44,regulation of synapse assembly,BP,
13280,GO:0051964,1,0.981594819011326,0,4,negative regulation of synapse assembly,BP,
13281,GO:0051965,1,0.84420961918065,0,34,positive regulation of synapse assembly,BP,
13282,GO:0051966,1,0.861603712501376,0,24,regulation of synaptic transmission, glutamatergic,BP,
13283,GO:0051967,1,0.973832252427796,0,3,negative regulation of synaptic transmission, glutamatergic,BP,
13284,GO:0051968,1,0.933723136825934,0,13,positive regulation of synaptic transmission, glutamatergic,BP,
13285,GO:0051969,1,0.976825856545866,0,4,regulation of transmission of nerve impulse,BP,
13286,GO:0051971,1,0.990547693470521,0,2,positive regulation of transmission of nerve impulse,BP,
13287,GO:0051972,1,0.779756244453121,0,42,regulation of telomerase activity,BP,
13288,GO:0051973,1,0.827712746622285,0,33,positive regulation of telomerase activity,BP,
13289,GO:0051974,1,0.94657194501338,0,8,negative regulation of telomerase activity,BP,
13290,GO:0051977,1,0.99463066023463,0,1,lysophospholipid transport,BP,
13291,GO:0051978,1,0.99463066023463,0,1,lysophospholipid transporter activity,MF,
13292,GO:0051983,1,0.541388865513038,0,89,regulation of chromosome segregation,BP,
13293,GO:0051984,1,0.853487866105294,0,26,positive regulation of chromosome segregation,BP,
13294,GO:0051985,1,0.76407920039656,0,36,negative regulation of chromosome segregation,BP,
13295,GO:0051987,1,0.973125701576219,0,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,
13296,GO:0051988,1,0.940311145844335,0,12,regulation of attachment of spindle microtubules to kinetochore,BP,
13297,GO:0051990,1,0.990386516801308,0,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
13298,GO:0051996,1,0.99430306699322,0,1,squalene synthase activity,MF,
13299,GO:0051998,1,0.954490710040051,0,7,protein carboxyl O-methyltransferase activity,MF,
13300,GO:0052027,1,0.990755081298326,0,2,modulation by symbiont of host signal transduction pathway,BP,
13301,GO:0052029,1,0.995366990826151,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
13302,GO:0052031,1,0.978518622522356,0,3,modulation by symbiont of host defense response,BP,
13303,GO:0052037,1,0.995366990826151,0,1,negative regulation by symbiont of host defense response,BP,
13304,GO:0052040,1,0.949367195545761,0,6,modulation by symbiont of host programmed cell death,BP,
13305,GO:0052041,1,0.967732578473727,0,4,negative regulation by symbiont of host programmed cell death,BP,
13306,GO:0052042,1,0.962822652183045,0,3,positive regulation by symbiont of host programmed cell death,BP,
13307,GO:0052047,1,0.995366990826008,0,1,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
13308,GO:0052053,1,0.995365991578734,0,1,negative regulation by symbiont of host catalytic activity,BP,
13309,GO:0052055,1,0.990754205178619,0,2,modulation by symbiont of host molecular function,BP,
13310,GO:0052056,1,0.990754205178619,0,2,negative regulation by symbiont of host molecular function,BP,
13311,GO:0052066,1,0.995366990826073,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
13312,GO:0052097,1,0.995366872685533,0,1,interspecies quorum sensing,BP,
13313,GO:0052106,1,0.995366872685533,0,1,quorum sensing involved in interaction with host,BP,
13314,GO:0052126,1,0.825005486354476,0,33,movement in host environment,BP,
13315,GO:0052148,1,0.995365991578734,0,1,modulation by symbiont of host catalytic activity,BP,
13316,GO:0052150,1,0.963247375121571,0,5,modulation by symbiont of host apoptotic process,BP,
13317,GO:0052151,1,0.976897262930799,0,2,positive regulation by symbiont of host apoptotic process,BP,
13318,GO:0052167,1,0.995366990826151,0,1,modulation by symbiont of host innate immune response,BP,
13319,GO:0052170,1,0.995366990826151,0,1,negative regulation by symbiont of host innate immune response,BP,
13320,GO:0052173,1,0.960701415682263,0,6,response to defenses of other organism involved in symbiotic interaction,BP,
13321,GO:0052190,1,0.995366990826073,0,1,modulation by symbiont of host phagocytosis,BP,
13322,GO:0052191,1,0.995366990826073,0,1,positive regulation by symbiont of host phagocytosis,BP,
13323,GO:0052192,1,0.825005486354476,0,33,movement in environment of other organism involved in symbiotic interaction,BP,
13324,GO:0052199,1,0.995365991578734,0,1,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
13325,GO:0052200,1,0.960701415682263,0,6,response to host defenses,BP,
13326,GO:0052203,1,0.987094638660424,0,2,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
13327,GO:0052204,1,0.954731538969798,0,5,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
13328,GO:0052205,1,0.950305905604651,0,6,modulation of molecular function in other organism involved in symbiotic interaction,BP,
13329,GO:0052214,1,0.990454298177577,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
13330,GO:0052227,1,0.990454298177577,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
13331,GO:0052229,1,0.990454298177577,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
13332,GO:0052231,1,0.995366990826073,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
13333,GO:0052248,1,0.949367195545761,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
13334,GO:0052250,1,0.990755081298326,0,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,
13335,GO:0052251,1,0.983074106908371,0,2,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
13336,GO:0052255,1,0.978518622522356,0,3,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
13337,GO:0052261,1,0.995366990826151,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
13338,GO:0052306,1,0.995366990826151,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13339,GO:0052309,1,0.995366990826151,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13340,GO:0052312,1,0.863130895154477,0,24,modulation of transcription in other organism involved in symbiotic interaction,BP,
13341,GO:0052314,1,0.993103767077917,0,1,phytoalexin metabolic process,BP,
13342,GO:0052330,1,0.962822652183045,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13343,GO:0052360,1,0.990454298177577,0,1,catabolism by host of symbiont macromolecule,BP,
13344,GO:0052361,1,0.990454298177577,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
13345,GO:0052362,1,0.990454298177577,0,1,catabolism by host of symbiont protein,BP,
13346,GO:0052363,1,0.990454298177577,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13347,GO:0052364,1,0.990454298177577,0,1,catabolism by host of substance in symbiont,BP,
13348,GO:0052370,1,0.995366990826073,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
13349,GO:0052381,1,0.994407934651307,0,1,tRNA dimethylallyltransferase activity,MF,
13350,GO:0052405,1,0.963644980634642,0,3,negative regulation by host of symbiont molecular function,BP,
13351,GO:0052416,1,0.990454298177577,0,1,metabolism by host of symbiont macromolecule,BP,
13352,GO:0052417,1,0.990454298177577,0,1,metabolism by host of symbiont protein,BP,
13353,GO:0052418,1,0.990454298177577,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13354,GO:0052419,1,0.990454298177577,0,1,metabolism by host of substance in symbiont,BP,
13355,GO:0052422,1,0.991690581605567,0,1,modulation by host of symbiont catalytic activity,BP,
13356,GO:0052428,1,0.95917850716155,0,4,modulation by host of symbiont molecular function,BP,
13357,GO:0052433,1,0.949367195545761,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
13358,GO:0052472,1,0.863130895154477,0,24,modulation by host of symbiont transcription,BP,
13359,GO:0052490,1,0.967732578473727,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13360,GO:0052493,1,0.995366990826151,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
13361,GO:0052501,1,0.962822652183045,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
13362,GO:0052509,1,0.983074106908371,0,2,positive regulation by symbiont of host defense response,BP,
13363,GO:0052510,1,0.983074106908371,0,2,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
13364,GO:0052522,1,0.995366990826073,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
13365,GO:0052547,1,0.0728198639214891,0,284,regulation of peptidase activity,BP,
13366,GO:0052548,1,0.0824639516950993,0,267,regulation of endopeptidase activity,BP,
13367,GO:0052550,1,0.990962446047837,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
13368,GO:0052552,1,0.978518622522356,0,3,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13369,GO:0052553,1,0.978518622522356,0,3,modulation by symbiont of host immune response,BP,
13370,GO:0052561,1,0.995366990826151,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13371,GO:0052562,1,0.995366990826151,0,1,negative regulation by symbiont of host immune response,BP,
13372,GO:0052564,1,0.965174901712521,0,5,response to immune response of other organism involved in symbiotic interaction,BP,
13373,GO:0052567,1,0.990962446047837,0,1,response to defense-related host reactive oxygen species production,BP,
13374,GO:0052572,1,0.965174901712521,0,5,response to host immune response,BP,
13375,GO:0052590,1,0.995366990826126,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
13376,GO:0052591,1,0.995366990826126,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
13377,GO:0052593,1,0.990733286286984,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
13378,GO:0052594,1,0.990733286286984,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
13379,GO:0052595,1,0.990733286286984,0,2,aliphatic-amine oxidase activity,MF,
13380,GO:0052596,1,0.990733286286984,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
13381,GO:0052629,1,0.949903598843741,0,11,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
13382,GO:0052642,1,0.992335192206827,0,1,lysophosphatidic acid phosphatase activity,MF,
13383,GO:0052646,1,0.960582234226779,0,8,alditol phosphate metabolic process,BP,
13384,GO:0052650,1,0.946189061000457,0,7,NADP-retinol dehydrogenase activity,MF,
13385,GO:0052651,1,0.987447971345129,0,2,monoacylglycerol catabolic process,BP,
13386,GO:0052652,1,0.78845172259657,0,35,cyclic purine nucleotide metabolic process,BP,
13387,GO:0052654,1,0.98565363550537,0,2,L-leucine transaminase activity,MF,
13388,GO:0052655,1,0.98565363550537,0,2,L-valine transaminase activity,MF,
13389,GO:0052656,1,0.98565363550537,0,2,L-isoleucine transaminase activity,MF,
13390,GO:0052657,1,0.987320871589949,0,1,guanine phosphoribosyltransferase activity,MF,
13391,GO:0052658,1,0.971964859693741,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
13392,GO:0052659,1,0.958512761491397,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
13393,GO:0052666,1,0.993477298997412,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
13394,GO:0052689,1,0.558198054423571,0,85,carboxylic ester hydrolase activity,MF,
13395,GO:0052692,1,0.98736875124752,0,1,raffinose alpha-galactosidase activity,MF,
13396,GO:0052695,1,0.965729205500968,0,7,cellular glucuronidation,BP,
13397,GO:0052696,1,0.974758693829511,0,5,flavonoid glucuronidation,BP,
13398,GO:0052697,1,0.974758693829511,0,5,xenobiotic glucuronidation,BP,
13399,GO:0052717,1,0.995366990826099,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
13400,GO:0052718,1,0.995366990826099,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
13401,GO:0052723,1,0.972291517048722,0,4,inositol hexakisphosphate 1-kinase activity,MF,
13402,GO:0052724,1,0.972291517048722,0,4,inositol hexakisphosphate 3-kinase activity,MF,
13403,GO:0052725,1,0.9953668603647,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
13404,GO:0052726,1,0.9953668603647,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
13405,GO:0052735,1,0.985344995816821,0,3,tRNA (cytosine-3-)-methyltransferase activity,MF,
13406,GO:0052739,1,0.994111772669677,0,1,phosphatidylserine 1-acylhydrolase activity,MF,
13407,GO:0052740,1,0.994111772669677,0,1,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
13408,GO:0052742,1,0.857184911472965,0,33,phosphatidylinositol kinase activity,MF,
13409,GO:0052743,1,0.94964674068128,0,11,inositol tetrakisphosphate phosphatase activity,MF,
13410,GO:0052744,1,0.936753287811005,0,14,phosphatidylinositol monophosphate phosphatase activity,MF,
13411,GO:0052745,1,0.907753692271172,0,19,inositol phosphate phosphatase activity,MF,
13412,GO:0052746,1,0.990755069985376,0,2,inositol phosphorylation,BP,
13413,GO:0052794,1,0.989519166684217,0,2,exo-alpha-(2->3)-sialidase activity,MF,
13414,GO:0052795,1,0.989519166684217,0,2,exo-alpha-(2->6)-sialidase activity,MF,
13415,GO:0052796,1,0.989519166684217,0,2,exo-alpha-(2->8)-sialidase activity,MF,
13416,GO:0052798,1,0.994257209385536,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
13417,GO:0052803,1,0.959131126034895,0,5,imidazole-containing compound metabolic process,BP,
13418,GO:0052805,1,0.968359602318785,0,3,imidazole-containing compound catabolic process,BP,
13419,GO:0052810,1,0.995366983919404,0,1,1-phosphatidylinositol-5-kinase activity,MF,
13420,GO:0052811,1,0.981594880050123,0,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
13421,GO:0052812,1,0.990755192974171,0,2,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
13422,GO:0052813,1,0.843734135758395,0,36,phosphatidylinositol bisphosphate kinase activity,MF,
13423,GO:0052815,1,0.982707584867652,0,1,medium-chain acyl-CoA hydrolase activity,MF,
13424,GO:0052821,1,0.981272802792047,0,1,DNA-7-methyladenine glycosylase activity,MF,
13425,GO:0052822,1,0.981272802792047,0,1,DNA-3-methylguanine glycosylase activity,MF,
13426,GO:0052825,1,0.9953668603647,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
13427,GO:0052826,1,0.995366521608773,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
13428,GO:0052827,1,0.990754602917161,0,2,inositol pentakisphosphate phosphatase activity,MF,
13429,GO:0052828,1,0.990755199849188,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
13430,GO:0052829,1,0.994226706671134,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
13431,GO:0052830,1,0.9953668603647,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
13432,GO:0052831,1,0.9953668603647,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
13433,GO:0052832,1,0.9749576470753,0,4,inositol monophosphate 3-phosphatase activity,MF,
13434,GO:0052833,1,0.9749576470753,0,4,inositol monophosphate 4-phosphatase activity,MF,
13435,GO:0052834,1,0.9749576470753,0,4,inositol monophosphate phosphatase activity,MF,
13436,GO:0052835,1,0.9953668603647,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
13437,GO:0052836,1,0.981366004698445,0,2,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
13438,GO:0052839,1,0.981366004698445,0,2,inositol diphosphate tetrakisphosphate kinase activity,MF,
13439,GO:0052840,1,0.970671105713102,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
13440,GO:0052841,1,0.970671105713102,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
13441,GO:0052842,1,0.970671105713102,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
13442,GO:0052843,1,0.970671105713102,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
13443,GO:0052844,1,0.970671105713102,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
13444,GO:0052845,1,0.970671105713102,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
13445,GO:0052846,1,0.970671105713102,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
13446,GO:0052847,1,0.970671105713102,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
13447,GO:0052848,1,0.970671105713102,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
13448,GO:0052851,1,0.967418600203968,0,5,ferric-chelate reductase (NADPH) activity,MF,
13449,GO:0052858,1,0.995366964886755,0,1,peptidyl-lysine acetyltransferase activity,MF,
13450,GO:0052866,1,0.885391732503249,0,26,phosphatidylinositol phosphate phosphatase activity,MF,
13451,GO:0052890,1,0.99321405027932,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
13452,GO:0052894,1,0.994139333069833,0,1,norspermine:oxygen oxidoreductase activity,MF,
13453,GO:0052895,1,0.994139333069833,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
13454,GO:0052899,1,0.991156461546762,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13455,GO:0052901,1,0.985347032142105,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
13456,GO:0052902,1,0.991156461546762,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
13457,GO:0052903,1,0.991156461546762,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13458,GO:0052904,1,0.991156461546762,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13459,GO:0052905,1,0.986163293387401,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
13460,GO:0052906,1,0.995366990826152,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
13461,GO:0052907,1,0.995366574475227,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
13462,GO:0052909,1,0.995366574475227,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
13463,GO:0052917,1,0.995112892559295,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
13464,GO:0052918,1,0.995366990826099,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13465,GO:0052925,1,0.988862806102603,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
13466,GO:0052926,1,0.995366990826099,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13467,GO:0052927,1,0.994896215629768,0,1,CTP:tRNA cytidylyltransferase activity,MF,
13468,GO:0052928,1,0.994896215629768,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
13469,GO:0052929,1,0.994896215629768,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
13471,GO:0055002,1,0.625827793544101,0,78,striated muscle cell development,BP,
13472,GO:0055003,1,0.963524687539024,0,8,cardiac myofibril assembly,BP,
13473,GO:0055005,1,0.995366990826139,0,1,ventricular cardiac myofibril assembly,BP,
13474,GO:0055006,1,0.793220079761619,0,43,cardiac cell development,BP,
13475,GO:0055007,1,0.68963752963203,0,65,cardiac muscle cell differentiation,BP,
13476,GO:0055008,1,0.829411442858283,0,35,cardiac muscle tissue morphogenesis,BP,
13477,GO:0055009,1,0.983205757900744,0,3,atrial cardiac muscle tissue morphogenesis,BP,
13478,GO:0055010,1,0.865648156867686,0,27,ventricular cardiac muscle tissue morphogenesis,BP,
13479,GO:0055011,1,0.991178934906124,0,1,atrial cardiac muscle cell differentiation,BP,
13480,GO:0055012,1,0.949843762482254,0,9,ventricular cardiac muscle cell differentiation,BP,
13481,GO:0055013,1,0.812060734592375,0,38,cardiac muscle cell development,BP,
13482,GO:0055014,1,0.991178934906124,0,1,atrial cardiac muscle cell development,BP,
13483,GO:0055015,1,0.958711241108465,0,7,ventricular cardiac muscle cell development,BP,
13484,GO:0055017,1,0.779037466009897,0,47,cardiac muscle tissue growth,BP,
13485,GO:0055018,1,0.992054598406672,0,1,regulation of cardiac muscle fiber development,BP,
13486,GO:0055020,1,0.992054598406672,0,1,positive regulation of cardiac muscle fiber development,BP,
13487,GO:0055021,1,0.839527315343866,0,32,regulation of cardiac muscle tissue growth,BP,
13488,GO:0055022,1,0.933552403891945,0,14,negative regulation of cardiac muscle tissue growth,BP,
13489,GO:0055023,1,0.899357829628374,0,18,positive regulation of cardiac muscle tissue growth,BP,
13490,GO:0055024,1,0.775324105052878,0,47,regulation of cardiac muscle tissue development,BP,
13491,GO:0055025,1,0.864849409619678,0,25,positive regulation of cardiac muscle tissue development,BP,
13492,GO:0055026,1,0.900826687472759,0,21,negative regulation of cardiac muscle tissue development,BP,
13493,GO:0055028,1,0.995366990826059,0,1,cortical microtubule,CC,
13494,GO:0055029,1,0.348463448039495,0,127,nuclear DNA-directed RNA polymerase complex,CC,
13495,GO:0055037,1,0.380020133876027,0,143,recycling endosome,CC,
13496,GO:0055038,1,0.656823579828139,0,63,recycling endosome membrane,CC,
13497,GO:0055048,1,0.995366990826059,0,1,anastral spindle assembly,BP,
13499,GO:0055057,1,0.954612894822254,0,10,neuroblast division,BP,
13500,GO:0055059,1,0.981594577316513,0,4,asymmetric neuroblast division,BP,
13501,GO:0055062,1,0.970947714595812,0,6,phosphate ion homeostasis,BP,
13502,GO:0055064,1,0.951562487728823,0,9,chloride ion homeostasis,BP,
13505,GO:0055069,1,0.781059373953581,0,21,zinc ion homeostasis,BP,
13506,GO:0055070,1,0.827331086163538,0,16,copper ion homeostasis,BP,
13507,GO:0055072,1,0.581171964348981,0,65,iron ion homeostasis,BP,
13509,GO:0055075,1,0.932204354357969,0,14,potassium ion homeostasis,BP,
13510,GO:0055076,1,0.391405443107622,0,99,transition metal ion homeostasis,BP,
13511,GO:0055077,1,0.990754139207205,0,2,gap junction hemi-channel activity,MF,
13512,GO:0055078,1,0.935040570173131,0,13,sodium ion homeostasis,BP,
13514,GO:0055081,1,0.837546505635979,0,32,anion homeostasis,BP,
13516,GO:0055083,1,0.923901826487926,0,15,monovalent inorganic anion homeostasis,BP,
13519,GO:0055087,1,0.974308785981332,0,3,Ski complex,CC,
13520,GO:0055088,1,0.626752068500589,0,70,lipid homeostasis,BP,
13521,GO:0055089,1,0.934509005980327,0,11,fatty acid homeostasis,BP,
13522,GO:0055090,1,0.887296866233825,0,14,acylglycerol homeostasis,BP,
13523,GO:0055091,1,0.981594570774126,0,4,phospholipid homeostasis,BP,
13524,GO:0055092,1,0.78263503499675,0,36,sterol homeostasis,BP,
13525,GO:0055093,1,0.897023309789452,0,17,response to hyperoxia,BP,
13526,GO:0055094,1,0.897992464552264,0,16,response to lipoprotein particle,BP,
13527,GO:0055095,1,0.9953669888051,0,1,lipoprotein particle mediated signaling,BP,
13528,GO:0055096,1,0.9953669888051,0,1,low-density lipoprotein particle mediated signaling,BP,
13529,GO:0055100,1,0.985216327130334,0,3,adiponectin binding,MF,
13530,GO:0055102,1,0.913139987332395,0,8,lipase inhibitor activity,MF,
13531,GO:0055103,1,0.99536685468278,0,1,ligase regulator activity,MF,
13532,GO:0055105,1,0.887619334518638,0,6,ubiquitin-protein transferase inhibitor activity,MF,
13533,GO:0055106,1,0.830290741180303,0,16,ubiquitin-protein transferase regulator activity,MF,
13534,GO:0055108,1,0.993600478812784,0,1,Golgi to transport vesicle transport,BP,
13535,GO:0055113,1,0.995366990825902,0,1,epiboly involved in gastrulation with mouth forming second,BP,
13538,GO:0055118,1,0.984568993656784,0,3,negative regulation of cardiac muscle contraction,BP,
13540,GO:0055120,1,0.980450428354035,0,1,striated muscle dense body,CC,
13542,GO:0055129,1,0.973363032356521,0,4,L-proline biosynthetic process,BP,
13543,GO:0055131,1,0.969323126813926,0,5,C3HC4-type RING finger domain binding,MF,
13544,GO:0060001,1,0.995366990825995,0,1,minus-end directed microfilament motor activity,MF,
13545,GO:0060002,1,0.990755197326768,0,2,plus-end directed microfilament motor activity,MF,
13546,GO:0060003,1,0.990755199849071,0,2,copper ion export,BP,
13547,GO:0060004,1,0.953882168321999,0,10,reflex,BP,
13548,GO:0060005,1,0.995366990826139,0,1,vestibular reflex,BP,
13549,GO:0060007,1,0.995366990826139,0,1,linear vestibuloocular reflex,BP,
13550,GO:0060008,1,0.905582671579228,0,14,Sertoli cell differentiation,BP,
13551,GO:0060009,1,0.922579401213066,0,10,Sertoli cell development,BP,
13552,GO:0060010,1,0.995366890102075,0,1,Sertoli cell fate commitment,BP,
13553,GO:0060011,1,0.966257651000714,0,3,Sertoli cell proliferation,BP,
13554,GO:0060012,1,0.995366841160869,0,1,synaptic transmission, glycinergic,BP,
13555,GO:0060013,1,0.977045795669767,0,5,righting reflex,BP,
13556,GO:0060014,1,0.995366595097125,0,1,granulosa cell differentiation,BP,
13557,GO:0060017,1,0.970918384862229,0,5,parathyroid gland development,BP,
13558,GO:0060018,1,0.99536699053359,0,1,astrocyte fate commitment,BP,
13560,GO:0060020,1,0.969171785264015,0,6,Bergmann glial cell differentiation,BP,
13562,GO:0060022,1,0.975317971858557,0,5,hard palate development,BP,
13563,GO:0060023,1,0.975439215794637,0,4,soft palate development,BP,
13564,GO:0060024,1,0.989648185306845,0,2,rhythmic synaptic transmission,BP,
13565,GO:0060025,1,0.990754785405328,0,2,regulation of synaptic activity,BP,
13566,GO:0060026,1,0.950125743556198,0,11,convergent extension,BP,
13567,GO:0060027,1,0.96798089622215,0,7,convergent extension involved in gastrulation,BP,
13568,GO:0060028,1,0.977012536755855,0,5,convergent extension involved in axis elongation,BP,
13569,GO:0060029,1,0.981594237893321,0,4,convergent extension involved in organogenesis,BP,
13570,GO:0060031,1,0.995366990826125,0,1,mediolateral intercalation,BP,
13571,GO:0060032,1,0.995366990826074,0,1,notochord regression,BP,
13572,GO:0060033,1,0.96236316955055,0,6,anatomical structure regression,BP,
13574,GO:0060038,1,0.859106078905229,0,31,cardiac muscle cell proliferation,BP,
13575,GO:0060039,1,0.934353511676792,0,14,pericardium development,BP,
13576,GO:0060040,1,0.989454805003243,0,2,retinal bipolar neuron differentiation,BP,
13577,GO:0060041,1,0.641314165406995,0,77,retina development in camera-type eye,BP,
13578,GO:0060042,1,0.884194702712023,0,24,retina morphogenesis in camera-type eye,BP,
13579,GO:0060043,1,0.895828816559476,0,22,regulation of cardiac muscle cell proliferation,BP,
13580,GO:0060044,1,0.952093968249904,0,10,negative regulation of cardiac muscle cell proliferation,BP,
13581,GO:0060045,1,0.940935913506985,0,12,positive regulation of cardiac muscle cell proliferation,BP,
13582,GO:0060046,1,0.959265179659681,0,5,regulation of acrosome reaction,BP,
13585,GO:0060049,1,0.925288051927435,0,11,regulation of protein glycosylation,BP,
13586,GO:0060050,1,0.942267889360491,0,8,positive regulation of protein glycosylation,BP,
13587,GO:0060051,1,0.986563498089853,0,2,negative regulation of protein glycosylation,BP,
13588,GO:0060052,1,0.951562351034444,0,7,neurofilament cytoskeleton organization,BP,
13589,GO:0060053,1,0.990520830332402,0,2,neurofilament cytoskeleton,CC,
13590,GO:0060054,1,0.982168556822801,0,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,
13591,GO:0060055,1,0.920279854189138,0,13,angiogenesis involved in wound healing,BP,
13592,GO:0060056,1,0.941281131265946,0,7,mammary gland involution,BP,
13593,GO:0060057,1,0.966257678802283,0,3,apoptotic process involved in mammary gland involution,BP,
13594,GO:0060058,1,0.966257678802283,0,3,positive regulation of apoptotic process involved in mammary gland involution,BP,
13595,GO:0060059,1,0.981594888732741,0,4,embryonic retina morphogenesis in camera-type eye,BP,
13596,GO:0060060,1,0.995366990826059,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
13597,GO:0060061,1,0.983954640591995,0,2,Spemann organizer formation,BP,
13598,GO:0060064,1,0.988535139043986,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
13600,GO:0060066,1,0.986740778123686,0,2,oviduct development,BP,
13601,GO:0060067,1,0.995366990826125,0,1,cervix development,BP,
13602,GO:0060068,1,0.952190345408748,0,6,vagina development,BP,
13604,GO:0060071,1,0.386714649320984,0,99,Wnt signaling pathway, planar cell polarity pathway,BP,
13605,GO:0060072,1,0.995366990826099,0,1,large conductance calcium-activated potassium channel activity,MF,
13606,GO:0060073,1,0.980843930295925,0,4,micturition,BP,
13607,GO:0060074,1,0.954785561302761,0,9,synapse maturation,BP,
13608,GO:0060075,1,0.985308291153413,0,3,regulation of resting membrane potential,BP,
13609,GO:0060076,1,0.940400491731182,0,13,excitatory synapse,CC,
13610,GO:0060077,1,0.955113618707247,0,9,inhibitory synapse,CC,
13611,GO:0060078,1,0.773501118370718,0,48,regulation of postsynaptic membrane potential,BP,
13612,GO:0060079,1,0.795417669110902,0,42,excitatory postsynaptic potential,BP,
13613,GO:0060080,1,0.97251830343202,0,6,inhibitory postsynaptic potential,BP,
13614,GO:0060081,1,0.936440282010759,0,7,membrane hyperpolarization,BP,
13615,GO:0060083,1,0.990755199849213,0,2,smooth muscle contraction involved in micturition,BP,
13616,GO:0060084,1,0.995366990826125,0,1,synaptic transmission involved in micturition,BP,
13619,GO:0060088,1,0.959121684204008,0,5,auditory receptor cell stereocilium organization,BP,
13621,GO:0060090,1,0.410659819219438,0,146,molecular adaptor activity,MF,
13622,GO:0060091,1,0.960765911514082,0,5,kinocilium,CC,
13623,GO:0060092,1,0.995366841160869,0,1,regulation of synaptic transmission, glycinergic,BP,
13624,GO:0060099,1,0.97444848539798,0,5,regulation of phagocytosis, engulfment,BP,
13625,GO:0060100,1,0.97444848539798,0,5,positive regulation of phagocytosis, engulfment,BP,
13627,GO:0060117,1,0.932750263187707,0,11,auditory receptor cell development,BP,
13631,GO:0060123,1,0.981594711227801,0,4,regulation of growth hormone secretion,BP,
13632,GO:0060124,1,0.990755020706394,0,2,positive regulation of growth hormone secretion,BP,
13633,GO:0060125,1,0.995366990826099,0,1,negative regulation of growth hormone secretion,BP,
13634,GO:0060126,1,0.990171071215583,0,2,somatotropin secreting cell differentiation,BP,
13635,GO:0060127,1,0.99478017495951,0,1,prolactin secreting cell differentiation,BP,
13636,GO:0060128,1,0.99536679727965,0,1,corticotropin hormone secreting cell differentiation,BP,
13637,GO:0060129,1,0.990755006674957,0,2,thyroid-stimulating hormone-secreting cell differentiation,BP,
13638,GO:0060134,1,0.990754827819573,0,2,prepulse inhibition,BP,
13639,GO:0060135,1,0.77755137512815,0,44,maternal process involved in female pregnancy,BP,
13640,GO:0060136,1,0.977751188704105,0,4,embryonic process involved in female pregnancy,BP,
13641,GO:0060137,1,0.962752089961393,0,6,maternal process involved in parturition,BP,
13642,GO:0060139,1,0.976897262930799,0,2,positive regulation of apoptotic process by virus,BP,
13643,GO:0060142,1,0.905124095828255,0,13,regulation of syncytium formation by plasma membrane fusion,BP,
13644,GO:0060143,1,0.911067020371113,0,12,positive regulation of syncytium formation by plasma membrane fusion,BP,
13646,GO:0060148,1,0.900000976264892,0,20,positive regulation of posttranscriptional gene silencing,BP,
13647,GO:0060149,1,0.889083719470161,0,14,negative regulation of posttranscriptional gene silencing,BP,
13648,GO:0060151,1,0.990755199849292,0,2,peroxisome localization,BP,
13649,GO:0060152,1,0.990755199849292,0,2,microtubule-based peroxisome localization,BP,
13650,GO:0060154,1,0.972239400605857,0,3,cellular process regulating host cell cycle in response to virus,BP,
13651,GO:0060155,1,0.926343814107155,0,7,platelet dense granule organization,BP,
13652,GO:0060156,1,0.99536678233859,0,1,milk ejection reflex,BP,
13653,GO:0060157,1,0.990755199849267,0,2,urinary bladder development,BP,
13654,GO:0060158,1,0.97294046980027,0,4,phospholipase C-activating dopamine receptor signaling pathway,BP,
13655,GO:0060159,1,0.973892386851201,0,4,regulation of dopamine receptor signaling pathway,BP,
13656,GO:0060161,1,0.986006776816154,0,3,positive regulation of dopamine receptor signaling pathway,BP,
13658,GO:0060166,1,0.982793554819337,0,2,olfactory pit development,BP,
13659,GO:0060167,1,0.989140067213088,0,1,regulation of adenosine receptor signaling pathway,BP,
13660,GO:0060169,1,0.989140067213088,0,1,negative regulation of adenosine receptor signaling pathway,BP,
13661,GO:0060170,1,0.78414400832857,0,45,ciliary membrane,CC,
13662,GO:0060171,1,0.995366990826165,0,1,stereocilium membrane,CC,
13664,GO:0060174,1,0.956908583473343,0,8,limb bud formation,BP,
13665,GO:0060178,1,0.994847366738983,0,1,regulation of exocyst localization,BP,
13666,GO:0060179,1,0.983528512461058,0,3,male mating behavior,BP,
13667,GO:0060180,1,0.985981476958626,0,3,female mating behavior,BP,
13668,GO:0060183,1,0.995366841160869,0,1,apelin receptor signaling pathway,BP,
13669,GO:0060184,1,0.995366672627586,0,1,cell cycle switching,BP,
13670,GO:0060187,1,0.990755199849279,0,2,cell pole,CC,
13673,GO:0060193,1,0.816265992720095,0,31,positive regulation of lipase activity,BP,
13674,GO:0060197,1,0.987457979160706,0,2,cloacal septation,BP,
13675,GO:0060198,1,0.967799933654335,0,6,clathrin-sculpted vesicle,CC,
13676,GO:0060199,1,0.98989391385001,0,2,clathrin-sculpted glutamate transport vesicle,CC,
13677,GO:0060200,1,0.995366990826165,0,1,clathrin-sculpted acetylcholine transport vesicle,CC,
13678,GO:0060201,1,0.995366990826165,0,1,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
13679,GO:0060203,1,0.98989391385001,0,2,clathrin-sculpted glutamate transport vesicle membrane,CC,
13681,GO:0060211,1,0.924964334722474,0,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
13682,GO:0060212,1,0.992407249780557,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
13683,GO:0060213,1,0.924964334722474,0,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
13684,GO:0060214,1,0.989362838152902,0,1,endocardium formation,BP,
13685,GO:0060215,1,0.977000983029261,0,5,primitive hemopoiesis,BP,
13688,GO:0060219,1,0.972300877502635,0,6,camera-type eye photoreceptor cell differentiation,BP,
13689,GO:0060221,1,0.99536699053359,0,1,retinal rod cell differentiation,BP,
13690,GO:0060228,1,0.950494198662048,0,2,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
13691,GO:0060229,1,0.942688557455344,0,8,lipase activator activity,MF,
13693,GO:0060232,1,0.979677352552169,0,4,delamination,BP,
13694,GO:0060235,1,0.982882413382241,0,3,lens induction in camera-type eye,BP,
13695,GO:0060236,1,0.813728809885517,0,35,regulation of mitotic spindle organization,BP,
13696,GO:0060242,1,0.944424831345308,0,7,contact inhibition,BP,
13697,GO:0060244,1,0.98317782198036,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
13698,GO:0060245,1,0.995366984341286,0,1,detection of cell density,BP,
13699,GO:0060246,1,0.995366984341286,0,1,detection of cell density by contact stimulus,BP,
13700,GO:0060248,1,0.995366984341286,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
13703,GO:0060252,1,0.942902914322445,0,8,positive regulation of glial cell proliferation,BP,
13706,GO:0060259,1,0.948555524621919,0,7,regulation of feeding behavior,BP,
13707,GO:0060260,1,0.851233961087867,0,23,regulation of transcription initiation from RNA polymerase II promoter,BP,
13708,GO:0060261,1,0.875871829351032,0,17,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
13709,GO:0060263,1,0.923557533893726,0,8,regulation of respiratory burst,BP,
13710,GO:0060264,1,0.971067018177993,0,2,regulation of respiratory burst involved in inflammatory response,BP,
13711,GO:0060265,1,0.976143191836315,0,1,positive regulation of respiratory burst involved in inflammatory response,BP,
13712,GO:0060266,1,0.971067018177993,0,2,negative regulation of respiratory burst involved in inflammatory response,BP,
13713,GO:0060267,1,0.965439243716675,0,3,positive regulation of respiratory burst,BP,
13714,GO:0060268,1,0.966566540443859,0,3,negative regulation of respiratory burst,BP,
13715,GO:0060271,1,0.161359330087048,0,285,cilium assembly,BP,
13716,GO:0060272,1,0.952170870644942,0,8,embryonic skeletal joint morphogenesis,BP,
13717,GO:0060278,1,0.994563254844199,0,1,regulation of ovulation,BP,
13718,GO:0060279,1,0.994563254844199,0,1,positive regulation of ovulation,BP,
13719,GO:0060281,1,0.965278751130181,0,7,regulation of oocyte development,BP,
13720,GO:0060282,1,0.983634865520971,0,3,positive regulation of oocyte development,BP,
13721,GO:0060283,1,0.9907551444475,0,2,negative regulation of oocyte development,BP,
13723,GO:0060285,1,0.926127783957209,0,15,cilium-dependent cell motility,BP,
13724,GO:0060287,1,0.970880841740021,0,4,epithelial cilium movement involved in determination of left/right asymmetry,BP,
13725,GO:0060290,1,0.995366990826126,0,1,transdifferentiation,BP,
13726,GO:0060291,1,0.790913629032883,0,39,long-term synaptic potentiation,BP,
13727,GO:0060292,1,0.914808407373827,0,15,long term synaptic depression,BP,
13728,GO:0060293,1,0.94300618628754,0,7,germ plasm,CC,
13729,GO:0060294,1,0.952314518521636,0,9,cilium movement involved in cell motility,BP,
13730,GO:0060295,1,0.976924576704834,0,5,regulation of cilium movement involved in cell motility,BP,
13731,GO:0060296,1,0.976924576704834,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,
13732,GO:0060297,1,0.985062587139731,0,3,regulation of sarcomere organization,BP,
13733,GO:0060298,1,0.989648185306727,0,2,positive regulation of sarcomere organization,BP,
13734,GO:0060300,1,0.978719411898962,0,3,regulation of cytokine activity,BP,
13735,GO:0060301,1,0.995259108849138,0,1,positive regulation of cytokine activity,BP,
13736,GO:0060302,1,0.983382418110245,0,2,negative regulation of cytokine activity,BP,
13737,GO:0060304,1,0.977044529192534,0,5,regulation of phosphatidylinositol dephosphorylation,BP,
13738,GO:0060306,1,0.925474331814314,0,16,regulation of membrane repolarization,BP,
13739,GO:0060307,1,0.954309432637796,0,10,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
13740,GO:0060309,1,0.974421722805744,0,1,elastin catabolic process,BP,
13741,GO:0060310,1,0.974421722805744,0,1,regulation of elastin catabolic process,BP,
13742,GO:0060311,1,0.974421722805744,0,1,negative regulation of elastin catabolic process,BP,
13743,GO:0060312,1,0.951104169528732,0,6,regulation of blood vessel remodeling,BP,
13744,GO:0060313,1,0.965410719199597,0,3,negative regulation of blood vessel remodeling,BP,
13745,GO:0060314,1,0.857363192147488,0,18,regulation of ryanodine-sensitive calcium-release channel activity,BP,
13746,GO:0060315,1,0.907967112967411,0,8,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
13747,GO:0060316,1,0.929101423492697,0,7,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
13749,GO:0060318,1,0.981594343796561,0,4,definitive erythrocyte differentiation,BP,
13750,GO:0060319,1,0.990755027690933,0,2,primitive erythrocyte differentiation,BP,
13752,GO:0060323,1,0.826389752174422,0,31,head morphogenesis,BP,
13753,GO:0060324,1,0.790537927179049,0,42,face development,BP,
13754,GO:0060325,1,0.853913927779342,0,26,face morphogenesis,BP,
13756,GO:0060327,1,0.995366574475227,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
13757,GO:0060330,1,0.868871575065828,0,20,regulation of response to interferon-gamma,BP,
13758,GO:0060331,1,0.951705151023198,0,6,negative regulation of response to interferon-gamma,BP,
13759,GO:0060332,1,0.986164394299407,0,3,positive regulation of response to interferon-gamma,BP,
13760,GO:0060333,1,0.612966240649156,0,63,interferon-gamma-mediated signaling pathway,BP,
13761,GO:0060334,1,0.868871575065828,0,20,regulation of interferon-gamma-mediated signaling pathway,BP,
13762,GO:0060335,1,0.986164394299407,0,3,positive regulation of interferon-gamma-mediated signaling pathway,BP,
13763,GO:0060336,1,0.951705151023198,0,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,
13765,GO:0060338,1,0.848793215476819,0,29,regulation of type I interferon-mediated signaling pathway,BP,
13766,GO:0060339,1,0.963446933662064,0,7,negative regulation of type I interferon-mediated signaling pathway,BP,
13767,GO:0060340,1,0.949770937717881,0,9,positive regulation of type I interferon-mediated signaling pathway,BP,
13769,GO:0060342,1,0.992911718424616,0,1,photoreceptor inner segment membrane,CC,
13770,GO:0060343,1,0.912611035601062,0,15,trabecula formation,BP,
13771,GO:0060346,1,0.967343371075245,0,7,bone trabecula formation,BP,
13772,GO:0060347,1,0.943440963448195,0,8,heart trabecula formation,BP,
13774,GO:0060349,1,0.757785854654137,0,52,bone morphogenesis,BP,
13775,GO:0060350,1,0.850641156683469,0,30,endochondral bone morphogenesis,BP,
13776,GO:0060351,1,0.940001769267872,0,13,cartilage development involved in endochondral bone morphogenesis,BP,
13777,GO:0060352,1,0.967621448723327,0,5,cell adhesion molecule production,BP,
13778,GO:0060353,1,0.976661326969355,0,3,regulation of cell adhesion molecule production,BP,
13779,GO:0060355,1,0.976661326969355,0,3,positive regulation of cell adhesion molecule production,BP,
13780,GO:0060359,1,0.647463552714517,0,67,response to ammonium ion,BP,
13781,GO:0060363,1,0.963408552860839,0,7,cranial suture morphogenesis,BP,
13782,GO:0060364,1,0.980231492195566,0,4,frontal suture morphogenesis,BP,
13783,GO:0060366,1,0.995366990826007,0,1,lambdoid suture morphogenesis,BP,
13784,GO:0060367,1,0.995366990826007,0,1,sagittal suture morphogenesis,BP,
13785,GO:0060368,1,0.969207133340229,0,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
13786,GO:0060369,1,0.979001041208185,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
13787,GO:0060370,1,0.995366990826125,0,1,susceptibility to T cell mediated cytotoxicity,BP,
13788,GO:0060371,1,0.986164142658371,0,3,regulation of atrial cardiac muscle cell membrane depolarization,BP,
13789,GO:0060372,1,0.995366990825994,0,1,regulation of atrial cardiac muscle cell membrane repolarization,BP,
13790,GO:0060373,1,0.981594266666436,0,4,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
13791,GO:0060374,1,0.98616414651283,0,3,mast cell differentiation,BP,
13792,GO:0060375,1,0.99536685468278,0,1,regulation of mast cell differentiation,BP,
13793,GO:0060377,1,0.99536685468278,0,1,negative regulation of mast cell differentiation,BP,
13794,GO:0060378,1,0.995366990826034,0,1,regulation of brood size,BP,
13795,GO:0060379,1,0.967490749820847,0,7,cardiac muscle cell myoblast differentiation,BP,
13796,GO:0060380,1,0.994086362767229,0,1,regulation of single-stranded telomeric DNA binding,BP,
13797,GO:0060381,1,0.994086362767229,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
13798,GO:0060382,1,0.990755199849202,0,2,regulation of DNA strand elongation,BP,
13799,GO:0060383,1,0.995366990826138,0,1,positive regulation of DNA strand elongation,BP,
13800,GO:0060384,1,0.917102208373149,0,15,innervation,BP,
13801,GO:0060385,1,0.990647811994295,0,2,axonogenesis involved in innervation,BP,
13802,GO:0060386,1,0.995366990826125,0,1,synapse assembly involved in innervation,BP,
13803,GO:0060389,1,0.790756598397827,0,37,pathway-restricted SMAD protein phosphorylation,BP,
13804,GO:0060390,1,0.924043116364399,0,14,regulation of SMAD protein signal transduction,BP,
13805,GO:0060391,1,0.94635986129482,0,11,positive regulation of SMAD protein signal transduction,BP,
13806,GO:0060392,1,0.980979000626339,0,2,negative regulation of SMAD protein signal transduction,BP,
13807,GO:0060393,1,0.801879037200998,0,34,regulation of pathway-restricted SMAD protein phosphorylation,BP,
13808,GO:0060394,1,0.958276819260612,0,7,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,
13809,GO:0060395,1,0.822018811161852,0,36,SMAD protein signal transduction,BP,
13810,GO:0060396,1,0.92543161599472,0,16,growth hormone receptor signaling pathway,BP,
13811,GO:0060397,1,0.952241893349475,0,10,JAK-STAT cascade involved in growth hormone signaling pathway,BP,
13812,GO:0060398,1,0.986164531023714,0,3,regulation of growth hormone receptor signaling pathway,BP,
13813,GO:0060399,1,0.990755199849241,0,2,positive regulation of growth hormone receptor signaling pathway,BP,
13814,GO:0060400,1,0.995366990826165,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
13817,GO:0060405,1,0.979994299332255,0,3,regulation of penile erection,BP,
13818,GO:0060406,1,0.990754975240101,0,2,positive regulation of penile erection,BP,
13819,GO:0060407,1,0.989140067213088,0,1,negative regulation of penile erection,BP,
13822,GO:0060413,1,0.954194068692277,0,10,atrial septum morphogenesis,BP,
13823,GO:0060414,1,0.990755199849149,0,2,aorta smooth muscle tissue morphogenesis,BP,
13824,GO:0060415,1,0.796362700783815,0,42,muscle tissue morphogenesis,BP,
13825,GO:0060416,1,0.891180953206128,0,24,response to growth hormone,BP,
13826,GO:0060419,1,0.762103648738875,0,51,heart growth,BP,
13827,GO:0060420,1,0.821294192350072,0,36,regulation of heart growth,BP,
13828,GO:0060421,1,0.883969767773175,0,21,positive regulation of heart growth,BP,
13829,GO:0060423,1,0.990193417929866,0,2,foregut regionalization,BP,
13830,GO:0060424,1,0.990193417929866,0,2,lung field specification,BP,
13831,GO:0060425,1,0.790446740845115,0,39,lung morphogenesis,BP,
13832,GO:0060426,1,0.972460024760175,0,3,lung vasculature development,BP,
13833,GO:0060428,1,0.871380714280219,0,23,lung epithelium development,BP,
13835,GO:0060430,1,0.990755199849045,0,2,lung saccule development,BP,
13836,GO:0060431,1,0.985605287899424,0,3,primary lung bud formation,BP,
13837,GO:0060433,1,0.951090507269451,0,8,bronchus development,BP,
13838,GO:0060434,1,0.990705535847122,0,2,bronchus morphogenesis,BP,
13839,GO:0060435,1,0.985857014101789,0,1,bronchiole development,BP,
13840,GO:0060437,1,0.989682254800409,0,2,lung growth,BP,
13841,GO:0060438,1,0.907140159730158,0,15,trachea development,BP,
13842,GO:0060439,1,0.944345072330552,0,9,trachea morphogenesis,BP,
13843,GO:0060440,1,0.966840989276349,0,6,trachea formation,BP,
13844,GO:0060441,1,0.881291119290286,0,20,epithelial tube branching involved in lung morphogenesis,BP,
13845,GO:0060442,1,0.955814925499467,0,9,branching involved in prostate gland morphogenesis,BP,
13846,GO:0060443,1,0.806676325069452,0,35,mammary gland morphogenesis,BP,
13847,GO:0060444,1,0.892555095115412,0,20,branching involved in mammary gland duct morphogenesis,BP,
13849,GO:0060447,1,0.995366990826034,0,1,bud outgrowth involved in lung branching,BP,
13850,GO:0060448,1,0.979077313705475,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
13851,GO:0060449,1,0.96804092324469,0,6,bud elongation involved in lung branching,BP,
13853,GO:0060453,1,0.957356032398052,0,5,regulation of gastric acid secretion,BP,
13854,GO:0060454,1,0.995366990826138,0,1,positive regulation of gastric acid secretion,BP,
13855,GO:0060455,1,0.970848090178296,0,2,negative regulation of gastric acid secretion,BP,
13856,GO:0060456,1,0.984935613942686,0,3,positive regulation of digestive system process,BP,
13857,GO:0060457,1,0.947301061195639,0,6,negative regulation of digestive system process,BP,
13858,GO:0060459,1,0.99478017495951,0,1,left lung development,BP,
13859,GO:0060460,1,0.99478017495951,0,1,left lung morphogenesis,BP,
13860,GO:0060462,1,0.977046177439032,0,5,lung lobe development,BP,
13861,GO:0060463,1,0.977046177439032,0,5,lung lobe morphogenesis,BP,
13862,GO:0060465,1,0.995366935169542,0,1,pharynx development,BP,
13863,GO:0060467,1,0.986900227879662,0,1,negative regulation of fertilization,BP,
13864,GO:0060474,1,0.962363484492811,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
13865,GO:0060478,1,0.98034172951118,0,2,acrosomal vesicle exocytosis,BP,
13866,GO:0060479,1,0.912437423185855,0,14,lung cell differentiation,BP,
13867,GO:0060480,1,0.985857014101789,0,1,lung goblet cell differentiation,BP,
13868,GO:0060481,1,0.981288782746821,0,2,lobar bronchus epithelium development,BP,
13869,GO:0060482,1,0.97674147635202,0,3,lobar bronchus development,BP,
13870,GO:0060484,1,0.967709201611412,0,5,lung-associated mesenchyme development,BP,
13872,GO:0060486,1,0.990470746392773,0,2,Clara cell differentiation,BP,
13873,GO:0060487,1,0.916688755722592,0,13,lung epithelial cell differentiation,BP,
13874,GO:0060488,1,0.990755199849006,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
13875,GO:0060489,1,0.990755199849006,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
13876,GO:0060490,1,0.990755199849006,0,2,lateral sprouting involved in lung morphogenesis,BP,
13878,GO:0060492,1,0.990193417929866,0,2,lung induction,BP,
13879,GO:0060501,1,0.980790571602152,0,4,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
13880,GO:0060502,1,0.959497264809579,0,8,epithelial cell proliferation involved in lung morphogenesis,BP,
13881,GO:0060503,1,0.992054598406672,0,1,bud dilation involved in lung branching,BP,
13882,GO:0060509,1,0.972133146819353,0,5,Type I pneumocyte differentiation,BP,
13883,GO:0060510,1,0.979278061127914,0,2,Type II pneumocyte differentiation,BP,
13884,GO:0060512,1,0.90998973717801,0,19,prostate gland morphogenesis,BP,
13885,GO:0060513,1,0.966942836250545,0,6,prostatic bud formation,BP,
13886,GO:0060516,1,0.99536699053359,0,1,primary prostatic bud elongation,BP,
13887,GO:0060517,1,0.99536699053359,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
13888,GO:0060523,1,0.990755199849216,0,2,prostate epithelial cord elongation,BP,
13889,GO:0060525,1,0.963334391686506,0,8,prostate glandular acinus development,BP,
13890,GO:0060526,1,0.981594888733427,0,4,prostate glandular acinus morphogenesis,BP,
13891,GO:0060527,1,0.981594888733427,0,4,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
13892,GO:0060528,1,0.985969815710101,0,3,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
13893,GO:0060529,1,0.990755199849266,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
13894,GO:0060532,1,0.990755199558051,0,2,bronchus cartilage development,BP,
13895,GO:0060534,1,0.9587590493374,0,7,trachea cartilage development,BP,
13896,GO:0060535,1,0.976741476776282,0,3,trachea cartilage morphogenesis,BP,
13900,GO:0060539,1,0.973821818349458,0,5,diaphragm development,BP,
13902,GO:0060542,1,0.995366990826125,0,1,regulation of strand invasion,BP,
13903,GO:0060544,1,0.867521859906402,0,19,regulation of necroptotic process,BP,
13904,GO:0060545,1,0.988640779630818,0,2,positive regulation of necroptotic process,BP,
13905,GO:0060546,1,0.956404220087094,0,9,negative regulation of necroptotic process,BP,
13906,GO:0060547,1,0.943711781741453,0,10,negative regulation of necrotic cell death,BP,
13909,GO:0060557,1,0.979496428396005,0,2,positive regulation of vitamin D biosynthetic process,BP,
13910,GO:0060558,1,0.965842303622156,0,5,regulation of calcidiol 1-monooxygenase activity,BP,
13911,GO:0060559,1,0.979496428396005,0,2,positive regulation of calcidiol 1-monooxygenase activity,BP,
13912,GO:0060560,1,0.411325285722943,0,156,developmental growth involved in morphogenesis,BP,
13913,GO:0060561,1,0.879392367700505,0,18,apoptotic process involved in morphogenesis,BP,
13916,GO:0060566,1,0.995366990825889,0,1,positive regulation of DNA-templated transcription, termination,BP,
13917,GO:0060571,1,0.911128687339677,0,15,morphogenesis of an epithelial fold,BP,
13918,GO:0060572,1,0.948600827392046,0,10,morphogenesis of an epithelial bud,BP,
13919,GO:0060573,1,0.986164531023532,0,3,cell fate specification involved in pattern specification,BP,
13920,GO:0060574,1,0.966086938310562,0,4,intestinal epithelial cell maturation,BP,
13921,GO:0060575,1,0.917676597206674,0,12,intestinal epithelial cell differentiation,BP,
13922,GO:0060576,1,0.930641941852114,0,9,intestinal epithelial cell development,BP,
13923,GO:0060577,1,0.99478017495951,0,1,pulmonary vein morphogenesis,BP,
13924,GO:0060578,1,0.99478017495951,0,1,superior vena cava morphogenesis,BP,
13925,GO:0060579,1,0.986164531023532,0,3,ventral spinal cord interneuron fate commitment,BP,
13926,GO:0060581,1,0.986164531023532,0,3,cell fate commitment involved in pattern specification,BP,
13927,GO:0060584,1,0.989648185306872,0,2,regulation of prostaglandin-endoperoxide synthase activity,BP,
13928,GO:0060585,1,0.989648185306872,0,2,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
13929,GO:0060586,1,0.978984088555675,0,4,multicellular organismal iron ion homeostasis,BP,
13931,GO:0060590,1,0.779888130671614,0,35,ATPase regulator activity,MF,
13932,GO:0060591,1,0.985735894211834,0,3,chondroblast differentiation,BP,
13933,GO:0060592,1,0.978327805763833,0,4,mammary gland formation,BP,
13934,GO:0060594,1,0.990755199849122,0,2,mammary gland specification,BP,
13935,GO:0060595,1,0.995366990826138,0,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
13936,GO:0060596,1,0.995366990826165,0,1,mammary placode formation,BP,
13937,GO:0060598,1,0.984191439909416,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
13938,GO:0060599,1,0.995366990826125,0,1,lateral sprouting involved in mammary gland duct morphogenesis,BP,
13939,GO:0060600,1,0.936522747328128,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
13940,GO:0060601,1,0.953559578287167,0,9,lateral sprouting from an epithelium,BP,
13941,GO:0060602,1,0.917318859271062,0,15,branch elongation of an epithelium,BP,
13942,GO:0060603,1,0.872040986412862,0,25,mammary gland duct morphogenesis,BP,
13943,GO:0060605,1,0.974109366945926,0,3,tube lumen cavitation,BP,
13944,GO:0060606,1,0.650461011877898,0,75,tube closure,BP,
13945,GO:0060611,1,0.995194333493049,0,1,mammary gland fat development,BP,
13948,GO:0060615,1,0.995366990826138,0,1,mammary gland bud formation,BP,
13949,GO:0060620,1,0.995366574475227,0,1,regulation of cholesterol import,BP,
13950,GO:0060623,1,0.985031891640639,0,3,regulation of chromosome condensation,BP,
13952,GO:0060628,1,0.941650576090387,0,12,regulation of ER to Golgi vesicle-mediated transport,BP,
13953,GO:0060631,1,0.986145526218032,0,3,regulation of meiosis I,BP,
13954,GO:0060632,1,0.9068378488211,0,14,regulation of microtubule-based movement,BP,
13955,GO:0060633,1,0.981412698009251,0,4,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
13956,GO:0060638,1,0.967160459281449,0,5,mesenchymal-epithelial cell signaling,BP,
13957,GO:0060644,1,0.914244146450856,0,12,mammary gland epithelial cell differentiation,BP,
13958,GO:0060648,1,0.995366990826138,0,1,mammary gland bud morphogenesis,BP,
13959,GO:0060661,1,0.994551950924641,0,1,submandibular salivary gland formation,BP,
13960,GO:0060662,1,0.974109366945926,0,3,salivary gland cavitation,BP,
13961,GO:0060664,1,0.981637853201626,0,3,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
13962,GO:0060665,1,0.995366990826138,0,1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
13963,GO:0060666,1,0.976940258920095,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
13964,GO:0060667,1,0.995366990826138,0,1,branch elongation involved in salivary gland morphogenesis,BP,
13965,GO:0060668,1,0.995366971653764,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
13966,GO:0060669,1,0.876716760920348,0,22,embryonic placenta morphogenesis,BP,
13967,GO:0060670,1,0.938639589886932,0,10,branching involved in labyrinthine layer morphogenesis,BP,
13968,GO:0060671,1,0.982211732004372,0,3,epithelial cell differentiation involved in embryonic placenta development,BP,
13969,GO:0060672,1,0.982211732004372,0,3,epithelial cell morphogenesis involved in placental branching,BP,
13973,GO:0060677,1,0.973794058924155,0,5,ureteric bud elongation,BP,
13974,GO:0060678,1,0.994858500969876,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
13975,GO:0060681,1,0.982882410862019,0,3,branch elongation involved in ureteric bud branching,BP,
13976,GO:0060683,1,0.995366221441924,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
13977,GO:0060684,1,0.977525797477402,0,4,epithelial-mesenchymal cell signaling,BP,
13978,GO:0060685,1,0.982882413382656,0,3,regulation of prostatic bud formation,BP,
13979,GO:0060686,1,0.982882413382656,0,3,negative regulation of prostatic bud formation,BP,
13980,GO:0060687,1,0.969281085899454,0,6,regulation of branching involved in prostate gland morphogenesis,BP,
13982,GO:0060689,1,0.983101420704254,0,3,cell differentiation involved in salivary gland development,BP,
13983,GO:0060690,1,0.992275793949614,0,1,epithelial cell differentiation involved in salivary gland development,BP,
13984,GO:0060691,1,0.992275793949614,0,1,epithelial cell maturation involved in salivary gland development,BP,
13986,GO:0060694,1,0.99272158279163,0,1,regulation of cholesterol transporter activity,BP,
13987,GO:0060696,1,0.948714632812826,0,5,regulation of phospholipid catabolic process,BP,
13988,GO:0060697,1,0.995366417561992,0,1,positive regulation of phospholipid catabolic process,BP,
13989,GO:0060698,1,0.990754954163191,0,2,endoribonuclease inhibitor activity,MF,
13990,GO:0060699,1,0.972658630326169,0,4,regulation of endoribonuclease activity,BP,
13991,GO:0060700,1,0.940760371426505,0,9,regulation of ribonuclease activity,BP,
13992,GO:0060701,1,0.990754954163191,0,2,negative regulation of ribonuclease activity,BP,
13993,GO:0060702,1,0.990754954163191,0,2,negative regulation of endoribonuclease activity,BP,
13994,GO:0060703,1,0.995363424876141,0,1,deoxyribonuclease inhibitor activity,MF,
13995,GO:0060706,1,0.878702634276983,0,21,cell differentiation involved in embryonic placenta development,BP,
13996,GO:0060707,1,0.939719786060432,0,10,trophoblast giant cell differentiation,BP,
13997,GO:0060708,1,0.97586636429583,0,3,spongiotrophoblast differentiation,BP,
13998,GO:0060709,1,0.995366542797979,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
13999,GO:0060710,1,0.970619637101363,0,6,chorio-allantoic fusion,BP,
14001,GO:0060712,1,0.912278375184409,0,12,spongiotrophoblast layer development,BP,
14002,GO:0060713,1,0.893177660199911,0,18,labyrinthine layer morphogenesis,BP,
14003,GO:0060715,1,0.984666765569192,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
14005,GO:0060717,1,0.965576848920893,0,7,chorion development,BP,
14006,GO:0060718,1,0.976071035350582,0,5,chorionic trophoblast cell differentiation,BP,
14007,GO:0060720,1,0.973155053614939,0,2,spongiotrophoblast cell proliferation,BP,
14008,GO:0060721,1,0.973155053614939,0,2,regulation of spongiotrophoblast cell proliferation,BP,
14009,GO:0060722,1,0.973155053614939,0,2,cell proliferation involved in embryonic placenta development,BP,
14010,GO:0060723,1,0.973155053614939,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
14011,GO:0060729,1,0.981460068544794,0,3,intestinal epithelial structure maintenance,BP,
14012,GO:0060730,1,0.995366872685533,0,1,regulation of intestinal epithelial structure maintenance,BP,
14013,GO:0060731,1,0.995366872685533,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14014,GO:0060732,1,0.972517499817138,0,6,positive regulation of inositol phosphate biosynthetic process,BP,
14015,GO:0060733,1,0.990755194669909,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
14016,GO:0060734,1,0.995366990826165,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
14017,GO:0060735,1,0.986486286624493,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
14018,GO:0060736,1,0.968010701656113,0,7,prostate gland growth,BP,
14019,GO:0060737,1,0.986164530733776,0,3,prostate gland morphogenetic growth,BP,
14020,GO:0060739,1,0.995366990826034,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
14021,GO:0060740,1,0.914246384737287,0,18,prostate gland epithelium morphogenesis,BP,
14022,GO:0060742,1,0.963282679446138,0,8,epithelial cell differentiation involved in prostate gland development,BP,
14023,GO:0060743,1,0.99531412320476,0,1,epithelial cell maturation involved in prostate gland development,BP,
14024,GO:0060744,1,0.957829866382157,0,5,mammary gland branching involved in thelarche,BP,
14025,GO:0060745,1,0.981594888223787,0,4,mammary gland branching involved in pregnancy,BP,
14026,GO:0060746,1,0.965431465292451,0,7,parental behavior,BP,
14027,GO:0060748,1,0.995366990309484,0,1,tertiary branching involved in mammary gland duct morphogenesis,BP,
14028,GO:0060749,1,0.914277303779853,0,11,mammary gland alveolus development,BP,
14029,GO:0060750,1,0.970572212510194,0,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,
14030,GO:0060751,1,0.965397869815208,0,5,branch elongation involved in mammary gland duct branching,BP,
14031,GO:0060753,1,0.947581491293648,0,6,regulation of mast cell chemotaxis,BP,
14032,GO:0060754,1,0.958983515653087,0,5,positive regulation of mast cell chemotaxis,BP,
14033,GO:0060759,1,0.384850793961086,0,135,regulation of response to cytokine stimulus,BP,
14034,GO:0060760,1,0.787419138963623,0,37,positive regulation of response to cytokine stimulus,BP,
14035,GO:0060761,1,0.71573456427308,0,42,negative regulation of response to cytokine stimulus,BP,
14036,GO:0060762,1,0.973219825796446,0,4,regulation of branching involved in mammary gland duct morphogenesis,BP,
14037,GO:0060763,1,0.99058333332315,0,2,mammary duct terminal end bud growth,BP,
14038,GO:0060764,1,0.981288783173265,0,2,cell-cell signaling involved in mammary gland development,BP,
14039,GO:0060765,1,0.856106603432337,0,22,regulation of androgen receptor signaling pathway,BP,
14040,GO:0060766,1,0.958759208237449,0,8,negative regulation of androgen receptor signaling pathway,BP,
14041,GO:0060767,1,0.937953360004501,0,9,epithelial cell proliferation involved in prostate gland development,BP,
14042,GO:0060768,1,0.942322128432075,0,8,regulation of epithelial cell proliferation involved in prostate gland development,BP,
14043,GO:0060769,1,0.995366929196251,0,1,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14044,GO:0060770,1,0.951120153536474,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14045,GO:0060775,1,0.995366990826125,0,1,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
14046,GO:0060784,1,0.99536699053359,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
14047,GO:0060788,1,0.938886657509078,0,10,ectodermal placode formation,BP,
14048,GO:0060789,1,0.956500151965105,0,6,hair follicle placode formation,BP,
14049,GO:0060795,1,0.907706990069343,0,17,cell fate commitment involved in formation of primary germ layer,BP,
14050,GO:0060800,1,0.990754713483019,0,2,regulation of cell differentiation involved in embryonic placenta development,BP,
14051,GO:0060804,1,0.99536679727965,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
14052,GO:0060809,1,0.995366990826125,0,1,mesodermal to mesenchymal transition involved in gastrulation,BP,
14053,GO:0060816,1,0.990755117770532,0,2,random inactivation of X chromosome,BP,
14054,GO:0060819,1,0.990755199849175,0,2,inactivation of X chromosome by genetic imprinting,BP,
14055,GO:0060821,1,0.995366990825995,0,1,inactivation of X chromosome by DNA methylation,BP,
14056,GO:0060823,1,0.995366920643499,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14057,GO:0060825,1,0.983793888648793,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14059,GO:0060830,1,0.969123517215465,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
14060,GO:0060831,1,0.941112534031069,0,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
14061,GO:0060836,1,0.981591873678502,0,4,lymphatic endothelial cell differentiation,BP,
14062,GO:0060837,1,0.969354087154025,0,6,blood vessel endothelial cell differentiation,BP,
14063,GO:0060838,1,0.990752156982471,0,2,lymphatic endothelial cell fate commitment,BP,
14064,GO:0060839,1,0.972130197439214,0,6,endothelial cell fate commitment,BP,
14066,GO:0060841,1,0.946911670087207,0,11,venous blood vessel development,BP,
14067,GO:0060842,1,0.985881278366336,0,3,arterial endothelial cell differentiation,BP,
14068,GO:0060843,1,0.995366990825967,0,1,venous endothelial cell differentiation,BP,
14069,GO:0060844,1,0.990470643794705,0,2,arterial endothelial cell fate commitment,BP,
14070,GO:0060846,1,0.985774412749766,0,3,blood vessel endothelial cell fate commitment,BP,
14071,GO:0060847,1,0.985774412749766,0,3,endothelial cell fate specification,BP,
14072,GO:0060849,1,0.995366990410423,0,1,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
14073,GO:0060850,1,0.96630092708369,0,6,regulation of transcription involved in cell fate commitment,BP,
14074,GO:0060853,1,0.995366887726606,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
14075,GO:0060856,1,0.953416233943958,0,9,establishment of blood-brain barrier,BP,
14076,GO:0060857,1,0.994898835683969,0,1,establishment of glial blood-brain barrier,BP,
14077,GO:0060872,1,0.975285338128119,0,4,semicircular canal development,BP,
14078,GO:0060873,1,0.995366990826007,0,1,anterior semicircular canal development,BP,
14079,GO:0060875,1,0.995366990826007,0,1,lateral semicircular canal development,BP,
14080,GO:0060876,1,0.995209950234741,0,1,semicircular canal formation,BP,
14081,GO:0060887,1,0.995366574475227,0,1,limb epidermis development,BP,
14082,GO:0060896,1,0.955630681447963,0,8,neural plate pattern specification,BP,
14083,GO:0060897,1,0.964551460107283,0,6,neural plate regionalization,BP,
14084,GO:0060900,1,0.968011025290463,0,7,embryonic camera-type eye formation,BP,
14085,GO:0060901,1,0.995366990826152,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
14086,GO:0060903,1,0.990736295022131,0,2,positive regulation of meiosis I,BP,
14087,GO:0060904,1,0.995366990774029,0,1,regulation of protein folding in endoplasmic reticulum,BP,
14088,GO:0060907,1,0.97646579503011,0,3,positive regulation of macrophage cytokine production,BP,
14089,GO:0060911,1,0.96469073966853,0,7,cardiac cell fate commitment,BP,
14090,GO:0060912,1,0.995366574475227,0,1,cardiac cell fate specification,BP,
14091,GO:0060913,1,0.995363240836546,0,1,cardiac cell fate determination,BP,
14093,GO:0060915,1,0.995366990826138,0,1,mesenchymal cell differentiation involved in lung development,BP,
14094,GO:0060916,1,0.981594826304671,0,4,mesenchymal cell proliferation involved in lung development,BP,
14095,GO:0060920,1,0.986164531023726,0,3,cardiac pacemaker cell differentiation,BP,
14096,GO:0060921,1,0.990755199849279,0,2,sinoatrial node cell differentiation,BP,
14097,GO:0060922,1,0.995366990826125,0,1,atrioventricular node cell differentiation,BP,
14098,GO:0060923,1,0.973699188001861,0,5,cardiac muscle cell fate commitment,BP,
14099,GO:0060926,1,0.986164531023726,0,3,cardiac pacemaker cell development,BP,
14100,GO:0060928,1,0.995366990826125,0,1,atrioventricular node cell development,BP,
14101,GO:0060931,1,0.990755199849279,0,2,sinoatrial node cell development,BP,
14102,GO:0060932,1,0.995366990826165,0,1,His-Purkinje system cell differentiation,BP,
14103,GO:0060935,1,0.98597052136089,0,3,cardiac fibroblast cell differentiation,BP,
14104,GO:0060936,1,0.98597052136089,0,3,cardiac fibroblast cell development,BP,
14105,GO:0060938,1,0.98597052136089,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
14106,GO:0060939,1,0.98597052136089,0,3,epicardium-derived cardiac fibroblast cell development,BP,
14107,GO:0060940,1,0.990560297444458,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
14108,GO:0060947,1,0.981594441773869,0,4,cardiac vascular smooth muscle cell differentiation,BP,
14109,GO:0060948,1,0.990755163210557,0,2,cardiac vascular smooth muscle cell development,BP,
14110,GO:0060956,1,0.981352402472518,0,4,endocardial cell differentiation,BP,
14111,GO:0060957,1,0.995366644625332,0,1,endocardial cell fate commitment,BP,
14113,GO:0060965,1,0.928720867061396,0,12,negative regulation of gene silencing by miRNA,BP,
14115,GO:0060967,1,0.889083719470161,0,14,negative regulation of gene silencing by RNA,BP,
14117,GO:0060969,1,0.855002459381553,0,22,negative regulation of gene silencing,BP,
14118,GO:0060971,1,0.982939331441337,0,3,embryonic heart tube left/right pattern formation,BP,
14119,GO:0060972,1,0.881722554015807,0,16,left/right pattern formation,BP,
14121,GO:0060976,1,0.848621097309913,0,30,coronary vasculature development,BP,
14122,GO:0060977,1,0.948522058697158,0,10,coronary vasculature morphogenesis,BP,
14123,GO:0060978,1,0.990647811994256,0,2,angiogenesis involved in coronary vascular morphogenesis,BP,
14124,GO:0060979,1,0.986164531023404,0,3,vasculogenesis involved in coronary vascular morphogenesis,BP,
14125,GO:0060982,1,0.961835433668262,0,7,coronary artery morphogenesis,BP,
14126,GO:0060986,1,0.870585621565702,0,23,endocrine hormone secretion,BP,
14127,GO:0060987,1,0.995004722973501,0,1,lipid tube,CC,
14128,GO:0060988,1,0.990394591261676,0,2,lipid tube assembly,BP,
14129,GO:0060992,1,0.944963950465451,0,11,response to fungicide,BP,
14131,GO:0060994,1,0.987457969941438,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
14132,GO:0060995,1,0.990754949088814,0,2,cell-cell signaling involved in kidney development,BP,
14133,GO:0060996,1,0.674475611474563,0,69,dendritic spine development,BP,
14134,GO:0060997,1,0.820421983832147,0,35,dendritic spine morphogenesis,BP,
14135,GO:0060998,1,0.743687766951282,0,50,regulation of dendritic spine development,BP,
14136,GO:0060999,1,0.841455067380766,0,30,positive regulation of dendritic spine development,BP,
14137,GO:0061000,1,0.957391234661217,0,8,negative regulation of dendritic spine development,BP,
14138,GO:0061001,1,0.867736343138859,0,24,regulation of dendritic spine morphogenesis,BP,
14139,GO:0061002,1,0.979889594992434,0,3,negative regulation of dendritic spine morphogenesis,BP,
14140,GO:0061003,1,0.945782851936419,0,12,positive regulation of dendritic spine morphogenesis,BP,
14145,GO:0061010,1,0.995366990825929,0,1,gall bladder development,BP,
14148,GO:0061015,1,0.972322393201852,0,2,snRNA import into nucleus,BP,
14150,GO:0061025,1,0.309698006343108,0,177,membrane fusion,BP,
14151,GO:0061028,1,0.840192832320957,0,33,establishment of endothelial barrier,BP,
14152,GO:0061029,1,0.945549224581886,0,11,eyelid development in camera-type eye,BP,
14153,GO:0061030,1,0.981814927733704,0,2,epithelial cell differentiation involved in mammary gland alveolus development,BP,
14154,GO:0061031,1,0.981236010743451,0,2,endodermal digestive tract morphogenesis,BP,
14155,GO:0061032,1,0.995366684921823,0,1,visceral serous pericardium development,BP,
14156,GO:0061034,1,0.995366990826152,0,1,olfactory bulb mitral cell layer development,BP,
14158,GO:0061036,1,0.911946385769312,0,19,positive regulation of cartilage development,BP,
14160,GO:0061038,1,0.977617220883425,0,4,uterus morphogenesis,BP,
14161,GO:0061040,1,0.995366990825981,0,1,female gonad morphogenesis,BP,
14162,GO:0061041,1,0.60064728714302,0,80,regulation of wound healing,BP,
14163,GO:0061042,1,0.966097885785729,0,6,vascular wound healing,BP,
14164,GO:0061043,1,0.983101405021139,0,3,regulation of vascular wound healing,BP,
14165,GO:0061044,1,0.995366806405613,0,1,negative regulation of vascular wound healing,BP,
14166,GO:0061045,1,0.762085513292962,0,46,negative regulation of wound healing,BP,
14167,GO:0061046,1,0.968773870493843,0,5,regulation of branching involved in lung morphogenesis,BP,
14168,GO:0061047,1,0.982325044626421,0,3,positive regulation of branching involved in lung morphogenesis,BP,
14169,GO:0061048,1,0.990798677411377,0,1,negative regulation of branching involved in lung morphogenesis,BP,
14170,GO:0061049,1,0.924251927535037,0,13,cell growth involved in cardiac muscle cell development,BP,
14171,GO:0061050,1,0.937228552632435,0,10,regulation of cell growth involved in cardiac muscle cell development,BP,
14172,GO:0061051,1,0.95584226016615,0,6,positive regulation of cell growth involved in cardiac muscle cell development,BP,
14173,GO:0061052,1,0.980536405622843,0,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,
14174,GO:0061053,1,0.772664888297131,0,52,somite development,BP,
14175,GO:0061054,1,0.995366990309484,0,1,dermatome development,BP,
14176,GO:0061055,1,0.990755199849241,0,2,myotome development,BP,
14177,GO:0061056,1,0.995366574475227,0,1,sclerotome development,BP,
14179,GO:0061072,1,0.960538415308303,0,6,iris morphogenesis,BP,
14180,GO:0061073,1,0.99075087298872,0,2,ciliary body morphogenesis,BP,
14181,GO:0061074,1,0.989884390067244,0,2,regulation of neural retina development,BP,
14182,GO:0061075,1,0.989884390067244,0,2,positive regulation of neural retina development,BP,
14183,GO:0061077,1,0.597872433520621,0,67,chaperone-mediated protein folding,BP,
14184,GO:0061078,1,0.969297794369347,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
14185,GO:0061081,1,0.942090060214005,0,5,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
14186,GO:0061082,1,0.886583454155343,0,14,myeloid leukocyte cytokine production,BP,
14187,GO:0061083,1,0.979512088090266,0,4,regulation of protein refolding,BP,
14188,GO:0061084,1,0.979512088090266,0,4,negative regulation of protein refolding,BP,
14189,GO:0061085,1,0.955903922556255,0,9,regulation of histone H3-K27 methylation,BP,
14190,GO:0061086,1,0.979057720177035,0,4,negative regulation of histone H3-K27 methylation,BP,
14191,GO:0061087,1,0.971414616932986,0,6,positive regulation of histone H3-K27 methylation,BP,
14192,GO:0061088,1,0.969932877138461,0,6,regulation of sequestering of zinc ion,BP,
14193,GO:0061091,1,0.995366990826164,0,1,regulation of phospholipid translocation,BP,
14194,GO:0061092,1,0.995366990826164,0,1,positive regulation of phospholipid translocation,BP,
14195,GO:0061097,1,0.705950328911362,0,56,regulation of protein tyrosine kinase activity,BP,
14196,GO:0061098,1,0.842595741185444,0,27,positive regulation of protein tyrosine kinase activity,BP,
14197,GO:0061099,1,0.858198169237999,0,24,negative regulation of protein tyrosine kinase activity,BP,
14202,GO:0061107,1,0.994857117983983,0,1,seminal vesicle development,BP,
14203,GO:0061108,1,0.994857117983983,0,1,seminal vesicle epithelium development,BP,
14204,GO:0061110,1,0.990755186100436,0,2,dense core granule biogenesis,BP,
14205,GO:0061113,1,0.995366984341286,0,1,pancreas morphogenesis,BP,
14206,GO:0061117,1,0.933552403891945,0,14,negative regulation of heart growth,BP,
14207,GO:0061133,1,0.932799866484675,0,5,endopeptidase activator activity,MF,
14208,GO:0061134,1,0.346189295128361,0,108,peptidase regulator activity,MF,
14209,GO:0061135,1,0.426632079361162,0,82,endopeptidase regulator activity,MF,
14212,GO:0061140,1,0.9654248443161,0,3,lung secretory cell differentiation,BP,
14213,GO:0061141,1,0.995366990826007,0,1,lung ciliated cell differentiation,BP,
14214,GO:0061145,1,0.990755199558051,0,2,lung smooth muscle development,BP,
14215,GO:0061146,1,0.982976742174716,0,3,Peyer's patch morphogenesis,BP,
14216,GO:0061149,1,0.992054598406672,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
14217,GO:0061150,1,0.992054598406672,0,1,renal system segmentation,BP,
14218,GO:0061151,1,0.992054598406672,0,1,BMP signaling pathway involved in renal system segmentation,BP,
14219,GO:0061152,1,0.978644916654576,0,2,trachea submucosa development,BP,
14220,GO:0061153,1,0.978644916654576,0,2,trachea gland development,BP,
14221,GO:0061154,1,0.929217021766983,0,11,endothelial tube morphogenesis,BP,
14222,GO:0061155,1,0.992054598406672,0,1,pulmonary artery endothelial tube morphogenesis,BP,
14223,GO:0061156,1,0.982882413382682,0,3,pulmonary artery morphogenesis,BP,
14226,GO:0061162,1,0.928358282343005,0,15,establishment of monopolar cell polarity,BP,
14227,GO:0061163,1,0.995366574475227,0,1,endoplasmic reticulum polarization,BP,
14229,GO:0061179,1,0.9019292326254,0,7,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
14230,GO:0061180,1,0.708631934007889,0,53,mammary gland epithelium development,BP,
14231,GO:0061183,1,0.995366990309484,0,1,regulation of dermatome development,BP,
14232,GO:0061184,1,0.995366990309484,0,1,positive regulation of dermatome development,BP,
14233,GO:0061187,1,0.99075519984924,0,2,regulation of chromatin silencing at rDNA,BP,
14234,GO:0061188,1,0.99075519984924,0,2,negative regulation of chromatin silencing at rDNA,BP,
14235,GO:0061193,1,0.979355933200066,0,1,taste bud development,BP,
14236,GO:0061196,1,0.980509374793079,0,4,fungiform papilla development,BP,
14237,GO:0061197,1,0.980509374793079,0,4,fungiform papilla morphogenesis,BP,
14238,GO:0061198,1,0.985074021759746,0,3,fungiform papilla formation,BP,
14239,GO:0061200,1,0.974529802396992,0,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,
14240,GO:0061202,1,0.974529802396992,0,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,
14241,GO:0061205,1,0.995366990309484,0,1,paramesonephric duct development,BP,
14242,GO:0061209,1,0.982881973445613,0,3,cell proliferation involved in mesonephros development,BP,
14244,GO:0061216,1,0.992054598406672,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
14246,GO:0061218,1,0.981632513653521,0,3,negative regulation of mesonephros development,BP,
14247,GO:0061227,1,0.992054598406672,0,1,pattern specification involved in mesonephros development,BP,
14248,GO:0061245,1,0.831646704687087,0,31,establishment or maintenance of bipolar cell polarity,BP,
14249,GO:0061289,1,0.990754949088814,0,2,Wnt signaling pathway involved in kidney development,BP,
14250,GO:0061290,1,0.990754949088814,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
14251,GO:0061298,1,0.958954767511355,0,9,retina vasculature development in camera-type eye,BP,
14252,GO:0061299,1,0.972412869796294,0,6,retina vasculature morphogenesis in camera-type eye,BP,
14253,GO:0061300,1,0.984302258572908,0,2,cerebellum vasculature development,BP,
14254,GO:0061301,1,0.995366990826047,0,1,cerebellum vasculature morphogenesis,BP,
14255,GO:0061302,1,0.98609024449289,0,3,smooth muscle cell-matrix adhesion,BP,
14256,GO:0061303,1,0.970076538288288,0,4,cornea development in camera-type eye,BP,
14257,GO:0061304,1,0.981594888733404,0,4,retinal blood vessel morphogenesis,BP,
14261,GO:0061311,1,0.918595157552857,0,16,cell surface receptor signaling pathway involved in heart development,BP,
14262,GO:0061312,1,0.97077478250119,0,5,BMP signaling pathway involved in heart development,BP,
14263,GO:0061314,1,0.976763254773195,0,5,Notch signaling involved in heart development,BP,
14264,GO:0061316,1,0.982787247820736,0,3,canonical Wnt signaling pathway involved in heart development,BP,
14265,GO:0061317,1,0.987362436814578,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
14266,GO:0061318,1,0.9431521227892,0,11,renal filtration cell differentiation,BP,
14268,GO:0061324,1,0.995366929196251,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
14269,GO:0061325,1,0.982302813140489,0,3,cell proliferation involved in outflow tract morphogenesis,BP,
14273,GO:0061339,1,0.928358282343005,0,15,establishment or maintenance of monopolar cell polarity,BP,
14274,GO:0061341,1,0.990755199849254,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
14275,GO:0061343,1,0.981594547268169,0,4,cell adhesion involved in heart morphogenesis,BP,
14276,GO:0061346,1,0.990755199849254,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
14277,GO:0061347,1,0.995366990826125,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
14278,GO:0061348,1,0.995366990826125,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
14279,GO:0061349,1,0.995366990826125,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
14280,GO:0061350,1,0.995366990826125,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
14281,GO:0061351,1,0.617208901851703,0,79,neural precursor cell proliferation,BP,
14282,GO:0061354,1,0.995366990826125,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
14283,GO:0061355,1,0.978867828616164,0,4,Wnt protein secretion,BP,
14284,GO:0061356,1,0.978867828616164,0,4,regulation of Wnt protein secretion,BP,
14285,GO:0061357,1,0.985984545016661,0,3,positive regulation of Wnt protein secretion,BP,
14286,GO:0061358,1,0.992783290737664,0,1,negative regulation of Wnt protein secretion,BP,
14287,GO:0061364,1,0.986164531023714,0,3,apoptotic process involved in luteolysis,BP,
14288,GO:0061365,1,0.974513001307793,0,4,positive regulation of triglyceride lipase activity,BP,
14289,GO:0061369,1,0.995366990309484,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
14290,GO:0061370,1,0.990745799517517,0,2,testosterone biosynthetic process,BP,
14291,GO:0061371,1,0.819962206880251,0,37,determination of heart left/right asymmetry,BP,
14292,GO:0061377,1,0.914277303779853,0,11,mammary gland lobule development,BP,
14293,GO:0061383,1,0.831144104543718,0,34,trabecula morphogenesis,BP,
14294,GO:0061384,1,0.877301959480354,0,23,heart trabecula morphogenesis,BP,
14295,GO:0061386,1,0.990755199849071,0,2,closure of optic fissure,BP,
14296,GO:0061387,1,0.643125527458602,0,74,regulation of extent of cell growth,BP,
14297,GO:0061394,1,0.985426502142092,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
14298,GO:0061395,1,0.991383271742141,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
14299,GO:0061400,1,0.995366574475227,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
14300,GO:0061408,1,0.985270207507342,0,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
14301,GO:0061418,1,0.449251583040471,0,71,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
14302,GO:0061419,1,0.976763787178744,0,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
14303,GO:0061428,1,0.976446921346168,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
14304,GO:0061430,1,0.953954628619262,0,10,bone trabecula morphogenesis,BP,
14305,GO:0061433,1,0.993396629402146,0,1,cellular response to caloric restriction,BP,
14306,GO:0061436,1,0.886139513127544,0,21,establishment of skin barrier,BP,
14308,GO:0061438,1,0.978221749574095,0,4,renal system vasculature morphogenesis,BP,
14309,GO:0061439,1,0.978221749574095,0,4,kidney vasculature morphogenesis,BP,
14311,GO:0061441,1,0.990647811994321,0,2,renal artery morphogenesis,BP,
14312,GO:0061443,1,0.990754855234092,0,2,endocardial cushion cell differentiation,BP,
14313,GO:0061444,1,0.995366990826113,0,1,endocardial cushion cell development,BP,
14314,GO:0061445,1,0.995366644625332,0,1,endocardial cushion cell fate commitment,BP,
14316,GO:0061450,1,0.918524979935525,0,8,trophoblast cell migration,BP,
14318,GO:0061459,1,0.995366990826045,0,1,L-arginine transmembrane transporter activity,MF,
14319,GO:0061462,1,0.830997250431115,0,32,protein localization to lysosome,BP,
14321,GO:0061470,1,0.978308742251268,0,4,T follicular helper cell differentiation,BP,
14322,GO:0061474,1,0.995307161514055,0,1,phagolysosome membrane,CC,
14323,GO:0061476,1,0.981594687577558,0,4,response to anticoagulant,BP,
14324,GO:0061478,1,0.953745205883085,0,9,response to platelet aggregation inhibitor,BP,
14325,GO:0061481,1,0.975961703099268,0,1,response to TNF agonist,BP,
14326,GO:0061484,1,0.986150585380395,0,3,hematopoietic stem cell homeostasis,BP,
14327,GO:0061485,1,0.995366990826047,0,1,memory T cell proliferation,BP,
14328,GO:0061495,1,0.995366574475227,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
14329,GO:0061502,1,0.976595887510599,0,4,early endosome to recycling endosome transport,BP,
14330,GO:0061505,1,0.990755199849254,0,2,DNA topoisomerase II activity,MF,
14331,GO:0061507,1,0.991077219946905,0,1,cyclic-GMP-AMP binding,MF,
14332,GO:0061511,1,0.963872039987836,0,4,centriole elongation,BP,
14333,GO:0061512,1,0.82940841387464,0,30,protein localization to cilium,BP,
14334,GO:0061513,1,0.985105626422284,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
14335,GO:0061515,1,0.764641077337175,0,48,myeloid cell development,BP,
14336,GO:0061517,1,0.995366520412405,0,1,macrophage proliferation,BP,
14337,GO:0061518,1,0.995366520412405,0,1,microglial cell proliferation,BP,
14338,GO:0061519,1,0.995366967885579,0,1,macrophage homeostasis,BP,
14339,GO:0061525,1,0.977045710033566,0,5,hindgut development,BP,
14340,GO:0061526,1,0.995352427354762,0,1,acetylcholine secretion,BP,
14341,GO:0061528,1,0.995366990826165,0,1,aspartate secretion,BP,
14342,GO:0061534,1,0.99536699082585,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
14343,GO:0061535,1,0.986164530683365,0,3,glutamate secretion, neurotransmission,BP,
14344,GO:0061536,1,0.995366841160869,0,1,glycine secretion,BP,
14345,GO:0061537,1,0.995366841160869,0,1,glycine secretion, neurotransmission,BP,
14346,GO:0061542,1,0.984741452522495,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
14347,GO:0061547,1,0.995366934880468,0,1,glycogen synthase activity, transferring glucose-1-phosphate,MF,
14348,GO:0061548,1,0.963371814588901,0,8,ganglion development,BP,
14349,GO:0061549,1,0.97241277500233,0,6,sympathetic ganglion development,BP,
14350,GO:0061550,1,0.981488421641612,0,4,cranial ganglion development,BP,
14351,GO:0061551,1,0.986057635053885,0,3,trigeminal ganglion development,BP,
14352,GO:0061552,1,0.995259108849138,0,1,ganglion morphogenesis,BP,
14355,GO:0061573,1,0.995366574475227,0,1,actin filament bundle retrograde transport,BP,
14356,GO:0061574,1,0.984008845136089,0,3,ASAP complex,CC,
14357,GO:0061575,1,0.929687822528015,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
14358,GO:0061577,1,0.960514004412309,0,8,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
14359,GO:0061578,1,0.943805705855021,0,11,Lys63-specific deubiquitinase activity,MF,
14360,GO:0061580,1,0.995366990826138,0,1,colon epithelial cell migration,BP,
14361,GO:0061582,1,0.990755199849213,0,2,intestinal epithelial cell migration,BP,
14362,GO:0061588,1,0.981518038319607,0,4,calcium activated phospholipid scrambling,BP,
14363,GO:0061589,1,0.981518038319607,0,4,calcium activated phosphatidylserine scrambling,BP,
14364,GO:0061590,1,0.981518038319607,0,4,calcium activated phosphatidylcholine scrambling,BP,
14365,GO:0061591,1,0.981518038319607,0,4,calcium activated galactosylceramide scrambling,BP,
14366,GO:0061598,1,0.995366990826152,0,1,molybdopterin adenylyltransferase activity,MF,
14367,GO:0061599,1,0.995366990826152,0,1,molybdopterin molybdotransferase activity,MF,
14368,GO:0061604,1,0.995225769074058,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
14369,GO:0061605,1,0.995225769074058,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
14370,GO:0061608,1,0.932771606978381,0,9,nuclear import signal receptor activity,MF,
14371,GO:0061611,1,0.991967176450215,0,1,mannose to fructose-6-phosphate metabolic process,BP,
14372,GO:0061614,1,0.849014479350411,0,33,pri-miRNA transcription by RNA polymerase II,BP,
14373,GO:0061615,1,0.87681362508695,0,18,glycolytic process through fructose-6-phosphate,BP,
14374,GO:0061617,1,0.910998749851492,0,8,MICOS complex,CC,
14375,GO:0061618,1,0.995366990825877,0,1,sublamina densa,CC,
14376,GO:0061620,1,0.87681362508695,0,18,glycolytic process through glucose-6-phosphate,BP,
14377,GO:0061621,1,0.888886684987135,0,17,canonical glycolysis,BP,
14378,GO:0061622,1,0.981864963954707,0,2,glycolytic process through glucose-1-phosphate,BP,
14379,GO:0061623,1,0.986435998580041,0,1,glycolytic process from galactose,BP,
14380,GO:0061624,1,0.980337427374436,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
14382,GO:0061627,1,0.993699964490529,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
14383,GO:0061628,1,0.990322217045493,0,2,H3K27me3 modified histone binding,MF,
14384,GO:0061629,1,0.972162722703898,0,4,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
14386,GO:0061631,1,0.804113873055815,0,26,ubiquitin conjugating enzyme activity,MF,
14387,GO:0061635,1,0.953380301334396,0,7,regulation of protein complex stability,BP,
14388,GO:0061640,1,0.636608639322617,0,69,cytoskeleton-dependent cytokinesis,BP,
14390,GO:0061642,1,0.995366990826125,0,1,chemoattraction of axon,BP,
14391,GO:0061643,1,0.990754840454181,0,2,chemorepulsion of axon,BP,
14392,GO:0061645,1,0.977046177790409,0,5,endocytic patch,CC,
14393,GO:0061646,1,0.995366990826165,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
14394,GO:0061647,1,0.809547514057139,0,36,histone H3-K9 modification,BP,
14395,GO:0061649,1,0.985257465423146,0,3,ubiquitin modification-dependent histone binding,MF,
14396,GO:0061650,1,0.790841294026436,0,27,ubiquitin-like protein conjugating enzyme activity,MF,
14397,GO:0061656,1,0.983535025082634,0,1,SUMO conjugating enzyme activity,MF,
14399,GO:0061663,1,0.995366990826047,0,1,NEDD8 ligase activity,MF,
14400,GO:0061665,1,0.97203830587095,0,5,SUMO ligase activity,MF,
14401,GO:0061668,1,0.963639844958568,0,6,mitochondrial ribosome assembly,BP,
14402,GO:0061669,1,0.990755199849279,0,2,spontaneous neurotransmitter secretion,BP,
14403,GO:0061673,1,0.976399984327601,0,5,mitotic spindle astral microtubule,CC,
14404,GO:0061676,1,0.958444538143868,0,6,importin-alpha family protein binding,MF,
14405,GO:0061684,1,0.950432151529953,0,10,chaperone-mediated autophagy,BP,
14406,GO:0061685,1,0.995366574475227,0,1,diphthine methylesterase activity,MF,
14407,GO:0061687,1,0.868903769362625,0,7,detoxification of inorganic compound,BP,
14408,GO:0061689,1,0.984708717052449,0,3,tricellular tight junction,CC,
14409,GO:0061695,1,0.156918082848087,0,240,transferase complex, transferring phosphorus-containing groups,CC,
14410,GO:0061697,1,0.995366799259991,0,1,protein-glutaryllysine deglutarylase activity,MF,
14411,GO:0061698,1,0.995366799259991,0,1,protein deglutarylation,BP,
14412,GO:0061699,1,0.995366799259991,0,1,peptidyl-lysine deglutarylation,BP,
14413,GO:0061700,1,0.950389404066495,0,9,GATOR2 complex,CC,
14414,GO:0061702,1,0.926371352893798,0,7,inflammasome complex,CC,
14415,GO:0061709,1,0.995366990826085,0,1,reticulophagy,BP,
14416,GO:0061711,1,0.984390430306794,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
14417,GO:0061712,1,0.995366872208265,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
14418,GO:0061718,1,0.888886684987135,0,17,glucose catabolic process to pyruvate,BP,
14419,GO:0061723,1,0.990608700884508,0,2,glycophagy,BP,
14420,GO:0061724,1,0.968147184184157,0,6,lipophagy,BP,
14421,GO:0061726,1,0.552667328058695,0,77,mitochondrion disassembly,BP,
14422,GO:0061727,1,0.98492142716432,0,2,methylglyoxal catabolic process to lactate,BP,
14423,GO:0061731,1,0.986164288990761,0,3,ribonucleoside-diphosphate reductase activity,MF,
14424,GO:0061732,1,0.966324837327918,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
14425,GO:0061733,1,0.725731588338019,0,53,peptide-lysine-N-acetyltransferase activity,MF,
14426,GO:0061734,1,0.97704615049234,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
14427,GO:0061736,1,0.995366990826138,0,1,engulfment of target by autophagosome,BP,
14428,GO:0061737,1,0.984027790130879,0,2,leukotriene signaling pathway,BP,
14429,GO:0061738,1,0.98398405923712,0,3,late endosomal microautophagy,BP,
14430,GO:0061739,1,0.98616432267438,0,3,protein lipidation involved in autophagosome assembly,BP,
14431,GO:0061740,1,0.984742389858706,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
14432,GO:0061741,1,0.989326514606752,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
14433,GO:0061743,1,0.992243492218644,0,1,motor learning,BP,
14434,GO:0061744,1,0.964340136578694,0,2,motor behavior,BP,
14435,GO:0061749,1,0.990755199849267,0,2,forked DNA-dependent helicase activity,MF,
14436,GO:0061750,1,0.995015630138606,0,1,acid sphingomyelin phosphodiesterase activity,MF,
14437,GO:0061752,1,0.988063469098955,0,2,telomeric repeat-containing RNA binding,MF,
14438,GO:0061753,1,0.995366990826138,0,1,substrate localization to autophagosome,BP,
14440,GO:0061757,1,0.986207438423393,0,2,leukocyte adhesion to arterial endothelial cell,BP,
14441,GO:0061760,1,0.995366611925401,0,1,antifungal innate immune response,BP,
14442,GO:0061762,1,0.99075519984928,0,2,CAMKK-AMPK signaling cascade,BP,
14443,GO:0061763,1,0.990734964685432,0,2,multivesicular body-lysosome fusion,BP,
14444,GO:0061767,1,0.995366990826126,0,1,negative regulation of lung blood pressure,BP,
14445,GO:0061768,1,0.995366990826165,0,1,magnesium:sodium antiporter activity,MF,
14446,GO:0061769,1,0.995366574475227,0,1,ribosylnicotinate kinase activity,MF,
14447,GO:0061770,1,0.994517404157083,0,1,translation elongation factor binding,MF,
14448,GO:0061771,1,0.972076420286688,0,3,response to caloric restriction,BP,
14449,GO:0061772,1,0.995366926692119,0,1,drug transport across blood-nerve barrier,BP,
14450,GO:0061778,1,0.954536789652528,0,10,intracellular chloride channel activity,MF,
14451,GO:0061780,1,0.995366990825929,0,1,mitotic cohesin loading,BP,
14452,GO:0061783,1,0.964782969515256,0,3,peptidoglycan muralytic activity,MF,
14453,GO:0061789,1,0.995366990826099,0,1,dense core granule priming,BP,
14454,GO:0061792,1,0.995366990826112,0,1,secretory granule maturation,BP,
14455,GO:0061798,1,0.995366990826138,0,1,GTP 3',8'-cyclase activity,MF,
14456,GO:0061799,1,0.995366990826138,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
14457,GO:0061809,1,0.988505615591278,0,1,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
14458,GO:0061817,1,0.986164531023703,0,3,endoplasmic reticulum-plasma membrane tethering,BP,
14459,GO:0061819,1,0.985136881984715,0,3,telomeric DNA-containing double minutes formation,BP,
14460,GO:0061820,1,0.959056798875804,0,9,telomeric D-loop disassembly,BP,
14461,GO:0061821,1,0.981594886740122,0,4,telomeric D-loop binding,MF,
14462,GO:0061825,1,0.995366990575074,0,1,podosome core,CC,
14463,GO:0061827,1,0.984484260872238,0,2,sperm head,CC,
14464,GO:0061828,1,0.995366990826034,0,1,apical tubulobulbar complex,CC,
14465,GO:0061829,1,0.995366990826034,0,1,basal tubulobulbar complex,CC,
14466,GO:0061833,1,0.990133992375021,0,2,protein localization to tricellular tight junction,BP,
14467,GO:0061842,1,0.867592501479952,0,24,microtubule organizing center localization,BP,
14468,GO:0061844,1,0.598579241814676,0,23,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,
14469,GO:0061845,1,0.9953668603647,0,1,neuron projection branch point,CC,
14470,GO:0061846,1,0.9953668603647,0,1,dendritic spine cytoplasm,CC,
14471,GO:0061847,1,0.994975311334276,0,1,response to cholecystokinin,BP,
14472,GO:0061849,1,0.990755199849267,0,2,telomeric G-quadruplex DNA binding,MF,
14473,GO:0061850,1,0.976975576064918,0,1,growth cone leading edge,CC,
14474,GO:0061851,1,0.995363934373988,0,1,leading edge of lamellipodium,CC,
14475,GO:0061857,1,0.990754784368798,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
14476,GO:0061880,1,0.991212505333156,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
14477,GO:0061881,1,0.991212505333156,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
14478,GO:0061884,1,0.99394869310473,0,1,regulation of mini excitatory postsynaptic potential,BP,
14479,GO:0061885,1,0.99394869310473,0,1,positive regulation of mini excitatory postsynaptic potential,BP,
14480,GO:0061888,1,0.97694577945675,0,3,regulation of astrocyte activation,BP,
14481,GO:0061889,1,0.995366990826152,0,1,negative regulation of astrocyte activation,BP,
14482,GO:0061890,1,0.981494025645465,0,2,positive regulation of astrocyte activation,BP,
14483,GO:0061896,1,0.995366990826165,0,1,all-trans retinol 3,4-desaturase activity,MF,
14484,GO:0061897,1,0.995366990826165,0,1,all-trans retinal 3,4-desaturase activity,MF,
14485,GO:0061898,1,0.995366990826165,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
14486,GO:0061899,1,0.995366990826165,0,1,11-cis-retinal 3,4-desaturase activity,MF,
14487,GO:0061900,1,0.915369723003646,0,17,glial cell activation,BP,
14488,GO:0061912,1,0.788129257172627,0,41,selective autophagy,BP,
14490,GO:0061920,1,0.995366990825981,0,1,protein propionyltransferase activity,MF,
14491,GO:0061921,1,0.995366990825981,0,1,peptidyl-lysine propionylation,BP,
14492,GO:0061930,1,0.995366990826151,0,1,regulation of erythrocyte enucleation,BP,
14493,GO:0061931,1,0.995366990826151,0,1,positive regulation of erythrocyte enucleation,BP,
14494,GO:0061944,1,0.995366990826152,0,1,negative regulation of protein K48-linked ubiquitination,BP,
14495,GO:0061945,1,0.97918900290786,0,3,regulation of protein K48-linked ubiquitination,BP,
14496,GO:0061951,1,0.802505372376901,0,38,establishment of protein localization to plasma membrane,BP,
14497,GO:0061953,1,0.983421801328675,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
14498,GO:0061971,1,0.850641156683469,0,30,replacement bone morphogenesis,BP,
14499,GO:0061980,1,0.855035898239463,0,28,regulatory RNA binding,MF,
14500,GO:0061982,1,0.621154927362445,0,69,meiosis I cell cycle process,BP,
14501,GO:0061983,1,0.954890688681337,0,6,meiosis II cell cycle process,BP,
14502,GO:0062009,1,0.955787112237003,0,8,secondary palate development,BP,
14506,GO:0065001,1,0.990755199849213,0,2,specification of axis polarity,BP,
14507,GO:0065002,1,0.608935884729858,0,50,intracellular protein transmembrane transport,BP,
14510,GO:0065005,1,0.871290202649874,0,18,protein-lipid complex assembly,BP,
14514,GO:0065010,1,0.995366574475227,0,1,extracellular membrane-bounded organelle,CC,
14515,GO:0070001,1,0.927014841130212,0,14,aspartic-type peptidase activity,MF,
14516,GO:0070003,1,0.706568218904565,0,18,threonine-type peptidase activity,MF,
14517,GO:0070004,1,0.995366574475227,0,1,cysteine-type exopeptidase activity,MF,
14518,GO:0070006,1,0.930938235375742,0,15,metalloaminopeptidase activity,MF,
14519,GO:0070008,1,0.947746247288979,0,10,serine-type exopeptidase activity,MF,
14520,GO:0070011,1,0.0777120145718776,0,357,peptidase activity, acting on L-amino acid peptides,MF,
14521,GO:0070012,1,0.990520376337219,0,2,oligopeptidase activity,MF,
14523,GO:0070016,1,0.954612337499768,0,10,armadillo repeat domain binding,MF,
14524,GO:0070022,1,0.98159469022233,0,4,transforming growth factor beta receptor complex,CC,
14525,GO:0070025,1,0.995337765554784,0,1,carbon monoxide binding,MF,
14526,GO:0070026,1,0.974040246271642,0,2,nitric oxide binding,MF,
14527,GO:0070032,1,0.988831269974932,0,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,
14528,GO:0070033,1,0.988831269974932,0,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,
14529,GO:0070034,1,0.816284421860884,0,21,telomerase RNA binding,MF,
14530,GO:0070035,1,0.639563806693508,0,88,purine NTP-dependent helicase activity,MF,
14531,GO:0070037,1,0.980533446815773,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
14532,GO:0070039,1,0.987905776726319,0,2,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
14533,GO:0070042,1,0.995366713211339,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
14534,GO:0070044,1,0.977006009059053,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
14535,GO:0070050,1,0.980294324647497,0,4,neuron cellular homeostasis,BP,
14536,GO:0070051,1,0.99071795712729,0,2,fibrinogen binding,MF,
14537,GO:0070052,1,0.990755020077511,0,2,collagen V binding,MF,
14538,GO:0070053,1,0.990729221394542,0,2,thrombospondin receptor activity,MF,
14539,GO:0070054,1,0.985985098180598,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
14540,GO:0070055,1,0.985985098180598,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
14542,GO:0070060,1,0.995366990825967,0,1,'de novo' actin filament nucleation,BP,
14543,GO:0070061,1,0.979980259761068,0,3,fructose binding,MF,
14545,GO:0070063,1,0.704939461490964,0,53,RNA polymerase binding,MF,
14546,GO:0070064,1,0.878259764793466,0,19,proline-rich region binding,MF,
14548,GO:0070070,1,0.956184327741174,0,8,proton-transporting V-type ATPase complex assembly,BP,
14549,GO:0070071,1,0.928181549371363,0,12,proton-transporting two-sector ATPase complex assembly,BP,
14550,GO:0070072,1,0.956184327741174,0,8,vacuolar proton-transporting V-type ATPase complex assembly,BP,
14551,GO:0070076,1,0.890266244115782,0,25,histone lysine demethylation,BP,
14552,GO:0070077,1,0.995366972215419,0,1,histone arginine demethylation,BP,
14553,GO:0070078,1,0.995366972215419,0,1,histone H3-R2 demethylation,BP,
14554,GO:0070079,1,0.995366972215419,0,1,histone H4-R3 demethylation,BP,
14555,GO:0070081,1,0.983059170959735,0,3,clathrin-sculpted monoamine transport vesicle,CC,
14556,GO:0070083,1,0.983059170959735,0,3,clathrin-sculpted monoamine transport vesicle membrane,CC,
14558,GO:0070086,1,0.960026109785975,0,4,ubiquitin-dependent endocytosis,BP,
14559,GO:0070087,1,0.972517886004328,0,6,chromo shadow domain binding,MF,
14560,GO:0070091,1,0.986127696298168,0,3,glucagon secretion,BP,
14561,GO:0070092,1,0.986127696298168,0,3,regulation of glucagon secretion,BP,
14562,GO:0070094,1,0.995329816337612,0,1,positive regulation of glucagon secretion,BP,
14563,GO:0070095,1,0.995366814307342,0,1,fructose-6-phosphate binding,MF,
14564,GO:0070096,1,0.995366914937935,0,1,mitochondrial outer membrane translocase complex assembly,BP,
14565,GO:0070097,1,0.99075519984928,0,2,delta-catenin binding,MF,
14566,GO:0070098,1,0.825662459811951,0,22,chemokine-mediated signaling pathway,BP,
14567,GO:0070099,1,0.960321843187443,0,6,regulation of chemokine-mediated signaling pathway,BP,
14568,GO:0070100,1,0.970370397680912,0,4,negative regulation of chemokine-mediated signaling pathway,BP,
14569,GO:0070101,1,0.989648185304677,0,2,positive regulation of chemokine-mediated signaling pathway,BP,
14570,GO:0070102,1,0.937485439639309,0,13,interleukin-6-mediated signaling pathway,BP,
14571,GO:0070103,1,0.991234792401661,0,1,regulation of interleukin-6-mediated signaling pathway,BP,
14572,GO:0070104,1,0.991234792401661,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
14573,GO:0070106,1,0.963524382554487,0,8,interleukin-27-mediated signaling pathway,BP,
14574,GO:0070110,1,0.990755037724745,0,2,ciliary neurotrophic factor receptor complex,CC,
14575,GO:0070119,1,0.995366990826138,0,1,ciliary neurotrophic factor binding,MF,
14576,GO:0070120,1,0.986164369641592,0,3,ciliary neurotrophic factor-mediated signaling pathway,BP,
14577,GO:0070121,1,0.995366990826138,0,1,Kupffer's vesicle development,BP,
14578,GO:0070122,1,0.981325665008135,0,4,isopeptidase activity,MF,
14579,GO:0070123,1,0.995366990826099,0,1,transforming growth factor beta receptor activity, type III,MF,
14580,GO:0070124,1,0.976050076180146,0,2,mitochondrial translational initiation,BP,
14581,GO:0070125,1,0.234938897932736,0,86,mitochondrial translational elongation,BP,
14582,GO:0070126,1,0.231346345607433,0,88,mitochondrial translational termination,BP,
14583,GO:0070127,1,0.957192849846582,0,8,tRNA aminoacylation for mitochondrial protein translation,BP,
14584,GO:0070129,1,0.883314058504761,0,18,regulation of mitochondrial translation,BP,
14585,GO:0070130,1,0.995366574475227,0,1,negative regulation of mitochondrial translation,BP,
14586,GO:0070131,1,0.926058026126189,0,11,positive regulation of mitochondrial translation,BP,
14587,GO:0070137,1,0.981594732132647,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
14588,GO:0070138,1,0.986164373250932,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
14589,GO:0070139,1,0.981594732132647,0,4,SUMO-specific endopeptidase activity,MF,
14590,GO:0070140,1,0.986164373250932,0,3,SUMO-specific isopeptidase activity,MF,
14591,GO:0070141,1,0.974238747341492,0,5,response to UV-A,BP,
14592,GO:0070142,1,0.970791330023286,0,6,synaptic vesicle budding,BP,
14593,GO:0070143,1,0.995366990826165,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
14594,GO:0070145,1,0.995366906480586,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
14595,GO:0070150,1,0.985326027555134,0,2,mitochondrial glycyl-tRNA aminoacylation,BP,
14596,GO:0070159,1,0.995126550500926,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
14597,GO:0070160,1,0.597921331918404,0,91,occluding junction,CC,
14599,GO:0070162,1,0.97039601798066,0,5,adiponectin secretion,BP,
14600,GO:0070163,1,0.97039601798066,0,5,regulation of adiponectin secretion,BP,
14601,GO:0070164,1,0.97491453142712,0,4,negative regulation of adiponectin secretion,BP,
14602,GO:0070165,1,0.995366574475227,0,1,positive regulation of adiponectin secretion,BP,
14603,GO:0070166,1,0.952384409875894,0,9,enamel mineralization,BP,
14604,GO:0070167,1,0.809546038185805,0,38,regulation of biomineral tissue development,BP,
14605,GO:0070168,1,0.966094077605684,0,7,negative regulation of biomineral tissue development,BP,
14606,GO:0070169,1,0.873993875985223,0,22,positive regulation of biomineral tissue development,BP,
14607,GO:0070170,1,0.990755091485713,0,2,regulation of tooth mineralization,BP,
14608,GO:0070171,1,0.995366990826099,0,1,negative regulation of tooth mineralization,BP,
14609,GO:0070172,1,0.995366881964039,0,1,positive regulation of tooth mineralization,BP,
14610,GO:0070176,1,0.99220630210088,0,1,DRM complex,CC,
14611,GO:0070178,1,0.995254133737912,0,1,D-serine metabolic process,BP,
14612,GO:0070179,1,0.995254133737912,0,1,D-serine biosynthetic process,BP,
14613,GO:0070180,1,0.969738995653797,0,1,large ribosomal subunit rRNA binding,MF,
14614,GO:0070181,1,0.872810538397953,0,8,small ribosomal subunit rRNA binding,MF,
14615,GO:0070182,1,0.846799046703895,0,18,DNA polymerase binding,MF,
14616,GO:0070183,1,0.995366487962849,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
14617,GO:0070184,1,0.994517404157083,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
14618,GO:0070187,1,0.968744381706753,0,6,shelterin complex,CC,
14619,GO:0070189,1,0.971040839608215,0,4,kynurenine metabolic process,BP,
14620,GO:0070191,1,0.988742121448436,0,2,methionine-R-sulfoxide reductase activity,MF,
14621,GO:0070192,1,0.820459553742293,0,36,chromosome organization involved in meiotic cell cycle,BP,
14622,GO:0070193,1,0.951503456706623,0,10,synaptonemal complex organization,BP,
14623,GO:0070194,1,0.989965348190058,0,2,synaptonemal complex disassembly,BP,
14624,GO:0070195,1,0.995366990826152,0,1,growth hormone receptor complex,CC,
14625,GO:0070197,1,0.981581574528167,0,4,meiotic attachment of telomere to nuclear envelope,BP,
14626,GO:0070198,1,0.85768121860372,0,26,protein localization to chromosome, telomeric region,BP,
14627,GO:0070199,1,0.851351811929157,0,23,establishment of protein localization to chromosome,BP,
14628,GO:0070200,1,0.926305761375094,0,14,establishment of protein localization to telomere,BP,
14630,GO:0070202,1,0.940521737972816,0,11,regulation of establishment of protein localization to chromosome,BP,
14631,GO:0070203,1,0.944902729339534,0,10,regulation of establishment of protein localization to telomere,BP,
14632,GO:0070206,1,0.786035819047427,0,35,protein trimerization,BP,
14633,GO:0070207,1,0.862106876950458,0,18,protein homotrimerization,BP,
14634,GO:0070208,1,0.953926379985678,0,10,protein heterotrimerization,BP,
14635,GO:0070209,1,0.995366899841122,0,1,ASTRA complex,CC,
14636,GO:0070212,1,0.981254648151249,0,4,protein poly-ADP-ribosylation,BP,
14637,GO:0070213,1,0.981529093325081,0,4,protein auto-ADP-ribosylation,BP,
14638,GO:0070221,1,0.937880780515728,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
14642,GO:0070230,1,0.882382597526533,0,12,positive regulation of lymphocyte apoptotic process,BP,
14646,GO:0070234,1,0.91786035136657,0,9,positive regulation of T cell apoptotic process,BP,
14649,GO:0070242,1,0.887232495255542,0,16,thymocyte apoptotic process,BP,
14650,GO:0070243,1,0.927500372513951,0,11,regulation of thymocyte apoptotic process,BP,
14651,GO:0070244,1,0.95708495249222,0,6,negative regulation of thymocyte apoptotic process,BP,
14652,GO:0070245,1,0.969104215594601,0,5,positive regulation of thymocyte apoptotic process,BP,
14653,GO:0070252,1,0.713094099493799,0,50,actin-mediated cell contraction,BP,
14654,GO:0070254,1,0.914856849815548,0,8,mucus secretion,BP,
14655,GO:0070255,1,0.939655543109265,0,7,regulation of mucus secretion,BP,
14656,GO:0070256,1,0.989140067213088,0,1,negative regulation of mucus secretion,BP,
14657,GO:0070257,1,0.949978287079351,0,6,positive regulation of mucus secretion,BP,
14658,GO:0070259,1,0.990754769760615,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
14659,GO:0070260,1,0.995366574475227,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
14660,GO:0070262,1,0.917826376054535,0,14,peptidyl-serine dephosphorylation,BP,
14661,GO:0070265,1,0.706559090875236,0,40,necrotic cell death,BP,
14662,GO:0070266,1,0.819237945671201,0,30,necroptotic process,BP,
14663,GO:0070267,1,0.995366966913196,0,1,oncosis,BP,
14665,GO:0070269,1,0.931997577551425,0,8,pyroptosis,BP,
14666,GO:0070273,1,0.878399435307709,0,23,phosphatidylinositol-4-phosphate binding,MF,
14667,GO:0070274,1,0.98285016633328,0,2,RES complex,CC,
14668,GO:0070278,1,0.990436505801022,0,2,extracellular matrix constituent secretion,BP,
14669,GO:0070279,1,0.834163081114893,0,33,vitamin B6 binding,MF,
14670,GO:0070280,1,0.995366988609227,0,1,pyridoxal binding,MF,
14671,GO:0070283,1,0.990910197408557,0,1,radical SAM enzyme activity,MF,
14672,GO:0070286,1,0.921841350337496,0,11,axonemal dynein complex assembly,BP,
14673,GO:0070288,1,0.960992352400417,0,2,ferritin complex,CC,
14674,GO:0070290,1,0.976642648834388,0,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
14675,GO:0070291,1,0.97833652074276,0,4,N-acylethanolamine metabolic process,BP,
14676,GO:0070292,1,0.990754785405313,0,2,N-acylphosphatidylethanolamine metabolic process,BP,
14677,GO:0070293,1,0.941026538539269,0,11,renal absorption,BP,
14678,GO:0070294,1,0.984863831221282,0,3,renal sodium ion absorption,BP,
14679,GO:0070295,1,0.982568670366451,0,3,renal water absorption,BP,
14680,GO:0070296,1,0.863155672598662,0,17,sarcoplasmic reticulum calcium ion transport,BP,
14681,GO:0070300,1,0.88127160129027,0,18,phosphatidic acid binding,MF,
14682,GO:0070301,1,0.578687640690463,0,70,cellular response to hydrogen peroxide,BP,
14683,GO:0070302,1,0.372963459851431,0,161,regulation of stress-activated protein kinase signaling cascade,BP,
14684,GO:0070303,1,0.799369945584046,0,37,negative regulation of stress-activated protein kinase signaling cascade,BP,
14685,GO:0070304,1,0.520904796941539,0,108,positive regulation of stress-activated protein kinase signaling cascade,BP,
14686,GO:0070305,1,0.986164531023663,0,3,response to cGMP,BP,
14687,GO:0070306,1,0.917996304121675,0,17,lens fiber cell differentiation,BP,
14688,GO:0070307,1,0.962527413479058,0,7,lens fiber cell development,BP,
14689,GO:0070309,1,0.990755199764762,0,2,lens fiber cell morphogenesis,BP,
14690,GO:0070314,1,0.97692771073308,0,5,G1 to G0 transition,BP,
14691,GO:0070315,1,0.990754889547653,0,2,G1 to G0 transition involved in cell differentiation,BP,
14692,GO:0070316,1,0.776582043431477,0,41,regulation of G0 to G1 transition,BP,
14693,GO:0070317,1,0.798245390711048,0,37,negative regulation of G0 to G1 transition,BP,
14694,GO:0070318,1,0.972930608683252,0,4,positive regulation of G0 to G1 transition,BP,
14695,GO:0070320,1,0.995357732214175,0,1,inward rectifier potassium channel inhibitor activity,MF,
14696,GO:0070324,1,0.9698436127457,0,5,thyroid hormone binding,MF,
14697,GO:0070325,1,0.890546839294973,0,18,lipoprotein particle receptor binding,MF,
14698,GO:0070326,1,0.968381648622001,0,3,very-low-density lipoprotein particle receptor binding,MF,
14699,GO:0070327,1,0.986163907286642,0,3,thyroid hormone transport,BP,
14700,GO:0070328,1,0.887296866233825,0,14,triglyceride homeostasis,BP,
14701,GO:0070329,1,0.9902195563411,0,2,tRNA seleno-modification,BP,
14702,GO:0070330,1,0.951815205616161,0,9,aromatase activity,MF,
14703,GO:0070335,1,0.995366990826059,0,1,aspartate binding,MF,
14704,GO:0070336,1,0.990754785405288,0,2,flap-structured DNA binding,MF,
14705,GO:0070337,1,0.995366990826125,0,1,3'-flap-structured DNA binding,MF,
14706,GO:0070339,1,0.982891875921994,0,3,response to bacterial lipopeptide,BP,
14707,GO:0070340,1,0.990755129483909,0,2,detection of bacterial lipopeptide,BP,
14708,GO:0070341,1,0.972446250691323,0,6,fat cell proliferation,BP,
14709,GO:0070343,1,0.995366990826152,0,1,white fat cell proliferation,BP,
14710,GO:0070344,1,0.972446250691323,0,6,regulation of fat cell proliferation,BP,
14711,GO:0070345,1,0.981525688199825,0,4,negative regulation of fat cell proliferation,BP,
14712,GO:0070346,1,0.995363424876141,0,1,positive regulation of fat cell proliferation,BP,
14713,GO:0070350,1,0.995366990826152,0,1,regulation of white fat cell proliferation,BP,
14714,GO:0070358,1,0.951483296856452,0,5,actin polymerization-dependent cell motility,BP,
14715,GO:0070365,1,0.933465136289147,0,8,hepatocyte differentiation,BP,
14716,GO:0070369,1,0.98616446993789,0,3,beta-catenin-TCF7L2 complex,CC,
14717,GO:0070370,1,0.95191702965273,0,5,cellular heat acclimation,BP,
14718,GO:0070371,1,0.30743696293845,0,186,ERK1 and ERK2 cascade,BP,
14719,GO:0070372,1,0.334445446825597,0,172,regulation of ERK1 and ERK2 cascade,BP,
14720,GO:0070373,1,0.753128376038633,0,49,negative regulation of ERK1 and ERK2 cascade,BP,
14721,GO:0070374,1,0.470153657264829,0,118,positive regulation of ERK1 and ERK2 cascade,BP,
14722,GO:0070375,1,0.985892006219756,0,3,ERK5 cascade,BP,
14723,GO:0070376,1,0.995366577777831,0,1,regulation of ERK5 cascade,BP,
14724,GO:0070377,1,0.995366577777831,0,1,negative regulation of ERK5 cascade,BP,
14725,GO:0070381,1,0.99075512824541,0,2,endosome to plasma membrane transport vesicle,CC,
14727,GO:0070383,1,0.951705001502412,0,6,DNA cytosine deamination,BP,
14728,GO:0070384,1,0.98616400936788,0,3,Harderian gland development,BP,
14729,GO:0070390,1,0.99133415856859,0,1,transcription export complex 2,CC,
14730,GO:0070391,1,0.950305817498051,0,6,response to lipoteichoic acid,BP,
14731,GO:0070401,1,0.985720863616094,0,2,NADP+ binding,MF,
14732,GO:0070402,1,0.89573956059423,0,13,NADPH binding,MF,
14733,GO:0070403,1,0.925704396241802,0,12,NAD+ binding,MF,
14734,GO:0070404,1,0.965248519147495,0,3,NADH binding,MF,
14735,GO:0070405,1,0.793567346396737,0,27,ammonium ion binding,MF,
14736,GO:0070407,1,0.995366780243492,0,1,oxidation-dependent protein catabolic process,BP,
14737,GO:0070408,1,0.995366990826125,0,1,carbamoyl phosphate metabolic process,BP,
14738,GO:0070409,1,0.995366990826125,0,1,carbamoyl phosphate biosynthetic process,BP,
14739,GO:0070410,1,0.961023217047604,0,7,co-SMAD binding,MF,
14740,GO:0070411,1,0.956100476267715,0,9,I-SMAD binding,MF,
14741,GO:0070412,1,0.931876910881393,0,15,R-SMAD binding,MF,
14742,GO:0070413,1,0.995366641197951,0,1,trehalose metabolism in response to stress,BP,
14743,GO:0070417,1,0.961005532569851,0,7,cellular response to cold,BP,
14744,GO:0070418,1,0.995366990826151,0,1,DNA-dependent protein kinase complex,CC,
14745,GO:0070419,1,0.96152174566261,0,7,nonhomologous end joining complex,CC,
14746,GO:0070423,1,0.825751491036995,0,31,nucleotide-binding oligomerization domain containing signaling pathway,BP,
14747,GO:0070424,1,0.972263898722943,0,6,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14748,GO:0070425,1,0.995366990826151,0,1,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14749,GO:0070426,1,0.990496086427013,0,2,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14750,GO:0070427,1,0.980357590188821,0,3,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14751,GO:0070428,1,0.995366990826151,0,1,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14752,GO:0070429,1,0.995366990826151,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14753,GO:0070431,1,0.957560173913306,0,8,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14754,GO:0070432,1,0.98590660445973,0,3,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14755,GO:0070433,1,0.995366990826151,0,1,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14756,GO:0070434,1,0.990496086427013,0,2,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14757,GO:0070435,1,0.990706592376459,0,2,Shc-EGFR complex,CC,
14758,GO:0070436,1,0.990755062496015,0,2,Grb2-EGFR complex,CC,
14759,GO:0070444,1,0.979082505943273,0,4,oligodendrocyte progenitor proliferation,BP,
14760,GO:0070445,1,0.979082505943273,0,4,regulation of oligodendrocyte progenitor proliferation,BP,
14761,GO:0070446,1,0.993396629402146,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
14762,GO:0070447,1,0.990179851953587,0,2,positive regulation of oligodendrocyte progenitor proliferation,BP,
14763,GO:0070458,1,0.964013518525769,0,3,cellular detoxification of nitrogen compound,BP,
14764,GO:0070459,1,0.949467500702253,0,5,prolactin secretion,BP,
14765,GO:0070460,1,0.995366989784868,0,1,thyroid-stimulating hormone secretion,BP,
14766,GO:0070461,1,0.816754761707353,0,26,SAGA-type complex,CC,
14767,GO:0070463,1,0.995366943125784,0,1,tubulin-dependent ATPase activity,MF,
14769,GO:0070470,1,0.944307112035796,0,4,plasma membrane respiratory chain,CC,
14770,GO:0070471,1,0.986164118478128,0,3,uterine smooth muscle contraction,BP,
14771,GO:0070472,1,0.986164118478128,0,3,regulation of uterine smooth muscle contraction,BP,
14772,GO:0070474,1,0.986164118478128,0,3,positive regulation of uterine smooth muscle contraction,BP,
14773,GO:0070475,1,0.911572540535793,0,9,rRNA base methylation,BP,
14774,GO:0070476,1,0.969738995653797,0,1,rRNA (guanine-N7)-methylation,BP,
14775,GO:0070478,1,0.995366990826139,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
14776,GO:0070481,1,0.995366599349951,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
14778,GO:0070483,1,0.995366820767689,0,1,detection of hypoxia,BP,
14779,GO:0070486,1,0.889315970907244,0,10,leukocyte aggregation,BP,
14780,GO:0070487,1,0.974914419153504,0,4,monocyte aggregation,BP,
14781,GO:0070488,1,0.936166898086882,0,2,neutrophil aggregation,BP,
14782,GO:0070489,1,0.995366990795137,0,1,T cell aggregation,BP,
14783,GO:0070491,1,0.71095876231389,0,56,repressing transcription factor binding,MF,
14784,GO:0070492,1,0.954136545003675,0,4,oligosaccharide binding,MF,
14785,GO:0070493,1,0.962900558393776,0,7,thrombin-activated receptor signaling pathway,BP,
14786,GO:0070494,1,0.98105478728896,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
14787,GO:0070495,1,0.98105478728896,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
14788,GO:0070498,1,0.393720239930143,0,93,interleukin-1-mediated signaling pathway,BP,
14789,GO:0070506,1,0.995359826602095,0,1,high-density lipoprotein particle receptor activity,MF,
14791,GO:0070508,1,0.966890890730654,0,5,cholesterol import,BP,
14792,GO:0070509,1,0.839563550684093,0,32,calcium ion import,BP,
14793,GO:0070510,1,0.995366990826059,0,1,regulation of histone H4-K20 methylation,BP,
14794,GO:0070512,1,0.995366990826059,0,1,positive regulation of histone H4-K20 methylation,BP,
14795,GO:0070513,1,0.925508269887179,0,8,death domain binding,MF,
14796,GO:0070522,1,0.980571536838147,0,4,ERCC4-ERCC1 complex,CC,
14797,GO:0070524,1,0.98721666416536,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
14798,GO:0070525,1,0.906153821614753,0,13,tRNA threonylcarbamoyladenosine metabolic process,BP,
14799,GO:0070527,1,0.760105126666454,0,40,platelet aggregation,BP,
14800,GO:0070528,1,0.90565904061174,0,19,protein kinase C signaling,BP,
14801,GO:0070530,1,0.911347564404201,0,19,K63-linked polyubiquitin modification-dependent protein binding,MF,
14802,GO:0070531,1,0.976991675035348,0,5,BRCA1-A complex,CC,
14803,GO:0070534,1,0.769489200030189,0,40,protein K63-linked ubiquitination,BP,
14804,GO:0070535,1,0.976468179836523,0,5,histone H2A K63-linked ubiquitination,BP,
14805,GO:0070536,1,0.883811071802224,0,25,protein K63-linked deubiquitination,BP,
14806,GO:0070537,1,0.98613938699215,0,3,histone H2A K63-linked deubiquitination,BP,
14807,GO:0070538,1,0.987384680721447,0,1,oleic acid binding,MF,
14808,GO:0070539,1,0.995366953024506,0,1,linoleic acid binding,MF,
14809,GO:0070541,1,0.97723166988591,0,3,response to platinum ion,BP,
14811,GO:0070544,1,0.963523881174064,0,8,histone H3-K36 demethylation,BP,
14812,GO:0070545,1,0.98045190508151,0,4,PeBoW complex,CC,
14813,GO:0070548,1,0.995366990825994,0,1,L-glutamine aminotransferase activity,MF,
14814,GO:0070550,1,0.995366990825929,0,1,rDNA condensation,BP,
14815,GO:0070551,1,0.995366574475227,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
14816,GO:0070552,1,0.985600132122854,0,3,BRISC complex,CC,
14817,GO:0070553,1,0.995366574475227,0,1,nicotinic acid receptor activity,MF,
14818,GO:0070555,1,0.268550282031179,0,144,response to interleukin-1,BP,
14819,GO:0070557,1,0.980752680781263,0,2,PCNA-p21 complex,CC,
14820,GO:0070560,1,0.995366574475227,0,1,protein secretion by platelet,BP,
14824,GO:0070564,1,0.989698992206677,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
14825,GO:0070566,1,0.872329631466102,0,25,adenylyltransferase activity,MF,
14826,GO:0070567,1,0.941354355810315,0,8,cytidylyltransferase activity,MF,
14827,GO:0070568,1,0.9621235980467,0,5,guanylyltransferase activity,MF,
14828,GO:0070569,1,0.95770530176416,0,7,uridylyltransferase activity,MF,
14829,GO:0070570,1,0.875326561859256,0,20,regulation of neuron projection regeneration,BP,
14830,GO:0070571,1,0.919807076876707,0,13,negative regulation of neuron projection regeneration,BP,
14831,GO:0070572,1,0.964927469535027,0,4,positive regulation of neuron projection regeneration,BP,
14832,GO:0070573,1,0.995366574475227,0,1,metallodipeptidase activity,MF,
14833,GO:0070574,1,0.984636275228886,0,3,cadmium ion transmembrane transport,BP,
14834,GO:0070576,1,0.990728669010368,0,2,vitamin D 24-hydroxylase activity,MF,
14835,GO:0070577,1,0.927776019346093,0,16,lysine-acetylated histone binding,MF,
14836,GO:0070578,1,0.945462903475989,0,9,RISC-loading complex,CC,
14837,GO:0070579,1,0.98155915776225,0,4,methylcytosine dioxygenase activity,MF,
14838,GO:0070584,1,0.813047988381016,0,21,mitochondrion morphogenesis,BP,
14840,GO:0070586,1,0.954709423603119,0,8,cell-cell adhesion involved in gastrulation,BP,
14841,GO:0070587,1,0.959159941916282,0,7,regulation of cell-cell adhesion involved in gastrulation,BP,
14843,GO:0070589,1,0.991967176450215,0,1,cellular component macromolecule biosynthetic process,BP,
14844,GO:0070593,1,0.995366990826059,0,1,dendrite self-avoidance,BP,
14845,GO:0070601,1,0.942767628076426,0,8,centromeric sister chromatid cohesion,BP,
14846,GO:0070602,1,0.967941162314462,0,3,regulation of centromeric sister chromatid cohesion,BP,
14848,GO:0070611,1,0.995349756230137,0,1,histone methyltransferase activity (H3-R2 specific),MF,
14849,GO:0070612,1,0.995349756230137,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
14850,GO:0070613,1,0.692846528771954,0,52,regulation of protein processing,BP,
14851,GO:0070615,1,0.995366990826138,0,1,nucleosome-dependent ATPase activity,MF,
14852,GO:0070618,1,0.995360417662975,0,1,Grb2-Sos complex,CC,
14853,GO:0070625,1,0.99417626142378,0,1,zymogen granule exocytosis,BP,
14854,GO:0070626,1,0.988297151840119,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
14855,GO:0070627,1,0.995366990826139,0,1,ferrous iron import,BP,
14856,GO:0070628,1,0.818517010339884,0,18,proteasome binding,MF,
14857,GO:0070631,1,0.995366574475227,0,1,spindle pole body localization,BP,
14858,GO:0070632,1,0.995366574475227,0,1,establishment of spindle pole body localization,BP,
14859,GO:0070633,1,0.924393204782193,0,11,transepithelial transport,BP,
14860,GO:0070634,1,0.98154845589443,0,3,transepithelial ammonium transport,BP,
14861,GO:0070637,1,0.995173393564846,0,1,pyridine nucleoside metabolic process,BP,
14862,GO:0070638,1,0.995173393564846,0,1,pyridine nucleoside catabolic process,BP,
14863,GO:0070640,1,0.980929135916186,0,3,vitamin D3 metabolic process,BP,
14864,GO:0070643,1,0.990184886160895,0,1,vitamin D 25-hydroxylase activity,MF,
14865,GO:0070644,1,0.986164531023741,0,3,vitamin D response element binding,MF,
14868,GO:0070649,1,0.990755068968956,0,2,formin-nucleated actin cable assembly,BP,
14869,GO:0070650,1,0.995366574475227,0,1,actin filament bundle distribution,BP,
14870,GO:0070651,1,0.995366599349951,0,1,nonfunctional rRNA decay,BP,
14871,GO:0070652,1,0.936991455352982,0,8,HAUS complex,CC,
14873,GO:0070662,1,0.990754946723402,0,2,mast cell proliferation,BP,
14877,GO:0070666,1,0.990754946723402,0,2,regulation of mast cell proliferation,BP,
14878,GO:0070667,1,0.995366736535581,0,1,negative regulation of mast cell proliferation,BP,
14879,GO:0070668,1,0.990754946723402,0,2,positive regulation of mast cell proliferation,BP,
14880,GO:0070669,1,0.95507521604543,0,9,response to interleukin-2,BP,
14881,GO:0070670,1,0.838209391986217,0,27,response to interleukin-4,BP,
14882,GO:0070671,1,0.67007585925539,0,41,response to interleukin-12,BP,
14883,GO:0070672,1,0.946997341044285,0,10,response to interleukin-15,BP,
14884,GO:0070673,1,0.943328142889901,0,8,response to interleukin-18,BP,
14885,GO:0070676,1,0.974384273555544,0,3,intralumenal vesicle formation,BP,
14886,GO:0070678,1,0.995359358730194,0,1,preprotein binding,MF,
14887,GO:0070679,1,0.972518303431441,0,6,inositol 1,4,5 trisphosphate binding,MF,
14888,GO:0070681,1,0.956635539619049,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
14889,GO:0070682,1,0.979236623747767,0,3,proteasome regulatory particle assembly,BP,
14890,GO:0070685,1,0.99431881368668,0,1,macropinocytic cup,CC,
14891,GO:0070694,1,0.995366574475227,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
14892,GO:0070695,1,0.97637632064128,0,5,FHF complex,CC,
14893,GO:0070696,1,0.932629676681525,0,10,transmembrane receptor protein serine/threonine kinase binding,MF,
14894,GO:0070697,1,0.989955145161092,0,2,activin receptor binding,MF,
14895,GO:0070699,1,0.989955145161092,0,2,type II activin receptor binding,MF,
14896,GO:0070700,1,0.942099395389972,0,8,BMP receptor binding,MF,
14897,GO:0070704,1,0.990754785405327,0,2,sterol desaturase activity,MF,
14898,GO:0070715,1,0.995366872685533,0,1,sodium-dependent organic cation transport,BP,
14899,GO:0070717,1,0.891521053427431,0,21,poly-purine tract binding,MF,
14900,GO:0070723,1,0.912940093674027,0,17,response to cholesterol,BP,
14901,GO:0070724,1,0.99536679727965,0,1,BMP receptor complex,CC,
14903,GO:0070728,1,0.970876123550426,0,6,leucine binding,MF,
14904,GO:0070733,1,0.990595020269879,0,1,protein adenylyltransferase activity,MF,
14906,GO:0070735,1,0.995366923794929,0,1,protein-glycine ligase activity,MF,
14907,GO:0070736,1,0.995366923794929,0,1,protein-glycine ligase activity, initiating,MF,
14908,GO:0070739,1,0.969680986396699,0,6,protein-glutamic acid ligase activity,MF,
14909,GO:0070740,1,0.969680986396699,0,6,tubulin-glutamic acid ligase activity,MF,
14910,GO:0070741,1,0.895415302437012,0,22,response to interleukin-6,BP,
14911,GO:0070742,1,0.920909348630084,0,12,C2H2 zinc finger domain binding,MF,
14912,GO:0070743,1,0.980325580791004,0,1,interleukin-23 complex,CC,
14913,GO:0070757,1,0.963524382554463,0,8,interleukin-35-mediated signaling pathway,BP,
14914,GO:0070761,1,0.94733731975195,0,6,pre-snoRNP complex,CC,
14915,GO:0070762,1,0.995366574475227,0,1,nuclear pore transmembrane ring,CC,
14916,GO:0070765,1,0.948095424666958,0,6,gamma-secretase complex,CC,
14917,GO:0070772,1,0.995366769557216,0,1,PAS complex,CC,
14918,GO:0070773,1,0.986199598582225,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
14919,GO:0070774,1,0.995366990826151,0,1,phytoceramidase activity,MF,
14920,GO:0070775,1,0.967149315781326,0,7,H3 histone acetyltransferase complex,CC,
14921,GO:0070776,1,0.967149315781326,0,7,MOZ/MORF histone acetyltransferase complex,CC,
14922,GO:0070777,1,0.990755185408676,0,2,D-aspartate transport,BP,
14923,GO:0070778,1,0.981594065599123,0,4,L-aspartate transmembrane transport,BP,
14924,GO:0070779,1,0.990755185408676,0,2,D-aspartate import across plasma membrane,BP,
14925,GO:0070780,1,0.978939520254359,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
14926,GO:0070781,1,0.995366990826113,0,1,response to biotin,BP,
14927,GO:0070782,1,0.994505675272189,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
14928,GO:0070813,1,0.950215789651671,0,5,hydrogen sulfide metabolic process,BP,
14929,GO:0070814,1,0.970891015099271,0,4,hydrogen sulfide biosynthetic process,BP,
14930,GO:0070815,1,0.981594266620999,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
14931,GO:0070816,1,0.912747595769058,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
14932,GO:0070818,1,0.991680251628529,0,1,protoporphyrinogen oxidase activity,MF,
14936,GO:0070826,1,0.995366990826139,0,1,paraferritin complex,CC,
14937,GO:0070827,1,0.981487512859472,0,4,chromatin maintenance,BP,
14938,GO:0070828,1,0.90306611794411,0,15,heterochromatin organization,BP,
14939,GO:0070829,1,0.990755199849201,0,2,heterochromatin maintenance,BP,
14941,GO:0070831,1,0.968010861767443,0,7,basement membrane assembly,BP,
14942,GO:0070836,1,0.985123251506416,0,3,caveola assembly,BP,
14945,GO:0070840,1,0.919763803127642,0,18,dynein complex binding,MF,
14946,GO:0070841,1,0.900976719357088,0,18,inclusion body assembly,BP,
14947,GO:0070842,1,0.986164529991931,0,3,aggresome assembly,BP,
14948,GO:0070843,1,0.995366990826138,0,1,misfolded protein transport,BP,
14949,GO:0070844,1,0.995366990826138,0,1,polyubiquitinated protein transport,BP,
14950,GO:0070845,1,0.995366990826138,0,1,polyubiquitinated misfolded protein transport,BP,
14951,GO:0070846,1,0.995366990826138,0,1,Hsp90 deacetylation,BP,
14952,GO:0070847,1,0.922518641588288,0,8,core mediator complex,CC,
14955,GO:0070851,1,0.589914196698497,0,81,growth factor receptor binding,MF,
14956,GO:0070852,1,0.985660447250011,0,3,cell body fiber,CC,
14957,GO:0070853,1,0.990755199849071,0,2,myosin VI binding,MF,
14958,GO:0070856,1,0.995366990826112,0,1,myosin VI light chain binding,MF,
14961,GO:0070860,1,0.994972985095231,0,1,RNA polymerase I core factor complex,CC,
14962,GO:0070861,1,0.887859005751863,0,19,regulation of protein exit from endoplasmic reticulum,BP,
14963,GO:0070862,1,0.933755661523905,0,10,negative regulation of protein exit from endoplasmic reticulum,BP,
14964,GO:0070863,1,0.955313357067572,0,8,positive regulation of protein exit from endoplasmic reticulum,BP,
14966,GO:0070874,1,0.976307356556496,0,5,negative regulation of glycogen metabolic process,BP,
14967,GO:0070875,1,0.954612861302019,0,10,positive regulation of glycogen metabolic process,BP,
14968,GO:0070876,1,0.981593656766463,0,4,SOSS complex,CC,
14969,GO:0070877,1,0.990754785405328,0,2,microprocessor complex,CC,
14970,GO:0070878,1,0.963506281425388,0,8,primary miRNA binding,MF,
14971,GO:0070883,1,0.952825220923267,0,5,pre-miRNA binding,MF,
14972,GO:0070884,1,0.909308606685985,0,15,regulation of calcineurin-NFAT signaling cascade,BP,
14973,GO:0070885,1,0.986161861666483,0,3,negative regulation of calcineurin-NFAT signaling cascade,BP,
14974,GO:0070886,1,0.939199822407268,0,9,positive regulation of calcineurin-NFAT signaling cascade,BP,
14977,GO:0070889,1,0.990420516217169,0,2,platelet alpha granule organization,BP,
14978,GO:0070890,1,0.995366990826073,0,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
14979,GO:0070893,1,0.990754642430978,0,2,transposon integration,BP,
14980,GO:0070894,1,0.990754642430978,0,2,regulation of transposon integration,BP,
14981,GO:0070895,1,0.990754642430978,0,2,negative regulation of transposon integration,BP,
14982,GO:0070897,1,0.745167645428582,0,39,DNA-templated transcriptional preinitiation complex assembly,BP,
14983,GO:0070898,1,0.995366990825889,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
14984,GO:0070899,1,0.995366686267964,0,1,mitochondrial tRNA wobble uridine modification,BP,
14985,GO:0070900,1,0.931782621251712,0,9,mitochondrial tRNA modification,BP,
14986,GO:0070901,1,0.962195087301444,0,4,mitochondrial tRNA methylation,BP,
14987,GO:0070902,1,0.990810493933111,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
14988,GO:0070903,1,0.993542819372737,0,1,mitochondrial tRNA thio-modification,BP,
14989,GO:0070904,1,0.995366990826073,0,1,transepithelial L-ascorbic acid transport,BP,
14990,GO:0070905,1,0.989592667551837,0,2,serine binding,MF,
14991,GO:0070911,1,0.743164068351653,0,32,global genome nucleotide-excision repair,BP,
14993,GO:0070915,1,0.974416813372963,0,4,lysophosphatidic acid receptor activity,MF,
14994,GO:0070918,1,0.778551132066429,0,41,production of small RNA involved in gene silencing by RNA,BP,
14995,GO:0070920,1,0.893128867145037,0,15,regulation of production of small RNA involved in gene silencing by RNA,BP,
14996,GO:0070922,1,0.948274384133177,0,9,small RNA loading onto RISC,BP,
14998,GO:0070926,1,0.995366989701375,0,1,regulation of ATP:ADP antiporter activity,BP,
14999,GO:0070931,1,0.995366990826125,0,1,Golgi-associated vesicle lumen,CC,
15000,GO:0070932,1,0.896394016076639,0,20,histone H3 deacetylation,BP,
15001,GO:0070933,1,0.952277602672996,0,9,histone H4 deacetylation,BP,
15002,GO:0070934,1,0.975563533645919,0,4,CRD-mediated mRNA stabilization,BP,
15003,GO:0070935,1,0.943484768223067,0,11,3'-UTR-mediated mRNA stabilization,BP,
15004,GO:0070936,1,0.720413075163991,0,49,protein K48-linked ubiquitination,BP,
15005,GO:0070937,1,0.971042452961334,0,5,CRD-mediated mRNA stability complex,CC,
15006,GO:0070938,1,0.945799026167404,0,11,contractile ring,CC,
15007,GO:0070939,1,0.986163799516717,0,3,Dsl1/NZR complex,CC,
15008,GO:0070940,1,0.967246200782299,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
15009,GO:0070942,1,0.969858370384958,0,4,neutrophil mediated cytotoxicity,BP,
15010,GO:0070943,1,0.974374221776632,0,3,neutrophil mediated killing of symbiont cell,BP,
15011,GO:0070944,1,0.986370401171664,0,2,neutrophil mediated killing of bacterium,BP,
15012,GO:0070945,1,0.986370401171664,0,2,neutrophil mediated killing of gram-negative bacterium,BP,
15013,GO:0070947,1,0.987839962517201,0,1,neutrophil mediated killing of fungus,BP,
15014,GO:0070948,1,0.978705652836034,0,3,regulation of neutrophil mediated cytotoxicity,BP,
15015,GO:0070949,1,0.983262221578974,0,2,regulation of neutrophil mediated killing of symbiont cell,BP,
15016,GO:0070950,1,0.995366558830144,0,1,regulation of neutrophil mediated killing of bacterium,BP,
15017,GO:0070951,1,0.995366558830144,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15018,GO:0070953,1,0.987839962517201,0,1,regulation of neutrophil mediated killing of fungus,BP,
15019,GO:0070960,1,0.983262221578974,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
15020,GO:0070961,1,0.983262221578974,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
15021,GO:0070962,1,0.995366558830144,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
15022,GO:0070963,1,0.995366558830144,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15023,GO:0070965,1,0.987839962517201,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
15024,GO:0070966,1,0.986164143125446,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
15025,GO:0070970,1,0.963336442568923,0,8,interleukin-2 secretion,BP,
15026,GO:0070971,1,0.917802251806518,0,15,endoplasmic reticulum exit site,CC,
15028,GO:0070973,1,0.975355689028527,0,4,protein localization to endoplasmic reticulum exit site,BP,
15029,GO:0070975,1,0.995366990826047,0,1,FHA domain binding,MF,
15030,GO:0070976,1,0.995363146070969,0,1,TIR domain binding,MF,
15032,GO:0070979,1,0.766421696291267,0,27,protein K11-linked ubiquitination,BP,
15033,GO:0070980,1,0.99507839797967,0,1,biphenyl catabolic process,BP,
15034,GO:0070981,1,0.995019930851158,0,1,L-asparagine biosynthetic process,BP,
15035,GO:0070982,1,0.995019930851158,0,1,L-asparagine metabolic process,BP,
15036,GO:0070984,1,0.995366990826139,0,1,SET domain binding,MF,
15037,GO:0070985,1,0.975808309337614,0,2,TFIIK complex,CC,
15038,GO:0070986,1,0.917035792216167,0,12,left/right axis specification,BP,
15039,GO:0070987,1,0.854144697811006,0,18,error-free translesion synthesis,BP,
15040,GO:0070988,1,0.730967830604495,0,55,demethylation,BP,
15041,GO:0070989,1,0.924675299349993,0,11,oxidative demethylation,BP,
15042,GO:0070990,1,0.940312407585608,0,6,snRNP binding,MF,
15043,GO:0070991,1,0.986104674536945,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
15044,GO:0070992,1,0.96017439285375,0,2,translation initiation complex,CC,
15045,GO:0070993,1,0.99075519984928,0,2,translation preinitiation complex,CC,
15046,GO:0070995,1,0.995366805441852,0,1,NADPH oxidation,BP,
15048,GO:0071001,1,0.966119410565193,0,3,U4/U6 snRNP,CC,
15049,GO:0071004,1,0.849760362936964,0,17,U2-type prespliceosome,CC,
15050,GO:0071005,1,0.990030596098877,0,2,U2-type precatalytic spliceosome,CC,
15051,GO:0071006,1,0.985567860574316,0,3,U2-type catalytic step 1 spliceosome,CC,
15053,GO:0071008,1,0.969886230919839,0,4,U2-type post-mRNA release spliceosomal complex,CC,
15054,GO:0071010,1,0.808716522492148,0,22,prespliceosome,CC,
15056,GO:0071012,1,0.96850286078662,0,6,catalytic step 1 spliceosome,CC,
15058,GO:0071014,1,0.93956477532808,0,9,post-mRNA release spliceosomal complex,CC,
15059,GO:0071020,1,0.98322846029205,0,2,post-spliceosomal complex,CC,
15060,GO:0071021,1,0.991290183108913,0,1,U2-type post-spliceosomal complex,CC,
15061,GO:0071025,1,0.854530808444914,0,15,RNA surveillance,BP,
15062,GO:0071026,1,0.995258125840563,0,1,cytoplasmic RNA surveillance,BP,
15063,GO:0071027,1,0.862612970210367,0,13,nuclear RNA surveillance,BP,
15064,GO:0071028,1,0.862612970210367,0,13,nuclear mRNA surveillance,BP,
15065,GO:0071029,1,0.934235802019204,0,6,nuclear ncRNA surveillance,BP,
15066,GO:0071030,1,0.986696474135944,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
15067,GO:0071031,1,0.977176613084561,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
15068,GO:0071033,1,0.955814436920096,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
15069,GO:0071034,1,0.968139842205957,0,4,CUT catabolic process,BP,
15070,GO:0071035,1,0.934235802019204,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
15071,GO:0071038,1,0.93858801208566,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
15072,GO:0071042,1,0.956068190007799,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
15073,GO:0071043,1,0.968139842205957,0,4,CUT metabolic process,BP,
15074,GO:0071044,1,0.911716084169356,0,11,histone mRNA catabolic process,BP,
15075,GO:0071045,1,0.990534128227314,0,1,nuclear histone mRNA catabolic process,BP,
15076,GO:0071046,1,0.934235802019204,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
15077,GO:0071047,1,0.956068190007799,0,4,polyadenylation-dependent mRNA catabolic process,BP,
15078,GO:0071048,1,0.986696474135944,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
15079,GO:0071049,1,0.977176613084561,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
15080,GO:0071051,1,0.926775766421824,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
15081,GO:0071062,1,0.995366990826152,0,1,alphav-beta3 integrin-vitronectin complex,CC,
15082,GO:0071065,1,0.995366798601386,0,1,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
15083,GO:0071071,1,0.954420492766203,0,8,regulation of phospholipid biosynthetic process,BP,
15084,GO:0071072,1,0.98159367358827,0,4,negative regulation of phospholipid biosynthetic process,BP,
15085,GO:0071073,1,0.977180481338712,0,3,positive regulation of phospholipid biosynthetic process,BP,
15086,GO:0071074,1,0.993148320529259,0,1,eukaryotic initiation factor eIF2 binding,MF,
15087,GO:0071077,1,0.985610701784583,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
15089,GO:0071104,1,0.99075519984928,0,2,response to interleukin-9,BP,
15090,GO:0071105,1,0.995366990826165,0,1,response to interleukin-11,BP,
15091,GO:0071106,1,0.985610701784583,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
15092,GO:0071107,1,0.98616432444139,0,3,response to parathyroid hormone,BP,
15093,GO:0071108,1,0.865653933196784,0,25,protein K48-linked deubiquitination,BP,
15094,GO:0071109,1,0.990755199848979,0,2,superior temporal gyrus development,BP,
15095,GO:0071110,1,0.995366990826113,0,1,histone biotinylation,BP,
15096,GO:0071133,1,0.995366798601386,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
15097,GO:0071139,1,0.990727694916488,0,2,resolution of recombination intermediates,BP,
15098,GO:0071140,1,0.990727694916488,0,2,resolution of mitotic recombination intermediates,BP,
15099,GO:0071141,1,0.968010355681915,0,7,SMAD protein complex,CC,
15100,GO:0071144,1,0.990755199849018,0,2,heteromeric SMAD protein complex,CC,
15101,GO:0071148,1,0.990755199849084,0,2,TEAD-1-YAP complex,CC,
15102,GO:0071149,1,0.989936333268549,0,2,TEAD-2-YAP complex,CC,
15103,GO:0071156,1,0.470316502188931,0,97,regulation of cell cycle arrest,BP,
15104,GO:0071157,1,0.857332556431049,0,18,negative regulation of cell cycle arrest,BP,
15105,GO:0071158,1,0.547357358427846,0,78,positive regulation of cell cycle arrest,BP,
15106,GO:0071159,1,0.97139988204906,0,2,NF-kappaB complex,CC,
15107,GO:0071163,1,0.972600341396833,0,3,DNA replication preinitiation complex assembly,BP,
15108,GO:0071164,1,0.995366980816202,0,1,RNA trimethylguanosine synthase activity,MF,
15109,GO:0071166,1,0.404981075124479,0,122,ribonucleoprotein complex localization,BP,
15110,GO:0071168,1,0.86235096981862,0,22,protein localization to chromatin,BP,
15111,GO:0071169,1,0.92343377171108,0,8,establishment of protein localization to chromatin,BP,
15112,GO:0071173,1,0.822833833598206,0,29,spindle assembly checkpoint,BP,
15113,GO:0071174,1,0.822833833598206,0,29,mitotic spindle checkpoint,BP,
15114,GO:0071203,1,0.968537054166789,0,6,WASH complex,CC,
15115,GO:0071204,1,0.949017935464055,0,6,histone pre-mRNA 3'end processing complex,CC,
15116,GO:0071205,1,0.981594888733129,0,4,protein localization to juxtaparanode region of axon,BP,
15117,GO:0071207,1,0.986902321564443,0,2,histone pre-mRNA stem-loop binding,MF,
15118,GO:0071208,1,0.937051390304563,0,4,histone pre-mRNA DCP binding,MF,
15119,GO:0071209,1,0.958705209645288,0,3,U7 snRNA binding,MF,
15120,GO:0071211,1,0.980179262019309,0,4,protein targeting to vacuole involved in autophagy,BP,
15122,GO:0071215,1,0.995366990826152,0,1,cellular response to abscisic acid stimulus,BP,
15124,GO:0071218,1,0.871189992063954,0,20,cellular response to misfolded protein,BP,
15126,GO:0071220,1,0.982891875921994,0,3,cellular response to bacterial lipoprotein,BP,
15127,GO:0071221,1,0.982891875921994,0,3,cellular response to bacterial lipopeptide,BP,
15129,GO:0071223,1,0.950305817498051,0,6,cellular response to lipoteichoic acid,BP,
15130,GO:0071224,1,0.986090963155777,0,3,cellular response to peptidoglycan,BP,
15131,GO:0071225,1,0.981560979057087,0,4,cellular response to muramyl dipeptide,BP,
15132,GO:0071226,1,0.995366990826164,0,1,cellular response to molecule of fungal origin,BP,
15135,GO:0071230,1,0.739809869095026,0,51,cellular response to amino acid stimulus,BP,
15136,GO:0071233,1,0.961897564688344,0,8,cellular response to leucine,BP,
15138,GO:0071241,1,0.430391771709965,0,120,cellular response to inorganic substance,BP,
15139,GO:0071242,1,0.803835118677577,0,33,cellular response to ammonium ion,BP,
15140,GO:0071243,1,0.862451279199755,0,16,cellular response to arsenic-containing substance,BP,
15141,GO:0071245,1,0.995366974796877,0,1,cellular response to carbon monoxide,BP,
15142,GO:0071247,1,0.981445284486209,0,1,cellular response to chromate,BP,
15143,GO:0071248,1,0.48390236368792,0,100,cellular response to metal ion,BP,
15144,GO:0071253,1,0.976926863212579,0,5,connexin binding,MF,
15145,GO:0071256,1,0.926286588424754,0,4,translocon complex,CC,
15146,GO:0071257,1,0.977044846060062,0,5,cellular response to electrical stimulus,BP,
15147,GO:0071258,1,0.995366990826138,0,1,cellular response to gravity,BP,
15148,GO:0071260,1,0.681790934257721,0,58,cellular response to mechanical stimulus,BP,
15149,GO:0071262,1,0.990755194669909,0,2,regulation of translational initiation in response to starvation,BP,
15150,GO:0071264,1,0.990755194669909,0,2,positive regulation of translational initiation in response to starvation,BP,
15151,GO:0071265,1,0.946652538179859,0,7,L-methionine biosynthetic process,BP,
15152,GO:0071266,1,0.991669902477171,0,1,'de novo' L-methionine biosynthetic process,BP,
15153,GO:0071267,1,0.954608748735379,0,6,L-methionine salvage,BP,
15154,GO:0071268,1,0.994936976655377,0,1,homocysteine biosynthetic process,BP,
15155,GO:0071275,1,0.994481894632558,0,1,cellular response to aluminum ion,BP,
15156,GO:0071276,1,0.780874334854497,0,24,cellular response to cadmium ion,BP,
15157,GO:0071277,1,0.79883435278156,0,42,cellular response to calcium ion,BP,
15158,GO:0071279,1,0.969389949997544,0,4,cellular response to cobalt ion,BP,
15159,GO:0071280,1,0.84896178124303,0,12,cellular response to copper ion,BP,
15160,GO:0071281,1,0.947876344744574,0,6,cellular response to iron ion,BP,
15161,GO:0071283,1,0.973507014832315,0,2,cellular response to iron(III) ion,BP,
15162,GO:0071284,1,0.981594660130249,0,4,cellular response to lead ion,BP,
15163,GO:0071285,1,0.948029604281653,0,8,cellular response to lithium ion,BP,
15164,GO:0071286,1,0.986164531023141,0,3,cellular response to magnesium ion,BP,
15165,GO:0071287,1,0.966421889279405,0,6,cellular response to manganese ion,BP,
15166,GO:0071294,1,0.862699124089166,0,8,cellular response to zinc ion,BP,
15168,GO:0071300,1,0.749195859562827,0,44,cellular response to retinoic acid,BP,
15169,GO:0071301,1,0.995366990826047,0,1,cellular response to vitamin B1,BP,
15171,GO:0071306,1,0.988121908514504,0,2,cellular response to vitamin E,BP,
15172,GO:0071307,1,0.990667722499669,0,2,cellular response to vitamin K,BP,
15174,GO:0071312,1,0.876660221913459,0,21,cellular response to alkaloid,BP,
15175,GO:0071313,1,0.976962763601965,0,3,cellular response to caffeine,BP,
15176,GO:0071314,1,0.995366456936023,0,1,cellular response to cocaine,BP,
15177,GO:0071315,1,0.98360444547424,0,3,cellular response to morphine,BP,
15178,GO:0071316,1,0.952299928774214,0,6,cellular response to nicotine,BP,
15179,GO:0071317,1,0.98360444547424,0,3,cellular response to isoquinoline alkaloid,BP,
15180,GO:0071318,1,0.919578075334653,0,12,cellular response to ATP,BP,
15181,GO:0071320,1,0.860164364190734,0,30,cellular response to cAMP,BP,
15182,GO:0071321,1,0.986164531023663,0,3,cellular response to cGMP,BP,
15184,GO:0071324,1,0.995366990826164,0,1,cellular response to disaccharide stimulus,BP,
15186,GO:0071329,1,0.995366990826164,0,1,cellular response to sucrose stimulus,BP,
15188,GO:0071332,1,0.987665726009256,0,2,cellular response to fructose stimulus,BP,
15190,GO:0071335,1,0.994551950924641,0,1,hair follicle cell proliferation,BP,
15191,GO:0071336,1,0.994551950924641,0,1,regulation of hair follicle cell proliferation,BP,
15192,GO:0071338,1,0.994551950924641,0,1,positive regulation of hair follicle cell proliferation,BP,
15193,GO:0071339,1,0.816009290463369,0,29,MLL1 complex,CC,
15194,GO:0071340,1,0.967278085079551,0,6,skeletal muscle acetylcholine-gated channel clustering,BP,
15195,GO:0071344,1,0.975498056463567,0,2,diphosphate metabolic process,BP,
15197,GO:0071346,1,0.43150943334378,0,110,cellular response to interferon-gamma,BP,
15198,GO:0071347,1,0.307614581596388,0,128,cellular response to interleukin-1,BP,
15199,GO:0071348,1,0.995366990826165,0,1,cellular response to interleukin-11,BP,
15200,GO:0071349,1,0.673232401111365,0,40,cellular response to interleukin-12,BP,
15201,GO:0071350,1,0.951407748426029,0,9,cellular response to interleukin-15,BP,
15202,GO:0071351,1,0.956618074264822,0,5,cellular response to interleukin-18,BP,
15203,GO:0071352,1,0.95507521604543,0,9,cellular response to interleukin-2,BP,
15204,GO:0071353,1,0.84211864946472,0,26,cellular response to interleukin-4,BP,
15205,GO:0071354,1,0.895415302437012,0,22,cellular response to interleukin-6,BP,
15206,GO:0071355,1,0.99075519984928,0,2,cellular response to interleukin-9,BP,
15209,GO:0071359,1,0.690075075526454,0,58,cellular response to dsRNA,BP,
15210,GO:0071360,1,0.920494092303323,0,12,cellular response to exogenous dsRNA,BP,
15211,GO:0071361,1,0.963245222604181,0,8,cellular response to ethanol,BP,
15212,GO:0071362,1,0.974075563241429,0,4,cellular response to ether,BP,
15215,GO:0071371,1,0.940546308182025,0,13,cellular response to gonadotropin stimulus,BP,
15216,GO:0071372,1,0.962653697480739,0,8,cellular response to follicle-stimulating hormone stimulus,BP,
15217,GO:0071373,1,0.990745268592003,0,2,cellular response to luteinizing hormone stimulus,BP,
15218,GO:0071374,1,0.990754992316458,0,2,cellular response to parathyroid hormone stimulus,BP,
15219,GO:0071375,1,0.238964417411743,0,224,cellular response to peptide hormone stimulus,BP,
15220,GO:0071376,1,0.990723365252667,0,2,cellular response to corticotropin-releasing hormone stimulus,BP,
15221,GO:0071377,1,0.86156233619486,0,22,cellular response to glucagon stimulus,BP,
15222,GO:0071378,1,0.921131509674238,0,17,cellular response to growth hormone stimulus,BP,
15223,GO:0071379,1,0.928094654480804,0,14,cellular response to prostaglandin stimulus,BP,
15224,GO:0071380,1,0.943267557526543,0,12,cellular response to prostaglandin E stimulus,BP,
15228,GO:0071386,1,0.990755199849097,0,2,cellular response to corticosterone stimulus,BP,
15229,GO:0071387,1,0.995366990826151,0,1,cellular response to cortisol stimulus,BP,
15230,GO:0071389,1,0.956735053891175,0,6,cellular response to mineralocorticoid stimulus,BP,
15231,GO:0071391,1,0.947654694627211,0,11,cellular response to estrogen stimulus,BP,
15232,GO:0071392,1,0.866469596990638,0,23,cellular response to estradiol stimulus,BP,
15233,GO:0071393,1,0.995366990826125,0,1,cellular response to progesterone stimulus,BP,
15234,GO:0071394,1,0.955621187206655,0,7,cellular response to testosterone stimulus,BP,
15235,GO:0071395,1,0.975408435411332,0,2,cellular response to jasmonic acid stimulus,BP,
15237,GO:0071397,1,0.949004067452057,0,11,cellular response to cholesterol,BP,
15239,GO:0071400,1,0.990615790143951,0,2,cellular response to oleic acid,BP,
15240,GO:0071401,1,0.994930769572645,0,1,cellular response to triglyceride,BP,
15241,GO:0071402,1,0.889680140699229,0,18,cellular response to lipoprotein particle stimulus,BP,
15242,GO:0071403,1,0.990754851190174,0,2,cellular response to high density lipoprotein particle stimulus,BP,
15243,GO:0071404,1,0.926285083765323,0,12,cellular response to low-density lipoprotein particle stimulus,BP,
15245,GO:0071409,1,0.981387572583021,0,3,cellular response to cycloheximide,BP,
15246,GO:0071415,1,0.976962763601965,0,3,cellular response to purine-containing compound,BP,
15247,GO:0071417,1,0.091105199509768,0,378,cellular response to organonitrogen compound,BP,
15248,GO:0071418,1,0.986351894952717,0,1,cellular response to amine stimulus,BP,
15249,GO:0071420,1,0.990755199849254,0,2,cellular response to histamine,BP,
15250,GO:0071421,1,0.990755199037193,0,2,manganese ion transmembrane transport,BP,
15251,GO:0071422,1,0.983801244923613,0,3,succinate transmembrane transport,BP,
15252,GO:0071423,1,0.992982056220991,0,1,malate transmembrane transport,BP,
15253,GO:0071424,1,0.995366574475227,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
15254,GO:0071425,1,0.926991452132199,0,14,hematopoietic stem cell proliferation,BP,
15255,GO:0071426,1,0.407186435604186,0,121,ribonucleoprotein complex export from nucleus,BP,
15256,GO:0071427,1,0.499349325561795,0,103,mRNA-containing ribonucleoprotein complex export from nucleus,BP,
15257,GO:0071428,1,0.835002028068184,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
15258,GO:0071431,1,0.822619948894952,0,32,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
15259,GO:0071435,1,0.990755199849292,0,2,potassium ion export,BP,
15260,GO:0071437,1,0.934109013549987,0,13,invadopodium,CC,
15261,GO:0071438,1,0.974001470650987,0,4,invadopodium membrane,CC,
15262,GO:0071439,1,0.950393636069014,0,8,clathrin complex,CC,
15263,GO:0071440,1,0.975104312714825,0,5,regulation of histone H3-K14 acetylation,BP,
15264,GO:0071441,1,0.99536698911949,0,1,negative regulation of histone H3-K14 acetylation,BP,
15265,GO:0071442,1,0.984205165506424,0,3,positive regulation of histone H3-K14 acetylation,BP,
15266,GO:0071447,1,0.955194790763355,0,6,cellular response to hydroperoxide,BP,
15267,GO:0071449,1,0.977641730235362,0,1,cellular response to lipid hydroperoxide,BP,
15268,GO:0071450,1,0.807225327565639,0,19,cellular response to oxygen radical,BP,
15269,GO:0071451,1,0.807225327565639,0,19,cellular response to superoxide,BP,
15270,GO:0071453,1,0.2259762177044,0,172,cellular response to oxygen levels,BP,
15271,GO:0071454,1,0.995366990826047,0,1,cellular response to anoxia,BP,
15272,GO:0071455,1,0.969886732807201,0,6,cellular response to hyperoxia,BP,
15273,GO:0071456,1,0.256678009336482,0,151,cellular response to hypoxia,BP,
15274,GO:0071458,1,0.972205082047208,0,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
15275,GO:0071459,1,0.881302608275033,0,20,protein localization to chromosome, centromeric region,BP,
15276,GO:0071460,1,0.967758444023307,0,2,cellular response to cell-matrix adhesion,BP,
15277,GO:0071461,1,0.979277542969409,0,2,cellular response to redox state,BP,
15278,GO:0071462,1,0.990755174114934,0,2,cellular response to water stimulus,BP,
15279,GO:0071464,1,0.995366990826164,0,1,cellular response to hydrostatic pressure,BP,
15281,GO:0071467,1,0.928511758193291,0,13,cellular response to pH,BP,
15282,GO:0071468,1,0.96757685847849,0,6,cellular response to acidic pH,BP,
15283,GO:0071470,1,0.838597054614514,0,26,cellular response to osmotic stress,BP,
15284,GO:0071471,1,0.995366990826164,0,1,cellular response to non-ionic osmotic stress,BP,
15285,GO:0071472,1,0.959074753365955,0,7,cellular response to salt stress,BP,
15286,GO:0071474,1,0.959074733343817,0,7,cellular hyperosmotic response,BP,
15287,GO:0071475,1,0.977063062702783,0,3,cellular hyperosmotic salinity response,BP,
15288,GO:0071476,1,0.947294854051394,0,7,cellular hypotonic response,BP,
15289,GO:0071477,1,0.990755013385272,0,2,cellular hypotonic salinity response,BP,
15292,GO:0071480,1,0.803989909534988,0,26,cellular response to gamma radiation,BP,
15293,GO:0071481,1,0.949307193982787,0,11,cellular response to X-ray,BP,
15295,GO:0071483,1,0.990755074494105,0,2,cellular response to blue light,BP,
15296,GO:0071484,1,0.99075508785174,0,2,cellular response to light intensity,BP,
15297,GO:0071485,1,0.995366878313285,0,1,cellular response to absence of light,BP,
15298,GO:0071486,1,0.995366990826152,0,1,cellular response to high light intensity,BP,
15299,GO:0071492,1,0.98795765354816,0,2,cellular response to UV-A,BP,
15300,GO:0071493,1,0.967555201403648,0,6,cellular response to UV-B,BP,
15301,GO:0071494,1,0.959827618958609,0,4,cellular response to UV-C,BP,
15304,GO:0071498,1,0.89930551451331,0,17,cellular response to fluid shear stress,BP,
15305,GO:0071499,1,0.960235665935434,0,7,cellular response to laminar fluid shear stress,BP,
15307,GO:0071501,1,0.959979372117669,0,8,cellular response to sterol depletion,BP,
15308,GO:0071502,1,0.973240403960748,0,3,cellular response to temperature stimulus,BP,
15309,GO:0071503,1,0.981594687577558,0,4,response to heparin,BP,
15310,GO:0071504,1,0.981594687577558,0,4,cellular response to heparin,BP,
15311,GO:0071505,1,0.990754566548339,0,2,response to mycophenolic acid,BP,
15312,GO:0071506,1,0.990754566548339,0,2,cellular response to mycophenolic acid,BP,
15313,GO:0071514,1,0.912165738889678,0,18,genetic imprinting,BP,
15314,GO:0071526,1,0.871264676737485,0,29,semaphorin-plexin signaling pathway,BP,
15315,GO:0071528,1,0.995366990044421,0,1,tRNA re-export from nucleus,BP,
15316,GO:0071532,1,0.981555199094078,0,4,ankyrin repeat binding,MF,
15317,GO:0071535,1,0.969924635001849,0,4,RING-like zinc finger domain binding,MF,
15318,GO:0071538,1,0.994975311334276,0,1,SH2 domain-mediated complex assembly,BP,
15320,GO:0071540,1,0.995366990826152,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
15321,GO:0071541,1,0.928249321435284,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
15322,GO:0071542,1,0.89735144552677,0,17,dopaminergic neuron differentiation,BP,
15323,GO:0071543,1,0.970671105713102,0,4,diphosphoinositol polyphosphate metabolic process,BP,
15324,GO:0071544,1,0.986199598582225,0,1,diphosphoinositol polyphosphate catabolic process,BP,
15325,GO:0071545,1,0.92966061821689,0,12,inositol phosphate catabolic process,BP,
15326,GO:0071546,1,0.990754298302759,0,2,pi-body,CC,
15327,GO:0071547,1,0.995366087105313,0,1,piP-body,CC,
15330,GO:0071550,1,0.927797662554121,0,9,death-inducing signaling complex assembly,BP,
15331,GO:0071554,1,0.976322923133385,0,3,cell wall organization or biogenesis,BP,
15332,GO:0071556,1,0.851605771418697,0,18,integral component of lumenal side of endoplasmic reticulum membrane,CC,
15333,GO:0071557,1,0.977045769015693,0,5,histone H3-K27 demethylation,BP,
15334,GO:0071558,1,0.977045769015693,0,5,histone demethylase activity (H3-K27 specific),MF,
15335,GO:0071559,1,0.340844636792294,0,167,response to transforming growth factor beta,BP,
15336,GO:0071560,1,0.347274057677563,0,164,cellular response to transforming growth factor beta stimulus,BP,
15337,GO:0071561,1,0.995366990826164,0,1,nucleus-vacuole junction,CC,
15338,GO:0071564,1,0.930851759519536,0,12,npBAF complex,CC,
15339,GO:0071565,1,0.937138360853238,0,12,nBAF complex,CC,
15340,GO:0071566,1,0.995366632280979,0,1,UFM1 activating enzyme activity,MF,
15341,GO:0071567,1,0.97447936281036,0,2,UFM1 hydrolase activity,MF,
15342,GO:0071568,1,0.977446742574503,0,2,UFM1 transferase activity,MF,
15343,GO:0071569,1,0.946670731222816,0,6,protein ufmylation,BP,
15344,GO:0071573,1,0.995366618623234,0,1,shelterin complex assembly,BP,
15345,GO:0071575,1,0.995366969447021,0,1,integral component of external side of plasma membrane,CC,
15346,GO:0071577,1,0.928339093694065,0,15,zinc ion transmembrane transport,BP,
15347,GO:0071578,1,0.970463136732416,0,6,zinc ion import across plasma membrane,BP,
15348,GO:0071579,1,0.993824779801663,0,1,regulation of zinc ion transport,BP,
15349,GO:0071580,1,0.993824779801663,0,1,regulation of zinc ion transmembrane transport,BP,
15350,GO:0071581,1,0.993824779801663,0,1,regulation of zinc ion transmembrane import,BP,
15351,GO:0071582,1,0.993824779801663,0,1,negative regulation of zinc ion transport,BP,
15352,GO:0071583,1,0.993824779801663,0,1,negative regulation of zinc ion transmembrane transport,BP,
15353,GO:0071584,1,0.993824779801663,0,1,negative regulation of zinc ion transmembrane import,BP,
15354,GO:0071585,1,0.993824779801663,0,1,detoxification of cadmium ion,BP,
15355,GO:0071586,1,0.983597583263327,0,2,CAAX-box protein processing,BP,
15356,GO:0071593,1,0.978979794659118,0,3,lymphocyte aggregation,BP,
15357,GO:0071595,1,0.990754370961523,0,2,Nem1-Spo7 phosphatase complex,CC,
15358,GO:0071596,1,0.986164531023494,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
15359,GO:0071598,1,0.960988913266334,0,5,neuronal ribonucleoprotein granule,CC,
15360,GO:0071599,1,0.972518055931235,0,6,otic vesicle development,BP,
15361,GO:0071600,1,0.986164530733697,0,3,otic vesicle morphogenesis,BP,
15362,GO:0071602,1,0.995366990826151,0,1,phytosphingosine biosynthetic process,BP,
15363,GO:0071603,1,0.990755119254983,0,2,endothelial cell-cell adhesion,BP,
15364,GO:0071604,1,0.915231520529275,0,18,transforming growth factor beta production,BP,
15365,GO:0071605,1,0.936383322263426,0,7,monocyte chemotactic protein-1 production,BP,
15366,GO:0071606,1,0.993619425430401,0,1,chemokine (C-C motif) ligand 4 production,BP,
15367,GO:0071608,1,0.979870743026305,0,4,macrophage inflammatory protein-1 alpha production,BP,
15368,GO:0071609,1,0.952610191947039,0,8,chemokine (C-C motif) ligand 5 production,BP,
15369,GO:0071611,1,0.990393048973453,0,2,granulocyte colony-stimulating factor production,BP,
15370,GO:0071612,1,0.995366990825863,0,1,IP-10 production,BP,
15371,GO:0071614,1,0.992742259796257,0,1,linoleic acid epoxygenase activity,MF,
15372,GO:0071615,1,0.995366784419756,0,1,oxidative deethylation,BP,
15373,GO:0071616,1,0.772394666055287,0,43,acyl-CoA biosynthetic process,BP,
15374,GO:0071617,1,0.899257391008568,0,20,lysophospholipid acyltransferase activity,MF,
15375,GO:0071619,1,0.994889622719127,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
15376,GO:0071621,1,0.607835404383928,0,48,granulocyte chemotaxis,BP,
15377,GO:0071622,1,0.783704393552166,0,26,regulation of granulocyte chemotaxis,BP,
15378,GO:0071623,1,0.995366990826165,0,1,negative regulation of granulocyte chemotaxis,BP,
15379,GO:0071624,1,0.834898724655644,0,16,positive regulation of granulocyte chemotaxis,BP,
15380,GO:0071625,1,0.949499592102125,0,11,vocalization behavior,BP,
15381,GO:0071629,1,0.990534128227314,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
15382,GO:0071630,1,0.9861093940777,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
15383,GO:0071633,1,0.995366528744437,0,1,dihydroceramidase activity,MF,
15384,GO:0071634,1,0.919495669798022,0,17,regulation of transforming growth factor beta production,BP,
15385,GO:0071635,1,0.971131985627163,0,6,negative regulation of transforming growth factor beta production,BP,
15386,GO:0071636,1,0.960136343729902,0,8,positive regulation of transforming growth factor beta production,BP,
15387,GO:0071637,1,0.936383322263426,0,7,regulation of monocyte chemotactic protein-1 production,BP,
15388,GO:0071638,1,0.974068853270783,0,2,negative regulation of monocyte chemotactic protein-1 production,BP,
15389,GO:0071639,1,0.961322658657795,0,5,positive regulation of monocyte chemotactic protein-1 production,BP,
15390,GO:0071640,1,0.979870743026305,0,4,regulation of macrophage inflammatory protein 1 alpha production,BP,
15391,GO:0071641,1,0.989015598459302,0,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
15392,GO:0071642,1,0.990754750243591,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
15393,GO:0071643,1,0.993619425430401,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
15394,GO:0071644,1,0.993619425430401,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
15395,GO:0071649,1,0.961301935617662,0,7,regulation of chemokine (C-C motif) ligand 5 production,BP,
15396,GO:0071650,1,0.979331372032833,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
15397,GO:0071651,1,0.981594443237064,0,4,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
15398,GO:0071655,1,0.990393048973453,0,2,regulation of granulocyte colony-stimulating factor production,BP,
15399,GO:0071656,1,0.995006922237278,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
15400,GO:0071657,1,0.995363240836546,0,1,positive regulation of granulocyte colony-stimulating factor production,BP,
15401,GO:0071658,1,0.995366990825863,0,1,regulation of IP-10 production,BP,
15402,GO:0071660,1,0.995366990825863,0,1,positive regulation of IP-10 production,BP,
15403,GO:0071664,1,0.981594748069869,0,4,catenin-TCF7L2 complex,CC,
15404,GO:0071665,1,0.995366909861015,0,1,gamma-catenin-TCF7L2 complex,CC,
15405,GO:0071670,1,0.958452794938699,0,5,smooth muscle cell chemotaxis,BP,
15406,GO:0071671,1,0.962916139237603,0,4,regulation of smooth muscle cell chemotaxis,BP,
15407,GO:0071672,1,0.967400018999296,0,3,negative regulation of smooth muscle cell chemotaxis,BP,
15408,GO:0071673,1,0.995366782686423,0,1,positive regulation of smooth muscle cell chemotaxis,BP,
15409,GO:0071674,1,0.798921419715041,0,27,mononuclear cell migration,BP,
15410,GO:0071675,1,0.865590940888674,0,20,regulation of mononuclear cell migration,BP,
15411,GO:0071676,1,0.989340671039388,0,2,negative regulation of mononuclear cell migration,BP,
15412,GO:0071677,1,0.907248753895894,0,11,positive regulation of mononuclear cell migration,BP,
15413,GO:0071678,1,0.995366990826034,0,1,olfactory bulb axon guidance,BP,
15414,GO:0071679,1,0.96341983217205,0,8,commissural neuron axon guidance,BP,
15415,GO:0071680,1,0.977046033297088,0,5,response to indole-3-methanol,BP,
15416,GO:0071681,1,0.977046033297088,0,5,cellular response to indole-3-methanol,BP,
15417,GO:0071682,1,0.926573664583884,0,8,endocytic vesicle lumen,CC,
15418,GO:0071684,1,0.995366857802029,0,1,organism emergence from protective structure,BP,
15419,GO:0071688,1,0.986164531024912,0,3,striated muscle myosin thick filament assembly,BP,
15420,GO:0071691,1,0.995366990826073,0,1,cardiac muscle thin filament assembly,BP,
15421,GO:0071692,1,0.971866645792359,0,5,protein localization to extracellular region,BP,
15422,GO:0071694,1,0.971866645792359,0,5,maintenance of protein location in extracellular region,BP,
15424,GO:0071696,1,0.93443227033482,0,11,ectodermal placode development,BP,
15425,GO:0071697,1,0.938886657509078,0,10,ectodermal placode morphogenesis,BP,
15426,GO:0071698,1,0.990755129988027,0,2,olfactory placode development,BP,
15427,GO:0071699,1,0.990755129988027,0,2,olfactory placode morphogenesis,BP,
15428,GO:0071701,1,0.995366990826165,0,1,regulation of MAPK export from nucleus,BP,
15433,GO:0071707,1,0.984777696859578,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
15434,GO:0071709,1,0.891495442977239,0,18,membrane assembly,BP,
15435,GO:0071711,1,0.928944134292759,0,15,basement membrane organization,BP,
15436,GO:0071712,1,0.917846894235242,0,11,ER-associated misfolded protein catabolic process,BP,
15437,GO:0071713,1,0.995366990826165,0,1,para-aminobenzoyl-glutamate hydrolase activity,MF,
15438,GO:0071715,1,0.875834672951164,0,19,icosanoid transport,BP,
15439,GO:0071723,1,0.986164456965655,0,3,lipopeptide binding,MF,
15440,GO:0071724,1,0.990755129483909,0,2,response to diacyl bacterial lipopeptide,BP,
15441,GO:0071725,1,0.995366920137051,0,1,response to triacyl bacterial lipopeptide,BP,
15442,GO:0071726,1,0.990755129483909,0,2,cellular response to diacyl bacterial lipopeptide,BP,
15443,GO:0071727,1,0.995366920137051,0,1,cellular response to triacyl bacterial lipopeptide,BP,
15444,GO:0071731,1,0.945601386415344,0,11,response to nitric oxide,BP,
15445,GO:0071732,1,0.950005368527094,0,10,cellular response to nitric oxide,BP,
15446,GO:0071733,1,0.979424178261011,0,3,transcriptional activation by promoter-enhancer looping,BP,
15447,GO:0071763,1,0.971463914001806,0,6,nuclear membrane organization,BP,
15448,GO:0071765,1,0.995366990826153,0,1,nuclear inner membrane organization,BP,
15452,GO:0071782,1,0.9033823692142,0,18,endoplasmic reticulum tubular network,CC,
15453,GO:0071786,1,0.916698370715367,0,15,endoplasmic reticulum tubular network organization,BP,
15454,GO:0071787,1,0.980920883467162,0,4,endoplasmic reticulum tubular network formation,BP,
15455,GO:0071789,1,0.995366574475227,0,1,spindle pole body localization to nuclear envelope,BP,
15456,GO:0071790,1,0.995366574475227,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
15457,GO:0071796,1,0.985190640677367,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
15458,GO:0071797,1,0.978643019912773,0,4,LUBAC complex,CC,
15459,GO:0071798,1,0.983925252373458,0,2,response to prostaglandin D,BP,
15460,GO:0071799,1,0.983925252373458,0,2,cellular response to prostaglandin D stimulus,BP,
15461,GO:0071800,1,0.882285505875666,0,18,podosome assembly,BP,
15462,GO:0071801,1,0.915472171333447,0,13,regulation of podosome assembly,BP,
15463,GO:0071802,1,0.995366990826139,0,1,negative regulation of podosome assembly,BP,
15464,GO:0071803,1,0.928328892362192,0,10,positive regulation of podosome assembly,BP,
15467,GO:0071806,1,0.579627853805846,0,54,protein transmembrane transport,BP,
15468,GO:0071812,1,0.995366784419756,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
15469,GO:0071813,1,0.933735939591938,0,12,lipoprotein particle binding,MF,
15470,GO:0071814,1,0.933735939591938,0,12,protein-lipid complex binding,MF,
15471,GO:0071816,1,0.973645717137902,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
15472,GO:0071817,1,0.94677879686628,0,5,MMXD complex,CC,
15473,GO:0071818,1,0.984634988929981,0,3,BAT3 complex,CC,
15474,GO:0071819,1,0.965025195001092,0,2,DUBm complex,CC,
15476,GO:0071821,1,0.995366990826059,0,1,FANCM-MHF complex,CC,
15478,GO:0071825,1,0.840841183761512,0,24,protein-lipid complex subunit organization,BP,
15480,GO:0071827,1,0.849011597569091,0,22,plasma lipoprotein particle organization,BP,
15481,GO:0071830,1,0.94167761399938,0,4,triglyceride-rich lipoprotein particle clearance,BP,
15482,GO:0071837,1,0.954094078530692,0,8,HMG box domain binding,MF,
15483,GO:0071838,1,0.966738163347606,0,4,cell proliferation in bone marrow,BP,
15484,GO:0071839,1,0.966608166106005,0,4,apoptotic process in bone marrow,BP,
15486,GO:0071847,1,0.990754994388264,0,2,TNFSF11-mediated signaling pathway,BP,
15487,GO:0071848,1,0.995366784419756,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
15488,GO:0071850,1,0.905907396300284,0,14,mitotic cell cycle arrest,BP,
15490,GO:0071863,1,0.962257516121694,0,5,regulation of cell proliferation in bone marrow,BP,
15491,GO:0071864,1,0.962257516121694,0,5,positive regulation of cell proliferation in bone marrow,BP,
15492,GO:0071865,1,0.966738092104662,0,4,regulation of apoptotic process in bone marrow,BP,
15493,GO:0071866,1,0.966738092104662,0,4,negative regulation of apoptotic process in bone marrow,BP,
15494,GO:0071867,1,0.867848053456244,0,24,response to monoamine,BP,
15495,GO:0071868,1,0.87225634070276,0,23,cellular response to monoamine stimulus,BP,
15496,GO:0071869,1,0.867848053456244,0,24,response to catecholamine,BP,
15497,GO:0071870,1,0.87225634070276,0,23,cellular response to catecholamine stimulus,BP,
15498,GO:0071871,1,0.956224654760153,0,9,response to epinephrine,BP,
15499,GO:0071872,1,0.961076420846596,0,8,cellular response to epinephrine stimulus,BP,
15500,GO:0071873,1,0.995366943385691,0,1,response to norepinephrine,BP,
15501,GO:0071874,1,0.995366943385691,0,1,cellular response to norepinephrine stimulus,BP,
15504,GO:0071878,1,0.99536699082598,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
15506,GO:0071880,1,0.961414997685435,0,8,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
15508,GO:0071885,1,0.995366574475227,0,1,N-terminal protein N-methyltransferase activity,MF,
15510,GO:0071888,1,0.933619073471777,0,8,macrophage apoptotic process,BP,
15512,GO:0071893,1,0.992054598406672,0,1,BMP signaling pathway involved in nephric duct formation,BP,
15513,GO:0071894,1,0.989804668261072,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
15514,GO:0071895,1,0.974210623435783,0,5,odontoblast differentiation,BP,
15515,GO:0071896,1,0.981594888733299,0,4,protein localization to adherens junction,BP,
15516,GO:0071897,1,0.290927967797652,0,178,DNA biosynthetic process,BP,
15517,GO:0071898,1,0.97942415396311,0,3,regulation of estrogen receptor binding,BP,
15518,GO:0071899,1,0.97942415396311,0,3,negative regulation of estrogen receptor binding,BP,
15521,GO:0071902,1,0.183976593411016,0,265,positive regulation of protein serine/threonine kinase activity,BP,
15522,GO:0071907,1,0.975401393723713,0,3,determination of digestive tract left/right asymmetry,BP,
15523,GO:0071908,1,0.995366990826153,0,1,determination of intestine left/right asymmetry,BP,
15524,GO:0071909,1,0.995366990826153,0,1,determination of stomach left/right asymmetry,BP,
15525,GO:0071910,1,0.99075519984928,0,2,determination of liver left/right asymmetry,BP,
15526,GO:0071914,1,0.995366989018618,0,1,prominosome,CC,
15527,GO:0071918,1,0.990754911598693,0,2,urea transmembrane transport,BP,
15528,GO:0071920,1,0.989263110599862,0,2,cleavage body,CC,
15529,GO:0071921,1,0.970082189307745,0,6,cohesin loading,BP,
15530,GO:0071922,1,0.974599259611318,0,5,regulation of cohesin loading,BP,
15531,GO:0071926,1,0.985941400661055,0,3,endocannabinoid signaling pathway,BP,
15532,GO:0071929,1,0.990754577179139,0,2,alpha-tubulin acetylation,BP,
15533,GO:0071930,1,0.986159678353149,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
15534,GO:0071931,1,0.981814516989232,0,2,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
15535,GO:0071933,1,0.964861526282016,0,7,Arp2/3 complex binding,MF,
15536,GO:0071934,1,0.985944456543045,0,2,thiamine transmembrane transport,BP,
15537,GO:0071936,1,0.963523860889708,0,8,coreceptor activity involved in Wnt signaling pathway,MF,
15538,GO:0071941,1,0.927085439016215,0,11,nitrogen cycle metabolic process,BP,
15539,GO:0071942,1,0.972037569631078,0,3,XPC complex,CC,
15541,GO:0071947,1,0.986164531023703,0,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
15542,GO:0071949,1,0.875926198776175,0,21,FAD binding,MF,
15543,GO:0071951,1,0.995365609716794,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
15544,GO:0071953,1,0.990701082032911,0,2,elastic fiber,CC,
15545,GO:0071955,1,0.990755199849202,0,2,recycling endosome to Golgi transport,BP,
15546,GO:0071960,1,0.976975576064918,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
15547,GO:0071962,1,0.965173618151441,0,3,mitotic sister chromatid cohesion, centromeric,BP,
15548,GO:0071963,1,0.991685419014591,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
15549,GO:0071971,1,0.965597889936212,0,6,extracellular exosome assembly,BP,
15550,GO:0071985,1,0.819846657982804,0,28,multivesicular body sorting pathway,BP,
15551,GO:0071986,1,0.97245779753621,0,6,Ragulator complex,CC,
15552,GO:0071987,1,0.981566951837719,0,4,WD40-repeat domain binding,MF,
15553,GO:0071988,1,0.995366990826059,0,1,protein localization to spindle pole body,BP,
15554,GO:0071997,1,0.995366990826099,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
15556,GO:0072003,1,0.995366989784868,0,1,kidney rudiment formation,BP,
15557,GO:0072004,1,0.995366989784868,0,1,kidney field specification,BP,
15559,GO:0072007,1,0.980584205287067,0,3,mesangial cell differentiation,BP,
15560,GO:0072008,1,0.980584205287067,0,3,glomerular mesangial cell differentiation,BP,
15562,GO:0072010,1,0.938779493460697,0,12,glomerular epithelium development,BP,
15564,GO:0072014,1,0.973122610632254,0,4,proximal tubule development,BP,
15565,GO:0072015,1,0.960315871875574,0,8,glomerular visceral epithelial cell development,BP,
15566,GO:0072017,1,0.968011170306496,0,7,distal tubule development,BP,
15567,GO:0072019,1,0.994437167450309,0,1,proximal convoluted tubule development,BP,
15568,GO:0072021,1,0.990755199848925,0,2,ascending thin limb development,BP,
15569,GO:0072025,1,0.995366989784868,0,1,distal convoluted tubule development,BP,
15571,GO:0072033,1,0.97251823607196,0,6,renal vesicle formation,BP,
15572,GO:0072034,1,0.990755199043749,0,2,renal vesicle induction,BP,
15573,GO:0072036,1,0.995366984341286,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
15574,GO:0072038,1,0.990755198812736,0,2,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
15575,GO:0072039,1,0.990755198812736,0,2,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
15576,GO:0072040,1,0.990755198812736,0,2,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
15577,GO:0072044,1,0.952333697203673,0,8,collecting duct development,BP,
15582,GO:0072053,1,0.990755138082319,0,2,renal inner medulla development,BP,
15583,GO:0072054,1,0.990755138082319,0,2,renal outer medulla development,BP,
15584,GO:0072055,1,0.995366990826164,0,1,renal cortex development,BP,
15585,GO:0072059,1,0.995366990826164,0,1,cortical collecting duct development,BP,
15586,GO:0072060,1,0.995366990404888,0,1,outer medullary collecting duct development,BP,
15587,GO:0072061,1,0.982521727329553,0,2,inner medullary collecting duct development,BP,
15588,GO:0072069,1,0.995366989784868,0,1,DCT cell differentiation,BP,
15592,GO:0072074,1,0.938777981821723,0,12,kidney mesenchyme development,BP,
15593,GO:0072075,1,0.955624999241735,0,9,metanephric mesenchyme development,BP,
15594,GO:0072076,1,0.985660688614724,0,3,nephrogenic mesenchyme development,BP,
15605,GO:0072092,1,0.990755199848874,0,2,ureteric bud invasion,BP,
15606,GO:0072093,1,0.986164524597743,0,3,metanephric renal vesicle formation,BP,
15607,GO:0072095,1,0.987457979160652,0,2,regulation of branch elongation involved in ureteric bud branching,BP,
15608,GO:0072096,1,0.992054598406672,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
15609,GO:0072097,1,0.992054598406672,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
15610,GO:0072098,1,0.992054598406672,0,1,anterior/posterior pattern specification involved in kidney development,BP,
15611,GO:0072099,1,0.992054598406672,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
15612,GO:0072100,1,0.992054598406672,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
15613,GO:0072101,1,0.992054598406672,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
15614,GO:0072102,1,0.982882413382576,0,3,glomerulus morphogenesis,BP,
15615,GO:0072103,1,0.987457979160563,0,2,glomerulus vasculature morphogenesis,BP,
15616,GO:0072104,1,0.987457979160563,0,2,glomerular capillary formation,BP,
15620,GO:0072109,1,0.947634450084147,0,9,glomerular mesangium development,BP,
15621,GO:0072110,1,0.961925743993772,0,7,glomerular mesangial cell proliferation,BP,
15622,GO:0072111,1,0.930876053903038,0,14,cell proliferation involved in kidney development,BP,
15623,GO:0072112,1,0.9431521227892,0,11,glomerular visceral epithelial cell differentiation,BP,
15624,GO:0072114,1,0.995366990826138,0,1,pronephros morphogenesis,BP,
15625,GO:0072124,1,0.961925743993772,0,7,regulation of glomerular mesangial cell proliferation,BP,
15626,GO:0072125,1,0.982882111271523,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
15627,GO:0072126,1,0.978682851537624,0,4,positive regulation of glomerular mesangial cell proliferation,BP,
15628,GO:0072127,1,0.994858500969876,0,1,renal capsule development,BP,
15629,GO:0072128,1,0.994858500969876,0,1,renal capsule morphogenesis,BP,
15630,GO:0072129,1,0.994858500969876,0,1,renal capsule formation,BP,
15631,GO:0072130,1,0.994858500969876,0,1,renal capsule specification,BP,
15632,GO:0072131,1,0.985887853115971,0,3,kidney mesenchyme morphogenesis,BP,
15634,GO:0072133,1,0.985887853115971,0,3,metanephric mesenchyme morphogenesis,BP,
15635,GO:0072134,1,0.990755199849082,0,2,nephrogenic mesenchyme morphogenesis,BP,
15636,GO:0072135,1,0.9907551733318,0,2,kidney mesenchymal cell proliferation,BP,
15637,GO:0072136,1,0.9907551733318,0,2,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
15639,GO:0072138,1,0.987457787134543,0,2,mesenchymal cell proliferation involved in ureteric bud development,BP,
15640,GO:0072139,1,0.994581861569669,0,1,glomerular parietal epithelial cell differentiation,BP,
15642,GO:0072143,1,0.980584205287067,0,3,mesangial cell development,BP,
15643,GO:0072144,1,0.980584205287067,0,3,glomerular mesangial cell development,BP,
15645,GO:0072156,1,0.990755199848837,0,2,distal tubule morphogenesis,BP,
15646,GO:0072160,1,0.953859619295425,0,10,nephron tubule epithelial cell differentiation,BP,
15647,GO:0072161,1,0.978327369762784,0,4,mesenchymal cell differentiation involved in kidney development,BP,
15648,GO:0072162,1,0.99075517281751,0,2,metanephric mesenchymal cell differentiation,BP,
15651,GO:0072166,1,0.995366684921823,0,1,posterior mesonephric tubule development,BP,
15656,GO:0072174,1,0.986164529190123,0,3,metanephric tubule formation,BP,
15658,GO:0072176,1,0.964788540897681,0,7,nephric duct development,BP,
15659,GO:0072177,1,0.990755199848925,0,2,mesonephric duct development,BP,
15660,GO:0072178,1,0.973793814905732,0,5,nephric duct morphogenesis,BP,
15661,GO:0072179,1,0.987457729225251,0,2,nephric duct formation,BP,
15662,GO:0072182,1,0.958301617123092,0,9,regulation of nephron tubule epithelial cell differentiation,BP,
15663,GO:0072183,1,0.995366964186677,0,1,negative regulation of nephron tubule epithelial cell differentiation,BP,
15664,GO:0072185,1,0.995087760842158,0,1,metanephric cap development,BP,
15665,GO:0072186,1,0.995087760842158,0,1,metanephric cap morphogenesis,BP,
15666,GO:0072189,1,0.964788423266657,0,7,ureter development,BP,
15667,GO:0072190,1,0.987457978870431,0,2,ureter urothelium development,BP,
15668,GO:0072191,1,0.987457978870431,0,2,ureter smooth muscle development,BP,
15669,GO:0072192,1,0.992054598406672,0,1,ureter epithelial cell differentiation,BP,
15670,GO:0072193,1,0.987457978870431,0,2,ureter smooth muscle cell differentiation,BP,
15671,GO:0072194,1,0.995366990826164,0,1,kidney smooth muscle tissue development,BP,
15672,GO:0072197,1,0.987457978870431,0,2,ureter morphogenesis,BP,
15673,GO:0072198,1,0.992054598406672,0,1,mesenchymal cell proliferation involved in ureter development,BP,
15674,GO:0072199,1,0.992054598406672,0,1,regulation of mesenchymal cell proliferation involved in ureter development,BP,
15675,GO:0072200,1,0.992054598406672,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
15676,GO:0072201,1,0.96928057078884,0,6,negative regulation of mesenchymal cell proliferation,BP,
15678,GO:0072203,1,0.972244886591976,0,6,cell proliferation involved in metanephros development,BP,
15679,GO:0072204,1,0.990754949088814,0,2,cell-cell signaling involved in metanephros development,BP,
15680,GO:0072205,1,0.973794059990512,0,5,metanephric collecting duct development,BP,
15682,GO:0072208,1,0.995366990826164,0,1,metanephric smooth muscle tissue development,BP,
15683,GO:0072209,1,0.995366558264269,0,1,metanephric mesangial cell differentiation,BP,
15685,GO:0072213,1,0.994858500969876,0,1,metanephric capsule development,BP,
15686,GO:0072214,1,0.995366990826164,0,1,metanephric cortex development,BP,
15689,GO:0072217,1,0.973793674675685,0,5,negative regulation of metanephros development,BP,
15690,GO:0072218,1,0.990755199848925,0,2,metanephric ascending thin limb development,BP,
15691,GO:0072219,1,0.995366990826164,0,1,metanephric cortical collecting duct development,BP,
15692,GO:0072221,1,0.995366989784868,0,1,metanephric distal convoluted tubule development,BP,
15693,GO:0072223,1,0.98616359751534,0,3,metanephric glomerular mesangium development,BP,
15694,GO:0072224,1,0.972517382694116,0,6,metanephric glomerulus development,BP,
15695,GO:0072229,1,0.994437167450309,0,1,metanephric proximal convoluted tubule development,BP,
15697,GO:0072235,1,0.986164529991618,0,3,metanephric distal tubule development,BP,
15698,GO:0072236,1,0.986164530605971,0,3,metanephric loop of Henle development,BP,
15699,GO:0072237,1,0.989829635278987,0,2,metanephric proximal tubule development,BP,
15700,GO:0072239,1,0.98616359751534,0,3,metanephric glomerulus vasculature development,BP,
15701,GO:0072240,1,0.995366989784868,0,1,metanephric DCT cell differentiation,BP,
15703,GO:0072244,1,0.995366990826125,0,1,metanephric glomerular epithelium development,BP,
15704,GO:0072248,1,0.995366990826125,0,1,metanephric glomerular visceral epithelial cell differentiation,BP,
15705,GO:0072249,1,0.995366990826125,0,1,metanephric glomerular visceral epithelial cell development,BP,
15706,GO:0072254,1,0.995366558264269,0,1,metanephric glomerular mesangial cell differentiation,BP,
15707,GO:0072255,1,0.995366558264269,0,1,metanephric glomerular mesangial cell development,BP,
15708,GO:0072257,1,0.972518276029342,0,6,metanephric nephron tubule epithelial cell differentiation,BP,
15709,GO:0072262,1,0.990754692625754,0,2,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
15710,GO:0072265,1,0.994858500969876,0,1,metanephric capsule morphogenesis,BP,
15711,GO:0072266,1,0.994858500969876,0,1,metanephric capsule formation,BP,
15712,GO:0072267,1,0.994858500969876,0,1,metanephric capsule specification,BP,
15713,GO:0072268,1,0.983020340389064,0,3,pattern specification involved in metanephros development,BP,
15714,GO:0072272,1,0.988101361371648,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
15716,GO:0072274,1,0.995366990826125,0,1,metanephric glomerular basement membrane development,BP,
15717,GO:0072278,1,0.987457978127585,0,2,metanephric comma-shaped body morphogenesis,BP,
15720,GO:0072284,1,0.978327504013082,0,4,metanephric S-shaped body morphogenesis,BP,
15721,GO:0072285,1,0.995366984341286,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
15722,GO:0072287,1,0.995366990825784,0,1,metanephric distal tubule morphogenesis,BP,
15723,GO:0072289,1,0.990755198521534,0,2,metanephric nephron tubule formation,BP,
15724,GO:0072298,1,0.986164026123543,0,3,regulation of metanephric glomerulus development,BP,
15725,GO:0072299,1,0.995366684921823,0,1,negative regulation of metanephric glomerulus development,BP,
15726,GO:0072300,1,0.990754997128938,0,2,positive regulation of metanephric glomerulus development,BP,
15727,GO:0072301,1,0.990754692625754,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
15728,GO:0072302,1,0.995366684921823,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
15729,GO:0072303,1,0.995366787173025,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
15730,GO:0072304,1,0.995366989784868,0,1,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15731,GO:0072305,1,0.995366989784868,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15732,GO:0072307,1,0.972518276029342,0,6,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
15733,GO:0072308,1,0.995366964186677,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
15734,GO:0072309,1,0.995366989784868,0,1,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
15735,GO:0072310,1,0.960315871875574,0,8,glomerular epithelial cell development,BP,
15736,GO:0072311,1,0.9431521227892,0,11,glomerular epithelial cell differentiation,BP,
15737,GO:0072312,1,0.995366990826125,0,1,metanephric glomerular epithelial cell differentiation,BP,
15738,GO:0072313,1,0.995366990826125,0,1,metanephric glomerular epithelial cell development,BP,
15739,GO:0072318,1,0.975490828999175,0,5,clathrin coat disassembly,BP,
15740,GO:0072319,1,0.970221850068998,0,6,vesicle uncoating,BP,
15741,GO:0072320,1,0.986164445165008,0,3,volume-sensitive chloride channel activity,MF,
15742,GO:0072321,1,0.885055761290168,0,10,chaperone-mediated protein transport,BP,
15743,GO:0072329,1,0.487607110650475,0,99,monocarboxylic acid catabolic process,BP,
15747,GO:0072334,1,0.974919957928035,0,2,UDP-galactose transmembrane transport,BP,
15748,GO:0072337,1,0.925942731890357,0,12,modified amino acid transport,BP,
15749,GO:0072338,1,0.977046177790488,0,5,cellular lactam metabolic process,BP,
15750,GO:0072341,1,0.654814453995234,0,51,modified amino acid binding,MF,
15751,GO:0072343,1,0.99272158279163,0,1,pancreatic stellate cell proliferation,BP,
15752,GO:0072344,1,0.97652025937001,0,4,rescue of stalled ribosome,BP,
15753,GO:0072345,1,0.975991934892203,0,5,NAADP-sensitive calcium-release channel activity,MF,
15754,GO:0072347,1,0.785312828581796,0,39,response to anesthetic,BP,
15755,GO:0072348,1,0.891860325449275,0,22,sulfur compound transport,BP,
15756,GO:0072349,1,0.959057973063336,0,9,modified amino acid transmembrane transporter activity,MF,
15757,GO:0072350,1,0.778735360549721,0,34,tricarboxylic acid metabolic process,BP,
15758,GO:0072354,1,0.991301205102377,0,1,histone kinase activity (H3-T3 specific),MF,
15759,GO:0072355,1,0.991301205102377,0,1,histone H3-T3 phosphorylation,BP,
15760,GO:0072356,1,0.995366990826125,0,1,chromosome passenger complex localization to kinetochore,BP,
15761,GO:0072357,1,0.960911989142482,0,7,PTW/PP1 phosphatase complex,CC,
15764,GO:0072361,1,0.990755199848928,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
15765,GO:0072362,1,0.99536699082602,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
15766,GO:0072363,1,0.995366990825928,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
15767,GO:0072364,1,0.9907551998489,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
15768,GO:0072365,1,0.995366990825994,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
15769,GO:0072366,1,0.995366990825928,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
15770,GO:0072367,1,0.981594540972138,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
15771,GO:0072368,1,0.990755199849149,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
15772,GO:0072369,1,0.990754848880065,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
15773,GO:0072376,1,0.871834255366073,0,22,protein activation cascade,BP,
15774,GO:0072378,1,0.951126892279565,0,7,blood coagulation, fibrin clot formation,BP,
15775,GO:0072379,1,0.984634988929981,0,3,ER membrane insertion complex,CC,
15776,GO:0072382,1,0.995366990825784,0,1,minus-end-directed vesicle transport along microtubule,BP,
15777,GO:0072383,1,0.968010832843626,0,7,plus-end-directed vesicle transport along microtubule,BP,
15778,GO:0072384,1,0.639165327962962,0,68,organelle transport along microtubule,BP,
15779,GO:0072385,1,0.981594764519074,0,4,minus-end-directed organelle transport along microtubule,BP,
15780,GO:0072386,1,0.963524350612401,0,8,plus-end-directed organelle transport along microtubule,BP,
15781,GO:0072387,1,0.988961848842433,0,2,flavin adenine dinucleotide metabolic process,BP,
15782,GO:0072388,1,0.993565389060168,0,1,flavin adenine dinucleotide biosynthetic process,BP,
15783,GO:0072389,1,0.995366989784868,0,1,flavin adenine dinucleotide catabolic process,BP,
15784,GO:0072393,1,0.950099799958024,0,11,microtubule anchoring at microtubule organizing center,BP,
15785,GO:0072395,1,0.583069216701816,0,73,signal transduction involved in cell cycle checkpoint,BP,
15786,GO:0072396,1,0.972003496445313,0,6,response to cell cycle checkpoint signaling,BP,
15787,GO:0072401,1,0.585799961186507,0,72,signal transduction involved in DNA integrity checkpoint,BP,
15788,GO:0072402,1,0.972003496445313,0,6,response to DNA integrity checkpoint signaling,BP,
15789,GO:0072413,1,0.617388260089355,0,61,signal transduction involved in mitotic cell cycle checkpoint,BP,
15790,GO:0072414,1,0.99536699082606,0,1,response to mitotic cell cycle checkpoint signaling,BP,
15791,GO:0072422,1,0.585799961186507,0,72,signal transduction involved in DNA damage checkpoint,BP,
15792,GO:0072423,1,0.972003496445313,0,6,response to DNA damage checkpoint signaling,BP,
15793,GO:0072425,1,0.949399868190423,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
15794,GO:0072428,1,0.992807703284488,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
15795,GO:0072429,1,0.985642996125541,0,3,response to intra-S DNA damage checkpoint signaling,BP,
15796,GO:0072431,1,0.620278023905295,0,60,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,
15797,GO:0072432,1,0.99536699082606,0,1,response to G1 DNA damage checkpoint signaling,BP,
15798,GO:0072434,1,0.990754879419871,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
15799,GO:0072487,1,0.976692917966422,0,5,MSL complex,CC,
15800,GO:0072488,1,0.960325802648323,0,7,ammonium transmembrane transport,BP,
15801,GO:0072492,1,0.991757258668049,0,1,host cell mitochondrial intermembrane space,CC,
15802,GO:0072497,1,0.965841490247049,0,6,mesenchymal stem cell differentiation,BP,
15803,GO:0072498,1,0.932817721428572,0,10,embryonic skeletal joint development,BP,
15804,GO:0072501,1,0.980010083717636,0,4,cellular divalent inorganic anion homeostasis,BP,
15805,GO:0072502,1,0.980010083717636,0,4,cellular trivalent inorganic anion homeostasis,BP,
15807,GO:0072505,1,0.970947714595812,0,6,divalent inorganic anion homeostasis,BP,
15808,GO:0072506,1,0.970947714595812,0,6,trivalent inorganic anion homeostasis,BP,
15810,GO:0072509,1,0.915484111443542,0,18,divalent inorganic cation transmembrane transporter activity,MF,
15811,GO:0072510,1,0.995366990826151,0,1,trivalent inorganic cation transmembrane transporter activity,MF,
15813,GO:0072512,1,0.75051384639467,0,32,trivalent inorganic cation transport,BP,
15814,GO:0072513,1,0.975138598117568,0,1,positive regulation of secondary heart field cardioblast proliferation,BP,
15815,GO:0072517,1,0.995366933567247,0,1,host cell viral assembly compartment,CC,
15816,GO:0072518,1,0.9953669908261,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
15817,GO:0072520,1,0.925512388579736,0,10,seminiferous tubule development,BP,
15820,GO:0072523,1,0.723722744121894,0,38,purine-containing compound catabolic process,BP,
15823,GO:0072526,1,0.97381451583882,0,4,pyridine-containing compound catabolic process,BP,
15826,GO:0072529,1,0.791501067294433,0,27,pyrimidine-containing compound catabolic process,BP,
15827,GO:0072530,1,0.95969229444039,0,8,purine-containing compound transmembrane transport,BP,
15828,GO:0072531,1,0.955586928489745,0,7,pyrimidine-containing compound transmembrane transport,BP,
15829,GO:0072534,1,0.995366990826007,0,1,perineuronal net,CC,
15830,GO:0072535,1,0.995366798601386,0,1,tumor necrosis factor (ligand) superfamily member 11 production,BP,
15831,GO:0072536,1,0.993653808561672,0,1,interleukin-23 receptor complex,CC,
15832,GO:0072537,1,0.975131193499017,0,5,fibroblast activation,BP,
15833,GO:0072538,1,0.941481690910747,0,9,T-helper 17 type immune response,BP,
15834,GO:0072539,1,0.951736335804012,0,7,T-helper 17 cell differentiation,BP,
15835,GO:0072540,1,0.965094542325433,0,4,T-helper 17 cell lineage commitment,BP,
15836,GO:0072542,1,0.950180386786311,0,7,protein phosphatase activator activity,MF,
15837,GO:0072545,1,0.994517404157083,0,1,tyrosine binding,MF,
15838,GO:0072546,1,0.954609681099385,0,10,ER membrane protein complex,CC,
15839,GO:0072553,1,0.966614993943275,0,4,terminal button organization,BP,
15840,GO:0072554,1,0.995081228517227,0,1,blood vessel lumenization,BP,
15841,GO:0072555,1,0.989953069159443,0,1,17-beta-ketosteroid reductase activity,MF,
15842,GO:0072556,1,0.995366990826139,0,1,other organism presynaptic membrane,CC,
15843,GO:0072557,1,0.967148862316295,0,2,IPAF inflammasome complex,CC,
15844,GO:0072558,1,0.954129045519642,0,3,NLRP1 inflammasome complex,CC,
15845,GO:0072559,1,0.930686788888619,0,6,NLRP3 inflammasome complex,CC,
15846,GO:0072560,1,0.995366783033864,0,1,type B pancreatic cell maturation,BP,
15847,GO:0072562,1,0.769752979908215,0,39,blood microparticle,CC,
15848,GO:0072563,1,0.985469130757792,0,2,endothelial microparticle,CC,
15849,GO:0072564,1,0.990798677411377,0,1,blood microparticle formation,BP,
15850,GO:0072566,1,0.987467369526126,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
15851,GO:0072567,1,0.903017174124388,0,12,chemokine (C-X-C motif) ligand 2 production,BP,
15852,GO:0072570,1,0.995366852840887,0,1,ADP-D-ribose binding,MF,
15853,GO:0072572,1,0.994441294431917,0,1,poly-ADP-D-ribose binding,MF,
15854,GO:0072573,1,0.995366990826151,0,1,tolerance induction to lipopolysaccharide,BP,
15855,GO:0072574,1,0.95153195420079,0,9,hepatocyte proliferation,BP,
15856,GO:0072575,1,0.95153195420079,0,9,epithelial cell proliferation involved in liver morphogenesis,BP,
15857,GO:0072576,1,0.947120977635616,0,10,liver morphogenesis,BP,
15858,GO:0072577,1,0.855767548796452,0,29,endothelial cell apoptotic process,BP,
15859,GO:0072578,1,0.964851500002993,0,5,neurotransmitter-gated ion channel clustering,BP,
15860,GO:0072579,1,0.995366990826152,0,1,glycine receptor clustering,BP,
15861,GO:0072582,1,0.989953069159443,0,1,17-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15862,GO:0072583,1,0.801307283978887,0,36,clathrin-dependent endocytosis,BP,
15863,GO:0072584,1,0.953819493403982,0,8,caveolin-mediated endocytosis,BP,
15864,GO:0072586,1,0.995366990826164,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
15865,GO:0072587,1,0.995366990826164,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
15866,GO:0072588,1,0.810041232259311,0,8,box H/ACA RNP complex,CC,
15867,GO:0072589,1,0.923381024573589,0,4,box H/ACA scaRNP complex,CC,
15868,GO:0072590,1,0.995366990826125,0,1,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
15869,GO:0072591,1,0.995366990826125,0,1,citrate-L-glutamate ligase activity,MF,
15870,GO:0072592,1,0.988830732345468,0,2,oxygen metabolic process,BP,
15873,GO:0072595,1,0.744720113915639,0,38,maintenance of protein localization in organelle,BP,
15875,GO:0072602,1,0.981312784015512,0,4,interleukin-4 secretion,BP,
15876,GO:0072603,1,0.98060639434743,0,4,interleukin-5 secretion,BP,
15877,GO:0072604,1,0.887228849649365,0,19,interleukin-6 secretion,BP,
15879,GO:0072608,1,0.945533901738955,0,6,interleukin-10 secretion,BP,
15880,GO:0072610,1,0.978991407243659,0,4,interleukin-12 secretion,BP,
15881,GO:0072611,1,0.974348154892599,0,5,interleukin-13 secretion,BP,
15882,GO:0072615,1,0.993619425430401,0,1,interleukin-17 secretion,BP,
15883,GO:0072616,1,0.995366990822582,0,1,interleukin-18 secretion,BP,
15884,GO:0072619,1,0.995366962840291,0,1,interleukin-21 secretion,BP,
15885,GO:0072641,1,0.972518192384808,0,6,type I interferon secretion,BP,
15886,GO:0072642,1,0.972518192384808,0,6,interferon-alpha secretion,BP,
15889,GO:0072656,1,0.956127885073885,0,5,maintenance of protein location in mitochondrion,BP,
15891,GO:0072658,1,0.995366990825942,0,1,maintenance of protein location in membrane,BP,
15893,GO:0072660,1,0.995366990825942,0,1,maintenance of protein location in plasma membrane,BP,
15894,GO:0072662,1,0.90776480546654,0,17,protein localization to peroxisome,BP,
15895,GO:0072663,1,0.90776480546654,0,17,establishment of protein localization to peroxisome,BP,
15896,GO:0072665,1,0.717500938666929,0,52,protein localization to vacuole,BP,
15897,GO:0072666,1,0.767973069240435,0,40,establishment of protein localization to vacuole,BP,
15898,GO:0072669,1,0.910219828792421,0,7,tRNA-splicing ligase complex,CC,
15899,GO:0072671,1,0.995311345297819,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
15900,GO:0072672,1,0.981594326441719,0,4,neutrophil extravasation,BP,
15901,GO:0072673,1,0.924524971859654,0,15,lamellipodium morphogenesis,BP,
15902,GO:0072674,1,0.980698016233715,0,4,multinuclear osteoclast differentiation,BP,
15903,GO:0072675,1,0.980698016233715,0,4,osteoclast fusion,BP,
15905,GO:0072677,1,0.953433476118696,0,6,eosinophil migration,BP,
15907,GO:0072679,1,0.96692508958314,0,3,thymocyte migration,BP,
15908,GO:0072680,1,0.995366798601386,0,1,extracellular matrix-dependent thymocyte migration,BP,
15909,GO:0072681,1,0.995366798601386,0,1,fibronectin-dependent thymocyte migration,BP,
15910,GO:0072682,1,0.995366924770142,0,1,eosinophil extravasation,BP,
15911,GO:0072683,1,0.985950783532134,0,2,T cell extravasation,BP,
15912,GO:0072684,1,0.995366988328917,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
15913,GO:0072686,1,0.589351888541209,0,88,mitotic spindle,CC,
15914,GO:0072687,1,0.979075876727167,0,4,meiotic spindle,CC,
15915,GO:0072695,1,0.989722517080882,0,2,regulation of DNA recombination at telomere,BP,
15916,GO:0072697,1,0.938887626137732,0,11,protein localization to cell cortex,BP,
15918,GO:0072702,1,0.995366990826138,0,1,response to methyl methanesulfonate,BP,
15919,GO:0072703,1,0.995366990826138,0,1,cellular response to methyl methanesulfonate,BP,
15920,GO:0072706,1,0.995322435700509,0,1,response to sodium dodecyl sulfate,BP,
15921,GO:0072707,1,0.995322435700509,0,1,cellular response to sodium dodecyl sulfate,BP,
15922,GO:0072708,1,0.979264736730924,0,4,response to sorbitol,BP,
15923,GO:0072709,1,0.988411867613281,0,2,cellular response to sorbitol,BP,
15924,GO:0072710,1,0.958507871294943,0,9,response to hydroxyurea,BP,
15925,GO:0072711,1,0.96297166744694,0,8,cellular response to hydroxyurea,BP,
15926,GO:0072714,1,0.991623094338587,0,1,response to selenite ion,BP,
15927,GO:0072715,1,0.991623094338587,0,1,cellular response to selenite ion,BP,
15928,GO:0072716,1,0.956283613906476,0,4,response to actinomycin D,BP,
15929,GO:0072717,1,0.960737163985913,0,3,cellular response to actinomycin D,BP,
15930,GO:0072718,1,0.952151709600219,0,9,response to cisplatin,BP,
15931,GO:0072719,1,0.966042023490781,0,6,cellular response to cisplatin,BP,
15932,GO:0072720,1,0.995366574475227,0,1,response to dithiothreitol,BP,
15933,GO:0072733,1,0.979800494332858,0,3,response to staurosporine,BP,
15934,GO:0072734,1,0.979800494332858,0,3,cellular response to staurosporine,BP,
15935,GO:0072737,1,0.989871329581766,0,2,response to diamide,BP,
15936,GO:0072738,1,0.989871329581766,0,2,cellular response to diamide,BP,
15937,GO:0072739,1,0.988411460176913,0,2,response to anisomycin,BP,
15938,GO:0072740,1,0.993012882178686,0,1,cellular response to anisomycin,BP,
15939,GO:0072741,1,0.985471120542398,0,3,protein localization to cell division site,BP,
15940,GO:0072749,1,0.992298730129102,0,1,cellular response to cytochalasin B,BP,
15942,GO:0072752,1,0.995366990826085,0,1,cellular response to rapamycin,BP,
15943,GO:0072755,1,0.99536698562297,0,1,cellular response to benomyl,BP,
15944,GO:0072757,1,0.981032017946732,0,4,cellular response to camptothecin,BP,
15945,GO:0075044,1,0.98159475445237,0,4,autophagy of host cells involved in interaction with symbiont,BP,
15946,GO:0075071,1,0.98159475445237,0,4,autophagy involved in symbiotic interaction,BP,
15947,GO:0075109,1,0.995366990826151,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
15948,GO:0075111,1,0.995366990826151,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
15949,GO:0075112,1,0.995366990826151,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15950,GO:0075114,1,0.995366990826151,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15951,GO:0075136,1,0.960701415682263,0,6,response to host,BP,
15952,GO:0075341,1,0.994945567116479,0,1,host cell PML body,CC,
15953,GO:0075509,1,0.986155199424776,0,3,endocytosis involved in viral entry into host cell,BP,
15954,GO:0075519,1,0.972587291990339,0,1,microtubule-dependent intracellular transport of viral material,BP,
15955,GO:0075521,1,0.972587291990339,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
15956,GO:0075522,1,0.937880731692904,0,10,IRES-dependent viral translational initiation,BP,
15957,GO:0075525,1,0.960430698405464,0,5,viral translational termination-reinitiation,BP,
15958,GO:0075528,1,0.978518622522356,0,3,modulation by virus of host immune response,BP,
15959,GO:0075606,1,0.972587291990339,0,1,transport of viral material towards nucleus,BP,
15960,GO:0075713,1,0.943080292660492,0,8,establishment of integrated proviral latency,BP,
15961,GO:0075732,1,0.990755199849267,0,2,viral penetration into host nucleus,BP,
15962,GO:0075733,1,0.677938190497954,0,52,intracellular transport of virus,BP,
15963,GO:0080008,1,0.824364732737828,0,32,Cul4-RING E3 ubiquitin ligase complex,CC,
15964,GO:0080009,1,0.945084977275147,0,10,mRNA methylation,BP,
15965,GO:0080019,1,0.989664330656425,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
15966,GO:0080023,1,0.990754370961523,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
15968,GO:0080058,1,0.986385579863497,0,1,protein deglutathionylation,BP,
15969,GO:0080084,1,0.973585373272598,0,5,5S rDNA binding,MF,
15971,GO:0080101,1,0.979334613632256,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
15972,GO:0080111,1,0.869291548573263,0,19,DNA demethylation,BP,
15973,GO:0080120,1,0.983597583263327,0,2,CAAX-box protein maturation,BP,
15974,GO:0080121,1,0.990257045343042,0,2,AMP transport,BP,
15975,GO:0080122,1,0.985610701784583,0,3,AMP transmembrane transporter activity,MF,
15976,GO:0080129,1,0.981394638666294,0,1,proteasome core complex assembly,BP,
15979,GO:0080144,1,0.988365746762485,0,2,amino acid homeostasis,BP,
15980,GO:0080146,1,0.991669902477171,0,1,L-cysteine desulfhydrase activity,MF,
15981,GO:0080147,1,0.974537838279069,0,1,root hair cell development,BP,
15982,GO:0080154,1,0.954818771909534,0,6,regulation of fertilization,BP,
15983,GO:0080163,1,0.995142121075209,0,1,regulation of protein serine/threonine phosphatase activity,BP,
15986,GO:0080184,1,0.990314506107293,0,2,response to phenylpropanoid,BP,
15987,GO:0085020,1,0.931248531134974,0,7,protein K6-linked ubiquitination,BP,
15988,GO:0085029,1,0.88766899950457,0,25,extracellular matrix assembly,BP,
15989,GO:0085032,1,0.995366871729712,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
15990,GO:0086001,1,0.828273536215317,0,35,cardiac muscle cell action potential,BP,
15991,GO:0086002,1,0.894180713776611,0,24,cardiac muscle cell action potential involved in contraction,BP,
15992,GO:0086003,1,0.865625109128924,0,29,cardiac muscle cell contraction,BP,
15993,GO:0086004,1,0.885039459263869,0,20,regulation of cardiac muscle cell contraction,BP,
15994,GO:0086005,1,0.932384089675586,0,15,ventricular cardiac muscle cell action potential,BP,
15995,GO:0086006,1,0.990755199849292,0,2,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
15996,GO:0086007,1,0.990755198478465,0,2,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
15997,GO:0086008,1,0.995366576678913,0,1,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
15998,GO:0086009,1,0.90374152310616,0,20,membrane repolarization,BP,
15999,GO:0086010,1,0.888466327269892,0,20,membrane depolarization during action potential,BP,
16000,GO:0086011,1,0.949583726906853,0,10,membrane repolarization during action potential,BP,
16001,GO:0086012,1,0.931392788372723,0,11,membrane depolarization during cardiac muscle cell action potential,BP,
16002,GO:0086013,1,0.962924999311034,0,7,membrane repolarization during cardiac muscle cell action potential,BP,
16003,GO:0086014,1,0.954612517904733,0,10,atrial cardiac muscle cell action potential,BP,
16004,GO:0086015,1,0.990755017229297,0,2,SA node cell action potential,BP,
16005,GO:0086016,1,0.976927068524574,0,5,AV node cell action potential,BP,
16006,GO:0086017,1,0.990755017229415,0,2,Purkinje myocyte action potential,BP,
16007,GO:0086018,1,0.990755017229297,0,2,SA node cell to atrial cardiac muscle cell signaling,BP,
16008,GO:0086019,1,0.914124543801677,0,15,cell-cell signaling involved in cardiac conduction,BP,
16009,GO:0086020,1,0.990755017229312,0,2,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
16010,GO:0086021,1,0.990755017229312,0,2,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
16011,GO:0086023,1,0.981594888732832,0,4,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
16012,GO:0086024,1,0.99536699082602,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
16013,GO:0086026,1,0.954612517904733,0,10,atrial cardiac muscle cell to AV node cell signaling,BP,
16014,GO:0086027,1,0.976927068524574,0,5,AV node cell to bundle of His cell signaling,BP,
16015,GO:0086028,1,0.962185410282181,0,4,bundle of His cell to Purkinje myocyte signaling,BP,
16016,GO:0086029,1,0.990755017229415,0,2,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
16017,GO:0086036,1,0.981594477604744,0,4,regulation of cardiac muscle cell membrane potential,BP,
16018,GO:0086038,1,0.995366574475227,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16019,GO:0086039,1,0.995366990826007,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
16020,GO:0086040,1,0.995366990826165,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16021,GO:0086042,1,0.972399839985071,0,6,cardiac muscle cell-cardiac muscle cell adhesion,BP,
16022,GO:0086043,1,0.962185410282181,0,4,bundle of His cell action potential,BP,
16023,GO:0086044,1,0.995366807366016,0,1,atrial cardiac muscle cell to AV node cell communication by electrical coupling,BP,
16024,GO:0086045,1,0.990755199849254,0,2,membrane depolarization during AV node cell action potential,BP,
16025,GO:0086046,1,0.99536699082602,0,1,membrane depolarization during SA node cell action potential,BP,
16026,GO:0086047,1,0.995366990826138,0,1,membrane depolarization during Purkinje myocyte cell action potential,BP,
16027,GO:0086048,1,0.990755198478467,0,2,membrane depolarization during bundle of His cell action potential,BP,
16028,GO:0086053,1,0.990755017229312,0,2,AV node cell to bundle of His cell communication by electrical coupling,BP,
16029,GO:0086054,1,0.995366807366016,0,1,bundle of His cell to Purkinje myocyte communication by electrical coupling,BP,
16030,GO:0086055,1,0.995366807366016,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,BP,
16031,GO:0086056,1,0.995366990826139,0,1,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
16032,GO:0086057,1,0.995366989449049,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
16033,GO:0086064,1,0.89958873033019,0,16,cell communication by electrical coupling involved in cardiac conduction,BP,
16034,GO:0086065,1,0.822246392753466,0,31,cell communication involved in cardiac conduction,BP,
16035,GO:0086066,1,0.954612517904733,0,10,atrial cardiac muscle cell to AV node cell communication,BP,
16036,GO:0086067,1,0.972399739828262,0,6,AV node cell to bundle of His cell communication,BP,
16037,GO:0086068,1,0.990755017229415,0,2,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
16038,GO:0086069,1,0.940089814026852,0,9,bundle of His cell to Purkinje myocyte communication,BP,
16039,GO:0086070,1,0.986164349240124,0,3,SA node cell to atrial cardiac muscle cell communication,BP,
16040,GO:0086072,1,0.995245857419641,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
16041,GO:0086073,1,0.977046098298491,0,5,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
16042,GO:0086075,1,0.986164142658253,0,3,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
16043,GO:0086076,1,0.995366807366016,0,1,gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,MF,
16044,GO:0086077,1,0.990755017229312,0,2,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
16045,GO:0086078,1,0.995366807366016,0,1,gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,MF,
16046,GO:0086079,1,0.995366807366016,0,1,gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,MF,
16047,GO:0086080,1,0.963407307098311,0,8,protein binding involved in heterotypic cell-cell adhesion,MF,
16048,GO:0086082,1,0.995245857419641,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
16049,GO:0086083,1,0.977046098298491,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
16050,GO:0086089,1,0.995366576678913,0,1,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
16051,GO:0086091,1,0.921479603884759,0,17,regulation of heart rate by cardiac conduction,BP,
16052,GO:0086092,1,0.995366990826165,0,1,regulation of the force of heart contraction by cardiac conduction,BP,
16054,GO:0086098,1,0.990745983643647,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
16055,GO:0086100,1,0.995366988506712,0,1,endothelin receptor signaling pathway,BP,
16057,GO:0089700,1,0.981594718391069,0,4,protein kinase D signaling,BP,
16058,GO:0089701,1,0.933637771618239,0,5,U2AF,CC,
16059,GO:0089709,1,0.990485707633011,0,2,L-histidine transmembrane transport,BP,
16060,GO:0089717,1,0.976951388261936,0,5,spanning component of membrane,CC,
16061,GO:0089718,1,0.946153040857544,0,11,amino acid import across plasma membrane,BP,
16062,GO:0089720,1,0.940100534067491,0,6,caspase binding,MF,
16063,GO:0090009,1,0.981594876519895,0,4,primitive streak formation,BP,
16064,GO:0090022,1,0.838659581360667,0,18,regulation of neutrophil chemotaxis,BP,
16065,GO:0090023,1,0.851703825170918,0,15,positive regulation of neutrophil chemotaxis,BP,
16066,GO:0090024,1,0.995366990826165,0,1,negative regulation of neutrophil chemotaxis,BP,
16067,GO:0090025,1,0.918364855227801,0,11,regulation of monocyte chemotaxis,BP,
16068,GO:0090026,1,0.932592411274654,0,8,positive regulation of monocyte chemotaxis,BP,
16069,GO:0090027,1,0.989340671039388,0,2,negative regulation of monocyte chemotaxis,BP,
16070,GO:0090030,1,0.967925842190885,0,7,regulation of steroid hormone biosynthetic process,BP,
16071,GO:0090031,1,0.990669554368605,0,2,positive regulation of steroid hormone biosynthetic process,BP,
16072,GO:0090032,1,0.981593238575465,0,4,negative regulation of steroid hormone biosynthetic process,BP,
16073,GO:0090034,1,0.985430739888604,0,2,regulation of chaperone-mediated protein complex assembly,BP,
16074,GO:0090035,1,0.985430739888604,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
16075,GO:0090036,1,0.944174382000689,0,11,regulation of protein kinase C signaling,BP,
16076,GO:0090037,1,0.966365013263867,0,6,positive regulation of protein kinase C signaling,BP,
16077,GO:0090038,1,0.99075497991632,0,2,negative regulation of protein kinase C signaling,BP,
16078,GO:0090042,1,0.940547069986675,0,9,tubulin deacetylation,BP,
16079,GO:0090043,1,0.951212590930377,0,7,regulation of tubulin deacetylation,BP,
16080,GO:0090044,1,0.99001803076833,0,1,positive regulation of tubulin deacetylation,BP,
16081,GO:0090045,1,0.955049458961868,0,7,positive regulation of deacetylase activity,BP,
16082,GO:0090049,1,0.83693431475414,0,28,regulation of cell migration involved in sprouting angiogenesis,BP,
16083,GO:0090050,1,0.90347443809568,0,15,positive regulation of cell migration involved in sprouting angiogenesis,BP,
16084,GO:0090051,1,0.92643361891287,0,13,negative regulation of cell migration involved in sprouting angiogenesis,BP,
16085,GO:0090063,1,0.981338143654569,0,4,positive regulation of microtubule nucleation,BP,
16086,GO:0090065,1,0.961814214726214,0,1,regulation of production of siRNA involved in RNA interference,BP,
16088,GO:0090067,1,0.995366990826164,0,1,regulation of thalamus size,BP,
16089,GO:0090068,1,0.211812184670173,0,220,positive regulation of cell cycle process,BP,
16090,GO:0090069,1,0.916278252959923,0,13,regulation of ribosome biogenesis,BP,
16091,GO:0090070,1,0.937821383031194,0,8,positive regulation of ribosome biogenesis,BP,
16092,GO:0090071,1,0.98159402114868,0,4,negative regulation of ribosome biogenesis,BP,
16093,GO:0090073,1,0.943136843891629,0,8,positive regulation of protein homodimerization activity,BP,
16094,GO:0090074,1,0.963463520009795,0,5,negative regulation of protein homodimerization activity,BP,
16096,GO:0090077,1,0.866071156364167,0,20,foam cell differentiation,BP,
16097,GO:0090079,1,0.886862233752262,0,17,translation regulator activity, nucleic acid binding,MF,
16098,GO:0090080,1,0.990755199849227,0,2,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
16099,GO:0090081,1,0.992243492218644,0,1,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
16100,GO:0090082,1,0.992243492218644,0,1,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
16101,GO:0090083,1,0.917887071436905,0,14,regulation of inclusion body assembly,BP,
16102,GO:0090084,1,0.951475082917237,0,10,negative regulation of inclusion body assembly,BP,
16104,GO:0090086,1,0.95707729520956,0,3,negative regulation of protein deubiquitination,BP,
16106,GO:0090088,1,0.986218899932089,0,2,regulation of oligopeptide transport,BP,
16107,GO:0090089,1,0.986218899932089,0,2,regulation of dipeptide transport,BP,
16109,GO:0090091,1,0.981591174414942,0,4,positive regulation of extracellular matrix disassembly,BP,
16111,GO:0090094,1,0.995087760842158,0,1,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
16112,GO:0090095,1,0.995087760842158,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
16113,GO:0090096,1,0.995087760842158,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
16115,GO:0090101,1,0.632132852615285,0,73,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
16117,GO:0090103,1,0.93803424801905,0,12,cochlea morphogenesis,BP,
16118,GO:0090107,1,0.975963927343939,0,3,regulation of high-density lipoprotein particle assembly,BP,
16119,GO:0090108,1,0.994126856148616,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
16120,GO:0090109,1,0.78144707383559,0,44,regulation of cell-substrate junction assembly,BP,
16121,GO:0090110,1,0.934401307172663,0,13,cargo loading into COPII-coated vesicle,BP,
16122,GO:0090113,1,0.994551950924641,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
16123,GO:0090114,1,0.626723548233048,0,63,COPII-coated vesicle budding,BP,
16124,GO:0090116,1,0.98616453094333,0,3,C-5 methylation of cytosine,BP,
16125,GO:0090118,1,0.972222506141654,0,5,receptor-mediated endocytosis involved in cholesterol transport,BP,
16126,GO:0090119,1,0.995366990826164,0,1,vesicle-mediated cholesterol transport,BP,
16127,GO:0090128,1,0.96818623215346,0,6,regulation of synapse maturation,BP,
16128,GO:0090129,1,0.972694168637198,0,5,positive regulation of synapse maturation,BP,
16130,GO:0090131,1,0.989735620720775,0,1,mesenchyme migration,BP,
16132,GO:0090135,1,0.983167623142466,0,3,actin filament branching,BP,
16133,GO:0090136,1,0.945007780283673,0,12,epithelial cell-cell adhesion,BP,
16134,GO:0090138,1,0.995366977905984,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
16135,GO:0090140,1,0.881054724007216,0,19,regulation of mitochondrial fission,BP,
16136,GO:0090141,1,0.907121096549609,0,13,positive regulation of mitochondrial fission,BP,
16137,GO:0090148,1,0.940891921243802,0,12,membrane fission,BP,
16138,GO:0090149,1,0.990407593377822,0,2,mitochondrial membrane fission,BP,
16140,GO:0090151,1,0.827942075019311,0,12,establishment of protein localization to mitochondrial membrane,BP,
16141,GO:0090153,1,0.914950666180684,0,13,regulation of sphingolipid biosynthetic process,BP,
16142,GO:0090154,1,0.953838127311635,0,8,positive regulation of sphingolipid biosynthetic process,BP,
16143,GO:0090155,1,0.970280400693854,0,4,negative regulation of sphingolipid biosynthetic process,BP,
16144,GO:0090156,1,0.97479797278145,0,3,cellular sphingolipid homeostasis,BP,
16145,GO:0090158,1,0.975563933381874,0,5,endoplasmic reticulum membrane organization,BP,
16146,GO:0090160,1,0.960749126687818,0,8,Golgi to lysosome transport,BP,
16147,GO:0090161,1,0.949100114957471,0,11,Golgi ribbon formation,BP,
16149,GO:0090164,1,0.990746606223693,0,2,asymmetric Golgi ribbon formation,BP,
16150,GO:0090166,1,0.961644998597028,0,6,Golgi disassembly,BP,
16151,GO:0090168,1,0.970646416579077,0,4,Golgi reassembly,BP,
16152,GO:0090169,1,0.860726747768216,0,25,regulation of spindle assembly,BP,
16153,GO:0090170,1,0.975337013627246,0,4,regulation of Golgi inheritance,BP,
16154,GO:0090174,1,0.450739196379401,0,126,organelle membrane fusion,BP,
16155,GO:0090175,1,0.383100269730332,0,101,regulation of establishment of planar polarity,BP,
16156,GO:0090176,1,0.995366990826138,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
16157,GO:0090177,1,0.939728579196655,0,13,establishment of planar polarity involved in neural tube closure,BP,
16158,GO:0090178,1,0.939728579196655,0,13,regulation of establishment of planar polarity involved in neural tube closure,BP,
16159,GO:0090179,1,0.944105525947054,0,12,planar cell polarity pathway involved in neural tube closure,BP,
16160,GO:0090181,1,0.729685399399178,0,49,regulation of cholesterol metabolic process,BP,
16161,GO:0090182,1,0.983633407078965,0,2,regulation of secretion of lysosomal enzymes,BP,
16164,GO:0090185,1,0.954646433406617,0,9,negative regulation of kidney development,BP,
16165,GO:0090186,1,0.970021696854439,0,5,regulation of pancreatic juice secretion,BP,
16166,GO:0090187,1,0.994126856148616,0,1,positive regulation of pancreatic juice secretion,BP,
16167,GO:0090188,1,0.975754055464748,0,4,negative regulation of pancreatic juice secretion,BP,
16170,GO:0090191,1,0.98620257734085,0,2,negative regulation of branching involved in ureteric bud morphogenesis,BP,
16171,GO:0090192,1,0.950729480929332,0,9,regulation of glomerulus development,BP,
16172,GO:0090193,1,0.967293797392241,0,6,positive regulation of glomerulus development,BP,
16173,GO:0090194,1,0.982882111271523,0,3,negative regulation of glomerulus development,BP,
16174,GO:0090195,1,0.940805907639109,0,9,chemokine secretion,BP,
16175,GO:0090196,1,0.949590162420763,0,7,regulation of chemokine secretion,BP,
16176,GO:0090197,1,0.954012916424305,0,6,positive regulation of chemokine secretion,BP,
16177,GO:0090198,1,0.995366558830144,0,1,negative regulation of chemokine secretion,BP,
16178,GO:0090199,1,0.676655374315505,0,40,regulation of release of cytochrome c from mitochondria,BP,
16179,GO:0090200,1,0.761795921550955,0,27,positive regulation of release of cytochrome c from mitochondria,BP,
16180,GO:0090201,1,0.883808252245213,0,14,negative regulation of release of cytochrome c from mitochondria,BP,
16181,GO:0090202,1,0.979424178261011,0,3,gene looping,BP,
16182,GO:0090204,1,0.960634308905574,0,3,protein localization to nuclear pore,BP,
16183,GO:0090205,1,0.972433538264947,0,6,positive regulation of cholesterol metabolic process,BP,
16184,GO:0090206,1,0.945371668120675,0,5,negative regulation of cholesterol metabolic process,BP,
16185,GO:0090207,1,0.877770433033604,0,19,regulation of triglyceride metabolic process,BP,
16186,GO:0090208,1,0.94164892093013,0,11,positive regulation of triglyceride metabolic process,BP,
16187,GO:0090209,1,0.969066018294451,0,4,negative regulation of triglyceride metabolic process,BP,
16188,GO:0090210,1,0.990754785405301,0,2,regulation of establishment of blood-brain barrier,BP,
16189,GO:0090212,1,0.995366990826138,0,1,negative regulation of establishment of blood-brain barrier,BP,
16190,GO:0090214,1,0.973155053614939,0,2,spongiotrophoblast layer developmental growth,BP,
16191,GO:0090218,1,0.907406733246753,0,19,positive regulation of lipid kinase activity,BP,
16192,GO:0090219,1,0.981429226167703,0,4,negative regulation of lipid kinase activity,BP,
16193,GO:0090220,1,0.963372464010595,0,8,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
16194,GO:0090222,1,0.990755199849084,0,2,centrosome-templated microtubule nucleation,BP,
16195,GO:0090224,1,0.802443600236648,0,38,regulation of spindle organization,BP,
16196,GO:0090226,1,0.975688488005749,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
16197,GO:0090230,1,0.981594123450609,0,4,regulation of centromere complex assembly,BP,
16198,GO:0090231,1,0.913250980485417,0,14,regulation of spindle checkpoint,BP,
16199,GO:0090232,1,0.951297207620445,0,8,positive regulation of spindle checkpoint,BP,
16200,GO:0090233,1,0.995359034839364,0,1,negative regulation of spindle checkpoint,BP,
16201,GO:0090234,1,0.986163762219126,0,3,regulation of kinetochore assembly,BP,
16202,GO:0090235,1,0.967146743725121,0,7,regulation of metaphase plate congression,BP,
16203,GO:0090237,1,0.951451246672361,0,5,regulation of arachidonic acid secretion,BP,
16204,GO:0090238,1,0.955882151246275,0,4,positive regulation of arachidonic acid secretion,BP,
16205,GO:0090239,1,0.919718093535911,0,11,regulation of histone H4 acetylation,BP,
16206,GO:0090240,1,0.937193663200458,0,7,positive regulation of histone H4 acetylation,BP,
16207,GO:0090241,1,0.970601785947592,0,4,negative regulation of histone H4 acetylation,BP,
16208,GO:0090244,1,0.983069580701846,0,3,Wnt signaling pathway involved in somitogenesis,BP,
16209,GO:0090245,1,0.981561424327153,0,4,axis elongation involved in somitogenesis,BP,
16210,GO:0090246,1,0.995366990826164,0,1,convergent extension involved in somitogenesis,BP,
16211,GO:0090247,1,0.995333062328682,0,1,cell motility involved in somitogenic axis elongation,BP,
16212,GO:0090249,1,0.995333062328682,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
16213,GO:0090251,1,0.995366990825876,0,1,protein localization involved in establishment of planar polarity,BP,
16215,GO:0090258,1,0.990744133304567,0,2,negative regulation of mitochondrial fission,BP,
16216,GO:0090259,1,0.986057598587148,0,3,regulation of retinal ganglion cell axon guidance,BP,
16217,GO:0090260,1,0.995366990826165,0,1,negative regulation of retinal ganglion cell axon guidance,BP,
16218,GO:0090261,1,0.963895129283794,0,4,positive regulation of inclusion body assembly,BP,
16219,GO:0090263,1,0.36303600266033,0,110,positive regulation of canonical Wnt signaling pathway,BP,
16220,GO:0090266,1,0.917506108034496,0,13,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16221,GO:0090267,1,0.955727516255324,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16222,GO:0090269,1,0.986164531023546,0,3,fibroblast growth factor production,BP,
16223,GO:0090270,1,0.986164531023546,0,3,regulation of fibroblast growth factor production,BP,
16224,GO:0090271,1,0.990755199849097,0,2,positive regulation of fibroblast growth factor production,BP,
16225,GO:0090272,1,0.995366990826138,0,1,negative regulation of fibroblast growth factor production,BP,
16227,GO:0090277,1,0.700980646432427,0,53,positive regulation of peptide hormone secretion,BP,
16228,GO:0090278,1,0.828975807825094,0,24,negative regulation of peptide hormone secretion,BP,
16229,GO:0090279,1,0.926714458721598,0,14,regulation of calcium ion import,BP,
16230,GO:0090280,1,0.96897249090753,0,5,positive regulation of calcium ion import,BP,
16231,GO:0090281,1,0.984635671052019,0,3,negative regulation of calcium ion import,BP,
16232,GO:0090283,1,0.981992029616587,0,3,regulation of protein glycosylation in Golgi,BP,
16233,GO:0090284,1,0.99536699082606,0,1,positive regulation of protein glycosylation in Golgi,BP,
16234,GO:0090285,1,0.986563498089853,0,2,negative regulation of protein glycosylation in Golgi,BP,
16235,GO:0090286,1,0.97704576141478,0,5,cytoskeletal anchoring at nuclear membrane,BP,
16237,GO:0090288,1,0.5635596083133,0,94,negative regulation of cellular response to growth factor stimulus,BP,
16238,GO:0090289,1,0.975761938971529,0,2,regulation of osteoclast proliferation,BP,
16239,GO:0090290,1,0.98030473570046,0,1,positive regulation of osteoclast proliferation,BP,
16240,GO:0090291,1,0.995366990826151,0,1,negative regulation of osteoclast proliferation,BP,
16241,GO:0090292,1,0.98616452335288,0,3,nuclear matrix anchoring at nuclear membrane,BP,
16242,GO:0090296,1,0.97132484807152,0,4,regulation of mitochondrial DNA replication,BP,
16243,GO:0090297,1,0.984958114879921,0,1,positive regulation of mitochondrial DNA replication,BP,
16244,GO:0090298,1,0.986160926272627,0,3,negative regulation of mitochondrial DNA replication,BP,
16245,GO:0090299,1,0.990763118632652,0,1,regulation of neural crest formation,BP,
16246,GO:0090301,1,0.990763118632652,0,1,negative regulation of neural crest formation,BP,
16247,GO:0090303,1,0.816169659432266,0,29,positive regulation of wound healing,BP,
16250,GO:0090306,1,0.980226811240746,0,4,spindle assembly involved in meiosis,BP,
16251,GO:0090307,1,0.706416961450393,0,61,mitotic spindle assembly,BP,
16252,GO:0090308,1,0.963523807254734,0,8,regulation of methylation-dependent chromatin silencing,BP,
16253,GO:0090309,1,0.981594557277047,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
16254,GO:0090310,1,0.990754647074187,0,2,negative regulation of methylation-dependent chromatin silencing,BP,
16255,GO:0090311,1,0.806243252364152,0,33,regulation of protein deacetylation,BP,
16256,GO:0090312,1,0.888910945579291,0,19,positive regulation of protein deacetylation,BP,
16257,GO:0090313,1,0.831976574570962,0,27,regulation of protein targeting to membrane,BP,
16258,GO:0090314,1,0.847726298851327,0,23,positive regulation of protein targeting to membrane,BP,
16259,GO:0090315,1,0.978787988662925,0,4,negative regulation of protein targeting to membrane,BP,
16261,GO:0090317,1,0.794677279056199,0,29,negative regulation of intracellular protein transport,BP,
16262,GO:0090322,1,0.837747730137406,0,19,regulation of superoxide metabolic process,BP,
16263,GO:0090323,1,0.969297794369347,0,1,prostaglandin secretion involved in immune response,BP,
16264,GO:0090324,1,0.974218800918701,0,5,negative regulation of oxidative phosphorylation,BP,
16266,GO:0090326,1,0.995366879233504,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
16268,GO:0090329,1,0.765725811914761,0,43,regulation of DNA-dependent DNA replication,BP,
16269,GO:0090330,1,0.917158712243249,0,16,regulation of platelet aggregation,BP,
16270,GO:0090331,1,0.947501516541884,0,9,negative regulation of platelet aggregation,BP,
16271,GO:0090335,1,0.953772624313484,0,8,regulation of brown fat cell differentiation,BP,
16272,GO:0090336,1,0.976741477189978,0,3,positive regulation of brown fat cell differentiation,BP,
16273,GO:0090340,1,0.994126856148616,0,1,positive regulation of secretion of lysosomal enzymes,BP,
16274,GO:0090341,1,0.989445267984401,0,1,negative regulation of secretion of lysosomal enzymes,BP,
16276,GO:0090343,1,0.909230221001407,0,10,positive regulation of cell aging,BP,
16278,GO:0090345,1,0.995280951782955,0,1,cellular organohalogen metabolic process,BP,
16279,GO:0090346,1,0.995280951782955,0,1,cellular organofluorine metabolic process,BP,
16280,GO:0090360,1,0.983851153677338,0,3,platelet-derived growth factor production,BP,
16281,GO:0090361,1,0.983851153677338,0,3,regulation of platelet-derived growth factor production,BP,
16282,GO:0090362,1,0.989689383606023,0,2,positive regulation of platelet-derived growth factor production,BP,
16283,GO:0090365,1,0.994603807741999,0,1,regulation of mRNA modification,BP,
16284,GO:0090367,1,0.994603807741999,0,1,negative regulation of mRNA modification,BP,
16285,GO:0090370,1,0.995366990826152,0,1,negative regulation of cholesterol efflux,BP,
16286,GO:0090381,1,0.992243492218644,0,1,regulation of heart induction,BP,
16287,GO:0090382,1,0.739994653640905,0,33,phagosome maturation,BP,
16288,GO:0090383,1,0.808615028564125,0,21,phagosome acidification,BP,
16289,GO:0090385,1,0.953299975429765,0,6,phagosome-lysosome fusion,BP,
16290,GO:0090386,1,0.990755199849162,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
16291,GO:0090387,1,0.990755199849162,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
16292,GO:0090389,1,0.995366990826034,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
16293,GO:0090394,1,0.97790217962049,0,4,negative regulation of excitatory postsynaptic potential,BP,
16295,GO:0090399,1,0.934974530598251,0,11,replicative senescence,BP,
16296,GO:0090400,1,0.965988429388578,0,7,stress-induced premature senescence,BP,
16297,GO:0090402,1,0.988986809585295,0,2,oncogene-induced cell senescence,BP,
16298,GO:0090403,1,0.986129500998407,0,3,oxidative stress-induced premature senescence,BP,
16300,GO:0090409,1,0.994929521022721,0,1,malonyl-CoA synthetase activity,MF,
16301,GO:0090410,1,0.994929521022721,0,1,malonate catabolic process,BP,
16302,GO:0090416,1,0.995319958278601,0,1,nicotinate transmembrane transporter activity,MF,
16303,GO:0090420,1,0.987095632384479,0,1,naphthalene-containing compound metabolic process,BP,
16304,GO:0090422,1,0.985930046197506,0,2,thiamine pyrophosphate transmembrane transporter activity,MF,
16305,GO:0090427,1,0.994680773914287,0,1,activation of meiosis,BP,
16306,GO:0090435,1,0.941925871873532,0,7,protein localization to nuclear envelope,BP,
16307,GO:0090461,1,0.995366990826152,0,1,glutamate homeostasis,BP,
16308,GO:0090472,1,0.995366990826139,0,1,dibasic protein processing,BP,
16309,GO:0090480,1,0.986163965148419,0,3,purine nucleotide-sugar transmembrane transport,BP,
16310,GO:0090481,1,0.930515772957148,0,10,pyrimidine nucleotide-sugar transmembrane transport,BP,
16314,GO:0090498,1,0.990215305820423,0,2,extrinsic component of Golgi membrane,CC,
16315,GO:0090500,1,0.984451268270459,0,2,endocardial cushion to mesenchymal transition,BP,
16316,GO:0090501,1,0.343233984575196,0,123,RNA phosphodiester bond hydrolysis,BP,
16317,GO:0090502,1,0.599962788792757,0,59,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
16318,GO:0090503,1,0.758020782137917,0,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,
16319,GO:0090504,1,0.855476227765642,0,26,epiboly,BP,
16320,GO:0090505,1,0.859465077796592,0,25,epiboly involved in wound healing,BP,
16322,GO:0090521,1,0.981593258219683,0,4,glomerular visceral epithelial cell migration,BP,
16323,GO:0090527,1,0.959055979028657,0,9,actin filament reorganization,BP,
16324,GO:0090529,1,0.992650471036551,0,1,cell septum assembly,BP,
16325,GO:0090533,1,0.96302363919804,0,7,cation-transporting ATPase complex,CC,
16326,GO:0090537,1,0.995366990826138,0,1,CERF complex,CC,
16327,GO:0090541,1,0.990754785405327,0,2,MIT domain binding,MF,
16328,GO:0090543,1,0.854815053468721,0,26,Flemming body,CC,
16330,GO:0090554,1,0.990755199848966,0,2,phosphatidylcholine-translocating ATPase activity,MF,
16331,GO:0090556,1,0.990755199848966,0,2,phosphatidylserine-translocating ATPase activity,MF,
16332,GO:0090557,1,0.963524494883118,0,8,establishment of endothelial intestinal barrier,BP,
16333,GO:0090558,1,0.974537838279069,0,1,plant epidermis development,BP,
16334,GO:0090559,1,0.579646114930666,0,71,regulation of membrane permeability,BP,
16335,GO:0090560,1,0.994507637535722,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
16337,GO:0090571,1,0.978967579636531,0,3,RNA polymerase II transcription repressor complex,CC,
16339,GO:0090576,1,0.946924425824258,0,8,RNA polymerase III transcription factor complex,CC,
16340,GO:0090579,1,0.979424178261011,0,3,dsDNA loop formation,BP,
16341,GO:0090594,1,0.952452092075942,0,7,inflammatory response to wounding,BP,
16343,GO:0090599,1,0.977046156478975,0,5,alpha-glucosidase activity,MF,
16344,GO:0090600,1,0.995366990346783,0,1,alpha-1,3-glucosidase activity,MF,
16345,GO:0090601,1,0.995366990826151,0,1,enucleation,BP,
16346,GO:0090611,1,0.96888573032269,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
16347,GO:0090615,1,0.988604915063674,0,2,mitochondrial mRNA processing,BP,
16348,GO:0090616,1,0.995366990826165,0,1,mitochondrial mRNA 3'-end processing,BP,
16349,GO:0090624,1,0.995366574475227,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
16350,GO:0090625,1,0.995366574475227,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
16351,GO:0090627,1,0.974537838279069,0,1,plant epidermal cell differentiation,BP,
16353,GO:0090646,1,0.918421793759879,0,12,mitochondrial tRNA processing,BP,
16354,GO:0090647,1,0.960399075314699,0,6,modulation of age-related behavioral decline,BP,
16355,GO:0090649,1,0.973491410252659,0,5,response to oxygen-glucose deprivation,BP,
16356,GO:0090650,1,0.973491410252659,0,5,cellular response to oxygen-glucose deprivation,BP,
16357,GO:0090656,1,0.932661379471688,0,15,t-circle formation,BP,
16358,GO:0090657,1,0.950159860171821,0,11,telomeric loop disassembly,BP,
16359,GO:0090659,1,0.923434156649354,0,13,walking behavior,BP,
16360,GO:0090661,1,0.892438152410417,0,5,box H/ACA telomerase RNP complex,CC,
16361,GO:0090662,1,0.810836549625144,0,21,ATP hydrolysis coupled transmembrane transport,BP,
16362,GO:0090665,1,0.931868713201262,0,12,glycoprotein complex,CC,
16363,GO:0090666,1,0.976665477253123,0,4,scaRNA localization to Cajal body,BP,
16364,GO:0090667,1,0.995366990826033,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
16365,GO:0090668,1,0.995366990826033,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
16366,GO:0090669,1,0.978182746463586,0,4,telomerase RNA stabilization,BP,
16367,GO:0090670,1,0.851055130582787,0,19,RNA localization to Cajal body,BP,
16368,GO:0090671,1,0.851055130582787,0,19,telomerase RNA localization to Cajal body,BP,
16369,GO:0090672,1,0.851055130582787,0,19,telomerase RNA localization,BP,
16370,GO:0090673,1,0.995366990826047,0,1,endothelial cell-matrix adhesion,BP,
16371,GO:0090677,1,0.988150264212325,0,2,reversible differentiation,BP,
16372,GO:0090678,1,0.988150264212325,0,2,cell dedifferentiation involved in phenotypic switching,BP,
16373,GO:0090685,1,0.851055130582787,0,19,RNA localization to nucleus,BP,
16374,GO:0090694,1,0.990754785405091,0,2,Scc2-Scc4 cohesin loading complex,CC,
16375,GO:0090713,1,0.960621459218893,0,5,immunological memory process,BP,
16376,GO:0090715,1,0.960621459218893,0,5,immunological memory formation process,BP,
16377,GO:0090722,1,0.990755199849188,0,2,receptor-receptor interaction,MF,
16378,GO:0090723,1,0.929790854296136,0,11,growth cone part,CC,
16379,GO:0090724,1,0.97863368045107,0,4,central region of growth cone,CC,
16380,GO:0090725,1,0.97244802997806,0,2,peripheral region of growth cone,CC,
16381,GO:0090731,1,0.983095265244906,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
16382,GO:0090734,1,0.836901327191395,0,35,site of DNA damage,CC,
16383,GO:0090735,1,0.937036705274744,0,10,DNA repair complex assembly,BP,
16384,GO:0090737,1,0.932661379471688,0,15,telomere maintenance via telomere trimming,BP,
16385,GO:0090741,1,0.94296934035846,0,6,pigment granule membrane,CC,
16386,GO:0093001,1,0.995366837220533,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
16387,GO:0095500,1,0.919925027893096,0,12,acetylcholine receptor signaling pathway,BP,
16388,GO:0097001,1,0.954878575194148,0,8,ceramide binding,MF,
16389,GO:0097003,1,0.989802634754305,0,2,adipokinetic hormone receptor activity,MF,
16390,GO:0097006,1,0.682596586543313,0,51,regulation of plasma lipoprotein particle levels,BP,
16391,GO:0097009,1,0.904351828752782,0,13,energy homeostasis,BP,
16392,GO:0097010,1,0.986086173467225,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
16393,GO:0097011,1,0.940316707090013,0,7,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
16394,GO:0097012,1,0.940316707090013,0,7,response to granulocyte macrophage colony-stimulating factor,BP,
16395,GO:0097014,1,0.651195483813552,0,63,ciliary plasm,CC,
16396,GO:0097016,1,0.990755199849292,0,2,L27 domain binding,MF,
16397,GO:0097017,1,0.99066586462741,0,2,renal protein absorption,BP,
16398,GO:0097018,1,0.995279256748665,0,1,renal albumin absorption,BP,
16399,GO:0097020,1,0.995366908744439,0,1,COPII adaptor activity,MF,
16400,GO:0097021,1,0.987552910764402,0,2,lymphocyte migration into lymphoid organs,BP,
16401,GO:0097025,1,0.986164531023767,0,3,MPP7-DLG1-LIN7 complex,CC,
16402,GO:0097026,1,0.99536699082602,0,1,dendritic cell dendrite assembly,BP,
16403,GO:0097027,1,0.948771546821703,0,7,ubiquitin-protein transferase activator activity,MF,
16404,GO:0097028,1,0.881075582904754,0,17,dendritic cell differentiation,BP,
16405,GO:0097029,1,0.995366558830144,0,1,mature conventional dendritic cell differentiation,BP,
16406,GO:0097035,1,0.853414012367714,0,26,regulation of membrane lipid distribution,BP,
16407,GO:0097036,1,0.987653142204455,0,1,regulation of plasma membrane sterol distribution,BP,
16408,GO:0097037,1,0.995366932233635,0,1,heme export,BP,
16409,GO:0097038,1,0.926664545736244,0,10,perinuclear endoplasmic reticulum,CC,
16410,GO:0097039,1,0.974108239100329,0,5,protein linear polyubiquitination,BP,
16411,GO:0097045,1,0.995366990826165,0,1,phosphatidylserine exposure on blood platelet,BP,
16412,GO:0097048,1,0.981508103937585,0,4,dendritic cell apoptotic process,BP,
16413,GO:0097049,1,0.974386877454183,0,5,motor neuron apoptotic process,BP,
16414,GO:0097050,1,0.958780911788139,0,8,type B pancreatic cell apoptotic process,BP,
16415,GO:0097051,1,0.986164527107497,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
16416,GO:0097052,1,0.989995873772845,0,2,L-kynurenine metabolic process,BP,
16417,GO:0097055,1,0.990051354285002,0,2,agmatine biosynthetic process,BP,
16418,GO:0097056,1,0.974066984646311,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
16419,GO:0097057,1,0.9736232824889,0,2,TRAF2-GSTP1 complex,CC,
16420,GO:0097058,1,0.992192280278478,0,1,CRLF-CLCF1 complex,CC,
16421,GO:0097059,1,0.992192280278478,0,1,CNTFR-CLCF1 complex,CC,
16422,GO:0097060,1,0.42515639285659,0,157,synaptic membrane,CC,
16423,GO:0097061,1,0.75192667987748,0,50,dendritic spine organization,BP,
16424,GO:0097062,1,0.927690757664412,0,13,dendritic spine maintenance,BP,
16425,GO:0097064,1,0.781969766049433,0,37,ncRNA export from nucleus,BP,
16426,GO:0097065,1,0.980444160965473,0,4,anterior head development,BP,
16427,GO:0097066,1,0.909560447443763,0,15,response to thyroid hormone,BP,
16428,GO:0097067,1,0.943609702156673,0,10,cellular response to thyroid hormone stimulus,BP,
16429,GO:0097068,1,0.98616427733781,0,3,response to thyroxine,BP,
16430,GO:0097069,1,0.990754948172085,0,2,cellular response to thyroxine stimulus,BP,
16431,GO:0097070,1,0.995366990826125,0,1,ductus arteriosus closure,BP,
16433,GO:0097086,1,0.995366977014221,0,1,amniotic stem cell differentiation,BP,
16434,GO:0097089,1,0.990786842679304,0,1,methyl-branched fatty acid metabolic process,BP,
16435,GO:0097090,1,0.964997773944201,0,5,presynaptic membrane organization,BP,
16436,GO:0097091,1,0.981594728672432,0,4,synaptic vesicle clustering,BP,
16437,GO:0097094,1,0.945668809503942,0,11,craniofacial suture morphogenesis,BP,
16438,GO:0097100,1,0.950997465362955,0,5,supercoiled DNA binding,MF,
16439,GO:0097101,1,0.985774412749766,0,3,blood vessel endothelial cell fate specification,BP,
16440,GO:0097102,1,0.990647709377978,0,2,endothelial tip cell fate specification,BP,
16441,GO:0097104,1,0.981594888733362,0,4,postsynaptic membrane assembly,BP,
16442,GO:0097105,1,0.981594888733428,0,4,presynaptic membrane assembly,BP,
16443,GO:0097106,1,0.96588846052133,0,7,postsynaptic density organization,BP,
16444,GO:0097107,1,0.981594888733274,0,4,postsynaptic density assembly,BP,
16445,GO:0097108,1,0.995366990826033,0,1,hedgehog family protein binding,MF,
16446,GO:0097109,1,0.990755199262004,0,2,neuroligin family protein binding,MF,
16447,GO:0097110,1,0.750113000187527,0,45,scaffold protein binding,MF,
16448,GO:0097111,1,0.990755199849136,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
16449,GO:0097112,1,0.995366990826152,0,1,gamma-aminobutyric acid receptor clustering,BP,
16450,GO:0097113,1,0.969344086712146,0,4,AMPA glutamate receptor clustering,BP,
16451,GO:0097114,1,0.978539685290339,0,2,NMDA glutamate receptor clustering,BP,
16452,GO:0097116,1,0.995366990826165,0,1,gephyrin clustering involved in postsynaptic density assembly,BP,
16453,GO:0097117,1,0.995366990826059,0,1,guanylate kinase-associated protein clustering,BP,
16454,GO:0097118,1,0.995366990826073,0,1,neuroligin clustering involved in postsynaptic membrane assembly,BP,
16455,GO:0097119,1,0.979442734605397,0,4,postsynaptic density protein 95 clustering,BP,
16456,GO:0097120,1,0.901985362769566,0,20,receptor localization to synapse,BP,
16457,GO:0097123,1,0.994802685576982,0,1,cyclin A1-CDK2 complex,CC,
16458,GO:0097124,1,0.990192948096178,0,2,cyclin A2-CDK2 complex,CC,
16459,GO:0097125,1,0.985967491755335,0,2,cyclin B1-CDK1 complex,CC,
16460,GO:0097129,1,0.968209844059648,0,3,cyclin D2-CDK4 complex,CC,
16461,GO:0097134,1,0.987667464112083,0,2,cyclin E1-CDK2 complex,CC,
16462,GO:0097135,1,0.990191150654899,0,2,cyclin E2-CDK2 complex,CC,
16463,GO:0097136,1,0.952062324012957,0,6,Bcl-2 family protein complex,CC,
16464,GO:0097144,1,0.97527649662577,0,1,BAX complex,CC,
16465,GO:0097145,1,0.994642972742358,0,1,BAK complex,CC,
16466,GO:0097149,1,0.986164387557888,0,3,centralspindlin complex,CC,
16468,GO:0097151,1,0.97251830343202,0,6,positive regulation of inhibitory postsynaptic potential,BP,
16469,GO:0097152,1,0.961276336299038,0,7,mesenchymal cell apoptotic process,BP,
16470,GO:0097153,1,0.87686138568587,0,12,cysteine-type endopeptidase activity involved in apoptotic process,MF,
16471,GO:0097154,1,0.965537371407335,0,4,GABAergic neuron differentiation,BP,
16472,GO:0097155,1,0.990755199848965,0,2,fasciculation of sensory neuron axon,BP,
16473,GO:0097156,1,0.995366990826099,0,1,fasciculation of motor neuron axon,BP,
16474,GO:0097157,1,0.955017630422231,0,8,pre-mRNA intronic binding,MF,
16475,GO:0097158,1,0.990521895941025,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
16477,GO:0097161,1,0.995366990826099,0,1,DH domain binding,MF,
16478,GO:0097162,1,0.995366870768743,0,1,MADS box domain binding,MF,
16479,GO:0097164,1,0.374287870431322,0,133,ammonium ion metabolic process,BP,
16480,GO:0097165,1,0.968843406738839,0,5,nuclear stress granule,CC,
16481,GO:0097166,1,0.995366990825995,0,1,lens epithelial cell proliferation,BP,
16482,GO:0097167,1,0.975978311077385,0,4,circadian regulation of translation,BP,
16483,GO:0097168,1,0.995366990826165,0,1,mesenchymal stem cell proliferation,BP,
16484,GO:0097169,1,0.945066567841535,0,3,AIM2 inflammasome complex,CC,
16485,GO:0097176,1,0.973897713275308,0,4,epoxide metabolic process,BP,
16486,GO:0097177,1,0.969906617513321,0,3,mitochondrial ribosome binding,MF,
16487,GO:0097178,1,0.815247244053933,0,32,ruffle assembly,BP,
16488,GO:0097179,1,0.922177137441271,0,4,protease inhibitor complex,CC,
16489,GO:0097180,1,0.965884097059818,0,2,serine protease inhibitor complex,CC,
16491,GO:0097187,1,0.985179089773966,0,3,dentinogenesis,BP,
16496,GO:0097194,1,0.611087627195391,0,70,execution phase of apoptosis,BP,
16497,GO:0097195,1,0.989997314180408,0,2,pilomotor reflex,BP,
16498,GO:0097196,1,0.988749016244345,0,2,Shu complex,CC,
16499,GO:0097197,1,0.967967625762386,0,6,tetraspanin-enriched microdomain,CC,
16500,GO:0097198,1,0.990754900239922,0,2,histone H3-K36 trimethylation,BP,
16501,GO:0097199,1,0.951956602131782,0,5,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
16502,GO:0097200,1,0.897367805892639,0,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
16503,GO:0097201,1,0.937557721188065,0,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,
16504,GO:0097202,1,0.909923781344238,0,12,activation of cysteine-type endopeptidase activity,BP,
16505,GO:0097205,1,0.945698430101355,0,12,renal filtration,BP,
16506,GO:0097208,1,0.969387248734721,0,5,alveolar lamellar body,CC,
16507,GO:0097209,1,0.971766599788842,0,4,epidermal lamellar body,CC,
16508,GO:0097210,1,0.989698397803982,0,2,response to gonadotropin-releasing hormone,BP,
16509,GO:0097211,1,0.989698397803982,0,2,cellular response to gonadotropin-releasing hormone,BP,
16510,GO:0097212,1,0.988425678033126,0,2,lysosomal membrane organization,BP,
16511,GO:0097213,1,0.994792253714053,0,1,regulation of lysosomal membrane permeability,BP,
16512,GO:0097222,1,0.995366990826165,0,1,mitochondrial mRNA polyadenylation,BP,
16513,GO:0097223,1,0.527048963659657,0,89,sperm part,CC,
16514,GO:0097224,1,0.991695739399954,0,1,sperm connecting piece,CC,
16515,GO:0097225,1,0.90688043129634,0,10,sperm midpiece,CC,
16516,GO:0097226,1,0.994919446641692,0,1,sperm mitochondrial sheath,CC,
16517,GO:0097227,1,0.981521896283925,0,4,sperm annulus,CC,
16518,GO:0097228,1,0.924764856078502,0,11,sperm principal piece,CC,
16519,GO:0097229,1,0.985874278131375,0,1,sperm end piece,CC,
16520,GO:0097231,1,0.991366943008934,0,1,cell motility in response to calcium ion,BP,
16521,GO:0097232,1,0.995366899037849,0,1,lamellar body membrane,CC,
16522,GO:0097233,1,0.995366899037849,0,1,alveolar lamellar body membrane,CC,
16523,GO:0097237,1,0.231907810423488,0,160,cellular response to toxic substance,BP,
16524,GO:0097238,1,0.965413370086851,0,2,cellular response to methylglyoxal,BP,
16525,GO:0097240,1,0.981581574528167,0,4,chromosome attachment to the nuclear envelope,BP,
16526,GO:0097241,1,0.990233682185993,0,2,hematopoietic stem cell migration to bone marrow,BP,
16527,GO:0097242,1,0.920127000085549,0,14,amyloid-beta clearance,BP,
16528,GO:0097252,1,0.98604306778916,0,3,oligodendrocyte apoptotic process,BP,
16529,GO:0097255,1,0.955691716509323,0,5,R2TP complex,CC,
16530,GO:0097264,1,0.97251666835872,0,6,self proteolysis,BP,
16531,GO:0097267,1,0.981568571528106,0,4,omega-hydroxylase P450 pathway,BP,
16532,GO:0097272,1,0.995366990826125,0,1,ammonia homeostasis,BP,
16533,GO:0097273,1,0.995366990826125,0,1,creatinine homeostasis,BP,
16534,GO:0097274,1,0.990755149728117,0,2,urea homeostasis,BP,
16535,GO:0097275,1,0.995366990826125,0,1,cellular ammonia homeostasis,BP,
16536,GO:0097276,1,0.995366990826125,0,1,cellular creatinine homeostasis,BP,
16537,GO:0097277,1,0.995366990826125,0,1,cellular urea homeostasis,BP,
16538,GO:0097278,1,0.990695773337553,0,2,complement-dependent cytotoxicity,BP,
16539,GO:0097283,1,0.969736502945595,0,5,keratinocyte apoptotic process,BP,
16540,GO:0097284,1,0.937365254783583,0,11,hepatocyte apoptotic process,BP,
16541,GO:0097286,1,0.924791133831815,0,11,iron ion import,BP,
16542,GO:0097291,1,0.993760207203912,0,1,renal phosphate ion absorption,BP,
16543,GO:0097296,1,0.910570867893948,0,12,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
16544,GO:0097298,1,0.995366990575074,0,1,regulation of nucleus size,BP,
16545,GO:0097300,1,0.758226373725898,0,35,programmed necrotic cell death,BP,
16546,GO:0097305,1,0.462616813321039,0,113,response to alcohol,BP,
16547,GO:0097306,1,0.810943810934945,0,43,cellular response to alcohol,BP,
16548,GO:0097309,1,0.990754370961523,0,2,cap1 mRNA methylation,BP,
16549,GO:0097310,1,0.995366574475227,0,1,cap2 mRNA methylation,BP,
16550,GO:0097320,1,0.927123117002991,0,14,plasma membrane tubulation,BP,
16551,GO:0097322,1,0.963067103756473,0,6,7SK snRNA binding,MF,
16552,GO:0097325,1,0.990754668404446,0,2,melanocyte proliferation,BP,
16554,GO:0097329,1,0.944910245588206,0,12,response to antimetabolite,BP,
16555,GO:0097332,1,0.974155014478956,0,2,response to antipsychotic drug,BP,
16556,GO:0097338,1,0.995366990826164,0,1,response to clozapine,BP,
16557,GO:0097340,1,0.91855530110248,0,11,inhibition of cysteine-type endopeptidase activity,BP,
16558,GO:0097341,1,0.91855530110248,0,11,zymogen inhibition,BP,
16559,GO:0097342,1,0.968030326061005,0,6,ripoptosome,CC,
16560,GO:0097343,1,0.986164523346095,0,3,ripoptosome assembly,BP,
16561,GO:0097344,1,0.984805720966602,0,2,Rix1 complex,CC,
16562,GO:0097345,1,0.686626552963764,0,49,mitochondrial outer membrane permeabilization,BP,
16564,GO:0097350,1,0.978032777230973,0,3,neutrophil clearance,BP,
16565,GO:0097352,1,0.752864768423876,0,34,autophagosome maturation,BP,
16566,GO:0097354,1,0.94628533178592,0,9,prenylation,BP,
16567,GO:0097356,1,0.995366990826045,0,1,perinucleolar compartment,CC,
16568,GO:0097359,1,0.990755199849032,0,2,UDP-glucosylation,BP,
16569,GO:0097360,1,0.990724878500195,0,2,chorionic trophoblast cell proliferation,BP,
16570,GO:0097361,1,0.959770604266901,0,4,CIA complex,CC,
16571,GO:0097362,1,0.990628174468523,0,2,MCM8-MCM9 complex,CC,
16572,GO:0097363,1,0.990754785405313,0,2,protein O-GlcNAc transferase activity,MF,
16573,GO:0097366,1,0.863221892209692,0,24,response to bronchodilator,BP,
16575,GO:0097368,1,0.969070025926117,0,4,establishment of Sertoli cell barrier,BP,
16576,GO:0097371,1,0.965671475193165,0,7,MDM2/MDM4 family protein binding,MF,
16577,GO:0097372,1,0.991388705237635,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
16578,GO:0097374,1,0.995259108849138,0,1,sensory neuron axon guidance,BP,
16579,GO:0097376,1,0.98736875124752,0,1,interneuron axon guidance,BP,
16580,GO:0097381,1,0.976562780708389,0,5,photoreceptor disc membrane,CC,
16581,GO:0097382,1,0.995366990826113,0,1,deoxynucleoside-diphosphatase activity,MF,
16582,GO:0097383,1,0.995366990826113,0,1,dIDP diphosphatase activity,MF,
16583,GO:0097384,1,0.950887771953086,0,7,cellular lipid biosynthetic process,BP,
16584,GO:0097386,1,0.940080332263947,0,11,glial cell projection,CC,
16585,GO:0097393,1,0.995366990825889,0,1,telomeric repeat-containing RNA transcription,BP,
16586,GO:0097394,1,0.995366990825889,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
16587,GO:0097396,1,0.981445865799892,0,4,response to interleukin-17,BP,
16588,GO:0097398,1,0.981445865799892,0,4,cellular response to interleukin-17,BP,
16589,GO:0097400,1,0.981445865799892,0,4,interleukin-17-mediated signaling pathway,BP,
16590,GO:0097403,1,0.995366698642032,0,1,cellular response to raffinose,BP,
16591,GO:0097409,1,0.993473982488023,0,1,glial cytoplasmic inclusion,CC,
16592,GO:0097411,1,0.969453012455705,0,4,hypoxia-inducible factor-1alpha signaling pathway,BP,
16593,GO:0097413,1,0.946954824537615,0,7,Lewy body,CC,
16594,GO:0097414,1,0.993473982488023,0,1,classical Lewy body,CC,
16595,GO:0097418,1,0.9770452918705,0,5,neurofibrillary tangle,CC,
16596,GO:0097421,1,0.8101268686331,0,27,liver regeneration,BP,
16597,GO:0097422,1,0.975998067632727,0,5,tubular endosome,CC,
16598,GO:0097425,1,0.975521369696752,0,3,smooth endoplasmic reticulum part,CC,
16599,GO:0097427,1,0.977045360241189,0,5,microtubule bundle,CC,
16600,GO:0097428,1,0.858297165768613,0,10,protein maturation by iron-sulfur cluster transfer,BP,
16601,GO:0097431,1,0.852876276762023,0,26,mitotic spindle pole,CC,
16602,GO:0097433,1,0.971918901667909,0,5,dense body,CC,
16604,GO:0097440,1,0.949467528855994,0,11,apical dendrite,CC,
16605,GO:0097441,1,0.978230651961741,0,3,basal dendrite,CC,
16606,GO:0097442,1,0.995366990826138,0,1,CA3 pyramidal cell dendrite,CC,
16607,GO:0097443,1,0.976940073233192,0,5,sorting endosome,CC,
16608,GO:0097444,1,0.995366990826151,0,1,spine apparatus,CC,
16610,GO:0097449,1,0.972165513498412,0,6,astrocyte projection,CC,
16611,GO:0097450,1,0.990754785405302,0,2,astrocyte end-foot,CC,
16612,GO:0097451,1,0.990754785405302,0,2,glial limiting end-foot,CC,
16613,GO:0097452,1,0.958996710488342,0,4,GAIT complex,CC,
16614,GO:0097454,1,0.977968577950259,0,3,Schwann cell microvillus,CC,
16615,GO:0097457,1,0.990755165765182,0,2,hippocampal mossy fiber,CC,
16617,GO:0097462,1,0.993473982488023,0,1,Lewy neurite,CC,
16618,GO:0097466,1,0.979455305761291,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
16619,GO:0097468,1,0.909025302093388,0,11,programmed cell death in response to reactive oxygen species,BP,
16620,GO:0097470,1,0.977045768174704,0,5,ribbon synapse,CC,
16621,GO:0097472,1,0.81314574942752,0,31,cyclin-dependent protein kinase activity,MF,
16622,GO:0097473,1,0.995366990826152,0,1,retinal rod cell apoptotic process,BP,
16623,GO:0097475,1,0.986057598587045,0,3,motor neuron migration,BP,
16624,GO:0097479,1,0.621990730294286,0,79,synaptic vesicle localization,BP,
16625,GO:0097480,1,0.630763796910383,0,76,establishment of synaptic vesicle localization,BP,
16626,GO:0097484,1,0.913023931783319,0,17,dendrite extension,BP,
16628,GO:0097486,1,0.983635241959161,0,2,multivesicular body lumen,CC,
16629,GO:0097487,1,0.97015381987169,0,3,multivesicular body, internal vesicle,CC,
16630,GO:0097489,1,0.995318255982901,0,1,multivesicular body, internal vesicle lumen,CC,
16631,GO:0097490,1,0.981488447927717,0,4,sympathetic neuron projection extension,BP,
16632,GO:0097491,1,0.981488447927717,0,4,sympathetic neuron projection guidance,BP,
16633,GO:0097493,1,0.972518303432608,0,6,structural molecule activity conferring elasticity,MF,
16634,GO:0097494,1,0.97361539802094,0,4,regulation of vesicle size,BP,
16635,GO:0097497,1,0.995366803504279,0,1,blood vessel endothelial cell delamination,BP,
16636,GO:0097498,1,0.988597693686467,0,2,endothelial tube lumen extension,BP,
16637,GO:0097499,1,0.961913090588121,0,6,protein localization to non-motile cilium,BP,
16638,GO:0097500,1,0.986114681979967,0,3,receptor localization to non-motile cilium,BP,
16639,GO:0097501,1,0.868903769317035,0,7,stress response to metal ion,BP,
16640,GO:0097502,1,0.80116184912548,0,27,mannosylation,BP,
16641,GO:0097503,1,0.924550317277552,0,14,sialylation,BP,
16642,GO:0097504,1,0.917450785031694,0,11,Gemini of coiled bodies,CC,
16643,GO:0097505,1,0.995366990826125,0,1,Rad6-Rad18 complex,CC,
16644,GO:0097506,1,0.955691301810265,0,5,deaminated base DNA N-glycosylase activity,MF,
16645,GO:0097510,1,0.994026624429889,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
16646,GO:0097512,1,0.972444477478627,0,1,cardiac myofibril,CC,
16647,GO:0097513,1,0.986164531023442,0,3,myosin II filament,CC,
16648,GO:0097517,1,0.77158757551295,0,43,contractile actin filament bundle,CC,
16649,GO:0097524,1,0.981536025640146,0,4,sperm plasma membrane,CC,
16652,GO:0097527,1,0.969876808431128,0,5,necroptotic signaling pathway,BP,
16653,GO:0097529,1,0.461810119788458,0,84,myeloid leukocyte migration,BP,
16654,GO:0097530,1,0.582743057052924,0,56,granulocyte migration,BP,
16655,GO:0097531,1,0.934214525824545,0,9,mast cell migration,BP,
16656,GO:0097532,1,0.98595659530862,0,2,stress response to acid chemical,BP,
16657,GO:0097533,1,0.98595659530862,0,2,cellular stress response to acid chemical,BP,
16658,GO:0097534,1,0.990749971778244,0,2,lymphoid lineage cell migration,BP,
16659,GO:0097535,1,0.990749971778244,0,2,lymphoid lineage cell migration into thymus,BP,
16660,GO:0097536,1,0.995361738699408,0,1,thymus epithelium morphogenesis,BP,
16661,GO:0097539,1,0.954611768061351,0,10,ciliary transition fiber,CC,
16662,GO:0097541,1,0.995366574475227,0,1,axonemal basal plate,CC,
16663,GO:0097542,1,0.737003357631791,0,41,ciliary tip,CC,
16664,GO:0097543,1,0.990754755025949,0,2,ciliary inversin compartment,CC,
16665,GO:0097546,1,0.849849831511123,0,25,ciliary base,CC,
16666,GO:0097550,1,0.951219408986573,0,6,transcriptional preinitiation complex,CC,
16668,GO:0097573,1,0.986385579863497,0,1,glutathione oxidoreductase activity,MF,
16669,GO:0097574,1,0.990754928506956,0,2,lateral part of cell,CC,
16670,GO:0097575,1,0.990754928506956,0,2,lateral cell cortex,CC,
16671,GO:0097576,1,0.990683021727618,0,2,vacuole fusion,BP,
16672,GO:0097577,1,0.954993229358273,0,3,sequestering of iron ion,BP,
16673,GO:0097581,1,0.696662290746681,0,65,lamellipodium organization,BP,
16674,GO:0097598,1,0.995366990826153,0,1,sperm cytoplasmic droplet,CC,
16675,GO:0097602,1,0.869216281962968,0,17,cullin family protein binding,MF,
16676,GO:0097603,1,0.995366990826138,0,1,temperature-gated ion channel activity,MF,
16677,GO:0097617,1,0.93355642569698,0,13,annealing activity,MF,
16678,GO:0097621,1,0.994954042250768,0,1,monoamine oxidase activity,MF,
16679,GO:0097623,1,0.995366990826164,0,1,potassium ion export across plasma membrane,BP,
16680,GO:0097625,1,0.995366990826045,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
16681,GO:0097626,1,0.995366990826045,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
16682,GO:0097627,1,0.995366990826045,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
16683,GO:0097629,1,0.973255600207749,0,5,extrinsic component of omegasome membrane,CC,
16684,GO:0097630,1,0.995366574475227,0,1,intrinsic component of omegasome membrane,CC,
16685,GO:0097631,1,0.995366574475227,0,1,integral component of omegasome membrane,CC,
16686,GO:0097632,1,0.990754785405313,0,2,extrinsic component of phagophore assembly site membrane,CC,
16687,GO:0097635,1,0.990755199849292,0,2,extrinsic component of autophagosome membrane,CC,
16688,GO:0097636,1,0.990754826796195,0,2,intrinsic component of autophagosome membrane,CC,
16689,GO:0097637,1,0.990754826796195,0,2,integral component of autophagosome membrane,CC,
16690,GO:0097638,1,0.990755199849071,0,2,L-arginine import across plasma membrane,BP,
16691,GO:0097639,1,0.995366990826045,0,1,L-lysine import across plasma membrane,BP,
16692,GO:0097640,1,0.995366990826045,0,1,L-ornithine import across plasma membrane,BP,
16693,GO:0097642,1,0.968377274883745,0,3,calcitonin family receptor activity,MF,
16694,GO:0097643,1,0.977420572404843,0,1,amylin receptor activity,MF,
16695,GO:0097644,1,0.9728909882692,0,2,calcitonin family binding,MF,
16696,GO:0097646,1,0.954843181085276,0,4,calcitonin family receptor signaling pathway,BP,
16697,GO:0097647,1,0.959289698537695,0,3,amylin receptor signaling pathway,BP,
16698,GO:0097648,1,0.96838215409786,0,3,G-protein coupled receptor complex,CC,
16699,GO:0097651,1,0.990755192002596,0,2,phosphatidylinositol 3-kinase complex, class I,CC,
16700,GO:0097655,1,0.995366574475227,0,1,serpin family protein binding,MF,
16702,GO:0097676,1,0.9853052369136,0,3,histone H3-K36 dimethylation,BP,
16703,GO:0097677,1,0.938941290954837,0,6,STAT family protein binding,MF,
16704,GO:0097680,1,0.98525137238674,0,3,double-strand break repair via classical nonhomologous end joining,BP,
16705,GO:0097681,1,0.99075519984877,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
16706,GO:0097682,1,0.9942939984981,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
16707,GO:0097688,1,0.969344086712146,0,4,glutamate receptor clustering,BP,
16708,GO:0097692,1,0.995366990826099,0,1,histone H3-K4 monomethylation,BP,
16709,GO:0097694,1,0.986164162222241,0,3,establishment of RNA localization to telomere,BP,
16710,GO:0097695,1,0.986164162222241,0,3,establishment of protein-containing complex localization to telomere,BP,
16712,GO:0097698,1,0.988461209569193,0,1,telomere maintenance via base-excision repair,BP,
16713,GO:0097699,1,0.995366990826164,0,1,vascular endothelial cell response to fluid shear stress,BP,
16714,GO:0097707,1,0.978190619441799,0,1,ferroptosis,BP,
16716,GO:0097709,1,0.962751051114109,0,6,connective tissue replacement,BP,
16717,GO:0097711,1,0.537215576826843,0,94,ciliary basal body-plasma membrane docking,BP,
16718,GO:0097712,1,0.995366574475227,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
16719,GO:0097718,1,0.844035361521178,0,30,disordered domain specific binding,MF,
16720,GO:0097720,1,0.861538340813956,0,25,calcineurin-mediated signaling,BP,
16721,GO:0097722,1,0.808213624470389,0,29,sperm motility,BP,
16722,GO:0097724,1,0.992482553402505,0,1,sperm flagellum movement,BP,
16723,GO:0097726,1,0.981967795416082,0,1,LEM domain binding,MF,
16724,GO:0097729,1,0.750178694485456,0,38,9+2 motile cilium,CC,
16725,GO:0097730,1,0.693046491486553,0,64,non-motile cilium,CC,
16726,GO:0097731,1,0.735095261152923,0,52,9+0 non-motile cilium,CC,
16727,GO:0097732,1,0.960765911514082,0,5,9+2 non-motile cilium,CC,
16728,GO:0097733,1,0.735095261152923,0,52,photoreceptor cell cilium,CC,
16729,GO:0097734,1,0.882780331268444,0,17,extracellular exosome biogenesis,BP,
16730,GO:0097742,1,0.986164528690966,0,3,de novo centriole assembly,BP,
16731,GO:0097745,1,0.969346398247442,0,3,mitochondrial tRNA 5'-end processing,BP,
16733,GO:0097747,1,0.634354822282604,0,43,RNA polymerase activity,MF,
16734,GO:0097749,1,0.995366990826099,0,1,membrane tubulation,BP,
16735,GO:0097752,1,0.9861631556902,0,3,regulation of DNA stability,BP,
16736,GO:0097753,1,0.995366987570659,0,1,membrane bending,BP,
16738,GO:0097756,1,0.79973668522148,0,40,negative regulation of blood vessel diameter,BP,
16739,GO:0098501,1,0.951527771423609,0,5,polynucleotide dephosphorylation,BP,
16740,GO:0098502,1,0.965122091166896,0,3,DNA dephosphorylation,BP,
16741,GO:0098503,1,0.991485701225143,0,1,DNA 3' dephosphorylation,BP,
16742,GO:0098504,1,0.991485701225143,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
16743,GO:0098505,1,0.947283887377168,0,10,G-rich strand telomeric DNA binding,MF,
16744,GO:0098506,1,0.991485701225143,0,1,polynucleotide 3' dephosphorylation,BP,
16745,GO:0098507,1,0.985920103013545,0,2,polynucleotide 5' dephosphorylation,BP,
16746,GO:0098508,1,0.988880262792458,0,2,endothelial to hematopoietic transition,BP,
16747,GO:0098518,1,0.977524322793103,0,3,polynucleotide phosphatase activity,MF,
16748,GO:0098519,1,0.970695028832607,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
16749,GO:0098528,1,0.975438851324443,0,4,skeletal muscle fiber differentiation,BP,
16750,GO:0098530,1,0.995366990826125,0,1,positive regulation of strand invasion,BP,
16753,GO:0098533,1,0.936545883651983,0,13,ATPase dependent transmembrane transport complex,CC,
16755,GO:0098535,1,0.986164528690966,0,3,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
16756,GO:0098536,1,0.986164528227894,0,3,deuterosome,CC,
16758,GO:0098543,1,0.953299392173003,0,7,detection of other organism,BP,
16759,GO:0098547,1,0.994824612585235,0,1,lumenal side of Golgi membrane,CC,
16761,GO:0098553,1,0.851605771418697,0,18,lumenal side of endoplasmic reticulum membrane,CC,
16762,GO:0098554,1,0.829447264714763,0,13,cytoplasmic side of endoplasmic reticulum membrane,CC,
16763,GO:0098556,1,0.870600500169024,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
16764,GO:0098559,1,0.986016676135885,0,3,cytoplasmic side of early endosome membrane,CC,
16765,GO:0098560,1,0.990697497907449,0,2,cytoplasmic side of late endosome membrane,CC,
16767,GO:0098563,1,0.907976474372855,0,15,intrinsic component of synaptic vesicle membrane,CC,
16768,GO:0098573,1,0.5782971427102,0,66,intrinsic component of mitochondrial membrane,CC,
16769,GO:0098574,1,0.981537265618977,0,4,cytoplasmic side of lysosomal membrane,CC,
16770,GO:0098575,1,0.988782101744594,0,2,lumenal side of lysosomal membrane,CC,
16771,GO:0098576,1,0.979105848781271,0,4,lumenal side of membrane,CC,
16772,GO:0098577,1,0.995366990826074,0,1,inactive sex chromosome,CC,
16773,GO:0098581,1,0.948873485524231,0,8,detection of external biotic stimulus,BP,
16774,GO:0098582,1,0.990755184204534,0,2,innate vocalization behavior,BP,
16777,GO:0098589,1,0.294987891251052,0,210,membrane region,CC,
16779,GO:0098592,1,0.986164190102634,0,3,cytoplasmic side of apical plasma membrane,CC,
16780,GO:0098594,1,0.973627305635028,0,1,mucin granule,CC,
16781,GO:0098596,1,0.9815948732312,0,4,imitative learning,BP,
16782,GO:0098597,1,0.977046162358847,0,5,observational learning,BP,
16783,GO:0098598,1,0.9815948732312,0,4,learned vocalization behavior or vocal learning,BP,
16784,GO:0098599,1,0.940640387161152,0,10,palmitoyl hydrolase activity,MF,
16786,GO:0098619,1,0.993066187613722,0,1,selenocysteine-tRNA ligase activity,MF,
16787,GO:0098621,1,0.995366990826138,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
16788,GO:0098625,1,0.995366987656852,0,1,methylselenol reductase activity,MF,
16789,GO:0098626,1,0.995366987656852,0,1,methylseleninic acid reductase activity,MF,
16790,GO:0098629,1,0.995366574475227,0,1,trans-Golgi network membrane organization,BP,
16791,GO:0098631,1,0.779983697992671,0,35,cell adhesion mediator activity,MF,
16792,GO:0098632,1,0.813188585748486,0,29,cell-cell adhesion mediator activity,MF,
16793,GO:0098633,1,0.995299607351568,0,1,collagen fibril binding,MF,
16794,GO:0098634,1,0.981594883775315,0,4,cell-matrix adhesion mediator activity,MF,
16795,GO:0098636,1,0.923870428615986,0,17,protein complex involved in cell adhesion,CC,
16796,GO:0098639,1,0.981594883775315,0,4,collagen binding involved in cell-matrix adhesion,MF,
16797,GO:0098641,1,0.852028341845387,0,19,cadherin binding involved in cell-cell adhesion,MF,
16798,GO:0098642,1,0.972498381740269,0,6,network-forming collagen trimer,CC,
16799,GO:0098643,1,0.959058562281559,0,9,banded collagen fibril,CC,
16800,GO:0098644,1,0.928345807563938,0,16,complex of collagen trimers,CC,
16801,GO:0098645,1,0.972498381740269,0,6,collagen network,CC,
16802,GO:0098646,1,0.995346606520723,0,1,collagen sheet,CC,
16803,GO:0098647,1,0.983932605447962,0,2,collagen beaded filament,CC,
16804,GO:0098648,1,0.995366990825969,0,1,collagen anchoring fibril,CC,
16805,GO:0098651,1,0.972498381740269,0,6,basement membrane collagen trimer,CC,
16806,GO:0098652,1,0.995366990825969,0,1,collagen type VII anchoring fibril,CC,
16814,GO:0098664,1,0.973240272848599,0,3,G-protein coupled serotonin receptor signaling pathway,BP,
16815,GO:0098679,1,0.990755199848928,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
16816,GO:0098680,1,0.961814214726214,0,1,template-free RNA nucleotidyltransferase,MF,
16818,GO:0098693,1,0.838496580605318,0,33,regulation of synaptic vesicle cycle,BP,
16819,GO:0098698,1,0.981594888733274,0,4,postsynaptic specialization assembly,BP,
16820,GO:0098700,1,0.986247117136137,0,2,neurotransmitter loading into synaptic vesicle,BP,
16821,GO:0098703,1,0.97133321601514,0,6,calcium ion import across plasma membrane,BP,
16822,GO:0098705,1,0.995366990826165,0,1,copper ion import across plasma membrane,BP,
16823,GO:0098706,1,0.981594801532457,0,4,ferric iron import across plasma membrane,BP,
16824,GO:0098711,1,0.970585900500386,0,6,iron ion import across plasma membrane,BP,
16825,GO:0098712,1,0.971059159911143,0,6,L-glutamate import across plasma membrane,BP,
16826,GO:0098713,1,0.994864007881305,0,1,leucine import across plasma membrane,BP,
16828,GO:0098722,1,0.959276388705957,0,6,asymmetric stem cell division,BP,
16829,GO:0098725,1,0.995366574475227,0,1,symmetric cell division,BP,
16831,GO:0098728,1,0.977268136151108,0,2,germline stem cell asymmetric division,BP,
16832,GO:0098732,1,0.550315873876033,0,101,macromolecule deacylation,BP,
16833,GO:0098734,1,0.940640387161152,0,10,macromolecule depalmitoylation,BP,
16834,GO:0098735,1,0.986164531023624,0,3,positive regulation of the force of heart contraction,BP,
16835,GO:0098736,1,0.99536699082598,0,1,negative regulation of the force of heart contraction,BP,
16838,GO:0098743,1,0.942539311084798,0,11,cell aggregation,BP,
16839,GO:0098745,1,0.991643945790632,0,1,Dcp1-Dcp2 complex,CC,
16840,GO:0098746,1,0.995366990826165,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
16841,GO:0098748,1,0.928970231768087,0,11,endocytic adaptor activity,MF,
16842,GO:0098749,1,0.995366990826165,0,1,cerebellar neuron development,BP,
16843,GO:0098751,1,0.884193920639,0,25,bone cell development,BP,
16844,GO:0098754,1,0.395865966037321,0,75,detoxification,BP,
16845,GO:0098756,1,0.981594862458488,0,4,response to interleukin-21,BP,
16846,GO:0098757,1,0.981594862458488,0,4,cellular response to interleukin-21,BP,
16847,GO:0098758,1,0.990643659432013,0,2,response to interleukin-8,BP,
16848,GO:0098759,1,0.990643659432013,0,2,cellular response to interleukin-8,BP,
16849,GO:0098760,1,0.603686032310768,0,26,response to interleukin-7,BP,
16850,GO:0098761,1,0.603686032310768,0,26,cellular response to interleukin-7,BP,
16851,GO:0098770,1,0.990755193255814,0,2,FBXO family protein binding,MF,
16855,GO:0098779,1,0.937882631731223,0,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
16856,GO:0098780,1,0.89815497927848,0,17,response to mitochondrial depolarisation,BP,
16857,GO:0098781,1,0.463842540844404,0,94,ncRNA transcription,BP,
16858,GO:0098787,1,0.931184715013423,0,14,mRNA cleavage involved in mRNA processing,BP,
16859,GO:0098789,1,0.94442947099625,0,11,pre-mRNA cleavage required for polyadenylation,BP,
16861,GO:0098792,1,0.95220822524649,0,10,xenophagy,BP,
16864,GO:0098795,1,0.99075476249019,0,2,mRNA cleavage involved in gene silencing,BP,
16868,GO:0098799,1,0.874726463033424,0,12,outer mitochondrial membrane protein complex,CC,
16870,GO:0098801,1,0.926695774080484,0,11,regulation of renal system process,BP,
16871,GO:0098802,1,0.612105901135411,0,87,plasma membrane receptor complex,CC,
16874,GO:0098808,1,0.988867143137849,0,2,mRNA cap binding,MF,
16875,GO:0098809,1,0.995337765554784,0,1,nitrite reductase activity,MF,
16878,GO:0098814,1,0.967911291159614,0,5,spontaneous synaptic transmission,BP,
16879,GO:0098815,1,0.883061994067378,0,24,modulation of excitatory postsynaptic potential,BP,
16880,GO:0098816,1,0.99394869310473,0,1,mini excitatory postsynaptic potential,BP,
16881,GO:0098821,1,0.986164512582809,0,3,BMP receptor activity,MF,
16882,GO:0098822,1,0.995225769074058,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
16883,GO:0098826,1,0.980932882930582,0,4,endoplasmic reticulum tubular network membrane,CC,
16885,GO:0098828,1,0.97251830343202,0,6,modulation of inhibitory postsynaptic potential,BP,
16886,GO:0098829,1,0.9953669908261,0,1,intestinal folate absorption,BP,
16887,GO:0098830,1,0.995366990826165,0,1,presynaptic endosome,CC,
16888,GO:0098831,1,0.977046177789468,0,5,presynaptic active zone cytoplasmic component,CC,
16889,GO:0098833,1,0.995366990826165,0,1,presynaptic endocytic zone,CC,
16890,GO:0098835,1,0.995366990826165,0,1,presynaptic endocytic zone membrane,CC,
16891,GO:0098837,1,0.983214473396553,0,3,postsynaptic recycling endosome,CC,
16892,GO:0098838,1,0.995366511980814,0,1,reduced folate transmembrane transport,BP,
16893,GO:0098839,1,0.95984545757914,0,7,postsynaptic density membrane,CC,
16894,GO:0098840,1,0.972647390717231,0,2,protein transport along microtubule,BP,
16895,GO:0098842,1,0.989660387729841,0,2,postsynaptic early endosome,CC,
16896,GO:0098843,1,0.947919802192591,0,6,postsynaptic endocytic zone,CC,
16897,GO:0098844,1,0.981594330553606,0,4,postsynaptic endocytic zone membrane,CC,
16898,GO:0098845,1,0.968536488413489,0,6,postsynaptic endosome,CC,
16899,GO:0098847,1,0.929897472200304,0,13,sequence-specific single stranded DNA binding,MF,
16900,GO:0098852,1,0.146568987026419,0,298,lytic vacuole membrane,CC,
16901,GO:0098856,1,0.982179937222984,0,2,intestinal lipid absorption,BP,
16902,GO:0098857,1,0.30795285930145,0,203,membrane microdomain,CC,
16904,GO:0098862,1,0.587054085887634,0,81,cluster of actin-based cell projections,CC,
16905,GO:0098868,1,0.93565018079793,0,14,bone growth,BP,
16906,GO:0098869,1,0.472093448277679,0,63,cellular oxidant detoxification,BP,
16907,GO:0098870,1,0.969800787626915,0,3,action potential propagation,BP,
16908,GO:0098871,1,0.991122612138284,0,1,postsynaptic actin cytoskeleton,CC,
16909,GO:0098875,1,0.995366990826165,0,1,epididymosome,CC,
16910,GO:0098876,1,0.677395137988155,0,65,vesicle-mediated transport to the plasma membrane,BP,
16911,GO:0098877,1,0.953388784960939,0,10,neurotransmitter receptor transport to plasma membrane,BP,
16912,GO:0098878,1,0.907891234456268,0,17,neurotransmitter receptor complex,CC,
16913,GO:0098881,1,0.985896568951786,0,3,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
16914,GO:0098883,1,0.992243492218644,0,1,synapse disassembly,BP,
16915,GO:0098884,1,0.981594330553606,0,4,postsynaptic neurotransmitter receptor internalization,BP,
16916,GO:0098885,1,0.995366990826059,0,1,modification of postsynaptic actin cytoskeleton,BP,
16917,GO:0098886,1,0.990754785405328,0,2,modification of dendritic spine,BP,
16918,GO:0098887,1,0.976822028393817,0,5,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
16919,GO:0098888,1,0.99536699082606,0,1,extrinsic component of presynaptic membrane,CC,
16920,GO:0098890,1,0.99536699082606,0,1,extrinsic component of postsynaptic membrane,CC,
16921,GO:0098900,1,0.84919272924722,0,29,regulation of action potential,BP,
16922,GO:0098901,1,0.897274852511347,0,19,regulation of cardiac muscle cell action potential,BP,
16923,GO:0098902,1,0.957725624482905,0,5,regulation of membrane depolarization during action potential,BP,
16924,GO:0098903,1,0.972505005480284,0,6,regulation of membrane repolarization during action potential,BP,
16925,GO:0098904,1,0.990634438661303,0,2,regulation of AV node cell action potential,BP,
16926,GO:0098905,1,0.97116665985805,0,2,regulation of bundle of His cell action potential,BP,
16927,GO:0098906,1,0.995366807366016,0,1,regulation of Purkinje myocyte action potential,BP,
16928,GO:0098907,1,0.99536699082602,0,1,regulation of SA node cell action potential,BP,
16929,GO:0098908,1,0.990547693470651,0,2,regulation of neuronal action potential,BP,
16930,GO:0098909,1,0.957716888667661,0,5,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
16931,GO:0098910,1,0.977045997636033,0,5,regulation of atrial cardiac muscle cell action potential,BP,
16932,GO:0098911,1,0.959049755825281,0,9,regulation of ventricular cardiac muscle cell action potential,BP,
16933,GO:0098912,1,0.995366990826139,0,1,membrane depolarization during atrial cardiac muscle cell action potential,BP,
16934,GO:0098914,1,0.990754787598752,0,2,membrane repolarization during atrial cardiac muscle cell action potential,BP,
16935,GO:0098915,1,0.986164120628971,0,3,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
16937,GO:0098917,1,0.970297175938638,0,3,retrograde trans-synaptic signaling,BP,
16938,GO:0098918,1,0.992298730129102,0,1,structural constituent of synapse,MF,
16939,GO:0098920,1,0.995364276335639,0,1,retrograde trans-synaptic signaling by lipid,BP,
16940,GO:0098921,1,0.995364276335639,0,1,retrograde trans-synaptic signaling by endocannabinoid,BP,
16941,GO:0098923,1,0.995366990826059,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
16942,GO:0098924,1,0.995366990826059,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
16943,GO:0098926,1,0.995366990826073,0,1,postsynaptic signal transduction,BP,
16944,GO:0098927,1,0.76417240720951,0,41,vesicle-mediated transport between endosomal compartments,BP,
16945,GO:0098928,1,0.990755199848391,0,2,presynaptic signal transduction,BP,
16946,GO:0098930,1,0.736750072707291,0,41,axonal transport,BP,
16947,GO:0098935,1,0.986164527082929,0,3,dendritic transport,BP,
16948,GO:0098936,1,0.990755199849216,0,2,intrinsic component of postsynaptic membrane,CC,
16949,GO:0098937,1,0.986164527082929,0,3,anterograde dendritic transport,BP,
16950,GO:0098939,1,0.995366990826086,0,1,dendritic transport of mitochondrion,BP,
16951,GO:0098943,1,0.982730018199957,0,2,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
16952,GO:0098948,1,0.995366990826085,0,1,intrinsic component of postsynaptic specialization membrane,CC,
16953,GO:0098953,1,0.978176109459279,0,3,receptor diffusion trapping,BP,
16954,GO:0098957,1,0.977497231042129,0,4,anterograde axonal transport of mitochondrion,BP,
16955,GO:0098960,1,0.975890865475588,0,5,postsynaptic neurotransmitter receptor activity,MF,
16956,GO:0098967,1,0.985896568951786,0,3,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
16957,GO:0098968,1,0.995366990826151,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
16958,GO:0098969,1,0.957828722821603,0,9,neurotransmitter receptor transport to postsynaptic membrane,BP,
16959,GO:0098970,1,0.978176109459279,0,3,postsynaptic neurotransmitter receptor diffusion trapping,BP,
16960,GO:0098971,1,0.990755195890397,0,2,anterograde dendritic transport of neurotransmitter receptor complex,BP,
16961,GO:0098972,1,0.995366990826086,0,1,anterograde dendritic transport of mitochondrion,BP,
16962,GO:0098973,1,0.992298730129102,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
16963,GO:0098974,1,0.992298730129102,0,1,postsynaptic actin cytoskeleton organization,BP,
16964,GO:0098976,1,0.985435225792237,0,3,excitatory chemical synaptic transmission,BP,
16965,GO:0098978,1,0.995366990826152,0,1,glutamatergic synapse,CC,
16966,GO:0098982,1,0.990755199849292,0,2,GABA-ergic synapse,CC,
16967,GO:0098983,1,0.990755199849292,0,2,symmetric, GABA-ergic, inhibitory synapse,CC,
16968,GO:0098984,1,0.445787924051961,0,151,neuron to neuron synapse,CC,
16969,GO:0098985,1,0.995366990826152,0,1,asymmetric, glutamatergic, excitatory synapse,CC,
16970,GO:0098988,1,0.995366990826112,0,1,G-protein coupled glutamate receptor activity,MF,
16971,GO:0098989,1,0.984107872091776,0,2,NMDA selective glutamate receptor signaling pathway,BP,
16972,GO:0098993,1,0.939808717628523,0,8,anchored component of synaptic vesicle membrane,CC,
16973,GO:0099003,1,0.590752918548765,0,90,vesicle-mediated transport in synapse,BP,
16974,GO:0099004,1,0.99075519984928,0,2,calmodulin dependent kinase signaling pathway,BP,
16975,GO:0099010,1,0.986164118478036,0,3,modification of postsynaptic structure,BP,
16976,GO:0099011,1,0.990755199507577,0,2,neuronal dense core vesicle exocytosis,BP,
16977,GO:0099022,1,0.985646873202123,0,2,vesicle tethering,BP,
16978,GO:0099023,1,0.653984790991687,0,65,tethering complex,CC,
16979,GO:0099024,1,0.807017978480778,0,34,plasma membrane invagination,BP,
16980,GO:0099039,1,0.995366990826099,0,1,sphingolipid translocation,BP,
16981,GO:0099044,1,0.985646873202123,0,2,vesicle tethering to endoplasmic reticulum,BP,
16982,GO:0099046,1,0.987746831482751,0,1,clearance of foreign intracellular nucleic acids,BP,
16983,GO:0099053,1,0.984742301234459,0,3,activating signal cointegrator 1 complex,CC,
16984,GO:0099054,1,0.946335725718612,0,11,presynapse assembly,BP,
16985,GO:0099055,1,0.990755199849216,0,2,integral component of postsynaptic membrane,CC,
16986,GO:0099060,1,0.995366990826085,0,1,integral component of postsynaptic specialization membrane,CC,
16987,GO:0099061,1,0.995366990826085,0,1,integral component of postsynaptic density membrane,CC,
16988,GO:0099068,1,0.955171378805847,0,9,postsynapse assembly,BP,
16989,GO:0099072,1,0.919657522981704,0,16,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,
16990,GO:0099073,1,0.99075508876776,0,2,mitochondrion-derived vesicle,CC,
16991,GO:0099074,1,0.990744022224277,0,2,mitochondrion to lysosome transport,BP,
16992,GO:0099075,1,0.990744022224277,0,2,mitochondrion-derived vesicle mediated transport,BP,
16993,GO:0099077,1,0.995366990826125,0,1,histone-dependent DNA binding,MF,
16994,GO:0099078,1,0.922663692244467,0,8,BORC complex,CC,
16997,GO:0099082,1,0.979355933200066,0,1,retrograde trans-synaptic signaling by neuropeptide,BP,
16998,GO:0099083,1,0.979355933200066,0,1,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
16999,GO:0099084,1,0.96588846052133,0,7,postsynaptic specialization organization,BP,
17000,GO:0099086,1,0.905844070699634,0,17,synaptonemal structure,CC,
17001,GO:0099089,1,0.995366990825851,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
17002,GO:0099093,1,0.990754785405313,0,2,calcium export from the mitochondrion,BP,
17003,GO:0099094,1,0.839687989193018,0,33,ligand-gated cation channel activity,MF,
17004,GO:0099095,1,0.995366801879365,0,1,ligand-gated anion channel activity,MF,
17005,GO:0099098,1,0.995366845033235,0,1,microtubule polymerization based movement,BP,
17006,GO:0099106,1,0.687321681755485,0,51,ion channel regulator activity,MF,
17007,GO:0099111,1,0.3905865551553,0,131,microtubule-based transport,BP,
17008,GO:0099116,1,0.820685372296915,0,16,tRNA 5'-end processing,BP,
17009,GO:0099118,1,0.972647390717231,0,2,microtubule-based protein transport,BP,
17010,GO:0099122,1,0.985295426358395,0,3,RNA polymerase II C-terminal domain binding,MF,
17011,GO:0099130,1,0.99474608773005,0,1,estrogen binding,MF,
17012,GO:0099131,1,0.810836549625144,0,21,ATP hydrolysis coupled ion transmembrane transport,BP,
17013,GO:0099132,1,0.777561267609836,0,30,ATP hydrolysis coupled cation transmembrane transport,BP,
17014,GO:0099133,1,0.963524655653009,0,8,ATP hydrolysis coupled anion transmembrane transport,BP,
17015,GO:0099146,1,0.995366990826085,0,1,intrinsic component of postsynaptic density membrane,CC,
17016,GO:0099159,1,0.995366990826059,0,1,regulation of modification of postsynaptic structure,BP,
17017,GO:0099163,1,0.995366990826059,0,1,synaptic signaling by nitric oxide,BP,
17018,GO:0099170,1,0.986163390293606,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
17019,GO:0099172,1,0.923265911269572,0,13,presynapse organization,BP,
17021,GO:0099174,1,0.986164241815905,0,3,regulation of presynapse organization,BP,
17022,GO:0099175,1,0.818941035932069,0,33,regulation of postsynapse organization,BP,
17024,GO:0099186,1,0.992298730129102,0,1,structural constituent of postsynapse,MF,
17025,GO:0099188,1,0.992298730129102,0,1,postsynaptic cytoskeleton organization,BP,
17026,GO:0099240,1,0.990755199849216,0,2,intrinsic component of synaptic membrane,CC,
17027,GO:0099243,1,0.99536699082606,0,1,extrinsic component of synaptic membrane,CC,
17028,GO:0099402,1,0.974537838279069,0,1,plant organ development,BP,
17029,GO:0099403,1,0.990755199848811,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
17030,GO:0099404,1,0.990755199848811,0,2,mitotic sister chromatid cohesion, telomeric,BP,
17031,GO:0099500,1,0.930221311169305,0,10,vesicle fusion to plasma membrane,BP,
17032,GO:0099501,1,0.6976789447631,0,52,exocytic vesicle membrane,CC,
17034,GO:0099504,1,0.64687569463086,0,79,synaptic vesicle cycle,BP,
17037,GO:0099514,1,0.877100132942651,0,15,synaptic vesicle cytoskeletal transport,BP,
17038,GO:0099515,1,0.959058340085179,0,9,actin filament-based transport,BP,
17040,GO:0099517,1,0.877100132942651,0,15,synaptic vesicle transport along microtubule,BP,
17041,GO:0099518,1,0.770712505983954,0,42,vesicle cytoskeletal trafficking,BP,
17042,GO:0099519,1,0.995366574475227,0,1,dense core granule cytoskeletal transport,BP,
17043,GO:0099522,1,0.993932201489667,0,1,region of cytosol,CC,
17044,GO:0099523,1,0.993932201489667,0,1,presynaptic cytosol,CC,
17045,GO:0099524,1,0.993932201489667,0,1,postsynaptic cytosol,CC,
17046,GO:0099525,1,0.990755199507577,0,2,presynaptic dense core vesicle exocytosis,BP,
17047,GO:0099526,1,0.990755199848391,0,2,presynapse to nucleus signaling pathway,BP,
17048,GO:0099527,1,0.995366990826073,0,1,postsynapse to nucleus signaling pathway,BP,
17049,GO:0099528,1,0.94402561682171,0,9,G-protein coupled neurotransmitter receptor activity,MF,
17050,GO:0099529,1,0.975890865475588,0,5,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
17052,GO:0099532,1,0.990755199849161,0,2,synaptic vesicle endosomal processing,BP,
17055,GO:0099538,1,0.979355933200066,0,1,synaptic signaling via neuropeptide,BP,
17056,GO:0099540,1,0.979355933200066,0,1,trans-synaptic signaling by neuropeptide,BP,
17057,GO:0099541,1,0.990752494803946,0,2,trans-synaptic signaling by lipid,BP,
17058,GO:0099542,1,0.990752494803946,0,2,trans-synaptic signaling by endocannabinoid,BP,
17059,GO:0099543,1,0.995366990826059,0,1,trans-synaptic signaling by soluble gas,BP,
17060,GO:0099545,1,0.995366990826165,0,1,trans-synaptic signaling by trans-synaptic complex,BP,
17061,GO:0099547,1,0.986163390293606,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
17062,GO:0099548,1,0.995366990826059,0,1,trans-synaptic signaling by nitric oxide,BP,
17063,GO:0099550,1,0.970299819913095,0,3,trans-synaptic signaling, modulating synaptic transmission,BP,
17064,GO:0099551,1,0.979355933200066,0,1,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
17065,GO:0099552,1,0.995366987824648,0,1,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,
17066,GO:0099553,1,0.995366987824648,0,1,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,
17067,GO:0099557,1,0.995366990826165,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
17068,GO:0099563,1,0.942947811061538,0,12,modification of synaptic structure,BP,
17069,GO:0099565,1,0.777111946257093,0,47,chemical synaptic transmission, postsynaptic,BP,
17071,GO:0099569,1,0.981594888732587,0,4,presynaptic cytoskeleton,CC,
17072,GO:0099571,1,0.991122612138284,0,1,postsynaptic cytoskeleton,CC,
17073,GO:0099572,1,0.452100818523276,0,148,postsynaptic specialization,CC,
17074,GO:0099578,1,0.986163390293606,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
17075,GO:0099580,1,0.995366990826112,0,1,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
17077,GO:0099589,1,0.973240272848599,0,3,serotonin receptor activity,MF,
17078,GO:0099590,1,0.964638620182066,0,6,neurotransmitter receptor internalization,BP,
17079,GO:0099601,1,0.877608071300617,0,23,regulation of neurotransmitter receptor activity,BP,
17080,GO:0099602,1,0.937522993410013,0,6,neurotransmitter receptor regulator activity,MF,
17081,GO:0099604,1,0.902215193581986,0,18,ligand-gated calcium channel activity,MF,
17082,GO:0099606,1,0.995366990825994,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
17083,GO:0099607,1,0.995366990825994,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
17084,GO:0099609,1,0.990755199849227,0,2,microtubule lateral binding,MF,
17085,GO:0099612,1,0.972517716889952,0,6,protein localization to axon,BP,
17086,GO:0099617,1,0.995366919116862,0,1,matrix side of mitochondrial inner membrane,CC,
17087,GO:0099622,1,0.927491567388114,0,15,cardiac muscle cell membrane repolarization,BP,
17088,GO:0099623,1,0.949885726949425,0,11,regulation of cardiac muscle cell membrane repolarization,BP,
17089,GO:0099624,1,0.990754787598752,0,2,atrial cardiac muscle cell membrane repolarization,BP,
17090,GO:0099625,1,0.949885331513765,0,11,ventricular cardiac muscle cell membrane repolarization,BP,
17091,GO:0099627,1,0.995366574475227,0,1,neurotransmitter receptor cycle,BP,
17092,GO:0099628,1,0.978176109459279,0,3,neurotransmitter receptor diffusion trapping,BP,
17093,GO:0099630,1,0.995366574475227,0,1,postsynaptic neurotransmitter receptor cycle,BP,
17094,GO:0099631,1,0.965701245973483,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
17095,GO:0099632,1,0.932570818057989,0,13,protein transport within plasma membrane,BP,
17096,GO:0099634,1,0.95984545757914,0,7,postsynaptic specialization membrane,CC,
17097,GO:0099637,1,0.932570818057989,0,13,neurotransmitter receptor transport,BP,
17098,GO:0099638,1,0.972295071871651,0,6,endosome to plasma membrane protein transport,BP,
17099,GO:0099639,1,0.972295071871651,0,6,neurotransmitter receptor transport, endosome to plasma membrane,BP,
17100,GO:0099640,1,0.977176262583746,0,1,axo-dendritic protein transport,BP,
17101,GO:0099641,1,0.977176262583746,0,1,anterograde axonal protein transport,BP,
17102,GO:0099643,1,0.641579635124646,0,75,signal release from synapse,BP,
17103,GO:0099699,1,0.990755199849216,0,2,integral component of synaptic membrane,CC,
17104,GO:0099738,1,0.832572763410915,0,28,cell cortex region,CC,
17105,GO:0100002,1,0.995366542797979,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
17106,GO:0100012,1,0.992243492218644,0,1,regulation of heart induction by canonical Wnt signaling pathway,BP,
17107,GO:0100057,1,0.995366990826034,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
17110,GO:0101005,1,0.590181733903329,0,87,ubiquitinyl hydrolase activity,MF,
17111,GO:0101006,1,0.970007091871985,0,3,protein histidine phosphatase activity,MF,
17112,GO:0101020,1,0.98672548679614,0,2,estrogen 16-alpha-hydroxylase activity,MF,
17113,GO:0101023,1,0.942975087286977,0,11,vascular endothelial cell proliferation,BP,
17114,GO:0101030,1,0.986011881134435,0,1,tRNA-guanine transglycosylation,BP,
17115,GO:0101031,1,0.937796206155205,0,11,chaperone complex,CC,
17116,GO:0102005,1,0.988739989975495,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
17117,GO:0102007,1,0.990472787608466,0,1,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
17118,GO:0102008,1,0.995366990826164,0,1,cytosolic dipeptidase activity,MF,
17119,GO:0102009,1,0.993020547021285,0,1,proline dipeptidase activity,MF,
17120,GO:0102077,1,0.994289444996161,0,1,oleamide hydrolase activity,MF,
17121,GO:0102084,1,0.990269130155397,0,2,L-dopa O-methyltransferase activity,MF,
17122,GO:0102092,1,0.990755199849254,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
17123,GO:0102113,1,0.995366990826073,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
17124,GO:0102121,1,0.990705075904616,0,2,ceramidase activity,MF,
17125,GO:0102131,1,0.995366990825994,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
17126,GO:0102132,1,0.995366990825994,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
17127,GO:0102148,1,0.983185084188198,0,3,N-acetyl-beta-D-galactosaminidase activity,MF,
17128,GO:0102158,1,0.981593246111093,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
17129,GO:0102166,1,0.995366990826151,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17130,GO:0102167,1,0.995366990826151,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17131,GO:0102200,1,0.995366990826151,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
17132,GO:0102250,1,0.990754685232654,0,2,linear malto-oligosaccharide phosphorylase activity,MF,
17133,GO:0102336,1,0.970177743393844,0,5,3-oxo-arachidoyl-CoA synthase activity,MF,
17134,GO:0102337,1,0.970177743393844,0,5,3-oxo-cerotoyl-CoA synthase activity,MF,
17135,GO:0102338,1,0.970177743393844,0,5,3-oxo-lignoceronyl-CoA synthase activity,MF,
17136,GO:0102339,1,0.995305832808185,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
17137,GO:0102340,1,0.995305832808185,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
17138,GO:0102341,1,0.995305832808185,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
17139,GO:0102342,1,0.995305832808185,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
17140,GO:0102343,1,0.981593246111093,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
17141,GO:0102344,1,0.981593246111093,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
17142,GO:0102345,1,0.981593246111093,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
17143,GO:0102389,1,0.995355450952031,0,1,polyprenol reductase activity,MF,
17144,GO:0102390,1,0.995351130689079,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
17145,GO:0102391,1,0.981594634352019,0,4,decanoate-CoA ligase activity,MF,
17146,GO:0102420,1,0.981593596320943,0,4,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
17147,GO:0102485,1,0.990754662417104,0,2,dATP phosphohydrolase activity,MF,
17148,GO:0102486,1,0.990754662417104,0,2,dCTP phosphohydrolase activity,MF,
17149,GO:0102487,1,0.990754662417104,0,2,dUTP phosphohydrolase activity,MF,
17150,GO:0102488,1,0.990754662417104,0,2,dTTP phosphohydrolase activity,MF,
17151,GO:0102489,1,0.990754662417104,0,2,GTP phosphohydrolase activity,MF,
17152,GO:0102490,1,0.990754662417104,0,2,8-oxo-dGTP phosphohydrolase activity,MF,
17153,GO:0102491,1,0.990754662417104,0,2,dGTP phosphohydrolase activity,MF,
17154,GO:0102499,1,0.990754685232654,0,2,SHG alpha-glucan phosphorylase activity,MF,
17155,GO:0102500,1,0.995366990826059,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
17156,GO:0102521,1,0.990523196875397,0,2,tRNA-4-demethylwyosine synthase activity,MF,
17157,GO:0102522,1,0.994710704551784,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
17158,GO:0102524,1,0.995366574475227,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
17159,GO:0102567,1,0.940193068445393,0,12,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,
17160,GO:0102568,1,0.940193068445393,0,12,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,
17161,GO:0102571,1,0.995366990826151,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17162,GO:0102704,1,0.995366588660317,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
17163,GO:0102707,1,0.99531532720628,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
17164,GO:0102751,1,0.992280390272765,0,1,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
17165,GO:0102752,1,0.995366771002472,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
17166,GO:0102756,1,0.970177743393844,0,5,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
17167,GO:0102758,1,0.982940776527806,0,1,very-long-chain enoyl-CoA reductase activity,MF,
17168,GO:0102769,1,0.990398588884564,0,1,dihydroceramide glucosyltransferase activity,MF,
17169,GO:0102773,1,0.995366990826151,0,1,dihydroceramide kinase activity,MF,
17170,GO:0102797,1,0.995366990826165,0,1,geranial:oxygen oxidoreductase activity,MF,
17171,GO:0102798,1,0.995366990826165,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
17172,GO:0102867,1,0.995365006131273,0,1,molybdenum cofactor sulfurtransferase activity,MF,
17173,GO:0102938,1,0.990269130155397,0,2,orcinol O-methyltransferase activity,MF,
17174,GO:0102953,1,0.985840800138348,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
17175,GO:0102965,1,0.989664330656425,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
17176,GO:0102991,1,0.96600321979699,0,4,myristoyl-CoA hydrolase activity,MF,
17177,GO:0103025,1,0.994611031178077,0,1,alpha-amylase activity (releasing maltohexaose),MF,
17178,GO:0103045,1,0.994136844408377,0,1,methione N-acyltransferase activity,MF,
17179,GO:0103046,1,0.995366990826164,0,1,alanylglutamate dipeptidase activity,MF,
17180,GO:0103053,1,0.973687235822062,0,2,1-ethyladenine demethylase activity,MF,
17181,GO:0103066,1,0.989979106038821,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
17182,GO:0103067,1,0.989979106038821,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
17183,GO:0103068,1,0.985840800138348,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
17184,GO:0103073,1,0.994289444996161,0,1,anandamide amidohydrolase activity,MF,
17186,GO:0104005,1,0.766604821304032,0,44,hijacked molecular function,MF,
17187,GO:0106001,1,0.986164326333803,0,3,intestinal hexose absorption,BP,
17188,GO:0106003,1,0.945121426229015,0,9,amyloid-beta complex,CC,
17189,GO:0106004,1,0.976362096561499,0,2,tRNA (guanine-N7)-methylation,BP,
17190,GO:0106005,1,0.995366990826112,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
17191,GO:0106014,1,0.98149373911862,0,2,regulation of inflammatory response to wounding,BP,
17192,GO:0106015,1,0.98149373911862,0,2,negative regulation of inflammatory response to wounding,BP,
17193,GO:0106017,1,0.986164531023637,0,3,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
17194,GO:0106018,1,0.936753295308809,0,14,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,
17195,GO:0106019,1,0.954035674679874,0,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
17196,GO:0106020,1,0.9902379554134,0,2,regulation of vesicle docking,BP,
17197,GO:0106022,1,0.995366990482937,0,1,positive regulation of vesicle docking,BP,
17198,GO:0106027,1,0.744952450555913,0,52,neuron projection organization,BP,
17199,GO:0106028,1,0.995366990826165,0,1,neuron projection retraction,BP,
17200,GO:0106030,1,0.934503594679803,0,14,neuron projection fasciculation,BP,
17201,GO:0106044,1,0.978037514283719,0,1,guanine deglycation,BP,
17202,GO:0106045,1,0.978037514283719,0,1,guanine deglycation, methylglyoxal removal,BP,
17203,GO:0106046,1,0.978037514283719,0,1,guanine deglycation, glyoxal removal,BP,
17204,GO:0106049,1,0.963377418941395,0,5,regulation of cellular response to osmotic stress,BP,
17205,GO:0106050,1,0.993477298997412,0,1,tRNA 2'-O-methyltransferase activity,MF,
17206,GO:0106056,1,0.909308606685985,0,15,regulation of calcineurin-mediated signaling,BP,
17207,GO:0106057,1,0.986161861666483,0,3,negative regulation of calcineurin-mediated signaling,BP,
17208,GO:0106058,1,0.939199822407268,0,9,positive regulation of calcineurin-mediated signaling,BP,
17209,GO:0106068,1,0.927560456051844,0,7,SUMO ligase complex,CC,
17210,GO:0106070,1,0.973772714997254,0,5,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
17211,GO:0106071,1,0.985419042338137,0,3,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
17212,GO:0106072,1,0.988183333816769,0,2,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
17213,GO:0106073,1,0.990754990230913,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
17214,GO:0106074,1,0.939282379298053,0,11,aminoacyl-tRNA metabolism involved in translational fidelity,BP,
17215,GO:0106075,1,0.995366781641782,0,1,peptide N-succinyltransferase activity,MF,
17216,GO:0106077,1,0.981594201733171,0,4,histone succinylation,BP,
17217,GO:0106078,1,0.995366781641782,0,1,histone succinyltransferase activity,MF,
17218,GO:0106083,1,0.97704576141478,0,5,nuclear membrane protein complex,CC,
17219,GO:0106088,1,0.995366990826073,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
17220,GO:0106089,1,0.995366990826073,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
17221,GO:0106094,1,0.97704576141478,0,5,nuclear membrane microtubule tethering complex,CC,
17222,GO:0106101,1,0.992620824102658,0,1,ER-dependent peroxisome localization,BP,
17223,GO:0106104,1,0.995216167640349,0,1,regulation of glutamate receptor clustering,BP,
17224,GO:0110008,1,0.995366726881011,0,1,ncRNA deadenylation,BP,
17225,GO:0110009,1,0.990755068968956,0,2,formin-nucleated actin cable organization,BP,
17226,GO:0110011,1,0.977046177790215,0,5,regulation of basement membrane organization,BP,
17227,GO:0110017,1,0.967067919405611,0,2,cap-independent translational initiation of linear mRNA,BP,
17228,GO:0110020,1,0.700806556893692,0,63,regulation of actomyosin structure organization,BP,
17229,GO:0110021,1,0.989740499667853,0,2,cardiac muscle myoblast proliferation,BP,
17230,GO:0110022,1,0.989740499667853,0,2,regulation of cardiac muscle myoblast proliferation,BP,
17231,GO:0110024,1,0.989740499667853,0,2,positive regulation of cardiac muscle myoblast proliferation,BP,
17232,GO:0110025,1,0.995366730529598,0,1,DNA strand resection involved in replication fork processing,BP,
17233,GO:0110026,1,0.995366730529598,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
17234,GO:0110028,1,0.995366990826059,0,1,positive regulation of mitotic spindle organization,BP,
17235,GO:0110029,1,0.995366802530454,0,1,negative regulation of meiosis I,BP,
17237,GO:0110057,1,0.995366990826139,0,1,regulation of blood vessel endothelial cell differentiation,BP,
17238,GO:0110059,1,0.995366990826139,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
17239,GO:0110075,1,0.978190619441799,0,1,regulation of ferroptosis,BP,
17240,GO:0110076,1,0.978190619441799,0,1,negative regulation of ferroptosis,BP,
17241,GO:0110095,1,0.95736442279215,0,3,cellular detoxification of aldehyde,BP,
17242,GO:0110096,1,0.939996248158679,0,5,cellular response to aldehyde,BP,
17243,GO:0120009,1,0.975049189171089,0,5,intermembrane lipid transfer,BP,
17244,GO:0120012,1,0.995366990826153,0,1,intermembrane sphingolipid transfer,BP,
17245,GO:0120013,1,0.975049189171089,0,5,intermembrane lipid transfer activity,MF,
17246,GO:0120016,1,0.995366990826153,0,1,intermembrane sphingolipid transfer activity,MF,
17247,GO:0120017,1,0.995366990826153,0,1,intermembrane ceramide transfer activity,MF,
17249,GO:0120031,1,0.0683395910999908,0,428,plasma membrane bounded cell projection assembly,BP,
17250,GO:0120032,1,0.451649636417353,0,123,regulation of plasma membrane bounded cell projection assembly,BP,
17251,GO:0120033,1,0.892043967735177,0,19,negative regulation of plasma membrane bounded cell projection assembly,BP,
17252,GO:0120034,1,0.640391587323245,0,72,positive regulation of plasma membrane bounded cell projection assembly,BP,
17253,GO:0120035,1,0.0661885942492763,0,429,regulation of plasma membrane bounded cell projection organization,BP,
17257,GO:0120043,1,0.995366990826165,0,1,stereocilium shaft,CC,
17258,GO:0120044,1,0.995366990826165,0,1,stereocilium base,CC,
17259,GO:0120048,1,0.995366574475227,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
17260,GO:0120049,1,0.995366574475227,0,1,snRNA (adenine-N6)-methylation,BP,
17261,GO:0120060,1,0.975368272283632,0,1,regulation of gastric emptying,BP,
17262,GO:0120061,1,0.975368272283632,0,1,negative regulation of gastric emptying,BP,
17263,GO:0120063,1,0.975368272283632,0,1,stomach smooth muscle contraction,BP,
17264,GO:0120068,1,0.975368272283632,0,1,regulation of stomach fundus smooth muscle contraction,BP,
17265,GO:0120069,1,0.975368272283632,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
17266,GO:0120077,1,0.995366990826073,0,1,angiogenic sprout fusion,BP,
17267,GO:0120078,1,0.995366990826073,0,1,cell adhesion involved in sprouting angiogenesis,BP,
17268,GO:0120092,1,0.995366908369985,0,1,crotonyl-CoA hydratase activity,MF,
17269,GO:0120093,1,0.995366908369985,0,1,regulation of peptidyl-lysine crotonylation,BP,
17270,GO:0120094,1,0.995366908369985,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
17271,GO:0120103,1,0.959057565033351,0,9,centriolar subdistal appendage,CC,
17272,GO:0120108,1,0.993859261278676,0,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,
17273,GO:0120111,1,0.644473407704549,0,59,neuron projection cytoplasm,CC,
17275,GO:0140007,1,0.977113941846264,0,4,KICSTOR complex,CC,
17276,GO:0140009,1,0.995366976319119,0,1,L-aspartate import across plasma membrane,BP,
17277,GO:0140013,1,0.521971296590861,0,103,meiotic nuclear division,BP,
17278,GO:0140014,1,0.206049109441008,0,240,mitotic nuclear division,BP,
17280,GO:0140030,1,0.530516561523828,0,114,modification-dependent protein binding,MF,
17281,GO:0140031,1,0.990234906876631,0,2,phosphorylation-dependent protein binding,MF,
17282,GO:0140033,1,0.927776019346093,0,16,acetylation-dependent protein binding,MF,
17283,GO:0140034,1,0.721938230920769,0,56,methylation-dependent protein binding,MF,
17284,GO:0140035,1,0.971622833458931,0,6,ubiquitination-like modification-dependent protein binding,MF,
17285,GO:0140036,1,0.971622833458931,0,6,ubiquitin-dependent protein binding,MF,
17286,GO:0140041,1,0.978037514283719,0,1,cellular detoxification of methylglyoxal,BP,
17287,GO:0140052,1,0.986155636503373,0,3,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
17288,GO:0140053,1,0.143235490913643,0,153,mitochondrial gene expression,BP,
17290,GO:0140058,1,0.940495494063097,0,13,neuron projection arborization,BP,
17291,GO:0140059,1,0.976109780865749,0,5,dendrite arborization,BP,
17292,GO:0140064,1,0.995366990825981,0,1,peptide crotonyltransferase activity,MF,
17293,GO:0140065,1,0.995366990825981,0,1,peptide butyryltransferase activity,MF,
17294,GO:0140066,1,0.990755117770613,0,2,peptidyl-lysine crotonylation,BP,
17295,GO:0140067,1,0.995366990825981,0,1,peptidyl-lysine butyrylation,BP,
17296,GO:0140068,1,0.995366990825981,0,1,histone crotonyltransferase activity,MF,
17297,GO:0140069,1,0.995366990825981,0,1,histone butyryltransferase activity,MF,
17298,GO:0140074,1,0.995366990826151,0,1,cardiac endothelial to mesenchymal transition,BP,
17299,GO:0140078,1,0.909071345931558,0,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
17300,GO:0140080,1,0.909071345931558,0,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
17302,GO:0140097,1,0.297790486862725,0,178,catalytic activity, acting on DNA,MF,
17303,GO:0140098,1,0.0837402092426658,0,331,catalytic activity, acting on RNA,MF,
17304,GO:0140101,1,0.423602183390063,0,117,catalytic activity, acting on a tRNA,MF,
17305,GO:0140102,1,0.862884158299057,0,16,catalytic activity, acting on a rRNA,MF,
17306,GO:0140103,1,0.90686022209676,0,19,catalytic activity, acting on a glycoprotein,MF,
17307,GO:0140104,1,0.731187449028269,0,27,molecular carrier activity,MF,
17309,GO:0140112,1,0.869866312553773,0,19,extracellular vesicle biogenesis,BP,
17310,GO:0140115,1,0.958560031678702,0,8,export across plasma membrane,BP,
17311,GO:0140131,1,0.949032704922235,0,8,positive regulation of lymphocyte chemotaxis,BP,
17312,GO:0140135,1,0.990755013385102,0,2,mechanosensitive cation channel activity,MF,
17313,GO:0140142,1,0.878783450682706,0,18,nucleocytoplasmic carrier activity,MF,
17314,GO:0140161,1,0.975536638019227,0,3,monocarboxylate:sodium symporter activity,MF,
17315,GO:0140192,1,0.990755199849017,0,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17318,GO:0140196,1,0.995366990826059,0,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17319,GO:0140199,1,0.99536699082598,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17320,GO:0140200,1,0.99536699082602,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
17321,GO:0150003,1,0.976945779456762,0,3,regulation of spontaneous synaptic transmission,BP,
17322,GO:0150005,1,0.922589309387685,0,10,enzyme activator complex,CC,
17323,GO:0150011,1,0.968010528809817,0,7,regulation of neuron projection arborization,BP,
17324,GO:0150012,1,0.968010528809817,0,7,positive regulation of neuron projection arborization,BP,
17325,GO:0150018,1,0.986057635053937,0,3,basal dendrite development,BP,
17326,GO:0150019,1,0.986057635053937,0,3,basal dendrite morphogenesis,BP,
17327,GO:0150020,1,0.986057635053937,0,3,basal dendrite arborization,BP,
17328,GO:0150031,1,0.9953669908261,0,1,regulation of protein localization to lysosome,BP,
17329,GO:0150033,1,0.9953669908261,0,1,negative regulation of protein localization to lysosome,BP,
17332,GO:1900003,1,0.96200743824289,0,3,regulation of serine-type endopeptidase activity,BP,
17333,GO:1900004,1,0.96200743824289,0,3,negative regulation of serine-type endopeptidase activity,BP,
17334,GO:1900006,1,0.757088444127196,0,52,positive regulation of dendrite development,BP,
17335,GO:1900015,1,0.885597405019515,0,20,regulation of cytokine production involved in inflammatory response,BP,
17336,GO:1900016,1,0.944572812820955,0,8,negative regulation of cytokine production involved in inflammatory response,BP,
17337,GO:1900017,1,0.950765524346336,0,9,positive regulation of cytokine production involved in inflammatory response,BP,
17338,GO:1900019,1,0.981546409874461,0,4,regulation of protein kinase C activity,BP,
17339,GO:1900020,1,0.981546409874461,0,4,positive regulation of protein kinase C activity,BP,
17340,GO:1900024,1,0.769079396291265,0,39,regulation of substrate adhesion-dependent cell spreading,BP,
17341,GO:1900025,1,0.941944167731078,0,12,negative regulation of substrate adhesion-dependent cell spreading,BP,
17342,GO:1900026,1,0.820406728623085,0,26,positive regulation of substrate adhesion-dependent cell spreading,BP,
17343,GO:1900027,1,0.851596331983124,0,23,regulation of ruffle assembly,BP,
17344,GO:1900028,1,0.975716512901578,0,4,negative regulation of ruffle assembly,BP,
17345,GO:1900029,1,0.918118948178433,0,11,positive regulation of ruffle assembly,BP,
17346,GO:1900034,1,0.655167810040486,0,72,regulation of cellular response to heat,BP,
17347,GO:1900036,1,0.995036782169551,0,1,positive regulation of cellular response to heat,BP,
17348,GO:1900037,1,0.913033183534477,0,10,regulation of cellular response to hypoxia,BP,
17349,GO:1900038,1,0.961186866467893,0,6,negative regulation of cellular response to hypoxia,BP,
17350,GO:1900039,1,0.983056716431645,0,1,positive regulation of cellular response to hypoxia,BP,
17351,GO:1900040,1,0.977045395893087,0,5,regulation of interleukin-2 secretion,BP,
17352,GO:1900041,1,0.986163741913574,0,3,negative regulation of interleukin-2 secretion,BP,
17353,GO:1900042,1,0.990755199849058,0,2,positive regulation of interleukin-2 secretion,BP,
17354,GO:1900044,1,0.963316067001439,0,8,regulation of protein K63-linked ubiquitination,BP,
17355,GO:1900045,1,0.976834669934703,0,5,negative regulation of protein K63-linked ubiquitination,BP,
17356,GO:1900046,1,0.74692125008823,0,46,regulation of hemostasis,BP,
17357,GO:1900047,1,0.829672065719822,0,30,negative regulation of hemostasis,BP,
17358,GO:1900048,1,0.904708410993616,0,14,positive regulation of hemostasis,BP,
17359,GO:1900060,1,0.970280400693854,0,4,negative regulation of ceramide biosynthetic process,BP,
17360,GO:1900062,1,0.995366982381698,0,1,regulation of replicative cell aging,BP,
17361,GO:1900063,1,0.984636415436962,0,3,regulation of peroxisome organization,BP,
17362,GO:1900076,1,0.731058795704802,0,55,regulation of cellular response to insulin stimulus,BP,
17363,GO:1900077,1,0.840209860424334,0,28,negative regulation of cellular response to insulin stimulus,BP,
17364,GO:1900078,1,0.908898352242269,0,20,positive regulation of cellular response to insulin stimulus,BP,
17365,GO:1900081,1,0.99536699082598,0,1,regulation of arginine catabolic process,BP,
17366,GO:1900082,1,0.99536699082598,0,1,negative regulation of arginine catabolic process,BP,
17367,GO:1900084,1,0.981585720462194,0,4,regulation of peptidyl-tyrosine autophosphorylation,BP,
17368,GO:1900085,1,0.995357732214175,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
17369,GO:1900086,1,0.986164494552939,0,3,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
17370,GO:1900087,1,0.855367232907276,0,23,positive regulation of G1/S transition of mitotic cell cycle,BP,
17371,GO:1900094,1,0.97912703402223,0,3,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
17372,GO:1900095,1,0.995366990825916,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
17373,GO:1900098,1,0.992275793949614,0,1,regulation of plasma cell differentiation,BP,
17374,GO:1900100,1,0.992275793949614,0,1,positive regulation of plasma cell differentiation,BP,
17375,GO:1900101,1,0.852219082575355,0,25,regulation of endoplasmic reticulum unfolded protein response,BP,
17376,GO:1900102,1,0.947166160623636,0,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,
17377,GO:1900103,1,0.914748463037172,0,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,
17378,GO:1900104,1,0.984460289876324,0,3,regulation of hyaluranon cable assembly,BP,
17379,GO:1900106,1,0.984460289876324,0,3,positive regulation of hyaluranon cable assembly,BP,
17380,GO:1900107,1,0.986912936499269,0,2,regulation of nodal signaling pathway,BP,
17381,GO:1900108,1,0.99150704774668,0,1,negative regulation of nodal signaling pathway,BP,
17382,GO:1900109,1,0.97569195494477,0,2,regulation of histone H3-K9 dimethylation,BP,
17383,GO:1900110,1,0.97569195494477,0,2,negative regulation of histone H3-K9 dimethylation,BP,
17384,GO:1900112,1,0.944470509986005,0,9,regulation of histone H3-K9 trimethylation,BP,
17385,GO:1900113,1,0.962189002883419,0,5,negative regulation of histone H3-K9 trimethylation,BP,
17386,GO:1900114,1,0.990755199849254,0,2,positive regulation of histone H3-K9 trimethylation,BP,
17387,GO:1900115,1,0.92853925417924,0,11,extracellular regulation of signal transduction,BP,
17388,GO:1900116,1,0.92853925417924,0,11,extracellular negative regulation of signal transduction,BP,
17389,GO:1900117,1,0.859595798570461,0,20,regulation of execution phase of apoptosis,BP,
17390,GO:1900118,1,0.97103269563465,0,6,negative regulation of execution phase of apoptosis,BP,
17391,GO:1900119,1,0.894142800030041,0,12,positive regulation of execution phase of apoptosis,BP,
17392,GO:1900120,1,0.869904568038354,0,16,regulation of receptor binding,BP,
17393,GO:1900121,1,0.923858131641408,0,10,negative regulation of receptor binding,BP,
17394,GO:1900122,1,0.949662246674474,0,6,positive regulation of receptor binding,BP,
17395,GO:1900125,1,0.971837129585083,0,6,regulation of hyaluronan biosynthetic process,BP,
17396,GO:1900126,1,0.985474458086418,0,3,negative regulation of hyaluronan biosynthetic process,BP,
17397,GO:1900127,1,0.98616398201739,0,3,positive regulation of hyaluronan biosynthetic process,BP,
17398,GO:1900130,1,0.995366971297062,0,1,regulation of lipid binding,BP,
17399,GO:1900131,1,0.995366971297062,0,1,negative regulation of lipid binding,BP,
17400,GO:1900133,1,0.986163918218688,0,3,regulation of renin secretion into blood stream,BP,
17401,GO:1900134,1,0.995366987824648,0,1,negative regulation of renin secretion into blood stream,BP,
17402,GO:1900135,1,0.995366558830144,0,1,positive regulation of renin secretion into blood stream,BP,
17403,GO:1900138,1,0.976686837531618,0,3,negative regulation of phospholipase A2 activity,BP,
17404,GO:1900139,1,0.995366990826164,0,1,negative regulation of arachidonic acid secretion,BP,
17405,GO:1900141,1,0.995279256748665,0,1,regulation of oligodendrocyte apoptotic process,BP,
17406,GO:1900142,1,0.995279256748665,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
17407,GO:1900145,1,0.986912936499269,0,2,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17408,GO:1900146,1,0.99150704774668,0,1,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17409,GO:1900147,1,0.990754785405222,0,2,regulation of Schwann cell migration,BP,
17410,GO:1900148,1,0.995366574475227,0,1,negative regulation of Schwann cell migration,BP,
17411,GO:1900149,1,0.995366990826059,0,1,positive regulation of Schwann cell migration,BP,
17412,GO:1900150,1,0.983262274035892,0,2,regulation of defense response to fungus,BP,
17413,GO:1900151,1,0.912155317851678,0,14,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
17414,GO:1900152,1,0.992407249780557,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
17415,GO:1900153,1,0.912155317851678,0,14,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
17416,GO:1900161,1,0.995366417561992,0,1,regulation of phospholipid scramblase activity,BP,
17417,GO:1900163,1,0.995366417561992,0,1,positive regulation of phospholipid scramblase activity,BP,
17418,GO:1900164,1,0.97912703402223,0,3,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17419,GO:1900165,1,0.986074154243938,0,3,negative regulation of interleukin-6 secretion,BP,
17420,GO:1900169,1,0.990754785404988,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
17421,GO:1900170,1,0.995366574475227,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
17422,GO:1900175,1,0.986912936499269,0,2,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17423,GO:1900176,1,0.99150704774668,0,1,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17424,GO:1900180,1,0.5853885991851,0,84,regulation of protein localization to nucleus,BP,
17425,GO:1900181,1,0.917876120588365,0,15,negative regulation of protein localization to nucleus,BP,
17426,GO:1900182,1,0.709918970528604,0,57,positive regulation of protein localization to nucleus,BP,
17427,GO:1900186,1,0.979698339821669,0,3,negative regulation of clathrin-dependent endocytosis,BP,
17428,GO:1900193,1,0.974288547963557,0,5,regulation of oocyte maturation,BP,
17429,GO:1900194,1,0.995366935169542,0,1,negative regulation of oocyte maturation,BP,
17430,GO:1900195,1,0.988213893846604,0,2,positive regulation of oocyte maturation,BP,
17431,GO:1900200,1,0.995366989784868,0,1,mesenchymal cell apoptotic process involved in metanephros development,BP,
17432,GO:1900204,1,0.995366989784868,0,1,apoptotic process involved in metanephric collecting duct development,BP,
17433,GO:1900205,1,0.995366989784868,0,1,apoptotic process involved in metanephric nephron tubule development,BP,
17434,GO:1900208,1,0.977840676574324,0,2,regulation of cardiolipin metabolic process,BP,
17435,GO:1900210,1,0.977840676574324,0,2,positive regulation of cardiolipin metabolic process,BP,
17436,GO:1900211,1,0.995366989784868,0,1,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17437,GO:1900212,1,0.995366989784868,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17438,GO:1900214,1,0.995366989784868,0,1,regulation of apoptotic process involved in metanephric collecting duct development,BP,
17439,GO:1900215,1,0.995366989784868,0,1,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
17440,GO:1900217,1,0.995366989784868,0,1,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17441,GO:1900218,1,0.995366989784868,0,1,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17442,GO:1900220,1,0.990755199849188,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
17443,GO:1900221,1,0.941758741337882,0,9,regulation of amyloid-beta clearance,BP,
17444,GO:1900222,1,0.985036296899256,0,2,negative regulation of amyloid-beta clearance,BP,
17445,GO:1900223,1,0.966903471944199,0,6,positive regulation of amyloid-beta clearance,BP,
17446,GO:1900224,1,0.995366990825915,0,1,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17447,GO:1900225,1,0.957154638295987,0,9,regulation of NLRP3 inflammasome complex assembly,BP,
17448,GO:1900226,1,0.979651029460012,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
17449,GO:1900227,1,0.981594478074119,0,4,positive regulation of NLRP3 inflammasome complex assembly,BP,
17450,GO:1900238,1,0.990754003408654,0,2,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
17451,GO:1900239,1,0.98357152734779,0,3,regulation of phenotypic switching,BP,
17452,GO:1900241,1,0.995366558264269,0,1,positive regulation of phenotypic switching,BP,
17453,GO:1900242,1,0.971319164045948,0,6,regulation of synaptic vesicle endocytosis,BP,
17454,GO:1900243,1,0.995366990826152,0,1,negative regulation of synaptic vesicle endocytosis,BP,
17455,GO:1900244,1,0.989682589432389,0,2,positive regulation of synaptic vesicle endocytosis,BP,
17456,GO:1900245,1,0.986144175325878,0,3,positive regulation of MDA-5 signaling pathway,BP,
17457,GO:1900246,1,0.977026008157006,0,5,positive regulation of RIG-I signaling pathway,BP,
17458,GO:1900247,1,0.94562751263946,0,11,regulation of cytoplasmic translational elongation,BP,
17459,GO:1900248,1,0.990755199849241,0,2,negative regulation of cytoplasmic translational elongation,BP,
17460,GO:1900259,1,0.993012882178686,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
17461,GO:1900260,1,0.993012882178686,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
17462,GO:1900262,1,0.956967188447677,0,6,regulation of DNA-directed DNA polymerase activity,BP,
17463,GO:1900264,1,0.956967188447677,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
17464,GO:1900271,1,0.878027080613213,0,19,regulation of long-term synaptic potentiation,BP,
17465,GO:1900272,1,0.951541153824283,0,6,negative regulation of long-term synaptic potentiation,BP,
17466,GO:1900273,1,0.937907029174538,0,11,positive regulation of long-term synaptic potentiation,BP,
17467,GO:1900274,1,0.902963079858207,0,17,regulation of phospholipase C activity,BP,
17468,GO:1900275,1,0.99075514285262,0,2,negative regulation of phospholipase C activity,BP,
17469,GO:1900276,1,0.995366933567247,0,1,regulation of proteinase activated receptor activity,BP,
17470,GO:1900363,1,0.939765313664845,0,12,regulation of mRNA polyadenylation,BP,
17471,GO:1900364,1,0.963367168550039,0,8,negative regulation of mRNA polyadenylation,BP,
17472,GO:1900365,1,0.985322709341657,0,3,positive regulation of mRNA polyadenylation,BP,
17473,GO:1900368,1,0.952918476251616,0,3,regulation of RNA interference,BP,
17474,GO:1900369,1,0.957356132398819,0,2,negative regulation of RNA interference,BP,
17475,GO:1900370,1,0.995366990826153,0,1,positive regulation of RNA interference,BP,
17479,GO:1900376,1,0.981594888733349,0,4,regulation of secondary metabolite biosynthetic process,BP,
17480,GO:1900377,1,0.990755199849175,0,2,negative regulation of secondary metabolite biosynthetic process,BP,
17481,GO:1900378,1,0.990755199849162,0,2,positive regulation of secondary metabolite biosynthetic process,BP,
17483,GO:1900390,1,0.972689675881266,0,2,regulation of iron ion import,BP,
17485,GO:1900407,1,0.662093175602181,0,55,regulation of cellular response to oxidative stress,BP,
17486,GO:1900408,1,0.762584361226424,0,33,negative regulation of cellular response to oxidative stress,BP,
17487,GO:1900409,1,0.89590671962478,0,12,positive regulation of cellular response to oxidative stress,BP,
17488,GO:1900424,1,0.905341683600413,0,13,regulation of defense response to bacterium,BP,
17489,GO:1900425,1,0.973047039638511,0,5,negative regulation of defense response to bacterium,BP,
17490,GO:1900426,1,0.934436133215212,0,7,positive regulation of defense response to bacterium,BP,
17491,GO:1900449,1,0.904121035923378,0,19,regulation of glutamate receptor signaling pathway,BP,
17492,GO:1900450,1,0.995366990826165,0,1,negative regulation of glutamate receptor signaling pathway,BP,
17493,GO:1900451,1,0.980185041422079,0,4,positive regulation of glutamate receptor signaling pathway,BP,
17494,GO:1900452,1,0.972418414095555,0,4,regulation of long term synaptic depression,BP,
17495,GO:1900453,1,0.981494072432237,0,2,negative regulation of long term synaptic depression,BP,
17496,GO:1900477,1,0.994161580232478,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
17497,GO:1900483,1,0.995334827886526,0,1,regulation of protein targeting to vacuolar membrane,BP,
17498,GO:1900533,1,0.989034172764745,0,1,palmitic acid metabolic process,BP,
17499,GO:1900535,1,0.989034172764745,0,1,palmitic acid biosynthetic process,BP,
17503,GO:1900619,1,0.995352427354762,0,1,acetate ester metabolic process,BP,
17504,GO:1900620,1,0.995352427354762,0,1,acetate ester biosynthetic process,BP,
17505,GO:1900623,1,0.990755078897291,0,2,regulation of monocyte aggregation,BP,
17506,GO:1900625,1,0.990755078897291,0,2,positive regulation of monocyte aggregation,BP,
17507,GO:1900673,1,0.990059140076675,0,2,olefin metabolic process,BP,
17508,GO:1900736,1,0.995366933567247,0,1,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17509,GO:1900737,1,0.995366933567247,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17510,GO:1900739,1,0.805373686701991,0,28,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
17511,GO:1900740,1,0.805373686701991,0,28,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
17512,GO:1900744,1,0.859885351476695,0,23,regulation of p38MAPK cascade,BP,
17513,GO:1900745,1,0.892989170450329,0,15,positive regulation of p38MAPK cascade,BP,
17514,GO:1900746,1,0.937569639672081,0,9,regulation of vascular endothelial growth factor signaling pathway,BP,
17515,GO:1900747,1,0.974834248578634,0,4,negative regulation of vascular endothelial growth factor signaling pathway,BP,
17516,GO:1900748,1,0.986164531023597,0,3,positive regulation of vascular endothelial growth factor signaling pathway,BP,
17517,GO:1900750,1,0.879130723826444,0,11,oligopeptide binding,MF,
17518,GO:1900753,1,0.995366990826152,0,1,doxorubicin transport,BP,
17519,GO:1900756,1,0.990753196689833,0,2,protein processing in phagocytic vesicle,BP,
17520,GO:1900825,1,0.962185411613722,0,4,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
17521,GO:1900827,1,0.995366990825942,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
17522,GO:1900864,1,0.931782621251712,0,9,mitochondrial RNA modification,BP,
17523,GO:1901003,1,0.995366574475227,0,1,negative regulation of fermentation,BP,
17524,GO:1901004,1,0.984868073654943,0,1,ubiquinone-6 metabolic process,BP,
17525,GO:1901006,1,0.984868073654943,0,1,ubiquinone-6 biosynthetic process,BP,
17526,GO:1901016,1,0.836795556018378,0,30,regulation of potassium ion transmembrane transporter activity,BP,
17527,GO:1901017,1,0.951809150645378,0,9,negative regulation of potassium ion transmembrane transporter activity,BP,
17528,GO:1901018,1,0.934141323835691,0,9,positive regulation of potassium ion transmembrane transporter activity,BP,
17529,GO:1901019,1,0.734745300579007,0,46,regulation of calcium ion transmembrane transporter activity,BP,
17530,GO:1901020,1,0.865190648793035,0,16,negative regulation of calcium ion transmembrane transporter activity,BP,
17531,GO:1901021,1,0.857826383137604,0,22,positive regulation of calcium ion transmembrane transporter activity,BP,
17532,GO:1901026,1,0.986164523346095,0,3,ripoptosome assembly involved in necroptotic process,BP,
17533,GO:1901028,1,0.712019703757916,0,43,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
17534,GO:1901029,1,0.941425853947673,0,7,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
17535,GO:1901030,1,0.761473206636885,0,35,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
17536,GO:1901031,1,0.809346322001616,0,29,regulation of response to reactive oxygen species,BP,
17537,GO:1901032,1,0.892528715873215,0,13,negative regulation of response to reactive oxygen species,BP,
17538,GO:1901033,1,0.932612519007522,0,7,positive regulation of response to reactive oxygen species,BP,
17540,GO:1901069,1,0.976330385637387,0,2,guanosine-containing compound catabolic process,BP,
17542,GO:1901071,1,0.916157878489361,0,16,glucosamine-containing compound metabolic process,BP,
17543,GO:1901072,1,0.971730470584538,0,5,glucosamine-containing compound catabolic process,BP,
17544,GO:1901073,1,0.990755196341989,0,2,glucosamine-containing compound biosynthetic process,BP,
17545,GO:1901074,1,0.995366990826073,0,1,regulation of engulfment of apoptotic cell,BP,
17546,GO:1901076,1,0.995366990826073,0,1,positive regulation of engulfment of apoptotic cell,BP,
17547,GO:1901077,1,0.980010075157212,0,4,regulation of relaxation of muscle,BP,
17548,GO:1901078,1,0.99536699082602,0,1,negative regulation of relaxation of muscle,BP,
17549,GO:1901086,1,0.995366990826164,0,1,benzylpenicillin metabolic process,BP,
17550,GO:1901090,1,0.988661936484625,0,2,regulation of protein tetramerization,BP,
17551,GO:1901091,1,0.988661936484625,0,2,negative regulation of protein tetramerization,BP,
17552,GO:1901093,1,0.988661936484625,0,2,regulation of protein homotetramerization,BP,
17553,GO:1901094,1,0.988661936484625,0,2,negative regulation of protein homotetramerization,BP,
17554,GO:1901096,1,0.951887648019055,0,10,regulation of autophagosome maturation,BP,
17555,GO:1901097,1,0.980190135080129,0,4,negative regulation of autophagosome maturation,BP,
17556,GO:1901098,1,0.971132082073996,0,6,positive regulation of autophagosome maturation,BP,
17559,GO:1901136,1,0.391018891204484,0,129,carbohydrate derivative catabolic process,BP,
17561,GO:1901142,1,0.972351721737786,0,6,insulin metabolic process,BP,
17562,GO:1901143,1,0.990755151847146,0,2,insulin catabolic process,BP,
17563,GO:1901145,1,0.990755198812736,0,2,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
17564,GO:1901147,1,0.995366989784868,0,1,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
17565,GO:1901159,1,0.944380803966037,0,5,xylulose 5-phosphate biosynthetic process,BP,
17566,GO:1901160,1,0.966823288709579,0,7,primary amino compound metabolic process,BP,
17567,GO:1901162,1,0.990051354285002,0,2,primary amino compound biosynthetic process,BP,
17568,GO:1901163,1,0.918524979935525,0,8,regulation of trophoblast cell migration,BP,
17569,GO:1901164,1,0.955285754261359,0,3,negative regulation of trophoblast cell migration,BP,
17570,GO:1901165,1,0.961538353076715,0,5,positive regulation of trophoblast cell migration,BP,
17571,GO:1901166,1,0.986057600400874,0,3,neural crest cell migration involved in autonomic nervous system development,BP,
17572,GO:1901184,1,0.611840030680007,0,79,regulation of ERBB signaling pathway,BP,
17573,GO:1901185,1,0.729595221650937,0,48,negative regulation of ERBB signaling pathway,BP,
17574,GO:1901186,1,0.822134337263736,0,27,positive regulation of ERBB signaling pathway,BP,
17575,GO:1901187,1,0.990470746392852,0,2,regulation of ephrin receptor signaling pathway,BP,
17576,GO:1901189,1,0.995081228517227,0,1,positive regulation of ephrin receptor signaling pathway,BP,
17577,GO:1901193,1,0.982097209269804,0,1,regulation of formation of translation preinitiation complex,BP,
17578,GO:1901194,1,0.982097209269804,0,1,negative regulation of formation of translation preinitiation complex,BP,
17579,GO:1901201,1,0.94923835441703,0,11,regulation of extracellular matrix assembly,BP,
17580,GO:1901202,1,0.995068827668363,0,1,negative regulation of extracellular matrix assembly,BP,
17581,GO:1901203,1,0.962850321273912,0,8,positive regulation of extracellular matrix assembly,BP,
17582,GO:1901207,1,0.995366990793145,0,1,regulation of heart looping,BP,
17583,GO:1901213,1,0.957064129447608,0,8,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
17589,GO:1901224,1,0.791966559152451,0,38,positive regulation of NIK/NF-kappaB signaling,BP,
17590,GO:1901228,1,0.995366990826152,0,1,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
17591,GO:1901229,1,0.995333062328682,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17592,GO:1901231,1,0.995333062328682,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17593,GO:1901232,1,0.995333062328682,0,1,regulation of convergent extension involved in axis elongation,BP,
17594,GO:1901233,1,0.995333062328682,0,1,negative regulation of convergent extension involved in axis elongation,BP,
17595,GO:1901252,1,0.973614010259963,0,2,regulation of intracellular transport of viral material,BP,
17596,GO:1901253,1,0.97814692190544,0,1,negative regulation of intracellular transport of viral material,BP,
17597,GO:1901254,1,0.995366990826152,0,1,positive regulation of intracellular transport of viral material,BP,
17598,GO:1901255,1,0.985195928521452,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
17599,GO:1901256,1,0.985804011245847,0,3,regulation of macrophage colony-stimulating factor production,BP,
17600,GO:1901257,1,0.995006922237278,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
17601,GO:1901258,1,0.995363240836546,0,1,positive regulation of macrophage colony-stimulating factor production,BP,
17602,GO:1901264,1,0.664908009566624,0,56,carbohydrate derivative transport,BP,
17604,GO:1901269,1,0.944033747523661,0,2,lipooligosaccharide metabolic process,BP,
17605,GO:1901271,1,0.944033747523661,0,2,lipooligosaccharide biosynthetic process,BP,
17606,GO:1901291,1,0.993166710841749,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
17609,GO:1901295,1,0.987362436814578,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17610,GO:1901296,1,0.992243492218644,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17611,GO:1901297,1,0.995081228517227,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17612,GO:1901298,1,0.927871529948496,0,9,regulation of hydrogen peroxide-mediated programmed cell death,BP,
17613,GO:1901299,1,0.959643407506753,0,5,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
17614,GO:1901300,1,0.966907395311316,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
17615,GO:1901301,1,0.990751650232067,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
17616,GO:1901303,1,0.995363424876141,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
17617,GO:1901304,1,0.991156461546762,0,1,regulation of spermidine biosynthetic process,BP,
17618,GO:1901307,1,0.991156461546762,0,1,positive regulation of spermidine biosynthetic process,BP,
17619,GO:1901314,1,0.985951107933656,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
17620,GO:1901315,1,0.985951107933656,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
17621,GO:1901317,1,0.957902483233792,0,3,regulation of flagellated sperm motility,BP,
17622,GO:1901318,1,0.995366574475227,0,1,negative regulation of flagellated sperm motility,BP,
17623,GO:1901321,1,0.992243492218644,0,1,positive regulation of heart induction,BP,
17624,GO:1901328,1,0.992298730129102,0,1,response to cytochalasin B,BP,
17625,GO:1901329,1,0.987914283855122,0,2,regulation of odontoblast differentiation,BP,
17626,GO:1901331,1,0.995366806405613,0,1,positive regulation of odontoblast differentiation,BP,
17627,GO:1901337,1,0.995355450952031,0,1,thioester transport,BP,
17628,GO:1901338,1,0.982112137854332,0,3,catecholamine binding,MF,
17629,GO:1901339,1,0.972517710914259,0,6,regulation of store-operated calcium channel activity,BP,
17630,GO:1901340,1,0.995366990826138,0,1,negative regulation of store-operated calcium channel activity,BP,
17631,GO:1901341,1,0.981594478077664,0,4,positive regulation of store-operated calcium channel activity,BP,
17632,GO:1901342,1,0.30141502561497,0,191,regulation of vasculature development,BP,
17633,GO:1901343,1,0.687798026256969,0,68,negative regulation of vasculature development,BP,
17635,GO:1901350,1,0.99536699082606,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
17636,GO:1901355,1,0.989905624615816,0,2,response to rapamycin,BP,
17641,GO:1901373,1,0.987384680721447,0,1,lipid hydroperoxide transport,BP,
17642,GO:1901374,1,0.995352427354762,0,1,acetate ester transport,BP,
17643,GO:1901376,1,0.995365164953568,0,1,organic heteropentacyclic compound metabolic process,BP,
17644,GO:1901377,1,0.995365164953568,0,1,organic heteropentacyclic compound catabolic process,BP,
17645,GO:1901379,1,0.80101249519417,0,36,regulation of potassium ion transmembrane transport,BP,
17646,GO:1901380,1,0.951809150645378,0,9,negative regulation of potassium ion transmembrane transport,BP,
17647,GO:1901381,1,0.925498627252564,0,11,positive regulation of potassium ion transmembrane transport,BP,
17648,GO:1901382,1,0.990724878500195,0,2,regulation of chorionic trophoblast cell proliferation,BP,
17649,GO:1901385,1,0.925218352031126,0,14,regulation of voltage-gated calcium channel activity,BP,
17650,GO:1901386,1,0.969008287419846,0,5,negative regulation of voltage-gated calcium channel activity,BP,
17651,GO:1901387,1,0.986164529184231,0,3,positive regulation of voltage-gated calcium channel activity,BP,
17652,GO:1901388,1,0.99530781851319,0,1,regulation of transforming growth factor beta activation,BP,
17653,GO:1901389,1,0.99530781851319,0,1,negative regulation of transforming growth factor beta activation,BP,
17654,GO:1901407,1,0.948657228301055,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17655,GO:1901409,1,0.95762722107755,0,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17656,GO:1901419,1,0.995366990826152,0,1,regulation of response to alcohol,BP,
17657,GO:1901421,1,0.995366990826152,0,1,positive regulation of response to alcohol,BP,
17658,GO:1901474,1,0.972285816764394,0,5,azole transmembrane transporter activity,MF,
17659,GO:1901475,1,0.986163673532741,0,3,pyruvate transmembrane transport,BP,
17660,GO:1901490,1,0.980420391157377,0,4,regulation of lymphangiogenesis,BP,
17661,GO:1901491,1,0.990755143581322,0,2,negative regulation of lymphangiogenesis,BP,
17662,GO:1901492,1,0.989569924270856,0,2,positive regulation of lymphangiogenesis,BP,
17663,GO:1901503,1,0.961690883943986,0,5,ether biosynthetic process,BP,
17664,GO:1901505,1,0.817923257907873,0,33,carbohydrate derivative transmembrane transporter activity,MF,
17665,GO:1901509,1,0.990755169450998,0,2,regulation of endothelial tube morphogenesis,BP,
17666,GO:1901522,1,0.894802813744106,0,20,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,
17667,GO:1901523,1,0.995366574475227,0,1,icosanoid catabolic process,BP,
17668,GO:1901524,1,0.91190100897558,0,14,regulation of mitophagy,BP,
17669,GO:1901525,1,0.972317739157616,0,6,negative regulation of mitophagy,BP,
17670,GO:1901526,1,0.937882631731223,0,8,positive regulation of mitophagy,BP,
17671,GO:1901529,1,0.990754785405301,0,2,positive regulation of anion channel activity,BP,
17674,GO:1901534,1,0.990755143546429,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
17675,GO:1901535,1,0.977045600521796,0,5,regulation of DNA demethylation,BP,
17676,GO:1901536,1,0.990754614574865,0,2,negative regulation of DNA demethylation,BP,
17677,GO:1901537,1,0.986164531023338,0,3,positive regulation of DNA demethylation,BP,
17678,GO:1901538,1,0.969006571504619,0,6,changes to DNA methylation involved in embryo development,BP,
17679,GO:1901545,1,0.995366698642032,0,1,response to raffinose,BP,
17680,GO:1901550,1,0.947514861456074,0,9,regulation of endothelial cell development,BP,
17681,GO:1901551,1,0.995366990826139,0,1,negative regulation of endothelial cell development,BP,
17682,GO:1901552,1,0.990755174882003,0,2,positive regulation of endothelial cell development,BP,
17683,GO:1901555,1,0.995366990826073,0,1,response to paclitaxel,BP,
17684,GO:1901558,1,0.99272158279163,0,1,response to metformin,BP,
17685,GO:1901561,1,0.99536698562297,0,1,response to benomyl,BP,
17686,GO:1901563,1,0.976485885490253,0,5,response to camptothecin,BP,
17690,GO:1901567,1,0.807965776184888,0,21,fatty acid derivative binding,MF,
17691,GO:1901568,1,0.480272747628298,0,99,fatty acid derivative metabolic process,BP,
17692,GO:1901569,1,0.96992093850986,0,5,fatty acid derivative catabolic process,BP,
17693,GO:1901570,1,0.627145148578049,0,59,fatty acid derivative biosynthetic process,BP,
17694,GO:1901571,1,0.875834672951164,0,19,fatty acid derivative transport,BP,
17697,GO:1901580,1,0.995366990825889,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17698,GO:1901581,1,0.995366990825889,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17699,GO:1901582,1,0.995366990825889,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17700,GO:1901585,1,0.995366493575117,0,1,regulation of acid-sensing ion channel activity,BP,
17701,GO:1901594,1,0.995366990826138,0,1,response to capsazepine,BP,
17702,GO:1901605,1,0.355634083289055,0,151,alpha-amino acid metabolic process,BP,
17703,GO:1901606,1,0.651414622674575,0,61,alpha-amino acid catabolic process,BP,
17704,GO:1901607,1,0.71646912364275,0,53,alpha-amino acid biosynthetic process,BP,
17705,GO:1901611,1,0.927284341302239,0,9,phosphatidylglycerol binding,MF,
17706,GO:1901612,1,0.94578943165895,0,6,cardiolipin binding,MF,
17708,GO:1901616,1,0.791331610046949,0,37,organic hydroxy compound catabolic process,BP,
17710,GO:1901618,1,0.917976980593407,0,15,organic hydroxy compound transmembrane transporter activity,MF,
17711,GO:1901620,1,0.967717378035812,0,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
17712,GO:1901621,1,0.976989054773603,0,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
17713,GO:1901622,1,0.995329336097906,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
17714,GO:1901623,1,0.94463278748395,0,9,regulation of lymphocyte chemotaxis,BP,
17715,GO:1901626,1,0.962735650221102,0,5,regulation of postsynaptic membrane organization,BP,
17716,GO:1901628,1,0.973857350071471,0,3,positive regulation of postsynaptic membrane organization,BP,
17717,GO:1901629,1,0.9785396852903,0,2,regulation of presynaptic membrane organization,BP,
17718,GO:1901630,1,0.983095265244906,0,1,negative regulation of presynaptic membrane organization,BP,
17719,GO:1901631,1,0.99536699082602,0,1,positive regulation of presynaptic membrane organization,BP,
17720,GO:1901639,1,0.995366990826113,0,1,XDP catabolic process,BP,
17721,GO:1901640,1,0.995366990826113,0,1,XTP binding,MF,
17722,GO:1901641,1,0.995366990826113,0,1,ITP binding,MF,
17723,GO:1901642,1,0.970780444998013,0,6,nucleoside transmembrane transport,BP,
17724,GO:1901652,1,0.104427279517094,0,340,response to peptide,BP,
17725,GO:1901653,1,0.184222286394323,0,255,cellular response to peptide,BP,
17728,GO:1901656,1,0.990754785405313,0,2,glycoside transport,BP,
17730,GO:1901658,1,0.798241722286606,0,27,glycosyl compound catabolic process,BP,
17732,GO:1901660,1,0.969812825290554,0,6,calcium ion export,BP,
17733,GO:1901661,1,0.799902160451917,0,23,quinone metabolic process,BP,
17734,GO:1901662,1,0.977168119506396,0,2,quinone catabolic process,BP,
17735,GO:1901663,1,0.877651868942666,0,14,quinone biosynthetic process,BP,
17736,GO:1901664,1,0.975538696359456,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
17737,GO:1901666,1,0.975538696359456,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
17738,GO:1901668,1,0.964544419876391,0,3,regulation of superoxide dismutase activity,BP,
17739,GO:1901671,1,0.969035995965092,0,2,positive regulation of superoxide dismutase activity,BP,
17740,GO:1901673,1,0.885084693828578,0,19,regulation of mitotic spindle assembly,BP,
17741,GO:1901674,1,0.986164118123338,0,3,regulation of histone H3-K27 acetylation,BP,
17742,GO:1901675,1,0.995366990826085,0,1,negative regulation of histone H3-K27 acetylation,BP,
17743,GO:1901676,1,0.995366990468174,0,1,positive regulation of histone H3-K27 acetylation,BP,
17744,GO:1901678,1,0.939056092069923,0,9,iron coordination entity transport,BP,
17745,GO:1901679,1,0.953320042341227,0,8,nucleotide transmembrane transport,BP,
17746,GO:1901680,1,0.995366990825956,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
17747,GO:1901681,1,0.353488015805616,0,139,sulfur compound binding,MF,
17748,GO:1901682,1,0.905851785341462,0,19,sulfur compound transmembrane transporter activity,MF,
17749,GO:1901685,1,0.754300042460756,0,16,glutathione derivative metabolic process,BP,
17750,GO:1901687,1,0.754300042460756,0,16,glutathione derivative biosynthetic process,BP,
17751,GO:1901698,1,0.00637864390618445,0,738,response to nitrogen compound,BP,
17752,GO:1901699,1,0.0559406439403028,0,452,cellular response to nitrogen compound,BP,
17755,GO:1901702,1,0.992807703284488,0,1,salt transmembrane transporter activity,MF,
17757,GO:1901722,1,0.94394481125566,0,11,regulation of cell proliferation involved in kidney development,BP,
17758,GO:1901723,1,0.973790365213164,0,5,negative regulation of cell proliferation involved in kidney development,BP,
17759,GO:1901724,1,0.969360387915166,0,6,positive regulation of cell proliferation involved in kidney development,BP,
17760,GO:1901725,1,0.968000187929202,0,7,regulation of histone deacetylase activity,BP,
17761,GO:1901726,1,0.995366990825903,0,1,negative regulation of histone deacetylase activity,BP,
17762,GO:1901727,1,0.977035093067365,0,5,positive regulation of histone deacetylase activity,BP,
17763,GO:1901731,1,0.990751742953595,0,2,positive regulation of platelet aggregation,BP,
17764,GO:1901739,1,0.924294743291555,0,10,regulation of myoblast fusion,BP,
17765,GO:1901740,1,0.993483920407201,0,1,negative regulation of myoblast fusion,BP,
17766,GO:1901741,1,0.930362072408224,0,9,positive regulation of myoblast fusion,BP,
17767,GO:1901748,1,0.985840800138348,0,3,leukotriene D4 metabolic process,BP,
17768,GO:1901750,1,0.985840800138348,0,3,leukotriene D4 biosynthetic process,BP,
17769,GO:1901751,1,0.995095103294964,0,1,leukotriene A4 metabolic process,BP,
17772,GO:1901798,1,0.826931181061923,0,16,positive regulation of signal transduction by p53 class mediator,BP,
17773,GO:1901799,1,0.721181771826943,0,42,negative regulation of proteasomal protein catabolic process,BP,
17775,GO:1901804,1,0.995158529651144,0,1,beta-glucoside metabolic process,BP,
17776,GO:1901805,1,0.995158529651144,0,1,beta-glucoside catabolic process,BP,
17777,GO:1901834,1,0.991643945790632,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
17778,GO:1901835,1,0.991643945790632,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
17779,GO:1901836,1,0.932878142788868,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17780,GO:1901837,1,0.987861241078677,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17781,GO:1901838,1,0.944348876510302,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17782,GO:1901841,1,0.96744424435193,0,5,regulation of high voltage-gated calcium channel activity,BP,
17783,GO:1901842,1,0.982606510130266,0,2,negative regulation of high voltage-gated calcium channel activity,BP,
17784,GO:1901843,1,0.990755198478465,0,2,positive regulation of high voltage-gated calcium channel activity,BP,
17785,GO:1901844,1,0.95626460776734,0,7,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
17786,GO:1901856,1,0.990365134947115,0,2,negative regulation of cellular respiration,BP,
17787,GO:1901857,1,0.943817367302986,0,5,positive regulation of cellular respiration,BP,
17788,GO:1901858,1,0.97132484807152,0,4,regulation of mitochondrial DNA metabolic process,BP,
17789,GO:1901859,1,0.986160926272627,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
17790,GO:1901860,1,0.984958114879921,0,1,positive regulation of mitochondrial DNA metabolic process,BP,
17793,GO:1901863,1,0.795477148825963,0,41,positive regulation of muscle tissue development,BP,
17794,GO:1901873,1,0.990754785405249,0,2,regulation of post-translational protein modification,BP,
17795,GO:1901874,1,0.990754785405249,0,2,negative regulation of post-translational protein modification,BP,
17798,GO:1901881,1,0.942840659382582,0,9,positive regulation of protein depolymerization,BP,
17800,GO:1901889,1,0.921556556348415,0,16,negative regulation of cell junction assembly,BP,
17801,GO:1901890,1,0.866101649063246,0,25,positive regulation of cell junction assembly,BP,
17802,GO:1901894,1,0.978720692347219,0,3,regulation of calcium-transporting ATPase activity,BP,
17803,GO:1901895,1,0.995366990826099,0,1,negative regulation of calcium-transporting ATPase activity,BP,
17804,GO:1901896,1,0.983277106645509,0,2,positive regulation of calcium-transporting ATPase activity,BP,
17805,GO:1901897,1,0.98616452240992,0,3,regulation of relaxation of cardiac muscle,BP,
17806,GO:1901898,1,0.99536699082602,0,1,negative regulation of relaxation of cardiac muscle,BP,
17807,GO:1901906,1,0.970671105713102,0,4,diadenosine pentaphosphate metabolic process,BP,
17808,GO:1901907,1,0.970671105713102,0,4,diadenosine pentaphosphate catabolic process,BP,
17809,GO:1901908,1,0.970671105713102,0,4,diadenosine hexaphosphate metabolic process,BP,
17810,GO:1901909,1,0.970671105713102,0,4,diadenosine hexaphosphate catabolic process,BP,
17811,GO:1901910,1,0.970671105713102,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
17812,GO:1901911,1,0.970671105713102,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
17813,GO:1901917,1,0.995365609716794,0,1,regulation of exoribonuclease activity,BP,
17814,GO:1901919,1,0.995365609716794,0,1,positive regulation of exoribonuclease activity,BP,
17815,GO:1901950,1,0.995366574475227,0,1,dense core granule transport,BP,
17816,GO:1901962,1,0.994758631763274,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
17817,GO:1901963,1,0.987457918014915,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
17818,GO:1901964,1,0.992054598406672,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
17819,GO:1901970,1,0.934282788098058,0,8,positive regulation of mitotic sister chromatid separation,BP,
17820,GO:1901976,1,0.83213675025185,0,30,regulation of cell cycle checkpoint,BP,
17821,GO:1901977,1,0.969038053102326,0,6,negative regulation of cell cycle checkpoint,BP,
17822,GO:1901978,1,0.946886911816439,0,9,positive regulation of cell cycle checkpoint,BP,
17823,GO:1901979,1,0.99074598364345,0,2,regulation of inward rectifier potassium channel activity,BP,
17824,GO:1901980,1,0.995366990825928,0,1,positive regulation of inward rectifier potassium channel activity,BP,
17825,GO:1901981,1,0.528703687778855,0,109,phosphatidylinositol phosphate binding,MF,
17827,GO:1901984,1,0.868676564118502,0,18,negative regulation of protein acetylation,BP,
17829,GO:1901987,1,0.05062456526342,0,380,regulation of cell cycle phase transition,BP,
17830,GO:1901988,1,0.162200473133521,0,215,negative regulation of cell cycle phase transition,BP,
17831,GO:1901989,1,0.619782760722097,0,66,positive regulation of cell cycle phase transition,BP,
17832,GO:1901990,1,0.0583325984941395,0,358,regulation of mitotic cell cycle phase transition,BP,
17833,GO:1901991,1,0.178495355320602,0,202,negative regulation of mitotic cell cycle phase transition,BP,
17834,GO:1901992,1,0.667470541199882,0,55,positive regulation of mitotic cell cycle phase transition,BP,
17835,GO:1901993,1,0.990754602974086,0,2,regulation of meiotic cell cycle phase transition,BP,
17836,GO:1901994,1,0.990754602974086,0,2,negative regulation of meiotic cell cycle phase transition,BP,
17837,GO:1901998,1,0.804699831090836,0,33,toxin transport,BP,
17838,GO:1902001,1,0.928556185399341,0,15,fatty acid transmembrane transport,BP,
17839,GO:1902003,1,0.905055872955953,0,17,regulation of amyloid-beta formation,BP,
17840,GO:1902004,1,0.951423322762151,0,9,positive regulation of amyloid-beta formation,BP,
17841,GO:1902010,1,0.995366946678943,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
17842,GO:1902017,1,0.74934673667244,0,37,regulation of cilium assembly,BP,
17843,GO:1902018,1,0.943939941722964,0,9,negative regulation of cilium assembly,BP,
17844,GO:1902019,1,0.976924576704834,0,5,regulation of cilium-dependent cell motility,BP,
17845,GO:1902022,1,0.983519057012409,0,3,L-lysine transport,BP,
17846,GO:1902023,1,0.973906437077066,0,4,L-arginine transport,BP,
17847,GO:1902031,1,0.971172666489938,0,5,regulation of NADP metabolic process,BP,
17848,GO:1902033,1,0.972678618212544,0,5,regulation of hematopoietic stem cell proliferation,BP,
17849,GO:1902035,1,0.977211294620509,0,4,positive regulation of hematopoietic stem cell proliferation,BP,
17851,GO:1902037,1,0.986151462647932,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
17852,GO:1902038,1,0.99536693429932,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
17853,GO:1902041,1,0.742593753157948,0,45,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
17854,GO:1902042,1,0.82419895917608,0,27,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
17855,GO:1902043,1,0.926784590910107,0,15,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
17856,GO:1902044,1,0.99046604011664,0,2,regulation of Fas signaling pathway,BP,
17857,GO:1902045,1,0.995076500585975,0,1,negative regulation of Fas signaling pathway,BP,
17858,GO:1902047,1,0.962244923076164,0,5,polyamine transmembrane transport,BP,
17859,GO:1902065,1,0.948243979068478,0,9,response to L-glutamate,BP,
17860,GO:1902071,1,0.983056716431645,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
17861,GO:1902073,1,0.983056716431645,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
17862,GO:1902074,1,0.937192282396418,0,12,response to salt,BP,
17863,GO:1902075,1,0.966671191073719,0,6,cellular response to salt,BP,
17864,GO:1902083,1,0.976736006788906,0,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
17865,GO:1902093,1,0.962363484492811,0,2,positive regulation of flagellated sperm motility,BP,
17866,GO:1902098,1,0.995366990826165,0,1,calcitriol binding,MF,
17867,GO:1902099,1,0.708003277232891,0,46,regulation of metaphase/anaphase transition of cell cycle,BP,
17868,GO:1902100,1,0.819013078256825,0,30,negative regulation of metaphase/anaphase transition of cell cycle,BP,
17869,GO:1902101,1,0.934282788098058,0,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,
17870,GO:1902102,1,0.995366709403035,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17871,GO:1902103,1,0.995366709403035,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17872,GO:1902105,1,0.352768379235898,0,161,regulation of leukocyte differentiation,BP,
17873,GO:1902106,1,0.71744600044475,0,53,negative regulation of leukocyte differentiation,BP,
17874,GO:1902107,1,0.544269862021258,0,88,positive regulation of leukocyte differentiation,BP,
17875,GO:1902108,1,0.663817473316548,0,54,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
17876,GO:1902109,1,0.969469508368374,0,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
17877,GO:1902110,1,0.67955144689668,0,51,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
17878,GO:1902115,1,0.412443527387087,0,143,regulation of organelle assembly,BP,
17879,GO:1902116,1,0.821193640398517,0,30,negative regulation of organelle assembly,BP,
17880,GO:1902117,1,0.712088475350727,0,59,positive regulation of organelle assembly,BP,
17881,GO:1902121,1,0.995366990826165,0,1,lithocholic acid binding,MF,
17882,GO:1902145,1,0.995366574475227,0,1,regulation of response to cell cycle checkpoint signaling,BP,
17883,GO:1902151,1,0.995366574475227,0,1,regulation of response to DNA integrity checkpoint signaling,BP,
17884,GO:1902153,1,0.995366574475227,0,1,regulation of response to DNA damage checkpoint signaling,BP,
17885,GO:1902162,1,0.965027609663413,0,2,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
17886,GO:1902164,1,0.965027609663413,0,2,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
17887,GO:1902165,1,0.826410318030984,0,15,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
17888,GO:1902166,1,0.856134457032783,0,13,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
17889,GO:1902167,1,0.969836818533531,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
17890,GO:1902170,1,0.94121758550268,0,12,cellular response to reactive nitrogen species,BP,
17891,GO:1902172,1,0.969736502945595,0,5,regulation of keratinocyte apoptotic process,BP,
17892,GO:1902173,1,0.995366818938245,0,1,negative regulation of keratinocyte apoptotic process,BP,
17893,GO:1902174,1,0.987036843307875,0,2,positive regulation of keratinocyte apoptotic process,BP,
17894,GO:1902175,1,0.818613189309299,0,23,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
17895,GO:1902176,1,0.860185558446268,0,16,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
17896,GO:1902177,1,0.943940666993177,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
17897,GO:1902178,1,0.995366990826152,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
17898,GO:1902186,1,0.843796027349777,0,29,regulation of viral release from host cell,BP,
17899,GO:1902187,1,0.935064517600223,0,14,negative regulation of viral release from host cell,BP,
17900,GO:1902188,1,0.902464687776969,0,15,positive regulation of viral release from host cell,BP,
17901,GO:1902202,1,0.986641828133855,0,2,regulation of hepatocyte growth factor receptor signaling pathway,BP,
17902,GO:1902205,1,0.991234792401661,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
17903,GO:1902206,1,0.991234792401661,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
17904,GO:1902211,1,0.995366574475227,0,1,regulation of prolactin signaling pathway,BP,
17905,GO:1902213,1,0.995366574475227,0,1,positive regulation of prolactin signaling pathway,BP,
17906,GO:1902214,1,0.986641928197538,0,2,regulation of interleukin-4-mediated signaling pathway,BP,
17907,GO:1902215,1,0.991234792401661,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
17908,GO:1902216,1,0.995366990826034,0,1,positive regulation of interleukin-4-mediated signaling pathway,BP,
17909,GO:1902218,1,0.963377418941395,0,5,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
17910,GO:1902219,1,0.981594478077677,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
17911,GO:1902220,1,0.981445284486209,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
17912,GO:1902221,1,0.945267453218616,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
17913,GO:1902222,1,0.945267453218616,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
17914,GO:1902224,1,0.960317505820771,0,7,ketone body metabolic process,BP,
17915,GO:1902226,1,0.986470767076318,0,2,regulation of macrophage colony-stimulating factor signaling pathway,BP,
17916,GO:1902227,1,0.991234792401661,0,1,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
17917,GO:1902228,1,0.995194333493049,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
17920,GO:1902231,1,0.92356313412941,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
17921,GO:1902232,1,0.986636721584676,0,2,regulation of positive thymic T cell selection,BP,
17922,GO:1902233,1,0.991234792401661,0,1,negative regulation of positive thymic T cell selection,BP,
17924,GO:1902236,1,0.911722768516265,0,13,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
17926,GO:1902238,1,0.995366990826139,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17927,GO:1902239,1,0.995366990826139,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17928,GO:1902253,1,0.759184058095245,0,23,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
17929,GO:1902254,1,0.836446533477921,0,18,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
17930,GO:1902255,1,0.923974347088723,0,3,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
17931,GO:1902256,1,0.990755143581362,0,2,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
17932,GO:1902257,1,0.99536693429932,0,1,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
17933,GO:1902259,1,0.950375216726544,0,9,regulation of delayed rectifier potassium channel activity,BP,
17934,GO:1902260,1,0.978721624650712,0,3,negative regulation of delayed rectifier potassium channel activity,BP,
17935,GO:1902261,1,0.990755199816187,0,2,positive regulation of delayed rectifier potassium channel activity,BP,
17936,GO:1902262,1,0.96107933360047,0,4,apoptotic process involved in blood vessel morphogenesis,BP,
17937,GO:1902263,1,0.966257678802106,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
17938,GO:1902267,1,0.966725512340532,0,4,regulation of polyamine transmembrane transport,BP,
17939,GO:1902268,1,0.975749057395819,0,2,negative regulation of polyamine transmembrane transport,BP,
17940,GO:1902269,1,0.990754785405313,0,2,positive regulation of polyamine transmembrane transport,BP,
17941,GO:1902271,1,0.995366990826165,0,1,D3 vitamins binding,MF,
17943,GO:1902282,1,0.995366576678913,0,1,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
17944,GO:1902283,1,0.995366990826125,0,1,negative regulation of primary amine oxidase activity,BP,
17945,GO:1902284,1,0.871860047949063,0,28,neuron projection extension involved in neuron projection guidance,BP,
17946,GO:1902285,1,0.945680770776322,0,12,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
17947,GO:1902287,1,0.950085119673117,0,11,semaphorin-plexin signaling pathway involved in axon guidance,BP,
17948,GO:1902292,1,0.983114521255413,0,1,cell cycle DNA replication initiation,BP,
17949,GO:1902296,1,0.995366877388016,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
17950,GO:1902298,1,0.990187561022606,0,2,cell cycle DNA replication maintenance of fidelity,BP,
17951,GO:1902299,1,0.97813575272127,0,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
17952,GO:1902302,1,0.990755199849292,0,2,regulation of potassium ion export,BP,
17953,GO:1902304,1,0.995366990826165,0,1,positive regulation of potassium ion export,BP,
17955,GO:1902306,1,0.9359294686391,0,9,negative regulation of sodium ion transmembrane transport,BP,
17956,GO:1902307,1,0.926441442950591,0,13,positive regulation of sodium ion transmembrane transport,BP,
17957,GO:1902308,1,0.983178077408851,0,3,regulation of peptidyl-serine dephosphorylation,BP,
17958,GO:1902309,1,0.988000401328279,0,2,negative regulation of peptidyl-serine dephosphorylation,BP,
17959,GO:1902310,1,0.995119784570559,0,1,positive regulation of peptidyl-serine dephosphorylation,BP,
17960,GO:1902311,1,0.991947543383096,0,1,regulation of copper ion transmembrane transport,BP,
17961,GO:1902315,1,0.983114521255413,0,1,nuclear cell cycle DNA replication initiation,BP,
17962,GO:1902319,1,0.995366877388016,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
17963,GO:1902336,1,0.990647775359712,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
17964,GO:1902337,1,0.948466585376717,0,7,regulation of apoptotic process involved in morphogenesis,BP,
17965,GO:1902338,1,0.986164473981755,0,3,negative regulation of apoptotic process involved in morphogenesis,BP,
17966,GO:1902339,1,0.966257678802283,0,3,positive regulation of apoptotic process involved in morphogenesis,BP,
17967,GO:1902356,1,0.992982056220991,0,1,oxaloacetate(2-) transmembrane transport,BP,
17968,GO:1902358,1,0.970174807004726,0,6,sulfate transmembrane transport,BP,
17969,GO:1902359,1,0.989912904417334,0,2,Notch signaling pathway involved in somitogenesis,BP,
17970,GO:1902362,1,0.995366456936023,0,1,melanocyte apoptotic process,BP,
17971,GO:1902363,1,0.995366990826059,0,1,regulation of protein localization to spindle pole body,BP,
17972,GO:1902365,1,0.995366990826059,0,1,positive regulation of protein localization to spindle pole body,BP,
17973,GO:1902366,1,0.989912904417334,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
17974,GO:1902367,1,0.989912904417334,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
17977,GO:1902378,1,0.995259108849138,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
17978,GO:1902379,1,0.995366990826125,0,1,chemoattractant activity involved in axon guidance,MF,
17979,GO:1902380,1,0.995186149668059,0,1,positive regulation of endoribonuclease activity,BP,
17980,GO:1902387,1,0.995366574475227,0,1,ceramide 1-phosphate binding,MF,
17981,GO:1902388,1,0.995366574475227,0,1,ceramide 1-phosphate transporter activity,MF,
17982,GO:1902389,1,0.995366574475227,0,1,ceramide 1-phosphate transport,BP,
17983,GO:1902396,1,0.995366990382245,0,1,protein localization to bicellular tight junction,BP,
17984,GO:1902400,1,0.620278023905295,0,60,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,
17985,GO:1902402,1,0.617388260089355,0,61,signal transduction involved in mitotic DNA damage checkpoint,BP,
17986,GO:1902403,1,0.617388260089355,0,61,signal transduction involved in mitotic DNA integrity checkpoint,BP,
17987,GO:1902410,1,0.966032749433738,0,6,mitotic cytokinetic process,BP,
17988,GO:1902412,1,0.986164430794865,0,3,regulation of mitotic cytokinesis,BP,
17989,GO:1902414,1,0.96140532771334,0,8,protein localization to cell junction,BP,
17990,GO:1902415,1,0.937719552095456,0,9,regulation of mRNA binding,BP,
17991,GO:1902416,1,0.950050707569579,0,7,positive regulation of mRNA binding,BP,
17992,GO:1902423,1,0.989874157599651,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
17993,GO:1902425,1,0.989874157599651,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
17994,GO:1902426,1,0.995359034839364,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
17995,GO:1902430,1,0.94607713212331,0,9,negative regulation of amyloid-beta formation,BP,
17996,GO:1902442,1,0.995366984202627,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
17997,GO:1902443,1,0.995366984202627,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
17998,GO:1902445,1,0.952338895901877,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
17999,GO:1902455,1,0.981593229058864,0,4,negative regulation of stem cell population maintenance,BP,
18000,GO:1902459,1,0.977045769015693,0,5,positive regulation of stem cell population maintenance,BP,
18001,GO:1902460,1,0.995366990826165,0,1,regulation of mesenchymal stem cell proliferation,BP,
18002,GO:1902462,1,0.995366990826165,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
18003,GO:1902463,1,0.975941516793229,0,2,protein localization to cell leading edge,BP,
18004,GO:1902464,1,0.995366990826151,0,1,regulation of histone H3-K27 trimethylation,BP,
18005,GO:1902466,1,0.995366990826151,0,1,positive regulation of histone H3-K27 trimethylation,BP,
18006,GO:1902473,1,0.964087156439982,0,7,regulation of protein localization to synapse,BP,
18007,GO:1902474,1,0.968576633054367,0,6,positive regulation of protein localization to synapse,BP,
18008,GO:1902475,1,0.827931955998974,0,31,L-alpha-amino acid transmembrane transport,BP,
18010,GO:1902480,1,0.99519027327761,0,1,protein localization to mitotic spindle,BP,
18011,GO:1902488,1,0.995366990825981,0,1,cholangiocyte apoptotic process,BP,
18014,GO:1902495,1,0.524275665320467,0,112,transmembrane transporter complex,CC,
18015,GO:1902498,1,0.986164066094628,0,3,regulation of protein autoubiquitination,BP,
18016,GO:1902499,1,0.995366521608773,0,1,positive regulation of protein autoubiquitination,BP,
18017,GO:1902504,1,0.995366668922624,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
18018,GO:1902510,1,0.939025548983432,0,6,regulation of apoptotic DNA fragmentation,BP,
18019,GO:1902511,1,0.995363424876141,0,1,negative regulation of apoptotic DNA fragmentation,BP,
18020,GO:1902512,1,0.952845421709456,0,3,positive regulation of apoptotic DNA fragmentation,BP,
18021,GO:1902513,1,0.96839972362525,0,6,regulation of organelle transport along microtubule,BP,
18022,GO:1902514,1,0.964990846093541,0,7,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
18023,GO:1902523,1,0.990755193256089,0,2,positive regulation of protein K63-linked ubiquitination,BP,
18024,GO:1902524,1,0.983747572332437,0,2,positive regulation of protein K48-linked ubiquitination,BP,
18025,GO:1902525,1,0.943104713027182,0,5,regulation of protein monoubiquitination,BP,
18026,GO:1902527,1,0.947497202088069,0,4,positive regulation of protein monoubiquitination,BP,
18027,GO:1902528,1,0.995366990826008,0,1,regulation of protein linear polyubiquitination,BP,
18028,GO:1902530,1,0.995366990826008,0,1,positive regulation of protein linear polyubiquitination,BP,
18032,GO:1902544,1,0.971438670956817,0,2,regulation of DNA N-glycosylase activity,BP,
18033,GO:1902546,1,0.975961703099268,0,1,positive regulation of DNA N-glycosylase activity,BP,
18034,GO:1902547,1,0.937569639672081,0,9,regulation of cellular response to vascular endothelial growth factor stimulus,BP,
18035,GO:1902548,1,0.974834248578634,0,4,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
18036,GO:1902554,1,0.589433921985561,0,78,serine/threonine protein kinase complex,CC,
18038,GO:1902559,1,0.988106137863915,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
18039,GO:1902560,1,0.992919600986792,0,1,GMP reductase complex,CC,
18040,GO:1902562,1,0.769170085083427,0,41,H4 histone acetyltransferase complex,CC,
18041,GO:1902563,1,0.981594888733481,0,4,regulation of neutrophil activation,BP,
18042,GO:1902564,1,0.990755199849201,0,2,negative regulation of neutrophil activation,BP,
18043,GO:1902565,1,0.995366990826138,0,1,positive regulation of neutrophil activation,BP,
18044,GO:1902566,1,0.982326791919221,0,2,regulation of eosinophil activation,BP,
18045,GO:1902568,1,0.982326791919221,0,2,positive regulation of eosinophil activation,BP,
18046,GO:1902570,1,0.908948922767293,0,9,protein localization to nucleolus,BP,
18047,GO:1902571,1,0.96200743824289,0,3,regulation of serine-type peptidase activity,BP,
18048,GO:1902572,1,0.96200743824289,0,3,negative regulation of serine-type peptidase activity,BP,
18049,GO:1902576,1,0.979069806254699,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
18050,GO:1902579,1,0.606852469398732,0,68,multi-organism localization,BP,
18051,GO:1902581,1,0.951555172782055,0,5,multi-organism cellular localization,BP,
18052,GO:1902583,1,0.951555172782055,0,5,multi-organism intracellular transport,BP,
18053,GO:1902594,1,0.990755199849267,0,2,multi-organism nuclear import,BP,
18054,GO:1902595,1,0.982777805050009,0,2,regulation of DNA replication origin binding,BP,
18056,GO:1902603,1,0.982943853352698,0,3,carnitine transmembrane transport,BP,
18057,GO:1902605,1,0.995365311673291,0,1,heterotrimeric G-protein complex assembly,BP,
18058,GO:1902606,1,0.974537838279069,0,1,regulation of large conductance calcium-activated potassium channel activity,BP,
18059,GO:1902608,1,0.974537838279069,0,1,positive regulation of large conductance calcium-activated potassium channel activity,BP,
18060,GO:1902612,1,0.995365530647531,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
18061,GO:1902613,1,0.995365530647531,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
18062,GO:1902616,1,0.992831961903632,0,1,acyl carnitine transmembrane transport,BP,
18063,GO:1902617,1,0.960106263226916,0,4,response to fluoride,BP,
18064,GO:1902618,1,0.995366990826126,0,1,cellular response to fluoride,BP,
18065,GO:1902622,1,0.827032504084272,0,21,regulation of neutrophil migration,BP,
18066,GO:1902623,1,0.995366990826165,0,1,negative regulation of neutrophil migration,BP,
18067,GO:1902624,1,0.839897991428593,0,18,positive regulation of neutrophil migration,BP,
18068,GO:1902626,1,0.939881130059585,0,3,assembly of large subunit precursor of preribosome,BP,
18069,GO:1902629,1,0.986486286624493,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
18070,GO:1902630,1,0.995366990826072,0,1,regulation of membrane hyperpolarization,BP,
18071,GO:1902631,1,0.995366990826072,0,1,negative regulation of membrane hyperpolarization,BP,
18072,GO:1902636,1,0.974382744026269,0,2,kinociliary basal body,CC,
18073,GO:1902652,1,0.4994004749521,0,104,secondary alcohol metabolic process,BP,
18074,GO:1902653,1,0.664612887581306,0,60,secondary alcohol biosynthetic process,BP,
18075,GO:1902656,1,0.97133321601514,0,6,calcium ion import into cytosol,BP,
18076,GO:1902659,1,0.971170288619222,0,3,regulation of glucose mediated signaling pathway,BP,
18077,GO:1902661,1,0.971170288619222,0,3,positive regulation of glucose mediated signaling pathway,BP,
18078,GO:1902667,1,0.866477357801863,0,29,regulation of axon guidance,BP,
18079,GO:1902668,1,0.909120701072814,0,19,negative regulation of axon guidance,BP,
18080,GO:1902669,1,0.966417276649411,0,7,positive regulation of axon guidance,BP,
18083,GO:1902683,1,0.990287886147541,0,2,regulation of receptor localization to synapse,BP,
18084,GO:1902685,1,0.995366990826152,0,1,positive regulation of receptor localization to synapse,BP,
18085,GO:1902686,1,0.67275299485491,0,53,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,
18086,GO:1902688,1,0.995366574475227,0,1,regulation of NAD metabolic process,BP,
18087,GO:1902689,1,0.995366574475227,0,1,negative regulation of NAD metabolic process,BP,
18088,GO:1902692,1,0.922599714326476,0,16,regulation of neuroblast proliferation,BP,
18089,GO:1902710,1,0.995366801879365,0,1,GABA receptor complex,CC,
18090,GO:1902711,1,0.995366801879365,0,1,GABA-A receptor complex,CC,
18091,GO:1902713,1,0.98159104899478,0,4,regulation of interferon-gamma secretion,BP,
18092,GO:1902714,1,0.990751324690912,0,2,negative regulation of interferon-gamma secretion,BP,
18093,GO:1902715,1,0.990755199849267,0,2,positive regulation of interferon-gamma secretion,BP,
18094,GO:1902722,1,0.966301285404426,0,3,positive regulation of prolactin secretion,BP,
18095,GO:1902723,1,0.995366893701033,0,1,negative regulation of skeletal muscle satellite cell proliferation,BP,
18096,GO:1902724,1,0.990755199849279,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
18097,GO:1902725,1,0.995366990826112,0,1,negative regulation of satellite cell differentiation,BP,
18098,GO:1902728,1,0.990755199849279,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
18099,GO:1902730,1,0.986164057392432,0,3,positive regulation of proteoglycan biosynthetic process,BP,
18100,GO:1902731,1,0.990755199848965,0,2,negative regulation of chondrocyte proliferation,BP,
18101,GO:1902732,1,0.990460465789248,0,1,positive regulation of chondrocyte proliferation,BP,
18102,GO:1902737,1,0.995366990826152,0,1,dendritic filopodium,CC,
18103,GO:1902739,1,0.972518192384808,0,6,regulation of interferon-alpha secretion,BP,
18104,GO:1902741,1,0.972518192384808,0,6,positive regulation of interferon-alpha secretion,BP,
18105,GO:1902742,1,0.863182933931681,0,22,apoptotic process involved in development,BP,
18106,GO:1902743,1,0.828147084067786,0,34,regulation of lamellipodium organization,BP,
18107,GO:1902744,1,0.981594478077651,0,4,negative regulation of lamellipodium organization,BP,
18108,GO:1902745,1,0.894187848281716,0,19,positive regulation of lamellipodium organization,BP,
18109,GO:1902746,1,0.995169011469033,0,1,regulation of lens fiber cell differentiation,BP,
18110,GO:1902749,1,0.198160104503642,0,195,regulation of cell cycle G2/M phase transition,BP,
18111,GO:1902750,1,0.37695595639596,0,97,negative regulation of cell cycle G2/M phase transition,BP,
18112,GO:1902751,1,0.856729230431445,0,23,positive regulation of cell cycle G2/M phase transition,BP,
18113,GO:1902766,1,0.979134495594711,0,2,skeletal muscle satellite cell migration,BP,
18114,GO:1902767,1,0.995366945682435,0,1,isoprenoid biosynthetic process via mevalonate,BP,
18115,GO:1902769,1,0.995366990825902,0,1,regulation of choline O-acetyltransferase activity,BP,
18116,GO:1902771,1,0.995366990825902,0,1,positive regulation of choline O-acetyltransferase activity,BP,
18117,GO:1902773,1,0.99536671531213,0,1,GTPase activator complex,CC,
18118,GO:1902774,1,0.955918127005663,0,6,late endosome to lysosome transport,BP,
18119,GO:1902775,1,0.986129558580366,0,3,mitochondrial large ribosomal subunit assembly,BP,
18120,GO:1902803,1,0.903510045255822,0,20,regulation of synaptic vesicle transport,BP,
18121,GO:1902804,1,0.983575685550654,0,3,negative regulation of synaptic vesicle transport,BP,
18122,GO:1902805,1,0.990755199849228,0,2,positive regulation of synaptic vesicle transport,BP,
18123,GO:1902806,1,0.328973421528503,0,147,regulation of cell cycle G1/S phase transition,BP,
18124,GO:1902807,1,0.489941444517545,0,96,negative regulation of cell cycle G1/S phase transition,BP,
18125,GO:1902808,1,0.811549769137435,0,30,positive regulation of cell cycle G1/S phase transition,BP,
18126,GO:1902809,1,0.979980163886718,0,3,regulation of skeletal muscle fiber differentiation,BP,
18127,GO:1902811,1,0.98454279703237,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
18128,GO:1902816,1,0.98159365676644,0,4,regulation of protein localization to microtubule,BP,
18129,GO:1902817,1,0.98159365676644,0,4,negative regulation of protein localization to microtubule,BP,
18130,GO:1902822,1,0.969391737820362,0,3,regulation of late endosome to lysosome transport,BP,
18131,GO:1902823,1,0.995366879233504,0,1,negative regulation of late endosome to lysosome transport,BP,
18132,GO:1902824,1,0.973905327778456,0,2,positive regulation of late endosome to lysosome transport,BP,
18133,GO:1902838,1,0.995366990826151,0,1,regulation of nuclear migration along microtubule,BP,
18134,GO:1902846,1,0.995366990826059,0,1,positive regulation of mitotic spindle elongation,BP,
18135,GO:1902847,1,0.995366520412405,0,1,regulation of neuronal signal transduction,BP,
18137,GO:1902855,1,0.93346252737406,0,10,regulation of non-motile cilium assembly,BP,
18138,GO:1902856,1,0.990755183893429,0,2,negative regulation of non-motile cilium assembly,BP,
18139,GO:1902857,1,0.946654580516181,0,7,positive regulation of non-motile cilium assembly,BP,
18140,GO:1902858,1,0.994437167450309,0,1,propionyl-CoA metabolic process,BP,
18141,GO:1902860,1,0.994437167450309,0,1,propionyl-CoA biosynthetic process,BP,
18142,GO:1902866,1,0.989884390067244,0,2,regulation of retina development in camera-type eye,BP,
18143,GO:1902868,1,0.989884390067244,0,2,positive regulation of retina development in camera-type eye,BP,
18144,GO:1902869,1,0.989884390067244,0,2,regulation of amacrine cell differentiation,BP,
18145,GO:1902871,1,0.989884390067244,0,2,positive regulation of amacrine cell differentiation,BP,
18146,GO:1902882,1,0.641318492476621,0,61,regulation of response to oxidative stress,BP,
18147,GO:1902883,1,0.755501776003039,0,35,negative regulation of response to oxidative stress,BP,
18148,GO:1902884,1,0.89590671962478,0,12,positive regulation of response to oxidative stress,BP,
18149,GO:1902889,1,0.995366990826074,0,1,protein localization to spindle microtubule,BP,
18150,GO:1902890,1,0.974537838279069,0,1,regulation of root hair elongation,BP,
18151,GO:1902891,1,0.974537838279069,0,1,negative regulation of root hair elongation,BP,
18152,GO:1902893,1,0.879405945062741,0,27,regulation of pri-miRNA transcription by RNA polymerase II,BP,
18153,GO:1902894,1,0.954580714028434,0,10,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,
18154,GO:1902895,1,0.912763373947008,0,19,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,
18155,GO:1902896,1,0.990754994217453,0,2,terminal web assembly,BP,
18156,GO:1902897,1,0.988583202549868,0,2,regulation of postsynaptic density protein 95 clustering,BP,
18157,GO:1902902,1,0.928243486027069,0,11,negative regulation of autophagosome assembly,BP,
18161,GO:1902908,1,0.995366990826152,0,1,regulation of melanosome transport,BP,
18162,GO:1902910,1,0.995366990826152,0,1,positive regulation of melanosome transport,BP,
18163,GO:1902911,1,0.55742114222425,0,89,protein kinase complex,CC,
18164,GO:1902912,1,0.995366574475227,0,1,pyruvate kinase complex,CC,
18165,GO:1902913,1,0.995366806405613,0,1,positive regulation of neuroepithelial cell differentiation,BP,
18166,GO:1902914,1,0.915062625927821,0,15,regulation of protein polyubiquitination,BP,
18167,GO:1902915,1,0.972307764534501,0,6,negative regulation of protein polyubiquitination,BP,
18168,GO:1902916,1,0.945526398258633,0,8,positive regulation of protein polyubiquitination,BP,
18169,GO:1902930,1,0.714472864091628,0,53,regulation of alcohol biosynthetic process,BP,
18170,GO:1902931,1,0.9365301228026,0,7,negative regulation of alcohol biosynthetic process,BP,
18171,GO:1902932,1,0.930613018420251,0,13,positive regulation of alcohol biosynthetic process,BP,
18172,GO:1902936,1,0.653764649265392,0,68,phosphatidylinositol bisphosphate binding,MF,
18173,GO:1902937,1,0.994517404157083,0,1,inward rectifier potassium channel complex,CC,
18174,GO:1902938,1,0.990752518209069,0,2,regulation of intracellular calcium activated chloride channel activity,BP,
18175,GO:1902939,1,0.995366574475227,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
18176,GO:1902941,1,0.995366990826138,0,1,regulation of voltage-gated chloride channel activity,BP,
18177,GO:1902943,1,0.995366990826138,0,1,positive regulation of voltage-gated chloride channel activity,BP,
18178,GO:1902946,1,0.963420024850114,0,8,protein localization to early endosome,BP,
18179,GO:1902947,1,0.973975187773786,0,5,regulation of tau-protein kinase activity,BP,
18180,GO:1902948,1,0.995366990825902,0,1,negative regulation of tau-protein kinase activity,BP,
18181,GO:1902949,1,0.978509765694535,0,4,positive regulation of tau-protein kinase activity,BP,
18182,GO:1902950,1,0.959353953305588,0,6,regulation of dendritic spine maintenance,BP,
18183,GO:1902951,1,0.989548147988885,0,2,negative regulation of dendritic spine maintenance,BP,
18184,GO:1902952,1,0.978539685290441,0,2,positive regulation of dendritic spine maintenance,BP,
18185,GO:1902953,1,0.979023685355871,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
18186,GO:1902954,1,0.990755199848915,0,2,regulation of early endosome to recycling endosome transport,BP,
18187,GO:1902955,1,0.995366990825902,0,1,positive regulation of early endosome to recycling endosome transport,BP,
18188,GO:1902956,1,0.968982454399213,0,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18189,GO:1902957,1,0.995366810543291,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18190,GO:1902958,1,0.973494227803959,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18191,GO:1902959,1,0.953772945138231,0,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18192,GO:1902960,1,0.990394591261427,0,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18193,GO:1902961,1,0.963027211935577,0,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18194,GO:1902962,1,0.990755196608446,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18195,GO:1902963,1,0.990755196608446,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18196,GO:1902965,1,0.97251810869155,0,6,regulation of protein localization to early endosome,BP,
18197,GO:1902966,1,0.97251810869155,0,6,positive regulation of protein localization to early endosome,BP,
18198,GO:1902969,1,0.942239358010924,0,9,mitotic DNA replication,BP,
18199,GO:1902975,1,0.983114521255413,0,1,mitotic DNA replication initiation,BP,
18200,GO:1902977,1,0.993228478672517,0,1,mitotic DNA replication preinitiation complex assembly,BP,
18201,GO:1902983,1,0.995366877388016,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
18202,GO:1902988,1,0.986164064909149,0,3,neurofibrillary tangle assembly,BP,
18203,GO:1902990,1,0.976886433401785,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
18204,GO:1902991,1,0.875813330812245,0,21,regulation of amyloid precursor protein catabolic process,BP,
18205,GO:1902992,1,0.9373090307499,0,11,negative regulation of amyloid precursor protein catabolic process,BP,
18206,GO:1902993,1,0.939400669931441,0,11,positive regulation of amyloid precursor protein catabolic process,BP,
18207,GO:1902994,1,0.978539685290351,0,2,regulation of phospholipid efflux,BP,
18208,GO:1902995,1,0.978539685290351,0,2,positive regulation of phospholipid efflux,BP,
18209,GO:1902996,1,0.990754731589869,0,2,regulation of neurofibrillary tangle assembly,BP,
18210,GO:1902997,1,0.995366990825902,0,1,negative regulation of neurofibrillary tangle assembly,BP,
18211,GO:1902998,1,0.995366520412405,0,1,positive regulation of neurofibrillary tangle assembly,BP,
18212,GO:1903000,1,0.983095265244906,0,1,regulation of lipid transport across blood brain barrier,BP,
18213,GO:1903002,1,0.983095265244906,0,1,positive regulation of lipid transport across blood brain barrier,BP,
18214,GO:1903003,1,0.964079465806526,0,6,positive regulation of protein deubiquitination,BP,
18215,GO:1903004,1,0.995366989784868,0,1,regulation of protein K63-linked deubiquitination,BP,
18216,GO:1903006,1,0.995366989784868,0,1,positive regulation of protein K63-linked deubiquitination,BP,
18217,GO:1903007,1,0.995366989784868,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
18218,GO:1903008,1,0.490740227678278,0,96,organelle disassembly,BP,
18219,GO:1903010,1,0.949071348425773,0,11,regulation of bone development,BP,
18220,GO:1903011,1,0.986164524460474,0,3,negative regulation of bone development,BP,
18221,GO:1903012,1,0.980526660779848,0,4,positive regulation of bone development,BP,
18222,GO:1903018,1,0.803018885020248,0,31,regulation of glycoprotein metabolic process,BP,
18223,GO:1903019,1,0.902123969683754,0,12,negative regulation of glycoprotein metabolic process,BP,
18224,GO:1903020,1,0.904283426600901,0,16,positive regulation of glycoprotein metabolic process,BP,
18227,GO:1903027,1,0.995366990826034,0,1,regulation of opsonization,BP,
18228,GO:1903028,1,0.995366990826034,0,1,positive regulation of opsonization,BP,
18229,GO:1903031,1,0.988210743607295,0,2,regulation of microtubule plus-end binding,BP,
18230,GO:1903033,1,0.988210743607295,0,2,positive regulation of microtubule plus-end binding,BP,
18231,GO:1903034,1,0.522800146192485,0,100,regulation of response to wounding,BP,
18232,GO:1903035,1,0.707511954700319,0,57,negative regulation of response to wounding,BP,
18233,GO:1903036,1,0.783820395847433,0,34,positive regulation of response to wounding,BP,
18237,GO:1903044,1,0.956567133695576,0,8,protein localization to membrane raft,BP,
18238,GO:1903045,1,0.995366990826138,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
18239,GO:1903046,1,0.488263067049708,0,116,meiotic cell cycle process,BP,
18242,GO:1903051,1,0.626346221384656,0,54,negative regulation of proteolysis involved in cellular protein catabolic process,BP,
18244,GO:1903053,1,0.877101736307387,0,23,regulation of extracellular matrix organization,BP,
18245,GO:1903054,1,0.955460923239504,0,5,negative regulation of extracellular matrix organization,BP,
18246,GO:1903055,1,0.943328239780476,0,12,positive regulation of extracellular matrix organization,BP,
18247,GO:1903059,1,0.972959151618354,0,4,regulation of protein lipidation,BP,
18248,GO:1903061,1,0.972959151618354,0,4,positive regulation of protein lipidation,BP,
18249,GO:1903069,1,0.943674557524396,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
18250,GO:1903070,1,0.97734010607333,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
18251,GO:1903071,1,0.960739757594996,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
18252,GO:1903072,1,0.978037514283719,0,1,regulation of death-inducing signaling complex assembly,BP,
18253,GO:1903073,1,0.978037514283719,0,1,negative regulation of death-inducing signaling complex assembly,BP,
18254,GO:1903076,1,0.647179494292778,0,65,regulation of protein localization to plasma membrane,BP,
18255,GO:1903077,1,0.917124721334123,0,17,negative regulation of protein localization to plasma membrane,BP,
18256,GO:1903078,1,0.783513595705044,0,39,positive regulation of protein localization to plasma membrane,BP,
18257,GO:1903093,1,0.959083714665487,0,3,regulation of protein K48-linked deubiquitination,BP,
18258,GO:1903094,1,0.963549750473666,0,2,negative regulation of protein K48-linked deubiquitination,BP,
18259,GO:1903095,1,0.990754785405328,0,2,ribonuclease III complex,CC,
18260,GO:1903096,1,0.995366709403035,0,1,protein localization to meiotic spindle midzone,BP,
18261,GO:1903108,1,0.995366990826164,0,1,regulation of mitochondrial transcription,BP,
18262,GO:1903109,1,0.995366990826164,0,1,positive regulation of mitochondrial transcription,BP,
18263,GO:1903115,1,0.880930592450427,0,21,regulation of actin filament-based movement,BP,
18264,GO:1903116,1,0.990755199816396,0,2,positive regulation of actin filament-based movement,BP,
18265,GO:1903119,1,0.985471120542398,0,3,protein localization to actin cytoskeleton,BP,
18266,GO:1903121,1,0.963169693260958,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
18267,GO:1903122,1,0.978037514283719,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
18268,GO:1903126,1,0.99441214774118,0,1,negative regulation of centriole-centriole cohesion,BP,
18269,GO:1903131,1,0.849756962403429,0,24,mononuclear cell differentiation,BP,
18270,GO:1903135,1,0.96899123821074,0,3,cupric ion binding,MF,
18271,GO:1903136,1,0.931566041722419,0,5,cuprous ion binding,MF,
18272,GO:1903140,1,0.947514861456074,0,9,regulation of establishment of endothelial barrier,BP,
18273,GO:1903141,1,0.995366990826139,0,1,negative regulation of establishment of endothelial barrier,BP,
18274,GO:1903142,1,0.990755174882003,0,2,positive regulation of establishment of endothelial barrier,BP,
18275,GO:1903143,1,0.995366990826164,0,1,adrenomedullin receptor complex,CC,
18276,GO:1903146,1,0.733602898740564,0,44,regulation of autophagy of mitochondrion,BP,
18277,GO:1903147,1,0.942698525297138,0,8,negative regulation of autophagy of mitochondrion,BP,
18278,GO:1903165,1,0.995361301061461,0,1,response to polycyclic arene,BP,
18279,GO:1903167,1,0.978037514283719,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
18280,GO:1903168,1,0.978037514283719,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
18281,GO:1903169,1,0.595555770508218,0,77,regulation of calcium ion transmembrane transport,BP,
18282,GO:1903170,1,0.852602519986769,0,19,negative regulation of calcium ion transmembrane transport,BP,
18283,GO:1903173,1,0.988279614457848,0,2,fatty alcohol metabolic process,BP,
18284,GO:1903176,1,0.978037514283719,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
18285,GO:1903178,1,0.978037514283719,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
18286,GO:1903179,1,0.973504994678875,0,2,regulation of dopamine biosynthetic process,BP,
18287,GO:1903181,1,0.973504994678875,0,2,positive regulation of dopamine biosynthetic process,BP,
18288,GO:1903182,1,0.983535025082634,0,1,regulation of SUMO transferase activity,BP,
18289,GO:1903184,1,0.978037514283719,0,1,L-dopa metabolic process,BP,
18290,GO:1903185,1,0.978037514283719,0,1,L-dopa biosynthetic process,BP,
18291,GO:1903189,1,0.978037514283719,0,1,glyoxal metabolic process,BP,
18292,GO:1903195,1,0.978037514283719,0,1,regulation of L-dopa biosynthetic process,BP,
18293,GO:1903197,1,0.978037514283719,0,1,positive regulation of L-dopa biosynthetic process,BP,
18294,GO:1903198,1,0.978037514283719,0,1,regulation of L-dopa decarboxylase activity,BP,
18295,GO:1903200,1,0.978037514283719,0,1,positive regulation of L-dopa decarboxylase activity,BP,
18296,GO:1903201,1,0.688588032962336,0,48,regulation of oxidative stress-induced cell death,BP,
18297,GO:1903202,1,0.762584361226424,0,33,negative regulation of oxidative stress-induced cell death,BP,
18298,GO:1903203,1,0.893867073844771,0,18,regulation of oxidative stress-induced neuron death,BP,
18299,GO:1903204,1,0.91064553115453,0,14,negative regulation of oxidative stress-induced neuron death,BP,
18300,GO:1903205,1,0.850964962662725,0,20,regulation of hydrogen peroxide-induced cell death,BP,
18301,GO:1903206,1,0.892528715873215,0,13,negative regulation of hydrogen peroxide-induced cell death,BP,
18302,GO:1903207,1,0.964095927649017,0,3,regulation of hydrogen peroxide-induced neuron death,BP,
18303,GO:1903208,1,0.964095927649017,0,3,negative regulation of hydrogen peroxide-induced neuron death,BP,
18304,GO:1903209,1,0.904236465047861,0,11,positive regulation of oxidative stress-induced cell death,BP,
18306,GO:1903215,1,0.994603807741999,0,1,negative regulation of protein targeting to mitochondrion,BP,
18307,GO:1903223,1,0.986164523418838,0,3,positive regulation of oxidative stress-induced neuron death,BP,
18308,GO:1903224,1,0.978483125972556,0,4,regulation of endodermal cell differentiation,BP,
18309,GO:1903225,1,0.990755199849044,0,2,negative regulation of endodermal cell differentiation,BP,
18310,GO:1903231,1,0.995366654294266,0,1,mRNA binding involved in posttranscriptional gene silencing,MF,
18311,GO:1903232,1,0.937777199378552,0,5,melanosome assembly,BP,
18312,GO:1903233,1,0.990755199849149,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
18313,GO:1903236,1,0.966325892995944,0,3,regulation of leukocyte tethering or rolling,BP,
18314,GO:1903237,1,0.975345340173749,0,1,negative regulation of leukocyte tethering or rolling,BP,
18315,GO:1903238,1,0.990755199849227,0,2,positive regulation of leukocyte tethering or rolling,BP,
18316,GO:1903242,1,0.972517906633748,0,6,regulation of cardiac muscle hypertrophy in response to stress,BP,
18317,GO:1903243,1,0.977045779165895,0,5,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
18318,GO:1903244,1,0.995366990826165,0,1,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
18319,GO:1903248,1,0.99536699082598,0,1,regulation of citrulline biosynthetic process,BP,
18320,GO:1903249,1,0.99536699082598,0,1,negative regulation of citrulline biosynthetic process,BP,
18321,GO:1903251,1,0.968264068982385,0,5,multi-ciliated epithelial cell differentiation,BP,
18322,GO:1903259,1,0.995366574475227,0,1,exon-exon junction complex disassembly,BP,
18323,GO:1903265,1,0.938758339493686,0,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
18324,GO:1903276,1,0.985651894538701,0,2,regulation of sodium ion export across plasma membrane,BP,
18325,GO:1903278,1,0.985651894538701,0,2,positive regulation of sodium ion export across plasma membrane,BP,
18326,GO:1903279,1,0.988299372079513,0,2,regulation of calcium:sodium antiporter activity,BP,
18327,GO:1903281,1,0.988299372079513,0,2,positive regulation of calcium:sodium antiporter activity,BP,
18328,GO:1903282,1,0.995366810543291,0,1,regulation of glutathione peroxidase activity,BP,
18329,GO:1903284,1,0.995366810543291,0,1,positive regulation of glutathione peroxidase activity,BP,
18330,GO:1903285,1,0.995366810543291,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
18331,GO:1903286,1,0.981084601846221,0,3,regulation of potassium ion import,BP,
18332,GO:1903288,1,0.985651894538701,0,2,positive regulation of potassium ion import,BP,
18333,GO:1903292,1,0.990754784575457,0,2,protein localization to Golgi membrane,BP,
18334,GO:1903293,1,0.772751650142181,0,46,phosphatase complex,CC,
18335,GO:1903294,1,0.990755199507644,0,2,regulation of glutamate secretion, neurotransmission,BP,
18336,GO:1903296,1,0.990755199507644,0,2,positive regulation of glutamate secretion, neurotransmission,BP,
18337,GO:1903297,1,0.965662586984615,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18338,GO:1903298,1,0.965662586984615,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18339,GO:1903299,1,0.931137628750546,0,7,regulation of hexokinase activity,BP,
18340,GO:1903300,1,0.977288069112851,0,2,negative regulation of hexokinase activity,BP,
18341,GO:1903301,1,0.952789180660191,0,5,positive regulation of hexokinase activity,BP,
18343,GO:1903306,1,0.937470877429386,0,12,negative regulation of regulated secretory pathway,BP,
18348,GO:1903317,1,0.689622999450772,0,53,regulation of protein maturation,BP,
18349,GO:1903318,1,0.812146220528226,0,26,negative regulation of protein maturation,BP,
18350,GO:1903319,1,0.930232962391741,0,13,positive regulation of protein maturation,BP,
18352,GO:1903321,1,0.558314683873348,0,67,negative regulation of protein modification by small protein conjugation or removal,BP,
18354,GO:1903332,1,0.940598773895955,0,7,regulation of protein folding,BP,
18355,GO:1903333,1,0.949431869112751,0,5,negative regulation of protein folding,BP,
18356,GO:1903335,1,0.964867744602576,0,4,regulation of vacuolar transport,BP,
18357,GO:1903336,1,0.995366879233504,0,1,negative regulation of vacuolar transport,BP,
18358,GO:1903337,1,0.973905327778456,0,2,positive regulation of vacuolar transport,BP,
18359,GO:1903347,1,0.977089064455155,0,4,negative regulation of bicellular tight junction assembly,BP,
18360,GO:1903348,1,0.98615633717414,0,3,positive regulation of bicellular tight junction assembly,BP,
18361,GO:1903349,1,0.968744686237035,0,6,omegasome membrane,CC,
18362,GO:1903350,1,0.924656830570082,0,11,response to dopamine,BP,
18363,GO:1903351,1,0.924656830570082,0,11,cellular response to dopamine,BP,
18364,GO:1903352,1,0.981328510625889,0,4,L-ornithine transmembrane transport,BP,
18365,GO:1903358,1,0.923011762899169,0,15,regulation of Golgi organization,BP,
18366,GO:1903361,1,0.963867277378772,0,5,protein localization to basolateral plasma membrane,BP,
18368,GO:1903363,1,0.587028180637499,0,64,negative regulation of cellular protein catabolic process,BP,
18370,GO:1903365,1,0.974004768939515,0,3,regulation of fear response,BP,
18371,GO:1903367,1,0.99536678233859,0,1,positive regulation of fear response,BP,
18372,GO:1903371,1,0.981098785865061,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
18373,GO:1903373,1,0.985666145194549,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
18374,GO:1903375,1,0.990647811994295,0,2,facioacoustic ganglion development,BP,
18375,GO:1903376,1,0.95114175120155,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18376,GO:1903377,1,0.964491465891152,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18377,GO:1903378,1,0.990755192209413,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18378,GO:1903381,1,0.995366990826164,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18379,GO:1903382,1,0.995366990826164,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18380,GO:1903383,1,0.973494227803959,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
18381,GO:1903384,1,0.973494227803959,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
18382,GO:1903385,1,0.990755151847146,0,2,regulation of homophilic cell adhesion,BP,
18383,GO:1903387,1,0.995366990826152,0,1,positive regulation of homophilic cell adhesion,BP,
18384,GO:1903391,1,0.77060481467058,0,47,regulation of adherens junction organization,BP,
18385,GO:1903392,1,0.938807396094307,0,13,negative regulation of adherens junction organization,BP,
18386,GO:1903393,1,0.880792229579882,0,22,positive regulation of adherens junction organization,BP,
18387,GO:1903394,1,0.995068827668363,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
18388,GO:1903400,1,0.985896927101863,0,3,L-arginine transmembrane transport,BP,
18389,GO:1903401,1,0.983519057012409,0,3,L-lysine transmembrane transport,BP,
18390,GO:1903405,1,0.948300505876629,0,9,protein localization to nuclear body,BP,
18391,GO:1903406,1,0.995366974796877,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
18392,GO:1903408,1,0.995366974796877,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
18393,GO:1903409,1,0.614007079088648,0,66,reactive oxygen species biosynthetic process,BP,
18394,GO:1903416,1,0.983065027103669,0,3,response to glycoside,BP,
18395,GO:1903420,1,0.995366990826099,0,1,protein localization to endoplasmic reticulum tubular network,BP,
18396,GO:1903421,1,0.928114096996654,0,13,regulation of synaptic vesicle recycling,BP,
18397,GO:1903422,1,0.986164530459604,0,3,negative regulation of synaptic vesicle recycling,BP,
18398,GO:1903423,1,0.975988108986045,0,5,positive regulation of synaptic vesicle recycling,BP,
18399,GO:1903426,1,0.691994515366746,0,51,regulation of reactive oxygen species biosynthetic process,BP,
18400,GO:1903427,1,0.861628920888093,0,18,negative regulation of reactive oxygen species biosynthetic process,BP,
18401,GO:1903428,1,0.804140088897702,0,31,positive regulation of reactive oxygen species biosynthetic process,BP,
18402,GO:1903429,1,0.894373618927011,0,15,regulation of cell maturation,BP,
18403,GO:1903430,1,0.958042543640416,0,4,negative regulation of cell maturation,BP,
18404,GO:1903431,1,0.965527541596164,0,7,positive regulation of cell maturation,BP,
18405,GO:1903432,1,0.857564075999994,0,24,regulation of TORC1 signaling,BP,
18406,GO:1903433,1,0.99075467329921,0,2,regulation of constitutive secretory pathway,BP,
18407,GO:1903434,1,0.99536698952126,0,1,negative regulation of constitutive secretory pathway,BP,
18408,GO:1903435,1,0.995366463158185,0,1,positive regulation of constitutive secretory pathway,BP,
18409,GO:1903436,1,0.990755099159295,0,2,regulation of mitotic cytokinetic process,BP,
18410,GO:1903438,1,0.990755099159295,0,2,positive regulation of mitotic cytokinetic process,BP,
18411,GO:1903439,1,0.9728909882692,0,2,calcitonin family receptor complex,CC,
18412,GO:1903440,1,0.977420572404843,0,1,amylin receptor complex,CC,
18413,GO:1903441,1,0.967702063505109,0,7,protein localization to ciliary membrane,BP,
18414,GO:1903442,1,0.995366988609227,0,1,response to lipoic acid,BP,
18415,GO:1903444,1,0.995366803504279,0,1,negative regulation of brown fat cell differentiation,BP,
18416,GO:1903445,1,0.969838633631857,0,3,protein transport from ciliary membrane to plasma membrane,BP,
18417,GO:1903450,1,0.995366990825994,0,1,regulation of G1 to G0 transition,BP,
18418,GO:1903452,1,0.995366990825994,0,1,positive regulation of G1 to G0 transition,BP,
18419,GO:1903461,1,0.99536676810565,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
18420,GO:1903463,1,0.9836286013587,0,3,regulation of mitotic cell cycle DNA replication,BP,
18421,GO:1903464,1,0.988207600858695,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
18422,GO:1903465,1,0.995366990826138,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
18423,GO:1903487,1,0.987678129892786,0,2,regulation of lactation,BP,
18424,GO:1903489,1,0.992275793949614,0,1,positive regulation of lactation,BP,
18425,GO:1903490,1,0.990755099159295,0,2,positive regulation of mitotic cytokinesis,BP,
18426,GO:1903504,1,0.917506108034496,0,13,regulation of mitotic spindle checkpoint,BP,
18431,GO:1903510,1,0.653323437993473,0,79,mucopolysaccharide metabolic process,BP,
18432,GO:1903513,1,0.832840612003442,0,25,endoplasmic reticulum to cytosol transport,BP,
18433,GO:1903514,1,0.867179905197442,0,16,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,
18434,GO:1903515,1,0.995366990826007,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
18435,GO:1903516,1,0.985136578433607,0,3,regulation of single strand break repair,BP,
18436,GO:1903517,1,0.99536658106292,0,1,negative regulation of single strand break repair,BP,
18437,GO:1903518,1,0.989722924543855,0,2,positive regulation of single strand break repair,BP,
18438,GO:1903519,1,0.966257678802283,0,3,regulation of mammary gland involution,BP,
18439,GO:1903521,1,0.966257678802283,0,3,positive regulation of mammary gland involution,BP,
18441,GO:1903523,1,0.899284177606823,0,17,negative regulation of blood circulation,BP,
18443,GO:1903525,1,0.977046162052806,0,5,regulation of membrane tubulation,BP,
18444,GO:1903526,1,0.990755183893429,0,2,negative regulation of membrane tubulation,BP,
18445,GO:1903527,1,0.986164531023636,0,3,positive regulation of membrane tubulation,BP,
18450,GO:1903537,1,0.990500038171143,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
18451,GO:1903538,1,0.990500038171143,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
18452,GO:1903539,1,0.957828722821603,0,9,protein localization to postsynaptic membrane,BP,
18453,GO:1903540,1,0.957828722821603,0,9,establishment of protein localization to postsynaptic membrane,BP,
18454,GO:1903541,1,0.901676194687003,0,14,regulation of exosomal secretion,BP,
18455,GO:1903542,1,0.9901649214586,0,2,negative regulation of exosomal secretion,BP,
18456,GO:1903543,1,0.901676194687003,0,14,positive regulation of exosomal secretion,BP,
18457,GO:1903544,1,0.995366926692119,0,1,response to butyrate,BP,
18458,GO:1903545,1,0.995366926692119,0,1,cellular response to butyrate,BP,
18459,GO:1903546,1,0.979501637156,0,4,protein localization to photoreceptor outer segment,BP,
18460,GO:1903547,1,0.964486660418717,0,2,regulation of growth hormone activity,BP,
18461,GO:1903551,1,0.965597889936212,0,6,regulation of extracellular exosome assembly,BP,
18462,GO:1903553,1,0.980761404928472,0,4,positive regulation of extracellular exosome assembly,BP,
18464,GO:1903556,1,0.815632209436165,0,27,negative regulation of tumor necrosis factor superfamily cytokine production,BP,
18467,GO:1903564,1,0.981331999383434,0,4,regulation of protein localization to cilium,BP,
18468,GO:1903565,1,0.995366921815792,0,1,negative regulation of protein localization to cilium,BP,
18469,GO:1903566,1,0.985900500275449,0,3,positive regulation of protein localization to cilium,BP,
18470,GO:1903567,1,0.990489885478243,0,2,regulation of protein localization to ciliary membrane,BP,
18471,GO:1903568,1,0.995366921815792,0,1,negative regulation of protein localization to ciliary membrane,BP,
18472,GO:1903569,1,0.995100524659271,0,1,positive regulation of protein localization to ciliary membrane,BP,
18473,GO:1903570,1,0.995366954019034,0,1,regulation of protein kinase D signaling,BP,
18474,GO:1903572,1,0.995366954019034,0,1,positive regulation of protein kinase D signaling,BP,
18475,GO:1903573,1,0.79026522059735,0,36,negative regulation of response to endoplasmic reticulum stress,BP,
18476,GO:1903575,1,0.983491890446498,0,2,cornified envelope assembly,BP,
18477,GO:1903576,1,0.994116813998554,0,1,response to L-arginine,BP,
18481,GO:1903584,1,0.995366990826151,0,1,regulation of histone deubiquitination,BP,
18482,GO:1903586,1,0.995366990826151,0,1,positive regulation of histone deubiquitination,BP,
18483,GO:1903587,1,0.961131118697886,0,5,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
18484,GO:1903588,1,0.97604582935672,0,3,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
18485,GO:1903589,1,0.984723474889656,0,2,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
18486,GO:1903593,1,0.964526365216734,0,3,regulation of histamine secretion by mast cell,BP,
18487,GO:1903595,1,0.964526365216734,0,3,positive regulation of histamine secretion by mast cell,BP,
18488,GO:1903596,1,0.995357732214175,0,1,regulation of gap junction assembly,BP,
18489,GO:1903598,1,0.995357732214175,0,1,positive regulation of gap junction assembly,BP,
18490,GO:1903599,1,0.876225253331205,0,17,positive regulation of autophagy of mitochondrion,BP,
18491,GO:1903608,1,0.95738684773306,0,7,protein localization to cytoplasmic stress granule,BP,
18492,GO:1903609,1,0.995357732214175,0,1,negative regulation of inward rectifier potassium channel activity,BP,
18493,GO:1903613,1,0.995366990826152,0,1,regulation of protein tyrosine phosphatase activity,BP,
18494,GO:1903615,1,0.995366990826152,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
18495,GO:1903621,1,0.99338638741337,0,1,protein localization to photoreceptor connecting cilium,BP,
18496,GO:1903624,1,0.934671892246024,0,7,regulation of DNA catabolic process,BP,
18497,GO:1903625,1,0.995363424876141,0,1,negative regulation of DNA catabolic process,BP,
18498,GO:1903626,1,0.948428434012651,0,4,positive regulation of DNA catabolic process,BP,
18499,GO:1903630,1,0.983837039027687,0,1,regulation of aminoacyl-tRNA ligase activity,BP,
18500,GO:1903632,1,0.983837039027687,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
18501,GO:1903636,1,0.969297794369347,0,1,regulation of protein import into mitochondrial outer membrane,BP,
18502,GO:1903638,1,0.969297794369347,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
18503,GO:1903644,1,0.964753570577734,0,2,regulation of chaperone-mediated protein folding,BP,
18504,GO:1903645,1,0.969297794369347,0,1,negative regulation of chaperone-mediated protein folding,BP,
18505,GO:1903649,1,0.880392096603138,0,19,regulation of cytoplasmic transport,BP,
18506,GO:1903650,1,0.95892018636818,0,2,negative regulation of cytoplasmic transport,BP,
18507,GO:1903651,1,0.95903923430959,0,9,positive regulation of cytoplasmic transport,BP,
18508,GO:1903659,1,0.99530781851319,0,1,regulation of complement-dependent cytotoxicity,BP,
18509,GO:1903660,1,0.99530781851319,0,1,negative regulation of complement-dependent cytotoxicity,BP,
18510,GO:1903670,1,0.769098908751857,0,44,regulation of sprouting angiogenesis,BP,
18511,GO:1903671,1,0.888191036588322,0,21,negative regulation of sprouting angiogenesis,BP,
18512,GO:1903672,1,0.866086015324003,0,23,positive regulation of sprouting angiogenesis,BP,
18513,GO:1903673,1,0.993199557245985,0,1,mitotic cleavage furrow formation,BP,
18514,GO:1903674,1,0.993148320529259,0,1,regulation of cap-dependent translational initiation,BP,
18515,GO:1903676,1,0.993148320529259,0,1,positive regulation of cap-dependent translational initiation,BP,
18516,GO:1903677,1,0.982103903159421,0,3,regulation of cap-independent translational initiation,BP,
18517,GO:1903679,1,0.982103903159421,0,3,positive regulation of cap-independent translational initiation,BP,
18518,GO:1903689,1,0.972518303431585,0,6,regulation of wound healing, spreading of epidermal cells,BP,
18519,GO:1903690,1,0.981594888733286,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
18520,GO:1903691,1,0.990755199848952,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
18521,GO:1903697,1,0.995366903787284,0,1,negative regulation of microvillus assembly,BP,
18522,GO:1903699,1,0.995366990825863,0,1,tarsal gland development,BP,
18523,GO:1903701,1,0.995366990826151,0,1,substantia propria of cornea development,BP,
18524,GO:1903704,1,0.961814214726214,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
18527,GO:1903708,1,0.465129718565849,0,114,positive regulation of hemopoiesis,BP,
18528,GO:1903709,1,0.995366990825863,0,1,uterine gland development,BP,
18529,GO:1903715,1,0.975411290801251,0,4,regulation of aerobic respiration,BP,
18530,GO:1903717,1,0.995366990826125,0,1,response to ammonia,BP,
18531,GO:1903718,1,0.995366990826125,0,1,cellular response to ammonia,BP,
18532,GO:1903719,1,0.974936642437173,0,3,regulation of I-kappaB phosphorylation,BP,
18533,GO:1903721,1,0.974936642437173,0,3,positive regulation of I-kappaB phosphorylation,BP,
18534,GO:1903722,1,0.972868849926754,0,2,regulation of centriole elongation,BP,
18535,GO:1903723,1,0.977398407059126,0,1,negative regulation of centriole elongation,BP,
18536,GO:1903724,1,0.995366914582547,0,1,positive regulation of centriole elongation,BP,
18537,GO:1903725,1,0.754865283483307,0,47,regulation of phospholipid metabolic process,BP,
18538,GO:1903726,1,0.935745680157274,0,8,negative regulation of phospholipid metabolic process,BP,
18539,GO:1903727,1,0.862978271894437,0,25,positive regulation of phospholipid metabolic process,BP,
18540,GO:1903729,1,0.934281988754529,0,9,regulation of plasma membrane organization,BP,
18542,GO:1903748,1,0.97476032899117,0,4,negative regulation of establishment of protein localization to mitochondrion,BP,
18544,GO:1903750,1,0.964112022245598,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18545,GO:1903751,1,0.964112022245598,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18546,GO:1903753,1,0.981036631985935,0,4,negative regulation of p38MAPK cascade,BP,
18547,GO:1903755,1,0.983535025082634,0,1,positive regulation of SUMO transferase activity,BP,
18548,GO:1903756,1,0.990525730417102,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
18549,GO:1903758,1,0.990525730417102,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
18550,GO:1903759,1,0.995366803504279,0,1,signal transduction involved in regulation of aerobic respiration,BP,
18551,GO:1903760,1,0.990755199816422,0,2,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18552,GO:1903762,1,0.995366990793145,0,1,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18553,GO:1903763,1,0.981024663934436,0,4,gap junction channel activity involved in cell communication by electrical coupling,MF,
18554,GO:1903764,1,0.995366990826164,0,1,regulation of potassium ion export across plasma membrane,BP,
18555,GO:1903767,1,0.995316512568758,0,1,sweet taste receptor complex,CC,
18556,GO:1903768,1,0.995316512568758,0,1,taste receptor complex,CC,
18557,GO:1903770,1,0.99536658106292,0,1,negative regulation of beta-galactosidase activity,BP,
18558,GO:1903772,1,0.958872298152581,0,5,regulation of viral budding via host ESCRT complex,BP,
18559,GO:1903774,1,0.979223929244354,0,3,positive regulation of viral budding via host ESCRT complex,BP,
18560,GO:1903775,1,0.989804651477249,0,2,regulation of DNA double-strand break processing,BP,
18561,GO:1903778,1,0.99072318422253,0,2,protein localization to vacuolar membrane,BP,
18563,GO:1903781,1,0.990755199816396,0,2,positive regulation of cardiac conduction,BP,
18564,GO:1903786,1,0.995365164953568,0,1,regulation of glutathione biosynthetic process,BP,
18565,GO:1903788,1,0.995365164953568,0,1,positive regulation of glutathione biosynthetic process,BP,
18566,GO:1903789,1,0.975580219562366,0,5,regulation of amino acid transmembrane transport,BP,
18567,GO:1903792,1,0.940457279353405,0,13,negative regulation of anion transport,BP,
18568,GO:1903793,1,0.831317332581592,0,21,positive regulation of anion transport,BP,
18569,GO:1903795,1,0.981592231603808,0,4,regulation of inorganic anion transmembrane transport,BP,
18570,GO:1903796,1,0.990754785405156,0,2,negative regulation of inorganic anion transmembrane transport,BP,
18571,GO:1903797,1,0.995366990826138,0,1,positive regulation of inorganic anion transmembrane transport,BP,
18572,GO:1903798,1,0.928618465206028,0,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,
18573,GO:1903799,1,0.961864652733669,0,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
18574,GO:1903800,1,0.960303552779026,0,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,
18575,GO:1903801,1,0.994864007881305,0,1,L-leucine import across plasma membrane,BP,
18576,GO:1903803,1,0.993257142109047,0,1,L-glutamine import across plasma membrane,BP,
18577,GO:1903817,1,0.974177013706435,0,4,negative regulation of voltage-gated potassium channel activity,BP,
18578,GO:1903818,1,0.986164530990582,0,3,positive regulation of voltage-gated potassium channel activity,BP,
18579,GO:1903823,1,0.99536658106292,0,1,telomere single strand break repair,BP,
18580,GO:1903824,1,0.99536658106292,0,1,negative regulation of telomere single strand break repair,BP,
18581,GO:1903825,1,0.646262950740125,0,80,organic acid transmembrane transport,BP,
18582,GO:1903826,1,0.978961533021844,0,4,arginine transmembrane transport,BP,
18584,GO:1903828,1,0.600437750579156,0,77,negative regulation of cellular protein localization,BP,
18586,GO:1903830,1,0.910570644992814,0,17,magnesium ion transmembrane transport,BP,
18587,GO:1903831,1,0.919925027893096,0,12,signal transduction involved in cellular response to ammonium ion,BP,
18588,GO:1903837,1,0.995247963377268,0,1,regulation of mRNA 3'-UTR binding,BP,
18589,GO:1903839,1,0.995247963377268,0,1,positive regulation of mRNA 3'-UTR binding,BP,
18590,GO:1903844,1,0.599258118741745,0,82,regulation of cellular response to transforming growth factor beta stimulus,BP,
18591,GO:1903845,1,0.701110245625907,0,55,negative regulation of cellular response to transforming growth factor beta stimulus,BP,
18592,GO:1903846,1,0.873405220215798,0,22,positive regulation of cellular response to transforming growth factor beta stimulus,BP,
18593,GO:1903847,1,0.990755199849082,0,2,regulation of aorta morphogenesis,BP,
18594,GO:1903849,1,0.990755199849082,0,2,positive regulation of aorta morphogenesis,BP,
18595,GO:1903850,1,0.995355873361166,0,1,regulation of cristae formation,BP,
18596,GO:1903852,1,0.995355873361166,0,1,positive regulation of cristae formation,BP,
18597,GO:1903859,1,0.954330653060482,0,10,regulation of dendrite extension,BP,
18598,GO:1903860,1,0.990601374113051,0,2,negative regulation of dendrite extension,BP,
18599,GO:1903861,1,0.963389066086292,0,8,positive regulation of dendrite extension,BP,
18600,GO:1903862,1,0.955380486128984,0,5,positive regulation of oxidative phosphorylation,BP,
18601,GO:1903867,1,0.96110151857745,0,8,extraembryonic membrane development,BP,
18602,GO:1903874,1,0.99075519984928,0,2,ferrous iron transmembrane transport,BP,
18603,GO:1903881,1,0.995366982257957,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
18604,GO:1903883,1,0.995366982257957,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
18605,GO:1903884,1,0.995366982257957,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
18606,GO:1903886,1,0.995366982257957,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
18607,GO:1903888,1,0.974537838279069,0,1,regulation of plant epidermal cell differentiation,BP,
18608,GO:1903889,1,0.974537838279069,0,1,negative regulation of plant epidermal cell differentiation,BP,
18609,GO:1903891,1,0.981479158342229,0,4,regulation of ATF6-mediated unfolded protein response,BP,
18610,GO:1903892,1,0.990733601406312,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
18611,GO:1903893,1,0.995271351275469,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
18612,GO:1903894,1,0.910480229099579,0,13,regulation of IRE1-mediated unfolded protein response,BP,
18613,GO:1903895,1,0.981328000864079,0,4,negative regulation of IRE1-mediated unfolded protein response,BP,
18614,GO:1903896,1,0.947603968228126,0,7,positive regulation of IRE1-mediated unfolded protein response,BP,
18615,GO:1903897,1,0.952288822726933,0,9,regulation of PERK-mediated unfolded protein response,BP,
18616,GO:1903898,1,0.97422586039238,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
18617,GO:1903899,1,0.9820400418849,0,3,positive regulation of PERK-mediated unfolded protein response,BP,
18618,GO:1903900,1,0.409447434283849,0,111,regulation of viral life cycle,BP,
18619,GO:1903901,1,0.597876317399643,0,61,negative regulation of viral life cycle,BP,
18620,GO:1903902,1,0.680045596360411,0,51,positive regulation of viral life cycle,BP,
18621,GO:1903903,1,0.986145459996478,0,3,regulation of establishment of T cell polarity,BP,
18622,GO:1903905,1,0.99073804419117,0,2,positive regulation of establishment of T cell polarity,BP,
18623,GO:1903906,1,0.995364978449716,0,1,regulation of plasma membrane raft polarization,BP,
18624,GO:1903909,1,0.980757381519552,0,4,regulation of receptor clustering,BP,
18625,GO:1903911,1,0.98532516207654,0,3,positive regulation of receptor clustering,BP,
18626,GO:1903912,1,0.979004880047746,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
18627,GO:1903916,1,0.995119784570559,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
18628,GO:1903917,1,0.995119784570559,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
18629,GO:1903918,1,0.995366990826045,0,1,regulation of actin filament severing,BP,
18630,GO:1903919,1,0.995366990826045,0,1,negative regulation of actin filament severing,BP,
18631,GO:1903921,1,0.990753196689833,0,2,regulation of protein processing in phagocytic vesicle,BP,
18632,GO:1903923,1,0.990753196689833,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
18633,GO:1903924,1,0.99474608773005,0,1,estradiol binding,MF,
18634,GO:1903925,1,0.992807703284488,0,1,response to bisphenol A,BP,
18635,GO:1903926,1,0.992807703284488,0,1,cellular response to bisphenol A,BP,
18636,GO:1903929,1,0.995366808641377,0,1,primary palate development,BP,
18637,GO:1903935,1,0.96671445457833,0,6,response to sodium arsenite,BP,
18638,GO:1903936,1,0.971215640798244,0,5,cellular response to sodium arsenite,BP,
18639,GO:1903937,1,0.995366966583062,0,1,response to acrylamide,BP,
18640,GO:1903939,1,0.995366899841122,0,1,regulation of TORC2 signaling,BP,
18641,GO:1903943,1,0.993483920407201,0,1,regulation of hepatocyte apoptotic process,BP,
18642,GO:1903944,1,0.993483920407201,0,1,negative regulation of hepatocyte apoptotic process,BP,
18643,GO:1903947,1,0.995366990793145,0,1,positive regulation of ventricular cardiac muscle cell action potential,BP,
18644,GO:1903949,1,0.990755199816396,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
18645,GO:1903952,1,0.995366990793145,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18646,GO:1903954,1,0.995366990793145,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18648,GO:1903959,1,0.922669185056373,0,17,regulation of anion transmembrane transport,BP,
18649,GO:1903960,1,0.953658953318094,0,10,negative regulation of anion transmembrane transport,BP,
18650,GO:1903961,1,0.985668446293283,0,3,positive regulation of anion transmembrane transport,BP,
18651,GO:1903963,1,0.913359808354167,0,12,arachidonate transport,BP,
18652,GO:1903964,1,0.990721202566383,0,2,monounsaturated fatty acid metabolic process,BP,
18653,GO:1903966,1,0.990721202566383,0,2,monounsaturated fatty acid biosynthetic process,BP,
18654,GO:1903969,1,0.986470767076318,0,2,regulation of response to macrophage colony-stimulating factor,BP,
18655,GO:1903970,1,0.991234792401661,0,1,negative regulation of response to macrophage colony-stimulating factor,BP,
18656,GO:1903971,1,0.995194333493049,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
18657,GO:1903972,1,0.986470767076318,0,2,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18658,GO:1903973,1,0.991234792401661,0,1,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18659,GO:1903974,1,0.995194333493049,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18660,GO:1903975,1,0.964500217251161,0,6,regulation of glial cell migration,BP,
18661,GO:1903976,1,0.981490714894351,0,3,negative regulation of glial cell migration,BP,
18662,GO:1903977,1,0.990583333323112,0,2,positive regulation of glial cell migration,BP,
18663,GO:1903978,1,0.972418367736316,0,4,regulation of microglial cell activation,BP,
18664,GO:1903979,1,0.995366990826152,0,1,negative regulation of microglial cell activation,BP,
18665,GO:1903980,1,0.981494025645465,0,2,positive regulation of microglial cell activation,BP,
18666,GO:1903984,1,0.984802159166402,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
18667,GO:1903995,1,0.994605617896706,0,1,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
18668,GO:1903997,1,0.994605617896706,0,1,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
18669,GO:1903998,1,0.966348615464972,0,3,regulation of eating behavior,BP,
18670,GO:1903999,1,0.970848090178296,0,2,negative regulation of eating behavior,BP,
18671,GO:1904000,1,0.995366990825981,0,1,positive regulation of eating behavior,BP,
18672,GO:1904016,1,0.981511664485454,0,4,response to Thyroglobulin triiodothyronine,BP,
18673,GO:1904017,1,0.990755199849149,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
18674,GO:1904018,1,0.489747583713612,0,112,positive regulation of vasculature development,BP,
18675,GO:1904019,1,0.710570855605515,0,62,epithelial cell apoptotic process,BP,
18676,GO:1904020,1,0.990754985437526,0,2,regulation of G-protein coupled receptor internalization,BP,
18677,GO:1904021,1,0.995366925093106,0,1,negative regulation of G-protein coupled receptor internalization,BP,
18678,GO:1904022,1,0.995366841160869,0,1,positive regulation of G-protein coupled receptor internalization,BP,
18679,GO:1904023,1,0.995366574475227,0,1,regulation of glucose catabolic process to lactate via pyruvate,BP,
18680,GO:1904024,1,0.995366574475227,0,1,negative regulation of glucose catabolic process to lactate via pyruvate,BP,
18681,GO:1904026,1,0.990687710588815,0,2,regulation of collagen fibril organization,BP,
18682,GO:1904027,1,0.995299607351568,0,1,negative regulation of collagen fibril organization,BP,
18683,GO:1904028,1,0.995366574475227,0,1,positive regulation of collagen fibril organization,BP,
18684,GO:1904029,1,0.570872140570885,0,75,regulation of cyclin-dependent protein kinase activity,BP,
18685,GO:1904030,1,0.830735552982341,0,28,negative regulation of cyclin-dependent protein kinase activity,BP,
18686,GO:1904031,1,0.801744282602342,0,30,positive regulation of cyclin-dependent protein kinase activity,BP,
18687,GO:1904035,1,0.793141463545154,0,43,regulation of epithelial cell apoptotic process,BP,
18688,GO:1904036,1,0.886384017614148,0,23,negative regulation of epithelial cell apoptotic process,BP,
18689,GO:1904037,1,0.910952576482071,0,17,positive regulation of epithelial cell apoptotic process,BP,
18690,GO:1904041,1,0.995366878313285,0,1,regulation of cystathionine beta-synthase activity,BP,
18691,GO:1904042,1,0.995366878313285,0,1,negative regulation of cystathionine beta-synthase activity,BP,
18692,GO:1904044,1,0.962786112589809,0,3,response to aldosterone,BP,
18693,GO:1904045,1,0.994704130129693,0,1,cellular response to aldosterone,BP,
18694,GO:1904046,1,0.97019960715141,0,2,negative regulation of vascular endothelial growth factor production,BP,
18695,GO:1904047,1,0.984269524126243,0,3,S-adenosyl-L-methionine binding,MF,
18696,GO:1904048,1,0.995366990826164,0,1,regulation of spontaneous neurotransmitter secretion,BP,
18697,GO:1904050,1,0.995366990826164,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
18698,GO:1904054,1,0.995366990825981,0,1,regulation of cholangiocyte proliferation,BP,
18699,GO:1904056,1,0.995366990825981,0,1,positive regulation of cholangiocyte proliferation,BP,
18700,GO:1904057,1,0.990348766719998,0,1,negative regulation of sensory perception of pain,BP,
18701,GO:1904058,1,0.966348615464958,0,3,positive regulation of sensory perception of pain,BP,
18702,GO:1904059,1,0.995366990825784,0,1,regulation of locomotor rhythm,BP,
18704,GO:1904063,1,0.746852541312152,0,40,negative regulation of cation transmembrane transport,BP,
18706,GO:1904073,1,0.99536699082606,0,1,regulation of trophectodermal cell proliferation,BP,
18707,GO:1904075,1,0.99536699082606,0,1,positive regulation of trophectodermal cell proliferation,BP,
18708,GO:1904090,1,0.922177137441271,0,4,peptidase inhibitor complex,CC,
18709,GO:1904098,1,0.982124756374103,0,3,regulation of protein O-linked glycosylation,BP,
18710,GO:1904100,1,0.982124756374103,0,3,positive regulation of protein O-linked glycosylation,BP,
18711,GO:1904106,1,0.995366585415899,0,1,protein localization to microvillus,BP,
18712,GO:1904115,1,0.737145495834657,0,37,axon cytoplasm,CC,
18713,GO:1904116,1,0.986163996225393,0,3,response to vasopressin,BP,
18714,GO:1904117,1,0.986163996225393,0,3,cellular response to vasopressin,BP,
18715,GO:1904121,1,0.990933464906061,0,1,phosphatidylethanolamine transporter activity,MF,
18716,GO:1904124,1,0.995194333493049,0,1,microglial cell migration,BP,
18717,GO:1904139,1,0.995194333493049,0,1,regulation of microglial cell migration,BP,
18718,GO:1904141,1,0.995194333493049,0,1,positive regulation of microglial cell migration,BP,
18719,GO:1904152,1,0.917232115290486,0,12,regulation of retrograde protein transport, ER to cytosol,BP,
18720,GO:1904153,1,0.938108466573321,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
18721,GO:1904154,1,0.977762490035434,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
18722,GO:1904155,1,0.995366900041206,0,1,DN2 thymocyte differentiation,BP,
18723,GO:1904156,1,0.995366900041206,0,1,DN3 thymocyte differentiation,BP,
18724,GO:1904167,1,0.995366990825915,0,1,regulation of thyroid hormone receptor activity,BP,
18725,GO:1904168,1,0.995366990825915,0,1,negative regulation of thyroid hormone receptor activity,BP,
18726,GO:1904170,1,0.995366990826165,0,1,regulation of bleb assembly,BP,
18727,GO:1904172,1,0.995366990826165,0,1,positive regulation of bleb assembly,BP,
18728,GO:1904177,1,0.986164529332538,0,3,regulation of adipose tissue development,BP,
18729,GO:1904179,1,0.986164529332538,0,3,positive regulation of adipose tissue development,BP,
18730,GO:1904180,1,0.957877538401898,0,5,negative regulation of membrane depolarization,BP,
18731,GO:1904181,1,0.927219012635942,0,7,positive regulation of membrane depolarization,BP,
18732,GO:1904192,1,0.995366990825981,0,1,regulation of cholangiocyte apoptotic process,BP,
18733,GO:1904193,1,0.995366990825981,0,1,negative regulation of cholangiocyte apoptotic process,BP,
18734,GO:1904195,1,0.995366990825981,0,1,regulation of granulosa cell proliferation,BP,
18735,GO:1904197,1,0.995366990825981,0,1,positive regulation of granulosa cell proliferation,BP,
18736,GO:1904199,1,0.995366990826138,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
18737,GO:1904200,1,0.995366990825981,0,1,iodide transmembrane transport,BP,
18738,GO:1904201,1,0.995366990825981,0,1,regulation of iodide transport,BP,
18739,GO:1904202,1,0.995366990825981,0,1,negative regulation of iodide transport,BP,
18740,GO:1904204,1,0.995366990825981,0,1,regulation of skeletal muscle hypertrophy,BP,
18741,GO:1904206,1,0.995366990825981,0,1,positive regulation of skeletal muscle hypertrophy,BP,
18742,GO:1904207,1,0.990251639759363,0,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,
18743,GO:1904209,1,0.990251639759363,0,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,
18744,GO:1904210,1,0.986818176556501,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18745,GO:1904211,1,0.987400132289678,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
18746,GO:1904212,1,0.995366990825981,0,1,regulation of iodide transmembrane transport,BP,
18747,GO:1904213,1,0.995366990825981,0,1,negative regulation of iodide transmembrane transport,BP,
18748,GO:1904217,1,0.982571366328156,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18749,GO:1904219,1,0.982571366328156,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18750,GO:1904220,1,0.978017774401952,0,4,regulation of serine C-palmitoyltransferase activity,BP,
18751,GO:1904222,1,0.982571366328156,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
18752,GO:1904226,1,0.994614625735962,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
18753,GO:1904227,1,0.994614625735962,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
18754,GO:1904229,1,0.995366990826059,0,1,regulation of succinate dehydrogenase activity,BP,
18755,GO:1904231,1,0.995366990826059,0,1,positive regulation of succinate dehydrogenase activity,BP,
18756,GO:1904232,1,0.995366990826059,0,1,regulation of aconitate hydratase activity,BP,
18757,GO:1904234,1,0.995366990826059,0,1,positive regulation of aconitate hydratase activity,BP,
18758,GO:1904235,1,0.995366990826008,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
18759,GO:1904237,1,0.995366990826008,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
18760,GO:1904238,1,0.980584205287067,0,3,pericyte cell differentiation,BP,
18761,GO:1904239,1,0.986818176556501,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18762,GO:1904240,1,0.986818176556501,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18763,GO:1904245,1,0.98704896502735,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
18764,GO:1904246,1,0.991643945790632,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
18765,GO:1904247,1,0.995366746339016,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
18768,GO:1904259,1,0.977046177790215,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
18769,GO:1904261,1,0.977046177790215,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
18770,GO:1904262,1,0.941277592878973,0,11,negative regulation of TORC1 signaling,BP,
18771,GO:1904263,1,0.940574707981889,0,8,positive regulation of TORC1 signaling,BP,
18772,GO:1904265,1,0.995366990826099,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
18773,GO:1904266,1,0.995366990826059,0,1,regulation of Schwann cell chemotaxis,BP,
18774,GO:1904268,1,0.995366990826059,0,1,positive regulation of Schwann cell chemotaxis,BP,
18775,GO:1904271,1,0.99524265188522,0,1,L-proline import across plasma membrane,BP,
18776,GO:1904274,1,0.994742924991196,0,1,tricellular tight junction assembly,BP,
18777,GO:1904282,1,0.993389805337357,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
18778,GO:1904283,1,0.993389805337357,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
18779,GO:1904288,1,0.981239722948182,0,4,BAT3 complex binding,MF,
18780,GO:1904289,1,0.990754879420144,0,2,regulation of mitotic DNA damage checkpoint,BP,
18781,GO:1904290,1,0.995366990826164,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
18782,GO:1904292,1,0.849630537637273,0,26,regulation of ERAD pathway,BP,
18783,GO:1904293,1,0.911077191106465,0,13,negative regulation of ERAD pathway,BP,
18784,GO:1904294,1,0.932288203209232,0,13,positive regulation of ERAD pathway,BP,
18785,GO:1904298,1,0.995366990826138,0,1,regulation of transcytosis,BP,
18786,GO:1904300,1,0.995366990826138,0,1,positive regulation of transcytosis,BP,
18787,GO:1904301,1,0.995366990826138,0,1,regulation of maternal process involved in parturition,BP,
18788,GO:1904303,1,0.995366990826138,0,1,positive regulation of maternal process involved in parturition,BP,
18789,GO:1904304,1,0.970848090178285,0,2,regulation of gastro-intestinal system smooth muscle contraction,BP,
18790,GO:1904306,1,0.970848090178285,0,2,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
18791,GO:1904313,1,0.995366990774029,0,1,response to methamphetamine hydrochloride,BP,
18792,GO:1904315,1,0.975890865475588,0,5,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
18793,GO:1904316,1,0.995366990826138,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
18794,GO:1904317,1,0.995366990826138,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
18795,GO:1904321,1,0.9611506504301,0,8,response to forskolin,BP,
18796,GO:1904322,1,0.9611506504301,0,8,cellular response to forskolin,BP,
18797,GO:1904327,1,0.990754785405249,0,2,protein localization to cytosolic proteasome complex,BP,
18798,GO:1904328,1,0.995363934373988,0,1,regulation of myofibroblast contraction,BP,
18799,GO:1904338,1,0.96796315639746,0,6,regulation of dopaminergic neuron differentiation,BP,
18800,GO:1904339,1,0.995366990826059,0,1,negative regulation of dopaminergic neuron differentiation,BP,
18801,GO:1904340,1,0.981546203742773,0,3,positive regulation of dopaminergic neuron differentiation,BP,
18802,GO:1904350,1,0.956211581912955,0,8,regulation of protein catabolic process in the vacuole,BP,
18803,GO:1904351,1,0.985594936329711,0,3,negative regulation of protein catabolic process in the vacuole,BP,
18804,GO:1904352,1,0.974913493312767,0,4,positive regulation of protein catabolic process in the vacuole,BP,
18805,GO:1904353,1,0.868877022693738,0,25,regulation of telomere capping,BP,
18806,GO:1904354,1,0.962519966812642,0,8,negative regulation of telomere capping,BP,
18807,GO:1904355,1,0.906958004386446,0,16,positive regulation of telomere capping,BP,
18808,GO:1904356,1,0.718670097203253,0,58,regulation of telomere maintenance via telomere lengthening,BP,
18809,GO:1904357,1,0.868088197168112,0,26,negative regulation of telomere maintenance via telomere lengthening,BP,
18810,GO:1904358,1,0.813375691886797,0,35,positive regulation of telomere maintenance via telomere lengthening,BP,
18811,GO:1904375,1,0.623288587233583,0,73,regulation of protein localization to cell periphery,BP,
18812,GO:1904376,1,0.908637216800613,0,19,negative regulation of protein localization to cell periphery,BP,
18813,GO:1904377,1,0.761716602844876,0,45,positive regulation of protein localization to cell periphery,BP,
18814,GO:1904378,1,0.985036601018768,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
18815,GO:1904379,1,0.990754785405249,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
18816,GO:1904380,1,0.866421226912882,0,19,endoplasmic reticulum mannose trimming,BP,
18817,GO:1904381,1,0.990755199849254,0,2,Golgi apparatus mannose trimming,BP,
18818,GO:1904382,1,0.979455305761291,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
18819,GO:1904383,1,0.99451350643876,0,1,response to sodium phosphate,BP,
18820,GO:1904385,1,0.899242927599548,0,14,cellular response to angiotensin,BP,
18821,GO:1904386,1,0.98616427733781,0,3,response to L-phenylalanine derivative,BP,
18822,GO:1904387,1,0.990754948172085,0,2,cellular response to L-phenylalanine derivative,BP,
18823,GO:1904393,1,0.99536699082602,0,1,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18824,GO:1904395,1,0.99536699082602,0,1,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18825,GO:1904396,1,0.986164531023469,0,3,regulation of neuromuscular junction development,BP,
18826,GO:1904398,1,0.990755199849045,0,2,positive regulation of neuromuscular junction development,BP,
18827,GO:1904404,1,0.995366990826047,0,1,response to formaldehyde,BP,
18828,GO:1904406,1,0.916766548727228,0,10,negative regulation of nitric oxide metabolic process,BP,
18829,GO:1904407,1,0.862771810326145,0,25,positive regulation of nitric oxide metabolic process,BP,
18830,GO:1904408,1,0.982374270715085,0,1,melatonin binding,MF,
18831,GO:1904412,1,0.995366972215419,0,1,regulation of cardiac ventricle development,BP,
18832,GO:1904414,1,0.995366972215419,0,1,positive regulation of cardiac ventricle development,BP,
18833,GO:1904415,1,0.970069253853473,0,6,regulation of xenophagy,BP,
18834,GO:1904417,1,0.970069253853473,0,6,positive regulation of xenophagy,BP,
18835,GO:1904424,1,0.953615411862814,0,9,regulation of GTP binding,BP,
18836,GO:1904426,1,0.990754662417365,0,2,positive regulation of GTP binding,BP,
18837,GO:1904427,1,0.769954824310346,0,38,positive regulation of calcium ion transmembrane transport,BP,
18838,GO:1904428,1,0.974749266121965,0,3,negative regulation of tubulin deacetylation,BP,
18839,GO:1904429,1,0.968009402573043,0,7,regulation of t-circle formation,BP,
18840,GO:1904430,1,0.986164069283873,0,3,negative regulation of t-circle formation,BP,
18841,GO:1904431,1,0.981593555077281,0,4,positive regulation of t-circle formation,BP,
18842,GO:1904432,1,0.972689675881266,0,2,regulation of ferrous iron binding,BP,
18843,GO:1904434,1,0.972689675881266,0,2,positive regulation of ferrous iron binding,BP,
18844,GO:1904435,1,0.972689675881266,0,2,regulation of transferrin receptor binding,BP,
18845,GO:1904437,1,0.972689675881266,0,2,positive regulation of transferrin receptor binding,BP,
18846,GO:1904447,1,0.9953669908261,0,1,folic acid import across plasma membrane,BP,
18847,GO:1904448,1,0.995366990826165,0,1,regulation of aspartate secretion,BP,
18848,GO:1904450,1,0.995366990826165,0,1,positive regulation of aspartate secretion,BP,
18849,GO:1904454,1,0.99536699082602,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
18850,GO:1904455,1,0.990755199849241,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
18851,GO:1904457,1,0.995158529651144,0,1,positive regulation of neuronal action potential,BP,
18852,GO:1904464,1,0.991570631535044,0,1,regulation of matrix metallopeptidase secretion,BP,
18853,GO:1904465,1,0.991570631535044,0,1,negative regulation of matrix metallopeptidase secretion,BP,
18854,GO:1904467,1,0.952588195319594,0,10,regulation of tumor necrosis factor secretion,BP,
18855,GO:1904468,1,0.984429499090041,0,3,negative regulation of tumor necrosis factor secretion,BP,
18856,GO:1904469,1,0.967660828115808,0,7,positive regulation of tumor necrosis factor secretion,BP,
18857,GO:1904475,1,0.990755199849149,0,2,regulation of Ras GTPase binding,BP,
18858,GO:1904477,1,0.995366990826099,0,1,positive regulation of Ras GTPase binding,BP,
18859,GO:1904481,1,0.995231557007906,0,1,response to tetrahydrofolate,BP,
18860,GO:1904482,1,0.995231557007906,0,1,cellular response to tetrahydrofolate,BP,
18861,GO:1904491,1,0.970111803773411,0,4,protein localization to ciliary transition zone,BP,
18862,GO:1904498,1,0.985471120542398,0,3,protein localization to mitotic actomyosin contractile ring,BP,
18863,GO:1904499,1,0.995366929196251,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
18864,GO:1904501,1,0.995366929196251,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
18865,GO:1904502,1,0.973234824976432,0,5,regulation of lipophagy,BP,
18866,GO:1904504,1,0.973234824976432,0,5,positive regulation of lipophagy,BP,
18867,GO:1904505,1,0.980571947070956,0,4,regulation of telomere maintenance in response to DNA damage,BP,
18868,GO:1904506,1,0.980571947070956,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
18869,GO:1904515,1,0.995366899841122,0,1,positive regulation of TORC2 signaling,BP,
18870,GO:1904526,1,0.953407959472141,0,9,regulation of microtubule binding,BP,
18871,GO:1904527,1,0.986143323936104,0,3,negative regulation of microtubule binding,BP,
18872,GO:1904528,1,0.966789461606965,0,6,positive regulation of microtubule binding,BP,
18873,GO:1904529,1,0.990754973409231,0,2,regulation of actin filament binding,BP,
18874,GO:1904530,1,0.99536676334421,0,1,negative regulation of actin filament binding,BP,
18875,GO:1904531,1,0.995366990826138,0,1,positive regulation of actin filament binding,BP,
18876,GO:1904533,1,0.986163756204676,0,3,regulation of telomeric loop disassembly,BP,
18877,GO:1904534,1,0.990754421464855,0,2,negative regulation of telomeric loop disassembly,BP,
18878,GO:1904535,1,0.995366990826165,0,1,positive regulation of telomeric loop disassembly,BP,
18879,GO:1904542,1,0.995355873361166,0,1,regulation of free ubiquitin chain polymerization,BP,
18880,GO:1904544,1,0.995355873361166,0,1,positive regulation of free ubiquitin chain polymerization,BP,
18881,GO:1904550,1,0.994111772669677,0,1,response to arachidonic acid,BP,
18882,GO:1904555,1,0.99524265188522,0,1,L-proline transmembrane transport,BP,
18883,GO:1904556,1,0.99524265188522,0,1,L-tryptophan transmembrane transport,BP,
18884,GO:1904562,1,0.990755199849071,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
18885,GO:1904565,1,0.995366782686423,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18886,GO:1904566,1,0.995366782686423,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18887,GO:1904567,1,0.995366690726578,0,1,response to wortmannin,BP,
18888,GO:1904568,1,0.995366690726578,0,1,cellular response to wortmannin,BP,
18889,GO:1904569,1,0.991623094338587,0,1,regulation of selenocysteine incorporation,BP,
18890,GO:1904570,1,0.991623094338587,0,1,negative regulation of selenocysteine incorporation,BP,
18891,GO:1904572,1,0.991623094338587,0,1,negative regulation of mRNA binding,BP,
18892,GO:1904573,1,0.991623094338587,0,1,regulation of selenocysteine insertion sequence binding,BP,
18893,GO:1904574,1,0.991623094338587,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
18894,GO:1904576,1,0.986052788434147,0,2,response to tunicamycin,BP,
18895,GO:1904577,1,0.986052788434147,0,2,cellular response to tunicamycin,BP,
18896,GO:1904578,1,0.964576551110312,0,3,response to thapsigargin,BP,
18897,GO:1904579,1,0.964576551110312,0,3,cellular response to thapsigargin,BP,
18898,GO:1904580,1,0.987048917724415,0,2,regulation of intracellular mRNA localization,BP,
18899,GO:1904582,1,0.987048917724415,0,2,positive regulation of intracellular mRNA localization,BP,
18900,GO:1904585,1,0.99451350643876,0,1,response to putrescine,BP,
18901,GO:1904586,1,0.99451350643876,0,1,cellular response to putrescine,BP,
18902,GO:1904587,1,0.979455305761291,0,4,response to glycoprotein,BP,
18903,GO:1904589,1,0.728908807738319,0,46,regulation of protein import,BP,
18904,GO:1904590,1,0.957654607643343,0,7,negative regulation of protein import,BP,
18905,GO:1904591,1,0.822834576753454,0,30,positive regulation of protein import,BP,
18906,GO:1904594,1,0.995366990825889,0,1,regulation of termination of RNA polymerase II transcription,BP,
18907,GO:1904595,1,0.995366990825889,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
18908,GO:1904596,1,0.986063248057595,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18909,GO:1904597,1,0.986063248057595,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18910,GO:1904599,1,0.986063248057595,0,1,advanced glycation end-product binding,MF,
18911,GO:1904603,1,0.986063248057595,0,1,regulation of advanced glycation end-product receptor activity,BP,
18912,GO:1904604,1,0.986063248057595,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
18913,GO:1904612,1,0.990755199849227,0,2,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
18914,GO:1904613,1,0.990755199849227,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
18915,GO:1904616,1,0.990754973409231,0,2,regulation of actin binding,BP,
18916,GO:1904617,1,0.99536676334421,0,1,negative regulation of actin binding,BP,
18917,GO:1904618,1,0.995366990826138,0,1,positive regulation of actin binding,BP,
18918,GO:1904627,1,0.987746831482751,0,1,response to phorbol 13-acetate 12-myristate,BP,
18919,GO:1904628,1,0.987746831482751,0,1,cellular response to phorbol 13-acetate 12-myristate,BP,
18920,GO:1904631,1,0.994796740125183,0,1,response to glucoside,BP,
18921,GO:1904636,1,0.978610601753127,0,3,response to ionomycin,BP,
18922,GO:1904637,1,0.978610601753127,0,3,cellular response to ionomycin,BP,
18923,GO:1904645,1,0.877074495628047,0,20,response to amyloid-beta,BP,
18924,GO:1904646,1,0.887103998310255,0,18,cellular response to amyloid-beta,BP,
18925,GO:1904647,1,0.995366990825969,0,1,response to rotenone,BP,
18927,GO:1904666,1,0.776906382437407,0,18,regulation of ubiquitin protein ligase activity,BP,
18928,GO:1904667,1,0.871061107494699,0,6,negative regulation of ubiquitin protein ligase activity,BP,
18929,GO:1904668,1,0.892069359345952,0,12,positive regulation of ubiquitin protein ligase activity,BP,
18930,GO:1904672,1,0.986164529991957,0,3,regulation of somatic stem cell population maintenance,BP,
18931,GO:1904673,1,0.990755198812736,0,2,negative regulation of somatic stem cell population maintenance,BP,
18932,GO:1904674,1,0.995366990826165,0,1,positive regulation of somatic stem cell population maintenance,BP,
18933,GO:1904680,1,0.7976265341709,0,21,peptide transmembrane transporter activity,MF,
18934,GO:1904681,1,0.995361301061461,0,1,response to 3-methylcholanthrene,BP,
18935,GO:1904683,1,0.972024046264986,0,6,regulation of metalloendopeptidase activity,BP,
18936,GO:1904684,1,0.98159488552234,0,4,negative regulation of metalloendopeptidase activity,BP,
18937,GO:1904685,1,0.990251784811628,0,2,positive regulation of metalloendopeptidase activity,BP,
18938,GO:1904688,1,0.960047415856896,0,5,regulation of cytoplasmic translational initiation,BP,
18939,GO:1904689,1,0.982097209269804,0,1,negative regulation of cytoplasmic translational initiation,BP,
18940,GO:1904690,1,0.977552861811877,0,4,positive regulation of cytoplasmic translational initiation,BP,
18941,GO:1904691,1,0.994395221069329,0,1,negative regulation of type B pancreatic cell proliferation,BP,
18942,GO:1904693,1,0.986164525817595,0,3,midbrain morphogenesis,BP,
18943,GO:1904694,1,0.986164118477868,0,3,negative regulation of vascular smooth muscle contraction,BP,
18944,GO:1904695,1,0.993199557245985,0,1,positive regulation of vascular smooth muscle contraction,BP,
18945,GO:1904700,1,0.995336529960046,0,1,granulosa cell apoptotic process,BP,
18946,GO:1904701,1,0.992243492218644,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
18947,GO:1904705,1,0.829748054528696,0,29,regulation of vascular smooth muscle cell proliferation,BP,
18948,GO:1904706,1,0.918154063853569,0,11,negative regulation of vascular smooth muscle cell proliferation,BP,
18949,GO:1904707,1,0.895070288647635,0,19,positive regulation of vascular smooth muscle cell proliferation,BP,
18950,GO:1904708,1,0.995336529960046,0,1,regulation of granulosa cell apoptotic process,BP,
18951,GO:1904711,1,0.992243492218644,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
18952,GO:1904713,1,0.995366574475227,0,1,beta-catenin destruction complex binding,MF,
18953,GO:1904714,1,0.969658272529838,0,6,regulation of chaperone-mediated autophagy,BP,
18954,GO:1904715,1,0.98353176732395,0,3,negative regulation of chaperone-mediated autophagy,BP,
18955,GO:1904716,1,0.995096918526632,0,1,positive regulation of chaperone-mediated autophagy,BP,
18956,GO:1904717,1,0.995216167640349,0,1,regulation of AMPA glutamate receptor clustering,BP,
18957,GO:1904719,1,0.995216167640349,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
18958,GO:1904720,1,0.990574941339945,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
18959,GO:1904721,1,0.995366744009593,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
18960,GO:1904722,1,0.995186149668059,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
18961,GO:1904723,1,0.992243492218644,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
18962,GO:1904724,1,0.684891368562637,0,37,tertiary granule lumen,CC,
18963,GO:1904732,1,0.961390996153839,0,2,regulation of electron transfer activity,BP,
18964,GO:1904734,1,0.9658676509004,0,1,positive regulation of electron transfer activity,BP,
18965,GO:1904738,1,0.942552673778391,0,12,vascular associated smooth muscle cell migration,BP,
18966,GO:1904742,1,0.965699336625506,0,4,regulation of telomeric DNA binding,BP,
18967,GO:1904743,1,0.990755199849006,0,2,negative regulation of telomeric DNA binding,BP,
18968,GO:1904744,1,0.974713005782304,0,2,positive regulation of telomeric DNA binding,BP,
18969,GO:1904746,1,0.986164473981755,0,3,negative regulation of apoptotic process involved in development,BP,
18970,GO:1904747,1,0.966257678802283,0,3,positive regulation of apoptotic process involved in development,BP,
18971,GO:1904748,1,0.948466585376717,0,7,regulation of apoptotic process involved in development,BP,
18972,GO:1904749,1,0.964338952602518,0,4,regulation of protein localization to nucleolus,BP,
18973,GO:1904750,1,0.995366990826085,0,1,negative regulation of protein localization to nucleolus,BP,
18974,GO:1904751,1,0.968829178866434,0,3,positive regulation of protein localization to nucleolus,BP,
18975,GO:1904752,1,0.942552673778391,0,12,regulation of vascular associated smooth muscle cell migration,BP,
18976,GO:1904753,1,0.982946947911296,0,3,negative regulation of vascular associated smooth muscle cell migration,BP,
18977,GO:1904754,1,0.95891290934786,0,9,positive regulation of vascular associated smooth muscle cell migration,BP,
18978,GO:1904760,1,0.986164512093428,0,3,regulation of myofibroblast differentiation,BP,
18979,GO:1904761,1,0.990755180835173,0,2,negative regulation of myofibroblast differentiation,BP,
18980,GO:1904762,1,0.995366990822807,0,1,positive regulation of myofibroblast differentiation,BP,
18981,GO:1904764,1,0.993932201489667,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
18982,GO:1904766,1,0.995366990826073,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
18983,GO:1904768,1,0.972714228687216,0,2,all-trans-retinol binding,MF,
18984,GO:1904772,1,0.995348746602618,0,1,response to tetrachloromethane,BP,
18985,GO:1904776,1,0.972517484412824,0,6,regulation of protein localization to cell cortex,BP,
18986,GO:1904777,1,0.995366574475227,0,1,negative regulation of protein localization to cell cortex,BP,
18987,GO:1904778,1,0.977045763776314,0,5,positive regulation of protein localization to cell cortex,BP,
18988,GO:1904779,1,0.972335941037722,0,6,regulation of protein localization to centrosome,BP,
18989,GO:1904781,1,0.977046022260481,0,5,positive regulation of protein localization to centrosome,BP,
18990,GO:1904782,1,0.995366990826165,0,1,negative regulation of NMDA glutamate receptor activity,BP,
18991,GO:1904783,1,0.990744133304592,0,2,positive regulation of NMDA glutamate receptor activity,BP,
18992,GO:1904784,1,0.995366990826139,0,1,NLRP1 inflammasome complex assembly,BP,
18993,GO:1904790,1,0.995366618623234,0,1,regulation of shelterin complex assembly,BP,
18994,GO:1904792,1,0.995366618623234,0,1,positive regulation of shelterin complex assembly,BP,
18995,GO:1904793,1,0.995366929196251,0,1,regulation of euchromatin binding,BP,
18996,GO:1904796,1,0.972324744068167,0,5,regulation of core promoter binding,BP,
18997,GO:1904797,1,0.995366990826112,0,1,negative regulation of core promoter binding,BP,
18998,GO:1904798,1,0.976851726259625,0,4,positive regulation of core promoter binding,BP,
18999,GO:1904799,1,0.99536699073736,0,1,regulation of neuron remodeling,BP,
19000,GO:1904800,1,0.99536699073736,0,1,negative regulation of neuron remodeling,BP,
19001,GO:1904803,1,0.969836818533531,0,1,regulation of translation involved in cellular response to UV,BP,
19002,GO:1904806,1,0.995366574475227,0,1,regulation of protein oxidation,BP,
19003,GO:1904808,1,0.995366574475227,0,1,positive regulation of protein oxidation,BP,
19004,GO:1904812,1,0.995366990731326,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
19005,GO:1904813,1,0.378420756343919,0,109,ficolin-1-rich granule lumen,CC,
19006,GO:1904814,1,0.928550345024607,0,13,regulation of protein localization to chromosome, telomeric region,BP,
19007,GO:1904815,1,0.988618939815962,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
19008,GO:1904816,1,0.939247654123915,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
19009,GO:1904823,1,0.990133704303109,0,2,purine nucleobase transmembrane transport,BP,
19010,GO:1904826,1,0.995366990826034,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
19011,GO:1904828,1,0.995366990826034,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
19012,GO:1904829,1,0.991669902477171,0,1,regulation of aortic smooth muscle cell differentiation,BP,
19013,GO:1904831,1,0.991669902477171,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
19014,GO:1904833,1,0.969035995965092,0,2,positive regulation of removal of superoxide radicals,BP,
19015,GO:1904835,1,0.995259108849138,0,1,dorsal root ganglion morphogenesis,BP,
19017,GO:1904842,1,0.994517404157083,0,1,response to nitroglycerin,BP,
19018,GO:1904843,1,0.994517404157083,0,1,cellular response to nitroglycerin,BP,
19019,GO:1904844,1,0.967087556275364,0,2,response to L-glutamine,BP,
19020,GO:1904845,1,0.967087556275364,0,2,cellular response to L-glutamine,BP,
19021,GO:1904847,1,0.986164528494694,0,3,regulation of cell chemotaxis to fibroblast growth factor,BP,
19022,GO:1904849,1,0.990755199849188,0,2,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
19023,GO:1904850,1,0.995366618623234,0,1,negative regulation of establishment of protein localization to telomere,BP,
19024,GO:1904851,1,0.949303848839604,0,9,positive regulation of establishment of protein localization to telomere,BP,
19025,GO:1904854,1,0.99536682318669,0,1,proteasome core complex binding,MF,
19026,GO:1904861,1,0.963633044289351,0,7,excitatory synapse assembly,BP,
19027,GO:1904862,1,0.990755199849267,0,2,inhibitory synapse assembly,BP,
19028,GO:1904867,1,0.948300505876629,0,9,protein localization to Cajal body,BP,
19029,GO:1904868,1,0.990755199848874,0,2,telomerase catalytic core complex assembly,BP,
19030,GO:1904869,1,0.955256913573942,0,8,regulation of protein localization to Cajal body,BP,
19031,GO:1904871,1,0.955256913573942,0,8,positive regulation of protein localization to Cajal body,BP,
19032,GO:1904872,1,0.857305967030143,0,18,regulation of telomerase RNA localization to Cajal body,BP,
19033,GO:1904874,1,0.869353889436486,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
19034,GO:1904875,1,0.989722515993915,0,2,regulation of DNA ligase activity,BP,
19035,GO:1904876,1,0.995366579969841,0,1,negative regulation of DNA ligase activity,BP,
19036,GO:1904877,1,0.994329965706444,0,1,positive regulation of DNA ligase activity,BP,
19037,GO:1904878,1,0.995366990825915,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19038,GO:1904879,1,0.990435695488828,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19039,GO:1904880,1,0.990639646535921,0,2,response to hydrogen sulfide,BP,
19040,GO:1904881,1,0.995355873361166,0,1,cellular response to hydrogen sulfide,BP,
19041,GO:1904882,1,0.990755199848874,0,2,regulation of telomerase catalytic core complex assembly,BP,
19042,GO:1904884,1,0.990755199848874,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
19043,GO:1904885,1,0.977045486051446,0,5,beta-catenin destruction complex assembly,BP,
19044,GO:1904886,1,0.910846999780408,0,18,beta-catenin destruction complex disassembly,BP,
19045,GO:1904888,1,0.785700545298857,0,46,cranial skeletal system development,BP,
19046,GO:1904889,1,0.99133415856859,0,1,regulation of excitatory synapse assembly,BP,
19047,GO:1904891,1,0.99133415856859,0,1,positive regulation of excitatory synapse assembly,BP,
19049,GO:1904893,1,0.835174955818405,0,32,negative regulation of STAT cascade,BP,
19051,GO:1904895,1,0.990798677411377,0,1,ESCRT complex assembly,BP,
19052,GO:1904896,1,0.93023096930988,0,10,ESCRT complex disassembly,BP,
19053,GO:1904902,1,0.990798677411377,0,1,ESCRT III complex assembly,BP,
19054,GO:1904903,1,0.93023096930988,0,10,ESCRT III complex disassembly,BP,
19055,GO:1904907,1,0.990755199848811,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19056,GO:1904908,1,0.990755199848811,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19057,GO:1904910,1,0.995366618623234,0,1,regulation of establishment of RNA localization to telomere,BP,
19058,GO:1904911,1,0.995366618623234,0,1,negative regulation of establishment of RNA localization to telomere,BP,
19059,GO:1904913,1,0.995366618623234,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
19060,GO:1904914,1,0.995366618623234,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
19061,GO:1904923,1,0.920096158701195,0,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
19062,GO:1904924,1,0.995162314705154,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
19063,GO:1904925,1,0.924572983208038,0,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
19064,GO:1904928,1,0.990755199849057,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
19065,GO:1904929,1,0.972517469156879,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
19066,GO:1904933,1,0.995366990826125,0,1,regulation of cell proliferation in midbrain,BP,
19067,GO:1904934,1,0.995366990826125,0,1,negative regulation of cell proliferation in midbrain,BP,
19068,GO:1904938,1,0.977045822919231,0,5,planar cell polarity pathway involved in axon guidance,BP,
19069,GO:1904947,1,0.99536670384091,0,1,folic acid import into mitochondrion,BP,
19070,GO:1904948,1,0.939241020677657,0,11,midbrain dopaminergic neuron differentiation,BP,
19074,GO:1904953,1,0.955425228182735,0,8,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
19075,GO:1904954,1,0.983954579660741,0,2,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
19076,GO:1904955,1,0.995366990826125,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
19077,GO:1904956,1,0.976997717176147,0,4,regulation of midbrain dopaminergic neuron differentiation,BP,
19078,GO:1904958,1,0.981546203742773,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
19079,GO:1904959,1,0.961390996153839,0,2,regulation of cytochrome-c oxidase activity,BP,
19080,GO:1904960,1,0.9658676509004,0,1,positive regulation of cytochrome-c oxidase activity,BP,
19081,GO:1904970,1,0.995366585415899,0,1,brush border assembly,BP,
19082,GO:1904971,1,0.995366990826165,0,1,regulation of viral translation,BP,
19083,GO:1904973,1,0.995366990826165,0,1,positive regulation of viral translation,BP,
19084,GO:1904975,1,0.990755199699492,0,2,response to bleomycin,BP,
19085,GO:1904976,1,0.990755199699492,0,2,cellular response to bleomycin,BP,
19086,GO:1904977,1,0.995366558830144,0,1,lymphatic endothelial cell migration,BP,
19087,GO:1904978,1,0.985577031886023,0,3,regulation of endosome organization,BP,
19088,GO:1904979,1,0.994774072587903,0,1,negative regulation of endosome organization,BP,
19089,GO:1904980,1,0.99536699082606,0,1,positive regulation of endosome organization,BP,
19090,GO:1904983,1,0.994382395639899,0,1,glycine import into mitochondrion,BP,
19091,GO:1904990,1,0.995208052108006,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
19092,GO:1904992,1,0.995208052108006,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
19093,GO:1904994,1,0.944177362994443,0,7,regulation of leukocyte adhesion to vascular endothelial cell,BP,
19094,GO:1904995,1,0.97082489648824,0,2,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
19095,GO:1904996,1,0.972560863659308,0,5,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
19096,GO:1904997,1,0.986207438423393,0,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,
19097,GO:1904998,1,0.995366615026597,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
19098,GO:1904999,1,0.990798677411377,0,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
19099,GO:1905000,1,0.995366990825994,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
19100,GO:1905005,1,0.970171799863052,0,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
19101,GO:1905006,1,0.988365746762487,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
19102,GO:1905007,1,0.977045640287614,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
19103,GO:1905024,1,0.990755199816422,0,2,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19104,GO:1905026,1,0.995366990793145,0,1,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19105,GO:1905031,1,0.986164530990881,0,3,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
19106,GO:1905033,1,0.995366990793145,0,1,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
19107,GO:1905034,1,0.995366611925401,0,1,regulation of antifungal innate immune response,BP,
19108,GO:1905035,1,0.995366611925401,0,1,negative regulation of antifungal innate immune response,BP,
19109,GO:1905037,1,0.581304831011403,0,87,autophagosome organization,BP,
19110,GO:1905038,1,0.914950666180684,0,13,regulation of membrane lipid metabolic process,BP,
19111,GO:1905039,1,0.646262950740125,0,80,carboxylic acid transmembrane transport,BP,
19112,GO:1905040,1,0.995259108849138,0,1,otic placode development,BP,
19113,GO:1905041,1,0.99019200356649,0,2,regulation of epithelium regeneration,BP,
19114,GO:1905042,1,0.994801203110428,0,1,negative regulation of epithelium regeneration,BP,
19115,GO:1905044,1,0.995366574475227,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
19116,GO:1905045,1,0.995366574475227,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
19117,GO:1905048,1,0.91055369429838,0,13,regulation of metallopeptidase activity,BP,
19118,GO:1905049,1,0.955216899236571,0,6,negative regulation of metallopeptidase activity,BP,
19119,GO:1905050,1,0.953266905955494,0,7,positive regulation of metallopeptidase activity,BP,
19120,GO:1905051,1,0.968081390824483,0,2,regulation of base-excision repair,BP,
19121,GO:1905053,1,0.968081390824483,0,2,positive regulation of base-excision repair,BP,
19122,GO:1905062,1,0.995362850572476,0,1,positive regulation of cardioblast proliferation,BP,
19123,GO:1905063,1,0.973415320039531,0,5,regulation of vascular smooth muscle cell differentiation,BP,
19124,GO:1905064,1,0.990754750254535,0,2,negative regulation of vascular smooth muscle cell differentiation,BP,
19125,GO:1905065,1,0.982500623869222,0,3,positive regulation of vascular smooth muscle cell differentiation,BP,
19126,GO:1905066,1,0.987362436814578,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
19127,GO:1905067,1,0.992243492218644,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
19128,GO:1905068,1,0.995081228517227,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
19129,GO:1905069,1,0.995366990826125,0,1,allantois development,BP,
19130,GO:1905071,1,0.990755030569668,0,2,occluding junction disassembly,BP,
19131,GO:1905073,1,0.990755030569668,0,2,regulation of occluding junction disassembly,BP,
19132,GO:1905075,1,0.990755030569668,0,2,positive regulation of occluding junction disassembly,BP,
19133,GO:1905076,1,0.993619425430401,0,1,regulation of interleukin-17 secretion,BP,
19134,GO:1905077,1,0.993619425430401,0,1,negative regulation of interleukin-17 secretion,BP,
19135,GO:1905089,1,0.995366990825851,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19136,GO:1905090,1,0.995366990825851,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19137,GO:1905097,1,0.96700018097216,0,6,regulation of guanyl-nucleotide exchange factor activity,BP,
19138,GO:1905098,1,0.976025857315036,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
19139,GO:1905099,1,0.995366990826099,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
19140,GO:1905103,1,0.99536699082396,0,1,integral component of lysosomal membrane,CC,
19142,GO:1905123,1,0.990755199847111,0,2,regulation of glucosylceramidase activity,BP,
19143,GO:1905132,1,0.995366709403035,0,1,regulation of meiotic chromosome separation,BP,
19144,GO:1905133,1,0.995366709403035,0,1,negative regulation of meiotic chromosome separation,BP,
19145,GO:1905143,1,0.989362838152902,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
19146,GO:1905144,1,0.919925027893096,0,12,response to acetylcholine,BP,
19147,GO:1905145,1,0.919925027893096,0,12,cellular response to acetylcholine,BP,
19148,GO:1905146,1,0.946418962353088,0,9,lysosomal protein catabolic process,BP,
19149,GO:1905150,1,0.990755199849254,0,2,regulation of voltage-gated sodium channel activity,BP,
19150,GO:1905152,1,0.995366990826126,0,1,positive regulation of voltage-gated sodium channel activity,BP,
19151,GO:1905153,1,0.969932511734158,0,6,regulation of membrane invagination,BP,
19152,GO:1905154,1,0.995366990826152,0,1,negative regulation of membrane invagination,BP,
19153,GO:1905155,1,0.97444848539798,0,5,positive regulation of membrane invagination,BP,
19154,GO:1905161,1,0.995366990826152,0,1,protein localization to phagocytic vesicle,BP,
19155,GO:1905162,1,0.995366990826152,0,1,regulation of phagosome maturation,BP,
19156,GO:1905165,1,0.971752886923474,0,6,regulation of lysosomal protein catabolic process,BP,
19157,GO:1905166,1,0.985594936329711,0,3,negative regulation of lysosomal protein catabolic process,BP,
19158,GO:1905167,1,0.990755199848889,0,2,positive regulation of lysosomal protein catabolic process,BP,
19159,GO:1905168,1,0.995366981879516,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
19160,GO:1905169,1,0.995366990826152,0,1,regulation of protein localization to phagocytic vesicle,BP,
19161,GO:1905171,1,0.995366990826152,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
19162,GO:1905172,1,0.995366990826165,0,1,RISC complex binding,MF,
19163,GO:1905174,1,0.988150264212325,0,2,regulation of vascular smooth muscle cell dedifferentiation,BP,
19164,GO:1905176,1,0.995366558264269,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
19165,GO:1905202,1,0.990697580587754,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
19166,GO:1905203,1,0.981494072432238,0,2,regulation of connective tissue replacement,BP,
19167,GO:1905204,1,0.986063248057595,0,1,negative regulation of connective tissue replacement,BP,
19168,GO:1905205,1,0.995366990826165,0,1,positive regulation of connective tissue replacement,BP,
19169,GO:1905206,1,0.962425971621111,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
19170,GO:1905207,1,0.849396198023917,0,29,regulation of cardiocyte differentiation,BP,
19171,GO:1905208,1,0.93738402066092,0,13,negative regulation of cardiocyte differentiation,BP,
19172,GO:1905209,1,0.906201260243607,0,16,positive regulation of cardiocyte differentiation,BP,
19173,GO:1905214,1,0.92904412856475,0,11,regulation of RNA binding,BP,
19174,GO:1905215,1,0.991623094338587,0,1,negative regulation of RNA binding,BP,
19175,GO:1905216,1,0.945646521620242,0,8,positive regulation of RNA binding,BP,
19176,GO:1905222,1,0.995366789561958,0,1,atrioventricular canal morphogenesis,BP,
19177,GO:1905223,1,0.995366990826099,0,1,epicardium morphogenesis,BP,
19178,GO:1905224,1,0.990755199849293,0,2,clathrin-coated pit assembly,BP,
19179,GO:1905232,1,0.980400984768681,0,4,cellular response to L-glutamate,BP,
19180,GO:1905242,1,0.995366914937935,0,1,response to 3,3',5-triiodo-L-thyronine,BP,
19181,GO:1905244,1,0.961424513779506,0,8,regulation of modification of synaptic structure,BP,
19182,GO:1905245,1,0.953772945138231,0,8,regulation of aspartic-type peptidase activity,BP,
19183,GO:1905246,1,0.990394591261427,0,2,negative regulation of aspartic-type peptidase activity,BP,
19184,GO:1905247,1,0.963027211935577,0,6,positive regulation of aspartic-type peptidase activity,BP,
19185,GO:1905255,1,0.9953669908261,0,1,regulation of RNA binding transcription factor activity,BP,
19186,GO:1905258,1,0.967468281589363,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
19187,GO:1905259,1,0.967468281589363,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
19188,GO:1905267,1,0.990158878406517,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
19189,GO:1905268,1,0.811273108395247,0,40,negative regulation of chromatin organization,BP,
19193,GO:1905274,1,0.995366990826059,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
19195,GO:1905277,1,0.995366738911866,0,1,negative regulation of epithelial tube formation,BP,
19197,GO:1905279,1,0.995366574475227,0,1,regulation of retrograde transport, endosome to Golgi,BP,
19198,GO:1905285,1,0.995366972215419,0,1,fibrous ring of heart morphogenesis,BP,
19199,GO:1905286,1,0.990254724018725,0,2,serine-type peptidase complex,CC,
19200,GO:1905288,1,0.969932914197662,0,6,vascular associated smooth muscle cell apoptotic process,BP,
19201,GO:1905292,1,0.982882413382682,0,3,regulation of neural crest cell differentiation,BP,
19202,GO:1905294,1,0.982882413382682,0,3,positive regulation of neural crest cell differentiation,BP,
19203,GO:1905301,1,0.995366990826164,0,1,regulation of macropinocytosis,BP,
19204,GO:1905302,1,0.995366990826164,0,1,negative regulation of macropinocytosis,BP,
19205,GO:1905304,1,0.995366990825981,0,1,regulation of cardiac myofibril assembly,BP,
19206,GO:1905305,1,0.995366990825981,0,1,negative regulation of cardiac myofibril assembly,BP,
19207,GO:1905309,1,0.995366990825929,0,1,positive regulation of cohesin loading,BP,
19208,GO:1905310,1,0.982882413382682,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
19209,GO:1905312,1,0.982882413382682,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
19210,GO:1905313,1,0.994670598384778,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
19211,GO:1905314,1,0.949781101650393,0,9,semi-lunar valve development,BP,
19212,GO:1905317,1,0.995366990826165,0,1,inferior endocardial cushion morphogenesis,BP,
19213,GO:1905319,1,0.995366574475227,0,1,mesenchymal stem cell migration,BP,
19214,GO:1905320,1,0.995366574475227,0,1,regulation of mesenchymal stem cell migration,BP,
19215,GO:1905322,1,0.995366574475227,0,1,positive regulation of mesenchymal stem cell migration,BP,
19216,GO:1905323,1,0.966993708269044,0,6,telomerase holoenzyme complex assembly,BP,
19218,GO:1905331,1,0.93273451373684,0,13,negative regulation of morphogenesis of an epithelium,BP,
19220,GO:1905333,1,0.966333131417304,0,2,regulation of gastric motility,BP,
19221,GO:1905335,1,0.995366990825813,0,1,regulation of aggrephagy,BP,
19222,GO:1905337,1,0.995366990825813,0,1,positive regulation of aggrephagy,BP,
19223,GO:1905340,1,0.977064639294965,0,4,regulation of protein localization to kinetochore,BP,
19224,GO:1905341,1,0.995359034839364,0,1,negative regulation of protein localization to kinetochore,BP,
19225,GO:1905342,1,0.977064639294965,0,4,positive regulation of protein localization to kinetochore,BP,
19226,GO:1905344,1,0.995366574475227,0,1,prostaglandin catabolic process,BP,
19228,GO:1905349,1,0.98350654582042,0,1,ciliary transition zone assembly,BP,
19229,GO:1905354,1,0.80207285078509,0,22,exoribonuclease complex,CC,
19230,GO:1905355,1,0.995366990826151,0,1,spine apparatus assembly,BP,
19231,GO:1905359,1,0.995366709403035,0,1,protein localization to meiotic spindle,BP,
19232,GO:1905360,1,0.87162354769466,0,19,GTPase complex,CC,
19233,GO:1905365,1,0.994774072587903,0,1,regulation of intralumenal vesicle formation,BP,
19234,GO:1905366,1,0.994774072587903,0,1,negative regulation of intralumenal vesicle formation,BP,
19235,GO:1905368,1,0.368380590748806,0,85,peptidase complex,CC,
19236,GO:1905369,1,0.44929352843268,0,64,endopeptidase complex,CC,
19237,GO:1905370,1,0.995162314705154,0,1,serine-type endopeptidase complex,CC,
19238,GO:1905371,1,0.984056992612054,0,2,ceramide phosphoethanolamine metabolic process,BP,
19239,GO:1905373,1,0.984056992612054,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
19240,GO:1905383,1,0.964215954318613,0,3,protein localization to presynapse,BP,
19241,GO:1905384,1,0.986740468686118,0,2,regulation of protein localization to presynapse,BP,
19242,GO:1905386,1,0.986740468686118,0,2,positive regulation of protein localization to presynapse,BP,
19243,GO:1905392,1,0.974537838279069,0,1,plant organ morphogenesis,BP,
19244,GO:1905394,1,0.985438342469253,0,3,retromer complex binding,MF,
19245,GO:1905395,1,0.969068327753373,0,2,response to flavonoid,BP,
19246,GO:1905397,1,0.982855899541171,0,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
19247,GO:1905402,1,0.982855899541171,0,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
19248,GO:1905403,1,0.993619425430401,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
19249,GO:1905404,1,0.989168147743294,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
19250,GO:1905405,1,0.995366990825929,0,1,regulation of mitotic cohesin loading,BP,
19251,GO:1905406,1,0.995366990825929,0,1,positive regulation of mitotic cohesin loading,BP,
19252,GO:1905407,1,0.9953668750527,0,1,regulation of creatine transmembrane transporter activity,BP,
19253,GO:1905408,1,0.9953668750527,0,1,negative regulation of creatine transmembrane transporter activity,BP,
19254,GO:1905419,1,0.992482553402505,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
19255,GO:1905421,1,0.974537838279069,0,1,regulation of plant organ morphogenesis,BP,
19256,GO:1905422,1,0.974537838279069,0,1,negative regulation of plant organ morphogenesis,BP,
19257,GO:1905424,1,0.989220049949098,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
19258,GO:1905426,1,0.989220049949098,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
19259,GO:1905429,1,0.994156659832839,0,1,response to glycine,BP,
19260,GO:1905430,1,0.994156659832839,0,1,cellular response to glycine,BP,
19261,GO:1905435,1,0.995366574475227,0,1,regulation of histone H3-K4 trimethylation,BP,
19262,GO:1905437,1,0.995366574475227,0,1,positive regulation of histone H3-K4 trimethylation,BP,
19263,GO:1905438,1,0.995366990826125,0,1,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
19264,GO:1905443,1,0.995366990826164,0,1,regulation of clathrin coat assembly,BP,
19265,GO:1905445,1,0.995366990826164,0,1,positive regulation of clathrin coat assembly,BP,
19266,GO:1905446,1,0.955380314007287,0,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19267,GO:1905447,1,0.995366810543291,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19268,GO:1905448,1,0.959829479251483,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19269,GO:1905449,1,0.988154788673483,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
19270,GO:1905451,1,0.988154788673483,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
19273,GO:1905458,1,0.995366990791056,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
19274,GO:1905459,1,0.969932914197662,0,6,regulation of vascular associated smooth muscle cell apoptotic process,BP,
19275,GO:1905460,1,0.99536699082606,0,1,negative regulation of vascular associated smooth muscle cell apoptotic process,BP,
19276,GO:1905461,1,0.974448889713887,0,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,
19277,GO:1905462,1,0.990755199849241,0,2,regulation of DNA duplex unwinding,BP,
19278,GO:1905463,1,0.995366990826125,0,1,negative regulation of DNA duplex unwinding,BP,
19279,GO:1905464,1,0.995366990826138,0,1,positive regulation of DNA duplex unwinding,BP,
19280,GO:1905468,1,0.995366990826152,0,1,regulation of clathrin-coated pit assembly,BP,
19281,GO:1905469,1,0.995366990826152,0,1,negative regulation of clathrin-coated pit assembly,BP,
19282,GO:1905474,1,0.988535139043986,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
19283,GO:1905475,1,0.42073375830626,0,126,regulation of protein localization to membrane,BP,
19284,GO:1905476,1,0.89348739781709,0,22,negative regulation of protein localization to membrane,BP,
19285,GO:1905477,1,0.518413225836787,0,94,positive regulation of protein localization to membrane,BP,
19286,GO:1905502,1,0.983344632049854,0,1,acetyl-CoA binding,MF,
19288,GO:1905515,1,0.755700935723824,0,47,non-motile cilium assembly,BP,
19289,GO:1905516,1,0.959265179659694,0,5,positive regulation of fertilization,BP,
19290,GO:1905517,1,0.796464447643078,0,21,macrophage migration,BP,
19291,GO:1905521,1,0.869355102475203,0,15,regulation of macrophage migration,BP,
19292,GO:1905522,1,0.929313181928637,0,4,negative regulation of macrophage migration,BP,
19293,GO:1905523,1,0.948968321785114,0,8,positive regulation of macrophage migration,BP,
19294,GO:1905524,1,0.995366990826034,0,1,negative regulation of protein autoubiquitination,BP,
19295,GO:1905535,1,0.995366990826152,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19296,GO:1905537,1,0.995366990826152,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19297,GO:1905538,1,0.990754785405328,0,2,polysome binding,MF,
19298,GO:1905547,1,0.990460465789248,0,1,regulation of telomeric heterochromatin assembly,BP,
19299,GO:1905549,1,0.990460465789248,0,1,positive regulation of telomeric heterochromatin assembly,BP,
19300,GO:1905550,1,0.979772138859704,0,2,regulation of protein localization to endoplasmic reticulum,BP,
19301,GO:1905552,1,0.979772138859704,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
19302,GO:1905553,1,0.972078429204358,0,3,regulation of blood vessel branching,BP,
19303,GO:1905555,1,0.985871148345869,0,2,positive regulation blood vessel branching,BP,
19304,GO:1905562,1,0.942975087286977,0,11,regulation of vascular endothelial cell proliferation,BP,
19305,GO:1905563,1,0.99272158279163,0,1,negative regulation of vascular endothelial cell proliferation,BP,
19306,GO:1905564,1,0.949892881460509,0,10,positive regulation of vascular endothelial cell proliferation,BP,
19307,GO:1905572,1,0.995366508336648,0,1,ganglioside GM1 transport to membrane,BP,
19308,GO:1905573,1,0.988560865394886,0,2,ganglioside GM1 binding,MF,
19309,GO:1905574,1,0.995366508336648,0,1,ganglioside GM2 binding,MF,
19310,GO:1905575,1,0.995366508336648,0,1,ganglioside GM3 binding,MF,
19311,GO:1905576,1,0.988560865394886,0,2,ganglioside GT1b binding,MF,
19312,GO:1905577,1,0.995366508336648,0,1,ganglioside GP1c binding,MF,
19313,GO:1905578,1,0.995212457382581,0,1,regulation of ERBB3 signaling pathway,BP,
19314,GO:1905580,1,0.995212457382581,0,1,positive regulation of ERBB3 signaling pathway,BP,
19315,GO:1905581,1,0.990454298177577,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
19316,GO:1905590,1,0.995366785110385,0,1,fibronectin fibril organization,BP,
19317,GO:1905594,1,0.982374270715085,0,1,resveratrol binding,MF,
19318,GO:1905595,1,0.985864993169016,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
19319,GO:1905596,1,0.995366974859718,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
19320,GO:1905597,1,0.990454298177577,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
19321,GO:1905598,1,0.995366974859718,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
19322,GO:1905599,1,0.990454298177577,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
19323,GO:1905600,1,0.981296359849898,0,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
19324,GO:1905601,1,0.995366974859718,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
19325,GO:1905602,1,0.985864642825315,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
19326,GO:1905606,1,0.986164241815905,0,3,regulation of presynapse assembly,BP,
19327,GO:1905610,1,0.995366990826152,0,1,regulation of mRNA cap binding,BP,
19328,GO:1905612,1,0.995366990826152,0,1,positive regulation of mRNA cap binding,BP,
19329,GO:1905616,1,0.990754785405313,0,2,regulation of miRNA mediated inhibition of translation,BP,
19330,GO:1905618,1,0.990754785405313,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
19331,GO:1905634,1,0.97008259520211,0,6,regulation of protein localization to chromatin,BP,
19332,GO:1905636,1,0.984486253799563,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19333,GO:1905642,1,0.995366574475227,0,1,negative regulation of DNA methylation,BP,
19334,GO:1905643,1,0.995366990826126,0,1,positive regulation of DNA methylation,BP,
19335,GO:1905647,1,0.99524265188522,0,1,proline import across plasma membrane,BP,
19336,GO:1905651,1,0.986151774195394,0,3,regulation of artery morphogenesis,BP,
19337,GO:1905653,1,0.986151774195394,0,3,positive regulation of artery morphogenesis,BP,
19338,GO:1905661,1,0.989905613862504,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
19339,GO:1905663,1,0.989905613862504,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
19340,GO:1905664,1,0.989548147988885,0,2,regulation of calcium ion import across plasma membrane,BP,
19341,GO:1905666,1,0.959057362510557,0,9,regulation of protein localization to endosome,BP,
19342,GO:1905668,1,0.959057362510557,0,9,positive regulation of protein localization to endosome,BP,
19343,GO:1905671,1,0.98471854085672,0,3,regulation of lysosome organization,BP,
19344,GO:1905672,1,0.994481894632558,0,1,negative regulation of lysosome organization,BP,
19345,GO:1905687,1,0.995366990826125,0,1,regulation of diacylglycerol kinase activity,BP,
19346,GO:1905689,1,0.995366990826125,0,1,positive regulation of diacylglycerol kinase activity,BP,
19347,GO:1905696,1,0.990755199849292,0,2,regulation of polysome binding,BP,
19348,GO:1905698,1,0.995366990826165,0,1,positive regulation of polysome binding,BP,
19349,GO:1905705,1,0.995366990826073,0,1,cellular response to paclitaxel,BP,
19350,GO:1905709,1,0.938513075006544,0,5,negative regulation of membrane permeability,BP,
19351,GO:1905710,1,0.659539654255942,0,55,positive regulation of membrane permeability,BP,
19352,GO:1905711,1,0.995366987635455,0,1,response to phosphatidylethanolamine,BP,
19353,GO:1905715,1,0.995306499618449,0,1,regulation of cornification,BP,
19354,GO:1905716,1,0.995306499618449,0,1,negative regulation of cornification,BP,
19355,GO:1905719,1,0.990754149943397,0,2,protein localization to perinuclear region of cytoplasm,BP,
19356,GO:1905720,1,0.995366990826059,0,1,cytoplasmic microtubule bundle,CC,
19357,GO:1905764,1,0.985136881984715,0,3,regulation of protection from non-homologous end joining at telomere,BP,
19358,GO:1905765,1,0.985136881984715,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
19359,GO:1905767,1,0.995366990826074,0,1,regulation of double-stranded telomeric DNA binding,BP,
19360,GO:1905768,1,0.995366990826074,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
19361,GO:1905770,1,0.983069562318622,0,3,regulation of mesodermal cell differentiation,BP,
19362,GO:1905771,1,0.992243492218644,0,1,negative regulation of mesodermal cell differentiation,BP,
19363,GO:1905773,1,0.986164531023714,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
19364,GO:1905774,1,0.995366990826138,0,1,regulation of DNA helicase activity,BP,
19365,GO:1905776,1,0.995366990826138,0,1,positive regulation of DNA helicase activity,BP,
19366,GO:1905777,1,0.98616238771927,0,3,regulation of exonuclease activity,BP,
19367,GO:1905778,1,0.990754421464855,0,2,negative regulation of exonuclease activity,BP,
19368,GO:1905779,1,0.995365609716794,0,1,positive regulation of exonuclease activity,BP,
19369,GO:1905793,1,0.990755199849017,0,2,protein localization to pericentriolar material,BP,
19370,GO:1905794,1,0.995366990825929,0,1,response to puromycin,BP,
19371,GO:1905795,1,0.995366990825929,0,1,cellular response to puromycin,BP,
19372,GO:1905799,1,0.972062517588559,0,1,regulation of intraciliary retrograde transport,BP,
19373,GO:1905809,1,0.931355514904456,0,11,negative regulation of synapse organization,BP,
19374,GO:1905818,1,0.666665657405791,0,53,regulation of chromosome separation,BP,
19375,GO:1905819,1,0.796842052337905,0,31,negative regulation of chromosome separation,BP,
19376,GO:1905820,1,0.92995086676579,0,9,positive regulation of chromosome separation,BP,
19377,GO:1905832,1,0.981594617617328,0,4,positive regulation of spindle assembly,BP,
19378,GO:1905838,1,0.990754421464855,0,2,regulation of telomeric D-loop disassembly,BP,
19379,GO:1905839,1,0.990754421464855,0,2,negative regulation of telomeric D-loop disassembly,BP,
19380,GO:1905843,1,0.995366990825889,0,1,regulation of cellular response to gamma radiation,BP,
19381,GO:1905853,1,0.983095265244906,0,1,regulation of heparan sulfate binding,BP,
19382,GO:1905855,1,0.983095265244906,0,1,positive regulation of heparan sulfate binding,BP,
19383,GO:1905858,1,0.983095265244906,0,1,regulation of heparan sulfate proteoglycan binding,BP,
19384,GO:1905860,1,0.983095265244906,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
19385,GO:1905863,1,0.990752157396088,0,2,invadopodium organization,BP,
19386,GO:1905867,1,0.97552595102723,0,3,epididymis development,BP,
19387,GO:1905874,1,0.988583202549868,0,2,regulation of postsynaptic density organization,BP,
19388,GO:1905878,1,0.99536699082594,0,1,invadopodium disassembly,BP,
19389,GO:1905879,1,0.965278751130181,0,7,regulation of oogenesis,BP,
19390,GO:1905880,1,0.9907551444475,0,2,negative regulation of oogenesis,BP,
19391,GO:1905881,1,0.983634865520971,0,3,positive regulation of oogenesis,BP,
19392,GO:1905890,1,0.983095265244906,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
19393,GO:1905891,1,0.995366520412405,0,1,regulation of cellular response to thapsigargin,BP,
19394,GO:1905892,1,0.995366520412405,0,1,negative regulation of cellular response to thapsigargin,BP,
19395,GO:1905894,1,0.995366520412405,0,1,regulation of cellular response to tunicamycin,BP,
19396,GO:1905895,1,0.995366520412405,0,1,negative regulation of cellular response to tunicamycin,BP,
19399,GO:1905902,1,0.983069562318622,0,3,regulation of mesoderm formation,BP,
19400,GO:1905903,1,0.992243492218644,0,1,negative regulation of mesoderm formation,BP,
19401,GO:1905906,1,0.927243747184392,0,8,regulation of amyloid fibril formation,BP,
19402,GO:1905907,1,0.957252111895915,0,4,negative regulation of amyloid fibril formation,BP,
19403,GO:1905908,1,0.969490529362212,0,4,positive regulation of amyloid fibril formation,BP,
19404,GO:1905912,1,0.992599516499081,0,1,regulation of calcium ion export across plasma membrane,BP,
19405,GO:1905913,1,0.992599516499081,0,1,negative regulation of calcium ion export across plasma membrane,BP,
19406,GO:1905918,1,0.994521289989502,0,1,regulation of CoA-transferase activity,BP,
19407,GO:1905920,1,0.994521289989502,0,1,positive regulation of CoA-transferase activity,BP,
19408,GO:1905927,1,0.99536699082594,0,1,regulation of invadopodium disassembly,BP,
19409,GO:1905929,1,0.99536699082594,0,1,positive regulation of invadopodium disassembly,BP,
19410,GO:1905936,1,0.957270388312499,0,2,regulation of germ cell proliferation,BP,
19411,GO:1905937,1,0.977796000263908,0,1,negative regulation of germ cell proliferation,BP,
19412,GO:1905938,1,0.979013623049402,0,1,positive regulation of germ cell proliferation,BP,
19414,GO:1905940,1,0.984171071190174,0,3,negative regulation of gonad development,BP,
19415,GO:1905941,1,0.961089084805402,0,6,positive regulation of gonad development,BP,
19416,GO:1905942,1,0.995212457382581,0,1,regulation of formation of growth cone in injured axon,BP,
19417,GO:1905943,1,0.995212457382581,0,1,negative regulation of formation of growth cone in injured axon,BP,
19418,GO:1905952,1,0.56953421228647,0,72,regulation of lipid localization,BP,
19419,GO:1905953,1,0.846707205121367,0,24,negative regulation of lipid localization,BP,
19420,GO:1905954,1,0.71032691334251,0,43,positive regulation of lipid localization,BP,
19421,GO:1905957,1,0.995366990826152,0,1,regulation of cellular response to alcohol,BP,
19422,GO:1905959,1,0.995366990826152,0,1,positive regulation of cellular response to alcohol,BP,
19423,GO:1905961,1,0.950053475112968,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
19424,GO:1990000,1,0.890145492641867,0,14,amyloid fibril formation,BP,
19425,GO:1990001,1,0.952583966885805,0,8,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
19426,GO:1990003,1,0.995366990826113,0,1,IDP phosphatase activity,MF,
19427,GO:1990005,1,0.986729510949629,0,2,granular vesicle,CC,
19428,GO:1990008,1,0.991323192844333,0,1,neurosecretory vesicle,CC,
19429,GO:1990009,1,0.995366990826152,0,1,retinal cell apoptotic process,BP,
19430,GO:1990023,1,0.914545445055183,0,13,mitotic spindle midzone,CC,
19431,GO:1990026,1,0.99536695658551,0,1,hippocampal mossy fiber expansion,CC,
19432,GO:1990029,1,0.995366807366016,0,1,vasomotion,BP,
19433,GO:1990031,1,0.995366805441852,0,1,pinceau fiber,CC,
19434,GO:1990032,1,0.995366990826164,0,1,parallel fiber,CC,
19435,GO:1990034,1,0.983421939513185,0,3,calcium ion export across plasma membrane,BP,
19436,GO:1990036,1,0.995366990826007,0,1,calcium ion import into sarcoplasmic reticulum,BP,
19437,GO:1990037,1,0.979575520616912,0,3,Lewy body core,CC,
19438,GO:1990038,1,0.993473982488023,0,1,Lewy body corona,CC,
19439,GO:1990046,1,0.984958114879921,0,1,stress-induced mitochondrial fusion,BP,
19440,GO:1990047,1,0.99490663741925,0,1,spindle matrix,CC,
19441,GO:1990048,1,0.995366574475227,0,1,anterograde neuronal dense core vesicle transport,BP,
19442,GO:1990050,1,0.943803377342313,0,6,phosphatidic acid transporter activity,MF,
19443,GO:1990051,1,0.995366990826138,0,1,activation of protein kinase C activity,BP,
19444,GO:1990070,1,0.974282140083162,0,1,TRAPPI protein complex,CC,
19445,GO:1990071,1,0.969766933875685,0,2,TRAPPII protein complex,CC,
19446,GO:1990072,1,0.969766528112304,0,2,TRAPPIII protein complex,CC,
19447,GO:1990074,1,0.995366953247038,0,1,polyuridylation-dependent mRNA catabolic process,BP,
19448,GO:1990075,1,0.986164227529609,0,3,periciliary membrane compartment,CC,
19449,GO:1990086,1,0.986159678353175,0,3,lens fiber cell apoptotic process,BP,
19450,GO:1990089,1,0.770777454248976,0,39,response to nerve growth factor,BP,
19451,GO:1990090,1,0.770777454248976,0,39,cellular response to nerve growth factor stimulus,BP,
19452,GO:1990108,1,0.990754785405156,0,2,protein linear deubiquitination,BP,
19453,GO:1990111,1,0.941940979760901,0,4,spermatoproteasome complex,CC,
19454,GO:1990112,1,0.990754370961523,0,2,RQC complex,CC,
19455,GO:1990116,1,0.990754370961523,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
19456,GO:1990117,1,0.97527649662577,0,1,B cell receptor apoptotic signaling pathway,BP,
19457,GO:1990124,1,0.950788573082478,0,7,messenger ribonucleoprotein complex,CC,
19458,GO:1990126,1,0.908903104036587,0,16,retrograde transport, endosome to plasma membrane,BP,
19459,GO:1990127,1,0.995366990826139,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19460,GO:1990130,1,0.972300039773799,0,5,GATOR1 complex,CC,
19461,GO:1990131,1,0.972915333657384,0,3,Gtr1-Gtr2 GTPase complex,CC,
19462,GO:1990134,1,0.995366990826164,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
19463,GO:1990136,1,0.995283452877703,0,1,linoleate 9S-lipoxygenase activity,MF,
19464,GO:1990138,1,0.549466761804467,0,112,neuron projection extension,BP,
19465,GO:1990144,1,0.955130559531816,0,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
19466,GO:1990145,1,0.990754977842074,0,2,maintenance of translational fidelity,BP,
19467,GO:1990164,1,0.990754480660136,0,2,histone H2A phosphorylation,BP,
19468,GO:1990165,1,0.993859261278676,0,1,single-strand break-containing DNA binding,MF,
19469,GO:1990166,1,0.985886109711582,0,3,protein localization to site of double-strand break,BP,
19470,GO:1990167,1,0.981857334219161,0,3,protein K27-linked deubiquitination,BP,
19471,GO:1990168,1,0.981857334219227,0,3,protein K33-linked deubiquitination,BP,
19472,GO:1990169,1,0.878386761028899,0,5,stress response to copper ion,BP,
19473,GO:1990170,1,0.993824779801663,0,1,stress response to cadmium ion,BP,
19474,GO:1990172,1,0.995366990826125,0,1,G-protein coupled receptor catabolic process,BP,
19475,GO:1990173,1,0.943904337970923,0,10,protein localization to nucleoplasm,BP,
19476,GO:1990174,1,0.995366989449049,0,1,phosphodiesterase decapping endonuclease activity,MF,
19477,GO:1990175,1,0.995366990590503,0,1,EH domain binding,MF,
19478,GO:1990179,1,0.985471120542398,0,3,protein localization to actomyosin contractile ring,BP,
19479,GO:1990180,1,0.968912838999578,0,3,mitochondrial tRNA 3'-end processing,BP,
19480,GO:1990182,1,0.882780331268444,0,17,exosomal secretion,BP,
19481,GO:1990188,1,0.995346287364232,0,1,euchromatin binding,MF,
19482,GO:1990189,1,0.972447939251941,0,2,peptide-serine-N-acetyltransferase activity,MF,
19483,GO:1990190,1,0.976975576064918,0,1,peptide-glutamate-N-acetyltransferase activity,MF,
19484,GO:1990204,1,0.259796761289394,0,89,oxidoreductase complex,CC,
19485,GO:1990226,1,0.972407164670933,0,5,histone methyltransferase binding,MF,
19487,GO:1990239,1,0.970406794325364,0,4,steroid hormone binding,MF,
19488,GO:1990246,1,0.981593246111093,0,4,uniplex complex,CC,
19489,GO:1990247,1,0.968010403965109,0,7,N6-methyladenosine-containing RNA binding,MF,
19490,GO:1990253,1,0.956659804845945,0,9,cellular response to leucine starvation,BP,
19491,GO:1990254,1,0.975838772789946,0,4,keratin filament binding,MF,
19492,GO:1990256,1,0.995366990825863,0,1,signal clustering,BP,
19493,GO:1990258,1,0.982902032395413,0,1,histone glutamine methylation,BP,
19494,GO:1990259,1,0.982902032395413,0,1,histone-glutamine methyltransferase activity,MF,
19495,GO:1990261,1,0.995366574475227,0,1,pre-mRNA catabolic process,BP,
19496,GO:1990262,1,0.995365530647531,0,1,anti-Mullerian hormone signaling pathway,BP,
19497,GO:1990264,1,0.990191903146879,0,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
19498,GO:1990266,1,0.636512998196738,0,43,neutrophil migration,BP,
19499,GO:1990269,1,0.989882095953772,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
19500,GO:1990275,1,0.995366566141779,0,1,preribosome binding,MF,
19501,GO:1990280,1,0.995366990826074,0,1,RNA localization to chromatin,BP,
19502,GO:1990298,1,0.994495819134088,0,1,bub1-bub3 complex,CC,
19503,GO:1990314,1,0.955368222068912,0,8,cellular response to insulin-like growth factor stimulus,BP,
19504,GO:1990316,1,0.963421939336986,0,8,Atg1/ULK1 kinase complex,CC,
19505,GO:1990332,1,0.995366990826125,0,1,Ire1 complex,CC,
19506,GO:1990351,1,0.475869862390146,0,120,transporter complex,CC,
19507,GO:1990356,1,0.983535025082634,0,1,sumoylated E2 ligase complex,CC,
19508,GO:1990357,1,0.977079786693031,0,3,terminal web,CC,
19509,GO:1990379,1,0.977815661801922,0,2,lipid transport across blood brain barrier,BP,
19510,GO:1990380,1,0.959052569500187,0,9,Lys48-specific deubiquitinase activity,MF,
19511,GO:1990381,1,0.922040131894565,0,13,ubiquitin-specific protease binding,MF,
19512,GO:1990384,1,0.984976082722581,0,1,hyaloid vascular plexus regression,BP,
19513,GO:1990386,1,0.993600478812784,0,1,mitotic cleavage furrow ingression,BP,
19514,GO:1990390,1,0.995366941546433,0,1,protein K33-linked ubiquitination,BP,
19515,GO:1990391,1,0.819760685508221,0,36,DNA repair complex,CC,
19516,GO:1990393,1,0.975727516549436,0,5,3M complex,CC,
19517,GO:1990399,1,0.99019200356649,0,2,epithelium regeneration,BP,
19518,GO:1990401,1,0.995366221441924,0,1,embryonic lung development,BP,
19519,GO:1990402,1,0.994670598384778,0,1,embryonic liver development,BP,
19520,GO:1990403,1,0.958345237343634,0,8,embryonic brain development,BP,
19521,GO:1990404,1,0.98828357828177,0,2,protein ADP-ribosylase activity,MF,
19522,GO:1990405,1,0.981342385972397,0,4,protein antigen binding,MF,
19523,GO:1990406,1,0.9728909882692,0,2,CGRP receptor complex,CC,
19524,GO:1990407,1,0.977420572404843,0,1,calcitonin gene-related peptide binding,MF,
19525,GO:1990408,1,0.9728909882692,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
19526,GO:1990409,1,0.995366990826164,0,1,adrenomedullin binding,MF,
19527,GO:1990410,1,0.983231808806861,0,2,adrenomedullin receptor signaling pathway,BP,
19528,GO:1990414,1,0.980010167702683,0,4,replication-born double-strand break repair via sister chromatid exchange,BP,
19529,GO:1990415,1,0.984073320953611,0,3,Pex17p-Pex14p docking complex,CC,
19530,GO:1990416,1,0.968858979951876,0,6,cellular response to brain-derived neurotrophic factor stimulus,BP,
19531,GO:1990418,1,0.987677716938173,0,2,response to insulin-like growth factor stimulus,BP,
19532,GO:1990421,1,0.995366990825889,0,1,subtelomeric heterochromatin,CC,
19533,GO:1990423,1,0.986163979648142,0,3,RZZ complex,CC,
19534,GO:1990425,1,0.980124114682386,0,2,ryanodine receptor complex,CC,
19535,GO:1990426,1,0.990187561022606,0,2,mitotic recombination-dependent replication fork processing,BP,
19536,GO:1990428,1,0.99075518908679,0,2,miRNA transport,BP,
19537,GO:1990429,1,0.984073320953611,0,3,peroxisomal importomer complex,CC,
19538,GO:1990430,1,0.990755199849032,0,2,extracellular matrix protein binding,MF,
19539,GO:1990439,1,0.995366631781183,0,1,MAP kinase serine/threonine phosphatase activity,MF,
19541,GO:1990441,1,0.979004537521428,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
19543,GO:1990446,1,0.960630025396295,0,4,U1 snRNP binding,MF,
19544,GO:1990448,1,0.995366990826085,0,1,exon-exon junction complex binding,MF,
19545,GO:1990450,1,0.994219589142222,0,1,linear polyubiquitin binding,MF,
19546,GO:1990452,1,0.990755047036469,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
19547,GO:1990454,1,0.986160222617662,0,3,L-type voltage-gated calcium channel complex,CC,
19548,GO:1990456,1,0.995366988929051,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
19549,GO:1990459,1,0.962736234391355,0,6,transferrin receptor binding,MF,
19550,GO:1990460,1,0.984892976910776,0,3,leptin receptor binding,MF,
19551,GO:1990462,1,0.964254775877296,0,7,omegasome,CC,
19552,GO:1990481,1,0.974344355048152,0,4,mRNA pseudouridine synthesis,BP,
19553,GO:1990498,1,0.990755199849044,0,2,mitotic spindle microtubule,CC,
19554,GO:1990502,1,0.995366990826112,0,1,dense core granule maturation,BP,
19555,GO:1990504,1,0.986164530683562,0,3,dense core granule exocytosis,BP,
19556,GO:1990505,1,0.990187561022606,0,2,mitotic DNA replication maintenance of fidelity,BP,
19557,GO:1990511,1,0.981594149278344,0,4,piRNA biosynthetic process,BP,
19558,GO:1990518,1,0.995366990826165,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
19559,GO:1990519,1,0.983446379709979,0,2,pyrimidine nucleotide import into mitochondrion,BP,
19560,GO:1990523,1,0.995366845033235,0,1,bone regeneration,BP,
19561,GO:1990535,1,0.981592595467271,0,4,neuron projection maintenance,BP,
19562,GO:1990542,1,0.540742890921592,0,67,mitochondrial transmembrane transport,BP,
19563,GO:1990546,1,0.99001803076833,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
19564,GO:1990564,1,0.953350215008722,0,5,protein polyufmylation,BP,
19565,GO:1990565,1,0.990892698675113,0,1,HSP90-CDC37 chaperone complex,CC,
19566,GO:1990569,1,0.989882095953693,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
19567,GO:1990570,1,0.995366574475227,0,1,GDP-mannose transmembrane transport,BP,
19568,GO:1990572,1,0.961814214726214,0,1,TERT-RMRP complex,CC,
19569,GO:1990573,1,0.983719537414907,0,3,potassium ion import across plasma membrane,BP,
19570,GO:1990575,1,0.990486364538557,0,2,mitochondrial L-ornithine transmembrane transport,BP,
19571,GO:1990578,1,0.995366990826125,0,1,perinuclear endoplasmic reticulum membrane,CC,
19572,GO:1990579,1,0.995366990826125,0,1,peptidyl-serine trans-autophosphorylation,BP,
19573,GO:1990583,1,0.993600478812784,0,1,phospholipase D activator activity,MF,
19574,GO:1990589,1,0.986789727440053,0,2,ATF4-CREB1 transcription factor complex,CC,
19575,GO:1990590,1,0.98663277171873,0,2,ATF1-ATF4 transcription factor complex,CC,
19576,GO:1990592,1,0.953350215008722,0,5,protein K69-linked ufmylation,BP,
19577,GO:1990597,1,0.985713490665092,0,3,AIP1-IRE1 complex,CC,
19578,GO:1990599,1,0.985136881984715,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
19579,GO:1990603,1,0.995366878313285,0,1,dark adaptation,BP,
19580,GO:1990604,1,0.985713490665092,0,3,IRE1-TRAF2-ASK1 complex,CC,
19581,GO:1990613,1,0.995366954780392,0,1,mitochondrial membrane fusion,BP,
19583,GO:1990619,1,0.985871146655313,0,2,histone H3-K9 deacetylation,BP,
19585,GO:1990630,1,0.995366990826125,0,1,IRE1-RACK1-PP2A complex,CC,
19586,GO:1990635,1,0.9796156900132,0,4,proximal dendrite,CC,
19587,GO:1990637,1,0.982157396752488,0,3,response to prolactin,BP,
19588,GO:1990641,1,0.988787070381514,0,2,response to iron ion starvation,BP,
19589,GO:1990646,1,0.995366690726578,0,1,cellular response to prolactin,BP,
19590,GO:1990654,1,0.995366990826165,0,1,sebum secreting cell proliferation,BP,
19591,GO:1990666,1,0.990755183955982,0,2,PCSK9-LDLR complex,CC,
19592,GO:1990667,1,0.985864993169016,0,2,PCSK9-AnxA2 complex,CC,
19593,GO:1990668,1,0.959252641745449,0,6,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
19594,GO:1990682,1,0.995194333493049,0,1,CSF1-CSF1R complex,CC,
19595,GO:1990698,1,0.987486652229202,0,2,palmitoleoyltransferase activity,MF,
19596,GO:1990700,1,0.995366990675672,0,1,nucleolar chromatin organization,BP,
19597,GO:1990705,1,0.995366990825981,0,1,cholangiocyte proliferation,BP,
19598,GO:1990707,1,0.995366990825889,0,1,nuclear subtelomeric heterochromatin,CC,
19599,GO:1990712,1,0.959227784309397,0,5,HFE-transferrin receptor complex,CC,
19600,GO:1990715,1,0.995366990826138,0,1,mRNA CDS binding,MF,
19601,GO:1990716,1,0.991366943008934,0,1,axonemal central apparatus,CC,
19602,GO:1990723,1,0.990754919291525,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
19603,GO:1990726,1,0.894338104920627,0,5,Lsm1-7-Pat1 complex,CC,
19604,GO:1990729,1,0.993483920407201,0,1,primary miRNA modification,BP,
19605,GO:1990730,1,0.990755168622327,0,2,VCP-NSFL1C complex,CC,
19606,GO:1990736,1,0.995366990826138,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
19607,GO:1990737,1,0.982217222685567,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
19608,GO:1990738,1,0.995366574475227,0,1,pseudouridine 5'-phosphatase activity,MF,
19609,GO:1990739,1,0.995366990825981,0,1,granulosa cell proliferation,BP,
19610,GO:1990742,1,0.962363572301406,0,2,microvesicle,CC,
19611,GO:1990743,1,0.981476478899602,0,3,protein sialylation,BP,
19612,GO:1990744,1,0.993483920407201,0,1,primary miRNA methylation,BP,
19613,GO:1990745,1,0.981593730270694,0,4,EARP complex,CC,
19614,GO:1990748,1,0.451603133426379,0,67,cellular detoxification,BP,
19615,GO:1990751,1,0.995366990826059,0,1,Schwann cell chemotaxis,BP,
19616,GO:1990752,1,0.888026568542648,0,25,microtubule end,CC,
19617,GO:1990755,1,0.995366574475227,0,1,mitotic spindle microtubule depolymerization,BP,
19618,GO:1990756,1,0.980354110905018,0,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,
19619,GO:1990758,1,0.99252189910814,0,1,mitotic sister chromatid biorientation,BP,
19620,GO:1990761,1,0.990738690871967,0,2,growth cone lamellipodium,CC,
19621,GO:1990763,1,0.968865327453888,0,5,arrestin family protein binding,MF,
19622,GO:1990764,1,0.995363934373988,0,1,myofibroblast contraction,BP,
19623,GO:1990769,1,0.990179911725022,0,2,proximal neuron projection,CC,
19624,GO:1990771,1,0.995366990826112,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
19625,GO:1990773,1,0.991570631535044,0,1,matrix metallopeptidase secretion,BP,
19626,GO:1990774,1,0.948172317828738,0,11,tumor necrosis factor secretion,BP,
19627,GO:1990776,1,0.890919479938486,0,16,response to angiotensin,BP,
19628,GO:1990777,1,0.841330044257854,0,16,lipoprotein particle,CC,
19630,GO:1990782,1,0.742401371455624,0,53,protein tyrosine kinase binding,MF,
19631,GO:1990784,1,0.995366990826125,0,1,response to dsDNA,BP,
19632,GO:1990785,1,0.986164405749111,0,3,response to water-immersion restraint stress,BP,
19633,GO:1990786,1,0.995366990826125,0,1,cellular response to dsDNA,BP,
19634,GO:1990791,1,0.990647750653254,0,2,dorsal root ganglion development,BP,
19635,GO:1990796,1,0.995366629275305,0,1,photoreceptor cell terminal bouton,CC,
19636,GO:1990809,1,0.980935583488832,0,4,endoplasmic reticulum tubular network membrane organization,BP,
19637,GO:1990812,1,0.98614809766501,0,3,growth cone filopodium,CC,
19638,GO:1990817,1,0.994896215629768,0,1,RNA adenylyltransferase activity,MF,
19639,GO:1990822,1,0.969059391454584,0,6,basic amino acid transmembrane transport,BP,
19640,GO:1990823,1,0.639630254215359,0,74,response to leukemia inhibitory factor,BP,
19641,GO:1990825,1,0.935155103448905,0,10,sequence-specific mRNA binding,MF,
19642,GO:1990828,1,0.99451350643876,0,1,hepatocyte dedifferentiation,BP,
19643,GO:1990830,1,0.639630254215359,0,74,cellular response to leukemia inhibitory factor,BP,
19644,GO:1990832,1,0.993932201489667,0,1,slow axonal transport,BP,
19645,GO:1990833,1,0.993932201489667,0,1,clathrin-uncoating ATPase activity,MF,
19646,GO:1990834,1,0.985934049994978,0,3,response to odorant,BP,
19648,GO:1990839,1,0.994975311334276,0,1,response to endothelin,BP,
19649,GO:1990841,1,0.850817854896986,0,33,promoter-specific chromatin binding,MF,
19650,GO:1990845,1,0.96896674873799,0,6,adaptive thermogenesis,BP,
19651,GO:1990851,1,0.986164360706622,0,3,Wnt-Frizzled-LRP5/6 complex,CC,
19652,GO:1990859,1,0.994975311334276,0,1,cellular response to endothelin,BP,
19653,GO:1990868,1,0.974914723627768,0,5,response to chemokine,BP,
19654,GO:1990869,1,0.974914723627768,0,5,cellular response to chemokine,BP,
19655,GO:1990874,1,0.829748054528696,0,29,vascular smooth muscle cell proliferation,BP,
19656,GO:1990876,1,0.995366990826085,0,1,cytoplasmic side of nuclear pore,CC,
19657,GO:1990879,1,0.990754370961523,0,2,CST complex,CC,
19658,GO:1990882,1,0.995366990731326,0,1,rRNA acetylation,BP,
19659,GO:1990883,1,0.995366990731326,0,1,rRNA cytidine N-acetyltransferase activity,MF,
19660,GO:1990884,1,0.995366990731326,0,1,RNA acetylation,BP,
19661,GO:1990889,1,0.99276692995436,0,1,H4K20me3 modified histone binding,MF,
19663,GO:1990907,1,0.949534007438161,0,11,beta-catenin-TCF complex,CC,
19664,GO:1990909,1,0.956908511788823,0,8,Wnt signalosome,CC,
19665,GO:1990910,1,0.963753405338155,0,3,response to hypobaric hypoxia,BP,
19666,GO:1990911,1,0.988498894267586,0,2,response to psychosocial stress,BP,
19667,GO:1990913,1,0.99530781851319,0,1,sperm head plasma membrane,CC,
19668,GO:1990917,1,0.99530781851319,0,1,ooplasm,CC,
19669,GO:1990918,1,0.990754785405328,0,2,double-strand break repair involved in meiotic recombination,BP,
19670,GO:1990923,1,0.990754829929434,0,2,PET complex,CC,
19671,GO:1990926,1,0.995366990826164,0,1,short-term synaptic potentiation,BP,
19672,GO:1990927,1,0.990755199849293,0,2,calcium ion regulated lysosome exocytosis,BP,
19673,GO:1990928,1,0.99075519910403,0,2,response to amino acid starvation,BP,
19674,GO:1990930,1,0.989635230793155,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
19675,GO:1990931,1,0.995366990826152,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
19676,GO:1990936,1,0.988150264212325,0,2,vascular smooth muscle cell dedifferentiation,BP,
19677,GO:1990938,1,0.99536699082396,0,1,peptidyl-aspartic acid autophosphorylation,BP,
19678,GO:1990939,1,0.813059021854091,0,34,ATP-dependent microtubule motor activity,MF,
19679,GO:1990948,1,0.892996162022853,0,5,ubiquitin ligase inhibitor activity,MF,
19680,GO:1990955,1,0.995366990826138,0,1,G-rich single-stranded DNA binding,MF,
19681,GO:1990966,1,0.9700554897754,0,4,ATP generation from poly-ADP-D-ribose,BP,
19682,GO:1990967,1,0.987222140188249,0,2,multi-organism toxin transport,BP,
19683,GO:1990968,1,0.9953669908261,0,1,modulation by host of RNA binding by virus,BP,
19684,GO:1990969,1,0.9953669908261,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
19685,GO:1990983,1,0.995330764330948,0,1,tRNA demethylation,BP,
19686,GO:1990984,1,0.995330764330948,0,1,tRNA demethylase activity,MF,
19687,GO:2000001,1,0.911269312865748,0,16,regulation of DNA damage checkpoint,BP,
19688,GO:2000002,1,0.973557693719441,0,5,negative regulation of DNA damage checkpoint,BP,
19689,GO:2000003,1,0.995366574475227,0,1,positive regulation of DNA damage checkpoint,BP,
19690,GO:2000004,1,0.992054598406672,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
19691,GO:2000005,1,0.992054598406672,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
19692,GO:2000006,1,0.992054598406672,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
19693,GO:2000007,1,0.992054598406672,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
19694,GO:2000008,1,0.813118076535002,0,28,regulation of protein localization to cell surface,BP,
19695,GO:2000009,1,0.921724370665778,0,10,negative regulation of protein localization to cell surface,BP,
19696,GO:2000010,1,0.914678335049462,0,12,positive regulation of protein localization to cell surface,BP,
19697,GO:2000011,1,0.994680773914287,0,1,regulation of adaxial/abaxial pattern formation,BP,
19700,GO:2000017,1,0.990754793886515,0,2,positive regulation of determination of dorsal identity,BP,
19701,GO:2000018,1,0.973850159151265,0,5,regulation of male gonad development,BP,
19702,GO:2000019,1,0.995366990309484,0,1,negative regulation of male gonad development,BP,
19703,GO:2000020,1,0.97838416217386,0,4,positive regulation of male gonad development,BP,
19706,GO:2000035,1,0.975880651409517,0,3,regulation of stem cell division,BP,
19707,GO:2000036,1,0.919771965032456,0,18,regulation of stem cell population maintenance,BP,
19708,GO:2000040,1,0.995366990826164,0,1,regulation of planar cell polarity pathway involved in axis elongation,BP,
19709,GO:2000041,1,0.995366990826164,0,1,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
19710,GO:2000042,1,0.954779051392771,0,9,negative regulation of double-strand break repair via homologous recombination,BP,
19711,GO:2000045,1,0.360749642484485,0,136,regulation of G1/S transition of mitotic cell cycle,BP,
19712,GO:2000047,1,0.95767730672423,0,5,regulation of cell-cell adhesion mediated by cadherin,BP,
19713,GO:2000048,1,0.973885460393477,0,2,negative regulation of cell-cell adhesion mediated by cadherin,BP,
19714,GO:2000049,1,0.983362244586025,0,3,positive regulation of cell-cell adhesion mediated by cadherin,BP,
19715,GO:2000050,1,0.923791235793425,0,16,regulation of non-canonical Wnt signaling pathway,BP,
19716,GO:2000051,1,0.981594888733221,0,4,negative regulation of non-canonical Wnt signaling pathway,BP,
19717,GO:2000052,1,0.950108600030839,0,10,positive regulation of non-canonical Wnt signaling pathway,BP,
19718,GO:2000053,1,0.990755199849057,0,2,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19719,GO:2000054,1,0.995366990826164,0,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19720,GO:2000055,1,0.995366990825929,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19722,GO:2000059,1,0.708827397014304,0,36,negative regulation of ubiquitin-dependent protein catabolic process,BP,
19724,GO:2000064,1,0.977044540090309,0,5,regulation of cortisol biosynthetic process,BP,
19725,GO:2000065,1,0.986162878727752,0,3,negative regulation of cortisol biosynthetic process,BP,
19726,GO:2000066,1,0.995366990309484,0,1,positive regulation of cortisol biosynthetic process,BP,
19727,GO:2000067,1,0.974537838279069,0,1,regulation of root morphogenesis,BP,
19728,GO:2000074,1,0.952589713037742,0,7,regulation of type B pancreatic cell development,BP,
19729,GO:2000077,1,0.990006280761436,0,2,negative regulation of type B pancreatic cell development,BP,
19730,GO:2000078,1,0.976897058950566,0,2,positive regulation of type B pancreatic cell development,BP,
19731,GO:2000079,1,0.995366990826164,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
19732,GO:2000080,1,0.995366990826164,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
19733,GO:2000095,1,0.955817133051237,0,9,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
19734,GO:2000096,1,0.969432582568632,0,6,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
19735,GO:2000097,1,0.990680573405312,0,2,regulation of smooth muscle cell-matrix adhesion,BP,
19736,GO:2000098,1,0.995366806405613,0,1,negative regulation of smooth muscle cell-matrix adhesion,BP,
19737,GO:2000104,1,0.88818558052024,0,19,negative regulation of DNA-dependent DNA replication,BP,
19738,GO:2000105,1,0.932233290152629,0,12,positive regulation of DNA-dependent DNA replication,BP,
19741,GO:2000108,1,0.832369153917424,0,20,positive regulation of leukocyte apoptotic process,BP,
19742,GO:2000109,1,0.947271608286628,0,6,regulation of macrophage apoptotic process,BP,
19743,GO:2000110,1,0.973151588143543,0,3,negative regulation of macrophage apoptotic process,BP,
19744,GO:2000111,1,0.978134357433119,0,2,positive regulation of macrophage apoptotic process,BP,
19747,GO:2000114,1,0.918774298879523,0,18,regulation of establishment of cell polarity,BP,
19748,GO:2000116,1,0.180613825715881,0,191,regulation of cysteine-type endopeptidase activity,BP,
19749,GO:2000117,1,0.521104220017377,0,77,negative regulation of cysteine-type endopeptidase activity,BP,
19750,GO:2000118,1,0.995366990826138,0,1,regulation of sodium-dependent phosphate transport,BP,
19751,GO:2000121,1,0.940552583460464,0,8,regulation of removal of superoxide radicals,BP,
19752,GO:2000124,1,0.990533744205019,0,2,regulation of endocannabinoid signaling pathway,BP,
19753,GO:2000134,1,0.512496104396954,0,93,negative regulation of G1/S transition of mitotic cell cycle,BP,
19755,GO:2000137,1,0.987457979160407,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
19756,GO:2000138,1,0.97351037162274,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
19757,GO:2000142,1,0.82017410920429,0,30,regulation of DNA-templated transcription, initiation,BP,
19758,GO:2000143,1,0.981412698009251,0,4,negative regulation of DNA-templated transcription, initiation,BP,
19759,GO:2000144,1,0.84785891122866,0,23,positive regulation of DNA-templated transcription, initiation,BP,
19761,GO:2000146,1,0.310998028008117,0,175,negative regulation of cell motility,BP,
19763,GO:2000152,1,0.946356142857681,0,4,regulation of ubiquitin-specific protease activity,BP,
19764,GO:2000156,1,0.990754774138908,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
19765,GO:2000157,1,0.963549750473666,0,2,negative regulation of ubiquitin-specific protease activity,BP,
19766,GO:2000158,1,0.982163498051361,0,2,positive regulation of ubiquitin-specific protease activity,BP,
19767,GO:2000167,1,0.995366990826153,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
19768,GO:2000169,1,0.976736006788906,0,5,regulation of peptidyl-cysteine S-nitrosylation,BP,
19769,GO:2000171,1,0.902440787008634,0,17,negative regulation of dendrite development,BP,
19770,GO:2000172,1,0.990601374113051,0,2,regulation of branching morphogenesis of a nerve,BP,
19771,GO:2000173,1,0.99536699073736,0,1,negative regulation of branching morphogenesis of a nerve,BP,
19772,GO:2000174,1,0.995366990791056,0,1,regulation of pro-T cell differentiation,BP,
19773,GO:2000176,1,0.995366990791056,0,1,positive regulation of pro-T cell differentiation,BP,
19774,GO:2000177,1,0.77792906890419,0,42,regulation of neural precursor cell proliferation,BP,
19775,GO:2000178,1,0.919311834493768,0,14,negative regulation of neural precursor cell proliferation,BP,
19776,GO:2000179,1,0.876268294709527,0,21,positive regulation of neural precursor cell proliferation,BP,
19777,GO:2000181,1,0.706383304971614,0,63,negative regulation of blood vessel morphogenesis,BP,
19778,GO:2000182,1,0.990754997128938,0,2,regulation of progesterone biosynthetic process,BP,
19779,GO:2000191,1,0.903935099821955,0,14,regulation of fatty acid transport,BP,
19780,GO:2000192,1,0.977045737914893,0,5,negative regulation of fatty acid transport,BP,
19781,GO:2000193,1,0.929500977455578,0,8,positive regulation of fatty acid transport,BP,
19783,GO:2000195,1,0.988752567459883,0,2,negative regulation of female gonad development,BP,
19784,GO:2000196,1,0.982327218320152,0,2,positive regulation of female gonad development,BP,
19785,GO:2000197,1,0.971542778956033,0,6,regulation of ribonucleoprotein complex localization,BP,
19786,GO:2000199,1,0.995366762975163,0,1,positive regulation of ribonucleoprotein complex localization,BP,
19787,GO:2000200,1,0.995366762975163,0,1,regulation of ribosomal subunit export from nucleus,BP,
19788,GO:2000202,1,0.995366762975163,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
19789,GO:2000206,1,0.995366762975163,0,1,regulation of ribosomal small subunit export from nucleus,BP,
19790,GO:2000208,1,0.995366762975163,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
19792,GO:2000210,1,0.93794973827246,0,6,positive regulation of anoikis,BP,
19793,GO:2000211,1,0.995366990826164,0,1,regulation of glutamate metabolic process,BP,
19794,GO:2000212,1,0.995366990826164,0,1,negative regulation of glutamate metabolic process,BP,
19795,GO:2000224,1,0.995366990309484,0,1,regulation of testosterone biosynthetic process,BP,
19796,GO:2000225,1,0.995366990309484,0,1,negative regulation of testosterone biosynthetic process,BP,
19799,GO:2000229,1,0.99272158279163,0,1,regulation of pancreatic stellate cell proliferation,BP,
19800,GO:2000230,1,0.99272158279163,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
19801,GO:2000232,1,0.92483622589361,0,11,regulation of rRNA processing,BP,
19802,GO:2000233,1,0.990754738705156,0,2,negative regulation of rRNA processing,BP,
19803,GO:2000234,1,0.937821383031194,0,8,positive regulation of rRNA processing,BP,
19805,GO:2000242,1,0.795079589072665,0,29,negative regulation of reproductive process,BP,
19806,GO:2000243,1,0.812248077556441,0,32,positive regulation of reproductive process,BP,
19807,GO:2000249,1,0.827303965245872,0,23,regulation of actin cytoskeleton reorganization,BP,
19808,GO:2000251,1,0.915669605424447,0,10,positive regulation of actin cytoskeleton reorganization,BP,
19809,GO:2000252,1,0.970848090178296,0,2,negative regulation of feeding behavior,BP,
19810,GO:2000253,1,0.990754785405156,0,2,positive regulation of feeding behavior,BP,
19811,GO:2000254,1,0.957270388312499,0,2,regulation of male germ cell proliferation,BP,
19812,GO:2000255,1,0.977796000263908,0,1,negative regulation of male germ cell proliferation,BP,
19813,GO:2000256,1,0.979013623049402,0,1,positive regulation of male germ cell proliferation,BP,
19814,GO:2000257,1,0.912429775243411,0,14,regulation of protein activation cascade,BP,
19815,GO:2000258,1,0.983820064982066,0,3,negative regulation of protein activation cascade,BP,
19816,GO:2000259,1,0.98787083921239,0,2,positive regulation of protein activation cascade,BP,
19817,GO:2000269,1,0.919896510983407,0,14,regulation of fibroblast apoptotic process,BP,
19818,GO:2000270,1,0.962295902502249,0,6,negative regulation of fibroblast apoptotic process,BP,
19819,GO:2000271,1,0.967327047720964,0,7,positive regulation of fibroblast apoptotic process,BP,
19820,GO:2000272,1,0.864931586861185,0,21,negative regulation of signaling receptor activity,BP,
19821,GO:2000273,1,0.834657641139895,0,21,positive regulation of signaling receptor activity,BP,
19822,GO:2000275,1,0.972807025066265,0,2,regulation of oxidative phosphorylation uncoupler activity,BP,
19823,GO:2000276,1,0.994653416395701,0,1,negative regulation of oxidative phosphorylation uncoupler activity,BP,
19824,GO:2000277,1,0.978037514283719,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
19825,GO:2000278,1,0.61750096541058,0,84,regulation of DNA biosynthetic process,BP,
19826,GO:2000279,1,0.859629563458353,0,27,negative regulation of DNA biosynthetic process,BP,
19827,GO:2000280,1,0.974537838279069,0,1,regulation of root development,BP,
19828,GO:2000282,1,0.973505103848074,0,2,regulation of cellular amino acid biosynthetic process,BP,
19829,GO:2000283,1,0.99536699082598,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
19830,GO:2000284,1,0.978037514283719,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
19831,GO:2000286,1,0.986084248637115,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
19832,GO:2000288,1,0.962687307427291,0,6,positive regulation of myoblast proliferation,BP,
19833,GO:2000291,1,0.945853905300885,0,8,regulation of myoblast proliferation,BP,
19834,GO:2000295,1,0.995366810543291,0,1,regulation of hydrogen peroxide catabolic process,BP,
19835,GO:2000297,1,0.995366990826152,0,1,negative regulation of synapse maturation,BP,
19836,GO:2000298,1,0.990533661019868,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
19837,GO:2000299,1,0.995366907239778,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
19838,GO:2000300,1,0.907730359134868,0,19,regulation of synaptic vesicle exocytosis,BP,
19839,GO:2000301,1,0.983575685550654,0,3,negative regulation of synaptic vesicle exocytosis,BP,
19840,GO:2000302,1,0.990755199849228,0,2,positive regulation of synaptic vesicle exocytosis,BP,
19841,GO:2000303,1,0.914950666180684,0,13,regulation of ceramide biosynthetic process,BP,
19842,GO:2000304,1,0.953838127311635,0,8,positive regulation of ceramide biosynthetic process,BP,
19843,GO:2000307,1,0.995366798601386,0,1,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
19844,GO:2000309,1,0.995366798601386,0,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
19845,GO:2000310,1,0.956557113155393,0,9,regulation of NMDA receptor activity,BP,
19846,GO:2000311,1,0.954355033766932,0,8,regulation of AMPA receptor activity,BP,
19847,GO:2000312,1,0.985833203870554,0,3,regulation of kainate selective glutamate receptor activity,BP,
19848,GO:2000313,1,0.983793888648793,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
19849,GO:2000314,1,0.990763118632652,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
19850,GO:2000316,1,0.950271903431936,0,7,regulation of T-helper 17 type immune response,BP,
19851,GO:2000317,1,0.986164071311109,0,3,negative regulation of T-helper 17 type immune response,BP,
19852,GO:2000318,1,0.963609992299885,0,4,positive regulation of T-helper 17 type immune response,BP,
19853,GO:2000319,1,0.960621176495284,0,5,regulation of T-helper 17 cell differentiation,BP,
19854,GO:2000320,1,0.986164071311109,0,3,negative regulation of T-helper 17 cell differentiation,BP,
19855,GO:2000321,1,0.97410283286961,0,2,positive regulation of T-helper 17 cell differentiation,BP,
19856,GO:2000322,1,0.963974055513981,0,7,regulation of glucocorticoid receptor signaling pathway,BP,
19857,GO:2000323,1,0.969685805331268,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
19858,GO:2000324,1,0.994111772669677,0,1,positive regulation of glucocorticoid receptor signaling pathway,BP,
19859,GO:2000325,1,0.995366990826112,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19860,GO:2000327,1,0.995366990826112,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19861,GO:2000328,1,0.969588246337571,0,3,regulation of T-helper 17 cell lineage commitment,BP,
19862,GO:2000329,1,0.995366785110385,0,1,negative regulation of T-helper 17 cell lineage commitment,BP,
19863,GO:2000330,1,0.97410283286961,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
19864,GO:2000331,1,0.995366879233504,0,1,regulation of terminal button organization,BP,
19865,GO:2000332,1,0.990798677411377,0,1,regulation of blood microparticle formation,BP,
19866,GO:2000334,1,0.990798677411377,0,1,positive regulation of blood microparticle formation,BP,
19867,GO:2000338,1,0.987467369526126,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
19868,GO:2000340,1,0.987467369526126,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
19869,GO:2000341,1,0.911452744682061,0,10,regulation of chemokine (C-X-C motif) ligand 2 production,BP,
19870,GO:2000342,1,0.990481458080692,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
19871,GO:2000343,1,0.920220241191301,0,8,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,
19872,GO:2000344,1,0.963732053421352,0,4,positive regulation of acrosome reaction,BP,
19873,GO:2000345,1,0.96317764026597,0,7,regulation of hepatocyte proliferation,BP,
19874,GO:2000346,1,0.990755145253956,0,2,negative regulation of hepatocyte proliferation,BP,
19875,GO:2000347,1,0.976694366315112,0,4,positive regulation of hepatocyte proliferation,BP,
19876,GO:2000348,1,0.978649089583461,0,4,regulation of CD40 signaling pathway,BP,
19877,GO:2000349,1,0.995366990826151,0,1,negative regulation of CD40 signaling pathway,BP,
19878,GO:2000351,1,0.888534612897257,0,23,regulation of endothelial cell apoptotic process,BP,
19879,GO:2000352,1,0.927367873580965,0,15,negative regulation of endothelial cell apoptotic process,BP,
19880,GO:2000353,1,0.958160908976959,0,8,positive regulation of endothelial cell apoptotic process,BP,
19881,GO:2000354,1,0.967329572356928,0,4,regulation of ovarian follicle development,BP,
19882,GO:2000355,1,0.993355448947599,0,1,negative regulation of ovarian follicle development,BP,
19883,GO:2000359,1,0.986900227879662,0,1,regulation of binding of sperm to zona pellucida,BP,
19884,GO:2000360,1,0.986900227879662,0,1,negative regulation of binding of sperm to zona pellucida,BP,
19885,GO:2000361,1,0.995366990826164,0,1,regulation of prostaglandin-E synthase activity,BP,
19886,GO:2000363,1,0.995366990826164,0,1,positive regulation of prostaglandin-E synthase activity,BP,
19887,GO:2000367,1,0.98034172951118,0,2,regulation of acrosomal vesicle exocytosis,BP,
19888,GO:2000368,1,0.98034172951118,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
19889,GO:2000369,1,0.926569818232425,0,15,regulation of clathrin-dependent endocytosis,BP,
19890,GO:2000370,1,0.98159488291297,0,4,positive regulation of clathrin-dependent endocytosis,BP,
19891,GO:2000371,1,0.971029925021869,0,6,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19892,GO:2000373,1,0.971029925021869,0,6,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19893,GO:2000374,1,0.993983990746379,0,1,regulation of oxygen metabolic process,BP,
19894,GO:2000377,1,0.427340536711523,0,114,regulation of reactive oxygen species metabolic process,BP,
19895,GO:2000378,1,0.760133030129998,0,37,negative regulation of reactive oxygen species metabolic process,BP,
19896,GO:2000379,1,0.644414640815462,0,57,positive regulation of reactive oxygen species metabolic process,BP,
19897,GO:2000380,1,0.961229123267793,0,7,regulation of mesoderm development,BP,
19898,GO:2000381,1,0.974718785027603,0,4,negative regulation of mesoderm development,BP,
19899,GO:2000382,1,0.995366990825915,0,1,positive regulation of mesoderm development,BP,
19900,GO:2000383,1,0.995366989216536,0,1,regulation of ectoderm development,BP,
19901,GO:2000384,1,0.995366989216536,0,1,negative regulation of ectoderm development,BP,
19902,GO:2000386,1,0.982327218320152,0,2,positive regulation of ovarian follicle development,BP,
19903,GO:2000387,1,0.986900227879662,0,1,regulation of antral ovarian follicle growth,BP,
19904,GO:2000388,1,0.986900227879662,0,1,positive regulation of antral ovarian follicle growth,BP,
19905,GO:2000389,1,0.986163966144366,0,3,regulation of neutrophil extravasation,BP,
19906,GO:2000391,1,0.986163966144366,0,3,positive regulation of neutrophil extravasation,BP,
19907,GO:2000392,1,0.956923868349167,0,9,regulation of lamellipodium morphogenesis,BP,
19908,GO:2000393,1,0.990754785405327,0,2,negative regulation of lamellipodium morphogenesis,BP,
19909,GO:2000394,1,0.974875112430559,0,5,positive regulation of lamellipodium morphogenesis,BP,
19910,GO:2000395,1,0.968987629748567,0,2,regulation of ubiquitin-dependent endocytosis,BP,
19911,GO:2000397,1,0.968987629748567,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
19913,GO:2000402,1,0.986164118478115,0,3,negative regulation of lymphocyte migration,BP,
19916,GO:2000405,1,0.995366990826139,0,1,negative regulation of T cell migration,BP,
19918,GO:2000407,1,0.985950783532134,0,2,regulation of T cell extravasation,BP,
19919,GO:2000409,1,0.992658902315459,0,1,positive regulation of T cell extravasation,BP,
19920,GO:2000410,1,0.995366798601386,0,1,regulation of thymocyte migration,BP,
19921,GO:2000412,1,0.995366798601386,0,1,positive regulation of thymocyte migration,BP,
19922,GO:2000413,1,0.995366798601386,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
19923,GO:2000415,1,0.995366798601386,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
19924,GO:2000416,1,0.986146342954747,0,3,regulation of eosinophil migration,BP,
19925,GO:2000417,1,0.995366924770142,0,1,negative regulation of eosinophil migration,BP,
19926,GO:2000418,1,0.990736993839619,0,2,positive regulation of eosinophil migration,BP,
19927,GO:2000419,1,0.995366924770142,0,1,regulation of eosinophil extravasation,BP,
19928,GO:2000420,1,0.995366924770142,0,1,negative regulation of eosinophil extravasation,BP,
19929,GO:2000422,1,0.995348893266823,0,1,regulation of eosinophil chemotaxis,BP,
19930,GO:2000424,1,0.995348893266823,0,1,positive regulation of eosinophil chemotaxis,BP,
19931,GO:2000425,1,0.9861644693429,0,3,regulation of apoptotic cell clearance,BP,
19932,GO:2000426,1,0.99536692857644,0,1,negative regulation of apoptotic cell clearance,BP,
19933,GO:2000427,1,0.990755199849202,0,2,positive regulation of apoptotic cell clearance,BP,
19934,GO:2000434,1,0.951252658382397,0,2,regulation of protein neddylation,BP,
19935,GO:2000435,1,0.951252658382397,0,2,negative regulation of protein neddylation,BP,
19936,GO:2000449,1,0.985950783532134,0,2,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19937,GO:2000451,1,0.992658902315459,0,1,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19938,GO:2000452,1,0.985950783532134,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
19939,GO:2000454,1,0.992658902315459,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
19940,GO:2000458,1,0.992035302004488,0,1,regulation of astrocyte chemotaxis,BP,
19941,GO:2000463,1,0.915860899206013,0,17,positive regulation of excitatory postsynaptic potential,BP,
19942,GO:2000465,1,0.971782508880728,0,6,regulation of glycogen (starch) synthase activity,BP,
19943,GO:2000466,1,0.985418894151745,0,3,negative regulation of glycogen (starch) synthase activity,BP,
19944,GO:2000467,1,0.985419042338294,0,3,positive regulation of glycogen (starch) synthase activity,BP,
19945,GO:2000468,1,0.995366810543291,0,1,regulation of peroxidase activity,BP,
19946,GO:2000470,1,0.995366810543291,0,1,positive regulation of peroxidase activity,BP,
19947,GO:2000474,1,0.995366990826125,0,1,regulation of opioid receptor signaling pathway,BP,
19948,GO:2000479,1,0.931476984551692,0,12,regulation of cAMP-dependent protein kinase activity,BP,
19949,GO:2000480,1,0.95503678247382,0,7,negative regulation of cAMP-dependent protein kinase activity,BP,
19950,GO:2000481,1,0.980195989686739,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
19953,GO:2000484,1,0.932355213133237,0,8,positive regulation of interleukin-8 secretion,BP,
19954,GO:2000489,1,0.98423218650902,0,3,regulation of hepatic stellate cell activation,BP,
19955,GO:2000490,1,0.988814140417541,0,2,negative regulation of hepatic stellate cell activation,BP,
19956,GO:2000491,1,0.995366812745418,0,1,positive regulation of hepatic stellate cell activation,BP,
19957,GO:2000501,1,0.977638236948104,0,2,regulation of natural killer cell chemotaxis,BP,
19958,GO:2000503,1,0.977638236948104,0,2,positive regulation of natural killer cell chemotaxis,BP,
19959,GO:2000504,1,0.995076500585975,0,1,positive regulation of blood vessel remodeling,BP,
19960,GO:2000508,1,0.966998943711726,0,4,regulation of dendritic cell chemotaxis,BP,
19961,GO:2000510,1,0.966998943711726,0,4,positive regulation of dendritic cell chemotaxis,BP,
19962,GO:2000514,1,0.846147699790283,0,25,regulation of CD4-positive, alpha-beta T cell activation,BP,
19963,GO:2000515,1,0.936113917413723,0,12,negative regulation of CD4-positive, alpha-beta T cell activation,BP,
19964,GO:2000516,1,0.900562375744239,0,14,positive regulation of CD4-positive, alpha-beta T cell activation,BP,
19965,GO:2000520,1,0.982214527872345,0,2,regulation of immunological synapse formation,BP,
19966,GO:2000521,1,0.982214527872345,0,2,negative regulation of immunological synapse formation,BP,
19967,GO:2000532,1,0.995279256748665,0,1,regulation of renal albumin absorption,BP,
19968,GO:2000533,1,0.995279256748665,0,1,negative regulation of renal albumin absorption,BP,
19969,GO:2000535,1,0.971415148223008,0,6,regulation of entry of bacterium into host cell,BP,
19970,GO:2000536,1,0.995366990826073,0,1,negative regulation of entry of bacterium into host cell,BP,
19971,GO:2000537,1,0.995366990826152,0,1,regulation of B cell chemotaxis,BP,
19972,GO:2000538,1,0.995366990826152,0,1,positive regulation of B cell chemotaxis,BP,
19973,GO:2000542,1,0.978514114111952,0,4,negative regulation of gastrulation,BP,
19974,GO:2000543,1,0.990754370961523,0,2,positive regulation of gastrulation,BP,
19975,GO:2000544,1,0.986164528494694,0,3,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
19976,GO:2000546,1,0.990755199849188,0,2,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
19977,GO:2000551,1,0.973189761833212,0,4,regulation of T-helper 2 cell cytokine production,BP,
19978,GO:2000552,1,0.987839962517201,0,1,negative regulation of T-helper 2 cell cytokine production,BP,
19979,GO:2000553,1,0.985171529817548,0,3,positive regulation of T-helper 2 cell cytokine production,BP,
19980,GO:2000561,1,0.979870773529846,0,4,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
19981,GO:2000562,1,0.989015633149584,0,2,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
19982,GO:2000563,1,0.99075474633146,0,2,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
19983,GO:2000564,1,0.986359274919087,0,2,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
19984,GO:2000566,1,0.990950867365765,0,1,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
19985,GO:2000567,1,0.994680773914287,0,1,regulation of memory T cell activation,BP,
19986,GO:2000568,1,0.994680773914287,0,1,positive regulation of memory T cell activation,BP,
19987,GO:2000569,1,0.995366868831338,0,1,regulation of T-helper 2 cell activation,BP,
19988,GO:2000570,1,0.995366868831338,0,1,positive regulation of T-helper 2 cell activation,BP,
19989,GO:2000573,1,0.719709497874443,0,56,positive regulation of DNA biosynthetic process,BP,
19990,GO:2000574,1,0.929368081075323,0,8,regulation of microtubule motor activity,BP,
19991,GO:2000576,1,0.942638818178652,0,5,positive regulation of microtubule motor activity,BP,
19992,GO:2000580,1,0.947029549557048,0,4,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
19993,GO:2000582,1,0.947029549557048,0,4,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
19994,GO:2000583,1,0.995366989161553,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
19995,GO:2000584,1,0.995366989161553,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
19996,GO:2000586,1,0.963989885378741,0,7,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
19997,GO:2000587,1,0.972987790696249,0,5,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
19998,GO:2000588,1,0.990755199849188,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
19999,GO:2000589,1,0.990754003408654,0,2,regulation of metanephric mesenchymal cell migration,BP,
20000,GO:2000591,1,0.990754003408654,0,2,positive regulation of metanephric mesenchymal cell migration,BP,
20001,GO:2000592,1,0.995366989784868,0,1,regulation of metanephric DCT cell differentiation,BP,
20002,GO:2000594,1,0.995366989784868,0,1,positive regulation of metanephric DCT cell differentiation,BP,
20003,GO:2000601,1,0.972517676525838,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
20004,GO:2000606,1,0.995366738911866,0,1,regulation of cell proliferation involved in mesonephros development,BP,
20005,GO:2000607,1,0.995366738911866,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
20006,GO:2000609,1,0.983747053634966,0,3,regulation of thyroid hormone generation,BP,
20007,GO:2000611,1,0.990754948052296,0,2,positive regulation of thyroid hormone generation,BP,
20008,GO:2000612,1,0.995366989784868,0,1,regulation of thyroid-stimulating hormone secretion,BP,
20009,GO:2000615,1,0.937769434106432,0,10,regulation of histone H3-K9 acetylation,BP,
20010,GO:2000616,1,0.988315098588422,0,2,negative regulation of histone H3-K9 acetylation,BP,
20011,GO:2000617,1,0.957728955216857,0,6,positive regulation of histone H3-K9 acetylation,BP,
20012,GO:2000618,1,0.966327312645832,0,5,regulation of histone H4-K16 acetylation,BP,
20013,GO:2000619,1,0.975346778325341,0,3,negative regulation of histone H4-K16 acetylation,BP,
20014,GO:2000620,1,0.990755199849149,0,2,positive regulation of histone H4-K16 acetylation,BP,
20015,GO:2000622,1,0.981594406497136,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
20016,GO:2000623,1,0.981594406497136,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
20017,GO:2000625,1,0.990751739133451,0,2,regulation of miRNA catabolic process,BP,
20018,GO:2000627,1,0.990751739133451,0,2,positive regulation of miRNA catabolic process,BP,
20019,GO:2000628,1,0.955520509202931,0,7,regulation of miRNA metabolic process,BP,
20020,GO:2000630,1,0.964440795181099,0,5,positive regulation of miRNA metabolic process,BP,
20021,GO:2000631,1,0.99536685468278,0,1,regulation of pre-miRNA processing,BP,
20022,GO:2000632,1,0.99536685468278,0,1,negative regulation of pre-miRNA processing,BP,
20023,GO:2000637,1,0.904194976995588,0,19,positive regulation of gene silencing by miRNA,BP,
20024,GO:2000638,1,0.99075164363889,0,2,regulation of SREBP signaling pathway,BP,
20025,GO:2000639,1,0.99075164363889,0,2,negative regulation of SREBP signaling pathway,BP,
20026,GO:2000641,1,0.888618698657055,0,17,regulation of early endosome to late endosome transport,BP,
20027,GO:2000642,1,0.95892018636818,0,2,negative regulation of early endosome to late endosome transport,BP,
20028,GO:2000643,1,0.963505073387369,0,8,positive regulation of early endosome to late endosome transport,BP,
20029,GO:2000644,1,0.942551554097895,0,9,regulation of receptor catabolic process,BP,
20030,GO:2000645,1,0.981296740075357,0,3,negative regulation of receptor catabolic process,BP,
20031,GO:2000646,1,0.964997660565947,0,5,positive regulation of receptor catabolic process,BP,
20033,GO:2000648,1,0.881775316294441,0,23,positive regulation of stem cell proliferation,BP,
20035,GO:2000650,1,0.961968598377346,0,8,negative regulation of sodium ion transmembrane transporter activity,BP,
20036,GO:2000651,1,0.943648962782323,0,10,positive regulation of sodium ion transmembrane transporter activity,BP,
20037,GO:2000653,1,0.986164190231233,0,3,regulation of genetic imprinting,BP,
20038,GO:2000654,1,0.99536698911949,0,1,regulation of cellular response to testosterone stimulus,BP,
20039,GO:2000655,1,0.99536698911949,0,1,negative regulation of cellular response to testosterone stimulus,BP,
20040,GO:2000656,1,0.992895902666105,0,1,regulation of apolipoprotein binding,BP,
20041,GO:2000657,1,0.992895902666105,0,1,negative regulation of apolipoprotein binding,BP,
20042,GO:2000659,1,0.959244280551414,0,6,regulation of interleukin-1-mediated signaling pathway,BP,
20043,GO:2000660,1,0.969982892681792,0,4,negative regulation of interleukin-1-mediated signaling pathway,BP,
20044,GO:2000661,1,0.995366990826165,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
20045,GO:2000662,1,0.98060639434743,0,4,regulation of interleukin-5 secretion,BP,
20046,GO:2000663,1,0.995366973703181,0,1,negative regulation of interleukin-5 secretion,BP,
20047,GO:2000664,1,0.985171504731309,0,3,positive regulation of interleukin-5 secretion,BP,
20048,GO:2000665,1,0.974348154892599,0,5,regulation of interleukin-13 secretion,BP,
20049,GO:2000666,1,0.989015621729571,0,2,negative regulation of interleukin-13 secretion,BP,
20050,GO:2000667,1,0.985171504731309,0,3,positive regulation of interleukin-13 secretion,BP,
20051,GO:2000668,1,0.981508103937585,0,4,regulation of dendritic cell apoptotic process,BP,
20052,GO:2000669,1,0.9906678676122,0,2,negative regulation of dendritic cell apoptotic process,BP,
20053,GO:2000670,1,0.990754946723336,0,2,positive regulation of dendritic cell apoptotic process,BP,
20054,GO:2000671,1,0.986164034049628,0,3,regulation of motor neuron apoptotic process,BP,
20055,GO:2000672,1,0.986164034049628,0,3,negative regulation of motor neuron apoptotic process,BP,
20056,GO:2000674,1,0.958780911788139,0,8,regulation of type B pancreatic cell apoptotic process,BP,
20057,GO:2000675,1,0.981594461936334,0,4,negative regulation of type B pancreatic cell apoptotic process,BP,
20058,GO:2000676,1,0.976763599544397,0,4,positive regulation of type B pancreatic cell apoptotic process,BP,
20061,GO:2000679,1,0.897151444179095,0,16,positive regulation of transcription regulatory region DNA binding,BP,
20062,GO:2000683,1,0.990754459660232,0,2,regulation of cellular response to X-ray,BP,
20063,GO:2000685,1,0.995366499145455,0,1,positive regulation of cellular response to X-ray,BP,
20064,GO:2000690,1,0.995366990826153,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
20065,GO:2000691,1,0.995366990826153,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
20067,GO:2000697,1,0.990755111984189,0,2,negative regulation of epithelial cell differentiation involved in kidney development,BP,
20069,GO:2000699,1,0.995366738911866,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20070,GO:2000701,1,0.995366738911866,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20071,GO:2000702,1,0.995366738911866,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20072,GO:2000703,1,0.995366738911866,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20073,GO:2000705,1,0.990755186100436,0,2,regulation of dense core granule biogenesis,BP,
20074,GO:2000706,1,0.995366977014221,0,1,negative regulation of dense core granule biogenesis,BP,
20075,GO:2000707,1,0.995366990825981,0,1,positive regulation of dense core granule biogenesis,BP,
20076,GO:2000718,1,0.976975576064918,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
20077,GO:2000719,1,0.976975576064918,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
20078,GO:2000721,1,0.995366990826165,0,1,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
20079,GO:2000722,1,0.995366574475227,0,1,regulation of cardiac vascular smooth muscle cell differentiation,BP,
20080,GO:2000724,1,0.995366574475227,0,1,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
20081,GO:2000725,1,0.873479872790593,0,23,regulation of cardiac muscle cell differentiation,BP,
20082,GO:2000726,1,0.946182779254239,0,11,negative regulation of cardiac muscle cell differentiation,BP,
20083,GO:2000727,1,0.923208907574027,0,12,positive regulation of cardiac muscle cell differentiation,BP,
20084,GO:2000733,1,0.995366738911866,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20085,GO:2000734,1,0.995366738911866,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20088,GO:2000738,1,0.947741361375316,0,10,positive regulation of stem cell differentiation,BP,
20089,GO:2000739,1,0.98159487482183,0,4,regulation of mesenchymal stem cell differentiation,BP,
20090,GO:2000740,1,0.995366977014221,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
20091,GO:2000741,1,0.986164530733684,0,3,positive regulation of mesenchymal stem cell differentiation,BP,
20092,GO:2000742,1,0.994200464464166,0,1,regulation of anterior head development,BP,
20093,GO:2000744,1,0.994200464464166,0,1,positive regulation of anterior head development,BP,
20094,GO:2000752,1,0.995366417561992,0,1,regulation of glucosylceramide catabolic process,BP,
20095,GO:2000753,1,0.995366417561992,0,1,positive regulation of glucosylceramide catabolic process,BP,
20096,GO:2000754,1,0.995366417561992,0,1,regulation of sphingomyelin catabolic process,BP,
20097,GO:2000755,1,0.995366417561992,0,1,positive regulation of sphingomyelin catabolic process,BP,
20099,GO:2000757,1,0.888210114066439,0,17,negative regulation of peptidyl-lysine acetylation,BP,
20101,GO:2000759,1,0.995366990826165,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
20102,GO:2000761,1,0.995366990826165,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
20103,GO:2000765,1,0.878464133362913,0,23,regulation of cytoplasmic translation,BP,
20104,GO:2000766,1,0.959549697322634,0,6,negative regulation of cytoplasmic translation,BP,
20105,GO:2000767,1,0.95955524811161,0,8,positive regulation of cytoplasmic translation,BP,
20106,GO:2000768,1,0.994581861569669,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
20109,GO:2000774,1,0.913466902162269,0,9,positive regulation of cellular senescence,BP,
20110,GO:2000775,1,0.994224337440378,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
20111,GO:2000777,1,0.988525554009166,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
20112,GO:2000778,1,0.899774114876876,0,16,positive regulation of interleukin-6 secretion,BP,
20113,GO:2000779,1,0.751065552531034,0,49,regulation of double-strand break repair,BP,
20114,GO:2000780,1,0.899471839568358,0,19,negative regulation of double-strand break repair,BP,
20115,GO:2000781,1,0.926197396624128,0,14,positive regulation of double-strand break repair,BP,
20116,GO:2000785,1,0.818171527161185,0,34,regulation of autophagosome assembly,BP,
20117,GO:2000786,1,0.94884656041872,0,11,positive regulation of autophagosome assembly,BP,
20118,GO:2000790,1,0.990755198192161,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
20119,GO:2000791,1,0.990755198192161,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
20120,GO:2000793,1,0.990755199848823,0,2,cell proliferation involved in heart valve development,BP,
20121,GO:2000794,1,0.971721338426248,0,6,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
20122,GO:2000795,1,0.995366990826007,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
20123,GO:2000797,1,0.995366977014221,0,1,regulation of amniotic stem cell differentiation,BP,
20124,GO:2000798,1,0.995366977014221,0,1,negative regulation of amniotic stem cell differentiation,BP,
20125,GO:2000804,1,0.995366990825889,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20126,GO:2000806,1,0.995366990825889,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20127,GO:2000807,1,0.986164531023663,0,3,regulation of synaptic vesicle clustering,BP,
20128,GO:2000808,1,0.995366990826138,0,1,negative regulation of synaptic vesicle clustering,BP,
20129,GO:2000809,1,0.990755199849216,0,2,positive regulation of synaptic vesicle clustering,BP,
20132,GO:2000812,1,0.995366989975282,0,1,regulation of barbed-end actin filament capping,BP,
20133,GO:2000816,1,0.796842052337905,0,31,negative regulation of mitotic sister chromatid separation,BP,
20134,GO:2000819,1,0.990747437990208,0,2,regulation of nucleotide-excision repair,BP,
20135,GO:2000820,1,0.995366990826126,0,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
20136,GO:2000821,1,0.970848089602672,0,2,regulation of grooming behavior,BP,
20137,GO:2000822,1,0.974004768939515,0,3,regulation of behavioral fear response,BP,
20138,GO:2000823,1,0.938301177187886,0,4,regulation of androgen receptor activity,BP,
20139,GO:2000825,1,0.938301177187886,0,4,positive regulation of androgen receptor activity,BP,
20141,GO:2000827,1,0.995258125840563,0,1,mitochondrial RNA surveillance,BP,
20142,GO:2000828,1,0.988400397984795,0,2,regulation of parathyroid hormone secretion,BP,
20143,GO:2000830,1,0.995366990826138,0,1,positive regulation of parathyroid hormone secretion,BP,
20144,GO:2000831,1,0.956592429260327,0,5,regulation of steroid hormone secretion,BP,
20145,GO:2000832,1,0.990755074494079,0,2,negative regulation of steroid hormone secretion,BP,
20146,GO:2000833,1,0.965522196413272,0,3,positive regulation of steroid hormone secretion,BP,
20147,GO:2000834,1,0.995366870768743,0,1,regulation of androgen secretion,BP,
20148,GO:2000836,1,0.995366870768743,0,1,positive regulation of androgen secretion,BP,
20149,GO:2000843,1,0.995366990826073,0,1,regulation of testosterone secretion,BP,
20150,GO:2000845,1,0.995366990826073,0,1,positive regulation of testosterone secretion,BP,
20151,GO:2000846,1,0.961047116131144,0,4,regulation of corticosteroid hormone secretion,BP,
20152,GO:2000847,1,0.990755074494079,0,2,negative regulation of corticosteroid hormone secretion,BP,
20153,GO:2000848,1,0.970017984463155,0,2,positive regulation of corticosteroid hormone secretion,BP,
20154,GO:2000849,1,0.965525650958653,0,3,regulation of glucocorticoid secretion,BP,
20155,GO:2000850,1,0.990755074494079,0,2,negative regulation of glucocorticoid secretion,BP,
20156,GO:2000851,1,0.974537838279069,0,1,positive regulation of glucocorticoid secretion,BP,
20157,GO:2000855,1,0.995363424876141,0,1,regulation of mineralocorticoid secretion,BP,
20158,GO:2000857,1,0.995363424876141,0,1,positive regulation of mineralocorticoid secretion,BP,
20159,GO:2000858,1,0.995363424876141,0,1,regulation of aldosterone secretion,BP,
20160,GO:2000860,1,0.995363424876141,0,1,positive regulation of aldosterone secretion,BP,
20161,GO:2000864,1,0.995366990826099,0,1,regulation of estradiol secretion,BP,
20162,GO:2000878,1,0.986218899932089,0,2,positive regulation of oligopeptide transport,BP,
20163,GO:2000880,1,0.986218899932089,0,2,positive regulation of dipeptide transport,BP,
20164,GO:2000909,1,0.995366574475227,0,1,regulation of sterol import,BP,
20165,GO:2000969,1,0.989343398277316,0,2,positive regulation of AMPA receptor activity,BP,
20172,GO:2000983,1,0.956565408536984,0,2,regulation of ATP citrate synthase activity,BP,
20173,GO:2000984,1,0.956565408536984,0,2,negative regulation of ATP citrate synthase activity,BP,
20174,GO:2000987,1,0.99536678233859,0,1,positive regulation of behavioral fear response,BP,
20175,GO:2001012,1,0.978327369762784,0,4,mesenchymal cell differentiation involved in renal system development,BP,
20176,GO:2001013,1,0.990755199849293,0,2,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
20177,GO:2001014,1,0.944225873687001,0,11,regulation of skeletal muscle cell differentiation,BP,
20178,GO:2001015,1,0.990755064329416,0,2,negative regulation of skeletal muscle cell differentiation,BP,
20179,GO:2001016,1,0.9754387522391,0,4,positive regulation of skeletal muscle cell differentiation,BP,
20182,GO:2001022,1,0.627148281753554,0,67,positive regulation of response to DNA damage stimulus,BP,
20184,GO:2001024,1,0.871143547362355,0,18,negative regulation of response to drug,BP,
20187,GO:2001027,1,0.990755199849057,0,2,negative regulation of endothelial cell chemotaxis,BP,
20189,GO:2001029,1,0.995366990826138,0,1,regulation of cellular glucuronidation,BP,
20190,GO:2001031,1,0.995366990826138,0,1,positive regulation of cellular glucuronidation,BP,
20191,GO:2001032,1,0.939197432714385,0,11,regulation of double-strand break repair via nonhomologous end joining,BP,
20192,GO:2001033,1,0.966591722797605,0,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,
20193,GO:2001034,1,0.976194270394375,0,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,
20194,GO:2001035,1,0.98454279703237,0,2,regulation of tongue muscle cell differentiation,BP,
20195,GO:2001037,1,0.98454279703237,0,2,positive regulation of tongue muscle cell differentiation,BP,
20196,GO:2001038,1,0.839168950925349,0,23,regulation of cellular response to drug,BP,
20197,GO:2001039,1,0.892528715873215,0,13,negative regulation of cellular response to drug,BP,
20198,GO:2001040,1,0.957964680038902,0,6,positive regulation of cellular response to drug,BP,
20199,GO:2001044,1,0.920432688162288,0,10,regulation of integrin-mediated signaling pathway,BP,
20200,GO:2001045,1,0.990755195293852,0,2,negative regulation of integrin-mediated signaling pathway,BP,
20201,GO:2001046,1,0.961783873844168,0,5,positive regulation of integrin-mediated signaling pathway,BP,
20202,GO:2001053,1,0.965752469971025,0,6,regulation of mesenchymal cell apoptotic process,BP,
20203,GO:2001054,1,0.970918757645029,0,5,negative regulation of mesenchymal cell apoptotic process,BP,
20204,GO:2001055,1,0.994680773914287,0,1,positive regulation of mesenchymal cell apoptotic process,BP,
20205,GO:2001056,1,0.348870750554483,0,119,positive regulation of cysteine-type endopeptidase activity,BP,
20207,GO:2001069,1,0.990608336019469,0,2,glycogen binding,MF,
20208,GO:2001070,1,0.990608700884573,0,2,starch binding,MF,
20209,GO:2001074,1,0.987486348809159,0,2,regulation of metanephric ureteric bud development,BP,
20210,GO:2001076,1,0.987486348809159,0,2,positive regulation of metanephric ureteric bud development,BP,
20211,GO:2001106,1,0.990755199849149,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
20212,GO:2001108,1,0.995366990826099,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
20213,GO:2001109,1,0.995366990825995,0,1,regulation of lens epithelial cell proliferation,BP,
20214,GO:2001111,1,0.995366990825995,0,1,positive regulation of lens epithelial cell proliferation,BP,
20215,GO:2001135,1,0.958628411787716,0,8,regulation of endocytic recycling,BP,
20216,GO:2001136,1,0.995366902615671,0,1,negative regulation of endocytic recycling,BP,
20217,GO:2001137,1,0.986164454609832,0,3,positive regulation of endocytic recycling,BP,
20218,GO:2001138,1,0.937194669139726,0,6,regulation of phospholipid transport,BP,
20219,GO:2001140,1,0.937194669139726,0,6,positive regulation of phospholipid transport,BP,
20221,GO:2001142,1,0.995319958278601,0,1,nicotinate transport,BP,
20222,GO:2001144,1,0.994603807741999,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
20223,GO:2001145,1,0.994603807741999,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
20224,GO:2001148,1,0.986218899932089,0,2,regulation of dipeptide transmembrane transport,BP,
20225,GO:2001150,1,0.986218899932089,0,2,positive regulation of dipeptide transmembrane transport,BP,
20226,GO:2001151,1,0.995366841160869,0,1,regulation of renal water transport,BP,
20227,GO:2001153,1,0.995366841160869,0,1,positive regulation of renal water transport,BP,
20228,GO:2001160,1,0.978844896469576,0,2,regulation of histone H3-K79 methylation,BP,
20229,GO:2001162,1,0.978844896469576,0,2,positive regulation of histone H3-K79 methylation,BP,
20230,GO:2001163,1,0.994889622719127,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20231,GO:2001165,1,0.994889622719127,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20232,GO:2001166,1,0.975991959099073,0,5,regulation of histone H2B ubiquitination,BP,
20233,GO:2001168,1,0.981477489304068,0,4,positive regulation of histone H2B ubiquitination,BP,
20237,GO:2001173,1,0.99441214774118,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
20238,GO:2001176,1,0.99043877770067,0,2,regulation of mediator complex assembly,BP,
20239,GO:2001178,1,0.99043877770067,0,2,positive regulation of mediator complex assembly,BP,
20240,GO:2001179,1,0.949937979078608,0,5,regulation of interleukin-10 secretion,BP,
20241,GO:2001180,1,0.988350220950259,0,2,negative regulation of interleukin-10 secretion,BP,
20242,GO:2001181,1,0.961140117975497,0,3,positive regulation of interleukin-10 secretion,BP,
20243,GO:2001182,1,0.978991407243659,0,4,regulation of interleukin-12 secretion,BP,
20244,GO:2001183,1,0.992950962869769,0,1,negative regulation of interleukin-12 secretion,BP,
20245,GO:2001184,1,0.990532156664968,0,2,positive regulation of interleukin-12 secretion,BP,
20246,GO:2001185,1,0.975297539722738,0,4,regulation of CD8-positive, alpha-beta T cell activation,BP,
20247,GO:2001186,1,0.993389805337357,0,1,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
20248,GO:2001187,1,0.990950867365765,0,1,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
20249,GO:2001188,1,0.982214527872345,0,2,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
20250,GO:2001189,1,0.982214527872345,0,2,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
20251,GO:2001197,1,0.977046177790215,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
20252,GO:2001198,1,0.971410895275562,0,3,regulation of dendritic cell differentiation,BP,
20253,GO:2001199,1,0.9897289580718,0,1,negative regulation of dendritic cell differentiation,BP,
20254,GO:2001200,1,0.981494011040277,0,2,positive regulation of dendritic cell differentiation,BP,
20255,GO:2001201,1,0.990755199849136,0,2,regulation of transforming growth factor-beta secretion,BP,
20256,GO:2001202,1,0.995366990826008,0,1,negative regulation of transforming growth factor-beta secretion,BP,
20257,GO:2001203,1,0.995366990826151,0,1,positive regulation of transforming growth factor-beta secretion,BP,
20258,GO:2001204,1,0.966957551119402,0,7,regulation of osteoclast development,BP,
20259,GO:2001205,1,0.986164524460474,0,3,negative regulation of osteoclast development,BP,
20260,GO:2001206,1,0.985091387293705,0,3,positive regulation of osteoclast development,BP,
20261,GO:2001212,1,0.95813618311254,0,7,regulation of vasculogenesis,BP,
20262,GO:2001213,1,0.995366990826125,0,1,negative regulation of vasculogenesis,BP,
20263,GO:2001214,1,0.967080077862214,0,5,positive regulation of vasculogenesis,BP,
20264,GO:2001222,1,0.890614200851973,0,24,regulation of neuron migration,BP,
20265,GO:2001223,1,0.968326907344033,0,6,negative regulation of neuron migration,BP,
20266,GO:2001224,1,0.937032975732017,0,14,positive regulation of neuron migration,BP,
20267,GO:2001225,1,0.972581362586713,0,5,regulation of chloride transport,BP,
20268,GO:2001226,1,0.990754597324017,0,2,negative regulation of chloride transport,BP,
20269,GO:2001228,1,0.990755199848679,0,2,regulation of response to gamma radiation,BP,
20270,GO:2001229,1,0.995366990825813,0,1,negative regulation of response to gamma radiation,BP,
20276,GO:2001238,1,0.707443319071205,0,46,positive regulation of extrinsic apoptotic signaling pathway,BP,
20279,GO:2001241,1,0.894979855532057,0,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
20283,GO:2001245,1,0.990755199744259,0,2,regulation of phosphatidylcholine biosynthetic process,BP,
20284,GO:2001246,1,0.99536699072066,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
20285,GO:2001247,1,0.995366990826152,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
20286,GO:2001251,1,0.513651107881591,0,111,negative regulation of chromosome organization,BP,
20288,GO:2001253,1,0.995366689838358,0,1,regulation of histone H3-K36 trimethylation,BP,
20289,GO:2001256,1,0.955742906457757,0,8,regulation of store-operated calcium entry,BP,
20290,GO:2001257,1,0.613929429985037,0,78,regulation of cation channel activity,BP,
20291,GO:2001258,1,0.844897627998763,0,20,negative regulation of cation channel activity,BP,
20292,GO:2001259,1,0.816172227074176,0,30,positive regulation of cation channel activity,BP,
20293,GO:2001267,1,0.844709180423944,0,20,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
20294,GO:2001268,1,0.941837970014963,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
20295,GO:2001269,1,0.896940303688841,0,15,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
20296,GO:2001270,1,0.961117280999137,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
20297,GO:2001271,1,0.984794171220579,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
20298,GO:2001272,1,0.975961703099268,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
20299,GO:2001273,1,0.937030329157158,0,14,regulation of glucose import in response to insulin stimulus,BP,
20300,GO:2001274,1,0.990751650232056,0,2,negative regulation of glucose import in response to insulin stimulus,BP,
20301,GO:2001275,1,0.95018774716725,0,11,positive regulation of glucose import in response to insulin stimulus,BP,
20302,GO:2001279,1,0.973500239703994,0,4,regulation of unsaturated fatty acid biosynthetic process,BP,
20303,GO:2001280,1,0.982586087238914,0,2,positive regulation of unsaturated fatty acid biosynthetic process,BP,
20304,GO:2001286,1,0.975158380947259,0,4,regulation of caveolin-mediated endocytosis,BP,
20305,GO:2001287,1,0.984259316379249,0,2,negative regulation of caveolin-mediated endocytosis,BP,
20306,GO:2001288,1,0.995366990826008,0,1,positive regulation of caveolin-mediated endocytosis,BP,
20307,GO:2001293,1,0.98544713025968,0,3,malonyl-CoA metabolic process,BP,
20308,GO:2001294,1,0.994642972742358,0,1,malonyl-CoA catabolic process,BP,
20309,GO:2001295,1,0.990755199848888,0,2,malonyl-CoA biosynthetic process,BP,
20310,GO:2001300,1,0.995095103294964,0,1,lipoxin metabolic process,BP,
20311,GO:2001301,1,0.995095103294964,0,1,lipoxin biosynthetic process,BP,
20312,GO:2001302,1,0.995095103294964,0,1,lipoxin A4 metabolic process,BP,
20313,GO:2001303,1,0.995095103294964,0,1,lipoxin A4 biosynthetic process,BP,
20314,GO:2001304,1,0.995095103294964,0,1,lipoxin B4 metabolic process,BP,
20315,GO:2001306,1,0.995095103294964,0,1,lipoxin B4 biosynthetic process,BP,
20316,GO:2001311,1,0.992335192206827,0,1,lysobisphosphatidic acid metabolic process,BP,
950,GO:0002367,1,0.670212543502083,0,52,cytokine production involved in immune response,BP,
3477,GO:0007339,1,0.878875369271424,0,15,binding of sperm to zona pellucida,BP,
12159,GO:0048268,1.00000000000001,0.891189861010276,0,15,clathrin coat assembly,BP,
5999,GO:0019003,1.00000000000001,0.694940010824711,0,52,GDP binding,MF,
150,GO:0000305,1.00000000000001,0.790916684156849,0,23,response to oxygen radical,BP,
200,GO:0000421,1.00000000000001,0.825171215699121,0,26,autophagosome membrane,CC,
6710,GO:0030118,1.00000000000001,0.758702589576953,0,45,clathrin coat,CC,
9038,GO:0035254,1.00000000000001,0.858586191514888,0,29,glutamate receptor binding,MF,
1593,GO:0004003,1.00000000000001,0.844161799204831,0,33,ATP-dependent DNA helicase activity,MF,
15967,GO:0080025,1.00000000000001,0.866270990612904,0,20,phosphatidylinositol-3,5-bisphosphate binding,MF,
15489,GO:0071855,1.00000000000001,0.918899630180221,0,7,neuropeptide receptor binding,MF,
